,trial_id,trial_status,pcd,scd,reg_results_status,other_results_1,other_results_2,last_updated,web_address,relevant_comp_date,tabular_results,potential_other_results
0,NCT04246242,,,,,,,,https://clinicaltrials.gov/show/NCT04246242,,0,0
1,NCT04337216,,,,,,,,https://clinicaltrials.gov/show/NCT04337216,,0,0
2,NCT04343677,,,,,,,,https://clinicaltrials.gov/show/NCT04343677,,0,0
3,NCT04380948,,,,,,,,https://clinicaltrials.gov/show/NCT04380948,,0,0
4,NCT04404634,,,,,,,,https://clinicaltrials.gov/show/NCT04404634,,0,0
5,NCT04471662,,,,,,,,https://clinicaltrials.gov/show/NCT04471662,,0,0
6,NCT04244591,Completed,13/04/2020,13/04/2020,No Results Posted,"['Sultana J, Crisafulli S, Gabbay F, Lynn E, Shakir S, Trifir√≤ G. Challenges for Drug Repurposing in the COVID-19 Pandemic Era. Front Pharmacol. 2020 Nov 6;11:588654. doi: 10.3389/fphar.2020.588654. eCollection 2020. Review.']",,16/06/2020,https://clinicaltrials.gov/show/NCT04244591,13/04/2020,0,1
7,NCT04251767,Withdrawn,30/04/2020,30/04/2020,No Results Posted,,,17/03/2020,https://clinicaltrials.gov/show/NCT04251767,30/04/2020,0,0
8,NCT04251871,Recruiting,22/01/2021,22/01/2021,No Results Posted,"['Akhtar S, Das JK, Ismail T, Wahid M, Saeed W, Bhutta ZA. Nutritional perspectives for the prevention and mitigation of COVID-19. Nutr Rev. 2021 Feb 11;79(3):289-300. doi: 10.1093/nutrit/nuaa063.', 'Wang JB, Wang ZX, Jing J, Zhao P, Dong JH, Zhou YF, Yang G, Niu M, Zhao X, Jiang TJ, Bi JF, Xu Z, Zhang P, Wu D, Bai ZF, Guo YM, Yu SM, Sun YQ, Zhang ZT, Zhan XY, Li PY, Ding JB, Zhao PF, Song XA, Tang JY, He DC, Chen Z, Qin EQ, Wang RL, Xiao XH. Exploring an Integrative Therapy for Treating COVID-19: A Randomized Controlled Trial. Chin J Integr Med. 2020 Sep;26(9):648-655. doi: 10.1007/s11655-020-3426-7. Epub 2020 Jul 16.']",,05/05/2020,https://clinicaltrials.gov/show/NCT04251871,22/01/2021,0,1
9,NCT04252118,Recruiting,01/12/2020,01/12/2021,No Results Posted,,,15/04/2020,https://clinicaltrials.gov/show/NCT04252118,01/12/2020,0,0
10,NCT04252274,Recruiting,31/08/2020,31/12/2020,No Results Posted,"['Chen J, Xia L, Liu L, Xu Q, Ling Y, Huang D, Huang W, Song S, Xu S, Shen Y, Lu H. Antiviral Activity and Safety of Darunavir/Cobicistat for the Treatment of COVID-19. Open Forum Infect Dis. 2020 Jun 21;7(7):ofaa241. doi: 10.1093/ofid/ofaa241. eCollection 2020 Jul.']",,13/04/2020,https://clinicaltrials.gov/show/NCT04252274,31/08/2020,0,1
11,NCT04252664,Suspended,10/04/2020,27/04/2020,No Results Posted,,,15/04/2020,https://clinicaltrials.gov/show/NCT04252664,10/04/2020,0,0
12,NCT04252885,Completed,30/04/2020,31/05/2020,No Results Posted,"['Li Y, Xie Z, Lin W, Cai W, Wen C, Guan Y, Mo X, Wang J, Wang Y, Peng P, Chen X, Hong W, Xiao G, Liu J, Zhang L, Hu F, Li F, Zhang F, Deng X, Li L. Efficacy and Safety of Lopinavir/Ritonavir or Arbidol in Adult Patients with Mild/Moderate COVID-19: An Exploratory Randomized Controlled Trial. Med (N Y). 2020 Dec 18;1(1):105-113.e4. doi: 10.1016/j.medj.2020.04.001. Epub 2020 May 19.']",,01/07/2020,https://clinicaltrials.gov/show/NCT04252885,30/04/2020,0,1
13,NCT04254874,Recruiting,01/06/2020,01/07/2020,No Results Posted,,,17/03/2020,https://clinicaltrials.gov/show/NCT04254874,01/06/2020,0,0
14,NCT04255017,Recruiting,01/06/2020,01/07/2020,No Results Posted,,,17/03/2020,https://clinicaltrials.gov/show/NCT04255017,01/06/2020,0,0
15,NCT04257656,Terminated,30/03/2020,10/04/2020,No Results Posted,"['Wang Y, Zhou F, Zhang D, Zhao J, Du R, Hu Y, Cheng Z, Gao L, Jin Y, Luo G, Fu S, Lu Q, Du G, Wang K, Lu Y, Fan G, Zhang Y, Liu Y, Ruan S, Liu W, Jaki T, Hayden FG, Horby PW, Cao B, Wang C. Evaluation of the efficacy and safety of intravenous remdesivir in adult patients with severe COVID-19: study protocol for a phase 3 randomized, double-blind, placebo-controlled, multicentre trial. Trials. 2020 May 24;21(1):422. doi: 10.1186/s13063-020-04352-9.', 'Wang Y, Zhang D, Du G, Du R, Zhao J, Jin Y, Fu S, Gao L, Cheng Z, Lu Q, Hu Y, Luo G, Wang K, Lu Y, Li H, Wang S, Ruan S, Yang C, Mei C, Wang Y, Ding D, Wu F, Tang X, Ye X, Ye Y, Liu B, Yang J, Yin W, Wang A, Fan G, Zhou F, Liu Z, Gu X, Xu J, Shang L, Zhang Y, Cao L, Guo T, Wan Y, Qin H, Jiang Y, Jaki T, Hayden FG, Horby PW, Cao B, Wang C. Remdesivir in adults with severe COVID-19: a randomised, double-blind, placebo-controlled, multicentre trial. Lancet. 2020 May 16;395(10236):1569-1578. doi: 10.1016/S0140-6736(20)31022-9. Epub 2020 Apr 29. Erratum in: Lancet. 2020 May 30;395(10238):1694.']",,15/04/2020,https://clinicaltrials.gov/show/NCT04257656,30/03/2020,0,1
16,NCT04260594,Not yet recruiting,01/07/2020,30/12/2020,No Results Posted,,,07/02/2020,https://clinicaltrials.gov/show/NCT04260594,01/07/2020,0,0
17,NCT04261270,Recruiting,01/05/2020,01/07/2020,No Results Posted,,,17/03/2020,https://clinicaltrials.gov/show/NCT04261270,01/05/2020,0,0
18,NCT04261426,Not yet recruiting,30/04/2020,30/06/2020,No Results Posted,,,07/02/2020,https://clinicaltrials.gov/show/NCT04261426,30/04/2020,0,0
19,NCT04261517,Completed,25/02/2020,25/02/2020,No Results Posted,"['Chen J, Liu D, Liu L, Liu P, Xu Q, Xia L, Ling Y, Huang D, Song S, Zhang D, Qian Z, Li T, Shen Y, Lu H. [A pilot study of hydroxychloroquine in treatment of patients with moderate COVID-19]. Zhejiang Da Xue Xue Bao Yi Xue Ban. 2020 May 25;49(2):215-219. doi: 10.3785/j.issn.1008-9292.2020.03.03. Chinese.']",,13/04/2020,https://clinicaltrials.gov/show/NCT04261517,25/02/2020,0,1
20,NCT04261907,Not yet recruiting,31/05/2020,30/06/2020,No Results Posted,,,10/02/2020,https://clinicaltrials.gov/show/NCT04261907,31/05/2020,0,0
21,NCT04263402,Recruiting,01/06/2020,01/07/2020,No Results Posted,,,17/03/2020,https://clinicaltrials.gov/show/NCT04263402,01/06/2020,0,0
22,NCT04264533,Terminated,02/03/2020,29/03/2020,No Results Posted,"['Liu F, Zhu Y, Zhang J, Li Y, Peng Z. Intravenous high-dose vitamin C for the treatment of severe COVID-19: study protocol for a multicentre randomised controlled trial. BMJ Open. 2020 Jul 8;10(7):e039519. doi: 10.1136/bmjopen-2020-039519.']",,12/10/2020,https://clinicaltrials.gov/show/NCT04264533,02/03/2020,0,1
23,NCT04264858,Not yet recruiting,30/04/2020,31/05/2020,No Results Posted,,,17/03/2020,https://clinicaltrials.gov/show/NCT04264858,30/04/2020,0,0
24,NCT04268537,Not yet recruiting,30/04/2020,31/10/2020,No Results Posted,,,13/02/2020,https://clinicaltrials.gov/show/NCT04268537,30/04/2020,0,0
25,NCT04269525,Recruiting,01/12/2020,30/12/2020,No Results Posted,,,01/07/2020,https://clinicaltrials.gov/show/NCT04269525,01/12/2020,0,0
26,NCT04273321,Completed,15/04/2020,15/04/2020,No Results Posted,"['Tang X, Feng YM, Ni JX, Zhang JY, Liu LM, Hu K, Wu XZ, Zhang JX, Chen JW, Zhang JC, Su J, Li YL, Zhao Y, Xie J, Ding Z, He XL, Wang W, Jin RH, Shi HZ, Sun B. Early Use of Corticosteroid May Prolong SARS-CoV-2 Shedding in Non-Intensive Care Unit Patients with COVID-19 Pneumonia: A Multicenter, Single-Blind, Randomized Control Trial. Respiration. 2021;100(2):116-126. doi: 10.1159/000512063. Epub 2021 Jan 22.']",,11/05/2020,https://clinicaltrials.gov/show/NCT04273321,15/04/2020,0,1
27,NCT04273529,Not yet recruiting,30/05/2020,30/06/2020,No Results Posted,,"['Bartlett JB, Dredge K, Dalgleish AG. The evolution of thalidomide and its IMiD derivatives as anticancer agents. Nat Rev Cancer. 2004 Apr;4(4):314-22. doi: 10.1038/nrc1323. Review.']",21/02/2020,https://clinicaltrials.gov/show/NCT04273529,30/05/2020,0,1
28,NCT04273581,Not yet recruiting,30/04/2020,30/05/2020,No Results Posted,,,21/02/2020,https://clinicaltrials.gov/show/NCT04273581,30/04/2020,0,0
29,NCT04273646,Not yet recruiting,30/06/2020,15/02/2022,No Results Posted,,,14/04/2020,https://clinicaltrials.gov/show/NCT04273646,30/06/2020,0,0
30,NCT04273763,"Active, not recruiting",10/05/2020,01/06/2020,No Results Posted,,,01/05/2020,https://clinicaltrials.gov/show/NCT04273763,10/05/2020,0,0
31,NCT04275414,Completed,05/04/2020,02/05/2020,No Results Posted,"['Pang J, Xu F, Aondio G, Li Y, Fumagalli A, Lu M, Valmadre G, Wei J, Bian Y, Canesi M, Damiani G, Zhang Y, Yu D, Chen J, Ji X, Sui W, Wang B, Wu S, Kovacs A, Revera M, Wang H, Jing X, Zhang Y, Chen Y, Cao Y. Efficacy and tolerability of bevacizumab in patients with severe Covid-19. Nat Commun. 2021 Feb 5;12(1):814. doi: 10.1038/s41467-021-21085-8.']",,14/09/2020,https://clinicaltrials.gov/show/NCT04275414,05/04/2020,0,1
32,NCT04276688,Completed,30/03/2020,31/03/2020,No Results Posted,"['Moschen AR. IBD in the time of corona - vigilance for immune-mediated diseases. Nat Rev Gastroenterol Hepatol. 2020 Sep;17(9):529-530. doi: 10.1038/s41575-020-0333-5. Review.', 'Hung IF, Lung KC, Tso EY, Liu R, Chung TW, Chu MY, Ng YY, Lo J, Chan J, Tam AR, Shum HP, Chan V, Wu AK, Sin KM, Leung WS, Law WL, Lung DC, Sin S, Yeung P, Yip CC, Zhang RR, Fung AY, Yan EY, Leung KH, Ip JD, Chu AW, Chan WM, Ng AC, Lee R, Fung K, Yeung A, Wu TC, Chan JW, Yan WW, Chan WM, Chan JF, Lie AK, Tsang OT, Cheng VC, Que TL, Lau CS, Chan KH, To KK, Yuen KY. Triple combination of interferon beta-1b, lopinavir-ritonavir, and ribavirin in the treatment of patients admitted to hospital with COVID-19: an open-label, randomised, phase 2 trial. Lancet. 2020 May 30;395(10238):1695-1704. doi: 10.1016/S0140-6736(20)31042-4. Epub 2020 May 10.']",,15/04/2020,https://clinicaltrials.gov/show/NCT04276688,30/03/2020,0,1
33,NCT04276896,Recruiting,31/07/2023,31/12/2024,No Results Posted,,,19/03/2020,https://clinicaltrials.gov/show/NCT04276896,31/07/2023,0,0
34,NCT04276987,Completed,31/05/2020,31/07/2020,Results Submitted,,,07/09/2020,https://clinicaltrials.gov/show/NCT04276987,31/05/2020,0,0
35,NCT04278963,Suspended,01/12/2022,01/05/2023,No Results Posted,,,07/07/2021,https://clinicaltrials.gov/show/NCT04278963,01/12/2022,0,0
36,NCT04279197,Recruiting,01/12/2021,01/12/2021,No Results Posted,,,23/09/2020,https://clinicaltrials.gov/show/NCT04279197,01/12/2021,0,0
37,NCT04280588,Withdrawn,01/07/2020,01/07/2020,No Results Posted,,,13/11/2020,https://clinicaltrials.gov/show/NCT04280588,01/07/2020,0,0
38,NCT04281693,Not yet recruiting,01/03/2020,01/03/2020,No Results Posted,,,24/02/2020,https://clinicaltrials.gov/show/NCT04281693,01/03/2020,0,0
39,NCT04282902,Recruiting,30/04/2020,01/06/2020,No Results Posted,,"['Dewage SNV, Organ L, Koumoundouros E, Derseh HB, Perera KUE, Samuel CS, Stent AW, Snibson KJ. The efficacy of pirfenidone in a sheep model of pulmonary fibrosis. Exp Lung Res. 2019 Nov - Dec;45(9-10):310-322. doi: 10.1080/01902148.2019.1695019. Epub 2019 Nov 25.', 'Lehmann M, Buhl L, Alsafadi HN, Klee S, Hermann S, Mutze K, Ota C, Lindner M, Behr J, Hilgendorff A, Wagner DE, K√∂nigshoff M. Differential effects of Nintedanib and Pirfenidone on lung alveolar epithelial cell function in ex vivo murine and human lung tissue cultures of pulmonary fibrosis. Respir Res. 2018 Sep 15;19(1):175. doi: 10.1186/s12931-018-0876-y.', 'Ikeda S, Sekine A, Baba T, Katano T, Tabata E, Shintani R, Sadoyama S, Yamakawa H, Oda T, Okuda R, Kitamura H, Iwasawa T, Takemura T, Ogura T. Negative impact of anorexia and weight loss during prior pirfenidone administration on subsequent nintedanib treatment in patients with idiopathic pulmonary fibrosis. BMC Pulm Med. 2019 Apr 11;19(1):78. doi: 10.1186/s12890-019-0841-7.', 'Epstein Shochet G, Wollin L, Shitrit D. Fibroblast-matrix interplay: Nintedanib and pirfenidone modulate the effect of IPF fibroblast-conditioned matrix on normal fibroblast phenotype. Respirology. 2018 Aug;23(8):756-763. doi: 10.1111/resp.13287. Epub 2018 Mar 12.']",25/02/2020,https://clinicaltrials.gov/show/NCT04282902,30/04/2020,0,1
40,NCT04285190,Withdrawn,15/04/2020,20/04/2020,No Results Posted,,,16/06/2020,https://clinicaltrials.gov/show/NCT04285190,15/04/2020,0,0
41,NCT04286503,Not yet recruiting,28/02/2021,28/02/2021,No Results Posted,,,27/02/2020,https://clinicaltrials.gov/show/NCT04286503,28/02/2021,0,0
42,NCT04287686,Withdrawn,01/04/2020,01/04/2020,No Results Posted,"['Zhang X, Li S, Niu S. ACE2 and COVID-19 and the resulting ARDS. Postgrad Med J. 2020 Jul;96(1137):403-407. doi: 10.1136/postgradmedj-2020-137935. Epub 2020 Jun 10. Review.']",,17/03/2020,https://clinicaltrials.gov/show/NCT04287686,01/04/2020,0,1
43,NCT04288102,Completed,12/05/2020,09/07/2020,No Results Posted,"['Shi L, Huang H, Lu X, Yan X, Jiang X, Xu R, Wang S, Zhang C, Yuan X, Xu Z, Huang L, Fu JL, Li Y, Zhang Y, Yao WQ, Liu T, Song J, Sun L, Yang F, Zhang X, Zhang B, Shi M, Meng F, Song Y, Yu Y, Wen J, Li Q, Mao Q, Maeurer M, Zumla A, Yao C, Xie WF, Wang FS. Effect of human umbilical cord-derived mesenchymal stem cells on lung damage in severe COVID-19 patients: a randomized, double-blind, placebo-controlled phase 2 trial. Signal Transduct Target Ther. 2021 Feb 10;6(1):58. doi: 10.1038/s41392-021-00488-5.']",,19/08/2020,https://clinicaltrials.gov/show/NCT04288102,12/05/2020,0,1
44,NCT04290858,Withdrawn,01/03/2021,01/02/2022,No Results Posted,,,24/03/2020,https://clinicaltrials.gov/show/NCT04290858,01/03/2021,0,0
45,NCT04290871,Withdrawn,01/03/2021,01/03/2022,No Results Posted,,,24/03/2020,https://clinicaltrials.gov/show/NCT04290871,01/03/2021,0,0
46,NCT04291053,Not yet recruiting,01/08/2020,01/09/2020,No Results Posted,,,17/03/2020,https://clinicaltrials.gov/show/NCT04291053,01/08/2020,0,0
47,NCT04291729,Completed,19/03/2020,19/03/2020,No Results Posted,,,13/04/2020,https://clinicaltrials.gov/show/NCT04291729,19/03/2020,0,0
48,NCT04292899,Completed,09/04/2020,30/06/2020,Study Results,,,31/12/2020,https://clinicaltrials.gov/show/NCT04292899,09/04/2020,1,0
49,NCT04293692,Withdrawn,25/02/2020,25/02/2020,No Results Posted,,,18/03/2020,https://clinicaltrials.gov/show/NCT04293692,25/02/2020,0,0
50,NCT04293887,Not yet recruiting,30/05/2020,30/06/2020,No Results Posted,,"['Falzarano D, de Wit E, Rasmussen AL, Feldmann F, Okumura A, Scott DP, Brining D, Bushmaker T, Martellaro C, Baseler L, Benecke AG, Katze MG, Munster VJ, Feldmann H. Treatment with interferon-Œ±2b and ribavirin improves outcome in MERS-CoV-infected rhesus macaques. Nat Med. 2013 Oct;19(10):1313-7. doi: 10.1038/nm.3362. Epub 2013 Sep 8.', 'Kim UJ, Won EJ, Kee SJ, Jung SI, Jang HC. Combination therapy with lopinavir/ritonavir, ribavirin and interferon-Œ± for Middle East respiratory syndrome. Antivir Ther. 2016;21(5):455-9. doi: 10.3851/IMP3002. Epub 2015 Oct 22.', 'Shalhoub S, Farahat F, Al-Jiffri A, Simhairi R, Shamma O, Siddiqi N, Mushtaq A. IFN-Œ±2a or IFN-Œ≤1a in combination with ribavirin to treat Middle East respiratory syndrome coronavirus pneumonia: a retrospective study. J Antimicrob Chemother. 2015 Jul;70(7):2129-32. doi: 10.1093/jac/dkv085. Epub 2015 Apr 21.', 'Min CK, Cheon S, Ha NY, Sohn KM, Kim Y, Aigerim A, Shin HM, Choi JY, Inn KS, Kim JH, Moon JY, Choi MS, Cho NH, Kim YS. Comparative and kinetic analysis of viral shedding and immunological responses in MERS patients representing a broad spectrum of disease severity. Sci Rep. 2016 May 5;6:25359. doi: 10.1038/srep25359.']",03/03/2020,https://clinicaltrials.gov/show/NCT04293887,30/05/2020,0,1
51,NCT04295551,Not yet recruiting,14/07/2020,14/04/2021,No Results Posted,,,04/03/2020,https://clinicaltrials.gov/show/NCT04295551,14/07/2020,0,0
52,NCT04298060,Not yet recruiting,01/03/2021,01/09/2022,No Results Posted,,,09/07/2020,https://clinicaltrials.gov/show/NCT04298060,01/03/2021,0,0
53,NCT04299152,Not yet recruiting,09/04/2022,10/06/2022,No Results Posted,,,30/06/2021,https://clinicaltrials.gov/show/NCT04299152,09/04/2022,0,0
54,NCT04299724,Recruiting,31/07/2023,31/12/2024,No Results Posted,,,09/03/2020,https://clinicaltrials.gov/show/NCT04299724,31/07/2023,0,0
55,NCT04302519,Not yet recruiting,30/06/2021,30/07/2021,No Results Posted,,,10/03/2020,https://clinicaltrials.gov/show/NCT04302519,30/06/2021,0,0
56,NCT04304053,Completed,15/06/2020,15/06/2020,No Results Posted,"['Akhtar S, Das JK, Ismail T, Wahid M, Saeed W, Bhutta ZA. Nutritional perspectives for the prevention and mitigation of COVID-19. Nutr Rev. 2021 Feb 11;79(3):289-300. doi: 10.1093/nutrit/nuaa063.', 'Mitj√† O, Corbacho-Monn√© M, Ubals M, Alemany A, Su√±er C, Teb√© C, Tobias A, Pe√±afiel J, Ballana E, P√©rez CA, Admella P, Riera-Mart√≠ N, Laporte P, Mitj√† J, Clua M, Bertran L, Sarquella M, Gavil√°n S, Ara J, Argimon JM, Cuatrecasas G, Ca√±adas P, Elizalde-Torrent A, Fabregat R, Farr√© M, Forcada A, Flores-Mateo G, L√≥pez C, Muntada E, Nadal N, Narejos S, Nieto A, Prat N, Puig J, Qui√±ones C, Ram√≠rez-Viaplana F, Reyes-Urue√±a J, Riveira-Mu√±oz E, Ruiz L, Sanz S, Sent√≠s A, Sierra A, Velasco C, Vivanco-Hidalgo RM, Zamora J, Casabona J, Vall-Mayans M, Gonz√°lez-Beiras C, Clotet B; BCN-PEP-CoV2 Research Group. A Cluster-Randomized Trial of Hydroxychloroquine for Prevention of Covid-19. N Engl J Med. 2021 Feb 4;384(5):417-427. doi: 10.1056/NEJMoa2021801. Epub 2020 Nov 24.']",,30/06/2020,https://clinicaltrials.gov/show/NCT04304053,15/06/2020,0,1
57,NCT04304313,Recruiting,01/03/2020,09/11/2020,No Results Posted,"['Sultana J, Crisafulli S, Gabbay F, Lynn E, Shakir S, Trifir√≤ G. Challenges for Drug Repurposing in the COVID-19 Pandemic Era. Front Pharmacol. 2020 Nov 6;11:588654. doi: 10.3389/fphar.2020.588654. eCollection 2020. Review.']",,17/03/2020,https://clinicaltrials.gov/show/NCT04304313,01/03/2020,0,1
58,NCT04305106,Recruiting,30/06/2020,31/07/2020,No Results Posted,,,26/03/2020,https://clinicaltrials.gov/show/NCT04305106,30/06/2020,0,0
59,NCT04305457,"Active, not recruiting",01/04/2021,01/04/2022,No Results Posted,,,29/12/2020,https://clinicaltrials.gov/show/NCT04305457,01/04/2021,0,0
60,NCT04306055,Completed,13/03/2020,03/04/2020,No Results Posted,,,13/04/2020,https://clinicaltrials.gov/show/NCT04306055,13/03/2020,0,0
61,NCT04307693,Terminated,30/04/2020,30/04/2020,No Results Posted,"['Lipsitch M, Perlman S, Waldor MK. Testing COVID-19 therapies to prevent progression of mild disease. Lancet Infect Dis. 2020 Dec;20(12):1367. doi: 10.1016/S1473-3099(20)30372-8. Epub 2020 May 6.']",,27/05/2020,https://clinicaltrials.gov/show/NCT04307693,30/04/2020,0,1
62,NCT04308317,Enrolling by invitation,01/03/2021,01/05/2021,No Results Posted,,,16/03/2020,https://clinicaltrials.gov/show/NCT04308317,01/03/2021,0,0
63,NCT04310228,Recruiting,01/05/2020,01/05/2020,No Results Posted,,,10/04/2020,https://clinicaltrials.gov/show/NCT04310228,01/05/2020,0,0
64,NCT04310865,Suspended,01/12/2022,01/04/2023,No Results Posted,,,07/07/2021,https://clinicaltrials.gov/show/NCT04310865,01/12/2022,0,0
65,NCT04313127,"Active, not recruiting",30/12/2020,20/12/2022,No Results Posted,"['Zhu FC, Li YH, Guan XH, Hou LH, Wang WJ, Li JX, Wu SP, Wang BS, Wang Z, Wang L, Jia SY, Jiang HD, Wang L, Jiang T, Hu Y, Gou JB, Xu SB, Xu JJ, Wang XW, Wang W, Chen W. Safety, tolerability, and immunogenicity of a recombinant adenovirus type-5 vectored COVID-19 vaccine: a dose-escalation, open-label, non-randomised, first-in-human trial. Lancet. 2020 Jun 13;395(10240):1845-1854. doi: 10.1016/S0140-6736(20)31208-3. Epub 2020 May 22.']",,19/05/2020,https://clinicaltrials.gov/show/NCT04313127,30/12/2020,0,1
66,NCT04313322,Recruiting,30/06/2020,30/09/2020,No Results Posted,,,18/03/2020,https://clinicaltrials.gov/show/NCT04313322,30/06/2020,0,0
67,NCT04315298,Completed,24/07/2020,02/09/2020,No Results Posted,,,01/10/2020,https://clinicaltrials.gov/show/NCT04315298,24/07/2020,0,0
68,NCT04315480,"Active, not recruiting",09/04/2020,01/05/2020,No Results Posted,"['Sabbatinelli J, Giuliani A, Matacchione G, Latini S, Laprovitera N, Pomponio G, Ferrarini A, Svegliati Baroni S, Pavani M, Moretti M, Gabrielli A, Procopio AD, Ferracin M, Bonaf√® M, Olivieri F. Decreased serum levels of the inflammaging marker miR-146a are associated with clinical non-response to tocilizumab in COVID-19 patients. Mech Ageing Dev. 2021 Jan;193:111413. doi: 10.1016/j.mad.2020.111413. Epub 2020 Dec 8.']",,13/04/2020,https://clinicaltrials.gov/show/NCT04315480,09/04/2020,0,1
69,NCT04315896,"Active, not recruiting",01/07/2020,15/08/2020,No Results Posted,,,27/07/2020,https://clinicaltrials.gov/show/NCT04315896,01/07/2020,0,0
70,NCT04315987,Not yet recruiting,01/08/2020,01/08/2020,No Results Posted,,,09/06/2020,https://clinicaltrials.gov/show/NCT04315987,01/08/2020,0,0
71,NCT04316377,"Active, not recruiting",25/05/2020,03/03/2025,No Results Posted,"['Lyngbakken MN, Berdal JE, Eskesen A, Kvale D, Olsen IC, Rueegg CS, Rangberg A, Jonassen CM, Omland T, R√∏sj√∏ H, Dalgard O. A pragmatic randomized controlled trial reports lack of efficacy of hydroxychloroquine on coronavirus disease 2019 viral kinetics. Nat Commun. 2020 Oct 20;11(1):5284. doi: 10.1038/s41467-020-19056-6.', 'Lyngbakken MN, Berdal JE, Eskesen A, Kvale D, Olsen IC, Rangberg A, Jonassen CM, Omland T, R√∏sj√∏ H, Dalgard O. Norwegian Coronavirus Disease 2019 (NO COVID-19) Pragmatic Open label Study to assess early use of hydroxychloroquine sulphate in moderately severe hospitalised patients with coronavirus disease 2019: A structured summary of a study protocol for a randomised controlled trial. Trials. 2020 Jun 5;21(1):485. doi: 10.1186/s13063-020-04420-0.']",,05/06/2020,https://clinicaltrials.gov/show/NCT04316377,25/05/2020,0,1
72,NCT04316728,Not yet recruiting,01/09/2020,01/11/2020,No Results Posted,,,20/03/2020,https://clinicaltrials.gov/show/NCT04316728,01/09/2020,0,0
73,NCT04318015,Recruiting,31/12/2020,31/03/2021,No Results Posted,,,17/04/2020,https://clinicaltrials.gov/show/NCT04318015,31/12/2020,0,0
74,NCT04318431,Completed,12/05/2020,01/06/2020,No Results Posted,"['Cohen R, Jung C, Ouldali N, Sellam A, Batard C, Cahn-Sellem F, Elbez A, Wollner A, Romain O, Corrard F, Aberrane S, Soismier N, Creidy R, Smati-Lafarge M, Launay O, B√©chet S, Varon E, Levy C. Assessment of SARS-CoV-2 infection by Reverse transcription-PCR and serology in the Paris area: a cross-sectional study. BMJ Paediatr Open. 2020 Dec 29;4(1):e000887. doi: 10.1136/bmjpo-2020-000887. eCollection 2020.']",,09/07/2020,https://clinicaltrials.gov/show/NCT04318431,12/05/2020,0,1
75,NCT04318444,Recruiting,01/03/2021,01/03/2022,No Results Posted,"['Akhtar S, Das JK, Ismail T, Wahid M, Saeed W, Bhutta ZA. Nutritional perspectives for the prevention and mitigation of COVID-19. Nutr Rev. 2021 Feb 11;79(3):289-300. doi: 10.1093/nutrit/nuaa063.']",,27/04/2020,https://clinicaltrials.gov/show/NCT04318444,01/03/2021,0,1
76,NCT04319731,Recruiting,20/03/2021,20/03/2021,No Results Posted,"['Selzman CH, Tonna JE, Pierce J, Vargas C, Skidmore C, Lewis G, Hatton ND, Phillips JD. A pilot trial of human amniotic fluid for the treatment of COVID-19. BMC Res Notes. 2021 Jan 22;14(1):32. doi: 10.1186/s13104-021-05443-9.']",,17/04/2020,https://clinicaltrials.gov/show/NCT04319731,20/03/2021,0,1
77,NCT04319900,Recruiting,30/04/2020,25/06/2020,No Results Posted,,,24/03/2020,https://clinicaltrials.gov/show/NCT04319900,30/04/2020,0,0
78,NCT04320056,Recruiting,30/04/2021,31/10/2021,No Results Posted,,,21/04/2020,https://clinicaltrials.gov/show/NCT04320056,30/04/2021,0,0
79,NCT04320238,Recruiting,01/05/2020,01/06/2020,No Results Posted,,,31/03/2020,https://clinicaltrials.gov/show/NCT04320238,01/05/2020,0,0
80,NCT04320277,Not yet recruiting,30/06/2020,30/07/2020,No Results Posted,"['Benucci M, Damiani A, Infantino M, Manfredi M, Quartuccio L. Old and new antirheumatic drugs for the treatment of COVID-19. Joint Bone Spine. 2020 May;87(3):195-197. doi: 10.1016/j.jbspin.2020.03.013.']",,22/04/2020,https://clinicaltrials.gov/show/NCT04320277,30/06/2020,0,1
81,NCT04320615,Completed,24/06/2020,28/07/2020,Study Results,"['Rosas IO, Br√§u N, Waters M, Go RC, Hunter BD, Bhagani S, Skiest D, Aziz MS, Cooper N, Douglas IS, Savic S, Youngstein T, Del Sorbo L, Cubillo Gracian A, De La Zerda DJ, Ustianowski A, Bao M, Dimonaco S, Graham E, Matharu B, Spotswood H, Tsai L, Malhotra A. Tocilizumab in Hospitalized Patients with Severe Covid-19 Pneumonia. N Engl J Med. 2021 Apr 22;384(16):1503-1516. doi: 10.1056/NEJMoa2028700. Epub 2021 Feb 25.']",,30/06/2021,https://clinicaltrials.gov/show/NCT04320615,24/06/2020,1,1
82,NCT04320953,Completed,26/03/2020,09/04/2020,No Results Posted,,,17/04/2020,https://clinicaltrials.gov/show/NCT04320953,26/03/2020,0,0
83,NCT04321174,Recruiting,31/03/2021,31/03/2022,No Results Posted,"['Tan DHS, Chan AK, J√ºni P, Tomlinson G, Daneman N, Walmsley S, Muller M, Fowler R, Murthy S, Press N, Cooper C, Lee T, Mazzulli T, McGeer A. Post-exposure prophylaxis against SARS-CoV-2 in close contacts of confirmed COVID-19 cases (CORIPREV): study protocol for a cluster-randomized trial. Trials. 2021 Mar 22;22(1):224. doi: 10.1186/s13063-021-05134-7.', 'Akhtar S, Das JK, Ismail T, Wahid M, Saeed W, Bhutta ZA. Nutritional perspectives for the prevention and mitigation of COVID-19. Nutr Rev. 2021 Feb 11;79(3):289-300. doi: 10.1093/nutrit/nuaa063.', 'Sultana J, Crisafulli S, Gabbay F, Lynn E, Shakir S, Trifir√≤ G. Challenges for Drug Repurposing in the COVID-19 Pandemic Era. Front Pharmacol. 2020 Nov 6;11:588654. doi: 10.3389/fphar.2020.588654. eCollection 2020. Review.']",,21/04/2020,https://clinicaltrials.gov/show/NCT04321174,31/03/2021,0,1
84,NCT04321421,Completed,28/04/2020,07/05/2020,No Results Posted,"['Piechotta V, Iannizzi C, Chai KL, Valk SJ, Kimber C, Dorando E, Monsef I, Wood EM, Lamikanra AA, Roberts DJ, McQuilten Z, So-Osman C, Estcourt LJ, Skoetz N. Convalescent plasma or hyperimmune immunoglobulin for people with COVID-19: a living systematic review. Cochrane Database Syst Rev. 2021 May 20;5:CD013600. doi: 10.1002/14651858.CD013600.pub4.', 'Chai KL, Valk SJ, Piechotta V, Kimber C, Monsef I, Doree C, Wood EM, Lamikanra AA, Roberts DJ, McQuilten Z, So-Osman C, Estcourt LJ, Skoetz N. Convalescent plasma or hyperimmune immunoglobulin for people with COVID-19: a living systematic review. Cochrane Database Syst Rev. 2020 Oct 12;10:CD013600. doi: 10.1002/14651858.CD013600.pub3. Update in: Cochrane Database Syst Rev. 2021 May 20;5:CD013600.', 'Piechotta V, Chai KL, Valk SJ, Doree C, Monsef I, Wood EM, Lamikanra A, Kimber C, McQuilten Z, So-Osman C, Estcourt LJ, Skoetz N. Convalescent plasma or hyperimmune immunoglobulin for people with COVID-19: a living systematic review. Cochrane Database Syst Rev. 2020 Jul 10;7:CD013600. doi: 10.1002/14651858.CD013600.pub2. Update in: Cochrane Database Syst Rev. 2020 Oct 12;10:CD013600.', 'Perotti C, Del Fante C, Baldanti F, Franchini M, Percivalle E, Vecchio Nepita E, Seminari E, De Silvestri A, Bruno R, Klersy C. Plasma from donors recovered from the new Coronavirus 2019 as therapy for critical patients with COVID-19 (COVID-19 plasma study): a multicentre study protocol. Intern Emerg Med. 2020 Aug;15(5):819-824. doi: 10.1007/s11739-020-02384-2. Epub 2020 May 28.']",,28/05/2020,https://clinicaltrials.gov/show/NCT04321421,28/04/2020,0,1
85,NCT04321616,Recruiting,01/08/2020,01/11/2020,No Results Posted,,,14/04/2020,https://clinicaltrials.gov/show/NCT04321616,01/08/2020,0,0
86,NCT04321928,Recruiting,21/04/2021,21/08/2021,No Results Posted,"['Er≈ëss B, Moln√°r Z, Szak√°cs Z, Z√°dori N, Szak√≥ L, V√°ncsa S, Juh√°sz MF, Ocskay K, V√∂rhendi N, M√°rta K, Szentesi A, P√°rniczky A, Hegyi PJ, Kiss S, F√∂ldi M, Dembrovszky F, Kanjo A, P√°zm√°ny P, Varr√≥ A, Csath√≥ √Å, Helyes Z, P√©terfi Z, Czopf L, Kiss I, Zempl√©nyi A, Czap√°ri D, Hegyi E, Dobszai D, Mikl√≥s E, M√°rta A, T√≥th D, Farkas R, Farkas N, Birk√°s B, Pint√©r E, Peth≈ë G, Zsigmond B, S√°rk√∂zi A, Nagy A, Hegyi P. Personalised health education against health damage of COVID-19 epidemic in the elderly Hungarian population (PROACTIVE-19): protocol of an adaptive randomised controlled clinical trial. Trials. 2020 Sep 29;21(1):809. doi: 10.1186/s13063-020-04733-0.']",,09/06/2020,https://clinicaltrials.gov/show/NCT04321928,21/04/2021,0,1
87,NCT04321993,Recruiting,01/02/2022,01/03/2022,No Results Posted,,,24/07/2020,https://clinicaltrials.gov/show/NCT04321993,01/02/2022,0,0
88,NCT04322344,Recruiting,30/06/2020,30/12/2020,No Results Posted,,,16/09/2020,https://clinicaltrials.gov/show/NCT04322344,30/06/2020,0,0
89,NCT04322565,Recruiting,20/12/2020,21/12/2020,No Results Posted,,,10/07/2020,https://clinicaltrials.gov/show/NCT04322565,20/12/2020,0,0
90,NCT04322773,Terminated,08/10/2020,08/10/2020,No Results Posted,,,09/10/2020,https://clinicaltrials.gov/show/NCT04322773,08/10/2020,0,0
91,NCT04323228,Recruiting,01/12/2020,30/12/2020,No Results Posted,,,22/09/2020,https://clinicaltrials.gov/show/NCT04323228,01/12/2020,0,0
92,NCT04323332,Not yet recruiting,01/03/2020,01/04/2020,No Results Posted,,,26/03/2020,https://clinicaltrials.gov/show/NCT04323332,01/03/2020,0,0
93,NCT04323345,Recruiting,15/12/2020,15/01/2021,No Results Posted,,,21/04/2020,https://clinicaltrials.gov/show/NCT04323345,15/12/2020,0,0
94,NCT04323514,Recruiting,13/03/2021,13/03/2021,No Results Posted,,,26/03/2020,https://clinicaltrials.gov/show/NCT04323514,13/03/2021,0,0
95,NCT04323631,Withdrawn,30/04/2020,30/04/2020,No Results Posted,,,30/06/2020,https://clinicaltrials.gov/show/NCT04323631,30/04/2020,0,0
96,NCT04324073,"Active, not recruiting",27/03/2021,31/12/2021,No Results Posted,,,15/04/2020,https://clinicaltrials.gov/show/NCT04324073,27/03/2021,0,0
97,NCT04324190,Recruiting,01/06/2020,01/12/2021,No Results Posted,,,14/04/2020,https://clinicaltrials.gov/show/NCT04324190,01/06/2020,0,0
98,NCT04324489,Completed,16/04/2020,30/04/2020,No Results Posted,,,05/05/2020,https://clinicaltrials.gov/show/NCT04324489,16/04/2020,0,0
99,NCT04324996,Recruiting,20/02/2022,31/08/2022,No Results Posted,,,17/11/2020,https://clinicaltrials.gov/show/NCT04324996,20/02/2022,0,0
100,NCT04325672,Withdrawn,31/12/2022,31/12/2022,No Results Posted,,,08/04/2020,https://clinicaltrials.gov/show/NCT04325672,31/12/2022,0,0
101,NCT04325867,Recruiting,01/10/2020,01/10/2020,No Results Posted,,,01/04/2020,https://clinicaltrials.gov/show/NCT04325867,01/10/2020,0,0
102,NCT04325893,Terminated,18/06/2020,18/06/2020,No Results Posted,"[""Dub√©e V, Roy PM, Vielle B, Parot-Schinkel E, Blanchet O, Darsonval A, Lefeuvre C, Abbara C, Boucher S, Devaud E, Robineau O, Rispal P, Guimard T, d'Anglejean E, Diamantis S, Custaud MA, Pellier I, Mercat A; HYCOVID study group; HYCOVID investigators; Angers University Hospital; Cholet Hospital; Laval Hospital; Le Mans Hospital; Tours University Hospital; Quimper Hospital; La Roche sur Yon Hospital; Tourcoing Hospital; Orl√©ans Hospital; Nantes University Hospital; Niort Hospital; Lorient Hospital; Brest University Hospital; Cherbourg Hospital; Saint-Brieuc Hospital; Cr√©teil - APHP University Hospital; Saint-Antoine - APHP University Hospital; Saint-Etienne University Hospital; Toulouse University Hospital; Melun Hospital; Dijon University Hospital; Princesse Grace - Monaco Hospital; Versailles Hospital; Colmar Hospital; Agen-Nerac Hospital; Caen University Hospital; Saint-Nazaire Hospital; Nantes - Confluent Hospital; Limoges University Hospital; Poitiers University Hospital; Amiens University Hospital; Bobigny - APHP University Hospital; Cergy-Pontoise Hospital; Valencienne Hospital; Valencienne - Clinique Tessier Hospital; Henri-Mondor - APHP University Hospital; Chalon-sur-Sa√¥ne Hospital; Marseille European Hospital; Auxerre Hospital; Diaconnesses Croix-Saint-Simon Hospital; Marseille - Saint Joseph Hospital; Composition of the HYCOVID management team; Steering committee; Independant data safety and monitoring board; Independent adjudication of clinical events committee; Study management Coordination; Data management. Hydroxychloroquine in mild-to-moderate coronavirus disease 2019: a placebo-controlled double blind trial. Clin Microbiol Infect. 2021 Apr 1. pii: S1198-743X(21)00140-3. doi: 10.1016/j.cmi.2021.03.005. [Epub ahead of print]""]",,06/10/2020,https://clinicaltrials.gov/show/NCT04325893,18/06/2020,0,1
103,NCT04326036,Recruiting,01/11/2021,31/12/2021,No Results Posted,,,12/10/2020,https://clinicaltrials.gov/show/NCT04326036,01/11/2021,0,0
104,NCT04326075,Recruiting,31/03/2021,31/05/2021,No Results Posted,,,17/12/2020,https://clinicaltrials.gov/show/NCT04326075,31/03/2021,0,0
105,NCT04326114,Not yet recruiting,15/12/2020,20/12/2020,No Results Posted,,,02/06/2020,https://clinicaltrials.gov/show/NCT04326114,15/12/2020,0,0
106,NCT04326426,Enrolling by invitation,01/08/2020,31/08/2020,No Results Posted,,,20/04/2020,https://clinicaltrials.gov/show/NCT04326426,01/08/2020,0,0
107,NCT04326452,Recruiting,27/03/2021,27/03/2021,No Results Posted,,,06/10/2020,https://clinicaltrials.gov/show/NCT04326452,27/03/2021,0,0
108,NCT04327349,Enrolling by invitation,20/05/2020,30/09/2020,No Results Posted,,,31/03/2020,https://clinicaltrials.gov/show/NCT04327349,20/05/2020,0,0
109,NCT04327401,Terminated,22/07/2020,22/07/2020,No Results Posted,"['Tomazini BM, Maia IS, Cavalcanti AB, Berwanger O, Rosa RG, Veiga VC, Avezum A, Lopes RD, Bueno FR, Silva MVAO, Baldassare FP, Costa ELV, Moura RAB, Honorato MO, Costa AN, Damiani LP, Lisboa T, Kawano-Dourado L, Zampieri FG, Olivato GB, Righy C, Amendola CP, Roepke RML, Freitas DHM, Forte DN, Freitas FGR, Fernandes CCF, Melro LMG, Junior GFS, Morais DC, Zung S, Machado FR, Azevedo LCP; COALITION COVID-19 Brazil III Investigators. Effect of Dexamethasone on Days Alive and Ventilator-Free in Patients With Moderate or Severe Acute Respiratory Distress Syndrome and COVID-19: The CoDEX Randomized Clinical Trial. JAMA. 2020 Oct 6;324(13):1307-1316. doi: 10.1001/jama.2020.17021.']",,07/08/2020,https://clinicaltrials.gov/show/NCT04327401,22/07/2020,0,1
110,NCT04328129,Recruiting,23/03/2022,23/03/2022,No Results Posted,,,23/09/2020,https://clinicaltrials.gov/show/NCT04328129,23/03/2022,0,0
111,NCT04328272,Not yet recruiting,28/05/2020,28/06/2020,No Results Posted,,,02/04/2020,https://clinicaltrials.gov/show/NCT04328272,28/05/2020,0,0
112,NCT04328285,"Active, not recruiting",30/03/2021,30/03/2021,No Results Posted,,,28/12/2020,https://clinicaltrials.gov/show/NCT04328285,30/03/2021,0,0
113,NCT04328467,Completed,13/07/2020,13/07/2020,Study Results,"['Lofgren SM, Nicol MR, Bangdiwala AS, Pastick KA, Okafor EC, Skipper CP, Pullen MF, Engen NW, Abassi M, Williams DA, Nascene AA, Axelrod ML, Lother SA, MacKenzie LJ, Drobot G, Marten N, Cheng MP, Zarychanski R, Schwartz IS, Silverman M, Chagla Z, Kelly LE, McDonald EG, Lee TC, Hullsiek KH, Boulware DR, Rajasingham R. Safety of Hydroxychloroquine Among Outpatient Clinical Trial Participants for COVID-19. Open Forum Infect Dis. 2020 Oct 19;7(11):ofaa500. doi: 10.1093/ofid/ofaa500. eCollection 2020 Nov.']","['Rajasingham R, Bangdiwala AS, Nicol MR, Skipper CP, Pastick KA, Axelrod ML, Pullen MF, Nascene AA, Williams DA, Engen NW, Okafor EC, Rini BI, Mayer IA, McDonald EG, Lee TC, Li P, MacKenzie LJ, Balko JM, Dunlop SJ, Hullsiek KH, Boulware DR, Lofgren SM; COVID PREP team. Hydroxychloroquine as Pre-exposure Prophylaxis for Coronavirus Disease 2019 (COVID-19) in Healthcare Workers: A Randomized Trial. Clin Infect Dis. 2021 Jun 1;72(11):e835-e843. doi: 10.1093/cid/ciaa1571.']",02/07/2021,https://clinicaltrials.gov/show/NCT04328467,13/07/2020,1,1
114,NCT04328961,Completed,24/09/2020,08/10/2020,No Results Posted,"['Barnabas RV, Brown ER, Bershteyn A, Stankiewicz Karita HC, Johnston C, Thorpe LE, Kottkamp A, Neuzil KM, Laufer MK, Deming M, Paasche-Orlow MK, Kissinger PJ, Luk A, Paolino K, Landovitz RJ, Hoffman R, Schaafsma TT, Krows ML, Thomas KK, Morrison S, Haugen HS, Kidoguchi L, Wener M, Greninger AL, Huang ML, Jerome KR, Wald A, Celum C, Chu HY, Baeten JM; Hydroxychloroquine COVID-19 PEP Study Team. Hydroxychloroquine as Postexposure Prophylaxis to Prevent Severe Acute Respiratory Syndrome Coronavirus 2 Infection : A Randomized Trial. Ann Intern Med. 2021 Mar;174(3):344-352. doi: 10.7326/M20-6519. Epub 2020 Dec 8. Erratum in: Ann Intern Med. 2021 Mar;174(3):435.', 'Barnabas RV, Brown E, Bershteyn A, Miller RS, Wener M, Celum C, Wald A, Chu H, Wesche D, Baeten JM; Hydroxychloroquine COVID-19 PEP Study Team. Efficacy of hydroxychloroquine for post-exposure prophylaxis to prevent severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection among adults exposed to coronavirus disease (COVID-19): a structured summary of a study protocol for a randomised controlled trial. Trials. 2020 Jun 3;21(1):475. doi: 10.1186/s13063-020-04446-4.']",,29/10/2020,https://clinicaltrials.gov/show/NCT04328961,24/09/2020,0,1
115,NCT04329533,Completed,01/11/2020,01/11/2020,No Results Posted,"['Smith RB, Mahnert ND, Foote J, Saunders KT, Mourad J, Huberty J. Mindfulness Effects in Obstetric and Gynecology Patients During the Coronavirus Disease 2019 (COVID-19) Pandemic: A Randomized Controlled Trial. Obstet Gynecol. 2021 Jun 1;137(6):1032-1040. doi: 10.1097/AOG.0000000000004316.']",,13/11/2020,https://clinicaltrials.gov/show/NCT04329533,01/11/2020,0,1
116,NCT04329572,Suspended,31/05/2020,30/06/2020,No Results Posted,,,22/04/2020,https://clinicaltrials.gov/show/NCT04329572,31/05/2020,0,0
117,NCT04329611,Terminated,20/07/2020,20/07/2020,No Results Posted,"['Schwartz I, Boesen ME, Cerchiaro G, Doram C, Edwards BD, Ganesh A, Greenfield J, Jamieson S, Karnik V, Kenney C, Lim R, Menon BK, Mponponsuo K, Rathwell S, Ryckborst KJ, Stewart B, Yaskina M, Metz L, Richer L, Hill MD; ALBERTA HOPE COVID-19 Collaborators. Assessing the efficacy and safety of hydroxychloroquine as outpatient treatment of COVID-19: a randomized controlled trial. CMAJ Open. 2021 Jun 18;9(2):E693-E702. doi: 10.9778/cmajo.20210069. Print 2021 Apr-Jun.']",,31/07/2020,https://clinicaltrials.gov/show/NCT04329611,20/07/2020,0,1
118,NCT04329650,Recruiting,20/05/2020,20/05/2020,No Results Posted,,,17/04/2020,https://clinicaltrials.gov/show/NCT04329650,20/05/2020,0,0
119,NCT04329832,"Active, not recruiting",18/12/2020,31/12/2021,No Results Posted,"['Brown SM, Peltan I, Kumar N, Leither L, Webb BJ, Starr N, Grissom CK, Buckel WR, Srivastava R, Butler AM, Groat D, Haaland B, Ying J, Harris E, Johnson S, Paine R 3rd, Greene T. Hydroxychloroquine vs. Azithromycin for Hospitalized Patients with COVID-19 (HAHPS): Results of a Randomized, Active Comparator Trial. Ann Am Thorac Soc. 2020 Nov 9. doi: 10.1513/AnnalsATS.202008-940OC. [Epub ahead of print]', 'Brown SM, Peltan ID, Webb B, Kumar N, Starr N, Grissom C, Buckel WR, Srivastava R, Harris ES, Leither LM, Johnson SA, Paine R 3rd, Greene T. Hydroxychloroquine versus Azithromycin for Hospitalized Patients with Suspected or Confirmed COVID-19 (HAHPS). Protocol for a Pragmatic, Open-Label, Active Comparator Trial. Ann Am Thorac Soc. 2020 Aug;17(8):1008-1015. doi: 10.1513/AnnalsATS.202004-309SD.']",,02/09/2020,https://clinicaltrials.gov/show/NCT04329832,18/12/2020,0,1
120,NCT04330144,Not yet recruiting,30/03/2021,30/03/2022,No Results Posted,,,01/04/2020,https://clinicaltrials.gov/show/NCT04330144,30/03/2021,0,0
121,NCT04330300,Suspended,31/07/2021,01/12/2021,No Results Posted,,,30/06/2020,https://clinicaltrials.gov/show/NCT04330300,31/07/2021,0,0
122,NCT04330495,Not yet recruiting,06/11/2020,06/11/2020,No Results Posted,,,13/04/2020,https://clinicaltrials.gov/show/NCT04330495,06/11/2020,0,0
123,NCT04331470,Recruiting,20/04/2020,20/05/2020,No Results Posted,"['Nicolau DV, Bafadhel M. Inhaled corticosteroids in virus pandemics: a treatment for COVID-19? Lancet Respir Med. 2020 Sep;8(9):846-847. doi: 10.1016/S2213-2600(20)30314-3. Epub 2020 Jul 30.']",,13/04/2020,https://clinicaltrials.gov/show/NCT04331470,20/04/2020,0,1
124,NCT04331613,Recruiting,01/12/2020,01/12/2020,No Results Posted,,,02/04/2020,https://clinicaltrials.gov/show/NCT04331613,01/12/2020,0,0
125,NCT04331808,"Active, not recruiting",31/03/2021,31/12/2021,No Results Posted,"['Tleyjeh IM. The Misleading ""Pooled Effect Estimate"" of Crude Data from Observational Studies at Critical Risk of Bias: The Case of Tocilizumab in Coronavirus Disease 2019 (COVID-19). Clin Infect Dis. 2021 Jun 15;72(12):e1154-e1155. doi: 10.1093/cid/ciaa1735.', 'Hermine O, Mariette X, Tharaux PL, Resche-Rigon M, Porcher R, Ravaud P; CORIMUNO-19 Collaborative Group. Effect of Tocilizumab vs Usual Care in Adults Hospitalized With COVID-19 and Moderate or Severe Pneumonia: A Randomized Clinical Trial. JAMA Intern Med. 2021 Jan 1;181(1):32-40. doi: 10.1001/jamainternmed.2020.6820. Erratum in: JAMA Intern Med. 2021 Jan 1;181(1):144.']",,28/04/2020,https://clinicaltrials.gov/show/NCT04331808,31/03/2021,0,1
126,NCT04332380,Completed,28/07/2020,28/07/2020,No Results Posted,,,17/08/2020,https://clinicaltrials.gov/show/NCT04332380,28/07/2020,0,0
127,NCT04332666,Not yet recruiting,30/12/2020,15/06/2021,No Results Posted,,,19/08/2020,https://clinicaltrials.gov/show/NCT04332666,30/12/2020,0,0
128,NCT04332835,Completed,31/10/2020,15/11/2020,No Results Posted,,,27/11/2020,https://clinicaltrials.gov/show/NCT04332835,31/10/2020,0,0
129,NCT04333251,Not yet recruiting,31/12/2022,31/12/2022,No Results Posted,,,06/04/2020,https://clinicaltrials.gov/show/NCT04333251,31/12/2022,0,0
130,NCT04333407,Recruiting,30/03/2021,30/03/2021,No Results Posted,,,09/04/2020,https://clinicaltrials.gov/show/NCT04333407,30/03/2021,0,0
131,NCT04333550,Recruiting,01/09/2020,01/03/2021,No Results Posted,,"['Drakesmith H, Prentice A. Viral infection and iron metabolism. Nat Rev Microbiol. 2008 Jul;6(7):541-52. doi: 10.1038/nrmicro1930. Review.', 'Nairz M, Haschka D, Demetz E, Weiss G. Iron at the interface of immunity and infection. Front Pharmacol. 2014 Jul 16;5:152. doi: 10.3389/fphar.2014.00152. eCollection 2014. Review.', 'Georgiou NA, van der Bruggen T, Oudshoorn M, Nottet HS, Marx JJ, van Asbeck BS. Inhibition of human immunodeficiency virus type 1 replication in human mononuclear blood cells by the iron chelators deferoxamine, deferiprone, and bleomycin. J Infect Dis. 2000 Feb;181(2):484-90.', 'Vlahakos D, Arkadopoulos N, Kostopanagiotou G, Siasiakou S, Kaklamanis L, Degiannis D, Demonakou M, Smyrniotis V. Deferoxamine attenuates lipid peroxidation, blocks interleukin-6 production, ameliorates sepsis inflammatory response syndrome, and confers renoprotection after acute hepatic ischemia in pigs. Artif Organs. 2012 Apr;36(4):400-8. doi: 10.1111/j.1525-1594.2011.01385.x. Epub 2011 Dec 21.', 'Wang H, Li Z, Niu J, Xu Y, Ma L, Lu A, Wang X, Qian Z, Huang Z, Jin X, Leng Q, Wang J, Zhong J, Sun B, Meng G. Antiviral effects of ferric ammonium citrate. Cell Discov. 2018 Mar 27;4:14. doi: 10.1038/s41421-018-0013-6. eCollection 2018.', 'Cinatl J Jr, Cinatl J, Rabenau H, G√ºmbel HO, Kornhuber B, Doerr HW. In vitro inhibition of human cytomegalovirus replication by desferrioxamine. Antiviral Res. 1994 Sep;25(1):73-7.', 'Visseren F, Verkerk MS, van der Bruggen T, Marx JJ, van Asbeck BS, Diepersloot RJ. Iron chelation and hydroxyl radical scavenging reduce the inflammatory response of endothelial cells after infection with Chlamydia pneumoniae or influenza A. Eur J Clin Invest. 2002 Mar;32 Suppl 1:84-90.', 'Sappey C, Boelaert JR, Legrand-Poels S, Forceille C, Favier A, Piette J. Iron chelation decreases NF-kappa B and HIV type 1 activation due to oxidative stress. AIDS Res Hum Retroviruses. 1995 Sep;11(9):1049-61.', 'Chang HC, Bayeva M, Taiwo B, Palella FJ Jr, Hope TJ, Ardehali H. Short communication: high cellular iron levels are associated with increased HIV infection and replication. AIDS Res Hum Retroviruses. 2015 Mar;31(3):305-12. doi: 10.1089/aid.2014.0169. Epub 2014 Oct 7.', 'Meyer D. Iron chelation as therapy for HIV and Mycobacterium tuberculosis co-infection under conditions of iron overload. Curr Pharm Des. 2006;12(16):1943-7. Review.', 'Cinatl J, Scholz M, Weber B, Cinatl J, Rabenau H, Markus BH, Encke A, Doerr HW. Effects of desferrioxamine on human cytomegalovirus replication and expression of HLA antigens and adhesion molecules in human vascular endothelial cells. Transpl Immunol. 1995 Dec;3(4):313-20.', 'Mabeza GF, Loyevsky M, Gordeuk VR, Weiss G. Iron chelation therapy for malaria: a review. Pharmacol Ther. 1999 Jan;81(1):53-75. Review.', 'Weinberg GA. Iron chelators as therapeutic agents against Pneumocystis carinii. Antimicrob Agents Chemother. 1994 May;38(5):997-1003.', 'Paradkar PN, De Domenico I, Durchfort N, Zohn I, Kaplan J, Ward DM. Iron depletion limits intracellular bacterial growth in macrophages. Blood. 2008 Aug 1;112(3):866-74. doi: 10.1182/blood-2007-12-126854. Epub 2008 Mar 27.', 'Giannakopoulou E, Pardali V, Zoidis G. Metal-chelating agents against viruses and parasites. Future Med Chem. 2018 Jun 1;10(11):1283-1285. doi: 10.4155/fmc-2018-0100. Epub 2018 May 3. Review.', 'Gordeuk V, Thuma P, Brittenham G, McLaren C, Parry D, Backenstose A, Biemba G, Msiska R, Holmes L, McKinley E, et al. Effect of iron chelation therapy on recovery from deep coma in children with cerebral malaria. N Engl J Med. 1992 Nov 19;327(21):1473-7.', 'Duchemin JB, Paradkar PN. Iron availability affects West Nile virus infection in its mosquito vector. Virol J. 2017 Jun 5;14(1):103. doi: 10.1186/s12985-017-0770-0.']",04/05/2020,https://clinicaltrials.gov/show/NCT04333550,01/09/2020,0,1
132,NCT04333589,Recruiting,01/06/2020,15/09/2020,No Results Posted,"['Li J, Zhang C, Wu Z, Wang G, Zhao H. The Mechanism and Clinical Outcome of patients with Corona Virus Disease 2019 Whose Nucleic Acid Test has changed from negative to positive, and the therapeutic efficacy of Favipiravir: A structured summary of a study protocol for a randomised controlled trial. Trials. 2020 Jun 5;21(1):488. doi: 10.1186/s13063-020-04430-y.']",,24/04/2020,https://clinicaltrials.gov/show/NCT04333589,01/06/2020,0,1
133,NCT04333628,Terminated,01/09/2020,01/09/2020,No Results Posted,,,14/10/2020,https://clinicaltrials.gov/show/NCT04333628,01/09/2020,0,0
134,NCT04333654,Terminated,26/05/2020,26/05/2020,No Results Posted,,,14/07/2020,https://clinicaltrials.gov/show/NCT04333654,26/05/2020,0,0
135,NCT04334005,Not yet recruiting,30/06/2020,30/06/2020,No Results Posted,,,07/04/2020,https://clinicaltrials.gov/show/NCT04334005,30/06/2020,0,0
136,NCT04334265,Recruiting,01/06/2020,01/12/2020,No Results Posted,"['Zhang C, Li J, Wu Z, Wang H, Que C, Zhao H, Wang G. Efficacy and safety of Anluohuaxian in the treatment of patients with severe Coronavirus disease 2019- a multicenter, open label, randomized controlled study: a structured summary of a study protocol for a randomised controlled trial. Trials. 2020 Jun 8;21(1):495. doi: 10.1186/s13063-020-04399-8.']",,24/04/2020,https://clinicaltrials.gov/show/NCT04334265,01/06/2020,0,1
137,NCT04334382,Recruiting,31/12/2020,31/12/2021,No Results Posted,,,09/04/2020,https://clinicaltrials.gov/show/NCT04334382,31/12/2020,0,0
138,NCT04334629,Recruiting,25/05/2021,25/09/2021,No Results Posted,,,23/10/2020,https://clinicaltrials.gov/show/NCT04334629,25/05/2021,0,0
139,NCT04334850,Recruiting,01/07/2020,01/08/2020,No Results Posted,,,27/05/2020,https://clinicaltrials.gov/show/NCT04334850,01/07/2020,0,0
140,NCT04334967,Suspended,27/05/2021,27/05/2022,No Results Posted,,,16/09/2020,https://clinicaltrials.gov/show/NCT04334967,27/05/2021,0,0
141,NCT04335032,Not yet recruiting,13/07/2021,31/07/2021,No Results Posted,,,02/11/2020,https://clinicaltrials.gov/show/NCT04335032,13/07/2021,0,0
142,NCT04335071,Terminated,27/09/2020,27/09/2020,No Results Posted,,,14/10/2020,https://clinicaltrials.gov/show/NCT04335071,27/09/2020,0,0
143,NCT04335279,Completed,03/06/2020,24/07/2020,No Results Posted,"['Thombs BD, Kwakkenbos L, Levis B, Bourgeault A, Henry RS, Levis AW, Harb S, Tao L, Carrier ME, Bustamante L, Duchek D, Dyas L, El-Baalbaki G, Ellis K, Rice DB, Wurz A, Nordlund J, Gagarine M, Turner KA, √òstb√∏ N, Culos-Reed N, Hebblethwaite S, Patten S, Bartlett SJ, Varga J, Mouthon L, Markham S, Martin MS, Benedetti A; SPIN-CHAT Patient Advisory Team and Program Facilitators; Scleroderma Patient-centered Intervention Network Investigators. Effects of a multi-faceted education and support programme on anxiety symptoms among people with systemic sclerosis and anxiety during COVID-19 (SPIN-CHAT): a two-arm parallel, partially nested, randomised, controlled trial. Lancet Rheumatol. 2021 Jun;3(6):e427-e437. doi: 10.1016/S2665-9913(21)00060-6. Epub 2021 Apr 16.']",,30/11/2020,https://clinicaltrials.gov/show/NCT04335279,03/06/2020,0,1
144,NCT04335305,Recruiting,31/12/2020,30/06/2021,No Results Posted,,,27/11/2020,https://clinicaltrials.gov/show/NCT04335305,31/12/2020,0,0
145,NCT04335786,Recruiting,01/12/2020,01/12/2021,No Results Posted,"['Gommans DHF, Nas J, Pinto-Sietsma SJ, Koop Y, Konst RE, Mensink F, Aarts GWA, Konijnenberg LSF, Cortenbach K, Verhaert DVM, Thannhauser J, Mol JQ, Rooijakkers MJP, Vos JL, van Rumund A, Vart P, Hassing RJ, Cornel JH, de Jager CPC, van den Heuvel MM, van der Hoeven HG, Verbon A, Pinto YM, van Royen N, van Kimmenade RRJ; Event committee, de Leeuw PW, van Agtmael MA, Bresser P; Data Safety Monitoring Board, van Gilst WH, Vonk-Noordergraaf A, Tijssen JGP; Steering committee, van Royen N, de Jager CPC, van den Heuvel MM, van der Hoeven HG, Verbon A, Pinto YM, van Kimmenade RRJ. Rationale and design of the PRAETORIAN-COVID trial: A double-blind, placebo-controlled randomized clinical trial with valsartan for PRevention of Acute rEspiraTORy dIstress syndrome in hospitAlized patieNts with SARS-COV-2 Infection Disease. Am Heart J. 2020 Aug;226:60-68. doi: 10.1016/j.ahj.2020.05.010. Epub 2020 May 21.']",,09/06/2020,https://clinicaltrials.gov/show/NCT04335786,01/12/2020,0,1
146,NCT04335851,Completed,15/05/2020,03/06/2020,No Results Posted,,,09/06/2020,https://clinicaltrials.gov/show/NCT04335851,15/05/2020,0,0
147,NCT04336462,Recruiting,21/02/2020,01/08/2020,No Results Posted,,,07/04/2020,https://clinicaltrials.gov/show/NCT04336462,21/02/2020,0,0
148,NCT04336748,Not yet recruiting,01/07/2020,01/08/2020,No Results Posted,,,07/04/2020,https://clinicaltrials.gov/show/NCT04336748,01/07/2020,0,0
149,NCT04336774,Withdrawn,01/11/2020,09/11/2020,No Results Posted,,,10/08/2020,https://clinicaltrials.gov/show/NCT04336774,01/11/2020,0,0
150,NCT04336904,"Active, not recruiting",01/07/2020,01/07/2020,No Results Posted,,,08/04/2020,https://clinicaltrials.gov/show/NCT04336904,01/07/2020,0,0
151,NCT04337008,Recruiting,03/06/2020,31/07/2020,No Results Posted,,,24/04/2020,https://clinicaltrials.gov/show/NCT04337008,03/06/2020,0,0
152,NCT04337541,Completed,02/06/2020,02/06/2020,No Results Posted,"['Bundgaard H, Bundgaard JS, Raaschou-Pedersen DET, von Buchwald C, Todsen T, Norsk JB, Pries-Heje MM, Vissing CR, Nielsen PB, Winsl√∏w UC, Fogh K, Hasselbalch R, Kristensen JH, Ringgaard A, Porsborg Andersen M, Goecke NB, Trebbien R, Skovgaard K, Benfield T, Ullum H, Torp-Pedersen C, Iversen K. Effectiveness of Adding a Mask Recommendation to Other Public Health Measures to Prevent SARS-CoV-2 Infection in Danish Mask Wearers : A Randomized Controlled Trial. Ann Intern Med. 2021 Mar;174(3):335-343. doi: 10.7326/M20-6817. Epub 2020 Nov 18.', 'Bundgaard H, Bundgaard JS, Raaschou-Pedersen DET, Mariager AF, Schytte N, von Buchwald C, Todsen T, Skovgaard K, Trebbien R, Andersen MP, Benfield T, Ullum H, Torp-Pedersen C, Iversen K. Face masks for the prevention of COVID-19 - Rationale and design of the randomised controlled trial DANMASK-19. Dan Med J. 2020 Aug 18;67(9). pii: A05200363.']",,03/08/2020,https://clinicaltrials.gov/show/NCT04337541,02/06/2020,0,1
153,NCT04337788,Not yet recruiting,01/07/2020,01/09/2020,No Results Posted,,,01/06/2020,https://clinicaltrials.gov/show/NCT04337788,01/07/2020,0,0
154,NCT04338568,Recruiting,30/11/2020,30/12/2020,No Results Posted,,"['Pisani L, Vercesi V, van Tongeren PSI, Lagrand WK, Leopold SJ, Huson MAM, Henwood PC, Walden A, Smit MR, Riviello ED, Pelosi P, Dondorp AM, Schultz MJ; Lung Ultrasound Consortium. The diagnostic accuracy for ARDS of global versus regional lung ultrasound scores - a post hoc analysis of an observational study in invasively ventilated ICU patients. Intensive Care Med Exp. 2019 Jul 25;7(Suppl 1):44. doi: 10.1186/s40635-019-0241-6.', 'Li K, Fang Y, Li W, Pan C, Qin P, Zhong Y, Liu X, Huang M, Liao Y, Li S. CT image visual quantitative evaluation and clinical classification of coronavirus disease (COVID-19). Eur Radiol. 2020 Aug;30(8):4407-4416. doi: 10.1007/s00330-020-06817-6. Epub 2020 Mar 25.']",17/08/2020,https://clinicaltrials.gov/show/NCT04338568,30/11/2020,0,1
155,NCT04338698,Recruiting,01/09/2020,30/11/2020,No Results Posted,"['Akram J, Azhar S, Shahzad M, Latif W, Khan KS. Pakistan Randomized and Observational Trial to Evaluate Coronavirus Treatment (PROTECT) of Hydroxychloroquine, Oseltamivir and Azithromycin to treat newly diagnosed patients with COVID-19 infection who have no comorbidities like diabetes mellitus: A structured summary of a study protocol for a randomized controlled trial. Trials. 2020 Aug 8;21(1):702. doi: 10.1186/s13063-020-04616-4. Erratum in: Trials. 2020 Aug 22;21(1):733.']",,15/07/2020,https://clinicaltrials.gov/show/NCT04338698,01/09/2020,0,1
156,NCT04338802,Not yet recruiting,04/05/2020,01/08/2020,No Results Posted,,,08/04/2020,https://clinicaltrials.gov/show/NCT04338802,04/05/2020,0,0
157,NCT04338906,Withdrawn,01/12/2021,01/12/2021,No Results Posted,,,21/12/2020,https://clinicaltrials.gov/show/NCT04338906,01/12/2021,0,0
158,NCT04339660,Recruiting,30/06/2020,30/06/2020,No Results Posted,,,09/04/2020,https://clinicaltrials.gov/show/NCT04339660,30/06/2020,0,0
159,NCT04339816,Terminated,04/11/2020,04/11/2020,No Results Posted,"['Du≈°ka F, Waldauf P, Halaƒçov√° M, Zvon√≠ƒçek V, Bala J, Bal√≠k M, Bene≈° J, Klementov√° O, Koz√°kov√° I, Kubricht V, Le Roy A, Vymazal T, ≈òeho≈ôov√° V, ƒåern√Ω V; Czech Anaesthesia Clinical Trials and Audit Network. Azithromycin added to hydroxychloroquine for patients admitted to intensive care due to coronavirus disease 2019 (COVID-19)-protocol of randomised controlled trial AZIQUINE-ICU. Trials. 2020 Jul 8;21(1):631. doi: 10.1186/s13063-020-04566-x.']",,06/11/2020,https://clinicaltrials.gov/show/NCT04339816,04/11/2020,0,1
160,NCT04340050,Completed,23/12/2020,23/12/2020,No Results Posted,"['Piechotta V, Iannizzi C, Chai KL, Valk SJ, Kimber C, Dorando E, Monsef I, Wood EM, Lamikanra AA, Roberts DJ, McQuilten Z, So-Osman C, Estcourt LJ, Skoetz N. Convalescent plasma or hyperimmune immunoglobulin for people with COVID-19: a living systematic review. Cochrane Database Syst Rev. 2021 May 20;5:CD013600. doi: 10.1002/14651858.CD013600.pub4.', 'Chai KL, Valk SJ, Piechotta V, Kimber C, Monsef I, Doree C, Wood EM, Lamikanra AA, Roberts DJ, McQuilten Z, So-Osman C, Estcourt LJ, Skoetz N. Convalescent plasma or hyperimmune immunoglobulin for people with COVID-19: a living systematic review. Cochrane Database Syst Rev. 2020 Oct 12;10:CD013600. doi: 10.1002/14651858.CD013600.pub3. Update in: Cochrane Database Syst Rev. 2021 May 20;5:CD013600.']",,28/12/2020,https://clinicaltrials.gov/show/NCT04340050,23/12/2020,0,1
161,NCT04340414,Recruiting,15/08/2020,15/10/2020,No Results Posted,,,16/06/2020,https://clinicaltrials.gov/show/NCT04340414,15/08/2020,0,0
162,NCT04341038,Recruiting,01/06/2020,01/07/2020,No Results Posted,"['Solanich X, Antol√≠ A, Rocamora-Blanch G, Padull√©s N, Fanlo-Maresma M, Iriarte A, Mitjavila F, Capdevila O, Riera-Mestre A, Bas J, Vicens-Zygmunt V, Niub√≥ J, Calvo N, Bolivar S, Rigo-Bonnin R, Mensa-Vilar√≥ A, Arregui L, Tebe C, Videla S, Hereu P, Corbella X. Methylprednisolone Pulses Plus Tacrolimus in Addition to Standard of Care vs. Standard of Care Alone in Patients With Severe COVID-19. A Randomized Controlled Trial. Front Med (Lausanne). 2021 Jun 14;8:691712. doi: 10.3389/fmed.2021.691712. eCollection 2021.', 'Solanich X, Antol√≠ A, Padull√©s N, Fanlo-Maresma M, Iriarte A, Mitjavila F, Capdevila O, Molina M, Sabater J, Bas J, Mensa-Vilar√≥ A, Niub√≥ J, Calvo N, Bolivar S, Rigo-Bonnin R, Arregui L, Teb√© C, Hereu P, Videla S, Corbella X. Pragmatic, open-label, single-center, randomized, phase II clinical trial to evaluate the efficacy and safety of methylprednisolone pulses and tacrolimus in patients with severe pneumonia secondary to COVID-19: The TACROVID trial protocol. Contemp Clin Trials Commun. 2021 Mar;21:100716. doi: 10.1016/j.conctc.2021.100716. Epub 2021 Jan 19. Review.']",,10/04/2020,https://clinicaltrials.gov/show/NCT04341038,01/06/2020,0,1
163,NCT04341142,Recruiting,09/04/2023,09/04/2024,No Results Posted,"['Trouillet-Assant S, Albert Vega C, Bal A, Nazare JA, Fascia P, Paul A, Massardier-Pilonchery A, D Aubarede C, Guibert N, Pitiot V, Lahousse M, Boibieux A, Makhloufi D, Simon C, Rabilloud M, Trabaud MA, Gueyffier F, Fassier JB; COVID-SER study group. Assessment of serological techniques for screening patients for COVID-19 (COVID-SER): a prospective, multicentric study. BMJ Open. 2020 Nov 24;10(11):e041268. doi: 10.1136/bmjopen-2020-041268.']",,31/07/2020,https://clinicaltrials.gov/show/NCT04341142,09/04/2023,0,1
164,NCT04341207,Recruiting,01/04/2022,01/04/2022,No Results Posted,,,10/04/2020,https://clinicaltrials.gov/show/NCT04341207,01/04/2022,0,0
165,NCT04341389,"Active, not recruiting",31/01/2021,31/01/2021,No Results Posted,"['Zhu FC, Guan XH, Li YH, Huang JY, Jiang T, Hou LH, Li JX, Yang BF, Wang L, Wang WJ, Wu SP, Wang Z, Wu XH, Xu JJ, Zhang Z, Jia SY, Wang BS, Hu Y, Liu JJ, Zhang J, Qian XA, Li Q, Pan HX, Jiang HD, Deng P, Gou JB, Wang XW, Wang XH, Chen W. Immunogenicity and safety of a recombinant adenovirus type-5-vectored COVID-19 vaccine in healthy adults aged 18 years or older: a randomised, double-blind, placebo-controlled, phase 2 trial. Lancet. 2020 Aug 15;396(10249):479-488. doi: 10.1016/S0140-6736(20)31605-6. Epub 2020 Jul 20.']",,18/05/2020,https://clinicaltrials.gov/show/NCT04341389,31/01/2021,0,1
166,NCT04341610,Withdrawn,30/01/2021,30/04/2021,No Results Posted,,,27/05/2020,https://clinicaltrials.gov/show/NCT04341610,30/01/2021,0,0
167,NCT04341675,Recruiting,01/07/2020,01/09/2020,No Results Posted,,,20/05/2020,https://clinicaltrials.gov/show/NCT04341675,01/07/2020,0,0
168,NCT04341870,Suspended,08/05/2020,01/08/2020,No Results Posted,,,06/05/2020,https://clinicaltrials.gov/show/NCT04341870,08/05/2020,0,0
169,NCT04341922,"Active, not recruiting",20/08/2020,10/09/2021,No Results Posted,"['Wahlund T, Mataix-Cols D, Olofsdotter Lauri K, de Schipper E, Lj√≥tsson B, Aspvall K, Andersson E. Brief Online Cognitive Behavioural Intervention for Dysfunctional Worry Related to the COVID-19 Pandemic: A Randomised Controlled Trial. Psychother Psychosom. 2021;90(3):191-199. doi: 10.1159/000512843. Epub 2020 Nov 19.']",,19/10/2020,https://clinicaltrials.gov/show/NCT04341922,20/08/2020,0,1
170,NCT04342156,Withdrawn,01/08/2020,01/10/2020,No Results Posted,,,08/10/2020,https://clinicaltrials.gov/show/NCT04342156,01/08/2020,0,0
171,NCT04342169,Recruiting,01/04/2021,01/04/2022,No Results Posted,,,13/11/2020,https://clinicaltrials.gov/show/NCT04342169,01/04/2021,0,0
172,NCT04342182,"Active, not recruiting",01/07/2021,31/07/2021,No Results Posted,"['Piechotta V, Iannizzi C, Chai KL, Valk SJ, Kimber C, Dorando E, Monsef I, Wood EM, Lamikanra AA, Roberts DJ, McQuilten Z, So-Osman C, Estcourt LJ, Skoetz N. Convalescent plasma or hyperimmune immunoglobulin for people with COVID-19: a living systematic review. Cochrane Database Syst Rev. 2021 May 20;5:CD013600. doi: 10.1002/14651858.CD013600.pub4.', 'Chai KL, Valk SJ, Piechotta V, Kimber C, Monsef I, Doree C, Wood EM, Lamikanra AA, Roberts DJ, McQuilten Z, So-Osman C, Estcourt LJ, Skoetz N. Convalescent plasma or hyperimmune immunoglobulin for people with COVID-19: a living systematic review. Cochrane Database Syst Rev. 2020 Oct 12;10:CD013600. doi: 10.1002/14651858.CD013600.pub3. Update in: Cochrane Database Syst Rev. 2021 May 20;5:CD013600.']",,16/11/2020,https://clinicaltrials.gov/show/NCT04342182,01/07/2021,0,1
173,NCT04342650,Completed,14/05/2020,08/06/2020,No Results Posted,,,07/07/2020,https://clinicaltrials.gov/show/NCT04342650,14/05/2020,0,0
174,NCT04342897,Terminated,12/10/2020,12/10/2020,No Results Posted,,,29/10/2020,https://clinicaltrials.gov/show/NCT04342897,12/10/2020,0,0
175,NCT04343001,Withdrawn,01/04/2021,01/08/2021,No Results Posted,,,19/11/2020,https://clinicaltrials.gov/show/NCT04343001,01/04/2021,0,0
176,NCT04343092,Completed,31/05/2020,01/06/2020,Study Results,,,04/11/2020,https://clinicaltrials.gov/show/NCT04343092,31/05/2020,1,0
177,NCT04343144,Not yet recruiting,31/07/2020,30/09/2020,No Results Posted,,,14/04/2020,https://clinicaltrials.gov/show/NCT04343144,31/07/2020,0,0
178,NCT04343183,Not yet recruiting,01/06/2020,01/06/2020,No Results Posted,,,13/04/2020,https://clinicaltrials.gov/show/NCT04343183,01/06/2020,0,0
179,NCT04343261,Completed,23/07/2020,13/08/2020,Study Results,"['Piechotta V, Iannizzi C, Chai KL, Valk SJ, Kimber C, Dorando E, Monsef I, Wood EM, Lamikanra AA, Roberts DJ, McQuilten Z, So-Osman C, Estcourt LJ, Skoetz N. Convalescent plasma or hyperimmune immunoglobulin for people with COVID-19: a living systematic review. Cochrane Database Syst Rev. 2021 May 20;5:CD013600. doi: 10.1002/14651858.CD013600.pub4.', 'Chai KL, Valk SJ, Piechotta V, Kimber C, Monsef I, Doree C, Wood EM, Lamikanra AA, Roberts DJ, McQuilten Z, So-Osman C, Estcourt LJ, Skoetz N. Convalescent plasma or hyperimmune immunoglobulin for people with COVID-19: a living systematic review. Cochrane Database Syst Rev. 2020 Oct 12;10:CD013600. doi: 10.1002/14651858.CD013600.pub3. Update in: Cochrane Database Syst Rev. 2021 May 20;5:CD013600.', 'Ibrahim D, Dulipsingh L, Zapatka L, Eadie R, Crowell R, Williams K, Wakefield DB, Cook L, Puff J, Hussain SA. Factors Associated with Good Patient Outcomes Following Convalescent Plasma in COVID-19: A Prospective Phase II Clinical Trial. Infect Dis Ther. 2020 Sep 20:1-14. doi: 10.1007/s40121-020-00341-2. [Epub ahead of print]']","['Dulipsingh L, Ibrahim D, Schaefer EJ, Crowell R, Diffenderfer MR, Williams K, Lima C, McKenzie J, Cook L, Puff J, Onoroski M, Wakefield DB, Eadie RJ, Kleiboeker SB, Nabors P, Hussain SA. SARS-CoV-2 serology and virology trends in donors and recipients of convalescent plasma. Transfus Apher Sci. 2020 Dec;59(6):102922. doi: 10.1016/j.transci.2020.102922. Epub 2020 Aug 25.', 'Ibrahim D, Dulipsingh L, Zapatka L, Eadie R, Crowell R, Williams K, Wakefield DB, Cook L, Puff J, Hussain SA. Factors Associated with Good Patient Outcomes Following Convalescent Plasma in COVID-19: A Prospective Phase II Clinical Trial. Infect Dis Ther. 2020 Dec;9(4):913-926. doi: 10.1007/s40121-020-00341-2. Epub 2020 Sep 20.']",24/09/2020,https://clinicaltrials.gov/show/NCT04343261,23/07/2020,1,1
180,NCT04343651,"Active, not recruiting",21/07/2020,31/08/2020,No Results Posted,,,20/08/2020,https://clinicaltrials.gov/show/NCT04343651,21/07/2020,0,0
181,NCT04343690,Withdrawn,01/05/2020,01/05/2020,No Results Posted,,,23/09/2020,https://clinicaltrials.gov/show/NCT04343690,01/05/2020,0,0
182,NCT04343768,Completed,27/04/2020,27/04/2020,No Results Posted,"['Alavi Darazam I, Shokouhi S, Pourhoseingholi MA, Naghibi Irvani SS, Mokhtari M, Shabani M, Amirdosara M, Torabinavid P, Golmohammadi M, Hashemi S, Azimi A, Jafarazadeh Maivan MH, Rezaei O, Zali A, Hajiesmaeili M, Shabanpour Dehbsneh H, Hoseyni Kusha A, Taleb Shoushtari M, Khalili N, Soleymaninia A, Gachkar L, Khoshkar A. Role of interferon therapy in severe COVID-19: the COVIFERON randomized controlled trial. Sci Rep. 2021 Apr 13;11(1):8059. doi: 10.1038/s41598-021-86859-y.', 'Irvani SSN, Golmohammadi M, Pourhoseingholi MA, Shokouhi S, Darazam IA. Effectiveness of Interferon Beta 1a, compared to Interferon Beta 1b and the usual therapeutic regimen to treat adults with moderate to severe COVID-19: structured summary of a study protocol for a randomized controlled trial. Trials. 2020 Jun 3;21(1):473. doi: 10.1186/s13063-020-04382-3.']",,05/05/2020,https://clinicaltrials.gov/show/NCT04343768,27/04/2020,0,1
183,NCT04343794,Recruiting,31/12/2021,31/01/2022,No Results Posted,,,15/04/2020,https://clinicaltrials.gov/show/NCT04343794,31/12/2021,0,0
184,NCT04343963,Recruiting,30/09/2020,30/04/2021,No Results Posted,"['Fragoso-Saavedra S, Iruegas-Nunez DA, Quintero-Villegas A, Garc√≠a-Gonz√°lez HB, Nu√±ez I, Carbajal-Morelos SL, Audelo-Cruz BM, Arias-Mart√≠nez S, Caro-Vega Y, Calva JJ, Luque√±o-Mart√≠nez V, Gonz√°lez-Duarte A, Crabtree-Ram√≠rez B, Crisp√≠n JC, Sierra-Madero J, Belaunzar√°n-Zamudio PF, Vald√©s-Ferrer SI. A parallel-group, multicenter randomized, double-blinded, placebo-controlled, phase 2/3, clinical trial to test the efficacy of pyridostigmine bromide at low doses to reduce mortality or invasive mechanical ventilation in adults with severe SARS-CoV-2 infection: the Pyridostigmine In Severe COvid-19 (PISCO) trial protocol. BMC Infect Dis. 2020 Oct 16;20(1):765. doi: 10.1186/s12879-020-05485-7.']",,07/07/2020,https://clinicaltrials.gov/show/NCT04343963,30/09/2020,0,1
185,NCT04344106,Recruiting,15/04/2020,01/05/2020,Results Submitted,,,14/04/2020,https://clinicaltrials.gov/show/NCT04344106,15/04/2020,0,0
186,NCT04344210,Completed,20/09/2020,20/09/2020,No Results Posted,,,14/10/2020,https://clinicaltrials.gov/show/NCT04344210,20/09/2020,0,0
187,NCT04344288,Terminated,18/08/2020,18/08/2020,No Results Posted,,,26/10/2020,https://clinicaltrials.gov/show/NCT04344288,18/08/2020,0,0
188,NCT04344379,Suspended,30/06/2020,15/07/2020,No Results Posted,,,12/06/2020,https://clinicaltrials.gov/show/NCT04344379,30/06/2020,0,0
189,NCT04344431,Recruiting,01/04/2022,01/04/2022,No Results Posted,,,27/10/2020,https://clinicaltrials.gov/show/NCT04344431,01/04/2022,0,0
190,NCT04344444,"Active, not recruiting",10/04/2021,10/12/2021,No Results Posted,,,24/08/2020,https://clinicaltrials.gov/show/NCT04344444,10/04/2021,0,0
191,NCT04344457,Recruiting,20/06/2020,30/09/2020,No Results Posted,,,01/07/2020,https://clinicaltrials.gov/show/NCT04344457,20/06/2020,0,0
192,NCT04344600,Recruiting,01/06/2021,01/12/2021,No Results Posted,"['Lee JS, Shin EC. The type I interferon response in COVID-19: implications for treatment. Nat Rev Immunol. 2020 Oct;20(10):585-586. doi: 10.1038/s41577-020-00429-3.']",,20/08/2020,https://clinicaltrials.gov/show/NCT04344600,01/06/2021,0,1
193,NCT04344756,Not yet recruiting,31/07/2020,30/09/2020,No Results Posted,"['Flumignan RL, Tin√¥co JDS, Pascoal PI, Areias LL, Cossi MS, Fernandes MI, Costa IK, Souza L, Matar CF, Tendal B, Trevisani VF, Atallah √ÅN, Nakano LC. Prophylactic anticoagulants for people hospitalised with COVID-19. Cochrane Database Syst Rev. 2020 Oct 2;10:CD013739. doi: 10.1002/14651858.CD013739.']",,15/04/2020,https://clinicaltrials.gov/show/NCT04344756,31/07/2020,0,1
194,NCT04344782,Not yet recruiting,30/09/2020,30/11/2020,No Results Posted,,,17/04/2020,https://clinicaltrials.gov/show/NCT04344782,30/09/2020,0,0
195,NCT04344951,Recruiting,01/04/2021,30/04/2021,No Results Posted,,"['Arabi YM, Murthy S, Webb S. COVID-19: a novel coronavirus and a novel challenge for critical care. Intensive Care Med. 2020 May;46(5):833-836. doi: 10.1007/s00134-020-05955-1. Epub 2020 Mar 3. Erratum in: Intensive Care Med. 2020 Mar 18;:.', 'Devaux CA, Rolain JM, Colson P, Raoult D. New insights on the antiviral effects of chloroquine against coronavirus: what to expect for COVID-19? Int J Antimicrob Agents. 2020 May;55(5):105938. doi: 10.1016/j.ijantimicag.2020.105938. Epub 2020 Mar 12.', 'Gautret P, Lagier JC, Parola P, Hoang VT, Meddeb L, Mailhe M, Doudier B, Courjon J, Giordanengo V, Vieira VE, Tissot Dupont H, Honor√© S, Colson P, Chabri√®re E, La Scola B, Rolain JM, Brouqui P, Raoult D. Hydroxychloroquine and azithromycin as a treatment of COVID-19: results of an open-label non-randomized clinical trial. Int J Antimicrob Agents. 2020 Jul;56(1):105949. doi: 10.1016/j.ijantimicag.2020.105949. Epub 2020 Mar 20.']",02/06/2020,https://clinicaltrials.gov/show/NCT04344951,01/04/2021,0,1
196,NCT04345276,Completed,15/04/2020,15/04/2020,No Results Posted,,,02/06/2020,https://clinicaltrials.gov/show/NCT04345276,15/04/2020,0,0
197,NCT04345289,Recruiting,15/06/2021,15/06/2021,No Results Posted,,,31/07/2020,https://clinicaltrials.gov/show/NCT04345289,15/06/2021,0,0
198,NCT04345406,Not yet recruiting,01/12/2029,01/12/2029,No Results Posted,,,14/04/2020,https://clinicaltrials.gov/show/NCT04345406,01/12/2029,0,0
199,NCT04345445,Not yet recruiting,31/10/2020,31/10/2020,No Results Posted,,,14/04/2020,https://clinicaltrials.gov/show/NCT04345445,31/10/2020,0,0
200,NCT04345549,Completed,30/03/2020,30/03/2020,No Results Posted,,,14/04/2020,https://clinicaltrials.gov/show/NCT04345549,30/03/2020,0,0
201,NCT04345692,Terminated,31/08/2020,31/08/2020,No Results Posted,,,17/11/2020,https://clinicaltrials.gov/show/NCT04345692,31/08/2020,0,0
202,NCT04345861,Terminated,08/06/2020,08/06/2020,No Results Posted,,,11/06/2020,https://clinicaltrials.gov/show/NCT04345861,08/06/2020,0,0
203,NCT04345887,Not yet recruiting,21/07/2020,21/10/2020,No Results Posted,,,15/04/2020,https://clinicaltrials.gov/show/NCT04345887,21/07/2020,0,0
204,NCT04345991,Recruiting,15/05/2020,01/06/2020,No Results Posted,,,20/05/2020,https://clinicaltrials.gov/show/NCT04345991,15/05/2020,0,0
205,NCT04346017,Recruiting,01/12/2020,01/12/2020,No Results Posted,,,15/04/2020,https://clinicaltrials.gov/show/NCT04346017,01/12/2020,0,0
206,NCT04346082,Not yet recruiting,30/07/2021,30/07/2021,No Results Posted,,,15/07/2020,https://clinicaltrials.gov/show/NCT04346082,30/07/2021,0,0
207,NCT04346355,Terminated,06/06/2020,06/06/2020,No Results Posted,"['Salvarani C, Dolci G, Massari M, Merlo DF, Cavuto S, Savoldi L, Bruzzi P, Boni F, Braglia L, Turr√† C, Ballerini PF, Sciascia R, Zammarchi L, Para O, Scotton PG, Inojosa WO, Ravagnani V, Salerno ND, Sainaghi PP, Brignone A, Codeluppi M, Teopompi E, Milesi M, Bertomoro P, Claudio N, Salio M, Falcone M, Cenderello G, Donghi L, Del Bono V, Colombelli PL, Angheben A, Passaro A, Secondo G, Pascale R, Piazza I, Facciolongo N, Costantini M; RCT-TCZ-COVID-19 Study Group. Effect of Tocilizumab vs Standard Care on Clinical Worsening in Patients Hospitalized With COVID-19 Pneumonia: A Randomized Clinical Trial. JAMA Intern Med. 2021 Jan 1;181(1):24-31. doi: 10.1001/jamainternmed.2020.6615.']",,22/06/2020,https://clinicaltrials.gov/show/NCT04346355,06/06/2020,0,1
208,NCT04346368,Not yet recruiting,01/12/2020,01/12/2020,No Results Posted,,,15/04/2020,https://clinicaltrials.gov/show/NCT04346368,01/12/2020,0,0
209,NCT04346420,Completed,01/05/2020,01/05/2020,No Results Posted,,,09/06/2020,https://clinicaltrials.gov/show/NCT04346420,01/05/2020,0,0
210,NCT04346446,Completed,30/05/2020,30/05/2020,No Results Posted,"['Piechotta V, Iannizzi C, Chai KL, Valk SJ, Kimber C, Dorando E, Monsef I, Wood EM, Lamikanra AA, Roberts DJ, McQuilten Z, So-Osman C, Estcourt LJ, Skoetz N. Convalescent plasma or hyperimmune immunoglobulin for people with COVID-19: a living systematic review. Cochrane Database Syst Rev. 2021 May 20;5:CD013600. doi: 10.1002/14651858.CD013600.pub4.']",,12/06/2020,https://clinicaltrials.gov/show/NCT04346446,30/05/2020,0,1
211,NCT04346589,Recruiting,01/08/2020,01/08/2020,No Results Posted,,,09/06/2020,https://clinicaltrials.gov/show/NCT04346589,01/08/2020,0,0
212,NCT04346797,Recruiting,30/09/2020,31/12/2020,No Results Posted,,,27/04/2020,https://clinicaltrials.gov/show/NCT04346797,30/09/2020,0,0
213,NCT04346953,Not yet recruiting,01/10/2020,30/11/2020,No Results Posted,,,21/07/2020,https://clinicaltrials.gov/show/NCT04346953,01/10/2020,0,0
214,NCT04347226,Recruiting,01/09/2021,01/09/2022,No Results Posted,,,08/10/2020,https://clinicaltrials.gov/show/NCT04347226,01/09/2021,0,0
215,NCT04347382,Completed,30/08/2020,30/08/2020,No Results Posted,,,12/11/2020,https://clinicaltrials.gov/show/NCT04347382,30/08/2020,0,0
216,NCT04347512,Withdrawn,02/06/2020,02/06/2020,No Results Posted,,,04/06/2020,https://clinicaltrials.gov/show/NCT04347512,02/06/2020,0,0
217,NCT04347681,Recruiting,31/12/2020,11/04/2021,No Results Posted,"['AlShehry N, Zaidi SZA, AlAskar A, Al Odayani A, Alotaibi JM, AlSagheir A, Al-Eyadhy A, Balelah S, Salam A, Zaidi ARZ, Alawami D, Alshahrani MS, AlMozain N, Abulhamayel YM, Al Qunfoidi R, Alfaraj M, Qushmaq N, Alansari R, Dayel A, Elgohary G, Al Bahrani A, Nabhan Abdelhameed AA, AlZahrani HA, Alturkistani H, AlShehry N, Albalawi MA, Elalfy I, Alhumaidan H, Al-Hashmi H; KSA COVID-19 Convalescent Plasma Study Group. Safety and Efficacy of Convalescent Plasma for Severe COVID-19: Interim Report of a Multicenter Phase II Study from Saudi Arabia. Saudi J Med Med Sci. 2021 Jan-Apr;9(1):16-23. doi: 10.4103/sjmms.sjmms_731_20. Epub 2020 Dec 26. Erratum in: Saudi J Med Med Sci. 2021 May-Aug;9(2):199.', 'Albalawi M, Zaidi SZA, AlShehry N, AlAskar A, Zaidi ARZ, Abdallah RNM, Salam A, AlSagheir A, AlMozain N, Elgohary G, Batarfi K, Alfaraedi A, Khojah O, Al-Ansari R, Alfaraj M, Dayel A, Al Bahrani A, Abdelhameed AN, Alhumaidan H, Al-Otaibi JM, Radwi G, Raizah A, Shatry H, Alsaleh S, AlZahrani H, Al-Hashmi H. Safety and Efficacy of Convalescent Plasma to Treat Severe COVID-19: Protocol for the Saudi Collaborative Multicenter Phase II Study. JMIR Res Protoc. 2020 Oct 2;9(10):e23543. doi: 10.2196/23543.']",,11/08/2020,https://clinicaltrials.gov/show/NCT04347681,31/12/2020,0,1
218,NCT04347889,Withdrawn,30/12/2020,30/12/2020,No Results Posted,,,02/11/2020,https://clinicaltrials.gov/show/NCT04347889,30/12/2020,0,0
219,NCT04347941,Recruiting,11/06/2021,11/09/2021,No Results Posted,"['Tavernier E, McNicholas B, Pavlov I, Roca O, Perez Y, Laffey J, Mirza S, Cosgrave D, Vines D, Frat JP, Ehrmann S, Li J. Awake prone positioning of hypoxaemic patients with COVID-19: protocol for a randomised controlled open-label superiority meta-trial. BMJ Open. 2020 Nov 11;10(11):e041520. doi: 10.1136/bmjopen-2020-041520.']",,13/08/2020,https://clinicaltrials.gov/show/NCT04347941,11/06/2021,0,1
220,NCT04347980,Recruiting,01/06/2020,01/08/2020,No Results Posted,,,17/04/2020,https://clinicaltrials.gov/show/NCT04347980,01/06/2020,0,0
221,NCT04348370,Recruiting,01/05/2021,01/11/2021,No Results Posted,,,27/05/2020,https://clinicaltrials.gov/show/NCT04348370,01/05/2021,0,0
222,NCT04348409,Recruiting,31/07/2020,31/07/2020,No Results Posted,"['Blum VF, Cimerman S, Hunter JR, Tierno P, Lacerda A, Soeiro A, Cardoso F, Bellei NC, Maricato J, Mantovani N, Vassao M, Dias D, Galinskas J, Janini LMR, Santos-Oliveira JR, Da-Cruz AM, Diaz RS. Nitazoxanide superiority to placebo to treat moderate COVID-19 - A Pilot prove of concept randomized double-blind clinical trial. EClinicalMedicine. 2021 Jun 27:100981. doi: 10.1016/j.eclinm.2021.100981. [Epub ahead of print]']",,09/06/2020,https://clinicaltrials.gov/show/NCT04348409,31/07/2020,0,1
223,NCT04348474,Suspended,30/06/2020,31/07/2020,No Results Posted,,,22/04/2020,https://clinicaltrials.gov/show/NCT04348474,30/06/2020,0,0
224,NCT04348513,Recruiting,02/05/2021,31/05/2021,No Results Posted,"['Pantos C, Apostolaki V, Kokkinos L, Trikas A, Mourouzis I. Acute triiodothyronine treatment and red blood cell sedimentation rate (ESR) in critically ill COVID-19 patients: A novel association? Clin Hemorheol Microcirc. 2021 Jun 11. doi: 10.3233/CH-211215. [Epub ahead of print]', 'Pantos C, Kostopanagiotou G, Armaganidis A, Trikas A, Tseti I, Mourouzis I. Triiodothyronine for the treatment of critically ill patients with COVID-19 infection: A structured summary of a study protocol for a randomised controlled trial. Trials. 2020 Jun 26;21(1):573. doi: 10.1186/s13063-020-04474-0.']",,02/06/2020,https://clinicaltrials.gov/show/NCT04348513,02/05/2021,0,1
225,NCT04348695,Recruiting,13/05/2020,13/05/2020,No Results Posted,"['Sultana J, Crisafulli S, Gabbay F, Lynn E, Shakir S, Trifir√≤ G. Challenges for Drug Repurposing in the COVID-19 Pandemic Era. Front Pharmacol. 2020 Nov 6;11:588654. doi: 10.3389/fphar.2020.588654. eCollection 2020. Review.']",,17/04/2020,https://clinicaltrials.gov/show/NCT04348695,13/05/2020,0,1
226,NCT04348877,Not yet recruiting,01/10/2020,01/12/2020,No Results Posted,,,20/04/2020,https://clinicaltrials.gov/show/NCT04348877,01/10/2020,0,0
227,NCT04348929,Recruiting,16/08/2021,01/10/2021,No Results Posted,"['Bertholdt C, Epstein J, Banasiak C, Ligier F, Dahlhoff S, Olieric MF, Mottet N, Beaumont M, Morel O. Birth experience during COVID-19 confinement (CONFINE): protocol for a multicentre prospective study. BMJ Open. 2020 Dec 10;10(12):e043057. doi: 10.1136/bmjopen-2020-043057.']",,05/10/2020,https://clinicaltrials.gov/show/NCT04348929,16/08/2021,0,1
228,NCT04349098,Completed,05/10/2020,05/10/2020,No Results Posted,,,24/12/2020,https://clinicaltrials.gov/show/NCT04349098,05/10/2020,0,0
229,NCT04349228,Withdrawn,15/07/2020,15/07/2020,No Results Posted,,,28/08/2020,https://clinicaltrials.gov/show/NCT04349228,15/07/2020,0,0
230,NCT04349241,Completed,01/06/2020,20/06/2020,No Results Posted,,,25/06/2020,https://clinicaltrials.gov/show/NCT04349241,01/06/2020,0,0
231,NCT04349410,Completed,14/09/2020,14/09/2020,No Results Posted,,,12/11/2020,https://clinicaltrials.gov/show/NCT04349410,14/09/2020,0,0
232,NCT04350086,Withdrawn,20/11/2020,20/11/2020,No Results Posted,,,02/09/2020,https://clinicaltrials.gov/show/NCT04350086,20/11/2020,0,0
233,NCT04350281,Completed,01/07/2020,07/07/2020,No Results Posted,,,28/07/2020,https://clinicaltrials.gov/show/NCT04350281,01/07/2020,0,0
234,NCT04350450,Withdrawn,01/08/2020,01/08/2020,No Results Posted,,,27/05/2020,https://clinicaltrials.gov/show/NCT04350450,01/08/2020,0,0
235,NCT04350476,Withdrawn,01/05/2020,01/05/2020,No Results Posted,,,20/08/2020,https://clinicaltrials.gov/show/NCT04350476,01/05/2020,0,0
236,NCT04350671,Enrolling by invitation,20/04/2020,24/04/2020,No Results Posted,,,20/04/2020,https://clinicaltrials.gov/show/NCT04350671,20/04/2020,0,0
237,NCT04350684,Enrolling by invitation,22/04/2020,24/04/2020,No Results Posted,,,20/04/2020,https://clinicaltrials.gov/show/NCT04350684,22/04/2020,0,0
238,NCT04350723,Recruiting,30/07/2021,30/08/2021,No Results Posted,"['Alhazzani W, Evans L, Alshamsi F, M√∏ller MH, Ostermann M, Prescott HC, Arabi YM, Loeb M, Ng Gong M, Fan E, Oczkowski S, Levy MM, Derde L, Dzierba A, Du B, Machado F, Wunsch H, Crowther M, Cecconi M, Koh Y, Burry L, Chertow DS, Szczeklik W, Belley-Cote E, Greco M, Bala M, Zarychanski R, Kesecioglu J, McGeer A, Mermel L, Mammen MJ, Nainan Myatra S, Arrington A, Kleinpell R, Citerio G, Lewis K, Bridges E, Memish ZA, Hammond N, Hayden FG, Alshahrani M, Al Duhailib Z, Martin GS, Kaplan LJ, Coopersmith CM, Antonelli M, Rhodes A. Surviving Sepsis Campaign Guidelines on the Management of Adults With Coronavirus Disease 2019 (COVID-19) in the ICU: First Update. Crit Care Med. 2021 Mar 1;49(3):e219-e234. doi: 10.1097/CCM.0000000000004899.']",,22/10/2020,https://clinicaltrials.gov/show/NCT04350723,30/07/2021,0,1
239,NCT04350736,Completed,24/06/2020,01/07/2020,No Results Posted,,,01/07/2021,https://clinicaltrials.gov/show/NCT04350736,24/06/2020,0,0
240,NCT04350931,Not yet recruiting,01/10/2020,01/12/2020,No Results Posted,,,20/04/2020,https://clinicaltrials.gov/show/NCT04350931,01/10/2020,0,0
241,NCT04351295,Recruiting,01/12/2020,01/12/2020,No Results Posted,"['Dabbous HM, Abd-Elsalam S, El-Sayed MH, Sherief AF, Ebeid FFS, El Ghafar MSA, Soliman S, Elbahnasawy M, Badawi R, Tageldin MA. Efficacy of favipiravir in COVID-19 treatment: a multi-center randomized study. Arch Virol. 2021 Mar;166(3):949-954. doi: 10.1007/s00705-021-04956-9. Epub 2021 Jan 25.']",,29/09/2020,https://clinicaltrials.gov/show/NCT04351295,01/12/2020,0,1
242,NCT04351542,Completed,06/04/2020,12/04/2020,No Results Posted,,,17/04/2020,https://clinicaltrials.gov/show/NCT04351542,06/04/2020,0,0
243,NCT04351620,Recruiting,01/06/2020,01/06/2020,No Results Posted,,,17/04/2020,https://clinicaltrials.gov/show/NCT04351620,01/06/2020,0,0
244,NCT04351763,Recruiting,02/03/2021,10/04/2021,No Results Posted,,,17/04/2020,https://clinicaltrials.gov/show/NCT04351763,02/03/2021,0,0
245,NCT04351789,Recruiting,01/04/2023,01/04/2023,No Results Posted,,,24/08/2020,https://clinicaltrials.gov/show/NCT04351789,01/04/2023,0,0
246,NCT04351906,Recruiting,01/06/2021,01/10/2021,No Results Posted,"['Husain-Syed F, Birk HW, Wilhelm J, Ronco C, Ranieri VM, Karle B, Kuhnert S, Tello K, Hecker M, Morty RE, Herold S, Kehl O, Walmrath HD, Seeger W, Vad√°sz I. Extracorporeal Carbon Dioxide Removal Using a Renal Replacement Therapy Platform to Enhance Lung-Protective Ventilation in Hypercapnic Patients With Coronavirus Disease 2019-Associated Acute Respiratory Distress Syndrome. Front Med (Lausanne). 2020 Nov 12;7:598379. doi: 10.3389/fmed.2020.598379. eCollection 2020.']","['Schmidt M, Jaber S, Zogheib E, Godet T, Capellier G, Combes A. Feasibility and safety of low-flow extracorporeal CO(2) removal managed with a renal replacement platform to enhance lung-protective ventilation of patients with mild-to-moderate ARDS. Crit Care. 2018 May 10;22(1):122. doi: 10.1186/s13054-018-2038-5.']",30/09/2020,https://clinicaltrials.gov/show/NCT04351906,01/06/2021,0,1
247,NCT04351919,Withdrawn,15/07/2020,15/07/2020,No Results Posted,,,28/08/2020,https://clinicaltrials.gov/show/NCT04351919,15/07/2020,0,0
248,NCT04352465,Not yet recruiting,30/06/2020,30/11/2020,No Results Posted,,,29/04/2020,https://clinicaltrials.gov/show/NCT04352465,30/06/2020,0,0
249,NCT04352608,"Active, not recruiting",10/07/2020,13/12/2020,No Results Posted,"['Zhang Y, Zeng G, Pan H, Li C, Hu Y, Chu K, Han W, Chen Z, Tang R, Yin W, Chen X, Hu Y, Liu X, Jiang C, Li J, Yang M, Song Y, Wang X, Gao Q, Zhu F. Safety, tolerability, and immunogenicity of an inactivated SARS-CoV-2 vaccine in healthy adults aged 18-59 years: a randomised, double-blind, placebo-controlled, phase 1/2 clinical trial. Lancet Infect Dis. 2021 Feb;21(2):181-192. doi: 10.1016/S1473-3099(20)30843-4. Epub 2020 Nov 17.']",,04/08/2020,https://clinicaltrials.gov/show/NCT04352608,10/07/2020,0,1
250,NCT04352751,Recruiting,01/04/2021,01/04/2021,No Results Posted,,,29/09/2020,https://clinicaltrials.gov/show/NCT04352751,01/04/2021,0,0
251,NCT04352803,Not yet recruiting,01/04/2024,01/04/2026,No Results Posted,,,21/04/2020,https://clinicaltrials.gov/show/NCT04352803,01/04/2024,0,0
252,NCT04352933,Recruiting,31/10/2020,01/04/2021,No Results Posted,,,13/05/2020,https://clinicaltrials.gov/show/NCT04352933,31/10/2020,0,0
253,NCT04352946,Not yet recruiting,24/06/2020,24/08/2020,No Results Posted,,,22/04/2020,https://clinicaltrials.gov/show/NCT04352946,24/06/2020,0,0
254,NCT04353128,Recruiting,01/10/2020,01/12/2020,No Results Posted,,,16/06/2020,https://clinicaltrials.gov/show/NCT04353128,01/10/2020,0,0
255,NCT04353206,Recruiting,01/05/2021,01/05/2021,No Results Posted,,,15/07/2020,https://clinicaltrials.gov/show/NCT04353206,01/05/2021,0,0
256,NCT04353271,Terminated,08/07/2020,08/07/2020,No Results Posted,,,20/08/2020,https://clinicaltrials.gov/show/NCT04353271,08/07/2020,0,0
257,NCT04353284,Recruiting,31/05/2021,31/05/2021,No Results Posted,,,24/11/2020,https://clinicaltrials.gov/show/NCT04353284,31/05/2021,0,0
258,NCT04353518,Recruiting,30/03/2021,30/05/2021,No Results Posted,,,22/12/2020,https://clinicaltrials.gov/show/NCT04353518,30/03/2021,0,0
259,NCT04354389,Withdrawn,30/09/2020,30/11/2020,No Results Posted,,,11/08/2020,https://clinicaltrials.gov/show/NCT04354389,30/09/2020,0,0
260,NCT04354428,"Active, not recruiting",01/12/2020,01/01/2021,No Results Posted,"['Johnston C, Brown ER, Stewart J, Karita HCS, Kissinger PJ, Dwyer J, Hosek S, Oyedele T, Paasche-Orlow MK, Paolino K, Heller KB, Leingang H, Haugen HS, Dong TQ, Bershteyn A, Sridhar AR, Poole J, Noseworthy PA, Ackerman MJ, Morrison S, Greninger AL, Huang ML, Jerome KR, Wener MH, Wald A, Schiffer JT, Celum C, Chu HY, Barnabas RV, Baeten JM; COVID-19 Early Treatment Study Team. Hydroxychloroquine with or without azithromycin for treatment of early SARS-CoV-2 infection among high-risk outpatient adults: A randomized clinical trial. EClinicalMedicine. 2021 Mar;33:100773. doi: 10.1016/j.eclinm.2021.100773. Epub 2021 Feb 27.']",,12/11/2020,https://clinicaltrials.gov/show/NCT04354428,01/12/2020,0,1
261,NCT04354441,Withdrawn,01/05/2020,01/05/2020,No Results Posted,,,25/06/2020,https://clinicaltrials.gov/show/NCT04354441,01/05/2020,0,0
262,NCT04354597,Not yet recruiting,15/08/2020,15/10/2020,No Results Posted,,,05/05/2020,https://clinicaltrials.gov/show/NCT04354597,15/08/2020,0,0
263,NCT04354714,Withdrawn,31/07/2021,31/12/2021,No Results Posted,,,21/05/2020,https://clinicaltrials.gov/show/NCT04354714,31/07/2021,0,0
264,NCT04354805,Not yet recruiting,01/10/2020,01/11/2020,No Results Posted,,,08/07/2020,https://clinicaltrials.gov/show/NCT04354805,01/10/2020,0,0
265,NCT04355026,Recruiting,30/06/2020,31/07/2020,No Results Posted,,,21/04/2020,https://clinicaltrials.gov/show/NCT04355026,30/06/2020,0,0
266,NCT04355052,Recruiting,11/10/2020,11/12/2020,No Results Posted,,,21/04/2020,https://clinicaltrials.gov/show/NCT04355052,11/10/2020,0,0
267,NCT04355247,Recruiting,31/07/2020,30/04/2021,No Results Posted,,,21/04/2020,https://clinicaltrials.gov/show/NCT04355247,31/07/2020,0,0
268,NCT04355351,Recruiting,22/10/2020,22/10/2020,No Results Posted,,,12/06/2020,https://clinicaltrials.gov/show/NCT04355351,22/10/2020,0,0
269,NCT04355429,Not yet recruiting,01/07/2020,01/08/2020,No Results Posted,,"['Guan WJ, Ni ZY, Hu Y, Liang WH, Ou CQ, He JX, Liu L, Shan H, Lei CL, Hui DSC, Du B, Li LJ, Zeng G, Yuen KY, Chen RC, Tang CL, Wang T, Chen PY, Xiang J, Li SY, Wang JL, Liang ZJ, Peng YX, Wei L, Liu Y, Hu YH, Peng P, Wang JM, Liu JY, Chen Z, Li G, Zheng ZJ, Qiu SQ, Luo J, Ye CJ, Zhu SY, Zhong NS; China Medical Treatment Expert Group for Covid-19. Clinical Characteristics of Coronavirus Disease 2019 in China. N Engl J Med. 2020 Apr 30;382(18):1708-1720. doi: 10.1056/NEJMoa2002032. Epub 2020 Feb 28.', 'Li F, Li W, Farzan M, Harrison SC. Structure of SARS coronavirus spike receptor-binding domain complexed with receptor. Science. 2005 Sep 16;309(5742):1864-8.', 'Imai Y, Kuba K, Rao S, Huan Y, Guo F, Guan B, Yang P, Sarao R, Wada T, Leong-Poi H, Crackower MA, Fukamizu A, Hui CC, Hein L, Uhlig S, Slutsky AS, Jiang C, Penninger JM. Angiotensin-converting enzyme 2 protects from severe acute lung failure. Nature. 2005 Jul 7;436(7047):112-6.', 'Zhang H, Penninger JM, Li Y, Zhong N, Slutsky AS. Angiotensin-converting enzyme 2 (ACE2) as a SARS-CoV-2 receptor: molecular mechanisms and potential therapeutic target. Intensive Care Med. 2020 Apr;46(4):586-590. doi: 10.1007/s00134-020-05985-9. Epub 2020 Mar 3.']",28/04/2020,https://clinicaltrials.gov/show/NCT04355429,01/07/2020,0,1
270,NCT04355754,Recruiting,01/05/2020,31/12/2020,No Results Posted,,,27/04/2020,https://clinicaltrials.gov/show/NCT04355754,01/05/2020,0,0
271,NCT04355897,Recruiting,01/07/2020,01/08/2020,No Results Posted,,,20/05/2020,https://clinicaltrials.gov/show/NCT04355897,01/07/2020,0,0
272,NCT04355936,Completed,02/11/2020,30/11/2020,No Results Posted,"['Duarte M, Pelorosso F, Nicolosi LN, Victoria Salgado M, Vetulli H, Aquieri A, Azzato F, Castro M, Coyle J, Davolos I, Criado IF, Gregori R, Mastrodonato P, Rubio MC, Sarquis S, Wahlmann F, Rothlin RP. Telmisartan for treatment of Covid-19 patients: An open multicenter randomized clinical trial. EClinicalMedicine. 2021 Jun 18;37:100962. doi: 10.1016/j.eclinm.2021.100962. eCollection 2021 Jul.', 'Rothlin RP, Vetulli HM, Duarte M, Pelorosso FG. Telmisartan as tentative angiotensin receptor blocker therapeutic for COVID-19. Drug Dev Res. 2020 Nov;81(7):768-770. doi: 10.1002/ddr.21679. Epub 2020 May 1.']",,24/12/2020,https://clinicaltrials.gov/show/NCT04355936,02/11/2020,0,1
273,NCT04356482,Recruiting,01/11/2020,01/12/2020,No Results Posted,,"['Ruan Q, Yang K, Wang W, Jiang L, Song J. Clinical predictors of mortality due to COVID-19 based on an analysis of data of 150 patients from Wuhan, China. Intensive Care Med. 2020 May;46(5):846-848. doi: 10.1007/s00134-020-05991-x. Epub 2020 Mar 3. Erratum in: Intensive Care Med. 2020 Apr 6;:.', 'Rajam G, Sampson J, Carlone GM, Ades EW. An augmented passive immune therapy to treat fulminant bacterial infections. Recent Pat Antiinfect Drug Discov. 2010 Jun;5(2):157-67. Review.', 'Keller MA, Stiehm ER. Passive immunity in prevention and treatment of infectious diseases. Clin Microbiol Rev. 2000 Oct;13(4):602-14. Review.', 'Burnouf T, Seghatchian J. Ebola virus convalescent blood products: where we are now and where we may need to go. Transfus Apher Sci. 2014 Oct;51(2):120-5. Review.', 'Jahrling PB, Frame JD, Rhoderick JB, Monson MH. Endemic Lassa fever in Liberia. IV. Selection of optimally effective plasma for treatment by passive immunization. Trans R Soc Trop Med Hyg. 1985;79(3):380-4.', 'Shen C, Wang Z, Zhao F, Yang Y, Li J, Yuan J, Wang F, Li D, Yang M, Xing L, Wei J, Xiao H, Yang Y, Qu J, Qing L, Chen L, Xu Z, Peng L, Li Y, Zheng H, Chen F, Huang K, Jiang Y, Liu D, Zhang Z, Liu Y, Liu L. Treatment of 5 Critically Ill Patients With COVID-19 With Convalescent Plasma. JAMA. 2020 Apr 28;323(16):1582-1589. doi: 10.1001/jama.2020.4783.']",05/06/2020,https://clinicaltrials.gov/show/NCT04356482,01/11/2020,0,1
274,NCT04356508,Not yet recruiting,30/06/2020,31/08/2021,No Results Posted,,,22/04/2020,https://clinicaltrials.gov/show/NCT04356508,30/06/2020,0,0
275,NCT04356534,Completed,15/06/2020,09/07/2020,No Results Posted,"['Piechotta V, Iannizzi C, Chai KL, Valk SJ, Kimber C, Dorando E, Monsef I, Wood EM, Lamikanra AA, Roberts DJ, McQuilten Z, So-Osman C, Estcourt LJ, Skoetz N. Convalescent plasma or hyperimmune immunoglobulin for people with COVID-19: a living systematic review. Cochrane Database Syst Rev. 2021 May 20;5:CD013600. doi: 10.1002/14651858.CD013600.pub4.', 'AlQahtani M, Abdulrahman A, Almadani A, Alali SY, Al Zamrooni AM, Hejab AH, Conroy RM, Wasif P, Otoom S, Atkin SL, Abduljalil M. Randomized controlled trial of convalescent plasma therapy against standard therapy in patients with severe COVID-19 disease. Sci Rep. 2021 May 11;11(1):9927. doi: 10.1038/s41598-021-89444-5.']",,28/07/2020,https://clinicaltrials.gov/show/NCT04356534,15/06/2020,0,1
276,NCT04356937,Completed,13/07/2020,27/08/2020,Results Submitted,"[""Stone JH, Frigault MJ, Serling-Boyd NJ, Fernandes AD, Harvey L, Foulkes AS, Horick NK, Healy BC, Shah R, Bensaci AM, Woolley AE, Nikiforow S, Lin N, Sagar M, Schrager H, Huckins DS, Axelrod M, Pincus MD, Fleisher J, Sacks CA, Dougan M, North CM, Halvorsen YD, Thurber TK, Dagher Z, Scherer A, Wallwork RS, Kim AY, Schoenfeld S, Sen P, Neilan TG, Perugino CA, Unizony SH, Collier DS, Matza MA, Yinh JM, Bowman KA, Meyerowitz E, Zafar A, Drobni ZD, Bolster MB, Kohler M, D'Silva KM, Dau J, Lockwood MM, Cubbison C, Weber BN, Mansour MK; BACC Bay Tocilizumab Trial Investigators. Efficacy of Tocilizumab in Patients Hospitalized with Covid-19. N Engl J Med. 2020 Dec 10;383(24):2333-2344. doi: 10.1056/NEJMoa2028836. Epub 2020 Oct 21.""]",,16/12/2020,https://clinicaltrials.gov/show/NCT04356937,13/07/2020,0,1
277,NCT04357028,Suspended,31/12/2020,01/01/2021,No Results Posted,,,22/12/2020,https://clinicaltrials.gov/show/NCT04357028,31/12/2020,0,0
278,NCT04357106,Recruiting,01/07/2020,01/08/2020,No Results Posted,"['Piechotta V, Iannizzi C, Chai KL, Valk SJ, Kimber C, Dorando E, Monsef I, Wood EM, Lamikanra AA, Roberts DJ, McQuilten Z, So-Osman C, Estcourt LJ, Skoetz N. Convalescent plasma or hyperimmune immunoglobulin for people with COVID-19: a living systematic review. Cochrane Database Syst Rev. 2021 May 20;5:CD013600. doi: 10.1002/14651858.CD013600.pub4.', 'Chai KL, Valk SJ, Piechotta V, Kimber C, Monsef I, Doree C, Wood EM, Lamikanra AA, Roberts DJ, McQuilten Z, So-Osman C, Estcourt LJ, Skoetz N. Convalescent plasma or hyperimmune immunoglobulin for people with COVID-19: a living systematic review. Cochrane Database Syst Rev. 2020 Oct 12;10:CD013600. doi: 10.1002/14651858.CD013600.pub3. Update in: Cochrane Database Syst Rev. 2021 May 20;5:CD013600.']",,22/04/2020,https://clinicaltrials.gov/show/NCT04357106,01/07/2020,0,1
279,NCT04357327,Completed,31/05/2020,31/07/2020,No Results Posted,,,04/11/2020,https://clinicaltrials.gov/show/NCT04357327,31/05/2020,0,0
280,NCT04357340,Completed,30/04/2020,30/05/2020,No Results Posted,,,02/06/2020,https://clinicaltrials.gov/show/NCT04357340,30/04/2020,0,0
281,NCT04357613,Not yet recruiting,01/12/2020,01/12/2021,No Results Posted,"['Zhao H, Mendenhall M, Deininger MW. Imatinib is not a potent anti-SARS-CoV-2 drug. Leukemia. 2020 Nov;34(11):3085-3087. doi: 10.1038/s41375-020-01045-9. Epub 2020 Sep 30.']",,07/08/2020,https://clinicaltrials.gov/show/NCT04357613,01/12/2020,0,1
282,NCT04357782,Completed,13/10/2020,13/10/2020,No Results Posted,,,23/12/2020,https://clinicaltrials.gov/show/NCT04357782,13/10/2020,0,0
283,NCT04357860,Completed,09/03/2021,06/04/2021,No Results Posted,"['Le√≥n L√≥pez R, Fern√°ndez SC, Limia P√©rez L, Romero Palacios A, Fern√°ndez-Rold√°n MC, Aguilar Alonso E, P√©rez Camacho I, Rodriguez-Ba√±o J, Merchante N, Olalla J, Esteban-Moreno M√Å, Santos M, Luque-Pineda A, Torre-Cisneros J. Efficacy and safety of early treatment with sarilumab in hospitalised adults with COVID-19 presenting cytokine release syndrome (SARICOR STUDY): protocol of a phase II, open-label, randomised, multicentre, controlled clinical trial. BMJ Open. 2020 Nov 14;10(11):e039951. doi: 10.1136/bmjopen-2020-039951.']",,07/07/2021,https://clinicaltrials.gov/show/NCT04357860,09/03/2021,0,1
284,NCT04357990,Recruiting,01/03/2021,01/03/2021,No Results Posted,,,17/09/2020,https://clinicaltrials.gov/show/NCT04357990,01/03/2021,0,0
285,NCT04358614,Completed,05/04/2020,07/04/2020,No Results Posted,,,24/04/2020,https://clinicaltrials.gov/show/NCT04358614,05/04/2020,0,0
286,NCT04358809,Recruiting,28/02/2021,30/04/2021,No Results Posted,,,22/12/2020,https://clinicaltrials.gov/show/NCT04358809,28/02/2021,0,0
287,NCT04358835,Withdrawn,01/09/2021,31/12/2021,No Results Posted,,,25/08/2020,https://clinicaltrials.gov/show/NCT04358835,01/09/2021,0,0
288,NCT04359251,Completed,25/03/2020,25/03/2020,No Results Posted,,,24/04/2020,https://clinicaltrials.gov/show/NCT04359251,25/03/2020,0,0
289,NCT04359264,"Active, not recruiting",29/05/2020,30/12/2020,No Results Posted,,,07/07/2020,https://clinicaltrials.gov/show/NCT04359264,29/05/2020,0,0
290,NCT04359277,Terminated,20/09/2020,20/09/2020,No Results Posted,"['Flumignan RL, Tin√¥co JDS, Pascoal PI, Areias LL, Cossi MS, Fernandes MI, Costa IK, Souza L, Matar CF, Tendal B, Trevisani VF, Atallah √ÅN, Nakano LC. Prophylactic anticoagulants for people hospitalised with COVID-19. Cochrane Database Syst Rev. 2020 Oct 2;10:CD013739. doi: 10.1002/14651858.CD013739.']",,08/10/2020,https://clinicaltrials.gov/show/NCT04359277,20/09/2020,0,1
291,NCT04359290,"Active, not recruiting",01/12/2020,01/07/2021,No Results Posted,,,01/12/2020,https://clinicaltrials.gov/show/NCT04359290,01/12/2020,0,0
292,NCT04359303,Not yet recruiting,01/11/2020,01/12/2020,No Results Posted,,,23/06/2020,https://clinicaltrials.gov/show/NCT04359303,01/11/2020,0,0
293,NCT04359316,Not yet recruiting,03/05/2020,05/05/2020,No Results Posted,,,24/04/2020,https://clinicaltrials.gov/show/NCT04359316,03/05/2020,0,0
294,NCT04359329,Recruiting,15/11/2020,15/11/2020,No Results Posted,"['Sultana J, Crisafulli S, Gabbay F, Lynn E, Shakir S, Trifir√≤ G. Challenges for Drug Repurposing in the COVID-19 Pandemic Era. Front Pharmacol. 2020 Nov 6;11:588654. doi: 10.3389/fphar.2020.588654. eCollection 2020. Review.']",,24/04/2020,https://clinicaltrials.gov/show/NCT04359329,15/11/2020,0,1
295,NCT04359537,Recruiting,25/08/2020,25/09/2020,No Results Posted,,,19/05/2020,https://clinicaltrials.gov/show/NCT04359537,25/08/2020,0,0
296,NCT04359615,Not yet recruiting,03/05/2020,05/05/2020,No Results Posted,,,28/04/2020,https://clinicaltrials.gov/show/NCT04359615,03/05/2020,0,0
297,NCT04359654,Recruiting,01/08/2021,01/11/2021,No Results Posted,,,19/10/2020,https://clinicaltrials.gov/show/NCT04359654,01/08/2021,0,0
298,NCT04359862,Recruiting,31/03/2021,30/04/2021,No Results Posted,,,14/10/2020,https://clinicaltrials.gov/show/NCT04359862,31/03/2021,0,0
299,NCT04359953,Recruiting,01/06/2021,01/06/2021,No Results Posted,,,27/07/2020,https://clinicaltrials.gov/show/NCT04359953,01/06/2021,0,0
300,NCT04360122,Not yet recruiting,01/11/2020,01/12/2020,No Results Posted,,,05/05/2020,https://clinicaltrials.gov/show/NCT04360122,01/11/2020,0,0
301,NCT04360356,Not yet recruiting,01/10/2020,01/12/2020,No Results Posted,,,24/04/2020,https://clinicaltrials.gov/show/NCT04360356,01/10/2020,0,0
302,NCT04360551,Recruiting,30/06/2021,30/06/2021,No Results Posted,,,03/08/2020,https://clinicaltrials.gov/show/NCT04360551,30/06/2021,0,0
303,NCT04360759,Withdrawn,30/05/2021,30/06/2021,No Results Posted,,,18/08/2020,https://clinicaltrials.gov/show/NCT04360759,30/05/2021,0,0
304,NCT04360811,Recruiting,01/04/2021,01/04/2022,No Results Posted,,,24/04/2020,https://clinicaltrials.gov/show/NCT04360811,01/04/2021,0,0
305,NCT04360824,Recruiting,16/04/2021,16/04/2021,No Results Posted,"['Flumignan RL, Tin√¥co JDS, Pascoal PI, Areias LL, Cossi MS, Fernandes MI, Costa IK, Souza L, Matar CF, Tendal B, Trevisani VF, Atallah √ÅN, Nakano LC. Prophylactic anticoagulants for people hospitalised with COVID-19. Cochrane Database Syst Rev. 2020 Oct 2;10:CD013739. doi: 10.1002/14651858.CD013739.']",,19/06/2020,https://clinicaltrials.gov/show/NCT04360824,16/04/2021,0,1
306,NCT04360837,Recruiting,01/06/2021,01/06/2021,No Results Posted,,"['Grasselli G, Zangrillo A, Zanella A, Antonelli M, Cabrini L, Castelli A, Cereda D, Coluccello A, Foti G, Fumagalli R, Iotti G, Latronico N, Lorini L, Merler S, Natalini G, Piatti A, Ranieri MV, Scandroglio AM, Storti E, Cecconi M, Pesenti A; COVID-19 Lombardy ICU Network. Baseline Characteristics and Outcomes of 1591 Patients Infected With SARS-CoV-2 Admitted to ICUs of the Lombardy Region, Italy. JAMA. 2020 Apr 28;323(16):1574-1581. doi: 10.1001/jama.2020.5394. Erratum in: JAMA. 2021 May 25;325(20):2120.']",21/05/2020,https://clinicaltrials.gov/show/NCT04360837,01/06/2021,0,1
307,NCT04360876,Withdrawn,31/12/2020,30/01/2021,No Results Posted,,,28/10/2020,https://clinicaltrials.gov/show/NCT04360876,31/12/2020,0,0
308,NCT04360980,Recruiting,01/09/2021,30/11/2021,No Results Posted,"['Dalili N, Kashefizadeh A, Nafar M, Poorrezagholi F, Firouzan A, Samadian F, Samavat S, Ziaie S, Fatemizadeh S. Adding Colchicine to the Antiretroviral Medication - Lopinavir/Ritonavir (Kaletra) in Hospitalized Patients with Non-Severe Covid-19 Pneumonia: A Structured Summary of a Study Protocol for a Randomized Controlled Trial. Trials. 2020 Jun 5;21(1):489. doi: 10.1186/s13063-020-04455-3.']",,31/12/2020,https://clinicaltrials.gov/show/NCT04360980,01/09/2021,0,1
309,NCT04361032,Not yet recruiting,04/09/2020,04/10/2020,No Results Posted,,,27/08/2020,https://clinicaltrials.gov/show/NCT04361032,04/09/2020,0,0
310,NCT04361214,Recruiting,01/02/2021,01/02/2021,No Results Posted,,,29/10/2020,https://clinicaltrials.gov/show/NCT04361214,01/02/2021,0,0
311,NCT04361253,Recruiting,01/06/2021,01/12/2021,No Results Posted,,,18/05/2020,https://clinicaltrials.gov/show/NCT04361253,01/06/2021,0,0
312,NCT04361318,Not yet recruiting,01/10/2020,01/12/2020,No Results Posted,,,24/04/2020,https://clinicaltrials.gov/show/NCT04361318,01/10/2020,0,0
313,NCT04361422,Not yet recruiting,01/08/2021,01/12/2021,No Results Posted,,,23/09/2020,https://clinicaltrials.gov/show/NCT04361422,01/08/2021,0,0
314,NCT04361435,Not yet recruiting,31/07/2020,31/12/2020,No Results Posted,"['Kawaguchi A, Bernier G, Lacroix J, El Salti S, Cheng MP, Lee TC, Khwaja K, Jouvet P. Comparison of two methods to clear the airways of critically ill children and adults with COVID-19 infection: a structured summary of a study protocol for a pilot randomized controlled trial. Trials. 2020 Jul 3;21(1):610. doi: 10.1186/s13063-020-04533-6.']","['Grasselli G, Zangrillo A, Zanella A, Antonelli M, Cabrini L, Castelli A, Cereda D, Coluccello A, Foti G, Fumagalli R, Iotti G, Latronico N, Lorini L, Merler S, Natalini G, Piatti A, Ranieri MV, Scandroglio AM, Storti E, Cecconi M, Pesenti A; COVID-19 Lombardy ICU Network. Baseline Characteristics and Outcomes of 1591 Patients Infected With SARS-CoV-2 Admitted to ICUs of the Lombardy Region, Italy. JAMA. 2020 Apr 28;323(16):1574-1581. doi: 10.1001/jama.2020.5394. Erratum in: JAMA. 2021 May 25;325(20):2120.', 'Huang C, Wang Y, Li X, Ren L, Zhao J, Hu Y, Zhang L, Fan G, Xu J, Gu X, Cheng Z, Yu T, Xia J, Wei Y, Wu W, Xie X, Yin W, Li H, Liu M, Xiao Y, Gao H, Guo L, Xie J, Wang G, Jiang R, Gao Z, Jin Q, Wang J, Cao B. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet. 2020 Feb 15;395(10223):497-506. doi: 10.1016/S0140-6736(20)30183-5. Epub 2020 Jan 24. Erratum in: Lancet. 2020 Jan 30;:.', 'Wang D, Hu B, Hu C, Zhu F, Liu X, Zhang J, Wang B, Xiang H, Cheng Z, Xiong Y, Zhao Y, Li Y, Wang X, Peng Z. Clinical Characteristics of 138 Hospitalized Patients With 2019 Novel Coronavirus-Infected Pneumonia in Wuhan, China. JAMA. 2020 Mar 17;323(11):1061-1069. doi: 10.1001/jama.2020.1585. Erratum in: JAMA. 2021 Mar 16;325(11):1113.', 'Wu Z, McGoogan JM. Characteristics of and Important Lessons From the Coronavirus Disease 2019 (COVID-19) Outbreak in China: Summary of a Report of 72 314 Cases From the Chinese Center for Disease Control and Prevention. JAMA. 2020 Apr 7;323(13):1239-1242. doi: 10.1001/jama.2020.2648.', 'Yang X, Yu Y, Xu J, Shu H, Xia J, Liu H, Wu Y, Zhang L, Yu Z, Fang M, Yu T, Wang Y, Pan S, Zou X, Yuan S, Shang Y. Clinical course and outcomes of critically ill patients with SARS-CoV-2 pneumonia in Wuhan, China: a single-centered, retrospective, observational study. Lancet Respir Med. 2020 May;8(5):475-481. doi: 10.1016/S2213-2600(20)30079-5. Epub 2020 Feb 24. Erratum in: Lancet Respir Med. 2020 Apr;8(4):e26.', 'Kanne JP, Little BP, Chung JH, Elicker BM, Ketai LH. Essentials for Radiologists on COVID-19: An Update-Radiology Scientific Expert Panel. Radiology. 2020 Aug;296(2):E113-E114. doi: 10.1148/radiol.2020200527. Epub 2020 Feb 27.', 'Pan F, Ye T, Sun P, Gui S, Liang B, Li L, Zheng D, Wang J, Hesketh RL, Yang L, Zheng C. Time Course of Lung Changes at Chest CT during Recovery from Coronavirus Disease 2019 (COVID-19). Radiology. 2020 Jun;295(3):715-721. doi: 10.1148/radiol.2020200370. Epub 2020 Feb 13.', 'Shi H, Han X, Jiang N, Cao Y, Alwalid O, Gu J, Fan Y, Zheng C. Radiological findings from 81 patients with COVID-19 pneumonia in Wuhan, China: a descriptive study. Lancet Infect Dis. 2020 Apr;20(4):425-434. doi: 10.1016/S1473-3099(20)30086-4. Epub 2020 Feb 24.', 'Roqu√© i Figuls M, Gin√©-Garriga M, Granados Rugeles C, Perrotta C, Vilar√≥ J. Chest physiotherapy for acute bronchiolitis in paediatric patients between 0 and 24 months old. Cochrane Database Syst Rev. 2016 Feb 1;2:CD004873. doi: 10.1002/14651858.CD004873.pub5. Review.', 'Chaves GS, Freitas DA, Santino TA, Nogueira PAM, Fregonezi GA, Mendon√ßa KM. Chest physiotherapy for pneumonia in children. Cochrane Database Syst Rev. 2019 Jan 2;1:CD010277. doi: 10.1002/14651858.CD010277.pub3.', 'Hough JL, Flenady V, Johnston L, Woodgate PG. Chest physiotherapy for reducing respiratory morbidity in infants requiring ventilatory support. Cochrane Database Syst Rev. 2008 Jul 16;(3):CD006445. doi: 10.1002/14651858.CD006445.pub2. Review.', 'Lauwers E, Ides K, Van Hoorenbeeck K, Verhulst S. The effect of intrapulmonary percussive ventilation in pediatric patients: A systematic review. Pediatr Pulmonol. 2018 Nov;53(11):1463-1474. doi: 10.1002/ppul.24135. Epub 2018 Jul 18.', 'Ferreira LL, Valenti VE, Vanderlei LC. Chest physiotherapy on intracranial pressure of critically ill patients admitted to the intensive care unit: a systematic review. Rev Bras Ter Intensiva. 2013 Oct-Dec;25(4):327-33. doi: 10.5935/0103-507X.20130055. Review. English, Portuguese.', 'Schieppati D, Germon R, Galli F, Rigamonti MG, Stucchi M, Boffito DC. Influence of frequency and amplitude on the mucus viscoelasticity of the novel mechano-acoustic Frequencer‚Ñ¢. Respir Med. 2019 Jul;153:52-59. doi: 10.1016/j.rmed.2019.04.011. Epub 2019 May 27.', 'Cantin AM, Bacon M, Berthiaume Y. Mechanical airway clearance using the frequencer electro-acoustical transducer in cystic fibrosis. Clin Invest Med. 2006 Jun;29(3):159-65.', 'Adams JY, Rogers AJ, Schuler A, Marelich GP, Fresco JM, Taylor SL, Riedl AW, Baker JM, Escobar GJ, Liu VX. Association Between Peripheral Blood Oxygen Saturation (SpO(2))/Fraction of Inspired Oxygen (FiO(2)) Ratio Time at Risk and Hospital Mortality in Mechanically Ventilated Patients. Perm J. 2020;24. doi: 10.7812/TPP/19.113. Epub 2020 Jan 31.', 'Bilan N, Dastranji A, Ghalehgolab Behbahani A. Comparison of the spo2/fio2 ratio and the pao2/fio2 ratio in patients with acute lung injury or acute respiratory distress syndrome. J Cardiovasc Thorac Res. 2015;7(1):28-31. doi: 10.15171/jcvtr.2014.06. Epub 2015 Mar 29.', 'Ghazal S, Sauthier M, Brossier D, Bouachir W, Jouvet PA, Noumeir R. Using machine learning models to predict oxygen saturation following ventilator support adjustment in critically ill children: A single center pilot study. PLoS One. 2019 Feb 20;14(2):e0198921. doi: 10.1371/journal.pone.0198921. eCollection 2019.', 'Koyauchi T, Yasui H, Enomoto N, Hasegawa H, Hozumi H, Suzuki Y, Karayama M, Furuhashi K, Fujisawa T, Nakamura Y, Inui N, Yokomura K, Suda T. Pulse oximetric saturation to fraction of inspired oxygen (SpO(2)/FIO(2)) ratio 24 hours after high-flow nasal cannula (HFNC) initiation is a good predictor of HFNC therapy in patients with acute exacerbation of interstitial lung disease. Ther Adv Respir Dis. 2020 Jan-Dec;14:1753466620906327. doi: 10.1177/1753466620906327.', 'Kwack WG, Lee DS, Min H, Choi YY, Yun M, Kim Y, Lee SH, Song I, Park JS, Cho YJ, Jo YH, Yoon HI, Lee JH, Lee CT, Lee YJ. Evaluation of the SpO2/FiO2 ratio as a predictor of intensive care unit transfers in respiratory ward patients for whom the rapid response system has been activated. PLoS One. 2018 Jul 31;13(7):e0201632. doi: 10.1371/journal.pone.0201632. eCollection 2018.', 'Wiedermann FJ, Stichlberger M, Glodny B. ARDS diagnosed by SpO(2)/FiO(2) ratio compared with PaO(2)/FiO(2) ratio: the role as a diagnostic tool for early enrolment into clinical trials. Open Med (Wars). 2016 Aug 2;11(1):297. doi: 10.1515/med-2016-0056. eCollection 2016.']",28/04/2020,https://clinicaltrials.gov/show/NCT04361435,31/07/2020,0,1
315,NCT04361461,Withdrawn,04/11/2020,04/11/2020,No Results Posted,,,19/11/2020,https://clinicaltrials.gov/show/NCT04361461,04/11/2020,0,0
316,NCT04361526,Recruiting,01/07/2020,01/07/2020,No Results Posted,,,24/04/2020,https://clinicaltrials.gov/show/NCT04361526,01/07/2020,0,0
317,NCT04361552,Withdrawn,02/06/2020,02/06/2020,No Results Posted,,,18/06/2020,https://clinicaltrials.gov/show/NCT04361552,02/06/2020,0,0
318,NCT04361643,Not yet recruiting,31/08/2021,31/12/2021,No Results Posted,,,31/07/2020,https://clinicaltrials.gov/show/NCT04361643,31/08/2021,0,0
319,NCT04361916,Terminated,30/06/2020,30/06/2020,No Results Posted,,,14/09/2020,https://clinicaltrials.gov/show/NCT04361916,30/06/2020,0,0
320,NCT04362059,Recruiting,27/07/2021,16/11/2021,No Results Posted,"['Dushianthan A, Clark H, Madsen J, Mogg R, Matthews L, Berry L, de la Serna JB, Batchelor J, Brealey D, Hussell T, Porter J, Djukanovic R, Feelisch M, Postle A, Grocott MPW. Nebulised surfactant for the treatment of severe COVID-19 in adults (COV-Surf): A structured summary of a study protocol for a randomized controlled trial. Trials. 2020 Dec 10;21(1):1014. doi: 10.1186/s13063-020-04944-5.']","['Anzueto A, Baughman RP, Guntupalli KK, Weg JG, Wiedemann HP, Ravent√≥s AA, Lemaire F, Long W, Zaccardelli DS, Pattishall EN. Aerosolized surfactant in adults with sepsis-induced acute respiratory distress syndrome. Exosurf Acute Respiratory Distress Syndrome Sepsis Study Group. N Engl J Med. 1996 May 30;334(22):1417-21.', 'Surfactant replacement therapy for severe neonatal respiratory distress syndrome: an international randomized clinical trial. Collaborative European Multicenter Study Group. Pediatrics. 1988 Nov;82(5):683-91.', 'Dushianthan A, Goss V, Cusack R, Grocott MP, Postle AD. Altered molecular specificity of surfactant phosphatidycholine synthesis in patients with acute respiratory distress syndrome. Respir Res. 2014 Nov 7;15:128. doi: 10.1186/s12931-014-0128-8.', 'Goss V, Hunt AN, Postle AD. Regulation of lung surfactant phospholipid synthesis and metabolism. Biochim Biophys Acta. 2013 Feb;1831(2):448-58. doi: 10.1016/j.bbalip.2012.11.009. Epub 2012 Nov 27. Review.', 'G√ºnther A, Schmidt R, Harodt J, Schmehl T, Walmrath D, Ruppert C, Grimminger F, Seeger W. Bronchoscopic administration of bovine natural surfactant in ARDS and septic shock: impact on biophysical and biochemical surfactant properties. Eur Respir J. 2002 May;19(5):797-804.', 'Hoffmann M, Kleine-Weber H, Schroeder S, Kr√ºger N, Herrler T, Erichsen S, Schiergens TS, Herrler G, Wu NH, Nitsche A, M√ºller MA, Drosten C, P√∂hlmann S. SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor. Cell. 2020 Apr 16;181(2):271-280.e8. doi: 10.1016/j.cell.2020.02.052. Epub 2020 Mar 5.', 'M√∂ller JC, Schaible T, Roll C, Schiffmann JH, Bindl L, Schrod L, Reiss I, Kohl M, Demirakca S, Hentschel R, Paul T, Vierzig A, Groneck P, von Seefeld H, Schumacher H, Gortner L; Surfactant ARDS Study Group. Treatment with bovine surfactant in severe acute respiratory distress syndrome in children: a randomized multicenter study. Intensive Care Med. 2003 Mar;29(3):437-46. Epub 2003 Feb 15.', 'Postle AD, Mander A, Reid KB, Wang JY, Wright SM, Moustaki M, Warner JO. Deficient hydrophilic lung surfactant proteins A and D with normal surfactant phospholipid molecular species in cystic fibrosis. Am J Respir Cell Mol Biol. 1999 Jan;20(1):90-8.', 'Qi F, Qian S, Zhang S, Zhang Z. Single cell RNA sequencing of 13 human tissues identify cell types and receptors of human coronaviruses. Biochem Biophys Res Commun. 2020 May 21;526(1):135-140. doi: 10.1016/j.bbrc.2020.03.044. Epub 2020 Mar 19.', 'Rebello CM, Jobe AH, Eisele JW, Ikegami M. Alveolar and tissue surfactant pool sizes in humans. Am J Respir Crit Care Med. 1996 Sep;154(3 Pt 1):625-8.', 'Rodr√≠guez-Capote K, Manzanares D, Haines T, Possmayer F. Reactive oxygen species inactivation of surfactant involves structural and functional alterations to surfactant proteins SP-B and SP-C. Biophys J. 2006 Apr 15;90(8):2808-21. Epub 2006 Jan 27.', 'Schmidt R, Markart P, Ruppert C, Wygrecka M, Kuchenbuch T, Walmrath D, Seeger W, Guenther A. Time-dependent changes in pulmonary surfactant function and composition in acute respiratory distress syndrome due to pneumonia or aspiration. Respir Res. 2007 Jul 27;8:55.', 'Schwarz KB. Oxidative stress during viral infection: a review. Free Radic Biol Med. 1996;21(5):641-9. Review.', 'Shi H, Han X, Jiang N, Cao Y, Alwalid O, Gu J, Fan Y, Zheng C. Radiological findings from 81 patients with COVID-19 pneumonia in Wuhan, China: a descriptive study. Lancet Infect Dis. 2020 Apr;20(4):425-434. doi: 10.1016/S1473-3099(20)30086-4. Epub 2020 Feb 24.']",09/09/2020,https://clinicaltrials.gov/show/NCT04362059,27/07/2021,0,1
321,NCT04362111,Recruiting,01/01/2021,01/03/2021,No Results Posted,,,11/09/2020,https://clinicaltrials.gov/show/NCT04362111,01/01/2021,0,0
322,NCT04362124,Withdrawn,01/06/2021,01/11/2021,No Results Posted,,,27/11/2020,https://clinicaltrials.gov/show/NCT04362124,01/06/2021,0,0
323,NCT04362332,Terminated,08/06/2020,08/06/2020,No Results Posted,,,19/06/2020,https://clinicaltrials.gov/show/NCT04362332,08/06/2020,0,0
324,NCT04362358,Not yet recruiting,01/10/2021,01/10/2021,No Results Posted,"['Weiner L, Berna F, Nourry N, Severac F, Vidailhet P, Mengin AC. Efficacy of an online cognitive behavioral therapy program developed for healthcare workers during the COVID-19 pandemic: the REduction of STress (REST) study protocol for a randomized controlled trial. Trials. 2020 Oct 21;21(1):870. doi: 10.1186/s13063-020-04772-7.']",,24/04/2020,https://clinicaltrials.gov/show/NCT04362358,01/10/2021,0,1
325,NCT04363060,Not yet recruiting,30/07/2020,30/07/2020,No Results Posted,,,29/04/2020,https://clinicaltrials.gov/show/NCT04363060,30/07/2020,0,0
326,NCT04363177,Not yet recruiting,01/06/2021,01/06/2023,No Results Posted,"['Schwank SE, Chung HF, Hsu M, Fu SC, Du L, Zhu L, Huang HY, Andersson E, Acharya G. Mental health of Urban Mothers (MUM) study: a multicentre randomised controlled trial, study protocol. BMJ Open. 2020 Nov 27;10(11):e041133. doi: 10.1136/bmjopen-2020-041133.']",,26/10/2020,https://clinicaltrials.gov/show/NCT04363177,01/06/2021,0,1
327,NCT04363203,Suspended,01/03/2021,01/08/2021,No Results Posted,,,22/06/2020,https://clinicaltrials.gov/show/NCT04363203,01/03/2021,0,0
328,NCT04363216,Not yet recruiting,01/05/2021,01/05/2021,No Results Posted,,,05/05/2020,https://clinicaltrials.gov/show/NCT04363216,01/05/2021,0,0
329,NCT04363385,Recruiting,31/05/2021,31/05/2021,No Results Posted,,,24/07/2020,https://clinicaltrials.gov/show/NCT04363385,31/05/2021,0,0
330,NCT04363437,Recruiting,31/05/2020,14/06/2020,No Results Posted,,,08/05/2020,https://clinicaltrials.gov/show/NCT04363437,31/05/2020,0,0
331,NCT04363450,Recruiting,31/03/2021,01/06/2021,No Results Posted,,,02/09/2020,https://clinicaltrials.gov/show/NCT04363450,31/03/2021,0,0
332,NCT04363528,Recruiting,30/10/2020,30/10/2020,No Results Posted,,,04/08/2020,https://clinicaltrials.gov/show/NCT04363528,30/10/2020,0,0
333,NCT04363541,Recruiting,01/04/2022,01/06/2022,No Results Posted,,,05/11/2020,https://clinicaltrials.gov/show/NCT04363541,01/04/2022,0,0
334,NCT04363736,Completed,12/08/2020,12/08/2020,No Results Posted,,,11/09/2020,https://clinicaltrials.gov/show/NCT04363736,12/08/2020,0,0
335,NCT04363814,Recruiting,01/07/2021,31/07/2021,No Results Posted,,,30/06/2020,https://clinicaltrials.gov/show/NCT04363814,01/07/2021,0,0
336,NCT04363840,Not yet recruiting,01/12/2020,01/12/2020,No Results Posted,,,27/04/2020,https://clinicaltrials.gov/show/NCT04363840,01/12/2020,0,0
337,NCT04363853,"Active, not recruiting",01/06/2021,01/08/2021,No Results Posted,,,30/11/2020,https://clinicaltrials.gov/show/NCT04363853,01/06/2021,0,0
338,NCT04363866,Withdrawn,01/03/2021,01/09/2021,No Results Posted,,,29/10/2020,https://clinicaltrials.gov/show/NCT04363866,01/03/2021,0,0
339,NCT04364594,Completed,24/04/2020,30/05/2020,No Results Posted,,,23/07/2020,https://clinicaltrials.gov/show/NCT04364594,24/04/2020,0,0
340,NCT04364815,Withdrawn,01/05/2021,01/05/2021,No Results Posted,,,06/11/2020,https://clinicaltrials.gov/show/NCT04364815,01/05/2021,0,0
341,NCT04364893,Recruiting,01/10/2020,01/12/2020,No Results Posted,"[""Lopes RD, Macedo AVS, de Barros E Silva PGM, Moll-Bernardes RJ, Dos Santos TM, Mazza L, Feldman A, D'Andr√©a Saba Arruda G, de Albuquerque DC, Camiletti AS, de Sousa AS, de Paula TC, Giusti KGD, Domiciano RAM, Noya-Rabelo MM, Hamilton AM, Loures VA, Dion√≠sio RM, Furquim TAB, De Luca FA, Dos Santos Sousa √çB, Bandeira BS, Zukowski CN, de Oliveira RGG, Ribeiro NB, de Moraes JL, Petriz JLF, Pimentel AM, Miranda JS, de Jesus Abufaiad BE, Gibson CM, Granger CB, Alexander JH, de Souza OF; BRACE CORONA Investigators. Effect of Discontinuing vs Continuing Angiotensin-Converting Enzyme Inhibitors and Angiotensin II Receptor Blockers on Days Alive and Out of the Hospital in Patients Admitted With COVID-19: A Randomized Clinical Trial. JAMA. 2021 Jan 19;325(3):254-264. doi: 10.1001/jama.2020.25864.""]",,02/07/2020,https://clinicaltrials.gov/show/NCT04364893,01/10/2020,0,1
342,NCT04365231,Withdrawn,01/06/2020,01/04/2021,No Results Posted,,,20/11/2020,https://clinicaltrials.gov/show/NCT04365231,01/06/2020,0,0
343,NCT04365309,Enrolling by invitation,01/04/2020,01/06/2020,No Results Posted,,,28/04/2020,https://clinicaltrials.gov/show/NCT04365309,01/04/2020,0,0
344,NCT04365517,Not yet recruiting,30/03/2021,30/12/2021,No Results Posted,,,03/11/2020,https://clinicaltrials.gov/show/NCT04365517,30/03/2021,0,0
345,NCT04365608,Completed,30/11/2020,10/12/2020,No Results Posted,,,19/12/2020,https://clinicaltrials.gov/show/NCT04365608,30/11/2020,0,0
346,NCT04365738,Completed,10/04/2020,26/04/2020,No Results Posted,,,28/04/2020,https://clinicaltrials.gov/show/NCT04365738,10/04/2020,0,0
347,NCT04365972,Completed,30/04/2020,30/04/2020,No Results Posted,,,08/05/2020,https://clinicaltrials.gov/show/NCT04365972,30/04/2020,0,0
348,NCT04365985,Recruiting,01/05/2021,01/08/2021,No Results Posted,,,02/07/2020,https://clinicaltrials.gov/show/NCT04365985,01/05/2021,0,0
349,NCT04366063,Recruiting,06/06/2020,10/12/2020,No Results Posted,,,30/04/2020,https://clinicaltrials.gov/show/NCT04366063,06/06/2020,0,0
350,NCT04366089,Recruiting,30/10/2020,31/12/2020,No Results Posted,,"['Hern√°ndez A, Papadakos PJ, Torres A, Gonz√°lez DA, Vives M, Ferrando C, Baeza J. Two known therapies could be useful as adjuvant therapy in critical patients infected by COVID-19. Rev Esp Anestesiol Reanim (Engl Ed). 2020 May;67(5):245-252. doi: 10.1016/j.redar.2020.03.004. Epub 2020 Apr 14. English, Spanish.', 'Conti P, Gallenga CE, Tet√® G, Caraffa A, Ronconi G, Younes A, Toniato E, Ross R, Kritas SK. How to reduce the likelihood of coronavirus-19 (CoV-19 or SARS-CoV-2) infection and lung inflammation mediated by IL-1. J Biol Regul Homeost Agents. 2020 March-April,;34(2):333-338. doi: 10.23812/Editorial-Conti-2.', 'Cascella M, Rajnik M, Aleem A, Dulebohn SC, Di Napoli R. Features, Evaluation, and Treatment of Coronavirus (COVID-19). 2021 Apr 20. StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2021 Jan-. Available from http://www.ncbi.nlm.nih.gov/books/NBK554776/', 'Xu K, Cai H, Shen Y, Ni Q, Chen Y, Hu S, Li J, Wang H, Yu L, Huang H, Qiu Y, Wei G, Fang Q, Zhou J, Sheng J, Liang T, Li L. [Management of corona virus disease-19 (COVID-19): the Zhejiang experience]. Zhejiang Da Xue Xue Bao Yi Xue Ban. 2020 Feb 21;49(1):147-157. doi: 10.3785/j.issn.1008-9292.2020.02.02. Chinese.']",28/04/2020,https://clinicaltrials.gov/show/NCT04366089,30/10/2020,0,1
351,NCT04366180,Recruiting,01/06/2020,01/10/2020,No Results Posted,,,30/04/2020,https://clinicaltrials.gov/show/NCT04366180,01/06/2020,0,0
352,NCT04366232,Terminated,02/10/2020,02/10/2020,No Results Posted,,"['Mehta P, McAuley DF, Brown M, Sanchez E, Tattersall RS, Manson JJ; HLH Across Speciality Collaboration, UK. COVID-19: consider cytokine storm syndromes and immunosuppression. Lancet. 2020 Mar 28;395(10229):1033-1034. doi: 10.1016/S0140-6736(20)30628-0. Epub 2020 Mar 16.', 'Wu Z, McGoogan JM. Characteristics of and Important Lessons From the Coronavirus Disease 2019 (COVID-19) Outbreak in China: Summary of a Report of 72 314 Cases From the Chinese Center for Disease Control and Prevention. JAMA. 2020 Apr 7;323(13):1239-1242. doi: 10.1001/jama.2020.2648.', 'Zalinger ZB, Elliott R, Weiss SR. Role of the inflammasome-related cytokines Il-1 and Il-18 during infection with murine coronavirus. J Neurovirol. 2017 Dec;23(6):845-854. doi: 10.1007/s13365-017-0574-4. Epub 2017 Sep 11.']",16/12/2020,https://clinicaltrials.gov/show/NCT04366232,02/10/2020,0,1
353,NCT04366245,Recruiting,01/12/2021,01/12/2021,No Results Posted,,,11/06/2020,https://clinicaltrials.gov/show/NCT04366245,01/12/2021,0,0
354,NCT04366271,Recruiting,31/07/2020,31/05/2021,No Results Posted,,,11/05/2020,https://clinicaltrials.gov/show/NCT04366271,31/07/2020,0,0
355,NCT04366297,Completed,25/02/2020,25/02/2020,No Results Posted,,,28/04/2020,https://clinicaltrials.gov/show/NCT04366297,25/02/2020,0,0
356,NCT04366323,"Active, not recruiting",01/10/2021,01/10/2021,No Results Posted,,,30/11/2020,https://clinicaltrials.gov/show/NCT04366323,01/10/2021,0,0
357,NCT04366739,Not yet recruiting,30/08/2020,30/09/2020,No Results Posted,,,29/04/2020,https://clinicaltrials.gov/show/NCT04366739,30/08/2020,0,0
358,NCT04366817,Not yet recruiting,01/04/2020,01/06/2020,No Results Posted,,,29/04/2020,https://clinicaltrials.gov/show/NCT04366817,01/04/2020,0,0
359,NCT04366856,Recruiting,01/12/2020,01/01/2021,No Results Posted,,,19/08/2020,https://clinicaltrials.gov/show/NCT04366856,01/12/2020,0,0
360,NCT04366882,Recruiting,01/12/2020,01/12/2020,No Results Posted,"[""D'Onofrio V, Donders E, Vanden Abeele ME, Dubois J, Cartuyvels R, Achten R, Lammens M, Dendooven A, Driessen A, Augsburg L, Vanrusselt J, Cox J. The clinical value of minimal invasive autopsy in COVID-19 patients. PLoS One. 2020 Nov 11;15(11):e0242300. doi: 10.1371/journal.pone.0242300. eCollection 2020.""]",,29/04/2020,https://clinicaltrials.gov/show/NCT04366882,01/12/2020,0,1
361,NCT04366947,Completed,20/09/2020,30/10/2020,No Results Posted,,,19/12/2020,https://clinicaltrials.gov/show/NCT04366947,20/09/2020,0,0
362,NCT04367168,Recruiting,27/04/2021,27/04/2021,No Results Posted,,,28/05/2020,https://clinicaltrials.gov/show/NCT04367168,27/04/2021,0,0
363,NCT04367545,Completed,17/05/2020,17/05/2020,No Results Posted,,,05/11/2020,https://clinicaltrials.gov/show/NCT04367545,17/05/2020,0,0
364,NCT04367662,Completed,14/05/2020,14/05/2020,No Results Posted,,,09/06/2020,https://clinicaltrials.gov/show/NCT04367662,14/05/2020,0,0
365,NCT04367831,Recruiting,01/11/2020,01/04/2021,No Results Posted,"['Flumignan RL, Tin√¥co JDS, Pascoal PI, Areias LL, Cossi MS, Fernandes MI, Costa IK, Souza L, Matar CF, Tendal B, Trevisani VF, Atallah √ÅN, Nakano LC. Prophylactic anticoagulants for people hospitalised with COVID-19. Cochrane Database Syst Rev. 2020 Oct 2;10:CD013739. doi: 10.1002/14651858.CD013739.', 'Levi M, Thachil J, Iba T, Levy JH. Coagulation abnormalities and thrombosis in patients with COVID-19. Lancet Haematol. 2020 Jun;7(6):e438-e440. doi: 10.1016/S2352-3026(20)30145-9. Epub 2020 May 11.']",,19/05/2020,https://clinicaltrials.gov/show/NCT04367831,01/11/2020,0,1
366,NCT04368013,Not yet recruiting,14/04/2026,14/04/2026,No Results Posted,,,29/04/2020,https://clinicaltrials.gov/show/NCT04368013,14/04/2026,0,0
367,NCT04368260,Recruiting,31/07/2020,31/07/2020,No Results Posted,,,29/04/2020,https://clinicaltrials.gov/show/NCT04368260,31/07/2020,0,0
368,NCT04368299,Recruiting,31/10/2021,31/12/2021,No Results Posted,,,15/07/2020,https://clinicaltrials.gov/show/NCT04368299,31/10/2021,0,0
369,NCT04368377,Completed,23/04/2020,23/04/2020,No Results Posted,"['Flumignan RL, Tin√¥co JDS, Pascoal PI, Areias LL, Cossi MS, Fernandes MI, Costa IK, Souza L, Matar CF, Tendal B, Trevisani VF, Atallah √ÅN, Nakano LC. Prophylactic anticoagulants for people hospitalised with COVID-19. Cochrane Database Syst Rev. 2020 Oct 2;10:CD013739. doi: 10.1002/14651858.CD013739.']",,29/04/2020,https://clinicaltrials.gov/show/NCT04368377,23/04/2020,0,1
370,NCT04368923,"Active, not recruiting",21/06/2020,23/06/2020,No Results Posted,"['Adly AS, Adly MS, Adly AS. Telemanagement of Home-Isolated COVID-19 Patients Using Oxygen Therapy With Noninvasive Positive Pressure Ventilation and Physical Therapy Techniques: Randomized Clinical Trial. J Med Internet Res. 2021 Apr 28;23(4):e23446. doi: 10.2196/23446.']",,23/06/2020,https://clinicaltrials.gov/show/NCT04368923,21/06/2020,0,1
371,NCT04368988,"Active, not recruiting",01/12/2020,18/11/2021,No Results Posted,"['Tian JH, Patel N, Haupt R, Zhou H, Weston S, Hammond H, Logue J, Portnoff AD, Norton J, Guebre-Xabier M, Zhou B, Jacobson K, Maciejewski S, Khatoon R, Wisniewska M, Moffitt W, Kluepfel-Stahl S, Ekechukwu B, Papin J, Boddapati S, Jason Wong C, Piedra PA, Frieman MB, Massare MJ, Fries L, Bengtsson KL, Stertman L, Ellingsworth L, Glenn G, Smith G. SARS-CoV-2 spike glycoprotein vaccine candidate NVX-CoV2373 immunogenicity in baboons and protection in mice. Nat Commun. 2021 Jan 14;12(1):372. doi: 10.1038/s41467-020-20653-8.', 'Guebre-Xabier M, Patel N, Tian JH, Zhou B, Maciejewski S, Lam K, Portnoff AD, Massare MJ, Frieman MB, Piedra PA, Ellingsworth L, Glenn G, Smith G. NVX-CoV2373 vaccine protects cynomolgus macaque upper and lower airways against SARS-CoV-2 challenge. Vaccine. 2020 Nov 25;38(50):7892-7896. doi: 10.1016/j.vaccine.2020.10.064. Epub 2020 Oct 23.', 'Keech C, Albert G, Cho I, Robertson A, Reed P, Neal S, Plested JS, Zhu M, Cloney-Clark S, Zhou H, Smith G, Patel N, Frieman MB, Haupt RE, Logue J, McGrath M, Weston S, Piedra PA, Desai C, Callahan K, Lewis M, Price-Abbott P, Formica N, Shinde V, Fries L, Lickliter JD, Griffin P, Wilkinson B, Glenn GM. Phase 1-2 Trial of a SARS-CoV-2 Recombinant Spike Protein Nanoparticle Vaccine. N Engl J Med. 2020 Dec 10;383(24):2320-2332. doi: 10.1056/NEJMoa2026920. Epub 2020 Sep 2.']",,09/10/2020,https://clinicaltrials.gov/show/NCT04368988,01/12/2020,0,1
372,NCT04369365,Recruiting,27/08/2020,27/12/2020,No Results Posted,,,01/05/2020,https://clinicaltrials.gov/show/NCT04369365,27/08/2020,0,0
373,NCT04369378,Recruiting,28/02/2021,30/04/2021,No Results Posted,"[""O'Donnell KT, Dunbar M, Speelman DL. Effectiveness of using a meditation app in reducing anxiety and improving well-being during the COVID-19 pandemic: A structured summary of a study protocol for a randomized controlled trial. Trials. 2020 Dec 9;21(1):1006. doi: 10.1186/s13063-020-04935-6.""]",,13/11/2020,https://clinicaltrials.gov/show/NCT04369378,28/02/2021,0,1
374,NCT04369456,Recruiting,22/10/2020,22/10/2020,No Results Posted,,,01/05/2020,https://clinicaltrials.gov/show/NCT04369456,22/10/2020,0,0
375,NCT04369794,Recruiting,01/06/2021,01/08/2023,No Results Posted,,,07/08/2020,https://clinicaltrials.gov/show/NCT04369794,01/06/2021,0,0
376,NCT04369820,Recruiting,01/09/2020,01/11/2020,No Results Posted,,,04/05/2020,https://clinicaltrials.gov/show/NCT04369820,01/09/2020,0,0
377,NCT04370015,Not yet recruiting,30/06/2020,15/10/2020,No Results Posted,,,06/05/2020,https://clinicaltrials.gov/show/NCT04370015,30/06/2020,0,0
378,NCT04370223,Not yet recruiting,25/10/2020,25/12/2020,No Results Posted,,,09/06/2020,https://clinicaltrials.gov/show/NCT04370223,25/10/2020,0,0
379,NCT04370288,Recruiting,20/09/2020,21/09/2020,No Results Posted,"['Hamidi-Alamdari D, Hafizi-Lotfabadi S, Bagheri-Moghaddam A, Safari H, Mozdourian M, Javidarabshahi Z, Peivandi-Yazdi A, Ali-Zeraati A, Sedaghat A, Poursadegh F, Barazandeh-Ahmadabadi F, Agheli-Rad M, Tavousi SM, Vojouhi S, Amini S, Amini M, Majid-Hosseini S, Tavanaee-Sani A, Ghiabi A, Nabavi-Mahalli S, Morovatdar N, Rajabi O, Koliakos G. METHYLENE BLUE FOR TREATMENT OF HOSPITALIZED COVID-19 PATIENTS: A RANDOMIZED, CONTROLLED, OPEN-LABEL CLINICAL TRIAL, PHASE 2. Rev Invest Clin. 2021;73(3):190-198. doi: 10.24875/RIC.21000028.', 'Alamdari DH, Moghaddam AB, Amini S, Keramati MR, Zarmehri AM, Alamdari AH, Damsaz M, Banpour H, Yarahmadi A, Koliakos G. Application of methylene blue -vitamin C -N-acetyl cysteine for treatment of critically ill COVID-19 patients, report of a phase-I clinical trial. Eur J Pharmacol. 2020 Oct 15;885:173494. doi: 10.1016/j.ejphar.2020.173494. Epub 2020 Aug 20.']",,04/05/2020,https://clinicaltrials.gov/show/NCT04370288,20/09/2020,0,1
380,NCT04370886,Completed,30/04/2020,10/05/2020,No Results Posted,,,01/06/2020,https://clinicaltrials.gov/show/NCT04370886,30/04/2020,0,0
381,NCT04370938,Withdrawn,29/10/2020,29/10/2020,No Results Posted,,,29/12/2020,https://clinicaltrials.gov/show/NCT04370938,29/10/2020,0,0
382,NCT04371107,Not yet recruiting,01/06/2020,01/07/2020,No Results Posted,,,06/05/2020,https://clinicaltrials.gov/show/NCT04371107,01/06/2020,0,0
383,NCT04371406,Withdrawn,01/08/2020,01/09/2020,No Results Posted,,,27/10/2020,https://clinicaltrials.gov/show/NCT04371406,01/08/2020,0,0
384,NCT04371419,Completed,24/05/2020,24/05/2020,Results Submitted,"['Alsan M, Stanford FC, Banerjee A, Breza E, Chandrasekhar AG, Eichmeyer S, Goldsmith-Pinkham P, Ogbu-Nwobodo L, Olken BA, Torres C, Sankar A, Vautrey PL, Duflo E. Comparison of Knowledge and Information-Seeking Behavior After General COVID-19 Public Health Messages and Messages Tailored for Black and Latinx Communities : A Randomized Controlled Trial. Ann Intern Med. 2021 Apr;174(4):484-492. doi: 10.7326/M20-6141. Epub 2020 Dec 21.']",,19/06/2020,https://clinicaltrials.gov/show/NCT04371419,24/05/2020,0,1
385,NCT04371510,Recruiting,22/10/2020,22/02/2021,No Results Posted,,,01/05/2020,https://clinicaltrials.gov/show/NCT04371510,22/10/2020,0,0
386,NCT04371523,Not yet recruiting,31/07/2020,30/08/2020,No Results Posted,,,01/05/2020,https://clinicaltrials.gov/show/NCT04371523,31/07/2020,0,0
387,NCT04371601,"Active, not recruiting",31/12/2021,31/12/2022,No Results Posted,,,01/05/2020,https://clinicaltrials.gov/show/NCT04371601,31/12/2021,0,0
388,NCT04371822,Not yet recruiting,01/10/2020,01/11/2020,No Results Posted,,,24/06/2020,https://clinicaltrials.gov/show/NCT04371822,01/10/2020,0,0
389,NCT04371926,Withdrawn,01/06/2021,01/07/2021,No Results Posted,,,04/06/2020,https://clinicaltrials.gov/show/NCT04371926,01/06/2021,0,0
390,NCT04371952,Not yet recruiting,01/12/2020,01/12/2020,No Results Posted,,,18/05/2020,https://clinicaltrials.gov/show/NCT04371952,01/12/2020,0,0
391,NCT04371965,Completed,23/10/2020,23/10/2020,No Results Posted,"['Guenezan J, Garcia M, Strasters D, Jousselin C, L√©v√™que N, Frasca D, Mimoz O. Povidone Iodine Mouthwash, Gargle, and Nasal Spray to Reduce Nasopharyngeal Viral Load in Patients With COVID-19: A Randomized Clinical Trial. JAMA Otolaryngol Head Neck Surg. 2021 Apr 1;147(4):400-401. doi: 10.1001/jamaoto.2020.5490.']",,26/10/2020,https://clinicaltrials.gov/show/NCT04371965,23/10/2020,0,1
392,NCT04372004,Recruiting,01/05/2021,01/06/2021,No Results Posted,,,11/08/2020,https://clinicaltrials.gov/show/NCT04372004,01/05/2021,0,0
393,NCT04372017,"Active, not recruiting",04/06/2020,04/06/2021,No Results Posted,,,09/06/2020,https://clinicaltrials.gov/show/NCT04372017,04/06/2020,0,0
394,NCT04372030,Not yet recruiting,30/06/2020,31/10/2021,No Results Posted,,,01/05/2020,https://clinicaltrials.gov/show/NCT04372030,30/06/2020,0,0
395,NCT04372693,Enrolling by invitation,30/01/2021,28/02/2021,No Results Posted,,,03/11/2020,https://clinicaltrials.gov/show/NCT04372693,30/01/2021,0,0
396,NCT04372979,Recruiting,01/05/2021,01/06/2021,No Results Posted,,,21/12/2020,https://clinicaltrials.gov/show/NCT04372979,01/05/2021,0,0
397,NCT04373135,"Active, not recruiting",01/02/2021,01/03/2021,No Results Posted,"['Wisk LE, Buhr RG. Rapid Deployment of A Community Engagement Study And Educational Trial Via Social Media: Implementation of The UC-COVID Study. Res Sq. 2021 May 7. pii: rs.3.rs-359099. doi: 10.21203/rs.3.rs-359099/v1.']",,14/10/2020,https://clinicaltrials.gov/show/NCT04373135,01/02/2021,0,1
398,NCT04373161,Completed,22/04/2020,22/04/2020,No Results Posted,,,06/05/2020,https://clinicaltrials.gov/show/NCT04373161,22/04/2020,0,0
399,NCT04373382,"Active, not recruiting",01/02/2022,01/02/2022,No Results Posted,,,05/11/2020,https://clinicaltrials.gov/show/NCT04373382,01/02/2022,0,0
400,NCT04373707,Recruiting,01/11/2021,01/11/2021,No Results Posted,"['Flumignan RL, Tin√¥co JDS, Pascoal PI, Areias LL, Cossi MS, Fernandes MI, Costa IK, Souza L, Matar CF, Tendal B, Trevisani VF, Atallah √ÅN, Nakano LC. Prophylactic anticoagulants for people hospitalised with COVID-19. Cochrane Database Syst Rev. 2020 Oct 2;10:CD013739. doi: 10.1002/14651858.CD013739.']",,23/11/2020,https://clinicaltrials.gov/show/NCT04373707,01/11/2021,0,1
401,NCT04373824,Recruiting,25/07/2020,25/07/2020,No Results Posted,,,04/05/2020,https://clinicaltrials.gov/show/NCT04373824,25/07/2020,0,0
402,NCT04374019,Recruiting,01/05/2022,01/05/2022,No Results Posted,,,30/06/2021,https://clinicaltrials.gov/show/NCT04374019,01/05/2022,0,0
403,NCT04374032,Completed,07/10/2020,03/11/2020,No Results Posted,,,24/12/2020,https://clinicaltrials.gov/show/NCT04374032,07/10/2020,0,0
404,NCT04374084,Recruiting,01/12/2021,01/12/2021,No Results Posted,,,05/06/2020,https://clinicaltrials.gov/show/NCT04374084,01/12/2021,0,0
405,NCT04374487,"Active, not recruiting",09/08/2021,09/08/2021,No Results Posted,,,22/07/2020,https://clinicaltrials.gov/show/NCT04374487,09/08/2021,0,0
406,NCT04374539,Recruiting,05/05/2021,29/08/2021,No Results Posted,,,07/07/2020,https://clinicaltrials.gov/show/NCT04374539,05/05/2021,0,0
407,NCT04374552,Withdrawn,01/11/2020,01/04/2021,No Results Posted,,,02/11/2020,https://clinicaltrials.gov/show/NCT04374552,01/11/2020,0,0
408,NCT04374565,"Active, not recruiting",05/04/2021,05/04/2021,Results Submitted,,,21/08/2020,https://clinicaltrials.gov/show/NCT04374565,05/04/2021,0,0
409,NCT04374591,"Active, not recruiting",01/11/2020,01/11/2020,No Results Posted,,,06/10/2020,https://clinicaltrials.gov/show/NCT04374591,01/11/2020,0,0
410,NCT04374786,Enrolling by invitation,01/09/2020,01/10/2020,No Results Posted,,"['Huberty J, Green J, Glissmann C, Larkey L, Puzia M, Lee C. Efficacy of the Mindfulness Meditation Mobile App ""Calm"" to Reduce Stress Among College Students: Randomized Controlled Trial. JMIR Mhealth Uhealth. 2019 Jun 25;7(6):e14273. doi: 10.2196/14273.', 'Huberty J, Vranceanu AM, Carney C, Breus M, Gordon M, Puzia ME. Characteristics and Usage Patterns Among 12,151 Paid Subscribers of the Calm Meditation App: Cross-Sectional Survey. JMIR Mhealth Uhealth. 2019 Nov 3;7(11):e15648. doi: 10.2196/15648.', ""Huberty J, Puzia M, Eckert R, Larkey L. Cancer Patients' and Survivors' Perceptions of the Calm App: Cross-Sectional Descriptive Study. JMIR Cancer. 2020 Jan 25;6(1):e16926. doi: 10.2196/16926."", 'Wen L, Sweeney TE, Welton L, Trockel M, Katznelson L. Encouraging Mindfulness in Medical House Staff via Smartphone App: A Pilot Study. Acad Psychiatry. 2017 Oct;41(5):646-650. doi: 10.1007/s40596-017-0768-3. Epub 2017 Aug 9.']",04/06/2020,https://clinicaltrials.gov/show/NCT04374786,01/09/2020,0,1
411,NCT04374903,Not yet recruiting,01/08/2020,01/09/2020,No Results Posted,,,05/05/2020,https://clinicaltrials.gov/show/NCT04374903,01/08/2020,0,0
412,NCT04375098,Completed,17/08/2020,17/08/2020,No Results Posted,"['Piechotta V, Iannizzi C, Chai KL, Valk SJ, Kimber C, Dorando E, Monsef I, Wood EM, Lamikanra AA, Roberts DJ, McQuilten Z, So-Osman C, Estcourt LJ, Skoetz N. Convalescent plasma or hyperimmune immunoglobulin for people with COVID-19: a living systematic review. Cochrane Database Syst Rev. 2021 May 20;5:CD013600. doi: 10.1002/14651858.CD013600.pub4.', 'Balcells ME, Rojas L, Le Corre N, Mart√≠nez-Valdebenito C, Ceballos ME, Ferr√©s M, Chang M, Vizcaya C, Mondaca S, Huete √Å, Castro R, Sarmiento M, Villarroel L, Pizarro A, Ross P, Santander J, Lara B, Ferrada M, Vargas-Salas S, Beltr√°n-Pavez C, Soto-Rifo R, Valiente-Echeverr√≠a F, Caglevic C, Mahave M, Selman C, Gazit√∫a R, Briones JL, Villarroel-Espindola F, Balmaceda C, Espinoza MA, Pereira J, Nervi B. Early versus deferred anti-SARS-CoV-2 convalescent plasma in patients admitted for COVID-19: A randomized phase II clinical trial. PLoS Med. 2021 Mar 3;18(3):e1003415. doi: 10.1371/journal.pmed.1003415. eCollection 2021 Mar.']",,16/09/2020,https://clinicaltrials.gov/show/NCT04375098,17/08/2020,0,1
413,NCT04375124,Recruiting,31/08/2020,30/09/2020,No Results Posted,,,15/05/2020,https://clinicaltrials.gov/show/NCT04375124,31/08/2020,0,0
414,NCT04375202,Recruiting,30/06/2021,31/10/2021,No Results Posted,,,05/11/2020,https://clinicaltrials.gov/show/NCT04375202,30/06/2021,0,0
415,NCT04375735,Not yet recruiting,01/01/2021,01/07/2021,No Results Posted,,,11/06/2020,https://clinicaltrials.gov/show/NCT04375735,01/01/2021,0,0
416,NCT04375774,Recruiting,01/05/2020,01/05/2020,No Results Posted,,,05/05/2020,https://clinicaltrials.gov/show/NCT04375774,01/05/2020,0,0
417,NCT04376034,Recruiting,30/03/2021,30/03/2021,No Results Posted,,,06/05/2020,https://clinicaltrials.gov/show/NCT04376034,30/03/2021,0,0
418,NCT04376476,Recruiting,05/06/2021,05/06/2021,No Results Posted,,,08/05/2020,https://clinicaltrials.gov/show/NCT04376476,05/06/2021,0,0
419,NCT04376788,Recruiting,01/07/2020,01/09/2020,No Results Posted,,,09/07/2020,https://clinicaltrials.gov/show/NCT04376788,01/07/2020,0,0
420,NCT04376814,Completed,05/04/2020,25/05/2020,No Results Posted,,,16/06/2020,https://clinicaltrials.gov/show/NCT04376814,05/04/2020,0,0
421,NCT04376840,Recruiting,28/01/2022,28/10/2022,No Results Posted,,,30/11/2020,https://clinicaltrials.gov/show/NCT04376840,28/01/2022,0,0
422,NCT04377308,Recruiting,20/04/2021,20/10/2021,No Results Posted,,,06/05/2020,https://clinicaltrials.gov/show/NCT04377308,20/04/2021,0,0
423,NCT04377477,Recruiting,10/08/2021,30/08/2022,No Results Posted,,,22/07/2020,https://clinicaltrials.gov/show/NCT04377477,10/08/2021,0,0
424,NCT04377503,Not yet recruiting,01/08/2020,01/11/2020,No Results Posted,,,06/05/2020,https://clinicaltrials.gov/show/NCT04377503,01/08/2020,0,0
425,NCT04377646,Not yet recruiting,24/05/2020,31/07/2020,No Results Posted,,,06/05/2020,https://clinicaltrials.gov/show/NCT04377646,24/05/2020,0,0
426,NCT04377659,"Active, not recruiting",01/05/2022,01/05/2022,No Results Posted,,,27/11/2020,https://clinicaltrials.gov/show/NCT04377659,01/05/2022,0,0
427,NCT04377737,Withdrawn,01/08/2020,01/09/2020,No Results Posted,,,27/05/2020,https://clinicaltrials.gov/show/NCT04377737,01/08/2020,0,0
428,NCT04377750,Recruiting,29/04/2020,08/05/2021,No Results Posted,,,06/05/2020,https://clinicaltrials.gov/show/NCT04377750,29/04/2020,0,0
429,NCT04377802,Not yet recruiting,16/11/2020,30/12/2020,No Results Posted,,,06/05/2020,https://clinicaltrials.gov/show/NCT04377802,16/11/2020,0,0
430,NCT04377997,Not yet recruiting,01/01/2021,01/01/2022,No Results Posted,,"['Arentz M, Yim E, Klaff L, Lokhandwala S, Riedo FX, Chong M, Lee M. Characteristics and Outcomes of 21 Critically Ill Patients With COVID-19 in Washington State. JAMA. 2020 Apr 28;323(16):1612-1614. doi: 10.1001/jama.2020.4326.', 'Huang C, Wang Y, Li X, Ren L, Zhao J, Hu Y, Zhang L, Fan G, Xu J, Gu X, Cheng Z, Yu T, Xia J, Wei Y, Wu W, Xie X, Yin W, Li H, Liu M, Xiao Y, Gao H, Guo L, Xie J, Wang G, Jiang R, Gao Z, Jin Q, Wang J, Cao B. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet. 2020 Feb 15;395(10223):497-506. doi: 10.1016/S0140-6736(20)30183-5. Epub 2020 Jan 24. Erratum in: Lancet. 2020 Jan 30;:.', 'Wang D, Hu B, Hu C, Zhu F, Liu X, Zhang J, Wang B, Xiang H, Cheng Z, Xiong Y, Zhao Y, Li Y, Wang X, Peng Z. Clinical Characteristics of 138 Hospitalized Patients With 2019 Novel Coronavirus-Infected Pneumonia in Wuhan, China. JAMA. 2020 Mar 17;323(11):1061-1069. doi: 10.1001/jama.2020.1585. Erratum in: JAMA. 2021 Mar 16;325(11):1113.', 'Frencken JF, Donker DW, Spitoni C, Koster-Brouwer ME, Soliman IW, Ong DSY, Horn J, van der Poll T, van Klei WA, Bonten MJM, Cremer OL. Myocardial Injury in Patients With Sepsis and Its Association With Long-Term Outcome. Circ Cardiovasc Qual Outcomes. 2018 Feb;11(2):e004040. doi: 10.1161/CIRCOUTCOMES.117.004040.', 'Shi S, Qin M, Shen B, Cai Y, Liu T, Yang F, Gong W, Liu X, Liang J, Zhao Q, Huang H, Yang B, Huang C. Association of Cardiac Injury With Mortality in Hospitalized Patients With COVID-19 in Wuhan, China. JAMA Cardiol. 2020 Jul 1;5(7):802-810. doi: 10.1001/jamacardio.2020.0950.', 'C. P. COVID-19: Abnormal Clotting Common in More Severe Disease. 2020.', 'Chan MY, Andreotti F, Becker RC. Hypercoagulable states in cardiovascular disease. Circulation. 2008 Nov 25;118(22):2286-97. doi: 10.1161/CIRCULATIONAHA.108.778837. Review.', 'Zarychanski R, Doucette S, Fergusson D, Roberts D, Houston DS, Sharma S, Gulati H, Kumar A. Early intravenous unfractionated heparin and mortality in septic shock. Crit Care Med. 2008 Nov;36(11):2973-9. doi: 10.1097/CCM.0b013e31818b8c6b.', 'Jaimes F, De La Rosa G, Morales C, Fortich F, Arango C, Aguirre D, Mu√±oz A. Unfractioned heparin for treatment of sepsis: A randomized clinical trial (The HETRASE Study). Crit Care Med. 2009 Apr;37(4):1185-96. doi: 10.1097/CCM.0b013e31819c06bc.', 'Safety of Heparin in Patients with Septic Shock.', 'Tang N, Bai H, Chen X, Gong J, Li D, Sun Z. Anticoagulant treatment is associated with decreased mortality in severe coronavirus disease 2019 patients with coagulopathy. J Thromb Haemost. 2020 May;18(5):1094-1099. doi: 10.1111/jth.14817. Epub 2020 Apr 27.', 'Iba T, Levy JH, Warkentin TE, Thachil J, van der Poll T, Levi M; Scientific and Standardization Committee on DIC, and the Scientific and Standardization Committee on Perioperative and Critical Care of the International Society on Thrombosis and Haemostasis. Diagnosis and management of sepsis-induced coagulopathy and disseminated intravascular coagulation. J Thromb Haemost. 2019 Nov;17(11):1989-1994. doi: 10.1111/jth.14578. Epub 2019 Aug 13. Review.', 'Zarychanski R, Abou-Setta AM, Kanji S, Turgeon AF, Kumar A, Houston DS, Rimmer E, Houston BL, McIntyre L, Fox-Robichaud AE, H√©bert P, Cook DJ, Fergusson DA; Canadian Critical Care Trials Group. The efficacy and safety of heparin in patients with sepsis: a systematic review and metaanalysis. Crit Care Med. 2015 Mar;43(3):511-8. doi: 10.1097/CCM.0000000000000763. Review.', 'Zidane M, Schram MT, Planken EW, Molendijk WH, Rosendaal FR, van der Meer FJ, Huisman MV. Frequency of major hemorrhage in patients treated with unfractionated intravenous heparin for deep venous thrombosis or pulmonary embolism: a study in routine clinical practice. Arch Intern Med. 2000 Aug 14-28;160(15):2369-73.', 'Schulman S, Kearon C; Subcommittee on Control of Anticoagulation of the Scientific and Standardization Committee of the International Society on Thrombosis and Haemostasis. Definition of major bleeding in clinical investigations of antihemostatic medicinal products in non-surgical patients. J Thromb Haemost. 2005 Apr;3(4):692-4.', 'Morris TA, Castrejon S, Devendra G, Gamst AC. No difference in risk for thrombocytopenia during treatment of pulmonary embolism and deep venous thrombosis with either low-molecular-weight heparin or unfractionated heparin: a metaanalysis. Chest. 2007 Oct;132(4):1131-9. Epub 2007 Jul 23.', 'Stein PD, Hull RD, Matta F, Yaekoub AY, Liang J. Incidence of thrombocytopenia in hospitalized patients with venous thromboembolism. Am J Med. 2009 Oct;122(10):919-30. doi: 10.1016/j.amjmed.2009.03.026. Epub 2009 Aug 13. Review.']",07/05/2020,https://clinicaltrials.gov/show/NCT04377997,01/01/2021,0,1
431,NCT04378244,Not yet recruiting,12/01/2022,12/03/2022,No Results Posted,,,12/11/2020,https://clinicaltrials.gov/show/NCT04378244,12/01/2022,0,0
432,NCT04378257,Not yet recruiting,30/09/2020,20/10/2020,No Results Posted,"['Al-Alawi M, McCall RK, Sultan A, Al Balushi N, Al-Mahrouqi T, Al Ghailani A, Al Sabti H, Al-Maniri A, Panchatcharam SM, Al Sinawi H. Efficacy of a Six-Week-Long Therapist-Guided Online Therapy Versus Self-help Internet-Based Therapy for COVID-19-Induced Anxiety and Depression: Open-label, Pragmatic, Randomized Controlled Trial. JMIR Ment Health. 2021 Feb 12;8(2):e26683. doi: 10.2196/26683.']",,08/05/2020,https://clinicaltrials.gov/show/NCT04378257,30/09/2020,0,1
433,NCT04378712,Completed,23/03/2020,23/03/2020,No Results Posted,,,15/05/2020,https://clinicaltrials.gov/show/NCT04378712,23/03/2020,0,0
434,NCT04378738,Enrolling by invitation,07/05/2020,08/05/2020,No Results Posted,,"['Khoong EC, Rivadeneira NA, Hiatt RA, Sarkar U. The Use of Technology for Communicating With Clinicians or Seeking Health Information in a Multilingual Urban Cohort: Cross-Sectional Survey. J Med Internet Res. 2020 Apr 6;22(4):e16951. doi: 10.2196/16951.']",07/05/2020,https://clinicaltrials.gov/show/NCT04378738,07/05/2020,0,1
435,NCT04378803,Completed,04/08/2020,04/08/2020,No Results Posted,,,17/08/2020,https://clinicaltrials.gov/show/NCT04378803,04/08/2020,0,0
436,NCT04379336,Recruiting,28/04/2021,28/04/2021,No Results Posted,,,07/05/2020,https://clinicaltrials.gov/show/NCT04379336,28/04/2021,0,0
437,NCT04379375,Terminated,30/09/2020,30/09/2020,No Results Posted,,,05/10/2020,https://clinicaltrials.gov/show/NCT04379375,30/09/2020,0,0
438,NCT04379453,Recruiting,27/04/2020,27/04/2020,No Results Posted,"['Lemos PA, Franken M, Mariani J Jr, Pitta FG, Oliveira FA, Cunha-Lima G, Caixeta AM, Almeida BO, Garcia RG. Use of robotic assistance to reduce proximity and air-sharing during percutaneous cardiovascular intervention. Future Cardiol. 2021 Apr 9. doi: 10.2217/fca-2021-0024. [Epub ahead of print]']",,08/05/2020,https://clinicaltrials.gov/show/NCT04379453,27/04/2020,0,1
439,NCT04379479,Not yet recruiting,01/08/2020,01/12/2020,No Results Posted,,,07/05/2020,https://clinicaltrials.gov/show/NCT04379479,01/08/2020,0,0
440,NCT04379492,Withdrawn,25/09/2020,25/09/2020,No Results Posted,,,30/10/2020,https://clinicaltrials.gov/show/NCT04379492,25/09/2020,0,0
441,NCT04379531,Completed,22/05/2020,22/05/2020,No Results Posted,,,12/06/2020,https://clinicaltrials.gov/show/NCT04379531,22/05/2020,0,0
442,NCT04380376,Recruiting,30/10/2020,30/10/2020,No Results Posted,,,12/05/2020,https://clinicaltrials.gov/show/NCT04380376,30/10/2020,0,0
443,NCT04380519,Completed,10/07/2020,24/07/2020,No Results Posted,,,29/09/2020,https://clinicaltrials.gov/show/NCT04380519,10/07/2020,0,0
444,NCT04380532,"Active, not recruiting",15/05/2021,15/06/2021,No Results Posted,,,27/05/2020,https://clinicaltrials.gov/show/NCT04380532,15/05/2021,0,0
445,NCT04380818,Recruiting,04/05/2021,01/07/2021,No Results Posted,"['Algara M, Arenas M, Marin J, Vallverdu I, Fernandez-Let√≥n P, Villar J, Fabrer G, Rubio C, Montero A. Low dose anti-inflammatory radiotherapy for the treatment of pneumonia by covid-19: A proposal for a multi-centric prospective trial. Clin Transl Radiat Oncol. 2020 Jun 15;24:29-33. doi: 10.1016/j.ctro.2020.06.005. eCollection 2020 Sep.']",,18/06/2020,https://clinicaltrials.gov/show/NCT04380818,04/05/2021,0,1
446,NCT04380935,Recruiting,31/10/2020,31/10/2020,No Results Posted,,,18/08/2020,https://clinicaltrials.gov/show/NCT04380935,31/10/2020,0,0
447,NCT04381000,Completed,29/05/2020,10/06/2020,No Results Posted,,,01/07/2020,https://clinicaltrials.gov/show/NCT04381000,29/05/2020,0,0
448,NCT04381052,Not yet recruiting,01/08/2020,01/08/2020,No Results Posted,,,08/05/2020,https://clinicaltrials.gov/show/NCT04381052,01/08/2020,0,0
449,NCT04381338,Not yet recruiting,30/09/2020,30/09/2020,No Results Posted,,,08/05/2020,https://clinicaltrials.gov/show/NCT04381338,30/09/2020,0,0
450,NCT04381845,Not yet recruiting,10/03/2021,10/03/2021,No Results Posted,,,26/10/2020,https://clinicaltrials.gov/show/NCT04381845,10/03/2021,0,0
451,NCT04381858,Completed,26/11/2020,26/11/2020,No Results Posted,"['Piechotta V, Iannizzi C, Chai KL, Valk SJ, Kimber C, Dorando E, Monsef I, Wood EM, Lamikanra AA, Roberts DJ, McQuilten Z, So-Osman C, Estcourt LJ, Skoetz N. Convalescent plasma or hyperimmune immunoglobulin for people with COVID-19: a living systematic review. Cochrane Database Syst Rev. 2021 May 20;5:CD013600. doi: 10.1002/14651858.CD013600.pub4.']",,30/11/2020,https://clinicaltrials.gov/show/NCT04381858,26/11/2020,0,1
452,NCT04381871,Not yet recruiting,01/08/2020,01/09/2020,No Results Posted,"['Kaddam L, Babiker R, Ali S, Satti S, Ali N, Elamin M, Mukhtar M, Elnimeiri M, Saeed A. Potential Role of Acacia Senegal (Gum Arabic) as Immunomodulatory Agent among newly diagnosed COVID 19 Patients: A structured summary of a protocol for a randomised, controlled, clinical trial. Trials. 2020 Sep 5;21(1):766. doi: 10.1186/s13063-020-04707-2.']",,12/05/2020,https://clinicaltrials.gov/show/NCT04381871,01/08/2020,0,1
453,NCT04381884,Completed,29/09/2020,29/09/2020,No Results Posted,"['Krolewiecki A, Lifschitz A, Moragas M, Travacio M, Valentini R, Alonso DF, Solari R, Tinelli MA, Cimino RO, √Ålvarez L, Fleitas PE, Ceballos L, Golemba M, Fern√°ndez F, Fern√°ndez de Oliveira D, Astudillo G, Baeck I, Farina J, Cardama GA, Mangano A, Spitzer E, Gold S, Lanusse C. Antiviral effect of high-dose ivermectin in adults with COVID-19: A proof-of-concept randomized trial. EClinicalMedicine. 2021 Jun 18;37:100959. doi: 10.1016/j.eclinm.2021.100959. eCollection 2021 Jul.']",,05/10/2020,https://clinicaltrials.gov/show/NCT04381884,29/09/2020,0,1
454,NCT04382066,Completed,23/12/2020,23/12/2020,No Results Posted,,,28/12/2020,https://clinicaltrials.gov/show/NCT04382066,23/12/2020,0,0
455,NCT04382092,Completed,24/04/2020,24/04/2020,No Results Posted,,,11/05/2020,https://clinicaltrials.gov/show/NCT04382092,24/04/2020,0,0
456,NCT04382131,Recruiting,31/10/2020,31/10/2020,No Results Posted,,,02/09/2020,https://clinicaltrials.gov/show/NCT04382131,31/10/2020,0,0
457,NCT04382547,Enrolling by invitation,30/06/2021,30/06/2021,No Results Posted,,,28/05/2020,https://clinicaltrials.gov/show/NCT04382547,30/06/2021,0,0
458,NCT04382729,Recruiting,01/07/2020,01/07/2020,No Results Posted,,,11/05/2020,https://clinicaltrials.gov/show/NCT04382729,01/07/2020,0,0
459,NCT04382768,Recruiting,01/01/2021,01/01/2021,No Results Posted,,"['Mu√±oz AJ, Alasino RV, Garro AG, Heredia V, Garc√≠a NH, Cremonezzi DC, Beltramo DM. High Concentrations of Sodium Chloride Improve Microbicidal Activity of Ibuprofen against Common Cystic Fibrosis Pathogens. Pharmaceuticals (Basel). 2018 May 17;11(2). pii: E47. doi: 10.3390/ph11020047.', 'He L, Ding Y, Zhang Q, Che X, He Y, Shen H, Wang H, Li Z, Zhao L, Geng J, Deng Y, Yang L, Li J, Cai J, Qiu L, Wen K, Xu X, Jiang S. Expression of elevated levels of pro-inflammatory cytokines in SARS-CoV-infected ACE2+ cells in SARS patients: relation to the acute lung injury and pathogenesis of SARS. J Pathol. 2006 Nov;210(3):288-97.', 'Veljkovic V, Vergara-Alert J, Segal√©s J, Paessler S. Use of the informational spectrum methodology for rapid biological analysis of the novel coronavirus 2019-nCoV: prediction of potential receptor, natural reservoir, tropism and therapeutic/vaccine target. Version 4. F1000Res. 2020 Jan 27 [revised 2021 Jan 1];9:52. doi: 10.12688/f1000research.22149.4. eCollection 2020.']",11/06/2020,https://clinicaltrials.gov/show/NCT04382768,01/01/2021,0,1
460,NCT04383535,Completed,27/09/2020,27/09/2020,No Results Posted,"['Piechotta V, Iannizzi C, Chai KL, Valk SJ, Kimber C, Dorando E, Monsef I, Wood EM, Lamikanra AA, Roberts DJ, McQuilten Z, So-Osman C, Estcourt LJ, Skoetz N. Convalescent plasma or hyperimmune immunoglobulin for people with COVID-19: a living systematic review. Cochrane Database Syst Rev. 2021 May 20;5:CD013600. doi: 10.1002/14651858.CD013600.pub4.', 'Simonovich VA, Burgos Pratx LD, Scibona P, Beruto MV, Vallone MG, V√°zquez C, Savoy N, Giunta DH, P√©rez LG, S√°nchez MDL, Gamarnik AV, Ojeda DS, Santoro DM, Camino PJ, Antelo S, Rainero K, Vidiella GP, Miyazaki EA, Cornistein W, Trabadelo OA, Ross FM, Spotti M, Funtowicz G, Scordo WE, Losso MH, Ferniot I, Pardo PE, Rodriguez E, Rucci P, Pasquali J, Fuentes NA, Esperatti M, Speroni GA, Nannini EC, Matteaccio A, Michelangelo HG, Follmann D, Lane HC, Belloso WH; PlasmAr Study Group. A Randomized Trial of Convalescent Plasma in Covid-19 Severe Pneumonia. N Engl J Med. 2021 Feb 18;384(7):619-629. doi: 10.1056/NEJMoa2031304. Epub 2020 Nov 24.']","['Luke TC, Kilbane EM, Jackson JL, Hoffman SL. Meta-analysis: convalescent blood products for Spanish influenza pneumonia: a future H5N1 treatment? Ann Intern Med. 2006 Oct 17;145(8):599-609. Epub 2006 Aug 29.']",30/09/2020,https://clinicaltrials.gov/show/NCT04383535,27/09/2020,0,1
461,NCT04383548,Not yet recruiting,01/12/2020,01/01/2021,No Results Posted,,,12/05/2020,https://clinicaltrials.gov/show/NCT04383548,01/12/2020,0,0
462,NCT04383574,"Active, not recruiting",28/08/2020,30/05/2021,No Results Posted,"['Wu Z, Hu Y, Xu M, Chen Z, Yang W, Jiang Z, Li M, Jin H, Cui G, Chen P, Wang L, Zhao G, Ding Y, Zhao Y, Yin W. Safety, tolerability, and immunogenicity of an inactivated SARS-CoV-2 vaccine (CoronaVac) in healthy adults aged 60 years and older: a randomised, double-blind, placebo-controlled, phase 1/2 clinical trial. Lancet Infect Dis. 2021 Jun;21(6):803-812. doi: 10.1016/S1473-3099(20)30987-7. Epub 2021 Feb 3.']",,10/09/2020,https://clinicaltrials.gov/show/NCT04383574,28/08/2020,0,1
463,NCT04383587,Completed,01/07/2020,31/07/2020,No Results Posted,,,01/09/2020,https://clinicaltrials.gov/show/NCT04383587,01/07/2020,0,0
464,NCT04383717,Not yet recruiting,30/08/2020,30/10/2020,No Results Posted,,,13/05/2020,https://clinicaltrials.gov/show/NCT04383717,30/08/2020,0,0
465,NCT04384380,Completed,31/05/2020,31/05/2020,No Results Posted,,"['Cheng SC, Chang YC, Fan Chiang YL, Chien YC, Cheng M, Yang CH, Huang CH, Hsu YN. First case of Coronavirus Disease 2019 (COVID-19) pneumonia in Taiwan. J Formos Med Assoc. 2020 Mar;119(3):747-751. doi: 10.1016/j.jfma.2020.02.007. Epub 2020 Feb 26.', 'Huang C, Wang Y, Li X, Ren L, Zhao J, Hu Y, Zhang L, Fan G, Xu J, Gu X, Cheng Z, Yu T, Xia J, Wei Y, Wu W, Xie X, Yin W, Li H, Liu M, Xiao Y, Gao H, Guo L, Xie J, Wang G, Jiang R, Gao Z, Jin Q, Wang J, Cao B. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet. 2020 Feb 15;395(10223):497-506. doi: 10.1016/S0140-6736(20)30183-5. Epub 2020 Jan 24. Erratum in: Lancet. 2020 Jan 30;:.', 'Zhang W, Du RH, Li B, Zheng XS, Yang XL, Hu B, Wang YY, Xiao GF, Yan B, Shi ZL, Zhou P. Molecular and serological investigation of 2019-nCoV infected patients: implication of multiple shedding routes. Emerg Microbes Infect. 2020 Feb 17;9(1):386-389. doi: 10.1080/22221751.2020.1729071. eCollection 2020.', 'Cortegiani A, Ingoglia G, Ippolito M, Giarratano A, Einav S. A systematic review on the efficacy and safety of chloroquine for the treatment of COVID-19. J Crit Care. 2020 Jun;57:279-283. doi: 10.1016/j.jcrc.2020.03.005. Epub 2020 Mar 10.', 'Gautret P, Lagier JC, Parola P, Hoang VT, Meddeb L, Mailhe M, Doudier B, Courjon J, Giordanengo V, Vieira VE, Tissot Dupont H, Honor√© S, Colson P, Chabri√®re E, La Scola B, Rolain JM, Brouqui P, Raoult D. Hydroxychloroquine and azithromycin as a treatment of COVID-19: results of an open-label non-randomized clinical trial. Int J Antimicrob Agents. 2020 Jul;56(1):105949. doi: 10.1016/j.ijantimicag.2020.105949. Epub 2020 Mar 20.']",04/08/2020,https://clinicaltrials.gov/show/NCT04384380,31/05/2020,0,1
466,NCT04384458,Recruiting,10/09/2020,01/04/2021,No Results Posted,,,06/10/2020,https://clinicaltrials.gov/show/NCT04384458,10/09/2020,0,0
467,NCT04384497,Recruiting,01/06/2020,01/12/2020,No Results Posted,,,27/05/2020,https://clinicaltrials.gov/show/NCT04384497,01/06/2020,0,0
468,NCT04384549,Recruiting,20/02/2021,20/02/2021,No Results Posted,,,18/08/2020,https://clinicaltrials.gov/show/NCT04384549,20/02/2021,0,0
469,NCT04384588,Recruiting,06/04/2021,06/04/2021,No Results Posted,,,12/05/2020,https://clinicaltrials.gov/show/NCT04384588,06/04/2021,0,0
470,NCT04385017,Recruiting,12/06/2021,12/06/2021,No Results Posted,"['Courjon J, Dufies O, Robert A, Bailly L, Torre C, Chirio D, Contenti J, Vitale S, Loubatier C, Doye A, Pomares-Estran C, Gonfrier G, Lotte R, Munro P, Visvikis O, Dellamonica J, Giordanengo V, Carles M, Yvan-Charvet L, Ivanov S, Auberger P, Jacquel A, Boyer L. Heterogeneous NLRP3 inflammasome signature in circulating myeloid cells as a biomarker of COVID-19 severity. Blood Adv. 2021 Mar 9;5(5):1523-1534. doi: 10.1182/bloodadvances.2020003918.']",,12/05/2020,https://clinicaltrials.gov/show/NCT04385017,12/06/2021,0,1
471,NCT04385043,Recruiting,15/10/2020,15/05/2021,No Results Posted,,"['Mair-Jenkins J, Saavedra-Campos M, Baillie JK, Cleary P, Khaw FM, Lim WS, Makki S, Rooney KD, Nguyen-Van-Tam JS, Beck CR; Convalescent Plasma Study Group. The effectiveness of convalescent plasma and hyperimmune immunoglobulin for the treatment of severe acute respiratory infections of viral etiology: a systematic review and exploratory meta-analysis. J Infect Dis. 2015 Jan 1;211(1):80-90. doi: 10.1093/infdis/jiu396. Epub 2014 Jul 16. Review.', 'Linee Guida Cinesi sulla Gestione di COVID-19 Versione 7¬∞ Pubblicate in data 3/3/2020 dalla Commissione della Salute Nazionale della R.P.C..', 'Arabi Y, Balkhy H, Hajeer AH, Bouchama A, Hayden FG, Al-Omari A, Al-Hameed FM, Taha Y, Shindo N, Whitehead J, Merson L, AlJohani S, Al-Khairy K, Carson G, Luke TC, Hensley L, Al-Dawood A, Al-Qahtani S, Modjarrad K, Sadat M, Rohde G, Leport C, Fowler R. Feasibility, safety, clinical, and laboratory effects of convalescent plasma therapy for patients with Middle East respiratory syndrome coronavirus infection: a study protocol. Springerplus. 2015 Nov 19;4:709. doi: 10.1186/s40064-015-1490-9. eCollection 2015.', 'Dean CL, Hooper JW, Dye JM, Zak SE, Koepsell SA, Corash L, Benjamin RJ, Kwilas S, Bonds S, Winkler AM, Kraft CS. Characterization of Ebola convalescent plasma donor immune response and psoralen treated plasma in the United States. Transfusion. 2020 May;60(5):1024-1031. doi: 10.1111/trf.15739. Epub 2020 Mar 4.']",12/05/2020,https://clinicaltrials.gov/show/NCT04385043,15/10/2020,0,1
472,NCT04385108,Recruiting,31/12/2021,31/12/2021,No Results Posted,,,28/12/2020,https://clinicaltrials.gov/show/NCT04385108,31/12/2021,0,0
473,NCT04385186,Not yet recruiting,30/11/2020,30/12/2020,No Results Posted,,,02/06/2020,https://clinicaltrials.gov/show/NCT04385186,30/11/2020,0,0
474,NCT04385576,Recruiting,15/09/2020,30/12/2020,No Results Posted,,"['Canelli R, Connor CW, Gonzalez M, Nozari A, Ortega R. Barrier Enclosure during Endotracheal Intubation. N Engl J Med. 2020 May 14;382(20):1957-1958. doi: 10.1056/NEJMc2007589. Epub 2020 Apr 3.']",13/05/2020,https://clinicaltrials.gov/show/NCT04385576,15/09/2020,0,1
475,NCT04385810,Completed,29/07/2020,29/07/2020,No Results Posted,,,16/11/2020,https://clinicaltrials.gov/show/NCT04385810,29/07/2020,0,0
476,NCT04386668,Terminated,12/07/2020,31/08/2020,No Results Posted,,,08/10/2020,https://clinicaltrials.gov/show/NCT04386668,12/07/2020,0,0
477,NCT04386694,Completed,17/09/2020,17/09/2020,No Results Posted,,,29/10/2020,https://clinicaltrials.gov/show/NCT04386694,17/09/2020,0,0
478,NCT04386850,Recruiting,15/11/2020,15/03/2021,No Results Posted,,,12/06/2020,https://clinicaltrials.gov/show/NCT04386850,15/11/2020,0,0
479,NCT04387253,Recruiting,23/07/2021,23/07/2021,No Results Posted,,,09/06/2020,https://clinicaltrials.gov/show/NCT04387253,23/07/2021,0,0
480,NCT04387292,Recruiting,01/05/2021,01/05/2021,No Results Posted,,,14/09/2020,https://clinicaltrials.gov/show/NCT04387292,01/05/2021,0,0
481,NCT04387409,"Active, not recruiting",01/05/2021,01/05/2021,No Results Posted,,,30/09/2020,https://clinicaltrials.gov/show/NCT04387409,01/05/2021,0,0
482,NCT04388410,Recruiting,30/11/2020,31/12/2020,No Results Posted,,,26/08/2020,https://clinicaltrials.gov/show/NCT04388410,30/11/2020,0,0
483,NCT04389333,Completed,26/04/2020,20/05/2020,No Results Posted,,,21/07/2020,https://clinicaltrials.gov/show/NCT04389333,26/04/2020,0,0
484,NCT04389372,Recruiting,01/03/2021,01/12/2021,No Results Posted,"['Rizzoli PB, Grazzi L. Adaptation of the management of chronic migraine patients with medication overuse to the suspension of treatment protocols during the COVID-19 pandemic: Lessons from a tertiary headache center in Milan-6-month results. Headache. 2021 Jun;61(6):961-962. doi: 10.1111/head.14140. Epub 2021 Jun 21.']",,18/05/2020,https://clinicaltrials.gov/show/NCT04389372,01/03/2021,0,1
485,NCT04389385,"Active, not recruiting",30/09/2020,31/05/2021,No Results Posted,,,15/05/2020,https://clinicaltrials.gov/show/NCT04389385,30/09/2020,0,0
486,NCT04389411,Not yet recruiting,01/09/2021,01/12/2021,No Results Posted,,,01/09/2020,https://clinicaltrials.gov/show/NCT04389411,01/09/2021,0,0
487,NCT04389450,Recruiting,01/05/2021,01/03/2022,No Results Posted,,,29/10/2020,https://clinicaltrials.gov/show/NCT04389450,01/05/2021,0,0
488,NCT04389580,Not yet recruiting,01/08/2020,01/09/2020,No Results Posted,,,04/06/2020,https://clinicaltrials.gov/show/NCT04389580,01/08/2020,0,0
489,NCT04389801,Not yet recruiting,30/09/2020,31/12/2020,No Results Posted,,,15/05/2020,https://clinicaltrials.gov/show/NCT04389801,30/09/2020,0,0
490,NCT04389944,Completed,30/06/2020,30/06/2020,No Results Posted,,,04/08/2020,https://clinicaltrials.gov/show/NCT04389944,30/06/2020,0,0
491,NCT04390022,Completed,17/09/2020,09/10/2020,Study Results,"['Chaccour C, Casellas A, Blanco-Di Matteo A, Pineda I, Fernandez-Montero A, Ruiz-Castillo P, Richardson MA, Rodr√≠guez-Mateos M, Jord√°n-Iborra C, Brew J, Carmona-Torre F, Gir√°ldez M, Laso E, Gabald√≥n-Figueira JC, Doba√±o C, Moncunill G, Yuste JR, Del Pozo JL, Rabinovich NR, Sch√∂ning V, Hammann F, Reina G, Sadaba B, Fern√°ndez-Alonso M. The effect of early treatment with ivermectin on viral load, symptoms and humoral response in patients with non-severe COVID-19: A pilot, double-blind, placebo-controlled, randomized clinical trial. EClinicalMedicine. 2021 Feb;32:100720. doi: 10.1016/j.eclinm.2020.100720. Epub 2021 Jan 19.']",,17/12/2020,https://clinicaltrials.gov/show/NCT04390022,17/09/2020,1,1
492,NCT04390061,Not yet recruiting,01/09/2020,01/10/2020,No Results Posted,,,15/05/2020,https://clinicaltrials.gov/show/NCT04390061,01/09/2020,0,0
493,NCT04390178,"Active, not recruiting",01/06/2020,01/12/2020,No Results Posted,,,15/05/2020,https://clinicaltrials.gov/show/NCT04390178,01/06/2020,0,0
494,NCT04390412,"Active, not recruiting",30/08/2020,01/12/2020,No Results Posted,,,10/11/2020,https://clinicaltrials.gov/show/NCT04390412,30/08/2020,0,0
495,NCT04390464,Recruiting,07/05/2021,01/05/2022,No Results Posted,"['Kulkarni S, Fisk M, Kostapanos M, Banham-Hall E, Bond S, Hernan-Sancho E, Norton S, Cheriyan J, Cope A, Galloway J, Hall F, Jayne D, Wilkinson IB. Repurposed immunomodulatory drugs for Covid-19 in pre-ICu patients - mulTi-Arm Therapeutic study in pre-ICu patients admitted with Covid-19 - Repurposed Drugs (TACTIC-R): A structured summary of a study protocol for a randomised controlled trial. Trials. 2020 Jul 8;21(1):626. doi: 10.1186/s13063-020-04535-4.']",,18/05/2020,https://clinicaltrials.gov/show/NCT04390464,07/05/2021,0,1
496,NCT04390516,Completed,04/05/2020,30/05/2020,No Results Posted,,,12/06/2020,https://clinicaltrials.gov/show/NCT04390516,04/05/2020,0,0
497,NCT04390594,Recruiting,12/02/2021,12/08/2021,No Results Posted,,,07/09/2020,https://clinicaltrials.gov/show/NCT04390594,12/02/2021,0,0
498,NCT04391101,Not yet recruiting,01/06/2021,01/12/2021,No Results Posted,,,20/05/2020,https://clinicaltrials.gov/show/NCT04391101,01/06/2021,0,0
499,NCT04391127,Completed,06/11/2020,06/11/2020,No Results Posted,,,09/11/2020,https://clinicaltrials.gov/show/NCT04391127,06/11/2020,0,0
500,NCT04391140,Recruiting,01/12/2020,01/06/2021,No Results Posted,"['Tavernier E, McNicholas B, Pavlov I, Roca O, Perez Y, Laffey J, Mirza S, Cosgrave D, Vines D, Frat JP, Ehrmann S, Li J. Awake prone positioning of hypoxaemic patients with COVID-19: protocol for a randomised controlled open-label superiority meta-trial. BMJ Open. 2020 Nov 11;10(11):e041520. doi: 10.1136/bmjopen-2020-041520.']",,18/08/2020,https://clinicaltrials.gov/show/NCT04391140,01/12/2020,0,1
501,NCT04391712,Completed,15/05/2020,16/07/2020,No Results Posted,,,05/08/2020,https://clinicaltrials.gov/show/NCT04391712,15/05/2020,0,0
502,NCT04391829,Recruiting,31/08/2021,31/08/2021,No Results Posted,,"['Li D, Jin M, Bao P, Zhao W, Zhang S. Clinical Characteristics and Results of Semen Tests Among Men With Coronavirus Disease 2019. JAMA Netw Open. 2020 May 1;3(5):e208292. doi: 10.1001/jamanetworkopen.2020.8292. Erratum in: JAMA Netw Open. 2020 Jun 1;3(6):e2010845.']",28/10/2020,https://clinicaltrials.gov/show/NCT04391829,31/08/2021,0,1
503,NCT04392115,Not yet recruiting,15/12/2020,15/09/2021,No Results Posted,,,18/05/2020,https://clinicaltrials.gov/show/NCT04392115,15/12/2020,0,0
504,NCT04392128,Withdrawn,02/09/2020,02/09/2020,No Results Posted,,,04/09/2020,https://clinicaltrials.gov/show/NCT04392128,02/09/2020,0,0
505,NCT04392219,Completed,11/08/2020,11/08/2020,Results Submitted,,,17/08/2020,https://clinicaltrials.gov/show/NCT04392219,11/08/2020,0,0
506,NCT04392232,Recruiting,31/12/2020,31/12/2020,No Results Posted,,,20/05/2020,https://clinicaltrials.gov/show/NCT04392232,31/12/2020,0,0
507,NCT04392323,Recruiting,01/07/2020,31/07/2020,No Results Posted,,"['Huang C, Wang Y, Li X, Ren L, Zhao J, Hu Y, Zhang L, Fan G, Xu J, Gu X, Cheng Z, Yu T, Xia J, Wei Y, Wu W, Xie X, Yin W, Li H, Liu M, Xiao Y, Gao H, Guo L, Xie J, Wang G, Jiang R, Gao Z, Jin Q, Wang J, Cao B. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet. 2020 Feb 15;395(10223):497-506. doi: 10.1016/S0140-6736(20)30183-5. Epub 2020 Jan 24. Erratum in: Lancet. 2020 Jan 30;:.', 'Guan WJ, Ni ZY, Hu Y, Liang WH, Ou CQ, He JX, Liu L, Shan H, Lei CL, Hui DSC, Du B, Li LJ, Zeng G, Yuen KY, Chen RC, Tang CL, Wang T, Chen PY, Xiang J, Li SY, Wang JL, Liang ZJ, Peng YX, Wei L, Liu Y, Hu YH, Peng P, Wang JM, Liu JY, Chen Z, Li G, Zheng ZJ, Qiu SQ, Luo J, Ye CJ, Zhu SY, Zhong NS; China Medical Treatment Expert Group for Covid-19. Clinical Characteristics of Coronavirus Disease 2019 in China. N Engl J Med. 2020 Apr 30;382(18):1708-1720. doi: 10.1056/NEJMoa2002032. Epub 2020 Feb 28.', 'Wu JT, Leung K, Leung GM. Nowcasting and forecasting the potential domestic and international spread of the 2019-nCoV outbreak originating in Wuhan, China: a modelling study. Lancet. 2020 Feb 29;395(10225):689-697. doi: 10.1016/S0140-6736(20)30260-9. Epub 2020 Jan 31. Erratum in: Lancet. 2020 Feb 4;:.', 'Li Q, Guan X, Wu P, Wang X, Zhou L, Tong Y, Ren R, Leung KSM, Lau EHY, Wong JY, Xing X, Xiang N, Wu Y, Li C, Chen Q, Li D, Liu T, Zhao J, Liu M, Tu W, Chen C, Jin L, Yang R, Wang Q, Zhou S, Wang R, Liu H, Luo Y, Liu Y, Shao G, Li H, Tao Z, Yang Y, Deng Z, Liu B, Ma Z, Zhang Y, Shi G, Lam TTY, Wu JT, Gao GF, Cowling BJ, Yang B, Leung GM, Feng Z. Early Transmission Dynamics in Wuhan, China, of Novel Coronavirus-Infected Pneumonia. N Engl J Med. 2020 Mar 26;382(13):1199-1207. doi: 10.1056/NEJMoa2001316. Epub 2020 Jan 29.', 'Hanna TP, Evans GA, Booth CM. Cancer, COVID-19 and the precautionary principle: prioritizing treatment during a global pandemic. Nat Rev Clin Oncol. 2020 May;17(5):268-270. doi: 10.1038/s41571-020-0362-6.', 'Brindle ME, Gawande A. Managing COVID-19 in Surgical Systems. Ann Surg. 2020 Jul;272(1):e1-e2. doi: 10.1097/SLA.0000000000003923.', 'Lei S, Jiang F, Su W, Chen C, Chen J, Mei W, Zhan LY, Jia Y, Zhang L, Liu D, Xia ZY, Xia Z. Clinical characteristics and outcomes of patients undergoing surgeries during the incubation period of COVID-19 infection. EClinicalMedicine. 2020 Apr 5;21:100331. doi: 10.1016/j.eclinm.2020.100331. eCollection 2020 Apr.', 'Aminian A, Kermansaravi M, Azizi S, Alibeigi P, Safamanesh S, Mousavimaleki A, Rezaei MT, Faridi M, Mokhber S, Pazouki A, Safari S. Bariatric Surgical Practice During the Initial Phase of COVID-19 Outbreak. Obes Surg. 2020 Sep;30(9):3624-3627. doi: 10.1007/s11695-020-04617-x.', 'Luong-Nguyen M, Hermand H, Abdalla S, Cabrit N, Hobeika C, Brouquet A, Go√©r√© D, Sauvanet A. Nosocomial infection with SARS-Cov-2 within Departments of Digestive Surgery. J Visc Surg. 2020 Jun;157(3S1):S13-S18. doi: 10.1016/j.jviscsurg.2020.04.016. Epub 2020 Apr 27.', 'Yang S, Zhang Y, Cai J, Wang Z. Clinical Characteristics of COVID-19 After Gynecologic Oncology Surgery in Three Women: A Retrospective Review of Medical Records. Oncologist. 2020 Jun;25(6):e982-e985. doi: 10.1634/theoncologist.2020-0157. Epub 2020 Apr 7.', 'Wong SCY, Kwong RT, Wu TC, Chan JWM, Chu MY, Lee SY, Wong HY, Lung DC. Risk of nosocomial transmission of coronavirus disease 2019: an experience in a general ward setting in Hong Kong. J Hosp Infect. 2020 Jun;105(2):119-127. doi: 10.1016/j.jhin.2020.03.036. Epub 2020 Apr 4.', 'Zhong Q, Liu YY, Luo Q, Zou YF, Jiang HX, Li H, Zhang JJ, Li Z, Yang X, Ma M, Tang LJ, Chen YY, Zheng F, Ke JJ, Zhang ZZ. Spinal anaesthesia for patients with coronavirus disease 2019 and possible transmission rates in anaesthetists: retrospective, single-centre, observational cohort study. Br J Anaesth. 2020 Jun;124(6):670-675. doi: 10.1016/j.bja.2020.03.007. Epub 2020 Mar 28. Erratum in: Br J Anaesth. 2020 Sep;125(3):408.']",18/05/2020,https://clinicaltrials.gov/show/NCT04392323,01/07/2020,0,1
508,NCT04392414,Completed,10/07/2020,23/09/2020,No Results Posted,"['Piechotta V, Iannizzi C, Chai KL, Valk SJ, Kimber C, Dorando E, Monsef I, Wood EM, Lamikanra AA, Roberts DJ, McQuilten Z, So-Osman C, Estcourt LJ, Skoetz N. Convalescent plasma or hyperimmune immunoglobulin for people with COVID-19: a living systematic review. Cochrane Database Syst Rev. 2021 May 20;5:CD013600. doi: 10.1002/14651858.CD013600.pub4.']",,25/09/2020,https://clinicaltrials.gov/show/NCT04392414,10/07/2020,0,1
509,NCT04392427,Not yet recruiting,01/05/2022,01/05/2022,No Results Posted,,"['Zhu N, Zhang D, Wang W, Li X, Yang B, Song J, Zhao X, Huang B, Shi W, Lu R, Niu P, Zhan F, Ma X, Wang D, Xu W, Wu G, Gao GF, Tan W; China Novel Coronavirus Investigating and Research Team. A Novel Coronavirus from Patients with Pneumonia in China, 2019. N Engl J Med. 2020 Feb 20;382(8):727-733. doi: 10.1056/NEJMoa2001017. Epub 2020 Jan 24.', 'Cui J, Li F, Shi ZL. Origin and evolution of pathogenic coronaviruses. Nat Rev Microbiol. 2019 Mar;17(3):181-192. doi: 10.1038/s41579-018-0118-9. Review.', 'Rossignol JF. Nitazoxanide: a first-in-class broad-spectrum antiviral agent. Antiviral Res. 2014 Oct;110:94-103. doi: 10.1016/j.antiviral.2014.07.014. Epub 2014 Aug 7. Review.', 'Graci JD, Cameron CE. Mechanisms of action of ribavirin against distinct viruses. Rev Med Virol. 2006 Jan-Feb;16(1):37-48. Review.', 'Caly L, Druce JD, Catton MG, Jans DA, Wagstaff KM. The FDA-approved drug ivermectin inhibits the replication of SARS-CoV-2 in vitro. Antiviral Res. 2020 Jun;178:104787. doi: 10.1016/j.antiviral.2020.104787. Epub 2020 Apr 3.']",03/09/2020,https://clinicaltrials.gov/show/NCT04392427,01/05/2022,0,1
510,NCT04392713,Recruiting,01/07/2020,01/07/2020,No Results Posted,,"['≈ûim≈üek Yavuz S, √únal S. Antiviral treatment of COVID-19. Turk J Med Sci. 2020 Apr 21;50(SI-1):611-619. doi: 10.3906/sag-2004-145. Review.']",19/05/2020,https://clinicaltrials.gov/show/NCT04392713,01/07/2020,0,1
511,NCT04392869,Completed,31/07/2020,31/10/2020,No Results Posted,,,03/11/2020,https://clinicaltrials.gov/show/NCT04392869,31/07/2020,0,0
512,NCT04392973,Recruiting,01/11/2021,01/11/2021,No Results Posted,"['Bosaeed M, Mahmoud E, Hussein M, Alharbi A, Alsaedy A, Alothman A, Aljeraisy M, Alqahtani H, Nashabat M, Almutairi B, Almaghaslah M, Aldibasi O, AlJohani S, Bouchama A, Arabi Y, Alaskar A. A Trial of Favipiravir and Hydroxychloroquine combination in Adults Hospitalized with moderate and severe Covid-19: A structured summary of a study protocol for a randomised controlled trial. Trials. 2020 Oct 31;21(1):904. doi: 10.1186/s13063-020-04825-x.']",,28/07/2020,https://clinicaltrials.gov/show/NCT04392973,01/11/2021,0,1
513,NCT04393038,Terminated,05/03/2021,16/04/2021,No Results Posted,,,30/06/2021,https://clinicaltrials.gov/show/NCT04393038,05/03/2021,0,0
514,NCT04393051,Not yet recruiting,30/06/2020,30/07/2020,No Results Posted,,"['Richardson P, Griffin I, Tucker C, Smith D, Oechsle O, Phelan A, Rawling M, Savory E, Stebbing J. Baricitinib as potential treatment for 2019-nCoV acute respiratory disease. Lancet. 2020 Feb 15;395(10223):e30-e31. doi: 10.1016/S0140-6736(20)30304-4. Epub 2020 Feb 4. Erratum in: Lancet. 2020 Jun 20;395(10241):1906.', 'Favalli EG, Biggioggero M, Maioli G, Caporali R. Baricitinib for COVID-19: a suitable treatment? Lancet Infect Dis. 2020 Sep;20(9):1012-1013. doi: 10.1016/S1473-3099(20)30262-0. Epub 2020 Apr 3.']",20/05/2020,https://clinicaltrials.gov/show/NCT04393051,30/06/2020,0,1
515,NCT04393077,Completed,15/05/2020,20/05/2020,No Results Posted,,,24/11/2020,https://clinicaltrials.gov/show/NCT04393077,15/05/2020,0,0
516,NCT04393415,Recruiting,25/08/2020,01/09/2020,No Results Posted,,,27/07/2020,https://clinicaltrials.gov/show/NCT04393415,25/08/2020,0,0
517,NCT04393636,Recruiting,31/12/2022,31/12/2022,No Results Posted,,"['Plomp J, Redekop WK, Dekker FW, van Geldorp TR, Haalebos MM, Jambroes G, Kingma JH, Zijlstra F, Tijssen JG. Death on the waiting list for cardiac surgery in The Netherlands in 1994 and 1995. Heart. 1999 Jun;81(6):593-7.', 'Morgan CD, Sykora K, Naylor CD. Analysis of deaths while waiting for cardiac surgery among 29,293 consecutive patients in Ontario, Canada. The Steering Committee of the Cardiac Care Network of Ontario. Heart. 1998 Apr;79(4):345-9.', 'Malaisrie SC, McDonald E, Kruse J, Li Z, McGee EC Jr, Abicht TO, Russell H, McCarthy PM, Andrei AC. Mortality while waiting for aortic valve replacement. Ann Thorac Surg. 2014 Nov;98(5):1564-70; discussion 1570-1. doi: 10.1016/j.athoracsur.2014.06.040. Epub 2014 Sep 18.', 'da Fonseca VBP, De Lorenzo A, Tura BR, Pittella FJM, da Rocha ASC. Mortality and morbidity of patients on the waiting list for coronary artery bypass graft surgery. Interact Cardiovasc Thorac Surg. 2018 Jan 1;26(1):34-40. doi: 10.1093/icvts/ivx276.', 'Turner AJ, Hiscox JA, Hooper NM. ACE2: from vasopeptidase to SARS virus receptor. Trends Pharmacol Sci. 2004 Jun;25(6):291-4. Review.', 'Chan JF, Yuan S, Kok KH, To KK, Chu H, Yang J, Xing F, Liu J, Yip CC, Poon RW, Tsoi HW, Lo SK, Chan KH, Poon VK, Chan WM, Ip JD, Cai JP, Cheng VC, Chen H, Hui CK, Yuen KY. A familial cluster of pneumonia associated with the 2019 novel coronavirus indicating person-to-person transmission: a study of a family cluster. Lancet. 2020 Feb 15;395(10223):514-523. doi: 10.1016/S0140-6736(20)30154-9. Epub 2020 Jan 24.', 'Al-Sarraf N, Thalib L, Hughes A, Tolan M, Young V, McGovern E. Effect of smoking on short-term outcome of patients undergoing coronary artery bypass surgery. Ann Thorac Surg. 2008 Aug;86(2):517-23. doi: 10.1016/j.athoracsur.2008.03.070.', 'Grabas MP, Hansen SM, Torp-Pedersen C, B√∏ggild H, Ullits LR, Deding U, Nielsen BJ, Jensen PF, Overgaard C. Alcohol consumption and mortality in patients undergoing coronary artery bypass graft (CABG)-a register-based cohort study. BMC Cardiovasc Disord. 2016 Nov 11;16(1):219.', 'Guo P. Preoperative education interventions to reduce anxiety and improve recovery among cardiac surgery patients: a review of randomised controlled trials. J Clin Nurs. 2015 Jan;24(1-2):34-46. doi: 10.1111/jocn.12618. Epub 2014 Jun 3. Review.', 'Hulzebos EH, Helders PJ, Favi√© NJ, De Bie RA, Brutel de la Riviere A, Van Meeteren NL. Preoperative intensive inspiratory muscle training to prevent postoperative pulmonary complications in high-risk patients undergoing CABG surgery: a randomized clinical trial. JAMA. 2006 Oct 18;296(15):1851-7.', 'Mariscalco G, Wozniak MJ, Dawson AG, Serraino GF, Porter R, Nath M, Klersy C, Kumar T, Murphy GJ. Body Mass Index and Mortality Among Adults Undergoing Cardiac Surgery: A Nationwide Study With a Systematic Review and Meta-Analysis. Circulation. 2017 Feb 28;135(9):850-863. doi: 10.1161/CIRCULATIONAHA.116.022840. Epub 2016 Dec 28. Review.', 'Navaratnarajah M, Rea R, Evans R, Gibson F, Antoniades C, Keiralla A, Demosthenous M, Kassimis G, Krasopoulos G. Effect of glycaemic control on complications following cardiac surgery: literature review. J Cardiothorac Surg. 2018 Jan 17;13(1):10. doi: 10.1186/s13019-018-0700-2. Review.', 'Marmelo F, Rocha V, Moreira-Gon√ßalves D. The impact of prehabilitation on post-surgical complications in patients undergoing non-urgent cardiovascular surgical intervention: Systematic review and meta-analysis. Eur J Prev Cardiol. 2018 Mar;25(4):404-417. doi: 10.1177/2047487317752373. Epub 2018 Jan 17. Erratum in: Eur J Prev Cardiol. 2018 Jun;25(9):NP2.']",09/06/2020,https://clinicaltrials.gov/show/NCT04393636,31/12/2022,0,1
518,NCT04393727,Terminated,30/09/2020,30/09/2020,No Results Posted,,"['Shen C, Wang Z, Zhao F, Yang Y, Li J, Yuan J, Wang F, Li D, Yang M, Xing L, Wei J, Xiao H, Yang Y, Qu J, Qing L, Chen L, Xu Z, Peng L, Li Y, Zheng H, Chen F, Huang K, Jiang Y, Liu D, Zhang Z, Liu Y, Liu L. Treatment of 5 Critically Ill Patients With COVID-19 With Convalescent Plasma. JAMA. 2020 Apr 28;323(16):1582-1589. doi: 10.1001/jama.2020.4783.']",12/11/2020,https://clinicaltrials.gov/show/NCT04393727,30/09/2020,0,1
519,NCT04393792,Recruiting,01/08/2020,01/08/2020,No Results Posted,,,19/05/2020,https://clinicaltrials.gov/show/NCT04393792,01/08/2020,0,0
520,NCT04393818,Completed,24/08/2020,24/08/2020,Results Submitted,"['Fiol-DeRoque MA, Serrano-Ripoll MJ, Jim√©nez R, Zamanillo-Campos R, Y√°√±ez-Juan AM, Bennasar-Veny M, Leiva A, Gervilla E, Garc√≠a-Buades ME, Garc√≠a-Toro M, Alonso-Coello P, Pastor-Moreno G, Ruiz-P√©rez I, Sitges C, Garc√≠a-Campayo J, Llobera-C√°naves J, Ricci-Cabello I. A Mobile Phone-Based Intervention to Reduce Mental Health Problems in Health Care Workers During the COVID-19 Pandemic (PsyCovidApp): Randomized Controlled Trial. JMIR Mhealth Uhealth. 2021 May 18;9(5):e27039. doi: 10.2196/27039.', 'Serrano-Ripoll MJ, Ricci-Cabello I, Jim√©nez R, Zamanillo-Campos R, Ya√±ez-Juan AM, Bennasar-Veny M, Sitges C, Gervilla E, Leiva A, Garc√≠a-Campayo J, Garc√≠a-Buades ME, Garc√≠a-Toro M, Pastor-Moreno G, Ruiz-Perez I, Alonso-Coello P, Llobera J, Fiol-deRoque MA. Effect of a mobile-based intervention on mental health in frontline healthcare workers against COVID-19: Protocol for a randomized controlled trial. J Adv Nurs. 2021 Jun;77(6):2898-2907. doi: 10.1111/jan.14813. Epub 2021 Mar 6.']",,10/09/2020,https://clinicaltrials.gov/show/NCT04393818,24/08/2020,0,1
521,NCT04393948,Recruiting,01/10/2020,01/11/2020,No Results Posted,,,25/06/2020,https://clinicaltrials.gov/show/NCT04393948,01/10/2020,0,0
522,NCT04393961,Recruiting,29/07/2020,29/08/2020,No Results Posted,,,19/05/2020,https://clinicaltrials.gov/show/NCT04393961,29/07/2020,0,0
523,NCT04394039,Not yet recruiting,01/08/2020,31/12/2020,No Results Posted,,,19/05/2020,https://clinicaltrials.gov/show/NCT04394039,01/08/2020,0,0
524,NCT04394117,Recruiting,30/06/2021,30/08/2021,No Results Posted,,,24/12/2020,https://clinicaltrials.gov/show/NCT04394117,30/06/2021,0,0
525,NCT04394169,Recruiting,25/09/2020,25/03/2021,No Results Posted,,,14/07/2020,https://clinicaltrials.gov/show/NCT04394169,25/09/2020,0,0
526,NCT04394182,Recruiting,31/12/2020,21/04/2021,No Results Posted,"['Moreno-Olmedo E, Su√°rez-Gironzini V, P√©rez M, Filigheddu T, M√≠nguez C, Sanjuan-Sanjuan A, Gonz√°lez JA, Rivas D, Gorospe L, Larrea L, L√≥pez E. COVID-19 pneumonia treated with ultra-low doses of radiotherapy (ULTRA-COVID study): a single institution report of two cases. Strahlenther Onkol. 2021 May;197(5):429-437. doi: 10.1007/s00066-020-01743-4. Epub 2021 Jan 27.']","['Kirkby C, Mackenzie M. Is low dose radiation therapy a potential treatment for COVID-19 pneumonia? Radiother Oncol. 2020 Jun;147:221. doi: 10.1016/j.radonc.2020.04.004. Epub 2020 Apr 6.', 'Berk LB, Hodes PJ. Roentgen therapy for infections: an historical review. Yale J Biol Med. 1991 Mar-Apr;64(2):155-65.', 'Calabrese EJ, Dhawan G. How radiotherapy was historically used to treat pneumonia: could it be useful today? Yale J Biol Med. 2013 Dec 13;86(4):555-70.', 'Cuttler JM. Application of Low Doses of Ionizing Radiation in Medical Therapies. Dose Response. 2020 Jan 6;18(1):1559325819895739. doi: 10.1177/1559325819895739. eCollection 2020 Jan-Mar.', 'Arenas M, Sabater S, Hern√°ndez V, Rovirosa A, Lara PC, Biete A, Pan√©s J. Anti-inflammatory effects of low-dose radiotherapy. Indications, dose, and radiobiological mechanisms involved. Strahlenther Onkol. 2012 Nov;188(11):975-81. doi: 10.1007/s00066-012-0170-8. Epub 2012 Aug 22. Review.', 'Calabrese EJ, Dhawan G, Kapoor R, Kozumbo WJ. Radiotherapy treatment of human inflammatory diseases and conditions: Optimal dose. Hum Exp Toxicol. 2019 Aug;38(8):888-898. doi: 10.1177/0960327119846925. Epub 2019 May 6. Review.', 'R√∂del F, Keilholz L, Herrmann M, Sauer R, Hildebrandt G. Radiobiological mechanisms in inflammatory diseases of low-dose radiation therapy. Int J Radiat Biol. 2007 Jun;83(6):357-66. Review.', 'Schaue D, Jahns J, Hildebrandt G, Trott KR. Radiation treatment of acute inflammation in mice. Int J Radiat Biol. 2005 Sep;81(9):657-67.', 'Torres Royo L, Antelo Redondo G, √Årquez Pianetta M, Arenas Prat M. Low-Dose radiation therapy for benign pathologies. Rep Pract Oncol Radiother. 2020 Mar-Apr;25(2):250-254. doi: 10.1016/j.rpor.2020.02.004. Epub 2020 Feb 22. Review.', 'Lara PC, Burgos J, Macias D. Low dose lung radiotherapy for COVID-19 pneumonia. The rationale for a cost-effective anti-inflammatory treatment. Clin Transl Radiat Oncol. 2020 Apr 25;23:27-29. doi: 10.1016/j.ctro.2020.04.006. eCollection 2020 Jul.']",19/05/2020,https://clinicaltrials.gov/show/NCT04394182,31/12/2020,0,1
527,NCT04394208,Recruiting,30/01/2021,28/02/2021,No Results Posted,,,18/08/2020,https://clinicaltrials.gov/show/NCT04394208,30/01/2021,0,0
528,NCT04394416,Recruiting,01/06/2022,01/06/2023,No Results Posted,"['Emadi A, Chua JV, Talwani R, Bentzen SM, Baddley J. Safety and Efficacy of Imatinib for Hospitalized Adults with COVID-19: A structured summary of a study protocol for a randomised controlled trial. Trials. 2020 Oct 28;21(1):897. doi: 10.1186/s13063-020-04819-9.', 'Zhao H, Mendenhall M, Deininger MW. Imatinib is not a potent anti-SARS-CoV-2 drug. Leukemia. 2020 Nov;34(11):3085-3087. doi: 10.1038/s41375-020-01045-9. Epub 2020 Sep 30.']",,04/06/2020,https://clinicaltrials.gov/show/NCT04394416,01/06/2022,0,1
529,NCT04394442,Recruiting,01/08/2020,01/08/2020,No Results Posted,,,19/05/2020,https://clinicaltrials.gov/show/NCT04394442,01/08/2020,0,0
530,NCT04394455,Enrolling by invitation,30/11/2020,30/12/2020,No Results Posted,,,02/07/2020,https://clinicaltrials.gov/show/NCT04394455,30/11/2020,0,0
531,NCT04394793,"Active, not recruiting",27/08/2020,01/09/2020,No Results Posted,,,01/09/2020,https://clinicaltrials.gov/show/NCT04394793,27/08/2020,0,0
532,NCT04395170,Not yet recruiting,01/12/2020,01/06/2021,No Results Posted,,"['Mair-Jenkins J, Saavedra-Campos M, Baillie JK, Cleary P, Khaw FM, Lim WS, Makki S, Rooney KD, Nguyen-Van-Tam JS, Beck CR; Convalescent Plasma Study Group. The effectiveness of convalescent plasma and hyperimmune immunoglobulin for the treatment of severe acute respiratory infections of viral etiology: a systematic review and exploratory meta-analysis. J Infect Dis. 2015 Jan 1;211(1):80-90. doi: 10.1093/infdis/jiu396. Epub 2014 Jul 16. Review.', 'Cheng Y, Wong R, Soo YO, Wong WS, Lee CK, Ng MH, Chan P, Wong KC, Leung CB, Cheng G. Use of convalescent plasma therapy in SARS patients in Hong Kong. Eur J Clin Microbiol Infect Dis. 2005 Jan;24(1):44-6.', 'Soo YO, Cheng Y, Wong R, Hui DS, Lee CK, Tsang KK, Ng MH, Chan P, Cheng G, Sung JJ. Retrospective comparison of convalescent plasma with continuing high-dose methylprednisolone treatment in SARS patients. Clin Microbiol Infect. 2004 Jul;10(7):676-8.', 'Duan K, Liu B, Li C, Zhang H, Yu T, Qu J, Zhou M, Chen L, Meng S, Hu Y, Peng C, Yuan M, Huang J, Wang Z, Yu J, Gao X, Wang D, Yu X, Li L, Zhang J, Wu X, Li B, Xu Y, Chen W, Peng Y, Hu Y, Lin L, Liu X, Huang S, Zhou Z, Zhang L, Wang Y, Zhang Z, Deng K, Xia Z, Gong Q, Zhang W, Zheng X, Liu Y, Yang H, Zhou D, Yu D, Hou J, Shi Z, Chen S, Chen Z, Zhang X, Yang X. Effectiveness of convalescent plasma therapy in severe COVID-19 patients. Proc Natl Acad Sci U S A. 2020 Apr 28;117(17):9490-9496. doi: 10.1073/pnas.2004168117. Epub 2020 Apr 6.', 'Francis F, Hall M, Surg, Gaines A. Early use of convalescent serum in influenza. Mil Surg. 1920;47:177-9.', 'rice H, Genereux M, Sinclair C. Hyperimmune Immunoglobulin G. In: Production of Plasma Proteins for Therapeutic Use [Internet]. Hoboken, NJ, USA: John Wiley & Sons, Inc.; 2012.', 'Vargas M, Segura √Å, Wu YW, Herrera M, Chou ML, Villalta M, Le√≥n G, Burnouf T. Human plasma-derived immunoglobulin G fractionated by an aqueous two-phase system, caprylic acid precipitation, and membrane chromatography has a high purity level and is free of detectable in vitro thrombogenic activity. Vox Sang. 2015 Feb;108(2):169-77. doi: 10.1111/vox.12209. Epub 2014 Dec 3.', 'Redden WR. Treatment of Influenza-Pneumonia by Use of Convalescent Human Serum. Bost Med Surg J. 1919 Dec 11;181(24):688-91.', 'Wong VW, Dai D, Wu AK, Sung JJ. Treatment of severe acute respiratory syndrome with convalescent plasma. Hong Kong Med J. 2003 Jun;9(3):199-201.', 'van Griensven J, Edwards T, Baize S; Ebola-Tx Consortium. Efficacy of Convalescent Plasma in Relation to Dose of Ebola Virus Antibodies. N Engl J Med. 2016 Dec 8;375(23):2307-2309. doi: 10.1056/NEJMc1609116. Epub 2016 Nov 14.', 'Zingher A, Mortimer P. Convalescent whole blood, plasma and serum in the prophylaxis of measles: JAMA, 12 April, 1926; 1180-1187. Rev Med Virol. 2005 Nov-Dec;15(6):407-18; discussion 418-21.', 'Use of Convalescent Whole Blood or Plasma Collected from Patients Recovered from Ebola Virus Disease for Transfusion, as an Empirical Treatment during Outbreaks Interim Guidance for National Health Authorities and Blood Transfusion Services Use of Convale. 2014.', 'FDA Guidance on Conduct of Clinical Trials of Medical Products during COVID-19 Public Health Emergency | FDA [Internet]. Available from: https://www.fda.gov/regulatory-information/search-fda-guidance-documents/fda-guidance-conduct-clinical-trials-medical-products-during-covid-19-public-health-emergency']",10/07/2020,https://clinicaltrials.gov/show/NCT04395170,01/12/2020,0,1
533,NCT04395768,Recruiting,30/09/2021,31/12/2021,No Results Posted,,,11/09/2020,https://clinicaltrials.gov/show/NCT04395768,30/09/2021,0,0
534,NCT04396067,Not yet recruiting,01/10/2020,01/12/2020,No Results Posted,,,27/10/2020,https://clinicaltrials.gov/show/NCT04396067,01/10/2020,0,0
535,NCT04396106,Recruiting,01/03/2021,01/05/2021,No Results Posted,,,17/12/2020,https://clinicaltrials.gov/show/NCT04396106,01/03/2021,0,0
536,NCT04397328,Not yet recruiting,30/04/2021,30/04/2021,No Results Posted,,,21/05/2020,https://clinicaltrials.gov/show/NCT04397328,30/04/2021,0,0
537,NCT04397497,Not yet recruiting,22/09/2020,22/11/2020,No Results Posted,,,26/05/2020,https://clinicaltrials.gov/show/NCT04397497,22/09/2020,0,0
538,NCT04397562,Completed,03/07/2020,03/08/2020,No Results Posted,,,18/11/2020,https://clinicaltrials.gov/show/NCT04397562,03/07/2020,0,0
539,NCT04397666,Recruiting,15/09/2020,15/11/2020,No Results Posted,,,18/08/2020,https://clinicaltrials.gov/show/NCT04397666,15/09/2020,0,0
540,NCT04397692,Recruiting,30/09/2020,30/09/2020,No Results Posted,,,08/07/2020,https://clinicaltrials.gov/show/NCT04397692,30/09/2020,0,0
541,NCT04398147,Not yet recruiting,20/12/2021,30/12/2021,No Results Posted,,,02/07/2020,https://clinicaltrials.gov/show/NCT04398147,20/12/2021,0,0
542,NCT04398277,Recruiting,01/04/2021,01/04/2021,No Results Posted,,,21/05/2020,https://clinicaltrials.gov/show/NCT04398277,01/04/2021,0,0
543,NCT04398290,Withdrawn,01/06/2021,15/07/2021,No Results Posted,,,19/08/2020,https://clinicaltrials.gov/show/NCT04398290,01/06/2021,0,0
544,NCT04398303,Not yet recruiting,01/10/2020,01/10/2020,No Results Posted,,,21/05/2020,https://clinicaltrials.gov/show/NCT04398303,01/10/2020,0,0
545,NCT04399005,Completed,05/06/2020,10/06/2020,No Results Posted,,,25/06/2020,https://clinicaltrials.gov/show/NCT04399005,05/06/2020,0,0
546,NCT04399109,Recruiting,19/05/2021,19/05/2021,No Results Posted,,,22/05/2020,https://clinicaltrials.gov/show/NCT04399109,19/05/2021,0,0
547,NCT04399317,Recruiting,01/07/2020,01/08/2020,No Results Posted,"['Roehrig S, Ait Hssain A, Shallik NAH, Elsaid IMA, Mustafa SF, Smain OAM, Molokhia AA, Lance MD. Flow controlled ventilation in Acute Respiratory Distress Syndrome associated with COVID-19: A structured summary of a study protocol for a randomised controlled trial. Trials. 2020 Sep 11;21(1):781. doi: 10.1186/s13063-020-04708-1.']",,25/06/2020,https://clinicaltrials.gov/show/NCT04399317,01/07/2020,0,1
548,NCT04399681,Recruiting,10/08/2020,10/09/2020,No Results Posted,,,22/05/2020,https://clinicaltrials.gov/show/NCT04399681,10/08/2020,0,0
549,NCT04399746,Recruiting,20/05/2020,10/06/2020,No Results Posted,,,22/05/2020,https://clinicaltrials.gov/show/NCT04399746,20/05/2020,0,0
550,NCT04399798,Not yet recruiting,15/09/2020,15/11/2020,No Results Posted,,,22/05/2020,https://clinicaltrials.gov/show/NCT04399798,15/09/2020,0,0
551,NCT04399967,Recruiting,30/06/2021,30/06/2022,No Results Posted,,,30/09/2020,https://clinicaltrials.gov/show/NCT04399967,30/06/2021,0,0
552,NCT04400019,Not yet recruiting,15/12/2020,01/04/2021,No Results Posted,,,29/09/2020,https://clinicaltrials.gov/show/NCT04400019,15/12/2020,0,0
553,NCT04400929,Recruiting,01/06/2021,01/06/2022,No Results Posted,,,07/07/2020,https://clinicaltrials.gov/show/NCT04400929,01/06/2021,0,0
554,NCT04401046,Recruiting,30/10/2020,30/10/2020,No Results Posted,,,28/07/2020,https://clinicaltrials.gov/show/NCT04401046,30/10/2020,0,0
555,NCT04401527,Withdrawn,15/08/2020,15/08/2020,No Results Posted,,,16/09/2020,https://clinicaltrials.gov/show/NCT04401527,15/08/2020,0,0
556,NCT04401644,Not yet recruiting,01/12/2021,01/12/2021,No Results Posted,,,26/05/2020,https://clinicaltrials.gov/show/NCT04401644,01/12/2021,0,0
557,NCT04402060,Recruiting,01/01/2021,01/01/2021,No Results Posted,,,19/12/2020,https://clinicaltrials.gov/show/NCT04402060,01/01/2021,0,0
558,NCT04402203,Recruiting,01/07/2020,01/07/2020,No Results Posted,,,26/05/2020,https://clinicaltrials.gov/show/NCT04402203,01/07/2020,0,0
559,NCT04402840,Recruiting,01/12/2021,01/12/2021,No Results Posted,,,03/11/2020,https://clinicaltrials.gov/show/NCT04402840,01/12/2021,0,0
560,NCT04402879,Recruiting,01/12/2021,01/06/2022,No Results Posted,,,17/12/2020,https://clinicaltrials.gov/show/NCT04402879,01/12/2021,0,0
561,NCT04402892,Not yet recruiting,01/03/2021,01/03/2021,No Results Posted,,,27/05/2020,https://clinicaltrials.gov/show/NCT04402892,01/03/2021,0,0
562,NCT04403243,Recruiting,22/07/2020,23/08/2020,No Results Posted,,,27/05/2020,https://clinicaltrials.gov/show/NCT04403243,22/07/2020,0,0
563,NCT04403269,Recruiting,05/05/2021,05/05/2021,No Results Posted,,,27/05/2020,https://clinicaltrials.gov/show/NCT04403269,05/05/2021,0,0
564,NCT04403477,Recruiting,20/07/2020,30/10/2020,No Results Posted,"['Chowdhury FR, Hoque A, Chowdhury FUH, Amin MR, Rahim A, Rahman MM, Yasmin R, Amin MR, Miah MT, Kalam MA, Rahman MS. Convalescent plasma transfusion therapy in severe COVID-19 patients- a safety, efficacy and dose response study: A structured summary of a study protocol of a phase II randomized controlled trial. Trials. 2020 Oct 26;21(1):883. doi: 10.1186/s13063-020-04734-z.']",,27/05/2020,https://clinicaltrials.gov/show/NCT04403477,20/07/2020,0,1
565,NCT04403646,Terminated,20/10/2020,01/11/2020,No Results Posted,"['Molino S, Pisarevsky A, Mingorance FL, Vega P, Stefanolo JP, Repetti J, Ludue√±a G, Pepa P, Olmos JI, Fermepin MR, Uehara T, Villapol S, Savidge T, Treangen T, Viciani E, Castagnetti A, Piskorz MM. Natural tannin extracts supplementation for COVID-19 patients (TanCOVID): a structured summary of a study protocol for a randomized controlled trial. Trials. 2021 Apr 28;22(1):310. doi: 10.1186/s13063-021-05281-x.']",,22/12/2020,https://clinicaltrials.gov/show/NCT04403646,20/10/2020,0,1
566,NCT04403685,Terminated,08/07/2020,21/07/2020,No Results Posted,"['Veiga VC, Prats JAGG, Farias DLC, Rosa RG, Dourado LK, Zampieri FG, Machado FR, Lopes RD, Berwanger O, Azevedo LCP, Avezum √Å, Lisboa TC, Rojas SSO, Coelho JC, Leite RT, Carvalho JC, Andrade LEC, Sandes AF, Pint√£o MCT, Castro CG Jr, Santos SV, de Almeida TML, Costa AN, Gebara OCE, de Freitas FGR, Pacheco ES, Machado DJB, Martin J, Concei√ß√£o FG, Siqueira SRR, Damiani LP, Ishihara LM, Schneider D, de Souza D, Cavalcanti AB, Scheinberg P; Coalition covid-19 Brazil VI Investigators. Effect of tocilizumab on clinical outcomes at 15 days in patients with severe or critical coronavirus disease 2019: randomised controlled trial. BMJ. 2021 Jan 20;372:n84. doi: 10.1136/bmj.n84.']",,26/08/2020,https://clinicaltrials.gov/show/NCT04403685,08/07/2020,0,1
567,NCT04403906,Not yet recruiting,01/06/2021,01/08/2021,No Results Posted,,,27/05/2020,https://clinicaltrials.gov/show/NCT04403906,01/06/2021,0,0
568,NCT04405271,Not yet recruiting,15/11/2020,15/11/2020,No Results Posted,,,28/07/2020,https://clinicaltrials.gov/show/NCT04405271,15/11/2020,0,0
569,NCT04405310,Completed,20/11/2020,10/12/2020,No Results Posted,,,21/12/2020,https://clinicaltrials.gov/show/NCT04405310,20/11/2020,0,0
570,NCT04405492,Not yet recruiting,25/03/2021,25/03/2021,No Results Posted,,,28/05/2020,https://clinicaltrials.gov/show/NCT04405492,25/03/2021,0,0
571,NCT04405544,Completed,22/07/2020,29/10/2020,No Results Posted,,,30/10/2020,https://clinicaltrials.gov/show/NCT04405544,22/07/2020,0,0
572,NCT04405921,Not yet recruiting,01/12/2020,01/03/2021,No Results Posted,,,19/06/2020,https://clinicaltrials.gov/show/NCT04405921,01/12/2020,0,0
573,NCT04405934,Not yet recruiting,01/10/2020,01/04/2021,No Results Posted,,,17/06/2020,https://clinicaltrials.gov/show/NCT04405934,01/10/2020,0,0
574,NCT04405999,Completed,09/08/2020,31/08/2020,No Results Posted,,,03/09/2020,https://clinicaltrials.gov/show/NCT04405999,09/08/2020,0,0
575,NCT04406181,Recruiting,31/12/2020,01/01/2021,No Results Posted,,,01/06/2020,https://clinicaltrials.gov/show/NCT04406181,31/12/2020,0,0
576,NCT04406493,Recruiting,28/04/2021,28/04/2021,No Results Posted,,,28/05/2020,https://clinicaltrials.gov/show/NCT04406493,28/04/2021,0,0
577,NCT04407208,Completed,22/06/2020,22/06/2020,No Results Posted,"['Rejeki MS, Sarnadi N, Wihastuti R, Fazharyasti V, Samin WY, Yudhaputri FA, Johar E, Nurainy N, Bachtiar NS, Muljono DH. Convalescent plasma therapy in patients with moderate-to-severe COVID-19: A study from Indonesia for clinical research in low- and middle-income countries. EClinicalMedicine. 2021 Jun;36:100931. doi: 10.1016/j.eclinm.2021.100931. Epub 2021 Jun 4.']",,30/06/2020,https://clinicaltrials.gov/show/NCT04407208,22/06/2020,0,1
578,NCT04407390,Recruiting,01/05/2021,01/05/2022,No Results Posted,,,02/06/2020,https://clinicaltrials.gov/show/NCT04407390,01/05/2021,0,0
579,NCT04408066,Recruiting,30/04/2022,30/04/2022,No Results Posted,,,04/06/2020,https://clinicaltrials.gov/show/NCT04408066,30/04/2022,0,0
580,NCT04408131,Recruiting,27/01/2021,27/01/2021,No Results Posted,,,29/05/2020,https://clinicaltrials.gov/show/NCT04408131,27/01/2021,0,0
581,NCT04408209,Recruiting,30/08/2021,15/09/2021,No Results Posted,"['Pappa V, Bouchla A, Terpos E, Thomopoulos TP, Rosati M, Stellas D, Antoniadou A, Mentis A, Papageorgiou SG, Politou M, Kotanidou A, Kalomenidis I, Poulakou G, Jahaj E, Korompoki E, Grigoropoulou S, Hu X, Bear J, Karaliota S, Burns R, Pagoni M, Trontzas I, Grouzi E, Labropoulou S, Stamoulis K, Bamias A, Tsiodras S, Felber BK, Pavlakis GN, Dimopoulos MA. A Phase II Study on the Use of Convalescent Plasma for the Treatment of Severe COVID-19- A Propensity Score-Matched Control Analysis. Microorganisms. 2021 Apr 11;9(4). pii: 806. doi: 10.3390/microorganisms9040806.']",,04/11/2020,https://clinicaltrials.gov/show/NCT04408209,30/08/2021,0,1
582,NCT04408235,Not yet recruiting,01/06/2021,01/06/2021,No Results Posted,"['Flumignan RL, Tin√¥co JDS, Pascoal PI, Areias LL, Cossi MS, Fernandes MI, Costa IK, Souza L, Matar CF, Tendal B, Trevisani VF, Atallah √ÅN, Nakano LC. Prophylactic anticoagulants for people hospitalised with COVID-19. Cochrane Database Syst Rev. 2020 Oct 2;10:CD013739. doi: 10.1002/14651858.CD013739.']",,29/05/2020,https://clinicaltrials.gov/show/NCT04408235,01/06/2021,0,1
583,NCT04408456,Completed,31/07/2020,31/07/2020,No Results Posted,,,04/08/2020,https://clinicaltrials.gov/show/NCT04408456,31/07/2020,0,0
584,NCT04409522,Recruiting,05/06/2020,25/09/2020,No Results Posted,,,01/06/2020,https://clinicaltrials.gov/show/NCT04409522,05/06/2020,0,0
585,NCT04409886,Terminated,31/01/2021,31/01/2021,Study Results,,,29/06/2021,https://clinicaltrials.gov/show/NCT04409886,31/01/2021,1,0
586,NCT04410016,Recruiting,31/07/2020,30/11/2020,No Results Posted,,,12/06/2020,https://clinicaltrials.gov/show/NCT04410016,31/07/2020,0,0
587,NCT04410159,Completed,29/06/2020,06/07/2020,Study Results,,,21/07/2020,https://clinicaltrials.gov/show/NCT04410159,29/06/2020,1,0
588,NCT04410328,Recruiting,15/03/2021,15/12/2021,No Results Posted,,"['Macatangay BJC, Jackson EK, Abebe KZ, Comer D, Cyktor J, Klamar-Blain C, Borowski L, Gillespie DG, Mellors JW, Rinaldo CR, Riddler SA. A Randomized, Placebo-Controlled, Pilot Clinical Trial of Dipyridamole to Decrease Human Immunodeficiency Virus-Associated Chronic Inflammation. J Infect Dis. 2020 Apr 27;221(10):1598-1606. doi: 10.1093/infdis/jiz344.', 'Li Z LX, Huang Yi-Y et al. FEP-based screening prompts drug repositioning against COVID-19. 2020.', 'Liu X LZ, Liu S et al. . Therapeutic effects of dipyridamole on COVID-19 patients with coagulation dysfunction. 2020.', 'K√∂hler D, Streienberger A, Morote-Garc√≠a JC, Granja TF, Schneider M, Straub A, Boison D, Rosenberger P. Inhibition of Adenosine Kinase Attenuates Acute Lung Injury. Crit Care Med. 2016 Apr;44(4):e181-9. doi: 10.1097/CCM.0000000000001370.', 'Fata-Hartley CL, Palmenberg AC. Dipyridamole reversibly inhibits mengovirus RNA replication. J Virol. 2005 Sep;79(17):11062-70.', 'Weyrich AS, Skalabrin EJ, Kraiss LW. Targeting the inflammatory response in secondary stroke prevention: a role for combining aspirin and extended-release dipyridamole. Am J Ther. 2009 Mar-Apr;16(2):164-70. doi: 10.1097/MJT.0b013e31814b17bf. Review.', 'Cao B, Wang Y, Wen D, Liu W, Wang J, Fan G, Ruan L, Song B, Cai Y, Wei M, Li X, Xia J, Chen N, Xiang J, Yu T, Bai T, Xie X, Zhang L, Li C, Yuan Y, Chen H, Li H, Huang H, Tu S, Gong F, Liu Y, Wei Y, Dong C, Zhou F, Gu X, Xu J, Liu Z, Zhang Y, Li H, Shang L, Wang K, Li K, Zhou X, Dong X, Qu Z, Lu S, Hu X, Ruan S, Luo S, Wu J, Peng L, Cheng F, Pan L, Zou J, Jia C, Wang J, Liu X, Wang S, Wu X, Ge Q, He J, Zhan H, Qiu F, Guo L, Huang C, Jaki T, Hayden FG, Horby PW, Zhang D, Wang C. A Trial of Lopinavir-Ritonavir in Adults Hospitalized with Severe Covid-19. N Engl J Med. 2020 May 7;382(19):1787-1799. doi: 10.1056/NEJMoa2001282. Epub 2020 Mar 18.']",23/10/2020,https://clinicaltrials.gov/show/NCT04410328,15/03/2021,0,1
589,NCT04410458,Enrolling by invitation,31/05/2020,12/06/2020,No Results Posted,,,01/06/2020,https://clinicaltrials.gov/show/NCT04410458,31/05/2020,0,0
590,NCT04410510,Recruiting,01/12/2020,01/06/2021,No Results Posted,,,05/10/2020,https://clinicaltrials.gov/show/NCT04410510,01/12/2020,0,0
591,NCT04410536,Recruiting,01/12/2021,01/07/2022,No Results Posted,,,09/10/2020,https://clinicaltrials.gov/show/NCT04410536,01/12/2021,0,0
592,NCT04410692,Completed,16/05/2020,17/05/2020,No Results Posted,,,02/06/2020,https://clinicaltrials.gov/show/NCT04410692,16/05/2020,0,0
593,NCT04411628,Completed,26/08/2020,26/08/2020,No Results Posted,,,30/10/2020,https://clinicaltrials.gov/show/NCT04411628,26/08/2020,0,0
594,NCT04412018,Recruiting,01/12/2020,01/12/2020,No Results Posted,,,11/09/2020,https://clinicaltrials.gov/show/NCT04412018,01/12/2020,0,0
595,NCT04412239,Recruiting,20/12/2020,20/12/2020,No Results Posted,,,18/11/2020,https://clinicaltrials.gov/show/NCT04412239,20/12/2020,0,0
596,NCT04412252,Withdrawn,16/09/2020,18/10/2020,No Results Posted,,,31/07/2020,https://clinicaltrials.gov/show/NCT04412252,16/09/2020,0,0
597,NCT04412343,Completed,05/10/2020,05/10/2020,No Results Posted,,,03/11/2020,https://clinicaltrials.gov/show/NCT04412343,05/10/2020,0,0
598,NCT04412486,Recruiting,31/05/2022,31/05/2022,No Results Posted,,,02/07/2020,https://clinicaltrials.gov/show/NCT04412486,31/05/2022,0,0
599,NCT04412538,Recruiting,01/09/2020,01/09/2021,No Results Posted,"['Pu J, Yu Q, Yin Z, Zhang Y, Li X, Yin Q, Chen H, Long R, Zhao Z, Mou T, Zhao H, Feng S, Xie Z, Wang L, He Z, Liao Y, Fan S, Jiang R, Wang J, Zhang L, Li J, Zheng H, Cui P, Jiang G, Guo L, Xu M, Yang H, Lu S, Wang X, Gao Y, Xu X, Cai L, Zhou J, Yu L, Chen Z, Hong C, Du D, Zhao H, Li Y, Ma K, Ma Y, Liu D, Yao S, Li C, Che Y, Liu L, Li Q. The safety and immunogenicity of an inactivated SARS-CoV-2 vaccine in Chinese adults aged 18-59 years: A phase I randomized, double-blinded, controlled trial. Vaccine. 2021 May 12;39(20):2746-2754. doi: 10.1016/j.vaccine.2021.04.006. Epub 2021 Apr 9.', 'Che Y, Liu X, Pu Y, Zhou M, Zhao Z, Jiang R, Yin Z, Xu M, Yin Q, Wang J, Pu J, Zhao H, Zhang Y, Wang L, Jiang Y, Lei J, Zheng Y, Liao Y, Long R, Yu L, Cui P, Yang H, Zhang Y, Li J, Chen W, He Z, Ma K, Hong C, Li D, Jiang G, Liu D, Xu X, Fan S, Cheng C, Zhao H, Yang J, Li Y, Zou Y, Zhu Y, Zhou Y, Guo Y, Yang T, Chen H, Xie Z, Li C, Li Q. Randomized, double-blinded and placebo-controlled phase II trial of an inactivated SARS-CoV-2 vaccine in healthy adults. Clin Infect Dis. 2020 Nov 9. pii: ciaa1703. doi: 10.1093/cid/ciaa1703. [Epub ahead of print]']",,04/06/2020,https://clinicaltrials.gov/show/NCT04412538,01/09/2020,0,1
600,NCT04412772,Recruiting,31/12/2021,31/12/2021,No Results Posted,,,17/11/2020,https://clinicaltrials.gov/show/NCT04412772,31/12/2021,0,0
601,NCT04413006,Recruiting,31/12/2020,31/03/2021,No Results Posted,,,02/06/2020,https://clinicaltrials.gov/show/NCT04413006,31/12/2020,0,0
602,NCT04413747,Not yet recruiting,01/06/2021,30/09/2021,No Results Posted,,,07/08/2020,https://clinicaltrials.gov/show/NCT04413747,01/06/2021,0,0
603,NCT04413838,Not yet recruiting,15/06/2021,15/09/2021,No Results Posted,,,04/06/2020,https://clinicaltrials.gov/show/NCT04413838,15/06/2021,0,0
604,NCT04413968,Completed,02/07/2020,02/10/2020,No Results Posted,"['Lachassinne E, de Pontual L, Caseris M, Lorrot M, Guilluy C, Naud A, Dommergues MA, Pinquier D, Wannepain E, Hausherr E, Jung C, Gajdos V, Cohen R, Zahar JR, Brichler S, Basmaci R, Boelle PY, Bloch-Queyrat C, Aupiais C; COVIDOCRECHE collaborators. SARS-CoV-2 transmission among children and staff in daycare centres during a nationwide lockdown in France: a cross-sectional, multicentre, seroprevalence study. Lancet Child Adolesc Health. 2021 Apr;5(4):256-264. doi: 10.1016/S2352-4642(21)00024-9. Epub 2021 Feb 8.']",,26/10/2020,https://clinicaltrials.gov/show/NCT04413968,02/07/2020,0,1
605,NCT04414098,Not yet recruiting,15/08/2020,15/09/2020,No Results Posted,,,04/06/2020,https://clinicaltrials.gov/show/NCT04414098,15/08/2020,0,0
606,NCT04414371,Recruiting,31/12/2020,31/12/2020,No Results Posted,,,04/06/2020,https://clinicaltrials.gov/show/NCT04414371,31/12/2020,0,0
607,NCT04415073,Suspended,15/11/2020,15/11/2020,No Results Posted,,,11/08/2020,https://clinicaltrials.gov/show/NCT04415073,15/11/2020,0,0
608,NCT04415086,Recruiting,20/04/2022,22/05/2022,No Results Posted,,,29/10/2020,https://clinicaltrials.gov/show/NCT04415086,20/04/2022,0,0
609,NCT04415879,Completed,01/08/2020,01/08/2020,No Results Posted,,,13/08/2020,https://clinicaltrials.gov/show/NCT04415879,01/08/2020,0,0
610,NCT04416113,Not yet recruiting,01/12/2020,01/02/2021,No Results Posted,,,05/06/2020,https://clinicaltrials.gov/show/NCT04416113,01/12/2020,0,0
611,NCT04416139,Recruiting,30/04/2021,01/05/2021,No Results Posted,,,04/06/2020,https://clinicaltrials.gov/show/NCT04416139,30/04/2021,0,0
612,NCT04416334,Recruiting,25/08/2021,31/12/2021,No Results Posted,,,20/11/2020,https://clinicaltrials.gov/show/NCT04416334,25/08/2021,0,0
613,NCT04416360,Recruiting,01/07/2020,01/01/2021,No Results Posted,,,04/06/2020,https://clinicaltrials.gov/show/NCT04416360,01/07/2020,0,0
614,NCT04417335,"Active, not recruiting",01/05/2021,01/05/2021,No Results Posted,,,04/06/2020,https://clinicaltrials.gov/show/NCT04417335,01/05/2021,0,0
615,NCT04418128,Not yet recruiting,30/03/2021,30/04/2021,No Results Posted,,"['Hoffmann M, Kleine-Weber H, Schroeder S, Kr√ºger N, Herrler T, Erichsen S, Schiergens TS, Herrler G, Wu NH, Nitsche A, M√ºller MA, Drosten C, P√∂hlmann S. SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor. Cell. 2020 Apr 16;181(2):271-280.e8. doi: 10.1016/j.cell.2020.02.052. Epub 2020 Mar 5.', 'Hoffmann M, Schroeder S, Kleine-Weber H, M√ºller MA, Drosten C, P√∂hlmann S. Nafamostat Mesylate Blocks Activation of SARS-CoV-2: New Treatment Option for COVID-19. Antimicrob Agents Chemother. 2020 May 21;64(6). pii: e00754-20. doi: 10.1128/AAC.00754-20. Print 2020 May 21.']",09/06/2020,https://clinicaltrials.gov/show/NCT04418128,30/03/2021,0,1
616,NCT04418206,Recruiting,01/12/2020,01/06/2021,No Results Posted,,,09/11/2020,https://clinicaltrials.gov/show/NCT04418206,01/12/2020,0,0
617,NCT04418518,Recruiting,01/06/2021,01/12/2021,No Results Posted,,"['Wu JT, Leung K, Leung GM. Nowcasting and forecasting the potential domestic and international spread of the 2019-nCoV outbreak originating in Wuhan, China: a modelling study. Lancet. 2020 Feb 29;395(10225):689-697. doi: 10.1016/S0140-6736(20)30260-9. Epub 2020 Jan 31. Erratum in: Lancet. 2020 Feb 4;:.']",07/07/2020,https://clinicaltrials.gov/show/NCT04418518,01/06/2021,0,1
618,NCT04418531,Not yet recruiting,01/09/2020,01/09/2020,No Results Posted,,,05/06/2020,https://clinicaltrials.gov/show/NCT04418531,01/09/2020,0,0
619,NCT04418947,Completed,17/07/2020,17/07/2020,No Results Posted,"['Cappola AR, Schriver ER, Mowery DL, Wollack C, Ives CT, Gonzales R, Cappella JN. Effect of Targeted Messaging on Return to In-Person Visits During the COVID-19 Pandemic: A Randomized Clinical Trial. JAMA Netw Open. 2021 Jun 1;4(6):e2115211. doi: 10.1001/jamanetworkopen.2021.15211.']",,31/07/2020,https://clinicaltrials.gov/show/NCT04418947,17/07/2020,0,1
620,NCT04420260,Not yet recruiting,01/09/2020,01/09/2020,No Results Posted,,"['Schindewolf C, Menachery VD. Middle East Respiratory Syndrome Vaccine Candidates: Cautious Optimism. Viruses. 2019 Jan 17;11(1). pii: E74. doi: 10.3390/v11010074. Review.']",09/06/2020,https://clinicaltrials.gov/show/NCT04420260,01/09/2020,0,1
621,NCT04420299,Recruiting,31/03/2021,31/03/2021,No Results Posted,,,11/06/2020,https://clinicaltrials.gov/show/NCT04420299,31/03/2021,0,0
622,NCT04420338,Recruiting,15/12/2020,15/12/2020,No Results Posted,,,17/06/2020,https://clinicaltrials.gov/show/NCT04420338,15/12/2020,0,0
623,NCT04420390,Recruiting,31/07/2020,08/09/2020,No Results Posted,,,09/06/2020,https://clinicaltrials.gov/show/NCT04420390,31/07/2020,0,0
624,NCT04420806,Completed,30/07/2020,30/10/2020,No Results Posted,"['Kemmler W, Hettchen M, Kohl M, Murphy M, Bragonzoni L, Julin M, Risto T, von Stengel S. Detraining Effects on Musculoskeletal Parameters in Early Postmenopausal Osteopenic Women: 3-Month Follow-Up of the Randomized Controlled ACTLIFE Study. Calcif Tissue Int. 2021 Mar 12. doi: 10.1007/s00223-021-00829-0. [Epub ahead of print]']",,13/11/2020,https://clinicaltrials.gov/show/NCT04420806,30/07/2020,0,1
625,NCT04421391,Recruiting,01/11/2020,08/11/2020,No Results Posted,,,09/06/2020,https://clinicaltrials.gov/show/NCT04421391,01/11/2020,0,0
626,NCT04421534,Not yet recruiting,01/09/2020,01/11/2020,No Results Posted,,,09/06/2020,https://clinicaltrials.gov/show/NCT04421534,01/09/2020,0,0
627,NCT04421664,Terminated,17/08/2020,17/08/2020,No Results Posted,,,22/09/2020,https://clinicaltrials.gov/show/NCT04421664,17/08/2020,0,0
628,NCT04422561,Completed,14/07/2020,27/07/2020,Study Results,,,27/08/2020,https://clinicaltrials.gov/show/NCT04422561,14/07/2020,1,0
629,NCT04422678,Not yet recruiting,01/09/2020,01/10/2020,No Results Posted,,,09/06/2020,https://clinicaltrials.gov/show/NCT04422678,01/09/2020,0,0
630,NCT04422977,Not yet recruiting,30/06/2020,30/06/2020,No Results Posted,"['Vivier E, Pariset C, Rio S, Armand S, Doroszewski F, Richard D, Chardon M, Romero G, Metral P, Pecquet M, Didelot A. Specific exposure of ICU staff to SARS-CoV-2 seropositivity: a wide seroprevalence study in a French city-center hospital. Ann Intensive Care. 2021 May 13;11(1):75. doi: 10.1186/s13613-021-00868-8.']",,09/06/2020,https://clinicaltrials.gov/show/NCT04422977,30/06/2020,0,1
631,NCT04423042,Not yet recruiting,01/06/2021,01/06/2021,No Results Posted,,,22/07/2020,https://clinicaltrials.gov/show/NCT04423042,01/06/2021,0,0
632,NCT04423289,Completed,04/05/2020,18/05/2020,No Results Posted,,,09/06/2020,https://clinicaltrials.gov/show/NCT04423289,04/05/2020,0,0
633,NCT04423861,Not yet recruiting,01/04/2021,01/05/2021,No Results Posted,,,27/11/2020,https://clinicaltrials.gov/show/NCT04423861,01/04/2021,0,0
634,NCT04423991,Completed,04/06/2020,04/06/2020,No Results Posted,,,09/06/2020,https://clinicaltrials.gov/show/NCT04423991,04/06/2020,0,0
635,NCT04424056,Not yet recruiting,30/09/2022,01/11/2022,No Results Posted,,,23/06/2020,https://clinicaltrials.gov/show/NCT04424056,30/09/2022,0,0
636,NCT04424134,Recruiting,18/07/2020,23/08/2020,No Results Posted,,,09/06/2020,https://clinicaltrials.gov/show/NCT04424134,18/07/2020,0,0
637,NCT04425317,Recruiting,06/07/2021,15/07/2022,No Results Posted,,,07/07/2021,https://clinicaltrials.gov/show/NCT04425317,06/07/2021,0,0
638,NCT04425460,Not yet recruiting,01/08/2020,01/09/2020,No Results Posted,,,11/06/2020,https://clinicaltrials.gov/show/NCT04425460,01/08/2020,0,0
639,NCT04425499,Not yet recruiting,01/06/2020,01/06/2020,No Results Posted,"['Gu√©rard-Poirier N, Beniey M, Meloche-Dumas L, Lebel-Guay F, Misheva B, Abbas M, Dhane M, Elraheb M, Dubrowski A, Patocskai E. An Educational Network for Surgical Education Supported by Gamification Elements: Protocol for a Randomized Controlled Trial. JMIR Res Protoc. 2020 Dec 14;9(12):e21273. doi: 10.2196/21273.']",,11/06/2020,https://clinicaltrials.gov/show/NCT04425499,01/06/2020,0,1
640,NCT04425707,Recruiting,01/07/2020,01/09/2020,No Results Posted,,,11/06/2020,https://clinicaltrials.gov/show/NCT04425707,01/07/2020,0,0
641,NCT04425720,Recruiting,01/06/2021,01/06/2021,No Results Posted,,,12/11/2020,https://clinicaltrials.gov/show/NCT04425720,01/06/2021,0,0
642,NCT04425733,Withdrawn,10/11/2020,10/11/2020,No Results Posted,,,14/08/2020,https://clinicaltrials.gov/show/NCT04425733,10/11/2020,0,0
643,NCT04425772,Not yet recruiting,12/08/2020,12/08/2020,No Results Posted,,,11/06/2020,https://clinicaltrials.gov/show/NCT04425772,12/08/2020,0,0
644,NCT04425837,Not yet recruiting,01/02/2021,01/02/2021,No Results Posted,,,11/06/2020,https://clinicaltrials.gov/show/NCT04425837,01/02/2021,0,0
645,NCT04426006,"Active, not recruiting",01/01/2022,01/01/2023,No Results Posted,,,09/07/2021,https://clinicaltrials.gov/show/NCT04426006,01/01/2022,0,0
646,NCT04426292,Recruiting,23/10/2020,12/05/2021,No Results Posted,,,11/06/2020,https://clinicaltrials.gov/show/NCT04426292,23/10/2020,0,0
647,NCT04426344,Withdrawn,01/12/2020,01/12/2020,No Results Posted,"['Bonfanti N, Gundert E, Drewry AM, Goff K, Bedimo R, Kulstad E. Core warming of coronavirus disease 2019 (COVID-19) patients undergoing mechanical ventilation-A protocol for a randomized controlled pilot study. PLoS One. 2020 Dec 1;15(12):e0243190. doi: 10.1371/journal.pone.0243190. eCollection 2020.']",,19/10/2020,https://clinicaltrials.gov/show/NCT04426344,01/12/2020,0,1
648,NCT04427098,Recruiting,30/10/2020,30/10/2020,No Results Posted,,,17/06/2020,https://clinicaltrials.gov/show/NCT04427098,30/10/2020,0,0
649,NCT04427137,Recruiting,01/06/2022,01/12/2022,No Results Posted,,,23/06/2020,https://clinicaltrials.gov/show/NCT04427137,01/06/2022,0,0
650,NCT04427631,Not yet recruiting,01/01/2021,01/06/2021,No Results Posted,,,11/06/2020,https://clinicaltrials.gov/show/NCT04427631,01/01/2021,0,0
651,NCT04427865,Not yet recruiting,01/09/2020,01/11/2020,No Results Posted,,,16/06/2020,https://clinicaltrials.gov/show/NCT04427865,01/09/2020,0,0
652,NCT04427878,Not yet recruiting,09/07/2020,09/07/2021,No Results Posted,,,11/06/2020,https://clinicaltrials.gov/show/NCT04427878,09/07/2020,0,0
653,NCT04428073,Not yet recruiting,01/07/2021,01/12/2021,No Results Posted,,,11/06/2020,https://clinicaltrials.gov/show/NCT04428073,01/07/2021,0,0
654,NCT04428099,Recruiting,12/01/2022,12/07/2022,No Results Posted,"['Navarro C, Y√°√±ez AM, Garcia A, Segu√≠ A, Gazquez F, Marino JA, Ibarra O, Serrano-Ripoll MJ, Gomez-Juanes R, Bennasar-Veny M, Salva J, Oliv√°n B, Roca M, Gili M, Garcia-Toro M. Effectiveness of a healthy lifestyle promotion program as adjunctive teletherapy for treatment-resistant major depression during COVID 19 pandemic: A randomized clinical trial protocol. Medicine (Baltimore). 2020 Nov 6;99(45):e22958. doi: 10.1097/MD.0000000000022958.']",,11/06/2020,https://clinicaltrials.gov/show/NCT04428099,12/01/2022,0,1
655,NCT04429334,Recruiting,01/06/2023,01/06/2023,No Results Posted,,,09/07/2021,https://clinicaltrials.gov/show/NCT04429334,01/06/2023,0,0
656,NCT04429594,Recruiting,15/07/2025,31/12/2025,No Results Posted,,,19/10/2020,https://clinicaltrials.gov/show/NCT04429594,15/07/2025,0,0
657,NCT04429711,Recruiting,30/09/2020,31/10/2020,No Results Posted,,,16/06/2020,https://clinicaltrials.gov/show/NCT04429711,30/09/2020,0,0
658,NCT04429763,Not yet recruiting,01/09/2020,01/11/2020,No Results Posted,,,12/06/2020,https://clinicaltrials.gov/show/NCT04429763,01/09/2020,0,0
659,NCT04429828,Not yet recruiting,30/09/2020,30/12/2020,No Results Posted,,,12/06/2020,https://clinicaltrials.gov/show/NCT04429828,30/09/2020,0,0
660,NCT04429867,"Active, not recruiting",07/12/2020,07/12/2020,No Results Posted,,,16/06/2020,https://clinicaltrials.gov/show/NCT04429867,07/12/2020,0,0
661,NCT04430608,Recruiting,25/04/2021,25/05/2021,No Results Posted,"['Klarskov CK, Lindegaard B, Pedersen-Bjergaard U, Kristensen PL. Remote continuous glucose monitoring during the COVID-19 pandemic in quarantined hospitalized patients in Denmark: A structured summary of a study protocol for a randomized controlled trial. Trials. 2020 Nov 25;21(1):968. doi: 10.1186/s13063-020-04872-4.']",,12/06/2020,https://clinicaltrials.gov/show/NCT04430608,25/04/2021,0,1
662,NCT04431180,Enrolling by invitation,13/06/2020,30/06/2020,No Results Posted,,,16/06/2020,https://clinicaltrials.gov/show/NCT04431180,13/06/2020,0,0
663,NCT04431466,Recruiting,01/12/2020,01/07/2021,No Results Posted,"['Pott-Junior H, Bastos Paoliello MM, Miguel AQC, da Cunha AF, de Melo Freire CC, Neves FF, da Silva de Av√≥ LR, Roscani MG, Dos Santos SS, Chach√° SGF. Use of ivermectin in the treatment of Covid-19: A pilot trial. Toxicol Rep. 2021;8:505-510. doi: 10.1016/j.toxrep.2021.03.003. Epub 2021 Mar 9.']",,02/09/2020,https://clinicaltrials.gov/show/NCT04431466,01/12/2020,0,1
664,NCT04432051,Recruiting,08/08/2020,10/08/2020,No Results Posted,,,07/08/2020,https://clinicaltrials.gov/show/NCT04432051,08/08/2020,0,0
665,NCT04432103,Not yet recruiting,30/07/2020,30/09/2020,No Results Posted,,"['Wu F, Zhao S, Yu B, Chen YM, Wang W, Song ZG, Hu Y, Tao ZW, Tian JH, Pei YY, Yuan ML, Zhang YL, Dai FH, Liu Y, Wang QM, Zheng JJ, Xu L, Holmes EC, Zhang YZ. A new coronavirus associated with human respiratory disease in China. Nature. 2020 Mar;579(7798):265-269. doi: 10.1038/s41586-020-2008-3. Epub 2020 Feb 3. Erratum in: Nature. 2020 Apr;580(7803):E7.', 'van Doremalen N, Bushmaker T, Morris DH, Holbrook MG, Gamble A, Williamson BN, Tamin A, Harcourt JL, Thornburg NJ, Gerber SI, Lloyd-Smith JO, de Wit E, Munster VJ. Aerosol and Surface Stability of SARS-CoV-2 as Compared with SARS-CoV-1. N Engl J Med. 2020 Apr 16;382(16):1564-1567. doi: 10.1056/NEJMc2004973. Epub 2020 Mar 17.', 'Zou L, Ruan F, Huang M, Liang L, Huang H, Hong Z, Yu J, Kang M, Song Y, Xia J, Guo Q, Song T, He J, Yen HL, Peiris M, Wu J. SARS-CoV-2 Viral Load in Upper Respiratory Specimens of Infected Patients. N Engl J Med. 2020 Mar 19;382(12):1177-1179. doi: 10.1056/NEJMc2001737. Epub 2020 Feb 19.', 'Burke RM, Midgley CM, Dratch A, Fenstersheib M, Haupt T, Holshue M, Ghinai I, Jarashow MC, Lo J, McPherson TD, Rudman S, Scott S, Hall AJ, Fry AM, Rolfes MA. Active Monitoring of Persons Exposed to Patients with Confirmed COVID-19 - United States, January-February 2020. MMWR Morb Mortal Wkly Rep. 2020 Mar 6;69(9):245-246. doi: 10.15585/mmwr.mm6909e1.', 'Bai Y, Yao L, Wei T, Tian F, Jin DY, Chen L, Wang M. Presumed Asymptomatic Carrier Transmission of COVID-19. JAMA. 2020 Apr 14;323(14):1406-1407. doi: 10.1001/jama.2020.2565.', 'Rothe C, Schunk M, Sothmann P, Bretzel G, Froeschl G, Wallrauch C, Zimmer T, Thiel V, Janke C, Guggemos W, Seilmaier M, Drosten C, Vollmar P, Zwirglmaier K, Zange S, W√∂lfel R, Hoelscher M. Transmission of 2019-nCoV Infection from an Asymptomatic Contact in Germany. N Engl J Med. 2020 Mar 5;382(10):970-971. doi: 10.1056/NEJMc2001468. Epub 2020 Jan 30.', 'Zhou P, Yang XL, Wang XG, Hu B, Zhang L, Zhang W, Si HR, Zhu Y, Li B, Huang CL, Chen HD, Chen J, Luo Y, Guo H, Jiang RD, Liu MQ, Chen Y, Shen XR, Wang X, Zheng XS, Zhao K, Chen QJ, Deng F, Liu LL, Yan B, Zhan FX, Wang YY, Xiao GF, Shi ZL. A pneumonia outbreak associated with a new coronavirus of probable bat origin. Nature. 2020 Mar;579(7798):270-273. doi: 10.1038/s41586-020-2012-7. Epub 2020 Feb 3.', 'Guan WJ, Ni ZY, Hu Y, Liang WH, Ou CQ, He JX, Liu L, Shan H, Lei CL, Hui DSC, Du B, Li LJ, Zeng G, Yuen KY, Chen RC, Tang CL, Wang T, Chen PY, Xiang J, Li SY, Wang JL, Liang ZJ, Peng YX, Wei L, Liu Y, Hu YH, Peng P, Wang JM, Liu JY, Chen Z, Li G, Zheng ZJ, Qiu SQ, Luo J, Ye CJ, Zhu SY, Zhong NS; China Medical Treatment Expert Group for Covid-19. Clinical Characteristics of Coronavirus Disease 2019 in China. N Engl J Med. 2020 Apr 30;382(18):1708-1720. doi: 10.1056/NEJMoa2002032. Epub 2020 Feb 28.', 'Li Q, Guan X, Wu P, Wang X, Zhou L, Tong Y, Ren R, Leung KSM, Lau EHY, Wong JY, Xing X, Xiang N, Wu Y, Li C, Chen Q, Li D, Liu T, Zhao J, Liu M, Tu W, Chen C, Jin L, Yang R, Wang Q, Zhou S, Wang R, Liu H, Luo Y, Liu Y, Shao G, Li H, Tao Z, Yang Y, Deng Z, Liu B, Ma Z, Zhang Y, Shi G, Lam TTY, Wu JT, Gao GF, Cowling BJ, Yang B, Leung GM, Feng Z. Early Transmission Dynamics in Wuhan, China, of Novel Coronavirus-Infected Pneumonia. N Engl J Med. 2020 Mar 26;382(13):1199-1207. doi: 10.1056/NEJMoa2001316. Epub 2020 Jan 29.', 'Lauer SA, Grantz KH, Bi Q, Jones FK, Zheng Q, Meredith HR, Azman AS, Reich NG, Lessler J. The Incubation Period of Coronavirus Disease 2019 (COVID-19) From Publicly Reported Confirmed Cases: Estimation and Application. Ann Intern Med. 2020 May 5;172(9):577-582. doi: 10.7326/M20-0504. Epub 2020 Mar 10.', 'Wu Z, McGoogan JM. Characteristics of and Important Lessons From the Coronavirus Disease 2019 (COVID-19) Outbreak in China: Summary of a Report of 72 314 Cases From the Chinese Center for Disease Control and Prevention. JAMA. 2020 Apr 7;323(13):1239-1242. doi: 10.1001/jama.2020.2648.', 'Huang C, Wang Y, Li X, Ren L, Zhao J, Hu Y, Zhang L, Fan G, Xu J, Gu X, Cheng Z, Yu T, Xia J, Wei Y, Wu W, Xie X, Yin W, Li H, Liu M, Xiao Y, Gao H, Guo L, Xie J, Wang G, Jiang R, Gao Z, Jin Q, Wang J, Cao B. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet. 2020 Feb 15;395(10223):497-506. doi: 10.1016/S0140-6736(20)30183-5. Epub 2020 Jan 24. Erratum in: Lancet. 2020 Jan 30;:.', 'Chen N, Zhou M, Dong X, Qu J, Gong F, Han Y, Qiu Y, Wang J, Liu Y, Wei Y, Xia J, Yu T, Zhang X, Zhang L. Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study. Lancet. 2020 Feb 15;395(10223):507-513. doi: 10.1016/S0140-6736(20)30211-7. Epub 2020 Jan 30.', 'Wang D, Hu B, Hu C, Zhu F, Liu X, Zhang J, Wang B, Xiang H, Cheng Z, Xiong Y, Zhao Y, Li Y, Wang X, Peng Z. Clinical Characteristics of 138 Hospitalized Patients With 2019 Novel Coronavirus-Infected Pneumonia in Wuhan, China. JAMA. 2020 Mar 17;323(11):1061-1069. doi: 10.1001/jama.2020.1585. Erratum in: JAMA. 2021 Mar 16;325(11):1113.', 'Liu K, Fang YY, Deng Y, Liu W, Wang MF, Ma JP, Xiao W, Wang YN, Zhong MH, Li CH, Li GC, Liu HG. Clinical characteristics of novel coronavirus cases in tertiary hospitals in Hubei Province. Chin Med J (Engl). 2020 May 5;133(9):1025-1031. doi: 10.1097/CM9.0000000000000744.', 'Yang X, Yu Y, Xu J, Shu H, Xia J, Liu H, Wu Y, Zhang L, Yu Z, Fang M, Yu T, Wang Y, Pan S, Zou X, Yuan S, Shang Y. Clinical course and outcomes of critically ill patients with SARS-CoV-2 pneumonia in Wuhan, China: a single-centered, retrospective, observational study. Lancet Respir Med. 2020 May;8(5):475-481. doi: 10.1016/S2213-2600(20)30079-5. Epub 2020 Feb 24. Erratum in: Lancet Respir Med. 2020 Apr;8(4):e26.', 'Wu C, Chen X, Cai Y, Xia J, Zhou X, Xu S, Huang H, Zhang L, Zhou X, Du C, Zhang Y, Song J, Wang S, Chao Y, Yang Z, Xu J, Zhou X, Chen D, Xiong W, Xu L, Zhou F, Jiang J, Bai C, Zheng J, Song Y. Risk Factors Associated With Acute Respiratory Distress Syndrome and Death in Patients With Coronavirus Disease 2019 Pneumonia in Wuhan, China. JAMA Intern Med. 2020 Jul 1;180(7):934-943. doi: 10.1001/jamainternmed.2020.0994. Erratum in: JAMA Intern Med. 2020 Jul 1;180(7):1031.', 'Zhou F, Yu T, Du R, Fan G, Liu Y, Liu Z, Xiang J, Wang Y, Song B, Gu X, Guan L, Wei Y, Li H, Wu X, Xu J, Tu S, Zhang Y, Chen H, Cao B. Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study. Lancet. 2020 Mar 28;395(10229):1054-1062. doi: 10.1016/S0140-6736(20)30566-3. Epub 2020 Mar 11. Erratum in: Lancet. 2020 Mar 28;395(10229):1038. Lancet. 2020 Mar 28;395(10229):1038.', 'Patel A, Jernigan DB; 2019-nCoV CDC Response Team. Initial Public Health Response and Interim Clinical Guidance for the 2019 Novel Coronavirus Outbreak - United States, December 31, 2019-February 4, 2020. MMWR Morb Mortal Wkly Rep. 2020 Feb 7;69(5):140-146. doi: 10.15585/mmwr.mm6905e1. Erratum in: MMWR Morb Mortal Wkly Rep. 2020 Feb 14;69(6):173.', 'Lu H. Drug treatment options for the 2019-new coronavirus (2019-nCoV). Biosci Trends. 2020 Mar 16;14(1):69-71. doi: 10.5582/bst.2020.01020. Epub 2020 Jan 28.', 'Kraft CS, Hewlett AL, Koepsell S, Winkler AM, Kratochvil CJ, Larson L, Varkey JB, Mehta AK, Lyon GM 3rd, Friedman-Moraco RJ, Marconi VC, Hill CE, Sullivan JN, Johnson DW, Lisco SJ, Mulligan MJ, Uyeki TM, McElroy AK, Sealy T, Campbell S, Spiropoulou C, Str√∂her U, Crozier I, Sacra R, Connor MJ Jr, Sueblinvong V, Franch HA, Smith PW, Ribner BS; Nebraska Biocontainment Unit and the Emory Serious Communicable Diseases Unit. The Use of TKM-100802 and Convalescent Plasma in 2 Patients With Ebola Virus Disease in the United States. Clin Infect Dis. 2015 Aug 15;61(4):496-502. doi: 10.1093/cid/civ334. Epub 2015 Apr 22.', 'van Griensven J, Edwards T, de Lamballerie X, Semple MG, Gallian P, Baize S, Horby PW, Raoul H, Magassouba N, Antierens A, Lomas C, Faye O, Sall AA, Fransen K, Buyze J, Ravinetto R, Tiberghien P, Claeys Y, De Crop M, Lynen L, Bah EI, Smith PG, Delamou A, De Weggheleire A, Haba N; Ebola-Tx Consortium. Evaluation of Convalescent Plasma for Ebola Virus Disease in Guinea. N Engl J Med. 2016 Jan 7;374(1):33-42. doi: 10.1056/NEJMoa1511812.', 'Florescu DF, Kalil AC, Hewlett AL, Schuh AJ, Stroher U, Uyeki TM, Smith PW. Administration of Brincidofovir and Convalescent Plasma in a Patient With Ebola Virus Disease. Clin Infect Dis. 2015 Sep 15;61(6):969-73. doi: 10.1093/cid/civ395. Epub 2015 May 19.', 'Zhou B, Zhong N, Guan Y. Treatment with convalescent plasma for influenza A (H5N1) infection. N Engl J Med. 2007 Oct 4;357(14):1450-1.', 'Hung IF, To KK, Lee CK, Lee KL, Chan K, Yan WW, Liu R, Watt CL, Chan WM, Lai KY, Koo CK, Buckley T, Chow FL, Wong KK, Chan HS, Ching CK, Tang BS, Lau CC, Li IW, Liu SH, Chan KH, Lin CK, Yuen KY. Convalescent plasma treatment reduced mortality in patients with severe pandemic influenza A (H1N1) 2009 virus infection. Clin Infect Dis. 2011 Feb 15;52(4):447-56. doi: 10.1093/cid/ciq106. Epub 2011 Jan 19.', 'Burnouf T, Radosevich M. Treatment of severe acute respiratory syndrome with convalescent plasma. Hong Kong Med J. 2003 Aug;9(4):309; author reply 310.', 'Cheng Y, Wong R, Soo YO, Wong WS, Lee CK, Ng MH, Chan P, Wong KC, Leung CB, Cheng G. Use of convalescent plasma therapy in SARS patients in Hong Kong. Eur J Clin Microbiol Infect Dis. 2005 Jan;24(1):44-6.', 'Mair-Jenkins J, Saavedra-Campos M, Baillie JK, Cleary P, Khaw FM, Lim WS, Makki S, Rooney KD, Nguyen-Van-Tam JS, Beck CR; Convalescent Plasma Study Group. The effectiveness of convalescent plasma and hyperimmune immunoglobulin for the treatment of severe acute respiratory infections of viral etiology: a systematic review and exploratory meta-analysis. J Infect Dis. 2015 Jan 1;211(1):80-90. doi: 10.1093/infdis/jiu396. Epub 2014 Jul 16. Review.', 'Casadevall A, Pirofski LA. The convalescent sera option for containing COVID-19. J Clin Invest. 2020 Apr 1;130(4):1545-1548. doi: 10.1172/JCI138003.', 'Shen C, Wang Z, Zhao F, Yang Y, Li J, Yuan J, Wang F, Li D, Yang M, Xing L, Wei J, Xiao H, Yang Y, Qu J, Qing L, Chen L, Xu Z, Peng L, Li Y, Zheng H, Chen F, Huang K, Jiang Y, Liu D, Zhang Z, Liu Y, Liu L. Treatment of 5 Critically Ill Patients With COVID-19 With Convalescent Plasma. JAMA. 2020 Apr 28;323(16):1582-1589. doi: 10.1001/jama.2020.4783.', 'Zhang B, Liu S, Tan T, Huang W, Dong Y, Chen L, Chen Q, Zhang L, Zhong Q, Zhang X, Zou Y, Zhang S. Treatment With Convalescent Plasma for Critically Ill Patients With Severe Acute Respiratory Syndrome Coronavirus 2 Infection. Chest. 2020 Jul;158(1):e9-e13. doi: 10.1016/j.chest.2020.03.039. Epub 2020 Mar 31.', 'Duan K, Liu B, Li C, Zhang H, Yu T, Qu J, Zhou M, Chen L, Meng S, Hu Y, Peng C, Yuan M, Huang J, Wang Z, Yu J, Gao X, Wang D, Yu X, Li L, Zhang J, Wu X, Li B, Xu Y, Chen W, Peng Y, Hu Y, Lin L, Liu X, Huang S, Zhou Z, Zhang L, Wang Y, Zhang Z, Deng K, Xia Z, Gong Q, Zhang W, Zheng X, Liu Y, Yang H, Zhou D, Yu D, Hou J, Shi Z, Chen S, Chen Z, Zhang X, Yang X. Effectiveness of convalescent plasma therapy in severe COVID-19 patients. Proc Natl Acad Sci U S A. 2020 Apr 28;117(17):9490-9496. doi: 10.1073/pnas.2004168117. Epub 2020 Apr 6.', 'Bloch EM, Shoham S, Casadevall A, Sachais BS, Shaz B, Winters JL, van Buskirk C, Grossman BJ, Joyner M, Henderson JP, Pekosz A, Lau B, Wesolowski A, Katz L, Shan H, Auwaerter PG, Thomas D, Sullivan DJ, Paneth N, Gehrie E, Spitalnik S, Hod EA, Pollack L, Nicholson WT, Pirofski LA, Bailey JA, Tobian AA. Deployment of convalescent plasma for the prevention and treatment of COVID-19. J Clin Invest. 2020 Jun 1;130(6):2757-2765. doi: 10.1172/JCI138745. Review.', ""O'Shaughnessy DF, Atterbury C, Bolton Maggs P, Murphy M, Thomas D, Yates S, Williamson LM; British Committee for Standards in Haematology, Blood Transfusion Task Force. Guidelines for the use of fresh-frozen plasma, cryoprecipitate and cryosupernatant. Br J Haematol. 2004 Jul;126(1):11-28.""]",17/06/2020,https://clinicaltrials.gov/show/NCT04432103,30/07/2020,0,1
666,NCT04432766,Not yet recruiting,20/01/2021,18/08/2021,No Results Posted,,,29/09/2020,https://clinicaltrials.gov/show/NCT04432766,20/01/2021,0,0
667,NCT04432805,Recruiting,15/06/2021,15/06/2021,No Results Posted,,,16/06/2020,https://clinicaltrials.gov/show/NCT04432805,15/06/2021,0,0
668,NCT04432987,Recruiting,25/08/2020,25/09/2020,No Results Posted,,,16/06/2020,https://clinicaltrials.gov/show/NCT04432987,25/08/2020,0,0
669,NCT04433013,Not yet recruiting,01/12/2020,01/02/2021,No Results Posted,,,17/06/2020,https://clinicaltrials.gov/show/NCT04433013,01/12/2020,0,0
670,NCT04433988,Not yet recruiting,30/12/2021,30/12/2021,No Results Posted,,,05/01/2021,https://clinicaltrials.gov/show/NCT04433988,30/12/2021,0,0
671,NCT04434131,Recruiting,28/04/2021,28/04/2025,Results Submitted,"['Piechotta V, Iannizzi C, Chai KL, Valk SJ, Kimber C, Dorando E, Monsef I, Wood EM, Lamikanra AA, Roberts DJ, McQuilten Z, So-Osman C, Estcourt LJ, Skoetz N. Convalescent plasma or hyperimmune immunoglobulin for people with COVID-19: a living systematic review. Cochrane Database Syst Rev. 2021 May 20;5:CD013600. doi: 10.1002/14651858.CD013600.pub4.', 'Chai KL, Valk SJ, Piechotta V, Kimber C, Monsef I, Doree C, Wood EM, Lamikanra AA, Roberts DJ, McQuilten Z, So-Osman C, Estcourt LJ, Skoetz N. Convalescent plasma or hyperimmune immunoglobulin for people with COVID-19: a living systematic review. Cochrane Database Syst Rev. 2020 Oct 12;10:CD013600. doi: 10.1002/14651858.CD013600.pub3. Update in: Cochrane Database Syst Rev. 2021 May 20;5:CD013600.', 'Bradfute SB, Hurwitz I, Yingling AV, Ye C, Cheng Q, Noonan TP, Raval JS, Sosa NR, Mertz GJ, Perkins DJ, Harkins MS. Severe Acute Respiratory Syndrome Coronavirus 2 Neutralizing Antibody Titers in Convalescent Plasma and Recipients in New Mexico: An Open Treatment Study in Patients With Coronavirus Disease 2019. J Infect Dis. 2020 Oct 13;222(10):1620-1628. doi: 10.1093/infdis/jiaa505.']",,16/06/2020,https://clinicaltrials.gov/show/NCT04434131,28/04/2021,0,1
672,NCT04434248,"Active, not recruiting",01/07/2020,01/07/2020,No Results Posted,,,16/06/2020,https://clinicaltrials.gov/show/NCT04434248,01/07/2020,0,0
673,NCT04435015,Not yet recruiting,30/07/2021,30/07/2021,No Results Posted,,,28/10/2020,https://clinicaltrials.gov/show/NCT04435015,30/07/2021,0,0
674,NCT04435314,Not yet recruiting,01/08/2020,01/08/2020,No Results Posted,,,17/06/2020,https://clinicaltrials.gov/show/NCT04435314,01/08/2020,0,0
675,NCT04435353,Recruiting,31/12/2020,01/02/2021,No Results Posted,,,17/06/2020,https://clinicaltrials.gov/show/NCT04435353,31/12/2020,0,0
676,NCT04435717,Recruiting,04/08/2020,04/08/2020,No Results Posted,,,17/06/2020,https://clinicaltrials.gov/show/NCT04435717,04/08/2020,0,0
677,NCT04435808,Terminated,15/07/2020,15/07/2020,Study Results,,,16/11/2020,https://clinicaltrials.gov/show/NCT04435808,15/07/2020,1,0
678,NCT04436471,Completed,03/08/2020,10/08/2020,No Results Posted,"['Logunov DY, Dolzhikova IV, Zubkova OV, Tukhvatulin AI, Shcheblyakov DV, Dzharullaeva AS, Grousova DM, Erokhova AS, Kovyrshina AV, Botikov AG, Izhaeva FM, Popova O, Ozharovskaya TA, Esmagambetov IB, Favorskaya IA, Zrelkin DI, Voronina DV, Shcherbinin DN, Semikhin AS, Simakova YV, Tokarskaya EA, Lubenets NL, Egorova DA, Shmarov MM, Nikitenko NA, Morozova LF, Smolyarchuk EA, Kryukov EV, Babira VF, Borisevich SV, Naroditsky BS, Gintsburg AL. Safety and immunogenicity of an rAd26 and rAd5 vector-based heterologous prime-boost COVID-19 vaccine in two formulations: two open, non-randomised phase 1/2 studies from Russia. Lancet. 2020 Sep 26;396(10255):887-897. doi: 10.1016/S0140-6736(20)31866-3. Epub 2020 Sep 4. Erratum in: Lancet. 2021 Jan 9;397(10269):98.']",,12/08/2020,https://clinicaltrials.gov/show/NCT04436471,03/08/2020,0,1
679,NCT04437693,Not yet recruiting,30/08/2021,31/12/2021,No Results Posted,,,11/08/2020,https://clinicaltrials.gov/show/NCT04437693,30/08/2021,0,0
680,NCT04437719,Recruiting,29/12/2021,31/12/2021,No Results Posted,,"['Chen N, Zhou M, Dong X, Qu J, Gong F, Han Y, Qiu Y, Wang J, Liu Y, Wei Y, Xia J, Yu T, Zhang X, Zhang L. Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study. Lancet. 2020 Feb 15;395(10223):507-513. doi: 10.1016/S0140-6736(20)30211-7. Epub 2020 Jan 30.', ""Gliklich RE, Dreyer NA, Leavy MB, Christian JB, editors. 21st Century Patient Registries: Registries for Evaluating Patient Outcomes: A User's Guide: 3rd Edition, Addendum [Internet]. Rockville (MD): Agency for Healthcare Research and Quality (US); 2018 Mar. Available from http://www.ncbi.nlm.nih.gov/books/NBK493818/""]",14/08/2020,https://clinicaltrials.gov/show/NCT04437719,29/12/2021,0,1
681,NCT04437823,Recruiting,31/05/2021,30/06/2021,No Results Posted,,,18/06/2020,https://clinicaltrials.gov/show/NCT04437823,31/05/2021,0,0
682,NCT04437875,Completed,03/08/2020,10/08/2020,No Results Posted,"['Logunov DY, Dolzhikova IV, Zubkova OV, Tukhvatulin AI, Shcheblyakov DV, Dzharullaeva AS, Grousova DM, Erokhova AS, Kovyrshina AV, Botikov AG, Izhaeva FM, Popova O, Ozharovskaya TA, Esmagambetov IB, Favorskaya IA, Zrelkin DI, Voronina DV, Shcherbinin DN, Semikhin AS, Simakova YV, Tokarskaya EA, Lubenets NL, Egorova DA, Shmarov MM, Nikitenko NA, Morozova LF, Smolyarchuk EA, Kryukov EV, Babira VF, Borisevich SV, Naroditsky BS, Gintsburg AL. Safety and immunogenicity of an rAd26 and rAd5 vector-based heterologous prime-boost COVID-19 vaccine in two formulations: two open, non-randomised phase 1/2 studies from Russia. Lancet. 2020 Sep 26;396(10255):887-897. doi: 10.1016/S0140-6736(20)31866-3. Epub 2020 Sep 4. Erratum in: Lancet. 2021 Jan 9;397(10269):98.']",,12/08/2020,https://clinicaltrials.gov/show/NCT04437875,03/08/2020,0,1
683,NCT04438057,Recruiting,12/08/2020,12/08/2021,No Results Posted,,,21/08/2020,https://clinicaltrials.gov/show/NCT04438057,12/08/2020,0,0
684,NCT04438070,Recruiting,01/06/2020,01/06/2020,No Results Posted,"[""O'Shea T, Mbuagbaw L, Mokashi V, Bulir D, Gilchrist J, Smieja N, Chong S, Marttala S, Vera V, Cvetkovic A, Smieja M. Comparison of four COVID-19 screening strategies to facilitate early case identification within the homeless shelter population: A structured summary of a study protocol for a randomised controlled trial. Trials. 2020 Nov 23;21(1):941. doi: 10.1186/s13063-020-04890-2.""]",,18/06/2020,https://clinicaltrials.gov/show/NCT04438070,01/06/2020,0,1
685,NCT04438694,Recruiting,31/05/2021,31/12/2021,No Results Posted,,,29/09/2020,https://clinicaltrials.gov/show/NCT04438694,31/05/2021,0,0
686,NCT04438837,Not yet recruiting,01/06/2022,01/06/2022,No Results Posted,,"['Wu Z, McGoogan JM. Characteristics of and Important Lessons From the Coronavirus Disease 2019 (COVID-19) Outbreak in China: Summary of a Report of 72 314 Cases From the Chinese Center for Disease Control and Prevention. JAMA. 2020 Apr 7;323(13):1239-1242. doi: 10.1001/jama.2020.2648.', 'Livingston E, Bucher K. Coronavirus Disease 2019 (COVID-19) in Italy. JAMA. 2020 Apr 14;323(14):1335. doi: 10.1001/jama.2020.4344.', 'Chan JF, Yuan S, Kok KH, To KK, Chu H, Yang J, Xing F, Liu J, Yip CC, Poon RW, Tsoi HW, Lo SK, Chan KH, Poon VK, Chan WM, Ip JD, Cai JP, Cheng VC, Chen H, Hui CK, Yuen KY. A familial cluster of pneumonia associated with the 2019 novel coronavirus indicating person-to-person transmission: a study of a family cluster. Lancet. 2020 Feb 15;395(10223):514-523. doi: 10.1016/S0140-6736(20)30154-9. Epub 2020 Jan 24.', 'Chang, Xu H, Rebaza A, Sharma L, Dela Cruz CS. Protecting health-care workers from subclinical coronavirus infection. Lancet Respir Med. 2020 Mar;8(3):e13. doi: 10.1016/S2213-2600(20)30066-7. Epub 2020 Feb 13.', 'Shiryaev SA, Mesci P, Pinto A, Fernandes I, Sheets N, Shresta S, Farhy C, Huang CT, Strongin AY, Muotri AR, Terskikh AV. Repurposing of the anti-malaria drug chloroquine for Zika Virus treatment and prophylaxis. Sci Rep. 2017 Nov 17;7(1):15771. doi: 10.1038/s41598-017-15467-6.', 'Devaux CA, Rolain JM, Colson P, Raoult D. New insights on the antiviral effects of chloroquine against coronavirus: what to expect for COVID-19? Int J Antimicrob Agents. 2020 May;55(5):105938. doi: 10.1016/j.ijantimicag.2020.105938. Epub 2020 Mar 12.']",23/07/2020,https://clinicaltrials.gov/show/NCT04438837,01/06/2022,0,1
687,NCT04439006,Recruiting,31/12/2021,31/12/2022,No Results Posted,,,19/08/2020,https://clinicaltrials.gov/show/NCT04439006,31/12/2021,0,0
688,NCT04441385,Recruiting,30/11/2020,20/12/2020,No Results Posted,,,09/07/2020,https://clinicaltrials.gov/show/NCT04441385,30/11/2020,0,0
689,NCT04441398,Not yet recruiting,01/09/2020,01/09/2020,No Results Posted,,,22/06/2020,https://clinicaltrials.gov/show/NCT04441398,01/09/2020,0,0
690,NCT04441424,Completed,01/06/2020,01/06/2020,No Results Posted,"['Piechotta V, Iannizzi C, Chai KL, Valk SJ, Kimber C, Dorando E, Monsef I, Wood EM, Lamikanra AA, Roberts DJ, McQuilten Z, So-Osman C, Estcourt LJ, Skoetz N. Convalescent plasma or hyperimmune immunoglobulin for people with COVID-19: a living systematic review. Cochrane Database Syst Rev. 2021 May 20;5:CD013600. doi: 10.1002/14651858.CD013600.pub4.', 'Chai KL, Valk SJ, Piechotta V, Kimber C, Monsef I, Doree C, Wood EM, Lamikanra AA, Roberts DJ, McQuilten Z, So-Osman C, Estcourt LJ, Skoetz N. Convalescent plasma or hyperimmune immunoglobulin for people with COVID-19: a living systematic review. Cochrane Database Syst Rev. 2020 Oct 12;10:CD013600. doi: 10.1002/14651858.CD013600.pub3. Update in: Cochrane Database Syst Rev. 2021 May 20;5:CD013600.']",,23/06/2020,https://clinicaltrials.gov/show/NCT04441424,01/06/2020,0,1
691,NCT04441632,Completed,26/07/2020,30/07/2020,No Results Posted,,,12/08/2020,https://clinicaltrials.gov/show/NCT04441632,26/07/2020,0,0
692,NCT04441684,Recruiting,07/05/2020,01/08/2021,No Results Posted,,,22/06/2020,https://clinicaltrials.gov/show/NCT04441684,07/05/2020,0,0
693,NCT04441918,Recruiting,11/12/2020,11/12/2020,No Results Posted,"['Wu X, Li N, Wang G, Liu W, Yu J, Cao G, Wang J, Chen Y, Ma J, Wu J, Yang H, Mao X, He J, Yu Y, Qiu C, Li N, Yao S, Feng H, Yan J, Zhang W, Zhang J. Tolerability, Safety, Pharmacokinetics, and Immunogenicity of a Novel SARS-CoV-2 Neutralizing Antibody, Etesevimab in Chinese Healthy Adults: A Randomized, Double-Blind, Placebo-Controlled, First-In-Human Phase 1 Study. Antimicrob Agents Chemother. 2021 May 10. pii: AAC.00350-21. doi: 10.1128/AAC.00350-21. [Epub ahead of print]']",,22/06/2020,https://clinicaltrials.gov/show/NCT04441918,11/12/2020,0,1
694,NCT04442152,Enrolling by invitation,01/08/2020,01/08/2020,No Results Posted,,,22/06/2020,https://clinicaltrials.gov/show/NCT04442152,01/08/2020,0,0
695,NCT04442191,Recruiting,05/05/2021,05/05/2021,No Results Posted,,,22/06/2020,https://clinicaltrials.gov/show/NCT04442191,05/05/2021,0,0
696,NCT04442958,Completed,15/06/2020,17/06/2020,No Results Posted,,,01/07/2020,https://clinicaltrials.gov/show/NCT04442958,15/06/2020,0,0
697,NCT04443270,Not yet recruiting,31/10/2020,31/01/2021,No Results Posted,,,14/07/2020,https://clinicaltrials.gov/show/NCT04443270,31/10/2020,0,0
698,NCT04443673,Recruiting,28/02/2021,30/06/2021,No Results Posted,,,24/08/2020,https://clinicaltrials.gov/show/NCT04443673,28/02/2021,0,0
699,NCT04443725,Not yet recruiting,01/10/2020,01/12/2020,No Results Posted,,,25/06/2020,https://clinicaltrials.gov/show/NCT04443725,01/10/2020,0,0
700,NCT04443868,Not yet recruiting,01/04/2021,01/07/2021,No Results Posted,,,08/10/2020,https://clinicaltrials.gov/show/NCT04443868,01/04/2021,0,0
701,NCT04444271,Recruiting,30/08/2020,30/09/2020,No Results Posted,,,30/06/2020,https://clinicaltrials.gov/show/NCT04444271,30/08/2020,0,0
702,NCT04444596,Recruiting,31/03/2021,31/03/2021,No Results Posted,,,23/06/2020,https://clinicaltrials.gov/show/NCT04444596,31/03/2021,0,0
703,NCT04444674,"Active, not recruiting",01/12/2020,01/12/2021,No Results Posted,"['Madhi SA, Baillie V, Cutland CL, Voysey M, Koen AL, Fairlie L, Padayachee SD, Dheda K, Barnabas SL, Bhorat QE, Briner C, Kwatra G, Ahmed K, Aley P, Bhikha S, Bhiman JN, Bhorat AE, du Plessis J, Esmail A, Groenewald M, Horne E, Hwa SH, Jose A, Lambe T, Laubscher M, Malahleha M, Masenya M, Masilela M, McKenzie S, Molapo K, Moultrie A, Oelofse S, Patel F, Pillay S, Rhead S, Rodel H, Rossouw L, Taoushanis C, Tegally H, Thombrayil A, van Eck S, Wibmer CK, Durham NM, Kelly EJ, Villafana TL, Gilbert S, Pollard AJ, de Oliveira T, Moore PL, Sigal A, Izu A; NGS-SA Group; Wits-VIDA COVID Group. Efficacy of the ChAdOx1 nCoV-19 Covid-19 Vaccine against the B.1.351 Variant. N Engl J Med. 2021 May 20;384(20):1885-1898. doi: 10.1056/NEJMoa2102214. Epub 2021 Mar 16.', 'Voysey M, Costa Clemens SA, Madhi SA, Weckx LY, Folegatti PM, Aley PK, Angus B, Baillie VL, Barnabas SL, Bhorat QE, Bibi S, Briner C, Cicconi P, Clutterbuck EA, Collins AM, Cutland CL, Darton TC, Dheda K, Dold C, Duncan CJA, Emary KRW, Ewer KJ, Flaxman A, Fairlie L, Faust SN, Feng S, Ferreira DM, Finn A, Galiza E, Goodman AL, Green CM, Green CA, Greenland M, Hill C, Hill HC, Hirsch I, Izu A, Jenkin D, Joe CCD, Kerridge S, Koen A, Kwatra G, Lazarus R, Libri V, Lillie PJ, Marchevsky NG, Marshall RP, Mendes AVA, Milan EP, Minassian AM, McGregor A, Mujadidi YF, Nana A, Padayachee SD, Phillips DJ, Pittella A, Plested E, Pollock KM, Ramasamy MN, Ritchie AJ, Robinson H, Schwarzbold AV, Smith A, Song R, Snape MD, Sprinz E, Sutherland RK, Thomson EC, T√∂r√∂k ME, Toshner M, Turner DPJ, Vekemans J, Villafana TL, White T, Williams CJ, Douglas AD, Hill AVS, Lambe T, Gilbert SC, Pollard AJ; Oxford COVID Vaccine Trial Group. Single-dose administration and the influence of the timing of the booster dose on immunogenicity and efficacy of ChAdOx1 nCoV-19 (AZD1222) vaccine: a pooled analysis of four randomised trials. Lancet. 2021 Mar 6;397(10277):881-891. doi: 10.1016/S0140-6736(21)00432-3. Epub 2021 Feb 19. Erratum in: Lancet. 2021 Mar 6;397(10277):880.', ""Voysey M, Clemens SAC, Madhi SA, Weckx LY, Folegatti PM, Aley PK, Angus B, Baillie VL, Barnabas SL, Bhorat QE, Bibi S, Briner C, Cicconi P, Collins AM, Colin-Jones R, Cutland CL, Darton TC, Dheda K, Duncan CJA, Emary KRW, Ewer KJ, Fairlie L, Faust SN, Feng S, Ferreira DM, Finn A, Goodman AL, Green CM, Green CA, Heath PT, Hill C, Hill H, Hirsch I, Hodgson SHC, Izu A, Jackson S, Jenkin D, Joe CCD, Kerridge S, Koen A, Kwatra G, Lazarus R, Lawrie AM, Lelliott A, Libri V, Lillie PJ, Mallory R, Mendes AVA, Milan EP, Minassian AM, McGregor A, Morrison H, Mujadidi YF, Nana A, O'Reilly PJ, Padayachee SD, Pittella A, Plested E, Pollock KM, Ramasamy MN, Rhead S, Schwarzbold AV, Singh N, Smith A, Song R, Snape MD, Sprinz E, Sutherland RK, Tarrant R, Thomson EC, T√∂r√∂k ME, Toshner M, Turner DPJ, Vekemans J, Villafana TL, Watson MEE, Williams CJ, Douglas AD, Hill AVS, Lambe T, Gilbert SC, Pollard AJ; Oxford COVID Vaccine Trial Group. Safety and efficacy of the ChAdOx1 nCoV-19 vaccine (AZD1222) against SARS-CoV-2: an interim analysis of four randomised controlled trials in Brazil, South Africa, and the UK. Lancet. 2021 Jan 9;397(10269):99-111. doi: 10.1016/S0140-6736(20)32661-1. Epub 2020 Dec 8. Erratum in: Lancet. 2021 Jan 9;397(10269):98.""]",,27/11/2020,https://clinicaltrials.gov/show/NCT04444674,01/12/2020,0,1
704,NCT04445246,Recruiting,31/05/2021,31/05/2021,No Results Posted,,,24/06/2020,https://clinicaltrials.gov/show/NCT04445246,31/05/2021,0,0
705,NCT04445311,Recruiting,30/07/2020,15/08/2020,No Results Posted,,,24/06/2020,https://clinicaltrials.gov/show/NCT04445311,30/07/2020,0,0
706,NCT04445324,"Active, not recruiting",25/08/2020,01/12/2020,No Results Posted,"['Pelletier JF, Houle J, Goulet MH, Juster RP, Gigu√®re C√â, Bordet J, H√©nault I, Lesage A, De Benedictis L, Denis F, Ng R. Online and Recovery-Oriented Support Groups Facilitated by Peer Support Workers in Times of COVID-19: Protocol for a Feasibility Pre-Post Study. JMIR Res Protoc. 2020 Dec 18;9(12):e22500. doi: 10.2196/22500.']",,23/11/2020,https://clinicaltrials.gov/show/NCT04445324,25/08/2020,0,1
707,NCT04445337,Not yet recruiting,01/07/2021,01/07/2021,No Results Posted,,,24/06/2020,https://clinicaltrials.gov/show/NCT04445337,01/07/2021,0,0
708,NCT04445376,Completed,10/09/2020,03/10/2020,No Results Posted,,,08/10/2020,https://clinicaltrials.gov/show/NCT04445376,10/09/2020,0,0
709,NCT04445389,Recruiting,17/03/2021,17/06/2022,No Results Posted,,,28/07/2020,https://clinicaltrials.gov/show/NCT04445389,17/03/2021,0,0
710,NCT04445454,Recruiting,30/09/2022,30/09/2022,No Results Posted,,,24/06/2020,https://clinicaltrials.gov/show/NCT04445454,30/09/2022,0,0
711,NCT04445467,Recruiting,01/11/2020,01/11/2020,No Results Posted,"['McMahon JH, Lau JSY, Roney J, Rogers BA, Trubiano J, Sasadeusz J, Molton JS, Gardiner B, Lee SJ, Hoy JF, Cheng A, Peleg AY. An adaptive randomised placebo controlled phase II trial of antivirals for COVID-19 infection (VIRCO): A structured summary of a study protocol for a randomised controlled trial. Trials. 2020 Oct 13;21(1):847. doi: 10.1186/s13063-020-04766-5.']",,19/08/2020,https://clinicaltrials.gov/show/NCT04445467,01/11/2020,0,1
712,NCT04445597,Recruiting,31/12/2022,31/12/2022,No Results Posted,,,01/12/2020,https://clinicaltrials.gov/show/NCT04445597,31/12/2022,0,0
713,NCT04445623,Not yet recruiting,01/10/2020,01/01/2021,No Results Posted,,,26/06/2020,https://clinicaltrials.gov/show/NCT04445623,01/10/2020,0,0
714,NCT04445935,Recruiting,28/09/2020,28/03/2021,No Results Posted,"['Kharma N, Roehrig S, Shible AA, Elshafei MS, Osman D, Elsaid IM, Mustafa SF, Aldabi A, Smain OAM, Lance MD. Anticoagulation in critically ill patients on mechanical ventilation suffering from COVID-19 disease, The ANTI-CO trial: A structured summary of a study protocol for a randomised controlled trial. Trials. 2020 Sep 7;21(1):769. doi: 10.1186/s13063-020-04689-1.']",,24/06/2020,https://clinicaltrials.gov/show/NCT04445935,28/09/2020,0,1
715,NCT04446065,Not yet recruiting,30/09/2021,30/10/2021,No Results Posted,,,09/09/2020,https://clinicaltrials.gov/show/NCT04446065,30/09/2021,0,0
716,NCT04446104,Completed,31/08/2020,31/08/2020,No Results Posted,,,19/10/2020,https://clinicaltrials.gov/show/NCT04446104,31/08/2020,0,0
717,NCT04446377,Recruiting,31/03/2021,30/04/2021,No Results Posted,,,04/11/2020,https://clinicaltrials.gov/show/NCT04446377,31/03/2021,0,0
718,NCT04447235,Recruiting,01/12/2020,01/02/2021,No Results Posted,,,29/07/2020,https://clinicaltrials.gov/show/NCT04447235,01/12/2020,0,0
719,NCT04447781,Recruiting,22/02/2022,22/02/2022,No Results Posted,,,19/08/2020,https://clinicaltrials.gov/show/NCT04447781,22/02/2022,0,0
720,NCT04448119,Recruiting,01/03/2021,01/03/2021,No Results Posted,,,23/10/2020,https://clinicaltrials.gov/show/NCT04448119,01/03/2021,0,0
721,NCT04448769,Completed,24/07/2020,24/07/2020,No Results Posted,,,19/08/2020,https://clinicaltrials.gov/show/NCT04448769,24/07/2020,0,0
722,NCT04449276,"Active, not recruiting",01/12/2021,01/12/2021,No Results Posted,,,22/12/2020,https://clinicaltrials.gov/show/NCT04449276,01/12/2021,0,0
723,NCT04449718,Completed,07/10/2020,07/10/2020,No Results Posted,"['Stroehlein JK, Wallqvist J, Iannizzi C, Mikolajewska A, Metzendorf MI, Benstoem C, Meybohm P, Becker M, Skoetz N, Stegemann M, Piechotta V. Vitamin D supplementation for the treatment of COVID-19: a living systematic review. Cochrane Database Syst Rev. 2021 May 24;5:CD015043. doi: 10.1002/14651858.CD015043.', 'Murai IH, Fernandes AL, Sales LP, Pinto AJ, Goessler KF, Duran CSC, Silva CBR, Franco AS, Macedo MB, Dalmolin HHH, Baggio J, Balbi GGM, Reis BZ, Antonangelo L, Caparbo VF, Gualano B, Pereira RMR. Effect of a Single High Dose of Vitamin D3 on Hospital Length of Stay in Patients With Moderate to Severe COVID-19: A Randomized Clinical Trial. JAMA. 2021 Mar 16;325(11):1053-1060. doi: 10.1001/jama.2020.26848.']",,17/11/2020,https://clinicaltrials.gov/show/NCT04449718,07/10/2020,0,1
724,NCT04449965,Not yet recruiting,01/11/2020,01/12/2020,No Results Posted,,,29/06/2020,https://clinicaltrials.gov/show/NCT04449965,01/11/2020,0,0
725,NCT04450004,"Active, not recruiting",20/09/2021,31/12/2021,No Results Posted,"[""Ward BJ, Gobeil P, S√©guin A, Atkins J, Boulay I, Charbonneau PY, Couture M, D'Aoust MA, Dhaliwall J, Finkle C, Hager K, Mahmood A, Makarkov A, Cheng MP, Pillet S, Schimke P, St-Martin S, Tr√©panier S, Landry N. Phase 1 randomized trial of a plant-derived virus-like particle vaccine for COVID-19. Nat Med. 2021 Jun;27(6):1071-1078. doi: 10.1038/s41591-021-01370-1. Epub 2021 May 18.""]",,23/10/2020,https://clinicaltrials.gov/show/NCT04450004,20/09/2021,0,1
726,NCT04451239,Not yet recruiting,01/07/2020,01/07/2020,No Results Posted,,,30/06/2020,https://clinicaltrials.gov/show/NCT04451239,01/07/2020,0,0
727,NCT04451889,Recruiting,01/07/2021,01/09/2021,No Results Posted,,,24/07/2020,https://clinicaltrials.gov/show/NCT04451889,01/07/2021,0,0
728,NCT04452474,Not yet recruiting,16/11/2020,29/01/2021,No Results Posted,,,30/06/2020,https://clinicaltrials.gov/show/NCT04452474,16/11/2020,0,0
729,NCT04452565,Recruiting,31/12/2020,15/02/2021,No Results Posted,,,07/09/2020,https://clinicaltrials.gov/show/NCT04452565,31/12/2020,0,0
730,NCT04452643,Withdrawn,01/12/2021,01/12/2021,No Results Posted,,,02/11/2020,https://clinicaltrials.gov/show/NCT04452643,01/12/2021,0,0
731,NCT04452773,Recruiting,01/09/2020,01/12/2021,No Results Posted,,,15/07/2020,https://clinicaltrials.gov/show/NCT04452773,01/09/2020,0,0
732,NCT04452799,Not yet recruiting,01/10/2020,30/10/2020,No Results Posted,,"['Haggag YA, El-Ashmawy NE, Okasha KM. Is hesperidin essential for prophylaxis and treatment of COVID-19 Infection? Med Hypotheses. 2020 Nov;144:109957. doi: 10.1016/j.mehy.2020.109957. Epub 2020 Jun 6.']",30/06/2020,https://clinicaltrials.gov/show/NCT04452799,01/10/2020,0,1
733,NCT04452812,Not yet recruiting,01/03/2021,01/04/2021,No Results Posted,,,07/07/2020,https://clinicaltrials.gov/show/NCT04452812,01/03/2021,0,0
734,NCT04453475,Recruiting,31/07/2021,31/12/2021,No Results Posted,,,27/08/2020,https://clinicaltrials.gov/show/NCT04453475,31/07/2021,0,0
735,NCT04453488,Not yet recruiting,01/12/2020,01/12/2020,No Results Posted,,,29/07/2020,https://clinicaltrials.gov/show/NCT04453488,01/12/2020,0,0
736,NCT04453514,Recruiting,01/10/2020,01/10/2020,No Results Posted,,,24/07/2020,https://clinicaltrials.gov/show/NCT04453514,01/10/2020,0,0
737,NCT04453553,Not yet recruiting,28/08/2020,28/09/2020,No Results Posted,,,01/07/2020,https://clinicaltrials.gov/show/NCT04453553,28/08/2020,0,0
738,NCT04454307,Not yet recruiting,01/08/2020,01/10/2020,No Results Posted,,,02/07/2020,https://clinicaltrials.gov/show/NCT04454307,01/08/2020,0,0
739,NCT04454606,Completed,15/05/2020,31/05/2020,No Results Posted,,"['Leung NHL, Chu DKW, Shiu EYC, Chan KH, McDevitt JJ, Hau BJP, Yen HL, Li Y, Ip DKM, Peiris JSM, Seto WH, Leung GM, Milton DK, Cowling BJ. Author Correction: Respiratory virus shedding in exhaled breath and efficacy of face masks. Nat Med. 2020 Jun;26(6):981. doi: 10.1038/s41591-020-0946-9.']",01/07/2020,https://clinicaltrials.gov/show/NCT04454606,15/05/2020,0,1
740,NCT04455243,Not yet recruiting,30/08/2021,30/08/2021,No Results Posted,,,21/07/2020,https://clinicaltrials.gov/show/NCT04455243,30/08/2021,0,0
741,NCT04455308,Completed,19/10/2020,19/10/2020,No Results Posted,,,04/11/2020,https://clinicaltrials.gov/show/NCT04455308,19/10/2020,0,0
742,NCT04455360,Recruiting,01/03/2021,01/09/2021,No Results Posted,"['Bates A, Rushbrook S, Shapiro E, Grocott M, Cusack R. CovEMERALD: Assessing the feasibility and preliminary effectiveness of remotely delivered Eye Movement Desensitisation and Reprocessing following Covid-19 related critical illness: A structured summary of a study protocol for a randomised controlled trial. Trials. 2020 Nov 17;21(1):929. doi: 10.1186/s13063-020-04805-1.']",,22/10/2020,https://clinicaltrials.gov/show/NCT04455360,01/03/2021,0,1
743,NCT04456049,Not yet recruiting,01/12/2021,01/12/2021,No Results Posted,,,02/07/2020,https://clinicaltrials.gov/show/NCT04456049,01/12/2021,0,0
744,NCT04456361,"Active, not recruiting",15/10/2020,15/12/2020,No Results Posted,,,04/08/2020,https://clinicaltrials.gov/show/NCT04456361,15/10/2020,0,0
745,NCT04457349,Recruiting,29/12/2020,20/01/2021,No Results Posted,,,05/01/2021,https://clinicaltrials.gov/show/NCT04457349,29/12/2020,0,0
746,NCT04457388,Completed,15/06/2020,15/06/2020,No Results Posted,,,08/07/2020,https://clinicaltrials.gov/show/NCT04457388,15/06/2020,0,0
747,NCT04457609,Recruiting,01/08/2020,01/09/2020,No Results Posted,,,07/07/2020,https://clinicaltrials.gov/show/NCT04457609,01/08/2020,0,0
748,NCT04457726,Recruiting,01/03/2021,01/12/2022,No Results Posted,,,07/07/2020,https://clinicaltrials.gov/show/NCT04457726,01/03/2021,0,0
749,NCT04458246,Recruiting,01/12/2020,01/06/2021,No Results Posted,,,07/07/2020,https://clinicaltrials.gov/show/NCT04458246,01/12/2020,0,0
750,NCT04458948,"Active, not recruiting",24/03/2021,24/03/2025,No Results Posted,,,07/07/2020,https://clinicaltrials.gov/show/NCT04458948,24/03/2021,0,0
751,NCT04459325,Completed,20/07/2020,20/07/2020,No Results Posted,,,14/10/2020,https://clinicaltrials.gov/show/NCT04459325,20/07/2020,0,0
752,NCT04459455,Completed,15/10/2020,15/10/2020,No Results Posted,,,20/10/2020,https://clinicaltrials.gov/show/NCT04459455,15/10/2020,0,0
753,NCT04459520,Completed,28/07/2020,29/07/2020,No Results Posted,,,20/08/2020,https://clinicaltrials.gov/show/NCT04459520,28/07/2020,0,0
754,NCT04460105,Withdrawn,27/01/2021,27/01/2021,No Results Posted,,,12/10/2020,https://clinicaltrials.gov/show/NCT04460105,27/01/2021,0,0
755,NCT04460534,Recruiting,31/07/2021,31/08/2021,No Results Posted,,,07/07/2020,https://clinicaltrials.gov/show/NCT04460534,31/07/2021,0,0
756,NCT04460677,Recruiting,31/03/2021,31/03/2021,No Results Posted,,,09/09/2020,https://clinicaltrials.gov/show/NCT04460677,31/03/2021,0,0
757,NCT04460690,Enrolling by invitation,01/07/2021,01/07/2021,No Results Posted,,,28/09/2020,https://clinicaltrials.gov/show/NCT04460690,01/07/2021,0,0
758,NCT04460703,Completed,08/07/2020,08/07/2020,No Results Posted,,,21/07/2020,https://clinicaltrials.gov/show/NCT04460703,08/07/2020,0,0
759,NCT04461340,Recruiting,30/10/2020,30/11/2020,No Results Posted,,,09/09/2020,https://clinicaltrials.gov/show/NCT04461340,30/10/2020,0,0
760,NCT04461379,"Active, not recruiting",01/01/2021,01/01/2021,No Results Posted,,,13/11/2020,https://clinicaltrials.gov/show/NCT04461379,01/01/2021,0,0
761,NCT04461925,Recruiting,02/05/2021,01/12/2021,No Results Posted,,,08/07/2020,https://clinicaltrials.gov/show/NCT04461925,02/05/2021,0,0
762,NCT04462848,Not yet recruiting,01/09/2024,01/12/2024,No Results Posted,,,08/07/2020,https://clinicaltrials.gov/show/NCT04462848,01/09/2024,0,0
763,NCT04463264,Recruiting,15/11/2020,26/12/2020,Results Submitted,,,08/10/2020,https://clinicaltrials.gov/show/NCT04463264,15/11/2020,0,0
764,NCT04463420,Recruiting,15/11/2020,15/12/2020,No Results Posted,,,04/11/2020,https://clinicaltrials.gov/show/NCT04463420,15/11/2020,0,0
765,NCT04463433,Recruiting,31/12/2021,31/01/2022,No Results Posted,,,09/07/2020,https://clinicaltrials.gov/show/NCT04463433,31/12/2021,0,0
766,NCT04463472,"Active, not recruiting",28/09/2020,31/07/2021,No Results Posted,,,16/11/2020,https://clinicaltrials.gov/show/NCT04463472,28/09/2020,0,0
767,NCT04464460,Withdrawn,30/10/2020,30/10/2020,No Results Posted,,,08/10/2020,https://clinicaltrials.gov/show/NCT04464460,30/10/2020,0,0
768,NCT04464486,Enrolling by invitation,30/07/2021,31/03/2022,No Results Posted,,,30/06/2021,https://clinicaltrials.gov/show/NCT04464486,30/07/2021,0,0
769,NCT04465695,Recruiting,30/06/2021,30/09/2021,No Results Posted,,,15/07/2020,https://clinicaltrials.gov/show/NCT04465695,30/06/2021,0,0
770,NCT04466280,Recruiting,15/11/2020,15/12/2020,No Results Posted,,,10/07/2020,https://clinicaltrials.gov/show/NCT04466280,15/11/2020,0,0
771,NCT04466540,Recruiting,28/01/2021,30/03/2021,No Results Posted,,,27/11/2020,https://clinicaltrials.gov/show/NCT04466540,28/01/2021,0,0
772,NCT04466605,Completed,30/06/2020,06/07/2020,No Results Posted,,,10/07/2020,https://clinicaltrials.gov/show/NCT04466605,30/06/2020,0,0
773,NCT04466657,Not yet recruiting,28/02/2021,30/04/2021,No Results Posted,,,02/09/2020,https://clinicaltrials.gov/show/NCT04466657,28/02/2021,0,0
774,NCT04467047,Not yet recruiting,30/10/2020,30/12/2020,No Results Posted,,,10/07/2020,https://clinicaltrials.gov/show/NCT04467047,30/10/2020,0,0
775,NCT04467151,Withdrawn,01/10/2021,01/12/2021,No Results Posted,,,22/10/2020,https://clinicaltrials.gov/show/NCT04467151,01/10/2021,0,0
776,NCT04467918,"Active, not recruiting",16/11/2020,16/12/2020,No Results Posted,,,03/11/2020,https://clinicaltrials.gov/show/NCT04467918,16/11/2020,0,0
777,NCT04468139,Recruiting,20/07/2020,30/07/2020,No Results Posted,,,13/07/2020,https://clinicaltrials.gov/show/NCT04468139,20/07/2020,0,0
778,NCT04468646,Recruiting,15/07/2020,30/08/2020,No Results Posted,,,13/07/2020,https://clinicaltrials.gov/show/NCT04468646,15/07/2020,0,0
779,NCT04469621,Completed,23/10/2020,23/10/2020,No Results Posted,,,13/11/2020,https://clinicaltrials.gov/show/NCT04469621,23/10/2020,0,0
780,NCT04470297,Not yet recruiting,01/11/2020,01/03/2021,No Results Posted,,,24/07/2020,https://clinicaltrials.gov/show/NCT04470297,01/11/2020,0,0
781,NCT04470531,Recruiting,12/10/2020,30/01/2021,No Results Posted,,,16/07/2020,https://clinicaltrials.gov/show/NCT04470531,12/10/2020,0,0
782,NCT04470609,Enrolling by invitation,01/11/2020,01/11/2021,No Results Posted,,,14/07/2020,https://clinicaltrials.gov/show/NCT04470609,01/11/2020,0,0
783,NCT04470739,Recruiting,30/09/2020,30/10/2020,No Results Posted,,,14/07/2020,https://clinicaltrials.gov/show/NCT04470739,30/09/2020,0,0
784,NCT04471831,Not yet recruiting,21/06/2021,31/12/2021,No Results Posted,,,15/07/2020,https://clinicaltrials.gov/show/NCT04471831,21/06/2021,0,0
785,NCT04472494,Recruiting,13/01/2021,14/01/2021,No Results Posted,,,17/11/2020,https://clinicaltrials.gov/show/NCT04472494,13/01/2021,0,0
786,NCT04473053,Recruiting,03/07/2021,03/12/2021,No Results Posted,,,21/08/2020,https://clinicaltrials.gov/show/NCT04473053,03/07/2021,0,0
787,NCT04473170,Completed,20/05/2020,14/07/2020,No Results Posted,,,16/07/2020,https://clinicaltrials.gov/show/NCT04473170,20/05/2020,0,0
788,NCT04473248,Completed,30/08/2020,30/08/2020,No Results Posted,,,13/11/2020,https://clinicaltrials.gov/show/NCT04473248,30/08/2020,0,0
789,NCT04473599,Recruiting,01/04/2021,01/04/2021,No Results Posted,"['Figueroa CA, Hernandez-Ramos R, Boone CE, G√≥mez-Pathak L, Yip V, Luo T, Sierra V, Xu J, Chakraborty B, Darrow S, Aguilera A. A Text Messaging Intervention for Coping With Social Distancing During COVID-19 (StayWell at Home): Protocol for a Randomized Controlled Trial. JMIR Res Protoc. 2021 Jan 14;10(1):e23592. doi: 10.2196/23592.']",,28/07/2020,https://clinicaltrials.gov/show/NCT04473599,01/04/2021,0,1
790,NCT04474080,Not yet recruiting,01/07/2021,01/07/2021,No Results Posted,,,22/10/2020,https://clinicaltrials.gov/show/NCT04474080,01/07/2021,0,0
791,NCT04474340,Recruiting,30/09/2020,30/12/2020,No Results Posted,,,21/07/2020,https://clinicaltrials.gov/show/NCT04474340,30/09/2020,0,0
792,NCT04475081,Not yet recruiting,31/10/2021,01/12/2021,No Results Posted,,,20/07/2020,https://clinicaltrials.gov/show/NCT04475081,31/10/2021,0,0
793,NCT04475185,Recruiting,01/12/2020,01/12/2020,No Results Posted,,,27/11/2020,https://clinicaltrials.gov/show/NCT04475185,01/12/2020,0,0
794,NCT04475562,Completed,06/05/2020,01/07/2020,No Results Posted,,,17/07/2020,https://clinicaltrials.gov/show/NCT04475562,06/05/2020,0,0
795,NCT04475575,Completed,30/06/2020,01/07/2020,No Results Posted,,,17/07/2020,https://clinicaltrials.gov/show/NCT04475575,30/06/2020,0,0
796,NCT04475601,Recruiting,08/07/2021,08/05/2022,No Results Posted,"['Wel√©n K, √ñverby AK, Ahlm C, Freyhult E, Robinsson D, Henningsson AJ, Stranne J, Bremell D, Angelin M, Lindquist E, Buckland R, Carlsson CT, Pauksens K, Bill-Axelsson A, Akre O, Ryden C, Wagenius M, Bjartell A, Nilsson AC, Styrke J, Repo J, Balkhed √Ö√ñ, Niward K, Gissl√©n M, Josefsson A. COVIDENZA - A prospective, multicenter, randomized PHASE II clinical trial of enzalutamide treatment to decrease the morbidity in patients with Corona virus disease 2019 (COVID-19): a structured summary of a study protocol for a randomised controlled trial. Trials. 2021 Mar 16;22(1):209. doi: 10.1186/s13063-021-05137-4.']",,17/07/2020,https://clinicaltrials.gov/show/NCT04475601,08/07/2021,0,1
797,NCT04476927,Not yet recruiting,30/05/2021,30/06/2021,No Results Posted,,,20/07/2020,https://clinicaltrials.gov/show/NCT04476927,30/05/2021,0,0
798,NCT04476940,Not yet recruiting,01/10/2021,01/06/2022,No Results Posted,,,20/07/2020,https://clinicaltrials.gov/show/NCT04476940,01/10/2021,0,0
799,NCT04477083,"Active, not recruiting",15/08/2020,15/08/2020,No Results Posted,,,20/07/2020,https://clinicaltrials.gov/show/NCT04477083,15/08/2020,0,0
800,NCT04477642,Withdrawn,01/10/2020,01/12/2020,No Results Posted,,,20/07/2020,https://clinicaltrials.gov/show/NCT04477642,01/10/2020,0,0
801,NCT04478071,Recruiting,01/08/2022,01/08/2022,No Results Posted,,,10/09/2020,https://clinicaltrials.gov/show/NCT04478071,01/08/2022,0,0
802,NCT04478539,Recruiting,01/06/2021,01/07/2021,No Results Posted,,,20/07/2020,https://clinicaltrials.gov/show/NCT04478539,01/06/2021,0,0
803,NCT04479163,Completed,25/10/2020,25/10/2020,No Results Posted,"['Piechotta V, Iannizzi C, Chai KL, Valk SJ, Kimber C, Dorando E, Monsef I, Wood EM, Lamikanra AA, Roberts DJ, McQuilten Z, So-Osman C, Estcourt LJ, Skoetz N. Convalescent plasma or hyperimmune immunoglobulin for people with COVID-19: a living systematic review. Cochrane Database Syst Rev. 2021 May 20;5:CD013600. doi: 10.1002/14651858.CD013600.pub4.', 'Libster R, P√©rez Marc G, Wappner D, Coviello S, Bianchi A, Braem V, Esteban I, Caballero MT, Wood C, Berrueta M, Rondan A, Lescano G, Cruz P, Ritou Y, Fern√°ndez Vi√±a V, √Ålvarez Paggi D, Esperante S, Ferreti A, Ofman G, Ciganda √Å, Rodriguez R, Lantos J, Valentini R, Itcovici N, Hintze A, Oyarvide ML, Etchegaray C, Neira A, Name I, Alfonso J, L√≥pez Castelo R, Caruso G, Rapelius S, Alvez F, Etchenique F, Dimase F, Alvarez D, Aranda SS, S√°nchez Yanotti C, De Luca J, Jares Baglivo S, Laudanno S, Nowogrodzki F, Larrea R, Silveyra M, Leberzstein G, Debonis A, Molinos J, Gonz√°lez M, Perez E, Kreplak N, Pastor Arg√ºello S, Gibbons L, Althabe F, Bergel E, Polack FP; Fundaci√≥n INFANT-COVID-19 Group. Early High-Titer Plasma Therapy to Prevent Severe Covid-19 in Older Adults. N Engl J Med. 2021 Feb 18;384(7):610-618. doi: 10.1056/NEJMoa2033700. Epub 2021 Jan 6.']",,22/12/2020,https://clinicaltrials.gov/show/NCT04479163,25/10/2020,0,1
804,NCT04479202,Completed,18/04/2020,23/04/2020,No Results Posted,,"['Effenberger M, Grabherr F, Mayr L, Schwaerzler J, Nairz M, Seifert M, Hilbe R, Seiwald S, Scholl-Buergi S, Fritsche G, Bellmann-Weiler R, Weiss G, M√ºller T, Adolph TE, Tilg H. Faecal calprotectin indicates intestinal inflammation in COVID-19. Gut. 2020 Aug;69(8):1543-1544. doi: 10.1136/gutjnl-2020-321388. Epub 2020 Apr 20.', 'Jin X, Lian JS, Hu JH, Gao J, Zheng L, Zhang YM, Hao SR, Jia HY, Cai H, Zhang XL, Yu GD, Xu KJ, Wang XY, Gu JQ, Zhang SY, Ye CY, Jin CL, Lu YF, Yu X, Yu XP, Huang JR, Xu KL, Ni Q, Yu CB, Zhu B, Li YT, Liu J, Zhao H, Zhang X, Yu L, Guo YZ, Su JW, Tao JJ, Lang GJ, Wu XX, Wu WR, Qv TT, Xiang DR, Yi P, Shi D, Chen Y, Ren Y, Qiu YQ, Li LJ, Sheng J, Yang Y. Epidemiological, clinical and virological characteristics of 74 cases of coronavirus-infected disease 2019 (COVID-19) with gastrointestinal symptoms. Gut. 2020 Jun;69(6):1002-1009. doi: 10.1136/gutjnl-2020-320926. Epub 2020 Mar 24.', 'Zhou F, Yu T, Du R, Fan G, Liu Y, Liu Z, Xiang J, Wang Y, Song B, Gu X, Guan L, Wei Y, Li H, Wu X, Xu J, Tu S, Zhang Y, Chen H, Cao B. Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study. Lancet. 2020 Mar 28;395(10229):1054-1062. doi: 10.1016/S0140-6736(20)30566-3. Epub 2020 Mar 11. Erratum in: Lancet. 2020 Mar 28;395(10229):1038. Lancet. 2020 Mar 28;395(10229):1038.']",21/07/2020,https://clinicaltrials.gov/show/NCT04479202,18/04/2020,0,1
805,NCT04479332,Not yet recruiting,31/07/2022,31/07/2022,No Results Posted,,,21/07/2020,https://clinicaltrials.gov/show/NCT04479332,31/07/2022,0,0
806,NCT04479358,Recruiting,01/12/2020,01/03/2021,No Results Posted,,,23/09/2020,https://clinicaltrials.gov/show/NCT04479358,01/12/2020,0,0
807,NCT04479540,Recruiting,26/05/2021,31/08/2021,No Results Posted,,,10/09/2020,https://clinicaltrials.gov/show/NCT04479540,26/05/2021,0,0
808,NCT04480333,Recruiting,31/12/2020,31/03/2021,No Results Posted,,,21/07/2020,https://clinicaltrials.gov/show/NCT04480333,31/12/2020,0,0
809,NCT04480593,Completed,30/08/2020,30/08/2020,No Results Posted,,"['Sanders JM, Monogue ML, Jodlowski TZ, Cutrell JB. Pharmacologic Treatments for Coronavirus Disease 2019 (COVID-19): A Review. JAMA. 2020 May 12;323(18):1824-1836. doi: 10.1001/jama.2020.6019. Review.', 'Maruta H, He H. PAK1-blockers: Potential Therapeutics against COVID-19. Med Drug Discov. 2020 Jun;6:100039. doi: 10.1016/j.medidd.2020.100039. Epub 2020 Apr 19. Review.', 'Serkedjieva J, Manolova N, Bankova V. Anti-influenza virus effect of some propolis constituents and their analogues (esters of substituted cinnamic acids). J Nat Prod. 1992 Mar;55(3):294-302.', 'Hoffmann M, Kleine-Weber H, Schroeder S, Kr√ºger N, Herrler T, Erichsen S, Schiergens TS, Herrler G, Wu NH, Nitsche A, M√ºller MA, Drosten C, P√∂hlmann S. SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor. Cell. 2020 Apr 16;181(2):271-280.e8. doi: 10.1016/j.cell.2020.02.052. Epub 2020 Mar 5.', 'Machado JL, Assun√ß√£o AK, da Silva MC, Dos Reis AS, Costa GC, Arruda Dde S, Rocha BA, Vaz MM, Paes AM, Guerra RN, Berretta AA, do Nascimento FR. Brazilian green propolis: anti-inflammatory property by an immunomodulatory activity. Evid Based Complement Alternat Med. 2012;2012:157652. doi: 10.1155/2012/157652. Epub 2012 Dec 19.', 'Mani JS, Johnson JB, Steel JC, Broszczak DA, Neilsen PM, Walsh KB, Naiker M. Natural product-derived phytochemicals as potential agents against coronaviruses: A review. Virus Res. 2020 Jul 15;284:197989. doi: 10.1016/j.virusres.2020.197989. Epub 2020 Apr 30. Review.', 'Silveira MAD, Teles F, Berretta AA, Sanches TR, Rodrigues CE, Seguro AC, Andrade L. Effects of Brazilian green propolis on proteinuria and renal function in patients with chronic kidney disease: a randomized, double-blind, placebo-controlled trial. BMC Nephrol. 2019 Apr 25;20(1):140. doi: 10.1186/s12882-019-1337-7.', 'Cusinato DAC, Martinez EZ, Cintra MTC, Filgueira GCO, Berretta AA, Lanchote VL, Coelho EB. Evaluation of potential herbal-drug interactions of a standardized propolis extract (EPP-AF¬Æ) using an in vivo cocktail approach. J Ethnopharmacol. 2019 Dec 5;245:112174. doi: 10.1016/j.jep.2019.112174. Epub 2019 Aug 20.']",30/09/2020,https://clinicaltrials.gov/show/NCT04480593,30/08/2020,0,1
810,NCT04480606,Not yet recruiting,20/11/2020,20/11/2020,No Results Posted,,,21/07/2020,https://clinicaltrials.gov/show/NCT04480606,20/11/2020,0,0
811,NCT04480632,Not yet recruiting,01/08/2021,01/08/2022,No Results Posted,,,22/07/2020,https://clinicaltrials.gov/show/NCT04480632,01/08/2021,0,0
812,NCT04481633,Recruiting,01/09/2021,01/09/2021,No Results Posted,,,12/11/2020,https://clinicaltrials.gov/show/NCT04481633,01/09/2021,0,0
813,NCT04482634,Recruiting,01/08/2022,01/08/2022,No Results Posted,,"['Held N, Moss M. Optimizing Post-Intensive Care Unit Rehabilitation. Turk Thorac J. 2019 Apr 1;20(2):147-152. doi: 10.5152/TurkThoracJ.2018.18172. Print 2019 Apr. Review.', 'Spruit MA, Singh SJ, Garvey C, ZuWallack R, Nici L, Rochester C, Hill K, Holland AE, Lareau SC, Man WD, Pitta F, Sewell L, Raskin J, Bourbeau J, Crouch R, Franssen FM, Casaburi R, Vercoulen JH, Vogiatzis I, Gosselink R, Clini EM, Effing TW, Maltais F, van der Palen J, Troosters T, Janssen DJ, Collins E, Garcia-Aymerich J, Brooks D, Fahy BF, Puhan MA, Hoogendoorn M, Garrod R, Schols AM, Carlin B, Benzo R, Meek P, Morgan M, Rutten-van M√∂lken MP, Ries AL, Make B, Goldstein RS, Dowson CA, Brozek JL, Donner CF, Wouters EF; ATS/ERS Task Force on Pulmonary Rehabilitation. An official American Thoracic Society/European Respiratory Society statement: key concepts and advances in pulmonary rehabilitation. Am J Respir Crit Care Med. 2013 Oct 15;188(8):e13-64. doi: 10.1164/rccm.201309-1634ST. Erratum in: Am J Respir Crit Care Med. 2014 Jun 15;189(12):1570.', 'Lau HM, Ng GY, Jones AY, Lee EW, Siu EH, Hui DS. A randomised controlled trial of the effectiveness of an exercise training program in patients recovering from severe acute respiratory syndrome. Aust J Physiother. 2005;51(4):213-9.', 'Bourne S, DeVos R, North M, Chauhan A, Green B, Brown T, Cornelius V, Wilkinson T. Online versus face-to-face pulmonary rehabilitation for patients with chronic obstructive pulmonary disease: randomised controlled trial. BMJ Open. 2017 Jul 17;7(7):e014580. doi: 10.1136/bmjopen-2016-014580.', 'Turan Z, √ñzyemi≈ü√ßi Ta≈ükƒ±ran √ñ, Erden Z, K√∂kt√ºrk N, Kaymak Karata≈ü G. Does hand grip strength decrease in chronic obstructive pulmonary disease exacerbation? A cross-sectional study. Turk J Med Sci. 2019 Jun 18;49(3):802-808. doi: 10.3906/sag-1811-22.', 'Bestall JC, Paul EA, Garrod R, Garnham R, Jones PW, Wedzicha JA. Usefulness of the Medical Research Council (MRC) dyspnoea scale as a measure of disability in patients with chronic obstructive pulmonary disease. Thorax. 1999 Jul;54(7):581-6.', 'Jones PW, Harding G, Berry P, Wiklund I, Chen WH, Kline Leidy N. Development and first validation of the COPD Assessment Test. Eur Respir J. 2009 Sep;34(3):648-54. doi: 10.1183/09031936.00102509.', ""Jones PW, Quirk FH, Baveystock CM, Littlejohns P. A self-complete measure of health status for chronic airflow limitation. The St. George's Respiratory Questionnaire. Am Rev Respir Dis. 1992 Jun;145(6):1321-7."", 'Bergland A, J√∏rgensen L, Emaus N, Strand BH. Mobility as a predictor of all-cause mortality in older men and women: 11.8 year follow-up in the Troms√∏ study. BMC Health Serv Res. 2017 Jan 10;17(1):22. doi: 10.1186/s12913-016-1950-0.', 'Beaudart C, McCloskey E, Bruy√®re O, Cesari M, Rolland Y, Rizzoli R, Araujo de Carvalho I, Amuthavalli Thiyagarajan J, Bautmans I, Berti√®re MC, Brandi ML, Al-Daghri NM, Burlet N, Cavalier E, Cerreta F, Cherubini A, Fielding R, Gielen E, Landi F, Petermans J, Reginster JY, Visser M, Kanis J, Cooper C. Sarcopenia in daily practice: assessment and management. BMC Geriatr. 2016 Oct 5;16(1):170. Review.']",05/11/2020,https://clinicaltrials.gov/show/NCT04482634,01/08/2022,0,1
814,NCT04482673,Recruiting,31/12/2021,31/12/2021,No Results Posted,,,04/08/2020,https://clinicaltrials.gov/show/NCT04482673,31/12/2021,0,0
815,NCT04483752,Recruiting,08/02/2021,08/11/2021,No Results Posted,,,23/07/2020,https://clinicaltrials.gov/show/NCT04483752,08/02/2021,0,0
816,NCT04483830,Completed,06/08/2020,07/09/2020,No Results Posted,,,09/09/2020,https://clinicaltrials.gov/show/NCT04483830,06/08/2020,0,0
817,NCT04484207,Recruiting,20/10/2020,26/10/2020,No Results Posted,"['Amsalem D, Lazarov A, Markowitz JC, Gorman D, Dixon LB, Neria Y. Increasing treatment-seeking intentions of US veterans in the Covid-19 era: A randomized controlled trial. Depress Anxiety. 2021 Jun;38(6):639-647. doi: 10.1002/da.23149. Epub 2021 Mar 18.']",,14/10/2020,https://clinicaltrials.gov/show/NCT04484207,20/10/2020,0,1
818,NCT04484493,Completed,25/10/2020,03/11/2020,No Results Posted,"['Abdelalim AA, Mohamady AA, Elsayed RA, Elawady MA, Ghallab AF. Corticosteroid nasal spray for recovery of smell sensation in COVID-19 patients: A randomized controlled trial. Am J Otolaryngol. 2021 Mar-Apr;42(2):102884. doi: 10.1016/j.amjoto.2020.102884. Epub 2021 Jan 4.']",,13/11/2020,https://clinicaltrials.gov/show/NCT04484493,25/10/2020,0,1
819,NCT04485169,Completed,31/07/2020,31/07/2020,No Results Posted,,"['Knaup H, Stahl K, Schmidt BMW, Idowu TO, Busch M, Wiesner O, Welte T, Haller H, Kielstein JT, Hoeper MM, David S. Early therapeutic plasma exchange in septic shock: a prospective open-label nonrandomized pilot study focusing on safety, hemodynamics, vascular barrier function, and biologic markers. Crit Care. 2018 Oct 30;22(1):285. doi: 10.1186/s13054-018-2220-9.']",28/09/2020,https://clinicaltrials.gov/show/NCT04485169,31/07/2020,0,1
820,NCT04485429,Recruiting,31/12/2020,31/12/2020,No Results Posted,,,24/07/2020,https://clinicaltrials.gov/show/NCT04485429,31/12/2020,0,0
821,NCT04487171,Recruiting,01/07/2021,01/08/2021,No Results Posted,,,27/07/2020,https://clinicaltrials.gov/show/NCT04487171,01/07/2021,0,0
822,NCT04487444,Recruiting,01/03/2021,01/06/2021,No Results Posted,,,14/09/2020,https://clinicaltrials.gov/show/NCT04487444,01/03/2021,0,0
823,NCT04487574,Completed,29/10/2020,29/10/2020,No Results Posted,,,13/11/2020,https://clinicaltrials.gov/show/NCT04487574,29/10/2020,0,0
824,NCT04487639,Recruiting,01/07/2021,01/07/2021,No Results Posted,,,27/07/2020,https://clinicaltrials.gov/show/NCT04487639,01/07/2021,0,0
825,NCT04487886,Recruiting,01/02/2022,01/02/2022,No Results Posted,,,16/12/2020,https://clinicaltrials.gov/show/NCT04487886,01/02/2022,0,0
826,NCT04487964,Recruiting,01/12/2020,01/01/2021,No Results Posted,"['Armanini D, Fiore C, Bielenberg J, Sabbadin C, Bordin L. Coronavirus-19: Possible Therapeutic Implications of Spironolactone and Dry Extract of Glycyrrhiza glabra L. (Licorice). Front Pharmacol. 2020 Oct 22;11:558418. doi: 10.3389/fphar.2020.558418. eCollection 2020.']",,28/07/2020,https://clinicaltrials.gov/show/NCT04487964,01/12/2020,0,1
827,NCT04488484,"Active, not recruiting",31/12/2021,31/12/2021,No Results Posted,,"['Janice Oh HL, Ken-En Gan S, Bertoletti A, Tan YJ. Understanding the T cell immune response in SARS coronavirus infection. Emerg Microbes Infect. 2012 Sep;1(9):e23. doi: 10.1038/emi.2012.26. Epub 2012 Sep 5. Review.', 'Li G, Fan Y, Lai Y, Han T, Li Z, Zhou P, Pan P, Wang W, Hu D, Liu X, Zhang Q, Wu J. Coronavirus infections and immune responses. J Med Virol. 2020 Apr;92(4):424-432. doi: 10.1002/jmv.25685. Epub 2020 Feb 7. Review.', 'Rajendran K, Krishnasamy N, Rangarajan J, Rathinam J, Natarajan M, Ramachandran A. Convalescent plasma transfusion for the treatment of COVID-19: Systematic review. J Med Virol. 2020 Sep;92(9):1475-1483. doi: 10.1002/jmv.25961. Epub 2020 May 12.', 'Prompetchara E, Ketloy C, Palaga T. Immune responses in COVID-19 and potential vaccines: Lessons learned from SARS and MERS epidemic. Asian Pac J Allergy Immunol. 2020 Mar;38(1):1-9. doi: 10.12932/AP-200220-0772. Review.', 'Salje H, Tran Kiem C, Lefrancq N, Courtejoie N, Bosetti P, Paireau J, Andronico A, Hoz√© N, Richet J, Dubost CL, Le Strat Y, Lessler J, Levy-Bruhl D, Fontanet A, Opatowski L, Boelle PY, Cauchemez S. Estimating the burden of SARS-CoV-2 in France. Science. 2020 Jul 10;369(6500):208-211. doi: 10.1126/science.abc3517. Epub 2020 May 13. Erratum in: Science. 2020 Jun 26;368(6498):.']",12/08/2020,https://clinicaltrials.gov/show/NCT04488484,31/12/2021,0,1
828,NCT04489628,Not yet recruiting,01/08/2021,01/08/2021,No Results Posted,,,31/07/2020,https://clinicaltrials.gov/show/NCT04489628,01/08/2021,0,0
829,NCT04490278,Recruiting,30/07/2021,30/07/2021,No Results Posted,,,05/10/2020,https://clinicaltrials.gov/show/NCT04490278,30/07/2021,0,0
830,NCT04490850,Recruiting,15/07/2021,15/07/2021,No Results Posted,,,29/07/2020,https://clinicaltrials.gov/show/NCT04490850,15/07/2021,0,0
831,NCT04491240,Completed,01/10/2020,20/10/2020,Study Results,,,04/11/2020,https://clinicaltrials.gov/show/NCT04491240,01/10/2020,1,0
832,NCT04491994,Completed,31/05/2020,31/05/2020,Study Results,,,21/08/2020,https://clinicaltrials.gov/show/NCT04491994,31/05/2020,1,0
833,NCT04492228,Recruiting,31/12/2020,30/05/2021,No Results Posted,,,30/09/2020,https://clinicaltrials.gov/show/NCT04492228,31/12/2020,0,0
834,NCT04492358,Recruiting,01/10/2021,01/10/2021,No Results Posted,,,09/11/2020,https://clinicaltrials.gov/show/NCT04492358,01/10/2021,0,0
835,NCT04492501,Completed,20/07/2020,20/07/2020,No Results Posted,,,30/07/2020,https://clinicaltrials.gov/show/NCT04492501,20/07/2020,0,0
836,NCT04492514,Recruiting,31/05/2021,31/05/2021,No Results Posted,"['Cremer PC, Abbate A, Hudock K, McWilliams C, Mehta J, Chang SY, Sheng CC, Van Tassell B, Bonaventura A, Vecchi√© A, Carey B, Wang Q, Wolski KE, Rajendram P, Duggal A, Wang TS, Paolini JF, Trapnell BC; MASH-COVID study group. Mavrilimumab in patients with severe COVID-19 pneumonia and systemic hyperinflammation (MASH-COVID): an investigator initiated, multicentre, double-blind, randomised, placebo-controlled trial. Lancet Rheumatol. 2021 Jun;3(6):e410-e418. doi: 10.1016/S2665-9913(21)00070-9. Epub 2021 Mar 17.']",,30/07/2020,https://clinicaltrials.gov/show/NCT04492514,31/05/2021,0,1
837,NCT04492891,Recruiting,23/11/2025,23/11/2025,No Results Posted,,,27/11/2020,https://clinicaltrials.gov/show/NCT04492891,23/11/2025,0,0
838,NCT04493242,Not yet recruiting,30/11/2020,31/12/2020,No Results Posted,,,30/07/2020,https://clinicaltrials.gov/show/NCT04493242,30/11/2020,0,0
839,NCT04493294,Not yet recruiting,01/12/2021,01/12/2021,No Results Posted,,,30/07/2020,https://clinicaltrials.gov/show/NCT04493294,01/12/2021,0,0
840,NCT04493359,Recruiting,14/02/2022,14/02/2022,No Results Posted,,,31/07/2020,https://clinicaltrials.gov/show/NCT04493359,14/02/2022,0,0
841,NCT04494204,Completed,01/12/2020,20/12/2020,No Results Posted,,,22/12/2020,https://clinicaltrials.gov/show/NCT04494204,01/12/2020,0,0
842,NCT04494399,Recruiting,01/07/2022,01/08/2022,No Results Posted,,,31/07/2020,https://clinicaltrials.gov/show/NCT04494399,01/07/2022,0,0
843,NCT04494724,Recruiting,31/12/2020,31/07/2021,No Results Posted,,"['Jones SA, Jenkins BJ. Recent insights into targeting the IL-6 cytokine family in inflammatory diseases and cancer. Nat Rev Immunol. 2018 Dec;18(12):773-789. doi: 10.1038/s41577-018-0066-7. Review.', 'Tanaka T, Kishimoto T. Targeting interleukin-6: all the way to treat autoimmune and inflammatory diseases. Int J Biol Sci. 2012;8(9):1227-36. doi: 10.7150/ijbs.4666. Epub 2012 Oct 24. Review.', 'Uciechowski P, Dempke WCM. Interleukin-6: A Masterplayer in the Cytokine Network. Oncology. 2020;98(3):131-137. doi: 10.1159/000505099. Epub 2020 Jan 20. Review.', 'Ruan Q, Yang K, Wang W, Jiang L, Song J. Correction to: Clinical predictors of mortality due to COVID-19 based on an analysis of data of 150 patients from Wuhan, China. Intensive Care Med. 2020 Jun;46(6):1294-1297. doi: 10.1007/s00134-020-06028-z.', 'Gao Y, Li T, Han M, Li X, Wu D, Xu Y, Zhu Y, Liu Y, Wang X, Wang L. Diagnostic utility of clinical laboratory data determinations for patients with the severe COVID-19. J Med Virol. 2020 Jul;92(7):791-796. doi: 10.1002/jmv.25770. Epub 2020 Apr 10.', 'Le RQ, Li L, Yuan W, Shord SS, Nie L, Habtemariam BA, Przepiorka D, Farrell AT, Pazdur R. FDA Approval Summary: Tocilizumab for Treatment of Chimeric Antigen Receptor T Cell-Induced Severe or Life-Threatening Cytokine Release Syndrome. Oncologist. 2018 Aug;23(8):943-947. doi: 10.1634/theoncologist.2018-0028. Epub 2018 Apr 5.', 'Mehta P, McAuley DF, Brown M, Sanchez E, Tattersall RS, Manson JJ; HLH Across Speciality Collaboration, UK. COVID-19: consider cytokine storm syndromes and immunosuppression. Lancet. 2020 Mar 28;395(10229):1033-1034. doi: 10.1016/S0140-6736(20)30628-0. Epub 2020 Mar 16.', 'Wu C, Chen X, Cai Y, Xia J, Zhou X, Xu S, Huang H, Zhang L, Zhou X, Du C, Zhang Y, Song J, Wang S, Chao Y, Yang Z, Xu J, Zhou X, Chen D, Xiong W, Xu L, Zhou F, Jiang J, Bai C, Zheng J, Song Y. Risk Factors Associated With Acute Respiratory Distress Syndrome and Death in Patients With Coronavirus Disease 2019 Pneumonia in Wuhan, China. JAMA Intern Med. 2020 Jul 1;180(7):934-943. doi: 10.1001/jamainternmed.2020.0994. Erratum in: JAMA Intern Med. 2020 Jul 1;180(7):1031.']",31/07/2020,https://clinicaltrials.gov/show/NCT04494724,31/12/2020,0,1
844,NCT04494867,Recruiting,01/12/2020,01/12/2020,No Results Posted,,,25/09/2020,https://clinicaltrials.gov/show/NCT04494867,01/12/2020,0,0
845,NCT04495543,Recruiting,01/08/2021,01/08/2021,No Results Posted,,,24/12/2020,https://clinicaltrials.gov/show/NCT04495543,01/08/2021,0,0
846,NCT04495842,Recruiting,31/03/2021,30/06/2021,No Results Posted,,,19/10/2020,https://clinicaltrials.gov/show/NCT04495842,31/03/2021,0,0
847,NCT04497272,Recruiting,07/08/2021,07/10/2021,No Results Posted,,,10/11/2020,https://clinicaltrials.gov/show/NCT04497272,07/08/2021,0,0
848,NCT04497389,Recruiting,15/09/2021,15/09/2021,No Results Posted,"['Tonna JE, Pierce J, Hatton N, Lewis G, Phillips JD, Messina A, Skidmore CR, Taylor K, Selzman CH. Safety and feasibility of using acellular sterile filtered amniotic fluid as a treatment for patients with COVID-19: protocol for a randomised, double-blinded, placebo-controlled clinical trial. BMJ Open. 2021 Feb 11;11(2):e045162. doi: 10.1136/bmjopen-2020-045162.']",,06/11/2020,https://clinicaltrials.gov/show/NCT04497389,15/09/2021,0,1
849,NCT04497415,Recruiting,30/11/2020,30/01/2021,No Results Posted,,,23/10/2020,https://clinicaltrials.gov/show/NCT04497415,30/11/2020,0,0
850,NCT04497454,Recruiting,01/07/2021,01/12/2021,No Results Posted,,,04/08/2020,https://clinicaltrials.gov/show/NCT04497454,01/07/2021,0,0
851,NCT04497519,Completed,15/10/2020,01/11/2020,No Results Posted,,,10/11/2020,https://clinicaltrials.gov/show/NCT04497519,15/10/2020,0,0
852,NCT04497623,Completed,13/08/2020,20/09/2020,No Results Posted,,,24/09/2020,https://clinicaltrials.gov/show/NCT04497623,13/08/2020,0,0
853,NCT04498936,Completed,30/10/2020,30/10/2020,No Results Posted,,,12/11/2020,https://clinicaltrials.gov/show/NCT04498936,30/10/2020,0,0
854,NCT04499313,Recruiting,15/11/2020,30/11/2020,No Results Posted,,,18/08/2020,https://clinicaltrials.gov/show/NCT04499313,15/11/2020,0,0
855,NCT04500067,Completed,15/09/2020,15/09/2020,No Results Posted,,,14/10/2020,https://clinicaltrials.gov/show/NCT04500067,15/09/2020,0,0
856,NCT04500132,Recruiting,01/08/2021,01/05/2022,No Results Posted,,,06/08/2020,https://clinicaltrials.gov/show/NCT04500132,01/08/2021,0,0
857,NCT04500366,Recruiting,01/04/2021,01/05/2021,No Results Posted,,,10/11/2020,https://clinicaltrials.gov/show/NCT04500366,01/04/2021,0,0
858,NCT04500418,Recruiting,30/09/2021,30/09/2021,No Results Posted,,,26/08/2020,https://clinicaltrials.gov/show/NCT04500418,30/09/2021,0,0
859,NCT04501783,"Active, not recruiting",29/07/2020,01/08/2020,No Results Posted,,,06/08/2020,https://clinicaltrials.gov/show/NCT04501783,29/07/2020,0,0
860,NCT04501965,Enrolling by invitation,30/08/2020,30/09/2020,No Results Posted,,"['Ayisi NK, Nyadedzor C. Comparative in vitro effects of AZT and extracts of Ocimum gratissimum, Ficus polita, Clausena anisata, Alchornea cordifolia, and Elaeophorbia drupifera against HIV-1 and HIV-2 infections. Antiviral Res. 2003 Mar;58(1):25-33.', 'Bald√© AM, Traor√© MS, Bald√© MA, Barry MS, Diallo A, Camara M, Traor√© S, Kouyat√© M, Traor√© S, Ouo-Ouo S, Myanth√© AL, Keita N, Haba NL, Goumou K, Bah F, Camara A, Diallo MS, Sylla M, Bald√© ES, Dian√© S, Pieters L, Oular√© K. Ethnomedical and ethnobotanical investigations on the response capacities of Guinean traditional health practioners in the management of outbreaks of infectious diseases: The case of the Ebola virus epidemic. J Ethnopharmacol. 2016 Apr 22;182:137-49. doi: 10.1016/j.jep.2016.02.021. Epub 2016 Feb 18.', 'Bald√© ES, Megalizzi V, Traor√© MS, Cos P, Maes L, Decaestecker C, Pieters L, Bald√© AM. In vitro antiprotozoal, antimicrobial and antitumor activity of Pavetta crassipes K. Schum leaf extracts. J Ethnopharmacol. 2010 Aug 9;130(3):529-35. doi: 10.1016/j.jep.2010.05.042. Epub 2010 May 31.', 'Camara A, Haddad M, Reybier K, Traor√© MS, Bald√© MA, Royo J, Bald√© AO, Batigne P, Haidara M, Bald√© ES, Coste A, Bald√© AM, Aubouy A. Terminalia albida treatment improves survival in experimental cerebral malaria through reactive oxygen species scavenging and anti-inflammatory properties. Malar J. 2019 Dec 18;18(1):431. doi: 10.1186/s12936-019-3071-9.', 'Colson P, Rolain JM, Lagier JC, Brouqui P, Raoult D. Chloroquine and hydroxychloroquine as available weapons to fight COVID-19. Int J Antimicrob Agents. 2020 Apr;55(4):105932. doi: 10.1016/j.ijantimicag.2020.105932. Epub 2020 Mar 4.', ""D'Alessandro S, Scaccabarozzi D, Signorini L, Perego F, Ilboudo DP, Ferrante P, Delbue S. The Use of Antimalarial Drugs against Viral Infection. Microorganisms. 2020 Jan 8;8(1). pii: E85. doi: 10.3390/microorganisms8010085. Review."", 'Ren JL, Zhang AH, Wang XJ. Corrigendum to ""Traditional Chinese medicine for COVID-19 treatment"" [Pharmacol. Res. 155 (2020) 104743]. Pharmacol Res. 2020 May;155:104768. doi: 10.1016/j.phrs.2020.104768. Epub 2020 Mar 25.', 'Langeder J, Grienke U, Chen Y, Kirchmair J, Schmidtke M, Rollinger JM. Natural products against acute respiratory infections: Strategies and lessons learned. J Ethnopharmacol. 2020 Feb 10;248:112298. doi: 10.1016/j.jep.2019.112298. Epub 2019 Oct 11. Review.', 'Ni L, Zhou L, Zhou M, Zhao J, Wang DW. Combination of western medicine and Chinese traditional patent medicine in treating a family case of COVID-19. Front Med. 2020 Apr;14(2):210-214. doi: 10.1007/s11684-020-0757-x. Epub 2020 Mar 13.', 'Liu BY, He LY, Liang ZW, Tong XY, Hu JQ, Jiao Q, Ni Q, Liu XM, Xie YM, Li P, Gao FZ, Wen TC, Liu WM. [Effect of glucocorticoid with traditional Chinese medicine in severe acute aespiratory syndrome (SARS)]. Zhongguo Zhong Yao Za Zhi. 2005 Dec;30(23):1874-7. Chinese.', 'Liu DH, Liang BZ, Huang LY. [Clinical observation on the preventive effect of kangdu bufei decoction on acute severe respiratory syndrome]. Zhongguo Zhong Xi Yi Jie He Za Zhi. 2004 Aug;24(8):685-8. Chinese.', 'Luo H, Tang QL, Shang YX, Liang SB, Yang M, Robinson N, Liu JP. Can Chinese Medicine Be Used for Prevention of Corona Virus Disease 2019 (COVID-19)? A Review of Historical Classics, Research Evidence and Current Prevention Programs. Chin J Integr Med. 2020 Apr;26(4):243-250. doi: 10.1007/s11655-020-3192-6. Epub 2020 Feb 17. Review.', 'Magassouba FB, Diallo A, Kouyat√© M, Mara F, Mara O, Bangoura O, Camara A, Traor√© S, Diallo AK, Zaoro M, Lamah K, Diallo S, Camara G, Traor√© S, K√©ita A, Camara MK, Barry R, K√©ita S, Oular√© K, Barry MS, Donzo M, Camara K, Tot√© K, Berghe DV, Tott√© J, Pieters L, Vlietinck AJ, Bald√© AM. Ethnobotanical survey and antibacterial activity of some plants used in Guinean traditional medicine. J Ethnopharmacol. 2007 Oct 8;114(1):44-53. Epub 2007 Jul 14. Erratum in: J Ethnopharmacol. 2010 Apr 21;128(3):705-8.', 'Mahase E. Covid-19: WHO declares pandemic because of ""alarming levels"" of spread, severity, and inaction. BMJ. 2020 Mar 12;368:m1036. doi: 10.1136/bmj.m1036.', 'Schlagenhauf P, Grobusch MP, Maier JD, Gautret P. Repurposing antimalarials and other drugs for COVID-19. Travel Med Infect Dis. 2020 Mar - Apr;34:101658. doi: 10.1016/j.tmaid.2020.101658. Epub 2020 Apr 2.', ""Sohrabi C, Alsafi Z, O'Neill N, Khan M, Kerwan A, Al-Jabir A, Iosifidis C, Agha R. World Health Organization declares global emergency: A review of the 2019 novel coronavirus (COVID-19). Int J Surg. 2020 Apr;76:71-76. doi: 10.1016/j.ijsu.2020.02.034. Epub 2020 Feb 26. Review. Erratum in: Int J Surg. 2020 May;77:217."", 'Tong X, Li A, Zhang Z, Duan J, Chen X, Hua C, Zhao D, Xu Y, Shi X, Li P, Tian X, Lin F, Cao Y, Jin L, Chang M, Wang Y. TCM treatment of infectious atypical pneumonia--a report of 16 cases. J Tradit Chin Med. 2004 Dec;24(4):266-9.', 'Traore MS, Bald√© MA, Diallo MS, Bald√© ES, Dian√© S, Camara A, Diallo A, Balde A, Ke√Øta A, Keita SM, Oular√© K, Magassouba FB, Diakit√© I, Diallo A, Pieters L, Bald√© AM. Ethnobotanical survey on medicinal plants used by Guinean traditional healers in the treatment of malaria. J Ethnopharmacol. 2013 Dec 12;150(3):1145-53. doi: 10.1016/j.jep.2013.10.048. Epub 2013 Oct 31.', '‚Ä¢ WHO, 2013. WHO Traditional medicine strategy 2014-2023. https://www.who.int/medicines/publications/traditional/trm_strategy14_23/en/.', 'Li Y, Liu X, Guo L, Li J, Zhong D, Zhang Y, Clarke M, Jin R. Traditional Chinese herbal medicine for treating novel coronavirus (COVID-19) pneumonia: protocol for a systematic review and meta-analysis. Syst Rev. 2020 Apr 8;9(1):75. doi: 10.1186/s13643-020-01343-4.']",07/08/2020,https://clinicaltrials.gov/show/NCT04501965,30/08/2020,0,1
861,NCT04502056,"Active, not recruiting",21/09/2020,01/09/2021,Results Submitted,,,17/11/2020,https://clinicaltrials.gov/show/NCT04502056,21/09/2020,0,0
862,NCT04502069,Withdrawn,01/02/2021,01/06/2021,No Results Posted,,,11/08/2020,https://clinicaltrials.gov/show/NCT04502069,01/02/2021,0,0
863,NCT04502342,Enrolling by invitation,30/08/2020,30/09/2020,No Results Posted,,"['Efferth T, Romero MR, Wolf DG, Stamminger T, Marin JJ, Marschall M. The antiviral activities of artemisinin and artesunate. Clin Infect Dis. 2008 Sep 15;47(6):804-11. doi: 10.1086/591195. Review.', '‚Ä¢ WHO | World Health Organization. Coronavirus (COVID-19) events as they happen [Internet]. 2020 [cited 2020 Mar 20]. Available from: https://www.who.int/emergencies/diseases/novel-coronavirus-2019/events-as-they-happen']",07/08/2020,https://clinicaltrials.gov/show/NCT04502342,30/08/2020,0,1
864,NCT04502472,Recruiting,31/12/2021,31/12/2021,No Results Posted,,,06/08/2020,https://clinicaltrials.gov/show/NCT04502472,31/12/2021,0,0
865,NCT04502667,Recruiting,01/02/2021,01/04/2021,No Results Posted,,,06/08/2020,https://clinicaltrials.gov/show/NCT04502667,01/02/2021,0,0
866,NCT04504877,"Active, not recruiting",16/11/2020,16/12/2020,No Results Posted,,,04/11/2020,https://clinicaltrials.gov/show/NCT04504877,16/11/2020,0,0
867,NCT04505098,Recruiting,07/08/2021,28/02/2023,No Results Posted,,,05/10/2020,https://clinicaltrials.gov/show/NCT04505098,07/08/2021,0,0
868,NCT04507867,Not yet recruiting,01/10/2020,01/12/2020,No Results Posted,,,11/08/2020,https://clinicaltrials.gov/show/NCT04507867,01/10/2020,0,0
869,NCT04508439,Recruiting,30/08/2020,30/12/2020,No Results Posted,,,11/08/2020,https://clinicaltrials.gov/show/NCT04508439,30/08/2020,0,0
870,NCT04508868,Terminated,23/12/2020,23/12/2020,No Results Posted,,,31/12/2020,https://clinicaltrials.gov/show/NCT04508868,23/12/2020,0,0
871,NCT04508985,Not yet recruiting,01/01/2021,01/09/2021,No Results Posted,"['Aflaki M, Flannery A, Ferreira JP, Cheng MP, Kronfli N, Marelli A, Zannad F, Brophy J, Afillalo J, Huynh T, Giannetti N, Bessissow A, Ezekowitz JA, Lopes RD, Ambrosy AP, Craig M, Sharma A. Management of Renin-Angiotensin-Aldosterone System blockade in patients admitted to hospital with confirmed coronavirus disease (COVID-19) infection (The McGill RAAS-COVID- 19): A structured summary of a study protocol for a randomized controlled trial. Trials. 2021 Feb 5;22(1):115. doi: 10.1186/s13063-021-05080-4.']",,19/08/2020,https://clinicaltrials.gov/show/NCT04508985,01/01/2021,0,1
872,NCT04510233,Not yet recruiting,01/10/2020,01/12/2020,No Results Posted,,,12/08/2020,https://clinicaltrials.gov/show/NCT04510233,01/10/2020,0,0
873,NCT04510402,Not yet recruiting,01/02/2021,01/04/2021,No Results Posted,,,12/08/2020,https://clinicaltrials.gov/show/NCT04510402,01/02/2021,0,0
874,NCT04510493,Recruiting,01/09/2023,01/09/2023,No Results Posted,,,04/11/2020,https://clinicaltrials.gov/show/NCT04510493,01/09/2023,0,0
875,NCT04510662,Recruiting,01/03/2021,01/04/2021,No Results Posted,,,12/08/2020,https://clinicaltrials.gov/show/NCT04510662,01/03/2021,0,0
876,NCT04512027,Completed,19/09/2020,16/10/2020,No Results Posted,,,19/10/2020,https://clinicaltrials.gov/show/NCT04512027,19/09/2020,0,0
877,NCT04513158,Recruiting,01/08/2021,31/12/2021,No Results Posted,,,19/10/2020,https://clinicaltrials.gov/show/NCT04513158,01/08/2021,0,0
878,NCT04513184,Recruiting,30/03/2021,31/07/2021,No Results Posted,,,12/11/2020,https://clinicaltrials.gov/show/NCT04513184,30/03/2021,0,0
879,NCT04513314,Not yet recruiting,01/11/2022,01/11/2022,No Results Posted,,,10/11/2020,https://clinicaltrials.gov/show/NCT04513314,01/11/2022,0,0
880,NCT04513470,"Active, not recruiting",01/01/2021,01/02/2021,No Results Posted,,,19/10/2020,https://clinicaltrials.gov/show/NCT04513470,01/01/2021,0,0
881,NCT04513990,Recruiting,30/04/2021,30/04/2021,No Results Posted,,,17/08/2020,https://clinicaltrials.gov/show/NCT04513990,30/04/2021,0,0
882,NCT04514302,Not yet recruiting,20/02/2021,20/06/2021,No Results Posted,,,14/08/2020,https://clinicaltrials.gov/show/NCT04514302,20/02/2021,0,0
883,NCT04514627,Recruiting,31/07/2021,31/07/2021,No Results Posted,,,19/08/2020,https://clinicaltrials.gov/show/NCT04514627,31/07/2021,0,0
884,NCT04514705,Recruiting,31/12/2021,31/12/2021,No Results Posted,,"['Kamalakannan S, Chakraborty S. Occupational therapy: The key to unlocking locked-up occupations during the COVID-19 pandemic. Wellcome Open Res. 2020 Jul 1;5:153. doi: 10.12688/wellcomeopenres.16089.1. eCollection 2020.', 'Torli≈Ñski T, Rakasz L, Wysota B, Czy≈º M, Snelson C. An interdisciplinary approach to the management of critically ill patients during covid-19 pandemic; an experience of a university hospital in England. Wiad Lek. 2020;73(7):1576-1579.', 'Rooney S, Webster A, Paul L. Systematic Review of Changes and Recovery in Physical Function and Fitness After Severe Acute Respiratory Syndrome-Related Coronavirus Infection: Implications for COVID-19 Rehabilitation. Phys Ther. 2020 Sep 28;100(10):1717-1729. doi: 10.1093/ptj/pzaa129.', 'Saeki T, Ogawa F, Chiba R, Nonogaki M, Uesugi J, Takeuchi I, Nakamura T. Rehabilitation Therapy for a COVID-19 Patient Who Received Mechanical Ventilation in Japan. Am J Phys Med Rehabil. 2020 Oct;99(10):873-875. doi: 10.1097/PHM.0000000000001545.', 'Grigoletto I, Cavalheri V, Lima FF, Ramos EMC. Recovery after COVID-19: The potential role of pulmonary rehabilitation. Braz J Phys Ther. 2020 Nov-Dec;24(6):463-464. doi: 10.1016/j.bjpt.2020.07.002. Epub 2020 Jul 19.', 'Abdullahi A, Bello B, Mukhtar NB, Kaka B, Abba MA, Usman JS, Shittu A, Mayana KI, Maiwada SA, Mohammed J. Physiotherapy management of COVID-19 in Africa: Ongoing efforts, challenges, and future directions. Physiother Theory Pract. 2020 Aug;36(8):871-872. doi: 10.1080/09593985.2020.1798163. Epub 2020 Jul 29.']",17/08/2020,https://clinicaltrials.gov/show/NCT04514705,31/12/2021,0,1
885,NCT04516512,Not yet recruiting,01/01/2021,01/01/2021,No Results Posted,,,18/08/2020,https://clinicaltrials.gov/show/NCT04516512,01/01/2021,0,0
886,NCT04516564,Recruiting,01/03/2021,01/04/2021,No Results Posted,,,21/09/2020,https://clinicaltrials.gov/show/NCT04516564,01/03/2021,0,0
887,NCT04516811,Recruiting,30/12/2021,31/07/2022,No Results Posted,,"['Yuen KS, Ye ZW, Fung SY, Chan CP, Jin DY. SARS-CoV-2 and COVID-19: The most important research questions. Cell Biosci. 2020 Mar 16;10:40. doi: 10.1186/s13578-020-00404-4. eCollection 2020.']",25/09/2020,https://clinicaltrials.gov/show/NCT04516811,30/12/2021,0,1
888,NCT04516837,Recruiting,01/08/2021,01/08/2022,No Results Posted,,,01/09/2020,https://clinicaltrials.gov/show/NCT04516837,01/08/2021,0,0
889,NCT04516915,Recruiting,01/05/2021,01/07/2021,No Results Posted,,,21/08/2020,https://clinicaltrials.gov/show/NCT04516915,01/05/2021,0,0
890,NCT04516941,Not yet recruiting,01/10/2021,31/12/2021,No Results Posted,,"['Huang C, Wang Y, Li X, Ren L, Zhao J, Hu Y, Zhang L, Fan G, Xu J, Gu X, Cheng Z, Yu T, Xia J, Wei Y, Wu W, Xie X, Yin W, Li H, Liu M, Xiao Y, Gao H, Guo L, Xie J, Wang G, Jiang R, Gao Z, Jin Q, Wang J, Cao B. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet. 2020 Feb 15;395(10223):497-506. doi: 10.1016/S0140-6736(20)30183-5. Epub 2020 Jan 24. Erratum in: Lancet. 2020 Jan 30;:.', 'Tang N, Li D, Wang X, Sun Z. Abnormal coagulation parameters are associated with poor prognosis in patients with novel coronavirus pneumonia. J Thromb Haemost. 2020 Apr;18(4):844-847. doi: 10.1111/jth.14768. Epub 2020 Mar 13.', ""Zhou F, Fan G, Liu Z, Cao B. SARS-CoV-2 shedding and infectivity - Authors' reply. Lancet. 2020 Apr 25;395(10233):1340. doi: 10.1016/S0140-6736(20)30869-2. Epub 2020 Apr 15."", 'Varga Z, Flammer AJ, Steiger P, Haberecker M, Andermatt R, Zinkernagel AS, Mehra MR, Schuepbach RA, Ruschitzka F, Moch H. Endothelial cell infection and endotheliitis in COVID-19. Lancet. 2020 May 2;395(10234):1417-1418. doi: 10.1016/S0140-6736(20)30937-5. Epub 2020 Apr 21.', 'Ranucci M, Ballotta A, Di Dedda U, Bayshnikova E, Dei Poli M, Resta M, Falco M, Albano G, Menicanti L. The procoagulant pattern of patients with COVID-19 acute respiratory distress syndrome. J Thromb Haemost. 2020 Jul;18(7):1747-1751. doi: 10.1111/jth.14854. Epub 2020 May 6.', 'Panigada M, Bottino N, Tagliabue P, Grasselli G, Novembrino C, Chantarangkul V, Pesenti A, Peyvandi F, Tripodi A. Hypercoagulability of COVID-19 patients in intensive care unit: A report of thromboelastography findings and other parameters of hemostasis. J Thromb Haemost. 2020 Jul;18(7):1738-1742. doi: 10.1111/jth.14850. Epub 2020 Jun 24.', 'Poissy J, Goutay J, Caplan M, Parmentier E, Duburcq T, Lassalle F, Jeanpierre E, Rauch A, Labreuche J, Susen S; Lille ICU Haemostasis COVID-19 Group. Pulmonary Embolism in Patients With COVID-19: Awareness of an Increased Prevalence. Circulation. 2020 Jul 14;142(2):184-186. doi: 10.1161/CIRCULATIONAHA.120.047430. Epub 2020 Apr 24.']",18/08/2020,https://clinicaltrials.gov/show/NCT04516941,01/10/2021,0,1
891,NCT04516954,Enrolling by invitation,30/11/2020,30/12/2020,No Results Posted,,,20/08/2020,https://clinicaltrials.gov/show/NCT04516954,30/11/2020,0,0
892,NCT04517123,Recruiting,31/12/2021,31/12/2021,No Results Posted,,,12/10/2020,https://clinicaltrials.gov/show/NCT04517123,31/12/2021,0,0
893,NCT04518514,Recruiting,31/10/2020,30/11/2020,No Results Posted,,,19/08/2020,https://clinicaltrials.gov/show/NCT04518514,31/10/2020,0,0
894,NCT04518969,Recruiting,01/12/2020,01/12/2020,No Results Posted,,,19/08/2020,https://clinicaltrials.gov/show/NCT04518969,01/12/2020,0,0
895,NCT04519125,Not yet recruiting,31/12/2020,01/04/2021,No Results Posted,,,19/08/2020,https://clinicaltrials.gov/show/NCT04519125,31/12/2020,0,0
896,NCT04519216,Recruiting,30/06/2021,30/09/2021,No Results Posted,,,19/08/2020,https://clinicaltrials.gov/show/NCT04519216,30/06/2021,0,0
897,NCT04519320,Recruiting,18/08/2021,18/08/2025,No Results Posted,,,24/08/2020,https://clinicaltrials.gov/show/NCT04519320,18/08/2021,0,0
898,NCT04519385,Completed,01/07/2020,05/08/2020,No Results Posted,,,25/08/2020,https://clinicaltrials.gov/show/NCT04519385,01/07/2020,0,0
899,NCT04519424,Withdrawn,01/04/2021,01/05/2021,No Results Posted,,,14/10/2020,https://clinicaltrials.gov/show/NCT04519424,01/04/2021,0,0
900,NCT04520620,Withdrawn,10/07/2020,10/07/2020,No Results Posted,,,20/08/2020,https://clinicaltrials.gov/show/NCT04520620,10/07/2020,0,0
901,NCT04521036,Not yet recruiting,30/06/2021,30/10/2021,No Results Posted,,,01/09/2020,https://clinicaltrials.gov/show/NCT04521036,30/06/2021,0,0
902,NCT04521296,Not yet recruiting,01/12/2020,01/12/2020,No Results Posted,,,20/08/2020,https://clinicaltrials.gov/show/NCT04521296,01/12/2020,0,0
903,NCT04521322,Recruiting,30/10/2020,30/11/2020,No Results Posted,,,21/08/2020,https://clinicaltrials.gov/show/NCT04521322,30/10/2020,0,0
904,NCT04521400,Not yet recruiting,04/09/2020,11/09/2020,No Results Posted,"['Alavi Darazam I, Hatami F, Mahdi Rabiei M, Amin Pourhoseingholi M, Shabani M, Shokouhi S, Mardani M, Moradi O, Javandoust Gharehbagh F, Mirtalaee N, Negahban H, Amirdosara M, Zangi M, Hajiesmaeili M, Kazempour M, Shafigh N. An investigation into the beneficial effects of high-dose interferon beta 1-a, compared to low-dose interferon beta 1-a in severe COVID-19: The COVIFERON II randomized controlled trial. Int Immunopharmacol. 2021 Jun 29;99:107916. doi: 10.1016/j.intimp.2021.107916. [Epub ahead of print]', 'Alavi Darazam I, Hatami F, Rabiei MM, Pourhoseingholi MA, Moradi O, Shokouhi S, Hajesmaeili MR, Shabani M, Irvani SSN. An investigation into the beneficial effects of high-dose interferon beta 1-a, compared to low-dose interferon beta 1-a (the base therapeutic regimen) in moderate to severe COVID-19: A structured summary of a study protocol for a randomized controlled l trial. Trials. 2020 Oct 26;21(1):880. doi: 10.1186/s13063-020-04812-2.']",,20/08/2020,https://clinicaltrials.gov/show/NCT04521400,04/09/2020,0,1
905,NCT04522128,Recruiting,31/03/2022,31/12/2022,No Results Posted,,,21/08/2020,https://clinicaltrials.gov/show/NCT04522128,31/03/2022,0,0
906,NCT04522466,Terminated,28/05/2020,28/05/2020,No Results Posted,,,07/09/2020,https://clinicaltrials.gov/show/NCT04522466,28/05/2020,0,0
907,NCT04522817,Withdrawn,01/05/2021,01/05/2021,No Results Posted,,,17/12/2020,https://clinicaltrials.gov/show/NCT04522817,01/05/2021,0,0
908,NCT04523831,Completed,22/08/2020,10/09/2020,Study Results,"['Mahmud R, Rahman MM, Alam I, Ahmed KGU, Kabir AKMH, Sayeed SKJB, Rassel MA, Monayem FB, Islam MS, Islam MM, Barshan AD, Hoque MM, Mallik MU, Yusuf MA, Hossain MZ. Ivermectin in combination with doxycycline for treating COVID-19 symptoms: a randomized trial. J Int Med Res. 2021 May;49(5):3000605211013550. doi: 10.1177/03000605211013550.']",,09/10/2020,https://clinicaltrials.gov/show/NCT04523831,22/08/2020,1,1
909,NCT04524052,Not yet recruiting,01/12/2020,01/12/2020,No Results Posted,,,24/08/2020,https://clinicaltrials.gov/show/NCT04524052,01/12/2020,0,0
910,NCT04524156,Not yet recruiting,04/09/2021,04/05/2023,No Results Posted,,,24/08/2020,https://clinicaltrials.gov/show/NCT04524156,04/09/2021,0,0
911,NCT04525378,Recruiting,30/09/2020,31/10/2020,No Results Posted,,,26/08/2020,https://clinicaltrials.gov/show/NCT04525378,30/09/2020,0,0
912,NCT04525742,Completed,30/08/2020,15/09/2020,No Results Posted,,,03/11/2020,https://clinicaltrials.gov/show/NCT04525742,30/08/2020,0,0
913,NCT04526054,Recruiting,03/09/2021,03/09/2021,No Results Posted,,,05/10/2020,https://clinicaltrials.gov/show/NCT04526054,03/09/2021,0,0
914,NCT04526821,Not yet recruiting,30/06/2021,01/11/2021,No Results Posted,,,02/09/2020,https://clinicaltrials.gov/show/NCT04526821,30/06/2021,0,0
915,NCT04527133,"Active, not recruiting",11/08/2020,31/08/2020,No Results Posted,,,26/08/2020,https://clinicaltrials.gov/show/NCT04527133,11/08/2020,0,0
916,NCT04527198,Not yet recruiting,01/06/2021,01/06/2021,No Results Posted,,,09/09/2020,https://clinicaltrials.gov/show/NCT04527198,01/06/2021,0,0
917,NCT04527211,Not yet recruiting,30/11/2020,16/12/2020,No Results Posted,,,26/08/2020,https://clinicaltrials.gov/show/NCT04527211,30/11/2020,0,0
918,NCT04527614,Enrolling by invitation,30/05/2021,30/05/2021,No Results Posted,,,19/10/2020,https://clinicaltrials.gov/show/NCT04527614,30/05/2021,0,0
919,NCT04528771,Not yet recruiting,31/03/2021,30/04/2021,No Results Posted,,,27/08/2020,https://clinicaltrials.gov/show/NCT04528771,31/03/2021,0,0
920,NCT04528927,Withdrawn,15/07/2020,15/07/2020,No Results Posted,,,27/08/2020,https://clinicaltrials.gov/show/NCT04528927,15/07/2020,0,0
921,NCT04530370,Recruiting,01/09/2020,01/09/2020,No Results Posted,"['Piechotta V, Iannizzi C, Chai KL, Valk SJ, Kimber C, Dorando E, Monsef I, Wood EM, Lamikanra AA, Roberts DJ, McQuilten Z, So-Osman C, Estcourt LJ, Skoetz N. Convalescent plasma or hyperimmune immunoglobulin for people with COVID-19: a living systematic review. Cochrane Database Syst Rev. 2021 May 20;5:CD013600. doi: 10.1002/14651858.CD013600.pub4.']",,28/08/2020,https://clinicaltrials.gov/show/NCT04530370,01/09/2020,0,1
922,NCT04530422,Completed,08/07/2020,23/07/2020,No Results Posted,,,28/08/2020,https://clinicaltrials.gov/show/NCT04530422,08/07/2020,0,0
923,NCT04530578,Recruiting,30/10/2020,01/06/2021,No Results Posted,,,31/08/2020,https://clinicaltrials.gov/show/NCT04530578,30/10/2020,0,0
924,NCT04530604,Recruiting,01/10/2021,01/10/2021,No Results Posted,,,14/10/2020,https://clinicaltrials.gov/show/NCT04530604,01/10/2021,0,0
925,NCT04531618,Recruiting,01/12/2021,01/12/2021,No Results Posted,,,31/08/2020,https://clinicaltrials.gov/show/NCT04531618,01/12/2021,0,0
926,NCT04531774,Recruiting,01/06/2021,01/06/2021,No Results Posted,,,19/10/2020,https://clinicaltrials.gov/show/NCT04531774,01/06/2021,0,0
927,NCT04532554,Withdrawn,10/12/2020,20/12/2020,No Results Posted,,"['Meazza C, Pagani S, Travaglino P, Bozzola M. Effect of growth hormone (GH) on the immune system. Pediatr Endocrinol Rev. 2004 Aug;1 Suppl 3:490-5. Review.']",16/09/2020,https://clinicaltrials.gov/show/NCT04532554,10/12/2020,0,1
928,NCT04532931,Recruiting,01/06/2021,01/10/2021,No Results Posted,,,23/12/2020,https://clinicaltrials.gov/show/NCT04532931,01/06/2021,0,0
929,NCT04533399,Recruiting,01/11/2021,01/11/2021,No Results Posted,"['Shinde V, Bhikha S, Hoosain Z, Archary M, Bhorat Q, Fairlie L, Lalloo U, Masilela MSL, Moodley D, Hanley S, Fouche L, Louw C, Tameris M, Singh N, Goga A, Dheda K, Grobbelaar C, Kruger G, Carrim-Ganey N, Baillie V, de Oliveira T, Lombard Koen A, Lombaard JJ, Mngqibisa R, Bhorat AE, Benad√© G, Lalloo N, Pitsi A, Vollgraaff PL, Luabeya A, Esmail A, Petrick FG, Oommen-Jose A, Foulkes S, Ahmed K, Thombrayil A, Fries L, Cloney-Clark S, Zhu M, Bennett C, Albert G, Faust E, Plested JS, Robertson A, Neal S, Cho I, Glenn GM, Dubovsky F, Madhi SA; 2019nCoV-501 Study Group. Efficacy of NVX-CoV2373 Covid-19 Vaccine against the B.1.351 Variant. N Engl J Med. 2021 May 20;384(20):1899-1909. doi: 10.1056/NEJMoa2103055. Epub 2021 May 5.']",,02/11/2020,https://clinicaltrials.gov/show/NCT04533399,01/11/2021,0,1
930,NCT04534478,Not yet recruiting,02/05/2021,15/12/2021,No Results Posted,,,01/09/2020,https://clinicaltrials.gov/show/NCT04534478,02/05/2021,0,0
931,NCT04534673,Recruiting,31/12/2021,31/12/2021,No Results Posted,,,01/09/2020,https://clinicaltrials.gov/show/NCT04534673,31/12/2021,0,0
932,NCT04534725,Recruiting,01/12/2021,01/12/2021,No Results Posted,,,05/01/2021,https://clinicaltrials.gov/show/NCT04534725,01/12/2021,0,0
933,NCT04535063,Recruiting,30/12/2020,25/02/2021,No Results Posted,,,02/09/2020,https://clinicaltrials.gov/show/NCT04535063,30/12/2020,0,0
934,NCT04535700,Recruiting,10/03/2021,10/04/2021,No Results Posted,,,17/11/2020,https://clinicaltrials.gov/show/NCT04535700,10/03/2021,0,0
935,NCT04535791,Recruiting,01/05/2021,01/07/2021,No Results Posted,,,02/09/2020,https://clinicaltrials.gov/show/NCT04535791,01/05/2021,0,0
936,NCT04536051,Recruiting,01/09/2021,01/09/2021,No Results Posted,,,27/11/2020,https://clinicaltrials.gov/show/NCT04536051,01/09/2021,0,0
937,NCT04536090,Not yet recruiting,01/04/2021,01/05/2021,No Results Posted,,,26/10/2020,https://clinicaltrials.gov/show/NCT04536090,01/04/2021,0,0
938,NCT04536363,Not yet recruiting,01/12/2020,01/03/2021,No Results Posted,,,02/09/2020,https://clinicaltrials.gov/show/NCT04536363,01/12/2020,0,0
939,NCT04536441,Completed,30/05/2020,30/06/2020,No Results Posted,,,02/09/2020,https://clinicaltrials.gov/show/NCT04536441,30/05/2020,0,0
940,NCT04537130,Not yet recruiting,01/06/2021,01/06/2022,No Results Posted,,,24/09/2020,https://clinicaltrials.gov/show/NCT04537130,01/06/2021,0,0
941,NCT04537572,Not yet recruiting,01/09/2022,01/09/2022,No Results Posted,,,03/09/2020,https://clinicaltrials.gov/show/NCT04537572,01/09/2022,0,0
942,NCT04537585,Not yet recruiting,01/11/2022,01/12/2022,No Results Posted,,,03/09/2020,https://clinicaltrials.gov/show/NCT04537585,01/11/2022,0,0
943,NCT04537858,"Active, not recruiting",20/08/2020,01/12/2020,No Results Posted,"['da Silva TD, de Oliveira PM, Dionizio JB, de Santana AP, Bahadori S, Dias ED, Ribeiro CM, Gomes RA, Ferreira M, Ferreira C, de Moraes √çAP, Silva DMM, Barnab√© V, de Ara√∫jo LV, Santana HBR, Monteiro CBM. Comparison Between Conventional Intervention and Non-immersive Virtual Reality in the Rehabilitation of Individuals in an Inpatient Unit for the Treatment of COVID-19: A Study Protocol for a Randomized Controlled Crossover Trial. Front Psychol. 2021 Feb 24;12:622618. doi: 10.3389/fpsyg.2021.622618. eCollection 2021.']",,03/09/2020,https://clinicaltrials.gov/show/NCT04537858,20/08/2020,0,1
944,NCT04540185,Enrolling by invitation,01/11/2022,31/12/2022,No Results Posted,,,09/09/2020,https://clinicaltrials.gov/show/NCT04540185,01/11/2022,0,0
945,NCT04540926,Not yet recruiting,01/09/2020,30/09/2020,No Results Posted,,"['Fehr AR, Perlman S. Coronaviruses: an overview of their replication and pathogenesis. Methods Mol Biol. 2015;1282:1-23. doi: 10.1007/978-1-4939-2438-7_1. Review.', 'Lake MA. What we know so far: COVID-19 current clinical knowledge and research. Clin Med (Lond). 2020 Mar;20(2):124-127. doi: 10.7861/clinmed.2019-coron. Epub 2020 Mar 5. Review.', 'Huang C, Wang Y, Li X, Ren L, Zhao J, Hu Y, Zhang L, Fan G, Xu J, Gu X, Cheng Z, Yu T, Xia J, Wei Y, Wu W, Xie X, Yin W, Li H, Liu M, Xiao Y, Gao H, Guo L, Xie J, Wang G, Jiang R, Gao Z, Jin Q, Wang J, Cao B. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet. 2020 Feb 15;395(10223):497-506. doi: 10.1016/S0140-6736(20)30183-5. Epub 2020 Jan 24. Erratum in: Lancet. 2020 Jan 30;:.', 'Chen N, Zhou M, Dong X, Qu J, Gong F, Han Y, Qiu Y, Wang J, Liu Y, Wei Y, Xia J, Yu T, Zhang X, Zhang L. Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study. Lancet. 2020 Feb 15;395(10223):507-513. doi: 10.1016/S0140-6736(20)30211-7. Epub 2020 Jan 30.', 'Wang D, Hu B, Hu C, Zhu F, Liu X, Zhang J, Wang B, Xiang H, Cheng Z, Xiong Y, Zhao Y, Li Y, Wang X, Peng Z. Clinical Characteristics of 138 Hospitalized Patients With 2019 Novel Coronavirus-Infected Pneumonia in Wuhan, China. JAMA. 2020 Mar 17;323(11):1061-1069. doi: 10.1001/jama.2020.1585. Erratum in: JAMA. 2021 Mar 16;325(11):1113.', 'Mehta P, McAuley DF, Brown M, Sanchez E, Tattersall RS, Manson JJ; HLH Across Speciality Collaboration, UK. COVID-19: consider cytokine storm syndromes and immunosuppression. Lancet. 2020 Mar 28;395(10229):1033-1034. doi: 10.1016/S0140-6736(20)30628-0. Epub 2020 Mar 16.', 'Jamilloux Y, Henry T, Belot A, Viel S, Fauter M, El Jammal T, Walzer T, Fran√ßois B, S√®ve P. Should we stimulate or suppress immune responses in COVID-19? Cytokine and anti-cytokine interventions. Autoimmun Rev. 2020 Jul;19(7):102567. doi: 10.1016/j.autrev.2020.102567. Epub 2020 May 4. Review.', 'Kupferschmidt K, Cohen J. Race to find COVID-19 treatments accelerates. Science. 2020 Mar 27;367(6485):1412-1413. doi: 10.1126/science.367.6485.1412.', 'Russell CD, Millar JE, Baillie JK. Clinical evidence does not support corticosteroid treatment for 2019-nCoV lung injury. Lancet. 2020 Feb 15;395(10223):473-475. doi: 10.1016/S0140-6736(20)30317-2. Epub 2020 Feb 7.', 'Villar J, Belda J, A√±√≥n JM, Blanco J, P√©rez-M√©ndez L, Ferrando C, Mart√≠nez D, Soler JA, Ambr√≥s A, Mu√±oz T, Rivas R, Corpas R, D√≠az-Dominguez FJ, Soro M, Garc√≠a-Bello MA, Fern√°ndez RL, Kacmarek RM; DEXA-ARDS Network. Evaluating the efficacy of dexamethasone in the treatment of patients with persistent acute respiratory distress syndrome: study protocol for a randomized controlled trial. Trials. 2016 Jul 22;17:342. doi: 10.1186/s13063-016-1456-4.', 'Lamontagne F, Rochwerg B, Lytvyn L, Guyatt GH, M√∏ller MH, Annane D, Kho ME, Adhikari NKJ, Machado F, Vandvik PO, Dodek P, Leboeuf R, Briel M, Hashmi M, Camsooksai J, Shankar-Hari M, Baraki MK, Fugate K, Chua S, Marti C, Cohen D, Botton E, Agoritsas T, Siemieniuk RAC. Corticosteroid therapy for sepsis: a clinical practice guideline. BMJ. 2018 Aug 10;362:k3284. doi: 10.1136/bmj.k3284.', 'Wu C, Chen X, Cai Y, Xia J, Zhou X, Xu S, Huang H, Zhang L, Zhou X, Du C, Zhang Y, Song J, Wang S, Chao Y, Yang Z, Xu J, Zhou X, Chen D, Xiong W, Xu L, Zhou F, Jiang J, Bai C, Zheng J, Song Y. Risk Factors Associated With Acute Respiratory Distress Syndrome and Death in Patients With Coronavirus Disease 2019 Pneumonia in Wuhan, China. JAMA Intern Med. 2020 Jul 1;180(7):934-943. doi: 10.1001/jamainternmed.2020.0994. Erratum in: JAMA Intern Med. 2020 Jul 1;180(7):1031.', 'Shang L, Zhao J, Hu Y, Du R, Cao B. On the use of corticosteroids for 2019-nCoV pneumonia. Lancet. 2020 Feb 29;395(10225):683-684. doi: 10.1016/S0140-6736(20)30361-5. Epub 2020 Feb 12.', 'RECOVERY Collaborative Group, Horby P, Lim WS, Emberson JR, Mafham M, Bell JL, Linsell L, Staplin N, Brightling C, Ustianowski A, Elmahi E, Prudon B, Green C, Felton T, Chadwick D, Rege K, Fegan C, Chappell LC, Faust SN, Jaki T, Jeffery K, Montgomery A, Rowan K, Juszczak E, Baillie JK, Haynes R, Landray MJ. Dexamethasone in Hospitalized Patients with Covid-19. N Engl J Med. 2021 Feb 25;384(8):693-704. doi: 10.1056/NEJMoa2021436. Epub 2020 Jul 17.', 'Zeidler HK, Kvien TK, Hannonen P, Wollheim FA, F√∏rre O, Geidel H, Hafstr√∂m I, Kaltwasser JP, Leirisalo-Repo M, Manger B, Laasonen L, Markert ER, Prestele H, Kurki P. Progression of joint damage in early active severe rheumatoid arthritis during 18 months of treatment: comparison of low-dose cyclosporin and parenteral gold. Br J Rheumatol. 1998 Aug;37(8):874-82.', 'Tokuda M, Kurata N, Mizoguchi A, Inoh M, Seto K, Kinashi M, Takahara J. Effect of low-dose cyclosporin A on systemic lupus erythematosus disease activity. Arthritis Rheum. 1994 Apr;37(4):551-8.', 'Liddicoat AM, Lavelle EC. Modulation of innate immunity by cyclosporine A. Biochem Pharmacol. 2019 May;163:472-480. doi: 10.1016/j.bcp.2019.03.022. Epub 2019 Mar 15. Review.', 'Li HS, Kuok DIT, Cheung MC, Ng MMT, Ng KC, Hui KPY, Peiris JSM, Chan MCW, Nicholls JM. Effect of interferon alpha and cyclosporine treatment separately and in combination on Middle East Respiratory Syndrome Coronavirus (MERS-CoV) replication in a human in-vitro and ex-vivo culture model. Antiviral Res. 2018 Jul;155:89-96. doi: 10.1016/j.antiviral.2018.05.007. Epub 2018 May 17.', 'Tanaka Y, Sato Y, Sasaki T. Suppression of coronavirus replication by cyclophilin inhibitors. Viruses. 2013 May 22;5(5):1250-60. doi: 10.3390/v5051250. Review.', 'de Wilde AH, Zevenhoven-Dobbe JC, van der Meer Y, Thiel V, Narayanan K, Makino S, Snijder EJ, van Hemert MJ. Cyclosporin A inhibits the replication of diverse coronaviruses. J Gen Virol. 2011 Nov;92(Pt 11):2542-2548. doi: 10.1099/vir.0.034983-0. Epub 2011 Jul 13.', 'Wang Y, Dong C, Hu Y, Li C, Ren Q, Zhang X, Shi H, Zhou M. Temporal Changes of CT Findings in 90 Patients with COVID-19 Pneumonia: A Longitudinal Study. Radiology. 2020 Aug;296(2):E55-E64. doi: 10.1148/radiol.2020200843. Epub 2020 Mar 19.', 'Ji D, Zhang D, Xu J, Chen Z, Yang T, Zhao P, Chen G, Cheng G, Wang Y, Bi J, Tan L, Lau G, Qin E. Prediction for Progression Risk in Patients With COVID-19 Pneumonia: The CALL Score. Clin Infect Dis. 2020 Sep 12;71(6):1393-1399. doi: 10.1093/cid/ciaa414.', 'Wiersinga WJ, Rhodes A, Cheng AC, Peacock SJ, Prescott HC. Pathophysiology, Transmission, Diagnosis, and Treatment of Coronavirus Disease 2019 (COVID-19): A Review. JAMA. 2020 Aug 25;324(8):782-793. doi: 10.1001/jama.2020.12839. Review.', 'Annane D, Renault A, Bellissant E. Glucocorticoids with or without Fludrocortisone in Septic Shock. N Engl J Med. 2018 Aug 30;379(9):895-6. doi: 10.1056/NEJMc1804993.', 'Venkatesh B, Finfer S, Myburgh J; ADRENAL investigators. Glucocorticoids with or without Fludrocortisone in Septic Shock. N Engl J Med. 2018 Aug 30;379(9):895. doi: 10.1056/NEJMc1804993.', 'Alhazzani W, M√∏ller MH, Arabi YM, Loeb M, Gong MN, Fan E, Oczkowski S, Levy MM, Derde L, Dzierba A, Du B, Aboodi M, Wunsch H, Cecconi M, Koh Y, Chertow DS, Maitland K, Alshamsi F, Belley-Cote E, Greco M, Laundy M, Morgan JS, Kesecioglu J, McGeer A, Mermel L, Mammen MJ, Alexander PE, Arrington A, Centofanti JE, Citerio G, Baw B, Memish ZA, Hammond N, Hayden FG, Evans L, Rhodes A. Surviving Sepsis Campaign: guidelines on the management of critically ill adults with Coronavirus Disease 2019 (COVID-19). Intensive Care Med. 2020 May;46(5):854-887. doi: 10.1007/s00134-020-06022-5. Epub 2020 Mar 28.', 'Wong SS, Yuen KY. The management of coronavirus infections with particular reference to SARS. J Antimicrob Chemother. 2008 Sep;62(3):437-41. doi: 10.1093/jac/dkn243. Epub 2008 Jun 18. Review.', 'Lee N, Allen Chan KC, Hui DS, Ng EK, Wu A, Chiu RW, Wong VW, Chan PK, Wong KT, Wong E, Cockram CS, Tam JS, Sung JJ, Lo YM. Effects of early corticosteroid treatment on plasma SARS-associated Coronavirus RNA concentrations in adult patients. J Clin Virol. 2004 Dec;31(4):304-9.', 'Arabi YM, Mandourah Y, Al-Hameed F, Sindi AA, Almekhlafi GA, Hussein MA, Jose J, Pinto R, Al-Omari A, Kharaba A, Almotairi A, Al Khatib K, Alraddadi B, Shalhoub S, Abdulmomen A, Qushmaq I, Mady A, Solaiman O, Al-Aithan AM, Al-Raddadi R, Ragab A, Balkhy HH, Al Harthy A, Deeb AM, Al Mutairi H, Al-Dawood A, Merson L, Hayden FG, Fowler RA; Saudi Critical Care Trial Group. Corticosteroid Therapy for Critically Ill Patients with Middle East Respiratory Syndrome. Am J Respir Crit Care Med. 2018 Mar 15;197(6):757-767. doi: 10.1164/rccm.201706-1172OC.', 'Russell B, Moss C, George G, Santaolalla A, Cope A, Papa S, Van Hemelrijck M. Associations between immune-suppressive and stimulating drugs and novel COVID-19-a systematic review of current evidence. Ecancermedicalscience. 2020 Mar 27;14:1022. doi: 10.3332/ecancer.2020.1022. eCollection 2020. Review.', 'Zhao Z, Zhang F, Xu M, Huang K, Zhong W, Cai W, Yin Z, Huang S, Deng Z, Wei M, Xiong J, Hawkey PM. Description and clinical treatment of an early outbreak of severe acute respiratory syndrome (SARS) in Guangzhou, PR China. J Med Microbiol. 2003 Aug;52(Pt 8):715-720. doi: 10.1099/jmm.0.05320-0.', 'Fadel R, Morrison AR, Vahia A, Smith ZR, Chaudhry Z, Bhargava P, Miller J, Kenney RM, Alangaden G, Ramesh MS; Henry Ford COVID-19 Management Task Force. Early Short-Course Corticosteroids in Hospitalized Patients With COVID-19. Clin Infect Dis. 2020 Nov 19;71(16):2114-2120. doi: 10.1093/cid/ciaa601.', 'Fern√°ndez-Cruz A, Ruiz-Antor√°n B, M√∫√±ez-Rubio E, Sancho-L√≥pez A, Callejas-D√≠az A, Avenda√±o-Sol√° C, Ramos-Mart√≠nez A. The Right Time for Steroids in COVID-19. Clin Infect Dis. 2021 Apr 26;72(8):1486-1487. doi: 10.1093/cid/ciaa865.', 'Selvaraj V, Dapaah-Afriyie K, Finn A, Flanigan TP. Short-Term Dexamethasone in Sars-CoV-2 Patients. R I Med J (2013). 2020 Jun 19;103(6):39-43.', 'Cour M, Ovize M, Argaud L. Cyclosporine A: a valid candidate to treat COVID-19 patients with acute respiratory failure? Crit Care. 2020 Jun 2;24(1):276. doi: 10.1186/s13054-020-03014-1.', 'Argaud L, Cour M, Dubien PY, Giraud F, Jossan C, Riche B, Hernu R, Darmon M, Poncelin Y, Tch√©nio X, Quenot JP, Freysz M, Kamga C, Beuret P, Usseglio P, Badet M, Anette B, Chaulier K, Alasan E, Sadoune S, Bobbia X, Z√©ni F, Gueugniaud PY, Robert D, Roy P, Ovize M; CYRUS Study Group. Effect of Cyclosporine in Nonshockable Out-of-Hospital Cardiac Arrest: The CYRUS Randomized Clinical Trial. JAMA Cardiol. 2016 Aug 1;1(5):557-65. doi: 10.1001/jamacardio.2016.1701.', 'Cung TT, Morel O, Cayla G, Rioufol G, Garcia-Dorado D, Angoulvant D, Bonnefoy-Cudraz E, Gu√©rin P, Elbaz M, Delarche N, Coste P, Vanzetto G, Metge M, Aupetit JF, Jouve B, Motreff P, Tron C, Labeque JN, Steg PG, Cottin Y, Range G, Clerc J, Claeys MJ, Coussement P, Prunier F, Moulin F, Roth O, Belle L, Dubois P, Barragan P, Gilard M, Piot C, Colin P, De Poli F, Morice MC, Ider O, Dubois-Rand√© JL, Unterseeh T, Le Breton H, B√©ard T, Blanchard D, Grollier G, Malquarti V, Staat P, Sudre A, Elmer E, Hansson MJ, Bergerot C, Boussaha I, Jossan C, Derumeaux G, Mewton N, Ovize M. Cyclosporine before PCI in Patients with Acute Myocardial Infarction. N Engl J Med. 2015 Sep 10;373(11):1021-31. doi: 10.1056/NEJMoa1505489. Epub 2015 Aug 30.', 'Kreitmann L, Argaud L, Ovize M, Cour M; CYRUS Study Group. Cyclosporine A prevents cardiac arrest-induced acute respiratory failure: a post-hoc analysis of the CYRUS trial. Intensive Care Med. 2020 Jun;46(6):1281-1283. doi: 10.1007/s00134-020-06043-0. Epub 2020 Apr 21.', 'Naesens M, Kuypers DR, Sarwal M. Calcineurin inhibitor nephrotoxicity. Clin J Am Soc Nephrol. 2009 Feb;4(2):481-508. doi: 10.2215/CJN.04800908. Review.', ""Sanchez-Pernaute O, Romero-Bueno FI, Selva-O'Callaghan A. Why Choose Cyclosporin A as First-line Therapy in COVID-19 Pneumonia. Reumatol Clin (Engl Ed). 2020 Apr 16. pii: S1699-258X(20)30044-9. doi: 10.1016/j.reuma.2020.03.001. [Epub ahead of print] English, Spanish."", 'Pino-Lagos K, Michea P, Sauma D, Alba A, Morales J, Bono MR, Fierro A, Rosemblatt M. Cyclosporin A-treated dendritic cells may affect the outcome of organ transplantation by decreasing CD4+CD25+ regulatory T cell proliferation. Biol Res. 2010;43(3):333-7. doi: /S0716-97602010000300010. Epub 2010 Nov 30.', 'Greenblatt MB, Aliprantis A, Hu B, Glimcher LH. Calcineurin regulates innate antifungal immunity in neutrophils. J Exp Med. 2010 May 10;207(5):923-31. doi: 10.1084/jem.20092531. Epub 2010 Apr 26.', 'Roilides E, Robinson T, Sein T, Pizzo PA, Walsh TJ. In vitro and ex vivo effects of cyclosporin A on phagocytic host defenses against Aspergillus fumigatus. Antimicrob Agents Chemother. 1994 Dec;38(12):2883-8.', 'Gupta AK, Giaglis S, Hasler P, Hahn S. Efficient neutrophil extracellular trap induction requires mobilization of both intracellular and extracellular calcium pools and is modulated by cyclosporine A. PLoS One. 2014 May 12;9(5):e97088. doi: 10.1371/journal.pone.0097088. eCollection 2014.', 'Edler C, Schr√∂der AS, Aepfelbacher M, Fitzek A, Heinemann A, Heinrich F, Klein A, Langenwalder F, L√ºtgehetmann M, Mei√üner K, P√ºschel K, Sch√§dler J, Steurer S, Mushumba H, Sperhake JP. Dying with SARS-CoV-2 infection-an autopsy study of the first consecutive 80 cases in Hamburg, Germany. Int J Legal Med. 2020 Jul;134(4):1275-1284. doi: 10.1007/s00414-020-02317-w. Epub 2020 Jun 4. Erratum in: Int J Legal Med. 2020 Sep;134(5):1977.', 'Barnes BJ, Adrover JM, Baxter-Stoltzfus A, Borczuk A, Cools-Lartigue J, Crawford JM, Da√üler-Plenker J, Guerci P, Huynh C, Knight JS, Loda M, Looney MR, McAllister F, Rayes R, Renaud S, Rousseau S, Salvatore S, Schwartz RE, Spicer JD, Yost CC, Weber A, Zuo Y, Egeblad M. Targeting potential drivers of COVID-19: Neutrophil extracellular traps. J Exp Med. 2020 Jun 1;217(6). pii: e20200652. doi: 10.1084/jem.20200652.', 'Narasaraju T, Tang BM, Herrmann M, Muller S, Chow VTK, Radic M. Neutrophilia and NETopathy as Key Pathologic Drivers of Progressive Lung Impairment in Patients With COVID-19. Front Pharmacol. 2020 Jun 5;11:870. doi: 10.3389/fphar.2020.00870. eCollection 2020.', 'de Wilde AH, Raj VS, Oudshoorn D, Bestebroer TM, van Nieuwkoop S, Limpens RWAL, Posthuma CC, van der Meer Y, B√°rcena M, Haagmans BL, Snijder EJ, van den Hoogen BG. MERS-coronavirus replication induces severe in vitro cytopathology and is strongly inhibited by cyclosporin A or interferon-Œ± treatment. J Gen Virol. 2013 Aug;94(Pt 8):1749-1760. doi: 10.1099/vir.0.052910-0. Epub 2013 Apr 25.', 'Softic L, Brillet R, Berry F, Ahnou N, Nevers Q, Morin-Dewaele M, Hamadat S, Bruscella P, Fourati S, Pawlotsky JM, Ahmed-Belkacem A. Inhibition of SARS-CoV-2 Infection by the Cyclophilin Inhibitor Alisporivir (Debio 025). Antimicrob Agents Chemother. 2020 Jun 23;64(7). pii: e00876-20. doi: 10.1128/AAC.00876-20. Print 2020 Jun 23.']",07/09/2020,https://clinicaltrials.gov/show/NCT04540926,01/09/2020,0,1
946,NCT04540939,Recruiting,01/12/2021,01/12/2021,No Results Posted,,,02/11/2020,https://clinicaltrials.gov/show/NCT04540939,01/12/2021,0,0
947,NCT04541485,Not yet recruiting,20/10/2020,29/01/2021,No Results Posted,,,09/09/2020,https://clinicaltrials.gov/show/NCT04541485,20/10/2020,0,0
948,NCT04542122,Not yet recruiting,30/04/2021,02/08/2021,No Results Posted,,,09/09/2020,https://clinicaltrials.gov/show/NCT04542122,30/04/2021,0,0
949,NCT04542330,Recruiting,01/01/2022,01/03/2022,No Results Posted,,,24/11/2020,https://clinicaltrials.gov/show/NCT04542330,01/01/2022,0,0
950,NCT04542408,Recruiting,31/05/2021,30/09/2021,No Results Posted,,,18/11/2020,https://clinicaltrials.gov/show/NCT04542408,31/05/2021,0,0
951,NCT04542421,Recruiting,01/07/2021,01/12/2021,No Results Posted,,,28/09/2020,https://clinicaltrials.gov/show/NCT04542421,01/07/2021,0,0
952,NCT04542447,Recruiting,30/09/2020,30/09/2020,No Results Posted,,,10/09/2020,https://clinicaltrials.gov/show/NCT04542447,30/09/2020,0,0
953,NCT04542694,Completed,10/08/2020,20/08/2020,Study Results,,,05/11/2020,https://clinicaltrials.gov/show/NCT04542694,10/08/2020,1,0
954,NCT04542876,Completed,31/07/2020,18/08/2020,No Results Posted,,,09/09/2020,https://clinicaltrials.gov/show/NCT04542876,31/07/2020,0,0
955,NCT04543006,Not yet recruiting,30/09/2021,31/12/2021,No Results Posted,,,16/09/2020,https://clinicaltrials.gov/show/NCT04543006,30/09/2021,0,0
956,NCT04546737,Recruiting,01/07/2021,01/05/2022,No Results Posted,,,17/09/2020,https://clinicaltrials.gov/show/NCT04546737,01/07/2021,0,0
957,NCT04546841,Recruiting,30/09/2021,20/12/2021,No Results Posted,,,01/12/2020,https://clinicaltrials.gov/show/NCT04546841,30/09/2021,0,0
958,NCT04547283,Completed,20/09/2020,30/09/2020,No Results Posted,,,07/07/2021,https://clinicaltrials.gov/show/NCT04547283,20/09/2020,0,0
959,NCT04547634,Enrolling by invitation,01/11/2020,01/12/2020,No Results Posted,,,14/09/2020,https://clinicaltrials.gov/show/NCT04547634,01/11/2020,0,0
960,NCT04548531,Enrolling by invitation,30/04/2021,30/05/2021,No Results Posted,,,30/09/2020,https://clinicaltrials.gov/show/NCT04548531,30/04/2021,0,0
961,NCT04548544,Completed,20/05/2020,20/05/2020,No Results Posted,,,14/09/2020,https://clinicaltrials.gov/show/NCT04548544,20/05/2020,0,0
962,NCT04548557,Not yet recruiting,15/10/2020,15/11/2020,No Results Posted,,,14/09/2020,https://clinicaltrials.gov/show/NCT04548557,15/10/2020,0,0
963,NCT04549337,Recruiting,01/05/2021,01/05/2021,No Results Posted,,,30/11/2020,https://clinicaltrials.gov/show/NCT04549337,01/05/2021,0,0
964,NCT04549376,Recruiting,20/10/2020,30/10/2020,No Results Posted,"['Hasan MJ, Rumi SKNF, Banu SS, Uddin AKMN, Islam MS, Arefin MK. Virucidal effect of povidone iodine on COVID-19 in the nasopharynx: A structured summary of a study protocol for an open-label randomized clinical trial. Trials. 2021 Jan 4;22(1):2. doi: 10.1186/s13063-020-04963-2.']",,16/09/2020,https://clinicaltrials.gov/show/NCT04549376,20/10/2020,0,1
965,NCT04551274,Not yet recruiting,30/11/2020,30/11/2020,No Results Posted,,,16/09/2020,https://clinicaltrials.gov/show/NCT04551274,30/11/2020,0,0
966,NCT04551755,Not yet recruiting,01/11/2020,01/12/2020,No Results Posted,,,16/09/2020,https://clinicaltrials.gov/show/NCT04551755,01/11/2020,0,0
967,NCT04551781,Completed,30/07/2020,30/07/2020,No Results Posted,,,16/09/2020,https://clinicaltrials.gov/show/NCT04551781,30/07/2020,0,0
968,NCT04552483,Completed,20/08/2020,05/09/2020,No Results Posted,,,03/11/2020,https://clinicaltrials.gov/show/NCT04552483,20/08/2020,0,0
969,NCT04552951,Recruiting,14/09/2020,30/12/2020,No Results Posted,,,17/09/2020,https://clinicaltrials.gov/show/NCT04552951,14/09/2020,0,0
970,NCT04553705,Recruiting,04/11/2020,04/12/2020,No Results Posted,,,18/09/2020,https://clinicaltrials.gov/show/NCT04553705,04/11/2020,0,0
971,NCT04554264,Recruiting,01/09/2021,01/09/2022,No Results Posted,,,18/09/2020,https://clinicaltrials.gov/show/NCT04554264,01/09/2021,0,0
972,NCT04554433,Not yet recruiting,01/10/2021,01/06/2022,No Results Posted,,,28/10/2020,https://clinicaltrials.gov/show/NCT04554433,01/10/2021,0,0
973,NCT04554992,"Active, not recruiting",01/06/2022,01/06/2022,No Results Posted,,,02/11/2020,https://clinicaltrials.gov/show/NCT04554992,01/06/2022,0,0
974,NCT04555005,Completed,26/04/2020,26/04/2020,No Results Posted,"['Rodriguez-Vega B, Palao √Å, Mu√±oz-Sanjose A, Torrijos M, Aguirre P, Fern√°ndez A, Amador B, Rocamora C, Blanco L, Marti-Esquitino J, Ortiz-Villalobos A, Alonso-Sa√±udo M, Cebolla S, Curto J, Villanueva R, de-la-Iglesia MJ, Carracedo D, Casado C, Vidal E, Trigo D, Iglesias N, Caba√±as D, Mellado L, Garc√≠a D, Fern√°ndez-Encinas C, Navarro R, Mediavilla R, Vidal-Villegas MP, Bravo-Ortiz MF, Bay√≥n C. Implementation of a Mindfulness-Based Crisis Intervention for Frontline Healthcare Workers During the COVID-19 Outbreak in a Public General Hospital in Madrid, Spain. Front Psychiatry. 2020 Oct 30;11:562578. doi: 10.3389/fpsyt.2020.562578. eCollection 2020.']",,18/09/2020,https://clinicaltrials.gov/show/NCT04555005,26/04/2020,0,1
975,NCT04555148,Recruiting,30/12/2020,01/08/2021,No Results Posted,,,18/09/2020,https://clinicaltrials.gov/show/NCT04555148,30/12/2020,0,0
976,NCT04557605,Completed,15/10/2020,15/10/2020,No Results Posted,"['Shaw K, Butcher S, Ko J, Zello GA, Chilibeck PD. Wearing of Cloth or Disposable Surgical Face Masks has no Effect on Vigorous Exercise Performance in Healthy Individuals. Int J Environ Res Public Health. 2020 Nov 3;17(21). pii: E8110. doi: 10.3390/ijerph17218110.']",,20/10/2020,https://clinicaltrials.gov/show/NCT04557605,15/10/2020,0,1
977,NCT04558021,Recruiting,30/01/2021,14/02/2021,No Results Posted,,,12/10/2020,https://clinicaltrials.gov/show/NCT04558021,30/01/2021,0,0
978,NCT04558411,Recruiting,15/12/2020,15/12/2020,No Results Posted,,,22/09/2020,https://clinicaltrials.gov/show/NCT04558411,15/12/2020,0,0
979,NCT04558424,Not yet recruiting,01/09/2021,01/09/2021,No Results Posted,,,22/09/2020,https://clinicaltrials.gov/show/NCT04558424,01/09/2021,0,0
980,NCT04558450,Not yet recruiting,01/06/2022,01/06/2032,No Results Posted,,,22/09/2020,https://clinicaltrials.gov/show/NCT04558450,01/06/2022,0,0
981,NCT04558463,Recruiting,30/09/2020,30/10/2020,No Results Posted,,,22/09/2020,https://clinicaltrials.gov/show/NCT04558463,30/09/2020,0,0
982,NCT04559035,Enrolling by invitation,31/12/2020,31/12/2020,No Results Posted,,,22/09/2020,https://clinicaltrials.gov/show/NCT04559035,31/12/2020,0,0
983,NCT04559074,Recruiting,30/04/2021,31/07/2021,No Results Posted,,,13/11/2020,https://clinicaltrials.gov/show/NCT04559074,30/04/2021,0,0
984,NCT04560231,Recruiting,30/11/2020,30/11/2020,No Results Posted,,,25/09/2020,https://clinicaltrials.gov/show/NCT04560231,30/11/2020,0,0
985,NCT04560881,"Active, not recruiting",01/12/2021,01/12/2021,No Results Posted,,,27/11/2020,https://clinicaltrials.gov/show/NCT04560881,01/12/2021,0,0
986,NCT04561063,Recruiting,01/07/2021,01/07/2021,No Results Posted,,,16/12/2020,https://clinicaltrials.gov/show/NCT04561063,01/07/2021,0,0
987,NCT04561076,Not yet recruiting,06/09/2021,18/09/2021,No Results Posted,,,24/09/2020,https://clinicaltrials.gov/show/NCT04561076,06/09/2021,0,0
988,NCT04561154,Recruiting,11/06/2021,11/06/2022,No Results Posted,,,23/09/2020,https://clinicaltrials.gov/show/NCT04561154,11/06/2021,0,0
989,NCT04561219,Completed,02/10/2020,02/10/2020,No Results Posted,,,28/10/2020,https://clinicaltrials.gov/show/NCT04561219,02/10/2020,0,0
990,NCT04563208,Recruiting,01/02/2021,01/03/2021,No Results Posted,,,16/12/2020,https://clinicaltrials.gov/show/NCT04563208,01/02/2021,0,0
991,NCT04563650,Recruiting,01/05/2021,01/11/2021,No Results Posted,,,24/09/2020,https://clinicaltrials.gov/show/NCT04563650,01/05/2021,0,0
992,NCT04563676,Recruiting,01/03/2021,01/03/2021,No Results Posted,,,24/09/2020,https://clinicaltrials.gov/show/NCT04563676,01/03/2021,0,0
993,NCT04563689,Completed,22/10/2020,23/10/2020,No Results Posted,,,20/11/2020,https://clinicaltrials.gov/show/NCT04563689,22/10/2020,0,0
994,NCT04564040,Completed,11/12/2020,11/12/2020,No Results Posted,,,29/12/2020,https://clinicaltrials.gov/show/NCT04564040,11/12/2020,0,0
995,NCT04565509,Recruiting,30/06/2022,21/09/2022,No Results Posted,,,30/11/2020,https://clinicaltrials.gov/show/NCT04565509,30/06/2022,0,0
996,NCT04566276,Not yet recruiting,01/03/2021,01/06/2021,No Results Posted,,,06/10/2020,https://clinicaltrials.gov/show/NCT04566276,01/03/2021,0,0
997,NCT04566770,Recruiting,21/08/2021,20/10/2022,No Results Posted,,,27/11/2020,https://clinicaltrials.gov/show/NCT04566770,21/08/2021,0,0
998,NCT04567173,Recruiting,30/06/2021,30/06/2021,No Results Posted,,,29/09/2020,https://clinicaltrials.gov/show/NCT04567173,30/06/2021,0,0
999,NCT04567810,Completed,14/12/2020,14/12/2020,No Results Posted,,,21/12/2020,https://clinicaltrials.gov/show/NCT04567810,14/12/2020,0,0
1000,NCT04567953,"Active, not recruiting",30/01/2021,27/06/2021,No Results Posted,,,29/09/2020,https://clinicaltrials.gov/show/NCT04567953,30/01/2021,0,0
1001,NCT04568096,Not yet recruiting,01/12/2020,01/12/2020,No Results Posted,,,26/10/2020,https://clinicaltrials.gov/show/NCT04568096,01/12/2020,0,0
1002,NCT04568356,Completed,12/06/2020,24/09/2020,No Results Posted,,"['Dinnes J, Deeks JJ, Adriano A, Berhane S, Davenport C, Dittrich S, Emperador D, Takwoingi Y, Cunningham J, Beese S, Dretzke J, Ferrante di Ruffano L, Harris IM, Price MJ, Taylor-Phillips S, Hooft L, Leeflang MM, Spijker R, Van den Bruel A; Cochrane COVID-19 Diagnostic Test Accuracy Group. Rapid, point-of-care antigen and molecular-based tests for diagnosis of SARS-CoV-2 infection. Cochrane Database Syst Rev. 2020 Aug 26;8:CD013705. doi: 10.1002/14651858.CD013705. Update in: Cochrane Database Syst Rev. 2021 Mar 24;3:CD013705.', 'Kyosei Y, Namba M, Yamura S, Takeuchi R, Aoki N, Nakaishi K, Watabe S, Ito E. Proposal of De Novo Antigen Test for COVID-19: Ultrasensitive Detection of Spike Proteins of SARS-CoV-2. Diagnostics (Basel). 2020 Aug 14;10(8). pii: E594. doi: 10.3390/diagnostics10080594.', 'Hirotsu Y, Maejima M, Shibusawa M, Nagakubo Y, Hosaka K, Amemiya K, Sueki H, Hayakawa M, Mochizuki H, Tsutsui T, Kakizaki Y, Miyashita Y, Yagi S, Kojima S, Omata M. Comparison of automated SARS-CoV-2 antigen test for COVID-19 infection with quantitative RT-PCR using 313 nasopharyngeal swabs, including from seven serially followed patients. Int J Infect Dis. 2020 Oct;99:397-402. doi: 10.1016/j.ijid.2020.08.029. Epub 2020 Aug 12.', 'Nagura-Ikeda M, Imai K, Tabata S, Miyoshi K, Murahara N, Mizuno T, Horiuchi M, Kato K, Imoto Y, Iwata M, Mimura S, Ito T, Tamura K, Kato Y. Clinical Evaluation of Self-Collected Saliva by Quantitative Reverse Transcription-PCR (RT-qPCR), Direct RT-qPCR, Reverse Transcription-Loop-Mediated Isothermal Amplification, and a Rapid Antigen Test To Diagnose COVID-19. J Clin Microbiol. 2020 Aug 24;58(9). pii: e01438-20. doi: 10.1128/JCM.01438-20. Print 2020 Aug 24.', 'Mak GC, Cheng PK, Lau SS, Wong KK, Lau CS, Lam ET, Chan RC, Tsang DN. Evaluation of rapid antigen test for detection of SARS-CoV-2 virus. J Clin Virol. 2020 Aug;129:104500. doi: 10.1016/j.jcv.2020.104500. Epub 2020 Jun 8.', 'Blairon L, Wilmet A, Beukinga I, Tr√©-Hardy M. Implementation of rapid SARS-CoV-2 antigenic testing in a laboratory without access to molecular methods: Experiences of a general hospital. J Clin Virol. 2020 Aug;129:104472. doi: 10.1016/j.jcv.2020.104472. Epub 2020 May 30.', 'Porte L, Legarraga P, Vollrath V, Aguilera X, Munita JM, Araos R, Pizarro G, Vial P, Iruretagoyena M, Dittrich S, Weitzel T. Evaluation of a novel antigen-based rapid detection test for the diagnosis of SARS-CoV-2 in respiratory samples. Int J Infect Dis. 2020 Oct;99:328-333. doi: 10.1016/j.ijid.2020.05.098. Epub 2020 Jun 1.', 'Scohy A, Anantharajah A, Bod√©us M, Kabamba-Mukadi B, Verroken A, Rodriguez-Villalobos H. Low performance of rapid antigen detection test as frontline testing for COVID-19 diagnosis. J Clin Virol. 2020 Aug;129:104455. doi: 10.1016/j.jcv.2020.104455. Epub 2020 May 21.', 'Lambert-Niclot S, Cuffel A, Le Pape S, Vauloup-Fellous C, Morand-Joubert L, Roque-Afonso AM, Le Goff J, Delaugerre C. Evaluation of a Rapid Diagnostic Assay for Detection of SARS-CoV-2 Antigen in Nasopharyngeal Swabs. J Clin Microbiol. 2020 Jul 23;58(8). pii: e00977-20. doi: 10.1128/JCM.00977-20. Print 2020 Jul 23.', 'Cui Z, Chang H, Wang H, Lim B, Hsu CC, Yu Y, Jia H, Wang Y, Zeng Y, Ji M, Liu W, Inverarity C, Huang WE. Development of a rapid test kit for SARS-CoV-2: an example of product design. Biodes Manuf. 2020 May 11:1-4. doi: 10.1007/s42242-020-00075-7. [Epub ahead of print]', ""Bosch I, de Puig H, Hiley M, Carr√©-Camps M, Perdomo-Celis F, Narv√°ez CF, Salgado DM, Senthoor D, O'Grady M, Phillips E, Durbin A, Fandos D, Miyazaki H, Yen CW, G√©lvez-Ram√≠rez M, Warke RV, Ribeiro LS, Teixeira MM, Almeida RP, Mu√±√≥z-Medina JE, Ludert JE, Nogueira ML, Colombo TE, Terzian ACB, Bozza PT, Calheiros AS, Vieira YR, Barbosa-Lima G, Vizzoni A, Cerbino-Neto J, Bozza FA, Souza TML, Trugilho MRO, de Filippis AMB, de Sequeira PC, Marques ETA, Magalhaes T, D√≠az FJ, Restrepo BN, Mar√≠n K, Mattar S, Olson D, Asturias EJ, Lucera M, Singla M, Medigeshi GR, de Bosch N, Tam J, G√≥mez-M√°rquez J, Clavet C, Villar L, Hamad-Schifferli K, Gehrke L. Rapid antigen tests for dengue virus serotypes and Zika virus in patient serum. Sci Transl Med. 2017 Sep 27;9(409). pii: eaan1589. doi: 10.1126/scitranslmed.aan1589."", 'Arnaout R, Lee RA, Lee GR, Callahan C, Yen CF, Smith KP, Arora R, Kirby JE. SARS-CoV2 Testing: The Limit of Detection Matters. bioRxiv. 2020 Jun 4. pii: 2020.06.02.131144. doi: 10.1101/2020.06.02.131144.', 'Carpenter CR, Mudd PA, West CP, Wilber E, Wilber ST. Diagnosing COVID-19 in the Emergency Department: A Scoping Review of Clinical Examinations, Laboratory Tests, Imaging Accuracy, and Biases. Acad Emerg Med. 2020 Aug;27(8):653-670. doi: 10.1111/acem.14048. Epub 2020 Jul 26. Review.', 'Kucirka LM, Lauer SA, Laeyendecker O, Boon D, Lessler J. Variation in False-Negative Rate of Reverse Transcriptase Polymerase Chain Reaction-Based SARS-CoV-2 Tests by Time Since Exposure. Ann Intern Med. 2020 Aug 18;173(4):262-267. doi: 10.7326/M20-1495. Epub 2020 May 13. Review.', 'Wang X, Tan L, Wang X, Liu W, Lu Y, Cheng L, Sun Z. Comparison of nasopharyngeal and oropharyngeal swabs for SARS-CoV-2 detection in 353 patients received tests with both specimens simultaneously. Int J Infect Dis. 2020 May;94:107-109. doi: 10.1016/j.ijid.2020.04.023. Epub 2020 Apr 18.', 'Buitrago-Garcia D, Egli-Gany D, Counotte MJ, Hossmann S, Imeri H, Ipekci AM, Salanti G, Low N. Occurrence and transmission potential of asymptomatic and presymptomatic SARS-CoV-2 infections: A living systematic review and meta-analysis. PLoS Med. 2020 Sep 22;17(9):e1003346. doi: 10.1371/journal.pmed.1003346. eCollection 2020 Sep.', 'Pondaven-Letourmy S, Alvin F, Boumghit Y, Simon F. How to perform a nasopharyngeal swab in adults and children in the COVID-19 era. Eur Ann Otorhinolaryngol Head Neck Dis. 2020 Sep;137(4):325-327. doi: 10.1016/j.anorl.2020.06.001. Epub 2020 Jun 5.']",19/10/2020,https://clinicaltrials.gov/show/NCT04568356,12/06/2020,0,1
1003,NCT04568525,Completed,25/07/2020,01/08/2020,No Results Posted,"['Osmonov B, Ovchinnikov L, Galazis C, Emilov B, Karaibragimov M, Seitov M, Vesnin S, Losev A, Levshinskii V, Popov I, Mustafin C, Kasymbekov T, Goryanin I. Passive Microwave Radiometry for the Diagnosis of Coronavirus Disease 2019 Lung Complications in Kyrgyzstan. Diagnostics (Basel). 2021 Feb 7;11(2). pii: 259. doi: 10.3390/diagnostics11020259.']",,29/09/2020,https://clinicaltrials.gov/show/NCT04568525,25/07/2020,0,1
1004,NCT04568876,Recruiting,01/11/2021,01/11/2021,No Results Posted,,,28/10/2020,https://clinicaltrials.gov/show/NCT04568876,01/11/2021,0,0
1005,NCT04569188,Completed,15/08/2020,03/09/2020,No Results Posted,"['Franchini M, Glingani C, Morandi M, Corghi G, Cerzosimo S, Beduzzi G, Storti A, Di Stasi V, Rastrelli G, Vignozzi L, Mengoli C, Garuti M, Beccaria M, Inglese F, Caruso B, Petilino RA, Amato M, Nicchio M, Pagani M, Bellani A, Castelli G, Casari S, De Donno G. Safety and Efficacy of Convalescent Plasma in Elderly COVID-19 Patients: The RESCUE Trial. Mayo Clin Proc Innov Qual Outcomes. 2021 Apr;5(2):403-412. doi: 10.1016/j.mayocpiqo.2021.01.010. Epub 2021 Feb 8.']",,05/10/2020,https://clinicaltrials.gov/show/NCT04569188,15/08/2020,0,1
1006,NCT04569266,Recruiting,07/11/2021,07/05/2022,No Results Posted,,,29/09/2020,https://clinicaltrials.gov/show/NCT04569266,07/11/2021,0,0
1007,NCT04569383,Recruiting,01/05/2021,01/05/2021,No Results Posted,,,01/12/2020,https://clinicaltrials.gov/show/NCT04569383,01/05/2021,0,0
1008,NCT04569825,Recruiting,30/09/2020,15/10/2020,No Results Posted,"['Rashid RA, Zgair A, Al-Ani RM. Effect of nasal corticosteroid in the treatment of anosmia due to COVID-19: A randomised double-blind placebo-controlled study. Am J Otolaryngol. 2021 Apr 7;42(5):103033. doi: 10.1016/j.amjoto.2021.103033. [Epub ahead of print]']",,30/09/2020,https://clinicaltrials.gov/show/NCT04569825,30/09/2020,0,1
1009,NCT04570449,Withdrawn,01/11/2021,01/12/2021,No Results Posted,,,24/12/2020,https://clinicaltrials.gov/show/NCT04570449,01/11/2021,0,0
1010,NCT04570462,Withdrawn,31/12/2020,31/12/2020,No Results Posted,,,29/06/2021,https://clinicaltrials.gov/show/NCT04570462,31/12/2020,0,0
1011,NCT04572399,Completed,28/12/2020,28/12/2020,No Results Posted,"['Rezaie A, Melmed GY, Leite G, Mathur R, Takakura W, Pedraza I, Lewis M, Murthy R, Chaux G, Pimentel M. Endotracheal Application of Ultraviolet A Light in Critically Ill Patients with Severe Acute Respiratory Syndrome Coronavirus 2: A First-in-Human Study. Adv Ther. 2021 Jun 26. doi: 10.1007/s12325-021-01830-7. [Epub ahead of print]']",,30/12/2020,https://clinicaltrials.gov/show/NCT04572399,28/12/2020,0,1
1012,NCT04573153,Recruiting,31/01/2021,31/03/2021,No Results Posted,,,06/10/2020,https://clinicaltrials.gov/show/NCT04573153,31/01/2021,0,0
1013,NCT04573270,Completed,20/08/2020,01/09/2020,No Results Posted,,,05/10/2020,https://clinicaltrials.gov/show/NCT04573270,20/08/2020,0,0
1014,NCT04573322,Recruiting,14/11/2021,14/12/2021,No Results Posted,,,05/10/2020,https://clinicaltrials.gov/show/NCT04573322,14/11/2021,0,0
1015,NCT04573361,Completed,27/05/2020,27/05/2020,No Results Posted,,,05/10/2020,https://clinicaltrials.gov/show/NCT04573361,27/05/2020,0,0
1016,NCT04573855,Not yet recruiting,28/02/2021,31/03/2021,No Results Posted,,,05/10/2020,https://clinicaltrials.gov/show/NCT04573855,28/02/2021,0,0
1017,NCT04574050,Not yet recruiting,04/04/2022,30/06/2022,No Results Posted,,,05/10/2020,https://clinicaltrials.gov/show/NCT04574050,04/04/2022,0,0
1018,NCT04574869,Not yet recruiting,01/03/2021,01/07/2021,No Results Posted,,,05/10/2020,https://clinicaltrials.gov/show/NCT04574869,01/03/2021,0,0
1019,NCT04575558,Withdrawn,01/09/2020,30/10/2020,No Results Posted,,,05/10/2020,https://clinicaltrials.gov/show/NCT04575558,01/09/2020,0,0
1020,NCT04577235,Completed,05/08/2020,05/09/2020,No Results Posted,,,06/10/2020,https://clinicaltrials.gov/show/NCT04577235,05/08/2020,0,0
1021,NCT04577378,Not yet recruiting,20/11/2020,20/11/2020,No Results Posted,,,06/10/2020,https://clinicaltrials.gov/show/NCT04577378,20/11/2020,0,0
1022,NCT04578210,Recruiting,01/01/2021,01/03/2021,No Results Posted,['Del Pozo Mart√≠n Y. 47th Annual Meeting of the EBMT. Lancet Haematol. 2021 May;8(5):e317-e318. doi: 10.1016/S2352-3026(21)00104-6. Epub 2021 Mar 31.'],,19/10/2020,https://clinicaltrials.gov/show/NCT04578210,01/01/2021,0,1
1023,NCT04578236,Not yet recruiting,01/12/2020,01/01/2021,No Results Posted,,,26/10/2020,https://clinicaltrials.gov/show/NCT04578236,01/12/2020,0,0
1024,NCT04579549,Enrolling by invitation,01/09/2021,01/09/2021,No Results Posted,,,14/10/2020,https://clinicaltrials.gov/show/NCT04579549,01/09/2021,0,0
1025,NCT04581018,Recruiting,30/10/2021,30/04/2022,No Results Posted,,,14/10/2020,https://clinicaltrials.gov/show/NCT04581018,30/10/2021,0,0
1026,NCT04581161,Recruiting,01/10/2020,01/10/2020,No Results Posted,,,09/10/2020,https://clinicaltrials.gov/show/NCT04581161,01/10/2020,0,0
1027,NCT04581291,Completed,01/06/2020,01/10/2020,No Results Posted,,,09/10/2020,https://clinicaltrials.gov/show/NCT04581291,01/06/2020,0,0
1028,NCT04582214,Recruiting,01/01/2021,01/01/2021,No Results Posted,,,09/10/2020,https://clinicaltrials.gov/show/NCT04582214,01/01/2021,0,0
1029,NCT04582318,Recruiting,01/06/2021,01/09/2021,No Results Posted,,,23/11/2020,https://clinicaltrials.gov/show/NCT04582318,01/06/2021,0,0
1030,NCT04583228,Not yet recruiting,10/04/2021,31/05/2021,No Results Posted,,,14/10/2020,https://clinicaltrials.gov/show/NCT04583228,10/04/2021,0,0
1031,NCT04583449,Recruiting,01/12/2020,01/12/2020,No Results Posted,,,12/10/2020,https://clinicaltrials.gov/show/NCT04583449,01/12/2020,0,0
1032,NCT04584580,Recruiting,31/10/2020,31/12/2020,No Results Posted,,,14/10/2020,https://clinicaltrials.gov/show/NCT04584580,31/10/2020,0,0
1033,NCT04584593,Recruiting,01/02/2022,01/02/2022,No Results Posted,,,03/11/2020,https://clinicaltrials.gov/show/NCT04584593,01/02/2022,0,0
1034,NCT04586153,Not yet recruiting,28/04/2021,30/09/2021,No Results Posted,,,17/11/2020,https://clinicaltrials.gov/show/NCT04586153,28/04/2021,0,0
1035,NCT04587414,"Active, not recruiting",31/10/2020,31/10/2020,No Results Posted,,,14/10/2020,https://clinicaltrials.gov/show/NCT04587414,31/10/2020,0,0
1036,NCT04587921,Recruiting,22/01/2021,22/06/2021,No Results Posted,,,14/10/2020,https://clinicaltrials.gov/show/NCT04587921,22/01/2021,0,0
1037,NCT04589104,Completed,17/08/2020,17/08/2020,No Results Posted,,,19/10/2020,https://clinicaltrials.gov/show/NCT04589104,17/08/2020,0,0
1038,NCT04589117,Completed,02/08/2020,02/08/2020,No Results Posted,,,19/10/2020,https://clinicaltrials.gov/show/NCT04589117,02/08/2020,0,0
1039,NCT04589936,Recruiting,30/06/2021,30/06/2021,No Results Posted,,,19/10/2020,https://clinicaltrials.gov/show/NCT04589936,30/06/2021,0,0
1040,NCT04589949,Recruiting,01/11/2022,01/11/2023,No Results Posted,,,19/10/2020,https://clinicaltrials.gov/show/NCT04589949,01/11/2022,0,0
1041,NCT04590053,Recruiting,01/02/2021,01/03/2021,No Results Posted,,,22/10/2020,https://clinicaltrials.gov/show/NCT04590053,01/02/2021,0,0
1042,NCT04590209,Not yet recruiting,01/12/2020,01/12/2020,No Results Posted,,,19/10/2020,https://clinicaltrials.gov/show/NCT04590209,01/12/2020,0,0
1043,NCT04590261,Not yet recruiting,01/11/2022,01/11/2023,No Results Posted,,,19/10/2020,https://clinicaltrials.gov/show/NCT04590261,01/11/2022,0,0
1044,NCT04590274,Not yet recruiting,01/12/2021,01/12/2021,No Results Posted,,,19/10/2020,https://clinicaltrials.gov/show/NCT04590274,01/12/2021,0,0
1045,NCT04591158,Recruiting,01/09/2021,01/09/2021,No Results Posted,,,19/10/2020,https://clinicaltrials.gov/show/NCT04591158,01/09/2021,0,0
1046,NCT04591600,Completed,30/09/2020,14/10/2020,No Results Posted,,,19/10/2020,https://clinicaltrials.gov/show/NCT04591600,30/09/2020,0,0
1047,NCT04592354,Recruiting,15/04/2021,15/06/2021,No Results Posted,,,19/10/2020,https://clinicaltrials.gov/show/NCT04592354,15/04/2021,0,0
1048,NCT04592705,Recruiting,30/08/2021,30/08/2021,No Results Posted,,,19/10/2020,https://clinicaltrials.gov/show/NCT04592705,30/08/2021,0,0
1049,NCT04592835,Not yet recruiting,13/12/2020,30/06/2021,No Results Posted,,,19/10/2020,https://clinicaltrials.gov/show/NCT04592835,13/12/2020,0,0
1050,NCT04593069,Recruiting,28/02/2021,28/02/2021,No Results Posted,,,22/10/2020,https://clinicaltrials.gov/show/NCT04593069,28/02/2021,0,0
1051,NCT04593641,"Active, not recruiting",22/10/2020,23/12/2020,No Results Posted,,,20/10/2020,https://clinicaltrials.gov/show/NCT04593641,22/10/2020,0,0
1052,NCT04594330,Recruiting,31/12/2020,31/12/2020,No Results Posted,,,20/10/2020,https://clinicaltrials.gov/show/NCT04594330,31/12/2020,0,0
1053,NCT04594460,Not yet recruiting,31/10/2021,31/12/2021,No Results Posted,,,22/10/2020,https://clinicaltrials.gov/show/NCT04594460,31/10/2021,0,0
1054,NCT04594668,Recruiting,24/04/2021,31/12/2021,No Results Posted,,,20/10/2020,https://clinicaltrials.gov/show/NCT04594668,24/04/2021,0,0
1055,NCT04596085,Recruiting,30/11/2020,30/01/2021,No Results Posted,,,29/10/2020,https://clinicaltrials.gov/show/NCT04596085,30/11/2020,0,0
1056,NCT04596657,Recruiting,01/10/2021,01/11/2021,No Results Posted,,,20/11/2020,https://clinicaltrials.gov/show/NCT04596657,01/10/2021,0,0
1057,NCT04597034,Recruiting,30/12/2021,30/03/2022,No Results Posted,,"['Ronco C, Reis T. Kidney involvement in COVID-19 and rationale for extracorporeal therapies. Nat Rev Nephrol. 2020 Jun;16(6):308-310. doi: 10.1038/s41581-020-0284-7.', 'Ronco C, Reis T, De Rosa S. Coronavirus Epidemic and Extracorporeal Therapies in Intensive Care: si vis pacem para bellum. Blood Purif. 2020;49(3):255-258. doi: 10.1159/000507039. Epub 2020 Mar 13.', 'RENAL Replacement Therapy Study Investigators, Bellomo R, Cass A, Cole L, Finfer S, Gallagher M, Lo S, McArthur C, McGuinness S, Myburgh J, Norton R, Scheinkestel C, Su S. Intensity of continuous renal-replacement therapy in critically ill patients. N Engl J Med. 2009 Oct 22;361(17):1627-38. doi: 10.1056/NEJMoa0902413.', 'Morgera S, Haase M, Kuss T, Vargas-Hein O, Zuckermann-Becker H, Melzer C, Krieg H, Wegner B, Bellomo R, Neumayer HH. Pilot study on the effects of high cutoff hemofiltration on the need for norepinephrine in septic patients with acute renal failure. Crit Care Med. 2006 Aug;34(8):2099-104.']",22/10/2020,https://clinicaltrials.gov/show/NCT04597034,30/12/2021,0,1
1058,NCT04597047,Recruiting,31/10/2022,31/12/2022,No Results Posted,,,22/10/2020,https://clinicaltrials.gov/show/NCT04597047,31/10/2022,0,0
1059,NCT04597216,Recruiting,31/12/2020,31/12/2021,No Results Posted,,,22/10/2020,https://clinicaltrials.gov/show/NCT04597216,31/12/2020,0,0
1060,NCT04597736,Not yet recruiting,01/11/2021,01/02/2022,No Results Posted,,,22/10/2020,https://clinicaltrials.gov/show/NCT04597736,01/11/2021,0,0
1061,NCT04597775,Not yet recruiting,15/01/2021,31/01/2021,No Results Posted,,,22/10/2020,https://clinicaltrials.gov/show/NCT04597775,15/01/2021,0,0
1062,NCT04598763,Recruiting,01/07/2020,01/01/2021,No Results Posted,,,22/10/2020,https://clinicaltrials.gov/show/NCT04598763,01/07/2020,0,0
1063,NCT04600440,Recruiting,31/12/2021,28/02/2022,No Results Posted,,,23/10/2020,https://clinicaltrials.gov/show/NCT04600440,31/12/2021,0,0
1064,NCT04600999,Recruiting,01/06/2021,01/06/2021,No Results Posted,,,23/10/2020,https://clinicaltrials.gov/show/NCT04600999,01/06/2021,0,0
1065,NCT04602000,Recruiting,01/12/2020,01/09/2021,No Results Posted,,,26/10/2020,https://clinicaltrials.gov/show/NCT04602000,01/12/2020,0,0
1066,NCT04602442,Enrolling by invitation,01/08/2021,30/12/2021,No Results Posted,,,26/10/2020,https://clinicaltrials.gov/show/NCT04602442,01/08/2021,0,0
1067,NCT04602832,Enrolling by invitation,01/12/2020,01/12/2020,No Results Posted,,,04/11/2020,https://clinicaltrials.gov/show/NCT04602832,01/12/2020,0,0
1068,NCT04603729,Completed,30/06/2020,01/07/2020,No Results Posted,,,27/10/2020,https://clinicaltrials.gov/show/NCT04603729,30/06/2020,0,0
1069,NCT04603794,Recruiting,01/11/2020,01/11/2020,No Results Posted,,,27/10/2020,https://clinicaltrials.gov/show/NCT04603794,01/11/2020,0,0
1070,NCT04603963,Terminated,10/10/2020,23/10/2020,No Results Posted,,,28/10/2020,https://clinicaltrials.gov/show/NCT04603963,10/10/2020,0,0
1071,NCT04604327,Recruiting,31/05/2021,31/07/2021,No Results Posted,,,27/10/2020,https://clinicaltrials.gov/show/NCT04604327,31/05/2021,0,0
1072,NCT04604977,Recruiting,01/10/2021,01/12/2021,No Results Posted,,,27/10/2020,https://clinicaltrials.gov/show/NCT04604977,01/10/2021,0,0
1073,NCT04606069,Not yet recruiting,30/11/2021,31/01/2022,No Results Posted,,,28/10/2020,https://clinicaltrials.gov/show/NCT04606069,30/11/2021,0,0
1074,NCT04606563,Recruiting,30/06/2021,30/06/2021,No Results Posted,,,28/10/2020,https://clinicaltrials.gov/show/NCT04606563,30/06/2021,0,0
1075,NCT04607928,Recruiting,01/08/2021,01/08/2021,No Results Posted,,,05/11/2020,https://clinicaltrials.gov/show/NCT04607928,01/08/2021,0,0
1076,NCT04608214,Not yet recruiting,06/05/2021,04/08/2021,No Results Posted,,,29/10/2020,https://clinicaltrials.gov/show/NCT04608214,06/05/2021,0,0
1077,NCT04609371,Enrolling by invitation,01/03/2021,01/05/2021,No Results Posted,,,18/11/2020,https://clinicaltrials.gov/show/NCT04609371,01/03/2021,0,0
1078,NCT04609423,Recruiting,01/05/2021,01/05/2023,No Results Posted,,,12/11/2020,https://clinicaltrials.gov/show/NCT04609423,01/05/2021,0,0
1079,NCT04610489,Not yet recruiting,31/01/2021,31/01/2021,Results Submitted,,,30/10/2020,https://clinicaltrials.gov/show/NCT04610489,31/01/2021,0,0
1080,NCT04610541,"Active, not recruiting",30/10/2021,30/11/2021,No Results Posted,,"['Wang Y, Zhang D, Du G, Du R, Zhao J, Jin Y, Fu S, Gao L, Cheng Z, Lu Q, Hu Y, Luo G, Wang K, Lu Y, Li H, Wang S, Ruan S, Yang C, Mei C, Wang Y, Ding D, Wu F, Tang X, Ye X, Ye Y, Liu B, Yang J, Yin W, Wang A, Fan G, Zhou F, Liu Z, Gu X, Xu J, Shang L, Zhang Y, Cao L, Guo T, Wan Y, Qin H, Jiang Y, Jaki T, Hayden FG, Horby PW, Cao B, Wang C. Remdesivir in adults with severe COVID-19: a randomised, double-blind, placebo-controlled, multicentre trial. Lancet. 2020 May 16;395(10236):1569-1578. doi: 10.1016/S0140-6736(20)31022-9. Epub 2020 Apr 29. Erratum in: Lancet. 2020 May 30;395(10238):1694.', 'Holshue ML, DeBolt C, Lindquist S, Lofy KH, Wiesman J, Bruce H, Spitters C, Ericson K, Wilkerson S, Tural A, Diaz G, Cohn A, Fox L, Patel A, Gerber SI, Kim L, Tong S, Lu X, Lindstrom S, Pallansch MA, Weldon WC, Biggs HM, Uyeki TM, Pillai SK; Washington State 2019-nCoV Case Investigation Team. First Case of 2019 Novel Coronavirus in the United States. N Engl J Med. 2020 Mar 5;382(10):929-936. doi: 10.1056/NEJMoa2001191. Epub 2020 Jan 31.', 'Lescure FX, Bouadma L, Nguyen D, Parisey M, Wicky PH, Behillil S, Gaymard A, Bouscambert-Duchamp M, Donati F, Le Hingrat Q, Enouf V, Houhou-Fidouh N, Valette M, Mailles A, Lucet JC, Mentre F, Duval X, Descamps D, Malvy D, Timsit JF, Lina B, van-der-Werf S, Yazdanpanah Y. Clinical and virological data of the first cases of COVID-19 in Europe: a case series. Lancet Infect Dis. 2020 Jun;20(6):697-706. doi: 10.1016/S1473-3099(20)30200-0. Epub 2020 Mar 27. Erratum in: Lancet Infect Dis. 2020 May 19;:. Erratum in: Lancet Infect Dis. 2020 Jun;20(6):e116.', 'de Wit E, Feldmann F, Cronin J, Jordan R, Okumura A, Thomas T, Scott D, Cihlar T, Feldmann H. Prophylactic and therapeutic remdesivir (GS-5734) treatment in the rhesus macaque model of MERS-CoV infection. Proc Natl Acad Sci U S A. 2020 Mar 24;117(12):6771-6776. doi: 10.1073/pnas.1922083117. Epub 2020 Feb 13.', 'Sheahan TP, Sims AC, Graham RL, Menachery VD, Gralinski LE, Case JB, Leist SR, Pyrc K, Feng JY, Trantcheva I, Bannister R, Park Y, Babusis D, Clarke MO, Mackman RL, Spahn JE, Palmiotti CA, Siegel D, Ray AS, Cihlar T, Jordan R, Denison MR, Baric RS. Broad-spectrum antiviral GS-5734 inhibits both epidemic and zoonotic coronaviruses. Sci Transl Med. 2017 Jun 28;9(396). pii: eaal3653. doi: 10.1126/scitranslmed.aal3653.', 'Sheahan TP, Sims AC, Leist SR, Sch√§fer A, Won J, Brown AJ, Montgomery SA, Hogg A, Babusis D, Clarke MO, Spahn JE, Bauer L, Sellers S, Porter D, Feng JY, Cihlar T, Jordan R, Denison MR, Baric RS. Comparative therapeutic efficacy of remdesivir and combination lopinavir, ritonavir, and interferon beta against MERS-CoV. Nat Commun. 2020 Jan 10;11(1):222. doi: 10.1038/s41467-019-13940-6.']",27/11/2020,https://clinicaltrials.gov/show/NCT04610541,30/10/2021,0,1
1081,NCT04610801,Recruiting,08/08/2021,08/08/2021,No Results Posted,,,10/11/2020,https://clinicaltrials.gov/show/NCT04610801,08/08/2021,0,0
1082,NCT04611256,Recruiting,30/11/2020,30/12/2020,No Results Posted,,,12/11/2020,https://clinicaltrials.gov/show/NCT04611256,30/11/2020,0,0
1083,NCT04613297,Recruiting,01/10/2021,01/10/2021,No Results Posted,,,03/11/2020,https://clinicaltrials.gov/show/NCT04613297,01/10/2021,0,0
1084,NCT04613310,Recruiting,31/12/2020,31/12/2020,No Results Posted,,,12/11/2020,https://clinicaltrials.gov/show/NCT04613310,31/12/2020,0,0
1085,NCT04614012,Recruiting,02/07/2022,02/07/2022,No Results Posted,,,03/11/2020,https://clinicaltrials.gov/show/NCT04614012,02/07/2022,0,0
1086,NCT04614025,Recruiting,01/05/2021,01/03/2022,No Results Posted,,,03/11/2020,https://clinicaltrials.gov/show/NCT04614025,01/05/2021,0,0
1087,NCT04615416,Recruiting,01/01/2021,01/01/2023,No Results Posted,,"[""Mennin DS, Fresco DM, O'Toole MS, Heimberg RG. A randomized controlled trial of emotion regulation therapy for generalized anxiety disorder with and without co-occurring depression. J Consult Clin Psychol. 2018 Mar;86(3):268-281. doi: 10.1037/ccp0000289."", 'Renna ME, Quintero JM, Soffer A, Pino M, Ader L, Fresco DM, Mennin DS. A Pilot Study of Emotion Regulation Therapy for Generalized Anxiety and Depression: Findings From a Diverse Sample of Young Adults. Behav Ther. 2018 May;49(3):403-418. doi: 10.1016/j.beth.2017.09.001. Epub 2017 Sep 8.']",04/11/2020,https://clinicaltrials.gov/show/NCT04615416,01/01/2021,0,1
1088,NCT04615871,Not yet recruiting,31/12/2021,31/03/2022,No Results Posted,,,04/11/2020,https://clinicaltrials.gov/show/NCT04615871,31/12/2021,0,0
1089,NCT04615936,Recruiting,31/05/2021,31/05/2021,No Results Posted,,,04/11/2020,https://clinicaltrials.gov/show/NCT04615936,31/05/2021,0,0
1090,NCT04615975,Recruiting,30/07/2021,30/08/2021,No Results Posted,,,04/11/2020,https://clinicaltrials.gov/show/NCT04615975,30/07/2021,0,0
1091,NCT04616001,Not yet recruiting,30/06/2021,30/06/2021,No Results Posted,,,04/11/2020,https://clinicaltrials.gov/show/NCT04616001,30/06/2021,0,0
1092,NCT04616846,Recruiting,15/09/2021,15/09/2021,No Results Posted,,,05/11/2020,https://clinicaltrials.gov/show/NCT04616846,15/09/2021,0,0
1093,NCT04617119,Not yet recruiting,06/02/2021,06/04/2021,No Results Posted,,,05/11/2020,https://clinicaltrials.gov/show/NCT04617119,06/02/2021,0,0
1094,NCT04617483,Recruiting,28/11/2020,31/05/2021,No Results Posted,,,05/11/2020,https://clinicaltrials.gov/show/NCT04617483,28/11/2020,0,0
1095,NCT04619290,Recruiting,30/11/2020,30/12/2020,No Results Posted,,,12/11/2020,https://clinicaltrials.gov/show/NCT04619290,30/11/2020,0,0
1096,NCT04620798,"Active, not recruiting",01/12/2020,01/12/2020,No Results Posted,,,09/11/2020,https://clinicaltrials.gov/show/NCT04620798,01/12/2020,0,0
1097,NCT04621058,Recruiting,30/11/2021,30/11/2021,No Results Posted,,,23/12/2020,https://clinicaltrials.gov/show/NCT04621058,30/11/2021,0,0
1098,NCT04621149,Recruiting,31/03/2021,31/03/2021,No Results Posted,,,29/12/2020,https://clinicaltrials.gov/show/NCT04621149,31/03/2021,0,0
1099,NCT04621903,Completed,27/10/2020,03/11/2020,No Results Posted,,,19/11/2020,https://clinicaltrials.gov/show/NCT04621903,27/10/2020,0,0
1100,NCT04622826,Recruiting,31/12/2020,31/12/2020,No Results Posted,,,10/11/2020,https://clinicaltrials.gov/show/NCT04622826,31/12/2020,0,0
1101,NCT04622865,Recruiting,01/06/2021,01/06/2021,No Results Posted,,,10/11/2020,https://clinicaltrials.gov/show/NCT04622865,01/06/2021,0,0
1102,NCT04622891,Completed,30/07/2020,30/07/2020,No Results Posted,,,10/11/2020,https://clinicaltrials.gov/show/NCT04622891,30/07/2020,0,0
1103,NCT04623255,Recruiting,15/10/2021,01/11/2021,No Results Posted,,,10/11/2020,https://clinicaltrials.gov/show/NCT04623255,15/10/2021,0,0
1104,NCT04623385,Not yet recruiting,01/12/2020,01/12/2021,No Results Posted,,,10/11/2020,https://clinicaltrials.gov/show/NCT04623385,01/12/2020,0,0
1105,NCT04623619,Not yet recruiting,29/04/2021,31/07/2021,No Results Posted,,,17/11/2020,https://clinicaltrials.gov/show/NCT04623619,29/04/2021,0,0
1106,NCT04625114,Recruiting,01/10/2022,01/01/2023,No Results Posted,,,12/11/2020,https://clinicaltrials.gov/show/NCT04625114,01/10/2022,0,0
1107,NCT04625738,Not yet recruiting,16/05/2022,06/08/2022,No Results Posted,,,12/11/2020,https://clinicaltrials.gov/show/NCT04625738,16/05/2022,0,0
1108,NCT04627233,Not yet recruiting,01/03/2021,01/04/2021,No Results Posted,,,13/11/2020,https://clinicaltrials.gov/show/NCT04627233,01/03/2021,0,0
1109,NCT04628143,Not yet recruiting,30/05/2021,30/06/2021,No Results Posted,,,13/11/2020,https://clinicaltrials.gov/show/NCT04628143,30/05/2021,0,0
1110,NCT04629105,Recruiting,01/08/2021,01/07/2025,No Results Posted,,,16/11/2020,https://clinicaltrials.gov/show/NCT04629105,01/08/2021,0,0
1111,NCT04629157,Recruiting,19/11/2020,19/11/2020,No Results Posted,,,16/11/2020,https://clinicaltrials.gov/show/NCT04629157,19/11/2020,0,0
1112,NCT04629755,Completed,03/08/2020,03/08/2020,No Results Posted,,,19/11/2020,https://clinicaltrials.gov/show/NCT04629755,03/08/2020,0,0
1113,NCT04631367,Not yet recruiting,20/05/2021,20/09/2021,No Results Posted,,,17/11/2020,https://clinicaltrials.gov/show/NCT04631367,20/05/2021,0,0
1114,NCT04631380,Recruiting,01/01/2021,01/01/2021,No Results Posted,,,17/11/2020,https://clinicaltrials.gov/show/NCT04631380,01/01/2021,0,0
1115,NCT04632082,Enrolling by invitation,13/07/2021,20/07/2021,No Results Posted,,,20/11/2020,https://clinicaltrials.gov/show/NCT04632082,13/07/2021,0,0
1116,NCT04632602,Recruiting,31/12/2020,31/01/2021,No Results Posted,,,17/11/2020,https://clinicaltrials.gov/show/NCT04632602,31/12/2020,0,0
1117,NCT04632719,Recruiting,29/12/2020,29/12/2023,No Results Posted,,,17/11/2020,https://clinicaltrials.gov/show/NCT04632719,29/12/2020,0,0
1118,NCT04633772,Recruiting,01/02/2021,28/02/2021,No Results Posted,,,23/11/2020,https://clinicaltrials.gov/show/NCT04633772,01/02/2021,0,0
1119,NCT04633980,Not yet recruiting,30/08/2021,30/09/2021,No Results Posted,,,18/11/2020,https://clinicaltrials.gov/show/NCT04633980,30/08/2021,0,0
1120,NCT04634370,Not yet recruiting,30/03/2021,30/03/2021,No Results Posted,,,18/11/2020,https://clinicaltrials.gov/show/NCT04634370,30/03/2021,0,0
1121,NCT04634422,Recruiting,30/06/2021,30/06/2022,No Results Posted,,,21/12/2020,https://clinicaltrials.gov/show/NCT04634422,30/06/2021,0,0
1122,NCT04635241,Recruiting,01/04/2021,01/06/2021,No Results Posted,"['van Haren FMP, Richardson A, Yoon HJ, Artigas A, Laffey JG, Dixon B, Smith R, Vilaseca AB, Barbera RA, Ismail TI, Mahrous RS, Badr M, De Nucci G, Sverdloff C, van Loon LM, Camprubi-Rimblas M, Cosgrave DW, Smoot TL, Staas S, Sann K, Sas C, Belani A, Hillman C, Shute J, Carroll M, Wilkinson T, Carroll M, Singh D, Page C. INHALEd nebulised unfractionated HEParin for the treatment of hospitalised patients with COVID-19 (INHALE-HEP): Protocol and statistical analysis plan for an investigator-initiated international metatrial of randomised studies. Br J Clin Pharmacol. 2020 Dec 29. doi: 10.1111/bcp.14714. [Epub ahead of print]']",,16/12/2020,https://clinicaltrials.gov/show/NCT04635241,01/04/2021,0,1
1123,NCT04635618,Enrolling by invitation,13/07/2021,20/07/2021,No Results Posted,,,19/11/2020,https://clinicaltrials.gov/show/NCT04635618,13/07/2021,0,0
1124,NCT04636320,Recruiting,13/01/2021,13/04/2021,No Results Posted,,,19/11/2020,https://clinicaltrials.gov/show/NCT04636320,13/01/2021,0,0
1125,NCT04637828,Recruiting,30/07/2021,30/10/2021,No Results Posted,,,20/11/2020,https://clinicaltrials.gov/show/NCT04637828,30/07/2021,0,0
1126,NCT04639349,Recruiting,01/03/2021,01/03/2021,No Results Posted,,,20/11/2020,https://clinicaltrials.gov/show/NCT04639349,01/03/2021,0,0
1127,NCT04642014,Not yet recruiting,21/02/2022,01/05/2022,No Results Posted,,,24/11/2020,https://clinicaltrials.gov/show/NCT04642014,21/02/2022,0,0
1128,NCT04642040,Recruiting,01/01/2021,01/01/2021,No Results Posted,,,24/11/2020,https://clinicaltrials.gov/show/NCT04642040,01/01/2021,0,0
1129,NCT04642326,"Active, not recruiting",01/07/2020,04/05/2021,No Results Posted,,"['Yin R, Dai T, Avci P, Jorge AE, de Melo WC, Vecchio D, Huang YY, Gupta A, Hamblin MR. Light based anti-infectives: ultraviolet C irradiation, photodynamic therapy, blue light, and beyond. Curr Opin Pharmacol. 2013 Oct;13(5):731-62. doi: 10.1016/j.coph.2013.08.009. Epub 2013 Sep 20. Review.', 'Mohr H, Steil L, Gravemann U, Thiele T, Hammer E, Greinacher A, M√ºller TH, V√∂lker U. A novel approach to pathogen reduction in platelet concentrates using short-wave ultraviolet light. Transfusion. 2009 Dec;49(12):2612-24. doi: 10.1111/j.1537-2995.2009.02334.x. Epub 2009 Aug 4.', 'Galasso M, Feld JJ, Watanabe Y, Pipkin M, Summers C, Ali A, Qaqish R, Chen M, Ribeiro RVP, Ramadan K, Pires L, Bagnato VS, Kurachi C, Cherepanov V, Moonen G, Gazzalle A, Waddell TK, Liu M, Keshavjee S, Wilson BC, Humar A, Cypel M. Inactivating hepatitis C virus in donor lungs using light therapies during normothermic ex vivo lung perfusion. Nat Commun. 2019 Jan 29;10(1):481. doi: 10.1038/s41467-018-08261-z.', 'Eickmann M, Gravemann U, Handke W, Tolksdorf F, Reichenberg S, M√ºller TH, Seltsam A. Inactivation of three emerging viruses - severe acute respiratory syndrome coronavirus, Crimean-Congo haemorrhagic fever virus and Nipah virus - in platelet concentrates by ultraviolet C light and in plasma by methylene blue plus visible light. Vox Sang. 2020 Apr;115(3):146-151. doi: 10.1111/vox.12888. Epub 2020 Jan 12.', ""Dai T, Kharkwal GB, Zhao J, St Denis TG, Wu Q, Xia Y, Huang L, Sharma SK, d'Enfert C, Hamblin MR. Ultraviolet-C light for treatment of Candida albicans burn infection in mice. Photochem Photobiol. 2011 Mar-Apr;87(2):342-9. doi: 10.1111/j.1751-1097.2011.00886.x. Epub 2011 Feb 10."", 'Cypel M, Feld JJ, Galasso M, Pinto Ribeiro RV, Marks N, Kuczynski M, Kumar D, Bahinskaya I, Bagnato VS, Kurachi C, Slutsky AS, Yeung JC, Donahoe L, de Perrot M, Yasufuku K, Pierre A, Binnie M, Chaparro C, Martinu T, Chen M, Tikkanen J, Chow CW, Sidhu A, Waddell TK, Keshavjee S, Singer LG, Humar A. Prevention of viral transmission during lung transplantation with hepatitis C-viraemic donors: an open-label, single-centre, pilot trial. Lancet Respir Med. 2020 Feb;8(2):192-201. doi: 10.1016/S2213-2600(19)30268-1. Epub 2019 Oct 9.', 'Bak J, J√∏rgensen TM, Helfmann J, Gravemann U, Vorontsova I. Potential in vivo UVC disinfection of catheter lumens: estimation of the doses received by the blood flow outside the catheter tip hole. Photochem Photobiol. 2011 Mar-Apr;87(2):350-6. doi: 10.1111/j.1751-1097.2011.00887.x. Epub 2011 Jan 31.', 'Ultroviolet,C lrrodiation for Prevention of Centrol Venous Cotheter-reloted ¬∑ lnfections: An in Vitro Study,Tianhong Dai 1,2, George P. Tegos 1,2¬ß, Tyler G. St. Denis l ,3, Don Anderson4,. Ed SinofskyS ond Michael R. Homblin* l ,2,6, Received 11 Moy 201 O, accepted 8 September 201 o; DOi: l 0.1111/ j.1751-1097.2010.00819 .x', 'Pathogen inactivation method using ultraviolet C light. Journal of Transfusion Medicine, 12(3), 83-87.']",24/11/2020,https://clinicaltrials.gov/show/NCT04642326,01/07/2020,0,1
1130,NCT04642339,Not yet recruiting,01/10/2021,01/12/2021,No Results Posted,,,24/11/2020,https://clinicaltrials.gov/show/NCT04642339,01/10/2021,0,0
1131,NCT04643054,Not yet recruiting,28/02/2021,30/03/2021,No Results Posted,,,24/11/2020,https://clinicaltrials.gov/show/NCT04643054,28/02/2021,0,0
1132,NCT04643561,"Active, not recruiting",31/12/2020,31/12/2020,No Results Posted,,,27/11/2020,https://clinicaltrials.gov/show/NCT04643561,31/12/2020,0,0
1133,NCT04643691,Recruiting,30/09/2022,30/10/2022,No Results Posted,,,25/11/2020,https://clinicaltrials.gov/show/NCT04643691,30/09/2022,0,0
1134,NCT04643964,Recruiting,01/11/2020,01/11/2020,No Results Posted,,,25/11/2020,https://clinicaltrials.gov/show/NCT04643964,01/11/2020,0,0
1135,NCT04644172,Recruiting,01/11/2023,01/11/2024,No Results Posted,,,25/11/2020,https://clinicaltrials.gov/show/NCT04644172,01/11/2023,0,0
1136,NCT04644705,Recruiting,31/05/2021,31/05/2021,No Results Posted,,,25/11/2020,https://clinicaltrials.gov/show/NCT04644705,31/05/2021,0,0
1137,NCT04645407,Completed,15/04/2020,15/04/2020,No Results Posted,,,27/11/2020,https://clinicaltrials.gov/show/NCT04645407,15/04/2020,0,0
1138,NCT04646655,Recruiting,31/05/2021,31/07/2021,No Results Posted,,,30/11/2020,https://clinicaltrials.gov/show/NCT04646655,31/05/2021,0,0
1139,NCT04647604,Recruiting,30/04/2021,30/04/2021,No Results Posted,"['Arnardottir H, Pawelzik SC, √ñhlund Wistbacka U, Artiach G, Hofmann R, Reinholdsson I, Braunschweig F, Tornvall P, Religa D, B√§ck M. Stimulating the Resolution of Inflammation Through Omega-3 Polyunsaturated Fatty Acids in COVID-19: Rationale for the COVID-Omega-F Trial. Front Physiol. 2021 Jan 11;11:624657. doi: 10.3389/fphys.2020.624657. eCollection 2020. Review.']",,01/12/2020,https://clinicaltrials.gov/show/NCT04647604,30/04/2021,0,1
1140,NCT04647656,Not yet recruiting,01/01/2022,01/01/2023,No Results Posted,,,01/12/2020,https://clinicaltrials.gov/show/NCT04647656,01/01/2022,0,0
1141,NCT04647734,Not yet recruiting,31/12/2021,31/12/2021,No Results Posted,,,01/12/2020,https://clinicaltrials.gov/show/NCT04647734,31/12/2021,0,0
1142,NCT04280705,Completed,21/05/2020,21/05/2020,Study Results,"['Sultana J, Crisafulli S, Gabbay F, Lynn E, Shakir S, Trifir√≤ G. Challenges for Drug Repurposing in the COVID-19 Pandemic Era. Front Pharmacol. 2020 Nov 6;11:588654. doi: 10.3389/fphar.2020.588654. eCollection 2020. Review.', 'Maleszewski JJ, Young PM, Ackerman MJ, Halushka MK. Urgent Need for Studies of the Late Effects of SARS-CoV-2 on the Cardiovascular System. Circulation. 2021 Mar 30;143(13):1271-1273. doi: 10.1161/CIRCULATIONAHA.120.051362. Epub 2020 Sep 24.', 'Beigel JH, Tomashek KM, Dodd LE, Mehta AK, Zingman BS, Kalil AC, Hohmann E, Chu HY, Luetkemeyer A, Kline S, Lopez de Castilla D, Finberg RW, Dierberg K, Tapson V, Hsieh L, Patterson TF, Paredes R, Sweeney DA, Short WR, Touloumi G, Lye DC, Ohmagari N, Oh MD, Ruiz-Palacios GM, Benfield T, F√§tkenheuer G, Kortepeter MG, Atmar RL, Creech CB, Lundgren J, Babiker AG, Pett S, Neaton JD, Burgess TH, Bonnett T, Green M, Makowski M, Osinusi A, Nayak S, Lane HC; ACTT-1 Study Group Members. Remdesivir for the Treatment of Covid-19 - Final Report. N Engl J Med. 2020 Nov 5;383(19):1813-1826. doi: 10.1056/NEJMoa2007764. Epub 2020 Oct 8.']",,09/12/2020,https://clinicaltrials.gov/show/NCT04280705,21/05/2020,1,1
1143,NCT04304690,"Active, not recruiting",16/05/2021,16/10/2021,No Results Posted,,,01/12/2020,https://clinicaltrials.gov/show/NCT04304690,16/05/2021,0,0
1144,NCT04324021,Terminated,13/11/2020,13/11/2020,No Results Posted,,,14/12/2020,https://clinicaltrials.gov/show/NCT04324021,13/11/2020,0,0
1145,NCT04329923,Terminated,11/11/2020,13/11/2020,Study Results,,"['Abella BS, Jolkovsky EL, Biney BT, Uspal JE, Hyman MC, Frank I, Hensley SE, Gill S, Vogl DT, Maillard I, Babushok DV, Huang AC, Nasta SD, Walsh JC, Wiletyo EP, Gimotty PA, Milone MC, Amaravadi RK; Prevention and Treatment of COVID-19 With Hydroxychloroquine (PATCH) Investigators. Efficacy and Safety of Hydroxychloroquine vs Placebo for Pre-exposure SARS-CoV-2 Prophylaxis Among Health Care Workers: A Randomized Clinical Trial. JAMA Intern Med. 2021 Feb 1;181(2):195-202. doi: 10.1001/jamainternmed.2020.6319.']",10/12/2020,https://clinicaltrials.gov/show/NCT04329923,11/11/2020,1,1
1146,NCT04333914,Recruiting,01/06/2021,01/08/2021,No Results Posted,,,04/12/2020,https://clinicaltrials.gov/show/NCT04333914,01/06/2021,0,0
1147,NCT04339426,Recruiting,01/07/2021,01/12/2021,No Results Posted,,,02/12/2020,https://clinicaltrials.gov/show/NCT04339426,01/07/2021,0,0
1148,NCT04341441,Terminated,15/12/2020,15/12/2020,No Results Posted,,,21/12/2020,https://clinicaltrials.gov/show/NCT04341441,15/12/2020,0,0
1149,NCT04353336,Recruiting,23/09/2030,23/12/2030,No Results Posted,,,03/12/2020,https://clinicaltrials.gov/show/NCT04353336,23/09/2030,0,0
1150,NCT04355676,Withdrawn,30/08/2020,30/08/2020,No Results Posted,,,07/12/2020,https://clinicaltrials.gov/show/NCT04355676,30/08/2020,0,0
1151,NCT04359797,"Active, not recruiting",17/12/2020,01/06/2021,No Results Posted,,,31/12/2020,https://clinicaltrials.gov/show/NCT04359797,17/12/2020,0,0
1152,NCT04363593,Completed,16/11/2020,16/11/2020,No Results Posted,,,10/12/2020,https://clinicaltrials.gov/show/NCT04363593,16/11/2020,0,0
1153,NCT04368000,Terminated,06/08/2020,06/08/2020,No Results Posted,,,03/12/2020,https://clinicaltrials.gov/show/NCT04368000,06/08/2020,0,0
1154,NCT04370262,Completed,07/09/2020,07/09/2020,No Results Posted,,,11/12/2020,https://clinicaltrials.gov/show/NCT04370262,07/09/2020,0,0
1155,NCT04370782,Completed,30/09/2020,30/09/2020,No Results Posted,,,09/12/2020,https://clinicaltrials.gov/show/NCT04370782,30/09/2020,0,0
1156,NCT04371640,Withdrawn,01/07/2021,01/08/2021,No Results Posted,,,07/12/2020,https://clinicaltrials.gov/show/NCT04371640,01/07/2021,0,0
1157,NCT04380688,Completed,16/11/2020,16/11/2020,No Results Posted,,,02/12/2020,https://clinicaltrials.gov/show/NCT04380688,16/11/2020,0,0
1158,NCT04382846,Recruiting,01/12/2030,01/12/2030,No Results Posted,,,04/12/2020,https://clinicaltrials.gov/show/NCT04382846,01/12/2030,0,0
1159,NCT04382924,"Active, not recruiting",01/01/2022,01/02/2022,No Results Posted,,,10/12/2020,https://clinicaltrials.gov/show/NCT04382924,01/01/2022,0,0
1160,NCT04401293,Completed,14/05/2021,14/05/2021,No Results Posted,"['Short SAP, Gupta S, Brenner SK, Hayek SS, Srivastava A, Shaefi S, Singh H, Wu B, Bagchi A, Al-Samkari H, Dy R, Wilkinson K, Zakai NA, Leaf DE; STOP-COVID Investigators. d-dimer and Death in Critically Ill Patients With Coronavirus Disease 2019. Crit Care Med. 2021 May 1;49(5):e500-e511. doi: 10.1097/CCM.0000000000004917.', 'Flumignan RL, Tin√¥co JDS, Pascoal PI, Areias LL, Cossi MS, Fernandes MI, Costa IK, Souza L, Matar CF, Tendal B, Trevisani VF, Atallah √ÅN, Nakano LC. Prophylactic anticoagulants for people hospitalised with COVID-19. Cochrane Database Syst Rev. 2020 Oct 2;10:CD013739. doi: 10.1002/14651858.CD013739.']",,29/06/2021,https://clinicaltrials.gov/show/NCT04401293,14/05/2021,0,1
1161,NCT04402983,Completed,01/12/2020,01/12/2020,No Results Posted,,,14/12/2020,https://clinicaltrials.gov/show/NCT04402983,01/12/2020,0,0
1162,NCT04405843,Completed,21/12/2020,21/12/2020,No Results Posted,"['L√≥pez-Medina E, L√≥pez P, Hurtado IC, D√°valos DM, Ramirez O, Mart√≠nez E, D√≠azgranados JA, O√±ate JM, Chavarriaga H, Herrera S, Parra B, Libreros G, Jaramillo R, Avenda√±o AC, Toro DF, Torres M, Lesmes MC, Rios CA, Caicedo I. Effect of Ivermectin on Time to Resolution of Symptoms Among Adults With Mild COVID-19: A Randomized Clinical Trial. JAMA. 2021 Apr 13;325(14):1426-1435. doi: 10.1001/jama.2021.3071.']",,28/12/2020,https://clinicaltrials.gov/show/NCT04405843,21/12/2020,0,1
1163,NCT04407286,Completed,30/08/2020,30/11/2020,No Results Posted,,,02/12/2020,https://clinicaltrials.gov/show/NCT04407286,30/08/2020,0,0
1164,NCT04410354,Terminated,01/12/2020,01/12/2020,No Results Posted,,,08/12/2020,https://clinicaltrials.gov/show/NCT04410354,01/12/2020,0,0
1165,NCT04431856,Completed,17/11/2020,17/11/2020,No Results Posted,,,01/12/2020,https://clinicaltrials.gov/show/NCT04431856,17/11/2020,0,0
1166,NCT04433546,Terminated,02/12/2020,02/12/2020,No Results Posted,,,11/12/2020,https://clinicaltrials.gov/show/NCT04433546,02/12/2020,0,0
1167,NCT04445194,"Active, not recruiting",22/10/2020,20/09/2021,No Results Posted,"['Yang S, Li Y, Dai L, Wang J, He P, Li C, Fang X, Wang C, Zhao X, Huang E, Wu C, Zhong Z, Wang F, Duan X, Tian S, Wu L, Liu Y, Luo Y, Chen Z, Li F, Li J, Yu X, Ren H, Liu L, Meng S, Yan J, Hu Z, Gao L, Gao GF. Safety and immunogenicity of a recombinant tandem-repeat dimeric RBD-based protein subunit vaccine (ZF2001) against COVID-19 in adults: two randomised, double-blind, placebo-controlled, phase 1 and 2 trials. Lancet Infect Dis. 2021 Mar 24. pii: S1473-3099(21)00127-4. doi: 10.1016/S1473-3099(21)00127-4. [Epub ahead of print]']",,03/12/2020,https://clinicaltrials.gov/show/NCT04445194,22/10/2020,0,1
1168,NCT04447534,Recruiting,01/10/2030,01/10/2030,No Results Posted,"['Abd-Elsalam S, Soliman S, Esmail ES, Khalaf M, Mostafa EF, Medhat MA, Ahmed OA, El Ghafar MSA, Alboraie M, Hassany SM. Do Zinc Supplements Enhance the Clinical Efficacy of Hydroxychloroquine?: a Randomized, Multicenter Trial. Biol Trace Elem Res. 2020 Nov 27. doi: 10.1007/s12011-020-02512-1. [Epub ahead of print]']",,03/12/2020,https://clinicaltrials.gov/show/NCT04447534,01/10/2030,0,1
1169,NCT04453384,Recruiting,01/12/2020,01/12/2021,No Results Posted,"['Gaborit B, Dailly E, Vanhove B, Josien R, Lacombe K, Dubee V, Ferre V, Brouard S, Ader F, Vibet MA, Le Thuaut A, Danger R, Flet L, Omnes A, Berly L, Chiffoleau A, Jobert A, Duvaux O, Raffi F. Pharmacokinetics and safety of XAV-19, a swine glyco-humanized polyclonal anti-SARS-CoV-2 antibody, for COVID-19-related moderate pneumonia: a randomized, double-blind, placebo-controlled, phase IIa study. Antimicrob Agents Chemother. 2021 Jun 28:AAC0123721. doi: 10.1128/AAC.01237-21. [Epub ahead of print]', 'Gaborit B, Vanhove B, Vibet MA, Le Thuaut A, Lacombe K, Dubee V, Ader F, Ferre V, Vicaut E, Orain J, Le Bras M, Omnes A, Berly L, Jobert A, Morineau-Le Houssine P, Botturi K, Josien R, Flet L, Degauque N, Brouard S, Duvaux O, Poinas A, Raffi F; POLYCOR study group. Evaluation of the safety and efficacy of XAV-19 in patients with COVID-19-induced moderate pneumonia: study protocol for a randomized, double-blinded, placebo-controlled phase 2 (2a and 2b) trial. Trials. 2021 Mar 9;22(1):199. doi: 10.1186/s13063-021-05132-9.']",,07/12/2020,https://clinicaltrials.gov/show/NCT04453384,01/12/2020,0,1
1170,NCT04460443,Recruiting,01/08/2021,31/08/2021,No Results Posted,,,08/12/2020,https://clinicaltrials.gov/show/NCT04460443,01/08/2021,0,0
1171,NCT04466085,"Active, not recruiting",22/10/2020,15/12/2021,No Results Posted,"['Yang S, Li Y, Dai L, Wang J, He P, Li C, Fang X, Wang C, Zhao X, Huang E, Wu C, Zhong Z, Wang F, Duan X, Tian S, Wu L, Liu Y, Luo Y, Chen Z, Li F, Li J, Yu X, Ren H, Liu L, Meng S, Yan J, Hu Z, Gao L, Gao GF. Safety and immunogenicity of a recombinant tandem-repeat dimeric RBD-based protein subunit vaccine (ZF2001) against COVID-19 in adults: two randomised, double-blind, placebo-controlled, phase 1 and 2 trials. Lancet Infect Dis. 2021 Mar 24. pii: S1473-3099(21)00127-4. doi: 10.1016/S1473-3099(21)00127-4. [Epub ahead of print]']",,03/12/2020,https://clinicaltrials.gov/show/NCT04466085,22/10/2020,0,1
1172,NCT04476745,Enrolling by invitation,15/12/2020,20/02/2021,No Results Posted,,,08/12/2020,https://clinicaltrials.gov/show/NCT04476745,15/12/2020,0,0
1173,NCT04483271,Enrolling by invitation,15/12/2020,10/02/2021,No Results Posted,,,08/12/2020,https://clinicaltrials.gov/show/NCT04483271,15/12/2020,0,0
1174,NCT04497649,Recruiting,01/04/2021,10/04/2021,No Results Posted,,,03/12/2020,https://clinicaltrials.gov/show/NCT04497649,01/04/2021,0,0
1175,NCT04497948,Terminated,18/11/2020,18/11/2020,No Results Posted,,,02/12/2020,https://clinicaltrials.gov/show/NCT04497948,18/11/2020,0,0
1176,NCT04519437,"Active, not recruiting",25/10/2021,25/10/2021,No Results Posted,,,02/12/2020,https://clinicaltrials.gov/show/NCT04519437,25/10/2021,0,0
1177,NCT04524715,Not yet recruiting,31/03/2022,31/03/2022,No Results Posted,,,04/12/2020,https://clinicaltrials.gov/show/NCT04524715,31/03/2022,0,0
1178,NCT04527081,"Active, not recruiting",09/11/2020,30/09/2021,No Results Posted,,,07/12/2020,https://clinicaltrials.gov/show/NCT04527081,09/11/2020,0,0
1179,NCT04530136,Recruiting,15/08/2021,30/11/2021,No Results Posted,,,10/12/2020,https://clinicaltrials.gov/show/NCT04530136,15/08/2021,0,0
1180,NCT04537975,Withdrawn,15/11/2020,15/01/2021,No Results Posted,,,14/12/2020,https://clinicaltrials.gov/show/NCT04537975,15/11/2020,0,0
1181,NCT04552366,"Active, not recruiting",31/12/2020,30/06/2021,No Results Posted,,,07/12/2020,https://clinicaltrials.gov/show/NCT04552366,31/12/2020,0,0
1182,NCT04552379,Recruiting,01/04/2021,01/12/2021,No Results Posted,,,02/12/2020,https://clinicaltrials.gov/show/NCT04552379,01/04/2021,0,0
1183,NCT04558372,Completed,12/12/2020,12/12/2020,No Results Posted,,,29/12/2020,https://clinicaltrials.gov/show/NCT04558372,12/12/2020,0,0
1184,NCT04559113,Recruiting,30/12/2020,30/12/2020,No Results Posted,,,08/12/2020,https://clinicaltrials.gov/show/NCT04559113,30/12/2020,0,0
1185,NCT04560205,Recruiting,30/12/2020,30/12/2020,No Results Posted,,,08/12/2020,https://clinicaltrials.gov/show/NCT04560205,30/12/2020,0,0
1186,NCT04560257,Recruiting,30/12/2020,30/12/2020,No Results Posted,,,08/12/2020,https://clinicaltrials.gov/show/NCT04560257,30/12/2020,0,0
1187,NCT04564716,"Active, not recruiting",28/03/2021,10/04/2021,No Results Posted,,,02/12/2020,https://clinicaltrials.gov/show/NCT04564716,28/03/2021,0,0
1188,NCT04565197,"Active, not recruiting",30/12/2020,30/12/2020,No Results Posted,,,08/12/2020,https://clinicaltrials.gov/show/NCT04565197,30/12/2020,0,0
1189,NCT04583189,Completed,25/11/2020,25/11/2020,No Results Posted,,,02/12/2020,https://clinicaltrials.gov/show/NCT04583189,25/11/2020,0,0
1190,NCT04601077,Recruiting,01/06/2021,31/07/2021,No Results Posted,,,09/12/2020,https://clinicaltrials.gov/show/NCT04601077,01/06/2021,0,0
1191,NCT04602507,Recruiting,01/03/2021,01/03/2021,No Results Posted,,,10/12/2020,https://clinicaltrials.gov/show/NCT04602507,01/03/2021,0,0
1192,NCT04603690,Withdrawn,14/05/2021,14/06/2021,No Results Posted,,,10/12/2020,https://clinicaltrials.gov/show/NCT04603690,14/05/2021,0,0
1193,NCT04606407,Recruiting,07/09/2021,07/09/2021,No Results Posted,,,03/12/2020,https://clinicaltrials.gov/show/NCT04606407,07/09/2021,0,0
1194,NCT04608201,Recruiting,01/12/2021,01/12/2021,No Results Posted,,,14/12/2020,https://clinicaltrials.gov/show/NCT04608201,01/12/2021,0,0
1195,NCT04609969,Completed,17/10/2020,17/10/2020,No Results Posted,,,07/12/2020,https://clinicaltrials.gov/show/NCT04609969,17/10/2020,0,0
1196,NCT04634318,Recruiting,01/12/2021,01/12/2022,No Results Posted,,,14/12/2020,https://clinicaltrials.gov/show/NCT04634318,01/12/2021,0,0
1197,NCT04638673,Recruiting,01/06/2021,01/06/2021,No Results Posted,,,07/12/2020,https://clinicaltrials.gov/show/NCT04638673,01/06/2021,0,0
1198,NCT04641858,Recruiting,01/02/2022,01/03/2022,No Results Posted,,,04/12/2020,https://clinicaltrials.gov/show/NCT04641858,01/02/2022,0,0
1199,NCT04646616,Recruiting,31/10/2021,31/10/2021,No Results Posted,,,30/06/2021,https://clinicaltrials.gov/show/NCT04646616,31/10/2021,0,0
1200,NCT04647695,Recruiting,31/07/2021,30/09/2021,No Results Posted,,"['Beigel JH, Tomashek KM, Dodd LE, Mehta AK, Zingman BS, Kalil AC, Hohmann E, Chu HY, Luetkemeyer A, Kline S, Lopez de Castilla D, Finberg RW, Dierberg K, Tapson V, Hsieh L, Patterson TF, Paredes R, Sweeney DA, Short WR, Touloumi G, Lye DC, Ohmagari N, Oh MD, Ruiz-Palacios GM, Benfield T, F√§tkenheuer G, Kortepeter MG, Atmar RL, Creech CB, Lundgren J, Babiker AG, Pett S, Neaton JD, Burgess TH, Bonnett T, Green M, Makowski M, Osinusi A, Nayak S, Lane HC; ACTT-1 Study Group Members. Remdesivir for the Treatment of Covid-19 - Final Report. N Engl J Med. 2020 Nov 5;383(19):1813-1826. doi: 10.1056/NEJMoa2007764. Epub 2020 Oct 8.', 'Hung IF, Lung KC, Tso EY, Liu R, Chung TW, Chu MY, Ng YY, Lo J, Chan J, Tam AR, Shum HP, Chan V, Wu AK, Sin KM, Leung WS, Law WL, Lung DC, Sin S, Yeung P, Yip CC, Zhang RR, Fung AY, Yan EY, Leung KH, Ip JD, Chu AW, Chan WM, Ng AC, Lee R, Fung K, Yeung A, Wu TC, Chan JW, Yan WW, Chan WM, Chan JF, Lie AK, Tsang OT, Cheng VC, Que TL, Lau CS, Chan KH, To KK, Yuen KY. Triple combination of interferon beta-1b, lopinavir-ritonavir, and ribavirin in the treatment of patients admitted to hospital with COVID-19: an open-label, randomised, phase 2 trial. Lancet. 2020 May 30;395(10238):1695-1704. doi: 10.1016/S0140-6736(20)31042-4. Epub 2020 May 10.']",10/12/2020,https://clinicaltrials.gov/show/NCT04647695,31/07/2021,0,1
1201,NCT04648800,Recruiting,01/12/2020,01/04/2021,No Results Posted,,,02/12/2020,https://clinicaltrials.gov/show/NCT04648800,01/12/2020,0,0
1202,NCT04649515,Recruiting,31/08/2021,30/12/2021,No Results Posted,,,14/12/2020,https://clinicaltrials.gov/show/NCT04649515,31/08/2021,0,0
1203,NCT04649879,Not yet recruiting,01/02/2022,01/02/2022,No Results Posted,,,02/12/2020,https://clinicaltrials.gov/show/NCT04649879,01/02/2022,0,0
1204,NCT04651374,Not yet recruiting,01/03/2021,01/04/2021,No Results Posted,,,24/12/2020,https://clinicaltrials.gov/show/NCT04651374,01/03/2021,0,0
1205,NCT04652115,Not yet recruiting,01/11/2022,01/11/2023,No Results Posted,,,03/12/2020,https://clinicaltrials.gov/show/NCT04652115,01/11/2022,0,0
1206,NCT04652648,Completed,31/10/2020,15/11/2020,No Results Posted,"['Liu HH, Ezekowitz MD, Columbo M, Khan O, Martin J, Spahr J, Yaron D, Cushinotto L, Kapelusznik L. Testing the feasibility of operationalizing a prospective, randomized trial with remote cardiac safety EKG monitoring during a pandemic. J Interv Card Electrophysiol. 2021 May 26. doi: 10.1007/s10840-021-00989-x. [Epub ahead of print]']",,03/12/2020,https://clinicaltrials.gov/show/NCT04652648,31/10/2020,0,1
1207,NCT04653831,Recruiting,01/11/2021,01/12/2021,No Results Posted,,,04/12/2020,https://clinicaltrials.gov/show/NCT04653831,01/11/2021,0,0
1208,NCT04654325,Not yet recruiting,01/12/2021,01/12/2021,No Results Posted,,,04/12/2020,https://clinicaltrials.gov/show/NCT04654325,01/12/2021,0,0
1209,NCT04654481,Recruiting,01/02/2021,01/11/2021,No Results Posted,,,04/12/2020,https://clinicaltrials.gov/show/NCT04654481,01/02/2021,0,0
1210,NCT04655716,Not yet recruiting,31/01/2022,30/03/2022,No Results Posted,,,07/12/2020,https://clinicaltrials.gov/show/NCT04655716,31/01/2022,0,0
1211,NCT04656613,Not yet recruiting,01/08/2021,01/12/2021,No Results Posted,,,07/12/2020,https://clinicaltrials.gov/show/NCT04656613,01/08/2021,0,0
1212,NCT04656626,Completed,21/07/2020,05/09/2020,No Results Posted,,,10/12/2020,https://clinicaltrials.gov/show/NCT04656626,21/07/2020,0,0
1213,NCT04658433,Recruiting,15/02/2021,30/03/2021,No Results Posted,,,08/12/2020,https://clinicaltrials.gov/show/NCT04658433,15/02/2021,0,0
1214,NCT04658979,Recruiting,01/03/2021,01/01/2022,No Results Posted,,,10/12/2020,https://clinicaltrials.gov/show/NCT04658979,01/03/2021,0,0
1215,NCT04659122,Not yet recruiting,01/06/2021,01/07/2021,No Results Posted,,,09/12/2020,https://clinicaltrials.gov/show/NCT04659122,01/06/2021,0,0
1216,NCT04659460,Not yet recruiting,31/03/2021,01/09/2021,No Results Posted,,,09/12/2020,https://clinicaltrials.gov/show/NCT04659460,31/03/2021,0,0
1217,NCT04659486,Enrolling by invitation,30/04/2021,30/04/2021,No Results Posted,,,09/12/2020,https://clinicaltrials.gov/show/NCT04659486,30/04/2021,0,0
1218,NCT04659746,Recruiting,28/02/2021,09/12/2021,No Results Posted,,,30/12/2020,https://clinicaltrials.gov/show/NCT04659746,28/02/2021,0,0
1219,NCT04659941,Recruiting,01/10/2021,01/10/2022,No Results Posted,,,09/12/2020,https://clinicaltrials.gov/show/NCT04659941,01/10/2021,0,0
1220,NCT04661423,Not yet recruiting,01/06/2022,01/06/2022,No Results Posted,,,10/12/2020,https://clinicaltrials.gov/show/NCT04661423,01/06/2022,0,0
1221,NCT04661527,Recruiting,30/12/2020,30/12/2020,No Results Posted,,,16/12/2020,https://clinicaltrials.gov/show/NCT04661527,30/12/2020,0,0
1222,NCT04661930,Recruiting,01/04/2021,01/12/2021,No Results Posted,,,10/12/2020,https://clinicaltrials.gov/show/NCT04661930,01/04/2021,0,0
1223,NCT04662684,Recruiting,30/04/2021,30/06/2021,No Results Posted,,,10/12/2020,https://clinicaltrials.gov/show/NCT04662684,30/04/2021,0,0
1224,NCT04662697,Recruiting,31/12/2021,30/04/2022,No Results Posted,,,24/05/2021,https://clinicaltrials.gov/show/NCT04662697,31/12/2021,0,0
1225,NCT04664010,"Active, not recruiting",14/01/2021,31/01/2021,No Results Posted,,,11/12/2020,https://clinicaltrials.gov/show/NCT04664010,14/01/2021,0,0
1226,NCT04666116,Recruiting,01/12/2020,01/02/2021,No Results Posted,,,16/12/2020,https://clinicaltrials.gov/show/NCT04666116,01/12/2020,0,0
1227,NCT04666493,Recruiting,30/11/2021,30/11/2021,No Results Posted,,,14/12/2020,https://clinicaltrials.gov/show/NCT04666493,30/11/2021,0,0
1228,NCT04666558,Recruiting,17/12/2021,17/12/2021,No Results Posted,,,14/12/2020,https://clinicaltrials.gov/show/NCT04666558,17/12/2021,0,0
1229,NCT04339712,Completed,01/12/2020,08/01/2021,No Results Posted,,,11/01/2021,https://clinicaltrials.gov/show/NCT04339712,01/12/2020,0,0
1230,NCT04342663,Completed,20/08/2020,12/12/2020,Study Results,"['Sultana J, Crisafulli S, Gabbay F, Lynn E, Shakir S, Trifir√≤ G. Challenges for Drug Repurposing in the COVID-19 Pandemic Era. Front Pharmacol. 2020 Nov 6;11:588654. doi: 10.3389/fphar.2020.588654. eCollection 2020. Review.', 'Lenze EJ, Mattar C, Zorumski CF, Stevens A, Schweiger J, Nicol GE, Miller JP, Yang L, Yingling M, Avidan MS, Reiersen AM. Fluvoxamine vs Placebo and Clinical Deterioration in Outpatients With Symptomatic COVID-19: A Randomized Clinical Trial. JAMA. 2020 Dec 8;324(22):2292-2300. doi: 10.1001/jama.2020.22760.']",,09/07/2021,https://clinicaltrials.gov/show/NCT04342663,20/08/2020,1,1
1231,NCT04352348,"Active, not recruiting",31/05/2022,31/05/2022,No Results Posted,,,08/07/2021,https://clinicaltrials.gov/show/NCT04352348,31/05/2022,0,0
1232,NCT04354831,"Active, not recruiting",01/05/2022,01/05/2023,No Results Posted,,,08/01/2021,https://clinicaltrials.gov/show/NCT04354831,01/05/2022,0,0
1233,NCT04366115,Not yet recruiting,01/06/2022,01/06/2023,No Results Posted,,,07/01/2021,https://clinicaltrials.gov/show/NCT04366115,01/06/2022,0,0
1234,NCT04373096,Recruiting,31/08/2021,31/10/2021,No Results Posted,,,11/01/2021,https://clinicaltrials.gov/show/NCT04373096,31/08/2021,0,0
1235,NCT04379661,Completed,07/07/2020,31/08/2020,No Results Posted,,,08/01/2021,https://clinicaltrials.gov/show/NCT04379661,07/07/2020,0,0
1236,NCT04398004,Completed,30/11/2020,30/11/2020,No Results Posted,,,11/01/2021,https://clinicaltrials.gov/show/NCT04398004,30/11/2020,0,0
1237,NCT04400279,Completed,28/11/2020,28/11/2020,No Results Posted,,,11/01/2021,https://clinicaltrials.gov/show/NCT04400279,28/11/2020,0,0
1238,NCT04407182,Completed,01/08/2020,01/10/2020,No Results Posted,,,08/01/2021,https://clinicaltrials.gov/show/NCT04407182,01/08/2020,0,0
1239,NCT04435275,Recruiting,31/03/2021,01/05/2021,No Results Posted,,,08/01/2021,https://clinicaltrials.gov/show/NCT04435275,31/03/2021,0,0
1240,NCT04435587,Recruiting,01/06/2021,01/11/2021,No Results Posted,,,11/01/2021,https://clinicaltrials.gov/show/NCT04435587,01/06/2021,0,0
1241,NCT04454398,Withdrawn,01/01/2021,01/01/2021,No Results Posted,,,08/01/2021,https://clinicaltrials.gov/show/NCT04454398,01/01/2021,0,0
1242,NCT04469634,"Active, not recruiting",01/07/2021,01/07/2021,No Results Posted,,,06/01/2021,https://clinicaltrials.gov/show/NCT04469634,01/07/2021,0,0
1243,NCT04470544,Recruiting,15/09/2022,15/09/2022,No Results Posted,,,11/01/2021,https://clinicaltrials.gov/show/NCT04470544,15/09/2022,0,0
1244,NCT04473261,Recruiting,15/08/2021,15/10/2021,No Results Posted,"['Ashraf S, Ashraf S, Ashraf M, Imran MA, Kalsoom L, Siddiqui UN, Farooq I, Ghufran M, Khokhar RA, Akram MK, Shahid I, Sohaib Ur Rehman M, Akmal R, Tahir A, Zahid A, Ashraf S, Rafique S, Matti N, Nadeem MF, Humayun A, Malik A, Saboor QA, Ahmad A, Ashraf M, Izhar M. A quadruple blinded placebo controlled randomised trial to evaluate the effectiveness of an Iodine complex for patients with mild to moderate COVID-19 in Pakistan (I-COVID-PK): A structured summary of a study protocol for a randomised controlled trial. Trials. 2021 Feb 10;22(1):127. doi: 10.1186/s13063-021-05081-3.']",,07/07/2021,https://clinicaltrials.gov/show/NCT04473261,15/08/2021,0,1
1245,NCT04527562,Completed,15/11/2020,10/12/2020,No Results Posted,,,11/01/2021,https://clinicaltrials.gov/show/NCT04527562,15/11/2020,0,0
1246,NCT04547257,Not yet recruiting,15/08/2021,15/10/2021,No Results Posted,,,06/01/2021,https://clinicaltrials.gov/show/NCT04547257,15/08/2021,0,0
1247,NCT04550325,Completed,26/11/2020,26/11/2020,No Results Posted,,,05/01/2021,https://clinicaltrials.gov/show/NCT04550325,26/11/2020,0,0
1248,NCT04574219,Recruiting,01/10/2022,01/12/2022,No Results Posted,,,07/01/2021,https://clinicaltrials.gov/show/NCT04574219,01/10/2022,0,0
1249,NCT04604678,Not yet recruiting,01/08/2021,01/10/2021,No Results Posted,,,07/01/2021,https://clinicaltrials.gov/show/NCT04604678,01/08/2021,0,0
1250,NCT04639466,Recruiting,10/11/2022,10/11/2022,No Results Posted,,,07/01/2021,https://clinicaltrials.gov/show/NCT04639466,10/11/2022,0,0
1251,NCT04662021,Enrolling by invitation,10/02/2021,25/02/2021,No Results Posted,,,11/01/2021,https://clinicaltrials.gov/show/NCT04662021,10/02/2021,0,0
1252,NCT04676971,Recruiting,07/07/2021,18/10/2021,No Results Posted,,,08/01/2021,https://clinicaltrials.gov/show/NCT04676971,07/07/2021,0,0
1253,NCT04679415,Recruiting,01/04/2021,01/05/2021,No Results Posted,,,06/01/2021,https://clinicaltrials.gov/show/NCT04679415,01/04/2021,0,0
1254,NCT04681001,Recruiting,30/05/2021,30/06/2021,No Results Posted,,,11/01/2021,https://clinicaltrials.gov/show/NCT04681001,30/05/2021,0,0
1255,NCT04695743,Recruiting,01/06/2022,01/09/2022,No Results Posted,,,05/01/2021,https://clinicaltrials.gov/show/NCT04695743,01/06/2022,0,0
1256,NCT04695821,Not yet recruiting,01/02/2021,01/03/2021,No Results Posted,,,05/01/2021,https://clinicaltrials.gov/show/NCT04695821,01/02/2021,0,0
1257,NCT04696562,Not yet recruiting,31/03/2021,31/03/2021,No Results Posted,,,06/01/2021,https://clinicaltrials.gov/show/NCT04696562,31/03/2021,0,0
1258,NCT04696601,Not yet recruiting,10/02/2021,10/02/2022,No Results Posted,,,06/01/2021,https://clinicaltrials.gov/show/NCT04696601,10/02/2021,0,0
1259,NCT04699227,Recruiting,30/04/2021,30/04/2021,No Results Posted,"['Davidson SM, Lukhna K, Gorog DA, Salama AD, Castillo AR, Giesz S, Golforoush P, Kalkhoran SB, Lecour S, Imamdin A, do Carmo HRP, Bovi TG, Perroud MW Jr, Ntsekhe M, Sposito AC, Yellon DM. RIC in COVID-19-a Clinical Trial to Investigate Whether Remote Ischemic Conditioning (RIC) Can Prevent Deterioration to Critical Care in Patients with COVID-19. Cardiovasc Drugs Ther. 2021 Jun 25. doi: 10.1007/s10557-021-07221-y. [Epub ahead of print]']",,07/01/2021,https://clinicaltrials.gov/show/NCT04699227,30/04/2021,0,1
1260,NCT04699851,Recruiting,18/04/2021,18/05/2021,No Results Posted,,,08/01/2021,https://clinicaltrials.gov/show/NCT04699851,18/04/2021,0,0
1261,NCT04701528,Recruiting,25/03/2022,25/10/2022,No Results Posted,,,08/01/2021,https://clinicaltrials.gov/show/NCT04701528,25/03/2022,0,0
1262,NCT04703478,Not yet recruiting,20/04/2021,20/04/2021,No Results Posted,,,12/01/2021,https://clinicaltrials.gov/show/NCT04703478,20/04/2021,0,0
1263,NCT04703907,Recruiting,01/08/2021,01/08/2021,No Results Posted,,,11/01/2021,https://clinicaltrials.gov/show/NCT04703907,01/08/2021,0,0
1264,NCT04705831,Recruiting,01/01/2022,01/01/2022,No Results Posted,,,12/01/2021,https://clinicaltrials.gov/show/NCT04705831,01/01/2022,0,0
1265,NCT04321278,Completed,14/06/2020,14/06/2020,No Results Posted,"['Furtado RHM, Berwanger O, Fonseca HA, Corr√™a TD, Ferraz LR, Lapa MG, Zampieri FG, Veiga VC, Azevedo LCP, Rosa RG, Lopes RD, Avezum A, Manoel ALO, Piza FMT, Martins PA, Lisboa TC, Pereira AJ, Olivato GB, Dantas VCS, Milan EP, Gebara OCE, Amazonas RB, Oliveira MB, Soares RVP, Moia DDF, Piano LPA, Castilho K, Momesso RGRAP, Schettino GPP, Rizzo LV, Neto AS, Machado FR, Cavalcanti AB; COALITION COVID-19 Brazil II Investigators. Azithromycin in addition to standard of care versus standard of care alone in the treatment of patients admitted to the hospital with severe COVID-19 in Brazil (COALITION II): a randomised clinical trial. Lancet. 2020 Oct 3;396(10256):959-967. doi: 10.1016/S0140-6736(20)31862-6. Epub 2020 Sep 5.', 'Lasheras I, Santab√°rbara J. Use of antimalarial drugs in the treatment of COVID-19: A window of opportunity? Med Clin (Barc). 2020 Jul 10;155(1):23-25. doi: 10.1016/j.medcli.2020.04.004. Epub 2020 Apr 22. English, Spanish.']",,20/01/2021,https://clinicaltrials.gov/show/NCT04321278,14/06/2020,0,1
1266,NCT04341688,Not yet recruiting,30/06/2021,31/07/2021,No Results Posted,"['Burton MJ, Clarkson JE, Goulao B, Glenny AM, McBain AJ, Schilder AG, Webster KE, Worthington HV. Antimicrobial mouthwashes (gargling) and nasal sprays administered to patients with suspected or confirmed COVID-19 infection to improve patient outcomes and to protect healthcare workers treating them. Cochrane Database Syst Rev. 2020 Sep 16;9:CD013627. doi: 10.1002/14651858.CD013627.pub2.', 'Khan FR, Kazmi SMR, Iqbal NT, Iqbal J, Ali ST, Abbas SA. A quadruple blind, randomised controlled trial of gargling agents in reducing intraoral viral load among hospitalised COVID-19 patients: A structured summary of a study protocol for a randomised controlled trial. Trials. 2020 Sep 14;21(1):785. doi: 10.1186/s13063-020-04634-2.']",,13/01/2021,https://clinicaltrials.gov/show/NCT04341688,30/06/2021,0,1
1267,NCT04347538,"Active, not recruiting",01/06/2021,01/06/2022,No Results Posted,,,19/01/2021,https://clinicaltrials.gov/show/NCT04347538,01/06/2021,0,0
1268,NCT04347954,Completed,13/12/2020,13/12/2020,No Results Posted,,,19/01/2021,https://clinicaltrials.gov/show/NCT04347954,13/12/2020,0,0
1269,NCT04350320,Completed,20/10/2020,30/12/2020,No Results Posted,,,12/01/2021,https://clinicaltrials.gov/show/NCT04350320,20/10/2020,0,0
1270,NCT04351516,Withdrawn,31/12/2020,01/05/2021,No Results Posted,"['G√∂pel S, Bethge W, Martus P, Kreth F, Iftner T, Joos S, D√∂bele S, Mordm√ºller B, Kremsner P, Ettrich T, Seufferlein T, Bitzer M, Malek N. Test and treat COVID 65 plus - Hydroxychloroquine versus placebo in early ambulatory diagnosis and treatment of older patients with COVID19: A structured summary of a study protocol for a randomised controlled trial. Trials. 2020 Jul 10;21(1):635. doi: 10.1186/s13063-020-04556-z.']",,15/01/2021,https://clinicaltrials.gov/show/NCT04351516,31/12/2020,0,1
1271,NCT04355637,Recruiting,31/08/2021,31/08/2021,No Results Posted,"['Agusti A, Torres F, Faner R. Early treatment with inhaled budesonide to prevent clinical deterioration in patients with COVID-19. Lancet Respir Med. 2021 Jul;9(7):682-683. doi: 10.1016/S2213-2600(21)00171-5. Epub 2021 Apr 9. Erratum in: Lancet Respir Med. 2021 Jun;9(6):e55.', 'Nicolau DV, Bafadhel M. Inhaled corticosteroids in virus pandemics: a treatment for COVID-19? Lancet Respir Med. 2020 Sep;8(9):846-847. doi: 10.1016/S2213-2600(20)30314-3. Epub 2020 Jul 30.']",,12/01/2021,https://clinicaltrials.gov/show/NCT04355637,31/08/2021,0,1
1272,NCT04364009,Terminated,20/10/2020,03/11/2020,No Results Posted,,,15/01/2021,https://clinicaltrials.gov/show/NCT04364009,20/10/2020,0,0
1273,NCT04364763,Recruiting,30/06/2021,31/12/2021,No Results Posted,,,14/01/2021,https://clinicaltrials.gov/show/NCT04364763,30/06/2021,0,0
1274,NCT04386447,Withdrawn,31/10/2020,31/12/2020,No Results Posted,,,14/01/2021,https://clinicaltrials.gov/show/NCT04386447,31/10/2020,0,0
1275,NCT04390152,Recruiting,01/12/2021,01/04/2022,No Results Posted,,,15/01/2021,https://clinicaltrials.gov/show/NCT04390152,01/12/2021,0,0
1276,NCT04405908,"Active, not recruiting",16/10/2020,25/05/2021,No Results Posted,"['Richmond P, Hatchuel L, Dong M, Ma B, Hu B, Smolenov I, Li P, Liang P, Han HH, Liang J, Clemens R. Safety and immunogenicity of S-Trimer (SCB-2019), a protein subunit vaccine candidate for COVID-19 in healthy adults: a phase 1, randomised, double-blind, placebo-controlled trial. Lancet. 2021 Feb 20;397(10275):682-694. doi: 10.1016/S0140-6736(21)00241-5. Epub 2021 Jan 29.']",,12/01/2021,https://clinicaltrials.gov/show/NCT04405908,16/10/2020,0,1
1277,NCT04406064,Withdrawn,01/06/2024,01/06/2025,No Results Posted,,,19/01/2021,https://clinicaltrials.gov/show/NCT04406064,01/06/2024,0,0
1278,NCT04407689,Recruiting,30/07/2021,30/12/2021,No Results Posted,,"['Zhou F, Yu T, Du R, Fan G, Liu Y, Liu Z, Xiang J, Wang Y, Song B, Gu X, Guan L, Wei Y, Li H, Wu X, Xu J, Tu S, Zhang Y, Chen H, Cao B. Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study. Lancet. 2020 Mar 28;395(10229):1054-1062. doi: 10.1016/S0140-6736(20)30566-3. Epub 2020 Mar 11. Erratum in: Lancet. 2020 Mar 28;395(10229):1038. Lancet. 2020 Mar 28;395(10229):1038.', 'Wang D, Hu B, Hu C, Zhu F, Liu X, Zhang J, Wang B, Xiang H, Cheng Z, Xiong Y, Zhao Y, Li Y, Wang X, Peng Z. Clinical Characteristics of 138 Hospitalized Patients With 2019 Novel Coronavirus-Infected Pneumonia in Wuhan, China. JAMA. 2020 Mar 17;323(11):1061-1069. doi: 10.1001/jama.2020.1585. Erratum in: JAMA. 2021 Mar 16;325(11):1113.']",15/01/2021,https://clinicaltrials.gov/show/NCT04407689,30/07/2021,0,1
1279,NCT04420676,Recruiting,01/12/2021,01/12/2022,No Results Posted,,,20/01/2021,https://clinicaltrials.gov/show/NCT04420676,01/12/2021,0,0
1280,NCT04425252,Completed,29/12/2020,29/12/2020,No Results Posted,,,19/01/2021,https://clinicaltrials.gov/show/NCT04425252,29/12/2020,0,0
1281,NCT04435184,Completed,28/11/2020,04/01/2021,No Results Posted,"['Metkus TS, Sokoll LJ, Barth AS, Czarny MJ, Hays AG, Lowenstein CJ, Michos ED, Nolley EP, Post WS, Resar JR, Thiemann DR, Trost JC, Hasan RK. Myocardial Injury in Severe COVID-19 Compared With Non-COVID-19 Acute Respiratory Distress Syndrome. Circulation. 2021 Feb 9;143(6):553-565. doi: 10.1161/CIRCULATIONAHA.120.050543. Epub 2020 Nov 13.']",,19/01/2021,https://clinicaltrials.gov/show/NCT04435184,28/11/2020,0,1
1282,NCT04456452,Completed,08/09/2020,30/11/2020,No Results Posted,,,13/01/2021,https://clinicaltrials.gov/show/NCT04456452,08/09/2020,0,0
1283,NCT04457817,Enrolling by invitation,01/07/2021,01/07/2021,No Results Posted,,,19/01/2021,https://clinicaltrials.gov/show/NCT04457817,01/07/2021,0,0
1284,NCT04458363,Completed,01/09/2020,01/09/2020,No Results Posted,,,19/01/2021,https://clinicaltrials.gov/show/NCT04458363,01/09/2020,0,0
1285,NCT04460014,Recruiting,01/03/2021,01/08/2021,No Results Posted,,,14/01/2021,https://clinicaltrials.gov/show/NCT04460014,01/03/2021,0,0
1286,NCT04460183,Recruiting,27/01/2021,23/04/2021,No Results Posted,,,12/01/2021,https://clinicaltrials.gov/show/NCT04460183,27/01/2021,0,0
1287,NCT04477954,Terminated,06/11/2020,30/12/2020,No Results Posted,,,15/01/2021,https://clinicaltrials.gov/show/NCT04477954,06/11/2020,0,0
1288,NCT04482387,Recruiting,01/07/2021,01/07/2021,No Results Posted,,,14/01/2021,https://clinicaltrials.gov/show/NCT04482387,01/07/2021,0,0
1289,NCT04515147,"Active, not recruiting",09/11/2021,09/11/2021,No Results Posted,,,12/01/2021,https://clinicaltrials.gov/show/NCT04515147,09/11/2021,0,0
1290,NCT04522089,Recruiting,20/11/2020,20/03/2021,No Results Posted,,,13/01/2021,https://clinicaltrials.gov/show/NCT04522089,20/11/2020,0,0
1291,NCT04542941,Completed,31/12/2020,31/12/2020,No Results Posted,,,15/01/2021,https://clinicaltrials.gov/show/NCT04542941,31/12/2020,0,0
1292,NCT04545541,Recruiting,01/04/2022,01/06/2022,No Results Posted,,,19/01/2021,https://clinicaltrials.gov/show/NCT04545541,01/04/2022,0,0
1293,NCT04565392,Not yet recruiting,01/11/2021,31/01/2022,No Results Posted,,,19/01/2021,https://clinicaltrials.gov/show/NCT04565392,01/11/2021,0,0
1294,NCT04570397,Recruiting,01/05/2021,01/11/2021,No Results Posted,,,14/01/2021,https://clinicaltrials.gov/show/NCT04570397,01/05/2021,0,0
1295,NCT04595695,Completed,12/11/2020,14/12/2020,No Results Posted,"['Kratzke IM, Rosenbaum ME, Cox C, Ollila DW, Kapadia MR. Effect of Clear vs Standard Covered Masks on Communication With Patients During Surgical Clinic Encounters: A Randomized Clinical Trial. JAMA Surg. 2021 Apr 1;156(4):372-378. doi: 10.1001/jamasurg.2021.0836.']",,14/01/2021,https://clinicaltrials.gov/show/NCT04595695,12/11/2020,0,1
1296,NCT04595903,Not yet recruiting,01/08/2021,01/08/2021,No Results Posted,,,14/01/2021,https://clinicaltrials.gov/show/NCT04595903,01/08/2021,0,0
1297,NCT04609722,Recruiting,01/02/2021,15/02/2021,No Results Posted,,,13/01/2021,https://clinicaltrials.gov/show/NCT04609722,01/02/2021,0,0
1298,NCT04610567,Recruiting,15/03/2021,15/07/2021,No Results Posted,,"[""Shah A, Kashyap R, Tosh P, Sampathkumar P, O'Horo JC. Guide to Understanding the 2019 Novel Coronavirus. Mayo Clin Proc. 2020 Apr;95(4):646-652. doi: 10.1016/j.mayocp.2020.02.003. Epub 2020 Feb 28."", 'Chen N, Zhou M, Dong X, Qu J, Gong F, Han Y, Qiu Y, Wang J, Liu Y, Wei Y, Xia J, Yu T, Zhang X, Zhang L. Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study. Lancet. 2020 Feb 15;395(10223):507-513. doi: 10.1016/S0140-6736(20)30211-7. Epub 2020 Jan 30.', 'Mitchell WB. Thromboinflammation in COVID-19 acute lung injury. Paediatr Respir Rev. 2020 Sep;35:20-24. doi: 10.1016/j.prrv.2020.06.004. Epub 2020 Jun 11. Review.', 'Zhou Z, Guo D, Li C, Fang Z, Chen L, Yang R, Li X, Zeng W. Coronavirus disease 2019: initial chest CT findings. Eur Radiol. 2020 Aug;30(8):4398-4406. doi: 10.1007/s00330-020-06816-7. Epub 2020 Mar 24.', 'Cronstein BN. Molecular therapeutics. Methotrexate and its mechanism of action. Arthritis Rheum. 1996 Dec;39(12):1951-60. Review.']",14/01/2021,https://clinicaltrials.gov/show/NCT04610567,15/03/2021,0,1
1299,NCT04636034,Recruiting,01/08/2021,01/11/2021,No Results Posted,,,14/01/2021,https://clinicaltrials.gov/show/NCT04636034,01/08/2021,0,0
1300,NCT04638842,Recruiting,01/06/2021,01/06/2021,No Results Posted,,"['Buysse DJ, Reynolds CF 3rd, Monk TH, Berman SR, Kupfer DJ. The Pittsburgh Sleep Quality Index: a new instrument for psychiatric practice and research. Psychiatry Res. 1989 May;28(2):193-213.', 'Carleton RN, Thibodeau MA, Teale MJ, Welch PG, Abrams MP, Robinson T, Asmundson GJ. The center for epidemiologic studies depression scale: a review with a theoretical and empirical examination of item content and factor structure. PLoS One. 2013;8(3):e58067. doi: 10.1371/journal.pone.0058067. Epub 2013 Mar 1. Review.', 'Norton PJ. Depression Anxiety and Stress Scales (DASS-21): psychometric analysis across four racial groups. Anxiety Stress Coping. 2007 Sep;20(3):253-65.', 'Koslowsky M, Bleich A, Greenspoon A, Wagner B, Apter A, Solomon Z. Assessing the validity of the Plutchik Suicide Risk Scale. J Psychiatr Res. 1991;25(4):155-8.', 'Spitzer RL, Kroenke K, Williams JB, L√∂we B. A brief measure for assessing generalized anxiety disorder: the GAD-7. Arch Intern Med. 2006 May 22;166(10):1092-7.', 'Beck AT, Weissman A, Lester D, Trexler L. The measurement of pessimism: the hopelessness scale. J Consult Clin Psychol. 1974 Dec;42(6):861-5.', 'Novy DM, Stanley MA, Averill P, Daza P. Psychometric comparability of English- and Spanish-language measures of anxiety and related affective symptoms. Psychol Assess. 2001 Sep;13(3):347-55.']",15/01/2021,https://clinicaltrials.gov/show/NCT04638842,01/06/2021,0,1
1301,NCT04663594,Recruiting,01/03/2021,01/03/2021,No Results Posted,,,15/01/2021,https://clinicaltrials.gov/show/NCT04663594,01/03/2021,0,0
1302,NCT04683328,Not yet recruiting,25/05/2021,25/11/2021,No Results Posted,,,20/01/2021,https://clinicaltrials.gov/show/NCT04683328,25/05/2021,0,0
1303,NCT04686773,Not yet recruiting,09/04/2021,20/09/2021,No Results Posted,,,14/01/2021,https://clinicaltrials.gov/show/NCT04686773,09/04/2021,0,0
1304,NCT04705753,Completed,15/10/2020,15/10/2020,No Results Posted,,"['Lionis C, Faresj√∂ A, Skoula M, Kapsokefalou M, Faresj√∂ T. Antioxidant effects of herbs in Crete. Lancet. 1998 Dec 19-26;352(9145):1987-8.', 'Duijker G, Bertsias A, Symvoulakis EK, Moschandreas J, Malliaraki N, Derdas SP, Tsikalas GK, Katerinopoulos HE, Pirintsos SA, Sourvinos G, Castanas E, Lionis C. Reporting effectiveness of an extract of three traditional Cretan herbs on upper respiratory tract infection: results from a double-blind randomized controlled trial. J Ethnopharmacol. 2015 Apr 2;163:157-66. doi: 10.1016/j.jep.2015.01.030. Epub 2015 Jan 30.', 'Tseliou, M., Pirintsos, S. A., Lionis, C., Castanas, E., and Sourvinos, G. (2019). Antiviral effect of an essential oil combination derived from three aromatic plants (Coridothymus capitatus (L.) Rchb. f., Origanum dictamnus L. and Salvia fruticosa Mill.) against viruses causing infections of the upper respiratory tract. J. Herb. Med. 17-18, 100288. doi:10.1016/j.hermed.2019.100288.', 'Pirintsos SA, Bariotakis M, Kampa M, Sourvinos G, Lionis C, Castanas E. The Therapeutic Potential of the Essential Oil of Thymbra capitata (L.) Cav., Origanum dictamnus L. and Salvia fruticosa Mill. And a Case of Plant-Based Pharmaceutical Development. Front Pharmacol. 2020 Nov 24;11:522213. doi: 10.3389/fphar.2020.522213. eCollection 2020. Review.', 'Anastasaki M, Bertsias A, Pirintsos SA, Castanas E, Lionis C. Post-market outcome of an extract of traditional Cretan herbs on upper respiratory tract infections: a pragmatic, prospective observational study. BMC Complement Altern Med. 2017 Sep 21;17(1):466. doi: 10.1186/s12906-017-1978-7.']",12/01/2021,https://clinicaltrials.gov/show/NCT04705753,15/10/2020,0,1
1305,NCT04706039,Not yet recruiting,01/03/2021,01/03/2021,No Results Posted,,,12/01/2021,https://clinicaltrials.gov/show/NCT04706039,01/03/2021,0,0
1306,NCT04706416,"Active, not recruiting",15/01/2021,15/01/2021,No Results Posted,,,12/01/2021,https://clinicaltrials.gov/show/NCT04706416,15/01/2021,0,0
1307,NCT04707742,Completed,18/11/2020,18/11/2020,No Results Posted,,,13/01/2021,https://clinicaltrials.gov/show/NCT04707742,18/11/2020,0,0
1308,NCT04707820,Recruiting,10/06/2021,10/06/2021,No Results Posted,,,13/01/2021,https://clinicaltrials.gov/show/NCT04707820,10/06/2021,0,0
1309,NCT04707833,Recruiting,01/12/2023,01/12/2023,No Results Posted,,,13/01/2021,https://clinicaltrials.gov/show/NCT04707833,01/12/2023,0,0
1310,NCT04708158,Not yet recruiting,01/05/2021,01/06/2021,No Results Posted,,,13/01/2021,https://clinicaltrials.gov/show/NCT04708158,01/05/2021,0,0
1311,NCT04708327,Not yet recruiting,01/04/2022,01/04/2022,No Results Posted,,,13/01/2021,https://clinicaltrials.gov/show/NCT04708327,01/04/2022,0,0
1312,NCT04708457,Not yet recruiting,01/12/2021,31/01/2022,No Results Posted,,,19/01/2021,https://clinicaltrials.gov/show/NCT04708457,01/12/2021,0,0
1313,NCT04709146,Not yet recruiting,28/02/2022,30/06/2022,No Results Posted,,,14/01/2021,https://clinicaltrials.gov/show/NCT04709146,28/02/2022,0,0
1314,NCT04709172,Recruiting,05/04/2021,30/09/2021,No Results Posted,,,20/01/2021,https://clinicaltrials.gov/show/NCT04709172,05/04/2021,0,0
1315,NCT04710316,Not yet recruiting,30/04/2022,30/09/2022,No Results Posted,,,14/01/2021,https://clinicaltrials.gov/show/NCT04710316,30/04/2022,0,0
1316,NCT04712045,Completed,12/12/2020,12/12/2020,No Results Posted,,,15/01/2021,https://clinicaltrials.gov/show/NCT04712045,12/12/2020,0,0
1317,NCT04712279,Not yet recruiting,21/03/2021,20/04/2021,No Results Posted,,"['Guan WJ, Ni ZY, Hu Y, Liang WH, Ou CQ, He JX, Liu L, Shan H, Lei CL, Hui DSC, Du B, Li LJ, Zeng G, Yuen KY, Chen RC, Tang CL, Wang T, Chen PY, Xiang J, Li SY, Wang JL, Liang ZJ, Peng YX, Wei L, Liu Y, Hu YH, Peng P, Wang JM, Liu JY, Chen Z, Li G, Zheng ZJ, Qiu SQ, Luo J, Ye CJ, Zhu SY, Zhong NS; China Medical Treatment Expert Group for Covid-19. Clinical Characteristics of Coronavirus Disease 2019 in China. N Engl J Med. 2020 Apr 30;382(18):1708-1720. doi: 10.1056/NEJMoa2002032. Epub 2020 Feb 28.', 'Zhou F, Yu T, Du R, Fan G, Liu Y, Liu Z, Xiang J, Wang Y, Song B, Gu X, Guan L, Wei Y, Li H, Wu X, Xu J, Tu S, Zhang Y, Chen H, Cao B. Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study. Lancet. 2020 Mar 28;395(10229):1054-1062. doi: 10.1016/S0140-6736(20)30566-3. Epub 2020 Mar 11. Erratum in: Lancet. 2020 Mar 28;395(10229):1038. Lancet. 2020 Mar 28;395(10229):1038.', 'Lauer SA, Grantz KH, Bi Q, Jones FK, Zheng Q, Meredith HR, Azman AS, Reich NG, Lessler J. The Incubation Period of Coronavirus Disease 2019 (COVID-19) From Publicly Reported Confirmed Cases: Estimation and Application. Ann Intern Med. 2020 May 5;172(9):577-582. doi: 10.7326/M20-0504. Epub 2020 Mar 10.', 'Li L, Liu J, Qin K. Comparison of double-dose vs standard-dose oseltamivir in the treatment of influenza: A systematic review and meta-analysis. J Clin Pharm Ther. 2020 Oct;45(5):918-926. doi: 10.1111/jcpt.13203. Epub 2020 Jun 4. Review.', 'Varghese FS, Kaukinen P, Gl√§sker S, Bespalov M, Hanski L, Wennerberg K, K√ºmmerer BM, Ahola T. Discovery of berberine, abamectin and ivermectin as antivirals against chikungunya and other alphaviruses. Antiviral Res. 2016 Feb;126:117-24. doi: 10.1016/j.antiviral.2015.12.012. Epub 2016 Jan 2.', 'Padhy BM, Mohanty RR, Das S, Meher BR. Therapeutic potential of ivermectin as add on treatment in COVID 19: A systematic review and meta-analysis. J Pharm Pharm Sci. 2020;23:462-469. doi: 10.18433/jpps31457.', 'Rajter JC, Sherman MS, Fatteh N, Vogel F, Sacks J, Rajter JJ. Use of Ivermectin Is Associated With Lower Mortality in Hospitalized Patients With Coronavirus Disease 2019: The Ivermectin in COVID Nineteen Study. Chest. 2021 Jan;159(1):85-92. doi: 10.1016/j.chest.2020.10.009. Epub 2020 Oct 13.', 'Elgazzar, A et al. Efficacy and Safety of Ivermectin for Treatment and prophylaxis of COVID-19 Pandemic. Research Square doi.org/10.21203, 2020', 'Chowdhury, ATMM et al. A Randomized Trial of Ivermectin-Doxycycline and Hydroxychloroquine-Azithromycin therapy on COVID19 patients. Research Square: https://doi.org/10.21203/rs.3.rs-38896/v1, 2020.', 'Niaee, MS et al. Ivermectin as an adjunct treatment for hospitalized adult COVID-19 patients: A randomized multi-center clinical trial. Research Square: https://doi.org/10.21203/rs.3.rs-109670/v1, 2020.', 'Franc√©s-Monerris, A et al. Has Ivermectin Virus-Directed Effects against SARS-CoV-2? Rationalizing the Action of a Potential Multitarget Antiviral Agent. ChemRxiv, 2020.']",15/01/2021,https://clinicaltrials.gov/show/NCT04712279,21/03/2021,0,1
1318,NCT04712357,Recruiting,01/01/2022,01/01/2023,No Results Posted,,,15/01/2021,https://clinicaltrials.gov/show/NCT04712357,01/01/2022,0,0
1319,NCT04713878,Completed,30/06/2020,15/07/2020,No Results Posted,,,20/01/2021,https://clinicaltrials.gov/show/NCT04713878,30/06/2020,0,0
1320,NCT04715360,Recruiting,29/11/2021,27/12/2021,No Results Posted,,,20/01/2021,https://clinicaltrials.gov/show/NCT04715360,29/11/2021,0,0
1321,NCT04292730,Completed,29/04/2020,26/06/2020,Study Results,,"['Spinner CD, Gottlieb RL, Criner GJ, Arribas L√≥pez JR, Cattelan AM, Soriano Viladomiu A, Ogbuagu O, Malhotra P, Mullane KM, Castagna A, Chai LYA, Roestenberg M, Tsang OTY, Bernasconi E, Le Turnier P, Chang SC, SenGupta D, Hyland RH, Osinusi AO, Cao H, Blair C, Wang H, Gaggar A, Brainard DM, McPhail MJ, Bhagani S, Ahn MY, Sanyal AJ, Huhn G, Marty FM; GS-US-540-5774 Investigators. Effect of Remdesivir vs Standard Care on Clinical Status at 11 Days in Patients With Moderate COVID-19: A Randomized Clinical Trial. JAMA. 2020 Sep 15;324(11):1048-1057. doi: 10.1001/jama.2020.16349.']",26/01/2021,https://clinicaltrials.gov/show/NCT04292730,29/04/2020,1,1
1322,NCT04322682,Completed,21/01/2021,21/01/2021,No Results Posted,"[""Tardif JC, Bouabdallaoui N, L'Allier PL, Gaudet D, Shah B, Pillinger MH, Lopez-Sendon J, da Luz P, Verret L, Audet S, Dupuis J, Denault A, Pelletier M, Tessier PA, Samson S, Fortin D, Tardif JD, Busseuil D, Goulet E, Lacoste C, Dubois A, Joshi AY, Waters DD, Hsue P, Lepor NE, Lesage F, Sainturet N, Roy-Clavel E, Bassevitch Z, Orfanos A, Stamatescu G, Gr√©goire JC, Busque L, Lavall√©e C, H√©tu PO, Paquette JS, Deftereos SG, Levesque S, Cossette M, Nozza A, Chabot-Blanchet M, Dub√© MP, Guertin MC, Boivin G; COLCORONA Investigators. Colchicine for community-treated patients with COVID-19 (COLCORONA): a phase 3, randomised, double-blinded, adaptive, placebo-controlled, multicentre trial. Lancet Respir Med. 2021 May 27. pii: S2213-2600(21)00222-8. doi: 10.1016/S2213-2600(21)00222-8. [Epub ahead of print]""]",,25/01/2021,https://clinicaltrials.gov/show/NCT04322682,21/01/2021,0,1
1323,NCT04335136,Completed,26/12/2020,26/12/2020,Results Submitted,,,22/01/2021,https://clinicaltrials.gov/show/NCT04335136,26/12/2020,0,0
1324,NCT04342689,Recruiting,01/06/2021,01/06/2021,No Results Posted,,,26/01/2021,https://clinicaltrials.gov/show/NCT04342689,01/06/2021,0,0
1325,NCT04366050,Recruiting,01/05/2021,01/05/2021,No Results Posted,"['Ajmera V, Thompson WK, Smith DM, Malhotra A, Mehta RL, Tolia V, Yin J, Sriram K, Insel PA, Collier S, Richards L, Loomba R. RAMIC: Design of a randomized, double-blind, placebo-controlled trial to evaluate the efficacy of ramipril in patients with COVID-19. Contemp Clin Trials. 2021 Apr;103:106330. doi: 10.1016/j.cct.2021.106330. Epub 2021 Feb 22.']",,20/01/2021,https://clinicaltrials.gov/show/NCT04366050,01/05/2021,0,1
1326,NCT04386239,Recruiting,01/01/2021,01/12/2021,No Results Posted,,,20/01/2021,https://clinicaltrials.gov/show/NCT04386239,01/01/2021,0,0
1327,NCT04406389,Recruiting,01/06/2021,01/12/2021,No Results Posted,,,26/01/2021,https://clinicaltrials.gov/show/NCT04406389,01/06/2021,0,0
1328,NCT04409509,Completed,12/01/2021,12/01/2021,No Results Posted,,,22/01/2021,https://clinicaltrials.gov/show/NCT04409509,12/01/2021,0,0
1329,NCT04409925,Recruiting,01/04/2021,01/08/2021,No Results Posted,,,22/01/2021,https://clinicaltrials.gov/show/NCT04409925,01/04/2021,0,0
1330,NCT04410562,Recruiting,13/05/2021,01/08/2021,No Results Posted,"['Gonz√°lez R, Garc√≠a-Otero L, Pons-Duran C, Marb√°n-Castro E, Gonc√© A, Llurba E, Gil MDM, Rodr√≠guez-Zambrano M√Å, Chen H, Ram√≠rez M, Bardaj√≠ A, Menendez C. Hydroxychloroquine efficacy and safety in preventing SARS-CoV-2 infection and COVID-19 disease severity during pregnancy (COVID-Preg): a structured summary of a study protocol for a randomised placebo controlled trial. Trials. 2020 Jul 2;21(1):607. doi: 10.1186/s13063-020-04557-y.']",,22/01/2021,https://clinicaltrials.gov/show/NCT04410562,13/05/2021,0,1
1331,NCT04414124,"Active, not recruiting",01/02/2021,01/02/2021,No Results Posted,,,22/01/2021,https://clinicaltrials.gov/show/NCT04414124,01/02/2021,0,0
1332,NCT04425005,Completed,07/12/2020,07/12/2020,No Results Posted,,,22/01/2021,https://clinicaltrials.gov/show/NCT04425005,07/12/2020,0,0
1333,NCT04425616,Recruiting,30/11/2021,30/11/2022,No Results Posted,,,25/01/2021,https://clinicaltrials.gov/show/NCT04425616,30/11/2021,0,0
1334,NCT04426318,Completed,12/01/2021,12/01/2021,No Results Posted,,,26/01/2021,https://clinicaltrials.gov/show/NCT04426318,12/01/2021,0,0
1335,NCT04455815,Recruiting,31/07/2021,31/07/2021,No Results Posted,,,02/07/2021,https://clinicaltrials.gov/show/NCT04455815,31/07/2021,0,0
1336,NCT04456088,Withdrawn,15/11/2020,15/12/2020,No Results Posted,,,22/01/2021,https://clinicaltrials.gov/show/NCT04456088,15/11/2020,0,0
1337,NCT04468009,Recruiting,19/01/2021,01/02/2021,No Results Posted,,,22/01/2021,https://clinicaltrials.gov/show/NCT04468009,19/01/2021,0,0
1338,NCT04476888,Completed,15/09/2020,10/10/2020,No Results Posted,,,20/01/2021,https://clinicaltrials.gov/show/NCT04476888,15/09/2020,0,0
1339,NCT04482595,Recruiting,01/08/2021,01/05/2022,No Results Posted,,,25/01/2021,https://clinicaltrials.gov/show/NCT04482595,01/08/2021,0,0
1340,NCT04483960,Recruiting,31/12/2021,31/12/2022,No Results Posted,,,25/01/2021,https://clinicaltrials.gov/show/NCT04483960,31/12/2021,0,0
1341,NCT04502433,Recruiting,31/07/2021,31/07/2021,No Results Posted,,,20/01/2021,https://clinicaltrials.gov/show/NCT04502433,31/07/2021,0,0
1342,NCT04522492,"Active, not recruiting",01/03/2021,01/06/2021,No Results Posted,,"['Xavier ACM, Souza CMB, Flores LHF, Prati C, Cassal C, Dreher CB. Improving skin picking diagnosis among Brazilians: validation of the Skin Picking Impact Scale and development of a photographic instrument. An Bras Dermatol. 2019 Sep - Oct;94(5):553-560. doi: 10.1016/j.abd.2018.10.001. Epub 2019 Sep 30.', 'Xavier ACM, de Souza CMB, Flores LHF, Bermudez MB, Silva RMF, de Oliveira AC, Dreher CB. Skin picking treatment with the Rothbaum cognitive behavioral therapy protocol: a randomized clinical trial. Braz J Psychiatry. 2020 Sep-Oct;42(5):510-518. doi: 10.1590/1516-4446-2019-0636.']",22/01/2021,https://clinicaltrials.gov/show/NCT04522492,01/03/2021,0,1
1343,NCT04526990,Recruiting,30/12/2021,30/01/2022,No Results Posted,,,22/01/2021,https://clinicaltrials.gov/show/NCT04526990,30/12/2021,0,0
1344,NCT04530396,"Active, not recruiting",01/05/2021,01/05/2021,No Results Posted,"['Logunov DY, Dolzhikova IV, Shcheblyakov DV, Tukhvatulin AI, Zubkova OV, Dzharullaeva AS, Kovyrshina AV, Lubenets NL, Grousova DM, Erokhova AS, Botikov AG, Izhaeva FM, Popova O, Ozharovskaya TA, Esmagambetov IB, Favorskaya IA, Zrelkin DI, Voronina DV, Shcherbinin DN, Semikhin AS, Simakova YV, Tokarskaya EA, Egorova DA, Shmarov MM, Nikitenko NA, Gushchin VA, Smolyarchuk EA, Zyryanov SK, Borisevich SV, Naroditsky BS, Gintsburg AL; Gam-COVID-Vac Vaccine Trial Group. Safety and efficacy of an rAd26 and rAd5 vector-based heterologous prime-boost COVID-19 vaccine: an interim analysis of a randomised controlled phase 3 trial in Russia. Lancet. 2021 Feb 20;397(10275):671-681. doi: 10.1016/S0140-6736(21)00234-8. Epub 2021 Feb 2. Erratum in: Lancet. 2021 Feb 20;397(10275):670.']",,22/01/2021,https://clinicaltrials.gov/show/NCT04530396,01/05/2021,0,1
1345,NCT04542343,Recruiting,30/09/2021,30/09/2021,No Results Posted,,,26/01/2021,https://clinicaltrials.gov/show/NCT04542343,30/09/2021,0,0
1346,NCT04545242,Not yet recruiting,30/09/2023,30/12/2023,No Results Posted,,,22/01/2021,https://clinicaltrials.gov/show/NCT04545242,30/09/2023,0,0
1347,NCT04572412,Recruiting,01/04/2021,01/04/2021,No Results Posted,,,25/01/2021,https://clinicaltrials.gov/show/NCT04572412,01/04/2021,0,0
1348,NCT04587219,"Active, not recruiting",30/03/2021,30/04/2021,No Results Posted,,,22/01/2021,https://clinicaltrials.gov/show/NCT04587219,30/03/2021,0,0
1349,NCT04605887,Recruiting,01/11/2023,01/04/2024,No Results Posted,,,22/01/2021,https://clinicaltrials.gov/show/NCT04605887,01/11/2023,0,0
1350,NCT04609865,Recruiting,31/12/2021,04/02/2024,No Results Posted,"['Muller M, Lefebvre F, Harlay ML, Glady L, Becker G, Muller C, Aberkane O, Tawk M, Julians M, Romoli A, Hecketsweiler S, Schneider F, Pottecher J, Chamaraux-Tran TN. Impact of intravenous lidocaine on clinical outcomes of patients with ARDS during COVID-19 pandemia (LidoCovid): A structured summary of a study protocol for a randomised controlled trial. Trials. 2021 Feb 11;22(1):131. doi: 10.1186/s13063-021-05095-x.']",,20/01/2021,https://clinicaltrials.gov/show/NCT04609865,31/12/2021,0,1
1351,NCT04630054,Recruiting,15/02/2021,15/02/2021,No Results Posted,,,22/01/2021,https://clinicaltrials.gov/show/NCT04630054,15/02/2021,0,0
1352,NCT04634799,Recruiting,30/11/2021,30/06/2022,No Results Posted,,,22/01/2021,https://clinicaltrials.gov/show/NCT04634799,30/11/2021,0,0
1353,NCT04661410,Recruiting,01/12/2021,30/03/2022,No Results Posted,,,22/01/2021,https://clinicaltrials.gov/show/NCT04661410,01/12/2021,0,0
1354,NCT04665115,Not yet recruiting,01/05/2022,01/05/2025,No Results Posted,,,22/01/2021,https://clinicaltrials.gov/show/NCT04665115,01/05/2022,0,0
1355,NCT04712344,Recruiting,01/09/2021,01/09/2021,No Results Posted,,,20/01/2021,https://clinicaltrials.gov/show/NCT04712344,01/09/2021,0,0
1356,NCT04715295,Recruiting,30/05/2021,05/09/2021,No Results Posted,,,20/01/2021,https://clinicaltrials.gov/show/NCT04715295,30/05/2021,0,0
1357,NCT04715997,Recruiting,30/05/2021,30/03/2022,No Results Posted,,,20/01/2021,https://clinicaltrials.gov/show/NCT04715997,30/05/2021,0,0
1358,NCT04716179,Recruiting,18/05/2021,18/05/2021,No Results Posted,,,20/01/2021,https://clinicaltrials.gov/show/NCT04716179,18/05/2021,0,0
1359,NCT04716647,Completed,12/12/2020,18/12/2020,No Results Posted,,,20/01/2021,https://clinicaltrials.gov/show/NCT04716647,12/12/2020,0,0
1360,NCT04716998,Recruiting,01/01/2022,01/01/2022,No Results Posted,,,02/07/2021,https://clinicaltrials.gov/show/NCT04716998,01/01/2022,0,0
1361,NCT04718285,Not yet recruiting,30/04/2021,30/05/2021,No Results Posted,,,22/01/2021,https://clinicaltrials.gov/show/NCT04718285,30/04/2021,0,0
1362,NCT04718480,Recruiting,01/08/2021,01/12/2021,No Results Posted,,,22/01/2021,https://clinicaltrials.gov/show/NCT04718480,01/08/2021,0,0
1363,NCT04718506,Recruiting,12/06/2021,12/12/2021,No Results Posted,,,22/01/2021,https://clinicaltrials.gov/show/NCT04718506,12/06/2021,0,0
1364,NCT04719208,Recruiting,01/05/2021,01/06/2021,No Results Posted,,,22/01/2021,https://clinicaltrials.gov/show/NCT04719208,01/05/2021,0,0
1365,NCT04719234,Completed,01/12/2020,01/12/2020,No Results Posted,"['√ñkmen K, Yƒ±ldƒ±z DK, Soyaslan E. Comparison of lung ultrasonography findings with chest computed tomography results in coronavirus (COVID-19) pneumonia. J Med Ultrason (2001). 2021 Apr;48(2):245-252. doi: 10.1007/s10396-021-01081-7. Epub 2021 Feb 26.']",,22/01/2021,https://clinicaltrials.gov/show/NCT04719234,01/12/2020,0,1
1366,NCT04720404,Recruiting,01/02/2022,01/02/2022,No Results Posted,,,22/01/2021,https://clinicaltrials.gov/show/NCT04720404,01/02/2022,0,0
1367,NCT04720612,Not yet recruiting,01/07/2021,01/01/2022,No Results Posted,,,22/01/2021,https://clinicaltrials.gov/show/NCT04720612,01/07/2021,0,0
1368,NCT04720794,Completed,20/10/2020,20/10/2020,No Results Posted,,,26/01/2021,https://clinicaltrials.gov/show/NCT04720794,20/10/2020,0,0
1369,NCT04721236,Recruiting,19/11/2021,19/05/2022,No Results Posted,,,22/01/2021,https://clinicaltrials.gov/show/NCT04721236,19/11/2021,0,0
1370,NCT04721457,Recruiting,28/02/2021,30/06/2021,No Results Posted,,"['To KK, Tsang OT, Yip CC, Chan KH, Wu TC, Chan JM, Leung WS, Chik TS, Choi CY, Kandamby DH, Lung DC, Tam AR, Poon RW, Fung AY, Hung IF, Cheng VC, Chan JF, Yuen KY. Consistent Detection of 2019 Novel Coronavirus in Saliva. Clin Infect Dis. 2020 Jul 28;71(15):841-843. doi: 10.1093/cid/ciaa149.', 'Ge ZY, Yang LM, Xia JJ, Fu XH, Zhang YZ. Possible aerosol transmission of COVID-19 and special precautions in dentistry. J Zhejiang Univ Sci B. 2020 May;21(5):361-368. doi: 10.1631/jzus.B2010010. Epub 2020 Mar 16. Review.', 'Vergara-Buenaventura A, Castro-Ruiz C. Use of mouthwashes against COVID-19 in dentistry. Br J Oral Maxillofac Surg. 2020 Oct;58(8):924-927. doi: 10.1016/j.bjoms.2020.08.016. Epub 2020 Aug 15. Review.', ""O'Donnell VB, Thomas D, Stanton R, Maillard JY, Murphy RC, Jones SA, Humphreys I, Wakelam MJO, Fegan C, Wise MP, Bosch A, Sattar SA. Potential Role of Oral Rinses Targeting the Viral Lipid Envelope in SARS-CoV-2 Infection. Function (Oxf). 2020;1(1):zqaa002. doi: 10.1093/function/zqaa002. Epub 2020 Jun 5."", 'Carrouel F, Conte MP, Fisher J, Gon√ßalves LS, Dussart C, Llodra JC, Bourgeois D. COVID-19: A Recommendation to Examine the Effect of Mouthrinses with Œ≤-Cyclodextrin Combined with Citrox in Preventing Infection and Progression. J Clin Med. 2020 Apr 15;9(4). pii: E1126. doi: 10.3390/jcm9041126.', 'Wang W, Xu Y, Gao R, Lu R, Han K, Wu G, Tan W. Detection of SARS-CoV-2 in Different Types of Clinical Specimens. JAMA. 2020 May 12;323(18):1843-1844. doi: 10.1001/jama.2020.3786.', 'Bruch MK. Toxicity and safety of topical sodium hypochlorite. Contrib Nephrol. 2007;154:24-38. doi: 10.1159/000096812. Review.', 'De Nardo R, Chiappe V, G√≥mez M, Romanelli H, Slots J. Effects of 0.05% sodium hypochlorite oral rinse on supragingival biofilm and gingival inflammation. Int Dent J. 2012 Aug;62(4):208-12. doi: 10.1111/j.1875-595X.2011.00111.x. Epub 2012 May 11.', 'Seo HW, Seo JP, Cho Y, Ko E, Kim YJ, Jung G. Cetylpyridinium chloride interaction with the hepatitis B virus core protein inhibits capsid assembly. Virus Res. 2019 Apr 2;263:102-111. doi: 10.1016/j.virusres.2019.01.004. Epub 2019 Jan 9.', 'Feres M, Figueiredo LC, Faveri M, Stewart B, de Vizio W. The effectiveness of a preprocedural mouthrinse containing cetylpyridinium chloride in reducing bacteria in the dental office. J Am Dent Assoc. 2010 Apr;141(4):415-22.', 'Marui VC, Souto MLS, Rovai ES, Romito GA, Chambrone L, Pannuti CM. Efficacy of preprocedural mouthrinses in the reduction of microorganisms in aerosol: A systematic review. J Am Dent Assoc. 2019 Dec;150(12):1015-1026.e1. doi: 10.1016/j.adaj.2019.06.024.', 'Pitten FA, Kramer A. Efficacy of cetylpyridinium chloride used as oropharyngeal antiseptic. Arzneimittelforschung. 2001;51(7):588-95.', 'Osso D, Kanani N. Antiseptic mouth rinses: an update on comparative effectiveness, risks and recommendations. J Dent Hyg. 2013 Feb;87(1):10-8. Epub 2013 Feb 5. Review.', 'Caruso AA, Del Prete A, Lazzarino AI. Hydrogen peroxide and viral infections: A literature review with research hypothesis definition in relation to the current covid-19 pandemic. Med Hypotheses. 2020 Nov;144:109910. doi: 10.1016/j.mehy.2020.109910. Epub 2020 Jun 1. Review.', 'Walsh LJ. Safety issues relating to the use of hydrogen peroxide in dentistry. Aust Dent J. 2000 Dec;45(4):257-69; quiz 289. Review.', 'Eggers M, Koburger-Janssen T, Eickmann M, Zorn J. In Vitro Bactericidal and Virucidal Efficacy of Povidone-Iodine Gargle/Mouthwash Against Respiratory and Oral Tract Pathogens. Infect Dis Ther. 2018 Jun;7(2):249-259. doi: 10.1007/s40121-018-0200-7. Epub 2018 Apr 9.', 'Kariwa H, Fujii N, Takashima I. Inactivation of SARS coronavirus by means of povidone-iodine, physical conditions and chemical reagents. Dermatology. 2006;212 Suppl 1:119-23.']",26/01/2021,https://clinicaltrials.gov/show/NCT04721457,28/02/2021,0,1
1371,NCT04723550,Recruiting,05/11/2021,05/01/2022,No Results Posted,,,26/01/2021,https://clinicaltrials.gov/show/NCT04723550,05/11/2021,0,0
1372,NCT04723576,Recruiting,01/02/2022,30/11/2023,No Results Posted,,,25/01/2021,https://clinicaltrials.gov/show/NCT04723576,01/02/2022,0,0
1373,NCT04723589,Withdrawn,30/04/2021,30/04/2021,No Results Posted,,,30/06/2021,https://clinicaltrials.gov/show/NCT04723589,30/04/2021,0,0
1374,NCT04724538,Completed,10/02/2021,15/03/2021,Study Results,,,07/07/2021,https://clinicaltrials.gov/show/NCT04724538,10/02/2021,1,0
1375,NCT04724616,Recruiting,01/06/2021,01/06/2021,No Results Posted,,,26/01/2021,https://clinicaltrials.gov/show/NCT04724616,01/06/2021,0,0
1376,NCT04724629,Recruiting,31/03/2021,30/07/2021,No Results Posted,,,26/01/2021,https://clinicaltrials.gov/show/NCT04724629,31/03/2021,0,0
1377,NCT04724681,Recruiting,31/12/2021,31/12/2021,No Results Posted,,,26/01/2021,https://clinicaltrials.gov/show/NCT04724681,31/12/2021,0,0
1378,NCT04728243,Not yet recruiting,01/02/2022,01/02/2022,No Results Posted,,,28/01/2021,https://clinicaltrials.gov/show/NCT04728243,01/02/2022,0,0
1379,NCT04333225,Completed,30/06/2020,30/06/2020,No Results Posted,,,26/01/2021,https://clinicaltrials.gov/show/NCT04333225,30/06/2020,0,0
1380,NCT04334434,Completed,15/09/2020,15/12/2020,No Results Posted,,,03/02/2021,https://clinicaltrials.gov/show/NCT04334434,15/09/2020,0,0
1381,NCT04337996,Completed,13/01/2021,13/01/2021,No Results Posted,,,26/01/2021,https://clinicaltrials.gov/show/NCT04337996,13/01/2021,0,0
1382,NCT04338958,Recruiting,31/07/2021,31/07/2021,No Results Posted,"['La Ros√©e F, Bremer HC, Gehrke I, Kehr A, Hochhaus A, Birndt S, Fellhauer M, Henkes M, Kumle B, Russo SG, La Ros√©e P. The Janus kinase 1/2 inhibitor ruxolitinib in COVID-19 with severe systemic hyperinflammation. Leukemia. 2020 Jul;34(7):1805-1815. doi: 10.1038/s41375-020-0891-0. Epub 2020 Jun 9.']",,28/01/2021,https://clinicaltrials.gov/show/NCT04338958,31/07/2021,0,1
1383,NCT04341584,Completed,10/05/2020,25/07/2020,No Results Posted,['CORIMUNO-19 Collaborative group. Effect of anakinra versus usual care in adults in hospital with COVID-19 and mild-to-moderate pneumonia (CORIMUNO-ANA-1): a randomised controlled trial. Lancet Respir Med. 2021 Mar;9(3):295-304. doi: 10.1016/S2213-2600(20)30556-7. Epub 2021 Jan 22.'],,01/02/2021,https://clinicaltrials.gov/show/NCT04341584,10/05/2020,0,1
1384,NCT04346693,Completed,01/11/2020,20/11/2020,No Results Posted,,,27/01/2021,https://clinicaltrials.gov/show/NCT04346693,01/11/2020,0,0
1385,NCT04347031,Completed,01/11/2020,20/11/2020,No Results Posted,,,27/01/2021,https://clinicaltrials.gov/show/NCT04347031,01/11/2020,0,0
1386,NCT04347174,Completed,10/08/2020,21/08/2020,No Results Posted,,,27/01/2021,https://clinicaltrials.gov/show/NCT04347174,10/08/2020,0,0
1387,NCT04347915,Recruiting,30/01/2021,31/03/2021,No Results Posted,,,27/01/2021,https://clinicaltrials.gov/show/NCT04347915,30/01/2021,0,0
1388,NCT04354155,Recruiting,01/09/2022,15/10/2022,No Results Posted,"['Flumignan RL, Tin√¥co JDS, Pascoal PI, Areias LL, Cossi MS, Fernandes MI, Costa IK, Souza L, Matar CF, Tendal B, Trevisani VF, Atallah √ÅN, Nakano LC. Prophylactic anticoagulants for people hospitalised with COVID-19. Cochrane Database Syst Rev. 2020 Oct 2;10:CD013739. doi: 10.1002/14651858.CD013739.']",,27/01/2021,https://clinicaltrials.gov/show/NCT04354155,01/09/2022,0,1
1389,NCT04365127,Completed,20/08/2020,20/08/2020,No Results Posted,"['Ghandehari S, Matusov Y, Pepkowitz S, Stein D, Kaderi T, Narayanan D, Hwang J, Chang S, Goodman R, Ghandehari H, Mirocha J, Bresee C, Tapson V, Lewis M. Progesterone in Addition to Standard of Care vs Standard of Care Alone in the Treatment of Men Hospitalized With Moderate to Severe COVID-19: A Randomized, Controlled Pilot Trial. Chest. 2021 Feb 20. pii: S0012-3692(21)00289-0. doi: 10.1016/j.chest.2021.02.024. [Epub ahead of print]']",,27/01/2021,https://clinicaltrials.gov/show/NCT04365127,20/08/2020,0,1
1390,NCT04368845,Recruiting,31/03/2021,31/03/2021,No Results Posted,,,28/01/2021,https://clinicaltrials.gov/show/NCT04368845,31/03/2021,0,0
1391,NCT04390477,Recruiting,01/07/2021,01/09/2021,No Results Posted,,,27/01/2021,https://clinicaltrials.gov/show/NCT04390477,01/07/2021,0,0
1392,NCT04403100,Recruiting,01/02/2021,01/02/2021,No Results Posted,"['Reis G, Moreira Silva EADS, Medeiros Silva DC, Thabane L, Singh G, Park JJH, Forrest JI, Harari O, Quirino Dos Santos CV, Guimar√£es de Almeida APF, Figueiredo Neto AD, Savassi LCM, Milagres AC, Teixeira MM, Simplicio MIC, Ribeiro LB, Oliveira R, Mills EJ; TOGETHER Investigators. Effect of Early Treatment With Hydroxychloroquine or Lopinavir and Ritonavir on Risk of Hospitalization Among Patients With COVID-19: The TOGETHER Randomized Clinical Trial. JAMA Netw Open. 2021 Apr 1;4(4):e216468. doi: 10.1001/jamanetworkopen.2021.6468.']",,26/01/2021,https://clinicaltrials.gov/show/NCT04403100,01/02/2021,0,1
1393,NCT04411433,"Active, not recruiting",31/12/2020,01/06/2021,No Results Posted,,,01/02/2021,https://clinicaltrials.gov/show/NCT04411433,31/12/2020,0,0
1394,NCT04412668,Completed,21/12/2020,21/12/2020,No Results Posted,,,29/01/2021,https://clinicaltrials.gov/show/NCT04412668,21/12/2020,0,0
1395,NCT04435379,"Active, not recruiting",30/09/2021,30/09/2021,No Results Posted,,,01/02/2021,https://clinicaltrials.gov/show/NCT04435379,30/09/2021,0,0
1396,NCT04452669,Recruiting,01/05/2021,01/09/2021,No Results Posted,,,01/02/2021,https://clinicaltrials.gov/show/NCT04452669,01/05/2021,0,0
1397,NCT04459962,Completed,07/01/2021,07/01/2021,No Results Posted,,,29/01/2021,https://clinicaltrials.gov/show/NCT04459962,07/01/2021,0,0
1398,NCT04462627,Recruiting,01/12/2021,01/12/2021,No Results Posted,,,28/01/2021,https://clinicaltrials.gov/show/NCT04462627,01/12/2021,0,0
1399,NCT04469114,"Active, not recruiting",01/03/2021,01/03/2021,No Results Posted,"['Guimar√£es PO, Quirk D, Furtado RH, Maia LN, Saraiva JF, Antunes MO, Kalil Filho R, Junior VM, Soeiro AM, Tognon AP, Veiga VC, Martins PA, Moia DDF, Sampaio BS, Assis SRL, Soares RVP, Piano LPA, Castilho K, Momesso RGRAP, Monfardini F, Guimar√£es HP, Ponce de Leon D, Dulcine M, Pinheiro MRT, Gunay LM, Deuring JJ, Rizzo LV, Koncz T, Berwanger O; STOP-COVID Trial Investigators. Tofacitinib in Patients Hospitalized with Covid-19 Pneumonia. N Engl J Med. 2021 Jun 16. doi: 10.1056/NEJMoa2101643. [Epub ahead of print]']",,02/02/2021,https://clinicaltrials.gov/show/NCT04469114,01/03/2021,0,1
1400,NCT04486001,Recruiting,15/01/2022,15/01/2022,No Results Posted,,"['Rogers CJ, Harman RJ, Bunnell BA, Schreiber MA, Xiang C, Wang FS, Santidrian AF, Minev BR. Rationale for the clinical use of adipose-derived mesenchymal stem cells for COVID-19 patients. J Transl Med. 2020 May 18;18(1):203. doi: 10.1186/s12967-020-02380-2. Review.']",02/02/2021,https://clinicaltrials.gov/show/NCT04486001,15/01/2022,0,1
1401,NCT04488575,Recruiting,06/07/2021,06/07/2021,No Results Posted,,,01/02/2021,https://clinicaltrials.gov/show/NCT04488575,06/07/2021,0,0
1402,NCT04497922,Recruiting,30/04/2021,15/05/2021,No Results Posted,,,27/01/2021,https://clinicaltrials.gov/show/NCT04497922,30/04/2021,0,0
1403,NCT04498377,Recruiting,30/09/2021,31/12/2021,No Results Posted,,,28/01/2021,https://clinicaltrials.gov/show/NCT04498377,30/09/2021,0,0
1404,NCT04498442,Completed,22/10/2020,22/10/2020,No Results Posted,,,01/02/2021,https://clinicaltrials.gov/show/NCT04498442,22/10/2020,0,0
1405,NCT04509999,Withdrawn,30/06/2021,30/06/2021,No Results Posted,,,01/07/2021,https://clinicaltrials.gov/show/NCT04509999,30/06/2021,0,0
1406,NCT04519411,Recruiting,31/12/2021,31/01/2022,No Results Posted,,,01/02/2021,https://clinicaltrials.gov/show/NCT04519411,31/12/2021,0,0
1407,NCT04528368,Recruiting,30/04/2021,30/05/2021,No Results Posted,,,01/02/2021,https://clinicaltrials.gov/show/NCT04528368,30/04/2021,0,0
1408,NCT04528667,Recruiting,01/05/2021,01/05/2021,No Results Posted,,,01/02/2021,https://clinicaltrials.gov/show/NCT04528667,01/05/2021,0,0
1409,NCT04535856,Completed,14/01/2021,14/01/2021,No Results Posted,,,27/01/2021,https://clinicaltrials.gov/show/NCT04535856,14/01/2021,0,0
1410,NCT04537208,"Active, not recruiting",01/11/2021,01/11/2021,No Results Posted,"['Goepfert PA, Fu B, Chabanon AL, Bonaparte MI, Davis MG, Essink BJ, Frank I, Haney O, Janosczyk H, Keefer MC, Koutsoukos M, Kimmel MA, Masotti R, Savarino SJ, Schuerman L, Schwartz H, Sher LD, Smith J, Tavares-Da-Silva F, Gurunathan S, DiazGranados CA, de Bruyn G. Safety and immunogenicity of SARS-CoV-2 recombinant protein vaccine formulations in healthy adults: interim results of a randomised, placebo-controlled, phase 1-2, dose-ranging study. Lancet Infect Dis. 2021 Apr 19. pii: S1473-3099(21)00147-X. doi: 10.1016/S1473-3099(21)00147-X. [Epub ahead of print]']",,27/01/2021,https://clinicaltrials.gov/show/NCT04537208,01/11/2021,0,1
1411,NCT04557046,Recruiting,30/11/2021,31/12/2021,No Results Posted,"['Drain PK, Ampajwala M, Chappel C, Gvozden AB, Hoppers M, Wang M, Rosen R, Young S, Zissman E, Montano M. A Rapid, High-Sensitivity SARS-CoV-2 Nucleocapsid Immunoassay to Aid Diagnosis of Acute COVID-19 at the Point of Care: A Clinical Performance Study. Infect Dis Ther. 2021 Jun;10(2):753-761. doi: 10.1007/s40121-021-00413-x. Epub 2021 Feb 24.']",,29/01/2021,https://clinicaltrials.gov/show/NCT04557046,30/11/2021,0,1
1412,NCT04581746,Recruiting,01/12/2021,01/12/2021,No Results Posted,,,26/01/2021,https://clinicaltrials.gov/show/NCT04581746,01/12/2021,0,0
1413,NCT04591613,Recruiting,01/08/2022,01/08/2022,No Results Posted,,,28/01/2021,https://clinicaltrials.gov/show/NCT04591613,01/08/2022,0,0
1414,NCT04595084,Not yet recruiting,01/11/2021,01/11/2022,No Results Posted,,,26/01/2021,https://clinicaltrials.gov/show/NCT04595084,01/11/2021,0,0
1415,NCT04599959,Completed,20/01/2021,20/01/2021,No Results Posted,,,26/01/2021,https://clinicaltrials.gov/show/NCT04599959,20/01/2021,0,0
1416,NCT04605926,Withdrawn,01/04/2021,01/06/2021,No Results Posted,,,27/01/2021,https://clinicaltrials.gov/show/NCT04605926,01/04/2021,0,0
1417,NCT04610138,Not yet recruiting,01/07/2021,01/08/2021,No Results Posted,,,01/02/2021,https://clinicaltrials.gov/show/NCT04610138,01/07/2021,0,0
1418,NCT04613050,Recruiting,24/12/2021,20/02/2022,No Results Posted,,,27/01/2021,https://clinicaltrials.gov/show/NCT04613050,24/12/2021,0,0
1419,NCT04613271,Suspended,30/06/2021,30/06/2021,No Results Posted,,,27/01/2021,https://clinicaltrials.gov/show/NCT04613271,30/06/2021,0,0
1420,NCT04623021,Completed,12/12/2020,12/12/2020,No Results Posted,,,02/02/2021,https://clinicaltrials.gov/show/NCT04623021,12/12/2020,0,0
1421,NCT04635605,Recruiting,31/12/2021,31/12/2022,No Results Posted,,,02/02/2021,https://clinicaltrials.gov/show/NCT04635605,31/12/2021,0,0
1422,NCT04640038,Recruiting,01/12/2022,01/12/2022,No Results Posted,,,27/01/2021,https://clinicaltrials.gov/show/NCT04640038,01/12/2022,0,0
1423,NCT04646109,Completed,02/09/2020,02/09/2020,Study Results,,,27/01/2021,https://clinicaltrials.gov/show/NCT04646109,02/09/2020,1,0
1424,NCT04674644,Completed,23/10/2020,23/10/2020,Study Results,,,02/02/2021,https://clinicaltrials.gov/show/NCT04674644,23/10/2020,1,0
1425,NCT04682041,Recruiting,30/06/2021,30/06/2021,No Results Posted,,,28/01/2021,https://clinicaltrials.gov/show/NCT04682041,30/06/2021,0,0
1426,NCT04689542,Recruiting,01/08/2021,01/08/2021,No Results Posted,,,28/01/2021,https://clinicaltrials.gov/show/NCT04689542,01/08/2021,0,0
1427,NCT04691180,Recruiting,01/08/2021,01/08/2021,No Results Posted,,,27/01/2021,https://clinicaltrials.gov/show/NCT04691180,01/08/2021,0,0
1428,NCT04695301,Recruiting,01/07/2021,01/08/2021,No Results Posted,,,29/01/2021,https://clinicaltrials.gov/show/NCT04695301,01/07/2021,0,0
1429,NCT04707534,Recruiting,21/08/2021,21/09/2021,No Results Posted,,,30/06/2021,https://clinicaltrials.gov/show/NCT04707534,21/08/2021,0,0
1430,NCT04715763,Not yet recruiting,31/01/2022,31/12/2022,No Results Posted,,,01/02/2021,https://clinicaltrials.gov/show/NCT04715763,31/01/2022,0,0
1431,NCT04721535,Not yet recruiting,01/04/2021,01/07/2021,No Results Posted,,,01/02/2021,https://clinicaltrials.gov/show/NCT04721535,01/04/2021,0,0
1432,NCT04723524,Recruiting,01/06/2021,01/08/2021,No Results Posted,,,29/01/2021,https://clinicaltrials.gov/show/NCT04723524,01/06/2021,0,0
1433,NCT04725110,Not yet recruiting,01/03/2021,01/03/2024,No Results Posted,,,26/01/2021,https://clinicaltrials.gov/show/NCT04725110,01/03/2021,0,0
1434,NCT04726098,Recruiting,30/06/2021,31/12/2022,No Results Posted,,,27/01/2021,https://clinicaltrials.gov/show/NCT04726098,30/06/2021,0,0
1435,NCT04726111,Recruiting,30/07/2021,30/08/2021,No Results Posted,,,27/01/2021,https://clinicaltrials.gov/show/NCT04726111,30/07/2021,0,0
1436,NCT04726163,Recruiting,14/06/2021,14/06/2021,No Results Posted,,,01/02/2021,https://clinicaltrials.gov/show/NCT04726163,14/06/2021,0,0
1437,NCT04726371,Recruiting,01/10/2022,01/10/2022,No Results Posted,,,27/01/2021,https://clinicaltrials.gov/show/NCT04726371,01/10/2022,0,0
1438,NCT04728594,Completed,17/01/2021,20/01/2021,No Results Posted,,,01/02/2021,https://clinicaltrials.gov/show/NCT04728594,17/01/2021,0,0
1439,NCT04728698,Not yet recruiting,01/09/2021,01/09/2021,No Results Posted,,,02/02/2021,https://clinicaltrials.gov/show/NCT04728698,01/09/2021,0,0
1440,NCT04728906,Not yet recruiting,19/10/2021,19/12/2021,No Results Posted,,,28/01/2021,https://clinicaltrials.gov/show/NCT04728906,19/10/2021,0,0
1441,NCT04728958,Not yet recruiting,01/04/2022,01/09/2022,No Results Posted,,,28/01/2021,https://clinicaltrials.gov/show/NCT04728958,01/04/2022,0,0
1442,NCT04729491,Completed,15/09/2020,07/10/2020,No Results Posted,,,28/01/2021,https://clinicaltrials.gov/show/NCT04729491,15/09/2020,0,0
1443,NCT04730284,Recruiting,30/09/2021,31/03/2022,No Results Posted,,,29/01/2021,https://clinicaltrials.gov/show/NCT04730284,30/09/2021,0,0
1444,NCT04730323,Completed,12/06/2020,12/06/2020,No Results Posted,"['Chachar AZK, Khan KA, Iqbal J, Shahid AH, Asif M, Fatima SA, Khan AA, Younis BB. ""Tocilizumab-an option for patients with COVID-19 associated cytokine release syndrome: A single center experience"", a retrospective study-original article. Ann Med Surg (Lond). 2021 Mar;63:102165. doi: 10.1016/j.amsu.2021.02.011. Epub 2021 Feb 8.']",,29/01/2021,https://clinicaltrials.gov/show/NCT04730323,12/06/2020,0,1
1445,NCT04730427,Recruiting,01/05/2021,01/04/2022,No Results Posted,,,29/01/2021,https://clinicaltrials.gov/show/NCT04730427,01/05/2021,0,0
1446,NCT04731051,Not yet recruiting,01/01/2022,01/01/2022,No Results Posted,,,02/07/2021,https://clinicaltrials.gov/show/NCT04731051,01/01/2022,0,0
1447,NCT04731116,Recruiting,31/12/2021,30/04/2022,No Results Posted,,,29/01/2021,https://clinicaltrials.gov/show/NCT04731116,31/12/2021,0,0
1448,NCT04733625,Completed,17/12/2020,17/12/2020,No Results Posted,,,02/02/2021,https://clinicaltrials.gov/show/NCT04733625,17/12/2020,0,0
1449,NCT04733833,Recruiting,30/06/2022,30/06/2022,No Results Posted,,,02/02/2021,https://clinicaltrials.gov/show/NCT04733833,30/06/2022,0,0
1450,NCT04734886,Recruiting,30/08/2021,31/12/2021,No Results Posted,,,02/02/2021,https://clinicaltrials.gov/show/NCT04734886,30/08/2021,0,0
1451,NCT04734912,Recruiting,15/06/2021,31/12/2021,No Results Posted,,,02/02/2021,https://clinicaltrials.gov/show/NCT04734912,15/06/2021,0,0
1452,NCT04325061,Terminated,19/06/2020,19/06/2020,No Results Posted,"['Villar J, A√±√≥n JM, Ferrando C, Aguilar G, Mu√±oz T, Ferreres J, Ambr√≥s A, Aldecoa C, Su√°rez-Sipmann F, Thorpe KE, J√ºni P, Slutsky AS; DEXA-COVID19 Network. Efficacy of dexamethasone treatment for patients with the acute respiratory distress syndrome caused by COVID-19: study protocol for a randomized controlled superiority trial. Trials. 2020 Aug 16;21(1):717. doi: 10.1186/s13063-020-04643-1.']","['Villar J, Belda J, A√±√≥n JM, Blanco J, P√©rez-M√©ndez L, Ferrando C, Mart√≠nez D, Soler JA, Ambr√≥s A, Mu√±oz T, Rivas R, Corpas R, D√≠az-Dominguez FJ, Soro M, Garc√≠a-Bello MA, Fern√°ndez RL, Kacmarek RM; DEXA-ARDS Network. Evaluating the efficacy of dexamethasone in the treatment of patients with persistent acute respiratory distress syndrome: study protocol for a randomized controlled trial. Trials. 2016 Jul 22;17:342. doi: 10.1186/s13063-016-1456-4.', 'Villar J, Ferrando C, Mart√≠nez D, Ambr√≥s A, Mu√±oz T, Soler JA, Aguilar G, Alba F, Gonz√°lez-Higueras E, Conesa LA, Mart√≠n-Rodr√≠guez C, D√≠az-Dom√≠nguez FJ, Serna-Grande P, Rivas R, Ferreres J, Belda J, Capilla L, Tallet A, A√±√≥n JM, Fern√°ndez RL, Gonz√°lez-Mart√≠n JM; dexamethasone in ARDS network. Dexamethasone treatment for the acute respiratory distress syndrome: a multicentre, randomised controlled trial. Lancet Respir Med. 2020 Mar;8(3):267-276. doi: 10.1016/S2213-2600(19)30417-5. Epub 2020 Feb 7.']",03/02/2021,https://clinicaltrials.gov/show/NCT04325061,19/06/2020,0,1
1453,NCT04334044,Completed,12/04/2021,30/04/2021,No Results Posted,,,07/07/2021,https://clinicaltrials.gov/show/NCT04334044,12/04/2021,0,0
1454,NCT04335084,Recruiting,01/12/2021,01/12/2021,No Results Posted,,,09/02/2021,https://clinicaltrials.gov/show/NCT04335084,01/12/2021,0,0
1455,NCT04344730,"Active, not recruiting",31/12/2021,31/12/2021,No Results Posted,,,09/02/2021,https://clinicaltrials.gov/show/NCT04344730,31/12/2021,0,0
1456,NCT04346199,Completed,17/11/2020,17/11/2020,No Results Posted,,,02/02/2021,https://clinicaltrials.gov/show/NCT04346199,17/11/2020,0,0
1457,NCT04348383,Recruiting,15/04/2021,15/05/2021,No Results Posted,,,09/02/2021,https://clinicaltrials.gov/show/NCT04348383,15/04/2021,0,0
1458,NCT04358926,Completed,15/10/2020,01/11/2020,No Results Posted,,,03/02/2021,https://clinicaltrials.gov/show/NCT04358926,15/10/2020,0,0
1459,NCT04359680,"Active, not recruiting",29/03/2021,29/03/2021,No Results Posted,,,08/02/2021,https://clinicaltrials.gov/show/NCT04359680,29/03/2021,0,0
1460,NCT04361344,Terminated,25/10/2020,25/10/2020,No Results Posted,,,04/02/2021,https://clinicaltrials.gov/show/NCT04361344,25/10/2020,0,0
1461,NCT04363346,"Active, not recruiting",01/01/2022,01/01/2022,No Results Posted,,,02/02/2021,https://clinicaltrials.gov/show/NCT04363346,01/01/2022,0,0
1462,NCT04370236,Recruiting,01/02/2021,01/02/2021,No Results Posted,,,05/02/2021,https://clinicaltrials.gov/show/NCT04370236,01/02/2021,0,0
1463,NCT04382625,Withdrawn,01/01/2022,01/06/2022,No Results Posted,,,05/02/2021,https://clinicaltrials.gov/show/NCT04382625,01/01/2022,0,0
1464,NCT04384731,Recruiting,29/05/2021,31/07/2021,No Results Posted,,,03/02/2021,https://clinicaltrials.gov/show/NCT04384731,29/05/2021,0,0
1465,NCT04385901,Completed,19/09/2020,19/09/2020,No Results Posted,,"['Holland AE, Hill CJ, Rochford P, Fiore J, Berlowitz DJ, McDonald CF. Telerehabilitation for people with chronic obstructive pulmonary disease: feasibility of a simple, real time model of supervised exercise training. J Telemed Telecare. 2013 Jun;19(4):222-6. doi: 10.1177/1357633X13487100. Epub 2013 May 23.', 'Cascella M, Rajnik M, Aleem A, Dulebohn SC, Di Napoli R. Features, Evaluation, and Treatment of Coronavirus (COVID-19). 2021 Apr 20. StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2021 Jan-. Available from http://www.ncbi.nlm.nih.gov/books/NBK554776/', 'Busija L, Pausenberger E, Haines TP, Haymes S, Buchbinder R, Osborne RH. Adult measures of general health and health-related quality of life: Medical Outcomes Study Short Form 36-Item (SF-36) and Short Form 12-Item (SF-12) Health Surveys, Nottingham Health Profile (NHP), Sickness Impact Profile (SIP), Medical Outcomes Study Short Form 6D (SF-6D), Health Utilities Index Mark 3 (HUI3), Quality of Well-Being Scale (QWB), and Assessment of Quality of Life (AQoL). Arthritis Care Res (Hoboken). 2011 Nov;63 Suppl 11:S383-412. doi: 10.1002/acr.20541. Review.']",08/02/2021,https://clinicaltrials.gov/show/NCT04385901,19/09/2020,0,1
1466,NCT04388683,"Active, not recruiting",30/04/2021,31/07/2021,No Results Posted,,,02/02/2021,https://clinicaltrials.gov/show/NCT04388683,30/04/2021,0,0
1467,NCT04407130,Completed,30/10/2020,20/11/2020,No Results Posted,,,04/02/2021,https://clinicaltrials.gov/show/NCT04407130,30/10/2020,0,0
1468,NCT04408027,Recruiting,01/06/2021,01/06/2021,No Results Posted,,,09/02/2021,https://clinicaltrials.gov/show/NCT04408027,01/06/2021,0,0
1469,NCT04409327,Terminated,27/12/2020,24/01/2021,Results Submitted,,,10/02/2021,https://clinicaltrials.gov/show/NCT04409327,27/12/2020,0,0
1470,NCT04409821,Recruiting,01/02/2022,01/02/2022,No Results Posted,,,03/02/2021,https://clinicaltrials.gov/show/NCT04409821,01/02/2022,0,0
1471,NCT04416399,Terminated,12/01/2021,12/01/2021,No Results Posted,"['Ramakrishnan S, Nicolau DV Jr, Langford B, Mahdi M, Jeffers H, Mwasuku C, Krassowska K, Fox R, Binnian I, Glover V, Bright S, Butler C, Cane JL, Halner A, Matthews PC, Donnelly LE, Simpson JL, Baker JR, Fadai NT, Peterson S, Bengtsson T, Barnes PJ, Russell REK, Bafadhel M. Inhaled budesonide in the treatment of early COVID-19 (STOIC): a phase 2, open-label, randomised controlled trial. Lancet Respir Med. 2021 Apr 9. pii: S2213-2600(21)00160-0. doi: 10.1016/S2213-2600(21)00160-0. [Epub ahead of print] Erratum in: Lancet Respir Med. 2021 Jun;9(6):e55.', 'Nicolau DV, Bafadhel M. Inhaled corticosteroids in virus pandemics: a treatment for COVID-19? Lancet Respir Med. 2020 Sep;8(9):846-847. doi: 10.1016/S2213-2600(20)30314-3. Epub 2020 Jul 30.']",,08/02/2021,https://clinicaltrials.gov/show/NCT04416399,12/01/2021,0,1
1472,NCT04435522,Completed,31/12/2020,31/12/2020,No Results Posted,,,04/02/2021,https://clinicaltrials.gov/show/NCT04435522,31/12/2020,0,0
1473,NCT04453657,Enrolling by invitation,01/09/2021,01/09/2021,No Results Posted,,,08/02/2021,https://clinicaltrials.gov/show/NCT04453657,01/09/2021,0,0
1474,NCT04459286,Recruiting,31/03/2021,30/04/2021,No Results Posted,"['Olagunju A, Fowotade A, Olagunoye A, Ojo TO, Adefuye BO, Fagbamigbe AF, Adebiyi AO, Olagunju OI, Ladipo OT, Akinloye A, Adeagbo BA, Onayade A, Bolaji OO, Happi C, Rannard S, Owen A. Efficacy and safety of nitazoxanide plus atazanavir/ritonavir for the treatment of moderate to severe COVID-19 (NACOVID): A structured summary of a study protocol for a randomised controlled trial. Trials. 2021 Jan 4;22(1):3. doi: 10.1186/s13063-020-04987-8.']",,02/02/2021,https://clinicaltrials.gov/show/NCT04459286,31/03/2021,0,1
1475,NCT04466241,Recruiting,26/03/2021,26/03/2021,No Results Posted,,,04/02/2021,https://clinicaltrials.gov/show/NCT04466241,26/03/2021,0,0
1476,NCT04490486,Not yet recruiting,01/06/2024,01/06/2024,No Results Posted,,,05/02/2021,https://clinicaltrials.gov/show/NCT04490486,01/06/2024,0,0
1477,NCT04492475,Completed,21/12/2020,21/12/2020,No Results Posted,"['Azzi Y, Bartash R, Scalea J, Loarte-Campos P, Akalin E. COVID-19 and Solid Organ Transplantation: A Review Article. Transplantation. 2021 Jan 1;105(1):37-55. doi: 10.1097/TP.0000000000003523. Review.']",,09/02/2021,https://clinicaltrials.gov/show/NCT04492475,21/12/2020,0,1
1478,NCT04510454,Recruiting,01/05/2021,01/05/2021,No Results Posted,,,09/02/2021,https://clinicaltrials.gov/show/NCT04510454,01/05/2021,0,0
1479,NCT04511923,Recruiting,01/12/2021,01/01/2022,No Results Posted,,,10/02/2021,https://clinicaltrials.gov/show/NCT04511923,01/12/2021,0,0
1480,NCT04511949,Completed,30/09/2020,30/11/2020,No Results Posted,,,03/02/2021,https://clinicaltrials.gov/show/NCT04511949,30/09/2020,0,0
1481,NCT04525417,Completed,25/09/2020,25/10/2020,No Results Posted,,,03/02/2021,https://clinicaltrials.gov/show/NCT04525417,25/09/2020,0,0
1482,NCT04529499,"Active, not recruiting",31/03/2021,31/03/2021,No Results Posted,,,03/02/2021,https://clinicaltrials.gov/show/NCT04529499,31/03/2021,0,0
1483,NCT04536376,"Active, not recruiting",02/08/2021,31/12/2021,No Results Posted,,,06/07/2021,https://clinicaltrials.gov/show/NCT04536376,02/08/2021,0,0
1484,NCT04542395,Not yet recruiting,30/11/2022,30/11/2022,No Results Posted,,,04/02/2021,https://clinicaltrials.gov/show/NCT04542395,30/11/2022,0,0
1485,NCT04548934,Completed,31/10/2020,31/01/2021,No Results Posted,,,02/02/2021,https://clinicaltrials.gov/show/NCT04548934,31/10/2020,0,0
1486,NCT04581200,Recruiting,31/07/2021,30/09/2021,No Results Posted,,,03/02/2021,https://clinicaltrials.gov/show/NCT04581200,31/07/2021,0,0
1487,NCT04584567,Recruiting,01/02/2021,01/03/2021,No Results Posted,,,05/02/2021,https://clinicaltrials.gov/show/NCT04584567,01/02/2021,0,0
1488,NCT04584710,"Active, not recruiting",01/02/2021,01/02/2021,Results Submitted,,,09/02/2021,https://clinicaltrials.gov/show/NCT04584710,01/02/2021,0,0
1489,NCT04603079,Not yet recruiting,01/08/2021,01/09/2021,No Results Posted,,,03/02/2021,https://clinicaltrials.gov/show/NCT04603079,01/08/2021,0,0
1490,NCT04607915,Not yet recruiting,31/03/2021,31/03/2021,No Results Posted,,,04/02/2021,https://clinicaltrials.gov/show/NCT04607915,31/03/2021,0,0
1491,NCT04615429,"Active, not recruiting",04/01/2021,01/01/2022,No Results Posted,"['Payares-Herrera C, Mart√≠nez-Mu√±oz ME, Vallhonrat IL, de Molina RM, Torres MP, Trisan A, de Diego IS, Alonso R, Zafra R, Donaire T, S√°nchez R, Rubio JJ, Duarte Palomino RF, Sol√° CA. Double-blind, randomized, controlled, trial to assess the efficacy of allogenic mesenchymal stromal cells in patients with acute respiratory distress syndrome due to COVID-19 (COVID-AT): A structured summary of a study protocol for a randomised controlled trial. Trials. 2021 Jan 6;22(1):9. doi: 10.1186/s13063-020-04964-1.']",,08/02/2021,https://clinicaltrials.gov/show/NCT04615429,04/01/2021,0,1
1492,NCT04639375,Recruiting,18/04/2021,18/04/2021,No Results Posted,,,02/02/2021,https://clinicaltrials.gov/show/NCT04639375,18/04/2021,0,0
1493,NCT04643678,Recruiting,30/04/2021,30/10/2021,No Results Posted,,,10/02/2021,https://clinicaltrials.gov/show/NCT04643678,30/04/2021,0,0
1494,NCT04647747,Recruiting,30/03/2021,31/12/2021,No Results Posted,,,04/02/2021,https://clinicaltrials.gov/show/NCT04647747,30/03/2021,0,0
1495,NCT04663555,Recruiting,31/03/2022,31/03/2023,No Results Posted,"['Mal√°ska J, Sta≈°ek J, Du≈°ka F, Bal√≠k M, M√°ca J, Hruda J, Vymazal T, Klementov√° O, Zatloukal J, Gabrhel√≠k T, Novotn√Ω P, Demlov√° R, Kub√°tov√° J, Vinklerov√° J, Svobodn√≠k A, Kratochv√≠l M, Kluƒçka J, G√°l R, Singer M; REMED Study Group. Effect of dexamethasone in patients with ARDS and COVID-19 - prospective, multi-centre, open-label, parallel-group, randomised controlled trial (REMED trial): A structured summary of a study protocol for a randomised controlled trial. Trials. 2021 Mar 1;22(1):172. doi: 10.1186/s13063-021-05116-9.']",,04/02/2021,https://clinicaltrials.gov/show/NCT04663555,31/03/2022,0,1
1496,NCT04663945,Recruiting,01/06/2021,01/08/2021,No Results Posted,,,05/02/2021,https://clinicaltrials.gov/show/NCT04663945,01/06/2021,0,0
1497,NCT04668625,Completed,20/12/2020,08/01/2021,No Results Posted,"['Revollo B, Blanco I, Soler P, Toro J, Izquierdo-Useros N, Puig J, Puig X, Navarro-P√©rez V, Casa√± C, Ruiz L, Perez-Zsolt D, Videla S, Clotet B, Llibre JM. Same-day SARS-CoV-2 antigen test screening in an indoor mass-gathering live music event: a randomised controlled trial. Lancet Infect Dis. 2021 May 27. pii: S1473-3099(21)00268-1. doi: 10.1016/S1473-3099(21)00268-1. [Epub ahead of print]']",,08/02/2021,https://clinicaltrials.gov/show/NCT04668625,20/12/2020,0,1
1498,NCT04672395,Not yet recruiting,01/07/2022,01/07/2022,No Results Posted,,,09/02/2021,https://clinicaltrials.gov/show/NCT04672395,01/07/2022,0,0
1499,NCT04678687,"Active, not recruiting",01/06/2021,01/01/2022,No Results Posted,,,03/02/2021,https://clinicaltrials.gov/show/NCT04678687,01/06/2021,0,0
1500,NCT04678700,Recruiting,01/06/2021,01/08/2021,No Results Posted,,,03/02/2021,https://clinicaltrials.gov/show/NCT04678700,01/06/2021,0,0
1501,NCT04703036,Recruiting,31/12/2021,31/12/2021,No Results Posted,,,04/02/2021,https://clinicaltrials.gov/show/NCT04703036,31/12/2021,0,0
1502,NCT04713488,"Active, not recruiting",20/07/2021,31/07/2021,No Results Posted,,,02/02/2021,https://clinicaltrials.gov/show/NCT04713488,20/07/2021,0,0
1503,NCT04730661,Recruiting,21/12/2021,28/12/2021,No Results Posted,,,09/02/2021,https://clinicaltrials.gov/show/NCT04730661,21/12/2021,0,0
1504,NCT04733651,Not yet recruiting,20/05/2021,15/08/2021,No Results Posted,,,05/02/2021,https://clinicaltrials.gov/show/NCT04733651,20/05/2021,0,0
1505,NCT04734171,Completed,16/04/2020,16/04/2020,No Results Posted,,,02/02/2021,https://clinicaltrials.gov/show/NCT04734171,16/04/2020,0,0
1506,NCT04734717,Enrolling by invitation,12/04/2021,12/04/2021,No Results Posted,,,02/02/2021,https://clinicaltrials.gov/show/NCT04734717,12/04/2021,0,0
1507,NCT04738175,Not yet recruiting,01/11/2021,01/11/2021,No Results Posted,,,04/02/2021,https://clinicaltrials.gov/show/NCT04738175,01/11/2021,0,0
1508,NCT04739410,Completed,30/06/2020,30/06/2020,No Results Posted,,,04/02/2021,https://clinicaltrials.gov/show/NCT04739410,30/06/2020,0,0
1509,NCT04742049,Recruiting,01/03/2021,01/03/2021,No Results Posted,,,05/02/2021,https://clinicaltrials.gov/show/NCT04742049,01/03/2021,0,0
1510,NCT04742595,Recruiting,31/03/2022,31/03/2022,No Results Posted,,,08/02/2021,https://clinicaltrials.gov/show/NCT04742595,31/03/2022,0,0
1511,NCT04742738,Recruiting,01/08/2021,01/04/2022,No Results Posted,"[""Arunachalam PS, Walls AC, Golden N, Atyeo C, Fischinger S, Li C, Aye P, Navarro MJ, Lai L, Edara VV, R√∂ltgen K, Rogers K, Shirreff L, Ferrell DE, Wrenn S, Pettie D, Kraft JC, Miranda MC, Kepl E, Sydeman C, Brunette N, Murphy M, Fiala B, Carter L, White AG, Trisal M, Hsieh CL, Russell-Lodrigue K, Monjure C, Dufour J, Spencer S, Doyle-Meyers L, Bohm RP, Maness NJ, Roy C, Plante JA, Plante KS, Zhu A, Gorman MJ, Shin S, Shen X, Fontenot J, Gupta S, O'Hagan DT, Van Der Most R, Rappuoli R, Coffman RL, Novack D, McLellan JS, Subramaniam S, Montefiori D, Boyd SD, Flynn JL, Alter G, Villinger F, Kleanthous H, Rappaport J, Suthar MS, King NP, Veesler D, Pulendran B. Adjuvanting a subunit COVID-19 vaccine to induce protective immunity. Nature. 2021 Jun;594(7862):253-258. doi: 10.1038/s41586-021-03530-2. Epub 2021 Apr 19.""]",,08/02/2021,https://clinicaltrials.gov/show/NCT04742738,01/08/2021,0,1
1512,NCT04742842,Not yet recruiting,30/06/2022,31/12/2022,No Results Posted,,,08/02/2021,https://clinicaltrials.gov/show/NCT04742842,30/06/2022,0,0
1513,NCT04742946,Not yet recruiting,30/05/2021,30/09/2021,No Results Posted,"['Pastora-Bernal JM, Estebanez-P√©rez MJ, Molina-Torres G, Garc√≠a-L√≥pez FJ, Sobrino-S√°nchez R, Mart√≠n-Valero R. Telerehabilitation Intervention in Patients with COVID-19 after Hospital Discharge to Improve Functional Capacity and Quality of Life. Study Protocol for a Multicenter Randomized Clinical Trial. Int J Environ Res Public Health. 2021 Mar 12;18(6). pii: 2924. doi: 10.3390/ijerph18062924.']","['Del Rio C, Malani PN. 2019 Novel Coronavirus-Important Information for Clinicians. JAMA. 2020 Mar 17;323(11):1039-1040. doi: 10.1001/jama.2020.1490.', ""Sohrabi C, Alsafi Z, O'Neill N, Khan M, Kerwan A, Al-Jabir A, Iosifidis C, Agha R. World Health Organization declares global emergency: A review of the 2019 novel coronavirus (COVID-19). Int J Surg. 2020 Apr;76:71-76. doi: 10.1016/j.ijsu.2020.02.034. Epub 2020 Feb 26. Review. Erratum in: Int J Surg. 2020 May;77:217."", 'Fu L, Wang B, Yuan T, Chen X, Ao Y, Fitzpatrick T, Li P, Zhou Y, Lin YF, Duan Q, Luo G, Fan S, Lu Y, Feng A, Zhan Y, Liang B, Cai W, Zhang L, Du X, Li L, Shu Y, Zou H. Clinical characteristics of coronavirus disease 2019 (COVID-19) in China: A systematic review and meta-analysis. J Infect. 2020 Jun;80(6):656-665. doi: 10.1016/j.jinf.2020.03.041. Epub 2020 Apr 10.']",10/02/2021,https://clinicaltrials.gov/show/NCT04742946,30/05/2021,0,1
1514,NCT04743232,Recruiting,31/12/2021,31/01/2022,No Results Posted,,,10/02/2021,https://clinicaltrials.gov/show/NCT04743232,31/12/2021,0,0
1515,NCT04743349,Recruiting,31/10/2021,31/10/2021,No Results Posted,,,08/02/2021,https://clinicaltrials.gov/show/NCT04743349,31/10/2021,0,0
1516,NCT04743908,Not yet recruiting,01/12/2023,01/12/2023,No Results Posted,,,08/02/2021,https://clinicaltrials.gov/show/NCT04743908,01/12/2023,0,0
1517,NCT04748471,Not yet recruiting,01/07/2021,25/01/2023,No Results Posted,,,10/02/2021,https://clinicaltrials.gov/show/NCT04748471,01/07/2021,0,0
1518,NCT04296643,Recruiting,01/02/2021,01/04/2021,No Results Posted,"['Sch√ºnemann HJ, Akl EA, Chou R, Chu DK, Loeb M, Lotfi T, Mustafa RA, Neumann I, Saxinger L, Sultan S, Mertz D. Use of facemasks during the COVID-19 pandemic. Lancet Respir Med. 2020 Oct;8(10):954-955. doi: 10.1016/S2213-2600(20)30352-0. Epub 2020 Aug 3.']",,12/02/2021,https://clinicaltrials.gov/show/NCT04296643,01/02/2021,0,1
1519,NCT04311177,Completed,01/02/2021,01/02/2021,No Results Posted,"['Puskarich MA, Cummins NW, Ingraham NE, Wacker DA, Reilkoff RA, Driver BE, Biros MH, Bellolio F, Chipman JG, Nelson AC, Beckman K, Langlois R, Bold T, Aliota MT, Schacker TW, Voelker HT, Murray TA, Koopmeiners JS, Tignanelli CJ. A multi-center phase II randomized clinical trial of losartan on symptomatic outpatients with COVID-19. EClinicalMedicine. 2021 Jun 17;37:100957. doi: 10.1016/j.eclinm.2021.100957. eCollection 2021 Jul.', 'Smolander J, Bruchfeld A. [COVID-19 and kidney disease]. Lakartidningen. 2020 Jul 13;117. pii: 20110. Swedish.']",,15/02/2021,https://clinicaltrials.gov/show/NCT04311177,01/02/2021,0,1
1520,NCT04322396,Terminated,02/02/2021,02/02/2021,Study Results,"['Sivapalan P, Ulrik CS, Lappere TS, Ekl√∂f JV, Shaker SB, B√∏dtger UCS, Browatzki A, Meyer CN, Weinreich UM, Laursen CB, Biering-S√∏rensen T, Knop FK, Lundgren JD, Jensen JS. Proactive prophylaxis with azithromycin and hydroxychloroquine in hospitalized patients with COVID-19 (ProPAC-COVID): a statistical analysis plan. Trials. 2020 Oct 20;21(1):867. doi: 10.1186/s13063-020-04795-0.', 'Sivapalan P, Ulrik CS, Bojesen RD, Lapperre TS, Ekl√∂f JV, H√•kansson KEJ, Browatzki A, Tidemansen C, Wilcke JT, Janner J, Gottlieb V, Meteran H, Porsbjerg C, Madsen BL, Moberg M, Pedersen L, Benfield TL, Lundgren JD, Knop FK, Biering-S√∏rensen T, Ghanizada M, Sonne TP, B√∏dtger UCS, Jensen SG, Rasmussen DB, Br√∏ndum E, Tupper OD, S√∏rensen SW, Alstrup G, Laursen CB, M√∏ller UW, Sverrild A, Jensen JS. Proactive Prophylaxis With Azithromycin and HydroxyChloroquine in Hospitalised Patients With COVID-19 (ProPAC-COVID): A structured summary of a study protocol for a randomised controlled trial. Trials. 2020 Jun 10;21(1):513. doi: 10.1186/s13063-020-04409-9.']",,29/06/2021,https://clinicaltrials.gov/show/NCT04322396,02/02/2021,1,1
1521,NCT04328012,Recruiting,01/06/2021,01/08/2021,No Results Posted,,,16/02/2021,https://clinicaltrials.gov/show/NCT04328012,01/06/2021,0,0
1522,NCT04331600,Completed,17/12/2020,17/12/2020,No Results Posted,,,11/02/2021,https://clinicaltrials.gov/show/NCT04331600,17/12/2020,0,0
1523,NCT04333355,Terminated,20/08/2020,20/08/2020,No Results Posted,,,10/02/2021,https://clinicaltrials.gov/show/NCT04333355,20/08/2020,0,0
1524,NCT04335201,Recruiting,20/06/2021,31/08/2021,No Results Posted,,,16/02/2021,https://clinicaltrials.gov/show/NCT04335201,20/06/2021,0,0
1525,NCT04336332,"Active, not recruiting",30/04/2021,30/04/2021,No Results Posted,,,12/02/2021,https://clinicaltrials.gov/show/NCT04336332,30/04/2021,0,0
1526,NCT04337918,Completed,31/01/2021,02/02/2021,No Results Posted,,,10/02/2021,https://clinicaltrials.gov/show/NCT04337918,31/01/2021,0,0
1527,NCT04338828,"Active, not recruiting",01/04/2021,01/04/2022,No Results Posted,,,16/02/2021,https://clinicaltrials.gov/show/NCT04338828,01/04/2021,0,0
1528,NCT04342728,Completed,30/12/2020,11/02/2021,No Results Posted,"[""Thomas S, Patel D, Bittel B, Wolski K, Wang Q, Kumar A, Il'Giovine ZJ, Mehra R, McWilliams C, Nissen SE, Desai MY. Effect of High-Dose Zinc and Ascorbic Acid Supplementation vs Usual Care on Symptom Length and Reduction Among Ambulatory Patients With SARS-CoV-2 Infection: The COVID A to Z Randomized Clinical Trial. JAMA Netw Open. 2021 Feb 1;4(2):e210369. doi: 10.1001/jamanetworkopen.2021.0369.""]",,16/02/2021,https://clinicaltrials.gov/show/NCT04342728,30/12/2020,0,1
1529,NCT04346147,Recruiting,01/06/2021,01/09/2021,No Results Posted,,,10/02/2021,https://clinicaltrials.gov/show/NCT04346147,01/06/2021,0,0
1530,NCT04348864,Recruiting,01/04/2021,01/04/2021,No Results Posted,,,16/02/2021,https://clinicaltrials.gov/show/NCT04348864,01/04/2021,0,0
1531,NCT04349371,Terminated,07/01/2021,07/01/2021,No Results Posted,,,10/02/2021,https://clinicaltrials.gov/show/NCT04349371,07/01/2021,0,0
1532,NCT04349618,Recruiting,15/04/2023,15/04/2023,No Results Posted,,,15/02/2021,https://clinicaltrials.gov/show/NCT04349618,15/04/2023,0,0
1533,NCT04352959,Completed,11/12/2020,11/12/2020,No Results Posted,"['Carrouel F, Viennot S, Valette M, Cohen JM, Dussart C, Bourgeois D. Salivary and Nasal Detection of the SARS-CoV-2 Virus After Antiviral Mouthrinses (BBCovid): A structured summary of a study protocol for a randomised controlled trial. Trials. 2020 Nov 2;21(1):906. doi: 10.1186/s13063-020-04846-6.', 'Burton MJ, Clarkson JE, Goulao B, Glenny AM, McBain AJ, Schilder AG, Webster KE, Worthington HV. Antimicrobial mouthwashes (gargling) and nasal sprays administered to patients with suspected or confirmed COVID-19 infection to improve patient outcomes and to protect healthcare workers treating them. Cochrane Database Syst Rev. 2020 Sep 16;9:CD013627. doi: 10.1002/14651858.CD013627.pub2.']",,11/02/2021,https://clinicaltrials.gov/show/NCT04352959,11/12/2020,0,1
1534,NCT04357366,Recruiting,15/04/2022,15/04/2022,No Results Posted,"['Kyriazopoulou E, Panagopoulos P, Metallidis S, Dalekos GN, Poulakou G, Gatselis N, Karakike E, Saridaki M, Loli G, Stefos A, Prasianaki D, Georgiadou S, Tsachouridou O, Petrakis V, Tsiakos K, Kosmidou M, Lygoura V, Dareioti M, Milionis H, Papanikolaou IC, Akinosoglou K, Myrodia DM, Gravvani A, Stamou A, Gkavogianni T, Katrini K, Marantos T, Trontzas IP, Syrigos K, Chatzis L, Chatzis S, Vechlidis N, Avgoustou C, Chalvatzis S, Kyprianou M, van der Meer JW, Eugen-Olsen J, Netea MG, Giamarellos-Bourboulis EJ. An open label trial of anakinra to prevent respiratory failure in COVID-19. Elife. 2021 Mar 8;10. pii: e66125. doi: 10.7554/eLife.66125.']",,15/02/2021,https://clinicaltrials.gov/show/NCT04357366,15/04/2022,0,1
1535,NCT04357808,Completed,30/11/2020,04/12/2020,No Results Posted,"['Garcia-Vicu√±a R, Abad-Santos F, Gonz√°lez-Alvaro I, Ramos-Lima F, Sanz JS. Subcutaneous Sarilumab in hospitalised patients with moderate-severe COVID-19 infection compared to the standard of care (SARCOVID): a structured summary of a study protocol for a randomised controlled trial. Trials. 2020 Sep 9;21(1):772. doi: 10.1186/s13063-020-04588-5.']",,11/02/2021,https://clinicaltrials.gov/show/NCT04357808,30/11/2020,0,1
1536,NCT04361448,Terminated,30/06/2020,30/06/2020,No Results Posted,,,15/02/2021,https://clinicaltrials.gov/show/NCT04361448,30/06/2020,0,0
1537,NCT04363827,"Active, not recruiting",01/06/2021,01/09/2021,No Results Posted,"['Nanni O, Viale P, Vertogen B, Lilli C, Zingaretti C, Donati C, Masini C, Monti M, Serra P, Vespignani R, Grossi V, Biggeri A, Scarpi E, Galardi F, Bertoni L, Colamartini A, Falcini F, Altini M, Massa I, Gaggeri R, Martinelli G. PROTECT Trial: A cluster-randomized study with hydroxychloroquine versus observational support for prevention or early-phase treatment of Coronavirus disease (COVID-19): A structured summary of a study protocol for a randomized controlled trial. Trials. 2020 Jul 31;21(1):689. doi: 10.1186/s13063-020-04527-4.']",,12/02/2021,https://clinicaltrials.gov/show/NCT04363827,01/06/2021,0,1
1538,NCT04366908,Recruiting,30/06/2021,30/06/2021,No Results Posted,"['Stroehlein JK, Wallqvist J, Iannizzi C, Mikolajewska A, Metzendorf MI, Benstoem C, Meybohm P, Becker M, Skoetz N, Stegemann M, Piechotta V. Vitamin D supplementation for the treatment of COVID-19: a living systematic review. Cochrane Database Syst Rev. 2021 May 24;5:CD015043. doi: 10.1002/14651858.CD015043.']",,15/02/2021,https://clinicaltrials.gov/show/NCT04366908,30/06/2021,0,1
1539,NCT04368156,"Active, not recruiting",23/02/2021,23/02/2021,No Results Posted,"['Tornero C, Vallejo R, Cede√±o D, Ordu√±a J, Pastor E, Belaouchi M, Escamilla B, Laredo M, Del Mar Garzando M. A prospective, randomized, controlled study assessing vagus nerve stimulation using the gammaCore¬Æ-Sapphire device for patients with moderate to severe CoViD-19 Respiratory Symptoms (SAVIOR): A structured summary of a study protocol for a randomised controlled trial"". Trials. 2020 Jun 26;21(1):576. doi: 10.1186/s13063-020-04486-w.']",,16/02/2021,https://clinicaltrials.gov/show/NCT04368156,23/02/2021,0,1
1540,NCT04378920,Recruiting,30/06/2021,30/06/2021,No Results Posted,,,16/02/2021,https://clinicaltrials.gov/show/NCT04378920,30/06/2021,0,0
1541,NCT04384965,Recruiting,01/05/2022,01/11/2022,No Results Posted,,,15/02/2021,https://clinicaltrials.gov/show/NCT04384965,01/05/2022,0,0
1542,NCT04389294,Completed,16/06/2020,04/09/2020,No Results Posted,,,11/02/2021,https://clinicaltrials.gov/show/NCT04389294,16/06/2020,0,0
1543,NCT04392453,Recruiting,01/12/2021,01/12/2021,No Results Posted,,,15/02/2021,https://clinicaltrials.gov/show/NCT04392453,01/12/2021,0,0
1544,NCT04392531,Recruiting,01/03/2021,01/03/2021,No Results Posted,,,10/02/2021,https://clinicaltrials.gov/show/NCT04392531,01/03/2021,0,0
1545,NCT04394403,Recruiting,31/12/2021,30/06/2022,No Results Posted,,,09/02/2021,https://clinicaltrials.gov/show/NCT04394403,31/12/2021,0,0
1546,NCT04397705,Recruiting,01/04/2021,01/04/2021,No Results Posted,,,11/02/2021,https://clinicaltrials.gov/show/NCT04397705,01/04/2021,0,0
1547,NCT04409483,Withdrawn,31/12/2020,31/12/2020,No Results Posted,,,10/02/2021,https://clinicaltrials.gov/show/NCT04409483,31/12/2020,0,0
1548,NCT04414293,Recruiting,31/07/2021,31/12/2021,No Results Posted,,,15/02/2021,https://clinicaltrials.gov/show/NCT04414293,31/07/2021,0,0
1549,NCT04436458,Not yet recruiting,01/08/2021,01/12/2021,No Results Posted,,,16/02/2021,https://clinicaltrials.gov/show/NCT04436458,01/08/2021,0,0
1550,NCT04449588,Recruiting,07/08/2021,07/08/2022,No Results Posted,,,11/02/2021,https://clinicaltrials.gov/show/NCT04449588,07/08/2021,0,0
1551,NCT04456595,"Active, not recruiting",17/12/2020,01/02/2022,No Results Posted,,,11/02/2021,https://clinicaltrials.gov/show/NCT04456595,17/12/2020,0,0
1552,NCT04472585,Recruiting,15/08/2021,30/10/2021,No Results Posted,,,17/02/2021,https://clinicaltrials.gov/show/NCT04472585,15/08/2021,0,0
1553,NCT04490824,Recruiting,30/03/2021,30/04/2021,No Results Posted,,,12/02/2021,https://clinicaltrials.gov/show/NCT04490824,30/03/2021,0,0
1554,NCT04494984,Completed,23/11/2020,30/12/2020,No Results Posted,"['Piechotta V, Iannizzi C, Chai KL, Valk SJ, Kimber C, Dorando E, Monsef I, Wood EM, Lamikanra AA, Roberts DJ, McQuilten Z, So-Osman C, Estcourt LJ, Skoetz N. Convalescent plasma or hyperimmune immunoglobulin for people with COVID-19: a living systematic review. Cochrane Database Syst Rev. 2021 May 20;5:CD013600. doi: 10.1002/14651858.CD013600.pub4.', 'Lopardo G, Belloso WH, Nannini E, Colonna M, Sanguineti S, Zylberman V, Mu√±oz L, Dobarro M, Lebersztein G, Farina J, Vidiella G, Bertetti A, Crudo F, Alzogaray MF, Barcelona L, Teijeiro R, Lambert S, Scublinsky D, Iacono M, Stanek V, Solari R, Cruz P, Casas MM, Abusamra L, Luciardi HL, Cremona A, Caruso D, de Miguel B, Lloret SP, Mill√°n S, Kilstein Y, Pereiro A, Sued O, Cahn P, Spatz L, Goldbaum F; INM005 Study Group. RBD-specific polyclonal F(ab¬¥)(2) fragments of equine antibodies in patients with moderate to severe COVID-19 disease: A randomized, multicenter, double-blind, placebo-controlled, adaptive phase 2/3 clinical trial. EClinicalMedicine. 2021 Apr;34:100843. doi: 10.1016/j.eclinm.2021.100843. Epub 2021 Apr 11.']",,11/02/2021,https://clinicaltrials.gov/show/NCT04494984,23/11/2020,0,1
1555,NCT04501458,"Active, not recruiting",10/06/2021,10/06/2021,No Results Posted,,,16/02/2021,https://clinicaltrials.gov/show/NCT04501458,10/06/2021,0,0
1556,NCT04512079,Recruiting,01/12/2021,01/03/2022,No Results Posted,,,11/02/2021,https://clinicaltrials.gov/show/NCT04512079,01/12/2021,0,0
1557,NCT04517162,Recruiting,19/02/2021,19/06/2021,No Results Posted,,"['Channappanavar R, Fehr AR, Vijay R, Mack M, Zhao J, Meyerholz DK, Perlman S. Dysregulated Type I Interferon and Inflammatory Monocyte-Macrophage Responses Cause Lethal Pneumonia in SARS-CoV-Infected Mice. Cell Host Microbe. 2016 Feb 10;19(2):181-93. doi: 10.1016/j.chom.2016.01.007.', 'Elhai M, Avouac J, Allanore Y. Circulating lung biomarkers in idiopathic lung fibrosis and interstitial lung diseases associated with connective tissue diseases: Where do we stand? Semin Arthritis Rheum. 2020 Jun;50(3):480-491. doi: 10.1016/j.semarthrit.2020.01.006. Epub 2020 Jan 28.', 'Feldmann M, Maini RN, Woody JN, Holgate ST, Winter G, Rowland M, Richards D, Hussell T. Trials of anti-tumour necrosis factor therapy for COVID-19 are urgently needed. Lancet. 2020 May 2;395(10234):1407-1409. doi: 10.1016/S0140-6736(20)30858-8. Epub 2020 Apr 9.', 'Furuzawa-Carballeda J, Lima G, Llorente L, Nu√±ez-√Ålvarez C, Ruiz-Ordaz BH, Echevarr√≠a-Zuno S, Hern√°ndez-Cuevas V. Polymerized-type I collagen downregulates inflammation and improves clinical outcomes in patients with symptomatic knee osteoarthritis following arthroscopic lavage: a randomized, double-blind, and placebo-controlled clinical trial. ScientificWorldJournal. 2012;2012:342854. doi: 10.1100/2012/342854. Epub 2012 Apr 1.', 'Furuzawa-Carballeda J, Mu√±oz-Chabl√© OA, Barrios-Pay√°n J, Hern√°ndez-Pando R. Effect of polymerized-type I collagen in knee osteoarthritis. I. In vitro study. Eur J Clin Invest. 2009 Jul;39(7):591-7. doi: 10.1111/j.1365-2362.2009.02154.x.', 'Furuzawa-Carballeda J, Mu√±oz-Chabl√© OA, Mac√≠as-Hern√°ndez SI, Agualimpia-Janning A. Effect of polymerized-type I collagen in knee osteoarthritis. II. In vivo study. Eur J Clin Invest. 2009 Jul;39(7):598-606. doi: 10.1111/j.1365-2362.2009.02144.x. Epub 2009 Apr 23.', 'Furuzawa-Carballeda J, Alcocer-Varela J, Diaz de Le√≥n L. Collagen-PVP decreases collagen turnover in synovial tissue cultures from rheumatoid arthritis patients. Ann N Y Acad Sci. 1999 Jun 30;878:598-602.', 'Furuzawa-Carballeda J, Cabral AR, Zapata-Zu√±iga M, Alcocer-Varela J. Subcutaneous administration of polymerized-type I collagen for the treatment of patients with rheumatoid arthritis. An open-label pilot trial. J Rheumatol. 2003 Feb;30(2):256-9.', 'Furuzawa-Carballeda J, Fenutria-Ausmequet R, Gil-Espinosa V, Lozano-Soto F, Teliz-Meneses MA, Romero-Trejo C, Alcocer-Varela J. Polymerized-type I collagen for the treatment of patients with rheumatoid arthritis. Effect of intramuscular administration in a double blind placebo-controlled clinical trial. Clin Exp Rheumatol. 2006 Sep-Oct;24(5):514-20.', 'Furuzawa-Carballeda J, Kr√∂tzsch E, Barile-Fabris L, Alcal√° M, Espinosa-Morales R. Subcutaneous administration of collagen-polyvinylpyrrolidone down regulates IL-1beta, TNF-alpha, TGF-beta1, ELAM-1 and VCAM-1 expression in scleroderma skin lesions. Clin Exp Dermatol. 2005 Jan;30(1):83-6.', 'Furuzawa-Carballeda J, Macip-Rodr√≠guez P, Galindo-Feria AS, Cruz-Robles D, Soto-Abraham V, Escobar-Hern√°ndez S, Aguilar D, Alpizar-Rodr√≠guez D, F√©rez-Blando K, Llorente L. Polymerized-type I collagen induces upregulation of Foxp3-expressing CD4 regulatory T cells and downregulation of IL-17-producing CD4‚Å∫ T cells (Th17) cells in collagen-induced arthritis. Clin Dev Immunol. 2012;2012:618608. doi: 10.1155/2012/618608. Epub 2011 Oct 19.', 'Furuzawa-Carballeda J, Ort√≠z-√Åvalos M, Lima G, Jurado-Santa Cruz F, Llorente L. Subcutaneous administration of polymerized type I collagen downregulates interleukin (IL)-17A, IL-22 and transforming growth factor-Œ≤1 expression, and increases Foxp3-expressing cells in localized scleroderma. Clin Exp Dermatol. 2012 Aug;37(6):599-609. doi: 10.1111/j.1365-2230.2012.04385.x. Epub 2012 Jun 25.', 'Furuzawa-Carballeda J, Rojas E, Valverde M, Castillo I, Diaz de Le√≥n L, Kr√∂tzsch E. Cellular and humoral responses to collagen-polyvinylpyrrolidone administered during short and long periods in humans. Can J Physiol Pharmacol. 2003 Nov;81(11):1029-35.', 'Huang C, Wang Y, Li X, Ren L, Zhao J, Hu Y, Zhang L, Fan G, Xu J, Gu X, Cheng Z, Yu T, Xia J, Wei Y, Wu W, Xie X, Yin W, Li H, Liu M, Xiao Y, Gao H, Guo L, Xie J, Wang G, Jiang R, Gao Z, Jin Q, Wang J, Cao B. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet. 2020 Feb 15;395(10223):497-506. doi: 10.1016/S0140-6736(20)30183-5. Epub 2020 Jan 24. Erratum in: Lancet. 2020 Jan 30;:.', 'Kr√∂tzsch-G√≥mez FE, Furuzawa-Carballeda J, Reyes-M√°rquez R, Quir√≥z-Hern√°ndez E, D√≠az de Le√≥n L. Cytokine expression is downregulated by collagen-polyvinylpyrrolidone in hypertrophic scars. J Invest Dermatol. 1998 Nov;111(5):828-34.', 'Leng Z, Zhu R, Hou W, Feng Y, Yang Y, Han Q, Shan G, Meng F, Du D, Wang S, Fan J, Wang W, Deng L, Shi H, Li H, Hu Z, Zhang F, Gao J, Liu H, Li X, Zhao Y, Yin K, He X, Gao Z, Wang Y, Yang B, Jin R, Stambler I, Lim LW, Su H, Moskalev A, Cano A, Chakrabarti S, Min KJ, Ellison-Hughes G, Caruso C, Jin K, Zhao RC. Transplantation of ACE2(-) Mesenchymal Stem Cells Improves the Outcome of Patients with COVID-19 Pneumonia. Aging Dis. 2020 Mar 9;11(2):216-228. doi: 10.14336/AD.2020.0228. eCollection 2020 Apr.', 'Liang W, Liang H, Ou L, Chen B, Chen A, Li C, Li Y, Guan W, Sang L, Lu J, Xu Y, Chen G, Guo H, Guo J, Chen Z, Zhao Y, Li S, Zhang N, Zhong N, He J; China Medical Treatment Expert Group for COVID-19. Development and Validation of a Clinical Risk Score to Predict the Occurrence of Critical Illness in Hospitalized Patients With COVID-19. JAMA Intern Med. 2020 Aug 1;180(8):1081-1089. doi: 10.1001/jamainternmed.2020.2033.', 'Mehta P, McAuley DF, Brown M, Sanchez E, Tattersall RS, Manson JJ; HLH Across Speciality Collaboration, UK. COVID-19: consider cytokine storm syndromes and immunosuppression. Lancet. 2020 Mar 28;395(10229):1033-1034. doi: 10.1016/S0140-6736(20)30628-0. Epub 2020 Mar 16.', 'Moreno-Alvarez P, S√°nchez-Guerrero E, Mart√≠nez-Cordero E, Hern√°ndez-Pando R, Campos MG, Cetina L, Baz√°n-Perkins B. Aerosolized polymerized type I collagen reduces airway inflammation and remodelling in a guinea pig model of allergic asthma. Lung. 2010 Apr;188(2):97-105. doi: 10.1007/s00408-009-9202-2. Epub 2009 Dec 9.', 'Olmos-Z√∫√±iga JR, Hern√°ndez-Jim√©nez C, D√≠az-Mart√≠nez E, Jasso-Victoria R, Sotres-Vega A, Gaxiola-Gaxiola MO, Villalba-Caloca J, Baltazares-Lipp M, Santill√°n-Doherty P, Santib√°√±ez-Salgado JA. Wound healing modulators in a tracheoplasty canine model. J Invest Surg. 2007 Nov-Dec;20(6):333-8.', 'Olmos-Zu√±iga JR, Silva-Mart√≠nez M, Jasso-Victoria R, Baltazares-Lipp M, Hern√°ndez-Jim√©nez C, Buend√≠a-Roldan I, Jasso-Arenas J, Mart√≠nez-Salas A, Calyeca-G√≥mez J, Guzm√°n-Cedillo AE, Gaxiola-Gaxiola M, Romero-Romero L. Effects of Pirfenidone and Collagen-Polyvinylpyrrolidone on Macroscopic and Microscopic Changes, TGF-Œ≤1 Expression, and Collagen Deposition in an Experimental Model of Tracheal Wound Healing. Biomed Res Int. 2017;2017:6471071. doi: 10.1155/2017/6471071. Epub 2017 May 11.', 'Saeidi A, Zandi K, Cheok YY, Saeidi H, Wong WF, Lee CYQ, Cheong HC, Yong YK, Larsson M, Shankar EM. T-Cell Exhaustion in Chronic Infections: Reversing the State of Exhaustion and Reinvigorating Optimal Protective Immune Responses. Front Immunol. 2018 Nov 9;9:2569. doi: 10.3389/fimmu.2018.02569. eCollection 2018. Review.', 'Stebbing J, Phelan A, Griffin I, Tucker C, Oechsle O, Smith D, Richardson P. COVID-19: combining antiviral and anti-inflammatory treatments. Lancet Infect Dis. 2020 Apr;20(4):400-402. doi: 10.1016/S1473-3099(20)30132-8. Epub 2020 Feb 27.', 'Sun L, Louie MC, Vannella KM, Wilke CA, LeVine AM, Moore BB, Shanley TP. New concepts of IL-10-induced lung fibrosis: fibrocyte recruitment and M2 activation in a CCL2/CCR2 axis. Am J Physiol Lung Cell Mol Physiol. 2011 Mar;300(3):L341-53. doi: 10.1152/ajplung.00122.2010. Epub 2010 Dec 3.', 'Wang W, Xu Y, Gao R, Lu R, Han K, Wu G, Tan W. Detection of SARS-CoV-2 in Different Types of Clinical Specimens. JAMA. 2020 May 12;323(18):1843-1844. doi: 10.1001/jama.2020.3786.', 'Yang Y, Shen C, Li J, Yuan J, Wei J, Huang F, Wang F, Li G, Li Y, Xing L, Peng L, Yang M, Cao M, Zheng H, Wu W, Zou R, Li D, Xu Z, Wang H, Zhang M, Zhang Z, Gao GF, Jiang C, Liu L, Liu Y. Plasma IP-10 and MCP-3 levels are highly associated with disease severity and predict the progression of COVID-19. J Allergy Clin Immunol. 2020 Jul;146(1):119-127.e4. doi: 10.1016/j.jaci.2020.04.027. Epub 2020 Apr 29.', ""Ye Q, Wang B, Mao J. The pathogenesis and treatment of the 'Cytokine Storm' in COVID-19. J Infect. 2020 Jun;80(6):607-613. doi: 10.1016/j.jinf.2020.03.037. Epub 2020 Apr 10. Review."", 'Zhang C, Wu Z, Li JW, Zhao H, Wang GQ. Cytokine release syndrome in severe COVID-19: interleukin-6 receptor antagonist tocilizumab may be the key to reduce mortality. Int J Antimicrob Agents. 2020 May;55(5):105954. doi: 10.1016/j.ijantimicag.2020.105954. Epub 2020 Mar 29.', 'Zhang H, Penninger JM, Li Y, Zhong N, Slutsky AS. Angiotensin-converting enzyme 2 (ACE2) as a SARS-CoV-2 receptor: molecular mechanisms and potential therapeutic target. Intensive Care Med. 2020 Apr;46(4):586-590. doi: 10.1007/s00134-020-05985-9. Epub 2020 Mar 3.', 'Zheng HY, Zhang M, Yang CX, Zhang N, Wang XC, Yang XP, Dong XQ, Zheng YT. Elevated exhaustion levels and reduced functional diversity of T cells in peripheral blood may predict severe progression in COVID-19 patients. Cell Mol Immunol. 2020 May;17(5):541-543. doi: 10.1038/s41423-020-0401-3. Epub 2020 Mar 17.', 'Zumla A, Hui DS, Azhar EI, Memish ZA, Maeurer M. Reducing mortality from 2019-nCoV: host-directed therapies should be an option. Lancet. 2020 Feb 22;395(10224):e35-e36. doi: 10.1016/S0140-6736(20)30305-6. Epub 2020 Feb 5.']",17/02/2021,https://clinicaltrials.gov/show/NCT04517162,19/02/2021,0,1
1558,NCT04517188,Not yet recruiting,01/07/2021,01/07/2021,No Results Posted,,,10/02/2021,https://clinicaltrials.gov/show/NCT04517188,01/07/2021,0,0
1559,NCT04524962,Recruiting,25/09/2021,25/09/2022,No Results Posted,,,10/02/2021,https://clinicaltrials.gov/show/NCT04524962,25/09/2021,0,0
1560,NCT04529525,Completed,22/02/2021,22/02/2021,No Results Posted,"['Vallejos J, Zoni R, Bangher M, Villamandos S, Bobadilla A, Plano F, Campias C, Chaparro Campias E, Medina MF, Achinelli F, Guglielmone HA, Ojeda J, Farizano Salazar D, Andino G, Kawerin P, Dellamea S, Aquino AC, Flores V, Martemucci CN, Martinez SM, Segovia JE, Reynoso PI, Sosa NC, Robledo ME, Guarrochena JM, Vernengo MM, Ruiz Diaz N, Meza E, Aguirre MG. Ivermectin to prevent hospitalizations in patients with COVID-19 (IVERCOR-COVID19) a randomized, double-blind, placebo-controlled trial. BMC Infect Dis. 2021 Jul 2;21(1):635. doi: 10.1186/s12879-021-06348-5.', 'Vallejos J, Zoni R, Bangher M, Villamandos S, Bobadilla A, Plano F, Campias C, Chaparro Campias E, Achinelli F, Guglielmone HA, Ojeda J, Medina F, Farizano Salazar D, Andino G, Ruiz Diaz NE, Kawerin P, Meza E, Dellamea S, Aquino A, Flores V, Martemucci CN, Vernengo MM, Martinez SM, Segovia JE, Aguirre MG. Ivermectin to prevent hospitalizations in patients with COVID-19 (IVERCOR-COVID19): a structured summary of a study protocol for a randomized controlled trial. Trials. 2020 Nov 24;21(1):965. doi: 10.1186/s13063-020-04813-1.']","['≈ûim≈üek Yavuz S, √únal S. Antiviral treatment of COVID-19. Turk J Med Sci. 2020 Apr 21;50(SI-1):611-619. doi: 10.3906/sag-2004-145. Review.', 'Gonz√°lez Canga A, Sahag√∫n Prieto AM, Diez Li√©bana MJ, Fern√°ndez Mart√≠nez N, Sierra Vega M, Garc√≠a Vieitez JJ. The pharmacokinetics and interactions of ivermectin in humans--a mini-review. AAPS J. 2008;10(1):42-6. doi: 10.1208/s12248-007-9000-9. Epub 2008 Jan 25. Review.', 'G√∂tz V, Magar L, Dornfeld D, Giese S, Pohlmann A, H√∂per D, Kong BW, Jans DA, Beer M, Haller O, Schwemmle M. Influenza A viruses escape from MxA restriction at the expense of efficient nuclear vRNP import. Sci Rep. 2016 Mar 18;6:23138. doi: 10.1038/srep23138. Erratum in: Sci Rep. 2016 May 09;6:25428.', 'Lundberg L, Pinkham C, Baer A, Amaya M, Narayanan A, Wagstaff KM, Jans DA, Kehn-Hall K. Nuclear import and export inhibitors alter capsid protein distribution in mammalian cells and reduce Venezuelan Equine Encephalitis Virus replication. Antiviral Res. 2013 Dec;100(3):662-72. doi: 10.1016/j.antiviral.2013.10.004. Epub 2013 Oct 22.', 'Tay MY, Fraser JE, Chan WK, Moreland NJ, Rathore AP, Wang C, Vasudevan SG, Jans DA. Nuclear localization of dengue virus (DENV) 1-4 non-structural protein 5; protection against all 4 DENV serotypes by the inhibitor Ivermectin. Antiviral Res. 2013 Sep;99(3):301-6. doi: 10.1016/j.antiviral.2013.06.002. Epub 2013 Jun 14.', 'Wagstaff KM, Sivakumaran H, Heaton SM, Harrich D, Jans DA. Ivermectin is a specific inhibitor of importin Œ±/Œ≤-mediated nuclear import able to inhibit replication of HIV-1 and dengue virus. Biochem J. 2012 May 1;443(3):851-6. doi: 10.1042/BJ20120150.', 'Chi NC, Adam EJ, Adam SA. Sequence and characterization of cytoplasmic nuclear protein import factor p97. J Cell Biol. 1995 Jul;130(2):265-74.', 'G√∂rlich D, Mattaj IW. Nucleocytoplasmic transport. Science. 1996 Mar 15;271(5255):1513-8. Review.', 'Rowland RR, Chauhan V, Fang Y, Pekosz A, Kerrigan M, Burton MD. Intracellular localization of the severe acute respiratory syndrome coronavirus nucleocapsid protein: absence of nucleolar accumulation during infection and after expression as a recombinant protein in vero cells. J Virol. 2005 Sep;79(17):11507-12.', 'Timani KA, Liao Q, Ye L, Zeng Y, Liu J, Zheng Y, Ye L, Yang X, Lingbao K, Gao J, Zhu Y. Nuclear/nucleolar localization properties of C-terminal nucleocapsid protein of SARS coronavirus. Virus Res. 2005 Dec;114(1-2):23-34. Epub 2005 Jun 29.', 'Caly L, Druce JD, Catton MG, Jans DA, Wagstaff KM. The FDA-approved drug ivermectin inhibits the replication of SARS-CoV-2 in vitro. Antiviral Res. 2020 Jun;178:104787. doi: 10.1016/j.antiviral.2020.104787. Epub 2020 Apr 3.']",07/07/2021,https://clinicaltrials.gov/show/NCT04529525,22/02/2021,0,1
1561,NCT04530409,Recruiting,01/04/2021,01/05/2021,No Results Posted,,,16/02/2021,https://clinicaltrials.gov/show/NCT04530409,01/04/2021,0,0
1562,NCT04530539,Recruiting,01/09/2021,01/12/2021,No Results Posted,,,16/02/2021,https://clinicaltrials.gov/show/NCT04530539,01/09/2021,0,0
1563,NCT04530656,"Active, not recruiting",28/10/2020,28/08/2021,No Results Posted,,,11/02/2021,https://clinicaltrials.gov/show/NCT04530656,28/10/2020,0,0
1564,NCT04534790,Completed,12/12/2020,08/01/2021,No Results Posted,,,09/02/2021,https://clinicaltrials.gov/show/NCT04534790,12/12/2020,0,0
1565,NCT04542434,Not yet recruiting,01/10/2021,01/12/2021,No Results Posted,,,16/02/2021,https://clinicaltrials.gov/show/NCT04542434,01/10/2021,0,0
1566,NCT04547660,Completed,07/01/2021,07/01/2021,No Results Posted,,,09/02/2021,https://clinicaltrials.gov/show/NCT04547660,07/01/2021,0,0
1567,NCT04557241,Completed,14/01/2021,31/01/2021,No Results Posted,"['Agley J, Xiao Y, Thompson EE, Golzarri-Arroyo L. COVID-19 Misinformation Prophylaxis: Protocol for a Randomized Trial of a Brief Informational Intervention. JMIR Res Protoc. 2020 Dec 7;9(12):e24383. doi: 10.2196/24383.']",,09/02/2021,https://clinicaltrials.gov/show/NCT04557241,14/01/2021,0,1
1568,NCT04568811,"Active, not recruiting",25/10/2020,27/09/2021,No Results Posted,,,10/02/2021,https://clinicaltrials.gov/show/NCT04568811,25/10/2020,0,0
1569,NCT04568889,"Active, not recruiting",26/10/2020,30/06/2021,No Results Posted,,"['Meyer, Bruce D., Wallace KC Mok, and James X. Sullivan. Household surveys in crisis. Journal of Economic Perspectives. 2015; 29(4): 199-226.']",10/02/2021,https://clinicaltrials.gov/show/NCT04568889,26/10/2020,0,1
1570,NCT04581863,"Active, not recruiting",05/02/2021,31/10/2021,No Results Posted,,,12/02/2021,https://clinicaltrials.gov/show/NCT04581863,05/02/2021,0,0
1571,NCT04584697,Withdrawn,01/04/2021,01/04/2021,No Results Posted,,,12/02/2021,https://clinicaltrials.gov/show/NCT04584697,01/04/2021,0,0
1572,NCT04593433,Not yet recruiting,04/07/2021,04/09/2021,No Results Posted,,,09/02/2021,https://clinicaltrials.gov/show/NCT04593433,04/07/2021,0,0
1573,NCT04621461,Completed,08/02/2021,08/02/2021,No Results Posted,,,11/02/2021,https://clinicaltrials.gov/show/NCT04621461,08/02/2021,0,0
1574,NCT04652596,Enrolling by invitation,01/06/2022,01/10/2022,No Results Posted,,,11/02/2021,https://clinicaltrials.gov/show/NCT04652596,01/06/2022,0,0
1575,NCT04652765,Recruiting,01/01/2023,01/01/2023,No Results Posted,,,11/02/2021,https://clinicaltrials.gov/show/NCT04652765,01/01/2023,0,0
1576,NCT04659239,Enrolling by invitation,01/09/2021,01/07/2022,No Results Posted,,,10/02/2021,https://clinicaltrials.gov/show/NCT04659239,01/09/2021,0,0
1577,NCT04662671,Completed,09/12/2020,30/01/2021,No Results Posted,,,11/02/2021,https://clinicaltrials.gov/show/NCT04662671,09/12/2020,0,0
1578,NCT04703140,Recruiting,11/08/2022,11/09/2022,No Results Posted,,,15/02/2021,https://clinicaltrials.gov/show/NCT04703140,11/08/2022,0,0
1579,NCT04739020,Recruiting,30/06/2021,31/12/2021,No Results Posted,,,10/02/2021,https://clinicaltrials.gov/show/NCT04739020,30/06/2021,0,0
1580,NCT04739462,Recruiting,01/02/2022,01/02/2022,No Results Posted,,,09/02/2021,https://clinicaltrials.gov/show/NCT04739462,01/02/2022,0,0
1581,NCT04745442,Completed,20/12/2020,15/01/2021,No Results Posted,,,09/02/2021,https://clinicaltrials.gov/show/NCT04745442,20/12/2020,0,0
1582,NCT04746365,Completed,31/01/2021,06/02/2021,No Results Posted,,,09/02/2021,https://clinicaltrials.gov/show/NCT04746365,31/01/2021,0,0
1583,NCT04747132,Completed,20/10/2020,16/11/2020,No Results Posted,,,10/02/2021,https://clinicaltrials.gov/show/NCT04747132,20/10/2020,0,0
1584,NCT04747249,Not yet recruiting,01/08/2021,01/03/2022,No Results Posted,,,10/02/2021,https://clinicaltrials.gov/show/NCT04747249,01/08/2021,0,0
1585,NCT04747405,Not yet recruiting,22/06/2022,22/08/2022,No Results Posted,,,15/02/2021,https://clinicaltrials.gov/show/NCT04747405,22/06/2022,0,0
1586,NCT04747756,Not yet recruiting,01/12/2022,01/12/2022,No Results Posted,,,10/02/2021,https://clinicaltrials.gov/show/NCT04747756,01/12/2022,0,0
1587,NCT04748120,Enrolling by invitation,28/06/2021,28/09/2021,No Results Posted,,,10/02/2021,https://clinicaltrials.gov/show/NCT04748120,28/06/2021,0,0
1588,NCT04749121,Completed,05/02/2021,05/02/2021,No Results Posted,,,11/02/2021,https://clinicaltrials.gov/show/NCT04749121,05/02/2021,0,0
1589,NCT04750317,Completed,01/08/2020,01/09/2020,No Results Posted,,,15/02/2021,https://clinicaltrials.gov/show/NCT04750317,01/08/2020,0,0
1590,NCT04750343,Recruiting,01/07/2021,01/06/2022,No Results Posted,"[""Arunachalam PS, Walls AC, Golden N, Atyeo C, Fischinger S, Li C, Aye P, Navarro MJ, Lai L, Edara VV, R√∂ltgen K, Rogers K, Shirreff L, Ferrell DE, Wrenn S, Pettie D, Kraft JC, Miranda MC, Kepl E, Sydeman C, Brunette N, Murphy M, Fiala B, Carter L, White AG, Trisal M, Hsieh CL, Russell-Lodrigue K, Monjure C, Dufour J, Spencer S, Doyle-Meyers L, Bohm RP, Maness NJ, Roy C, Plante JA, Plante KS, Zhu A, Gorman MJ, Shin S, Shen X, Fontenot J, Gupta S, O'Hagan DT, Van Der Most R, Rappuoli R, Coffman RL, Novack D, McLellan JS, Subramaniam S, Montefiori D, Boyd SD, Flynn JL, Alter G, Villinger F, Kleanthous H, Rappaport J, Suthar MS, King NP, Veesler D, Pulendran B. Adjuvanting a subunit COVID-19 vaccine to induce protective immunity. Nature. 2021 Jun;594(7862):253-258. doi: 10.1038/s41586-021-03530-2. Epub 2021 Apr 19.""]",,11/02/2021,https://clinicaltrials.gov/show/NCT04750343,01/07/2021,0,1
1591,NCT04751604,Recruiting,01/09/2021,01/12/2021,No Results Posted,,,12/02/2021,https://clinicaltrials.gov/show/NCT04751604,01/09/2021,0,0
1592,NCT04751617,Enrolling by invitation,31/01/2021,31/03/2021,No Results Posted,,,12/02/2021,https://clinicaltrials.gov/show/NCT04751617,31/01/2021,0,0
1593,NCT04751630,Not yet recruiting,01/10/2021,01/02/2022,No Results Posted,,,16/02/2021,https://clinicaltrials.gov/show/NCT04751630,01/10/2021,0,0
1594,NCT04751695,Not yet recruiting,01/03/2021,01/04/2021,No Results Posted,,,12/02/2021,https://clinicaltrials.gov/show/NCT04751695,01/03/2021,0,0
1595,NCT04751721,Not yet recruiting,01/03/2021,01/04/2021,No Results Posted,,,12/02/2021,https://clinicaltrials.gov/show/NCT04751721,01/03/2021,0,0
1596,NCT04754113,Not yet recruiting,20/02/2021,27/02/2021,No Results Posted,,,15/02/2021,https://clinicaltrials.gov/show/NCT04754113,20/02/2021,0,0
1597,NCT04331366,Completed,31/08/2020,31/08/2020,Study Results,,,18/02/2021,https://clinicaltrials.gov/show/NCT04331366,31/08/2020,1,0
1598,NCT04331834,Completed,25/06/2020,31/12/2020,No Results Posted,"['Grau-Pujol B, Camprub√≠ D, Marti-Soler H, Fern√°ndez-Pardos M, Guinovart C, Mu√±oz J. Pre-exposure prophylaxis with hydroxychloroquine for high-risk healthcare workers during the COVID-19 pandemic: A structured summary of a study protocol for a multicentre, double-blind randomized controlled trial. Trials. 2020 Jul 29;21(1):688. doi: 10.1186/s13063-020-04621-7.']",,16/02/2021,https://clinicaltrials.gov/show/NCT04331834,25/06/2020,0,1
1599,NCT04349592,Completed,14/08/2020,30/08/2020,No Results Posted,"['Omrani AS, Pathan SA, Thomas SA, Harris TRE, Coyle PV, Thomas CE, Qureshi I, Bhutta ZA, Mawlawi NA, Kahlout RA, Elmalik A, Azad AM, Daghfal J, Mustafa M, Jeremijenko A, Soub HA, Khattab MA, Maslamani MA, Thomas SH. Randomized double-blinded placebo-controlled trial of hydroxychloroquine with or without azithromycin for virologic cure of non-severe Covid-19. EClinicalMedicine. 2020 Dec;29:100645. doi: 10.1016/j.eclinm.2020.100645. Epub 2020 Nov 20.']",,23/02/2021,https://clinicaltrials.gov/show/NCT04349592,14/08/2020,0,1
1600,NCT04355962,Recruiting,31/03/2022,31/03/2022,No Results Posted,,,23/02/2021,https://clinicaltrials.gov/show/NCT04355962,31/03/2022,0,0
1601,NCT04361838,Recruiting,30/06/2021,31/08/2021,No Results Posted,,,21/02/2021,https://clinicaltrials.gov/show/NCT04361838,30/06/2021,0,0
1602,NCT04364828,Recruiting,01/04/2022,01/08/2022,No Results Posted,,,17/02/2021,https://clinicaltrials.gov/show/NCT04364828,01/04/2022,0,0
1603,NCT04367636,Recruiting,01/09/2021,01/09/2021,No Results Posted,,,21/02/2021,https://clinicaltrials.gov/show/NCT04367636,01/09/2021,0,0
1604,NCT04374474,Withdrawn,10/12/2021,10/03/2022,No Results Posted,,,21/02/2021,https://clinicaltrials.gov/show/NCT04374474,10/12/2021,0,0
1605,NCT04377789,Completed,31/07/2020,31/08/2020,No Results Posted,,,18/02/2021,https://clinicaltrials.gov/show/NCT04377789,31/07/2020,0,0
1606,NCT04381377,"Active, not recruiting",01/04/2021,01/04/2021,No Results Posted,,,16/02/2021,https://clinicaltrials.gov/show/NCT04381377,01/04/2021,0,0
1607,NCT04386616,Completed,02/01/2021,12/02/2021,No Results Posted,,,17/02/2021,https://clinicaltrials.gov/show/NCT04386616,02/01/2021,0,0
1608,NCT04390217,Not yet recruiting,31/12/2021,31/03/2022,No Results Posted,,,18/02/2021,https://clinicaltrials.gov/show/NCT04390217,31/12/2021,0,0
1609,NCT04395430,Recruiting,01/06/2021,01/10/2021,No Results Posted,,,21/02/2021,https://clinicaltrials.gov/show/NCT04395430,01/06/2021,0,0
1610,NCT04395456,Not yet recruiting,01/09/2022,01/12/2022,No Results Posted,,,21/02/2021,https://clinicaltrials.gov/show/NCT04395456,01/09/2022,0,0
1611,NCT04408040,Recruiting,31/07/2024,31/07/2024,No Results Posted,,,21/02/2021,https://clinicaltrials.gov/show/NCT04408040,31/07/2024,0,0
1612,NCT04408287,Recruiting,28/02/2021,31/10/2021,No Results Posted,,,21/02/2021,https://clinicaltrials.gov/show/NCT04408287,28/02/2021,0,0
1613,NCT04412291,Recruiting,01/03/2021,01/06/2021,No Results Posted,,,18/02/2021,https://clinicaltrials.gov/show/NCT04412291,01/03/2021,0,0
1614,NCT04414631,Recruiting,01/06/2021,01/07/2021,No Results Posted,"['Urwyler P, Charitos P, Moser S, Heijnen IAFM, Trendelenburg M, Thoma R, Sumer J, Camacho-Ortiz A, Bacci MR, Huber LC, St√ºssi-Helbling M, Albrich WC, Sendi P, Osthoff M. Recombinant human C1 esterase inhibitor (conestat alfa) in the prevention of severe SARS-CoV-2 infection in hospitalized patients with COVID-19: A structured summary of a study protocol for a randomized, parallel-group, open-label, multi-center pilot trial (PROTECT-COVID-19). Trials. 2021 Jan 4;22(1):1. doi: 10.1186/s13063-020-04976-x.']",,17/02/2021,https://clinicaltrials.gov/show/NCT04414631,01/06/2021,0,1
1615,NCT04425538,Completed,22/01/2021,22/01/2021,No Results Posted,,,18/02/2021,https://clinicaltrials.gov/show/NCT04425538,22/01/2021,0,0
1616,NCT04428268,Withdrawn,10/06/2020,16/02/2021,No Results Posted,,,18/02/2021,https://clinicaltrials.gov/show/NCT04428268,10/06/2020,0,0
1617,NCT04431297,Not yet recruiting,30/06/2021,01/06/2022,No Results Posted,,,18/02/2021,https://clinicaltrials.gov/show/NCT04431297,30/06/2021,0,0
1618,NCT04442178,Recruiting,30/10/2021,31/12/2021,No Results Posted,,"['Zhou F, Yu T, Du R, Fan G, Liu Y, Liu Z, Xiang J, Wang Y, Song B, Gu X, Guan L, Wei Y, Li H, Wu X, Xu J, Tu S, Zhang Y, Chen H, Cao B. Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study. Lancet. 2020 Mar 28;395(10229):1054-1062. doi: 10.1016/S0140-6736(20)30566-3. Epub 2020 Mar 11. Erratum in: Lancet. 2020 Mar 28;395(10229):1038. Lancet. 2020 Mar 28;395(10229):1038.', 'Wang D, Hu B, Hu C, Zhu F, Liu X, Zhang J, Wang B, Xiang H, Cheng Z, Xiong Y, Zhao Y, Li Y, Wang X, Peng Z. Clinical Characteristics of 138 Hospitalized Patients With 2019 Novel Coronavirus-Infected Pneumonia in Wuhan, China. JAMA. 2020 Mar 17;323(11):1061-1069. doi: 10.1001/jama.2020.1585. Erratum in: JAMA. 2021 Mar 16;325(11):1113.', 'Francois B, Jeannet R, Daix T, Walton AH, Shotwell MS, Unsinger J, Monneret G, Rimmel√© T, Blood T, Morre M, Gregoire A, Mayo GA, Blood J, Durum SK, Sherwood ER, Hotchkiss RS. Interleukin-7 restores lymphocytes in septic shock: the IRIS-7 randomized clinical trial. JCI Insight. 2018 Mar 8;3(5). pii: 98960. doi: 10.1172/jci.insight.98960.', 'Venet F, Foray AP, Villars-M√©chin A, Malcus C, Poitevin-Later F, Lepape A, Monneret G. IL-7 restores lymphocyte functions in septic patients. J Immunol. 2012 Nov 15;189(10):5073-81. doi: 10.4049/jimmunol.1202062. Epub 2012 Oct 10.']",16/02/2021,https://clinicaltrials.gov/show/NCT04442178,30/10/2021,0,1
1619,NCT04456153,Completed,31/01/2021,31/01/2021,No Results Posted,,,21/02/2021,https://clinicaltrials.gov/show/NCT04456153,31/01/2021,0,0
1620,NCT04463004,"Active, not recruiting",01/08/2021,01/08/2021,No Results Posted,"['Cremer PC, Abbate A, Hudock K, McWilliams C, Mehta J, Chang SY, Sheng CC, Van Tassell B, Bonaventura A, Vecchi√© A, Carey B, Wang Q, Wolski KE, Rajendram P, Duggal A, Wang TS, Paolini JF, Trapnell BC; MASH-COVID study group. Mavrilimumab in patients with severe COVID-19 pneumonia and systemic hyperinflammation (MASH-COVID): an investigator initiated, multicentre, double-blind, randomised, placebo-controlled trial. Lancet Rheumatol. 2021 Jun;3(6):e410-e418. doi: 10.1016/S2665-9913(21)00070-9. Epub 2021 Mar 17.']",,17/02/2021,https://clinicaltrials.gov/show/NCT04463004,01/08/2021,0,1
1621,NCT04463849,Recruiting,30/06/2021,30/06/2021,No Results Posted,,,17/02/2021,https://clinicaltrials.gov/show/NCT04463849,30/06/2021,0,0
1622,NCT04473898,Completed,19/10/2020,17/02/2021,No Results Posted,,,18/02/2021,https://clinicaltrials.gov/show/NCT04473898,19/10/2020,0,0
1623,NCT04476667,Recruiting,01/05/2021,01/05/2021,No Results Posted,"[""Alavi N, Yang M, Stephenson C, Nikjoo N, Malakouti N, Layzell G, Jagayat J, Shirazi A, Groll D, Omrani M, O'Riordan A, Khalid-Khan S, Freire R, Brietzke E, Gomes FA, Milev R, Soares CN. Using the Online Psychotherapy Tool to Address Mental Health Problems in the Context of the COVID-19 Pandemic: Protocol for an Electronically Delivered Cognitive Behavioral Therapy Program. JMIR Res Protoc. 2020 Dec 18;9(12):e24913. doi: 10.2196/24913.""]",,18/02/2021,https://clinicaltrials.gov/show/NCT04476667,01/05/2021,0,1
1624,NCT04476953,Enrolling by invitation,01/07/2021,01/07/2021,No Results Posted,,,18/02/2021,https://clinicaltrials.gov/show/NCT04476953,01/07/2021,0,0
1625,NCT04477668,Recruiting,01/09/2021,01/02/2022,No Results Posted,,,09/07/2021,https://clinicaltrials.gov/show/NCT04477668,01/09/2021,0,0
1626,NCT04486482,Recruiting,01/03/2021,01/03/2021,No Results Posted,"['Haran JP, Pinero JC, Zheng Y, Palma NA, Wingertzahn M. Virtualized clinical studies to assess the natural history and impact of gut microbiome modulation in non-hospitalized patients with mild to moderate COVID-19 a randomized, open-label, prospective study with a parallel group study evaluating the physiologic effects of KB109 on gut microbiota structure and function: a structured summary of a study protocol for a randomized controlled study. Trials. 2021 Apr 2;22(1):245. doi: 10.1186/s13063-021-05157-0.']",,23/02/2021,https://clinicaltrials.gov/show/NCT04486482,01/03/2021,0,1
1627,NCT04527575,"Active, not recruiting",01/05/2021,01/05/2021,No Results Posted,,,23/02/2021,https://clinicaltrials.gov/show/NCT04527575,01/05/2021,0,0
1628,NCT04533347,Recruiting,08/06/2021,22/06/2021,No Results Posted,,"['Beigel JH, Tomashek KM, Dodd LE, Mehta AK, Zingman BS, Kalil AC, Hohmann E, Chu HY, Luetkemeyer A, Kline S, Lopez de Castilla D, Finberg RW, Dierberg K, Tapson V, Hsieh L, Patterson TF, Paredes R, Sweeney DA, Short WR, Touloumi G, Lye DC, Ohmagari N, Oh MD, Ruiz-Palacios GM, Benfield T, F√§tkenheuer G, Kortepeter MG, Atmar RL, Creech CB, Lundgren J, Babiker AG, Pett S, Neaton JD, Burgess TH, Bonnett T, Green M, Makowski M, Osinusi A, Nayak S, Lane HC; ACTT-1 Study Group Members. Remdesivir for the Treatment of Covid-19 - Final Report. N Engl J Med. 2020 Nov 5;383(19):1813-1826. doi: 10.1056/NEJMoa2007764. Epub 2020 Oct 8.', 'Brueckner RP, Lasseter KC, Lin ET, Schuster BG. First-time-in-humans safety and pharmacokinetics of WR 238605, a new antimalarial. Am J Trop Med Hyg. 1998 May;58(5):645-9.', 'Crisafulli E, Clini EM. Measures of dyspnea in pulmonary rehabilitation. Multidiscip Respir Med. 2010 Jun 30;5(3):202-10. doi: 10.1186/2049-6958-5-3-202.', 'Dow GS, Luttick A, Fenner J, Wesche D, Yeo KR, Rayner C. Tafenoquine inhibits replication of SARS-Cov-2 at pharmacologically relevant concentrations in vitro. bioRxiv. January 2020:2020.07.12.199059. doi:10.1101/2020.07.12.199059', 'Jia HP, Look DC, Shi L, Hickey M, Pewe L, Netland J, Farzan M, Wohlford-Lenane C, Perlman S, McCray PB Jr. ACE2 receptor expression and severe acute respiratory syndrome coronavirus infection depend on differentiation of human airway epithelia. J Virol. 2005 Dec;79(23):14614-21.', 'Skipper CP, Pastick KA, Engen NW, Bangdiwala AS, Abassi M, Lofgren SM, Williams DA, Okafor EC, Pullen MF, Nicol MR, Nascene AA, Hullsiek KH, Cheng MP, Luke D, Lother SA, MacKenzie LJ, Drobot G, Kelly LE, Schwartz IS, Zarychanski R, McDonald EG, Lee TC, Rajasingham R, Boulware DR. Hydroxychloroquine in Nonhospitalized Adults With Early COVID-19 : A Randomized Trial. Ann Intern Med. 2020 Oct 20;173(8):623-631. doi: 10.7326/M20-4207. Epub 2020 Jul 16. Erratum in: Ann Intern Med. 2021 Mar;174(3):435.', 'Velavan TP, Meyer CG. The COVID-19 epidemic. Trop Med Int Health. 2020 Mar;25(3):278-280. doi: 10.1111/tmi.13383. Epub 2020 Feb 16.', 'Wang Y, Zhang D, Du G, Du R, Zhao J, Jin Y, Fu S, Gao L, Cheng Z, Lu Q, Hu Y, Luo G, Wang K, Lu Y, Li H, Wang S, Ruan S, Yang C, Mei C, Wang Y, Ding D, Wu F, Tang X, Ye X, Ye Y, Liu B, Yang J, Yin W, Wang A, Fan G, Zhou F, Liu Z, Gu X, Xu J, Shang L, Zhang Y, Cao L, Guo T, Wan Y, Qin H, Jiang Y, Jaki T, Hayden FG, Horby PW, Cao B, Wang C. Remdesivir in adults with severe COVID-19: a randomised, double-blind, placebo-controlled, multicentre trial. Lancet. 2020 May 16;395(10236):1569-1578. doi: 10.1016/S0140-6736(20)31022-9. Epub 2020 Apr 29. Erratum in: Lancet. 2020 May 30;395(10238):1694.', 'Worldometer. Coronavirus Update (Live). https://www.worldometers.info/coronavirus/. Accessed March 7, 2020.', 'Zhou P, Yang XL, Wang XG, Hu B, Zhang L, Zhang W, Si HR, Zhu Y, Li B, Huang CL, Chen HD, Chen J, Luo Y, Guo H, Jiang RD, Liu MQ, Chen Y, Shen XR, Wang X, Zheng XS, Zhao K, Chen QJ, Deng F, Liu LL, Yan B, Zhan FX, Wang YY, Xiao GF, Shi ZL. A pneumonia outbreak associated with a new coronavirus of probable bat origin. Nature. 2020 Mar;579(7798):270-273. doi: 10.1038/s41586-020-2012-7. Epub 2020 Feb 3.']",21/02/2021,https://clinicaltrials.gov/show/NCT04533347,08/06/2021,0,1
1629,NCT04534803,Withdrawn,01/05/2022,01/07/2022,No Results Posted,,,28/06/2021,https://clinicaltrials.gov/show/NCT04534803,01/05/2022,0,0
1630,NCT04540419,"Active, not recruiting",30/05/2021,31/07/2021,No Results Posted,,,16/02/2021,https://clinicaltrials.gov/show/NCT04540419,30/05/2021,0,0
1631,NCT04561180,Not yet recruiting,01/10/2021,01/12/2021,No Results Posted,,,21/02/2021,https://clinicaltrials.gov/show/NCT04561180,01/10/2021,0,0
1632,NCT04582344,Recruiting,15/02/2021,15/04/2021,No Results Posted,"['Akova M, Unal S. A randomized, double-blind, placebo-controlled phase III clinical trial to evaluate the efficacy and safety of SARS-CoV-2 vaccine (inactivated, Vero cell): a structured summary of a study protocol for a randomised controlled trial. Trials. 2021 Apr 13;22(1):276. doi: 10.1186/s13063-021-05180-1.']",,17/02/2021,https://clinicaltrials.gov/show/NCT04582344,15/02/2021,0,1
1633,NCT04583410,Recruiting,01/12/2021,01/06/2022,No Results Posted,,,17/02/2021,https://clinicaltrials.gov/show/NCT04583410,01/12/2021,0,0
1634,NCT04594525,Not yet recruiting,01/09/2021,01/06/2022,No Results Posted,"['Naja S, Elyamani R, Chehab M, Siddig M, Al Ibrahim A, Mohamad T, Singh R, Bougmiza I. Maternal low-intensity psychosocial telemental interventions in response to COVID-19 in Qatar: study protocol for a randomized controlled trial. Trials. 2021 Jun 7;22(1):382. doi: 10.1186/s13063-021-05339-w.']",,21/02/2021,https://clinicaltrials.gov/show/NCT04594525,01/09/2021,0,1
1635,NCT04600141,Recruiting,20/10/2021,31/12/2021,No Results Posted,,,21/02/2021,https://clinicaltrials.gov/show/NCT04600141,20/10/2021,0,0
1636,NCT04657809,"Active, not recruiting",18/02/2021,20/02/2021,No Results Posted,,,21/02/2021,https://clinicaltrials.gov/show/NCT04657809,18/02/2021,0,0
1637,NCT04673292,Enrolling by invitation,01/08/2021,01/08/2021,No Results Posted,,,18/02/2021,https://clinicaltrials.gov/show/NCT04673292,01/08/2021,0,0
1638,NCT04704544,Not yet recruiting,30/11/2022,30/11/2022,No Results Posted,,,29/06/2021,https://clinicaltrials.gov/show/NCT04704544,30/11/2022,0,0
1639,NCT04715854,"Active, not recruiting",01/04/2021,01/07/2021,No Results Posted,,,21/02/2021,https://clinicaltrials.gov/show/NCT04715854,01/04/2021,0,0
1640,NCT04741061,Recruiting,31/12/2021,31/01/2022,No Results Posted,,,21/02/2021,https://clinicaltrials.gov/show/NCT04741061,31/12/2021,0,0
1641,NCT04749173,Recruiting,28/03/2021,30/06/2021,No Results Posted,,,16/02/2021,https://clinicaltrials.gov/show/NCT04749173,28/03/2021,0,0
1642,NCT04750759,Recruiting,30/06/2021,30/06/2021,No Results Posted,,,18/02/2021,https://clinicaltrials.gov/show/NCT04750759,30/06/2021,0,0
1643,NCT04756128,Enrolling by invitation,31/12/2021,31/12/2021,No Results Posted,,,18/02/2021,https://clinicaltrials.gov/show/NCT04756128,31/12/2021,0,0
1644,NCT04756271,Recruiting,01/08/2021,01/08/2021,No Results Posted,,,21/02/2021,https://clinicaltrials.gov/show/NCT04756271,01/08/2021,0,0
1645,NCT04756323,"Active, not recruiting",30/06/2021,28/02/2022,No Results Posted,,,17/02/2021,https://clinicaltrials.gov/show/NCT04756323,30/06/2021,0,0
1646,NCT04756609,Not yet recruiting,01/06/2021,01/06/2021,No Results Posted,,,16/02/2021,https://clinicaltrials.gov/show/NCT04756609,01/06/2021,0,0
1647,NCT04756830,"Active, not recruiting",01/09/2021,01/06/2023,No Results Posted,,,09/07/2021,https://clinicaltrials.gov/show/NCT04756830,01/09/2021,0,0
1648,NCT04757298,Recruiting,30/01/2022,31/12/2022,No Results Posted,,,18/02/2021,https://clinicaltrials.gov/show/NCT04757298,30/01/2022,0,0
1649,NCT04757818,Recruiting,25/03/2021,25/03/2021,No Results Posted,,,17/02/2021,https://clinicaltrials.gov/show/NCT04757818,25/03/2021,0,0
1650,NCT04758273,"Active, not recruiting",30/06/2021,28/02/2022,No Results Posted,,,17/02/2021,https://clinicaltrials.gov/show/NCT04758273,30/06/2021,0,0
1651,NCT04758286,Completed,01/02/2021,11/02/2021,No Results Posted,,,17/02/2021,https://clinicaltrials.gov/show/NCT04758286,01/02/2021,0,0
1652,NCT04760418,Not yet recruiting,01/08/2022,01/08/2022,No Results Posted,,,18/02/2021,https://clinicaltrials.gov/show/NCT04760418,01/08/2022,0,0
1653,NCT04760561,Not yet recruiting,20/03/2021,20/04/2021,No Results Posted,,,18/02/2021,https://clinicaltrials.gov/show/NCT04760561,20/03/2021,0,0
1654,NCT04760730,Not yet recruiting,01/05/2021,31/12/2021,No Results Posted,,,18/02/2021,https://clinicaltrials.gov/show/NCT04760730,01/05/2021,0,0
1655,NCT04760743,"Active, not recruiting",01/04/2021,01/04/2022,No Results Posted,,,18/02/2021,https://clinicaltrials.gov/show/NCT04760743,01/04/2021,0,0
1656,NCT04760821,Recruiting,30/04/2021,30/04/2021,No Results Posted,,,21/02/2021,https://clinicaltrials.gov/show/NCT04760821,30/04/2021,0,0
1657,NCT04761692,Not yet recruiting,31/10/2026,31/12/2026,No Results Posted,,,21/02/2021,https://clinicaltrials.gov/show/NCT04761692,31/10/2026,0,0
1658,NCT04762186,Not yet recruiting,01/09/2022,01/12/2022,No Results Posted,,,21/02/2021,https://clinicaltrials.gov/show/NCT04762186,01/09/2022,0,0
1659,NCT04762628,"Active, not recruiting",01/11/2021,10/01/2022,No Results Posted,,,24/02/2021,https://clinicaltrials.gov/show/NCT04762628,01/11/2021,0,0
1660,NCT04764721,Not yet recruiting,12/04/2022,12/05/2022,No Results Posted,,,21/02/2021,https://clinicaltrials.gov/show/NCT04764721,12/04/2022,0,0
1661,NCT04764981,Enrolling by invitation,01/05/2022,01/05/2024,No Results Posted,,,21/02/2021,https://clinicaltrials.gov/show/NCT04764981,01/05/2022,0,0
1662,NCT04765436,"Active, not recruiting",12/02/2022,12/02/2022,No Results Posted,,,30/06/2021,https://clinicaltrials.gov/show/NCT04765436,12/02/2022,0,0
1663,NCT04767087,Recruiting,15/02/2022,15/04/2022,No Results Posted,,,02/07/2021,https://clinicaltrials.gov/show/NCT04767087,15/02/2022,0,0
1664,NCT04311697,Completed,22/02/2021,22/02/2021,No Results Posted,,,26/02/2021,https://clinicaltrials.gov/show/NCT04311697,22/02/2021,0,0
1665,NCT04325633,Terminated,15/12/2020,15/12/2020,No Results Posted,,,25/02/2021,https://clinicaltrials.gov/show/NCT04325633,15/12/2020,0,0
1666,NCT04334460,"Active, not recruiting",11/11/2020,01/11/2021,No Results Posted,,,23/02/2021,https://clinicaltrials.gov/show/NCT04334460,11/11/2020,0,0
1667,NCT04345679,Recruiting,01/06/2021,01/09/2021,No Results Posted,,,25/02/2021,https://clinicaltrials.gov/show/NCT04345679,01/06/2021,0,0
1668,NCT04351724,Recruiting,01/12/2021,31/03/2022,No Results Posted,,,02/03/2021,https://clinicaltrials.gov/show/NCT04351724,01/12/2021,0,0
1669,NCT04353596,Completed,16/02/2021,24/02/2021,No Results Posted,"['Bauer A, Schreinlechner M, Sappler N, Dolejsi T, Tilg H, Aulinger BA, Weiss G, Bellmann-Weiler R, Adolf C, Wolf D, Pirklbauer M, Graziadei I, G√§nzer H, von Bary C, May AE, W√∂ll E, von Scheidt W, Rassaf T, Duerschmied D, Brenner C, K√§√§b S, Metzler B, Joannidis M, Kain HU, Kaiser N, Schwinger R, Witzenbichler B, Alber H, Straube F, Hartmann N, Achenbach S, von Bergwelt-Baildon M, von St√ºlpnagel L, Schoenherr S, Forer L, Embacher-Aichhorn S, Mansmann U, Rizas KD, Massberg S; ACEI-COVID investigators. Discontinuation versus continuation of renin-angiotensin-system inhibitors in COVID-19 (ACEI-COVID): a prospective, parallel group, randomised, controlled, open-label trial. Lancet Respir Med. 2021 Jun 11. pii: S2213-2600(21)00214-9. doi: 10.1016/S2213-2600(21)00214-9. [Epub ahead of print]']",,02/03/2021,https://clinicaltrials.gov/show/NCT04353596,16/02/2021,0,1
1670,NCT04355728,Completed,31/10/2020,31/10/2020,No Results Posted,,,01/03/2021,https://clinicaltrials.gov/show/NCT04355728,31/10/2020,0,0
1671,NCT04358003,Recruiting,01/08/2021,01/12/2021,No Results Posted,,,23/02/2021,https://clinicaltrials.gov/show/NCT04358003,01/08/2021,0,0
1672,NCT04366141,Completed,01/02/2021,01/02/2021,No Results Posted,"['Jen TTH, Gusti V, Badh C, Mehta S, Denomme J, Lockhart S, Shams B, Klaibert B, Chau A. The impact of a barrier enclosure on time to tracheal intubation: a randomized controlled trial. Can J Anaesth. 2021 May 10. doi: 10.1007/s12630-021-02024-z. [Epub ahead of print]']",,24/02/2021,https://clinicaltrials.gov/show/NCT04366141,01/02/2021,0,1
1673,NCT04369274,Not yet recruiting,01/11/2021,01/11/2021,No Results Posted,,,24/02/2021,https://clinicaltrials.gov/show/NCT04369274,01/11/2021,0,0
1674,NCT04384445,Recruiting,30/06/2021,31/07/2021,No Results Posted,,,23/02/2021,https://clinicaltrials.gov/show/NCT04384445,30/06/2021,0,0
1675,NCT04388709,Withdrawn,05/02/2021,05/02/2021,No Results Posted,"['Lee JS, Shin EC. The type I interferon response in COVID-19: implications for treatment. Nat Rev Immunol. 2020 Oct;20(10):585-586. doi: 10.1038/s41577-020-00429-3.']",,26/02/2021,https://clinicaltrials.gov/show/NCT04388709,05/02/2021,0,1
1676,NCT04394013,Completed,31/12/2020,31/12/2020,No Results Posted,,,24/02/2021,https://clinicaltrials.gov/show/NCT04394013,31/12/2020,0,0
1677,NCT04395976,Withdrawn,10/06/2020,01/09/2020,No Results Posted,,,02/03/2021,https://clinicaltrials.gov/show/NCT04395976,10/06/2020,0,0
1678,NCT04397510,Enrolling by invitation,31/12/2021,31/12/2021,No Results Posted,"['Flumignan RL, Tin√¥co JDS, Pascoal PI, Areias LL, Cossi MS, Fernandes MI, Costa IK, Souza L, Matar CF, Tendal B, Trevisani VF, Atallah √ÅN, Nakano LC. Prophylactic anticoagulants for people hospitalised with COVID-19. Cochrane Database Syst Rev. 2020 Oct 2;10:CD013739. doi: 10.1002/14651858.CD013739.']",,23/02/2021,https://clinicaltrials.gov/show/NCT04397510,31/12/2021,0,1
1679,NCT04405570,Completed,21/02/2021,21/02/2021,No Results Posted,"['Fischer W, Eron JJ, Holman W, Cohen MS, Fang L, Szewczyk LJ, Sheahan TP, Baric R, Mollan KR, Wolfe CR, Duke ER, Azizad MM, Borroto-Esoda K, Wohl DA, Loftis AJ, Alabanza P, Lipansky F, Painter WP. Molnupiravir, an Oral Antiviral Treatment for COVID-19. medRxiv. 2021 Jun 17. pii: 2021.06.17.21258639. doi: 10.1101/2021.06.17.21258639.', 'Mollan KR, Eron JJ, Krajewski TJ, Painter W, Duke ER, Morse CG, Goecker EA, Premkumar L, Wolfe CR, Szewczyk LJ, Alabanza PL, Loftis AJ, Degli-Angeli EJ, Brown AJ, Dragavon JA, Won JJ, Keys J, Hudgens MG, Wohl DA, Cohen MS, Baric RS, Coombs RW, Sheahan TP, Fischer WA. SARS-CoV-2 infectious virus, viral RNA in nasopharyngeal swabs, and serostatus of symptomatic COVID-19 outpatients in the United States. medRxiv. 2021 Jun 1. pii: 2021.05.28.21258011. doi: 10.1101/2021.05.28.21258011.', 'Cox RM, Wolf JD, Plemper RK. Therapeutically administered ribonucleoside analogue MK-4482/EIDD-2801 blocks SARS-CoV-2 transmission in ferrets. Nat Microbiol. 2021 Jan;6(1):11-18. doi: 10.1038/s41564-020-00835-2. Epub 2020 Dec 3.']",,23/02/2021,https://clinicaltrials.gov/show/NCT04405570,21/02/2021,0,1
1680,NCT04410549,Recruiting,31/12/2021,31/12/2021,No Results Posted,,,25/02/2021,https://clinicaltrials.gov/show/NCT04410549,31/12/2021,0,0
1681,NCT04411602,Withdrawn,07/04/2021,07/04/2021,No Results Posted,,,09/07/2021,https://clinicaltrials.gov/show/NCT04411602,07/04/2021,0,0
1682,NCT04429555,Recruiting,30/06/2021,01/12/2021,No Results Posted,,,23/02/2021,https://clinicaltrials.gov/show/NCT04429555,30/06/2021,0,0
1683,NCT04456413,Recruiting,01/11/2021,01/11/2021,No Results Posted,,,01/03/2021,https://clinicaltrials.gov/show/NCT04456413,01/11/2021,0,0
1684,NCT04472611,Recruiting,30/10/2021,01/08/2022,No Results Posted,,,02/03/2021,https://clinicaltrials.gov/show/NCT04472611,30/10/2021,0,0
1685,NCT04472728,Recruiting,01/07/2021,01/09/2021,No Results Posted,"['Dioh W, Chabane M, Tourette C, Azbekyan A, Morelot-Panzini C, Hajjar LA, Lins M, Nair GB, Whitehouse T, Mariani J, Latil M, Camelo S, Lafont R, Dilda PJ, Veillet S, Agus S. Testing the efficacy and safety of BIO101, for the prevention of respiratory deterioration, in patients with COVID-19 pneumonia (COVA study): a structured summary of a study protocol for a randomised controlled trial. Trials. 2021 Jan 11;22(1):42. doi: 10.1186/s13063-020-04998-5.']",,23/02/2021,https://clinicaltrials.gov/show/NCT04472728,01/07/2021,0,1
1686,NCT04475913,Completed,11/07/2020,20/08/2020,No Results Posted,,,01/03/2021,https://clinicaltrials.gov/show/NCT04475913,11/07/2020,0,0
1687,NCT04495816,Recruiting,01/08/2021,01/08/2021,No Results Posted,"['Lerner D, Garvey K, Arrighi-Allisan A, Filimonov A, Filip P, Liu K, Ninan S, Schaberg M, Colley P, Del Signore A, Govindaraj S, Iloreta AM. Letter to the editor: Study Summary - Randomized Control Trial of Omega-3 Fatty Acid Supplementation for the Treatment of COVID-19 Related Olfactory Dysfunction. Trials. 2020 Nov 23;21(1):942. doi: 10.1186/s13063-020-04905-y.']",,01/03/2021,https://clinicaltrials.gov/show/NCT04495816,01/08/2021,0,1
1688,NCT04505774,Recruiting,01/09/2021,01/12/2021,No Results Posted,,,02/03/2021,https://clinicaltrials.gov/show/NCT04505774,01/09/2021,0,0
1689,NCT04533048,Completed,16/11/2020,02/12/2020,No Results Posted,,,26/02/2021,https://clinicaltrials.gov/show/NCT04533048,16/11/2020,0,0
1690,NCT04535674,Recruiting,01/07/2021,01/12/2021,No Results Posted,,,07/07/2021,https://clinicaltrials.gov/show/NCT04535674,01/07/2021,0,0
1691,NCT04535869,Recruiting,01/04/2021,03/09/2021,No Results Posted,,"['Phelan AL, Katz R, Gostin LO. The Novel Coronavirus Originating in Wuhan, China: Challenges for Global Health Governance. JAMA. 2020 Feb 25;323(8):709-710. doi: 10.1001/jama.2020.1097.']",24/02/2021,https://clinicaltrials.gov/show/NCT04535869,01/04/2021,0,1
1692,NCT04541979,Recruiting,01/05/2021,01/06/2021,No Results Posted,,,25/02/2021,https://clinicaltrials.gov/show/NCT04541979,01/05/2021,0,0
1693,NCT04542850,Recruiting,15/06/2021,15/09/2021,No Results Posted,,,26/02/2021,https://clinicaltrials.gov/show/NCT04542850,15/06/2021,0,0
1694,NCT04568707,Recruiting,15/10/2022,15/10/2022,No Results Posted,,,25/02/2021,https://clinicaltrials.gov/show/NCT04568707,15/10/2022,0,0
1695,NCT04588415,Enrolling by invitation,01/12/2021,01/01/2022,No Results Posted,,,01/03/2021,https://clinicaltrials.gov/show/NCT04588415,01/12/2021,0,0
1696,NCT04603781,Recruiting,31/12/2021,31/12/2021,No Results Posted,,,26/02/2021,https://clinicaltrials.gov/show/NCT04603781,31/12/2021,0,0
1697,NCT04613739,Recruiting,01/09/2021,31/01/2023,No Results Posted,,,02/03/2021,https://clinicaltrials.gov/show/NCT04613739,01/09/2021,0,0
1698,NCT04614844,Recruiting,15/09/2022,15/11/2022,No Results Posted,,,25/02/2021,https://clinicaltrials.gov/show/NCT04614844,15/09/2022,0,0
1699,NCT04627584,Recruiting,01/05/2021,01/09/2021,No Results Posted,,,26/02/2021,https://clinicaltrials.gov/show/NCT04627584,01/05/2021,0,0
1700,NCT04632043,Recruiting,01/05/2021,01/06/2021,No Results Posted,,"['Marini JJ, Gattinoni L. Management of COVID-19 Respiratory Distress. JAMA. 2020 Jun 9;323(22):2329-2330. doi: 10.1001/jama.2020.6825.', 'Fan E, Beitler JR, Brochard L, Calfee CS, Ferguson ND, Slutsky AS, Brodie D. COVID-19-associated acute respiratory distress syndrome: is a different approach to management warranted? Lancet Respir Med. 2020 Aug;8(8):816-821. doi: 10.1016/S2213-2600(20)30304-0. Epub 2020 Jul 6. Review.', 'Goyal P, Choi JJ, Pinheiro LC, Schenck EJ, Chen R, Jabri A, Satlin MJ, Campion TR Jr, Nahid M, Ringel JB, Hoffman KL, Alshak MN, Li HA, Wehmeyer GT, Rajan M, Reshetnyak E, Hupert N, Horn EM, Martinez FJ, Gulick RM, Safford MM. Clinical Characteristics of Covid-19 in New York City. N Engl J Med. 2020 Jun 11;382(24):2372-2374. doi: 10.1056/NEJMc2010419. Epub 2020 Apr 17.', 'Bauer PR, Gajic O, Nanchal R, Kashyap R, Martin-Loeches I, Sakr Y, Jakob SM, Fran√ßois B, Wittebole X, Wunderink RG, Vincent JL; ICON Investigators (Supplemental Appendix 1). Association between timing of intubation and outcome in critically ill patients: A secondary analysis of the ICON audit. J Crit Care. 2017 Dec;42:1-5. doi: 10.1016/j.jcrc.2017.06.010. Epub 2017 Jun 16.', 'Kang BJ, Koh Y, Lim CM, Huh JW, Baek S, Han M, Seo HS, Suh HJ, Seo GJ, Kim EY, Hong SB. Failure of high-flow nasal cannula therapy may delay intubation and increase mortality. Intensive Care Med. 2015 Apr;41(4):623-32. doi: 10.1007/s00134-015-3693-5. Epub 2015 Feb 18.']",03/03/2021,https://clinicaltrials.gov/show/NCT04632043,01/05/2021,0,1
1701,NCT04651790,Recruiting,01/01/2022,01/03/2022,No Results Posted,,,02/03/2021,https://clinicaltrials.gov/show/NCT04651790,01/01/2022,0,0
1702,NCT04659707,Recruiting,31/12/2021,31/12/2021,No Results Posted,,,24/02/2021,https://clinicaltrials.gov/show/NCT04659707,31/12/2021,0,0
1703,NCT04678843,Enrolling by invitation,01/10/2021,01/12/2021,No Results Posted,"['Couturier J, Pellegrini D, Miller C, Agar P, Webb C, Anderson K, Barwick M, Dimitropoulos G, Findlay S, Kimber M, McVey G, Lock J. Adapting and adopting highly specialized pediatric eating disorder treatment to virtual care: a protocol for an implementation study in the COVID-19 context. Implement Sci Commun. 2021 Apr 8;2(1):38. doi: 10.1186/s43058-021-00143-8.']",,02/03/2021,https://clinicaltrials.gov/show/NCT04678843,01/10/2021,0,1
1704,NCT04679909,Recruiting,01/02/2022,01/02/2022,No Results Posted,,,24/02/2021,https://clinicaltrials.gov/show/NCT04679909,01/02/2022,0,0
1705,NCT04681053,Recruiting,30/04/2021,31/12/2021,No Results Posted,,,24/02/2021,https://clinicaltrials.gov/show/NCT04681053,30/04/2021,0,0
1706,NCT04695197,Recruiting,01/11/2022,31/07/2023,No Results Posted,,,24/02/2021,https://clinicaltrials.gov/show/NCT04695197,01/11/2022,0,0
1707,NCT04700462,Recruiting,30/10/2021,30/10/2021,No Results Posted,,,24/02/2021,https://clinicaltrials.gov/show/NCT04700462,30/10/2021,0,0
1708,NCT04701502,Completed,15/02/2021,15/02/2021,No Results Posted,,,26/02/2021,https://clinicaltrials.gov/show/NCT04701502,15/02/2021,0,0
1709,NCT04701710,Completed,18/12/2020,31/12/2020,No Results Posted,,,23/02/2021,https://clinicaltrials.gov/show/NCT04701710,18/12/2020,0,0
1710,NCT04713176,Recruiting,30/06/2021,30/06/2021,No Results Posted,,,03/03/2021,https://clinicaltrials.gov/show/NCT04713176,30/06/2021,0,0
1711,NCT04723563,Enrolling by invitation,01/05/2021,29/05/2021,No Results Posted,,,24/02/2021,https://clinicaltrials.gov/show/NCT04723563,01/05/2021,0,0
1712,NCT04729595,Not yet recruiting,30/12/2021,30/01/2022,No Results Posted,,,26/02/2021,https://clinicaltrials.gov/show/NCT04729595,30/12/2021,0,0
1713,NCT04747158,Completed,10/12/2020,10/01/2021,No Results Posted,,,02/03/2021,https://clinicaltrials.gov/show/NCT04747158,10/12/2020,0,0
1714,NCT04757857,Recruiting,28/02/2021,30/04/2021,No Results Posted,,,25/02/2021,https://clinicaltrials.gov/show/NCT04757857,28/02/2021,0,0
1715,NCT04760132,Recruiting,31/12/2024,31/12/2024,No Results Posted,,,26/02/2021,https://clinicaltrials.gov/show/NCT04760132,31/12/2024,0,0
1716,NCT04768179,Not yet recruiting,30/06/2021,30/09/2021,No Results Posted,,,24/02/2021,https://clinicaltrials.gov/show/NCT04768179,30/06/2021,0,0
1717,NCT04769297,"Active, not recruiting",01/04/2021,01/04/2021,No Results Posted,,,24/02/2021,https://clinicaltrials.gov/show/NCT04769297,01/04/2021,0,0
1718,NCT04769999,Completed,16/10/2020,30/10/2020,No Results Posted,,,25/02/2021,https://clinicaltrials.gov/show/NCT04769999,16/10/2020,0,0
1719,NCT04770740,Recruiting,01/06/2021,01/10/2021,No Results Posted,,,03/03/2021,https://clinicaltrials.gov/show/NCT04770740,01/06/2021,0,0
1720,NCT04771585,Recruiting,31/01/2022,31/01/2022,No Results Posted,,,25/02/2021,https://clinicaltrials.gov/show/NCT04771585,31/01/2022,0,0
1721,NCT04771598,Not yet recruiting,30/06/2021,30/07/2021,No Results Posted,,,01/03/2021,https://clinicaltrials.gov/show/NCT04771598,30/06/2021,0,0
1722,NCT04773756,Completed,30/11/2020,12/12/2020,No Results Posted,,,26/02/2021,https://clinicaltrials.gov/show/NCT04773756,30/11/2020,0,0
1723,NCT04776941,Recruiting,31/12/2021,31/12/2021,No Results Posted,,,02/03/2021,https://clinicaltrials.gov/show/NCT04776941,31/12/2021,0,0
1724,NCT04779138,Not yet recruiting,31/10/2023,30/11/2023,No Results Posted,,,03/03/2021,https://clinicaltrials.gov/show/NCT04779138,31/10/2023,0,0
1725,NCT04317092,"Active, not recruiting",19/12/2021,19/12/2022,No Results Posted,"['Perrone F, Piccirillo MC, Ascierto PA, Salvarani C, Parrella R, Marata AM, Popoli P, Ferraris L, Marrocco-Trischitta MM, Ripamonti D, Binda F, Bonfanti P, Squillace N, Castelli F, Muiesan ML, Lichtner M, Calzetti C, Salerno ND, Atripaldi L, Cascella M, Costantini M, Dolci G, Facciolongo NC, Fraganza F, Massari M, Montesarchio V, Mussini C, Negri EA, Botti G, Cardone C, Gargiulo P, Gravina A, Schettino C, Arenare L, Chiodini P, Gallo C; TOCIVID-19 investigators, Italy. Tocilizumab for patients with COVID-19 pneumonia. The single-arm TOCIVID-19 prospective trial. J Transl Med. 2020 Oct 21;18(1):405. doi: 10.1186/s12967-020-02573-9.', 'Chiodini P, Arenare L, Piccirillo MC, Perrone F, Gallo C. A phase 2, open label, multicenter, single arm study of tocilizumab on the efficacy and tolerability of tocilizumab in the treatment of patients with COVID-19 pneumonia (TOCIVID-19 trial): Statistical analysis plan. Contemp Clin Trials Commun. 2020 Dec;20:100665. doi: 10.1016/j.conctc.2020.100665. Epub 2020 Oct 7.', 'Piccirillo MC, Ascierto P, Atripaldi L, Cascella M, Costantini M, Dolci G, Facciolongo N, Fraganza F, Marata A, Massari M, Montesarchio V, Mussini C, Negri EA, Parrella R, Popoli P, Botti G, Arenare L, Chiodini P, Gallo C, Salvarani C, Perrone F. TOCIVID-19 - A multicenter study on the efficacy and tolerability of tocilizumab in the treatment of patients with COVID-19 pneumonia. Study protocol. Contemp Clin Trials. 2020 Nov;98:106165. doi: 10.1016/j.cct.2020.106165. Epub 2020 Oct 6.']",,03/03/2021,https://clinicaltrials.gov/show/NCT04317092,19/12/2021,0,1
1726,NCT04326920,Completed,28/09/2020,26/02/2021,No Results Posted,"['Mehta P, Porter JC, Manson JJ, Isaacs JD, Openshaw PJM, McInnes IB, Summers C, Chambers RC. Therapeutic blockade of granulocyte macrophage colony-stimulating factor in COVID-19-associated hyperinflammation: challenges and opportunities. Lancet Respir Med. 2020 Aug;8(8):822-830. doi: 10.1016/S2213-2600(20)30267-8. Epub 2020 Jun 16. Review.', 'Bosteels C, Maes B, Van Damme K, De Leeuw E, Declercq J, Delporte A, Demeyere B, Vermeersch S, Vuylsteke M, Willaert J, Boll√© L, Vanbiervliet Y, Decuypere J, Libeer F, Vandecasteele S, Peene I, Lambrecht B. Sargramostim to treat patients with acute hypoxic respiratory failure due to COVID-19 (SARPAC): A structured summary of a study protocol for a randomised controlled trial. Trials. 2020 Jun 5;21(1):491. doi: 10.1186/s13063-020-04451-7. Erratum in: Trials. 2020 Jun 22;21(1):554.']",,02/03/2021,https://clinicaltrials.gov/show/NCT04326920,28/09/2020,0,1
1727,NCT04330638,"Active, not recruiting",18/12/2020,12/04/2021,No Results Posted,"['Maes B, Bosteels C, De Leeuw E, Declercq J, Van Damme K, Delporte A, Demeyere B, Vermeersch S, Vuylsteke M, Willaert J, Boll√© L, Vanbiervliet Y, Decuypere J, Libeer F, Vandecasteele S, Peene I, Lambrecht B. Treatment of severely ill COVID-19 patients with anti-interleukin drugs (COV-AID): A structured summary of a study protocol for a randomised controlled trial. Trials. 2020 Jun 3;21(1):468. doi: 10.1186/s13063-020-04453-5. Erratum in: Trials. 2020 Jun 22;21(1):556.']",,02/03/2021,https://clinicaltrials.gov/show/NCT04330638,18/12/2020,0,1
1728,NCT04331795,Completed,05/06/2020,05/06/2020,Results Submitted,,"['Strohbehn GW, Heiss BL, Rouhani SJ, Trujillo JA, Yu J, Kacew AJ, Higgs EF, Bloodworth JC, Cabanov A, Wright RC, Koziol AK, Weiss A, Danahey K, Karrison TG, Edens CC, Bauer Ventura I, Pettit NN, Patel BK, Pisano J, Strek ME, Gajewski TF, Ratain MJ, Reid PD. COVIDOSE: A Phase II Clinical Trial of Low-Dose Tocilizumab in the Treatment of Noncritical COVID-19 Pneumonia. Clin Pharmacol Ther. 2021 Mar;109(3):688-696. doi: 10.1002/cpt.2117. Epub 2020 Dec 10.']",09/03/2021,https://clinicaltrials.gov/show/NCT04331795,05/06/2020,0,1
1729,NCT04334980,"Active, not recruiting",08/02/2022,28/02/2022,No Results Posted,,,04/03/2021,https://clinicaltrials.gov/show/NCT04334980,08/02/2022,0,0
1730,NCT04340232,Withdrawn,01/08/2021,01/10/2021,No Results Posted,,,08/03/2021,https://clinicaltrials.gov/show/NCT04340232,01/08/2021,0,0
1731,NCT04343729,Completed,16/06/2020,20/10/2020,No Results Posted,"['Jeronimo CMP, Farias MEL, Val FFA, Sampaio VS, Alexandre MAA, Melo GC, Safe IP, Borba MGS, Netto RLA, Maciel ABS, Neto JRS, Oliveira LB, Figueiredo EFG, Oliveira Dinelly KM, de Almeida Rodrigues MG, Brito M, Mour√£o MPG, Pivoto Jo√£o GA, Hajjar LA, Bassat Q, Romero GAS, Naveca FG, Vasconcelos HL, de Ara√∫jo Tavares M, Brito-Sousa JD, Costa FTM, Nogueira ML, Ba√≠a-da-Silva DC, Xavier MS, Monteiro WM, Lacerda MVG; Metcovid Team. Methylprednisolone as Adjunctive Therapy for Patients Hospitalized With Coronavirus Disease 2019 (COVID-19; Metcovid): A Randomized, Double-blind, Phase IIb, Placebo-controlled Trial. Clin Infect Dis. 2021 May 4;72(9):e373-e381. doi: 10.1093/cid/ciaa1177.']",,09/03/2021,https://clinicaltrials.gov/show/NCT04343729,16/06/2020,0,1
1732,NCT04345601,Recruiting,01/10/2022,01/10/2022,No Results Posted,,,04/03/2021,https://clinicaltrials.gov/show/NCT04345601,01/10/2022,0,0
1733,NCT04348071,Withdrawn,01/08/2021,01/10/2021,No Results Posted,,,08/03/2021,https://clinicaltrials.gov/show/NCT04348071,01/08/2021,0,0
1734,NCT04351152,"Active, not recruiting",01/03/2021,01/03/2021,No Results Posted,"['Temesgen Z, Burger CD, Baker J, Polk C, Libertin C, Kelley C, Marconi VC, Orenstein R, Durrant C, Chappell D, Ahmed O, Chappell G, Badley AD. LENZILUMAB EFFICACY AND SAFETY IN NEWLY HOSPITALIZED COVID-19 SUBJECTS: RESULTS FROM THE LIVE-AIR PHASE 3 RANDOMIZED DOUBLE-BLIND PLACEBO-CONTROLLED TRIAL. medRxiv. 2021 May 5. pii: 2021.05.01.21256470. doi: 10.1101/2021.05.01.21256470.', 'Aroldi A, Chiarle R, Gambacorti-Passerini C. Clinical Benefit of Lenzilumab in Cases of Coronavirus Disease 2019. Mayo Clin Proc. 2021 Mar;96(3):817. doi: 10.1016/j.mayocp.2020.12.030. Epub 2021 Jan 11.', 'Temesgen Z, Assi M, Shweta FNU, Vergidis P, Rizza SA, Bauer PR, Pickering BW, Razonable RR, Libertin CR, Burger CD, Orenstein R, Vargas HE, Palraj R, Dababneh AS, Chappell G, Chappell D, Ahmed O, Sakemura R, Durrant C, Kenderian SS, Badley AD. GM-CSF Neutralization With Lenzilumab in Severe COVID-19 Pneumonia: A Case-Cohort Study. Mayo Clin Proc. 2020 Nov;95(11):2382-2394. doi: 10.1016/j.mayocp.2020.08.038. Epub 2020 Sep 3.']",,03/03/2021,https://clinicaltrials.gov/show/NCT04351152,01/03/2021,0,1
1735,NCT04359901,"Active, not recruiting",01/04/2022,01/04/2023,No Results Posted,,,08/03/2021,https://clinicaltrials.gov/show/NCT04359901,01/04/2022,0,0
1736,NCT04363463,Recruiting,28/08/2022,28/08/2022,No Results Posted,,,05/03/2021,https://clinicaltrials.gov/show/NCT04363463,28/08/2022,0,0
1737,NCT04372680,Recruiting,22/10/2021,22/10/2021,No Results Posted,,,04/03/2021,https://clinicaltrials.gov/show/NCT04372680,22/10/2021,0,0
1738,NCT04374279,Withdrawn,01/01/2022,01/01/2022,No Results Posted,,,05/03/2021,https://clinicaltrials.gov/show/NCT04374279,01/01/2022,0,0
1739,NCT04377165,Terminated,26/08/2020,26/08/2020,No Results Posted,,,09/03/2021,https://clinicaltrials.gov/show/NCT04377165,26/08/2020,0,0
1740,NCT04382040,Completed,05/11/2020,21/12/2020,No Results Posted,,,03/03/2021,https://clinicaltrials.gov/show/NCT04382040,05/11/2020,0,0
1741,NCT04382391,Recruiting,01/09/2021,30/06/2022,No Results Posted,,,10/03/2021,https://clinicaltrials.gov/show/NCT04382391,01/09/2021,0,0
1742,NCT04382755,Completed,29/12/2020,09/04/2021,No Results Posted,"['Declercq J, Bosteels C, Van Damme K, De Leeuw E, Maes B, Vandecauter A, Vermeersch S, Delporte A, Demeyere B, Vuylsteke M, Lalla M, Smart T, Detalle L, Bouw R, Streffer J, Degeeter T, Vergotte M, Guisez T, Van Braeckel E, Van Der Straeten C, Lambrecht BN. Zilucoplan in patients with acute hypoxic respiratory failure due to COVID-19 (ZILU-COV): A structured summary of a study protocol for a randomised controlled trial. Trials. 2020 Nov 19;21(1):934. doi: 10.1186/s13063-020-04884-0.']",,02/07/2021,https://clinicaltrials.gov/show/NCT04382755,29/12/2020,0,1
1743,NCT04387760,Recruiting,14/04/2021,14/05/2021,No Results Posted,,,09/03/2021,https://clinicaltrials.gov/show/NCT04387760,14/04/2021,0,0
1744,NCT04389359,Withdrawn,01/08/2021,01/08/2025,No Results Posted,,,08/03/2021,https://clinicaltrials.gov/show/NCT04389359,01/08/2021,0,0
1745,NCT04390503,Recruiting,01/04/2022,01/04/2022,No Results Posted,,,07/07/2021,https://clinicaltrials.gov/show/NCT04390503,01/04/2022,0,0
1746,NCT04397718,Completed,08/06/2021,08/06/2021,No Results Posted,"['Nickols NG, Goetz MB, Graber CJ, Bhattacharya D, Soo Hoo G, Might M, Goldstein DB, Wang X, Ramoni R, Myrie K, Tran S, Ghayouri L, Tsai S, Geelhoed M, Makarov D, Becker DJ, Tsay JC, Diamond M, George A, Al-Ajam M, Belligund P, Montgomery RB, Mostaghel EA, Sulpizio C, Mi Z, Dematt E, Tadalan J, Norman LE, Briones D, Clise CE, Taylor ZW, Huminik JR, Biswas K, Rettig MB. Hormonal intervention for the treatment of veterans with COVID-19 requiring hospitalization (HITCH): a multicenter, phase 2 randomized controlled trial of best supportive care vs best supportive care plus degarelix: study protocol for a randomized controlled trial. Trials. 2021 Jul 5;22(1):431. doi: 10.1186/s13063-021-05389-0.']",,02/07/2021,https://clinicaltrials.gov/show/NCT04397718,08/06/2021,0,1
1747,NCT04402918,Recruiting,19/05/2020,28/02/2021,No Results Posted,,,05/03/2021,https://clinicaltrials.gov/show/NCT04402918,19/05/2020,0,0
1748,NCT04403555,Recruiting,01/12/2030,03/12/2030,No Results Posted,,,05/03/2021,https://clinicaltrials.gov/show/NCT04403555,01/12/2030,0,0
1749,NCT04409496,Completed,22/01/2021,22/01/2021,No Results Posted,,,04/03/2021,https://clinicaltrials.gov/show/NCT04409496,22/01/2021,0,0
1750,NCT04412057,Completed,02/12/2020,19/01/2021,No Results Posted,"['Perlin DS, Zafir-Lavie I, Roadcap L, Raines S, Ware CF, Neil GA. Levels of the TNF-Related Cytokine LIGHT Increase in Hospitalized COVID-19 Patients with Cytokine Release Syndrome and ARDS. mSphere. 2020 Aug 12;5(4). pii: e00699-20. doi: 10.1128/mSphere.00699-20.']",,02/03/2021,https://clinicaltrials.gov/show/NCT04412057,02/12/2020,0,1
1751,NCT04416919,"Active, not recruiting",01/06/2020,01/07/2021,No Results Posted,,"['van Doremalen N, Bushmaker T, Morris DH, Holbrook MG, Gamble A, Williamson BN, Tamin A, Harcourt JL, Thornburg NJ, Gerber SI, Lloyd-Smith JO, de Wit E, Munster VJ. Aerosol and Surface Stability of SARS-CoV-2 as Compared with SARS-CoV-1. N Engl J Med. 2020 Apr 16;382(16):1564-1567. doi: 10.1056/NEJMc2004973. Epub 2020 Mar 17.', 'Qian Y, Willeke K, Grinshpun SA, Donnelly J, Coffey CC. Performance of N95 respirators: filtration efficiency for airborne microbial and inert particles. Am Ind Hyg Assoc J. 1998 Feb;59(2):128-32.']",05/03/2021,https://clinicaltrials.gov/show/NCT04416919,01/06/2020,0,1
1752,NCT04417270,Completed,30/11/2020,30/11/2020,No Results Posted,,,02/03/2021,https://clinicaltrials.gov/show/NCT04417270,30/11/2020,0,0
1753,NCT04420273,Completed,01/03/2021,01/03/2021,No Results Posted,,,03/03/2021,https://clinicaltrials.gov/show/NCT04420273,01/03/2021,0,0
1754,NCT04427254,Recruiting,01/01/2023,01/01/2023,No Results Posted,,,02/03/2021,https://clinicaltrials.gov/show/NCT04427254,01/01/2023,0,0
1755,NCT04447469,Recruiting,01/12/2021,01/02/2022,No Results Posted,,,09/03/2021,https://clinicaltrials.gov/show/NCT04447469,01/12/2021,0,0
1756,NCT04447833,"Active, not recruiting",30/01/2021,30/06/2025,No Results Posted,,,04/03/2021,https://clinicaltrials.gov/show/NCT04447833,30/01/2021,0,0
1757,NCT04464408,Recruiting,01/12/2021,01/12/2021,No Results Posted,"['Bosaeed M, Alharbi A, Hussein M, Abalkhail M, Sultana K, Musattat A, Alqahtani H, Alshamrani M, Mahmoud E, Alothman A, Alsaedy A, Aldibasi O, Alhagan K, Asiri AM, AlJohani S, Al-Jeraisy M, Alaskar A. Multicentre randomised double-blinded placebo-controlled trial of favipiravir in adults with mild COVID-19. BMJ Open. 2021 Apr 14;11(4):e047495. doi: 10.1136/bmjopen-2020-047495.']",,05/03/2021,https://clinicaltrials.gov/show/NCT04464408,01/12/2021,0,1
1758,NCT04465604,Recruiting,01/11/2021,01/05/2022,No Results Posted,,,05/03/2021,https://clinicaltrials.gov/show/NCT04465604,01/11/2021,0,0
1759,NCT04469491,Recruiting,01/09/2021,01/09/2021,No Results Posted,,,04/03/2021,https://clinicaltrials.gov/show/NCT04469491,01/09/2021,0,0
1760,NCT04470622,Recruiting,01/06/2021,01/07/2021,No Results Posted,,,09/03/2021,https://clinicaltrials.gov/show/NCT04470622,01/06/2021,0,0
1761,NCT04471766,"Active, not recruiting",01/06/2021,01/08/2021,No Results Posted,,,08/03/2021,https://clinicaltrials.gov/show/NCT04471766,01/06/2021,0,0
1762,NCT04490200,Recruiting,30/12/2021,15/02/2022,No Results Posted,,,03/03/2021,https://clinicaltrials.gov/show/NCT04490200,30/12/2021,0,0
1763,NCT04517396,Enrolling by invitation,31/10/2021,31/10/2021,No Results Posted,,,08/03/2021,https://clinicaltrials.gov/show/NCT04517396,31/10/2021,0,0
1764,NCT04530435,"Active, not recruiting",30/04/2021,30/04/2021,No Results Posted,"['Mollerup A, Larsen SC, Bennetzen AS, Henriksen M, Simonsen MK, Weis N, Kofod LM, Heitmann BL. PEP-CoV protocol: a PEP flute-self-care randomised controlled trial to prevent respiratory deterioration and hospitalisation in early COVID-19. BMJ Open. 2021 Jun 30;11(6):e050582. doi: 10.1136/bmjopen-2021-050582.']",,08/03/2021,https://clinicaltrials.gov/show/NCT04530435,30/04/2021,0,1
1765,NCT04542993,"Active, not recruiting",05/02/2021,01/06/2022,No Results Posted,,,03/03/2021,https://clinicaltrials.gov/show/NCT04542993,05/02/2021,0,0
1766,NCT04547127,Completed,04/02/2021,04/02/2021,No Results Posted,,,03/03/2021,https://clinicaltrials.gov/show/NCT04547127,04/02/2021,0,0
1767,NCT04551898,Completed,25/01/2021,25/01/2021,No Results Posted,,,04/03/2021,https://clinicaltrials.gov/show/NCT04551898,25/01/2021,0,0
1768,NCT04555096,Recruiting,01/11/2021,01/12/2021,No Results Posted,"['Karlsson JOG, Jynge P, Ignarro LJ. May Mangafodipir or Other SOD Mimetics Contribute to Better Care in COVID-19 Patients? Antioxidants (Basel). 2020 Oct 10;9(10). pii: E971. doi: 10.3390/antiox9100971.']",,02/03/2021,https://clinicaltrials.gov/show/NCT04555096,01/11/2021,0,1
1769,NCT04569786,Terminated,18/02/2021,18/02/2021,No Results Posted,,,04/03/2021,https://clinicaltrials.gov/show/NCT04569786,18/02/2021,0,0
1770,NCT04590430,"Active, not recruiting",01/04/2021,01/07/2021,No Results Posted,,,05/03/2021,https://clinicaltrials.gov/show/NCT04590430,01/04/2021,0,0
1771,NCT04604704,Recruiting,01/08/2021,01/10/2021,No Results Posted,,,03/03/2021,https://clinicaltrials.gov/show/NCT04604704,01/08/2021,0,0
1772,NCT04617262,Recruiting,01/08/2021,01/09/2021,No Results Posted,,,03/03/2021,https://clinicaltrials.gov/show/NCT04617262,01/08/2021,0,0
1773,NCT04649424,Recruiting,30/04/2021,30/05/2021,No Results Posted,,,03/03/2021,https://clinicaltrials.gov/show/NCT04649424,30/04/2021,0,0
1774,NCT04659772,Completed,01/02/2021,01/02/2021,No Results Posted,,,03/03/2021,https://clinicaltrials.gov/show/NCT04659772,01/02/2021,0,0
1775,NCT04690413,Completed,31/12/2020,31/12/2020,No Results Posted,,,03/03/2021,https://clinicaltrials.gov/show/NCT04690413,31/12/2020,0,0
1776,NCT04695704,Not yet recruiting,31/03/2022,31/12/2022,No Results Posted,,,08/03/2021,https://clinicaltrials.gov/show/NCT04695704,31/03/2022,0,0
1777,NCT04706403,"Active, not recruiting",01/06/2021,26/12/2021,No Results Posted,,,08/03/2021,https://clinicaltrials.gov/show/NCT04706403,01/06/2021,0,0
1778,NCT04716556,"Active, not recruiting",01/05/2021,01/05/2021,No Results Posted,,,05/03/2021,https://clinicaltrials.gov/show/NCT04716556,01/05/2021,0,0
1779,NCT04730401,Recruiting,31/08/2021,31/12/2021,No Results Posted,,,08/03/2021,https://clinicaltrials.gov/show/NCT04730401,31/08/2021,0,0
1780,NCT04747574,Recruiting,25/02/2021,25/03/2021,No Results Posted,,,04/03/2021,https://clinicaltrials.gov/show/NCT04747574,25/02/2021,0,0
1781,NCT04756466,"Active, not recruiting",30/04/2021,31/12/2021,No Results Posted,,,05/03/2021,https://clinicaltrials.gov/show/NCT04756466,30/04/2021,0,0
1782,NCT04771559,Not yet recruiting,01/06/2021,01/07/2021,No Results Posted,,,04/03/2021,https://clinicaltrials.gov/show/NCT04771559,01/06/2021,0,0
1783,NCT04777981,Not yet recruiting,05/05/2021,28/05/2021,No Results Posted,,,08/03/2021,https://clinicaltrials.gov/show/NCT04777981,05/05/2021,0,0
1784,NCT04778059,Not yet recruiting,01/03/2022,01/03/2022,No Results Posted,,,08/03/2021,https://clinicaltrials.gov/show/NCT04778059,01/03/2022,0,0
1785,NCT04779879,Recruiting,01/03/2022,01/04/2023,No Results Posted,,,02/07/2021,https://clinicaltrials.gov/show/NCT04779879,01/03/2022,0,0
1786,NCT04780035,"Active, not recruiting",01/08/2021,01/09/2021,No Results Posted,,,03/03/2021,https://clinicaltrials.gov/show/NCT04780035,01/08/2021,0,0
1787,NCT04780581,Recruiting,01/12/2021,31/12/2021,No Results Posted,,,07/07/2021,https://clinicaltrials.gov/show/NCT04780581,01/12/2021,0,0
1788,NCT04780659,Recruiting,31/12/2022,31/12/2022,No Results Posted,,,03/03/2021,https://clinicaltrials.gov/show/NCT04780659,31/12/2022,0,0
1789,NCT04780685,Recruiting,31/08/2021,31/12/2021,No Results Posted,,,03/03/2021,https://clinicaltrials.gov/show/NCT04780685,31/08/2021,0,0
1790,NCT04781400,Recruiting,08/02/2022,08/02/2022,No Results Posted,,,04/03/2021,https://clinicaltrials.gov/show/NCT04781400,08/02/2022,0,0
1791,NCT04782336,Recruiting,31/03/2022,31/05/2022,No Results Posted,,,04/03/2021,https://clinicaltrials.gov/show/NCT04782336,31/03/2022,0,0
1792,NCT04785781,Recruiting,15/03/2021,15/04/2021,No Results Posted,,,08/03/2021,https://clinicaltrials.gov/show/NCT04785781,15/03/2021,0,0
1793,NCT04785807,Not yet recruiting,01/01/2022,01/01/2022,No Results Posted,,,08/03/2021,https://clinicaltrials.gov/show/NCT04785807,01/01/2022,0,0
1794,NCT04785898,"Active, not recruiting",22/12/2020,30/04/2021,No Results Posted,,,08/03/2021,https://clinicaltrials.gov/show/NCT04785898,22/12/2020,0,0
1795,NCT04786080,Not yet recruiting,30/09/2021,30/11/2021,No Results Posted,"['Kostyrka-Allchorne K, Creswell C, Byford S, Day C, Goldsmith K, Koch M, Gutierrez WM, Palmer M, Raw J, Robertson O, Shearer J, Shum A, Slovak P, Waite P, Sonuga-Barke EJS. Supporting Parents & Kids Through Lockdown Experiences (SPARKLE): A digital parenting support app implemented in an ongoing general population cohort study during the COVID-19 pandemic: A structured summary of a study protocol for a randomised controlled trial. Trials. 2021 Apr 10;22(1):267. doi: 10.1186/s13063-021-05226-4.']",,08/03/2021,https://clinicaltrials.gov/show/NCT04786080,30/09/2021,0,1
1796,NCT04786483,"Active, not recruiting",30/01/2021,10/05/2021,No Results Posted,,['Sahu P. Closure of Universities Due to Coronavirus Disease 2019 (COVID-19): Impact on Education and Mental Health of Students and Academic Staff. Cureus. 2020 Apr 4;12(4):e7541. doi: 10.7759/cureus.7541. Review.'],08/03/2021,https://clinicaltrials.gov/show/NCT04786483,30/01/2021,0,1
1797,NCT04788355,Completed,15/11/2020,23/12/2020,No Results Posted,,,09/03/2021,https://clinicaltrials.gov/show/NCT04788355,15/11/2020,0,0
1798,NCT04303299,Recruiting,31/12/2021,31/12/2021,No Results Posted,,,10/03/2021,https://clinicaltrials.gov/show/NCT04303299,31/12/2021,0,0
1799,NCT04312243,"Active, not recruiting",07/04/2021,07/04/2022,No Results Posted,"['Akhtar S, Das JK, Ismail T, Wahid M, Saeed W, Bhutta ZA. Nutritional perspectives for the prevention and mitigation of COVID-19. Nutr Rev. 2021 Feb 11;79(3):289-300. doi: 10.1093/nutrit/nuaa063.']",,10/03/2021,https://clinicaltrials.gov/show/NCT04312243,07/04/2021,0,1
1800,NCT04324528,Completed,27/01/2021,27/01/2021,No Results Posted,"['Supady A, Weber E, Rieder M, Lother A, Niklaus T, Zahn T, Frech F, M√ºller S, Kuhl M, Benk C, Maier S, Trummer G, Fl√ºgler A, Kr√ºger K, Sekandarzad A, Stachon P, Zotzmann V, Bode C, Biever PM, Staudacher D, Wengenmayer T, Graf E, Duerschmied D. Cytokine adsorption in patients with severe COVID-19 pneumonia requiring extracorporeal membrane oxygenation (CYCOV): a single centre, open-label, randomised, controlled trial. Lancet Respir Med. 2021 May 14. pii: S2213-2600(21)00177-6. doi: 10.1016/S2213-2600(21)00177-6. [Epub ahead of print] Erratum in: Lancet Respir Med. 2021 Jun 4;:.']",,15/03/2021,https://clinicaltrials.gov/show/NCT04324528,27/01/2021,0,1
1801,NCT04332991,Completed,19/06/2020,23/07/2020,Study Results,"[""Self WH, Semler MW, Leither LM, Casey JD, Angus DC, Brower RG, Chang SY, Collins SP, Eppensteiner JC, Filbin MR, Files DC, Gibbs KW, Ginde AA, Gong MN, Harrell FE Jr, Hayden DL, Hough CL, Johnson NJ, Khan A, Lindsell CJ, Matthay MA, Moss M, Park PK, Rice TW, Robinson BRH, Schoenfeld DA, Shapiro NI, Steingrub JS, Ulysse CA, Weissman A, Yealy DM, Thompson BT, Brown SM; National Heart, Lung, and Blood Institute PETAL Clinical Trials Network, Steingrub J, Smithline H, Tiru B, Tidswell M, Kozikowski L, Thornton-Thompson S, De Souza L, Hou P, Baron R, Massaro A, Aisiku I, Fredenburgh L, Seethala R, Johnsky L, Riker R, Seder D, May T, Baumann M, Eldridge A, Lord C, Shapiro N, Talmor D, O'Mara T, Kirk C, Harrison K, Kurt L, Schermerhorn M, Banner-Goodspeed V, Boyle K, Dubosh N, Filbin M, Hibbert K, Parry B, Lavin-Parsons K, Pulido N, Lilley B, Lodenstein C, Margolin J, Brait K, Jones A, Galbraith J, Peacock R, Nandi U, Wachs T, Matthay M, Liu K, Kangelaris K, Wang R, Calfee C, Yee K, Hendey G, Chang S, Lim G, Qadir N, Tam A, Beutler R, Levitt J, Wilson J, Rogers A, Vojnik R, Roque J, Albertson T, Chenoweth J, Adams J, Pearson S, Juarez M, Almasri E, Fayed M, Hughes A, Hillard S, Huebinger R, Wang H, Vidales E, Patel B, Ginde A, Moss M, Baduashvili A, McKeehan J, Finck L, Higgins C, Howell M, Douglas I, Haukoos J, Hiller T, Lyle C, Cupelo A, Caruso E, Camacho C, Gravitz S, Finigan J, Griesmer C, Park P, Hyzy R, Nelson K, McDonough K, Olbrich N, Williams M, Kapoor R, Nash J, Willig M, Ford H, Gardner-Gray J, Ramesh M, Moses M, Ng Gong M, Aboodi M, Asghar A, Amosu O, Torres M, Kaur S, Chen JT, Hope A, Lopez B, Rosales K, Young You J, Mosier J, Hypes C, Natt B, Borg B, Salvagio Campbell E, Hite RD, Hudock K, Cresie A, Alhasan F, Gomez-Arroyo J, Duggal A, Mehkri O, Hastings A, Sahoo D, Abi Fadel F, Gole S, Shaner V, Wimer A, Meli Y, King A, Terndrup T, Exline M, Pannu S, Robart E, Karow S, Hough C, Robinson B, Johnson N, Henning D, Campo M, Gundel S, Seghal S, Katsandres S, Dean S, Khan A, Krol O, Jouzestani M, Huynh P, Weissman A, Yealy D, Scholl D, Adams P, McVerry B, Huang D, Angus D, Schooler J, Moore S, Files C, Miller C, Gibbs K, LaRose M, Flores L, Koehler L, Morse C, Sanders J, Langford C, Nanney K, MdalaGausi M, Yeboah P, Morris P, Sturgill J, Seif S, Cassity E, Dhar S, de Wit M, Mason J, Goodwin A, Hall G, Grady A, Chamberlain A, Brown S, Bledsoe J, Leither L, Peltan I, Starr N, Fergus M, Aston V, Montgomery Q, Smith R, Merrill M, Brown K, Armbruster B, Harris E, Middleton E, Paine R, Johnson S, Barrios M, Eppensteiner J, Limkakeng A, McGowan L, Porter T, Bouffler A, Leahy JC, deBoisblanc B, Lammi M, Happel K, Lauto P, Self W, Casey J, Semler M, Collins S, Harrell F, Lindsell C, Rice T, Stubblefield W, Gray C, Johnson J, Roth M, Hays M, Torr D, Zakaria A, Schoenfeld D, Thompson T, Hayden D, Ringwood N, Oldmixon C, Ulysse C, Morse R, Muzikansky A, Fitzgerald L, Whitaker S, Lagakos A, Brower R, Reineck L, Aggarwal N, Bienstock K, Freemer M, Maclawiw M, Weinmann G, Morrison L, Gillespie M, Kryscio R, Brodie D, Zareba W, Rompalo A, Boeckh M, Parsons P, Christie J, Hall J, Horton N, Zoloth L, Dickert N, Diercks D. Effect of Hydroxychloroquine on Clinical Status at 14 Days in Hospitalized Patients With COVID-19: A Randomized Clinical Trial. JAMA. 2020 Dec 1;324(21):2165-2176. doi: 10.1001/jama.2020.22240."", 'Casey JD, Johnson NJ, Semler MW, Collins SP, Aggarwal NR, Brower RG, Chang SY, Eppensteiner J, Filbin M, Gibbs KW, Ginde AA, Gong MN, Harrell F, Hayden DL, Hough CL, Khan A, Leither LM, Moss M, Oldmixon CF, Park PK, Reineck LA, Ringwood NJ, Robinson BRH, Schoenfeld DA, Shapiro NI, Steingrub JS, Torr DK, Weissman A, Lindsell CJ, Rice TW, Thompson BT, Brown SM, Self WH. Rationale and Design of ORCHID: A Randomized Placebo-controlled Clinical Trial of Hydroxychloroquine for Adults Hospitalized with COVID-19. Ann Am Thorac Soc. 2020 Sep;17(9):1144-1153. doi: 10.1513/AnnalsATS.202005-478SD.']",,17/03/2021,https://clinicaltrials.gov/show/NCT04332991,19/06/2020,1,1
1802,NCT04336254,Recruiting,30/11/2021,31/12/2021,No Results Posted,"['Ye Q, Wang H, Xia X, Zhou C, Liu Z, Xia ZE, Zhang Z, Zhao Y, Yehenala J, Wang S, Zhou G, Hu K, Wu B, Wu CT, Wang S, He Y. Safety and efficacy assessment of allogeneic human dental pulp stem cells to treat patients with severe COVID-19: structured summary of a study protocol for a randomized controlled trial (Phase I / II). Trials. 2020 Jun 12;21(1):520. doi: 10.1186/s13063-020-04380-5.']",,10/03/2021,https://clinicaltrials.gov/show/NCT04336254,30/11/2021,0,1
1803,NCT04345419,Recruiting,01/12/2029,01/12/2029,No Results Posted,,,10/03/2021,https://clinicaltrials.gov/show/NCT04345419,01/12/2029,0,0
1804,NCT04346667,Terminated,23/08/2020,30/08/2020,No Results Posted,,,10/03/2021,https://clinicaltrials.gov/show/NCT04346667,23/08/2020,0,0
1805,NCT04348305,"Active, not recruiting",10/09/2020,08/06/2021,No Results Posted,,,09/03/2021,https://clinicaltrials.gov/show/NCT04348305,10/09/2020,0,0
1806,NCT04351191,Terminated,23/08/2020,30/08/2020,No Results Posted,,,10/03/2021,https://clinicaltrials.gov/show/NCT04351191,23/08/2020,0,0
1807,NCT04351347,Recruiting,01/12/2030,01/12/2030,No Results Posted,,,10/03/2021,https://clinicaltrials.gov/show/NCT04351347,01/12/2030,0,0
1808,NCT04351490,Withdrawn,01/07/2020,01/07/2020,No Results Posted,,,11/03/2021,https://clinicaltrials.gov/show/NCT04351490,01/07/2020,0,0
1809,NCT04353037,Terminated,11/07/2020,11/07/2020,No Results Posted,,,12/03/2021,https://clinicaltrials.gov/show/NCT04353037,11/07/2020,0,0
1810,NCT04358406,"Active, not recruiting",01/05/2021,01/06/2021,No Results Posted,,,16/03/2021,https://clinicaltrials.gov/show/NCT04358406,01/05/2021,0,0
1811,NCT04361942,Recruiting,30/11/2021,31/12/2021,No Results Posted,,"['Vega A, Mart√≠n-Ferrero MA, Del Canto F, Alberca M, Garc√≠a V, Munar A, Orozco L, Soler R, Fuertes JJ, Huguet M, S√°nchez A, Garc√≠a-Sancho J. Treatment of Knee Osteoarthritis With Allogeneic Bone Marrow Mesenchymal Stem Cells: A Randomized Controlled Trial. Transplantation. 2015 Aug;99(8):1681-90. doi: 10.1097/TP.0000000000000678.', 'Noriega DC, Ardura F, Hern√°ndez-Ramajo R, Mart√≠n-Ferrero M√Å, S√°nchez-Lite I, Toribio B, Alberca M, Garc√≠a V, Moraleda JM, S√°nchez A, Garc√≠a-Sancho J. Intervertebral Disc Repair by Allogeneic Mesenchymal Bone Marrow Cells: A Randomized Controlled Trial. Transplantation. 2017 Aug;101(8):1945-1951. doi: 10.1097/TP.0000000000001484.', 'Barbado J, Tabera S, S√°nchez A, Garc√≠a-Sancho J. Therapeutic potential of allogeneic mesenchymal stromal cells transplantation for lupus nephritis. Lupus. 2018 Nov;27(13):2161-2165. doi: 10.1177/0961203318804922. Epub 2018 Oct 5.', 'Leng Z, Zhu R, Hou W, Feng Y, Yang Y, Han Q, Shan G, Meng F, Du D, Wang S, Fan J, Wang W, Deng L, Shi H, Li H, Hu Z, Zhang F, Gao J, Liu H, Li X, Zhao Y, Yin K, He X, Gao Z, Wang Y, Yang B, Jin R, Stambler I, Lim LW, Su H, Moskalev A, Cano A, Chakrabarti S, Min KJ, Ellison-Hughes G, Caruso C, Jin K, Zhao RC. Transplantation of ACE2(-) Mesenchymal Stem Cells Improves the Outcome of Patients with COVID-19 Pneumonia. Aging Dis. 2020 Mar 9;11(2):216-228. doi: 10.14336/AD.2020.0228. eCollection 2020 Apr.']",10/03/2021,https://clinicaltrials.gov/show/NCT04361942,30/11/2021,0,1
1812,NCT04372082,Withdrawn,01/05/2023,01/05/2023,No Results Posted,,,11/03/2021,https://clinicaltrials.gov/show/NCT04372082,01/05/2023,0,0
1813,NCT04373200,Recruiting,25/09/2022,25/09/2022,No Results Posted,,,29/06/2021,https://clinicaltrials.gov/show/NCT04373200,25/09/2022,0,0
1814,NCT04374461,Recruiting,01/05/2023,01/05/2023,No Results Posted,,,10/03/2021,https://clinicaltrials.gov/show/NCT04374461,01/05/2023,0,0
1815,NCT04377620,Terminated,26/02/2021,26/02/2021,No Results Posted,,,15/03/2021,https://clinicaltrials.gov/show/NCT04377620,26/02/2021,0,0
1816,NCT04382378,Recruiting,30/09/2021,31/12/2021,No Results Posted,,,15/03/2021,https://clinicaltrials.gov/show/NCT04382378,30/09/2021,0,0
1817,NCT04385771,Suspended,31/05/2021,31/10/2021,No Results Posted,"['Shekar K, McAuley DF, Brodie D. Cytokine adsorption during ECMO for COVID-19-related ARDS. Lancet Respir Med. 2021 Jul;9(7):680-682. doi: 10.1016/S2213-2600(21)00207-1. Epub 2021 May 14.', 'Rieder M, Duerschmied D, Zahn T, Lang C, Benk C, Lother A, Biever P, Bode C, Wengenmayer T, Staudacher D, Supady A. Cytokine Adsorption in Severe Acute Respiratory Failure Requiring Veno-Venous Extracorporeal Membrane Oxygenation. ASAIO J. 2021 Mar 1;67(3):332-338. doi: 10.1097/MAT.0000000000001302.', 'Rieder M, Schubach F, Schmoor C, von Spee-Mayer C, Wengenmayer T, Rilinger J, Staudacher D, Bode C, Duerschmied D, Supady A. Cytokine adsorption in patients with severe COVID-19 pneumonia requiring extracorporeal membrane oxygenation: protocol for a randomised, controlled, open-label intervention, multicentre trial. BMJ Open. 2021 Jan 17;11(1):e043345. doi: 10.1136/bmjopen-2020-043345.']",,15/03/2021,https://clinicaltrials.gov/show/NCT04385771,31/05/2021,0,1
1818,NCT04387240,Not yet recruiting,01/09/2022,01/12/2022,No Results Posted,,,16/03/2021,https://clinicaltrials.gov/show/NCT04387240,01/09/2022,0,0
1819,NCT04400058,Completed,07/01/2021,31/01/2021,No Results Posted,,,10/03/2021,https://clinicaltrials.gov/show/NCT04400058,07/01/2021,0,0
1820,NCT04409262,Completed,01/02/2021,08/03/2021,No Results Posted,,,11/03/2021,https://clinicaltrials.gov/show/NCT04409262,01/02/2021,0,0
1821,NCT04412395,Not yet recruiting,31/08/2021,30/09/2021,No Results Posted,,,11/03/2021,https://clinicaltrials.gov/show/NCT04412395,31/08/2021,0,0
1822,NCT04414618,Completed,26/11/2020,23/12/2020,No Results Posted,,,10/03/2021,https://clinicaltrials.gov/show/NCT04414618,26/11/2020,0,0
1823,NCT04420741,"Active, not recruiting",23/02/2021,23/04/2021,No Results Posted,"['Johansson PI, Bestle M, S√∏e-Jensen P, Kristiansen KT, Stensballe J, Clausen NE, Perner A. The effect of prostacyclin (Iloprost) infusion at a dose of 1 ng/kg/min for 72 hours compared to placebo in mechanically ventilated patients with COVID-19: A structured summary of a study protocol for a randomized controlled trial. Trials. 2020 Aug 26;21(1):746. doi: 10.1186/s13063-020-04696-2.']",,10/03/2021,https://clinicaltrials.gov/show/NCT04420741,23/02/2021,0,1
1824,NCT04427566,Recruiting,31/12/2021,31/12/2021,No Results Posted,,,15/03/2021,https://clinicaltrials.gov/show/NCT04427566,31/12/2021,0,0
1825,NCT04432324,Completed,03/03/2021,03/03/2021,No Results Posted,,,10/03/2021,https://clinicaltrials.gov/show/NCT04432324,03/03/2021,0,0
1826,NCT04439825,Completed,03/09/2020,01/12/2020,Results Submitted,,"['Dayan SH. Mind, Mood, and Aesthetics. Aesthet Surg J. 2015 Aug;35(6):759-61. doi: 10.1093/asj/sjv032. Epub 2015 Jun 4.']",15/03/2021,https://clinicaltrials.gov/show/NCT04439825,03/09/2020,0,1
1827,NCT04453371,Withdrawn,15/01/2021,15/02/2021,No Results Posted,,,12/03/2021,https://clinicaltrials.gov/show/NCT04453371,15/01/2021,0,0
1828,NCT04466683,Recruiting,31/12/2021,31/12/2022,No Results Posted,,,15/03/2021,https://clinicaltrials.gov/show/NCT04466683,31/12/2021,0,0
1829,NCT04494386,Recruiting,30/10/2021,30/12/2021,No Results Posted,,,09/03/2021,https://clinicaltrials.gov/show/NCT04494386,30/10/2021,0,0
1830,NCT04498247,Terminated,05/03/2021,05/03/2021,No Results Posted,,,11/03/2021,https://clinicaltrials.gov/show/NCT04498247,05/03/2021,0,0
1831,NCT04504240,"Active, not recruiting",10/04/2021,10/04/2021,No Results Posted,,,11/03/2021,https://clinicaltrials.gov/show/NCT04504240,10/04/2021,0,0
1832,NCT04506268,Completed,30/10/2020,30/10/2020,No Results Posted,,,11/03/2021,https://clinicaltrials.gov/show/NCT04506268,30/10/2020,0,0
1833,NCT04508075,"Active, not recruiting",09/01/2021,01/09/2021,No Results Posted,,,10/03/2021,https://clinicaltrials.gov/show/NCT04508075,09/01/2021,0,0
1834,NCT04510038,Suspended,12/03/2021,01/01/2022,No Results Posted,,,16/03/2021,https://clinicaltrials.gov/show/NCT04510038,12/03/2021,0,0
1835,NCT04525820,Recruiting,31/05/2021,30/06/2021,No Results Posted,,,12/03/2021,https://clinicaltrials.gov/show/NCT04525820,31/05/2021,0,0
1836,NCT04539626,Recruiting,01/07/2021,01/12/2022,No Results Posted,,,11/03/2021,https://clinicaltrials.gov/show/NCT04539626,01/07/2021,0,0
1837,NCT04545008,Recruiting,30/09/2021,31/10/2021,No Results Posted,,,10/03/2021,https://clinicaltrials.gov/show/NCT04545008,30/09/2021,0,0
1838,NCT04575038,"Active, not recruiting",28/04/2021,28/04/2021,No Results Posted,,,12/03/2021,https://clinicaltrials.gov/show/NCT04575038,28/04/2021,0,0
1839,NCT04629989,Completed,05/03/2021,05/03/2021,No Results Posted,,,09/03/2021,https://clinicaltrials.gov/show/NCT04629989,05/03/2021,0,0
1840,NCT04661540,Recruiting,01/05/2021,01/06/2021,No Results Posted,,,12/03/2021,https://clinicaltrials.gov/show/NCT04661540,01/05/2021,0,0
1841,NCT04666441,"Active, not recruiting",04/03/2021,13/08/2021,No Results Posted,,,16/03/2021,https://clinicaltrials.gov/show/NCT04666441,04/03/2021,0,0
1842,NCT04671017,"Active, not recruiting",26/02/2021,28/08/2021,No Results Posted,,,09/03/2021,https://clinicaltrials.gov/show/NCT04671017,26/02/2021,0,0
1843,NCT04684446,Not yet recruiting,08/04/2022,08/04/2022,No Results Posted,,,02/07/2021,https://clinicaltrials.gov/show/NCT04684446,08/04/2022,0,0
1844,NCT04710303,Recruiting,01/04/2022,01/04/2022,No Results Posted,,,11/03/2021,https://clinicaltrials.gov/show/NCT04710303,01/04/2022,0,0
1845,NCT04713111,Completed,30/11/2020,30/11/2020,No Results Posted,,,12/03/2021,https://clinicaltrials.gov/show/NCT04713111,30/11/2020,0,0
1846,NCT04715607,Recruiting,05/05/2021,30/05/2021,No Results Posted,"['Todsen T, Tolsgaard M, Folke F, Jakobsen KK, Ersb√∏ll AK, Benfield T, von Buchwald C, Kirkby N. SARS-CoV-2 in saliva, oropharyngeal and nasopharyngeal specimens. Dan Med J. 2021 Apr 7;68(5). pii: A01210087.']",,10/03/2021,https://clinicaltrials.gov/show/NCT04715607,05/05/2021,0,1
1847,NCT04750720,Recruiting,01/12/2023,01/12/2023,No Results Posted,,,16/03/2021,https://clinicaltrials.gov/show/NCT04750720,01/12/2023,0,0
1848,NCT04776044,Recruiting,01/12/2021,01/03/2022,No Results Posted,,,02/07/2021,https://clinicaltrials.gov/show/NCT04776044,01/12/2021,0,0
1849,NCT04780425,"Active, not recruiting",22/05/2021,31/05/2021,No Results Posted,,,11/03/2021,https://clinicaltrials.gov/show/NCT04780425,22/05/2021,0,0
1850,NCT04780672,Recruiting,19/08/2021,19/10/2021,No Results Posted,,,15/03/2021,https://clinicaltrials.gov/show/NCT04780672,19/08/2021,0,0
1851,NCT04787211,Not yet recruiting,01/12/2021,01/12/2021,No Results Posted,,,11/03/2021,https://clinicaltrials.gov/show/NCT04787211,01/12/2021,0,0
1852,NCT04788407,Recruiting,30/04/2022,30/04/2022,No Results Posted,,,02/07/2021,https://clinicaltrials.gov/show/NCT04788407,30/04/2022,0,0
1853,NCT04789525,Completed,01/10/2020,25/12/2020,No Results Posted,,,11/03/2021,https://clinicaltrials.gov/show/NCT04789525,01/10/2020,0,0
1854,NCT04791072,Not yet recruiting,01/03/2021,01/03/2021,No Results Posted,,,10/03/2021,https://clinicaltrials.gov/show/NCT04791072,01/03/2021,0,0
1855,NCT04791241,Recruiting,03/05/2021,04/05/2021,No Results Posted,,,10/03/2021,https://clinicaltrials.gov/show/NCT04791241,03/05/2021,0,0
1856,NCT04792021,Recruiting,01/06/2021,01/11/2021,No Results Posted,,,10/03/2021,https://clinicaltrials.gov/show/NCT04792021,01/06/2021,0,0
1857,NCT04793243,Completed,10/10/2020,24/10/2020,No Results Posted,,,11/03/2021,https://clinicaltrials.gov/show/NCT04793243,10/10/2020,0,0
1858,NCT04793984,Recruiting,30/06/2021,30/10/2021,No Results Posted,,,11/03/2021,https://clinicaltrials.gov/show/NCT04793984,30/06/2021,0,0
1859,NCT04794374,Recruiting,16/01/2022,16/01/2022,No Results Posted,,,15/03/2021,https://clinicaltrials.gov/show/NCT04794374,16/01/2022,0,0
1860,NCT04794803,Terminated,30/11/2020,02/02/2021,No Results Posted,,,16/03/2021,https://clinicaltrials.gov/show/NCT04794803,30/11/2020,0,0
1861,NCT04795557,Not yet recruiting,01/12/2021,01/01/2022,No Results Posted,,,12/03/2021,https://clinicaltrials.gov/show/NCT04795557,01/12/2021,0,0
1862,NCT04796064,Completed,05/11/2020,15/12/2020,No Results Posted,,,12/03/2021,https://clinicaltrials.gov/show/NCT04796064,05/11/2020,0,0
1863,NCT04797871,Enrolling by invitation,15/03/2022,15/03/2022,No Results Posted,,,15/03/2021,https://clinicaltrials.gov/show/NCT04797871,15/03/2022,0,0
1864,NCT04797936,Completed,19/12/2020,08/01/2021,No Results Posted,,,15/03/2021,https://clinicaltrials.gov/show/NCT04797936,19/12/2020,0,0
1865,NCT04798599,Recruiting,30/06/2021,30/06/2022,No Results Posted,,,15/03/2021,https://clinicaltrials.gov/show/NCT04798599,30/06/2021,0,0
1866,NCT04799561,Not yet recruiting,15/09/2022,15/12/2022,No Results Posted,,,16/03/2021,https://clinicaltrials.gov/show/NCT04799561,15/09/2022,0,0
1867,NCT04802187,Recruiting,31/08/2022,31/08/2022,No Results Posted,,,17/03/2021,https://clinicaltrials.gov/show/NCT04802187,31/08/2022,0,0
1868,NCT04332107,"Active, not recruiting",30/09/2021,30/12/2021,No Results Posted,,,18/03/2021,https://clinicaltrials.gov/show/NCT04332107,30/09/2021,0,0
1869,NCT04348461,Suspended,15/09/2020,30/09/2021,No Results Posted,,,17/03/2021,https://clinicaltrials.gov/show/NCT04348461,15/09/2020,0,0
1870,NCT04379154,Recruiting,01/04/2021,01/04/2021,No Results Posted,,,17/03/2021,https://clinicaltrials.gov/show/NCT04379154,01/04/2021,0,0
1871,NCT04380402,Recruiting,31/12/2021,08/05/2022,No Results Posted,,,19/03/2021,https://clinicaltrials.gov/show/NCT04380402,31/12/2021,0,0
1872,NCT04385095,"Active, not recruiting",17/02/2021,31/05/2021,No Results Posted,"['Monk PD, Marsden RJ, Tear VJ, Brookes J, Batten TN, Mankowski M, Gabbay FJ, Davies DE, Holgate ST, Ho LP, Clark T, Djukanovic R, Wilkinson TMA; Inhaled Interferon Beta COVID-19 Study Group. Safety and efficacy of inhaled nebulised interferon beta-1a (SNG001) for treatment of SARS-CoV-2 infection: a randomised, double-blind, placebo-controlled, phase 2 trial. Lancet Respir Med. 2021 Feb;9(2):196-206. doi: 10.1016/S2213-2600(20)30511-7. Epub 2020 Nov 12.', 'Lee JS, Shin EC. The type I interferon response in COVID-19: implications for treatment. Nat Rev Immunol. 2020 Oct;20(10):585-586. doi: 10.1038/s41577-020-00429-3.']",,23/03/2021,https://clinicaltrials.gov/show/NCT04385095,17/02/2021,0,1
1873,NCT04391179,Completed,22/02/2021,22/02/2021,No Results Posted,,,18/03/2021,https://clinicaltrials.gov/show/NCT04391179,22/02/2021,0,0
1874,NCT04395144,Completed,15/03/2021,15/03/2021,No Results Posted,"['Tavernier E, McNicholas B, Pavlov I, Roca O, Perez Y, Laffey J, Mirza S, Cosgrave D, Vines D, Frat JP, Ehrmann S, Li J. Awake prone positioning of hypoxaemic patients with COVID-19: protocol for a randomised controlled open-label superiority meta-trial. BMJ Open. 2020 Nov 11;10(11):e041520. doi: 10.1136/bmjopen-2020-041520.']",,23/03/2021,https://clinicaltrials.gov/show/NCT04395144,15/03/2021,0,1
1875,NCT04396314,Not yet recruiting,30/12/2021,30/04/2022,No Results Posted,,"['Bravo C, Skjaerven LH, Espart A, Guitard Sein-Echaluce L, Catalan-Matamoros D. Basic Body Awareness Therapy in patients suffering from fibromyalgia: A randomized clinical trial. Physiother Theory Pract. 2019 Oct;35(10):919-929. doi: 10.1080/09593985.2018.1467520. Epub 2018 May 3.', 'Madsen TS, Carlsson J, Nordbrandt M, Jensen JA. Refugee experiences of individual basic body awareness therapy and the level of transference into daily life. An interview study. J Bodyw Mov Ther. 2016 Apr;20(2):243-51. doi: 10.1016/j.jbmt.2015.10.007. Epub 2015 Oct 26.']",19/03/2021,https://clinicaltrials.gov/show/NCT04396314,30/12/2021,0,1
1876,NCT04408157,"Active, not recruiting",22/08/2021,22/12/2021,No Results Posted,,,16/03/2021,https://clinicaltrials.gov/show/NCT04408157,22/08/2021,0,0
1877,NCT04429854,"Active, not recruiting",30/04/2021,02/11/2021,No Results Posted,"['Devos T, Geukens T, Schauwvlieghe A, Ari√´n KK, Barbezange C, Cleeren M, Compernolle V, Dauby N, Desmecht D, Grimaldi D, Lambrecht BN, Luyten A, Maes P, Moutschen M, Romano M, Seyler L, Nevessignsky MT, Vandenberghe K, van Griensven J, Verbeke G, Vlieghe E, Yombi JC, Liesenborghs L, Verhamme P, Meyfroidt G. A randomized, multicentre, open-label phase II proof-of-concept trial investigating the clinical efficacy and safety of the addition of convalescent plasma to the standard of care in patients hospitalized with COVID-19: the Donated Antibodies Working against nCoV (DAWn-Plasma) trial. Trials. 2020 Nov 27;21(1):981. doi: 10.1186/s13063-020-04876-0. Erratum in: Trials. 2020 Dec 14;21(1):1024.']",,18/03/2021,https://clinicaltrials.gov/show/NCT04429854,30/04/2021,0,1
1878,NCT04433910,Completed,21/01/2021,22/02/2021,No Results Posted,"['Conzelmann C, Gilg A, Gro√ü R, Sch√ºtz D, Preising N, St√§ndker L, Jahrsd√∂rfer B, Schrezenmeier H, Sparrer KMJ, Stamminger T, Stenger S, M√ºnch J, M√ºller JA. An enzyme-based immunodetection assay to quantify SARS-CoV-2 infection. Antiviral Res. 2020 Sep;181:104882. doi: 10.1016/j.antiviral.2020.104882. Epub 2020 Jul 29.']",,17/03/2021,https://clinicaltrials.gov/show/NCT04433910,21/01/2021,0,1
1879,NCT04439045,"Active, not recruiting",02/09/2021,01/12/2021,No Results Posted,,,22/03/2021,https://clinicaltrials.gov/show/NCT04439045,02/09/2021,0,0
1880,NCT04445220,Recruiting,01/06/2021,01/12/2021,No Results Posted,,,16/03/2021,https://clinicaltrials.gov/show/NCT04445220,01/06/2021,0,0
1881,NCT04452097,Not yet recruiting,31/03/2022,31/03/2022,No Results Posted,,,18/03/2021,https://clinicaltrials.gov/show/NCT04452097,31/03/2022,0,0
1882,NCT04470999,Recruiting,30/09/2021,31/12/2021,No Results Posted,,,17/03/2021,https://clinicaltrials.gov/show/NCT04470999,30/09/2021,0,0
1883,NCT04476680,Recruiting,28/04/2021,28/04/2021,No Results Posted,,,23/03/2021,https://clinicaltrials.gov/show/NCT04476680,28/04/2021,0,0
1884,NCT04483375,Completed,17/11/2020,17/11/2020,No Results Posted,,,23/03/2021,https://clinicaltrials.gov/show/NCT04483375,17/11/2020,0,0
1885,NCT04487691,"Active, not recruiting",01/06/2021,30/12/2021,No Results Posted,,,17/03/2021,https://clinicaltrials.gov/show/NCT04487691,01/06/2021,0,0
1886,NCT04495803,Recruiting,01/08/2022,01/08/2022,No Results Posted,,,17/03/2021,https://clinicaltrials.gov/show/NCT04495803,01/08/2022,0,0
1887,NCT04497324,Recruiting,30/04/2021,15/05/2021,No Results Posted,"['Soto A, Krapp F, Vargas A, Cabrejos L, Argumanis E, Garc√≠a PL, Altamirano K, Montes M, Chac√≥n-Uscamaita PR, Garc√≠a PJ. Randomized clinical trial to evaluate safety and efficacy of convalescent plasma use among hospitalized patients with COVID-19 (PERUCONPLASMA): a structured summary of a study protocol for a randomized controlled trial. Trials. 2021 May 17;22(1):342. doi: 10.1186/s13063-021-05189-6.']",,18/03/2021,https://clinicaltrials.gov/show/NCT04497324,30/04/2021,0,1
1888,NCT04521309,Completed,26/01/2021,08/02/2021,No Results Posted,"['Ali S, Uddin SM, Shalim E, Sayeed MA, Anjum F, Saleem F, Muhaymin SM, Ali A, Ali MR, Ahmed I, Mushtaq T, Khan S, Shahab F, Luxmi S, Kumar S, Arain H, Khan M, Khan AS, Mehmood H, Rasheed A, Jahangeer A, Baig S, Quraishy S. Hyperimmune anti-COVID-19 IVIG (C-IVIG) treatment in severe and critical COVID-19 patients: A phase I/II randomized control trial. EClinicalMedicine. 2021 Jun;36:100926. doi: 10.1016/j.eclinm.2021.100926. Epub 2021 Jun 4.', 'Ali S, Uddin SM, Ali A, Anjum F, Ali R, Shalim E, Khan M, Ahmed I, M Muhaymin S, Bukhari U, Luxmi S, Khan AS, Quraishy S. Production of hyperimmune anti-SARS-CoV-2 intravenous immunoglobulin from pooled COVID-19 convalescent plasma. Immunotherapy. 2021 Apr;13(5):397-407. doi: 10.2217/imt-2020-0263. Epub 2021 Feb 9.', 'Ali S, Luxmi S, Anjum F, Muhaymin SM, Uddin SM, Ali A, Ali MR, Tauheed S, Khan M, Bajwa M, Baig SU, Shalim E, Ahmed I, Khan AS, Quraishy S. Hyperimmune anti-COVID-19 IVIG (C-IVIG) Therapy for Passive Immunization of Severe and Critically Ill COVID-19 Patients: A structured summary of a study protocol for a randomised controlled trial. Trials. 2020 Nov 2;21(1):905. doi: 10.1186/s13063-020-04839-5.']",,24/03/2021,https://clinicaltrials.gov/show/NCT04521309,26/01/2021,0,1
1889,NCT04522986,Completed,02/02/2021,02/02/2021,No Results Posted,,,18/03/2021,https://clinicaltrials.gov/show/NCT04522986,02/02/2021,0,0
1890,NCT04542213,Completed,28/02/2021,28/02/2021,No Results Posted,,,23/03/2021,https://clinicaltrials.gov/show/NCT04542213,28/02/2021,0,0
1891,NCT04551339,"Active, not recruiting",14/06/2021,14/09/2021,No Results Posted,,,18/03/2021,https://clinicaltrials.gov/show/NCT04551339,14/06/2021,0,0
1892,NCT04565379,Recruiting,30/04/2021,30/04/2021,No Results Posted,,,17/03/2021,https://clinicaltrials.gov/show/NCT04565379,30/04/2021,0,0
1893,NCT04568863,Completed,30/11/2020,30/11/2020,No Results Posted,,,18/03/2021,https://clinicaltrials.gov/show/NCT04568863,30/11/2020,0,0
1894,NCT04570202,Recruiting,20/08/2021,20/08/2022,No Results Posted,,,23/03/2021,https://clinicaltrials.gov/show/NCT04570202,20/08/2021,0,0
1895,NCT04604223,Recruiting,29/06/2021,29/06/2021,No Results Posted,,,17/03/2021,https://clinicaltrials.gov/show/NCT04604223,29/06/2021,0,0
1896,NCT04610502,Completed,06/10/2020,06/12/2020,No Results Posted,,,19/03/2021,https://clinicaltrials.gov/show/NCT04610502,06/10/2020,0,0
1897,NCT04611399,Recruiting,05/03/2022,05/03/2022,No Results Posted,,,19/03/2021,https://clinicaltrials.gov/show/NCT04611399,05/03/2022,0,0
1898,NCT04619719,Recruiting,15/06/2021,15/02/2022,No Results Posted,,,17/03/2021,https://clinicaltrials.gov/show/NCT04619719,15/06/2021,0,0
1899,NCT04621123,Recruiting,15/06/2021,01/10/2021,No Results Posted,,,17/03/2021,https://clinicaltrials.gov/show/NCT04621123,15/06/2021,0,0
1900,NCT04635943,Recruiting,30/04/2021,30/04/2021,No Results Posted,"['Garcia PJ, Mundaca H, Ugarte-Gil C, Leon P, Malaga G, Chaccour C, Carcamo CP. Randomized clinical trial to compare the efficacy of ivermectin versus placebo to negativize nasopharyngeal PCR in patients with early COVID-19 in Peru (SAINT-Peru): a structured summary of a study protocol for randomized controlled trial. Trials. 2021 Apr 9;22(1):262. doi: 10.1186/s13063-021-05236-2.']",,18/03/2021,https://clinicaltrials.gov/show/NCT04635943,30/04/2021,0,1
1901,NCT04637906,Recruiting,18/04/2021,18/09/2021,Results Submitted,,,16/03/2021,https://clinicaltrials.gov/show/NCT04637906,18/04/2021,0,0
1902,NCT04641481,"Active, not recruiting",08/01/2021,01/12/2022,No Results Posted,,,19/03/2021,https://clinicaltrials.gov/show/NCT04641481,08/01/2021,0,0
1903,NCT04661813,Recruiting,31/12/2022,31/12/2022,No Results Posted,,,22/03/2021,https://clinicaltrials.gov/show/NCT04661813,31/12/2022,0,0
1904,NCT04663737,Recruiting,31/05/2021,30/06/2021,No Results Posted,,,17/03/2021,https://clinicaltrials.gov/show/NCT04663737,31/05/2021,0,0
1905,NCT04705844,Not yet recruiting,01/11/2021,01/01/2022,No Results Posted,,,24/03/2021,https://clinicaltrials.gov/show/NCT04705844,01/11/2021,0,0
1906,NCT04716569,Recruiting,20/02/2021,20/03/2021,Results Submitted,"['Aref ZF, Bazeed SEES, Hassan MH, Hassan AS, Rashad A, Hassan RG, Abdelmaksoud AA. Clinical, Biochemical and Molecular Evaluations of Ivermectin Mucoadhesive Nanosuspension Nasal Spray in Reducing Upper Respiratory Symptoms of Mild COVID-19. Int J Nanomedicine. 2021 Jun 15;16:4063-4072. doi: 10.2147/IJN.S313093. eCollection 2021.']",,17/03/2021,https://clinicaltrials.gov/show/NCT04716569,20/02/2021,0,1
1907,NCT04723459,Recruiting,19/02/2021,28/03/2021,No Results Posted,,,17/03/2021,https://clinicaltrials.gov/show/NCT04723459,19/02/2021,0,0
1908,NCT04727424,Recruiting,01/02/2022,01/03/2022,No Results Posted,,,08/07/2021,https://clinicaltrials.gov/show/NCT04727424,01/02/2022,0,0
1909,NCT04738045,Recruiting,28/03/2021,01/04/2021,No Results Posted,,,17/03/2021,https://clinicaltrials.gov/show/NCT04738045,28/03/2021,0,0
1910,NCT04741282,Not yet recruiting,15/08/2022,15/08/2022,No Results Posted,,,17/03/2021,https://clinicaltrials.gov/show/NCT04741282,15/08/2022,0,0
1911,NCT04746339,Recruiting,01/08/2021,01/12/2021,No Results Posted,,,17/03/2021,https://clinicaltrials.gov/show/NCT04746339,01/08/2021,0,0
1912,NCT04750265,Recruiting,01/11/2021,01/12/2021,No Results Posted,,,18/03/2021,https://clinicaltrials.gov/show/NCT04750265,01/11/2021,0,0
1913,NCT04765384,Not yet recruiting,16/01/2023,20/06/2023,No Results Posted,,,17/03/2021,https://clinicaltrials.gov/show/NCT04765384,16/01/2023,0,0
1914,NCT04779047,Recruiting,10/03/2021,05/04/2021,No Results Posted,,,17/03/2021,https://clinicaltrials.gov/show/NCT04779047,10/03/2021,0,0
1915,NCT04780061,Not yet recruiting,01/10/2021,01/12/2021,No Results Posted,,,22/03/2021,https://clinicaltrials.gov/show/NCT04780061,01/10/2021,0,0
1916,NCT04788459,Recruiting,01/09/2021,01/06/2022,No Results Posted,,,16/03/2021,https://clinicaltrials.gov/show/NCT04788459,01/09/2021,0,0
1917,NCT04789356,Recruiting,01/06/2021,01/03/2022,No Results Posted,,,22/03/2021,https://clinicaltrials.gov/show/NCT04789356,01/06/2021,0,0
1918,NCT04790851,Recruiting,01/10/2021,01/12/2021,No Results Posted,,,17/03/2021,https://clinicaltrials.gov/show/NCT04790851,01/10/2021,0,0
1919,NCT04797208,Not yet recruiting,01/12/2021,01/03/2022,No Results Posted,,,17/03/2021,https://clinicaltrials.gov/show/NCT04797208,01/12/2021,0,0
1920,NCT04797975,Not yet recruiting,01/11/2021,01/11/2021,No Results Posted,,,18/03/2021,https://clinicaltrials.gov/show/NCT04797975,01/11/2021,0,0
1921,NCT04798716,Not yet recruiting,01/09/2021,01/12/2021,No Results Posted,,,16/03/2021,https://clinicaltrials.gov/show/NCT04798716,01/09/2021,0,0
1922,NCT04799743,Not yet recruiting,01/05/2022,01/05/2022,No Results Posted,,,16/03/2021,https://clinicaltrials.gov/show/NCT04799743,01/05/2022,0,0
1923,NCT04800120,Recruiting,01/12/2021,01/12/2021,No Results Posted,,,16/03/2021,https://clinicaltrials.gov/show/NCT04800120,01/12/2021,0,0
1924,NCT04801017,Not yet recruiting,01/08/2021,01/10/2021,No Results Posted,,,16/03/2021,https://clinicaltrials.gov/show/NCT04801017,01/08/2021,0,0
1925,NCT04801030,Not yet recruiting,30/05/2023,30/05/2023,No Results Posted,,,16/03/2021,https://clinicaltrials.gov/show/NCT04801030,30/05/2023,0,0
1926,NCT04801134,Not yet recruiting,22/03/2022,30/05/2022,No Results Posted,,"['Shi Q, Castillo F, Viswanathan K, Kupferman F, MacDermid JC. Facilitators and Barriers to Access to Pediatric Medical Services in a Community Hospital. J Prim Care Community Health. 2020 Jan-Dec;11:2150132720904518. doi: 10.1177/2150132720904518.', 'Peltz A, Garg A. Food Insecurity and Health Care Use. Pediatrics. 2019 Oct;144(4). pii: e20190347. doi: 10.1542/peds.2019-0347. Epub 2019 Sep 9.', 'COUNCIL ON COMMUNITY PEDIATRICS; COMMITTEE ON NUTRITION. Promoting Food Security for All Children. Pediatrics. 2015 Nov;136(5):e1431-8. doi: 10.1542/peds.2015-3301.', 'Nicola M, Alsafi Z, Sohrabi C, Kerwan A, Al-Jabir A, Iosifidis C, Agha M, Agha R. The socio-economic implications of the coronavirus pandemic (COVID-19): A review. Int J Surg. 2020 Jun;78:185-193. doi: 10.1016/j.ijsu.2020.04.018. Epub 2020 Apr 17. Review.', 'Keenan DP, Olson C, Hersey JC, Parmer SM. Measures of food insecurity/security. J Nutr Educ. 2001;33 Suppl 1:S49-58. Review.', 'Kaiser LL, Melgar-Qui√±onez H, Townsend MS, Nicholson Y, Fujii ML, Martin AC, Lamp CL. Food insecurity and food supplies in Latino households with young children. J Nutr Educ Behav. 2003 May-Jun;35(3):148-53.', 'Matheson DM, Varady J, Varady A, Killen JD. Household food security and nutritional status of Hispanic children in the fifth grade. Am J Clin Nutr. 2002 Jul;76(1):210-7.']",23/03/2021,https://clinicaltrials.gov/show/NCT04801134,22/03/2022,0,1
1927,NCT04801888,Not yet recruiting,01/07/2021,01/07/2021,No Results Posted,,,17/03/2021,https://clinicaltrials.gov/show/NCT04801888,01/07/2021,0,0
1928,NCT04801940,Not yet recruiting,31/01/2024,31/01/2024,No Results Posted,,,17/03/2021,https://clinicaltrials.gov/show/NCT04801940,31/01/2024,0,0
1929,NCT04802382,Recruiting,01/12/2021,01/12/2021,No Results Posted,,,29/06/2021,https://clinicaltrials.gov/show/NCT04802382,01/12/2021,0,0
1930,NCT04802408,Not yet recruiting,30/08/2021,30/04/2022,No Results Posted,,,17/03/2021,https://clinicaltrials.gov/show/NCT04802408,30/08/2021,0,0
1931,NCT04803227,Recruiting,01/04/2021,01/06/2021,No Results Posted,,,17/03/2021,https://clinicaltrials.gov/show/NCT04803227,01/04/2021,0,0
1932,NCT04803370,Recruiting,01/09/2021,01/09/2021,No Results Posted,,,17/03/2021,https://clinicaltrials.gov/show/NCT04803370,01/09/2021,0,0
1933,NCT04803812,Recruiting,04/05/2021,04/05/2021,No Results Posted,,,18/03/2021,https://clinicaltrials.gov/show/NCT04803812,04/05/2021,0,0
1934,NCT04805086,Recruiting,01/06/2022,05/03/2023,No Results Posted,,,18/03/2021,https://clinicaltrials.gov/show/NCT04805086,01/06/2022,0,0
1935,NCT04805203,Recruiting,01/12/2022,01/12/2022,No Results Posted,,,18/03/2021,https://clinicaltrials.gov/show/NCT04805203,01/12/2022,0,0
1936,NCT04805684,Completed,05/03/2021,05/03/2021,No Results Posted,,,18/03/2021,https://clinicaltrials.gov/show/NCT04805684,05/03/2021,0,0
1937,NCT04806061,Not yet recruiting,15/05/2022,31/12/2022,No Results Posted,,,19/03/2021,https://clinicaltrials.gov/show/NCT04806061,15/05/2022,0,0
1938,NCT04806074,"Active, not recruiting",06/12/2020,06/09/2021,No Results Posted,,,22/03/2021,https://clinicaltrials.gov/show/NCT04806074,06/12/2020,0,0
1939,NCT04806529,Withdrawn,15/12/2020,09/04/2022,No Results Posted,,,23/03/2021,https://clinicaltrials.gov/show/NCT04806529,15/12/2020,0,0
1940,NCT04808284,Not yet recruiting,01/04/2022,01/04/2022,No Results Posted,,,22/03/2021,https://clinicaltrials.gov/show/NCT04808284,01/04/2022,0,0
1941,NCT04808882,Not yet recruiting,01/12/2021,01/02/2022,No Results Posted,,,22/03/2021,https://clinicaltrials.gov/show/NCT04808882,01/12/2021,0,0
1942,NCT04808895,Not yet recruiting,01/07/2021,31/08/2021,No Results Posted,,,22/03/2021,https://clinicaltrials.gov/show/NCT04808895,01/07/2021,0,0
1943,NCT04808986,Not yet recruiting,31/08/2021,15/11/2021,No Results Posted,,,22/03/2021,https://clinicaltrials.gov/show/NCT04808986,31/08/2021,0,0
1944,NCT04809272,Recruiting,01/07/2021,01/09/2021,No Results Posted,,,22/03/2021,https://clinicaltrials.gov/show/NCT04809272,01/07/2021,0,0
1945,NCT04810689,Recruiting,01/03/2022,01/09/2022,No Results Posted,,,23/03/2021,https://clinicaltrials.gov/show/NCT04810689,01/03/2022,0,0
1946,NCT04819919,,,,,,,,https://clinicaltrials.gov/show/NCT04819919,,0,0
1947,NCT04317040,Completed,20/10/2020,20/10/2020,No Results Posted,,,26/03/2021,https://clinicaltrials.gov/show/NCT04317040,20/10/2020,0,0
1948,NCT04326790,Terminated,27/04/2020,27/04/2020,No Results Posted,"['Deftereos SG, Giannopoulos G, Vrachatis DA, Siasos GD, Giotaki SG, Gargalianos P, Metallidis S, Sianos G, Baltagiannis S, Panagopoulos P, Dolianitis K, Randou E, Syrigos K, Kotanidou A, Koulouris NG, Milionis H, Sipsas N, Gogos C, Tsoukalas G, Olympios CD, Tsagalou E, Migdalis I, Gerakari S, Angelidis C, Alexopoulos D, Davlouros P, Hahalis G, Kanonidis I, Katritsis D, Kolettis T, Manolis AS, Michalis L, Naka KK, Pyrgakis VN, Toutouzas KP, Triposkiadis F, Tsioufis K, Vavouranakis E, Martin√®z-Dolz L, Reimers B, Stefanini GG, Cleman M, Goudevenos J, Tsiodras S, Tousoulis D, Iliodromitis E, Mehran R, Dangas G, Stefanadis C; GRECCO-19 investigators. Effect of Colchicine vs Standard Care on Cardiac and Inflammatory Biomarkers and Clinical Outcomes in Patients Hospitalized With Coronavirus Disease 2019: The GRECCO-19 Randomized Clinical Trial. JAMA Netw Open. 2020 Jun 1;3(6):e2013136. doi: 10.1001/jamanetworkopen.2020.13136.', 'Deftereos SG, Siasos G, Giannopoulos G, Vrachatis DA, Angelidis C, Giotaki SG, Gargalianos P, Giamarellou H, Gogos C, Daikos G, Lazanas M, Lagiou P, Saroglou G, Sipsas N, Tsiodras S, Chatzigeorgiou D, Moussas N, Kotanidou A, Koulouris N, Oikonomou E, Kaoukis A, Kossyvakis C, Raisakis K, Fountoulaki K, Comis M, Tsiachris D, Sarri E, Theodorakis A, Martinez-Dolz L, Sanz-S√°nchez J, Reimers B, Stefanini GG, Cleman M, Filippou D, Olympios CD, Pyrgakis VN, Goudevenos J, Hahalis G, Kolettis TM, Iliodromitis E, Tousoulis D, Stefanadis C. The Greek study in the effects of colchicine in COvid-19 complications prevention (GRECCO-19 study): Rationale and study design. Hellenic J Cardiol. 2020 Jan - Feb;61(1):42-45. doi: 10.1016/j.hjc.2020.03.002. Epub 2020 Apr 3.']",,06/04/2021,https://clinicaltrials.gov/show/NCT04326790,27/04/2020,0,1
1949,NCT04333472,Recruiting,06/03/2022,06/07/2022,No Results Posted,,,24/03/2021,https://clinicaltrials.gov/show/NCT04333472,06/03/2022,0,0
1950,NCT04334148,Completed,10/12/2020,09/01/2021,No Results Posted,,,25/03/2021,https://clinicaltrials.gov/show/NCT04334148,10/12/2020,0,0
1951,NCT04340349,Enrolling by invitation,30/05/2021,30/06/2021,No Results Posted,,"['Lai C, Yu R, Wang M, Xian W, Zhao X, Tang Q, Chen R, Zhou X, Li X, Li Z, Li Z, Deng G, Wang F. Shorter incubation period is associated with severe disease progression in patients with COVID-19. Virulence. 2020 Dec;11(1):1443-1452. doi: 10.1080/21505594.2020.1836894.', 'Guan WJ, Ni ZY, Hu Y, Liang WH, Ou CQ, He JX, Liu L, Shan H, Lei CL, Hui DSC, Du B, Li LJ, Zeng G, Yuen KY, Chen RC, Tang CL, Wang T, Chen PY, Xiang J, Li SY, Wang JL, Liang ZJ, Peng YX, Wei L, Liu Y, Hu YH, Peng P, Wang JM, Liu JY, Chen Z, Li G, Zheng ZJ, Qiu SQ, Luo J, Ye CJ, Zhu SY, Zhong NS; China Medical Treatment Expert Group for Covid-19. Clinical Characteristics of Coronavirus Disease 2019 in China. N Engl J Med. 2020 Apr 30;382(18):1708-1720. doi: 10.1056/NEJMoa2002032. Epub 2020 Feb 28.', 'Li C, Ji F, Wang L, Wang L, Hao J, Dai M, Liu Y, Pan X, Fu J, Li L, Yang G, Yang J, Yan X, Gu B. Asymptomatic and Human-to-Human Transmission of SARS-CoV-2 in a 2-Family Cluster, Xuzhou, China. Emerg Infect Dis. 2020 Jul;26(7):1626-1628. doi: 10.3201/eid2607.200718. Epub 2020 Jun 21.', 'Xu H, Zhong L, Deng J, Peng J, Dan H, Zeng X, Li T, Chen Q. High expression of ACE2 receptor of 2019-nCoV on the epithelial cells of oral mucosa. Int J Oral Sci. 2020 Feb 24;12(1):8. doi: 10.1038/s41368-020-0074-x.', 'Levy A, Yagil Y, Bursztyn M, Barkalifa R, Scharf S, Yagil C. ACE2 expression and activity are enhanced during pregnancy. Am J Physiol Regul Integr Comp Physiol. 2008 Dec;295(6):R1953-61. doi: 10.1152/ajpregu.90592.2008. Epub 2008 Oct 22.', 'Baig AM, Khaleeq A, Ali U, Syeda H. Evidence of the COVID-19 Virus Targeting the CNS: Tissue Distribution, Host-Virus Interaction, and Proposed Neurotropic Mechanisms. ACS Chem Neurosci. 2020 Apr 1;11(7):995-998. doi: 10.1021/acschemneuro.0c00122. Epub 2020 Mar 13.', 'Zhan M, Qin Y, Xue X, Zhu S. Death from Covid-19 of 23 Health Care Workers in China. N Engl J Med. 2020 Jun 4;382(23):2267-2268. doi: 10.1056/NEJMc2005696. Epub 2020 Apr 15.', 'Wu Z, McGoogan JM. Characteristics of and Important Lessons From the Coronavirus Disease 2019 (COVID-19) Outbreak in China: Summary of a Report of 72 314 Cases From the Chinese Center for Disease Control and Prevention. JAMA. 2020 Apr 7;323(13):1239-1242. doi: 10.1001/jama.2020.2648.', 'Liu Q, Bi G, Chen G, Guo X, Tu S, Tong X, Xu M, Liu M, Wang B, Jiang H, Wang J, Li H, Wang K, Liu D, Song C. Time-Dependent Distribution of Hydroxychloroquine in Cynomolgus Macaques Using Population Pharmacokinetic Modeling Method. Front Pharmacol. 2021 Jan 14;11:602880. doi: 10.3389/fphar.2020.602880. eCollection 2020.', 'Wang LF, Lin YS, Huang NC, Yu CY, Tsai WL, Chen JJ, Kubota T, Matsuoka M, Chen SR, Yang CS, Lu RW, Lin YL, Chang TH. Hydroxychloroquine-inhibited dengue virus is associated with host defense machinery. J Interferon Cytokine Res. 2015 Mar;35(3):143-56. doi: 10.1089/jir.2014.0038. Epub 2014 Oct 16.', 'Helal GK, Gad MA, Abd-Ellah MF, Eid MS. Hydroxychloroquine augments early virological response to pegylated interferon plus ribavirin in genotype-4 chronic hepatitis C patients. J Med Virol. 2016 Dec;88(12):2170-2178. doi: 10.1002/jmv.24575. Epub 2016 May 25.', 'Wang M, Cao R, Zhang L, Yang X, Liu J, Xu M, Shi Z, Hu Z, Zhong W, Xiao G. Remdesivir and chloroquine effectively inhibit the recently emerged novel coronavirus (2019-nCoV) in vitro. Cell Res. 2020 Mar;30(3):269-271. doi: 10.1038/s41422-020-0282-0. Epub 2020 Feb 4.', 'Yao X, Ye F, Zhang M, Cui C, Huang B, Niu P, Liu X, Zhao L, Dong E, Song C, Zhan S, Lu R, Li H, Tan W, Liu D. In Vitro Antiviral Activity and Projection of Optimized Dosing Design of Hydroxychloroquine for the Treatment of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2). Clin Infect Dis. 2020 Jul 28;71(15):732-739. doi: 10.1093/cid/ciaa237.', 'Han H, Ma Q, Li C, Liu R, Zhao L, Wang W, Zhang P, Liu X, Gao G, Liu F, Jiang Y, Cheng X, Zhu C, Xia Y. Profiling serum cytokines in COVID-19 patients reveals IL-6 and IL-10 are disease severity predictors. Emerg Microbes Infect. 2020 Dec;9(1):1123-1130. doi: 10.1080/22221751.2020.1770129.', 'Chude CI, Amaravadi RK. Targeting Autophagy in Cancer: Update on Clinical Trials and Novel Inhibitors. Int J Mol Sci. 2017 Jun 16;18(6). pii: E1279. doi: 10.3390/ijms18061279. Review.', 'Geleris J, Sun Y, Platt J, Zucker J, Baldwin M, Hripcsak G, Labella A, Manson DK, Kubin C, Barr RG, Sobieszczyk ME, Schluger NW. Observational Study of Hydroxychloroquine in Hospitalized Patients with Covid-19. N Engl J Med. 2020 Jun 18;382(25):2411-2418. doi: 10.1056/NEJMoa2012410. Epub 2020 May 7.', 'Zahr N, Urien S, Llopis B, Pourcher V, Paccoud O, Bleibtreu A, Mayaux J, Gandjbakhch E, Hekimian G, Combes A, Benveniste O, Saadoun D, Allenbach Y, Pinna B, Cacoub P, Funck-Brentano C, Salem JE. Pharmacokinetics and pharmacodynamics of hydroxychloroquine in hospitalized patients with COVID-19. Therapie. 2021 Jan 28. pii: S0040-5957(21)00066-4. doi: 10.1016/j.therap.2021.01.056. [Epub ahead of print]', 'Hoffmann M, Kleine-Weber H, Schroeder S, Kr√ºger N, Herrler T, Erichsen S, Schiergens TS, Herrler G, Wu NH, Nitsche A, M√ºller MA, Drosten C, P√∂hlmann S. SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor. Cell. 2020 Apr 16;181(2):271-280.e8. doi: 10.1016/j.cell.2020.02.052. Epub 2020 Mar 5.', 'Mareev VY, Orlova YA, Pavlikova EP, Matskeplishvili ST, Akopyan ZA, Plisyk AG, Seredenina EM, Asratyan DA, Potapenko AV, Malakhov PS, Samokhodskaya LM, Mershina EA, Sinitsyn VE, Bulanova MM, Fuks AA, Mareev YV, Begrambekova YL, Kamalov AA. [Combination therapy at an early stage of the novel coronavirus infection (COVID-19). Case series and design of the clinical trial ""BromhexIne and Spironolactone for Coron–∞virUs Infection requiring hospiTalization (BISCUIT)""]. Kardiologiia. 2020 Sep 7;60(8):4-15. doi: 10.18087/cardio.2020.8.n1307. Russian.']",29/06/2021,https://clinicaltrials.gov/show/NCT04340349,30/05/2021,0,1
1952,NCT04341493,Terminated,30/08/2020,30/12/2020,No Results Posted,"['Calder√≥n JM, Zer√≥n HM, Padmanabhan S. Treatment with Hydroxychloroquine vs Hydroxychloroquine + Nitazoxanide in COVID-19 patients with risk factors for poor prognosis: A structured summary of a study protocol for a randomised controlled trial. Trials. 2020 Jun 8;21(1):504. doi: 10.1186/s13063-020-04448-2.']",,01/04/2021,https://clinicaltrials.gov/show/NCT04341493,30/08/2020,0,1
1953,NCT04343248,"Active, not recruiting",30/06/2021,30/06/2021,No Results Posted,,,01/04/2021,https://clinicaltrials.gov/show/NCT04343248,30/06/2021,0,0
1954,NCT04346927,Completed,10/10/2020,30/11/2020,No Results Posted,,,26/03/2021,https://clinicaltrials.gov/show/NCT04346927,10/10/2020,0,0
1955,NCT04348435,"Active, not recruiting",09/07/2021,30/07/2021,No Results Posted,,,06/07/2021,https://clinicaltrials.gov/show/NCT04348435,09/07/2021,0,0
1956,NCT04351243,Completed,01/12/2020,01/04/2021,No Results Posted,,,05/04/2021,https://clinicaltrials.gov/show/NCT04351243,01/12/2020,0,0
1957,NCT04353674,Recruiting,01/12/2021,01/12/2021,No Results Posted,,"['Wu Z, McGoogan JM. Characteristics of and Important Lessons From the Coronavirus Disease 2019 (COVID-19) Outbreak in China: Summary of a Report of 72 314 Cases From the Chinese Center for Disease Control and Prevention. JAMA. 2020 Apr 7;323(13):1239-1242. doi: 10.1001/jama.2020.2648.', 'Deng Y, Liu W, Liu K, Fang YY, Shang J, Zhou L, Wang K, Leng F, Wei S, Chen L, Liu HG. Clinical characteristics of fatal and recovered cases of coronavirus disease 2019 in Wuhan, China: a retrospective study. Chin Med J (Engl). 2020 Jun 5;133(11):1261-1267. doi: 10.1097/CM9.0000000000000824.', 'Wu C, Chen X, Cai Y, Xia J, Zhou X, Xu S, Huang H, Zhang L, Zhou X, Du C, Zhang Y, Song J, Wang S, Chao Y, Yang Z, Xu J, Zhou X, Chen D, Xiong W, Xu L, Zhou F, Jiang J, Bai C, Zheng J, Song Y. Risk Factors Associated With Acute Respiratory Distress Syndrome and Death in Patients With Coronavirus Disease 2019 Pneumonia in Wuhan, China. JAMA Intern Med. 2020 Jul 1;180(7):934-943. doi: 10.1001/jamainternmed.2020.0994. Erratum in: JAMA Intern Med. 2020 Jul 1;180(7):1031.', ""Rosenbaum L. Facing Covid-19 in Italy - Ethics, Logistics, and Therapeutics on the Epidemic's Front Line. N Engl J Med. 2020 May 14;382(20):1873-1875. doi: 10.1056/NEJMp2005492. Epub 2020 Mar 18."", 'Perlman S, Dandekar AA. Immunopathogenesis of coronavirus infections: implications for SARS. Nat Rev Immunol. 2005 Dec;5(12):917-27. Review.', 'Mehta P, McAuley DF, Brown M, Sanchez E, Tattersall RS, Manson JJ; HLH Across Speciality Collaboration, UK. COVID-19: consider cytokine storm syndromes and immunosuppression. Lancet. 2020 Mar 28;395(10229):1033-1034. doi: 10.1016/S0140-6736(20)30628-0. Epub 2020 Mar 16.', 'Ruan Q, Yang K, Wang W, Jiang L, Song J. Clinical predictors of mortality due to COVID-19 based on an analysis of data of 150 patients from Wuhan, China. Intensive Care Med. 2020 May;46(5):846-848. doi: 10.1007/s00134-020-05991-x. Epub 2020 Mar 3. Erratum in: Intensive Care Med. 2020 Apr 6;:.', 'Perlman S, Netland J. Coronaviruses post-SARS: update on replication and pathogenesis. Nat Rev Microbiol. 2009 Jun;7(6):439-50. doi: 10.1038/nrmicro2147. Review.', 'Jiang Y, Xu J, Zhou C, Wu Z, Zhong S, Liu J, Luo W, Chen T, Qin Q, Deng P. Characterization of cytokine/chemokine profiles of severe acute respiratory syndrome. Am J Respir Crit Care Med. 2005 Apr 15;171(8):850-7. Epub 2005 Jan 18.', 'Cheung CY, Poon LL, Ng IH, Luk W, Sia SF, Wu MH, Chan KH, Yuen KY, Gordon S, Guan Y, Peiris JS. Cytokine responses in severe acute respiratory syndrome coronavirus-infected macrophages in vitro: possible relevance to pathogenesis. J Virol. 2005 Jun;79(12):7819-26.', 'He L, Ding Y, Zhang Q, Che X, He Y, Shen H, Wang H, Li Z, Zhao L, Geng J, Deng Y, Yang L, Li J, Cai J, Qiu L, Wen K, Xu X, Jiang S. Expression of elevated levels of pro-inflammatory cytokines in SARS-CoV-infected ACE2+ cells in SARS patients: relation to the acute lung injury and pathogenesis of SARS. J Pathol. 2006 Nov;210(3):288-97.', 'Nicholls JM, Poon LL, Lee KC, Ng WF, Lai ST, Leung CY, Chu CM, Hui PK, Mak KL, Lim W, Yan KW, Chan KH, Tsang NC, Guan Y, Yuen KY, Peiris JS. Lung pathology of fatal severe acute respiratory syndrome. Lancet. 2003 May 24;361(9371):1773-8.', 'Alhazzani W, M√∏ller MH, Arabi YM, Loeb M, Gong MN, Fan E, Oczkowski S, Levy MM, Derde L, Dzierba A, Du B, Aboodi M, Wunsch H, Cecconi M, Koh Y, Chertow DS, Maitland K, Alshamsi F, Belley-Cote E, Greco M, Laundy M, Morgan JS, Kesecioglu J, McGeer A, Mermel L, Mammen MJ, Alexander PE, Arrington A, Centofanti JE, Citerio G, Baw B, Memish ZA, Hammond N, Hayden FG, Evans L, Rhodes A. Surviving Sepsis Campaign: Guidelines on the Management of Critically Ill Adults with Coronavirus Disease 2019 (COVID-19). Crit Care Med. 2020 Jun;48(6):e440-e469. doi: 10.1097/CCM.0000000000004363.', 'Ding F, Song JH, Jung JY, Lou L, Wang M, Charles L, Westover A, Smith PL, Pino CJ, Buffington DA, Humes HD. A biomimetic membrane device that modulates the excessive inflammatory response to sepsis. PLoS One. 2011 Apr 14;6(4):e18584. doi: 10.1371/journal.pone.0018584.', 'Ding F, Yevzlin AS, Xu ZY, Zhou Y, Xie QH, Liu JF, Zheng Y, DaSilva JR, Humes HD. The effects of a novel therapeutic device on acute kidney injury outcomes in the intensive care unit: a pilot study. ASAIO J. 2011 Sep-Oct;57(5):426-32. doi: 10.1097/MAT.0b013e31820a1494.', 'Humes HD, Sobota JT, Ding F, Song JH; RAD Investigator Group. A selective cytopheretic inhibitory device to treat the immunological dysregulation of acute and chronic renal failure. Blood Purif. 2010;29(2):183-90. doi: 10.1159/000245645. Epub 2010 Jan 8.', 'Tumlin JA, Galphin CM, Tolwani AJ, Chan MR, Vijayan A, Finkel K, Szamosfalvi B, Dev D, DaSilva JR, Astor BC, Yevzlin AS, Humes HD; SCD Investigator Group. A Multi-Center, Randomized, Controlled, Pivotal Study to Assess the Safety and Efficacy of a Selective Cytopheretic Device in Patients with Acute Kidney Injury. PLoS One. 2015 Aug 5;10(8):e0132482. doi: 10.1371/journal.pone.0132482. eCollection 2015.']",01/04/2021,https://clinicaltrials.gov/show/NCT04353674,01/12/2021,0,1
1958,NCT04355234,"Active, not recruiting",31/08/2021,31/08/2021,No Results Posted,,,05/04/2021,https://clinicaltrials.gov/show/NCT04355234,31/08/2021,0,0
1959,NCT04355533,Recruiting,01/07/2022,01/12/2022,No Results Posted,,,26/03/2021,https://clinicaltrials.gov/show/NCT04355533,01/07/2022,0,0
1960,NCT04356833,Recruiting,30/04/2021,30/04/2021,No Results Posted,,,06/04/2021,https://clinicaltrials.gov/show/NCT04356833,30/04/2021,0,0
1961,NCT04358081,Completed,27/07/2020,27/07/2020,Study Results,,,02/04/2021,https://clinicaltrials.gov/show/NCT04358081,27/07/2020,1,0
1962,NCT04362189,"Active, not recruiting",31/10/2021,31/10/2021,No Results Posted,,,06/07/2021,https://clinicaltrials.gov/show/NCT04362189,31/10/2021,0,0
1963,NCT04365439,"Active, not recruiting",20/12/2020,30/06/2021,No Results Posted,,,29/03/2021,https://clinicaltrials.gov/show/NCT04365439,20/12/2020,0,0
1964,NCT04368676,"Active, not recruiting",30/06/2022,30/06/2022,No Results Posted,"['Lai KSP, Watt C, Ionson E, Baruss I, Forchuk C, Sukhera J, Burhan AM, Vasudev A. Breath Regulation and yogic Exercise An online Therapy for calm and Happiness (BREATH) for frontline hospital and long-term care home staff managing the COVID-19 pandemic: A structured summary of a study protocol for a feasibility study for a randomised controlled trial. Trials. 2020 Jul 14;21(1):648. doi: 10.1186/s13063-020-04583-w.', 'Kunzler AM, Helmreich I, Chmitorz A, K√∂nig J, Binder H, Wessa M, Lieb K. Psychological interventions to foster resilience in healthcare professionals. Cochrane Database Syst Rev. 2020 Jul 5;7:CD012527. doi: 10.1002/14651858.CD012527.pub2.']",,01/04/2021,https://clinicaltrials.gov/show/NCT04368676,30/06/2022,0,1
1965,NCT04371393,"Active, not recruiting",14/01/2021,01/02/2022,No Results Posted,,,05/04/2021,https://clinicaltrials.gov/show/NCT04371393,14/01/2021,0,0
1966,NCT04374149,Completed,30/09/2020,01/12/2020,No Results Posted,"['Gluck WL, Callahan SP, Brevetta RA, Stenbit AE, Smith WM, Martin JC, Blenda AV, Arce S, Edenfield WJ. Efficacy of therapeutic plasma exchange in the treatment of penn class 3 and 4 cytokine release syndrome complicating COVID-19. Respir Med. 2020 Dec;175:106188. doi: 10.1016/j.rmed.2020.106188. Epub 2020 Nov 7.']",,25/03/2021,https://clinicaltrials.gov/show/NCT04374149,30/09/2020,0,1
1967,NCT04382560,Completed,31/05/2020,31/05/2020,No Results Posted,,,01/04/2021,https://clinicaltrials.gov/show/NCT04382560,31/05/2020,0,0
1968,NCT04397614,Recruiting,01/12/2021,01/12/2021,No Results Posted,,,24/03/2021,https://clinicaltrials.gov/show/NCT04397614,01/12/2021,0,0
1969,NCT04400305,Recruiting,31/07/2021,31/07/2021,No Results Posted,,,29/03/2021,https://clinicaltrials.gov/show/NCT04400305,31/07/2021,0,0
1970,NCT04401150,Recruiting,01/11/2021,01/01/2022,No Results Posted,,,24/03/2021,https://clinicaltrials.gov/show/NCT04401150,01/11/2021,0,0
1971,NCT04401410,Recruiting,15/08/2021,15/08/2021,No Results Posted,,,01/04/2021,https://clinicaltrials.gov/show/NCT04401410,15/08/2021,0,0
1972,NCT04401423,Recruiting,01/06/2021,01/12/2021,No Results Posted,,,02/04/2021,https://clinicaltrials.gov/show/NCT04401423,01/06/2021,0,0
1973,NCT04406246,Completed,31/12/2020,31/12/2020,No Results Posted,,,30/03/2021,https://clinicaltrials.gov/show/NCT04406246,31/12/2020,0,0
1974,NCT04408183,Recruiting,01/08/2021,01/09/2021,No Results Posted,,,25/03/2021,https://clinicaltrials.gov/show/NCT04408183,01/08/2021,0,0
1975,NCT04411446,Recruiting,15/05/2021,28/10/2021,No Results Posted,"['Mariani J, Tajer C, Antonietti L, Inserra F, Ferder L, Manucha W. High-dose vitamin D versus placebo to prevent complications in COVID-19 patients: A structured summary of a study protocol for a randomised controlled trial (CARED-TRIAL). Trials. 2021 Feb 1;22(1):111. doi: 10.1186/s13063-021-05073-3.']","['Mart√≠n Gim√©nez VM, Inserra F, Tajer CD, Mariani J, Ferder L, Reiter RJ, Manucha W. Lungs as target of COVID-19 infection: Protective common molecular mechanisms of vitamin D and melatonin as a new potential synergistic treatment. Life Sci. 2020 Aug 1;254:117808. doi: 10.1016/j.lfs.2020.117808. Epub 2020 May 15. Review.']",01/04/2021,https://clinicaltrials.gov/show/NCT04411446,15/05/2021,0,1
1976,NCT04428801,Not yet recruiting,01/06/2022,15/06/2024,No Results Posted,,,01/04/2021,https://clinicaltrials.gov/show/NCT04428801,01/06/2022,0,0
1977,NCT04432298,Terminated,22/03/2021,22/03/2021,No Results Posted,,,02/04/2021,https://clinicaltrials.gov/show/NCT04432298,22/03/2021,0,0
1978,NCT04441996,Completed,18/03/2021,18/03/2021,No Results Posted,,,29/03/2021,https://clinicaltrials.gov/show/NCT04441996,18/03/2021,0,0
1979,NCT04458298,"Active, not recruiting",14/05/2021,14/05/2021,No Results Posted,,,02/04/2021,https://clinicaltrials.gov/show/NCT04458298,14/05/2021,0,0
1980,NCT04466098,"Active, not recruiting",01/12/2021,01/12/2021,No Results Posted,,,23/03/2021,https://clinicaltrials.gov/show/NCT04466098,01/12/2021,0,0
1981,NCT04466800,Recruiting,31/01/2022,31/12/2022,No Results Posted,,,06/07/2021,https://clinicaltrials.gov/show/NCT04466800,31/01/2022,0,0
1982,NCT04476992,"Active, not recruiting",17/07/2021,17/09/2021,No Results Posted,,,06/04/2021,https://clinicaltrials.gov/show/NCT04476992,17/07/2021,0,0
1983,NCT04482647,Recruiting,01/07/2021,01/07/2021,No Results Posted,"['Narayanan S, Tennison J, Cohen L, Urso C, Subramaniam B, Bruera E. Yoga-Based Breathing Techniques for Health Care Workers During COVID-19 Pandemic: Interests, Feasibility, and Acceptance. J Altern Complement Med. 2021 Apr 9. doi: 10.1089/acm.2020.0536. [Epub ahead of print]']",,29/03/2021,https://clinicaltrials.gov/show/NCT04482647,01/07/2021,0,1
1984,NCT04486313,Completed,08/02/2021,08/02/2021,No Results Posted,,,01/04/2021,https://clinicaltrials.gov/show/NCT04486313,08/02/2021,0,0
1985,NCT04496245,"Active, not recruiting",30/06/2021,30/06/2021,No Results Posted,,,01/04/2021,https://clinicaltrials.gov/show/NCT04496245,30/06/2021,0,0
1986,NCT04510207,Recruiting,16/06/2021,16/09/2021,No Results Posted,"['Al Kaabi N, Zhang Y, Xia S, Yang Y, Al Qahtani MM, Abdulrazzaq N, Al Nusair M, Hassany M, Jawad JS, Abdalla J, Hussein SE, Al Mazrouei SK, Al Karam M, Li X, Yang X, Wang W, Lai B, Chen W, Huang S, Wang Q, Yang T, Liu Y, Ma R, Hussain ZM, Khan T, Saifuddin Fasihuddin M, You W, Xie Z, Zhao Y, Jiang Z, Zhao G, Zhang Y, Mahmoud S, ElTantawy I, Xiao P, Koshy A, Zaher WA, Wang H, Duan K, Pan A, Yang X. Effect of 2 Inactivated SARS-CoV-2 Vaccines on Symptomatic COVID-19 Infection in Adults: A Randomized Clinical Trial. JAMA. 2021 May 26. doi: 10.1001/jama.2021.8565. [Epub ahead of print]']",,05/04/2021,https://clinicaltrials.gov/show/NCT04510207,16/06/2021,0,1
1987,NCT04511819,"Active, not recruiting",01/06/2021,01/06/2021,No Results Posted,,,05/04/2021,https://clinicaltrials.gov/show/NCT04511819,01/06/2021,0,0
1988,NCT04523246,Recruiting,01/07/2021,01/09/2021,No Results Posted,,,29/03/2021,https://clinicaltrials.gov/show/NCT04523246,01/07/2021,0,0
1989,NCT04526145,Not yet recruiting,01/12/2021,30/01/2022,No Results Posted,,,01/04/2021,https://clinicaltrials.gov/show/NCT04526145,01/12/2021,0,0
1990,NCT04527224,Not yet recruiting,01/10/2022,01/04/2023,No Results Posted,,,01/04/2021,https://clinicaltrials.gov/show/NCT04527224,01/10/2022,0,0
1991,NCT04527354,Completed,10/02/2021,10/02/2021,No Results Posted,,,05/04/2021,https://clinicaltrials.gov/show/NCT04527354,10/02/2021,0,0
1992,NCT04528329,Recruiting,01/04/2021,15/04/2021,No Results Posted,,,29/03/2021,https://clinicaltrials.gov/show/NCT04528329,01/04/2021,0,0
1993,NCT04528641,"Active, not recruiting",31/07/2021,31/07/2021,No Results Posted,"['Capone S, Raggioli A, Gentile M, Battella S, Lahm A, Sommella A, Contino AM, Urbanowicz RA, Scala R, Barra F, Leuzzi A, Lilli E, Miselli G, Noto A, Ferraiuolo M, Talotta F, Tsoleridis T, Castilletti C, Matusali G, Colavita F, Lapa D, Meschi S, Capobianchi M, Soriani M, Folgori A, Ball JK, Colloca S, Vitelli A. Immunogenicity of a new gorilla adenovirus vaccine candidate for COVID-19. Mol Ther. 2021 Apr 23. pii: S1525-0016(21)00210-0. doi: 10.1016/j.ymthe.2021.04.022. [Epub ahead of print]']",,05/04/2021,https://clinicaltrials.gov/show/NCT04528641,31/07/2021,0,1
1994,NCT04583592,Completed,31/03/2021,31/03/2021,No Results Posted,,,02/04/2021,https://clinicaltrials.gov/show/NCT04583592,31/03/2021,0,0
1995,NCT04594278,Not yet recruiting,01/04/2022,01/07/2022,No Results Posted,,,02/04/2021,https://clinicaltrials.gov/show/NCT04594278,01/04/2022,0,0
1996,NCT04600713,Not yet recruiting,01/08/2025,01/10/2025,No Results Posted,,,01/04/2021,https://clinicaltrials.gov/show/NCT04600713,01/08/2025,0,0
1997,NCT04600895,Recruiting,01/08/2021,01/10/2021,No Results Posted,,,25/03/2021,https://clinicaltrials.gov/show/NCT04600895,01/08/2021,0,0
1998,NCT04603742,Not yet recruiting,01/12/2021,01/02/2022,No Results Posted,,,25/03/2021,https://clinicaltrials.gov/show/NCT04603742,01/12/2021,0,0
1999,NCT04606784,"Active, not recruiting",18/03/2021,18/06/2021,No Results Posted,,,24/03/2021,https://clinicaltrials.gov/show/NCT04606784,18/03/2021,0,0
2000,NCT04608266,Recruiting,01/01/2022,01/03/2022,No Results Posted,,,05/04/2021,https://clinicaltrials.gov/show/NCT04608266,01/01/2022,0,0
2001,NCT04609462,Completed,13/01/2021,10/02/2021,No Results Posted,,,01/04/2021,https://clinicaltrials.gov/show/NCT04609462,13/01/2021,0,0
2002,NCT04619680,Recruiting,01/04/2024,01/04/2024,No Results Posted,,,01/04/2021,https://clinicaltrials.gov/show/NCT04619680,01/04/2024,0,0
2003,NCT04626050,Not yet recruiting,01/01/2022,01/01/2022,No Results Posted,,,25/03/2021,https://clinicaltrials.gov/show/NCT04626050,01/01/2022,0,0
2004,NCT04631536,Recruiting,31/05/2021,01/06/2021,No Results Posted,,,29/03/2021,https://clinicaltrials.gov/show/NCT04631536,31/05/2021,0,0
2005,NCT04632537,Withdrawn,23/03/2021,23/03/2021,No Results Posted,,,26/03/2021,https://clinicaltrials.gov/show/NCT04632537,23/03/2021,0,0
2006,NCT04640402,Recruiting,18/02/2021,18/11/2021,No Results Posted,,,30/03/2021,https://clinicaltrials.gov/show/NCT04640402,18/02/2021,0,0
2007,NCT04642638,"Active, not recruiting",01/09/2022,01/09/2022,No Results Posted,,,29/03/2021,https://clinicaltrials.gov/show/NCT04642638,01/09/2022,0,0
2008,NCT04644276,Recruiting,31/08/2021,31/08/2021,No Results Posted,,,08/07/2021,https://clinicaltrials.gov/show/NCT04644276,31/08/2021,0,0
2009,NCT04655586,Recruiting,30/04/2021,31/05/2021,No Results Posted,,,05/04/2021,https://clinicaltrials.gov/show/NCT04655586,30/04/2021,0,0
2010,NCT04666012,Recruiting,01/03/2021,01/04/2022,No Results Posted,,,29/03/2021,https://clinicaltrials.gov/show/NCT04666012,01/03/2021,0,0
2011,NCT04668209,Recruiting,30/09/2021,30/09/2021,No Results Posted,,,06/04/2021,https://clinicaltrials.gov/show/NCT04668209,30/09/2021,0,0
2012,NCT04668339,"Active, not recruiting",30/04/2022,30/04/2022,No Results Posted,,,29/03/2021,https://clinicaltrials.gov/show/NCT04668339,30/04/2022,0,0
2013,NCT04678739,Completed,30/01/2021,10/02/2021,No Results Posted,,,02/04/2021,https://clinicaltrials.gov/show/NCT04678739,30/01/2021,0,0
2014,NCT04679493,"Active, not recruiting",01/04/2021,01/04/2021,No Results Posted,,,06/04/2021,https://clinicaltrials.gov/show/NCT04679493,01/04/2021,0,0
2015,NCT04680949,"Active, not recruiting",31/03/2021,20/12/2021,No Results Posted,,,05/04/2021,https://clinicaltrials.gov/show/NCT04680949,31/03/2021,0,0
2016,NCT04689399,Completed,25/03/2021,25/03/2021,No Results Posted,,,30/03/2021,https://clinicaltrials.gov/show/NCT04689399,25/03/2021,0,0
2017,NCT04690387,Completed,13/01/2021,15/01/2021,No Results Posted,,,05/04/2021,https://clinicaltrials.gov/show/NCT04690387,13/01/2021,0,0
2018,NCT04695652,"Active, not recruiting",02/06/2021,01/06/2022,No Results Posted,,,06/07/2021,https://clinicaltrials.gov/show/NCT04695652,02/06/2021,0,0
2019,NCT04700163,"Active, not recruiting",31/03/2022,30/06/2022,No Results Posted,,"['Robbiani DF, Gaebler C, Muecksch F, Lorenzi JCC, Wang Z, Cho A, Agudelo M, Barnes CO, Gazumyan A, Finkin S, H√§ggl√∂f T, Oliveira TY, Viant C, Hurley A, Hoffmann HH, Millard KG, Kost RG, Cipolla M, Gordon K, Bianchini F, Chen ST, Ramos V, Patel R, Dizon J, Shimeliovich I, Mendoza P, Hartweger H, Nogueira L, Pack M, Horowitz J, Schmidt F, Weisblum Y, Michailidis E, Ashbrook AW, Waltari E, Pak JE, Huey-Tubman KE, Koranda N, Hoffman PR, West AP Jr, Rice CM, Hatziioannou T, Bjorkman PJ, Bieniasz PD, Caskey M, Nussenzweig MC. Convergent antibody responses to SARS-CoV-2 in convalescent individuals. Nature. 2020 Aug;584(7821):437-442. doi: 10.1038/s41586-020-2456-9. Epub 2020 Jun 18.']",08/07/2021,https://clinicaltrials.gov/show/NCT04700163,31/03/2022,0,1
2020,NCT04701606,Recruiting,15/10/2021,15/10/2021,No Results Posted,,,30/03/2021,https://clinicaltrials.gov/show/NCT04701606,15/10/2021,0,0
2021,NCT04709328,Not yet recruiting,01/01/2022,01/03/2022,No Results Posted,,,29/03/2021,https://clinicaltrials.gov/show/NCT04709328,01/01/2022,0,0
2022,NCT04710394,"Active, not recruiting",11/03/2022,11/03/2022,No Results Posted,,,05/04/2021,https://clinicaltrials.gov/show/NCT04710394,11/03/2022,0,0
2023,NCT04712110,"Active, not recruiting",04/04/2022,04/04/2022,No Results Posted,,,05/04/2021,https://clinicaltrials.gov/show/NCT04712110,04/04/2022,0,0
2024,NCT04723290,Completed,31/10/2020,31/12/2020,No Results Posted,,,25/03/2021,https://clinicaltrials.gov/show/NCT04723290,31/10/2020,0,0
2025,NCT04729140,Recruiting,28/12/2021,28/03/2022,No Results Posted,,,01/04/2021,https://clinicaltrials.gov/show/NCT04729140,28/12/2021,0,0
2026,NCT04737486,Completed,10/03/2021,10/03/2021,No Results Posted,,,24/03/2021,https://clinicaltrials.gov/show/NCT04737486,10/03/2021,0,0
2027,NCT04756141,Recruiting,28/01/2022,28/01/2022,No Results Posted,,,25/03/2021,https://clinicaltrials.gov/show/NCT04756141,28/01/2022,0,0
2028,NCT04764422,Recruiting,01/04/2022,01/04/2023,No Results Posted,,,01/04/2021,https://clinicaltrials.gov/show/NCT04764422,01/04/2022,0,0
2029,NCT04765475,Recruiting,01/02/2022,01/09/2022,No Results Posted,,,24/03/2021,https://clinicaltrials.gov/show/NCT04765475,01/02/2022,0,0
2030,NCT04766931,Recruiting,01/08/2021,01/12/2021,No Results Posted,,,02/04/2021,https://clinicaltrials.gov/show/NCT04766931,01/08/2021,0,0
2031,NCT04767958,Recruiting,28/02/2022,31/07/2022,No Results Posted,,,25/03/2021,https://clinicaltrials.gov/show/NCT04767958,28/02/2022,0,0
2032,NCT04793464,Recruiting,31/08/2021,31/08/2022,No Results Posted,,,01/04/2021,https://clinicaltrials.gov/show/NCT04793464,31/08/2021,0,0
2033,NCT04794088,Recruiting,01/12/2021,01/02/2022,No Results Posted,,,24/03/2021,https://clinicaltrials.gov/show/NCT04794088,01/12/2021,0,0
2034,NCT04798677,Recruiting,01/04/2021,01/04/2021,No Results Posted,,"['Salem ML, El-Hennawy D. The possible beneficial adjuvant effect of influenza vaccine to minimize the severity of COVID-19. Med Hypotheses. 2020 Apr 22;140:109752. doi: 10.1016/j.mehy.2020.109752. [Epub ahead of print]', 'Arokiaraj MC. Considering Interim Interventions to Control COVID-19 Associated Morbidity and Mortality-Perspectives. Front Public Health. 2020 Sep 22;8:444. doi: 10.3389/fpubh.2020.00444. eCollection 2020.', 'Menachery VD, Debbink K, Baric RS. Coronavirus non-structural protein 16: evasion, attenuation, and possible treatments. Virus Res. 2014 Dec 19;194:191-9. doi: 10.1016/j.virusres.2014.09.009. Epub 2014 Sep 30. Review.', 'Zeng Q, Langereis MA, van Vliet AL, Huizinga EG, de Groot RJ. Structure of coronavirus hemagglutinin-esterase offers insight into corona and influenza virus evolution. Proc Natl Acad Sci U S A. 2008 Jul 1;105(26):9065-9. doi: 10.1073/pnas.0800502105. Epub 2008 Jun 11.', 'Wang J, Tang K, Feng K, Lin X, Lv W, Chen K, Wang F. Impact of temperature and relative humidity on the transmission of COVID-19: a modelling study in China and the United States. BMJ Open. 2021 Feb 17;11(2):e043863. doi: 10.1136/bmjopen-2020-043863.', 'Rayman MP. Selenium and human health. Lancet. 2012 Mar 31;379(9822):1256-68. doi: 10.1016/S0140-6736(11)61452-9. Epub 2012 Feb 29. Review.', 'Goldson AJ, Fairweather-Tait SJ, Armah CN, Bao Y, Broadley MR, Dainty JR, Furniss C, Hart DJ, Teucher B, Hurst R. Effects of selenium supplementation on selenoprotein gene expression and response to influenza vaccine challenge: a randomised controlled trial. PLoS One. 2011 Mar 21;6(3):e14771. doi: 10.1371/journal.pone.0014771.', 'Prasad AS, Beck FW, Bao B, Fitzgerald JT, Snell DC, Steinberg JD, Cardozo LJ. Zinc supplementation decreases incidence of infections in the elderly: effect of zinc on generation of cytokines and oxidative stress. Am J Clin Nutr. 2007 Mar;85(3):837-44.', 'Meydani SN, Barnett JB, Dallal GE, Fine BC, Jacques PF, Leka LS, Hamer DH. Serum zinc and pneumonia in nursing home elderly. Am J Clin Nutr. 2007 Oct;86(4):1167-73. Erratum in: Am J Clin Nutr. 2008 Apr;87(4):1071.', 'Barnett JB, Dao MC, Hamer DH, Kandel R, Brandeis G, Wu D, Dallal GE, Jacques PF, Schreiber R, Kong E, Meydani SN. Effect of zinc supplementation on serum zinc concentration and T cell proliferation in nursing home elderly: a randomized, double-blind, placebo-controlled trial. Am J Clin Nutr. 2016 Mar;103(3):942-51. doi: 10.3945/ajcn.115.115188. Epub 2016 Jan 27.', 'Vetvicka V, Vannucci L, Sima P, Richter J. Beta Glucan: Supplement or Drug? From Laboratory to Clinical Trials. Molecules. 2019 Mar 30;24(7). pii: E1251. doi: 10.3390/molecules24071251. Review.', 'Engstad RE, Robertsen B. Recognition of yeast cell wall glucan by Atlantic salmon (Salmo salar L.) macrophages. Dev Comp Immunol. 1993 Jul-Aug;17(4):319-30.', 'Raa J. Immune modulation by non-digestible and non-absorbable beta-1,3/1,6-glucan. Microb Ecol Health Dis. 2015 May 29;26:27824. doi: 10.3402/mehd.v26.27824. eCollection 2015.', 'Vetvicka V, Vannucci L, Sima P. Œ≤-glucan as a new tool in vaccine development. Scand J Immunol. 2020 Feb;91(2):e12833. doi: 10.1111/sji.12833. Epub 2019 Nov 13. Review.', 'Novak M, Vetvicka V. Glucans as biological response modifiers. Endocr Metab Immune Disord Drug Targets. 2009 Mar;9(1):67-75. Review.', 'De Marco Castro E, Calder PC, Roche HM. Œ≤-1,3/1,6-Glucans and Immunity: State of the Art and Future Directions. Mol Nutr Food Res. 2021 Jan;65(1):e1901071. doi: 10.1002/mnfr.201901071. Epub 2020 Apr 27. Review.', 'F√ºl√∂p T, Dupuis G, Witkowski JM, Larbi A. The Role of Immunosenescence in the Development of Age-Related Diseases. Rev Invest Clin. 2016 Mar-Apr;68(2):84-91. Review.', 'Goodwin K, Viboud C, Simonsen L. Antibody response to influenza vaccination in the elderly: a quantitative review. Vaccine. 2006 Feb 20;24(8):1159-69. Epub 2005 Sep 19. Review.', 'Polack FP, Thomas SJ, Kitchin N, Absalon J, Gurtman A, Lockhart S, Perez JL, P√©rez Marc G, Moreira ED, Zerbini C, Bailey R, Swanson KA, Roychoudhury S, Koury K, Li P, Kalina WV, Cooper D, Frenck RW Jr, Hammitt LL, T√ºreci √ñ, Nell H, Schaefer A, √únal S, Tresnan DB, Mather S, Dormitzer PR, ≈ûahin U, Jansen KU, Gruber WC; C4591001 Clinical Trial Group. Safety and Efficacy of the BNT162b2 mRNA Covid-19 Vaccine. N Engl J Med. 2020 Dec 31;383(27):2603-2615. doi: 10.1056/NEJMoa2034577. Epub 2020 Dec 10.']",29/03/2021,https://clinicaltrials.gov/show/NCT04798677,01/04/2021,0,1
2035,NCT04800965,Enrolling by invitation,31/12/2021,01/01/2022,No Results Posted,,,24/03/2021,https://clinicaltrials.gov/show/NCT04800965,31/12/2021,0,0
2036,NCT04801524,Enrolling by invitation,31/12/2021,01/01/2022,No Results Posted,,,24/03/2021,https://clinicaltrials.gov/show/NCT04801524,31/12/2021,0,0
2037,NCT04802018,"Active, not recruiting",01/06/2021,01/09/2021,No Results Posted,,,26/03/2021,https://clinicaltrials.gov/show/NCT04802018,01/06/2021,0,0
2038,NCT04810637,Recruiting,01/06/2021,01/09/2021,No Results Posted,,,24/03/2021,https://clinicaltrials.gov/show/NCT04810637,01/06/2021,0,0
2039,NCT04810949,Terminated,01/03/2021,01/03/2021,No Results Posted,,,23/03/2021,https://clinicaltrials.gov/show/NCT04810949,01/03/2021,0,0
2040,NCT04811339,Recruiting,31/08/2023,31/08/2023,No Results Posted,,,26/03/2021,https://clinicaltrials.gov/show/NCT04811339,31/08/2023,0,0
2041,NCT04811859,Recruiting,10/01/2022,10/03/2022,No Results Posted,,,23/03/2021,https://clinicaltrials.gov/show/NCT04811859,10/01/2022,0,0
2042,NCT04812184,Completed,30/10/2020,30/10/2020,No Results Posted,,,23/03/2021,https://clinicaltrials.gov/show/NCT04812184,30/10/2020,0,0
2043,NCT04813471,Recruiting,20/03/2021,30/04/2021,No Results Posted,,,24/03/2021,https://clinicaltrials.gov/show/NCT04813471,20/03/2021,0,0
2044,NCT04813497,Recruiting,30/05/2021,31/12/2021,No Results Posted,,,24/03/2021,https://clinicaltrials.gov/show/NCT04813497,30/05/2021,0,0
2045,NCT04813575,Enrolling by invitation,01/04/2022,01/06/2022,No Results Posted,,"['Spagnolo P, Balestro E, Aliberti S, Cocconcelli E, Biondini D, Casa GD, Sverzellati N, Maher TM. Pulmonary fibrosis secondary to COVID-19: a call to arms? Lancet Respir Med. 2020 Aug;8(8):750-752. doi: 10.1016/S2213-2600(20)30222-8. Epub 2020 May 15.', 'Bikdeli B, Madhavan MV, Jimenez D, Chuich T, Dreyfus I, Driggin E, Nigoghossian C, Ageno W, Madjid M, Guo Y, Tang LV, Hu Y, Giri J, Cushman M, Qu√©r√© I, Dimakakos EP, Gibson CM, Lippi G, Favaloro EJ, Fareed J, Caprini JA, Tafur AJ, Burton JR, Francese DP, Wang EY, Falanga A, McLintock C, Hunt BJ, Spyropoulos AC, Barnes GD, Eikelboom JW, Weinberg I, Schulman S, Carrier M, Piazza G, Beckman JA, Steg PG, Stone GW, Rosenkranz S, Goldhaber SZ, Parikh SA, Monreal M, Krumholz HM, Konstantinides SV, Weitz JI, Lip GYH; Global COVID-19 Thrombosis Collaborative Group, Endorsed by the ISTH, NATF, ESVM, and the IUA, Supported by the ESC Working Group on Pulmonary Circulation and Right Ventricular Function. COVID-19 and Thrombotic or Thromboembolic Disease: Implications for Prevention, Antithrombotic Therapy, and Follow-Up: JACC State-of-the-Art Review. J Am Coll Cardiol. 2020 Jun 16;75(23):2950-2973. doi: 10.1016/j.jacc.2020.04.031. Epub 2020 Apr 17. Review.', 'Claudia R, Sara T, GianLuca C etl. Complications and mortality of transbronchial lung cryobiopsy and surgical lung biopsy in interstitial lung diseases. Europpean Respiratory Journal. 2015 46: PA2031; DOI: 10.1183/13993003.congress-2015.PA2031.', 'WHO Statement: Knowing the risks for COVID 19. https://www.who.int/indonesia/news/detail/08-03-2020-knowing-the-risk-for-covid-19.', 'Alsofayan YM, Althunayyan SM, Khan AA, Hakawi AM, Assiri AM. Clinical characteristics of COVID-19 in Saudi Arabia: A national retrospective study. J Infect Public Health. 2020 Jul;13(7):920-925. doi: 10.1016/j.jiph.2020.05.026. Epub 2020 Jun 8.']",24/03/2021,https://clinicaltrials.gov/show/NCT04813575,01/04/2022,0,1
2046,NCT04815096,Recruiting,01/03/2023,01/03/2023,No Results Posted,,,29/03/2021,https://clinicaltrials.gov/show/NCT04815096,01/03/2023,0,0
2047,NCT04816084,Completed,01/12/2020,15/03/2021,No Results Posted,,,25/03/2021,https://clinicaltrials.gov/show/NCT04816084,01/12/2020,0,0
2048,NCT04816656,Completed,01/02/2021,22/03/2021,No Results Posted,,,26/03/2021,https://clinicaltrials.gov/show/NCT04816656,01/02/2021,0,0
2049,NCT04816682,Recruiting,30/06/2021,30/12/2021,No Results Posted,,"['Bosch-Barrera J, Martin-Castillo B, Bux√≥ M, Brunet J, Encinar JA, Menendez JA. Silibinin and SARS-CoV-2: Dual Targeting of Host Cytokine Storm and Virus Replication Machinery for Clinical Management of COVID-19 Patients. J Clin Med. 2020 Jun 7;9(6). pii: E1770. doi: 10.3390/jcm9061770.']",25/03/2021,https://clinicaltrials.gov/show/NCT04816682,30/06/2021,0,1
2050,NCT04816942,Completed,21/07/2020,12/10/2020,No Results Posted,,,25/03/2021,https://clinicaltrials.gov/show/NCT04816942,21/07/2020,0,0
2051,NCT04817332,Completed,28/02/2021,28/02/2021,No Results Posted,,,26/03/2021,https://clinicaltrials.gov/show/NCT04817332,28/02/2021,0,0
2052,NCT04817371,Recruiting,01/03/2022,01/03/2022,No Results Posted,,,30/03/2021,https://clinicaltrials.gov/show/NCT04817371,01/03/2022,0,0
2053,NCT04818489,Recruiting,25/05/2021,10/07/2021,No Results Posted,,,30/03/2021,https://clinicaltrials.gov/show/NCT04818489,25/05/2021,0,0
2054,NCT04818801,Not yet recruiting,01/07/2021,01/06/2022,No Results Posted,,,26/03/2021,https://clinicaltrials.gov/show/NCT04818801,01/07/2021,0,0
2055,NCT04820751,Not yet recruiting,01/11/2021,01/01/2022,No Results Posted,,,02/04/2021,https://clinicaltrials.gov/show/NCT04820751,01/11/2021,0,0
2056,NCT04820803,Completed,29/04/2021,30/06/2021,No Results Posted,,,07/07/2021,https://clinicaltrials.gov/show/NCT04820803,29/04/2021,0,0
2057,NCT04821674,"Active, not recruiting",31/07/2022,31/12/2022,No Results Posted,,,08/07/2021,https://clinicaltrials.gov/show/NCT04821674,31/07/2022,0,0
2058,NCT04821934,Recruiting,01/06/2021,01/12/2021,No Results Posted,,,30/03/2021,https://clinicaltrials.gov/show/NCT04821934,01/06/2021,0,0
2059,NCT04821973,Recruiting,15/05/2021,15/11/2021,No Results Posted,,,30/03/2021,https://clinicaltrials.gov/show/NCT04821973,15/05/2021,0,0
2060,NCT04822285,Completed,22/04/2020,21/03/2021,No Results Posted,,,30/03/2021,https://clinicaltrials.gov/show/NCT04822285,22/04/2020,0,0
2061,NCT04822818,Not yet recruiting,01/02/2022,01/06/2022,No Results Posted,,,30/03/2021,https://clinicaltrials.gov/show/NCT04822818,01/02/2022,0,0
2062,NCT04823351,Not yet recruiting,08/07/2021,01/11/2021,No Results Posted,,,30/03/2021,https://clinicaltrials.gov/show/NCT04823351,08/07/2021,0,0
2063,NCT04824222,Not yet recruiting,01/07/2022,01/12/2022,No Results Posted,,,01/04/2021,https://clinicaltrials.gov/show/NCT04824222,01/07/2022,0,0
2064,NCT04824391,Recruiting,30/04/2021,30/04/2022,No Results Posted,,,01/04/2021,https://clinicaltrials.gov/show/NCT04824391,30/04/2021,0,0
2065,NCT04824638,Recruiting,08/08/2021,08/12/2023,No Results Posted,,,01/04/2021,https://clinicaltrials.gov/show/NCT04824638,08/08/2021,0,0
2066,NCT04825093,Not yet recruiting,30/10/2022,30/12/2023,No Results Posted,,,01/04/2021,https://clinicaltrials.gov/show/NCT04825093,30/10/2022,0,0
2067,NCT04826367,Recruiting,01/12/2021,01/02/2022,No Results Posted,,,02/04/2021,https://clinicaltrials.gov/show/NCT04826367,01/12/2021,0,0
2068,NCT04826822,Recruiting,08/07/2021,02/09/2021,No Results Posted,,,01/04/2021,https://clinicaltrials.gov/show/NCT04826822,08/07/2021,0,0
2069,NCT04828161,Recruiting,01/05/2022,01/06/2022,No Results Posted,,,09/07/2021,https://clinicaltrials.gov/show/NCT04828161,01/05/2022,0,0
2070,NCT04828538,Recruiting,01/07/2021,01/07/2021,No Results Posted,,,02/04/2021,https://clinicaltrials.gov/show/NCT04828538,01/07/2021,0,0
2071,NCT04828564,Not yet recruiting,30/09/2021,31/12/2021,No Results Posted,,,02/04/2021,https://clinicaltrials.gov/show/NCT04828564,30/09/2021,0,0
2072,NCT04828668,Recruiting,31/10/2021,30/11/2021,No Results Posted,,"['Lu D, Vemuri VK, Duclos RI Jr, Makriyannis A. The cannabinergic system as a target for anti-inflammatory therapies. Curr Top Med Chem. 2006;6(13):1401-26. Review.', 'Moreira FA, Lutz B. The endocannabinoid system: emotion, learning and addiction. Addict Biol. 2008 Jun;13(2):196-212. doi: 10.1111/j.1369-1600.2008.00104.x. Epub 2008 Apr 16. Review.', 'Nagarkatti P, Pandey R, Rieder SA, Hegde VL, Nagarkatti M. Cannabinoids as novel anti-inflammatory drugs. Future Med Chem. 2009 Oct;1(7):1333-49. doi: 10.4155/fmc.09.93. Review.', 'Pini A, Mannaioni G, Pellegrini-Giampietro D, Passani MB, Mastroianni R, Bani D, Masini E. The role of cannabinoids in inflammatory modulation of allergic respiratory disorders, inflammatory pain and ischemic stroke. Curr Drug Targets. 2012 Jun;13(7):984-93. Review.', 'Russo EB. Clinical Endocannabinoid Deficiency Reconsidered: Current Research Supports the Theory in Migraine, Fibromyalgia, Irritable Bowel, and Other Treatment-Resistant Syndromes. Cannabis Cannabinoid Res. 2016 Jul 1;1(1):154-165. doi: 10.1089/can.2016.0009. eCollection 2016. Review.', 'Ruhaak LR, Felth J, Karlsson PC, Rafter JJ, Verpoorte R, Bohlin L. Evaluation of the cyclooxygenase inhibiting effects of six major cannabinoids isolated from Cannabis sativa. Biol Pharm Bull. 2011;34(5):774-8.', ""Greenhalgh T, Knight M, A'Court C, Buxton M, Husain L. Management of post-acute covid-19 in primary care. BMJ. 2020 Aug 11;370:m3026. doi: 10.1136/bmj.m3026.""]",06/04/2021,https://clinicaltrials.gov/show/NCT04828668,31/10/2021,0,1
2073,NCT04829188,Recruiting,01/04/2023,01/07/2023,No Results Posted,,,02/04/2021,https://clinicaltrials.gov/show/NCT04829188,01/04/2023,0,0
2074,NCT04830020,Recruiting,31/08/2021,31/08/2021,No Results Posted,,,02/04/2021,https://clinicaltrials.gov/show/NCT04830020,31/08/2021,0,0
2075,NCT04830800,Recruiting,30/05/2022,30/09/2022,No Results Posted,,,05/04/2021,https://clinicaltrials.gov/show/NCT04830800,30/05/2022,0,0
2076,NCT04830943,Completed,28/02/2021,30/03/2021,No Results Posted,,"['Lechien JR, Chiesa-Estomba CM, De Siati DR, Horoi M, Le Bon SD, Rodriguez A, Dequanter D, Blecic S, El Afia F, Distinguin L, Chekkoury-Idrissi Y, Hans S, Delgado IL, Calvo-Henriquez C, Lavigne P, Falanga C, Barillari MR, Cammaroto G, Khalife M, Leich P, Souchay C, Rossi C, Journe F, Hsieh J, Edjlali M, Carlier R, Ris L, Lovato A, De Filippis C, Coppee F, Fakhry N, Ayad T, Saussez S. Olfactory and gustatory dysfunctions as a clinical presentation of mild-to-moderate forms of the coronavirus disease (COVID-19): a multicenter European study. Eur Arch Otorhinolaryngol. 2020 Aug;277(8):2251-2261. doi: 10.1007/s00405-020-05965-1. Epub 2020 Apr 6.']",05/04/2021,https://clinicaltrials.gov/show/NCT04830943,28/02/2021,0,1
2077,NCT04831853,Not yet recruiting,01/10/2021,01/12/2021,No Results Posted,,,05/04/2021,https://clinicaltrials.gov/show/NCT04831853,01/10/2021,0,0
2078,NCT04832880,Not yet recruiting,01/03/2022,01/12/2022,No Results Posted,,,06/04/2021,https://clinicaltrials.gov/show/NCT04832880,01/03/2022,0,0
2079,NCT04833010,Recruiting,01/09/2021,01/09/2021,No Results Posted,,,06/04/2021,https://clinicaltrials.gov/show/NCT04833010,01/09/2021,0,0
2080,NCT04834115,Recruiting,30/04/2021,30/05/2021,No Results Posted,,,06/04/2021,https://clinicaltrials.gov/show/NCT04834115,30/04/2021,0,0
2081,NCT04834375,Recruiting,19/03/2022,19/04/2022,No Results Posted,,,08/04/2021,https://clinicaltrials.gov/show/NCT04834375,19/03/2022,0,0
2082,NCT04275245,Completed,09/03/2020,09/03/2020,No Results Posted,,,09/04/2021,https://clinicaltrials.gov/show/NCT04275245,09/03/2020,0,0
2083,NCT04280224,Recruiting,30/12/2021,30/12/2022,No Results Posted,,,08/04/2021,https://clinicaltrials.gov/show/NCT04280224,30/12/2021,0,0
2084,NCT04312009,Completed,01/02/2021,01/02/2021,No Results Posted,"['Smolander J, Bruchfeld A. [COVID-19 and kidney disease]. Lakartidningen. 2020 Jul 13;117. pii: 20110. Swedish.']",,13/04/2021,https://clinicaltrials.gov/show/NCT04312009,01/02/2021,0,1
2085,NCT04323800,"Active, not recruiting",31/12/2022,01/01/2023,No Results Posted,,,08/04/2021,https://clinicaltrials.gov/show/NCT04323800,31/12/2022,0,0
2086,NCT04324606,"Active, not recruiting",01/10/2021,01/10/2021,No Results Posted,"['Voysey M, Costa Clemens SA, Madhi SA, Weckx LY, Folegatti PM, Aley PK, Angus B, Baillie VL, Barnabas SL, Bhorat QE, Bibi S, Briner C, Cicconi P, Clutterbuck EA, Collins AM, Cutland CL, Darton TC, Dheda K, Dold C, Duncan CJA, Emary KRW, Ewer KJ, Flaxman A, Fairlie L, Faust SN, Feng S, Ferreira DM, Finn A, Galiza E, Goodman AL, Green CM, Green CA, Greenland M, Hill C, Hill HC, Hirsch I, Izu A, Jenkin D, Joe CCD, Kerridge S, Koen A, Kwatra G, Lazarus R, Libri V, Lillie PJ, Marchevsky NG, Marshall RP, Mendes AVA, Milan EP, Minassian AM, McGregor A, Mujadidi YF, Nana A, Padayachee SD, Phillips DJ, Pittella A, Plested E, Pollock KM, Ramasamy MN, Ritchie AJ, Robinson H, Schwarzbold AV, Smith A, Song R, Snape MD, Sprinz E, Sutherland RK, Thomson EC, T√∂r√∂k ME, Toshner M, Turner DPJ, Vekemans J, Villafana TL, White T, Williams CJ, Douglas AD, Hill AVS, Lambe T, Gilbert SC, Pollard AJ; Oxford COVID Vaccine Trial Group. Single-dose administration and the influence of the timing of the booster dose on immunogenicity and efficacy of ChAdOx1 nCoV-19 (AZD1222) vaccine: a pooled analysis of four randomised trials. Lancet. 2021 Mar 6;397(10277):881-891. doi: 10.1016/S0140-6736(21)00432-3. Epub 2021 Feb 19. Erratum in: Lancet. 2021 Mar 6;397(10277):880.', 'Barrett JR, Belij-Rammerstorfer S, Dold C, Ewer KJ, Folegatti PM, Gilbride C, Halkerston R, Hill J, Jenkin D, Stockdale L, Verheul MK, Aley PK, Angus B, Bellamy D, Berrie E, Bibi S, Bittaye M, Carroll MW, Cavell B, Clutterbuck EA, Edwards N, Flaxman A, Fuskova M, Gorringe A, Hallis B, Kerridge S, Lawrie AM, Linder A, Liu X, Madhavan M, Makinson R, Mellors J, Minassian A, Moore M, Mujadidi Y, Plested E, Poulton I, Ramasamy MN, Robinson H, Rollier CS, Song R, Snape MD, Tarrant R, Taylor S, Thomas KM, Voysey M, Watson MEE, Wright D, Douglas AD, Green CM, Hill AVS, Lambe T, Gilbert S, Pollard AJ; Oxford COVID Vaccine Trial Group. Phase 1/2 trial of SARS-CoV-2 vaccine ChAdOx1 nCoV-19 with a booster dose induces multifunctional antibody responses. Nat Med. 2021 Feb;27(2):279-288. doi: 10.1038/s41591-020-01179-4. Epub 2020 Dec 17. Erratum in: Nat Med. 2021 May 6;:.', ""Voysey M, Clemens SAC, Madhi SA, Weckx LY, Folegatti PM, Aley PK, Angus B, Baillie VL, Barnabas SL, Bhorat QE, Bibi S, Briner C, Cicconi P, Collins AM, Colin-Jones R, Cutland CL, Darton TC, Dheda K, Duncan CJA, Emary KRW, Ewer KJ, Fairlie L, Faust SN, Feng S, Ferreira DM, Finn A, Goodman AL, Green CM, Green CA, Heath PT, Hill C, Hill H, Hirsch I, Hodgson SHC, Izu A, Jackson S, Jenkin D, Joe CCD, Kerridge S, Koen A, Kwatra G, Lazarus R, Lawrie AM, Lelliott A, Libri V, Lillie PJ, Mallory R, Mendes AVA, Milan EP, Minassian AM, McGregor A, Morrison H, Mujadidi YF, Nana A, O'Reilly PJ, Padayachee SD, Pittella A, Plested E, Pollock KM, Ramasamy MN, Rhead S, Schwarzbold AV, Singh N, Smith A, Song R, Snape MD, Sprinz E, Sutherland RK, Tarrant R, Thomson EC, T√∂r√∂k ME, Toshner M, Turner DPJ, Vekemans J, Villafana TL, Watson MEE, Williams CJ, Douglas AD, Hill AVS, Lambe T, Gilbert SC, Pollard AJ; Oxford COVID Vaccine Trial Group. Safety and efficacy of the ChAdOx1 nCoV-19 vaccine (AZD1222) against SARS-CoV-2: an interim analysis of four randomised controlled trials in Brazil, South Africa, and the UK. Lancet. 2021 Jan 9;397(10269):99-111. doi: 10.1016/S0140-6736(20)32661-1. Epub 2020 Dec 8. Erratum in: Lancet. 2021 Jan 9;397(10269):98."", 'Folegatti PM, Ewer KJ, Aley PK, Angus B, Becker S, Belij-Rammerstorfer S, Bellamy D, Bibi S, Bittaye M, Clutterbuck EA, Dold C, Faust SN, Finn A, Flaxman AL, Hallis B, Heath P, Jenkin D, Lazarus R, Makinson R, Minassian AM, Pollock KM, Ramasamy M, Robinson H, Snape M, Tarrant R, Voysey M, Green C, Douglas AD, Hill AVS, Lambe T, Gilbert SC, Pollard AJ; Oxford COVID Vaccine Trial Group. Safety and immunogenicity of the ChAdOx1 nCoV-19 vaccine against SARS-CoV-2: a preliminary report of a phase 1/2, single-blind, randomised controlled trial. Lancet. 2020 Aug 15;396(10249):467-478. doi: 10.1016/S0140-6736(20)31604-4. Epub 2020 Jul 20. Erratum in: Lancet. 2020 Aug 15;396(10249):466. Erratum in: Lancet. 2020 Dec 12;396(10266):1884.']",,13/04/2021,https://clinicaltrials.gov/show/NCT04324606,01/10/2021,0,1
2087,NCT04329195,Terminated,09/12/2020,09/01/2021,No Results Posted,,,09/04/2021,https://clinicaltrials.gov/show/NCT04329195,09/12/2020,0,0
2088,NCT04338009,Completed,20/08/2020,20/08/2020,Study Results,"['Cohen JB, Hanff TC, William P, Sweitzer N, Rosado-Santander NR, Medina C, Rodriguez-Mori JE, Renna N, Chang TI, Corrales-Medina V, Andrade-Villanueva JF, Barbagelata A, Cristodulo-Cortez R, D√≠az-Cucho OA, Spaak J, Alfonso CE, Valdivia-Vega R, Villavicencio-Carranza M, Ayala-Garc√≠a RJ, Castro-Callirgos CA, Gonz√°lez-Hern√°ndez LA, Bernales-Salas EF, Coacalla-Guerra JC, Salinas-Herrera CD, Nicolosi L, Basconcel M, Byrd JB, Sharkoski T, Bendez√∫-Huasasquiche LE, Chittams J, Edmonston DL, Vasquez CR, Chirinos JA. Continuation versus discontinuation of renin-angiotensin system inhibitors in patients admitted to hospital with COVID-19: a prospective, randomised, open-label trial. Lancet Respir Med. 2021 Mar;9(3):275-284. doi: 10.1016/S2213-2600(20)30558-0. Epub 2021 Jan 7.']",,09/04/2021,https://clinicaltrials.gov/show/NCT04338009,20/08/2020,1,1
2089,NCT04341415,Terminated,20/11/2020,15/01/2021,No Results Posted,,,13/04/2021,https://clinicaltrials.gov/show/NCT04341415,20/11/2020,0,0
2090,NCT04343976,Enrolling by invitation,01/09/2021,30/12/2021,No Results Posted,"['Lee JS, Shin EC. The type I interferon response in COVID-19: implications for treatment. Nat Rev Immunol. 2020 Oct;20(10):585-586. doi: 10.1038/s41577-020-00429-3.']",,08/04/2021,https://clinicaltrials.gov/show/NCT04343976,01/09/2021,0,1
2091,NCT04345614,Recruiting,01/07/2021,01/07/2021,No Results Posted,"['Miller J, Bruen C, Schnaus M, Zhang J, Ali S, Lind A, Stoecker Z, Stauderman K, Hebbar S. Auxora versus standard of care for the treatment of severe or critical COVID-19 pneumonia: results from a randomized controlled trial. Crit Care. 2020 Aug 14;24(1):502. doi: 10.1186/s13054-020-03220-x.']",,12/04/2021,https://clinicaltrials.gov/show/NCT04345614,01/07/2021,0,1
2092,NCT04353180,Not yet recruiting,01/06/2021,01/07/2021,No Results Posted,,,09/04/2021,https://clinicaltrials.gov/show/NCT04353180,01/06/2021,0,0
2093,NCT04357444,"Active, not recruiting",02/11/2020,23/04/2021,No Results Posted,,,09/04/2021,https://clinicaltrials.gov/show/NCT04357444,02/11/2020,0,0
2094,NCT04359875,Completed,30/06/2020,31/12/2020,No Results Posted,,,12/04/2021,https://clinicaltrials.gov/show/NCT04359875,30/06/2020,0,0
2095,NCT04364022,Completed,24/03/2021,24/03/2021,No Results Posted,"['Smit M, Marinosci A, Nicoletti GJ, Perneger T, Ragozzino S, Andrey DO, Stoeckle M, Jacquerioz F, Lebowitz D, Agoritsas T, Meyer B, Spechbach H, Salamun J, Back M, Schaubhut C, Fuchs S, Decosterd L, Battegay M, Guessous I, Chappuis F, Kaiser L, Labhardt ND, Calmy A. Efficacy of pragmatic same-day ring prophylaxis for adult individuals exposed to SARS-CoV-2 in Switzerland (COPEP): protocol of an open-label cluster randomised trial. BMJ Open. 2020 Nov 12;10(11):e040110. doi: 10.1136/bmjopen-2020-040110.']",,12/04/2021,https://clinicaltrials.gov/show/NCT04364022,24/03/2021,0,1
2096,NCT04367077,Recruiting,01/01/2023,01/12/2023,No Results Posted,,,13/04/2021,https://clinicaltrials.gov/show/NCT04367077,01/01/2023,0,0
2097,NCT04369599,Enrolling by invitation,01/07/2021,01/07/2021,No Results Posted,,,12/04/2021,https://clinicaltrials.gov/show/NCT04369599,01/07/2021,0,0
2098,NCT04373460,Recruiting,21/12/2022,31/01/2023,No Results Posted,,,08/04/2021,https://clinicaltrials.gov/show/NCT04373460,21/12/2022,0,0
2099,NCT04390139,Recruiting,01/10/2021,01/12/2021,No Results Posted,,,08/04/2021,https://clinicaltrials.gov/show/NCT04390139,01/10/2021,0,0
2100,NCT04395716,Withdrawn,01/06/2021,01/11/2021,No Results Posted,,,08/04/2021,https://clinicaltrials.gov/show/NCT04395716,01/06/2021,0,0
2101,NCT04402944,Recruiting,31/05/2021,31/12/2021,No Results Posted,,,09/04/2021,https://clinicaltrials.gov/show/NCT04402944,31/05/2021,0,0
2102,NCT04405986,Completed,10/03/2021,10/03/2021,No Results Posted,,,08/04/2021,https://clinicaltrials.gov/show/NCT04405986,10/03/2021,0,0
2103,NCT04415060,Recruiting,15/06/2023,15/06/2023,No Results Posted,,,14/04/2021,https://clinicaltrials.gov/show/NCT04415060,15/06/2023,0,0
2104,NCT04428021,"Active, not recruiting",31/03/2021,31/10/2021,No Results Posted,,,06/04/2021,https://clinicaltrials.gov/show/NCT04428021,31/03/2021,0,0
2105,NCT04429529,Completed,19/11/2020,20/01/2021,No Results Posted,,,08/04/2021,https://clinicaltrials.gov/show/NCT04429529,19/11/2020,0,0
2106,NCT04436276,"Active, not recruiting",03/12/2021,02/02/2024,No Results Posted,"['Stephenson KE, Le Gars M, Sadoff J, de Groot AM, Heerwegh D, Truyers C, Atyeo C, Loos C, Chandrashekar A, McMahan K, Tostanoski LH, Yu J, Gebre MS, Jacob-Dolan C, Li Z, Patel S, Peter L, Liu J, Borducchi EN, Nkolola JP, Souza M, Tan CS, Zash R, Julg B, Nathavitharana RR, Shapiro RL, Azim AA, Alonso CD, Jaegle K, Ansel JL, Kanjilal DG, Guiney CJ, Bradshaw C, Tyler A, Makoni T, Yanosick KE, Seaman MS, Lauffenburger DA, Alter G, Struyf F, Douoguih M, Van Hoof J, Schuitemaker H, Barouch DH. Immunogenicity of the Ad26.COV2.S Vaccine for COVID-19. JAMA. 2021 Apr 20;325(15):1535-1544. doi: 10.1001/jama.2021.3645.', 'Sadoff J, Le Gars M, Shukarev G, Heerwegh D, Truyers C, de Groot AM, Stoop J, Tete S, Van Damme W, Leroux-Roels I, Berghmans PJ, Kimmel M, Van Damme P, de Hoon J, Smith W, Stephenson KE, De Rosa SC, Cohen KW, McElrath MJ, Cormier E, Scheper G, Barouch DH, Hendriks J, Struyf F, Douoguih M, Van Hoof J, Schuitemaker H. Interim Results of a Phase 1-2a Trial of Ad26.COV2.S Covid-19 Vaccine. N Engl J Med. 2021 May 13;384(19):1824-1835. doi: 10.1056/NEJMoa2034201. Epub 2021 Jan 13.', 'Bos R, Rutten L, van der Lubbe JEM, Bakkers MJG, Hardenberg G, Wegmann F, Zuijdgeest D, de Wilde AH, Koornneef A, Verwilligen A, van Manen D, Kwaks T, Vogels R, Dalebout TJ, Myeni SK, Kikkert M, Snijder EJ, Li Z, Barouch DH, Vellinga J, Langedijk JPM, Zahn RC, Custers J, Schuitemaker H. Ad26 vector-based COVID-19 vaccine encoding a prefusion-stabilized SARS-CoV-2 Spike immunogen induces potent humoral and cellular immune responses. NPJ Vaccines. 2020 Sep 28;5:91. doi: 10.1038/s41541-020-00243-x. eCollection 2020.']",,12/04/2021,https://clinicaltrials.gov/show/NCT04436276,03/12/2021,0,1
2107,NCT04440007,"Active, not recruiting",05/05/2021,01/07/2021,No Results Posted,,,12/04/2021,https://clinicaltrials.gov/show/NCT04440007,05/05/2021,0,0
2108,NCT04459247,"Active, not recruiting",30/08/2021,10/09/2021,No Results Posted,"['Stroehlein JK, Wallqvist J, Iannizzi C, Mikolajewska A, Metzendorf MI, Benstoem C, Meybohm P, Becker M, Skoetz N, Stegemann M, Piechotta V. Vitamin D supplementation for the treatment of COVID-19: a living systematic review. Cochrane Database Syst Rev. 2021 May 24;5:CD015043. doi: 10.1002/14651858.CD015043.', 'Rastogi A, Bhansali A, Khare N, Suri V, Yaddanapudi N, Sachdeva N, Puri GD, Malhotra P. Short term, high-dose vitamin D supplementation for COVID-19 disease: a randomised, placebo-controlled, study (SHADE study). Postgrad Med J. 2020 Nov 12. pii: postgradmedj-2020-139065. doi: 10.1136/postgradmedj-2020-139065. [Epub ahead of print]']",,08/04/2021,https://clinicaltrials.gov/show/NCT04459247,30/08/2021,0,1
2109,NCT04459702,Withdrawn,01/07/2021,01/12/2021,No Results Posted,,,08/04/2021,https://clinicaltrials.gov/show/NCT04459702,01/07/2021,0,0
2110,NCT04471636,Recruiting,01/11/2021,01/12/2021,No Results Posted,,,14/04/2021,https://clinicaltrials.gov/show/NCT04471636,01/11/2021,0,0
2111,NCT04477993,Terminated,29/03/2021,29/03/2021,No Results Posted,,,08/04/2021,https://clinicaltrials.gov/show/NCT04477993,29/03/2021,0,0
2112,NCT04478019,Recruiting,30/04/2022,30/04/2022,No Results Posted,,,08/04/2021,https://clinicaltrials.gov/show/NCT04478019,30/04/2022,0,0
2113,NCT04479631,Completed,29/01/2021,29/01/2021,No Results Posted,,,12/04/2021,https://clinicaltrials.gov/show/NCT04479631,29/01/2021,0,0
2114,NCT04479644,Completed,03/02/2021,03/02/2021,No Results Posted,,,12/04/2021,https://clinicaltrials.gov/show/NCT04479644,03/02/2021,0,0
2115,NCT04482699,Recruiting,30/12/2021,01/06/2022,No Results Posted,,,12/04/2021,https://clinicaltrials.gov/show/NCT04482699,30/12/2021,0,0
2116,NCT04488796,Completed,16/12/2020,16/12/2020,No Results Posted,,,08/04/2021,https://clinicaltrials.gov/show/NCT04488796,16/12/2020,0,0
2117,NCT04497298,Completed,12/05/2021,12/05/2021,No Results Posted,,,09/07/2021,https://clinicaltrials.gov/show/NCT04497298,12/05/2021,0,0
2118,NCT04505761,Completed,01/02/2021,31/03/2021,No Results Posted,,,06/04/2021,https://clinicaltrials.gov/show/NCT04505761,01/02/2021,0,0
2119,NCT04522830,Completed,28/02/2021,28/02/2021,No Results Posted,,,13/04/2021,https://clinicaltrials.gov/show/NCT04522830,28/02/2021,0,0
2120,NCT04539262,Completed,26/02/2021,22/03/2021,No Results Posted,,,09/04/2021,https://clinicaltrials.gov/show/NCT04539262,26/02/2021,0,0
2121,NCT04558125,Recruiting,31/12/2021,30/06/2022,No Results Posted,,,09/04/2021,https://clinicaltrials.gov/show/NCT04558125,31/12/2021,0,0
2122,NCT04563702,"Active, not recruiting",10/05/2021,01/10/2021,No Results Posted,,,08/04/2021,https://clinicaltrials.gov/show/NCT04563702,10/05/2021,0,0
2123,NCT04573764,Recruiting,01/10/2021,01/01/2022,No Results Posted,,,13/04/2021,https://clinicaltrials.gov/show/NCT04573764,01/10/2021,0,0
2124,NCT04581915,Recruiting,31/12/2021,31/12/2021,No Results Posted,,,12/04/2021,https://clinicaltrials.gov/show/NCT04581915,31/12/2021,0,0
2125,NCT04594343,Recruiting,20/07/2021,01/09/2021,No Results Posted,,,08/04/2021,https://clinicaltrials.gov/show/NCT04594343,20/07/2021,0,0
2126,NCT04602871,Completed,30/01/2021,30/01/2021,No Results Posted,,,13/04/2021,https://clinicaltrials.gov/show/NCT04602871,30/01/2021,0,0
2127,NCT04602884,Suspended,30/12/2021,30/12/2021,No Results Posted,,,13/04/2021,https://clinicaltrials.gov/show/NCT04602884,30/12/2021,0,0
2128,NCT04602949,Recruiting,28/07/2021,28/07/2021,No Results Posted,,,14/04/2021,https://clinicaltrials.gov/show/NCT04602949,28/07/2021,0,0
2129,NCT04621071,Recruiting,01/06/2021,01/07/2021,No Results Posted,,,09/04/2021,https://clinicaltrials.gov/show/NCT04621071,01/06/2021,0,0
2130,NCT04625985,Completed,08/03/2021,18/03/2021,No Results Posted,,"['Musi N, Hirshman MF, Nygren J, Svanfeldt M, Bavenholm P, Rooyackers O, Zhou G, Williamson JM, Ljunqvist O, Efendic S, Moller DE, Thorell A, Goodyear LJ. Metformin increases AMP-activated protein kinase activity in skeletal muscle of subjects with type 2 diabetes. Diabetes. 2002 Jul;51(7):2074-81.', 'Shaw RJ, Lamia KA, Vasquez D, Koo SH, Bardeesy N, Depinho RA, Montminy M, Cantley LC. The kinase LKB1 mediates glucose homeostasis in liver and therapeutic effects of metformin. Science. 2005 Dec 9;310(5754):1642-6. Epub 2005 Nov 24.', 'Detaille D, Guigas B, Leverve X, Wiernsperger N, Devos P. Obligatory role of membrane events in the regulatory effect of metformin on the respiratory chain function. Biochem Pharmacol. 2002 Apr 1;63(7):1259-72.', 'Tamura Y, Watada H, Sato F, Kumashiro N, Sakurai Y, Hirose T, Tanaka Y, Kawamori R. Effects of metformin on peripheral insulin sensitivity and intracellular lipid contents in muscle and liver of overweight Japanese subjects. Diabetes Obes Metab. 2008 Sep;10(9):733-8. Epub 2007 Oct 15.', 'Standeven KF, Ari√´ns RA, Whitaker P, Ashcroft AE, Weisel JW, Grant PJ. The effect of dimethylbiguanide on thrombin activity, FXIII activation, fibrin polymerization, and fibrin clot formation. Diabetes. 2002 Jan;51(1):189-97.', 'Gonz√°lez-Ortiz M, Mart√≠nez-Abundis E, Robles-Cervantes JA, Ramos-Zavala MG, Barrera-Dur√°n C, Gonz√°lez-Canudas J. Efficacy and Safety of Metformin Glycinate vs. Metformin Hydrochloride in Metabolic Control and Inflammatory Mediators in Type 2 Diabetes Mellitus Patients (T2DM). Diabetes Technol Ther. 2012 Dec;14(12):1140-4. Diabetes Technol Ther. 2012 Dec;14(12):1140-4. doi: 10.1089/dia.2012.0097', 'Jorge Gonz√°lez Canudas, COMET GROUP Diabetes Efficacy and Safety of Metformin Glycinate vs. Metformin Hydrochloride in Metabolic Control and Inflammatory Mediators in Type 2 Diabetes Mellitus Patients. Diabetes 2019 Jun; 68(Supplement 1)', 'Garza-Oca√±as L, Tamez-de la O E, Iglesias-Chiesa J, Gonzalez Canudas J, Rivas-Ruiz R: Pharmacokinetics and gastrointestinal tolerability of DMMET 01 (glycinate of metformin): results of a prospective randomized trial in healthy volunteers [abstract]. Diabetes 2009;58(Suppl 1):A533']",08/04/2021,https://clinicaltrials.gov/show/NCT04625985,08/03/2021,0,1
2131,NCT04626089,Withdrawn,01/02/2021,01/02/2021,No Results Posted,,"['Saus J, Wieslander J, Langeveld JP, Quinones S, Hudson BG. Identification of the Goodpasture antigen as the alpha 3(IV) chain of collagen IV. J Biol Chem. 1988 Sep 15;263(26):13374-80.', ""Hudson BG, Tryggvason K, Sundaramoorthy M, Neilson EG. Alport's syndrome, Goodpasture's syndrome, and type IV collagen. N Engl J Med. 2003 Jun 19;348(25):2543-56. Review."", 'Quinones S, Bernal D, Garc√≠a-Sogo M, Elena SF, Saus J. Exon/intron structure of the human alpha 3(IV) gene encompassing the Goodpasture antigen (alpha 3(IV)NC1). Identification of a potentially antigenic region at the triple helix/NC1 domain junction. J Biol Chem. 1992 Oct 5;267(28):19780-4. Erratum in: J Biol Chem. 1994 Jun 24;269(25):17358.', 'Revert F, Penad√©s JR, Plana M, Bernal D, Johansson C, Itarte E, Cervera J, Wieslander J, Quinones S, Saus J. Phosphorylation of the Goodpasture antigen by type A protein kinases. J Biol Chem. 1995 Jun 2;270(22):13254-61.', 'Borza CM, Borza DB, Pedchenko V, Saleem MA, Mathieson PW, Sado Y, Hudson HM, Pozzi A, Saus J, Abrahamson DR, Zent R, Hudson BG. Human podocytes adhere to the KRGDS motif of the alpha3alpha4alpha5 collagen IV network. J Am Soc Nephrol. 2008 Apr;19(4):677-84. doi: 10.1681/ASN.2007070793. Epub 2008 Jan 30.', 'Raya A, Revert-Ros F, Martinez-Martinez P, Navarro S, Rosello E, Vieites B, Granero F, Forteza J, Saus J. Goodpasture antigen-binding protein, the kinase that phosphorylates the goodpasture antigen, is an alternatively spliced variant implicated in autoimmune pathogenesis. J Biol Chem. 2000 Dec 22;275(51):40392-9.', 'Hanada K, Kumagai K, Yasuda S, Miura Y, Kawano M, Fukasawa M, Nishijima M. Molecular machinery for non-vesicular trafficking of ceramide. Nature. 2003 Dec 18;426(6968):803-9.', 'Revert F, Merino R, Monteagudo C, Macias J, Peydr√≥ A, Alc√°cer J, Muniesa P, Marquina R, Blanco M, Iglesias M, Revert-Ros F, Merino J, Saus J. Increased Goodpasture antigen-binding protein expression induces type IV collagen disorganization and deposit of immunoglobulin A in glomerular basement membrane. Am J Pathol. 2007 Nov;171(5):1419-30. Epub 2007 Oct 4.', 'Revert-Ros F, L√≥pez-Pascual E, Granero-Molt√≥ F, Mac√≠as J, Breyer R, Zent R, Hudson BG, Saadeddin A, Revert F, Blasco R, Navarro C, Burks D, Saus J. Goodpasture antigen-binding protein (GPBP) directs myofibril formation: identification of intracellular downstream effector 130-kDa GPBP-interacting protein (GIP130). J Biol Chem. 2011 Oct 7;286(40):35030-43. doi: 10.1074/jbc.M111.249458. Epub 2011 Aug 9.', 'Darris C, Revert F, Revert-Ros F, Gozalbo-Rovira R, Feigley A, Fidler A, Lopez-Pascual E, Saus J, Hudson BG. Unicellular ancestry and mechanisms of diversification of Goodpasture antigen-binding protein. J Biol Chem. 2019 Jan 18;294(3):759-769. doi: 10.1074/jbc.RA118.006225. Epub 2018 Oct 30.', 'Revert F, Revert-Ros F, Blasco R, Artigot A, L√≥pez-Pascual E, Gozalbo-Rovira R, Ventura I, Guti√©rrez-Carbonell E, Roda N, Ru√≠z-Sanchis D, Forteza J, Alc√°cer J, P√©rez-Sastre A, D√≠az A, P√©rez-Pay√° E, Sanz-Cervera JF, Saus J. Selective targeting of collagen IV in the cancer cell microenvironment reduces tumor burden. Oncotarget. 2018 Jan 19;9(13):11020-11045. doi: 10.18632/oncotarget.24280. eCollection 2018 Feb 16.', 'Swanton C, Marani M, Pardo O, Warne PH, Kelly G, Sahai E, Elustondo F, Chang J, Temple J, Ahmed AA, Brenton JD, Downward J, Nicke B. Regulators of mitotic arrest and ceramide metabolism are determinants of sensitivity to paclitaxel and other chemotherapeutic drugs. Cancer Cell. 2007 Jun;11(6):498-512.', 'Szegezdi E, Logue SE, Gorman AM, Samali A. Mediators of endoplasmic reticulum stress-induced apoptosis. EMBO Rep. 2006 Sep;7(9):880-5. Review.', 'Fung TS, Liu DX. Human Coronavirus: Host-Pathogen Interaction. Annu Rev Microbiol. 2019 Sep 8;73:529-557. doi: 10.1146/annurev-micro-020518-115759. Epub 2019 Jun 21. Review.', 'Catanzaro N, Meng XJ. Induction of the unfolded protein response (UPR) suppresses porcine reproductive and respiratory syndrome virus (PRRSV) replication. Virus Res. 2020 Jan 15;276:197820. doi: 10.1016/j.virusres.2019.197820. Epub 2019 Nov 16.', 'Schimmack G, Defronzo RA, Musi N. AMP-activated protein kinase: Role in metabolism and therapeutic implications. Diabetes Obes Metab. 2006 Nov;8(6):591-602. Review.', 'Sriwijitkamol A, Musi N. Advances in the development of AMPK-activating compounds. Expert Opin Drug Discov. 2008 Oct;3(10):1167-76. doi: 10.1517/17460441.3.10.1167.', 'Musi N, Hirshman MF, Nygren J, Svanfeldt M, Bavenholm P, Rooyackers O, Zhou G, Williamson JM, Ljunqvist O, Efendic S, Moller DE, Thorell A, Goodyear LJ. Metformin increases AMP-activated protein kinase activity in skeletal muscle of subjects with type 2 diabetes. Diabetes. 2002 Jul;51(7):2074-81.', 'Shaw RJ, Lamia KA, Vasquez D, Koo SH, Bardeesy N, Depinho RA, Montminy M, Cantley LC. The kinase LKB1 mediates glucose homeostasis in liver and therapeutic effects of metformin. Science. 2005 Dec 9;310(5754):1642-6. Epub 2005 Nov 24.', 'Detaille D, Guigas B, Leverve X, Wiernsperger N, Devos P. Obligatory role of membrane events in the regulatory effect of metformin on the respiratory chain function. Biochem Pharmacol. 2002 Apr 1;63(7):1259-72.', 'Stumvoll M, Nurjhan N, Perriello G, Dailey G, Gerich JE. Metabolic effects of metformin in non-insulin-dependent diabetes mellitus. N Engl J Med. 1995 Aug 31;333(9):550-4.', 'Otto M, Breinholt J, Westergaard N. Metformin inhibits glycogen synthesis and gluconeogenesis in cultured rat hepatocytes. Diabetes Obes Metab. 2003 May;5(3):189-94.', 'F√©ry F, Plat L, Balasse EO. Effects of metformin on the pathways of glucose utilization after oral glucose in non-insulin-dependent diabetes mellitus patients. Metabolism. 1997 Feb;46(2):227-33.', 'Hother-Nielsen O, Schmitz O, Andersen PH, Beck-Nielsen H, Pedersen O. Metformin improves peripheral but not hepatic insulin action in obese patients with type II diabetes. Acta Endocrinol (Copenh). 1989 Mar;120(3):257-65.', 'Tamura Y, Watada H, Sato F, Kumashiro N, Sakurai Y, Hirose T, Tanaka Y, Kawamori R. Effects of metformin on peripheral insulin sensitivity and intracellular lipid contents in muscle and liver of overweight Japanese subjects. Diabetes Obes Metab. 2008 Sep;10(9):733-8. Epub 2007 Oct 15.', 'Fischer M, Timper K, Radimerski T, Dembinski K, Frey DM, Zulewski H, Keller U, M√ºller B, Christ-Crain M, Grisouard J. Metformin induces glucose uptake in human preadipocyte-derived adipocytes from various fat depots. Diabetes Obes Metab. 2010 Apr;12(4):356-9. doi: 10.1111/j.1463-1326.2009.01169.x.', 'Cataldo NA, Abbasi F, McLaughlin TL, Basina M, Fechner PY, Giudice LC, Reaven GM. Metabolic and ovarian effects of rosiglitazone treatment for 12 weeks in insulin-resistant women with polycystic ovary syndrome. Hum Reprod. 2006 Jan;21(1):109-20. Epub 2005 Sep 9.', ""Cuthbertson J, Patterson S, O'Harte FP, Bell PM. Investigation of the effect of oral metformin on dipeptidylpeptidase-4 (DPP-4) activity in Type 2 diabetes. Diabet Med. 2009 Jun;26(6):649-54. doi: 10.1111/j.1464-5491.2009.02748.x."", 'Standeven KF, Ari√´ns RA, Whitaker P, Ashcroft AE, Weisel JW, Grant PJ. The effect of dimethylbiguanide on thrombin activity, FXIII activation, fibrin polymerization, and fibrin clot formation. Diabetes. 2002 Jan;51(1):189-97.', 'Nichols GA, Gomez-Caminero A. Weight changes following the initiation of new anti-hyperglycaemic therapies. Diabetes Obes Metab. 2007 Jan;9(1):96-102.', 'Landman GW, Kleefstra N, van Hateren KJ, Groenier KH, Gans RO, Bilo HJ. Metformin associated with lower cancer mortality in type 2 diabetes: ZODIAC-16. Diabetes Care. 2010 Feb;33(2):322-6. doi: 10.2337/dc09-1380. Epub 2009 Nov 16.', 'Gonz√°lez-Ortiz M, Mart√≠nez-Abundis E, Robles-Cervantes JA, Ramos-Zavala MG, Barrera-Dur√°n C, Gonz√°lez-Canudas J. Diabetes Technol Ther. 2012 Dec;14(12):1140-4. doi: 10.1089/dia.2012.0097. Epub 2012 Sep 13. Efficacy and Safety of Metformin Glycinate vs. Metformin Hydrochloride in Metabolic Control and Inflammatory Mediators in Type 2 Diabetes Mellitus Patients (T2DM)', 'JORGE GONZ√ÅLEZ-CANUDAS, COMET GROUP Diabetes Efficacy and Safety of Metformin Glycinate vs. Metformin Hydrochloride in Metabolic Control and Inflammatory Mediators in Type 2 Diabetes Mellitus Patients. Diabetes 2019 Jun; 68(Supplement 1):', 'Garza-Oca√±as L, Tamez-de la O E, Iglesias-Chiesa J, Gonzalez Canudas J, Rivas-Ruiz R: Pharmacokinetics and gastrointestinal tolerability of DMMET 01 (glycinate of metformin): results of a prospective randomized trial in healthy volunteers [abstract]. Diabetes 2009;58(Suppl 1):A533.', 'Granero F, Revert F, Revert-Ros F, Lainez S, Mart√≠nez-Mart√≠nez P, Saus J. A human-specific TNF-responsive promoter for Goodpasture antigen-binding protein. FEBS J. 2005 Oct;272(20):5291-305.', 'Foretz M, H√©brard S, Leclerc J, Zarrinpashneh E, Soty M, Mithieux G, Sakamoto K, Andreelli F, Viollet B. Metformin inhibits hepatic gluconeogenesis in mice independently of the LKB1/AMPK pathway via a decrease in hepatic energy state. J Clin Invest. 2010 Jul;120(7):2355-69. doi: 10.1172/JCI40671. Epub 2010 Jun 23.', 'Rada P, Mosquera A, Muntan√© J, Ferrandiz F, Rodriguez-Ma√±as L, de Pablo F, Gonz√°lez-Canudas J, Valverde √ÅM. Differential effects of metformin glycinate and hydrochloride in glucose production, AMPK phosphorylation and insulin sensitivity in hepatocytes from non-diabetic and diabetic mice. Food Chem Toxicol. 2019 Jan;123:470-480. doi: 10.1016/j.fct.2018.11.019. Epub 2018 Nov 9.', 'Food Chem Toxicol. 2019 Jan;123:470-480. doi: 10.1016/j.fct.2018.11.019. Epub 2018 Nov 9.', 'Choi YH, Lee MG. Effects of enzyme inducers and inhibitors on the pharmacokinetics of metformin in rats: involvement of CYP2C11, 2D1 and 3A1/2 for the metabolism of metformin. Br J Pharmacol. 2006 Oct;149(4):424-30. Epub 2006 Aug 29.', 'Dianben¬Æ 1000 mg polvo para soluci√≥n oral. Ficha t√©cnica del producto. N¬∫ de autorizaci√≥n de comercializaci√≥n: 70545. Merck Sant√© S.A.S. 37 rue Saint Romain. 69008 Lyon. Francia. Fecha de revision 2010. Consultada en la web de la Agencia Espa√±ola del Medicamento y de Productos Sanitarios (www.aemps.gob.es) el 27 de Marzo del 2013', ""Giugliano D, De Rosa N, Di Maro G, Marfella R, Acampora R, Buoninconti R, D'Onofrio F. Metformin improves glucose, lipid metabolism, and reduces blood pressure in hypertensive, obese women. Diabetes Care. 1993 Oct;16(10):1387-90."", 'Landin K, Tengborn L, Smith U. Treating insulin resistance in hypertension with metformin reduces both blood pressure and metabolic risk factors. J Intern Med. 1991 Feb;229(2):181-7.', 'Quaile MP, Melich DH, Jordan HL, Nold JB, Chism JP, Polli JW, Smith GA, Rhodes MC. Toxicity and toxicokinetics of metformin in rats. Toxicol Appl Pharmacol. 2010 Mar 15;243(3):340-7. doi: 10.1016/j.taap.2009.11.026. Epub 2010 Jan 13.', 'Santur√© M, Pitre M, Gaudreault N, Marette A, Nadeau A, Bachelard H. Effect of metformin on the vascular and glucose metabolic actions of insulin in hypertensive rats. Am J Physiol Gastrointest Liver Physiol. 2000 May;278(5):G682-92.', 'Verma S, Bhanot S, McNeill JH. Antihypertensive effects of metformin in fructose-fed hyperinsulinemic, hypertensive rats. J Pharmacol Exp Ther. 1994 Dec;271(3):1334-7.']",08/04/2021,https://clinicaltrials.gov/show/NCT04626089,01/02/2021,0,1
2132,NCT04627467,"Active, not recruiting",09/07/2020,01/07/2021,No Results Posted,,"['WHO. Coronavirus disease 2019 (COVID-19). Situation Report - 43 2020 [Available from: https://www.who.int/emergencies/diseases/novel-coronavirus2019/technicalguidance/laboratoryguidance', 'Wang M, Su S, Lv J, Zhou G, Wang Q, Guo C. Analysis of clinical features and prognostic factors in Chinese patients with rheumatic diseases in an intensive care unit. The Egyptian Rheumatologist. 2018;40(1):63-6.', 'Livingston E, Bucher K. Coronavirus Disease 2019 (COVID-19) in Italy. JAMA. 2020 Apr 14;323(14):1335. doi: 10.1001/jama.2020.4344.', 'Wang M, Cao R, Zhang L, Yang X, Liu J, Xu M, Shi Z, Hu Z, Zhong W, Xiao G. Remdesivir and chloroquine effectively inhibit the recently emerged novel coronavirus (2019-nCoV) in vitro. Cell Res. 2020 Mar;30(3):269-271. doi: 10.1038/s41422-020-0282-0. Epub 2020 Feb 4.', 'Gautret P, Lagier JC, Parola P, Hoang VT, Meddeb L, Mailhe M, Doudier B, Courjon J, Giordanengo V, Vieira VE, Tissot Dupont H, Honor√© S, Colson P, Chabri√®re E, La Scola B, Rolain JM, Brouqui P, Raoult D. Hydroxychloroquine and azithromycin as a treatment of COVID-19: results of an open-label non-randomized clinical trial. Int J Antimicrob Agents. 2020 Jul;56(1):105949. doi: 10.1016/j.ijantimicag.2020.105949. Epub 2020 Mar 20.', 'Zhou D, Dai SM, Tong Q. COVID-19: a recommendation to examine the effect of hydroxychloroquine in preventing infection and progression. J Antimicrob Chemother. 2020 Jul 1;75(7):1667-1670. doi: 10.1093/jac/dkaa114.', 'Rodriguez-Morales AJ, Cardona-Ospina JA, Guti√©rrez-Ocampo E, Villamizar-Pe√±a R, Holguin-Rivera Y, Escalera-Antezana JP, Alvarado-Arnez LE, Bonilla-Aldana DK, Franco-Paredes C, Henao-Martinez AF, Paniz-Mondolfi A, Lagos-Grisales GJ, Ram√≠rez-Vallejo E, Su√°rez JA, Zambrano LI, Villamil-G√≥mez WE, Balbin-Ramon GJ, Rabaan AA, Harapan H, Dhama K, Nishiura H, Kataoka H, Ahmad T, Sah R; Latin American Network of Coronavirus Disease 2019-COVID-19 Research (LANCOVID-19). Electronic address: https://www.lancovid.org. Clinical, laboratory and imaging features of COVID-19: A systematic review and meta-analysis. Travel Med Infect Dis. 2020 Mar - Apr;34:101623. doi: 10.1016/j.tmaid.2020.101623. Epub 2020 Mar 13.', 'Xu X, Yu C, Qu J, Zhang L, Jiang S, Huang D, Chen B, Zhang Z, Guan W, Ling Z, Jiang R, Hu T, Ding Y, Lin L, Gan Q, Luo L, Tang X, Liu J. Imaging and clinical features of patients with 2019 novel coronavirus SARS-CoV-2. Eur J Nucl Med Mol Imaging. 2020 May;47(5):1275-1280. doi: 10.1007/s00259-020-04735-9. Epub 2020 Feb 28.', 'Huang C, Wang Y, Li X, Ren L, Zhao J, Hu Y, Zhang L, Fan G, Xu J, Gu X, Cheng Z, Yu T, Xia J, Wei Y, Wu W, Xie X, Yin W, Li H, Liu M, Xiao Y, Gao H, Guo L, Xie J, Wang G, Jiang R, Gao Z, Jin Q, Wang J, Cao B. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet. 2020 Feb 15;395(10223):497-506. doi: 10.1016/S0140-6736(20)30183-5. Epub 2020 Jan 24. Erratum in: Lancet. 2020 Jan 30;:.', 'Gostic K, Gomez AC, Mummah RO, Kucharski AJ, Lloyd-Smith JO. Estimated effectiveness of symptom and risk screening to prevent the spread of COVID-19. Elife. 2020 Feb 24;9. pii: e55570. doi: 10.7554/eLife.55570.', 'Chowell G, Abdirizak F, Lee S, Lee J, Jung E, Nishiura H, Viboud C. Transmission characteristics of MERS and SARS in the healthcare setting: a comparative study. BMC Med. 2015 Sep 3;13:210. doi: 10.1186/s12916-015-0450-0.', 'Epidemiology Working Group for NCIP Epidemic Response, Chinese Center for Disease Control and Prevention. [The epidemiological characteristics of an outbreak of 2019 novel coronavirus diseases (COVID-19) in China]. Zhonghua Liu Xing Bing Xue Za Zhi. 2020 Feb 10;41(2):145-151. doi: 10.3760/cma.j.issn.0254-6450.2020.02.003. Chinese.', 'Su A. Doctors and nurses fighting coronavirus in China die of both infection and fatigue. Los Angeles Times. 2020.', 'Liu M, He P, Liu HG, Wang XJ, Li FJ, Chen S, Lin J, Chen P, Liu JH, Li CH. [Clinical characteristics of 30 medical workers infected with new coronavirus pneumonia]. Zhonghua Jie He He Hu Xi Za Zhi. 2020 Feb 17;43(0):E016. doi: 10.3760/cma.j.issn.1001-0939.2020.0016. [Epub ahead of print] Chinese.', 'Mitj√† O, Clotet B. Use of antiviral drugs to reduce COVID-19 transmission. Lancet Glob Health. 2020 May;8(5):e639-e640. doi: 10.1016/S2214-109X(20)30114-5. Epub 2020 Mar 19.', 'Welliver R, Monto AS, Carewicz O, Schatteman E, Hassman M, Hedrick J, Jackson HC, Huson L, Ward P, Oxford JS; Oseltamivir Post Exposure Prophylaxis Investigator Group. Effectiveness of oseltamivir in preventing influenza in household contacts: a randomized controlled trial. JAMA. 2001 Feb 14;285(6):748-54.', 'Hydroxychloroquine Chemoprophylaxis in Healthcare Personnel in Contact With COVID-19 Patients (PHYDRA Trial) - Full Text View. ClinicalTrials.gov.', 'Chloroquine Prevention of Coronavirus Disease (COVID-19) in the Healthcare Setting - Full Text View. ClinicalTrials.gov', 'Treatment of COVID-19 Cases and Chemoprophylaxis of Contacts as Prevention - Full Text View. ClinicalTrials.gov', 'Ruiz-Irastorza G, Ramos-Casals M, Brito-Zeron P, Khamashta MA. Clinical efficacy and side effects of antimalarials in systemic lupus erythematosus: a systematic review. Ann Rheum Dis. 2010 Jan;69(1):20-8. doi: 10.1136/ard.2008.101766. Review.', 'Kuznik A, Bencina M, Svajger U, Jeras M, Rozman B, Jerala R. Mechanism of endosomal TLR inhibition by antimalarial drugs and imidazoquinolines. J Immunol. 2011 Apr 15;186(8):4794-804. doi: 10.4049/jimmunol.1000702. Epub 2011 Mar 11.', ""Savarino A, Boelaert JR, Cassone A, Majori G, Cauda R. Effects of chloroquine on viral infections: an old drug against today's diseases? Lancet Infect Dis. 2003 Nov;3(11):722-7. Review."", 'Yan Y, Zou Z, Sun Y, Li X, Xu KF, Wei Y, Jin N, Jiang C. Anti-malaria drug chloroquine is highly effective in treating avian influenza A H5N1 virus infection in an animal model. Cell Res. 2013 Feb;23(2):300-2. doi: 10.1038/cr.2012.165. Epub 2012 Dec 4.', 'IDOATE A, IDOIPE √Å. 2.4. Investigaci√≥n y ensayos cl√≠nicos.', 'Schwartz E. Prophylaxis of malaria. Mediterr J Hematol Infect Dis. 2012;4(1):e2012045. doi: 10.4084/MJHID.2012.45. Epub 2012 Jun 29.', 'Gozal D, Hengy C, Fadat G. Prolonged malaria prophylaxis with chloroquine and proguanil (chloroguanide) in a nonimmune resident population of an endemic area with a high prevalence of chloroquine resistance. Antimicrob Agents Chemother. 1991 Feb;35(2):373-6.', 'Yao X, Ye F, Zhang M, Cui C, Huang B, Niu P, Liu X, Zhao L, Dong E, Song C, Zhan S, Lu R, Li H, Tan W, Liu D. In Vitro Antiviral Activity and Projection of Optimized Dosing Design of Hydroxychloroquine for the Treatment of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2). Clin Infect Dis. 2020 Jul 28;71(15):732-739. doi: 10.1093/cid/ciaa237.', 'Chen W, Huang Y. To Protect Health Care Workers Better, To Save More Lives With COVID-19. Anesth Analg. 2020 Jul;131(1):97-101. doi: 10.1213/ANE.0000000000004834. Review.']",06/04/2021,https://clinicaltrials.gov/show/NCT04627467,09/07/2020,0,1
2133,NCT04644185,Recruiting,27/06/2021,27/12/2021,No Results Posted,,,12/04/2021,https://clinicaltrials.gov/show/NCT04644185,27/06/2021,0,0
2134,NCT04685447,Recruiting,20/04/2020,01/12/2021,No Results Posted,,,13/04/2021,https://clinicaltrials.gov/show/NCT04685447,20/04/2020,0,0
2135,NCT04710199,Recruiting,01/08/2021,01/10/2021,No Results Posted,,,06/04/2021,https://clinicaltrials.gov/show/NCT04710199,01/08/2021,0,0
2136,NCT04716426,Completed,25/03/2021,25/03/2021,Study Results,,,08/04/2021,https://clinicaltrials.gov/show/NCT04716426,25/03/2021,1,0
2137,NCT04718220,Recruiting,01/11/2022,01/11/2022,No Results Posted,,,08/04/2021,https://clinicaltrials.gov/show/NCT04718220,01/11/2022,0,0
2138,NCT04720235,Completed,09/03/2021,30/03/2021,No Results Posted,,,12/04/2021,https://clinicaltrials.gov/show/NCT04720235,09/03/2021,0,0
2139,NCT04732468,Recruiting,01/04/2022,01/04/2022,No Results Posted,,,12/04/2021,https://clinicaltrials.gov/show/NCT04732468,01/04/2022,0,0
2140,NCT04734561,Recruiting,30/07/2022,30/07/2022,No Results Posted,,,09/04/2021,https://clinicaltrials.gov/show/NCT04734561,30/07/2022,0,0
2141,NCT04734860,Recruiting,01/09/2021,01/11/2021,No Results Posted,,,13/04/2021,https://clinicaltrials.gov/show/NCT04734860,01/09/2021,0,0
2142,NCT04747821,"Active, not recruiting",01/05/2021,01/02/2022,No Results Posted,,,08/04/2021,https://clinicaltrials.gov/show/NCT04747821,01/05/2021,0,0
2143,NCT04748783,Terminated,07/04/2021,07/04/2021,No Results Posted,,,12/04/2021,https://clinicaltrials.gov/show/NCT04748783,07/04/2021,0,0
2144,NCT04751669,Not yet recruiting,31/10/2021,31/12/2021,No Results Posted,,,08/04/2021,https://clinicaltrials.gov/show/NCT04751669,31/10/2021,0,0
2145,NCT04762173,"Active, not recruiting",03/06/2021,03/06/2021,No Results Posted,,,14/04/2021,https://clinicaltrials.gov/show/NCT04762173,03/06/2021,0,0
2146,NCT04762771,Suspended,12/03/2021,01/11/2021,No Results Posted,,,08/04/2021,https://clinicaltrials.gov/show/NCT04762771,12/03/2021,0,0
2147,NCT04771351,Recruiting,01/08/2021,01/10/2021,No Results Posted,,,12/04/2021,https://clinicaltrials.gov/show/NCT04771351,01/08/2021,0,0
2148,NCT04789499,Recruiting,31/08/2021,01/12/2021,No Results Posted,,,07/07/2021,https://clinicaltrials.gov/show/NCT04789499,31/08/2021,0,0
2149,NCT04791423,"Active, not recruiting",30/05/2021,30/04/2022,No Results Posted,,,14/04/2021,https://clinicaltrials.gov/show/NCT04791423,30/05/2021,0,0
2150,NCT04794036,Recruiting,30/06/2021,30/09/2021,No Results Posted,,,12/04/2021,https://clinicaltrials.gov/show/NCT04794036,30/06/2021,0,0
2151,NCT04796402,Recruiting,30/06/2021,31/12/2021,No Results Posted,,,09/04/2021,https://clinicaltrials.gov/show/NCT04796402,30/06/2021,0,0
2152,NCT04798053,Recruiting,01/10/2022,01/10/2022,No Results Posted,,,09/04/2021,https://clinicaltrials.gov/show/NCT04798053,01/10/2022,0,0
2153,NCT04800133,Recruiting,31/03/2025,31/03/2025,No Results Posted,,,12/04/2021,https://clinicaltrials.gov/show/NCT04800133,31/03/2025,0,0
2154,NCT04800939,Recruiting,22/06/2021,22/07/2022,No Results Posted,,,09/04/2021,https://clinicaltrials.gov/show/NCT04800939,22/06/2021,0,0
2155,NCT04808921,Completed,18/01/2021,28/01/2021,No Results Posted,,,08/04/2021,https://clinicaltrials.gov/show/NCT04808921,18/01/2021,0,0
2156,NCT04810065,Recruiting,01/07/2021,30/09/2021,No Results Posted,,,14/04/2021,https://clinicaltrials.gov/show/NCT04810065,01/07/2021,0,0
2157,NCT04815057,Completed,23/11/2020,08/03/2021,No Results Posted,,,14/04/2021,https://clinicaltrials.gov/show/NCT04815057,23/11/2020,0,0
2158,NCT04818281,Recruiting,01/01/2022,01/03/2022,No Results Posted,,,08/04/2021,https://clinicaltrials.gov/show/NCT04818281,01/01/2022,0,0
2159,NCT04830761,Recruiting,01/04/2022,01/04/2022,No Results Posted,,,12/04/2021,https://clinicaltrials.gov/show/NCT04830761,01/04/2022,0,0
2160,NCT04833088,Not yet recruiting,01/04/2022,01/04/2022,No Results Posted,,,06/04/2021,https://clinicaltrials.gov/show/NCT04833088,01/04/2022,0,0
2161,NCT04834089,Not yet recruiting,01/05/2022,01/05/2022,No Results Posted,,,08/04/2021,https://clinicaltrials.gov/show/NCT04834089,01/05/2022,0,0
2162,NCT04834128,Not yet recruiting,01/08/2022,01/08/2022,No Results Posted,,,06/04/2021,https://clinicaltrials.gov/show/NCT04834128,01/08/2022,0,0
2163,NCT04834739,Recruiting,28/03/2021,30/04/2021,No Results Posted,,,08/04/2021,https://clinicaltrials.gov/show/NCT04834739,28/03/2021,0,0
2164,NCT04834856,"Active, not recruiting",31/10/2021,31/10/2021,No Results Posted,,,09/07/2021,https://clinicaltrials.gov/show/NCT04834856,31/10/2021,0,0
2165,NCT04836052,Recruiting,24/08/2021,24/12/2021,No Results Posted,,,08/04/2021,https://clinicaltrials.gov/show/NCT04836052,24/08/2021,0,0
2166,NCT04836260,Recruiting,31/12/2021,31/12/2021,No Results Posted,,,08/04/2021,https://clinicaltrials.gov/show/NCT04836260,31/12/2021,0,0
2167,NCT04836299,Not yet recruiting,08/07/2021,05/12/2021,No Results Posted,,,08/04/2021,https://clinicaltrials.gov/show/NCT04836299,08/07/2021,0,0
2168,NCT04836351,Recruiting,30/12/2023,30/12/2023,No Results Posted,,,08/04/2021,https://clinicaltrials.gov/show/NCT04836351,30/12/2023,0,0
2169,NCT04836780,Not yet recruiting,30/06/2021,30/06/2021,No Results Posted,,"['Yang X, Yu Y, Xu J, Shu H, Xia J, Liu H, Wu Y, Zhang L, Yu Z, Fang M, Yu T, Wang Y, Pan S, Zou X, Yuan S, Shang Y. Clinical course and outcomes of critically ill patients with SARS-CoV-2 pneumonia in Wuhan, China: a single-centered, retrospective, observational study. Lancet Respir Med. 2020 May;8(5):475-481. doi: 10.1016/S2213-2600(20)30079-5. Epub 2020 Feb 24. Erratum in: Lancet Respir Med. 2020 Apr;8(4):e26.', 'Siddiqi HK, Mehra MR. COVID-19 illness in native and immunosuppressed states: A clinical-therapeutic staging proposal. J Heart Lung Transplant. 2020 May;39(5):405-407. doi: 10.1016/j.healun.2020.03.012. Epub 2020 Mar 20.', 'Chen G, Wu D, Guo W, Cao Y, Huang D, Wang H, Wang T, Zhang X, Chen H, Yu H, Zhang X, Zhang M, Wu S, Song J, Chen T, Han M, Li S, Luo X, Zhao J, Ning Q. Clinical and immunological features of severe and moderate coronavirus disease 2019. J Clin Invest. 2020 May 1;130(5):2620-2629. doi: 10.1172/JCI137244.', 'RECOVERY Collaborative Group, Horby P, Lim WS, Emberson JR, Mafham M, Bell JL, Linsell L, Staplin N, Brightling C, Ustianowski A, Elmahi E, Prudon B, Green C, Felton T, Chadwick D, Rege K, Fegan C, Chappell LC, Faust SN, Jaki T, Jeffery K, Montgomery A, Rowan K, Juszczak E, Baillie JK, Haynes R, Landray MJ. Dexamethasone in Hospitalized Patients with Covid-19. N Engl J Med. 2021 Feb 25;384(8):693-704. doi: 10.1056/NEJMoa2021436. Epub 2020 Jul 17.', 'WHO/2019-nCoV/Corticosteroids/2020.1', 'Baud D, Qi X, Nielsen-Saines K, Musso D, Pomar L, Favre G. Real estimates of mortality following COVID-19 infection. Lancet Infect Dis. 2020 Jul;20(7):773. doi: 10.1016/S1473-3099(20)30195-X. Epub 2020 Mar 12.', 'Monedero P, Gea A, Castro P, Candela-Toha AM, Hern√°ndez-Sanz ML, Arruti E, Villar J, Ferrando C; COVID-19 Spanish ICU Network. Early corticosteroids are associated with lower mortality in critically ill patients with COVID-19: a cohort study. Crit Care. 2021 Jan 4;25(1):2. doi: 10.1186/s13054-020-03422-3.', 'Fadel R, Morrison AR, Vahia A, Smith ZR, Chaudhry Z, Bhargava P, Miller J, Kenney RM, Alangaden G, Ramesh MS; Henry Ford COVID-19 Management Task Force. Early Short-Course Corticosteroids in Hospitalized Patients With COVID-19. Clin Infect Dis. 2020 Nov 19;71(16):2114-2120. doi: 10.1093/cid/ciaa601.', 'Zhou F, Yu T, Du R, Fan G, Liu Y, Liu Z, Xiang J, Wang Y, Song B, Gu X, Guan L, Wei Y, Li H, Wu X, Xu J, Tu S, Zhang Y, Chen H, Cao B. Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study. Lancet. 2020 Mar 28;395(10229):1054-1062. doi: 10.1016/S0140-6736(20)30566-3. Epub 2020 Mar 11. Erratum in: Lancet. 2020 Mar 28;395(10229):1038. Lancet. 2020 Mar 28;395(10229):1038.', 'Ruan Q, Yang K, Wang W, Jiang L, Song J. Clinical predictors of mortality due to COVID-19 based on an analysis of data of 150 patients from Wuhan, China. Intensive Care Med. 2020 May;46(5):846-848. doi: 10.1007/s00134-020-05991-x. Epub 2020 Mar 3. Erratum in: Intensive Care Med. 2020 Apr 6;:.', 'Huang C, Wang Y, Li X, Ren L, Zhao J, Hu Y, Zhang L, Fan G, Xu J, Gu X, Cheng Z, Yu T, Xia J, Wei Y, Wu W, Xie X, Yin W, Li H, Liu M, Xiao Y, Gao H, Guo L, Xie J, Wang G, Jiang R, Gao Z, Jin Q, Wang J, Cao B. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet. 2020 Feb 15;395(10223):497-506. doi: 10.1016/S0140-6736(20)30183-5. Epub 2020 Jan 24. Erratum in: Lancet. 2020 Jan 30;:.', 'Guan WJ, Ni ZY, Hu Y, Liang WH, Ou CQ, He JX, Liu L, Shan H, Lei CL, Hui DSC, Du B, Li LJ, Zeng G, Yuen KY, Chen RC, Tang CL, Wang T, Chen PY, Xiang J, Li SY, Wang JL, Liang ZJ, Peng YX, Wei L, Liu Y, Hu YH, Peng P, Wang JM, Liu JY, Chen Z, Li G, Zheng ZJ, Qiu SQ, Luo J, Ye CJ, Zhu SY, Zhong NS; China Medical Treatment Expert Group for Covid-19. Clinical Characteristics of Coronavirus Disease 2019 in China. N Engl J Med. 2020 Apr 30;382(18):1708-1720. doi: 10.1056/NEJMoa2002032. Epub 2020 Feb 28.']",08/04/2021,https://clinicaltrials.gov/show/NCT04836780,30/06/2021,0,1
2170,NCT04838080,Recruiting,01/06/2021,20/10/2021,No Results Posted,,,13/04/2021,https://clinicaltrials.gov/show/NCT04838080,01/06/2021,0,0
2171,NCT04838847,Not yet recruiting,01/08/2021,01/06/2022,No Results Posted,,,09/04/2021,https://clinicaltrials.gov/show/NCT04838847,01/08/2021,0,0
2172,NCT04839315,Recruiting,01/12/2021,01/12/2021,No Results Posted,,,09/04/2021,https://clinicaltrials.gov/show/NCT04839315,01/12/2021,0,0
2173,NCT04840082,Completed,08/03/2021,08/03/2021,No Results Posted,,,09/04/2021,https://clinicaltrials.gov/show/NCT04840082,08/03/2021,0,0
2174,NCT04840459,Recruiting,31/12/2021,31/01/2022,No Results Posted,,,12/04/2021,https://clinicaltrials.gov/show/NCT04840459,31/12/2021,0,0
2175,NCT04840992,Not yet recruiting,15/04/2022,15/07/2022,No Results Posted,,,12/04/2021,https://clinicaltrials.gov/show/NCT04840992,15/04/2022,0,0
2176,NCT04841681,Completed,25/08/2020,26/08/2020,No Results Posted,,"['Wei N, Huang BC, Lu SJ, Hu JB, Zhou XY, Hu CC, Chen JK, Huang JW, Li SG, Wang Z, Wang DD, Xu Y, Hu SH. Efficacy of internet-based integrated intervention on depression and anxiety symptoms in patients with COVID-19. J Zhejiang Univ Sci B. 2020 May;21(5):400-404. doi: 10.1631/jzus.B2010013. Epub 2020 Apr 1.', 'Liu K, Chen Y, Wu D, Lin R, Wang Z, Pan L. Effects of progressive muscle relaxation on anxiety and sleep quality in patients with COVID-19. Complement Ther Clin Pract. 2020 May;39:101132. doi: 10.1016/j.ctcp.2020.101132. Epub 2020 Mar 6.', 'Dekker RL, Moser DK, Peden AR, Lennie TA. Cognitive therapy improves three-month outcomes in hospitalized patients with heart failure. J Card Fail. 2012 Jan;18(1):10-20. doi: 10.1016/j.cardfail.2011.09.008. Epub 2011 Nov 9.', 'Conversano C, Di Giuseppe M, Miccoli M, Ciacchini R, Gemignani A, Orr√π G. Mindfulness, Age and Gender as Protective Factors Against Psychological Distress During COVID-19 Pandemic. Front Psychol. 2020 Sep 11;11:1900. doi: 10.3389/fpsyg.2020.01900. eCollection 2020.', 'Behan C. The benefits of meditation and mindfulness practices during times of crisis such as COVID-19. Ir J Psychol Med. 2020 Dec;37(4):256-258. doi: 10.1017/ipm.2020.38. Epub 2020 May 14.', 'Grazzi L, Rizzoli P, Andrasik F. Effectiveness of mindfulness by smartphone, for patients with chronic migraine and medication overuse during the Covid-19 emergency. Neurol Sci. 2020 Dec;41(Suppl 2):461-462. doi: 10.1007/s10072-020-04659-0.', 'Reyes AT. A Mindfulness Mobile App for Traumatized COVID-19 Healthcare Workers and Recovered Patients: A Response to ""The Use of Digital Applications and COVID-19"". Community Ment Health J. 2020 Oct;56(7):1204-1205. doi: 10.1007/s10597-020-00690-9. Epub 2020 Aug 9.']",12/04/2021,https://clinicaltrials.gov/show/NCT04841681,25/08/2020,0,1
2177,NCT04842708,Recruiting,24/10/2021,24/10/2021,No Results Posted,,,13/04/2021,https://clinicaltrials.gov/show/NCT04842708,24/10/2021,0,0
2178,NCT04842734,"Active, not recruiting",27/06/2021,27/06/2021,No Results Posted,,,13/04/2021,https://clinicaltrials.gov/show/NCT04842734,27/06/2021,0,0
2179,NCT04322123,"Active, not recruiting",30/08/2020,30/08/2021,No Results Posted,"['Cavalcanti AB, Zampieri FG, Rosa RG, Azevedo LCP, Veiga VC, Avezum A, Damiani LP, Marcadenti A, Kawano-Dourado L, Lisboa T, Junqueira DLM, de Barros E Silva PGM, Tramujas L, Abreu-Silva EO, Laranjeira LN, Soares AT, Echenique LS, Pereira AJ, Freitas FGR, Gebara OCE, Dantas VCS, Furtado RHM, Milan EP, Golin NA, Cardoso FF, Maia IS, Hoffmann Filho CR, Kormann APM, Amazonas RB, Bocchi de Oliveira MF, Serpa-Neto A, Falavigna M, Lopes RD, Machado FR, Berwanger O; Coalition Covid-19 Brazil I Investigators. Hydroxychloroquine with or without Azithromycin in Mild-to-Moderate Covid-19. N Engl J Med. 2020 Nov 19;383(21):2041-2052. doi: 10.1056/NEJMoa2019014. Epub 2020 Jul 23. Erratum in: N Engl J Med. 2020 Nov 19;383(21):e119.']",,19/04/2021,https://clinicaltrials.gov/show/NCT04322123,30/08/2020,0,1
2180,NCT04344080,Completed,10/04/2021,28/04/2021,No Results Posted,,,02/07/2021,https://clinicaltrials.gov/show/NCT04344080,10/04/2021,0,0
2181,NCT04347239,Recruiting,15/06/2021,15/10/2021,No Results Posted,,,14/04/2021,https://clinicaltrials.gov/show/NCT04347239,15/06/2021,0,0
2182,NCT04358939,Completed,21/02/2021,21/02/2021,No Results Posted,"['Tavernier E, McNicholas B, Pavlov I, Roca O, Perez Y, Laffey J, Mirza S, Cosgrave D, Vines D, Frat JP, Ehrmann S, Li J. Awake prone positioning of hypoxaemic patients with COVID-19: protocol for a randomised controlled open-label superiority meta-trial. BMJ Open. 2020 Nov 11;10(11):e041520. doi: 10.1136/bmjopen-2020-041520.']",,19/04/2021,https://clinicaltrials.gov/show/NCT04358939,21/02/2021,0,1
2183,NCT04365153,Completed,02/02/2021,01/04/2021,Study Results,,,15/04/2021,https://clinicaltrials.gov/show/NCT04365153,02/02/2021,1,0
2184,NCT04377711,Completed,05/01/2021,05/01/2021,No Results Posted,"['Nicolau DV, Bafadhel M. Inhaled corticosteroids in virus pandemics: a treatment for COVID-19? Lancet Respir Med. 2020 Sep;8(9):846-847. doi: 10.1016/S2213-2600(20)30314-3. Epub 2020 Jul 30.']",,15/04/2021,https://clinicaltrials.gov/show/NCT04377711,05/01/2021,0,1
2185,NCT04392141,Completed,01/11/2020,01/11/2020,Study Results,,,20/04/2021,https://clinicaltrials.gov/show/NCT04392141,01/11/2020,1,0
2186,NCT04393311,Not yet recruiting,01/03/2022,01/03/2022,No Results Posted,,,09/07/2021,https://clinicaltrials.gov/show/NCT04393311,01/03/2022,0,0
2187,NCT04395807,Terminated,12/04/2021,12/04/2021,No Results Posted,"['Tverring J, √Ökesson A, Nielsen N. Helmet continuous positive airway pressure versus high-flow nasal cannula in COVID-19: a pragmatic randomised clinical trial (COVID HELMET). Trials. 2020 Dec 3;21(1):994. doi: 10.1186/s13063-020-04863-5.']",,15/04/2021,https://clinicaltrials.gov/show/NCT04395807,12/04/2021,0,1
2188,NCT04416308,Completed,10/07/2020,12/10/2020,No Results Posted,,,14/04/2021,https://clinicaltrials.gov/show/NCT04416308,10/07/2020,0,0
2189,NCT04433078,Withdrawn,13/04/2021,13/04/2021,No Results Posted,,,19/04/2021,https://clinicaltrials.gov/show/NCT04433078,13/04/2021,0,0
2190,NCT04459676,"Active, not recruiting",30/04/2021,30/04/2021,No Results Posted,,,15/04/2021,https://clinicaltrials.gov/show/NCT04459676,30/04/2021,0,0
2191,NCT04470258,Completed,30/08/2020,30/11/2020,No Results Posted,,,20/04/2021,https://clinicaltrials.gov/show/NCT04470258,30/08/2020,0,0
2192,NCT04476979,Recruiting,30/06/2021,31/12/2021,No Results Posted,,,19/04/2021,https://clinicaltrials.gov/show/NCT04476979,30/06/2021,0,0
2193,NCT04477655,Completed,26/01/2021,26/01/2021,No Results Posted,"['Ibarra-Estrada M√Å, Mar√≠n-Rosales M, Garc√≠a-Salcido R, Aguirre-D√≠az SA, Vargas-Obieta A, Ch√°vez-Pe√±a Q, L√≥pez-Pulgar√≠n JA, Mijangos-M√©ndez JC, Aguirre-Avalos G. Prone positioning in non-intubated patients with COVID-19 associated acute respiratory failure, the PRO-CARF trial: A structured summary of a study protocol for a randomised controlled trial. Trials. 2020 Nov 23;21(1):940. doi: 10.1186/s13063-020-04882-2.']",,13/04/2021,https://clinicaltrials.gov/show/NCT04477655,26/01/2021,0,1
2194,NCT04486508,"Active, not recruiting",04/04/2021,03/05/2021,No Results Posted,"['INSPIRATION Investigators, Sadeghipour P, Talasaz AH, Rashidi F, Sharif-Kashani B, Beigmohammadi MT, Farrokhpour M, Sezavar SH, Payandemehr P, Dabbagh A, Moghadam KG, Jamalkhani S, Khalili H, Yadollahzadeh M, Riahi T, Rezaeifar P, Tahamtan O, Matin S, Abedini A, Lookzadeh S, Rahmani H, Zoghi E, Mohammadi K, Sadeghipour P, Abri H, Tabrizi S, Mousavian SM, Shahmirzaei S, Bakhshandeh H, Amin A, Rafiee F, Baghizadeh E, Mohebbi B, Parhizgar SE, Aliannejad R, Eslami V, Kashefizadeh A, Kakavand H, Hosseini SH, Shafaghi S, Ghazi SF, Najafi A, Jimenez D, Gupta A, Madhavan MV, Sethi SS, Parikh SA, Monreal M, Hadavand N, Hajighasemi A, Maleki M, Sadeghian S, Piazza G, Kirtane AJ, Van Tassell BW, Dobesh PP, Stone GW, Lip GYH, Krumholz HM, Goldhaber SZ, Bikdeli B. Effect of Intermediate-Dose vs Standard-Dose Prophylactic Anticoagulation on Thrombotic Events, Extracorporeal Membrane Oxygenation Treatment, or Mortality Among Patients With COVID-19 Admitted to the Intensive Care Unit: The INSPIRATION Randomized Clinical Trial. JAMA. 2021 Apr 27;325(16):1620-1630. doi: 10.1001/jama.2021.4152.']","['Bikdeli B, Talasaz AH, Rashidi F, Sharif-Kashani B, Farrokhpour M, Bakhshandeh H, Sezavar H, Dabbagh A, Beigmohammadi MT, Payandemehr P, Yadollahzadeh M, Riahi T, Khalili H, Jamalkhani S, Rezaeifar P, Abedini A, Lookzadeh S, Shahmirzaei S, Tahamtan O, Matin S, Amin A, Parhizgar SE, Jimenez D, Gupta A, Madhavan MV, Parikh SA, Monreal M, Hadavand N, Hajighasemi A, Maleki M, Sadeghian S, Mohebbi B, Piazza G, Kirtane AJ, Lip GYH, Krumholz HM, Goldhaber SZ, Sadeghipour P. Intermediate versus standard-dose prophylactic anticoagulation and statin therapy versus placebo in critically-ill patients with COVID-19: Rationale and design of the INSPIRATION/INSPIRATION-S studies. Thromb Res. 2020 Dec;196:382-394. doi: 10.1016/j.thromres.2020.09.027. Epub 2020 Sep 24.']",19/04/2021,https://clinicaltrials.gov/show/NCT04486508,04/04/2021,0,1
2195,NCT04492254,Recruiting,01/07/2021,01/09/2021,No Results Posted,,,19/04/2021,https://clinicaltrials.gov/show/NCT04492254,01/07/2021,0,0
2196,NCT04500626,Recruiting,01/08/2022,01/08/2022,No Results Posted,,,19/04/2021,https://clinicaltrials.gov/show/NCT04500626,01/08/2022,0,0
2197,NCT04501796,Recruiting,01/10/2021,01/12/2021,No Results Posted,,,15/04/2021,https://clinicaltrials.gov/show/NCT04501796,01/10/2021,0,0
2198,NCT04504032,Terminated,10/03/2021,29/03/2021,No Results Posted,,,19/04/2021,https://clinicaltrials.gov/show/NCT04504032,10/03/2021,0,0
2199,NCT04509947,"Active, not recruiting",22/02/2021,08/12/2021,No Results Posted,,,14/04/2021,https://clinicaltrials.gov/show/NCT04509947,22/02/2021,0,0
2200,NCT04523181,Recruiting,30/04/2021,31/05/2021,No Results Posted,,,20/04/2021,https://clinicaltrials.gov/show/NCT04523181,30/04/2021,0,0
2201,NCT04524598,Recruiting,01/09/2021,30/09/2021,No Results Posted,,,19/04/2021,https://clinicaltrials.gov/show/NCT04524598,01/09/2021,0,0
2202,NCT04530448,Recruiting,01/12/2021,01/03/2022,No Results Posted,,,19/04/2021,https://clinicaltrials.gov/show/NCT04530448,01/12/2021,0,0
2203,NCT04549922,"Active, not recruiting",01/02/2022,01/02/2022,No Results Posted,,,19/04/2021,https://clinicaltrials.gov/show/NCT04549922,01/02/2022,0,0
2204,NCT04565665,Recruiting,30/04/2021,30/04/2021,No Results Posted,,,20/04/2021,https://clinicaltrials.gov/show/NCT04565665,30/04/2021,0,0
2205,NCT04570384,Recruiting,30/07/2021,30/10/2021,No Results Posted,,,30/06/2021,https://clinicaltrials.gov/show/NCT04570384,30/07/2021,0,0
2206,NCT04570501,Not yet recruiting,01/03/2022,01/03/2022,No Results Posted,,,09/07/2021,https://clinicaltrials.gov/show/NCT04570501,01/03/2022,0,0
2207,NCT04584684,Recruiting,01/09/2022,01/09/2023,No Results Posted,,,15/04/2021,https://clinicaltrials.gov/show/NCT04584684,01/09/2022,0,0
2208,NCT04591015,Recruiting,31/07/2021,31/08/2021,No Results Posted,,,19/04/2021,https://clinicaltrials.gov/show/NCT04591015,31/07/2021,0,0
2209,NCT04598581,Completed,09/04/2021,09/04/2021,No Results Posted,,"['Papachristofilou A, Finazzi T, Blum A, Zehnder T, Zellweger N, Lustenberger J, Bauer T, Dott C, Avcu Y, Kohler G, Zimmermann F, Pargger H, Siegemund M. Low-Dose Radiation Therapy for Severe COVID-19 Pneumonia: A Randomized Double-Blind Study. Int J Radiat Oncol Biol Phys. 2021 Mar 5. pii: S0360-3016(21)00239-X. doi: 10.1016/j.ijrobp.2021.02.054. [Epub ahead of print]']",19/04/2021,https://clinicaltrials.gov/show/NCT04598581,09/04/2021,0,1
2210,NCT04611425,Recruiting,01/05/2021,01/05/2021,No Results Posted,,,14/04/2021,https://clinicaltrials.gov/show/NCT04611425,01/05/2021,0,0
2211,NCT04622332,Recruiting,15/12/2021,15/12/2021,No Results Posted,,,14/04/2021,https://clinicaltrials.gov/show/NCT04622332,15/12/2021,0,0
2212,NCT04659304,Not yet recruiting,01/03/2022,01/06/2022,No Results Posted,,,15/04/2021,https://clinicaltrials.gov/show/NCT04659304,01/03/2022,0,0
2213,NCT04667286,Recruiting,01/06/2021,01/07/2021,No Results Posted,,,19/04/2021,https://clinicaltrials.gov/show/NCT04667286,01/06/2021,0,0
2214,NCT04678830,"Active, not recruiting",23/06/2021,23/07/2021,No Results Posted,,,14/04/2021,https://clinicaltrials.gov/show/NCT04678830,23/06/2021,0,0
2215,NCT04685655,Recruiting,31/12/2021,31/12/2022,No Results Posted,,,19/04/2021,https://clinicaltrials.gov/show/NCT04685655,31/12/2021,0,0
2216,NCT04711863,Suspended,31/05/2021,31/07/2021,No Results Posted,,,19/04/2021,https://clinicaltrials.gov/show/NCT04711863,31/05/2021,0,0
2217,NCT04737161,Withdrawn,01/09/2022,01/09/2022,No Results Posted,,,19/04/2021,https://clinicaltrials.gov/show/NCT04737161,01/09/2022,0,0
2218,NCT04743011,Not yet recruiting,30/11/2021,31/12/2021,No Results Posted,,,19/04/2021,https://clinicaltrials.gov/show/NCT04743011,30/11/2021,0,0
2219,NCT04751474,Completed,01/03/2021,31/03/2021,No Results Posted,,,20/04/2021,https://clinicaltrials.gov/show/NCT04751474,01/03/2021,0,0
2220,NCT04773665,"Active, not recruiting",01/06/2022,01/06/2022,No Results Posted,,,21/04/2021,https://clinicaltrials.gov/show/NCT04773665,01/06/2022,0,0
2221,NCT04800224,Recruiting,30/06/2021,30/07/2021,No Results Posted,,,14/04/2021,https://clinicaltrials.gov/show/NCT04800224,30/06/2021,0,0
2222,NCT04810728,Completed,04/12/2020,30/01/2021,No Results Posted,,,20/04/2021,https://clinicaltrials.gov/show/NCT04810728,04/12/2020,0,0
2223,NCT04830774,Not yet recruiting,31/12/2021,31/12/2023,No Results Posted,,,20/04/2021,https://clinicaltrials.gov/show/NCT04830774,31/12/2021,0,0
2224,NCT04834908,Recruiting,01/03/2022,01/09/2022,No Results Posted,,,01/07/2021,https://clinicaltrials.gov/show/NCT04834908,01/03/2022,0,0
2225,NCT04838795,Recruiting,31/03/2022,31/03/2022,No Results Posted,,,19/04/2021,https://clinicaltrials.gov/show/NCT04838795,31/03/2022,0,0
2226,NCT04839146,Recruiting,20/12/2021,20/12/2021,No Results Posted,,,19/04/2021,https://clinicaltrials.gov/show/NCT04839146,20/12/2021,0,0
2227,NCT04844268,Not yet recruiting,01/09/2021,01/07/2022,No Results Posted,,,19/04/2021,https://clinicaltrials.gov/show/NCT04844268,01/09/2021,0,0
2228,NCT04844346,Recruiting,31/08/2021,31/08/2021,No Results Posted,,,20/04/2021,https://clinicaltrials.gov/show/NCT04844346,31/08/2021,0,0
2229,NCT04844554,Not yet recruiting,12/04/2022,12/10/2022,No Results Posted,,,14/04/2021,https://clinicaltrials.gov/show/NCT04844554,12/04/2022,0,0
2230,NCT04844567,Recruiting,31/12/2021,31/12/2021,No Results Posted,,,14/04/2021,https://clinicaltrials.gov/show/NCT04844567,31/12/2021,0,0
2231,NCT04844658,Recruiting,01/09/2021,01/09/2021,No Results Posted,,,14/04/2021,https://clinicaltrials.gov/show/NCT04844658,01/09/2021,0,0
2232,NCT04844710,Completed,15/11/2020,20/11/2020,No Results Posted,,,14/04/2021,https://clinicaltrials.gov/show/NCT04844710,15/11/2020,0,0
2233,NCT04845880,Completed,01/03/2021,01/04/2021,No Results Posted,,,15/04/2021,https://clinicaltrials.gov/show/NCT04845880,01/03/2021,0,0
2234,NCT04845971,Recruiting,30/04/2021,30/06/2021,No Results Posted,,,19/04/2021,https://clinicaltrials.gov/show/NCT04845971,30/04/2021,0,0
2235,NCT04846790,Enrolling by invitation,01/12/2022,01/06/2023,No Results Posted,,,15/04/2021,https://clinicaltrials.gov/show/NCT04846790,01/12/2022,0,0
2236,NCT04847349,Recruiting,13/10/2021,01/10/2022,No Results Posted,,,20/04/2021,https://clinicaltrials.gov/show/NCT04847349,13/10/2021,0,0
2237,NCT04847362,Recruiting,30/05/2021,30/09/2021,No Results Posted,,,19/04/2021,https://clinicaltrials.gov/show/NCT04847362,30/05/2021,0,0
2238,NCT04847375,Not yet recruiting,20/07/2021,20/09/2021,No Results Posted,,"['Takian A, Raoofi A, Kazempour-Ardebili S. COVID-19 battle during the toughest sanctions against Iran. Lancet. 2020 Mar 28;395(10229):1035-1036. doi: 10.1016/S0140-6736(20)30668-1. Epub 2020 Mar 18. Erratum in: Lancet. 2020 Apr 18;395(10232):1258.', 'Zhang Y, Xu J, Li H, Cao B. A Novel Coronavirus (COVID-19) Outbreak: A Call for Action. Chest. 2020 Apr;157(4):e99-e101. doi: 10.1016/j.chest.2020.02.014. Epub 2020 Feb 19.', 'Yue H, Bai X, Wang J, Yu Q, Liu W, Pu J, Wang X, Hu J, Xu D, Li X, Kang N, Li L, Lu W, Feng T, Ding L, Li X, Qi X; Gansu Provincial Medical Treatment Expert Group of COVID-19. Clinical characteristics of coronavirus disease 2019 in Gansu province, China. Ann Palliat Med. 2020 Jul;9(4):1404-1412. doi: 10.21037/apm-20-887. Epub 2020 Jul 13.', 'INSPIRATION Investigators, Sadeghipour P, Talasaz AH, Rashidi F, Sharif-Kashani B, Beigmohammadi MT, Farrokhpour M, Sezavar SH, Payandemehr P, Dabbagh A, Moghadam KG, Jamalkhani S, Khalili H, Yadollahzadeh M, Riahi T, Rezaeifar P, Tahamtan O, Matin S, Abedini A, Lookzadeh S, Rahmani H, Zoghi E, Mohammadi K, Sadeghipour P, Abri H, Tabrizi S, Mousavian SM, Shahmirzaei S, Bakhshandeh H, Amin A, Rafiee F, Baghizadeh E, Mohebbi B, Parhizgar SE, Aliannejad R, Eslami V, Kashefizadeh A, Kakavand H, Hosseini SH, Shafaghi S, Ghazi SF, Najafi A, Jimenez D, Gupta A, Madhavan MV, Sethi SS, Parikh SA, Monreal M, Hadavand N, Hajighasemi A, Maleki M, Sadeghian S, Piazza G, Kirtane AJ, Van Tassell BW, Dobesh PP, Stone GW, Lip GYH, Krumholz HM, Goldhaber SZ, Bikdeli B. Effect of Intermediate-Dose vs Standard-Dose Prophylactic Anticoagulation on Thrombotic Events, Extracorporeal Membrane Oxygenation Treatment, or Mortality Among Patients With COVID-19 Admitted to the Intensive Care Unit: The INSPIRATION Randomized Clinical Trial. JAMA. 2021 Apr 27;325(16):1620-1630. doi: 10.1001/jama.2021.4152.', 'Dabbagh A, Rajaei S, Ghahremani M, Fathi M, Massoudi N, Tavana S, Fani K, Nooraee N, Malekpour Alamdari N, Besharat S, Najafi Abrandabadi A, Pirsalehi A, Khabiri Khatiri MA. The effect of surfactant on clinical outcome of patients with COVID-19 under mechanical ventilation: A structured summary of a study protocol for a randomised controlled trial. Trials. 2020 Nov 11;21(1):919. doi: 10.1186/s13063-020-04815-z.', 'Alamdari NM, Afaghi S, Rahimi FS, Tarki FE, Tavana S, Zali A, Fathi M, Besharat S, Bagheri L, Pourmotahari F, Irvani SSN, Dabbagh A, Mousavi SA. Mortality Risk Factors among Hospitalized COVID-19 Patients in a Major Referral Center in Iran. Tohoku J Exp Med. 2020 Sep;252(1):73-84. doi: 10.1620/tjem.252.73.', 'Xu Z, Shi L, Wang Y, Zhang J, Huang L, Zhang C, Liu S, Zhao P, Liu H, Zhu L, Tai Y, Bai C, Gao T, Song J, Xia P, Dong J, Zhao J, Wang FS. Pathological findings of COVID-19 associated with acute respiratory distress syndrome. Lancet Respir Med. 2020 Apr;8(4):420-422. doi: 10.1016/S2213-2600(20)30076-X. Epub 2020 Feb 18. Erratum in: Lancet Respir Med. 2020 Feb 25;:.']",19/04/2021,https://clinicaltrials.gov/show/NCT04847375,20/07/2021,0,1
2239,NCT04847518,Not yet recruiting,01/01/2022,01/03/2022,No Results Posted,,,19/04/2021,https://clinicaltrials.gov/show/NCT04847518,01/01/2022,0,0
2240,NCT04847544,Recruiting,31/12/2021,31/12/2021,No Results Posted,,,19/04/2021,https://clinicaltrials.gov/show/NCT04847544,31/12/2021,0,0
2241,NCT04847661,Recruiting,30/07/2021,30/08/2021,No Results Posted,,,19/04/2021,https://clinicaltrials.gov/show/NCT04847661,30/07/2021,0,0
2242,NCT04847791,Recruiting,31/01/2022,31/12/2022,No Results Posted,,,19/04/2021,https://clinicaltrials.gov/show/NCT04847791,31/01/2022,0,0
2243,NCT04849598,Recruiting,01/09/2021,01/09/2022,No Results Posted,,,19/04/2021,https://clinicaltrials.gov/show/NCT04849598,01/09/2021,0,0
2244,NCT04849637,Recruiting,30/06/2021,30/06/2021,No Results Posted,,,19/04/2021,https://clinicaltrials.gov/show/NCT04849637,30/06/2021,0,0
2245,NCT04849793,Recruiting,13/06/2021,13/12/2021,No Results Posted,,,19/04/2021,https://clinicaltrials.gov/show/NCT04849793,13/06/2021,0,0
2246,NCT04852055,Not yet recruiting,01/09/2021,01/12/2021,No Results Posted,,,21/04/2021,https://clinicaltrials.gov/show/NCT04852055,01/09/2021,0,0
2247,NCT04853901,Completed,01/01/2021,01/03/2021,No Results Posted,,,22/04/2021,https://clinicaltrials.gov/show/NCT04853901,01/01/2021,0,0
2248,NCT04853966,Recruiting,17/04/2022,18/04/2022,No Results Posted,,,22/04/2021,https://clinicaltrials.gov/show/NCT04853966,17/04/2022,0,0
2249,NCT04325906,Completed,26/01/2021,21/02/2021,No Results Posted,,,23/04/2021,https://clinicaltrials.gov/show/NCT04325906,26/01/2021,0,0
2250,NCT04338126,Withdrawn,15/12/2021,31/12/2021,No Results Posted,,,23/04/2021,https://clinicaltrials.gov/show/NCT04338126,15/12/2021,0,0
2251,NCT04346628,Completed,16/04/2021,16/04/2021,No Results Posted,,,20/04/2021,https://clinicaltrials.gov/show/NCT04346628,16/04/2021,0,0
2252,NCT04348500,"Active, not recruiting",31/12/2020,31/12/2021,No Results Posted,,,21/04/2021,https://clinicaltrials.gov/show/NCT04348500,31/12/2020,0,0
2253,NCT04355364,Recruiting,21/12/2021,21/04/2022,No Results Posted,"['Desilles JP, Gregoire C, Le Cossec C, Lambert J, Mophawe O, Losser MR, Lambiotte F, Le Tacon S, Cantier M, Engrand N, Trouiller P, Pottecher J. Efficacy and safety of aerosolized intra-tracheal dornase alfa administration in patients with SARS-CoV-2-induced acute respiratory distress syndrome (ARDS): a structured summary of a study protocol for a randomised controlled trial. Trials. 2020 Jun 19;21(1):548. doi: 10.1186/s13063-020-04488-8.']",,22/04/2021,https://clinicaltrials.gov/show/NCT04355364,21/12/2021,0,1
2254,NCT04358068,Terminated,08/07/2020,08/07/2020,Study Results,,,22/04/2021,https://clinicaltrials.gov/show/NCT04358068,08/07/2020,1,0
2255,NCT04362176,Recruiting,31/05/2021,31/07/2021,No Results Posted,"[""Self WH, Stewart TG, Wheeler AP, El Atrouni W, Bistran-Hall AJ, Casey JD, Cataldo VD, Chappell JD, Cohn CS, Collins JB, Denison MR, de Wit M, Dixon SL, Duggal A, Edwards TL, Fontaine MJ, Ginde AA, Harkins MS, Harrington T, Harris ES, Hoda D, Ipe TS, Jaiswal SJ, Johnson NJ, Jones AE, Laguio-Vila M, Lindsell CJ, Mallada J, Mammen MJ, Metcalf RA, Middleton EA, Mucha S, O'Neal HR Jr, Pannu SR, Pulley JM, Qiao X, Raval JS, Rhoads JP, Schrager H, Shanholtz C, Shapiro NI, Schrantz SJ, Thomsen I, Vermillion KK, Bernard GR, Rice TW; Passive Immunity Trial for Our Nation (PassITON) Investigators. Passive Immunity Trial for Our Nation (PassITON): study protocol for a randomized placebo-control clinical trial evaluating COVID-19 convalescent plasma in hospitalized adults. Trials. 2021 Mar 20;22(1):221. doi: 10.1186/s13063-021-05171-2."", ""Self WH, Stewart TG, Wheeler AP, El Atrouni W, Bistran-Hall AJ, Casey JD, Cataldo VD, Chappell JD, Cohn CS, Collins JB, Denison MR, de Wit M, Dixon SL, Duggal A, Edwards TL, Fontaine MJ, Ginde AA, Harkins MS, Harrington T, Harris ES, Hoda D, Ipe TS, Jaiswal SJ, Johnson NJ, Jones AE, Laguio-Vila M, Lindsell CJ, Mallada J, Mammen MJ, Metcalf RA, Middleton EA, Mucha S, O'Neal HR, Pannu SR, Pulley JM, Qiao X, Raval JS, Rhoads JP, Schrager H, Shanholtz C, Shapiro NI, Schrantz SJ, Thomsen I, Vermillion KK, Bernard GR, Rice TW. Passive Immunity Trial for Our Nation (PassITON): study protocol for a randomized placebo-control clinical trial evaluating COVID-19 convalescent plasma in hospitalized adults. Res Sq. 2021 Mar 2. pii: rs.3.rs-227796. doi: 10.21203/rs.3.rs-227796/v1. Update in: Trials. 2021 Mar 20;22(1):221.""]",,23/04/2021,https://clinicaltrials.gov/show/NCT04362176,31/05/2021,0,1
2256,NCT04363606,Recruiting,01/04/2022,01/12/2022,No Results Posted,,,20/04/2021,https://clinicaltrials.gov/show/NCT04363606,01/04/2022,0,0
2257,NCT04377568,Withdrawn,01/12/2021,01/05/2022,No Results Posted,,,23/04/2021,https://clinicaltrials.gov/show/NCT04377568,01/12/2021,0,0
2258,NCT04380701,Recruiting,01/04/2023,01/04/2023,No Results Posted,"['Vogel AB, Kanevsky I, Che Y, Swanson KA, Muik A, Vormehr M, Kranz LM, Walzer KC, Hein S, G√ºler A, Loschko J, Maddur MS, Ota-Setlik A, Tompkins K, Cole J, Lui BG, Ziegenhals T, Plaschke A, Eisel D, Dany SC, Fesser S, Erbar S, Bates F, Schneider D, Jesionek B, S√§nger B, Wallisch AK, Feuchter Y, Junginger H, Krumm SA, Heinen AP, Adams-Quack P, Schlereth J, Schille S, Kr√∂ner C, de la Caridad G√ºimil Garcia R, Hiller T, Fischer L, Sellers RS, Choudhary S, Gonzalez O, Vascotto F, Gutman MR, Fontenot JA, Hall-Ursone S, Brasky K, Griffor MC, Han S, Su AAH, Lees JA, Nedoma NL, Mashalidis EH, Sahasrabudhe PV, Tan CY, Pavliakova D, Singh G, Fontes-Garfias C, Pride M, Scully IL, Ciolino T, Obregon J, Gazi M, Carrion R Jr, Alfson KJ, Kalina WV, Kaushal D, Shi PY, Klamp T, Rosenbaum C, Kuhn AN, T√ºreci √ñ, Dormitzer PR, Jansen KU, Sahin U. BNT162b vaccines protect rhesus macaques from SARS-CoV-2. Nature. 2021 Apr;592(7853):283-289. doi: 10.1038/s41586-021-03275-y. Epub 2021 Feb 1.']",,22/04/2021,https://clinicaltrials.gov/show/NCT04380701,01/04/2023,0,1
2259,NCT04381923,Not yet recruiting,15/02/2022,15/05/2022,No Results Posted,,,20/04/2021,https://clinicaltrials.gov/show/NCT04381923,15/02/2022,0,0
2260,NCT04381988,Terminated,21/04/2021,21/04/2021,No Results Posted,,,26/04/2021,https://clinicaltrials.gov/show/NCT04381988,21/04/2021,0,0
2261,NCT04395599,Not yet recruiting,01/07/2022,01/07/2022,No Results Posted,,,23/04/2021,https://clinicaltrials.gov/show/NCT04395599,01/07/2022,0,0
2262,NCT04400032,Completed,22/04/2021,22/04/2021,No Results Posted,,,26/04/2021,https://clinicaltrials.gov/show/NCT04400032,22/04/2021,0,0
2263,NCT04404361,"Active, not recruiting",31/07/2021,31/10/2021,No Results Posted,,,23/04/2021,https://clinicaltrials.gov/show/NCT04404361,31/07/2021,0,0
2264,NCT04412356,"Active, not recruiting",01/06/2021,01/09/2021,No Results Posted,,,23/04/2021,https://clinicaltrials.gov/show/NCT04412356,01/06/2021,0,0
2265,NCT04428008,Recruiting,01/08/2021,01/05/2022,No Results Posted,,,23/04/2021,https://clinicaltrials.gov/show/NCT04428008,01/08/2021,0,0
2266,NCT04451291,Recruiting,25/09/2021,25/03/2022,No Results Posted,,,21/04/2021,https://clinicaltrials.gov/show/NCT04451291,25/09/2021,0,0
2267,NCT04455958,Withdrawn,01/11/2021,01/11/2021,No Results Posted,,,26/04/2021,https://clinicaltrials.gov/show/NCT04455958,01/11/2021,0,0
2268,NCT04463602,Completed,25/01/2021,31/03/2021,No Results Posted,,,23/04/2021,https://clinicaltrials.gov/show/NCT04463602,25/01/2021,0,0
2269,NCT04465513,Recruiting,31/08/2021,31/08/2021,No Results Posted,,,06/07/2021,https://clinicaltrials.gov/show/NCT04465513,31/08/2021,0,0
2270,NCT04486144,Completed,23/07/2020,23/07/2020,No Results Posted,,,22/04/2021,https://clinicaltrials.gov/show/NCT04486144,23/07/2020,0,0
2271,NCT04495933,Recruiting,09/10/2020,08/11/2021,No Results Posted,"['Chappell KJ, Mordant FL, Li Z, Wijesundara DK, Ellenberg P, Lackenby JA, Cheung STM, Modhiran N, Avumegah MS, Henderson CL, Hoger K, Griffin P, Bennet J, Hensen L, Zhang W, Nguyen THO, Marrero-Hernandez S, Selva KJ, Chung AW, Tran MH, Tapley P, Barnes J, Reading PC, Nicholson S, Corby S, Holgate T, Wines BD, Hogarth PM, Kedzierska K, Purcell DFJ, Ranasinghe C, Subbarao K, Watterson D, Young PR, Munro TP. Safety and immunogenicity of an MF59-adjuvanted spike glycoprotein-clamp vaccine for SARS-CoV-2: a randomised, double-blind, placebo-controlled, phase 1 trial. Lancet Infect Dis. 2021 Apr 19. pii: S1473-3099(21)00200-0. doi: 10.1016/S1473-3099(21)00200-0. [Epub ahead of print]']",,23/04/2021,https://clinicaltrials.gov/show/NCT04495933,09/10/2020,0,1
2272,NCT04527471,"Active, not recruiting",15/02/2021,15/05/2021,No Results Posted,,,20/04/2021,https://clinicaltrials.gov/show/NCT04527471,15/02/2021,0,0
2273,NCT04539873,Not yet recruiting,30/10/2021,15/12/2021,No Results Posted,,"['Huang C, Wang Y, Li X, Ren L, Zhao J, Hu Y, Zhang L, Fan G, Xu J, Gu X, Cheng Z, Yu T, Xia J, Wei Y, Wu W, Xie X, Yin W, Li H, Liu M, Xiao Y, Gao H, Guo L, Xie J, Wang G, Jiang R, Gao Z, Jin Q, Wang J, Cao B. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet. 2020 Feb 15;395(10223):497-506. doi: 10.1016/S0140-6736(20)30183-5. Epub 2020 Jan 24. Erratum in: Lancet. 2020 Jan 30;:.', 'Wang M, Cao R, Zhang L, Yang X, Liu J, Xu M, Shi Z, Hu Z, Zhong W, Xiao G. Remdesivir and chloroquine effectively inhibit the recently emerged novel coronavirus (2019-nCoV) in vitro. Cell Res. 2020 Mar;30(3):269-271. doi: 10.1038/s41422-020-0282-0. Epub 2020 Feb 4.', 'Montealegre-G√≥mez G, Garavito E, G√≥mez-L√≥pez A, Rojas-Villarraga A, Parra-Medina R. [Colchicine: a potential therapeutic tool against COVID-19. Experience of 5 patients]. Reumatol Clin (Engl Ed). 2020 May 16. doi: 10.1016/j.reuma.2020.05.001. [Epub ahead of print] Spanish.', 'Savarino A, Di Trani L, Donatelli I, Cauda R, Cassone A. New insights into the antiviral effects of chloroquine. Lancet Infect Dis. 2006 Feb;6(2):67-9.', 'Tay MZ, Poh CM, R√©nia L, MacAry PA, Ng LFP. The trinity of COVID-19: immunity, inflammation and intervention. Nat Rev Immunol. 2020 Jun;20(6):363-374. doi: 10.1038/s41577-020-0311-8. Epub 2020 Apr 28. Review.']",23/04/2021,https://clinicaltrials.gov/show/NCT04539873,30/10/2021,0,1
2274,NCT04542031,Recruiting,01/10/2021,01/10/2021,No Results Posted,,,22/04/2021,https://clinicaltrials.gov/show/NCT04542031,01/10/2021,0,0
2275,NCT04550338,Withdrawn,31/12/2022,31/03/2023,No Results Posted,,,23/04/2021,https://clinicaltrials.gov/show/NCT04550338,31/12/2022,0,0
2276,NCT04570488,Recruiting,30/12/2021,30/12/2021,No Results Posted,,,20/04/2021,https://clinicaltrials.gov/show/NCT04570488,30/12/2021,0,0
2277,NCT04578158,Completed,28/03/2021,15/04/2021,No Results Posted,,"['Colunga Biancatelli RML, Berrill M, Catravas JD, Marik PE. Quercetin and Vitamin C: An Experimental, Synergistic Therapy for the Prevention and Treatment of SARS-CoV-2 Related Disease (COVID-19). Front Immunol. 2020 Jun 19;11:1451. doi: 10.3389/fimmu.2020.01451. eCollection 2020. Review.', 'Abian O, Ortega-Alarcon D, Jimenez-Alesanco A, Ceballos-Laita L, Vega S, Reyburn HT, Rizzuti B, Velazquez-Campoy A. Structural stability of SARS-CoV-2 3CLpro and identification of quercetin as an inhibitor by experimental screening. Int J Biol Macromol. 2020 Dec 1;164:1693-1703. doi: 10.1016/j.ijbiomac.2020.07.235. Epub 2020 Aug 1.', 'Liu X, Raghuvanshi R, Ceylan FD, Bolling BW. Quercetin and Its Metabolites Inhibit Recombinant Human Angiotensin-Converting Enzyme 2 (ACE2) Activity. J Agric Food Chem. 2020 Nov 25;68(47):13982-13989. doi: 10.1021/acs.jafc.0c05064. Epub 2020 Nov 12.']",22/04/2021,https://clinicaltrials.gov/show/NCT04578158,28/03/2021,0,1
2278,NCT04588792,Recruiting,01/01/2022,01/03/2022,No Results Posted,,,21/04/2021,https://clinicaltrials.gov/show/NCT04588792,01/01/2022,0,0
2279,NCT04591184,Recruiting,01/08/2021,01/08/2022,No Results Posted,,,27/04/2021,https://clinicaltrials.gov/show/NCT04591184,01/08/2021,0,0
2280,NCT04608305,Recruiting,01/05/2021,01/06/2022,No Results Posted,,,27/04/2021,https://clinicaltrials.gov/show/NCT04608305,01/05/2021,0,0
2281,NCT04623671,Recruiting,30/09/2021,30/12/2021,No Results Posted,,,30/06/2021,https://clinicaltrials.gov/show/NCT04623671,30/09/2021,0,0
2282,NCT04641195,Recruiting,30/11/2021,31/03/2022,No Results Posted,,,27/04/2021,https://clinicaltrials.gov/show/NCT04641195,30/11/2021,0,0
2283,NCT04649775,Recruiting,31/07/2021,31/07/2021,No Results Posted,,,21/04/2021,https://clinicaltrials.gov/show/NCT04649775,31/07/2021,0,0
2284,NCT04651387,Not yet recruiting,01/12/2021,01/12/2021,No Results Posted,,,26/04/2021,https://clinicaltrials.gov/show/NCT04651387,01/12/2021,0,0
2285,NCT04659109,Recruiting,01/07/2021,01/07/2021,No Results Posted,,,27/04/2021,https://clinicaltrials.gov/show/NCT04659109,01/07/2021,0,0
2286,NCT04681092,Enrolling by invitation,30/06/2021,30/06/2021,No Results Posted,,,23/04/2021,https://clinicaltrials.gov/show/NCT04681092,30/06/2021,0,0
2287,NCT04681859,Recruiting,01/07/2021,01/07/2021,No Results Posted,,,27/04/2021,https://clinicaltrials.gov/show/NCT04681859,01/07/2021,0,0
2288,NCT04682197,Not yet recruiting,01/07/2022,01/07/2022,No Results Posted,,,01/07/2021,https://clinicaltrials.gov/show/NCT04682197,01/07/2022,0,0
2289,NCT04685213,Recruiting,18/08/2021,18/08/2021,No Results Posted,,,26/04/2021,https://clinicaltrials.gov/show/NCT04685213,18/08/2021,0,0
2290,NCT04723446,Recruiting,01/07/2021,01/01/2022,No Results Posted,,,23/04/2021,https://clinicaltrials.gov/show/NCT04723446,01/07/2021,0,0
2291,NCT04748536,Completed,05/04/2021,05/04/2021,No Results Posted,,,26/04/2021,https://clinicaltrials.gov/show/NCT04748536,05/04/2021,0,0
2292,NCT04748757,Recruiting,01/03/2022,01/12/2022,No Results Posted,,,27/04/2021,https://clinicaltrials.gov/show/NCT04748757,01/03/2022,0,0
2293,NCT04751643,Recruiting,01/12/2022,01/12/2022,No Results Posted,,,21/04/2021,https://clinicaltrials.gov/show/NCT04751643,01/12/2022,0,0
2294,NCT04756856,Recruiting,01/12/2021,01/12/2021,No Results Posted,,,23/04/2021,https://clinicaltrials.gov/show/NCT04756856,01/12/2021,0,0
2295,NCT04761874,Completed,29/06/2020,29/09/2020,No Results Posted,,,22/04/2021,https://clinicaltrials.gov/show/NCT04761874,29/06/2020,0,0
2296,NCT04765371,Recruiting,01/10/2021,01/10/2021,No Results Posted,,,22/04/2021,https://clinicaltrials.gov/show/NCT04765371,01/10/2021,0,0
2297,NCT04772859,"Active, not recruiting",01/07/2021,01/07/2021,No Results Posted,,,21/04/2021,https://clinicaltrials.gov/show/NCT04772859,01/07/2021,0,0
2298,NCT04780321,Recruiting,01/10/2021,30/10/2021,No Results Posted,,,22/04/2021,https://clinicaltrials.gov/show/NCT04780321,01/10/2021,0,0
2299,NCT04783311,Recruiting,01/03/2022,01/01/2023,No Results Posted,,,26/04/2021,https://clinicaltrials.gov/show/NCT04783311,01/03/2022,0,0
2300,NCT04784481,Completed,20/12/2020,18/01/2021,No Results Posted,,"['Caly L, Druce JD, Catton MG, Jans DA, Wagstaff KM. The FDA-approved drug ivermectin inhibits the replication of SARS-CoV-2 in vitro. Antiviral Res. 2020 Jun;178:104787. doi: 10.1016/j.antiviral.2020.104787. Epub 2020 Apr 3.']",26/04/2021,https://clinicaltrials.gov/show/NCT04784481,20/12/2020,0,1
2301,NCT04784767,Recruiting,30/10/2022,30/10/2023,No Results Posted,,,20/04/2021,https://clinicaltrials.gov/show/NCT04784767,30/10/2022,0,0
2302,NCT04803409,Recruiting,22/09/2021,01/10/2021,No Results Posted,,,22/04/2021,https://clinicaltrials.gov/show/NCT04803409,22/09/2021,0,0
2303,NCT04809974,Not yet recruiting,31/12/2022,31/12/2022,No Results Posted,,,26/04/2021,https://clinicaltrials.gov/show/NCT04809974,31/12/2022,0,0
2304,NCT04833101,"Active, not recruiting",15/06/2021,15/12/2021,No Results Posted,,,30/06/2021,https://clinicaltrials.gov/show/NCT04833101,15/06/2021,0,0
2305,NCT04839042,Recruiting,31/12/2021,31/12/2021,No Results Posted,,,08/07/2021,https://clinicaltrials.gov/show/NCT04839042,31/12/2021,0,0
2306,NCT04847583,Not yet recruiting,31/12/2021,31/05/2022,No Results Posted,,,22/04/2021,https://clinicaltrials.gov/show/NCT04847583,31/12/2021,0,0
2307,NCT04852705,Not yet recruiting,01/11/2021,01/11/2022,No Results Posted,,,22/04/2021,https://clinicaltrials.gov/show/NCT04852705,01/11/2021,0,0
2308,NCT04852770,Recruiting,30/09/2021,30/11/2021,No Results Posted,,"['Neufeld CB, Palma PC, Caetano KAS, Brust-Renck PG, Curtiss J, Hofmann SG. A randomized clinical trial of group and individual Cognitive-Behavioral Therapy approaches for Social Anxiety Disorder. Int J Clin Health Psychol. 2020 Jan-Apr;20(1):29-37. doi: 10.1016/j.ijchp.2019.11.004. Epub 2019 Dec 24.', 'Powell VB, Oliveira OH, Seixas C, Almeida C, Grangeon MC, Caldas M, Bonfim TD, Castro M, Galv√£o-de Almeida A, Moraes Rde O, Sudak D, de-Oliveira IR. Changing core beliefs with trial-based cognitive therapy may improve quality of life in social phobia: a randomized study. Braz J Psychiatry. 2013 Jul-Sep;35(3):243-7. doi: 10.1590/1516-4446-2012-0863. Erratum in: Rev Bras Psiquiatr. 2013 Dec;35(4):445. Galv√£o-de Almeida [corrected to Galv√£o-de Almeida, Amanda].', 'Oliveira IR. Trial-Based Thought Record (TBTR): preliminary data on a strategy to deal with core beliefs by combining sentence reversion and the use of analogy with a judicial process. Braz J Psychiatry. 2008 Mar;30(1):12-8.', 'de Oliveira IR, Powell VB, Wenzel A, Caldas M, Seixas C, Almeida C, Bonfim T, Grangeon MC, Castro M, Galv√£o A, de Oliveira Moraes R, Sudak D. Efficacy of the trial-based thought record, a new cognitive therapy strategy designed to change core beliefs, in social phobia. J Clin Pharm Ther. 2012 Jun;37(3):328-34. doi: 10.1111/j.1365-2710.2011.01299.x. Epub 2011 Sep 28.', 'Hemanny C, Carvalho C, Maia N, Reis D, Botelho AC, Bonavides D, Seixas C, de Oliveira IR. Efficacy of trial-based cognitive therapy, behavioral activation and treatment as usual in the treatment of major depressive disorder: preliminary findings from a randomized clinical trial. CNS Spectr. 2020 Aug;25(4):535-544. doi: 10.1017/S1092852919001457. Epub 2019 Nov 26.', 'de Oliveira IR, Hemmany C, Powell VB, Bonfim TD, Duran EP, Novais N, Velasquez M, Di Sarno E, Alves GL, Cesnik JA; Brazilian TBTR Study Group. Trial-based psychotherapy and the efficacy of trial-based thought record in changing unhelpful core beliefs and reducing self-criticism. CNS Spectr. 2012 Mar;17(1):16-23. doi: 10.1017/S1092852912000399.', 'Duran √âP, Corchs F, Vianna A, Ara√∫jo √ÅC, Del Real N, Silva C, Ferreira AP, De Vitto Francez P, God√≥i C, Silveira H, Matsumoto L, Gebara CM, de Barros Neto TP, Chilvarquer R, de Siqueira LL, Bernik M, Neto FL. A randomized clinical trial to assess the efficacy of trial-based cognitive therapy compared to prolonged exposure for post-traumatic stress disorder: preliminary findings. CNS Spectr. 2020 May 26:1-8. doi: 10.1017/S1092852920001455. [Epub ahead of print]', 'Seligman MEP. Positive Psychology: A Personal History. Annu Rev Clin Psychol. 2019 May 7;15:1-23. doi: 10.1146/annurev-clinpsy-050718-095653. Epub 2018 Dec 10.', 'Duckworth AL, Steen TA, Seligman ME. Positive psychology in clinical practice. Annu Rev Clin Psychol. 2005;1:629-51. Review.', 'Mongrain M, Anselmo-Matthews T. Do positive psychology exercises work? A replication of Seligman et al. (2005). J Clin Psychol. 2012 Apr;68(4):382-9. doi: 10.1002/jclp.21839.', 'Bovin MJ, Marx BP, Weathers FW, Gallagher MW, Rodriguez P, Schnurr PP, Keane TM. Psychometric properties of the PTSD Checklist for Diagnostic and Statistical Manual of Mental Disorders-Fifth Edition (PCL-5) in veterans. Psychol Assess. 2016 Nov;28(11):1379-1391. doi: 10.1037/pas0000254. Epub 2015 Dec 14.', 'Trombka M, Demarzo M, Bacas DC, Antonio SB, Cicuto K, Salvo V, Claudino FCA, Ribeiro L, Christopher M, Garcia-Campayo J, Rocha NS. Study protocol of a multicenter randomized controlled trial of mindfulness training to reduce burnout and promote quality of life in police officers: the POLICE study. BMC Psychiatry. 2018 May 25;18(1):151. doi: 10.1186/s12888-018-1726-7.', ""de Oliveira IR. Kafka's trial dilemma: proposal of a practical solution to Joseph K.'s unknown accusation. Med Hypotheses. 2011 Jul;77(1):5-6. doi: 10.1016/j.mehy.2011.03.010. Epub 2011 Mar 31."", 'de Souza CM, Hidalgo MP. World Health Organization 5-item well-being index: validation of the Brazilian Portuguese version. Eur Arch Psychiatry Clin Neurosci. 2012 Apr;262(3):239-44. doi: 10.1007/s00406-011-0255-x. Epub 2011 Sep 7.']",21/04/2021,https://clinicaltrials.gov/show/NCT04852770,30/09/2021,0,1
2309,NCT04852978,Not yet recruiting,30/07/2021,30/05/2022,No Results Posted,,,21/04/2021,https://clinicaltrials.gov/show/NCT04852978,30/07/2021,0,0
2310,NCT04853069,Not yet recruiting,28/02/2022,31/03/2022,No Results Posted,,,21/04/2021,https://clinicaltrials.gov/show/NCT04853069,28/02/2022,0,0
2311,NCT04853134,"Active, not recruiting",01/05/2021,01/05/2021,No Results Posted,,,21/04/2021,https://clinicaltrials.gov/show/NCT04853134,01/05/2021,0,0
2312,NCT04853836,Not yet recruiting,30/09/2021,31/12/2021,No Results Posted,,,06/07/2021,https://clinicaltrials.gov/show/NCT04853836,30/09/2021,0,0
2313,NCT04853927,Recruiting,30/10/2021,31/12/2021,No Results Posted,,,26/04/2021,https://clinicaltrials.gov/show/NCT04853927,30/10/2021,0,0
2314,NCT04854759,Recruiting,31/03/2022,31/05/2022,No Results Posted,,,27/04/2021,https://clinicaltrials.gov/show/NCT04854759,31/03/2022,0,0
2315,NCT04854941,Completed,10/03/2021,10/04/2021,No Results Posted,,,22/04/2021,https://clinicaltrials.gov/show/NCT04854941,10/03/2021,0,0
2316,NCT04858412,Recruiting,31/03/2022,31/03/2022,No Results Posted,,,26/04/2021,https://clinicaltrials.gov/show/NCT04858412,31/03/2022,0,0
2317,NCT04858542,Recruiting,01/05/2021,01/07/2021,No Results Posted,,,26/04/2021,https://clinicaltrials.gov/show/NCT04858542,01/05/2021,0,0
2318,NCT04858581,Not yet recruiting,01/07/2021,01/07/2021,No Results Posted,,,26/04/2021,https://clinicaltrials.gov/show/NCT04858581,01/07/2021,0,0
2319,NCT04858620,Recruiting,30/08/2021,30/08/2021,No Results Posted,,,26/04/2021,https://clinicaltrials.gov/show/NCT04858620,30/08/2021,0,0
2320,NCT04860219,Recruiting,18/09/2020,30/04/2021,No Results Posted,,,27/04/2021,https://clinicaltrials.gov/show/NCT04860219,18/09/2020,0,0
2321,NCT04860271,Recruiting,30/04/2021,31/12/2021,No Results Posted,,,26/04/2021,https://clinicaltrials.gov/show/NCT04860271,30/04/2021,0,0
2322,NCT04860284,"Active, not recruiting",09/02/2021,01/12/2021,No Results Posted,,,26/04/2021,https://clinicaltrials.gov/show/NCT04860284,09/02/2021,0,0
2323,NCT04860518,Not yet recruiting,01/11/2021,01/03/2022,No Results Posted,,,27/04/2021,https://clinicaltrials.gov/show/NCT04860518,01/11/2021,0,0
2324,NCT04319445,Completed,31/08/2020,30/03/2021,No Results Posted,,,06/05/2021,https://clinicaltrials.gov/show/NCT04319445,31/08/2020,0,0
2325,NCT04321096,Recruiting,31/01/2022,01/05/2022,No Results Posted,"['Gunst JD, Staerke NB, Pahus MH, Kristensen LH, Bodilsen J, Lohse N, Dalgaard LS, Br√∏nnum D, Fr√∂bert O, H√∏nge B, Johansen IS, Monrad I, Erikstrup C, Rosendal R, Vilstrup E, Mariager T, Bove DG, Offersen R, Shakar S, Cajander S, J√∏rgensen NP, Sritharan SS, Breining P, Jespersen S, Mortensen KL, Jensen ML, Kolte L, Frattari GS, Larsen CS, Storgaard M, Nielsen LP, Tolstrup M, S√¶dder EA, √òstergaard LJ, Ngo HTT, Jensen MH, H√∏jen JF, Kjolby M, S√∏gaard OS. Efficacy of the TMPRSS2 inhibitor camostat mesilate in patients hospitalized with Covid-19-a double-blind randomized controlled trial. EClinicalMedicine. 2021 May;35:100849. doi: 10.1016/j.eclinm.2021.100849. Epub 2021 Apr 22.']",,30/04/2021,https://clinicaltrials.gov/show/NCT04321096,31/01/2022,0,1
2326,NCT04324463,Recruiting,30/11/2021,30/04/2022,No Results Posted,,,04/05/2021,https://clinicaltrials.gov/show/NCT04324463,30/11/2021,0,0
2327,NCT04328480,Completed,25/04/2021,26/04/2021,No Results Posted,,"['Mehta P, McAuley DF, Brown M, Sanchez E, Tattersall RS, Manson JJ; HLH Across Speciality Collaboration, UK. COVID-19: consider cytokine storm syndromes and immunosuppression. Lancet. 2020 Mar 28;395(10229):1033-1034. doi: 10.1016/S0140-6736(20)30628-0. Epub 2020 Mar 16.']",27/04/2021,https://clinicaltrials.gov/show/NCT04328480,25/04/2021,0,1
2328,NCT04344041,Completed,14/01/2021,14/01/2021,No Results Posted,"['Annweiler C, Beaudenon M, Gautier J, Simon R, Dub√©e V, Gonsard J, Parot-Schinkel E; COVIT-TRIAL study group. COvid-19 and high-dose VITamin D supplementation TRIAL in high-risk older patients (COVIT-TRIAL): study protocol for a randomized controlled trial. Trials. 2020 Dec 28;21(1):1031. doi: 10.1186/s13063-020-04928-5.']",,30/04/2021,https://clinicaltrials.gov/show/NCT04344041,14/01/2021,0,1
2329,NCT04344535,Terminated,01/01/2021,01/02/2021,No Results Posted,"['Piechotta V, Iannizzi C, Chai KL, Valk SJ, Kimber C, Dorando E, Monsef I, Wood EM, Lamikanra AA, Roberts DJ, McQuilten Z, So-Osman C, Estcourt LJ, Skoetz N. Convalescent plasma or hyperimmune immunoglobulin for people with COVID-19: a living systematic review. Cochrane Database Syst Rev. 2021 May 20;5:CD013600. doi: 10.1002/14651858.CD013600.pub4.', 'Bennett-Guerrero E, Romeiser JL, Talbot LR, Ahmed T, Mamone LJ, Singh SM, Hearing JC, Salman H, Holiprosad DD, Freedenberg AT, Carter JA, Browne NJ, Cosgrove ME, Shevik ME, Generale LM, Andrew MA, Nachman S, Fries BC; Stony Brook Medicine COVID Plasma Trial Group; Stony Brook Medicine COVID Plasma Trial Group are as follows: Investigators; Principal Investigator, Critical Care; Pathology/Blood Bank; Infectious Disease; Safety Monitor; Biostatistics; Hematology; (Blood Bank; and; Pathology, Laboratory Services). Team 1 (Online Survey/In Person Scheduling); Team Leader; and; Team 2 (In Person Screening Visits); Team Leader; and; Team 3 (Patient/Recipient Screening, Plasma Administration, Data Capture); Team Leader; and; and; and; and; Team M (Antibody Testing/Randomization):; Team Leader; and; Plaque Reduction Neutralization Assay: Janet Hearing. Regulatory (Investigational New Drug [IND] and Institutional Review Board [IRB] support); (IND support); (IRB support), and; Data and Safety Monitoring Board (DSMB); and; (Chair) and; (unblinded DSMB statistician); Stony Brook Medicine COVID Plasma Trial Group and Stony Brook Medicine COVID Plasma Trial Group are as follows: Investigators and Principal Investigator, Critical Care and Pathology/Blood Bank and Infectious Disease and Safety Monitor and Biostatistics and Hematology and (Blood Bank and and and Pathology, Laboratory Services). Team 1 (Online Survey/In Person Scheduling) and Team Leader and and and Team 2 (In Person Screening Visits) and Team Leader and and and Team 3 (Patient/Recipient Screening, Plasma Administration, Data Capture) and Team Leader and and and and and and and and and Team M (Antibody Testing/Randomization): and Team Leader and and and Plaque Reduction Neutralization Assay: Janet Hearing. Regulatory (Investigational New Drug [IND] and Institutional Review Board [IRB] support) and (IND support) and (IRB support), and and Data and Safety Monitoring Board (DSMB) and and and (Chair) and and (unblinded DSMB statistician). Severe Acute Respiratory Syndrome Coronavirus 2 Convalescent Plasma Versus Standard Plasma in Coronavirus Disease 2019 Infected Hospitalized Patients in New York: A Double-Blind Randomized Trial. Crit Care Med. 2021 Jul 1;49(7):1015-1025. doi: 10.1097/CCM.0000000000005066.']",,04/05/2021,https://clinicaltrials.gov/show/NCT04344535,01/01/2021,0,1
2330,NCT04344548,Withdrawn,30/06/2020,30/10/2020,No Results Posted,,,05/05/2021,https://clinicaltrials.gov/show/NCT04344548,30/06/2020,0,0
2331,NCT04344665,"Active, not recruiting",28/10/2020,01/06/2021,No Results Posted,"[""McGillion MH, Parlow J, Borges FK, Marcucci M, Jacka M, Adili A, Lalu MM, Yang H, Patel A, O'Leary S, Tandon V, Hamilton GM, Mrkobrada M, Ouellette C, Bird M, Ofori S, Conen D, Roshanov PS, Harvey V, Guyatt GH, Le Manach Y, Bangdiwala SI, Arellano R, Scott T, Lounsbury J, Taylor DA, Nenshi R, Forster AJ, Nagappa M, Lamy A, Peter E, Levesque K, Marosi K, Chaudhry S, Haider S, Deuchar L, LeBlanc B, McCartney CJL, Schemitsch EH, Vincent J, Pettit SM, Paul J, DuMerton D, Paulin AD, Simunovic M, Williams DC, Halman S, Schlachta CM, Shelley J, Harlock J, Meyer RM, Graham M, Shanthanna H, Parry N, Pichora DR, Yousef H, Moloo H, Sehmbi H, Waggott M, Belley-Cote EP, Whitlock R, Devereaux PJ; PVC-RAM Investigators. Post Discharge after Surgery Virtual Care with Remote Automated Monitoring Technology (PVC-RAM): protocol for a randomized controlled trial. CMAJ Open. 2021 Mar 2;9(1):E142-E148. doi: 10.9778/cmajo.20200176. Print 2021 Jan-Mar. Erratum in: CMAJ Open. 2021 Jun 18;9(2):E680.""]",,30/04/2021,https://clinicaltrials.gov/show/NCT04344665,28/10/2020,0,1
2332,NCT04346329,Withdrawn,30/06/2020,30/10/2020,No Results Posted,,,05/05/2021,https://clinicaltrials.gov/show/NCT04346329,30/06/2020,0,0
2333,NCT04356690,"Active, not recruiting",01/12/2021,01/06/2022,No Results Posted,,,29/04/2021,https://clinicaltrials.gov/show/NCT04356690,01/12/2021,0,0
2334,NCT04365582,Withdrawn,31/12/2020,19/04/2021,No Results Posted,,,27/04/2021,https://clinicaltrials.gov/show/NCT04365582,31/12/2020,0,0
2335,NCT04374942,Terminated,31/03/2021,31/03/2021,No Results Posted,,,29/04/2021,https://clinicaltrials.gov/show/NCT04374942,31/03/2021,0,0
2336,NCT04376515,Not yet recruiting,01/11/2021,01/12/2021,No Results Posted,,,28/04/2021,https://clinicaltrials.gov/show/NCT04376515,01/11/2021,0,0
2337,NCT04386070,Not yet recruiting,30/05/2022,14/05/2026,No Results Posted,,,28/04/2021,https://clinicaltrials.gov/show/NCT04386070,30/05/2022,0,0
2338,NCT04400799,Recruiting,14/03/2022,14/04/2022,No Results Posted,"['Barco S, Bingisser R, Colucci G, Frenk A, Gerber B, Held U, Mach F, Mazzolai L, Righini M, Rosemann T, Sebastian T, Spescha R, Stortecky S, Windecker S, Kucher N. Enoxaparin for primary thromboprophylaxis in ambulatory patients with coronavirus disease-2019 (the OVID study): a structured summary of a study protocol for a randomized controlled trial. Trials. 2020 Sep 9;21(1):770. doi: 10.1186/s13063-020-04678-4.']",,28/06/2021,https://clinicaltrials.gov/show/NCT04400799,14/03/2022,0,1
2339,NCT04401475,Recruiting,01/04/2021,01/04/2021,No Results Posted,,,03/05/2021,https://clinicaltrials.gov/show/NCT04401475,01/04/2021,0,0
2340,NCT04406532,Withdrawn,01/01/2022,01/03/2022,No Results Posted,,,04/05/2021,https://clinicaltrials.gov/show/NCT04406532,01/01/2022,0,0
2341,NCT04421508,Terminated,28/12/2020,22/01/2021,No Results Posted,,,28/04/2021,https://clinicaltrials.gov/show/NCT04421508,28/12/2020,0,0
2342,NCT04424901,Recruiting,01/05/2021,30/05/2021,No Results Posted,,,28/04/2021,https://clinicaltrials.gov/show/NCT04424901,01/05/2021,0,0
2343,NCT04445428,"Active, not recruiting",01/09/2021,01/12/2021,No Results Posted,,,03/05/2021,https://clinicaltrials.gov/show/NCT04445428,01/09/2021,0,0
2344,NCT04449380,Terminated,30/03/2021,30/03/2021,No Results Posted,"['Bosi E, Bosi C, Rovere Querini P, Mancini N, Calori G, Ruggeri A, Canzonieri C, Callegaro L, Clementi M, De Cobelli F, Filippi M, Bregni M. Interferon Œ≤-1a (IFNŒ≤-1a) in COVID-19 patients (INTERCOP): study protocol for a randomized controlled trial. Trials. 2020 Nov 23;21(1):939. doi: 10.1186/s13063-020-04864-4.']",,03/05/2021,https://clinicaltrials.gov/show/NCT04449380,30/03/2021,0,1
2345,NCT04452318,"Active, not recruiting",25/09/2021,25/09/2021,No Results Posted,"[""O'Brien MP, Forleo-Neto E, Musser BJ, Isa F, Chan KC, Sarkar N, Bar KJ, Barnabas RV, Barouch DH, Cohen MS, Hurt CB, Burwen DR, Marovich MA, Hou P, Heirman I, Davis JD, Turner KC, Ramesh D, Mahmood A, Hooper AT, Hamilton JD, Kim Y, Purcell LA, Baum A, Kyratsous CA, Krainson J, Perez-Perez R, Mohseni R, Kowal B, DiCioccio AT, Stahl N, Lipsich L, Braunstein N, Herman G, Yancopoulos GD, Weinreich DM; Covid-19 Phase 3 Prevention Trial Team. Subcutaneous REGEN-COV Antibody Combination for Covid-19 Prevention. medRxiv. 2021 Jun 17. pii: 2021.06.14.21258567. doi: 10.1101/2021.06.14.21258567."", ""O'Brien MP, Forleo-Neto E, Sarkar N, Isa F, Hou P, Chan KC, Musser BJ, Bar KJ, Barnabas RV, Barouch DH, Cohen MS, Hurt CB, Burwen DR, Marovich MA, Heirman I, Davis JD, Turner KC, Ramesh D, Mahmood A, Hooper AT, Hamilton JD, Kim Y, Purcell LA, Baum A, Kyratsous CA, Krainson J, Perez-Perez R, Mohseni R, Kowal B, DiCioccio AT, Stahl N, Lipsich L, Braunstein N, Herman G, Yancopoulos GD, Weinreich DM; Covid-19 Phase 3 Prevention Trial Team. Subcutaneous REGEN-COV Antibody Combination in Early SARS-CoV-2 Infection. medRxiv. 2021 Jun 14. pii: 2021.06.14.21258569. doi: 10.1101/2021.06.14.21258569.""]",,04/05/2021,https://clinicaltrials.gov/show/NCT04452318,25/09/2021,0,1
2346,NCT04460027,Completed,30/11/2020,30/11/2020,No Results Posted,,,28/04/2021,https://clinicaltrials.gov/show/NCT04460027,30/11/2020,0,0
2347,NCT04462757,Terminated,31/08/2020,23/12/2020,No Results Posted,,,30/04/2021,https://clinicaltrials.gov/show/NCT04462757,31/08/2020,0,0
2348,NCT04462783,Withdrawn,01/11/2021,01/11/2021,No Results Posted,,,01/07/2021,https://clinicaltrials.gov/show/NCT04462783,01/11/2021,0,0
2349,NCT04468893,Recruiting,31/07/2021,31/07/2021,No Results Posted,"['Dominguez-Rodriguez A, De La Rosa-G√≥mez A, Hern√°ndez Jim√©nez MJ, Arenas-Landgrave P, Mart√≠nez-Luna SC, Alvarez Silva J, Garc√≠a Hern√°ndez JE, Arzola-S√°nchez C, Acosta Guzm√°n V. A Self-Administered Multicomponent Web-Based Mental Health Intervention for the Mexican Population During the COVID-19 Pandemic: Protocol for a Randomized Controlled Trial. JMIR Res Protoc. 2020 Nov 16;9(11):e23117. doi: 10.2196/23117.']","['Beck AT, Steer RA, Ranieri WF. Scale for Suicide Ideation: psychometric properties of a self-report version. J Clin Psychol. 1988 Jul;44(4):499-505.', 'Buysse DJ, Reynolds CF 3rd, Monk TH, Berman SR, Kupfer DJ. The Pittsburgh Sleep Quality Index: a new instrument for psychiatric practice and research. Psychiatry Res. 1989 May;28(2):193-213.', 'Hishinuma ES, Miyamoto RH, Nishimura ST, Nahulu LB, Andrade NN, Makini GK Jr, Yuen NY, Johnson RC, Kim SP, Goebert DA, Guerrero AP. Psychometric properties of the state-trait anxiety inventory for Asian/Pacific-islander adolescents. Assessment. 2000 Mar;7(1):17-36.', 'Walsh S, Szymczynska P, Taylor SJC, Priebe S. The acceptability of an online intervention using positive psychology for depression: A qualitative study. Internet Interv. 2018 Jul 8;13:60-66. doi: 10.1016/j.invent.2018.07.003. eCollection 2018 Sep.', 'L√∂we B, Decker O, M√ºller S, Br√§hler E, Schellberg D, Herzog W, Herzberg PY. Validation and standardization of the Generalized Anxiety Disorder Screener (GAD-7) in the general population. Med Care. 2008 Mar;46(3):266-74. doi: 10.1097/MLR.0b013e318160d093.']",27/04/2021,https://clinicaltrials.gov/show/NCT04468893,31/07/2021,0,1
2350,NCT04480424,Recruiting,01/07/2021,01/10/2021,No Results Posted,,,08/07/2021,https://clinicaltrials.gov/show/NCT04480424,01/07/2021,0,0
2351,NCT04489446,"Active, not recruiting",01/04/2021,01/08/2021,No Results Posted,,,28/04/2021,https://clinicaltrials.gov/show/NCT04489446,01/04/2021,0,0
2352,NCT04490239,Completed,18/11/2020,18/11/2020,Study Results,,,30/04/2021,https://clinicaltrials.gov/show/NCT04490239,18/11/2020,1,0
2353,NCT04495101,Completed,26/04/2021,10/06/2021,No Results Posted,,,08/07/2021,https://clinicaltrials.gov/show/NCT04495101,26/04/2021,0,0
2354,NCT04499677,Recruiting,30/11/2021,31/12/2021,No Results Posted,"['Brown LK, Freemantle N, Breuer J, Dehbi HM, Chowdhury K, Jones G, Ikeji F, Ndoutoumou A, Santhirakumar K, Longley N, Checkley AM, Standing JF, Lowe DM. Early antiviral treatment in outpatients with COVID-19 (FLARE): a structured summary of a study protocol for a randomised controlled trial. Trials. 2021 Mar 8;22(1):193. doi: 10.1186/s13063-021-05139-2.']",,30/04/2021,https://clinicaltrials.gov/show/NCT04499677,30/11/2021,0,1
2355,NCT04514900,Completed,08/03/2021,08/03/2021,No Results Posted,,,30/04/2021,https://clinicaltrials.gov/show/NCT04514900,08/03/2021,0,0
2356,NCT04517422,Completed,02/02/2021,02/02/2021,No Results Posted,,"['Bottari B, Castellone V, Neviani E. Probiotics and Covid-19. Int J Food Sci Nutr. 2021 May;72(3):293-299. doi: 10.1080/09637486.2020.1807475. Epub 2020 Aug 12. Review.', 'Klann E, Rich S, Mai V. Gut Microbiota and Coronavirus Disease 2019 (COVID-19): A Superfluous Diagnostic Biomarker or Therapeutic Target? Clin Infect Dis. 2021 Jun 15;72(12):2247-2248. doi: 10.1093/cid/ciaa1191.', ""d'Ettorre G, Ceccarelli G, Marazzato M, Campagna G, Pinacchio C, Alessandri F, Ruberto F, Rossi G, Celani L, Scagnolari C, Mastropietro C, Trinchieri V, Recchia GE, Mauro V, Antonelli G, Pugliese F, Mastroianni CM. Challenges in the Management of SARS-CoV2 Infection: The Role of Oral Bacteriotherapy as Complementary Therapeutic Strategy to Avoid the Progression of COVID-19. Front Med (Lausanne). 2020 Jul 7;7:389. doi: 10.3389/fmed.2020.00389. eCollection 2020."", 'De Maio F, Posteraro B, Ponziani FR, Cattani P, Gasbarrini A, Sanguinetti M. Nasopharyngeal Microbiota Profiling of SARS-CoV-2 Infected Patients. Biol Proced Online. 2020 Jul 25;22:18. doi: 10.1186/s12575-020-00131-7. eCollection 2020.', 'Villena J, Kitazawa H. The Modulation of Mucosal Antiviral Immunity by Immunobiotics: Could They Offer Any Benefit in the SARS-CoV-2 Pandemic? Front Physiol. 2020 Jun 16;11:699. doi: 10.3389/fphys.2020.00699. eCollection 2020. Review.', 'Marcialis MA, Bardanzellu F, Fanos V. Microbiota and Coronavirus Disease 2019. Which Came First, the Chicken or the Egg? Clin Infect Dis. 2021 Jun 15;72(12):2245-2246. doi: 10.1093/cid/ciaa965.', 'Aktas B, Aslim B. Gut-lung axis and dysbiosis in COVID-19. Turk J Biol. 2020 Jun 21;44(3):265-272. doi: 10.3906/biy-2005-102. eCollection 2020.']",06/05/2021,https://clinicaltrials.gov/show/NCT04517422,02/02/2021,0,1
2357,NCT04530357,Completed,25/11/2020,25/04/2021,No Results Posted,,,04/05/2021,https://clinicaltrials.gov/show/NCT04530357,25/11/2020,0,0
2358,NCT04539795,Recruiting,30/09/2021,30/09/2021,No Results Posted,,,29/04/2021,https://clinicaltrials.gov/show/NCT04539795,30/09/2021,0,0
2359,NCT04540120,Recruiting,01/10/2021,01/11/2021,No Results Posted,,,02/07/2021,https://clinicaltrials.gov/show/NCT04540120,01/10/2021,0,0
2360,NCT04540406,Recruiting,01/10/2021,01/11/2021,No Results Posted,,,29/04/2021,https://clinicaltrials.gov/show/NCT04540406,01/10/2021,0,0
2361,NCT04555122,Withdrawn,28/05/2022,28/07/2022,No Results Posted,,,28/04/2021,https://clinicaltrials.gov/show/NCT04555122,28/05/2022,0,0
2362,NCT04563065,Recruiting,30/11/2020,31/12/2023,No Results Posted,,,28/04/2021,https://clinicaltrials.gov/show/NCT04563065,30/11/2020,0,0
2363,NCT04581031,Recruiting,01/12/2021,01/12/2021,No Results Posted,,,30/04/2021,https://clinicaltrials.gov/show/NCT04581031,01/12/2021,0,0
2364,NCT04584541,Recruiting,01/07/2023,01/12/2023,No Results Posted,,,03/05/2021,https://clinicaltrials.gov/show/NCT04584541,01/07/2023,0,0
2365,NCT04588441,Not yet recruiting,01/12/2022,01/12/2022,No Results Posted,,,29/04/2021,https://clinicaltrials.gov/show/NCT04588441,01/12/2022,0,0
2366,NCT04588480,"Active, not recruiting",30/11/2021,30/11/2021,No Results Posted,,,30/04/2021,https://clinicaltrials.gov/show/NCT04588480,30/11/2021,0,0
2367,NCT04590365,Recruiting,01/11/2021,01/12/2021,No Results Posted,,,28/04/2021,https://clinicaltrials.gov/show/NCT04590365,01/11/2021,0,0
2368,NCT04608097,Completed,12/03/2021,12/03/2021,No Results Posted,,"['James EL, Lau-Zhu A, Clark IA, Visser RM, Hagenaars MA, Holmes EA. The trauma film paradigm as an experimental psychopathology model of psychological trauma: intrusive memories and beyond. Clin Psychol Rev. 2016 Jul;47:106-42. doi: 10.1016/j.cpr.2016.04.010. Epub 2016 Apr 21. Review.']",30/04/2021,https://clinicaltrials.gov/show/NCT04608097,12/03/2021,0,1
2369,NCT04612972,"Active, not recruiting",19/02/2021,19/12/2021,No Results Posted,,,30/04/2021,https://clinicaltrials.gov/show/NCT04612972,19/02/2021,0,0
2370,NCT04613986,Not yet recruiting,01/12/2021,01/07/2022,No Results Posted,,,29/04/2021,https://clinicaltrials.gov/show/NCT04613986,01/12/2021,0,0
2371,NCT04615741,Completed,22/01/2021,20/04/2021,No Results Posted,,,29/04/2021,https://clinicaltrials.gov/show/NCT04615741,22/01/2021,0,0
2372,NCT04636086,Recruiting,31/01/2022,28/02/2022,No Results Posted,,,28/04/2021,https://clinicaltrials.gov/show/NCT04636086,31/01/2022,0,0
2373,NCT04636671,Recruiting,01/08/2021,01/10/2021,No Results Posted,,,05/05/2021,https://clinicaltrials.gov/show/NCT04636671,01/08/2021,0,0
2374,NCT04647305,Completed,04/03/2021,04/03/2021,No Results Posted,,,27/04/2021,https://clinicaltrials.gov/show/NCT04647305,04/03/2021,0,0
2375,NCT04652518,Recruiting,01/08/2021,01/12/2021,No Results Posted,,,29/04/2021,https://clinicaltrials.gov/show/NCT04652518,01/08/2021,0,0
2376,NCT04656691,Completed,18/04/2021,18/04/2021,No Results Posted,,,29/04/2021,https://clinicaltrials.gov/show/NCT04656691,18/04/2021,0,0
2377,NCT04659928,Not yet recruiting,01/12/2022,01/12/2022,No Results Posted,,,30/04/2021,https://clinicaltrials.gov/show/NCT04659928,01/12/2022,0,0
2378,NCT04665193,Completed,28/02/2021,28/04/2021,No Results Posted,,,04/05/2021,https://clinicaltrials.gov/show/NCT04665193,28/02/2021,0,0
2379,NCT04668222,Not yet recruiting,30/11/2022,30/11/2022,No Results Posted,,"[""Sohrabi C, Alsafi Z, O'Neill N, Khan M, Kerwan A, Al-Jabir A, Iosifidis C, Agha R. World Health Organization declares global emergency: A review of the 2019 novel coronavirus (COVID-19). Int J Surg. 2020 Apr;76:71-76. doi: 10.1016/j.ijsu.2020.02.034. Epub 2020 Feb 26. Review. Erratum in: Int J Surg. 2020 May;77:217."", 'Mahase E. Coronavirus covid-19 has killed more people than SARS and MERS combined, despite lower case fatality rate. BMJ. 2020 Feb 18;368:m641. doi: 10.1136/bmj.m641.', 'Guan WJ, Ni ZY, Hu Y, Liang WH, Ou CQ, He JX, Liu L, Shan H, Lei CL, Hui DSC, Du B, Li LJ, Zeng G, Yuen KY, Chen RC, Tang CL, Wang T, Chen PY, Xiang J, Li SY, Wang JL, Liang ZJ, Peng YX, Wei L, Liu Y, Hu YH, Peng P, Wang JM, Liu JY, Chen Z, Li G, Zheng ZJ, Qiu SQ, Luo J, Ye CJ, Zhu SY, Zhong NS; China Medical Treatment Expert Group for Covid-19. Clinical Characteristics of Coronavirus Disease 2019 in China. N Engl J Med. 2020 Apr 30;382(18):1708-1720. doi: 10.1056/NEJMoa2002032. Epub 2020 Feb 28.', 'Huang C, Wang Y, Li X, Ren L, Zhao J, Hu Y, Zhang L, Fan G, Xu J, Gu X, Cheng Z, Yu T, Xia J, Wei Y, Wu W, Xie X, Yin W, Li H, Liu M, Xiao Y, Gao H, Guo L, Xie J, Wang G, Jiang R, Gao Z, Jin Q, Wang J, Cao B. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet. 2020 Feb 15;395(10223):497-506. doi: 10.1016/S0140-6736(20)30183-5. Epub 2020 Jan 24. Erratum in: Lancet. 2020 Jan 30;:.']",28/04/2021,https://clinicaltrials.gov/show/NCT04668222,30/11/2022,0,1
2380,NCT04673318,Recruiting,01/12/2024,01/12/2024,No Results Posted,,,28/04/2021,https://clinicaltrials.gov/show/NCT04673318,01/12/2024,0,0
2381,NCT04678778,Completed,19/02/2021,19/02/2021,No Results Posted,,,29/04/2021,https://clinicaltrials.gov/show/NCT04678778,19/02/2021,0,0
2382,NCT04685681,Completed,06/04/2021,06/04/2021,No Results Posted,,,04/05/2021,https://clinicaltrials.gov/show/NCT04685681,06/04/2021,0,0
2383,NCT04688502,Not yet recruiting,28/09/2021,15/10/2021,No Results Posted,,,06/05/2021,https://clinicaltrials.gov/show/NCT04688502,28/09/2021,0,0
2384,NCT04691908,"Active, not recruiting",20/07/2021,30/07/2021,No Results Posted,,,04/05/2021,https://clinicaltrials.gov/show/NCT04691908,20/07/2021,0,0
2385,NCT04697654,Recruiting,31/12/2021,31/12/2021,No Results Posted,,,30/04/2021,https://clinicaltrials.gov/show/NCT04697654,31/12/2021,0,0
2386,NCT04700137,Enrolling by invitation,17/01/2022,17/01/2022,No Results Posted,,,03/05/2021,https://clinicaltrials.gov/show/NCT04700137,17/01/2022,0,0
2387,NCT04703114,"Active, not recruiting",18/08/2021,18/08/2021,No Results Posted,,,07/07/2021,https://clinicaltrials.gov/show/NCT04703114,18/08/2021,0,0
2388,NCT04715438,Recruiting,01/07/2021,01/04/2023,No Results Posted,,,28/04/2021,https://clinicaltrials.gov/show/NCT04715438,01/07/2021,0,0
2389,NCT04732819,Completed,30/03/2021,16/04/2021,No Results Posted,,,03/05/2021,https://clinicaltrials.gov/show/NCT04732819,30/03/2021,0,0
2390,NCT04748588,Recruiting,31/01/2023,31/03/2023,No Results Posted,,,03/05/2021,https://clinicaltrials.gov/show/NCT04748588,31/01/2023,0,0
2391,NCT04750278,Recruiting,01/02/2022,01/02/2022,No Results Posted,,,03/05/2021,https://clinicaltrials.gov/show/NCT04750278,01/02/2022,0,0
2392,NCT04767477,Recruiting,01/06/2021,01/08/2021,No Results Posted,,,30/04/2021,https://clinicaltrials.gov/show/NCT04767477,01/06/2021,0,0
2393,NCT04790786,Recruiting,01/02/2022,01/12/2022,No Results Posted,"['Huang DT, McCreary EK, Bariola JR, Wadas RJ, Kip KE, Marroquin OC, Koscumb S, Collins K, Shovel JA, Schmidhofer M, Wisniewski MK, Sullivan C, Yealy DM, Axe M, Nace DA, Haidar G, Khadem T, Linstrum K, Snyder GM, Seymour CW, Montgomery SK, McVerry BJ, Berry L, Berry S, Meyers R, Weissman A, Peck-Palmer OM, Wells A, Bart R, Albin DL, Minnier T, Angus DC. The UPMC OPTIMISE-C19 (OPtimizing Treatment and Impact of Monoclonal antIbodieS through Evaluation for COVID-19) trial: a structured summary of a study protocol for an open-label, pragmatic, comparative effectiveness platform trial with response-adaptive randomization. Trials. 2021 May 25;22(1):363. doi: 10.1186/s13063-021-05316-3.']",,05/05/2021,https://clinicaltrials.gov/show/NCT04790786,01/02/2022,0,1
2394,NCT04809389,Recruiting,01/09/2022,01/09/2022,No Results Posted,,,03/05/2021,https://clinicaltrials.gov/show/NCT04809389,01/09/2022,0,0
2395,NCT04817319,Not yet recruiting,15/05/2021,15/05/2022,No Results Posted,,,03/05/2021,https://clinicaltrials.gov/show/NCT04817319,15/05/2021,0,0
2396,NCT04824365,Recruiting,01/05/2022,01/06/2022,No Results Posted,,,29/04/2021,https://clinicaltrials.gov/show/NCT04824365,01/05/2022,0,0
2397,NCT04841746,Not yet recruiting,16/09/2022,16/09/2022,No Results Posted,,,28/04/2021,https://clinicaltrials.gov/show/NCT04841746,16/09/2022,0,0
2398,NCT04842721,Not yet recruiting,01/10/2021,01/12/2021,No Results Posted,,,06/05/2021,https://clinicaltrials.gov/show/NCT04842721,01/10/2021,0,0
2399,NCT04843787,Not yet recruiting,01/10/2021,01/10/2021,No Results Posted,,,04/05/2021,https://clinicaltrials.gov/show/NCT04843787,01/10/2021,0,0
2400,NCT04844580,Recruiting,01/09/2022,01/12/2022,No Results Posted,,,27/04/2021,https://clinicaltrials.gov/show/NCT04844580,01/09/2022,0,0
2401,NCT04854486,Recruiting,16/05/2021,16/11/2021,No Results Posted,,,28/04/2021,https://clinicaltrials.gov/show/NCT04854486,16/05/2021,0,0
2402,NCT04854928,Recruiting,01/05/2021,01/06/2021,No Results Posted,,,28/04/2021,https://clinicaltrials.gov/show/NCT04854928,01/05/2021,0,0
2403,NCT04856111,Recruiting,31/12/2021,31/12/2021,No Results Posted,,,28/04/2021,https://clinicaltrials.gov/show/NCT04856111,31/12/2021,0,0
2404,NCT04857060,Not yet recruiting,01/01/2023,01/04/2024,No Results Posted,,,03/05/2021,https://clinicaltrials.gov/show/NCT04857060,01/01/2023,0,0
2405,NCT04859244,"Active, not recruiting",01/05/2021,01/05/2021,No Results Posted,,,29/04/2021,https://clinicaltrials.gov/show/NCT04859244,01/05/2021,0,0
2406,NCT04860297,Recruiting,26/08/2021,26/08/2022,No Results Posted,,,29/04/2021,https://clinicaltrials.gov/show/NCT04860297,26/08/2021,0,0
2407,NCT04860739,"Active, not recruiting",20/05/2021,30/04/2022,No Results Posted,"['Borobia AM, Carcas AJ, P√©rez-Olmeda M, Casta√±o L, Bertran MJ, Garc√≠a-P√©rez J, Campins M, Portol√©s A, Gonz√°lez-P√©rez M, Garc√≠a Morales MT, Arana-Arri E, Aldea M, D√≠ez-Fuertes F, Fuentes I, Ascaso A, Lora D, Imaz-Ayo N, Bar√≥n-Mira LE, Agust√≠ A, P√©rez-Ingidua C, G√≥mez de la C√°mara A, Arribas JR, Ochando J, Alcam√≠ J, Belda-Iniesta C, Fr√≠as J; CombiVacS Study Group. Immunogenicity and reactogenicity of BNT162b2 booster in ChAdOx1-S-primed participants (CombiVacS): a multicentre, open-label, randomised, controlled, phase 2 trial. Lancet. 2021 Jun 25. pii: S0140-6736(21)01420-3. doi: 10.1016/S0140-6736(21)01420-3. [Epub ahead of print]']",,04/05/2021,https://clinicaltrials.gov/show/NCT04860739,20/05/2021,0,1
2408,NCT04860895,Recruiting,01/05/2021,15/05/2021,No Results Posted,,,06/05/2021,https://clinicaltrials.gov/show/NCT04860895,01/05/2021,0,0
2409,NCT04861298,Recruiting,10/07/2021,10/08/2021,No Results Posted,,,29/04/2021,https://clinicaltrials.gov/show/NCT04861298,10/07/2021,0,0
2410,NCT04862806,Recruiting,01/09/2021,01/03/2022,No Results Posted,,,29/04/2021,https://clinicaltrials.gov/show/NCT04862806,01/09/2021,0,0
2411,NCT04863131,Recruiting,31/01/2023,31/01/2023,No Results Posted,,,30/04/2021,https://clinicaltrials.gov/show/NCT04863131,31/01/2023,0,0
2412,NCT04864015,"Active, not recruiting",15/05/2021,30/06/2021,No Results Posted,,,03/05/2021,https://clinicaltrials.gov/show/NCT04864015,15/05/2021,0,0
2413,NCT04864899,Recruiting,30/03/2023,31/12/2023,No Results Posted,,,29/04/2021,https://clinicaltrials.gov/show/NCT04864899,30/03/2023,0,0
2414,NCT04864925,"Active, not recruiting",31/05/2021,31/05/2021,No Results Posted,,,29/04/2021,https://clinicaltrials.gov/show/NCT04864925,31/05/2021,0,0
2415,NCT04865029,Not yet recruiting,01/05/2022,01/05/2022,No Results Posted,,,04/05/2021,https://clinicaltrials.gov/show/NCT04865029,01/05/2022,0,0
2416,NCT04865237,Enrolling by invitation,03/06/2022,03/06/2022,No Results Posted,,,29/04/2021,https://clinicaltrials.gov/show/NCT04865237,03/06/2022,0,0
2417,NCT04866303,Recruiting,01/08/2021,01/10/2021,No Results Posted,,,05/05/2021,https://clinicaltrials.gov/show/NCT04866303,01/08/2021,0,0
2418,NCT04868890,Recruiting,01/10/2021,01/12/2021,No Results Posted,,,03/05/2021,https://clinicaltrials.gov/show/NCT04868890,01/10/2021,0,0
2419,NCT04868903,Recruiting,30/06/2022,30/12/2022,No Results Posted,,,03/05/2021,https://clinicaltrials.gov/show/NCT04868903,30/06/2022,0,0
2420,NCT04869072,Completed,30/11/2020,30/03/2021,No Results Posted,,,03/05/2021,https://clinicaltrials.gov/show/NCT04869072,30/11/2020,0,0
2421,NCT04869579,Not yet recruiting,01/09/2021,01/10/2021,No Results Posted,,,05/05/2021,https://clinicaltrials.gov/show/NCT04869579,01/09/2021,0,0
2422,NCT04870307,Recruiting,01/09/2023,01/09/2023,No Results Posted,,,03/05/2021,https://clinicaltrials.gov/show/NCT04870307,01/09/2023,0,0
2423,NCT04870333,Recruiting,01/12/2021,01/03/2022,No Results Posted,,,03/05/2021,https://clinicaltrials.gov/show/NCT04870333,01/12/2021,0,0
2424,NCT04870723,Recruiting,31/08/2021,31/12/2021,No Results Posted,,,03/05/2021,https://clinicaltrials.gov/show/NCT04870723,31/08/2021,0,0
2425,NCT04870775,Recruiting,01/11/2021,01/11/2022,No Results Posted,,,03/05/2021,https://clinicaltrials.gov/show/NCT04870775,01/11/2021,0,0
2426,NCT04871633,Completed,15/11/2020,30/12/2020,No Results Posted,,,04/05/2021,https://clinicaltrials.gov/show/NCT04871633,15/11/2020,0,0
2427,NCT04871776,Not yet recruiting,01/11/2021,01/06/2022,No Results Posted,,,04/05/2021,https://clinicaltrials.gov/show/NCT04871776,01/11/2021,0,0
2428,NCT04871802,Not yet recruiting,01/09/2021,01/10/2021,No Results Posted,,,04/05/2021,https://clinicaltrials.gov/show/NCT04871802,01/09/2021,0,0
2429,NCT04871815,Recruiting,01/05/2022,01/06/2022,No Results Posted,,,04/05/2021,https://clinicaltrials.gov/show/NCT04871815,01/05/2022,0,0
2430,NCT04871893,Not yet recruiting,01/07/2022,31/12/2022,No Results Posted,,,04/05/2021,https://clinicaltrials.gov/show/NCT04871893,01/07/2022,0,0
2431,NCT04871958,Enrolling by invitation,31/08/2021,30/09/2021,No Results Posted,,,04/05/2021,https://clinicaltrials.gov/show/NCT04871958,31/08/2021,0,0
2432,NCT04872712,Not yet recruiting,07/04/2022,07/04/2022,No Results Posted,,,04/05/2021,https://clinicaltrials.gov/show/NCT04872712,07/04/2022,0,0
2433,NCT04303507,Recruiting,01/12/2021,01/12/2021,No Results Posted,"['Akhtar S, Das JK, Ismail T, Wahid M, Saeed W, Bhutta ZA. Nutritional perspectives for the prevention and mitigation of COVID-19. Nutr Rev. 2021 Feb 11;79(3):289-300. doi: 10.1093/nutrit/nuaa063.']",,11/05/2021,https://clinicaltrials.gov/show/NCT04303507,01/12/2021,0,1
2434,NCT04328441,"Active, not recruiting",31/03/2021,30/05/2021,No Results Posted,"['Ten Doesschate T, Moorlag SJCFM, van der Vaart TW, Taks E, Debisarun P, Ten Oever J, Bleeker-Rovers CP, Verhagen PB, Lalmohamed A, Ter Heine R, van Crevel R, van de Wijgert J, Janssen AB, Bonten MJ, van Werkhoven CH, Netea MG; BCG-CORONA study team#. Two Randomized Controlled Trials of Bacillus Calmette-Gu√©rin Vaccination to reduce absenteeism among health care workers and hospital admission by elderly persons during the COVID-19 pandemic: A structured summary of the study protocols for two randomised controlled trials. Trials. 2020 Jun 5;21(1):481. doi: 10.1186/s13063-020-04389-w. Erratum in: Trials. 2020 Jun 22;21(1):555.']",,11/05/2021,https://clinicaltrials.gov/show/NCT04328441,31/03/2021,0,1
2435,NCT04332094,Recruiting,01/06/2021,01/07/2021,No Results Posted,,,06/05/2021,https://clinicaltrials.gov/show/NCT04332094,01/06/2021,0,0
2436,NCT04335123,Completed,21/06/2020,17/08/2020,No Results Posted,"['Smolander J, Bruchfeld A. [COVID-19 and kidney disease]. Lakartidningen. 2020 Jul 13;117. pii: 20110. Swedish.']",,10/05/2021,https://clinicaltrials.gov/show/NCT04335123,21/06/2020,0,1
2437,NCT04344015,Completed,02/06/2020,02/06/2020,No Results Posted,,,10/05/2021,https://clinicaltrials.gov/show/NCT04344015,02/06/2020,0,0
2438,NCT04344236,Withdrawn,01/05/2020,09/05/2020,No Results Posted,,,10/05/2021,https://clinicaltrials.gov/show/NCT04344236,01/05/2020,0,0
2439,NCT04354259,Recruiting,15/09/2021,15/10/2021,No Results Posted,"[""Feld JJ, Kandel C, Biondi MJ, Kozak RA, Zahoor MA, Lemieux C, Borgia SM, Boggild AK, Powis J, McCready J, Tan DHS, Chan T, Coburn B, Kumar D, Humar A, Chan A, O'Neil B, Noureldin S, Booth J, Hong R, Smookler D, Aleyadeh W, Patel A, Barber B, Casey J, Hiebert R, Mistry H, Choong I, Hislop C, Santer DM, Lorne Tyrrell D, Glenn JS, Gehring AJ, Janssen HLA, Hansen BE. Peginterferon lambda for the treatment of outpatients with COVID-19: a phase 2, placebo-controlled randomised trial. Lancet Respir Med. 2021 May;9(5):498-510. doi: 10.1016/S2213-2600(20)30566-X. Epub 2021 Feb 5."", 'Lee JS, Shin EC. The type I interferon response in COVID-19: implications for treatment. Nat Rev Immunol. 2020 Oct;20(10):585-586. doi: 10.1038/s41577-020-00429-3.', 'Moschen AR. IBD in the time of corona - vigilance for immune-mediated diseases. Nat Rev Gastroenterol Hepatol. 2020 Sep;17(9):529-530. doi: 10.1038/s41575-020-0333-5. Review.']",,10/05/2021,https://clinicaltrials.gov/show/NCT04354259,15/09/2021,0,1
2440,NCT04355767,Completed,29/03/2021,29/03/2021,No Results Posted,,,12/05/2021,https://clinicaltrials.gov/show/NCT04355767,29/03/2021,0,0
2441,NCT04357730,"Active, not recruiting",21/03/2021,01/11/2021,No Results Posted,"['Moore HB, Barrett CD, Moore EE, Jhunjhnuwala R, McIntyre RC, Moore PK, Wang J, Hajizadeh N, Talmor DS, Sauaia A, Yaffe MB. STudy of Alteplase for Respiratory failure in SARS-Cov2/COVID-19: Study Design of the Phase IIa STARS Trial. Res Pract Thromb Haemost. 2020 May 21. doi: 10.1002/rth2.12395. [Epub ahead of print]']",,10/05/2021,https://clinicaltrials.gov/show/NCT04357730,21/03/2021,0,1
2442,NCT04366791,Suspended,16/03/2022,16/03/2022,No Results Posted,,,10/05/2021,https://clinicaltrials.gov/show/NCT04366791,16/03/2022,0,0
2443,NCT04372589,"Active, not recruiting",01/05/2021,01/05/2021,No Results Posted,"['Flumignan RL, Tin√¥co JDS, Pascoal PI, Areias LL, Cossi MS, Fernandes MI, Costa IK, Souza L, Matar CF, Tendal B, Trevisani VF, Atallah √ÅN, Nakano LC. Prophylactic anticoagulants for people hospitalised with COVID-19. Cochrane Database Syst Rev. 2020 Oct 2;10:CD013739. doi: 10.1002/14651858.CD013739.', 'Houston BL, Lawler PR, Goligher EC, Farkouh ME, Bradbury C, Carrier M, Dzavik V, Fergusson DA, Fowler RA, Galanaud JP, Gross PL, McDonald EG, Husain M, Kahn SR, Kumar A, Marshall J, Murthy S, Slutsky AS, Turgeon AF, Berry SM, Rosenson RS, Escobedo J, Nicolau JC, Bond L, Kirwan BA, de Brouwer S, Zarychanski R. Anti-Thrombotic Therapy to Ameliorate Complications of COVID-19 (ATTACC): Study design and methodology for an international, adaptive Bayesian randomized controlled trial. Clin Trials. 2020 Oct;17(5):491-500. doi: 10.1177/1740774520943846. Epub 2020 Aug 20.', 'Levi M, Thachil J, Iba T, Levy JH. Coagulation abnormalities and thrombosis in patients with COVID-19. Lancet Haematol. 2020 Jun;7(6):e438-e440. doi: 10.1016/S2352-3026(20)30145-9. Epub 2020 May 11.']",,04/05/2021,https://clinicaltrials.gov/show/NCT04372589,01/05/2021,0,1
2444,NCT04372628,Recruiting,01/04/2022,01/06/2022,No Results Posted,,,04/05/2021,https://clinicaltrials.gov/show/NCT04372628,01/04/2022,0,0
2445,NCT04377672,"Active, not recruiting",28/06/2021,28/06/2022,No Results Posted,,,10/05/2021,https://clinicaltrials.gov/show/NCT04377672,28/06/2021,0,0
2446,NCT04379518,Recruiting,04/09/2021,06/04/2022,No Results Posted,,,10/05/2021,https://clinicaltrials.gov/show/NCT04379518,04/09/2021,0,0
2447,NCT04380909,"Active, not recruiting",01/07/2021,01/07/2021,No Results Posted,"['Brog NA, Hegy JK, Berger T, Znoj H. An internet-based self-help intervention for people with psychological distress due to COVID-19: study protocol for a randomized controlled trial. Trials. 2021 Mar 1;22(1):171. doi: 10.1186/s13063-021-05089-9.']",,05/05/2021,https://clinicaltrials.gov/show/NCT04380909,01/07/2021,0,1
2448,NCT04381364,Recruiting,01/12/2021,01/05/2022,No Results Posted,,,10/05/2021,https://clinicaltrials.gov/show/NCT04381364,01/12/2021,0,0
2449,NCT04381962,Completed,29/01/2021,20/04/2021,No Results Posted,,,06/05/2021,https://clinicaltrials.gov/show/NCT04381962,29/01/2021,0,0
2450,NCT04385264,Suspended,01/08/2022,01/12/2022,No Results Posted,,,11/05/2021,https://clinicaltrials.gov/show/NCT04385264,01/08/2022,0,0
2451,NCT04387955,Recruiting,30/06/2021,30/06/2021,No Results Posted,,,10/05/2021,https://clinicaltrials.gov/show/NCT04387955,30/06/2021,0,0
2452,NCT04402957,"Active, not recruiting",31/05/2021,30/06/2021,No Results Posted,,,06/05/2021,https://clinicaltrials.gov/show/NCT04402957,31/05/2021,0,0
2453,NCT04405076,"Active, not recruiting",01/11/2021,01/11/2021,No Results Posted,"['Chu L, McPhee R, Huang W, Bennett H, Pajon R, Nestorova B, Leav B; mRNA-1273 Study Group. A preliminary report of a randomized controlled phase 2 trial of the safety and immunogenicity of mRNA-1273 SARS-CoV-2 vaccine. Vaccine. 2021 May 12;39(20):2791-2799. doi: 10.1016/j.vaccine.2021.02.007. Epub 2021 Feb 9.']",,05/05/2021,https://clinicaltrials.gov/show/NCT04405076,01/11/2021,0,1
2454,NCT04409743,"Active, not recruiting",01/10/2021,01/04/2022,No Results Posted,,,11/05/2021,https://clinicaltrials.gov/show/NCT04409743,01/10/2021,0,0
2455,NCT04409873,Recruiting,30/09/2021,30/09/2021,No Results Posted,,,06/05/2021,https://clinicaltrials.gov/show/NCT04409873,30/09/2021,0,0
2456,NCT04412785,"Active, not recruiting",01/10/2021,01/12/2021,No Results Posted,,,06/05/2021,https://clinicaltrials.gov/show/NCT04412785,01/10/2021,0,0
2457,NCT04420364,Withdrawn,04/05/2021,04/05/2021,No Results Posted,,,06/05/2021,https://clinicaltrials.gov/show/NCT04420364,04/05/2021,0,0
2458,NCT04421404,Completed,30/04/2021,30/04/2021,Results Submitted,,,05/05/2021,https://clinicaltrials.gov/show/NCT04421404,30/04/2021,0,0
2459,NCT04421612,Completed,01/01/2021,01/01/2021,No Results Posted,,,06/05/2021,https://clinicaltrials.gov/show/NCT04421612,01/01/2021,0,0
2460,NCT04421625,Recruiting,15/06/2022,15/06/2022,No Results Posted,,,05/05/2021,https://clinicaltrials.gov/show/NCT04421625,15/06/2022,0,0
2461,NCT04422509,Completed,25/02/2021,30/04/2021,No Results Posted,,,05/05/2021,https://clinicaltrials.gov/show/NCT04422509,25/02/2021,0,0
2462,NCT04432272,Completed,13/11/2020,28/11/2020,No Results Posted,,,06/05/2021,https://clinicaltrials.gov/show/NCT04432272,13/11/2020,0,0
2463,NCT04453852,Completed,01/02/2021,14/04/2021,No Results Posted,,,06/05/2021,https://clinicaltrials.gov/show/NCT04453852,01/02/2021,0,0
2464,NCT04485130,Recruiting,31/12/2021,30/04/2022,No Results Posted,,"['Lee SA, Elliott JH, McMahon J, Hartogenesis W, Bumpus NN, Lifson JD, Gorelick RJ, Bacchetti P, Deeks SG, Lewin SR, Savic RM. Population Pharmacokinetics and Pharmacodynamics of Disulfiram on Inducing Latent HIV-1 Transcription in a Phase IIb Trial. Clin Pharmacol Ther. 2019 Mar;105(3):692-702. doi: 10.1002/cpt.1220. Epub 2018 Oct 9.', 'Elliott JH, McMahon JH, Chang CC, Lee SA, Hartogensis W, Bumpus N, Savic R, Roney J, Hoh R, Solomon A, Piatak M, Gorelick RJ, Lifson J, Bacchetti P, Deeks SG, Lewin SR. Short-term administration of disulfiram for reversal of latent HIV infection: a phase 2 dose-escalation study. Lancet HIV. 2015 Dec;2(12):e520-9. doi: 10.1016/S2352-3018(15)00226-X. Epub 2015 Nov 17.', 'Jin Z, Du X, Xu Y, Deng Y, Liu M, Zhao Y, Zhang B, Li X, Zhang L, Peng C, Duan Y, Yu J, Wang L, Yang K, Liu F, Jiang R, Yang X, You T, Liu X, Yang X, Bai F, Liu H, Liu X, Guddat LW, Xu W, Xiao G, Qin C, Shi Z, Jiang H, Rao Z, Yang H. Structure of M(pro) from SARS-CoV-2 and discovery of its inhibitors. Nature. 2020 Jun;582(7811):289-293. doi: 10.1038/s41586-020-2223-y. Epub 2020 Apr 9.', 'Lin MH, Moses DC, Hsieh CH, Cheng SC, Chen YH, Sun CY, Chou CY. Disulfiram can inhibit MERS and SARS coronavirus papain-like proteases via different modes. Antiviral Res. 2018 Feb;150:155-163. doi: 10.1016/j.antiviral.2017.12.015. Epub 2017 Dec 28.', 'Hu JJ, Liu X, Xia S, Zhang Z, Zhang Y, Zhao J, Ruan J, Luo X, Lou X, Bai Y, Wang J, Hollingsworth LR, Magupalli VG, Zhao L, Luo HR, Kim J, Lieberman J, Wu H. FDA-approved disulfiram inhibits pyroptosis by blocking gasdermin D pore formation. Nat Immunol. 2020 Jul;21(7):736-745. doi: 10.1038/s41590-020-0669-6. Epub 2020 May 4.', 'Lobo-Galo N, Terrazas-L√≥pez M, Mart√≠nez-Mart√≠nez A, D√≠az-S√°nchez √ÅG. FDA-approved thiol-reacting drugs that potentially bind into the SARS-CoV-2 main protease, essential for viral replication. J Biomol Struct Dyn. 2021 Jun;39(9):3419-3427. doi: 10.1080/07391102.2020.1764393. Epub 2020 May 14.']",10/05/2021,https://clinicaltrials.gov/show/NCT04485130,31/12/2021,0,1
2465,NCT04527432,"Active, not recruiting",31/03/2022,31/03/2022,No Results Posted,,,06/05/2021,https://clinicaltrials.gov/show/NCT04527432,31/03/2022,0,0
2466,NCT04528888,Recruiting,30/06/2021,30/07/2021,No Results Posted,,,06/05/2021,https://clinicaltrials.gov/show/NCT04528888,30/06/2021,0,0
2467,NCT04531748,Withdrawn,01/09/2022,01/09/2022,No Results Posted,,,10/05/2021,https://clinicaltrials.gov/show/NCT04531748,01/09/2022,0,0
2468,NCT04532372,Recruiting,18/09/2022,18/09/2022,No Results Posted,,,06/05/2021,https://clinicaltrials.gov/show/NCT04532372,18/09/2022,0,0
2469,NCT04537962,Enrolling by invitation,30/12/2020,30/08/2021,No Results Posted,,,10/05/2021,https://clinicaltrials.gov/show/NCT04537962,30/12/2020,0,0
2470,NCT04540393,Suspended,11/05/2021,11/05/2021,No Results Posted,,,10/05/2021,https://clinicaltrials.gov/show/NCT04540393,11/05/2021,0,0
2471,NCT04542967,Completed,02/09/2020,30/09/2020,No Results Posted,,,10/05/2021,https://clinicaltrials.gov/show/NCT04542967,02/09/2020,0,0
2472,NCT04545060,"Active, not recruiting",08/04/2021,01/07/2021,No Results Posted,,,07/05/2021,https://clinicaltrials.gov/show/NCT04545060,08/04/2021,0,0
2473,NCT04551768,Recruiting,01/07/2021,01/07/2021,No Results Posted,,,05/05/2021,https://clinicaltrials.gov/show/NCT04551768,01/07/2021,0,0
2474,NCT04551911,Recruiting,01/08/2021,01/08/2021,No Results Posted,,,05/05/2021,https://clinicaltrials.gov/show/NCT04551911,01/08/2021,0,0
2475,NCT04592549,Recruiting,30/09/2021,30/09/2021,No Results Posted,,,11/05/2021,https://clinicaltrials.gov/show/NCT04592549,30/09/2021,0,0
2476,NCT04602286,Recruiting,01/06/2021,01/06/2021,No Results Posted,,,06/05/2021,https://clinicaltrials.gov/show/NCT04602286,01/06/2021,0,0
2477,NCT04602312,Recruiting,01/06/2021,01/06/2021,No Results Posted,,,06/05/2021,https://clinicaltrials.gov/show/NCT04602312,01/06/2021,0,0
2478,NCT04603924,Recruiting,01/06/2021,01/06/2022,No Results Posted,,,04/05/2021,https://clinicaltrials.gov/show/NCT04603924,01/06/2021,0,0
2479,NCT04611802,Recruiting,30/06/2023,30/06/2023,No Results Posted,,,06/05/2021,https://clinicaltrials.gov/show/NCT04611802,30/06/2023,0,0
2480,NCT04615052,Recruiting,31/10/2021,21/12/2021,No Results Posted,,,07/05/2021,https://clinicaltrials.gov/show/NCT04615052,31/10/2021,0,0
2481,NCT04619628,"Active, not recruiting",01/06/2021,01/05/2022,No Results Posted,,,06/05/2021,https://clinicaltrials.gov/show/NCT04619628,01/06/2021,0,0
2482,NCT04632381,Not yet recruiting,29/10/2021,31/12/2021,No Results Posted,,,06/05/2021,https://clinicaltrials.gov/show/NCT04632381,29/10/2021,0,0
2483,NCT04642950,Recruiting,31/10/2021,31/10/2021,No Results Posted,,,10/05/2021,https://clinicaltrials.gov/show/NCT04642950,31/10/2021,0,0
2484,NCT04644328,"Active, not recruiting",14/01/2021,26/11/2021,No Results Posted,,,10/05/2021,https://clinicaltrials.gov/show/NCT04644328,14/01/2021,0,0
2485,NCT04646590,Recruiting,01/04/2022,01/04/2022,No Results Posted,,,07/05/2021,https://clinicaltrials.gov/show/NCT04646590,01/04/2022,0,0
2486,NCT04646603,"Active, not recruiting",31/12/2021,01/03/2022,No Results Posted,,,10/05/2021,https://clinicaltrials.gov/show/NCT04646603,31/12/2021,0,0
2487,NCT04652674,Recruiting,30/06/2021,30/06/2021,No Results Posted,,,07/05/2021,https://clinicaltrials.gov/show/NCT04652674,30/06/2021,0,0
2488,NCT04668235,Recruiting,01/11/2021,01/12/2021,No Results Posted,,,05/05/2021,https://clinicaltrials.gov/show/NCT04668235,01/11/2021,0,0
2489,NCT04681430,Recruiting,01/11/2021,01/11/2021,No Results Posted,"['Keitel V, Jensen B, Feldt T, Fischer JC, Bode JG, Matuschek C, B√∂lke E, Budach W, Plettenberg C, Scheckenbach K, Kindgen-Milles D, Timm J, M√ºller L, Kolbe H, St√∂hr A, Calles C, Hippe A, Verde P, Spinner CD, Schneider J, Wolf T, Kern WV, Nattermann J, Zoufaly A, Ohmann C, Luedde T; RES-Q-HR Trial Team. Reconvalescent plasma/camostat mesylate in early SARS-CoV-2 Q-PCR positive high-risk individuals (RES-Q-HR): a structured summary of a study protocol for a randomized controlled trial. Trials. 2021 May 17;22(1):343. doi: 10.1186/s13063-021-05181-0.']",,04/05/2021,https://clinicaltrials.gov/show/NCT04681430,01/11/2021,0,1
2490,NCT04715932,"Active, not recruiting",01/05/2021,01/05/2021,No Results Posted,,,10/05/2021,https://clinicaltrials.gov/show/NCT04715932,01/05/2021,0,0
2491,NCT04746430,Terminated,23/04/2021,23/04/2021,No Results Posted,,,11/05/2021,https://clinicaltrials.gov/show/NCT04746430,23/04/2021,0,0
2492,NCT04753645,"Active, not recruiting",01/05/2021,01/05/2021,No Results Posted,,,12/05/2021,https://clinicaltrials.gov/show/NCT04753645,01/05/2021,0,0
2493,NCT04766333,Recruiting,01/02/2022,01/08/2022,No Results Posted,,,05/05/2021,https://clinicaltrials.gov/show/NCT04766333,01/02/2022,0,0
2494,NCT04779827,Recruiting,30/10/2022,30/12/2022,No Results Posted,,,07/05/2021,https://clinicaltrials.gov/show/NCT04779827,30/10/2022,0,0
2495,NCT04797858,Recruiting,30/03/2022,31/10/2022,No Results Posted,,,10/05/2021,https://clinicaltrials.gov/show/NCT04797858,30/03/2022,0,0
2496,NCT04813770,Completed,26/04/2021,26/04/2021,No Results Posted,"[""Young B, Kotzur M, Gatting L, Bonner C, Ayre J, McConnachie A, Batcup C, McCaffery K, O'Carroll R, Robb KA. The impact of theory-based messages on COVID-19 vaccination intentions: a structured summary of a study protocol for a randomised controlled trial. Trials. 2021 Apr 29;22(1):311. doi: 10.1186/s13063-021-05277-7.""]",,10/05/2021,https://clinicaltrials.gov/show/NCT04813770,26/04/2021,0,1
2497,NCT04813796,Recruiting,13/04/2022,13/04/2022,No Results Posted,,,10/05/2021,https://clinicaltrials.gov/show/NCT04813796,13/04/2022,0,0
2498,NCT04816019,Enrolling by invitation,01/02/2022,01/02/2022,No Results Posted,,,07/07/2021,https://clinicaltrials.gov/show/NCT04816019,01/02/2022,0,0
2499,NCT04816071,Withdrawn,01/03/2022,01/03/2022,No Results Posted,,,07/05/2021,https://clinicaltrials.gov/show/NCT04816071,01/03/2022,0,0
2500,NCT04834726,Enrolling by invitation,04/06/2021,30/07/2021,No Results Posted,,,02/07/2021,https://clinicaltrials.gov/show/NCT04834726,04/06/2021,0,0
2501,NCT04841759,Recruiting,30/09/2021,31/10/2021,No Results Posted,,,11/05/2021,https://clinicaltrials.gov/show/NCT04841759,30/09/2021,0,0
2502,NCT04847479,Recruiting,10/05/2022,30/10/2022,No Results Posted,,,10/05/2021,https://clinicaltrials.gov/show/NCT04847479,10/05/2022,0,0
2503,NCT04852861,Enrolling by invitation,30/07/2021,30/09/2022,No Results Posted,,,10/05/2021,https://clinicaltrials.gov/show/NCT04852861,30/07/2021,0,0
2504,NCT04858425,Recruiting,01/12/2021,01/03/2022,No Results Posted,,,30/06/2021,https://clinicaltrials.gov/show/NCT04858425,01/12/2021,0,0
2505,NCT04859023,Completed,28/02/2021,28/02/2021,No Results Posted,,,06/05/2021,https://clinicaltrials.gov/show/NCT04859023,28/02/2021,0,0
2506,NCT04860258,Recruiting,15/09/2021,01/09/2022,No Results Posted,,,11/05/2021,https://clinicaltrials.gov/show/NCT04860258,15/09/2021,0,0
2507,NCT04865107,Recruiting,01/04/2022,01/04/2022,No Results Posted,,,05/05/2021,https://clinicaltrials.gov/show/NCT04865107,01/04/2022,0,0
2508,NCT04866069,Recruiting,01/10/2021,01/04/2022,No Results Posted,,,06/05/2021,https://clinicaltrials.gov/show/NCT04866069,01/10/2021,0,0
2509,NCT04866589,Not yet recruiting,21/05/2021,21/05/2021,No Results Posted,,,06/05/2021,https://clinicaltrials.gov/show/NCT04866589,21/05/2021,0,0
2510,NCT04869228,Not yet recruiting,28/02/2022,30/05/2022,No Results Posted,,,06/05/2021,https://clinicaltrials.gov/show/NCT04869228,28/02/2022,0,0
2511,NCT04869592,Recruiting,25/10/2022,25/10/2022,No Results Posted,,,07/05/2021,https://clinicaltrials.gov/show/NCT04869592,25/10/2022,0,0
2512,NCT04870164,Recruiting,01/07/2021,01/07/2021,No Results Posted,,,06/05/2021,https://clinicaltrials.gov/show/NCT04870164,01/07/2021,0,0
2513,NCT04871672,Not yet recruiting,25/08/2021,25/09/2021,No Results Posted,,,06/05/2021,https://clinicaltrials.gov/show/NCT04871672,25/08/2021,0,0
2514,NCT04871828,Recruiting,01/09/2021,01/12/2021,No Results Posted,,,10/05/2021,https://clinicaltrials.gov/show/NCT04871828,01/09/2021,0,0
2515,NCT04873349,Not yet recruiting,30/07/2021,30/09/2021,No Results Posted,,,07/05/2021,https://clinicaltrials.gov/show/NCT04873349,30/07/2021,0,0
2516,NCT04873401,Recruiting,31/10/2022,31/10/2022,No Results Posted,,,01/07/2021,https://clinicaltrials.gov/show/NCT04873401,31/10/2022,0,0
2517,NCT04874805,Not yet recruiting,01/11/2021,01/11/2021,No Results Posted,,,06/05/2021,https://clinicaltrials.gov/show/NCT04874805,01/11/2021,0,0
2518,NCT04875520,Not yet recruiting,31/12/2022,31/03/2023,No Results Posted,,,06/05/2021,https://clinicaltrials.gov/show/NCT04875520,31/12/2022,0,0
2519,NCT04876417,Recruiting,01/02/2023,01/02/2023,No Results Posted,,,06/05/2021,https://clinicaltrials.gov/show/NCT04876417,01/02/2023,0,0
2520,NCT04876560,Completed,10/10/2020,15/04/2021,No Results Posted,,,06/05/2021,https://clinicaltrials.gov/show/NCT04876560,10/10/2020,0,0
2521,NCT04876573,Not yet recruiting,31/12/2021,31/01/2022,No Results Posted,,,06/05/2021,https://clinicaltrials.gov/show/NCT04876573,31/12/2021,0,0
2522,NCT04876885,Not yet recruiting,06/06/2021,06/06/2021,No Results Posted,,,11/05/2021,https://clinicaltrials.gov/show/NCT04876885,06/06/2021,0,0
2523,NCT04877002,Recruiting,01/05/2021,01/05/2021,No Results Posted,,,07/05/2021,https://clinicaltrials.gov/show/NCT04877002,01/05/2021,0,0
2524,NCT04877704,Not yet recruiting,30/04/2022,30/04/2022,No Results Posted,,,07/05/2021,https://clinicaltrials.gov/show/NCT04877704,30/04/2022,0,0
2525,NCT04877769,Recruiting,01/08/2021,01/08/2021,No Results Posted,,,07/05/2021,https://clinicaltrials.gov/show/NCT04877769,01/08/2021,0,0
2526,NCT04878042,Recruiting,01/06/2021,01/07/2021,No Results Posted,,,07/05/2021,https://clinicaltrials.gov/show/NCT04878042,01/06/2021,0,0
2527,NCT04878328,Not yet recruiting,01/07/2026,01/07/2026,No Results Posted,,,10/05/2021,https://clinicaltrials.gov/show/NCT04878328,01/07/2026,0,0
2528,NCT04880122,Completed,30/09/2020,30/09/2020,No Results Posted,,,10/05/2021,https://clinicaltrials.gov/show/NCT04880122,30/09/2020,0,0
2529,NCT04880135,Recruiting,30/05/2021,30/05/2021,No Results Posted,,,11/05/2021,https://clinicaltrials.gov/show/NCT04880135,30/05/2021,0,0
2530,NCT04880161,Recruiting,01/10/2021,01/12/2021,No Results Posted,,,10/05/2021,https://clinicaltrials.gov/show/NCT04880161,01/10/2021,0,0
2531,NCT04880174,Recruiting,01/03/2022,01/03/2022,No Results Posted,,,10/05/2021,https://clinicaltrials.gov/show/NCT04880174,01/03/2022,0,0
2532,NCT04880317,Recruiting,01/08/2021,01/12/2021,No Results Posted,,,10/05/2021,https://clinicaltrials.gov/show/NCT04880317,01/08/2021,0,0
2533,NCT04880668,Not yet recruiting,01/12/2022,01/07/2023,No Results Posted,,,11/05/2021,https://clinicaltrials.gov/show/NCT04880668,01/12/2022,0,0
2534,NCT04884490,Not yet recruiting,14/10/2021,14/11/2021,No Results Posted,,,13/05/2021,https://clinicaltrials.gov/show/NCT04884490,14/10/2021,0,0
2535,NCT04884776,Not yet recruiting,26/04/2024,26/04/2024,No Results Posted,,,13/05/2021,https://clinicaltrials.gov/show/NCT04884776,26/04/2024,0,0
2536,NCT04885764,Recruiting,01/10/2021,01/12/2021,No Results Posted,,,13/05/2021,https://clinicaltrials.gov/show/NCT04885764,01/10/2021,0,0
2537,NCT04308668,Completed,20/05/2020,20/05/2020,Study Results,"['Akhtar S, Das JK, Ismail T, Wahid M, Saeed W, Bhutta ZA. Nutritional perspectives for the prevention and mitigation of COVID-19. Nutr Rev. 2021 Feb 11;79(3):289-300. doi: 10.1093/nutrit/nuaa063.']","['Boulware DR, Pullen MF, Bangdiwala AS, Pastick KA, Lofgren SM, Okafor EC, Skipper CP, Nascene AA, Nicol MR, Abassi M, Engen NW, Cheng MP, LaBar D, Lother SA, MacKenzie LJ, Drobot G, Marten N, Zarychanski R, Kelly LE, Schwartz IS, McDonald EG, Rajasingham R, Lee TC, Hullsiek KH. A Randomized Trial of Hydroxychloroquine as Postexposure Prophylaxis for Covid-19. N Engl J Med. 2020 Aug 6;383(6):517-525. doi: 10.1056/NEJMoa2016638. Epub 2020 Jun 3.', 'Skipper CP, Pastick KA, Engen NW, Bangdiwala AS, Abassi M, Lofgren SM, Williams DA, Okafor EC, Pullen MF, Nicol MR, Nascene AA, Hullsiek KH, Cheng MP, Luke D, Lother SA, MacKenzie LJ, Drobot G, Kelly LE, Schwartz IS, Zarychanski R, McDonald EG, Lee TC, Rajasingham R, Boulware DR. Hydroxychloroquine in Nonhospitalized Adults With Early COVID-19 : A Randomized Trial. Ann Intern Med. 2020 Oct 20;173(8):623-631. doi: 10.7326/M20-4207. Epub 2020 Jul 16. Erratum in: Ann Intern Med. 2021 Mar;174(3):435.', 'Lofgren SM, Nicol MR, Bangdiwala AS, Pastick KA, Okafor EC, Skipper CP, Pullen MF, Engen NW, Abassi M, Williams DA, Nascene AA, Axelrod ML, Lother SA, MacKenzie LJ, Drobot G, Marten N, Cheng MP, Zarychanski R, Schwartz IS, Silverman M, Chagla Z, Kelly LE, McDonald EG, Lee TC, Hullsiek KH, Boulware DR, Rajasingham R. Safety of Hydroxychloroquine Among Outpatient Clinical Trial Participants for COVID-19. Open Forum Infect Dis. 2020 Oct 19;7(11):ofaa500. doi: 10.1093/ofid/ofaa500. eCollection 2020 Nov.', 'Skipper CP, Boulware DR. Hydroxychloroquine in Nonhospitalized Adults With Early COVID-19. Ann Intern Med. 2021 Mar;174(3):434-435. doi: 10.7326/L20-1426.', 'Nicol MR, Boulware DR, Rajasingham R. Reply to author. Clin Infect Dis. 2020 Dec 4. pii: ciaa1809. doi: 10.1093/cid/ciaa1809. [Epub ahead of print]']",13/05/2021,https://clinicaltrials.gov/show/NCT04308668,20/05/2020,1,1
2538,NCT04327388,Completed,31/07/2020,02/09/2020,Study Results,"['Lescure FX, Honda H, Fowler RA, Lazar JS, Shi G, Wung P, Patel N, Hagino O; Sarilumab COVID-19 Global Study Group. Sarilumab in patients admitted to hospital with severe or critical COVID-19: a randomised, double-blind, placebo-controlled, phase 3 trial. Lancet Respir Med. 2021 May;9(5):522-532. doi: 10.1016/S2213-2600(21)00099-0. Epub 2021 Mar 4.']",,13/05/2021,https://clinicaltrials.gov/show/NCT04327388,31/07/2020,1,1
2539,NCT04331054,"Active, not recruiting",13/01/2022,13/01/2022,No Results Posted,,,17/05/2021,https://clinicaltrials.gov/show/NCT04331054,13/01/2022,0,0
2540,NCT04333732,Recruiting,01/08/2021,01/08/2021,No Results Posted,,,12/05/2021,https://clinicaltrials.gov/show/NCT04333732,01/08/2021,0,0
2541,NCT04335097,Recruiting,08/04/2022,20/12/2025,No Results Posted,,"['Samsudin MI, Liu N, Prabhakar SM, Chong SL, Kit Lye W, Koh ZX, Guo D, Rajesh R, Ho AFW, Ong MEH. A novel heart rate variability based risk prediction model for septic patients presenting to the emergency department. Medicine (Baltimore). 2018 Jun;97(23):e10866. doi: 10.1097/MD.0000000000010866.', 'Melillo P, Izzo R, Orrico A, Scala P, Attanasio M, Mirra M, De Luca N, Pecchia L. Automatic prediction of cardiovascular and cerebrovascular events using heart rate variability analysis. PLoS One. 2015 Mar 20;10(3):e0118504. doi: 10.1371/journal.pone.0118504. eCollection 2015.']",17/05/2021,https://clinicaltrials.gov/show/NCT04335097,08/04/2022,0,1
2542,NCT04338074,Terminated,21/04/2021,21/04/2021,Study Results,,,13/05/2021,https://clinicaltrials.gov/show/NCT04338074,21/04/2021,1,0
2543,NCT04343989,Completed,03/02/2021,12/03/2021,No Results Posted,,,13/05/2021,https://clinicaltrials.gov/show/NCT04343989,03/02/2021,0,0
2544,NCT04344561,Recruiting,01/05/2022,01/06/2022,No Results Posted,,,17/05/2021,https://clinicaltrials.gov/show/NCT04344561,01/05/2022,0,0
2545,NCT04345523,Completed,05/02/2021,05/04/2021,No Results Posted,"['Piechotta V, Iannizzi C, Chai KL, Valk SJ, Kimber C, Dorando E, Monsef I, Wood EM, Lamikanra AA, Roberts DJ, McQuilten Z, So-Osman C, Estcourt LJ, Skoetz N. Convalescent plasma or hyperimmune immunoglobulin for people with COVID-19: a living systematic review. Cochrane Database Syst Rev. 2021 May 20;5:CD013600. doi: 10.1002/14651858.CD013600.pub4.', 'Diago-Sempere E, Bueno JL, Sancho-L√≥pez A, Rubio EM, Torres F, de Molina RM, Fern√°ndez-Cruz A, de Diego IS, Velasco-Iglesias A, Payares-Herrera C, Flecha IC, Avenda√±o-Sol√† C, Palomino RD, Ramos-Mart√≠nez A, Ruiz-Antor√°n B. Evaluation of convalescent plasma versus standard of care for the treatment of COVID-19 in hospitalized patients: study protocol for a phase 2 randomized, open-label, controlled, multicenter trial. Trials. 2021 Jan 20;22(1):70. doi: 10.1186/s13063-020-05011-9.']",,13/05/2021,https://clinicaltrials.gov/show/NCT04345523,05/02/2021,0,1
2546,NCT04345653,Completed,05/06/2020,10/05/2021,Study Results,,,12/05/2021,https://clinicaltrials.gov/show/NCT04345653,05/06/2020,1,0
2547,NCT04350593,"Active, not recruiting",01/04/2021,01/06/2021,No Results Posted,,,12/05/2021,https://clinicaltrials.gov/show/NCT04350593,01/04/2021,0,0
2548,NCT04354610,Completed,19/12/2020,26/03/2021,No Results Posted,,,12/05/2021,https://clinicaltrials.gov/show/NCT04354610,19/12/2020,0,0
2549,NCT04354870,Completed,15/09/2020,01/10/2020,No Results Posted,,,12/05/2021,https://clinicaltrials.gov/show/NCT04354870,15/09/2020,0,0
2550,NCT04357457,Recruiting,01/07/2021,01/07/2021,No Results Posted,,,12/05/2021,https://clinicaltrials.gov/show/NCT04357457,01/07/2021,0,0
2551,NCT04359511,Withdrawn,03/07/2020,03/07/2020,No Results Posted,,,12/05/2021,https://clinicaltrials.gov/show/NCT04359511,03/07/2020,0,0
2552,NCT04359810,Completed,30/12/2020,30/12/2020,No Results Posted,"['Piechotta V, Iannizzi C, Chai KL, Valk SJ, Kimber C, Dorando E, Monsef I, Wood EM, Lamikanra AA, Roberts DJ, McQuilten Z, So-Osman C, Estcourt LJ, Skoetz N. Convalescent plasma or hyperimmune immunoglobulin for people with COVID-19: a living systematic review. Cochrane Database Syst Rev. 2021 May 20;5:CD013600. doi: 10.1002/14651858.CD013600.pub4.', ""O'Donnell MR, Grinsztejn B, Cummings MJ, Justman JE, Lamb MR, Eckhardt CM, Philip NM, Cheung YK, Gupta V, Jo√£o E, Pilotto JH, Diniz MP, Cardoso SW, Abrams D, Rajagopalan KN, Borden SE, Wolf A, Sidi LC, Vizzoni A, Veloso VG, Bitan ZC, Scotto DE, Meyer BJ, Jacobson SD, Kantor A, Mishra N, Chauhan LV, Stone EF, Dei Zotti F, La Carpia F, Hudson KE, Ferrara SA, Schwartz J, Stotler BA, Lin WW, Wontakal SN, Shaz B, Briese T, Hod EA, Spitalnik SL, Eisenberger A, Lipkin WI. A randomized double-blind controlled trial of convalescent plasma in adults with severe COVID-19. J Clin Invest. 2021 May 11. pii: 150646. doi: 10.1172/JCI150646. [Epub ahead of print]"", ""Eckhardt CM, Cummings MJ, Rajagopalan KN, Borden S, Bitan ZC, Wolf A, Kantor A, Briese T, Meyer BJ, Jacobson SD, Scotto D, Mishra N, Philip NM, Stotler BA, Schwartz J, Shaz B, Spitalnik SL, Eisenberger A, Hod EA, Justman J, Cheung K, Lipkin WI, O'Donnell MR. Evaluating the efficacy and safety of human anti-SARS-CoV-2 convalescent plasma in severely ill adults with COVID-19: A structured summary of a study protocol for a randomized controlled trial. Trials. 2020 Jun 8;21(1):499. doi: 10.1186/s13063-020-04422-y. Erratum in: Trials. 2020 Jun 16;21(1):536. Trials. 2020 Nov 17;21(1):927.""]",,18/05/2021,https://clinicaltrials.gov/show/NCT04359810,30/12/2020,0,1
2553,NCT04361474,"Active, not recruiting",24/11/2020,25/06/2021,No Results Posted,"['Daval M, Corr√© A, Palpacuer C, Housset J, Poillon G, Eliezer M, Verillaud B, Slama D, Ayache D, Herman P, Jourdaine C, Herv√© C, El Bakkouri W, Salmon D, Hautefort C. Efficacy of local budesonide therapy in the management of persistent hyposmia in COVID-19 patients without signs of severity: A structured summary of a study protocol for a randomised controlled trial. Trials. 2020 Jul 20;21(1):666. doi: 10.1186/s13063-020-04585-8.']",,12/05/2021,https://clinicaltrials.gov/show/NCT04361474,24/11/2020,0,1
2554,NCT04362085,"Active, not recruiting",10/05/2021,01/07/2021,No Results Posted,"['Sholzberg M, Tang GH, Negri E, Rahhal H, Kreuziger LB, Pompilio CE, James P, Fralick M, AlHamzah M, Alomran F, Tseng E, Lim G, Lillicrap D, Carrier M, √Åinle FN, Beckett A, da Costa BR, Thorpe K, Middeldorp S, Lee A, Cushman M, J√ºni P. Coagulopathy of hospitalised COVID-19: A Pragmatic Randomised Controlled Trial of Therapeutic Anticoagulation versus Standard Care as a Rapid Response to the COVID-19 Pandemic (RAPID COVID COAG - RAPID Trial): A structured summary of a study protocol for a randomised controlled trial. Trials. 2021 Mar 10;22(1):202. doi: 10.1186/s13063-021-05076-0.', 'Flumignan RL, Tin√¥co JDS, Pascoal PI, Areias LL, Cossi MS, Fernandes MI, Costa IK, Souza L, Matar CF, Tendal B, Trevisani VF, Atallah √ÅN, Nakano LC. Prophylactic anticoagulants for people hospitalised with COVID-19. Cochrane Database Syst Rev. 2020 Oct 2;10:CD013739. doi: 10.1002/14651858.CD013739.']",,14/05/2021,https://clinicaltrials.gov/show/NCT04362085,10/05/2021,0,1
2555,NCT04364737,"Active, not recruiting",29/03/2021,14/06/2021,No Results Posted,,,13/05/2021,https://clinicaltrials.gov/show/NCT04364737,29/03/2021,0,0
2556,NCT04365699,Completed,31/01/2021,31/01/2021,No Results Posted,,,12/05/2021,https://clinicaltrials.gov/show/NCT04365699,31/01/2021,0,0
2557,NCT04373291,"Active, not recruiting",31/07/2021,31/12/2021,No Results Posted,"['Madsen AMR, Schaltz-Buchholzer F, Benfield T, Bjerregaard-Andersen M, Dalgaard LS, Dam C, Ditlev SB, Faizi G, Johansen IS, Kofoed PE, Kristensen GS, Loekkegaard ECL, Mogensen CB, Mohamed L, Ostenfeld A, Oedegaard ES, Soerensen MK, Wejse C, Jensen AKG, Nielsen S, Krause TG, Netea MG, Aaby P, Benn CS. Using BCG vaccine to enhance non-specific protection of health care workers during the COVID-19 pandemic: A structured summary of a study protocol for a randomised controlled trial in Denmark. Trials. 2020 Sep 17;21(1):799. doi: 10.1186/s13063-020-04714-3.']",,12/05/2021,https://clinicaltrials.gov/show/NCT04373291,31/07/2021,0,1
2558,NCT04375397,Completed,10/05/2021,08/06/2021,No Results Posted,,,08/07/2021,https://clinicaltrials.gov/show/NCT04375397,10/05/2021,0,0
2559,NCT04383002,"Active, not recruiting",11/05/2021,11/06/2021,No Results Posted,,,13/05/2021,https://clinicaltrials.gov/show/NCT04383002,11/05/2021,0,0
2560,NCT04383613,"Active, not recruiting",01/06/2021,01/06/2021,No Results Posted,,,13/05/2021,https://clinicaltrials.gov/show/NCT04383613,01/06/2021,0,0
2561,NCT04397523,Completed,10/05/2021,10/05/2021,No Results Posted,,,11/05/2021,https://clinicaltrials.gov/show/NCT04397523,10/05/2021,0,0
2562,NCT04399980,Completed,23/04/2021,23/04/2021,Study Results,"['Cremer PC, Abbate A, Hudock K, McWilliams C, Mehta J, Chang SY, Sheng CC, Van Tassell B, Bonaventura A, Vecchi√© A, Carey B, Wang Q, Wolski KE, Rajendram P, Duggal A, Wang TS, Paolini JF, Trapnell BC; MASH-COVID study group. Mavrilimumab in patients with severe COVID-19 pneumonia and systemic hyperinflammation (MASH-COVID): an investigator initiated, multicentre, double-blind, randomised, placebo-controlled trial. Lancet Rheumatol. 2021 Jun;3(6):e410-e418. doi: 10.1016/S2665-9913(21)00070-9. Epub 2021 Mar 17.']",,13/05/2021,https://clinicaltrials.gov/show/NCT04399980,23/04/2021,1,1
2563,NCT04409834,Recruiting,01/11/2021,01/11/2021,No Results Posted,,,17/05/2021,https://clinicaltrials.gov/show/NCT04409834,01/11/2021,0,0
2564,NCT04419623,Completed,22/09/2020,15/12/2020,No Results Posted,,,12/05/2021,https://clinicaltrials.gov/show/NCT04419623,22/09/2020,0,0
2565,NCT04420247,Completed,20/08/2020,03/09/2020,No Results Posted,"['R√©a-Neto √Å, Bernardelli RS, C√¢mara BMD, Reese FB, Queiroga MVO, Oliveira MC. An open-label randomized controlled trial evaluating the efficacy of chloroquine/hydroxychloroquine in severe COVID-19 patients. Sci Rep. 2021 Apr 27;11(1):9023. doi: 10.1038/s41598-021-88509-9.']",,12/05/2021,https://clinicaltrials.gov/show/NCT04420247,20/08/2020,0,1
2566,NCT04422353,Recruiting,30/06/2021,30/12/2024,No Results Posted,,"[""Monteiro EP, Franzoni LT, Cubillos DM, de Oliveira Fagundes A, Carvalho AR, Oliveira HB, Pantoja PD, Schuch FB, Rieder CR, Martinez FG, Peyr√©-Tartaruga LA. Effects of Nordic walking training on functional parameters in Parkinson's disease: a randomized controlled clinical trial. Scand J Med Sci Sports. 2017 Mar;27(3):351-358. doi: 10.1111/sms.12652. Epub 2016 Feb 2.""]",14/05/2021,https://clinicaltrials.gov/show/NCT04422353,30/06/2021,0,1
2567,NCT04426695,"Active, not recruiting",07/05/2021,04/06/2021,No Results Posted,,,12/05/2021,https://clinicaltrials.gov/show/NCT04426695,07/05/2021,0,0
2568,NCT04438980,Completed,12/03/2021,09/04/2021,No Results Posted,"['Les Bujanda I, Loureiro-Amigo J, Bastons FC, Guerra IE, S√°nchez JA, Murgadella-Sancho A, Rey RG, L√≥pez JL, √Ålvarez JS. Treatment of COVID-19 pneumonia with glucocorticoids (CORTIVID): a structured summary of a study protocol for a randomised controlled trial. Trials. 2021 Jan 11;22(1):43. doi: 10.1186/s13063-020-04999-4.']",,17/05/2021,https://clinicaltrials.gov/show/NCT04438980,12/03/2021,0,1
2569,NCT04442230,Recruiting,01/06/2021,01/06/2021,No Results Posted,,,12/05/2021,https://clinicaltrials.gov/show/NCT04442230,01/06/2021,0,0
2570,NCT04444700,"Active, not recruiting",10/05/2021,01/07/2021,No Results Posted,,,17/05/2021,https://clinicaltrials.gov/show/NCT04444700,10/05/2021,0,0
2571,NCT04475120,Completed,02/07/2020,02/07/2020,No Results Posted,,,14/05/2021,https://clinicaltrials.gov/show/NCT04475120,02/07/2020,0,0
2572,NCT04482621,Recruiting,01/09/2021,01/11/2021,No Results Posted,,,12/05/2021,https://clinicaltrials.gov/show/NCT04482621,01/09/2021,0,0
2573,NCT04482686,Recruiting,01/05/2022,01/07/2022,No Results Posted,,,14/05/2021,https://clinicaltrials.gov/show/NCT04482686,01/05/2022,0,0
2574,NCT04487990,"Active, not recruiting",31/03/2021,01/08/2021,No Results Posted,"['Lins PRG, de Albuquerque CCC, Assis CF, Rodrigues BCD, E Siqueira Campos BP, de Oliveira Valle E, Cabrera CPS, de Oliveira Gois J, Segura GC, Strufaldi FL, Mainardes LC, Ribeiro RG, Via Reque Cortes DDP, Lutf LG, de Oliveira MFA, Sales GTM, Smolentzov I, Reichert BV, Andrade L, Seabra VF, Rodrigues CE. Cov-hep study: heparin in standard anticoagulation based on citrate for continuous veno-venous hemodialysis in patients with COVID-19: a structured summary of a study protocol for a randomized controlled trial. Trials. 2020 Nov 11;21(1):920. doi: 10.1186/s13063-020-04814-0.']",,17/05/2021,https://clinicaltrials.gov/show/NCT04487990,31/03/2021,0,1
2575,NCT04494646,Completed,08/01/2021,08/01/2021,No Results Posted,,,12/05/2021,https://clinicaltrials.gov/show/NCT04494646,08/01/2021,0,0
2576,NCT04501445,"Active, not recruiting",08/04/2021,31/07/2021,No Results Posted,,,17/05/2021,https://clinicaltrials.gov/show/NCT04501445,08/04/2021,0,0
2577,NCT04505592,Recruiting,01/09/2021,01/12/2021,No Results Posted,,,18/05/2021,https://clinicaltrials.gov/show/NCT04505592,01/09/2021,0,0
2578,NCT04516759,Completed,25/04/2021,12/05/2021,No Results Posted,,,14/05/2021,https://clinicaltrials.gov/show/NCT04516759,25/04/2021,0,0
2579,NCT04537806,Recruiting,01/10/2021,01/10/2021,No Results Posted,,,12/05/2021,https://clinicaltrials.gov/show/NCT04537806,01/10/2021,0,0
2580,NCT04555213,"Active, not recruiting",01/08/2021,01/12/2021,No Results Posted,,,17/05/2021,https://clinicaltrials.gov/show/NCT04555213,01/08/2021,0,0
2581,NCT04579393,Completed,30/03/2021,30/04/2021,No Results Posted,"['Strich JR, Ramos-Benitez MJ, Randazzo D, Stein SR, Babyak A, Davey RT, Suffredini AF, Childs RW, Chertow DS. Fostamatinib Inhibits Neutrophils Extracellular Traps Induced by COVID-19 Patient Plasma: A Potential Therapeutic. J Infect Dis. 2021 Mar 29;223(6):981-984. doi: 10.1093/infdis/jiaa789.']",,07/07/2021,https://clinicaltrials.gov/show/NCT04579393,30/03/2021,0,1
2582,NCT04584437,Withdrawn,10/05/2022,10/07/2022,No Results Posted,,,17/05/2021,https://clinicaltrials.gov/show/NCT04584437,10/05/2022,0,0
2583,NCT04604184,Terminated,24/03/2021,24/03/2021,No Results Posted,,,13/05/2021,https://clinicaltrials.gov/show/NCT04604184,24/03/2021,0,0
2584,NCT04619706,Recruiting,14/08/2021,05/12/2021,No Results Posted,,,17/05/2021,https://clinicaltrials.gov/show/NCT04619706,14/08/2021,0,0
2585,NCT04631666,"Active, not recruiting",10/08/2021,10/08/2021,No Results Posted,,,13/05/2021,https://clinicaltrials.gov/show/NCT04631666,10/08/2021,0,0
2586,NCT04632368,"Active, not recruiting",24/06/2021,24/06/2021,No Results Posted,,,14/05/2021,https://clinicaltrials.gov/show/NCT04632368,24/06/2021,0,0
2587,NCT04644198,Recruiting,01/12/2021,01/12/2021,No Results Posted,,,12/05/2021,https://clinicaltrials.gov/show/NCT04644198,01/12/2021,0,0
2588,NCT04647669,Not yet recruiting,30/11/2021,31/12/2021,No Results Posted,,,13/05/2021,https://clinicaltrials.gov/show/NCT04647669,30/11/2021,0,0
2589,NCT04649736,Recruiting,15/06/2021,15/06/2021,No Results Posted,,,14/05/2021,https://clinicaltrials.gov/show/NCT04649736,15/06/2021,0,0
2590,NCT04674566,Recruiting,30/06/2021,30/06/2021,No Results Posted,,,17/05/2021,https://clinicaltrials.gov/show/NCT04674566,30/06/2021,0,0
2591,NCT04707703,Recruiting,01/01/2022,01/03/2022,No Results Posted,,,13/05/2021,https://clinicaltrials.gov/show/NCT04707703,01/01/2022,0,0
2592,NCT04742725,Recruiting,25/07/2021,25/08/2021,No Results Posted,,,02/07/2021,https://clinicaltrials.gov/show/NCT04742725,25/07/2021,0,0
2593,NCT04771013,Completed,14/05/2021,14/05/2021,No Results Posted,,,18/05/2021,https://clinicaltrials.gov/show/NCT04771013,14/05/2021,0,0
2594,NCT04779450,Recruiting,01/08/2021,01/12/2021,No Results Posted,,,13/05/2021,https://clinicaltrials.gov/show/NCT04779450,01/08/2021,0,0
2595,NCT04783025,Recruiting,31/03/2022,31/03/2022,No Results Posted,,,12/05/2021,https://clinicaltrials.gov/show/NCT04783025,31/03/2022,0,0
2596,NCT04789603,Recruiting,01/06/2021,01/06/2021,No Results Posted,,,11/05/2021,https://clinicaltrials.gov/show/NCT04789603,01/06/2021,0,0
2597,NCT04799392,Recruiting,30/06/2021,30/06/2021,No Results Posted,,,17/05/2021,https://clinicaltrials.gov/show/NCT04799392,30/06/2021,0,0
2598,NCT04801836,"Active, not recruiting",30/06/2021,30/06/2021,No Results Posted,,,14/05/2021,https://clinicaltrials.gov/show/NCT04801836,30/06/2021,0,0
2599,NCT04818736,Withdrawn,01/09/2021,01/12/2021,No Results Posted,,,14/05/2021,https://clinicaltrials.gov/show/NCT04818736,01/09/2021,0,0
2600,NCT04824469,Not yet recruiting,01/11/2021,01/06/2022,No Results Posted,,,19/05/2021,https://clinicaltrials.gov/show/NCT04824469,01/11/2021,0,0
2601,NCT04832919,Not yet recruiting,01/05/2022,01/05/2022,No Results Posted,,,18/05/2021,https://clinicaltrials.gov/show/NCT04832919,01/05/2022,0,0
2602,NCT04839965,Recruiting,01/10/2021,01/11/2021,No Results Posted,,,12/05/2021,https://clinicaltrials.gov/show/NCT04839965,01/10/2021,0,0
2603,NCT04842435,Recruiting,30/09/2021,05/10/2021,No Results Posted,,,14/05/2021,https://clinicaltrials.gov/show/NCT04842435,30/09/2021,0,0
2604,NCT04847102,Not yet recruiting,30/10/2021,30/05/2023,No Results Posted,,,17/05/2021,https://clinicaltrials.gov/show/NCT04847102,30/10/2021,0,0
2605,NCT04863638,Recruiting,31/03/2022,31/03/2024,No Results Posted,,,13/05/2021,https://clinicaltrials.gov/show/NCT04863638,31/03/2022,0,0
2606,NCT04870606,Recruiting,24/08/2021,24/01/2022,No Results Posted,,,18/05/2021,https://clinicaltrials.gov/show/NCT04870606,24/08/2021,0,0
2607,NCT04871646,Not yet recruiting,01/03/2022,01/08/2022,No Results Posted,,,12/05/2021,https://clinicaltrials.gov/show/NCT04871646,01/03/2022,0,0
2608,NCT04872686,Recruiting,01/05/2021,01/05/2021,No Results Posted,,,13/05/2021,https://clinicaltrials.gov/show/NCT04872686,01/05/2021,0,0
2609,NCT04880109,Not yet recruiting,01/02/2022,01/03/2022,No Results Posted,,,12/05/2021,https://clinicaltrials.gov/show/NCT04880109,01/02/2022,0,0
2610,NCT04880642,Not yet recruiting,01/02/2022,01/03/2022,No Results Posted,,,07/07/2021,https://clinicaltrials.gov/show/NCT04880642,01/02/2022,0,0
2611,NCT04881214,Recruiting,01/07/2022,25/11/2022,No Results Posted,,,11/05/2021,https://clinicaltrials.gov/show/NCT04881214,01/07/2022,0,0
2612,NCT04883203,Completed,30/09/2020,31/10/2020,No Results Posted,,,12/05/2021,https://clinicaltrials.gov/show/NCT04883203,30/09/2020,0,0
2613,NCT04883528,Not yet recruiting,30/08/2022,30/08/2022,No Results Posted,,,12/05/2021,https://clinicaltrials.gov/show/NCT04883528,30/08/2022,0,0
2614,NCT04884529,Not yet recruiting,01/12/2021,01/12/2021,No Results Posted,,,14/05/2021,https://clinicaltrials.gov/show/NCT04884529,01/12/2021,0,0
2615,NCT04885517,Recruiting,01/08/2021,01/08/2021,No Results Posted,,"['Gattinoni L, Coppola S, Cressoni M, Busana M, Rossi S, Chiumello D. COVID-19 Does Not Lead to a ""Typical"" Acute Respiratory Distress Syndrome. Am J Respir Crit Care Med. 2020 May 15;201(10):1299-1300. doi: 10.1164/rccm.202003-0817LE.', ""Couzin-Frankel J. The mystery of the pandemic's 'happy hypoxia'. Science. 2020 May 1;368(6490):455-456. doi: 10.1126/science.368.6490.455."", 'Aliberti S, Radovanovic D, Billi F, Sotgiu G, Costanzo M, Pilocane T, Saderi L, Gramegna A, Rovellini A, Perotto L, Monzani V, Santus P, Blasi F. Helmet CPAP treatment in patients with COVID-19 pneumonia: a multicentre cohort study. Eur Respir J. 2020 Oct 15;56(4). pii: 2001935. doi: 10.1183/13993003.01935-2020. Print 2020 Oct.', ""Elharrar X, Trigui Y, Dols AM, Touchon F, Martinez S, Prud'homme E, Papazian L. Use of Prone Positioning in Nonintubated Patients With COVID-19 and Hypoxemic Acute Respiratory Failure. JAMA. 2020 Jun 9;323(22):2336-2338. doi: 10.1001/jama.2020.8255."", 'Chiumello D, Busana M, Coppola S, Romitti F, Formenti P, Bonifazi M, Pozzi T, Palumbo MM, Cressoni M, Herrmann P, Meissner K, Quintel M, Camporota L, Marini JJ, Gattinoni L. Physiological and quantitative CT-scan characterization of COVID-19 and typical ARDS: a matched cohort study. Intensive Care Med. 2020 Dec;46(12):2187-2196. doi: 10.1007/s00134-020-06281-2. Epub 2020 Oct 21.', 'Marini JJ, Gattinoni L. Management of COVID-19 Respiratory Distress. JAMA. 2020 Jun 9;323(22):2329-2330. doi: 10.1001/jama.2020.6825.', 'Poston JT, Patel BK, Davis AM. Management of Critically Ill Adults With COVID-19. JAMA. 2020 May 12;323(18):1839-1841. doi: 10.1001/jama.2020.4914.', 'Gattinoni L, Giosa L, Bonifazi M, Pasticci I, Busana M, Macri M, Romitti F, Vassalli F, Quintel M. Targeting transpulmonary pressure to prevent ventilator-induced lung injury. Expert Rev Respir Med. 2019 Aug;13(8):737-746. doi: 10.1080/17476348.2019.1638767. Epub 2019 Jul 5. Review.', 'Brochard L, Slutsky A, Pesenti A. Mechanical Ventilation to Minimize Progression of Lung Injury in Acute Respiratory Failure. Am J Respir Crit Care Med. 2017 Feb 15;195(4):438-442. doi: 10.1164/rccm.201605-1081CP.', ""Tonelli R, Fantini R, Tabb√¨ L, Castaniere I, Pisani L, Pellegrino MR, Della Casa G, D'Amico R, Girardis M, Nava S, Clini EM, Marchioni A. Early Inspiratory Effort Assessment by Esophageal Manometry Predicts Noninvasive Ventilation Outcome in De Novo Respiratory Failure. A Pilot Study. Am J Respir Crit Care Med. 2020 Aug 15;202(4):558-567. doi: 10.1164/rccm.201912-2512OC."", 'Goligher EC, Jonkman AH, Dianti J, Vaporidi K, Beitler JR, Patel BK, Yoshida T, Jaber S, Dres M, Mauri T, Bellani G, Demoule A, Brochard L, Heunks L. Clinical strategies for implementing lung and diaphragm-protective ventilation: avoiding insufficient and excessive effort. Intensive Care Med. 2020 Dec;46(12):2314-2326. doi: 10.1007/s00134-020-06288-9. Epub 2020 Nov 2. Review.', 'Apigo M, Schechtman J, Dhliwayo N, Al Tameemi M, Gazmuri RJ. Development of a work of breathing scale and monitoring need of intubation in COVID-19 pneumonia. Crit Care. 2020 Jul 31;24(1):477. doi: 10.1186/s13054-020-03176-y.', 'Vaporidi K, Akoumianaki E, Telias I, Goligher EC, Brochard L, Georgopoulos D. Respiratory Drive in Critically Ill Patients. Pathophysiology and Clinical Implications. Am J Respir Crit Care Med. 2020 Jan 1;201(1):20-32. doi: 10.1164/rccm.201903-0596SO.', 'Gattinoni L, Chiumello D, Caironi P, Busana M, Romitti F, Brazzi L, Camporota L. COVID-19 pneumonia: different respiratory treatments for different phenotypes? Intensive Care Med. 2020 Jun;46(6):1099-1102. doi: 10.1007/s00134-020-06033-2. Epub 2020 Apr 14.']",14/05/2021,https://clinicaltrials.gov/show/NCT04885517,01/08/2021,0,1
2616,NCT04886362,Not yet recruiting,01/09/2021,01/12/2021,No Results Posted,,,14/05/2021,https://clinicaltrials.gov/show/NCT04886362,01/09/2021,0,0
2617,NCT04886414,Not yet recruiting,01/01/2022,01/09/2022,No Results Posted,,,14/05/2021,https://clinicaltrials.gov/show/NCT04886414,01/01/2022,0,0
2618,NCT04887116,Not yet recruiting,01/12/2022,01/12/2022,No Results Posted,,,14/05/2021,https://clinicaltrials.gov/show/NCT04887116,01/12/2022,0,0
2619,NCT04887129,Recruiting,31/12/2022,31/12/2022,No Results Posted,,,14/05/2021,https://clinicaltrials.gov/show/NCT04887129,31/12/2022,0,0
2620,NCT04887207,Enrolling by invitation,28/02/2022,31/12/2022,No Results Posted,,,30/06/2021,https://clinicaltrials.gov/show/NCT04887207,28/02/2022,0,0
2621,NCT04887233,Not yet recruiting,31/05/2022,30/06/2022,No Results Posted,,,17/05/2021,https://clinicaltrials.gov/show/NCT04887233,31/05/2022,0,0
2622,NCT04887272,Not yet recruiting,30/08/2021,30/11/2021,No Results Posted,,,14/05/2021,https://clinicaltrials.gov/show/NCT04887272,30/08/2021,0,0
2623,NCT04887350,Not yet recruiting,01/06/2022,01/06/2022,No Results Posted,,,14/05/2021,https://clinicaltrials.gov/show/NCT04887350,01/06/2022,0,0
2624,NCT04888832,Not yet recruiting,01/12/2023,01/12/2023,No Results Posted,,,17/05/2021,https://clinicaltrials.gov/show/NCT04888832,01/12/2023,0,0
2625,NCT04889274,Recruiting,01/08/2021,10/05/2022,No Results Posted,,"[""Rathod KS, Kapil V, Velmurugan S, Khambata RS, Siddique U, Khan S, Van Eijl S, Gee LC, Bansal J, Pitrola K, Shaw C, D'Acquisto F, Colas RA, Marelli-Berg F, Dalli J, Ahluwalia A. Accelerated resolution of inflammation underlies sex differences in inflammatory responses in humans. J Clin Invest. 2017 Jan 3;127(1):169-182. doi: 10.1172/JCI89429. Epub 2016 Nov 28."", 'Kapil V, Khambata RS, Jones DA, Rathod K, Primus C, Massimo G, Fukuto JM, Ahluwalia A. The Noncanonical Pathway for In Vivo Nitric Oxide Generation: The Nitrate-Nitrite-Nitric Oxide Pathway. Pharmacol Rev. 2020 Jul;72(3):692-766. doi: 10.1124/pr.120.019240. Review.', 'Shabbir A, Rathod KS, Khambata RS, Ahluwalia A. Sex Differences in the Inflammatory Response: Pharmacological Opportunities for Therapeutics for Coronary Artery Disease. Annu Rev Pharmacol Toxicol. 2021 Jan 6;61:333-359. doi: 10.1146/annurev-pharmtox-010919-023229. Epub 2020 Oct 9.']",17/05/2021,https://clinicaltrials.gov/show/NCT04889274,01/08/2021,0,1
2626,NCT04894721,Recruiting,30/05/2021,30/05/2021,No Results Posted,,,20/05/2021,https://clinicaltrials.gov/show/NCT04894721,30/05/2021,0,0
2627,NCT04895449,Not yet recruiting,01/03/2022,01/03/2022,No Results Posted,,,20/05/2021,https://clinicaltrials.gov/show/NCT04895449,01/03/2022,0,0
2628,NCT04306393,"Active, not recruiting",21/12/2021,21/12/2022,No Results Posted,"['Gibson LE, Fenza RD, Lang M, Capriles MI, Li MD, Kalpathy-Cramer J, Little BP, Arora P, Mueller AL, Ichinose F, Bittner EA, Berra L, G Chang M. Right Ventricular Strain Is Common in Intubated COVID-19 Patients and Does Not Reflect Severity of Respiratory Illness. J Intensive Care Med. 2021 Mar 30:8850666211006335. doi: 10.1177/08850666211006335. [Epub ahead of print]', 'Lei C, Su B, Dong H, Bellavia A, Di Fenza R, Safaee Fakhr B, Gianni S, Grassi LG, Kacmarek R, Araujo Morais CC, Pinciroli R, Vassena E, Berra L. Protocol of a randomized controlled trial testing inhaled Nitric Oxide in mechanically ventilated patients with severe acute respiratory syndrome in COVID-19 (SARS-CoV-2). medRxiv. 2020 Mar 13. pii: 2020.03.09.20033530. doi: 10.1101/2020.03.09.20033530.']",,25/05/2021,https://clinicaltrials.gov/show/NCT04306393,21/12/2021,0,1
2629,NCT04328493,Completed,10/09/2020,10/09/2020,No Results Posted,"['Kestelyn E, Dung NTP, Lam Minh Y, Hung LM, Quan NM, Dung NT, Minh NNQ, Xuan TC, Phong NT, Ninh Thi Thanh V, Donovan J, Tu TNH, Nhat LTH, Truong NT, Man DNH, Thao HP, Ngoc NM, Lam VT, Phat HH, Phuong PM, Geskus RB, Ha VTN, Quang NN, Tran Tinh H, Tan LV, Thwaites GE, Day JN, Chau NVV; OUCRU COVID-19 Research Group. A multi centre randomized open label trial of chloroquine for the treatment of adults with SARS-CoV-2 infection in Vietnam. Wellcome Open Res. 2020 Jun 12;5:141. doi: 10.12688/wellcomeopenres.15936.1. eCollection 2020.']",,24/05/2021,https://clinicaltrials.gov/show/NCT04328493,10/09/2020,0,1
2630,NCT04330690,Recruiting,18/03/2022,18/05/2022,No Results Posted,,,21/05/2021,https://clinicaltrials.gov/show/NCT04330690,18/03/2022,0,0
2631,NCT04331899,Completed,14/08/2020,06/05/2021,Study Results,,"['Jagannathan P, Andrews JR, Bonilla H, Hedlin H, Jacobson KB, Balasubramanian V, Purington N, Kamble S, de Vries CR, Quintero O, Feng K, Ley C, Winslow D, Newberry J, Edwards K, Hislop C, Choong I, Maldonado Y, Glenn J, Bhatt A, Blish C, Wang T, Khosla C, Pinsky BA, Desai M, Parsonnet J, Singh U. Peginterferon Lambda-1a for treatment of outpatients with uncomplicated COVID-19: a randomized placebo-controlled trial. Nat Commun. 2021 Mar 30;12(1):1967. doi: 10.1038/s41467-021-22177-1.']",21/05/2021,https://clinicaltrials.gov/show/NCT04331899,14/08/2020,1,1
2632,NCT04336410,"Active, not recruiting",01/01/2022,01/01/2022,No Results Posted,"['Tebas P, Yang S, Boyer JD, Reuschel EL, Patel A, Christensen-Quick A, Andrade VM, Morrow MP, Kraynyak K, Agnes J, Purwar M, Sylvester A, Pawlicki J, Gillespie E, Maricic I, Zaidi FI, Kim KY, Dia Y, Frase D, Pezzoli P, Schultheis K, Smith TRF, Ramos SJ, McMullan T, Buttigieg K, Carroll MW, Ervin J, Diehl MC, Blackwood E, Mammen MP, Lee J, Dallas MJ, Brown AS, Shea JE, Kim JJ, Weiner DB, Broderick KE, Humeau LM. Safety and immunogenicity of INO-4800 DNA vaccine against SARS-CoV-2: A preliminary report of an open-label, Phase 1 clinical trial. EClinicalMedicine. 2021 Jan;31:100689. doi: 10.1016/j.eclinm.2020.100689. Epub 2020 Dec 24.']",,01/06/2021,https://clinicaltrials.gov/show/NCT04336410,01/01/2022,0,1
2633,NCT04340557,Completed,13/06/2020,13/06/2020,Study Results,"['Geriak M, Haddad F, Kullar R, Greenwood KL, Habib M, Habib C, Willms D, Sakoulas G. Randomized Prospective Open Label Study Shows No Impact on Clinical Outcome of Adding Losartan to Hospitalized COVID-19 Patients with Mild Hypoxemia. Infect Dis Ther. 2021 May 11. doi: 10.1007/s40121-021-00453-3. [Epub ahead of print]']",,26/05/2021,https://clinicaltrials.gov/show/NCT04340557,13/06/2020,1,1
2634,NCT04341116,Recruiting,01/12/2021,01/12/2021,No Results Posted,,,24/05/2021,https://clinicaltrials.gov/show/NCT04341116,01/12/2021,0,0
2635,NCT04345848,Recruiting,30/09/2021,30/09/2021,No Results Posted,"['Flumignan RL, Tin√¥co JDS, Pascoal PI, Areias LL, Cossi MS, Fernandes MI, Costa IK, Souza L, Matar CF, Tendal B, Trevisani VF, Atallah √ÅN, Nakano LC. Prophylactic anticoagulants for people hospitalised with COVID-19. Cochrane Database Syst Rev. 2020 Oct 2;10:CD013739. doi: 10.1002/14651858.CD013739.', 'Levi M, Thachil J, Iba T, Levy JH. Coagulation abnormalities and thrombosis in patients with COVID-19. Lancet Haematol. 2020 Jun;7(6):e438-e440. doi: 10.1016/S2352-3026(20)30145-9. Epub 2020 May 11.']",,21/05/2021,https://clinicaltrials.gov/show/NCT04345848,30/09/2021,0,1
2636,NCT04358549,"Active, not recruiting",01/11/2020,01/07/2021,No Results Posted,,,26/05/2021,https://clinicaltrials.gov/show/NCT04358549,01/11/2020,0,0
2637,NCT04358783,Completed,01/05/2021,01/05/2021,No Results Posted,,,26/05/2021,https://clinicaltrials.gov/show/NCT04358783,01/05/2021,0,0
2638,NCT04359095,Recruiting,20/03/2021,30/06/2021,No Results Posted,,"['Hatem A, Mohamed S, Abu Elhassan UE, Ismael EAM, Rizk MS, El-Kholy A, El-Harras M. Clinical characteristics and outcomes of patients with severe acute respiratory infections (SARI): results from the Egyptian surveillance study 2010-2014. Multidiscip Respir Med. 2019 Apr 1;14:11. doi: 10.1186/s40248-019-0174-7. eCollection 2019.', 'Guan WJ, Ni ZY, Hu Y, Liang WH, Ou CQ, He JX, Liu L, Shan H, Lei CL, Hui DSC, Du B, Li LJ, Zeng G, Yuen KY, Chen RC, Tang CL, Wang T, Chen PY, Xiang J, Li SY, Wang JL, Liang ZJ, Peng YX, Wei L, Liu Y, Hu YH, Peng P, Wang JM, Liu JY, Chen Z, Li G, Zheng ZJ, Qiu SQ, Luo J, Ye CJ, Zhu SY, Zhong NS; China Medical Treatment Expert Group for Covid-19. Clinical Characteristics of Coronavirus Disease 2019 in China. N Engl J Med. 2020 Apr 30;382(18):1708-1720. doi: 10.1056/NEJMoa2002032. Epub 2020 Feb 28.', 'Munster VJ, Koopmans M, van Doremalen N, van Riel D, de Wit E. A Novel Coronavirus Emerging in China - Key Questions for Impact Assessment. N Engl J Med. 2020 Feb 20;382(8):692-694. doi: 10.1056/NEJMp2000929. Epub 2020 Jan 24.', 'Zu ZY, Jiang MD, Xu PP, Chen W, Ni QQ, Lu GM, Zhang LJ. Coronavirus Disease 2019 (COVID-19): A Perspective from China. Radiology. 2020 Aug;296(2):E15-E25. doi: 10.1148/radiol.2020200490. Epub 2020 Feb 21. Review.', 'Asociaci√≥n Colombiana de Infectolog√≠a. Consenso Colombiano de atenci√≥n, diagn√≥stico y manejo de la Infecci√≥n por SARS COV-2 / COVID 19 en establecimientos de atenci√≥n de la salud. 2020.', 'Wang M, Cao R, Zhang L, Yang X, Liu J, Xu M, Shi Z, Hu Z, Zhong W, Xiao G. Remdesivir and chloroquine effectively inhibit the recently emerged novel coronavirus (2019-nCoV) in vitro. Cell Res. 2020 Mar;30(3):269-271. doi: 10.1038/s41422-020-0282-0. Epub 2020 Feb 4.', 'Yao X, Ye F, Zhang M, Cui C, Huang B, Niu P, Liu X, Zhao L, Dong E, Song C, Zhan S, Lu R, Li H, Tan W, Liu D. In Vitro Antiviral Activity and Projection of Optimized Dosing Design of Hydroxychloroquine for the Treatment of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2). Clin Infect Dis. 2020 Jul 28;71(15):732-739. doi: 10.1093/cid/ciaa237.', 'Mo Y, Fisher D. A review of treatment modalities for Middle East Respiratory Syndrome. J Antimicrob Chemother. 2016 Dec;71(12):3340-3350. Epub 2016 Sep 1. Review.', 'Cao B, Wang Y, Wen D, Liu W, Wang J, Fan G, Ruan L, Song B, Cai Y, Wei M, Li X, Xia J, Chen N, Xiang J, Yu T, Bai T, Xie X, Zhang L, Li C, Yuan Y, Chen H, Li H, Huang H, Tu S, Gong F, Liu Y, Wei Y, Dong C, Zhou F, Gu X, Xu J, Liu Z, Zhang Y, Li H, Shang L, Wang K, Li K, Zhou X, Dong X, Qu Z, Lu S, Hu X, Ruan S, Luo S, Wu J, Peng L, Cheng F, Pan L, Zou J, Jia C, Wang J, Liu X, Wang S, Wu X, Ge Q, He J, Zhan H, Qiu F, Guo L, Huang C, Jaki T, Hayden FG, Horby PW, Zhang D, Wang C. A Trial of Lopinavir-Ritonavir in Adults Hospitalized with Severe Covid-19. N Engl J Med. 2020 May 7;382(19):1787-1799. doi: 10.1056/NEJMoa2001282. Epub 2020 Mar 18.', 'Devaux CA, Rolain JM, Colson P, Raoult D. New insights on the antiviral effects of chloroquine against coronavirus: what to expect for COVID-19? Int J Antimicrob Agents. 2020 May;55(5):105938. doi: 10.1016/j.ijantimicag.2020.105938. Epub 2020 Mar 12.', 'Romanelli F, Smith KM, Hoven AD. Chloroquine and hydroxychloroquine as inhibitors of human immunodeficiency virus (HIV-1) activity. Curr Pharm Des. 2004;10(21):2643-8. Review.', 'Yan Y, Zou Z, Sun Y, Li X, Xu KF, Wei Y, Jin N, Jiang C. Anti-malaria drug chloroquine is highly effective in treating avian influenza A H5N1 virus infection in an animal model. Cell Res. 2013 Feb;23(2):300-2. doi: 10.1038/cr.2012.165. Epub 2012 Dec 4.', 'Khan M, Santhosh SR, Tiwari M, Lakshmana Rao PV, Parida M. Assessment of in vitro prophylactic and therapeutic efficacy of chloroquine against Chikungunya virus in vero cells. J Med Virol. 2010 May;82(5):817-24. doi: 10.1002/jmv.21663.', 'Farias KJ, Machado PR, de Almeida Junior RF, de Aquino AA, da Fonseca BA. Chloroquine interferes with dengue-2 virus replication in U937 cells. Microbiol Immunol. 2014 Jun;58(6):318-26. doi: 10.1111/1348-0421.12154.', 'Gao J, Tian Z, Yang X. Breakthrough: Chloroquine phosphate has shown apparent efficacy in treatment of COVID-19 associated pneumonia in clinical studies. Biosci Trends. 2020 Mar 16;14(1):72-73. doi: 10.5582/bst.2020.01047. Epub 2020 Feb 19.', 'Gautret P, Lagier JC, Parola P, Hoang VT, Meddeb L, Mailhe M, Doudier B, Courjon J, Giordanengo V, Vieira VE, Tissot Dupont H, Honor√© S, Colson P, Chabri√®re E, La Scola B, Rolain JM, Brouqui P, Raoult D. Hydroxychloroquine and azithromycin as a treatment of COVID-19: results of an open-label non-randomized clinical trial. Int J Antimicrob Agents. 2020 Jul;56(1):105949. doi: 10.1016/j.ijantimicag.2020.105949. Epub 2020 Mar 20.', 'Ruuskanen O, Lahti E, Jennings LC, Murdoch DR. Viral pneumonia. Lancet. 2011 Apr 9;377(9773):1264-75. doi: 10.1016/S0140-6736(10)61459-6. Epub 2011 Mar 22. Review.', 'de Wit E, van Doremalen N, Falzarano D, Munster VJ. SARS and MERS: recent insights into emerging coronaviruses. Nat Rev Microbiol. 2016 Aug;14(8):523-34. doi: 10.1038/nrmicro.2016.81. Epub 2016 Jun 27. Review.', 'Short KR, Kedzierska K, van de Sandt CE. Back to the Future: Lessons Learned From the 1918 Influenza Pandemic. Front Cell Infect Microbiol. 2018 Oct 8;8:343. doi: 10.3389/fcimb.2018.00343. eCollection 2018. Review.', 'Lipatov AS, Govorkova EA, Webby RJ, Ozaki H, Peiris M, Guan Y, Poon L, Webster RG. Influenza: emergence and control. J Virol. 2004 Sep;78(17):8951-9. Review.', 'Remolina YA, Ulloa MM, Vargas H, D√≠az L, G√≥mez SL, Saavedra A, S√°nchez E, Cort√©s JA. Viral Infection in Adults with Severe Acute Respiratory Infection in Colombia. PLoS One. 2015 Nov 17;10(11):e0143152. doi: 10.1371/journal.pone.0143152. eCollection 2015.', 'Lachin JM. A review of methods for futility stopping based on conditional power. Stat Med. 2005 Sep 30;24(18):2747-64. Review.']",25/05/2021,https://clinicaltrials.gov/show/NCT04359095,20/03/2021,0,1
2639,NCT04362137,Completed,17/10/2020,17/10/2020,Study Results,,,02/06/2021,https://clinicaltrials.gov/show/NCT04362137,17/10/2020,1,0
2640,NCT04368728,Recruiting,02/11/2021,02/05/2023,No Results Posted,"['Frenck RW Jr, Klein NP, Kitchin N, Gurtman A, Absalon J, Lockhart S, Perez JL, Walter EB, Senders S, Bailey R, Swanson KA, Ma H, Xu X, Koury K, Kalina WV, Cooper D, Jennings T, Brandon DM, Thomas SJ, T√ºreci √ñ, Tresnan DB, Mather S, Dormitzer PR, ≈ûahin U, Jansen KU, Gruber WC; C4591001 Clinical Trial Group. Safety, Immunogenicity, and Efficacy of the BNT162b2 Covid-19 Vaccine in Adolescents. N Engl J Med. 2021 May 27. doi: 10.1056/NEJMoa2107456. [Epub ahead of print]', 'Vogel AB, Kanevsky I, Che Y, Swanson KA, Muik A, Vormehr M, Kranz LM, Walzer KC, Hein S, G√ºler A, Loschko J, Maddur MS, Ota-Setlik A, Tompkins K, Cole J, Lui BG, Ziegenhals T, Plaschke A, Eisel D, Dany SC, Fesser S, Erbar S, Bates F, Schneider D, Jesionek B, S√§nger B, Wallisch AK, Feuchter Y, Junginger H, Krumm SA, Heinen AP, Adams-Quack P, Schlereth J, Schille S, Kr√∂ner C, de la Caridad G√ºimil Garcia R, Hiller T, Fischer L, Sellers RS, Choudhary S, Gonzalez O, Vascotto F, Gutman MR, Fontenot JA, Hall-Ursone S, Brasky K, Griffor MC, Han S, Su AAH, Lees JA, Nedoma NL, Mashalidis EH, Sahasrabudhe PV, Tan CY, Pavliakova D, Singh G, Fontes-Garfias C, Pride M, Scully IL, Ciolino T, Obregon J, Gazi M, Carrion R Jr, Alfson KJ, Kalina WV, Kaushal D, Shi PY, Klamp T, Rosenbaum C, Kuhn AN, T√ºreci √ñ, Dormitzer PR, Jansen KU, Sahin U. BNT162b vaccines protect rhesus macaques from SARS-CoV-2. Nature. 2021 Apr;592(7853):283-289. doi: 10.1038/s41586-021-03275-y. Epub 2021 Feb 1.', 'Polack FP, Thomas SJ, Kitchin N, Absalon J, Gurtman A, Lockhart S, Perez JL, P√©rez Marc G, Moreira ED, Zerbini C, Bailey R, Swanson KA, Roychoudhury S, Koury K, Li P, Kalina WV, Cooper D, Frenck RW Jr, Hammitt LL, T√ºreci √ñ, Nell H, Schaefer A, √únal S, Tresnan DB, Mather S, Dormitzer PR, ≈ûahin U, Jansen KU, Gruber WC; C4591001 Clinical Trial Group. Safety and Efficacy of the BNT162b2 mRNA Covid-19 Vaccine. N Engl J Med. 2020 Dec 31;383(27):2603-2615. doi: 10.1056/NEJMoa2034577. Epub 2020 Dec 10.', 'Walsh EE, Frenck RW Jr, Falsey AR, Kitchin N, Absalon J, Gurtman A, Lockhart S, Neuzil K, Mulligan MJ, Bailey R, Swanson KA, Li P, Koury K, Kalina W, Cooper D, Fontes-Garfias C, Shi PY, T√ºreci √ñ, Tompkins KR, Lyke KE, Raabe V, Dormitzer PR, Jansen KU, ≈ûahin U, Gruber WC. Safety and Immunogenicity of Two RNA-Based Covid-19 Vaccine Candidates. N Engl J Med. 2020 Dec 17;383(25):2439-2450. doi: 10.1056/NEJMoa2027906. Epub 2020 Oct 14.', 'Mulligan MJ, Lyke KE, Kitchin N, Absalon J, Gurtman A, Lockhart S, Neuzil K, Raabe V, Bailey R, Swanson KA, Li P, Koury K, Kalina W, Cooper D, Fontes-Garfias C, Shi PY, T√ºreci √ñ, Tompkins KR, Walsh EE, Frenck R, Falsey AR, Dormitzer PR, Gruber WC, ≈ûahin U, Jansen KU. Phase I/II study of COVID-19 RNA vaccine BNT162b1 in adults. Nature. 2020 Oct;586(7830):589-593. doi: 10.1038/s41586-020-2639-4. Epub 2020 Aug 12. Erratum in: Nature. 2021 Feb;590(7844):E26.']",,01/06/2021,https://clinicaltrials.gov/show/NCT04368728,02/11/2021,0,1
2641,NCT04369066,"Active, not recruiting",01/12/2021,01/02/2022,No Results Posted,,,19/05/2021,https://clinicaltrials.gov/show/NCT04369066,01/12/2021,0,0
2642,NCT04370834,Terminated,14/01/2021,14/01/2021,Study Results,,,04/06/2021,https://clinicaltrials.gov/show/NCT04370834,14/01/2021,1,0
2643,NCT04371367,Completed,30/03/2021,30/03/2021,No Results Posted,,,27/05/2021,https://clinicaltrials.gov/show/NCT04371367,30/03/2021,0,0
2644,NCT04371978,Terminated,04/04/2021,04/05/2021,No Results Posted,,,02/06/2021,https://clinicaltrials.gov/show/NCT04371978,04/04/2021,0,0
2645,NCT04372602,Recruiting,30/11/2021,30/04/2022,No Results Posted,,,25/05/2021,https://clinicaltrials.gov/show/NCT04372602,30/11/2021,0,0
2646,NCT04373044,Terminated,12/05/2021,12/05/2021,No Results Posted,,,26/05/2021,https://clinicaltrials.gov/show/NCT04373044,12/05/2021,0,0
2647,NCT04374526,Completed,26/05/2021,26/05/2021,No Results Posted,"['Teofili L, Landolfi R, Cingolani A, Antinori A, Vecchiet J, Sanguinetti M, Gasbarrini A, Pasciuto T, Orlando N, Lamonica S. ""Early transfusion of convalescent plasma in older patients with COVID-19 to prevent disease progression: A structured summary of a study protocol for a randomised controlled trial"". Trials. 2020 Oct 22;21(1):875. doi: 10.1186/s13063-020-04821-1.']",,28/05/2021,https://clinicaltrials.gov/show/NCT04374526,26/05/2021,0,1
2648,NCT04384900,Withdrawn,25/05/2021,25/05/2021,No Results Posted,,,28/05/2021,https://clinicaltrials.gov/show/NCT04384900,25/05/2021,0,0
2649,NCT04385199,Completed,01/08/2020,01/08/2020,No Results Posted,,,27/05/2021,https://clinicaltrials.gov/show/NCT04385199,01/08/2020,0,0
2650,NCT04385849,"Active, not recruiting",11/07/2022,11/07/2022,No Results Posted,,,01/06/2021,https://clinicaltrials.gov/show/NCT04385849,11/07/2022,0,0
2651,NCT04385940,Recruiting,01/01/2023,01/01/2023,No Results Posted,,,19/05/2021,https://clinicaltrials.gov/show/NCT04385940,01/01/2023,0,0
2652,NCT04386252,Not yet recruiting,01/02/2022,01/09/2022,No Results Posted,,,01/06/2021,https://clinicaltrials.gov/show/NCT04386252,01/02/2022,0,0
2653,NCT04386291,"Active, not recruiting",19/04/2021,30/01/2022,No Results Posted,,,01/06/2021,https://clinicaltrials.gov/show/NCT04386291,19/04/2021,0,0
2654,NCT04389840,Terminated,20/05/2021,20/05/2021,No Results Posted,"['Lasky JA, Fuloria J, Morrison ME, Lanier R, Naderer O, Brundage T, Melemed A. Design and Rationale of a Randomized, Double-Blind, Placebo-Controlled, Phase 2/3 Study Evaluating Dociparstat in Acute Lung Injury Associated with Severe COVID-19. Adv Ther. 2021 Jan;38(1):782-791. doi: 10.1007/s12325-020-01539-z. Epub 2020 Oct 27.']",,26/05/2021,https://clinicaltrials.gov/show/NCT04389840,20/05/2021,0,1
2655,NCT04392778,Completed,01/11/2020,30/11/2020,No Results Posted,,,25/05/2021,https://clinicaltrials.gov/show/NCT04392778,01/11/2020,0,0
2656,NCT04395105,Terminated,05/04/2021,21/05/2021,No Results Posted,"['Maskin LP, Olarte GL, Palizas F Jr, Velo AE, Lurbet MF, Bonelli I, Baredes ND, Rodr√≠guez PO. High dose dexamethasone treatment for Acute Respiratory Distress Syndrome secondary to COVID-19: a structured summary of a study protocol for a randomised controlled trial. Trials. 2020 Aug 26;21(1):743. doi: 10.1186/s13063-020-04646-y.']",,02/06/2021,https://clinicaltrials.gov/show/NCT04395105,05/04/2021,0,1
2657,NCT04397796,"Active, not recruiting",01/06/2021,01/06/2021,No Results Posted,,,27/05/2021,https://clinicaltrials.gov/show/NCT04397796,01/06/2021,0,0
2658,NCT04399889,Recruiting,01/04/2022,31/07/2022,No Results Posted,,,24/05/2021,https://clinicaltrials.gov/show/NCT04399889,01/04/2022,0,0
2659,NCT04400890,Terminated,01/03/2021,01/03/2021,No Results Posted,,,25/05/2021,https://clinicaltrials.gov/show/NCT04400890,01/03/2021,0,0
2660,NCT04401202,Completed,31/12/2020,31/12/2020,Study Results,"['Koshak AE, Koshak EA, Mobeireek AF, Badawi MA, Wali SO, Malibary HM, Atwah AF, Alhamdan MM, Almalki RA, Madani TA. Nigella sativa supplementation to treat symptomatic mild COVID-19: A structured summary of a protocol for a randomised, controlled, clinical trial. Trials. 2020 Aug 8;21(1):703. doi: 10.1186/s13063-020-04647-x.']",,26/05/2021,https://clinicaltrials.gov/show/NCT04401202,31/12/2020,1,1
2661,NCT04404426,Completed,25/03/2021,28/05/2021,No Results Posted,,,02/06/2021,https://clinicaltrials.gov/show/NCT04404426,25/03/2021,0,0
2662,NCT04405102,Recruiting,01/01/2023,01/01/2024,No Results Posted,,,01/06/2021,https://clinicaltrials.gov/show/NCT04405102,01/01/2023,0,0
2663,NCT04405739,Recruiting,16/08/2021,08/12/2021,No Results Posted,"['Cox RM, Wolf JD, Plemper RK. Therapeutically administered ribonucleoside analogue MK-4482/EIDD-2801 blocks SARS-CoV-2 transmission in ferrets. Nat Microbiol. 2021 Jan;6(1):11-18. doi: 10.1038/s41564-020-00835-2. Epub 2020 Dec 3.']",,20/05/2021,https://clinicaltrials.gov/show/NCT04405739,16/08/2021,0,1
2664,NCT04407507,Completed,29/01/2021,29/01/2021,Study Results,,"['Caly L, Druce JD, Catton MG, Jans DA, Wagstaff KM. The FDA-approved drug ivermectin inhibits the replication of SARS-CoV-2 in vitro. Antiviral Res. 2020 Jun;178:104787. doi: 10.1016/j.antiviral.2020.104787. Epub 2020 Apr 3.', 'Chaccour CJ, Kobylinski KC, Bassat Q, Bousema T, Drakeley C, Alonso P, Foy BD. Ivermectin to reduce malaria transmission: a research agenda for a promising new tool for elimination. Malar J. 2013 May 7;12:153. doi: 10.1186/1475-2875-12-153.', ""Smit MR, Ochomo E, Aljayyoussi G, Kwambai T, Abong'o B, Bayoh N, Gimnig J, Samuels A, Desai M, Phillips-Howard PA, Kariuki S, Wang D, Ward S, Ter Kuile FO. Efficacy and Safety of High-Dose Ivermectin for Reducing Malaria Transmission (IVERMAL): Protocol for a Double-Blind, Randomized, Placebo-Controlled, Dose-Finding Trial in Western Kenya. JMIR Res Protoc. 2016 Nov 17;5(4):e213."", 'Xie M, Chen Q. Insight into 2019 novel coronavirus - An updated interim review and lessons from SARS-CoV and MERS-CoV. Int J Infect Dis. 2020 May;94:119-124. doi: 10.1016/j.ijid.2020.03.071. Epub 2020 Apr 1. Review.', 'Yang SNY, Atkinson SC, Wang C, Lee A, Bogoyevitch MA, Borg NA, Jans DA. The broad spectrum antiviral ivermectin targets the host nuclear transport importin Œ±/Œ≤1 heterodimer. Antiviral Res. 2020 May;177:104760. doi: 10.1016/j.antiviral.2020.104760. Epub 2020 Mar 3.']",21/05/2021,https://clinicaltrials.gov/show/NCT04407507,29/01/2021,1,1
2665,NCT04415151,Recruiting,31/12/2021,31/12/2021,No Results Posted,,,21/05/2021,https://clinicaltrials.gov/show/NCT04415151,31/12/2021,0,0
2666,NCT04417257,"Active, not recruiting",15/07/2021,15/08/2021,No Results Posted,,,01/07/2021,https://clinicaltrials.gov/show/NCT04417257,15/07/2021,0,0
2667,NCT04419025,Completed,14/05/2021,14/05/2021,No Results Posted,,,28/05/2021,https://clinicaltrials.gov/show/NCT04419025,14/05/2021,0,0
2668,NCT04419610,Completed,12/05/2021,12/05/2021,No Results Posted,,,27/05/2021,https://clinicaltrials.gov/show/NCT04419610,12/05/2021,0,0
2669,NCT04420182,Recruiting,30/06/2021,31/12/2021,No Results Posted,,,21/05/2021,https://clinicaltrials.gov/show/NCT04420182,30/06/2021,0,0
2670,NCT04424082,Completed,25/06/2020,27/05/2021,No Results Posted,,,28/05/2021,https://clinicaltrials.gov/show/NCT04424082,25/06/2020,0,0
2671,NCT04425629,Recruiting,18/06/2021,26/11/2021,No Results Posted,"['Weinreich DM, Sivapalasingam S, Norton T, Ali S, Gao H, Bhore R, Musser BJ, Soo Y, Rofail D, Im J, Perry C, Pan C, Hosain R, Mahmood A, Davis JD, Turner KC, Hooper AT, Hamilton JD, Baum A, Kyratsous CA, Kim Y, Cook A, Kampman W, Kohli A, Sachdeva Y, Graber X, Kowal B, DiCioccio T, Stahl N, Lipsich L, Braunstein N, Herman G, Yancopoulos GD; Trial Investigators. REGN-COV2, a Neutralizing Antibody Cocktail, in Outpatients with Covid-19. N Engl J Med. 2021 Jan 21;384(3):238-251. doi: 10.1056/NEJMoa2035002. Epub 2020 Dec 17.']",,20/05/2021,https://clinicaltrials.gov/show/NCT04425629,18/06/2021,0,1
2672,NCT04429724,"Active, not recruiting",16/03/2021,01/12/2021,No Results Posted,,,24/05/2021,https://clinicaltrials.gov/show/NCT04429724,16/03/2021,0,0
2673,NCT04441047,Recruiting,20/06/2022,31/12/2022,No Results Posted,,,29/06/2021,https://clinicaltrials.gov/show/NCT04441047,20/06/2022,0,0
2674,NCT04442048,"Active, not recruiting",31/12/2021,31/03/2022,No Results Posted,,,18/05/2021,https://clinicaltrials.gov/show/NCT04442048,31/12/2021,0,0
2675,NCT04443881,Completed,31/03/2021,31/03/2021,No Results Posted,,,01/06/2021,https://clinicaltrials.gov/show/NCT04443881,31/03/2021,0,0
2676,NCT04445285,Recruiting,30/11/2021,28/02/2022,No Results Posted,,,28/05/2021,https://clinicaltrials.gov/show/NCT04445285,30/11/2021,0,0
2677,NCT04451174,Terminated,30/01/2021,30/01/2021,No Results Posted,"['Salinas M, Andino P, Palma L, Valencia J, Figueroa E, Ortega J. Early use of corticosteroids in non-critical patients with COVID-19 pneumonia (PREDCOVID): a structured summary of a study protocol for a randomised controlled trial. Trials. 2021 Jan 26;22(1):92. doi: 10.1186/s13063-021-05046-6.']",,03/06/2021,https://clinicaltrials.gov/show/NCT04451174,30/01/2021,0,1
2678,NCT04453774,Recruiting,01/02/2022,01/04/2023,No Results Posted,,,24/05/2021,https://clinicaltrials.gov/show/NCT04453774,01/02/2022,0,0
2679,NCT04456062,"Active, not recruiting",20/07/2021,31/07/2021,No Results Posted,,,21/05/2021,https://clinicaltrials.gov/show/NCT04456062,20/07/2021,0,0
2680,NCT04458519,Completed,27/05/2021,27/05/2021,No Results Posted,,,01/06/2021,https://clinicaltrials.gov/show/NCT04458519,27/05/2021,0,0
2681,NCT04460651,Recruiting,01/06/2021,01/07/2021,No Results Posted,,,24/05/2021,https://clinicaltrials.gov/show/NCT04460651,01/06/2021,0,0
2682,NCT04467086,Recruiting,01/06/2021,01/07/2021,No Results Posted,,,20/05/2021,https://clinicaltrials.gov/show/NCT04467086,01/06/2021,0,0
2683,NCT04468087,Recruiting,28/07/2021,30/07/2021,No Results Posted,,,28/05/2021,https://clinicaltrials.gov/show/NCT04468087,28/07/2021,0,0
2684,NCT04471519,"Active, not recruiting",31/07/2020,30/06/2021,No Results Posted,"['Ella R, Reddy S, Jogdand H, Sarangi V, Ganneru B, Prasad S, Das D, Raju D, Praturi U, Sapkal G, Yadav P, Reddy P, Verma S, Singh C, Redkar SV, Gillurkar CS, Kushwaha JS, Mohapatra S, Bhate A, Rai S, Panda S, Abraham P, Gupta N, Ella K, Bhargava B, Vadrevu KM. Safety and immunogenicity of an inactivated SARS-CoV-2 vaccine, BBV152: interim results from a double-blind, randomised, multicentre, phase 2 trial, and 3-month follow-up of a double-blind, randomised phase 1 trial. Lancet Infect Dis. 2021 Mar 8. pii: S1473-3099(21)00070-0. doi: 10.1016/S1473-3099(21)00070-0. [Epub ahead of print]', 'Yadav PD, Ella R, Kumar S, Patil DR, Mohandas S, Shete AM, Vadrevu KM, Bhati G, Sapkal G, Kaushal H, Patil S, Jain R, Deshpande G, Gupta N, Agarwal K, Gokhale M, Mathapati B, Metkari S, Mote C, Nyayanit D, Patil DY, Sai Prasad BS, Suryawanshi A, Kadam M, Kumar A, Daigude S, Gopale S, Majumdar T, Mali D, Sarkale P, Baradkar S, Gawande P, Joshi Y, Fulari S, Dighe H, Sharma S, Gunjikar R, Kumar A, Kalele K, Srinivas VK, Gangakhedkar RR, Ella KM, Abraham P, Panda S, Bhargava B. Immunogenicity and protective efficacy of inactivated SARS-CoV-2 vaccine candidate, BBV152 in rhesus macaques. Nat Commun. 2021 Mar 2;12(1):1386. doi: 10.1038/s41467-021-21639-w.', 'Ella R, Vadrevu KM, Jogdand H, Prasad S, Reddy S, Sarangi V, Ganneru B, Sapkal G, Yadav P, Abraham P, Panda S, Gupta N, Reddy P, Verma S, Kumar Rai S, Singh C, Redkar SV, Gillurkar CS, Kushwaha JS, Mohapatra S, Rao V, Guleria R, Ella K, Bhargava B. Safety and immunogenicity of an inactivated SARS-CoV-2 vaccine, BBV152: a double-blind, randomised, phase 1 trial. Lancet Infect Dis. 2021 May;21(5):637-646. doi: 10.1016/S1473-3099(20)30942-7. Epub 2021 Jan 21. Erratum in: Lancet Infect Dis. 2021 Apr;21(4):e81.']",,20/05/2021,https://clinicaltrials.gov/show/NCT04471519,31/07/2020,0,1
2685,NCT04475107,Completed,25/03/2021,15/04/2021,No Results Posted,,,01/06/2021,https://clinicaltrials.gov/show/NCT04475107,25/03/2021,0,0
2686,NCT04475991,Recruiting,01/10/2021,01/02/2022,No Results Posted,,,09/07/2021,https://clinicaltrials.gov/show/NCT04475991,01/10/2021,0,0
2687,NCT04480138,"Active, not recruiting",31/07/2021,31/08/2021,No Results Posted,,,29/06/2021,https://clinicaltrials.gov/show/NCT04480138,31/07/2021,0,0
2688,NCT04482712,Withdrawn,01/01/2022,01/01/2023,No Results Posted,,,01/06/2021,https://clinicaltrials.gov/show/NCT04482712,01/01/2022,0,0
2689,NCT04483635,Terminated,04/05/2021,25/05/2021,No Results Posted,,,28/05/2021,https://clinicaltrials.gov/show/NCT04483635,04/05/2021,0,0
2690,NCT04487210,"Active, not recruiting",30/06/2021,30/11/2021,No Results Posted,"['Hsieh SM, Liu WD, Huang YS, Lin YJ, Hsieh EF, Lian WC, Chen C, Janssen R, Shih SR, Huang CG, Tai IC, Chang SC. Safety and immunogenicity of a Recombinant Stabilized Prefusion SARS-CoV-2 Spike Protein Vaccine (MVC-COV1901) Adjuvanted with CpG 1018 and Aluminum Hydroxide in healthy adults: A Phase 1, dose-escalation study. EClinicalMedicine. 2021 Jun 26:100989. doi: 10.1016/j.eclinm.2021.100989. [Epub ahead of print]']",,24/05/2021,https://clinicaltrials.gov/show/NCT04487210,30/06/2021,0,1
2691,NCT04492527,"Active, not recruiting",30/06/2021,31/07/2021,No Results Posted,,,21/05/2021,https://clinicaltrials.gov/show/NCT04492527,30/06/2021,0,0
2692,NCT04517006,Completed,04/04/2021,04/04/2021,No Results Posted,,,26/05/2021,https://clinicaltrials.gov/show/NCT04517006,04/04/2021,0,0
2693,NCT04530474,Withdrawn,30/06/2021,30/06/2021,No Results Posted,,,26/05/2021,https://clinicaltrials.gov/show/NCT04530474,30/06/2021,0,0
2694,NCT04532294,Completed,15/01/2021,13/02/2021,No Results Posted,,,18/05/2021,https://clinicaltrials.gov/show/NCT04532294,15/01/2021,0,0
2695,NCT04536350,Recruiting,01/12/2021,01/04/2022,No Results Posted,,,21/05/2021,https://clinicaltrials.gov/show/NCT04536350,01/12/2021,0,0
2696,NCT04537351,Recruiting,31/12/2021,31/12/2021,No Results Posted,,,20/05/2021,https://clinicaltrials.gov/show/NCT04537351,31/12/2021,0,0
2697,NCT04537663,Recruiting,25/06/2021,25/07/2021,No Results Posted,,,21/05/2021,https://clinicaltrials.gov/show/NCT04537663,25/06/2021,0,0
2698,NCT04543760,Completed,15/01/2021,14/03/2021,No Results Posted,,,19/05/2021,https://clinicaltrials.gov/show/NCT04543760,15/01/2021,0,0
2699,NCT04558476,Recruiting,01/09/2022,01/09/2022,No Results Posted,"['Misset B, Hoste E, Donneau AF, Grimaldi D, Meyfroidt G, Moutschen M, Compernolle V, Gothot A, Desmecht D, Garigliany M, Najdovski T, Laterre PF. A multicenter randomized trial to assess the efficacy of CONvalescent plasma therapy in patients with Invasive COVID-19 and acute respiratory failure treated with mechanical ventilation: the CONFIDENT trial protocol. BMC Pulm Med. 2020 Dec 7;20(1):317. doi: 10.1186/s12890-020-01361-x.']",,28/05/2021,https://clinicaltrials.gov/show/NCT04558476,01/09/2022,0,1
2700,NCT04565249,Recruiting,31/08/2021,31/10/2021,No Results Posted,,,01/06/2021,https://clinicaltrials.gov/show/NCT04565249,31/08/2021,0,0
2701,NCT04569877,Recruiting,25/12/2022,25/12/2022,No Results Posted,,,19/05/2021,https://clinicaltrials.gov/show/NCT04569877,25/12/2022,0,0
2702,NCT04570254,Completed,01/12/2020,01/12/2020,No Results Posted,,"['Rahman I, MacNee W. Regulation of redox glutathione levels and gene transcription in lung inflammation: therapeutic approaches. Free Radic Biol Med. 2000 May 1;28(9):1405-20. Review.', 'Paterson RL, Galley HF, Webster NR. The effect of N-acetylcysteine on nuclear factor-kappa B activation, interleukin-6, interleukin-8, and intercellular adhesion molecule-1 expression in patients with sepsis. Crit Care Med. 2003 Nov;31(11):2574-8.', 'Moradi M, Mojtahedzadeh M, Mandegari A, Soltan-Sharifi MS, Najafi A, Khajavi MR, Hajibabayee M, Ghahremani MH. The role of glutathione-S-transferase polymorphisms on clinical outcome of ALI/ARDS patient treated with N-acetylcysteine. Respir Med. 2009 Mar;103(3):434-41. doi: 10.1016/j.rmed.2008.09.013. Epub 2008 Nov 7.', 'Peake SL, Moran JL, Leppard PI. N-acetyl-L-cysteine depresses cardiac performance in patients with septic shock. Crit Care Med. 1996 Aug;24(8):1302-10.', 'Escames G, Guerrero JM, Reiter RJ, Garcia JJ, Munoz-Hoyos A, Ortiz GG, Oh CS. Melatonin and vitamin E limit nitric oxide-induced lipid peroxidation in rat brain homogenates. Neurosci Lett. 1997 Jul 25;230(3):147-50.', 'Galano A, Tan DX, Reiter RJ. Melatonin as a natural ally against oxidative stress: a physicochemical examination. J Pineal Res. 2011 Aug;51(1):1-16. doi: 10.1111/j.1600-079X.2011.00916.x. Review.', 'Hemil√§ H, Douglas RM. Vitamin C and acute respiratory infections. Int J Tuberc Lung Dis. 1999 Sep;3(9):756-61. Review.', 'Shabaan AE, Nasef N, Shouman B, Nour I, Mesbah A, Abdel-Hady H. Pentoxifylline therapy for late-onset sepsis in preterm infants: a randomized controlled trial. Pediatr Infect Dis J. 2015 Jun;34(6):e143-8. doi: 10.1097/INF.0000000000000698.', 'Akdag A, Dilmen U, Haque K, Dilli D, Erdeve O, Goekmen T. Role of pentoxifylline and/or IgM-enriched intravenous immunoglobulin in the management of neonatal sepsis. Am J Perinatol. 2014 Nov;31(10):905-12. doi: 10.1055/s-0033-1363771. Epub 2014 Feb 10.', 'Fowler AA 3rd, Truwit JD, Hite RD, Morris PE, DeWilde C, Priday A, Fisher B, Thacker LR 2nd, Natarajan R, Brophy DF, Sculthorpe R, Nanchal R, Syed A, Sturgill J, Martin GS, Sevransky J, Kashiouris M, Hamman S, Egan KF, Hastings A, Spencer W, Tench S, Mehkri O, Bindas J, Duggal A, Graf J, Zellner S, Yanny L, McPolin C, Hollrith T, Kramer D, Ojielo C, Damm T, Cassity E, Wieliczko A, Halquist M. Effect of Vitamin C Infusion on Organ Failure and Biomarkers of Inflammation and Vascular Injury in Patients With Sepsis and Severe Acute Respiratory Failure: The CITRIS-ALI Randomized Clinical Trial. JAMA. 2019 Oct 1;322(13):1261-1270. doi: 10.1001/jama.2019.11825. Erratum in: JAMA. 2020 Jan 28;323(4):379.', 'Protti A, Singer M. Bench-to-bedside review: potential strategies to protect or reverse mitochondrial dysfunction in sepsis-induced organ failure. Crit Care. 2006;10(5):228. Review.', 'Vincent JL, Moreno R, Takala J, Willatts S, De Mendon√ßa A, Bruining H, Reinhart CK, Suter PM, Thijs LG. The SOFA (Sepsis-related Organ Failure Assessment) score to describe organ dysfunction/failure. On behalf of the Working Group on Sepsis-Related Problems of the European Society of Intensive Care Medicine. Intensive Care Med. 1996 Jul;22(7):707-10.']",21/05/2021,https://clinicaltrials.gov/show/NCT04570254,01/12/2020,0,1
2703,NCT04575610,Recruiting,31/12/2021,31/12/2021,No Results Posted,,,20/05/2021,https://clinicaltrials.gov/show/NCT04575610,31/12/2021,0,0
2704,NCT04579640,"Active, not recruiting",30/06/2021,30/06/2021,No Results Posted,,,26/05/2021,https://clinicaltrials.gov/show/NCT04579640,30/06/2021,0,0
2705,NCT04581811,Completed,20/03/2021,20/03/2021,No Results Posted,,,25/05/2021,https://clinicaltrials.gov/show/NCT04581811,20/03/2021,0,0
2706,NCT04581954,Recruiting,30/06/2021,31/07/2021,No Results Posted,"['Vergis N, Phillips R, Cornelius V, Katsarou A, Youngstein T, Cook L, Willicombe M, Pilay C, Shturova T, Almonte M, Charania A, Turner R, Kon OM, Cooke G, Thursz M, Cherlin S, Wason J, Milojkovic D, Innes AJ, Cooper N. Multi-arm Trial of Inflammatory Signal Inhibitors (MATIS) for hospitalised patients with mild or moderate COVID-19 pneumonia: a structured summary of a study protocol for a randomised controlled trial. Trials. 2021 Apr 12;22(1):270. doi: 10.1186/s13063-021-05190-z.']",,02/06/2021,https://clinicaltrials.gov/show/NCT04581954,30/06/2021,0,1
2707,NCT04590469,Recruiting,01/12/2021,01/01/2022,No Results Posted,,"['Ballard C, Orrell M, YongZhong S, Moniz-Cook E, Stafford J, Whittaker R, Woods B, Corbett A, Garrod L, Khan Z, Woodward-Carlton B, Wenborn J, Fossey J. Impact of Antipsychotic Review and Nonpharmacological Intervention on Antipsychotic Use, Neuropsychiatric Symptoms, and Mortality in People With Dementia Living in Nursing Homes: A Factorial Cluster-Randomized Controlled Trial by the Well-Being and Health for People With Dementia (WHELD) Program. Am J Psychiatry. 2016 Mar 1;173(3):252-62. doi: 10.1176/appi.ajp.2015.15010130. Epub 2015 Nov 20.']",28/05/2021,https://clinicaltrials.gov/show/NCT04590469,01/12/2021,0,1
2708,NCT04591717,Recruiting,19/11/2021,19/11/2021,No Results Posted,,,27/05/2021,https://clinicaltrials.gov/show/NCT04591717,19/11/2021,0,0
2709,NCT04595136,Recruiting,30/07/2021,30/08/2021,No Results Posted,,,26/05/2021,https://clinicaltrials.gov/show/NCT04595136,30/07/2021,0,0
2710,NCT04595773,Recruiting,31/12/2023,31/12/2023,No Results Posted,,,28/05/2021,https://clinicaltrials.gov/show/NCT04595773,31/12/2023,0,0
2711,NCT04596839,"Active, not recruiting",30/04/2021,31/07/2021,No Results Posted,,,01/06/2021,https://clinicaltrials.gov/show/NCT04596839,30/04/2021,0,0
2712,NCT04604145,Recruiting,01/09/2021,01/09/2021,No Results Posted,,,25/05/2021,https://clinicaltrials.gov/show/NCT04604145,01/09/2021,0,0
2713,NCT04604743,Recruiting,30/06/2023,30/06/2023,No Results Posted,,,25/05/2021,https://clinicaltrials.gov/show/NCT04604743,30/06/2023,0,0
2714,NCT04625725,"Active, not recruiting",05/05/2021,22/06/2022,No Results Posted,,,27/05/2021,https://clinicaltrials.gov/show/NCT04625725,05/05/2021,0,0
2715,NCT04625972,"Active, not recruiting",07/04/2021,20/06/2022,No Results Posted,,,26/05/2021,https://clinicaltrials.gov/show/NCT04625972,07/04/2021,0,0
2716,NCT04634903,Completed,15/03/2021,15/03/2021,Study Results,,,25/05/2021,https://clinicaltrials.gov/show/NCT04634903,15/03/2021,1,0
2717,NCT04636333,Recruiting,07/12/2021,07/01/2022,No Results Posted,,,25/05/2021,https://clinicaltrials.gov/show/NCT04636333,07/12/2021,0,0
2718,NCT04636697,Recruiting,31/12/2021,30/04/2022,No Results Posted,,,24/05/2021,https://clinicaltrials.gov/show/NCT04636697,31/12/2021,0,0
2719,NCT04638634,"Active, not recruiting",01/06/2021,01/06/2021,No Results Posted,,,20/05/2021,https://clinicaltrials.gov/show/NCT04638634,01/06/2021,0,0
2720,NCT04640168,"Active, not recruiting",22/05/2021,30/06/2021,No Results Posted,,,26/05/2021,https://clinicaltrials.gov/show/NCT04640168,22/05/2021,0,0
2721,NCT04644120,"Active, not recruiting",28/08/2021,28/08/2021,No Results Posted,,,19/05/2021,https://clinicaltrials.gov/show/NCT04644120,28/08/2021,0,0
2722,NCT04646044,"Active, not recruiting",11/05/2021,05/09/2021,No Results Posted,,,28/06/2021,https://clinicaltrials.gov/show/NCT04646044,11/05/2021,0,0
2723,NCT04649086,Recruiting,01/10/2022,01/10/2022,No Results Posted,,,19/05/2021,https://clinicaltrials.gov/show/NCT04649086,01/10/2022,0,0
2724,NCT04650087,Recruiting,01/08/2021,01/09/2021,No Results Posted,,,25/05/2021,https://clinicaltrials.gov/show/NCT04650087,01/08/2021,0,0
2725,NCT04652102,"Active, not recruiting",16/04/2021,15/05/2022,No Results Posted,,,19/05/2021,https://clinicaltrials.gov/show/NCT04652102,16/04/2021,0,0
2726,NCT04662060,Recruiting,01/03/2022,01/03/2022,No Results Posted,,,20/05/2021,https://clinicaltrials.gov/show/NCT04662060,01/03/2022,0,0
2727,NCT04662073,"Active, not recruiting",01/03/2022,01/03/2022,No Results Posted,,,02/07/2021,https://clinicaltrials.gov/show/NCT04662073,01/03/2022,0,0
2728,NCT04662086,Recruiting,01/03/2022,01/03/2022,No Results Posted,,,19/05/2021,https://clinicaltrials.gov/show/NCT04662086,01/03/2022,0,0
2729,NCT04664101,Not yet recruiting,01/10/2023,01/10/2023,No Results Posted,,,28/06/2021,https://clinicaltrials.gov/show/NCT04664101,01/10/2023,0,0
2730,NCT04668950,"Active, not recruiting",01/07/2021,01/09/2021,No Results Posted,,,21/05/2021,https://clinicaltrials.gov/show/NCT04668950,01/07/2021,0,0
2731,NCT04672564,Recruiting,30/10/2021,30/10/2021,No Results Posted,,,02/07/2021,https://clinicaltrials.gov/show/NCT04672564,30/10/2021,0,0
2732,NCT04677660,"Active, not recruiting",03/03/2022,03/03/2022,No Results Posted,,,19/05/2021,https://clinicaltrials.gov/show/NCT04677660,03/03/2022,0,0
2733,NCT04686760,Recruiting,15/11/2021,15/11/2021,No Results Posted,,,24/05/2021,https://clinicaltrials.gov/show/NCT04686760,15/11/2021,0,0
2734,NCT04699916,"Active, not recruiting",23/05/2021,31/12/2021,No Results Posted,,,25/05/2021,https://clinicaltrials.gov/show/NCT04699916,23/05/2021,0,0
2735,NCT04706299,Completed,21/05/2021,21/05/2021,No Results Posted,,,24/05/2021,https://clinicaltrials.gov/show/NCT04706299,21/05/2021,0,0
2736,NCT04708340,Recruiting,01/10/2022,01/02/2023,No Results Posted,,,19/05/2021,https://clinicaltrials.gov/show/NCT04708340,01/10/2022,0,0
2737,NCT04715243,Recruiting,30/09/2021,30/12/2021,No Results Posted,,,29/06/2021,https://clinicaltrials.gov/show/NCT04715243,30/09/2021,0,0
2738,NCT04716985,Recruiting,22/07/2021,22/12/2022,No Results Posted,,,27/05/2021,https://clinicaltrials.gov/show/NCT04716985,22/07/2021,0,0
2739,NCT04718467,Withdrawn,15/05/2021,15/03/2022,No Results Posted,,,25/05/2021,https://clinicaltrials.gov/show/NCT04718467,15/05/2021,0,0
2740,NCT04730895,Not yet recruiting,01/09/2021,01/12/2023,No Results Posted,,,02/06/2021,https://clinicaltrials.gov/show/NCT04730895,01/09/2021,0,0
2741,NCT04732949,Recruiting,01/10/2021,01/10/2021,No Results Posted,,,01/07/2021,https://clinicaltrials.gov/show/NCT04732949,01/10/2021,0,0
2742,NCT04743401,Not yet recruiting,30/09/2022,31/03/2023,No Results Posted,,,19/05/2021,https://clinicaltrials.gov/show/NCT04743401,30/09/2022,0,0
2743,NCT04746183,Recruiting,18/11/2021,30/04/2022,No Results Posted,,,20/05/2021,https://clinicaltrials.gov/show/NCT04746183,18/11/2021,0,0
2744,NCT04753476,Recruiting,01/02/2022,01/03/2022,No Results Posted,,"['Harrell CR, Jovicic BP, Djonov V, Volarevic V. Therapeutic Potential of Mesenchymal Stem Cells and Their Secretome in the Treatment of SARS-CoV-2-Induced Acute Respiratory Distress Syndrome. Anal Cell Pathol (Amst). 2020 Nov 20;2020:1939768. doi: 10.1155/2020/1939768. eCollection 2020. Review.', 'Johnson BS, Laloraya M. A cytokine super cyclone in COVID-19 patients with risk factors: the therapeutic potential of BCG immunization. Cytokine Growth Factor Rev. 2020 Aug;54:32-42. doi: 10.1016/j.cytogfr.2020.06.014. Epub 2020 Jul 1. Review.']",24/05/2021,https://clinicaltrials.gov/show/NCT04753476,01/02/2022,0,1
2745,NCT04758299,Completed,15/04/2021,30/04/2021,No Results Posted,,,25/05/2021,https://clinicaltrials.gov/show/NCT04758299,15/04/2021,0,0
2746,NCT04762680,"Active, not recruiting",01/12/2022,01/12/2022,No Results Posted,,,20/05/2021,https://clinicaltrials.gov/show/NCT04762680,01/12/2022,0,0
2747,NCT04765839,Completed,03/04/2021,03/04/2021,No Results Posted,,,26/05/2021,https://clinicaltrials.gov/show/NCT04765839,03/04/2021,0,0
2748,NCT04775069,Recruiting,31/12/2021,31/03/2022,No Results Posted,,,25/05/2021,https://clinicaltrials.gov/show/NCT04775069,31/12/2021,0,0
2749,NCT04776174,Recruiting,30/10/2021,01/01/2022,No Results Posted,,,20/05/2021,https://clinicaltrials.gov/show/NCT04776174,30/10/2021,0,0
2750,NCT04790240,Recruiting,01/12/2022,01/03/2023,No Results Posted,,"['Wanzhu Hou, et al. Treating Autoimmune disease with Chinses Medicine, Elsevier, 2011']",26/05/2021,https://clinicaltrials.gov/show/NCT04790240,01/12/2022,0,1
2751,NCT04798001,Recruiting,31/10/2022,31/10/2022,No Results Posted,,,07/07/2021,https://clinicaltrials.gov/show/NCT04798001,31/10/2022,0,0
2752,NCT04805671,Not yet recruiting,01/01/2022,01/02/2023,No Results Posted,,,24/05/2021,https://clinicaltrials.gov/show/NCT04805671,01/01/2022,0,0
2753,NCT04805931,Recruiting,01/05/2021,01/11/2021,No Results Posted,,,28/06/2021,https://clinicaltrials.gov/show/NCT04805931,01/05/2021,0,0
2754,NCT04813562,Recruiting,30/07/2021,30/06/2022,No Results Posted,,,25/05/2021,https://clinicaltrials.gov/show/NCT04813562,30/07/2021,0,0
2755,NCT04816643,Recruiting,04/03/2022,01/09/2023,No Results Posted,,,01/06/2021,https://clinicaltrials.gov/show/NCT04816643,04/03/2022,0,0
2756,NCT04816669,"Active, not recruiting",06/07/2021,06/07/2021,No Results Posted,,,19/05/2021,https://clinicaltrials.gov/show/NCT04816669,06/07/2021,0,0
2757,NCT04818970,Recruiting,31/12/2021,31/12/2021,No Results Posted,,,25/05/2021,https://clinicaltrials.gov/show/NCT04818970,31/12/2021,0,0
2758,NCT04821037,Recruiting,01/07/2021,01/08/2021,No Results Posted,,,02/06/2021,https://clinicaltrials.gov/show/NCT04821037,01/07/2021,0,0
2759,NCT04828135,Recruiting,30/12/2022,30/12/2022,No Results Posted,,,08/07/2021,https://clinicaltrials.gov/show/NCT04828135,30/12/2022,0,0
2760,NCT04838821,Recruiting,29/07/2021,29/09/2021,No Results Posted,,,21/05/2021,https://clinicaltrials.gov/show/NCT04838821,29/07/2021,0,0
2761,NCT04842448,Not yet recruiting,01/06/2022,01/12/2023,No Results Posted,,,01/06/2021,https://clinicaltrials.gov/show/NCT04842448,01/06/2022,0,0
2762,NCT04844138,Recruiting,31/12/2021,31/12/2021,No Results Posted,,,03/06/2021,https://clinicaltrials.gov/show/NCT04844138,31/12/2021,0,0
2763,NCT04846010,Recruiting,01/05/2022,01/10/2022,No Results Posted,,,26/05/2021,https://clinicaltrials.gov/show/NCT04846010,01/05/2022,0,0
2764,NCT04847141,Recruiting,01/10/2021,01/10/2021,No Results Posted,,,01/06/2021,https://clinicaltrials.gov/show/NCT04847141,01/10/2021,0,0
2765,NCT04870385,"Active, not recruiting",01/06/2021,01/08/2021,No Results Posted,,,18/05/2021,https://clinicaltrials.gov/show/NCT04870385,01/06/2021,0,0
2766,NCT04871737,Recruiting,01/08/2021,01/06/2022,No Results Posted,,,27/05/2021,https://clinicaltrials.gov/show/NCT04871737,01/08/2021,0,0
2767,NCT04874766,Recruiting,15/07/2021,31/07/2021,No Results Posted,,,02/06/2021,https://clinicaltrials.gov/show/NCT04874766,15/07/2021,0,0
2768,NCT04884295,Recruiting,01/09/2021,01/09/2021,No Results Posted,,,27/05/2021,https://clinicaltrials.gov/show/NCT04884295,01/09/2021,0,0
2769,NCT04885491,Recruiting,15/07/2021,15/08/2021,No Results Posted,,,20/05/2021,https://clinicaltrials.gov/show/NCT04885491,15/07/2021,0,0
2770,NCT04890483,Recruiting,17/05/2021,24/12/2021,No Results Posted,,,18/05/2021,https://clinicaltrials.gov/show/NCT04890483,17/05/2021,0,0
2771,NCT04890509,"Active, not recruiting",09/06/2021,09/06/2021,No Results Posted,,,18/05/2021,https://clinicaltrials.gov/show/NCT04890509,09/06/2021,0,0
2772,NCT04890626,Recruiting,30/11/2021,30/11/2022,No Results Posted,,,20/05/2021,https://clinicaltrials.gov/show/NCT04890626,30/11/2021,0,0
2773,NCT04890665,Not yet recruiting,20/06/2022,20/06/2022,No Results Posted,,"['Buysse DJ, Reynolds CF 3rd, Monk TH, Berman SR, Kupfer DJ. The Pittsburgh Sleep Quality Index: a new instrument for psychiatric practice and research. Psychiatry Res. 1989 May;28(2):193-213.', 'Spitzer RL, Kroenke K, Williams JB, L√∂we B. A brief measure for assessing generalized anxiety disorder: the GAD-7. Arch Intern Med. 2006 May 22;166(10):1092-7.', 'Novy DM, Stanley MA, Averill P, Daza P. Psychometric comparability of English- and Spanish-language measures of anxiety and related affective symptoms. Psychol Assess. 2001 Sep;13(3):347-55.', 'Foa EB, Cashman L, Jaycox L, Perry K. The validation of a self-report measure of posttraumatic stress disorder: the Posttraumatic Diagnostic Scale. Psychological assessment. 1997 Dec;9(4):445.', 'Beck AT, Kovacs M, Weissman A. Assessment of suicidal intention: the Scale for Suicide Ideation. J Consult Clin Psychol. 1979 Apr;47(2):343-52.', 'Gonz√°lez-Forteza C, Torres CS, Tapia AJ, Fern√°ndez IH, Gonz√°lez-Gonz√°lez A, Garcia FJ, Medina-Mora ME, Mej√≠a HFV. Confiabilidad y validez de la escala de depresi√≥n CES-D en un censo de estudiantes de nivel medio superior y superior, en la Ciudad de M√©xico [Reliability and validity of the depression scale CES-D in high school and college students from Mexico City: Results from a census]. Salud Mental. 2011; 34(1): 53-59.', 'Garc√≠a-Campayo J, Zamorano E, Ruiz MA, Pardo A, P√©rez-P√°ramo M, L√≥pez-G√≥mez V, Freire O, Rejas J. Cultural adaptation into Spanish of the generalized anxiety disorder-7 (GAD-7) scale as a screening tool. Health Qual Life Outcomes. 2010 Jan 20;8:8. doi: 10.1186/1477-7525-8-8.', 'Connor KM, Davidson JR. Development of a new resilience scale: the Connor-Davidson Resilience Scale (CD-RISC). Depress Anxiety. 2003;18(2):76-82.', 'Ahorsu DK, Lin CY, Imani V, Saffari M, Griffiths MD, Pakpour AH. The Fear of COVID-19 Scale: Development and Initial Validation. Int J Ment Health Addict. 2020 Mar 27:1-9. doi: 10.1007/s11469-020-00270-8. [Epub ahead of print]', 'Healy DJ, Barry K, Blow F, Welsh D, Milner KK. Routine use of the Beck Scale for Suicide Ideation in a psychiatric emergency department. Gen Hosp Psychiatry. 2006 Jul-Aug;28(4):323-9.']",18/05/2021,https://clinicaltrials.gov/show/NCT04890665,20/06/2022,0,1
2774,NCT04891172,Recruiting,01/03/2022,02/08/2022,No Results Posted,,,18/05/2021,https://clinicaltrials.gov/show/NCT04891172,01/03/2022,0,0
2775,NCT04891250,Not yet recruiting,01/12/2021,01/06/2022,No Results Posted,,,18/05/2021,https://clinicaltrials.gov/show/NCT04891250,01/12/2021,0,0
2776,NCT04891302,Recruiting,31/07/2021,31/10/2021,No Results Posted,,,18/05/2021,https://clinicaltrials.gov/show/NCT04891302,31/07/2021,0,0
2777,NCT04892979,Recruiting,31/03/2022,31/03/2022,No Results Posted,,,19/05/2021,https://clinicaltrials.gov/show/NCT04892979,31/03/2022,0,0
2778,NCT04893265,Not yet recruiting,30/10/2022,30/10/2022,No Results Posted,,,19/05/2021,https://clinicaltrials.gov/show/NCT04893265,30/10/2022,0,0
2779,NCT04894227,"Active, not recruiting",30/07/2021,30/11/2021,No Results Posted,,,01/06/2021,https://clinicaltrials.gov/show/NCT04894227,30/07/2021,0,0
2780,NCT04894266,Not yet recruiting,22/03/2022,22/09/2022,No Results Posted,,,20/05/2021,https://clinicaltrials.gov/show/NCT04894266,22/03/2022,0,0
2781,NCT04894409,Completed,30/06/2020,29/09/2020,No Results Posted,,,20/05/2021,https://clinicaltrials.gov/show/NCT04894409,30/06/2020,0,0
2782,NCT04895085,Enrolling by invitation,01/07/2022,01/07/2022,No Results Posted,,,01/06/2021,https://clinicaltrials.gov/show/NCT04895085,01/07/2022,0,0
2783,NCT04895267,Enrolling by invitation,30/06/2021,01/07/2021,No Results Posted,,,24/05/2021,https://clinicaltrials.gov/show/NCT04895267,30/06/2021,0,0
2784,NCT04895683,Not yet recruiting,31/12/2021,11/05/2022,No Results Posted,,,24/05/2021,https://clinicaltrials.gov/show/NCT04895683,31/12/2021,0,0
2785,NCT04895982,Not yet recruiting,04/01/2023,04/01/2023,No Results Posted,,,21/05/2021,https://clinicaltrials.gov/show/NCT04895982,04/01/2023,0,0
2786,NCT04896541,"Active, not recruiting",04/07/2022,04/07/2022,No Results Posted,,,28/06/2021,https://clinicaltrials.gov/show/NCT04896541,04/07/2022,0,0
2787,NCT04896606,Not yet recruiting,31/12/2024,31/12/2025,No Results Posted,,,21/05/2021,https://clinicaltrials.gov/show/NCT04896606,31/12/2024,0,0
2788,NCT04896788,Recruiting,01/11/2023,01/05/2024,No Results Posted,,,24/05/2021,https://clinicaltrials.gov/show/NCT04896788,01/11/2023,0,0
2789,NCT04896840,Recruiting,06/06/2021,06/07/2021,No Results Posted,,,21/05/2021,https://clinicaltrials.gov/show/NCT04896840,06/06/2021,0,0
2790,NCT04896853,Recruiting,30/09/2024,31/12/2024,No Results Posted,,,21/05/2021,https://clinicaltrials.gov/show/NCT04896853,30/09/2024,0,0
2791,NCT04896866,Recruiting,01/12/2021,01/01/2022,No Results Posted,,,21/05/2021,https://clinicaltrials.gov/show/NCT04896866,01/12/2021,0,0
2792,NCT04896970,Not yet recruiting,01/07/2021,01/07/2021,No Results Posted,,,21/05/2021,https://clinicaltrials.gov/show/NCT04896970,01/07/2021,0,0
2793,NCT04898062,Recruiting,30/06/2022,31/10/2022,No Results Posted,,,28/05/2021,https://clinicaltrials.gov/show/NCT04898062,30/06/2022,0,0
2794,NCT04898088,Completed,30/08/2020,30/09/2020,No Results Posted,,,24/05/2021,https://clinicaltrials.gov/show/NCT04898088,30/08/2020,0,0
2795,NCT04898127,Not yet recruiting,01/06/2021,01/12/2021,No Results Posted,,,27/05/2021,https://clinicaltrials.gov/show/NCT04898127,01/06/2021,0,0
2796,NCT04898205,Recruiting,20/01/2022,20/01/2022,No Results Posted,,,25/05/2021,https://clinicaltrials.gov/show/NCT04898205,20/01/2022,0,0
2797,NCT04898738,Not yet recruiting,01/09/2022,01/09/2022,No Results Posted,,,24/05/2021,https://clinicaltrials.gov/show/NCT04898738,01/09/2022,0,0
2798,NCT04899232,Recruiting,01/12/2021,19/12/2021,No Results Posted,,,08/07/2021,https://clinicaltrials.gov/show/NCT04899232,01/12/2021,0,0
2799,NCT04899245,Enrolling by invitation,01/08/2022,01/08/2022,No Results Posted,,,01/06/2021,https://clinicaltrials.gov/show/NCT04899245,01/08/2022,0,0
2800,NCT04900129,Completed,30/12/2020,30/12/2020,No Results Posted,,"['de Wit E, van Doremalen N, Falzarano D, Munster VJ. SARS and MERS: recent insights into emerging coronaviruses. Nat Rev Microbiol. 2016 Aug;14(8):523-34. doi: 10.1038/nrmicro.2016.81. Epub 2016 Jun 27. Review.']",25/05/2021,https://clinicaltrials.gov/show/NCT04900129,30/12/2020,0,1
2801,NCT04900155,Recruiting,01/01/2022,01/05/2022,No Results Posted,,,25/05/2021,https://clinicaltrials.gov/show/NCT04900155,01/01/2022,0,0
2802,NCT04900337,Recruiting,31/12/2021,31/12/2021,No Results Posted,,,25/05/2021,https://clinicaltrials.gov/show/NCT04900337,31/12/2021,0,0
2803,NCT04900415,Recruiting,12/03/2021,30/06/2021,No Results Posted,,,25/05/2021,https://clinicaltrials.gov/show/NCT04900415,12/03/2021,0,0
2804,NCT04900428,Not yet recruiting,01/01/2022,01/03/2022,No Results Posted,,,28/05/2021,https://clinicaltrials.gov/show/NCT04900428,01/01/2022,0,0
2805,NCT04900454,Not yet recruiting,31/10/2022,31/12/2022,No Results Posted,,,26/05/2021,https://clinicaltrials.gov/show/NCT04900454,31/10/2022,0,0
2806,NCT04900961,Not yet recruiting,30/04/2023,31/07/2033,No Results Posted,,,25/05/2021,https://clinicaltrials.gov/show/NCT04900961,30/04/2023,0,0
2807,NCT04901065,Recruiting,31/07/2021,31/07/2021,No Results Posted,,,25/05/2021,https://clinicaltrials.gov/show/NCT04901065,31/07/2021,0,0
2808,NCT04901624,Enrolling by invitation,01/04/2022,01/08/2022,No Results Posted,,,02/07/2021,https://clinicaltrials.gov/show/NCT04901624,01/04/2022,0,0
2809,NCT04901676,Not yet recruiting,01/01/2022,01/02/2022,No Results Posted,,,25/05/2021,https://clinicaltrials.gov/show/NCT04901676,01/01/2022,0,0
2810,NCT04901689,Not yet recruiting,01/11/2021,01/12/2021,No Results Posted,,,25/05/2021,https://clinicaltrials.gov/show/NCT04901689,01/11/2021,0,0
2811,NCT04902976,Recruiting,31/05/2021,30/08/2021,No Results Posted,,,28/05/2021,https://clinicaltrials.gov/show/NCT04902976,31/05/2021,0,0
2812,NCT04903184,Recruiting,01/09/2021,01/01/2022,No Results Posted,,,28/05/2021,https://clinicaltrials.gov/show/NCT04903184,01/09/2021,0,0
2813,NCT04903327,Not yet recruiting,01/12/2021,01/02/2022,No Results Posted,,,03/06/2021,https://clinicaltrials.gov/show/NCT04903327,01/12/2021,0,0
2814,NCT04904471,Enrolling by invitation,28/02/2022,31/12/2022,No Results Posted,,,30/06/2021,https://clinicaltrials.gov/show/NCT04904471,28/02/2022,0,0
2815,NCT04904484,Not yet recruiting,01/06/2022,01/10/2022,No Results Posted,,,27/05/2021,https://clinicaltrials.gov/show/NCT04904484,01/06/2022,0,0
2816,NCT04904497,Recruiting,01/12/2021,31/12/2021,No Results Posted,,,27/05/2021,https://clinicaltrials.gov/show/NCT04904497,01/12/2021,0,0
2817,NCT04904510,Completed,09/03/2021,09/03/2021,No Results Posted,,,27/05/2021,https://clinicaltrials.gov/show/NCT04904510,09/03/2021,0,0
2818,NCT04904536,Not yet recruiting,01/01/2023,01/06/2023,No Results Posted,,,27/05/2021,https://clinicaltrials.gov/show/NCT04904536,01/01/2023,0,0
2819,NCT04904744,Not yet recruiting,31/10/2021,31/12/2021,No Results Posted,,,27/05/2021,https://clinicaltrials.gov/show/NCT04904744,31/10/2021,0,0
2820,NCT04905836,Not yet recruiting,01/11/2021,01/02/2022,No Results Posted,,,02/06/2021,https://clinicaltrials.gov/show/NCT04905836,01/11/2021,0,0
2821,NCT04906694,Not yet recruiting,01/12/2021,01/01/2022,No Results Posted,,,28/05/2021,https://clinicaltrials.gov/show/NCT04906694,01/12/2021,0,0
2822,NCT04907877,Not yet recruiting,01/03/2022,01/09/2022,No Results Posted,,"['Pan L, Mu M, Yang P, Sun Y, Wang R, Yan J, Li P, Hu B, Wang J, Hu C, Jin Y, Niu X, Ping R, Du Y, Li T, Xu G, Hu Q, Tu L. Clinical Characteristics of COVID-19 Patients With Digestive Symptoms in Hubei, China: A Descriptive, Cross-Sectional, Multicenter Study. Am J Gastroenterol. 2020 May;115(5):766-773. doi: 10.14309/ajg.0000000000000620.', 'Smyk W, Janik MK, Portincasa P, Milkiewicz P, Lammert F, Krawczyk M. COVID-19: Focus on the lungs but do not forget the gastrointestinal tract. Eur J Clin Invest. 2020 Sep;50(9):e13276. doi: 10.1111/eci.13276. Epub 2020 Jul 5. Review.', 'Westermann C, Gleinser M, Corr SC, Riedel CU. A Critical Evaluation of Bifidobacterial Adhesion to the Host Tissue. Front Microbiol. 2016 Aug 5;7:1220. doi: 10.3389/fmicb.2016.01220. eCollection 2016. Review.', 'Van Tassell ML, Miller MJ. Lactobacillus adhesion to mucus. Nutrients. 2011 May;3(5):613-36. doi: 10.3390/nu3050613. Epub 2011 May 20. Review.', 'Olaimat AN, Aolymat I, Al-Holy M, Ayyash M, Abu Ghoush M, Al-Nabulsi AA, Osaili T, Apostolopoulos V, Liu SQ, Shah NP. The potential application of probiotics and prebiotics for the prevention and treatment of COVID-19. NPJ Sci Food. 2020 Oct 5;4:17. doi: 10.1038/s41538-020-00078-9. eCollection 2020. Review.', 'Yeoh YK, Zuo T, Lui GC, Zhang F, Liu Q, Li AY, Chung AC, Cheung CP, Tso EY, Fung KS, Chan V, Ling L, Joynt G, Hui DS, Chow KM, Ng SSS, Li TC, Ng RW, Yip TC, Wong GL, Chan FK, Wong CK, Chan PK, Ng SC. Gut microbiota composition reflects disease severity and dysfunctional immune responses in patients with COVID-19. Gut. 2021 Apr;70(4):698-706. doi: 10.1136/gutjnl-2020-323020. Epub 2021 Jan 11.', 'Chai W, Burwinkel M, Wang Z, Palissa C, Esch B, Twardziok S, Rieger J, Wrede P, Schmidt MF. Antiviral effects of a probiotic Enterococcus faecium strain against transmissible gastroenteritis coronavirus. Arch Virol. 2013 Apr;158(4):799-807. doi: 10.1007/s00705-012-1543-0. Epub 2012 Nov 28.', 'Miettinen M, Pietil√§ TE, Kekkonen RA, Kankainen M, Latvala S, Pirhonen J, √ñsterlund P, Korpela R, Julkunen I. Nonpathogenic Lactobacillus rhamnosus activates the inflammasome and antiviral responses in human macrophages. Gut Microbes. 2012 Nov-Dec;3(6):510-22. doi: 10.4161/gmic.21736. Epub 2012 Aug 16.', 'Nakayama Y, Moriya T, Sakai F, Ikeda N, Shiozaki T, Hosoya T, Nakagawa H, Miyazaki T. Oral administration of Lactobacillus gasseri SBT2055 is effective for preventing influenza in mice. Sci Rep. 2014 Apr 10;4:4638. doi: 10.1038/srep04638.', 'Gao X, Huang L, Zhu L, Mou C, Hou Q, Yu Q. Inhibition of H9N2 Virus Invasion into Dendritic Cells by the S-Layer Protein from L. acidophilus ATCC 4356. Front Cell Infect Microbiol. 2016 Oct 25;6:137. eCollection 2016.', 'Vouloumanou EK, Makris GC, Karageorgopoulos DE, Falagas ME. Probiotics for the prevention of respiratory tract infections: a systematic review. Int J Antimicrob Agents. 2009 Sep;34(3):197.e1-10. doi: 10.1016/j.ijantimicag.2008.11.005. Epub 2009 Jan 28. Review.', 'Zimmermann P, Curtis N. The influence of probiotics on vaccine responses - A systematic review. Vaccine. 2018 Jan 4;36(2):207-213. doi: 10.1016/j.vaccine.2017.08.069. Epub 2017 Sep 18. Review.']",02/06/2021,https://clinicaltrials.gov/show/NCT04907877,01/03/2022,0,1
2823,NCT04907903,Not yet recruiting,01/06/2022,01/06/2022,No Results Posted,,,01/06/2021,https://clinicaltrials.gov/show/NCT04907903,01/06/2022,0,0
2824,NCT04907942,"Active, not recruiting",18/12/2020,19/06/2021,No Results Posted,,,01/06/2021,https://clinicaltrials.gov/show/NCT04907942,18/12/2020,0,0
2825,NCT04909892,Not yet recruiting,01/01/2022,01/01/2022,No Results Posted,,,02/06/2021,https://clinicaltrials.gov/show/NCT04909892,01/01/2022,0,0
2826,NCT04909918,Recruiting,01/08/2021,01/08/2021,No Results Posted,,,02/06/2021,https://clinicaltrials.gov/show/NCT04909918,01/08/2021,0,0
2827,NCT04909996,Recruiting,31/07/2021,31/07/2021,No Results Posted,,,02/06/2021,https://clinicaltrials.gov/show/NCT04909996,31/07/2021,0,0
2828,NCT04910191,Recruiting,01/12/2021,01/12/2021,No Results Posted,,,02/06/2021,https://clinicaltrials.gov/show/NCT04910191,01/12/2021,0,0
2829,NCT04910542,Recruiting,12/11/2021,12/05/2022,No Results Posted,,,02/06/2021,https://clinicaltrials.gov/show/NCT04910542,12/11/2021,0,0
2830,NCT04331665,Completed,05/01/2021,24/03/2021,No Results Posted,,,03/06/2021,https://clinicaltrials.gov/show/NCT04331665,05/01/2021,0,0
2831,NCT04341285,Withdrawn,01/04/2022,01/05/2022,No Results Posted,,,09/06/2021,https://clinicaltrials.gov/show/NCT04341285,01/04/2022,0,0
2832,NCT04343755,"Active, not recruiting",01/04/2022,01/04/2022,No Results Posted,,,02/06/2021,https://clinicaltrials.gov/show/NCT04343755,01/04/2022,0,0
2833,NCT04344184,Recruiting,01/03/2022,01/03/2022,No Results Posted,,,03/06/2021,https://clinicaltrials.gov/show/NCT04344184,01/03/2022,0,0
2834,NCT04344587,Completed,07/05/2021,07/05/2021,No Results Posted,"['Garcia MA, Rampon GL, Doros G, Jia S, Jagan N, Gillmeyer K, Berical A, Hudspeth J, Ieong M, Modzelewski KL, Schechter-Perkins EM, Ross CS, Rucci JM, Simpson S, Walkey AJ, Bosch NA. Rationale and Design of the Awake Prone Position for Early Hypoxemia in COVID-19 (APPEX-19) Study Protocol. Ann Am Thorac Soc. 2021 Mar 1. doi: 10.1513/AnnalsATS.202009-1124SD. [Epub ahead of print]']",,03/06/2021,https://clinicaltrials.gov/show/NCT04344587,07/05/2021,0,1
2835,NCT04350580,Completed,20/11/2020,15/03/2021,No Results Posted,"['Mazeraud A, Gon√ßalves B, Aegerter P, Mancusi L, Rieu C, Bozza F, Sylla K, Siami S, Sharshar T. Effect of early treatment with polyvalent immunoglobulin on acute respiratory distress syndrome associated with SARS-CoV-2 infections (ICAR trial): study protocol for a randomized controlled trial. Trials. 2021 Feb 28;22(1):170. doi: 10.1186/s13063-021-05118-7.']",,08/06/2021,https://clinicaltrials.gov/show/NCT04350580,20/11/2020,0,1
2836,NCT04352400,Recruiting,01/12/2021,01/12/2021,No Results Posted,"['Flumignan RL, Tin√¥co JDS, Pascoal PI, Areias LL, Cossi MS, Fernandes MI, Costa IK, Souza L, Matar CF, Tendal B, Trevisani VF, Atallah √ÅN, Nakano LC. Prophylactic anticoagulants for people hospitalised with COVID-19. Cochrane Database Syst Rev. 2020 Oct 2;10:CD013739. doi: 10.1002/14651858.CD013739.']","['Yamamoto M, Matsuyama S, Li X, Takeda M, Kawaguchi Y, Inoue JI, Matsuda Z. Identification of Nafamostat as a Potent Inhibitor of Middle East Respiratory Syndrome Coronavirus S Protein-Mediated Membrane Fusion Using the Split-Protein-Based Cell-Cell Fusion Assay. Antimicrob Agents Chemother. 2016 Oct 21;60(11):6532-6539. doi: 10.1128/AAC.01043-16. Print 2016 Nov.', 'Hoffmann M, Kleine-Weber H, Schroeder S, Kr√ºger N, Herrler T, Erichsen S, Schiergens TS, Herrler G, Wu NH, Nitsche A, M√ºller MA, Drosten C, P√∂hlmann S. SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor. Cell. 2020 Apr 16;181(2):271-280.e8. doi: 10.1016/j.cell.2020.02.052. Epub 2020 Mar 5.', 'Zhou F, Yu T, Du R, Fan G, Liu Y, Liu Z, Xiang J, Wang Y, Song B, Gu X, Guan L, Wei Y, Li H, Wu X, Xu J, Tu S, Zhang Y, Chen H, Cao B. Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study. Lancet. 2020 Mar 28;395(10229):1054-1062. doi: 10.1016/S0140-6736(20)30566-3. Epub 2020 Mar 11. Erratum in: Lancet. 2020 Mar 28;395(10229):1038. Lancet. 2020 Mar 28;395(10229):1038.', 'Cao B, Wang Y, Wen D, Liu W, Wang J, Fan G, Ruan L, Song B, Cai Y, Wei M, Li X, Xia J, Chen N, Xiang J, Yu T, Bai T, Xie X, Zhang L, Li C, Yuan Y, Chen H, Li H, Huang H, Tu S, Gong F, Liu Y, Wei Y, Dong C, Zhou F, Gu X, Xu J, Liu Z, Zhang Y, Li H, Shang L, Wang K, Li K, Zhou X, Dong X, Qu Z, Lu S, Hu X, Ruan S, Luo S, Wu J, Peng L, Cheng F, Pan L, Zou J, Jia C, Wang J, Liu X, Wang S, Wu X, Ge Q, He J, Zhan H, Qiu F, Guo L, Huang C, Jaki T, Hayden FG, Horby PW, Zhang D, Wang C. A Trial of Lopinavir-Ritonavir in Adults Hospitalized with Severe Covid-19. N Engl J Med. 2020 May 7;382(19):1787-1799. doi: 10.1056/NEJMoa2001282. Epub 2020 Mar 18.', 'Minakata D, Fujiwara SI, Ikeda T, Kawaguchi SI, Toda Y, Ito S, Ochi SI, Nagayama T, Mashima K, Umino K, Nakano H, Yamasaki R, Morita K, Kawasaki Y, Sugimoto M, Yamamoto C, Ashizawa M, Hatano K, Sato K, Oh I, Ohmine K, Muroi K, Ohmori T, Kanda Y. Comparison of gabexate mesilate and nafamostat mesilate for disseminated intravascular coagulation associated with hematological malignancies. Int J Hematol. 2019 Feb;109(2):141-146. doi: 10.1007/s12185-018-02567-w. Epub 2018 Dec 8.', 'Yu G, Li S, Wan R, Wang X, Hu G. Nafamostat mesilate for prevention of post-ERCP pancreatitis: a meta-analysis of prospective, randomized, controlled trials. Pancreas. 2015 May;44(4):561-9. doi: 10.1097/MPA.0000000000000310.', 'Ferreira FL, Bota DP, Bross A, M√©lot C, Vincent JL. Serial evaluation of the SOFA score to predict outcome in critically ill patients. JAMA. 2001 Oct 10;286(14):1754-8.']",09/06/2021,https://clinicaltrials.gov/show/NCT04352400,01/12/2021,0,1
2837,NCT04359225,Not yet recruiting,31/12/2021,31/12/2021,No Results Posted,,,08/06/2021,https://clinicaltrials.gov/show/NCT04359225,31/12/2021,0,0
2838,NCT04364802,Recruiting,01/04/2022,01/04/2022,No Results Posted,"['Burton MJ, Clarkson JE, Goulao B, Glenny AM, McBain AJ, Schilder AG, Webster KE, Worthington HV. Use of antimicrobial mouthwashes (gargling) and nasal sprays by healthcare workers to protect them when treating patients with suspected or confirmed COVID-19 infection. Cochrane Database Syst Rev. 2020 Sep 16;9:CD013626. doi: 10.1002/14651858.CD013626.pub2.']",,07/06/2021,https://clinicaltrials.gov/show/NCT04364802,01/04/2022,0,1
2839,NCT04371029,Completed,09/09/2020,09/12/2020,No Results Posted,,,07/06/2021,https://clinicaltrials.gov/show/NCT04371029,09/09/2020,0,0
2840,NCT04375046,Not yet recruiting,01/08/2021,01/10/2021,No Results Posted,,,09/06/2021,https://clinicaltrials.gov/show/NCT04375046,01/08/2021,0,0
2841,NCT04376593,Enrolling by invitation,01/11/2021,01/05/2022,No Results Posted,,,04/06/2021,https://clinicaltrials.gov/show/NCT04376593,01/11/2021,0,0
2842,NCT04377334,Not yet recruiting,01/03/2022,01/06/2022,No Results Posted,,,07/06/2021,https://clinicaltrials.gov/show/NCT04377334,01/03/2022,0,0
2843,NCT04379037,Completed,01/09/2020,01/11/2020,No Results Posted,,,04/06/2021,https://clinicaltrials.gov/show/NCT04379037,01/09/2020,0,0
2844,NCT04382651,Completed,06/01/2021,21/04/2021,No Results Posted,,,08/07/2021,https://clinicaltrials.gov/show/NCT04382651,06/01/2021,0,0
2845,NCT04382950,Not yet recruiting,01/08/2021,01/10/2021,No Results Posted,,,09/06/2021,https://clinicaltrials.gov/show/NCT04382950,01/08/2021,0,0
2846,NCT04389710,Completed,03/11/2020,07/12/2020,No Results Posted,,,04/06/2021,https://clinicaltrials.gov/show/NCT04389710,03/11/2020,0,0
2847,NCT04391309,Recruiting,01/11/2021,01/02/2022,No Results Posted,,,03/06/2021,https://clinicaltrials.gov/show/NCT04391309,01/11/2021,0,0
2848,NCT04422613,"Active, not recruiting",01/12/2021,01/05/2022,No Results Posted,,,07/06/2021,https://clinicaltrials.gov/show/NCT04422613,01/12/2021,0,0
2849,NCT04426201,Recruiting,30/12/2021,31/12/2021,No Results Posted,,"['Zhou F, Yu T, Du R, Fan G, Liu Y, Liu Z, Xiang J, Wang Y, Song B, Gu X, Guan L, Wei Y, Li H, Wu X, Xu J, Tu S, Zhang Y, Chen H, Cao B. Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study. Lancet. 2020 Mar 28;395(10229):1054-1062. doi: 10.1016/S0140-6736(20)30566-3. Epub 2020 Mar 11. Erratum in: Lancet. 2020 Mar 28;395(10229):1038. Lancet. 2020 Mar 28;395(10229):1038.', 'Wang D, Hu B, Hu C, Zhu F, Liu X, Zhang J, Wang B, Xiang H, Cheng Z, Xiong Y, Zhao Y, Li Y, Wang X, Peng Z. Clinical Characteristics of 138 Hospitalized Patients With 2019 Novel Coronavirus-Infected Pneumonia in Wuhan, China. JAMA. 2020 Mar 17;323(11):1061-1069. doi: 10.1001/jama.2020.1585. Erratum in: JAMA. 2021 Mar 16;325(11):1113.', 'Francois B, Jeannet R, Daix T, Walton AH, Shotwell MS, Unsinger J, Monneret G, Rimmel√© T, Blood T, Morre M, Gregoire A, Mayo GA, Blood J, Durum SK, Sherwood ER, Hotchkiss RS. Interleukin-7 restores lymphocytes in septic shock: the IRIS-7 randomized clinical trial. JCI Insight. 2018 Mar 8;3(5). pii: 98960. doi: 10.1172/jci.insight.98960.', 'Venet F, Foray AP, Villars-M√©chin A, Malcus C, Poitevin-Later F, Lepape A, Monneret G. IL-7 restores lymphocyte functions in septic patients. J Immunol. 2012 Nov 15;189(10):5073-81. doi: 10.4049/jimmunol.1202062. Epub 2012 Oct 10.']",03/06/2021,https://clinicaltrials.gov/show/NCT04426201,30/12/2021,0,1
2850,NCT04439071,Recruiting,31/07/2021,31/07/2021,No Results Posted,,,04/06/2021,https://clinicaltrials.gov/show/NCT04439071,31/07/2021,0,0
2851,NCT04444297,Not yet recruiting,31/12/2021,31/12/2021,No Results Posted,,,08/06/2021,https://clinicaltrials.gov/show/NCT04444297,31/12/2021,0,0
2852,NCT04444323,Not yet recruiting,01/12/2021,01/12/2021,No Results Posted,,,08/06/2021,https://clinicaltrials.gov/show/NCT04444323,01/12/2021,0,0
2853,NCT04445272,Completed,23/12/2020,23/12/2020,No Results Posted,,,02/06/2021,https://clinicaltrials.gov/show/NCT04445272,23/12/2020,0,0
2854,NCT04466670,Recruiting,30/12/2021,30/05/2022,No Results Posted,,"['Huang C, Wang Y, Li X, Ren L, Zhao J, Hu Y, Zhang L, Fan G, Xu J, Gu X, Cheng Z, Yu T, Xia J, Wei Y, Wu W, Xie X, Yin W, Li H, Liu M, Xiao Y, Gao H, Guo L, Xie J, Wang G, Jiang R, Gao Z, Jin Q, Wang J, Cao B. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet. 2020 Feb 15;395(10223):497-506. doi: 10.1016/S0140-6736(20)30183-5. Epub 2020 Jan 24. Erratum in: Lancet. 2020 Jan 30;:.', 'Fu L, Wang B, Yuan T, Chen X, Ao Y, Fitzpatrick T, Li P, Zhou Y, Lin YF, Duan Q, Luo G, Fan S, Lu Y, Feng A, Zhan Y, Liang B, Cai W, Zhang L, Du X, Li L, Shu Y, Zou H. Clinical characteristics of coronavirus disease 2019 (COVID-19) in China: A systematic review and meta-analysis. J Infect. 2020 Jun;80(6):656-665. doi: 10.1016/j.jinf.2020.03.041. Epub 2020 Apr 10.', 'Arachchillage DRJ, Laffan M. Abnormal coagulation parameters are associated with poor prognosis in patients with novel coronavirus pneumonia. J Thromb Haemost. 2020 May;18(5):1233-1234. doi: 10.1111/jth.14820.', 'Lillicrap D. Disseminated intravascular coagulation in patients with 2019-nCoV pneumonia. J Thromb Haemost. 2020 Apr;18(4):786-787. doi: 10.1111/jth.14781. Epub 2020 Mar 24.', 'Lippi G, Favaloro EJ. D-dimer is Associated with Severity of Coronavirus Disease 2019: A Pooled Analysis. Thromb Haemost. 2020 May;120(5):876-878. doi: 10.1055/s-0040-1709650. Epub 2020 Apr 3.', 'Feng Y, Ling Y, Bai T, Xie Y, Huang J, Li J, Xiong W, Yang D, Chen R, Lu F, Lu Y, Liu X, Chen Y, Li X, Li Y, Summah HD, Lin H, Yan J, Zhou M, Lu H, Qu J. COVID-19 with Different Severities: A Multicenter Study of Clinical Features. Am J Respir Crit Care Med. 2020 Jun 1;201(11):1380-1388. doi: 10.1164/rccm.202002-0445OC.', 'Cui S, Chen S, Li X, Liu S, Wang F. Prevalence of venous thromboembolism in patients with severe novel coronavirus pneumonia. J Thromb Haemost. 2020 Jun;18(6):1421-1424. doi: 10.1111/jth.14830. Epub 2020 May 6.', 'Klok FA, Kruip MJHA, van der Meer NJM, Arbous MS, Gommers DAMPJ, Kant KM, Kaptein FHJ, van Paassen J, Stals MAM, Huisman MV, Endeman H. Incidence of thrombotic complications in critically ill ICU patients with COVID-19. Thromb Res. 2020 Jul;191:145-147. doi: 10.1016/j.thromres.2020.04.013. Epub 2020 Apr 10.', 'Helms J, Tacquard C, Severac F, Leonard-Lorant I, Ohana M, Delabranche X, Merdji H, Clere-Jehl R, Schenck M, Fagot Gandet F, Fafi-Kremer S, Castelain V, Schneider F, Grunebaum L, Angl√©s-Cano E, Sattler L, Mertes PM, Meziani F; CRICS TRIGGERSEP Group (Clinical Research in Intensive Care and Sepsis Trial Group for Global Evaluation and Research in Sepsis). High risk of thrombosis in patients with severe SARS-CoV-2 infection: a multicenter prospective cohort study. Intensive Care Med. 2020 Jun;46(6):1089-1098. doi: 10.1007/s00134-020-06062-x. Epub 2020 May 4.', 'Lodigiani C, Iapichino G, Carenzo L, Cecconi M, Ferrazzi P, Sebastian T, Kucher N, Studt JD, Sacco C, Bertuzzi A, Sandri MT, Barco S; Humanitas COVID-19 Task Force. Venous and arterial thromboembolic complications in COVID-19 patients admitted to an academic hospital in Milan, Italy. Thromb Res. 2020 Jul;191:9-14. doi: 10.1016/j.thromres.2020.04.024. Epub 2020 Apr 23.', 'Middeldorp S, Coppens M, van Haaps TF, Foppen M, Vlaar AP, M√ºller MCA, Bouman CCS, Beenen LFM, Kootte RS, Heijmans J, Smits LP, Bonta PI, van Es N. Incidence of venous thromboembolism in hospitalized patients with COVID-19. J Thromb Haemost. 2020 Aug;18(8):1995-2002. doi: 10.1111/jth.14888. Epub 2020 Jul 27.', 'Llitjos JF, Leclerc M, Chochois C, Monsallier JM, Ramakers M, Auvray M, Merouani K. High incidence of venous thromboembolic events in anticoagulated severe COVID-19 patients. J Thromb Haemost. 2020 Jul;18(7):1743-1746. doi: 10.1111/jth.14869. Epub 2020 May 27.', 'Gralinski LE, Bankhead A 3rd, Jeng S, Menachery VD, Proll S, Belisle SE, Matzke M, Webb-Robertson BJ, Luna ML, Shukla AK, Ferris MT, Bolles M, Chang J, Aicher L, Waters KM, Smith RD, Metz TO, Law GL, Katze MG, McWeeney S, Baric RS. Mechanisms of severe acute respiratory syndrome coronavirus-induced acute lung injury. mBio. 2013 Aug 6;4(4). pii: e00271-13. doi: 10.1128/mBio.00271-13.', 'Walls AC, Park YJ, Tortorici MA, Wall A, McGuire AT, Veesler D. Structure, Function, and Antigenicity of the SARS-CoV-2 Spike Glycoprotein. Cell. 2020 Apr 16;181(2):281-292.e6. doi: 10.1016/j.cell.2020.02.058. Epub 2020 Mar 9. Erratum in: Cell. 2020 Dec 10;183(6):1735.', 'Hoffmann M, Kleine-Weber H, Schroeder S, Kr√ºger N, Herrler T, Erichsen S, Schiergens TS, Herrler G, Wu NH, Nitsche A, M√ºller MA, Drosten C, P√∂hlmann S. SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor. Cell. 2020 Apr 16;181(2):271-280.e8. doi: 10.1016/j.cell.2020.02.052. Epub 2020 Mar 5.', 'Hamming I, Timens W, Bulthuis ML, Lely AT, Navis G, van Goor H. Tissue distribution of ACE2 protein, the functional receptor for SARS coronavirus. A first step in understanding SARS pathogenesis. J Pathol. 2004 Jun;203(2):631-7.', 'Vaduganathan M, Vardeny O, Michel T, McMurray JJV, Pfeffer MA, Solomon SD. Renin-Angiotensin-Aldosterone System Inhibitors in Patients with Covid-19. N Engl J Med. 2020 Apr 23;382(17):1653-1659. doi: 10.1056/NEJMsr2005760. Epub 2020 Mar 30.', 'Ackermann M, Verleden SE, Kuehnel M, Haverich A, Welte T, Laenger F, Vanstapel A, Werlein C, Stark H, Tzankov A, Li WW, Li VW, Mentzer SJ, Jonigk D. Pulmonary Vascular Endothelialitis, Thrombosis, and Angiogenesis in Covid-19. N Engl J Med. 2020 Jul 9;383(2):120-128. doi: 10.1056/NEJMoa2015432. Epub 2020 May 21.', 'Dolhnikoff M, Duarte-Neto AN, de Almeida Monteiro RA, da Silva LFF, de Oliveira EP, Saldiva PHN, Mauad T, Negri EM. Pathological evidence of pulmonary thrombotic phenomena in severe COVID-19. J Thromb Haemost. 2020 Jun;18(6):1517-1519. doi: 10.1111/jth.14844.', 'Panigada M, Bottino N, Tagliabue P, Grasselli G, Novembrino C, Chantarangkul V, Pesenti A, Peyvandi F, Tripodi A. Hypercoagulability of COVID-19 patients in intensive care unit: A report of thromboelastography findings and other parameters of hemostasis. J Thromb Haemost. 2020 Jul;18(7):1738-1742. doi: 10.1111/jth.14850. Epub 2020 Jun 24.', 'Escher R, Breakey N, L√§mmle B. Severe COVID-19 infection associated with endothelial activation. Thromb Res. 2020 Jun;190:62. doi: 10.1016/j.thromres.2020.04.014. Epub 2020 Apr 15.', 'Mehta P, McAuley DF, Brown M, Sanchez E, Tattersall RS, Manson JJ; HLH Across Speciality Collaboration, UK. COVID-19: consider cytokine storm syndromes and immunosuppression. Lancet. 2020 Mar 28;395(10229):1033-1034. doi: 10.1016/S0140-6736(20)30628-0. Epub 2020 Mar 16.', 'Whyte CS, Morrow GB, Mitchell JL, Chowdary P, Mutch NJ. Fibrinolytic abnormalities in acute respiratory distress syndrome (ARDS) and versatility of thrombolytic drugs to treat COVID-19. J Thromb Haemost. 2020 Jul;18(7):1548-1555. doi: 10.1111/jth.14872. Epub 2020 Jun 3. Review.', 'White D, MacDonald S, Bull T, Hayman M, de Monteverde-Robb R, Sapsford D, Lavinio A, Varley J, Johnston A, Besser M, Thomas W. Heparin resistance in COVID-19 patients in the intensive care unit. J Thromb Thrombolysis. 2020 Aug;50(2):287-291. doi: 10.1007/s11239-020-02145-0. Erratum in: J Thromb Thrombolysis. 2020 Jun 22;:.', 'Garcia DA, Baglin TP, Weitz JI, Samama MM. Parenteral anticoagulants: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines. Chest. 2012 Feb;141(2 Suppl):e24S-e43S. doi: 10.1378/chest.11-2291. Review. Erratum in: Chest. 2012 May;141(5):1369. Dosage error in article text. Chest. 2013 Aug;144(2):721. Dosage error in article text.', 'Barrett CD, Moore HB, Yaffe MB, Moore EE. ISTH interim guidance on recognition and management of coagulopathy in COVID-19: A comment. J Thromb Haemost. 2020 Aug;18(8):2060-2063. doi: 10.1111/jth.14860. Epub 2020 Jun 14.', 'Bikdeli B, Madhavan MV, Jimenez D, Chuich T, Dreyfus I, Driggin E, Nigoghossian C, Ageno W, Madjid M, Guo Y, Tang LV, Hu Y, Giri J, Cushman M, Qu√©r√© I, Dimakakos EP, Gibson CM, Lippi G, Favaloro EJ, Fareed J, Caprini JA, Tafur AJ, Burton JR, Francese DP, Wang EY, Falanga A, McLintock C, Hunt BJ, Spyropoulos AC, Barnes GD, Eikelboom JW, Weinberg I, Schulman S, Carrier M, Piazza G, Beckman JA, Steg PG, Stone GW, Rosenkranz S, Goldhaber SZ, Parikh SA, Monreal M, Krumholz HM, Konstantinides SV, Weitz JI, Lip GYH; Global COVID-19 Thrombosis Collaborative Group, Endorsed by the ISTH, NATF, ESVM, and the IUA, Supported by the ESC Working Group on Pulmonary Circulation and Right Ventricular Function. COVID-19 and Thrombotic or Thromboembolic Disease: Implications for Prevention, Antithrombotic Therapy, and Follow-Up: JACC State-of-the-Art Review. J Am Coll Cardiol. 2020 Jun 16;75(23):2950-2973. doi: 10.1016/j.jacc.2020.04.031. Epub 2020 Apr 17. Review.', 'Maatman TK, Jalali F, Feizpour C, Douglas A 2nd, McGuire SP, Kinnaman G, Hartwell JL, Maatman BT, Kreutz RP, Kapoor R, Rahman O, Zyromski NJ, Meagher AD. Routine Venous Thromboembolism Prophylaxis May Be Inadequate in the Hypercoagulable State of Severe Coronavirus Disease 2019. Crit Care Med. 2020 Sep;48(9):e783-e790. doi: 10.1097/CCM.0000000000004466.', 'Nahum J, Morichau-Beauchant T, Daviaud F, Echegut P, Fichet J, Maillet JM, Thierry S. Venous Thrombosis Among Critically Ill Patients With Coronavirus Disease 2019 (COVID-19). JAMA Netw Open. 2020 May 1;3(5):e2010478. doi: 10.1001/jamanetworkopen.2020.10478.', 'Tremblay D, van Gerwen M, Alsen M, Thibaud S, Kessler A, Venugopal S, Makki I, Qin Q, Dharmapuri S, Jun T, Bhalla S, Berwick S, Feld J, Mascarenhas J, Troy K, Cromwell C, Dunn A, Oh WK, Naymagon L. Impact of anticoagulation prior to COVID-19 infection: a propensity score-matched cohort study. Blood. 2020 Jul 2;136(1):144-147. doi: 10.1182/blood.2020006941.', 'Paranjpe I, Fuster V, Lala A, Russak AJ, Glicksberg BS, Levin MA, Charney AW, Narula J, Fayad ZA, Bagiella E, Zhao S, Nadkarni GN. Association of Treatment Dose Anticoagulation With In-Hospital Survival Among Hospitalized Patients With COVID-19. J Am Coll Cardiol. 2020 Jul 7;76(1):122-124. doi: 10.1016/j.jacc.2020.05.001. Epub 2020 May 6.', 'Juschten J, Tuinman PR, Juffermans NP, Dixon B, Levi M, Schultz MJ. Nebulized anticoagulants in lung injury in critically ill patients-an updated systematic review of preclinical and clinical studies. Ann Transl Med. 2017 Nov;5(22):444. doi: 10.21037/atm.2017.08.23. Review.', 'Dixon B, Schultz MJ, Smith R, Fink JB, Santamaria JD, Campbell DJ. Nebulized heparin is associated with fewer days of mechanical ventilation in critically ill patients: a randomized controlled trial. Crit Care. 2010;14(5):R180. doi: 10.1186/cc9286. Epub 2010 Oct 11.', 'Viecca M, Radovanovic D, Forleo GB, Santus P. Enhanced platelet inhibition treatment improves hypoxemia in patients with severe Covid-19 and hypercoagulability. A case control, proof of concept study. Pharmacol Res. 2020 Aug;158:104950. doi: 10.1016/j.phrs.2020.104950. Epub 2020 May 23.', 'Connor JT, Elm JJ, Broglio KR; ESETT and ADAPT-IT Investigators. Bayesian adaptive trials offer advantages in comparative effectiveness trials: an example in status epilepticus. J Clin Epidemiol. 2013 Aug;66(8 Suppl):S130-7. doi: 10.1016/j.jclinepi.2013.02.015.', 'Gsponer T, Gerber F, Bornkamp B, Ohlssen D, Vandemeulebroecke M, Schmidli H. A practical guide to Bayesian group sequential designs. Pharm Stat. 2014 Jan-Feb;13(1):71-80. doi: 10.1002/pst.1593. Epub 2013 Aug 24.']",09/06/2021,https://clinicaltrials.gov/show/NCT04466670,30/12/2021,0,1
2855,NCT04498325,Not yet recruiting,30/04/2022,30/04/2022,No Results Posted,,,07/06/2021,https://clinicaltrials.gov/show/NCT04498325,30/04/2022,0,0
2856,NCT04501952,Terminated,06/05/2021,06/05/2021,No Results Posted,,,07/06/2021,https://clinicaltrials.gov/show/NCT04501952,06/05/2021,0,0
2857,NCT04505722,"Active, not recruiting",22/01/2021,02/01/2023,No Results Posted,"['Sadoff J, Gray G, Vandebosch A, C√°rdenas V, Shukarev G, Grinsztejn B, Goepfert PA, Truyers C, Fennema H, Spiessens B, Offergeld K, Scheper G, Taylor KL, Robb ML, Treanor J, Barouch DH, Stoddard J, Ryser MF, Marovich MA, Neuzil KM, Corey L, Cauwenberghs N, Tanner T, Hardt K, Ruiz-Gui√±az√∫ J, Le Gars M, Schuitemaker H, Van Hoof J, Struyf F, Douoguih M; ENSEMBLE Study Group. Safety and Efficacy of Single-Dose Ad26.COV2.S Vaccine against Covid-19. N Engl J Med. 2021 Jun 10;384(23):2187-2201. doi: 10.1056/NEJMoa2101544. Epub 2021 Apr 21.', 'Williams TC, Burgers WA. SARS-CoV-2 evolution and vaccines: cause for concern? Lancet Respir Med. 2021 Apr;9(4):333-335. doi: 10.1016/S2213-2600(21)00075-8. Epub 2021 Jan 29.']",,07/06/2021,https://clinicaltrials.gov/show/NCT04505722,22/01/2021,0,1
2858,NCT04510194,Recruiting,01/10/2021,01/12/2021,No Results Posted,,,04/06/2021,https://clinicaltrials.gov/show/NCT04510194,01/10/2021,0,0
2859,NCT04523090,Recruiting,01/12/2021,01/02/2022,No Results Posted,,,07/06/2021,https://clinicaltrials.gov/show/NCT04523090,01/12/2021,0,0
2860,NCT04524507,Completed,04/06/2021,04/06/2021,No Results Posted,,,07/06/2021,https://clinicaltrials.gov/show/NCT04524507,04/06/2021,0,0
2861,NCT04535778,Recruiting,01/06/2021,01/06/2021,No Results Posted,,,09/06/2021,https://clinicaltrials.gov/show/NCT04535778,01/06/2021,0,0
2862,NCT04537299,Enrolling by invitation,01/12/2023,01/12/2023,No Results Posted,,,02/06/2021,https://clinicaltrials.gov/show/NCT04537299,01/12/2023,0,0
2863,NCT04539821,"Active, not recruiting",31/05/2021,30/07/2021,No Results Posted,,,02/06/2021,https://clinicaltrials.gov/show/NCT04539821,31/05/2021,0,0
2864,NCT04545749,Completed,18/01/2021,24/05/2021,No Results Posted,,,07/06/2021,https://clinicaltrials.gov/show/NCT04545749,18/01/2021,0,0
2865,NCT04547140,Recruiting,01/11/2021,01/02/2022,No Results Posted,,,04/06/2021,https://clinicaltrials.gov/show/NCT04547140,01/11/2021,0,0
2866,NCT04616989,Completed,30/01/2021,30/01/2021,No Results Posted,,,02/06/2021,https://clinicaltrials.gov/show/NCT04616989,30/01/2021,0,0
2867,NCT04627675,"Active, not recruiting",01/07/2021,01/05/2022,No Results Posted,,,03/06/2021,https://clinicaltrials.gov/show/NCT04627675,01/07/2021,0,0
2868,NCT04628039,Recruiting,01/08/2024,31/10/2024,No Results Posted,,,07/06/2021,https://clinicaltrials.gov/show/NCT04628039,01/08/2024,0,0
2869,NCT04637867,Completed,12/05/2021,12/05/2021,No Results Posted,,,04/06/2021,https://clinicaltrials.gov/show/NCT04637867,12/05/2021,0,0
2870,NCT04640233,"Active, not recruiting",01/08/2021,01/09/2021,No Results Posted,,,02/06/2021,https://clinicaltrials.gov/show/NCT04640233,01/08/2021,0,0
2871,NCT04649151,"Active, not recruiting",30/06/2022,30/06/2022,No Results Posted,,,07/06/2021,https://clinicaltrials.gov/show/NCT04649151,30/06/2022,0,0
2872,NCT04655638,Recruiting,10/01/2022,01/03/2022,No Results Posted,,,03/06/2021,https://clinicaltrials.gov/show/NCT04655638,10/01/2022,0,0
2873,NCT04667247,Recruiting,01/09/2021,01/12/2021,No Results Posted,,,02/07/2021,https://clinicaltrials.gov/show/NCT04667247,01/09/2021,0,0
2874,NCT04676867,Completed,17/05/2021,17/05/2021,No Results Posted,,,02/06/2021,https://clinicaltrials.gov/show/NCT04676867,17/05/2021,0,0
2875,NCT04701489,Completed,15/03/2021,07/04/2021,No Results Posted,,,04/06/2021,https://clinicaltrials.gov/show/NCT04701489,15/03/2021,0,0
2876,NCT04703608,Recruiting,01/03/2022,01/07/2022,No Results Posted,,,04/06/2021,https://clinicaltrials.gov/show/NCT04703608,01/03/2022,0,0
2877,NCT04710381,Recruiting,15/06/2021,30/06/2021,No Results Posted,,,04/06/2021,https://clinicaltrials.gov/show/NCT04710381,15/06/2021,0,0
2878,NCT04720378,Recruiting,01/10/2021,01/10/2021,No Results Posted,,,03/06/2021,https://clinicaltrials.gov/show/NCT04720378,01/10/2021,0,0
2879,NCT04730206,Not yet recruiting,01/05/2022,01/05/2023,No Results Posted,,,03/06/2021,https://clinicaltrials.gov/show/NCT04730206,01/05/2022,0,0
2880,NCT04730856,Recruiting,01/06/2021,31/07/2021,No Results Posted,,"['Huang C, Wang Y, Li X, Ren L, Zhao J, Hu Y, Zhang L, Fan G, Xu J, Gu X, Cheng Z, Yu T, Xia J, Wei Y, Wu W, Xie X, Yin W, Li H, Liu M, Xiao Y, Gao H, Guo L, Xie J, Wang G, Jiang R, Gao Z, Jin Q, Wang J, Cao B. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet. 2020 Feb 15;395(10223):497-506. doi: 10.1016/S0140-6736(20)30183-5. Epub 2020 Jan 24. Erratum in: Lancet. 2020 Jan 30;:.']",04/06/2021,https://clinicaltrials.gov/show/NCT04730856,01/06/2021,0,1
2881,NCT04763681,Recruiting,31/08/2021,31/08/2021,No Results Posted,,,08/06/2021,https://clinicaltrials.gov/show/NCT04763681,31/08/2021,0,0
2882,NCT04765449,Not yet recruiting,31/08/2023,29/02/2024,No Results Posted,,,04/06/2021,https://clinicaltrials.gov/show/NCT04765449,31/08/2023,0,0
2883,NCT04770467,Withdrawn,01/10/2022,01/10/2022,No Results Posted,,,07/06/2021,https://clinicaltrials.gov/show/NCT04770467,01/10/2022,0,0
2884,NCT04771000,Recruiting,31/07/2021,31/10/2021,No Results Posted,,,03/06/2021,https://clinicaltrials.gov/show/NCT04771000,31/07/2021,0,0
2885,NCT04771611,Enrolling by invitation,01/12/2022,01/06/2023,No Results Posted,,,02/06/2021,https://clinicaltrials.gov/show/NCT04771611,01/12/2022,0,0
2886,NCT04773067,Recruiting,30/06/2021,30/06/2022,No Results Posted,,,07/06/2021,https://clinicaltrials.gov/show/NCT04773067,30/06/2021,0,0
2887,NCT04773899,Not yet recruiting,09/07/2022,09/09/2022,No Results Posted,,,03/06/2021,https://clinicaltrials.gov/show/NCT04773899,09/07/2022,0,0
2888,NCT04780152,Recruiting,01/08/2022,01/09/2022,No Results Posted,,"['Jiang N, Wei J, Li G, Wei B, Zhu FF, Hu Y. Effect of dry-electrode-based transcranial direct current stimulation on chronic low back pain and low back muscle activities: A double-blind sham-controlled study. Restor Neurol Neurosci. 2020;38(1):41-54. doi: 10.3233/RNN-190922.', 'Kontoangelos K, Economou M, Papageorgiou C. Mental Health Effects of COVID-19 Pandemia: A Review of Clinical and Psychological Traits. Psychiatry Investig. 2020 Jun;17(6):491-505. doi: 10.30773/pi.2020.0161. Epub 2020 Jun 15.', 'Kuo MF, Paulus W, Nitsche MA. Boosting focally-induced brain plasticity by dopamine. Cereb Cortex. 2008 Mar;18(3):648-51. Epub 2007 Jun 24.', 'Kupfer DJ, Frank E, Phillips ML. Major depressive disorder: new clinical, neurobiological, and treatment perspectives. Lancet. 2012 Mar 17;379(9820):1045-55. doi: 10.1016/S0140-6736(11)60602-8. Epub 2011 Dec 19. Review.', 'Lefaucheur JP, Antal A, Ayache SS, Benninger DH, Brunelin J, Cogiamanian F, Cotelli M, De Ridder D, Ferrucci R, Langguth B, Marangolo P, Mylius V, Nitsche MA, Padberg F, Palm U, Poulet E, Priori A, Rossi S, Schecklmann M, Vanneste S, Ziemann U, Garcia-Larrea L, Paulus W. Evidence-based guidelines on the therapeutic use of transcranial direct current stimulation (tDCS). Clin Neurophysiol. 2017 Jan;128(1):56-92. doi: 10.1016/j.clinph.2016.10.087. Epub 2016 Oct 29. Review.', 'Lewinsohn PM, Rohde P, Seeley JR. Major depressive disorder in older adolescents: prevalence, risk factors, and clinical implications. Clin Psychol Rev. 1998 Nov;18(7):765-94. Review.', 'Liebetanz D, Nitsche MA, Tergau F, Paulus W. Pharmacological approach to the mechanisms of transcranial DC-stimulation-induced after-effects of human motor cortex excitability. Brain. 2002 Oct;125(Pt 10):2238-47.', 'Liebetanz D, Koch R, Mayenfels S, K√∂nig F, Paulus W, Nitsche MA. Safety limits of cathodal transcranial direct current stimulation in rats. Clin Neurophysiol. 2009 Jun;120(6):1161-7. doi: 10.1016/j.clinph.2009.01.022. Epub 2009 Apr 28.', 'Loo CK, Sachdev P, Martin D, Pigot M, Alonzo A, Malhi GS, Lagopoulos J, Mitchell P. A double-blind, sham-controlled trial of transcranial direct current stimulation for the treatment of depression. Int J Neuropsychopharmacol. 2010 Feb;13(1):61-9. doi: 10.1017/S1461145709990411. Epub 2009 Aug 12.', 'Loo CK, Alonzo A, Martin D, Mitchell PB, Galvez V, Sachdev P. Transcranial direct current stimulation for depression: 3-week, randomised, sham-controlled trial. Br J Psychiatry. 2012 Jan;200(1):52-9. doi: 10.1192/bjp.bp.111.097634.', ""Loo CK, Husain MM, McDonald WM, Aaronson S, O'Reardon JP, Alonzo A, Weickert CS, Martin DM, McClintock SM, Mohan A, Lisanby SH; International Consortium of Research in tDCS (ICRT). International randomized-controlled trial of transcranial Direct Current Stimulation in depression. Brain Stimul. 2018 Jan - Feb;11(1):125-133. doi: 10.1016/j.brs.2017.10.011. Epub 2017 Oct 27."", 'L√∂scher W, Cole AJ, McLean MJ. Commentary: physical approaches for the treatment of epilepsy: electrical and magnetic stimulation and cooling. Neurotherapeutics. 2009 Apr;6(2):258-62. doi: 10.1016/j.nurt.2009.01.014. Review.', 'Maceira-Elvira P, Popa T, Schmid AC, Hummel FC. Feasibility of home-based, self-applied transcranial direct current stimulation to enhance motor learning in middle-aged and older adults. Brain Stimul. 2020 Jan - Feb;13(1):247-249. doi: 10.1016/j.brs.2019.08.014. Epub 2019 Sep 24.', 'Malhi GS, Mann JJ. Depression. Lancet. 2018 Nov 24;392(10161):2299-2312. doi: 10.1016/S0140-6736(18)31948-2. Epub 2018 Nov 2. Review.', 'Mattai A, Miller R, Weisinger B, Greenstein D, Bakalar J, Tossell J, David C, Wassermann EM, Rapoport J, Gogtay N. Tolerability of transcranial direct current stimulation in childhood-onset schizophrenia. Brain Stimul. 2011 Oct;4(4):275-80. doi: 10.1016/j.brs.2011.01.001. Epub 2011 Feb 1.', 'Mayberg HS, Brannan SK, Tekell JL, Silva JA, Mahurin RK, McGinnis S, Jerabek PA. Regional metabolic effects of fluoxetine in major depression: serial changes and relationship to clinical response. Biol Psychiatry. 2000 Oct 15;48(8):830-43.', 'McCaig CD, Rajnicek AM, Song B, Zhao M. Controlling cell behavior electrically: current views and future potential. Physiol Rev. 2005 Jul;85(3):943-78. Review.', 'McLaren ME, Nissim NR, Woods AJ. The effects of medication use in transcranial direct current stimulation: A brief review. Brain Stimul. 2018 Jan - Feb;11(1):52-58. doi: 10.1016/j.brs.2017.10.006. Epub 2017 Oct 12. Review.', 'Merzagora AC, Foffani G, Panyavin I, Mordillo-Mateos L, Aguilar J, Onaral B, Oliviero A. Prefrontal hemodynamic changes produced by anodal direct current stimulation. Neuroimage. 2010 Feb 1;49(3):2304-10. doi: 10.1016/j.neuroimage.2009.10.044. Epub 2009 Oct 21.', 'Munz MT, Prehn-Kristensen A, Thielking F, M√∂lle M, G√∂der R, Baving L. Slow oscillating transcranial direct current stimulation during non-rapid eye movement sleep improves behavioral inhibition in attention-deficit/hyperactivity disorder. Front Cell Neurosci. 2015 Aug 11;9:307. doi: 10.3389/fncel.2015.00307. eCollection 2015.', 'Murray CJ, Lopez AD. Global mortality, disability, and the contribution of risk factors: Global Burden of Disease Study. Lancet. 1997 May 17;349(9063):1436-42.', 'Musazzi L, Treccani G, Mallei A, Popoli M. The action of antidepressants on the glutamate system: regulation of glutamate release and glutamate receptors. Biol Psychiatry. 2013 Jun 15;73(12):1180-8. doi: 10.1016/j.biopsych.2012.11.009. Epub 2012 Dec 28. Review.', 'Ngernyam N, Jensen MP, Auvichayapat N, Punjaruk W, Auvichayapat P. Transcranial Direct Current Stimulation in Neuropathic Pain. J Pain Relief. 2013 Apr 21;Suppl 3. pii: 001.', 'Nitsche MA, Liebetanz D, Antal A, Lang N, Tergau F, Paulus W. Modulation of cortical excitability by weak direct current stimulation--technical, safety and functional aspects. Suppl Clin Neurophysiol. 2003;56:255-76. Review.', 'Nitsche MA, Fricke K, Henschke U, Schlitterlau A, Liebetanz D, Lang N, Henning S, Tergau F, Paulus W. Pharmacological modulation of cortical excitability shifts induced by transcranial direct current stimulation in humans. J Physiol. 2003 Nov 15;553(Pt 1):293-301. Epub 2003 Aug 29.', 'Nitsche MA, Liebetanz D, Schlitterlau A, Henschke U, Fricke K, Frommann K, Lang N, Henning S, Paulus W, Tergau F. GABAergic modulation of DC stimulation-induced motor cortex excitability shifts in humans. Eur J Neurosci. 2004 May;19(10):2720-6.', 'Nitsche MA, Niehaus L, Hoffmann KT, Hengst S, Liebetanz D, Paulus W, Meyer BU. MRI study of human brain exposed to weak direct current stimulation of the frontal cortex. Clin Neurophysiol. 2004 Oct;115(10):2419-23.', 'Nitsche MA, Seeber A, Frommann K, Klein CC, Rochford C, Nitsche MS, Fricke K, Liebetanz D, Lang N, Antal A, Paulus W, Tergau F. Modulating parameters of excitability during and after transcranial direct current stimulation of the human motor cortex. J Physiol. 2005 Oct 1;568(Pt 1):291-303. Epub 2005 Jul 7.', 'Nitsche MA, Cohen LG, Wassermann EM, Priori A, Lang N, Antal A, Paulus W, Hummel F, Boggio PS, Fregni F, Pascual-Leone A. Transcranial direct current stimulation: State of the art 2008. Brain Stimul. 2008 Jul;1(3):206-23. doi: 10.1016/j.brs.2008.06.004. Epub 2008 Jul 1. Review.', 'Nitsche MA, Paulus W. Excitability changes induced in the human motor cortex by weak transcranial direct current stimulation. J Physiol. 2000 Sep 15;527 Pt 3:633-9.', 'Nitsche MA, Paulus W. Sustained excitability elevations induced by transcranial DC motor cortex stimulation in humans. Neurology. 2001 Nov 27;57(10):1899-901.', 'Opitz A, Falchier A, Yan CG, Yeagle EM, Linn GS, Megevand P, Thielscher A, Deborah A R, Milham MP, Mehta AD, Schroeder CE. Spatiotemporal structure of intracranial electric fields induced by transcranial electric stimulation in humans and nonhuman primates. Sci Rep. 2016 Aug 18;6:31236. doi: 10.1038/srep31236.', 'Otto WR, Geoghegan S, Posch LC, Bell LM, Coffin SE, Sammons JS, Harris RM, Odom John AR, Luan X, Gerber JS. The Epidemiology of Severe Acute Respiratory Syndrome Coronavirus 2 in a Pediatric Healthcare Network in the United States. J Pediatric Infect Dis Soc. 2020 Nov 10;9(5):523-529. doi: 10.1093/jpids/piaa074.', 'Palm U, Segmiller FM, Epple AN, Freisleder FJ, Koutsouleris N, Schulte-K√∂rne G, Padberg F. Transcranial direct current stimulation in children and adolescents: a comprehensive review. J Neural Transm (Vienna). 2016 Oct;123(10):1219-34. doi: 10.1007/s00702-016-1572-z. Epub 2016 May 12. Review.', 'Paniccia M, Paniccia D, Thomas S, Taha T, Reed N. Clinical and non-clinical depression and anxiety in young people: A scoping review on heart rate variability. Auton Neurosci. 2017 Dec;208:1-14. doi: 10.1016/j.autneu.2017.08.008. Epub 2017 Aug 26. Review.', 'Pelletier SJ, Cicchetti F. Cellular and molecular mechanisms of action of transcranial direct current stimulation: evidence from in vitro and in vivo models. Int J Neuropsychopharmacol. 2014 Oct 31;18(2). pii: pyu047. doi: 10.1093/ijnp/pyu047. Review.', 'Posner K, Brown GK, Stanley B, Brent DA, Yershova KV, Oquendo MA, Currier GW, Melvin GA, Greenhill L, Shen S, Mann JJ. The Columbia-Suicide Severity Rating Scale: initial validity and internal consistency findings from three multisite studies with adolescents and adults. Am J Psychiatry. 2011 Dec;168(12):1266-77. doi: 10.1176/appi.ajp.2011.10111704.', 'Prehn-Kristensen A, Munz M, G√∂der R, Wilhelm I, Korr K, Vahl W, Wiesner CD, Baving L. Transcranial oscillatory direct current stimulation during sleep improves declarative memory consolidation in children with attention-deficit/hyperactivity disorder to a level comparable to healthy controls. Brain Stimul. 2014 Nov-Dec;7(6):793-9. doi: 10.1016/j.brs.2014.07.036. Epub 2014 Jul 23.', 'Priori A, Berardelli A, Rona S, Accornero N, Manfredi M. Polarization of the human motor cortex through the scalp. Neuroreport. 1998 Jul 13;9(10):2257-60.', 'Rafful C, Medina-Mora ME, Borges G, Benjet C, Orozco R. Depression, gender, and the treatment gap in Mexico. J Affect Disord. 2012 Apr;138(1-2):165-9. doi: 10.1016/j.jad.2011.12.040. Epub 2012 Feb 14.', 'Reato D, Rahman A, Bikson M, Parra LC. Low-intensity electrical stimulation affects network dynamics by modulating population rate and spike timing. J Neurosci. 2010 Nov 10;30(45):15067-79. doi: 10.1523/JNEUROSCI.2059-10.2010.', 'Rush AJ, Kraemer HC, Sackeim HA, Fava M, Trivedi MH, Frank E, Ninan PT, Thase ME, Gelenberg AJ, Kupfer DJ, Regier DA, Rosenbaum JF, Ray O, Schatzberg AF; ACNP Task Force. Report by the ACNP Task Force on response and remission in major depressive disorder. Neuropsychopharmacology. 2006 Sep;31(9):1841-53. Epub 2006 Jun 21. Review.', 'Sacher J, Neumann J, F√ºnfst√ºck T, Soliman A, Villringer A, Schroeter ML. Mapping the depressed brain: a meta-analysis of structural and functional alterations in major depressive disorder. J Affect Disord. 2012 Oct;140(2):142-8. doi: 10.1016/j.jad.2011.08.001. Epub 2011 Sep 3.', 'Salloum NC, Fava M, Ball S, Papakostas GI. Success and efficiency of phase 2/3 adjunctive trials for MDD funded by industry: a systematic review. Mol Psychiatry. 2020 Sep;25(9):1967-1974. doi: 10.1038/s41380-020-0646-3. Epub 2020 Jan 27. Review.', 'S√§mann PG, H√∂hn D, Chechko N, Kloiber S, Lucae S, Ising M, Holsboer F, Czisch M. Prediction of antidepressant treatment response from gray matter volume across diagnostic categories. Eur Neuropsychopharmacol. 2013 Nov;23(11):1503-15. doi: 10.1016/j.euroneuro.2013.07.004. Epub 2013 Aug 3.', ""San-Juan D, Calc√°neo Jde D, Gonz√°lez-Arag√≥n MF, Berm√∫dez Maldonado L, Avell√°n AM, Argumosa EV, Fregni F. Transcranial direct current stimulation in adolescent and adult Rasmussen's encephalitis. Epilepsy Behav. 2011 Jan;20(1):126-31. doi: 10.1016/j.yebeh.2010.10.031. Epub 2010 Dec 17."", 'Schestatsky P, Morales-Quezada L, Fregni F. Simultaneous EEG monitoring during transcranial direct current stimulation. J Vis Exp. 2013 Jun 17;(76). doi: 10.3791/50426.', 'Schneider HD, Hopp JP. The use of the Bilingual Aphasia Test for assessment and transcranial direct current stimulation to modulate language acquisition in minimally verbal children with autism. Clin Linguist Phon. 2011 Jun;25(6-7):640-54. doi: 10.3109/02699206.2011.570852. Epub 2011 Jun 1.', 'Segrave RA, Arnold S, Hoy K, Fitzgerald PB. Concurrent cognitive control training augments the antidepressant efficacy of tDCS: a pilot study. Brain Stimul. 2014 Mar-Apr;7(2):325-31. doi: 10.1016/j.brs.2013.12.008. Epub 2013 Dec 19.', 'Sorbello M, El-Boghdadly K, Di Giacinto I, Cataldo R, Esposito C, Falcetta S, Merli G, Cortese G, Corso RM, Bressan F, Pintaudi S, Greif R, Donati A, Petrini F; Societ√† Italiana di Anestesia Analgesia Rianimazione e Terapia Intensiva (SIAARTI) Airway Research Group, and The European Airway Management Society. The Italian coronavirus disease 2019 outbreak: recommendations from clinical practice. Anaesthesia. 2020 Jun;75(6):724-732. doi: 10.1111/anae.15049. Epub 2020 Mar 30.', ""Thair H, Holloway AL, Newport R, Smith AD. Transcranial Direct Current Stimulation (tDCS): A Beginner's Guide for Design and Implementation. Front Neurosci. 2017 Nov 22;11:641. doi: 10.3389/fnins.2017.00641. eCollection 2017."", 'Verity R, Okell LC, Dorigatti I, Winskill P, Whittaker C, Imai N, Cuomo-Dannenburg G, Thompson H, Walker PGT, Fu H, Dighe A, Griffin JT, Baguelin M, Bhatia S, Boonyasiri A, Cori A, Cucunub√° Z, FitzJohn R, Gaythorpe K, Green W, Hamlet A, Hinsley W, Laydon D, Nedjati-Gilani G, Riley S, van Elsland S, Volz E, Wang H, Wang Y, Xi X, Donnelly CA, Ghani AC, Ferguson NM. Estimates of the severity of coronavirus disease 2019: a model-based analysis. Lancet Infect Dis. 2020 Jun;20(6):669-677. doi: 10.1016/S1473-3099(20)30243-7. Epub 2020 Mar 30. Erratum in: Lancet Infect Dis. 2020 Apr 15;:. Lancet Infect Dis. 2020 May 4;:.', 'Villamar MF, Volz MS, Bikson M, Datta A, Dasilva AF, Fregni F. Technique and considerations in the use of 4x1 ring high-definition transcranial direct current stimulation (HD-tDCS). J Vis Exp. 2013 Jul 14;(77):e50309. doi: 10.3791/50309.', 'V√∂r√∂slakos M, Takeuchi Y, Brinyiczki K, Zombori T, Oliva A, Fern√°ndez-Ruiz A, Koz√°k G, Kincses ZT, Iv√°nyi B, Buzs√°ki G, Ber√©nyi A. Direct effects of transcranial electric stimulation on brain circuits in rats and humans. Nat Commun. 2018 Feb 2;9(1):483. doi: 10.1038/s41467-018-02928-3.', 'Wang C, Horby PW, Hayden FG, Gao GF. A novel coronavirus outbreak of global health concern. Lancet. 2020 Feb 15;395(10223):470-473. doi: 10.1016/S0140-6736(20)30185-9. Epub 2020 Jan 24. Erratum in: Lancet. 2020 Jan 29;:.', 'Xie X, Xue Q, Zhou Y, Zhu K, Liu Q, Zhang J, Song R. Mental Health Status Among Children in Home Confinement During the Coronavirus Disease 2019 Outbreak in Hubei Province, China. JAMA Pediatr. 2020 Sep 1;174(9):898-900. doi: 10.1001/jamapediatrics.2020.1619.', 'Yan T, Goldman RD. Time-to-effect of fluoxetine in children with depression. Can Fam Physician. 2019 Aug;65(8):549-551.', 'Yi Y, Lagniton PNP, Ye S, Li E, Xu RH. COVID-19: what has been learned and to be learned about the novel coronavirus disease. Int J Biol Sci. 2020 Mar 15;16(10):1753-1766. doi: 10.7150/ijbs.45134. eCollection 2020. Review.', 'Yip AG, George MS, Tendler A, Roth Y, Zangen A, Carpenter LL. 61% of unmedicated treatment resistant depression patients who did not respond to acute TMS treatment responded after four weeks of twice weekly deep TMS in the Brainsway pivotal trial. Brain Stimul. 2017 Jul - Aug;10(4):847-849. doi: 10.1016/j.brs.2017.02.013. Epub 2017 Mar 10.', 'Wu Z, McGoogan JM. Characteristics of and Important Lessons From the Coronavirus Disease 2019 (COVID-19) Outbreak in China: Summary of a Report of 72 314 Cases From the Chinese Center for Disease Control and Prevention. JAMA. 2020 Apr 7;323(13):1239-1242. doi: 10.1001/jama.2020.2648.', 'Zewdie E, Ciechanski P, Kuo HC, Giuffre A, Kahl C, King R, Cole L, Godfrey H, Seeger T, Swansburg R, Damji O, Rajapakse T, Hodge J, Nelson S, Selby B, Gan L, Jadavji Z, Larson JR, MacMaster F, Yang JF, Barlow K, Gorassini M, Brunton K, Kirton A. Safety and tolerability of transcranial magnetic and direct current stimulation in children: Prospective single center evidence from 3.5 million stimulations. Brain Stimul. 2020 May - Jun;13(3):565-575. doi: 10.1016/j.brs.2019.12.025. Epub 2019 Dec 30.', 'Zhou SJ, Zhang LG, Wang LL, Guo ZC, Wang JQ, Chen JC, Liu M, Chen X, Chen JX. Prevalence and socio-demographic correlates of psychological health problems in Chinese adolescents during the outbreak of COVID-19. Eur Child Adolesc Psychiatry. 2020 Jun;29(6):749-758. doi: 10.1007/s00787-020-01541-4. Epub 2020 May 3.']",04/06/2021,https://clinicaltrials.gov/show/NCT04780152,01/08/2022,0,1
2889,NCT04784897,"Active, not recruiting",01/07/2021,01/07/2021,No Results Posted,,,04/06/2021,https://clinicaltrials.gov/show/NCT04784897,01/07/2021,0,0
2890,NCT04793997,Suspended,01/02/2022,01/02/2022,No Results Posted,,,03/06/2021,https://clinicaltrials.gov/show/NCT04793997,01/02/2022,0,0
2891,NCT04794400,Completed,31/03/2021,31/03/2021,No Results Posted,,,09/06/2021,https://clinicaltrials.gov/show/NCT04794400,31/03/2021,0,0
2892,NCT04813718,Recruiting,01/05/2022,31/12/2022,No Results Posted,,,07/06/2021,https://clinicaltrials.gov/show/NCT04813718,01/05/2022,0,0
2893,NCT04828434,Recruiting,01/04/2023,01/09/2025,No Results Posted,,,02/06/2021,https://clinicaltrials.gov/show/NCT04828434,01/04/2023,0,0
2894,NCT04841707,Recruiting,22/02/2022,22/02/2023,No Results Posted,,,04/06/2021,https://clinicaltrials.gov/show/NCT04841707,22/02/2022,0,0
2895,NCT04848467,Not yet recruiting,30/11/2021,15/11/2022,No Results Posted,,,28/06/2021,https://clinicaltrials.gov/show/NCT04848467,30/11/2021,0,0
2896,NCT04851821,Recruiting,30/05/2021,30/06/2021,No Results Posted,,,07/06/2021,https://clinicaltrials.gov/show/NCT04851821,30/05/2021,0,0
2897,NCT04854798,Enrolling by invitation,01/08/2021,01/09/2021,No Results Posted,,,04/06/2021,https://clinicaltrials.gov/show/NCT04854798,01/08/2021,0,0
2898,NCT04854876,Not yet recruiting,20/07/2021,20/08/2021,No Results Posted,,,08/06/2021,https://clinicaltrials.gov/show/NCT04854876,20/07/2021,0,0
2899,NCT04867265,Completed,02/06/2021,02/06/2021,No Results Posted,,,03/06/2021,https://clinicaltrials.gov/show/NCT04867265,02/06/2021,0,0
2900,NCT04869358,Recruiting,22/12/2021,16/01/2023,No Results Posted,,,06/07/2021,https://clinicaltrials.gov/show/NCT04869358,22/12/2021,0,0
2901,NCT04873414,Recruiting,30/10/2021,31/12/2021,No Results Posted,,,02/06/2021,https://clinicaltrials.gov/show/NCT04873414,30/10/2021,0,0
2902,NCT04878211,Not yet recruiting,26/11/2021,18/11/2022,No Results Posted,,,03/06/2021,https://clinicaltrials.gov/show/NCT04878211,26/11/2021,0,0
2903,NCT04883138,Recruiting,15/08/2021,30/08/2021,No Results Posted,,,07/06/2021,https://clinicaltrials.gov/show/NCT04883138,15/08/2021,0,0
2904,NCT04884685,"Active, not recruiting",15/07/2021,03/01/2022,No Results Posted,,,04/06/2021,https://clinicaltrials.gov/show/NCT04884685,15/07/2021,0,0
2905,NCT04885907,"Active, not recruiting",30/07/2021,30/08/2021,No Results Posted,,,07/06/2021,https://clinicaltrials.gov/show/NCT04885907,30/07/2021,0,0
2906,NCT04891133,Recruiting,01/12/2022,01/12/2025,No Results Posted,,,02/06/2021,https://clinicaltrials.gov/show/NCT04891133,01/12/2022,0,0
2907,NCT04892459,"Active, not recruiting",25/07/2021,25/12/2021,No Results Posted,,,30/06/2021,https://clinicaltrials.gov/show/NCT04892459,25/07/2021,0,0
2908,NCT04893512,Not yet recruiting,21/06/2021,15/09/2022,No Results Posted,,,07/06/2021,https://clinicaltrials.gov/show/NCT04893512,21/06/2021,0,0
2909,NCT04894305,"Active, not recruiting",01/12/2021,17/12/2021,No Results Posted,,,09/07/2021,https://clinicaltrials.gov/show/NCT04894305,01/12/2021,0,0
2910,NCT04895371,Not yet recruiting,23/09/2021,15/10/2021,No Results Posted,,"['Cort√©s-Telles A, L√≥pez-Romero S, Figueroa-Hurtado E, Pou-Aguilar YN, Wong AW, Milne KM, Ryerson CJ, Guenette JA. Pulmonary function and functional capacity in COVID-19 survivors with persistent dyspnoea. Respir Physiol Neurobiol. 2021 Jun;288:103644. doi: 10.1016/j.resp.2021.103644. Epub 2021 Feb 27.', 'Jenkins SC. 6-Minute walk test in patients with COPD: clinical applications in pulmonary rehabilitation. Physiotherapy. 2007 Sep 1;93(3):175-82.', 'Javaherian M, Shadmehr A, Keshtkar A, Beigmohammadi MT, Dabbaghipour N, Syed A, Moghaddam BA. Safety and efficacy of Pulmonary physiotherapy in hospitalized patients with severe COVID-19 pneumonia (PPTCOVID): A prospective, randomised, single-blind, controlled trial. medRxiv. 2021 Jan 1.']",04/06/2021,https://clinicaltrials.gov/show/NCT04895371,23/09/2021,0,1
2911,NCT04896710,Enrolling by invitation,31/08/2021,31/08/2021,No Results Posted,,,02/06/2021,https://clinicaltrials.gov/show/NCT04896710,31/08/2021,0,0
2912,NCT04909879,Not yet recruiting,01/02/2022,01/04/2022,No Results Posted,,,07/06/2021,https://clinicaltrials.gov/show/NCT04909879,01/02/2022,0,0
2913,NCT04909905,Recruiting,01/08/2021,01/08/2021,No Results Posted,,,02/06/2021,https://clinicaltrials.gov/show/NCT04909905,01/08/2021,0,0
2914,NCT04910230,Completed,02/04/2020,02/04/2020,No Results Posted,,,02/06/2021,https://clinicaltrials.gov/show/NCT04910230,02/04/2020,0,0
2915,NCT04910516,"Active, not recruiting",25/05/2021,01/07/2021,Results Submitted,,,02/06/2021,https://clinicaltrials.gov/show/NCT04910516,25/05/2021,0,0
2916,NCT04911790,Not yet recruiting,05/06/2021,31/12/2022,No Results Posted,,,03/06/2021,https://clinicaltrials.gov/show/NCT04911790,05/06/2021,0,0
2917,NCT04912011,Recruiting,31/08/2021,31/12/2021,No Results Posted,,,08/06/2021,https://clinicaltrials.gov/show/NCT04912011,31/08/2021,0,0
2918,NCT04912817,Not yet recruiting,30/08/2022,31/12/2022,No Results Posted,,,07/06/2021,https://clinicaltrials.gov/show/NCT04912817,30/08/2022,0,0
2919,NCT04912895,Recruiting,01/12/2022,01/12/2022,No Results Posted,,,03/06/2021,https://clinicaltrials.gov/show/NCT04912895,01/12/2022,0,0
2920,NCT04912921,Recruiting,01/10/2021,01/05/2022,No Results Posted,,,03/06/2021,https://clinicaltrials.gov/show/NCT04912921,01/10/2021,0,0
2921,NCT04913129,Not yet recruiting,14/06/2022,14/06/2022,No Results Posted,,,28/06/2021,https://clinicaltrials.gov/show/NCT04913129,14/06/2022,0,0
2922,NCT04913740,"Active, not recruiting",01/09/2021,01/01/2022,No Results Posted,,,04/06/2021,https://clinicaltrials.gov/show/NCT04913740,01/09/2021,0,0
2923,NCT04913779,Recruiting,30/11/2021,31/12/2021,No Results Posted,,,04/06/2021,https://clinicaltrials.gov/show/NCT04913779,30/11/2021,0,0
2924,NCT04914377,Recruiting,01/07/2021,01/10/2021,No Results Posted,,,28/06/2021,https://clinicaltrials.gov/show/NCT04914377,01/07/2021,0,0
2925,NCT04914767,Recruiting,30/10/2021,30/11/2021,No Results Posted,,,07/06/2021,https://clinicaltrials.gov/show/NCT04914767,30/10/2021,0,0
2926,NCT04914832,Not yet recruiting,31/05/2022,31/05/2022,No Results Posted,,"['Fischer, R. J., N. van Doremalen, D. R. Adney, C. K. Yinda, J. R. Port, M. G. Holbrook, J. E. Schulz, B. N. Williamson, T. Thomas, K. Barbian, S. L. Anzick, S. Ricklefs, B. J. Smith, D. Long, C. Martens, G. Saturday, E. de Wit, S. C. Gilbert, T. Lambe and V. J. Munster (2021).']",07/06/2021,https://clinicaltrials.gov/show/NCT04914832,31/05/2022,0,1
2927,NCT04915989,"Active, not recruiting",31/07/2021,31/03/2022,No Results Posted,,,07/06/2021,https://clinicaltrials.gov/show/NCT04915989,31/07/2021,0,0
2928,NCT04916639,Not yet recruiting,10/10/2021,27/10/2021,No Results Posted,,,07/06/2021,https://clinicaltrials.gov/show/NCT04916639,10/10/2021,0,0
2929,NCT04916886,Recruiting,01/05/2022,01/08/2022,No Results Posted,,,08/06/2021,https://clinicaltrials.gov/show/NCT04916886,01/05/2022,0,0
2930,NCT04917523,Not yet recruiting,06/02/2022,06/02/2022,No Results Posted,,,08/06/2021,https://clinicaltrials.gov/show/NCT04917523,06/02/2022,0,0
2931,NCT04315948,"Active, not recruiting",01/03/2023,01/03/2023,No Results Posted,"['Taccone FS, Gorham J, Vincent JL. Hydroxychloroquine in the management of critically ill patients with COVID-19: the need for an evidence base. Lancet Respir Med. 2020 Jun;8(6):539-541. doi: 10.1016/S2213-2600(20)30172-7. Epub 2020 Apr 15.']","['WHO Solidarity Trial Consortium, Pan H, Peto R, Henao-Restrepo AM, Preziosi MP, Sathiyamoorthy V, Abdool Karim Q, Alejandria MM, Hern√°ndez Garc√≠a C, Kieny MP, Malekzadeh R, Murthy S, Reddy KS, Roses Periago M, Abi Hanna P, Ader F, Al-Bader AM, Alhasawi A, Allum E, Alotaibi A, Alvarez-Moreno CA, Appadoo S, Asiri A, Aukrust P, Barratt-Due A, Bellani S, Branca M, Cappel-Porter HBC, Cerrato N, Chow TS, Como N, Eustace J, Garc√≠a PJ, Godbole S, Gotuzzo E, Griskevicius L, Hamra R, Hassan M, Hassany M, Hutton D, Irmansyah I, Jancoriene L, Kirwan J, Kumar S, Lennon P, Lopardo G, Lydon P, Magrini N, Maguire T, Manevska S, Manuel O, McGinty S, Medina MT, Mesa Rubio ML, Miranda-Montoya MC, Nel J, Nunes EP, Perola M, Portol√©s A, Rasmin MR, Raza A, Rees H, Reges PPS, Rogers CA, Salami K, Salvadori MI, Sinani N, Sterne JAC, Stevanovikj M, Tacconelli E, Tikkinen KAO, Trelle S, Zaid H, R√∏ttingen JA, Swaminathan S. Repurposed Antiviral Drugs for Covid-19 - Interim WHO Solidarity Trial Results. N Engl J Med. 2021 Feb 11;384(6):497-511. doi: 10.1056/NEJMoa2023184. Epub 2020 Dec 2.', 'Ader F, Peiffer-Smadja N, Poissy J, Bouscambert-Duchamp M, Belhadi D, Diallo A, Delmas C, Saillard J, Dechanet A, Mercier N, Dupont A, Alfaiate T, Lescure FX, Raffi F, Goehringer F, Kimmoun A, Jaureguiberry S, Reignier J, Nseir S, Danion F, Clere-Jehl R, Bouiller K, Navellou JC, Tolsma V, Cabi√© A, Dubost C, Courjon J, Leroy S, Mootien J, Gaci R, Mourvillier B, Faure E, Pourcher V, Gallien S, Launay O, Lacombe K, Lanoix JP, Makinson A, Martin-Blondel G, Bouadma L, Botelho-Nevers E, Gagneux-Brunon A, Epaulard O, Piroth L, Wallet F, Richard JC, Reuter J, Staub T, Lina B, Noret M, Andrejak C, L√™ MP, Peytavin G, Hites M, Costagliola D, Yazdanpanah Y, Burdet C, Mentr√© F; DisCoVeRy study group. An open-label randomized controlled trial of the effect of lopinavir/ritonavir, lopinavir/ritonavir plus IFN-Œ≤-1a and hydroxychloroquine in hospitalized patients with COVID-19. Clin Microbiol Infect. 2021 May 26. pii: S1198-743X(21)00259-7. doi: 10.1016/j.cmi.2021.05.020. [Epub ahead of print]']",16/06/2021,https://clinicaltrials.gov/show/NCT04315948,01/03/2023,0,1
2932,NCT04327206,"Active, not recruiting",30/06/2021,30/03/2022,No Results Posted,"['Crisan-Dabija R, Grigorescu C, Pavel CA, Artene B, Popa IV, Cernomaz A, Burlacu A. Tuberculosis and COVID-19: Lessons from the Past Viral Outbreaks and Possible Future Outcomes. Can Respir J. 2020 Sep 5;2020:1401053. doi: 10.1155/2020/1401053. eCollection 2020. Review.']",,28/06/2021,https://clinicaltrials.gov/show/NCT04327206,30/06/2021,0,1
2933,NCT04334512,Recruiting,01/06/2023,01/09/2024,No Results Posted,,,09/06/2021,https://clinicaltrials.gov/show/NCT04334512,01/06/2023,0,0
2934,NCT04341935,Withdrawn,30/12/2021,30/12/2021,No Results Posted,,"['Vankadari N, Wilce JA. Emerging WuHan (COVID-19) coronavirus: glycan shield and structure prediction of spike glycoprotein and its interaction with human CD26. Emerg Microbes Infect. 2020 Mar 17;9(1):601-604. doi: 10.1080/22221751.2020.1739565. eCollection 2020.', 'Iacobellis G. COVID-19 and diabetes: Can DPP4 inhibition play a role? Diabetes Res Clin Pract. 2020 Apr;162:108125. doi: 10.1016/j.diabres.2020.108125. Epub 2020 Mar 26.']",10/06/2021,https://clinicaltrials.gov/show/NCT04341935,30/12/2021,0,1
2935,NCT04349631,Completed,24/11/2020,01/05/2021,No Results Posted,,,07/07/2021,https://clinicaltrials.gov/show/NCT04349631,24/11/2020,0,0
2936,NCT04360096,Recruiting,15/08/2021,01/09/2021,No Results Posted,,,10/06/2021,https://clinicaltrials.gov/show/NCT04360096,15/08/2021,0,0
2937,NCT04361396,Recruiting,01/12/2021,01/12/2021,No Results Posted,,,11/06/2021,https://clinicaltrials.gov/show/NCT04361396,01/12/2021,0,0
2938,NCT04362813,Completed,16/09/2020,22/12/2020,No Results Posted,,,10/06/2021,https://clinicaltrials.gov/show/NCT04362813,16/09/2020,0,0
2939,NCT04363372,Withdrawn,01/12/2020,01/01/2021,No Results Posted,,,16/06/2021,https://clinicaltrials.gov/show/NCT04363372,01/12/2020,0,0
2940,NCT04363502,Recruiting,01/05/2022,01/05/2022,No Results Posted,,,14/06/2021,https://clinicaltrials.gov/show/NCT04363502,01/05/2022,0,0
2941,NCT04365257,Recruiting,30/12/2021,30/12/2021,No Results Posted,,,09/06/2021,https://clinicaltrials.gov/show/NCT04365257,30/12/2021,0,0
2942,NCT04366960,Completed,25/05/2021,25/05/2021,No Results Posted,"['Flumignan RL, Tin√¥co JDS, Pascoal PI, Areias LL, Cossi MS, Fernandes MI, Costa IK, Souza L, Matar CF, Tendal B, Trevisani VF, Atallah √ÅN, Nakano LC. Prophylactic anticoagulants for people hospitalised with COVID-19. Cochrane Database Syst Rev. 2020 Oct 2;10:CD013739. doi: 10.1002/14651858.CD013739.', 'Levi M, Thachil J, Iba T, Levy JH. Coagulation abnormalities and thrombosis in patients with COVID-19. Lancet Haematol. 2020 Jun;7(6):e438-e440. doi: 10.1016/S2352-3026(20)30145-9. Epub 2020 May 11.']",,08/06/2021,https://clinicaltrials.gov/show/NCT04366960,25/05/2021,0,1
2943,NCT04369742,Terminated,01/04/2021,01/04/2021,No Results Posted,,,14/06/2021,https://clinicaltrials.gov/show/NCT04369742,01/04/2021,0,0
2944,NCT04373733,"Active, not recruiting",25/06/2021,25/06/2021,No Results Posted,,,16/06/2021,https://clinicaltrials.gov/show/NCT04373733,25/06/2021,0,0
2945,NCT04379076,Recruiting,30/10/2021,30/12/2021,No Results Posted,,,08/06/2021,https://clinicaltrials.gov/show/NCT04379076,30/10/2021,0,0
2946,NCT04380961,"Active, not recruiting",09/04/2021,30/06/2021,No Results Posted,,,09/06/2021,https://clinicaltrials.gov/show/NCT04380961,09/04/2021,0,0
2947,NCT04388527,Completed,25/01/2021,30/01/2021,No Results Posted,,,10/06/2021,https://clinicaltrials.gov/show/NCT04388527,25/01/2021,0,0
2948,NCT04389671,Recruiting,01/07/2021,01/08/2021,No Results Posted,,,09/06/2021,https://clinicaltrials.gov/show/NCT04389671,01/07/2021,0,0
2949,NCT04393246,Recruiting,15/02/2022,15/06/2022,No Results Posted,"['Lu IN, Kulkarni S, Fisk M, Kostapanos M, Banham-Hall E, Kadyan S, Bond S, Norton S, Cope A, Galloway J, Hall F, Jayne D, Wilkinson IB, Cheriyan J. muLTi-Arm Therapeutic study in pre-ICu patients admitted with Covid-19-Experimental drugs and mechanisms (TACTIC-E): A structured summary of a study protocol for a randomized controlled trial. Trials. 2020 Jul 31;21(1):690. doi: 10.1186/s13063-020-04618-2.']",,10/06/2021,https://clinicaltrials.gov/show/NCT04393246,15/02/2022,0,1
2950,NCT04394377,Completed,26/03/2021,30/05/2021,No Results Posted,"['Lopes RD, de Barros E Silva PGM, Furtado RHM, Macedo AVS, Bronhara B, Damiani LP, Barbosa LM, de Aveiro Morata J, Ramacciotti E, de Aquino Martins P, de Oliveira AL, Nunes VS, Ritt LEF, Rocha AT, Tramujas L, Santos SV, Diaz DRA, Viana LS, Melro LMG, de Alc√¢ntara Chaud MS, Figueiredo EL, Neuenschwander FC, Dracoulakis MDA, Lima RGSD, de Souza Dantas VC, Fernandes ACS, Gebara OCE, Hernandes ME, Queiroz DAR, Veiga VC, Canesin MF, de Faria LM, Feitosa-Filho GS, Gazzana MB, Liporace IL, de Oliveira Twardowsky A, Maia LN, Machado FR, de Matos Soeiro A, Concei√ß√£o-Souza GE, Armaganijan L, Guimar√£es PO, Rosa RG, Azevedo LCP, Alexander JH, Avezum A, Cavalcanti AB, Berwanger O; ACTION Coalition COVID-19 Brazil IV Investigators. Therapeutic versus prophylactic anticoagulation for patients admitted to hospital with COVID-19 and elevated D-dimer concentration (ACTION): an open-label, multicentre, randomised, controlled trial. Lancet. 2021 Jun 12;397(10291):2253-2263. doi: 10.1016/S0140-6736(21)01203-4. Epub 2021 Jun 4.', 'Lopes RD, de Barros E Silva PGM, Furtado RHM, Macedo AVS, Ramacciotti E, Damini LP, Bronhara B, Cavalcanti AB, Rosa RG, Azevedo LCP, Veiga VC, Machado FR, Ritt LE, Martins PA, Alexander JH, Avezum A, Berwanger O; Coalition COVID-19 Brazil IV Investigators. Randomized clinical trial to evaluate a routine full anticoagulation Strategy in Patients with Coronavirus Infection (SARS-CoV2) admitted to hospital: Rationale and design of the ACTION (AntiCoagulaTlon cOroNavirus)-Coalition IV trial. Am Heart J. 2021 Apr 20;238:1-11. doi: 10.1016/j.ahj.2021.04.005. [Epub ahead of print]', 'Flumignan RL, Tin√¥co JDS, Pascoal PI, Areias LL, Cossi MS, Fernandes MI, Costa IK, Souza L, Matar CF, Tendal B, Trevisani VF, Atallah √ÅN, Nakano LC. Prophylactic anticoagulants for people hospitalised with COVID-19. Cochrane Database Syst Rev. 2020 Oct 2;10:CD013739. doi: 10.1002/14651858.CD013739.']",,10/06/2021,https://clinicaltrials.gov/show/NCT04394377,26/03/2021,0,1
2951,NCT04397757,Completed,06/02/2021,08/03/2021,No Results Posted,,,10/06/2021,https://clinicaltrials.gov/show/NCT04397757,06/02/2021,0,0
2952,NCT04399252,"Active, not recruiting",15/07/2021,15/07/2021,No Results Posted,"['Tang H, Bohannon L, Lew M, Jensen D, Jung SH, Zhao A, Sung AD, Wischmeyer PE. Randomised, double-blind, placebo-controlled trial of Probiotics To Eliminate COVID-19 Transmission in Exposed Household Contacts (PROTECT-EHC): a clinical trial protocol. BMJ Open. 2021 May 5;11(5):e047069. doi: 10.1136/bmjopen-2020-047069.']",,11/06/2021,https://clinicaltrials.gov/show/NCT04399252,15/07/2021,0,1
2953,NCT04412330,Completed,05/05/2021,05/05/2021,No Results Posted,,,11/06/2021,https://clinicaltrials.gov/show/NCT04412330,05/05/2021,0,0
2954,NCT04416048,Recruiting,31/12/2021,31/01/2022,No Results Posted,"['Flumignan RL, Tin√¥co JDS, Pascoal PI, Areias LL, Cossi MS, Fernandes MI, Costa IK, Souza L, Matar CF, Tendal B, Trevisani VF, Atallah √ÅN, Nakano LC. Prophylactic anticoagulants for people hospitalised with COVID-19. Cochrane Database Syst Rev. 2020 Oct 2;10:CD013739. doi: 10.1002/14651858.CD013739.']",,09/06/2021,https://clinicaltrials.gov/show/NCT04416048,31/12/2021,0,1
2955,NCT04418505,"Active, not recruiting",30/07/2021,30/09/2021,No Results Posted,,,14/06/2021,https://clinicaltrials.gov/show/NCT04418505,30/07/2021,0,0
2956,NCT04421027,Completed,12/02/2021,10/06/2021,No Results Posted,,,06/07/2021,https://clinicaltrials.gov/show/NCT04421027,12/02/2021,0,0
2957,NCT04426305,Completed,20/06/2020,30/10/2020,No Results Posted,,,08/06/2021,https://clinicaltrials.gov/show/NCT04426305,20/06/2020,0,0
2958,NCT04464395,"Active, not recruiting",18/07/2021,31/08/2021,No Results Posted,,,15/06/2021,https://clinicaltrials.gov/show/NCT04464395,18/07/2021,0,0
2959,NCT04467840,"Active, not recruiting",01/07/2021,01/07/2021,No Results Posted,,,15/06/2021,https://clinicaltrials.gov/show/NCT04467840,01/07/2021,0,0
2960,NCT04470427,"Active, not recruiting",27/10/2022,27/10/2022,No Results Posted,"['Baden LR, El Sahly HM, Essink B, Kotloff K, Frey S, Novak R, Diemert D, Spector SA, Rouphael N, Creech CB, McGettigan J, Khetan S, Segall N, Solis J, Brosz A, Fierro C, Schwartz H, Neuzil K, Corey L, Gilbert P, Janes H, Follmann D, Marovich M, Mascola J, Polakowski L, Ledgerwood J, Graham BS, Bennett H, Pajon R, Knightly C, Leav B, Deng W, Zhou H, Han S, Ivarsson M, Miller J, Zaks T; COVE Study Group. Efficacy and Safety of the mRNA-1273 SARS-CoV-2 Vaccine. N Engl J Med. 2021 Feb 4;384(5):403-416. doi: 10.1056/NEJMoa2035389. Epub 2020 Dec 30.']",,10/06/2021,https://clinicaltrials.gov/show/NCT04470427,27/10/2022,0,1
2961,NCT04473690,Recruiting,31/07/2021,31/07/2022,No Results Posted,,,10/06/2021,https://clinicaltrials.gov/show/NCT04473690,31/07/2021,0,0
2962,NCT04474483,Recruiting,31/12/2021,31/12/2021,No Results Posted,,,11/06/2021,https://clinicaltrials.gov/show/NCT04474483,31/12/2021,0,0
2963,NCT04475302,Recruiting,30/06/2021,30/06/2021,No Results Posted,,,15/06/2021,https://clinicaltrials.gov/show/NCT04475302,30/06/2021,0,0
2964,NCT04475588,Completed,07/07/2020,07/07/2020,Study Results,,,14/06/2021,https://clinicaltrials.gov/show/NCT04475588,07/07/2020,1,0
2965,NCT04492410,"Active, not recruiting",12/05/2021,01/11/2021,No Results Posted,,,10/06/2021,https://clinicaltrials.gov/show/NCT04492410,12/05/2021,0,0
2966,NCT04497987,Completed,16/01/2021,20/05/2021,No Results Posted,"['Cohen MS, Nirula A, Mulligan MJ, Novak RM, Marovich M, Yen C, Stemer A, Mayer SM, Wohl D, Brengle B, Montague BT, Frank I, McCulloh RJ, Fichtenbaum CJ, Lipson B, Gabra N, Ramirez JA, Thai C, Chege W, Gomez Lorenzo MM, Sista N, Farrior J, Clement ME, Brown ER, Custer KL, Van Naarden J, Adams AC, Schade AE, Dabora MC, Knorr J, Price KL, Sabo J, Tuttle JL, Klekotka P, Shen L, Skovronsky DM; BLAZE-2 Investigators. Effect of Bamlanivimab vs Placebo on Incidence of COVID-19 Among Residents and Staff of Skilled Nursing and Assisted Living Facilities: A Randomized Clinical Trial. JAMA. 2021 Jun 3. doi: 10.1001/jama.2021.8828. [Epub ahead of print]']",,06/07/2021,https://clinicaltrials.gov/show/NCT04497987,16/01/2021,0,1
2967,NCT04504734,Enrolling by invitation,25/07/2021,25/08/2021,No Results Posted,,,15/06/2021,https://clinicaltrials.gov/show/NCT04504734,25/07/2021,0,0
2968,NCT04524663,Completed,15/05/2021,15/05/2021,No Results Posted,,,11/06/2021,https://clinicaltrials.gov/show/NCT04524663,15/05/2021,0,0
2969,NCT04526717,Withdrawn,01/12/2022,01/12/2022,No Results Posted,,,11/06/2021,https://clinicaltrials.gov/show/NCT04526717,01/12/2022,0,0
2970,NCT04536298,Recruiting,31/12/2021,31/12/2021,No Results Posted,,,14/06/2021,https://clinicaltrials.gov/show/NCT04536298,31/12/2021,0,0
2971,NCT04539275,"Active, not recruiting",30/06/2021,30/09/2021,No Results Posted,,,08/07/2021,https://clinicaltrials.gov/show/NCT04539275,30/06/2021,0,0
2972,NCT04569227,Recruiting,01/09/2021,01/11/2021,No Results Posted,,,10/06/2021,https://clinicaltrials.gov/show/NCT04569227,01/09/2021,0,0
2973,NCT04576312,Completed,04/12/2020,04/12/2020,No Results Posted,,,14/06/2021,https://clinicaltrials.gov/show/NCT04576312,04/12/2020,0,0
2974,NCT04582201,Recruiting,30/11/2021,28/02/2022,No Results Posted,,,10/06/2021,https://clinicaltrials.gov/show/NCT04582201,30/11/2021,0,0
2975,NCT04583956,Recruiting,31/12/2021,31/12/2021,No Results Posted,,,10/06/2021,https://clinicaltrials.gov/show/NCT04583956,31/12/2021,0,0
2976,NCT04591210,Recruiting,01/08/2022,01/12/2022,No Results Posted,,,14/06/2021,https://clinicaltrials.gov/show/NCT04591210,01/08/2022,0,0
2977,NCT04593940,Recruiting,01/08/2021,01/09/2021,No Results Posted,,,30/06/2021,https://clinicaltrials.gov/show/NCT04593940,01/08/2021,0,0
2978,NCT04595097,Recruiting,30/11/2021,31/05/2022,No Results Posted,,,14/06/2021,https://clinicaltrials.gov/show/NCT04595097,30/11/2021,0,0
2979,NCT04605588,Terminated,17/01/2021,04/02/2021,No Results Posted,,,08/07/2021,https://clinicaltrials.gov/show/NCT04605588,17/01/2021,0,0
2980,NCT04614883,Completed,26/02/2021,26/02/2021,No Results Posted,,,16/06/2021,https://clinicaltrials.gov/show/NCT04614883,26/02/2021,0,0
2981,NCT04627519,"Active, not recruiting",19/05/2021,01/09/2021,No Results Posted,,"['Stebbing J, Phelan A, Griffin I, Tucker C, Oechsle O, Smith D, Richardson P. COVID-19: combining antiviral and anti-inflammatory treatments. Lancet Infect Dis. 2020 Apr;20(4):400-402. doi: 10.1016/S1473-3099(20)30132-8. Epub 2020 Feb 27.', 'Tay MZ, Poh CM, R√©nia L, MacAry PA, Ng LFP. The trinity of COVID-19: immunity, inflammation and intervention. Nat Rev Immunol. 2020 Jun;20(6):363-374. doi: 10.1038/s41577-020-0311-8. Epub 2020 Apr 28. Review.', 'Swamy MK, Akhtar MS, Sinniah UR. Antimicrobial Properties of Plant Essential Oils against Human Pathogens and Their Mode of Action: An Updated Review. Evid Based Complement Alternat Med. 2016;2016:3012462. doi: 10.1155/2016/3012462. Epub 2016 Dec 20. Review.', 'Yang L, Peng K, Zhao S, Zhao F, Chen L, Qiu F. 2-methyl-L-erythritol glycosides from Gardenia jasminoides. Fitoterapia. 2013 Sep;89:126-30. doi: 10.1016/j.fitote.2013.05.018. Epub 2013 May 31.', 'Zhang Y, Yao J, Qi X, Liu X, Lu X, Feng G. Geniposide demonstrates anti-inflammatory and antiviral activity against pandemic A/Jiangsu/1/2009 (H1N1) influenza virus infection in vitro and in vivo. Antivir Ther. 2017;22(7):599-611. doi: 10.3851/IMP3152. Epub 2017 Mar 8.', 'Wu S, Patel KB, Booth LJ, Metcalf JP, Lin HK, Wu W. Protective essential oil attenuates influenza virus infection: an in vitro study in MDCK cells. BMC Complement Altern Med. 2010 Nov 15;10:69. doi: 10.1186/1472-6882-10-69.', 'Su S, Hua Y, Wang Y, Gu W, Zhou W, Duan JA, Jiang H, Chen T, Tang Y. Evaluation of the anti-inflammatory and analgesic properties of individual and combined extracts from Commiphora myrrha, and Boswellia carterii. J Ethnopharmacol. 2012 Jan 31;139(2):649-56. doi: 10.1016/j.jep.2011.12.013. Epub 2011 Dec 13.', 'Tipton DA, Lyle B, Babich H, Dabbous MKh. In vitro cytotoxic and anti-inflammatory effects of myrrh oil on human gingival fibroblasts and epithelial cells. Toxicol In Vitro. 2003 Jun;17(3):301-10.', 'Nomicos EY. Myrrh: medical marvel or myth of the Magi? Holist Nurs Pract. 2007 Nov-Dec;21(6):308-23. Review.', 'Sharopov F, Valiev A, Satyal P, Gulmurodov I, Yusufi S, Setzer WN, Wink M. Cytotoxicity of the Essential Oil of Fennel (Foeniculum vulgare) from Tajikistan. Foods. 2017 Aug 28;6(9). pii: E73. doi: 10.3390/foods6090073.', 'Lee HS, Kang P, Kim KY, Seol GH. Foeniculum vulgare Mill. Protects against Lipopolysaccharide-induced Acute Lung Injury in Mice through ERK-dependent NF-Œ∫B Activation. Korean J Physiol Pharmacol. 2015 Mar;19(2):183-9. doi: 10.4196/kjpp.2015.19.2.183. Epub 2015 Feb 25.', 'Shalaby NM, Maghraby AS, el-Hagrassy AM. Effect of Daucus carota var. boissieri extracts on immune response of Schistosoma mansoni infected mice. Folia Microbiol (Praha). 1999;44(4):441-8. Erratum in: Folia Microbiol (Praha) 2000;45(2):191.', 'Alves-Silva JM, Zuzarte M, Gon√ßalves MJ, Cavaleiro C, Cruz MT, Cardoso SM, Salgueiro L. New Claims for Wild Carrot (Daucus carota subsp. carota) Essential Oil. Evid Based Complement Alternat Med. 2016;2016:9045196. doi: 10.1155/2016/9045196. Epub 2016 Feb 14.', 'Yuan H, Ma Q, Cui H, Liu G, Zhao X, Li W, Piao G. How Can Synergism of Traditional Medicines Benefit from Network Pharmacology? Molecules. 2017 Jul 7;22(7). pii: E1135. doi: 10.3390/molecules22071135. Review.']",10/06/2021,https://clinicaltrials.gov/show/NCT04627519,19/05/2021,0,1
2982,NCT04640181,Completed,28/06/2021,28/06/2021,No Results Posted,,,30/06/2021,https://clinicaltrials.gov/show/NCT04640181,28/06/2021,0,0
2983,NCT04657497,Completed,26/03/2021,09/04/2021,No Results Posted,,,14/06/2021,https://clinicaltrials.gov/show/NCT04657497,26/03/2021,0,0
2984,NCT04672291,Not yet recruiting,31/12/2023,16/01/2024,No Results Posted,,"['Antonelli LR, Gigliotti Rothfuchs A, Gon√ßalves R, Roff√™ E, Cheever AW, Bafica A, Salazar AM, Feng CG, Sher A. Intranasal Poly-IC treatment exacerbates tuberculosis in mice through the pulmonary recruitment of a pathogen-permissive monocyte/macrophage population. J Clin Invest. 2010 May;120(5):1674-82. doi: 10.1172/JCI40817. Epub 2010 Apr 12.', 'Balan S, Arnold-Schrauf C, Abbas A, Couespel N, Savoret J, Imperatore F, Villani AC, Vu Manh TP, Bhardwaj N, Dalod M. Large-Scale Human Dendritic Cell Differentiation Revealing Notch-Dependent Lineage Bifurcation and Heterogeneity. Cell Rep. 2018 Aug 14;24(7):1902-1915.e6. doi: 10.1016/j.celrep.2018.07.033.', 'Benveniste EN, Qin H. Type I interferons as anti-inflammatory mediators. Sci STKE. 2007 Dec 11;2007(416):pe70.', 'Boukhvalova MS, Sotomayor TB, Point RC, Pletneva LM, Prince GA, Blanco JC. Activation of interferon response through toll-like receptor 3 impacts viral pathogenesis and pulmonary toll-like receptor expression during respiratory syncytial virus and influenza infections in the cotton rat Sigmodon hispidus model. J Interferon Cytokine Res. 2010 Apr;30(4):229-42. doi: 10.1089/jir.2009.0025.', 'Burrer S, Ma D, Hughes M, Kuhar D, Luckhaupt S, McDaniel C, et al. Characteristics of Health Care Personnel with COVID-19 - United States, February 12-April 9, 2020. CDC Morbidity and Mortality Report. 2020;69.', 'Caskey M, Lefebvre F, Filali-Mouhim A, Cameron MJ, Goulet JP, Haddad EK, Breton G, Trumpfheller C, Pollak S, Shimeliovich I, Duque-Alarcon A, Pan L, Nelkenbaum A, Salazar AM, Schlesinger SJ, Steinman RM, S√©kaly RP. Synthetic double-stranded RNA induces innate immune responses similar to a live viral vaccine in humans. J Exp Med. 2011 Nov 21;208(12):2357-66. doi: 10.1084/jem.20111171. Epub 2011 Nov 7.', 'Christopher ME, Wong JP. Use of TLR3 receptor agaonists against respiratory viral infections. Anti-inflammatory & Anti-Allergy Agents in Medicinal Chemistry. 2011;10:327-38.', 'Flynn BJ, Kastenm√ºller K, Wille-Reece U, Tomaras GD, Alam M, Lindsay RW, Salazar AM, Perdiguero B, Gomez CE, Wagner R, Esteban M, Park CG, Trumpfheller C, Keler T, Pantaleo G, Steinman RM, Seder R. Immunization with HIV Gag targeted to dendritic cells followed by recombinant New York vaccinia virus induces robust T-cell immunity in nonhuman primates. Proc Natl Acad Sci U S A. 2011 Apr 26;108(17):7131-6. doi: 10.1073/pnas.1103869108. Epub 2011 Apr 5.', 'Guerrero-Plata A, Baron S, Poast JS, Adegboyega PA, Casola A, Garofalo RP. Activity and regulation of alpha interferon in respiratory syncytial virus and human metapneumovirus experimental infections. J Virol. 2005 Aug;79(16):10190-9.', 'Hill DA, Baron S, Perkins JC, Worthington M, Van Kirk JE, Mills J, Kapikian AZ, Chanock RM. Evaluation of an interferon inducer in viral respiratory disease. JAMA. 1972 Feb 28;219(9):1179-84.', 'Huang C, Wang Y, Li X, Ren L, Zhao J, Hu Y, Zhang L, Fan G, Xu J, Gu X, Cheng Z, Yu T, Xia J, Wei Y, Wu W, Xie X, Yin W, Li H, Liu M, Xiao Y, Gao H, Guo L, Xie J, Wang G, Jiang R, Gao Z, Jin Q, Wang J, Cao B. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet. 2020 Feb 15;395(10223):497-506. doi: 10.1016/S0140-6736(20)30183-5. Epub 2020 Jan 24. Erratum in: Lancet. 2020 Jan 30;:.', 'Kato H, Takeuchi O, Sato S, Yoneyama M, Yamamoto M, Matsui K, Uematsu S, Jung A, Kawai T, Ishii KJ, Yamaguchi O, Otsu K, Tsujimura T, Koh CS, Reis e Sousa C, Matsuura Y, Fujita T, Akira S. Differential roles of MDA5 and RIG-I helicases in the recognition of RNA viruses. Nature. 2006 May 4;441(7089):101-5. Epub 2006 Apr 9.', 'Kende M, Paragas J, Salazar AM. The efficacy of poly-ICLC against Ebola-Zaire virus (EBOV) infection in mice and cynomolgus monkeys. Antiviral Res. 2019 Mar;163:179-184. doi: 10.1016/j.antiviral.2018.12.020. Epub 2019 Jan 3.', ""Kindler E, Gil-Cruz C, Spanier J, Li Y, Wilhelm J, Rabouw HH, Z√ºst R, Hwang M, V'kovski P, Stalder H, Marti S, Habjan M, Cervantes-Barragan L, Elliot R, Karl N, Gaughan C, van Kuppeveld FJ, Silverman RH, Keller M, Ludewig B, Bergmann CC, Ziebuhr J, Weiss SR, Kalinke U, Thiel V. Early endonuclease-mediated evasion of RNA sensing ensures efficient coronavirus replication. PLoS Pathog. 2017 Feb 3;13(2):e1006195. doi: 10.1371/journal.ppat.1006195. eCollection 2017 Feb."", 'Kumaki Y, Salazar AM, Wandersee MK, Barnard DL. Prophylactic and therapeutic intranasal administration with an immunomodulator, Hiltonol(¬Æ) (Poly IC:LC), in a lethal SARS-CoV-infected BALB/c mouse model. Antiviral Res. 2017 Mar;139:1-12. doi: 10.1016/j.antiviral.2016.12.007. Epub 2016 Dec 9.', 'Longhi MP, Trumpfheller C, Idoyaga J, Caskey M, Matos I, Kluger C, Salazar AM, Colonna M, Steinman RM. Dendritic cells require a systemic type I interferon response to mature and induce CD4+ Th1 immunity with poly IC as adjuvant. J Exp Med. 2009 Jul 6;206(7):1589-602. doi: 10.1084/jem.20090247. Epub 2009 Jun 29.', 'Marcus PI, Sekellick MJ. Combined sequential treatment with interferon and dsRNA abrogates virus resistance to interferon action. J Interferon Cytokine Res. 2001 Jun;21(6):423-9.', 'Packard AE, Hedges JC, Bahjat FR, Stevens SL, Conlin MJ, Salazar AM, Stenzel-Poore MP. Poly-IC preconditioning protects against cerebral and renal ischemia-reperfusion injury. J Cereb Blood Flow Metab. 2012 Feb;32(2):242-7. doi: 10.1038/jcbfm.2011.160. Epub 2011 Nov 16.', 'Pavlick A, Blazquez AB, Meseck M, Lattanzi M, Ott PA, Marron TU, Holman RM, Mandeli J, Salazar AM, McClain CB, Gimenez G, Balan S, Gnjatic S, Sabado RL, Bhardwaj N. Combined Vaccination with NY-ESO-1 Protein, Poly-ICLC, and Montanide Improves Humoral and Cellular Immune Responses in Patients with High-Risk Melanoma. Cancer Immunol Res. 2020 Jan;8(1):70-80. doi: 10.1158/2326-6066.CIR-19-0545. Epub 2019 Nov 7.', 'Rockx B, Baas T, Zornetzer GA, Haagmans B, Sheahan T, Frieman M, Dyer MD, Teal TH, Proll S, van den Brand J, Baric R, Katze MG. Early upregulation of acute respiratory distress syndrome-associated cytokines promotes lethal disease in an aged-mouse model of severe acute respiratory syndrome coronavirus infection. J Virol. 2009 Jul;83(14):7062-74. doi: 10.1128/JVI.00127-09. Epub 2009 May 6. Erratum in: J Virol. 2009 Sep;83(17):9022.', 'Ruan Q, Yang K, Wang W, Jiang L, Song J. Clinical predictors of mortality due to COVID-19 based on an analysis of data of 150 patients from Wuhan, China. Intensive Care Med. 2020 May;46(5):846-848. doi: 10.1007/s00134-020-05991-x. Epub 2020 Mar 3. Erratum in: Intensive Care Med. 2020 Apr 6;:.', 'Sabbatini P, Tsuji T, Ferran L, Ritter E, Sedrak C, Tuballes K, Jungbluth AA, Ritter G, Aghajanian C, Bell-McGuinn K, Hensley ML, Konner J, Tew W, Spriggs DR, Hoffman EW, Venhaus R, Pan L, Salazar AM, Diefenbach CM, Old LJ, Gnjatic S. Phase I trial of overlapping long peptides from a tumor self-antigen and poly-ICLC shows rapid induction of integrated immune response in ovarian cancer patients. Clin Cancer Res. 2012 Dec 1;18(23):6497-508. doi: 10.1158/1078-0432.CCR-12-2189. Epub 2012 Oct 2.', 'Salazar AM, Levy HB, Ondra S, Kende M, Scherokman B, Brown D, Mena H, Martin N, Schwab K, Donovan D, Dougherty D, Pulliam M, Ippolito M, Graves M, Brown H, Ommaya A. Long-term treatment of malignant gliomas with intramuscularly administered polyinosinic-polycytidylic acid stabilized with polylysine and carboxymethylcellulose: an open pilot study. Neurosurgery. 1996 Jun;38(6):1096-103; discussion 1103-4.', 'Sultan H, Wu J, Kumai T, Salazar AM, Celis E. Role of MDA5 and interferon-I in dendritic cells for T cell expansion by anti-tumor peptide vaccines in mice. Cancer Immunol Immunother. 2018 Jul;67(7):1091-1103. doi: 10.1007/s00262-018-2164-6. Epub 2018 Apr 25.', 'Walberg K, Baron S, Poast J, Schwartz B, Izotova L, Pestka S, Peterson JW. Interferon protects mice against inhalation anthrax. J Interferon Cytokine Res. 2008 Oct;28(10):597-601. doi: 10.1089/jir.2007.0143.', 'Wang Y, Wang Y, Chen Y, Qin Q. Unique epidemiological and clinical features of the emerging 2019 novel coronavirus pneumonia (COVID-19) implicate special control measures. J Med Virol. 2020 Jun;92(6):568-576. doi: 10.1002/jmv.25748. Epub 2020 Mar 29. Review.', 'Wong JP, Christopher ME, Viswanathan S, Dai X, Salazar AM, Sun LQ, Wang M. Antiviral role of toll-like receptor-3 agonists against seasonal and avian influenza viruses. Curr Pharm Des. 2009;15(11):1269-74. Review.', 'Wong JP, Saravolac EG, Sabuda D, Levy HB, Kende M. Prophylactic and therapeutic efficacies of poly(IC.LC) against respiratory influenza A virus infection in mice. Antimicrob Agents Chemother. 1995 Nov;39(11):2574-6.', 'Zhou Q, Chen V, Shannon CP, Wei XS, Xiang X, Wang X, Wang ZH, Tebbutt SJ, Kollmann TR, Fish EN. Interferon-Œ±2b Treatment for COVID-19. Front Immunol. 2020 May 15;11:1061. doi: 10.3389/fimmu.2020.01061. eCollection 2020. Erratum in: Front Immunol. 2020 Oct 27;11:615275.', 'Zhu X, Fallert-Junecko BA, Fujita M, Ueda R, Kohanbash G, Kastenhuber ER, McDonald HA, Liu Y, Kalinski P, Reinhart TA, Salazar AM, Okada H. Poly-ICLC promotes the infiltration of effector T cells into intracranial gliomas via induction of CXCL10 in IFN-alpha and IFN-gamma dependent manners. Cancer Immunol Immunother. 2010 Sep;59(9):1401-9. doi: 10.1007/s00262-010-0876-3. Epub 2010 Jun 12.', 'Field AK, Tytell AA, Piperno E, Lampson GP, Nemes MM, Hilleman MR. Poly I:C, an inducer of interferon and interference against virus infections. Medicine (Baltimore). 1972 May;51(3):169-74.', 'Gesuete R, Christensen SN, Bahjat FR, Packard AE, Stevens SL, Liu M, Salazar AM, Stenzel-Poore MP. Cytosolic Receptor Melanoma Differentiation-Associated Protein 5 Mediates Preconditioning-Induced Neuroprotection Against Cerebral Ischemic Injury. Stroke. 2016 Jan;47(1):262-6. doi: 10.1161/STROKEAHA.115.010329. Epub 2015 Nov 12.', 'Harrington DG, Crabbs CL, Hilmas DE, Brown JR, Higbee GA, Cole FE Jr, Levy HB. Adjuvant effects of low doses of a nuclease-resistant derivative of polyinosinic acid . polycytidylic acid on antibody responses of monkeys to inactivated Venezuelan equine encephalomyelitis virus vaccine. Infect Immun. 1979 Apr;24(1):160-6.', 'Ivanova A, Qaqish BF, Schell MJ. Continuous toxicity monitoring in phase II trials in oncology. Biometrics. 2005 Jun;61(2):540-5.', 'Levine AS, Sivulich M, Wiernik PH, Levy HB. Initial clinical trials in cancer patients of polyriboinosinic-polyribocytidylic acid stabilized with poly-L-lysine, in carboxymethylcellulose [poly(ICLC)], a highly effective interferon inducer. Cancer Res. 1979 May;39(5):1645-50.', 'Martins KAO, Cooper CL, Stronsky SM, Norris SLW, Kwilas SA, Steffens JT, Benko JG, van Tongeren SA, Bavari S. Adjuvant-enhanced CD4 T Cell Responses are Critical to Durable Vaccine Immunity. EBioMedicine. 2015 Nov 27;3:67-78. doi: 10.1016/j.ebiom.2015.11.041. eCollection 2016 Jan.', 'Okada H, Butterfield LH, Hamilton RL, Hoji A, Sakaki M, Ahn BJ, Kohanbash G, Drappatz J, Engh J, Amankulor N, Lively MO, Chan MD, Salazar AM, Shaw EG, Potter DM, Lieberman FS. Induction of robust type-I CD8+ T-cell responses in WHO grade 2 low-grade glioma patients receiving peptide-based vaccines in combination with poly-ICLC. Clin Cancer Res. 2015 Jan 15;21(2):286-94. doi: 10.1158/1078-0432.CCR-14-1790. Epub 2014 Nov 25.', 'Rosenfeld MR, Chamberlain MC, Grossman SA, Peereboom DM, Lesser GJ, Batchelor TT, Desideri S, Salazar AM, Ye X. A multi-institution phase II study of poly-ICLC and radiotherapy with concurrent and adjuvant temozolomide in adults with newly diagnosed glioblastoma. Neuro Oncol. 2010 Oct;12(10):1071-7. doi: 10.1093/neuonc/noq071. Epub 2010 Jul 8.', 'Sahin U, Muik A, Derhovanessian E, Vogler I, Kranz LM, Vormehr M, Baum A, Pascal K, Quandt J, Maurus D, Brachtendorf S, L√∂rks V, Sikorski J, Hilker R, Becker D, Eller AK, Gr√ºtzner J, Boesler C, Rosenbaum C, K√ºhnle MC, Luxemburger U, Kemmer-Br√ºck A, Langer D, Bexon M, Bolte S, Karik√≥ K, Palanche T, Fischer B, Schultz A, Shi PY, Fontes-Garfias C, Perez JL, Swanson KA, Loschko J, Scully IL, Cutler M, Kalina W, Kyratsous CA, Cooper D, Dormitzer PR, Jansen KU, T√ºreci √ñ. COVID-19 vaccine BNT162b1 elicits human antibody and T(H)1 T cell responses. Nature. 2020 Oct;586(7830):594-599. doi: 10.1038/s41586-020-2814-7. Epub 2020 Sep 30. Erratum in: Nature. 2021 Feb;590(7844):E17.', 'Stephen EL, Hilmas DE, Mangiafico JA, Levy HB. Swine influenza virus vaccine: potentiation of antibody responses in rhesus monkeys. Science. 1977 Sep 23;197(4310):1289-90.', 'Food and Drug Administration, HHS. International Conference on Harmonisation; Guidance on E7 Studies in Support of Special Populations; Geriatrics; Questions and Answers; availability. Notice. Fed Regist. 2012 Feb 21;77(34):9948-9.']",14/06/2021,https://clinicaltrials.gov/show/NCT04672291,31/12/2023,0,1
2985,NCT04708236,Withdrawn,01/05/2021,01/07/2021,No Results Posted,,,14/06/2021,https://clinicaltrials.gov/show/NCT04708236,01/05/2021,0,0
2986,NCT04713553,Recruiting,22/07/2021,22/07/2021,No Results Posted,,,11/06/2021,https://clinicaltrials.gov/show/NCT04713553,22/07/2021,0,0
2987,NCT04724720,"Active, not recruiting",03/05/2021,01/12/2021,No Results Posted,,,15/06/2021,https://clinicaltrials.gov/show/NCT04724720,03/05/2021,0,0
2988,NCT04738136,Not yet recruiting,31/10/2021,31/12/2021,No Results Posted,,,16/06/2021,https://clinicaltrials.gov/show/NCT04738136,31/10/2021,0,0
2989,NCT04739449,Not yet recruiting,01/02/2022,01/03/2022,No Results Posted,,,14/06/2021,https://clinicaltrials.gov/show/NCT04739449,01/02/2022,0,0
2990,NCT04745351,Recruiting,01/02/2023,01/03/2023,No Results Posted,,,06/07/2021,https://clinicaltrials.gov/show/NCT04745351,01/02/2023,0,0
2991,NCT04784754,Recruiting,30/09/2021,31/12/2021,No Results Posted,,,11/06/2021,https://clinicaltrials.gov/show/NCT04784754,30/09/2021,0,0
2992,NCT04798027,Recruiting,01/09/2022,01/09/2022,No Results Posted,,,29/06/2021,https://clinicaltrials.gov/show/NCT04798027,01/09/2022,0,0
2993,NCT04801056,Withdrawn,01/09/2021,01/09/2021,No Results Posted,,,16/06/2021,https://clinicaltrials.gov/show/NCT04801056,01/09/2021,0,0
2994,NCT04804072,Enrolling by invitation,30/11/2024,30/11/2024,No Results Posted,,,14/06/2021,https://clinicaltrials.gov/show/NCT04804072,30/11/2024,0,0
2995,NCT04805892,Recruiting,27/07/2021,17/08/2021,No Results Posted,,,16/06/2021,https://clinicaltrials.gov/show/NCT04805892,27/07/2021,0,0
2996,NCT04806113,"Active, not recruiting",13/06/2021,15/06/2022,No Results Posted,,,15/06/2021,https://clinicaltrials.gov/show/NCT04806113,13/06/2021,0,0
2997,NCT04811664,Recruiting,22/12/2021,22/12/2021,No Results Posted,,,16/06/2021,https://clinicaltrials.gov/show/NCT04811664,22/12/2021,0,0
2998,NCT04822025,Recruiting,01/09/2021,01/01/2022,No Results Posted,,,15/06/2021,https://clinicaltrials.gov/show/NCT04822025,01/09/2021,0,0
2999,NCT04826809,Recruiting,01/09/2021,01/10/2021,No Results Posted,,,10/06/2021,https://clinicaltrials.gov/show/NCT04826809,01/09/2021,0,0
3000,NCT04830735,Not yet recruiting,15/07/2023,15/07/2024,No Results Posted,,,10/06/2021,https://clinicaltrials.gov/show/NCT04830735,15/07/2023,0,0
3001,NCT04842292,Recruiting,28/02/2022,31/03/2022,No Results Posted,,,15/06/2021,https://clinicaltrials.gov/show/NCT04842292,28/02/2022,0,0
3002,NCT04843722,Not yet recruiting,01/09/2021,01/08/2022,No Results Posted,,,10/06/2021,https://clinicaltrials.gov/show/NCT04843722,01/09/2021,0,0
3003,NCT04843761,Recruiting,01/10/2022,01/04/2023,No Results Posted,,,07/07/2021,https://clinicaltrials.gov/show/NCT04843761,01/10/2022,0,0
3004,NCT04845191,Not yet recruiting,01/09/2021,01/08/2022,No Results Posted,,,10/06/2021,https://clinicaltrials.gov/show/NCT04845191,01/09/2021,0,0
3005,NCT04847050,Recruiting,01/01/2022,25/02/2023,No Results Posted,,,10/06/2021,https://clinicaltrials.gov/show/NCT04847050,01/01/2022,0,0
3006,NCT04853979,Recruiting,30/08/2021,16/09/2021,No Results Posted,,,11/06/2021,https://clinicaltrials.gov/show/NCT04853979,30/08/2021,0,0
3007,NCT04858633,Recruiting,30/06/2021,30/06/2021,No Results Posted,,,11/06/2021,https://clinicaltrials.gov/show/NCT04858633,30/06/2021,0,0
3008,NCT04864561,"Active, not recruiting",15/07/2021,30/06/2022,No Results Posted,,,08/06/2021,https://clinicaltrials.gov/show/NCT04864561,15/07/2021,0,0
3009,NCT04867174,Recruiting,01/09/2021,24/05/2022,No Results Posted,,,16/06/2021,https://clinicaltrials.gov/show/NCT04867174,01/09/2021,0,0
3010,NCT04869397,Recruiting,30/06/2022,30/07/2022,No Results Posted,,,15/06/2021,https://clinicaltrials.gov/show/NCT04869397,30/06/2022,0,0
3011,NCT04871854,Recruiting,26/07/2021,26/10/2021,No Results Posted,,,15/06/2021,https://clinicaltrials.gov/show/NCT04871854,26/07/2021,0,0
3012,NCT04873128,Recruiting,01/07/2022,01/07/2023,No Results Posted,,,15/06/2021,https://clinicaltrials.gov/show/NCT04873128,01/07/2022,0,0
3013,NCT04880694,Recruiting,01/11/2021,01/11/2021,No Results Posted,,,14/06/2021,https://clinicaltrials.gov/show/NCT04880694,01/11/2021,0,0
3014,NCT04885361,Recruiting,30/09/2021,31/03/2022,No Results Posted,,,09/06/2021,https://clinicaltrials.gov/show/NCT04885361,30/09/2021,0,0
3015,NCT04885530,Recruiting,01/12/2022,01/03/2023,No Results Posted,,,10/06/2021,https://clinicaltrials.gov/show/NCT04885530,01/12/2022,0,0
3016,NCT04887948,Recruiting,29/11/2021,29/11/2021,No Results Posted,,,15/06/2021,https://clinicaltrials.gov/show/NCT04887948,29/11/2021,0,0
3017,NCT04894435,Recruiting,01/03/2023,01/03/2023,No Results Posted,,,10/06/2021,https://clinicaltrials.gov/show/NCT04894435,01/03/2023,0,0
3018,NCT04894474,Not yet recruiting,23/05/2022,24/07/2022,No Results Posted,,,02/07/2021,https://clinicaltrials.gov/show/NCT04894474,23/05/2022,0,0
3019,NCT04900467,Recruiting,01/08/2021,01/01/2022,No Results Posted,,,09/06/2021,https://clinicaltrials.gov/show/NCT04900467,01/08/2021,0,0
3020,NCT04902183,Recruiting,01/09/2021,01/09/2021,No Results Posted,,,15/06/2021,https://clinicaltrials.gov/show/NCT04902183,01/09/2021,0,0
3021,NCT04904549,Recruiting,13/01/2023,13/01/2023,No Results Posted,,,09/07/2021,https://clinicaltrials.gov/show/NCT04904549,13/01/2023,0,0
3022,NCT04904783,Recruiting,31/07/2021,31/12/2021,No Results Posted,,,15/06/2021,https://clinicaltrials.gov/show/NCT04904783,31/07/2021,0,0
3023,NCT04910269,Not yet recruiting,01/06/2023,01/06/2023,No Results Posted,,,08/07/2021,https://clinicaltrials.gov/show/NCT04910269,01/06/2023,0,0
3024,NCT04910932,Recruiting,05/08/2021,05/08/2021,No Results Posted,,,14/06/2021,https://clinicaltrials.gov/show/NCT04910932,05/08/2021,0,0
3025,NCT04913675,Recruiting,31/03/2022,29/11/2022,No Results Posted,,,06/07/2021,https://clinicaltrials.gov/show/NCT04913675,31/03/2022,0,0
3026,NCT04916574,Completed,28/03/2021,03/06/2021,No Results Posted,,,09/06/2021,https://clinicaltrials.gov/show/NCT04916574,28/03/2021,0,0
3027,NCT04916821,"Active, not recruiting",15/07/2021,15/08/2021,No Results Posted,,,08/06/2021,https://clinicaltrials.gov/show/NCT04916821,15/07/2021,0,0
3028,NCT04918914,Recruiting,31/12/2021,31/12/2021,No Results Posted,,,09/06/2021,https://clinicaltrials.gov/show/NCT04918914,31/12/2021,0,0
3029,NCT04918927,Not yet recruiting,01/01/2022,01/03/2022,No Results Posted,,,09/06/2021,https://clinicaltrials.gov/show/NCT04918927,01/01/2022,0,0
3030,NCT04918940,Recruiting,21/08/2021,21/05/2022,No Results Posted,,,09/06/2021,https://clinicaltrials.gov/show/NCT04918940,21/08/2021,0,0
3031,NCT04919031,Recruiting,03/08/2021,01/10/2021,No Results Posted,,,14/06/2021,https://clinicaltrials.gov/show/NCT04919031,03/08/2021,0,0
3032,NCT04920760,Not yet recruiting,21/11/2021,19/12/2021,No Results Posted,,,18/06/2021,https://clinicaltrials.gov/show/NCT04920760,21/11/2021,0,0
3033,NCT04920773,Completed,21/05/2021,06/06/2021,No Results Posted,,,10/06/2021,https://clinicaltrials.gov/show/NCT04920773,21/05/2021,0,0
3034,NCT04920838,Recruiting,01/12/2021,01/12/2021,No Results Posted,,,10/06/2021,https://clinicaltrials.gov/show/NCT04920838,01/12/2021,0,0
3035,NCT04920890,Recruiting,20/03/2022,20/05/2022,No Results Posted,,,10/06/2021,https://clinicaltrials.gov/show/NCT04920890,20/03/2022,0,0
3036,NCT04920916,Recruiting,14/08/2022,01/12/2022,No Results Posted,,,18/06/2021,https://clinicaltrials.gov/show/NCT04920916,14/08/2022,0,0
3037,NCT04921228,Not yet recruiting,01/01/2022,01/01/2022,No Results Posted,,,10/06/2021,https://clinicaltrials.gov/show/NCT04921228,01/01/2022,0,0
3038,NCT04922632,Not yet recruiting,01/10/2022,01/10/2022,No Results Posted,,,14/06/2021,https://clinicaltrials.gov/show/NCT04922632,01/10/2022,0,0
3039,NCT04922788,Recruiting,07/07/2022,07/08/2022,No Results Posted,,,11/06/2021,https://clinicaltrials.gov/show/NCT04922788,07/07/2022,0,0
3040,NCT04922814,Not yet recruiting,01/03/2022,01/08/2022,No Results Posted,,"['Mason RJ. Pathogenesis of COVID-19 from a cell biology perspective. Eur Respir J. 2020 Apr 16;55(4). pii: 2000607. doi: 10.1183/13993003.00607-2020. Print 2020 Apr.', 'Neto AS, Pereira VG, Esp√≥sito DC, Damasceno MC, Schultz MJ. Neuromuscular blocking agents in patients with acute respiratory distress syndrome: a summary of the current evidence from three randomized controlled trials. Ann Intensive Care. 2012 Jul 26;2(1):33. doi: 10.1186/2110-5820-2-33.', 'Papazian L, Forel JM, Gacouin A, Penot-Ragon C, Perrin G, Loundou A, Jaber S, Arnal JM, Perez D, Seghboyan JM, Constantin JM, Courant P, Lefrant JY, Gu√©rin C, Prat G, Morange S, Roch A; ACURASYS Study Investigators. Neuromuscular blockers in early acute respiratory distress syndrome. N Engl J Med. 2010 Sep 16;363(12):1107-16. doi: 10.1056/NEJMoa1005372.']",11/06/2021,https://clinicaltrials.gov/show/NCT04922814,01/03/2022,0,1
3041,NCT04922827,Recruiting,01/09/2022,01/07/2023,No Results Posted,,,07/07/2021,https://clinicaltrials.gov/show/NCT04922827,01/09/2022,0,0
3042,NCT04922905,Completed,07/05/2020,02/04/2021,No Results Posted,,,11/06/2021,https://clinicaltrials.gov/show/NCT04922905,07/05/2020,0,0
3043,NCT04922918,Recruiting,24/06/2021,01/07/2021,No Results Posted,,,11/06/2021,https://clinicaltrials.gov/show/NCT04922918,24/06/2021,0,0
3044,NCT04922957,Not yet recruiting,01/06/2022,01/12/2022,No Results Posted,,,11/06/2021,https://clinicaltrials.gov/show/NCT04922957,01/06/2022,0,0
3045,NCT04923061,Recruiting,30/06/2021,01/07/2022,No Results Posted,,,15/06/2021,https://clinicaltrials.gov/show/NCT04923061,30/06/2021,0,0
3046,NCT04924660,Not yet recruiting,31/05/2022,30/12/2022,No Results Posted,,,06/07/2021,https://clinicaltrials.gov/show/NCT04924660,31/05/2022,0,0
3047,NCT04924803,Not yet recruiting,01/06/2023,01/12/2023,No Results Posted,,,14/06/2021,https://clinicaltrials.gov/show/NCT04924803,01/06/2023,0,0
3048,NCT04924881,Not yet recruiting,30/06/2022,31/12/2022,No Results Posted,,,14/06/2021,https://clinicaltrials.gov/show/NCT04924881,30/06/2022,0,0
3049,NCT04925258,Recruiting,30/06/2021,30/09/2021,No Results Posted,,,16/06/2021,https://clinicaltrials.gov/show/NCT04925258,30/06/2021,0,0
3050,NCT04930185,Not yet recruiting,31/12/2022,31/01/2023,No Results Posted,,,18/06/2021,https://clinicaltrials.gov/show/NCT04930185,31/12/2022,0,0
3051,NCT04283461,"Active, not recruiting",22/11/2022,22/11/2022,No Results Posted,"[""Anderson EJ, Rouphael NG, Widge AT, Jackson LA, Roberts PC, Makhene M, Chappell JD, Denison MR, Stevens LJ, Pruijssers AJ, McDermott AB, Flach B, Lin BC, Doria-Rose NA, O'Dell S, Schmidt SD, Corbett KS, Swanson PA 2nd, Padilla M, Neuzil KM, Bennett H, Leav B, Makowski M, Albert J, Cross K, Edara VV, Floyd K, Suthar MS, Martinez DR, Baric R, Buchanan W, Luke CJ, Phadke VK, Rostad CA, Ledgerwood JE, Graham BS, Beigel JH; mRNA-1273 Study Group. Safety and Immunogenicity of SARS-CoV-2 mRNA-1273 Vaccine in Older Adults. N Engl J Med. 2020 Dec 17;383(25):2427-2438. doi: 10.1056/NEJMoa2028436. Epub 2020 Sep 29."", ""Jackson LA, Anderson EJ, Rouphael NG, Roberts PC, Makhene M, Coler RN, McCullough MP, Chappell JD, Denison MR, Stevens LJ, Pruijssers AJ, McDermott A, Flach B, Doria-Rose NA, Corbett KS, Morabito KM, O'Dell S, Schmidt SD, Swanson PA 2nd, Padilla M, Mascola JR, Neuzil KM, Bennett H, Sun W, Peters E, Makowski M, Albert J, Cross K, Buchanan W, Pikaart-Tautges R, Ledgerwood JE, Graham BS, Beigel JH; mRNA-1273 Study Group. An mRNA Vaccine against SARS-CoV-2 - Preliminary Report. N Engl J Med. 2020 Nov 12;383(20):1920-1931. doi: 10.1056/NEJMoa2022483. Epub 2020 Jul 14.""]",,02/07/2021,https://clinicaltrials.gov/show/NCT04283461,22/11/2022,0,1
3052,NCT04312997,"Active, not recruiting",02/07/2021,01/08/2021,No Results Posted,,,18/06/2021,https://clinicaltrials.gov/show/NCT04312997,02/07/2021,0,0
3053,NCT04313023,Recruiting,01/08/2021,01/09/2021,No Results Posted,,,18/06/2021,https://clinicaltrials.gov/show/NCT04313023,01/08/2021,0,0
3054,NCT04327505,Recruiting,31/12/2021,31/12/2022,No Results Posted,"['Kjellberg A, Douglas J, Pawlik MT, Kraus M, Oscarsson N, Zheng X, Bergman P, Fr√•nberg O, Kowalski JH, Nyren SP, Silvanius M, Skold M, Catrina SB, Rodriguez-Wallberg KA, Lindholm P. Randomised, controlled, open label, multicentre clinical trial to explore safety and efficacy of hyperbaric oxygen for preventing ICU admission, morbidity and mortality in adult patients with COVID-19. BMJ Open. 2021 Jul 5;11(7):e046738. doi: 10.1136/bmjopen-2020-046738.']",,16/06/2021,https://clinicaltrials.gov/show/NCT04327505,31/12/2021,0,1
3055,NCT04330586,Completed,31/03/2021,31/03/2021,No Results Posted,"['Nicolau DV, Bafadhel M. Inhaled corticosteroids in virus pandemics: a treatment for COVID-19? Lancet Respir Med. 2020 Sep;8(9):846-847. doi: 10.1016/S2213-2600(20)30314-3. Epub 2020 Jul 30.']",,24/06/2021,https://clinicaltrials.gov/show/NCT04330586,31/03/2021,0,1
3056,NCT04332081,Terminated,29/05/2020,29/05/2020,Study Results,,,22/06/2021,https://clinicaltrials.gov/show/NCT04332081,29/05/2020,1,0
3057,NCT04334928,"Active, not recruiting",14/06/2021,31/07/2021,No Results Posted,,,18/06/2021,https://clinicaltrials.gov/show/NCT04334928,14/06/2021,0,0
3058,NCT04346615,Recruiting,31/07/2021,31/07/2021,No Results Posted,,,16/06/2021,https://clinicaltrials.gov/show/NCT04346615,31/07/2021,0,0
3059,NCT04348656,Terminated,05/03/2021,16/06/2021,No Results Posted,"['B√©gin P, Callum J, Heddle NM, Cook R, Zeller MP, Tinmouth A, Fergusson DA, Cushing MM, Glesby MJ, Chass√© M, Devine DV, Robitalle N, Bazin R, Shehata N, Finzi A, McGeer A, Scales DC, Schwartz L, Turgeon AF, Zarychanski R, Daneman N, Carl R, Amorim L, Gabe C, Ellis M, Sachais BS, Loftsgard KC, Jamula E, Carruthers J, Duncan J, Lucier K, Li N, Liu Y, Armali C, Kron A, Modi D, Auclair MC, Cerro S, Avram M, Arnold DM. Convalescent plasma for adults with acute COVID-19 respiratory illness (CONCOR-1): study protocol for an international, multicentre, randomized, open-label trial. Trials. 2021 May 4;22(1):323. doi: 10.1186/s13063-021-05235-3.']",,25/06/2021,https://clinicaltrials.gov/show/NCT04348656,05/03/2021,0,1
3060,NCT04351581,Recruiting,01/06/2022,01/06/2022,No Results Posted,,,25/06/2021,https://clinicaltrials.gov/show/NCT04351581,01/06/2022,0,0
3061,NCT04355143,"Active, not recruiting",08/09/2021,08/09/2021,No Results Posted,,,15/06/2021,https://clinicaltrials.gov/show/NCT04355143,08/09/2021,0,0
3062,NCT04356677,Withdrawn,01/08/2021,01/08/2021,No Results Posted,,,22/06/2021,https://clinicaltrials.gov/show/NCT04356677,01/08/2021,0,0
3063,NCT04363749,"Active, not recruiting",11/01/2021,11/08/2021,No Results Posted,,,15/06/2021,https://clinicaltrials.gov/show/NCT04363749,11/01/2021,0,0
3064,NCT04365101,"Active, not recruiting",30/12/2021,30/06/2022,No Results Posted,,,21/06/2021,https://clinicaltrials.gov/show/NCT04365101,30/12/2021,0,0
3065,NCT04372186,"Active, not recruiting",18/08/2020,01/12/2021,No Results Posted,"['Salama C, Han J, Yau L, Reiss WG, Kramer B, Neidhart JD, Criner GJ, Kaplan-Lewis E, Baden R, Pandit L, Cameron ML, Garcia-Diaz J, Ch√°vez V, Mekebeb-Reuter M, Lima de Menezes F, Shah R, Gonz√°lez-Lara MF, Assman B, Freedman J, Mohan SV. Tocilizumab in Patients Hospitalized with Covid-19 Pneumonia. N Engl J Med. 2021 Jan 7;384(1):20-30. doi: 10.1056/NEJMoa2030340. Epub 2020 Dec 17.', 'Tleyjeh IM. The Misleading ""Pooled Effect Estimate"" of Crude Data from Observational Studies at Critical Risk of Bias: The Case of Tocilizumab in Coronavirus Disease 2019 (COVID-19). Clin Infect Dis. 2021 Jun 15;72(12):e1154-e1155. doi: 10.1093/cid/ciaa1735.']",,16/06/2021,https://clinicaltrials.gov/show/NCT04372186,18/08/2020,0,1
3066,NCT04377100,Recruiting,28/02/2022,28/02/2022,No Results Posted,,,09/07/2021,https://clinicaltrials.gov/show/NCT04377100,28/02/2022,0,0
3067,NCT04381013,Withdrawn,01/07/2021,01/07/2021,No Results Posted,,,25/06/2021,https://clinicaltrials.gov/show/NCT04381013,01/07/2021,0,0
3068,NCT04382586,Completed,01/02/2021,01/02/2021,No Results Posted,,,16/06/2021,https://clinicaltrials.gov/show/NCT04382586,01/02/2021,0,0
3069,NCT04388826,"Active, not recruiting",18/12/2020,30/07/2021,No Results Posted,,,16/06/2021,https://clinicaltrials.gov/show/NCT04388826,18/12/2020,0,0
3070,NCT04390191,Recruiting,01/04/2022,01/04/2022,No Results Posted,,,18/06/2021,https://clinicaltrials.gov/show/NCT04390191,01/04/2022,0,0
3071,NCT04395911,"Active, not recruiting",01/07/2021,01/09/2021,No Results Posted,,,24/06/2021,https://clinicaltrials.gov/show/NCT04395911,01/07/2021,0,0
3072,NCT04399356,"Active, not recruiting",20/04/2021,30/07/2021,No Results Posted,,,25/06/2021,https://clinicaltrials.gov/show/NCT04399356,20/04/2021,0,0
3073,NCT04404218,Recruiting,01/12/2021,01/03/2022,No Results Posted,,,23/06/2021,https://clinicaltrials.gov/show/NCT04404218,01/12/2021,0,0
3074,NCT04411667,Completed,23/06/2020,23/06/2020,Study Results,,,25/06/2021,https://clinicaltrials.gov/show/NCT04411667,23/06/2020,1,0
3075,NCT04411680,Completed,02/03/2021,19/05/2021,No Results Posted,,,21/06/2021,https://clinicaltrials.gov/show/NCT04411680,02/03/2021,0,0
3076,NCT04413864,Recruiting,24/10/2022,24/10/2022,No Results Posted,,,21/06/2021,https://clinicaltrials.gov/show/NCT04413864,24/10/2022,0,0
3077,NCT04424797,Recruiting,31/07/2022,31/07/2022,No Results Posted,,,18/06/2021,https://clinicaltrials.gov/show/NCT04424797,31/07/2022,0,0
3078,NCT04425915,Completed,15/12/2020,15/12/2020,No Results Posted,,,18/06/2021,https://clinicaltrials.gov/show/NCT04425915,15/12/2020,0,0
3079,NCT04427501,Recruiting,20/09/2020,24/06/2022,No Results Posted,"['Gottlieb RL, Nirula A, Chen P, Boscia J, Heller B, Morris J, Huhn G, Cardona J, Mocherla B, Stosor V, Shawa I, Kumar P, Adams AC, Van Naarden J, Custer KL, Durante M, Oakley G, Schade AE, Holzer TR, Ebert PJ, Higgs RE, Kallewaard NL, Sabo J, Patel DR, Klekotka P, Shen L, Skovronsky DM. Effect of Bamlanivimab as Monotherapy or in Combination With Etesevimab on Viral Load in Patients With Mild to Moderate COVID-19: A Randomized Clinical Trial. JAMA. 2021 Feb 16;325(7):632-644. doi: 10.1001/jama.2021.0202.', 'Chen P, Nirula A, Heller B, Gottlieb RL, Boscia J, Morris J, Huhn G, Cardona J, Mocherla B, Stosor V, Shawa I, Adams AC, Van Naarden J, Custer KL, Shen L, Durante M, Oakley G, Schade AE, Sabo J, Patel DR, Klekotka P, Skovronsky DM; BLAZE-1 Investigators. SARS-CoV-2 Neutralizing Antibody LY-CoV555 in Outpatients with Covid-19. N Engl J Med. 2021 Jan 21;384(3):229-237. doi: 10.1056/NEJMoa2029849. Epub 2020 Oct 28.']",,18/06/2021,https://clinicaltrials.gov/show/NCT04427501,20/09/2020,0,1
3080,NCT04431453,Recruiting,01/02/2022,01/02/2022,No Results Posted,,,21/06/2021,https://clinicaltrials.gov/show/NCT04431453,01/02/2022,0,0
3081,NCT04433949,Recruiting,30/05/2022,30/05/2022,No Results Posted,,,22/06/2021,https://clinicaltrials.gov/show/NCT04433949,30/05/2022,0,0
3082,NCT04435795,"Active, not recruiting",01/07/2021,01/08/2021,No Results Posted,,,22/06/2021,https://clinicaltrials.gov/show/NCT04435795,01/07/2021,0,0
3083,NCT04438850,Terminated,08/06/2021,08/06/2021,No Results Posted,,,23/06/2021,https://clinicaltrials.gov/show/NCT04438850,08/06/2021,0,0
3084,NCT04446429,Completed,24/12/2020,21/01/2021,Study Results,,,16/06/2021,https://clinicaltrials.gov/show/NCT04446429,24/12/2020,1,0
3085,NCT04448756,Recruiting,22/08/2021,22/08/2021,No Results Posted,,,18/06/2021,https://clinicaltrials.gov/show/NCT04448756,22/08/2021,0,0
3086,NCT04452435,Completed,13/10/2020,13/10/2020,Study Results,,,23/06/2021,https://clinicaltrials.gov/show/NCT04452435,13/10/2020,1,0
3087,NCT04468958,"Active, not recruiting",23/02/2021,01/07/2021,No Results Posted,,,21/06/2021,https://clinicaltrials.gov/show/NCT04468958,23/02/2021,0,0
3088,NCT04468971,"Active, not recruiting",30/09/2021,30/09/2021,No Results Posted,,,22/06/2021,https://clinicaltrials.gov/show/NCT04468971,30/09/2021,0,0
3089,NCT04469179,"Active, not recruiting",01/06/2021,01/07/2021,No Results Posted,,,21/06/2021,https://clinicaltrials.gov/show/NCT04469179,01/06/2021,0,0
3090,NCT04472559,Recruiting,01/10/2021,25/12/2021,No Results Posted,,,18/06/2021,https://clinicaltrials.gov/show/NCT04472559,01/10/2021,0,0
3091,NCT04480112,Enrolling by invitation,01/08/2021,01/08/2021,No Results Posted,,,22/06/2021,https://clinicaltrials.gov/show/NCT04480112,01/08/2021,0,0
3092,NCT04480411,Not yet recruiting,01/06/2022,01/06/2022,No Results Posted,,,24/06/2021,https://clinicaltrials.gov/show/NCT04480411,01/06/2022,0,0
3093,NCT04481685,Completed,25/02/2021,01/06/2021,No Results Posted,,,23/06/2021,https://clinicaltrials.gov/show/NCT04481685,25/02/2021,0,0
3094,NCT04483973,Enrolling by invitation,01/04/2022,01/04/2022,No Results Posted,,,18/06/2021,https://clinicaltrials.gov/show/NCT04483973,01/04/2022,0,0
3095,NCT04484025,Enrolling by invitation,01/04/2022,01/04/2022,No Results Posted,,,18/06/2021,https://clinicaltrials.gov/show/NCT04484025,01/04/2022,0,0
3096,NCT04488081,Recruiting,24/07/2022,01/11/2022,No Results Posted,,,23/06/2021,https://clinicaltrials.gov/show/NCT04488081,24/07/2022,0,0
3097,NCT04498273,"Active, not recruiting",01/09/2021,01/09/2021,No Results Posted,,,22/06/2021,https://clinicaltrials.gov/show/NCT04498273,01/09/2021,0,0
3098,NCT04499391,Recruiting,01/07/2021,01/07/2022,No Results Posted,,,23/06/2021,https://clinicaltrials.gov/show/NCT04499391,01/07/2021,0,0
3099,NCT04501978,Recruiting,01/07/2022,01/07/2022,No Results Posted,"['ACTIV-3/TICO LY-CoV555 Study Group, Lundgren JD, Grund B, Barkauskas CE, Holland TL, Gottlieb RL, Sandkovsky U, Brown SM, Knowlton KU, Self WH, Files DC, Jain MK, Benfield T, Bowdish ME, Leshnower BG, Baker JV, Jensen JU, Gardner EM, Ginde AA, Harris ES, Johansen IS, Markowitz N, Matthay MA, √òstergaard L, Chang CC, Davey VJ, Goodman A, Higgs ES, Murray DD, Murray TA, Paredes R, Parmar MKB, Phillips AN, Reilly C, Sharma S, Dewar RL, Teitelbaum M, Wentworth D, Cao H, Klekotka P, Babiker AG, Gelijns AC, Kan VL, Polizzotto MN, Thompson BT, Lane HC, Neaton JD. A Neutralizing Monoclonal Antibody for Hospitalized Patients with Covid-19. N Engl J Med. 2021 Mar 11;384(10):905-914. doi: 10.1056/NEJMoa2033130. Epub 2020 Dec 22.']",,07/07/2021,https://clinicaltrials.gov/show/NCT04501978,01/07/2022,0,1
3100,NCT04507256,"Active, not recruiting",25/10/2021,25/10/2021,No Results Posted,,,21/06/2021,https://clinicaltrials.gov/show/NCT04507256,25/10/2021,0,0
3101,NCT04508023,Recruiting,22/02/2022,22/02/2022,No Results Posted,,,25/06/2021,https://clinicaltrials.gov/show/NCT04508023,22/02/2022,0,0
3102,NCT04511650,Terminated,26/02/2021,26/02/2021,No Results Posted,,,18/06/2021,https://clinicaltrials.gov/show/NCT04511650,26/02/2021,0,0
3103,NCT04518410,Recruiting,01/05/2023,01/05/2023,No Results Posted,,,06/07/2021,https://clinicaltrials.gov/show/NCT04518410,01/05/2023,0,0
3104,NCT04526912,Terminated,02/03/2021,19/05/2021,No Results Posted,,,22/06/2021,https://clinicaltrials.gov/show/NCT04526912,02/03/2021,0,0
3105,NCT04530617,Terminated,10/06/2021,10/06/2021,No Results Posted,,"['Del Rio C, Malani PN. COVID-19-New Insights on a Rapidly Changing Epidemic. JAMA. 2020 Apr 14;323(14):1339-1340. doi: 10.1001/jama.2020.3072.', 'Huang C, Wang Y, Li X, Ren L, Zhao J, Hu Y, Zhang L, Fan G, Xu J, Gu X, Cheng Z, Yu T, Xia J, Wei Y, Wu W, Xie X, Yin W, Li H, Liu M, Xiao Y, Gao H, Guo L, Xie J, Wang G, Jiang R, Gao Z, Jin Q, Wang J, Cao B. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet. 2020 Feb 15;395(10223):497-506. doi: 10.1016/S0140-6736(20)30183-5. Epub 2020 Jan 24. Erratum in: Lancet. 2020 Jan 30;:.', ""Sohrabi C, Alsafi Z, O'Neill N, Khan M, Kerwan A, Al-Jabir A, Iosifidis C, Agha R. World Health Organization declares global emergency: A review of the 2019 novel coronavirus (COVID-19). Int J Surg. 2020 Apr;76:71-76. doi: 10.1016/j.ijsu.2020.02.034. Epub 2020 Feb 26. Review. Erratum in: Int J Surg. 2020 May;77:217."", 'Guan WJ, Ni ZY, Hu Y, Liang WH, Ou CQ, He JX, Liu L, Shan H, Lei CL, Hui DSC, Du B, Li LJ, Zeng G, Yuen KY, Chen RC, Tang CL, Wang T, Chen PY, Xiang J, Li SY, Wang JL, Liang ZJ, Peng YX, Wei L, Liu Y, Hu YH, Peng P, Wang JM, Liu JY, Chen Z, Li G, Zheng ZJ, Qiu SQ, Luo J, Ye CJ, Zhu SY, Zhong NS; China Medical Treatment Expert Group for Covid-19. Clinical Characteristics of Coronavirus Disease 2019 in China. N Engl J Med. 2020 Apr 30;382(18):1708-1720. doi: 10.1056/NEJMoa2002032. Epub 2020 Feb 28.', 'Wu C, Chen X, Cai Y, Xia J, Zhou X, Xu S, Huang H, Zhang L, Zhou X, Du C, Zhang Y, Song J, Wang S, Chao Y, Yang Z, Xu J, Zhou X, Chen D, Xiong W, Xu L, Zhou F, Jiang J, Bai C, Zheng J, Song Y. Risk Factors Associated With Acute Respiratory Distress Syndrome and Death in Patients With Coronavirus Disease 2019 Pneumonia in Wuhan, China. JAMA Intern Med. 2020 Jul 1;180(7):934-943. doi: 10.1001/jamainternmed.2020.0994. Erratum in: JAMA Intern Med. 2020 Jul 1;180(7):1031.', 'Wang D, Hu B, Hu C, Zhu F, Liu X, Zhang J, Wang B, Xiang H, Cheng Z, Xiong Y, Zhao Y, Li Y, Wang X, Peng Z. Clinical Characteristics of 138 Hospitalized Patients With 2019 Novel Coronavirus-Infected Pneumonia in Wuhan, China. JAMA. 2020 Mar 17;323(11):1061-1069. doi: 10.1001/jama.2020.1585. Erratum in: JAMA. 2021 Mar 16;325(11):1113.', 'Xu XW, Wu XX, Jiang XG, Xu KJ, Ying LJ, Ma CL, Li SB, Wang HY, Zhang S, Gao HN, Sheng JF, Cai HL, Qiu YQ, Li LJ. Clinical findings in a group of patients infected with the 2019 novel coronavirus (SARS-Cov-2) outside of Wuhan, China: retrospective case series. BMJ. 2020 Feb 19;368:m606. doi: 10.1136/bmj.m606. Erratum in: BMJ. 2020 Feb 27;368:m792.', 'Giacomelli A, Pezzati L, Conti F, Bernacchia D, Siano M, Oreni L, Rusconi S, Gervasoni C, Ridolfo AL, Rizzardini G, Antinori S, Galli M. Self-reported Olfactory and Taste Disorders in Patients With Severe Acute Respiratory Coronavirus 2 Infection: A Cross-sectional Study. Clin Infect Dis. 2020 Jul 28;71(15):889-890. doi: 10.1093/cid/ciaa330.', ""Garg S, Kim L, Whitaker M, O'Halloran A, Cummings C, Holstein R, Prill M, Chai SJ, Kirley PD, Alden NB, Kawasaki B, Yousey-Hindes K, Niccolai L, Anderson EJ, Openo KP, Weigel A, Monroe ML, Ryan P, Henderson J, Kim S, Como-Sabetti K, Lynfield R, Sosin D, Torres S, Muse A, Bennett NM, Billing L, Sutton M, West N, Schaffner W, Talbot HK, Aquino C, George A, Budd A, Brammer L, Langley G, Hall AJ, Fry A. Hospitalization Rates and Characteristics of Patients Hospitalized with Laboratory-Confirmed Coronavirus Disease 2019 - COVID-NET, 14 States, March 1-30, 2020. MMWR Morb Mortal Wkly Rep. 2020 Apr 17;69(15):458-464. doi: 10.15585/mmwr.mm6915e3."", 'Ortiz-Brizuela E, Villanueva-Reza M, Gonz√°lez-Lara MF, Tamez-Torres KM, Rom√°n-Montes CM, D√≠az-Mej√≠a BA, P√©rez-Garc√≠a E, Olivas-Mart√≠nez A, Rajme-L√≥pez S, Martinez-Guerra BA, de-Le√≥n-Cividanes NA, Fern√°ndez-Garc√≠a OA, Guerrero-Torres L, Torres-Gonz√°lez L, Carrera-Pati√±o FA, Corral-Herrera EA, Hern√°ndez-Alem√≥n AN, Tovar-Vargas ML√Å, Serrano-Pinto YG, Espejo-Ortiz CE, Morales-Ortega ML, Lozano-Cruz √ìA, C√°rdenas-Fragoso JL, Vidal-Mayo JJ, Hern√°ndez-Gilsoul T, Rivero-Sigarroa E, Dom√≠nguez-Cherit G, Cervantes-Villar LE, Ramos-Cervantes MDP, Ibarra-Gonz√°lez V, Calva-Mercado JJ, Sierra-Madero JG, L√≥pez-√ç√±iguez √Å, Ochoa-Hein E, Crabtree-Ram√≠rez BE, Galindo-Fraga A, Guerrero-Almeida ML, Ruiz-Palacios GM, Gul√≠as-Herrero A, Sifuentes-Osornio J, Kershenobich-Stalnikowitz D, Ponce-de-Le√≥n A. CLINICAL AND EPIDEMIOLOGICAL CHARACTERISTICS OF PATIENTS DIAGNOSED WITH COVID-19 IN A TERTIARY CARE CENTER IN MEXICO CITY: A PROSPECTIVE COHORT STUDY. Rev Invest Clin. 2020;72(3):165-177. doi: 10.24875/RIC.20000211. Erratum in: Rev Invest Clin. 2020;72(4):252-258.', ""Bhimraj A, Morgan RL, Shumaker AH, Lavergne V, Baden L, Cheng VC, Edwards KM, Gandhi R, Muller WJ, O'Horo JC, Shoham S, Murad MH, Mustafa RA, Sultan S, Falck-Ytter Y. Infectious Diseases Society of America Guidelines on the Treatment and Management of Patients with COVID-19. Clin Infect Dis. 2020 Apr 27. pii: ciaa478. doi: 10.1093/cid/ciaa478. [Epub ahead of print]"", 'Yamaya M, Shimotai Y, Hatachi Y, Lusamba Kalonji N, Tando Y, Kitajima Y, Matsuo K, Kubo H, Nagatomi R, Hongo S, Homma M, Nishimura H. The serine protease inhibitor camostat inhibits influenza virus replication and cytokine production in primary cultures of human tracheal epithelial cells. Pulm Pharmacol Ther. 2015 Aug;33:66-74. doi: 10.1016/j.pupt.2015.07.001. Epub 2015 Jul 10.', 'Hoffmann M, Kleine-Weber H, Schroeder S, Kr√ºger N, Herrler T, Erichsen S, Schiergens TS, Herrler G, Wu NH, Nitsche A, M√ºller MA, Drosten C, P√∂hlmann S. SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor. Cell. 2020 Apr 16;181(2):271-280.e8. doi: 10.1016/j.cell.2020.02.052. Epub 2020 Mar 5.', 'Kawase M, Shirato K, van der Hoek L, Taguchi F, Matsuyama S. Simultaneous treatment of human bronchial epithelial cells with serine and cysteine protease inhibitors prevents severe acute respiratory syndrome coronavirus entry. J Virol. 2012 Jun;86(12):6537-45. doi: 10.1128/JVI.00094-12. Epub 2012 Apr 11.', 'Zhou Y, Vedantham P, Lu K, Agudelo J, Carrion R Jr, Nunneley JW, Barnard D, P√∂hlmann S, McKerrow JH, Renslo AR, Simmons G. Protease inhibitors targeting coronavirus and filovirus entry. Antiviral Res. 2015 Apr;116:76-84. doi: 10.1016/j.antiviral.2015.01.011. Epub 2015 Feb 7.', 'Coote K, Atherton-Watson HC, Sugar R, Young A, MacKenzie-Beevor A, Gosling M, Bhalay G, Bloomfield G, Dunstan A, Bridges RJ, Sabater JR, Abraham WM, Tully D, Pacoma R, Schumacher A, Harris J, Danahay H. Camostat attenuates airway epithelial sodium channel function in vivo through the inhibition of a channel-activating protease. J Pharmacol Exp Ther. 2009 May;329(2):764-74. doi: 10.1124/jpet.108.148155. Epub 2009 Feb 3.', 'Rowe SM, Reeves G, Hathorne H, Solomon GM, Abbi S, Renard D, Lock R, Zhou P, Danahay H, Clancy JP, Waltz DA. Reduced sodium transport with nasal administration of the prostasin inhibitor camostat in subjects with cystic fibrosis. Chest. 2013 Jul;144(1):200-207. doi: 10.1378/chest.12-2431.', 'Krishna S, Bustamante L, Haynes RK, Staines HM. Artemisinins: their growing importance in medicine. Trends Pharmacol Sci. 2008 Oct;29(10):520-7. doi: 10.1016/j.tips.2008.07.004. Epub 2008 Aug 25. Review.', 'Rosenthal PJ. Artesunate for the treatment of severe falciparum malaria. N Engl J Med. 2008 Apr 24;358(17):1829-36. doi: 10.1056/NEJMct0709050. Review.', 'Zhang X, Zhao Y, Guo L, Qiu Z, Huang L, Qu X. Differences in chemical constituents of Artemisia annua L from different geographical regions in China. PLoS One. 2017 Sep 7;12(9):e0183047. doi: 10.1371/journal.pone.0183047. eCollection 2017.', 'Munyangi J, Cornet-Vernet L, Idumbo M, Lu C, Lutgen P, Perronne C, Ngombe N, Bianga J, Mupenda B, Lalukala P, Mergeai G, Mumba D, Towler M, Weathers P. Artemisia annua and Artemisia afra tea infusions vs. artesunate-amodiaquine (ASAQ) in treating Plasmodium falciparum malaria in a large scale, double blind, randomized clinical trial. Phytomedicine. 2019 Apr;57:49-56. doi: 10.1016/j.phymed.2018.12.002. Epub 2018 Dec 5. Retraction in: Phytomedicine. 2020 Nov;78:153304.\n\nRetraction in:\nPhytomedicine. 2020 Nov;78:153304', 'Retraction in:\nPhytomedicine. 2020 Nov;78:153304', 'Naesens L, Bonnafous P, Agut H, De Clercq E. Antiviral activity of diverse classes of broad-acting agents and natural compounds in HHV-6-infected lymphoblasts. J Clin Virol. 2006 Dec;37 Suppl 1:S69-75.', 'Li SY, Chen C, Zhang HQ, Guo HY, Wang H, Wang L, Zhang X, Hua SN, Yu J, Xiao PG, Li RS, Tan X. Identification of natural compounds with antiviral activities against SARS-associated coronavirus. Antiviral Res. 2005 Jul;67(1):18-23.', 'Wang C, Xuan X, Yao W, Huang G, Jin J. Anti-profibrotic effects of artesunate on bleomycin-induced pulmonary fibrosis in Sprague Dawley rats. Mol Med Rep. 2015 Jul;12(1):1291-7. doi: 10.3892/mmr.2015.3500. Epub 2015 Mar 17.', 'Berry SM, Alarid ET, Beebe DJ. One-step purification of nucleic acid for gene expression analysis via Immiscible Filtration Assisted by Surface Tension (IFAST). Lab Chip. 2011 May 21;11(10):1747-53. doi: 10.1039/c1lc00004g. Epub 2011 Mar 21.', 'Wong CK, Lam CW, Wu AK, Ip WK, Lee NL, Chan IH, Lit LC, Hui DS, Chan MH, Chung SS, Sung JJ. Plasma inflammatory cytokines and chemokines in severe acute respiratory syndrome. Clin Exp Immunol. 2004 Apr;136(1):95-103.', 'Mahallawi WH, Khabour OF, Zhang Q, Makhdoum HM, Suliman BA. MERS-CoV infection in humans is associated with a pro-inflammatory Th1 and Th17 cytokine profile. Cytokine. 2018 Apr;104:8-13. doi: 10.1016/j.cyto.2018.01.025. Epub 2018 Feb 2.', 'Gee JR, Saltzstein DR, Kim K, Kolesar J, Huang W, Havighurst TC, Wollmer BW, Stublaski J, Downs T, Mukhtar H, House MG, Parnes HL, Bailey HH. A Phase II Randomized, Double-blind, Presurgical Trial of Polyphenon E in Bladder Cancer Patients to Evaluate Pharmacodynamics and Bladder Tissue Biomarkers. Cancer Prev Res (Phila). 2017 May;10(5):298-307. doi: 10.1158/1940-6207.CAPR-16-0167. Epub 2017 Mar 21.']",21/06/2021,https://clinicaltrials.gov/show/NCT04530617,10/06/2021,0,1
3106,NCT04535167,Completed,07/06/2021,07/06/2021,No Results Posted,,,24/06/2021,https://clinicaltrials.gov/show/NCT04535167,07/06/2021,0,0
3107,NCT04535453,Suspended,15/12/2021,26/03/2023,No Results Posted,,,07/07/2021,https://clinicaltrials.gov/show/NCT04535453,15/12/2021,0,0
3108,NCT04537949,"Active, not recruiting",12/03/2021,01/02/2022,No Results Posted,,,25/06/2021,https://clinicaltrials.gov/show/NCT04537949,12/03/2021,0,0
3109,NCT04546581,"Active, not recruiting",01/07/2021,01/07/2021,No Results Posted,"['Vandeberg P, Cruz M, Diez JM, Merritt WK, Santos B, Trukawinski S, Wellhouse A, Jose M, Willis T. Production of anti-SARS-CoV-2 hyperimmune globulin from convalescent plasma. Transfusion. 2021 Jun;61(6):1705-1709. doi: 10.1111/trf.16378. Epub 2021 Mar 22.']",,30/06/2021,https://clinicaltrials.gov/show/NCT04546581,01/07/2021,0,1
3110,NCT04551547,Enrolling by invitation,30/04/2021,01/02/2022,No Results Posted,"['Han B, Song Y, Li C, Yang W, Ma Q, Jiang Z, Li M, Lian X, Jiao W, Wang L, Shu Q, Wu Z, Zhao Y, Li Q, Gao Q. Safety, tolerability, and immunogenicity of an inactivated SARS-CoV-2 vaccine (CoronaVac) in healthy children and adolescents: a double-blind, randomised, controlled, phase 1/2 clinical trial. Lancet Infect Dis. 2021 Jun 28. pii: S1473-3099(21)00319-4. doi: 10.1016/S1473-3099(21)00319-4. [Epub ahead of print]']",,25/06/2021,https://clinicaltrials.gov/show/NCT04551547,30/04/2021,0,1
3111,NCT04568031,"Active, not recruiting",15/11/2021,15/11/2021,No Results Posted,,,15/06/2021,https://clinicaltrials.gov/show/NCT04568031,15/11/2021,0,0
3112,NCT04568122,Recruiting,01/06/2021,01/10/2021,No Results Posted,,,23/06/2021,https://clinicaltrials.gov/show/NCT04568122,01/06/2021,0,0
3113,NCT04572360,Recruiting,31/12/2022,30/06/2023,No Results Posted,"['Gao Y, Zhong LLD, Quach B, Davies B, Ash GI, Lin ZX, Feng Y, Lau BWM, Wagner PD, Yang X, Guo Y, Jia W, Bian Z, Baker JS. COVID-19 Rehabilitation With Herbal Medicine and Cardiorespiratory Exercise: Protocol for a Clinical Study. JMIR Res Protoc. 2021 May 26;10(5):e25556. doi: 10.2196/25556.']",,24/06/2021,https://clinicaltrials.gov/show/NCT04572360,31/12/2022,0,1
3114,NCT04575597,Recruiting,20/10/2021,19/04/2022,No Results Posted,,,08/07/2021,https://clinicaltrials.gov/show/NCT04575597,20/10/2021,0,0
3115,NCT04576728,"Active, not recruiting",01/07/2021,01/07/2021,No Results Posted,,,16/06/2021,https://clinicaltrials.gov/show/NCT04576728,01/07/2021,0,0
3116,NCT04577534,Completed,16/06/2021,16/06/2021,No Results Posted,,,21/06/2021,https://clinicaltrials.gov/show/NCT04577534,16/06/2021,0,0
3117,NCT04583969,Recruiting,31/12/2021,31/12/2021,No Results Posted,,,09/07/2021,https://clinicaltrials.gov/show/NCT04583969,31/12/2021,0,0
3118,NCT04590547,Recruiting,01/05/2022,01/09/2022,No Results Posted,,,25/06/2021,https://clinicaltrials.gov/show/NCT04590547,01/05/2022,0,0
3119,NCT04590586,"Active, not recruiting",07/08/2021,07/08/2021,No Results Posted,,,30/06/2021,https://clinicaltrials.gov/show/NCT04590586,07/08/2021,0,0
3120,NCT04598594,Completed,29/04/2021,20/06/2021,No Results Posted,,,22/06/2021,https://clinicaltrials.gov/show/NCT04598594,29/04/2021,0,0
3121,NCT04615949,Recruiting,01/11/2021,01/12/2021,No Results Posted,,,25/06/2021,https://clinicaltrials.gov/show/NCT04615949,01/11/2021,0,0
3122,NCT04618042,Completed,14/05/2021,13/06/2021,No Results Posted,,,22/06/2021,https://clinicaltrials.gov/show/NCT04618042,14/05/2021,0,0
3123,NCT04629703,Recruiting,01/08/2021,01/10/2021,No Results Posted,,,30/06/2021,https://clinicaltrials.gov/show/NCT04629703,01/08/2021,0,0
3124,NCT04631705,Recruiting,15/09/2021,15/09/2021,No Results Posted,,,15/06/2021,https://clinicaltrials.gov/show/NCT04631705,15/09/2021,0,0
3125,NCT04632706,Completed,09/03/2021,09/03/2021,No Results Posted,,,22/06/2021,https://clinicaltrials.gov/show/NCT04632706,09/03/2021,0,0
3126,NCT04634409,Recruiting,25/08/2021,04/11/2021,No Results Posted,,,06/07/2021,https://clinicaltrials.gov/show/NCT04634409,25/08/2021,0,0
3127,NCT04640194,Recruiting,29/05/2022,01/09/2022,No Results Posted,,,29/06/2021,https://clinicaltrials.gov/show/NCT04640194,29/05/2022,0,0
3128,NCT04657484,Recruiting,07/12/2021,07/12/2021,No Results Posted,,,25/06/2021,https://clinicaltrials.gov/show/NCT04657484,07/12/2021,0,0
3129,NCT04661839,"Active, not recruiting",01/07/2021,01/07/2021,No Results Posted,,,21/06/2021,https://clinicaltrials.gov/show/NCT04661839,01/07/2021,0,0
3130,NCT04667780,Completed,09/06/2021,09/06/2021,No Results Posted,,,22/06/2021,https://clinicaltrials.gov/show/NCT04667780,09/06/2021,0,0
3131,NCT04669015,Recruiting,01/08/2021,01/08/2021,No Results Posted,,,22/06/2021,https://clinicaltrials.gov/show/NCT04669015,01/08/2021,0,0
3132,NCT04674189,"Active, not recruiting",30/06/2021,30/04/2022,No Results Posted,,,18/06/2021,https://clinicaltrials.gov/show/NCT04674189,30/06/2021,0,0
3133,NCT04698993,Terminated,22/03/2021,22/03/2021,Study Results,,,28/06/2021,https://clinicaltrials.gov/show/NCT04698993,22/03/2021,1,0
3134,NCT04701658,Completed,29/06/2021,29/06/2021,No Results Posted,,,06/07/2021,https://clinicaltrials.gov/show/NCT04701658,29/06/2021,0,0
3135,NCT04703205,Recruiting,30/09/2021,31/05/2022,No Results Posted,,,24/06/2021,https://clinicaltrials.gov/show/NCT04703205,30/09/2021,0,0
3136,NCT04705597,Recruiting,01/09/2021,01/11/2021,No Results Posted,,,09/07/2021,https://clinicaltrials.gov/show/NCT04705597,01/09/2021,0,0
3137,NCT04707664,Recruiting,01/08/2021,01/08/2021,No Results Posted,,,25/06/2021,https://clinicaltrials.gov/show/NCT04707664,01/08/2021,0,0
3138,NCT04723394,Recruiting,30/07/2021,29/09/2022,No Results Posted,,,02/07/2021,https://clinicaltrials.gov/show/NCT04723394,30/07/2021,0,0
3139,NCT04723537,Recruiting,01/09/2021,01/09/2021,No Results Posted,,,24/06/2021,https://clinicaltrials.gov/show/NCT04723537,01/09/2021,0,0
3140,NCT04728802,Completed,15/04/2021,15/04/2021,Study Results,,,24/06/2021,https://clinicaltrials.gov/show/NCT04728802,15/04/2021,1,0
3141,NCT04734873,Recruiting,30/12/2021,30/01/2022,No Results Posted,,,30/06/2021,https://clinicaltrials.gov/show/NCT04734873,30/12/2021,0,0
3142,NCT04751682,"Active, not recruiting",25/06/2021,30/11/2021,No Results Posted,,,22/06/2021,https://clinicaltrials.gov/show/NCT04751682,25/06/2021,0,0
3143,NCT04753619,Recruiting,03/12/2021,03/12/2021,No Results Posted,,,22/06/2021,https://clinicaltrials.gov/show/NCT04753619,03/12/2021,0,0
3144,NCT04754594,Recruiting,25/07/2022,25/07/2022,No Results Posted,,,21/06/2021,https://clinicaltrials.gov/show/NCT04754594,25/07/2022,0,0
3145,NCT04754698,"Active, not recruiting",21/06/2021,31/05/2022,No Results Posted,,,23/06/2021,https://clinicaltrials.gov/show/NCT04754698,21/06/2021,0,0
3146,NCT04758962,"Active, not recruiting",04/06/2021,02/05/2022,No Results Posted,,,21/06/2021,https://clinicaltrials.gov/show/NCT04758962,04/06/2021,0,0
3147,NCT04761822,Recruiting,01/07/2021,01/08/2021,No Results Posted,,,06/07/2021,https://clinicaltrials.gov/show/NCT04761822,01/07/2021,0,0
3148,NCT04765540,"Active, not recruiting",06/05/2021,30/06/2021,No Results Posted,,,22/06/2021,https://clinicaltrials.gov/show/NCT04765540,06/05/2021,0,0
3149,NCT04776317,Recruiting,19/09/2022,19/09/2022,No Results Posted,,,02/07/2021,https://clinicaltrials.gov/show/NCT04776317,19/09/2022,0,0
3150,NCT04780698,Recruiting,01/10/2021,01/02/2022,No Results Posted,,,23/06/2021,https://clinicaltrials.gov/show/NCT04780698,01/10/2021,0,0
3151,NCT04782700,Completed,08/06/2021,08/06/2021,No Results Posted,,,18/06/2021,https://clinicaltrials.gov/show/NCT04782700,08/06/2021,0,0
3152,NCT04784559,Recruiting,01/11/2021,01/11/2021,No Results Posted,,,08/07/2021,https://clinicaltrials.gov/show/NCT04784559,01/11/2021,0,0
3153,NCT04785144,"Active, not recruiting",31/08/2022,31/08/2022,No Results Posted,,,02/07/2021,https://clinicaltrials.gov/show/NCT04785144,31/08/2022,0,0
3154,NCT04794946,Recruiting,19/03/2022,19/03/2022,No Results Posted,,,23/06/2021,https://clinicaltrials.gov/show/NCT04794946,19/03/2022,0,0
3155,NCT04795583,Not yet recruiting,01/04/2022,01/08/2022,No Results Posted,,,22/06/2021,https://clinicaltrials.gov/show/NCT04795583,01/04/2022,0,0
3156,NCT04796896,Recruiting,12/06/2023,12/06/2023,No Results Posted,,,25/06/2021,https://clinicaltrials.gov/show/NCT04796896,12/06/2023,0,0
3157,NCT04805125,"Active, not recruiting",01/07/2022,01/07/2022,No Results Posted,,,15/06/2021,https://clinicaltrials.gov/show/NCT04805125,01/07/2022,0,0
3158,NCT04818216,Recruiting,01/06/2022,01/06/2023,No Results Posted,,,16/06/2021,https://clinicaltrials.gov/show/NCT04818216,01/06/2022,0,0
3159,NCT04818320,"Active, not recruiting",31/08/2021,31/12/2021,No Results Posted,,,18/06/2021,https://clinicaltrials.gov/show/NCT04818320,31/08/2021,0,0
3160,NCT04821531,Not yet recruiting,23/02/2022,01/12/2022,No Results Posted,,,23/06/2021,https://clinicaltrials.gov/show/NCT04821531,23/02/2022,0,0
3161,NCT04822701,Recruiting,03/05/2022,30/06/2022,No Results Posted,,,02/07/2021,https://clinicaltrials.gov/show/NCT04822701,03/05/2022,0,0
3162,NCT04824443,Recruiting,29/03/2023,29/03/2023,No Results Posted,,,24/06/2021,https://clinicaltrials.gov/show/NCT04824443,29/03/2023,0,0
3163,NCT04826588,Recruiting,01/04/2022,01/04/2022,No Results Posted,,,18/06/2021,https://clinicaltrials.gov/show/NCT04826588,01/04/2022,0,0
3164,NCT04830033,Recruiting,01/12/2021,01/12/2021,No Results Posted,,,25/06/2021,https://clinicaltrials.gov/show/NCT04830033,01/12/2021,0,0
3165,NCT04836806,Recruiting,01/07/2022,01/07/2022,No Results Posted,,,23/06/2021,https://clinicaltrials.gov/show/NCT04836806,01/07/2022,0,0
3166,NCT04843930,Recruiting,01/07/2022,01/09/2022,No Results Posted,,,24/06/2021,https://clinicaltrials.gov/show/NCT04843930,01/07/2022,0,0
3167,NCT04844307,Not yet recruiting,01/10/2021,01/02/2022,No Results Posted,,,22/06/2021,https://clinicaltrials.gov/show/NCT04844307,01/10/2021,0,0
3168,NCT04844489,Recruiting,16/04/2023,31/07/2023,No Results Posted,,,21/06/2021,https://clinicaltrials.gov/show/NCT04844489,16/04/2023,0,0
3169,NCT04854772,Recruiting,01/05/2022,01/08/2022,No Results Posted,,,23/06/2021,https://clinicaltrials.gov/show/NCT04854772,01/05/2022,0,0
3170,NCT04858789,Recruiting,01/12/2021,01/12/2021,No Results Posted,,,25/06/2021,https://clinicaltrials.gov/show/NCT04858789,01/12/2021,0,0
3171,NCT04859517,Recruiting,01/07/2022,01/03/2023,No Results Posted,,,21/06/2021,https://clinicaltrials.gov/show/NCT04859517,01/07/2022,0,0
3172,NCT04864548,Recruiting,01/11/2022,01/11/2022,No Results Posted,,,18/06/2021,https://clinicaltrials.gov/show/NCT04864548,01/11/2022,0,0
3173,NCT04867226,Completed,18/06/2021,18/06/2021,No Results Posted,,,22/06/2021,https://clinicaltrials.gov/show/NCT04867226,18/06/2021,0,0
3174,NCT04870593,"Active, not recruiting",10/07/2021,10/07/2021,No Results Posted,,,23/06/2021,https://clinicaltrials.gov/show/NCT04870593,10/07/2021,0,0
3175,NCT04872075,"Active, not recruiting",13/06/2021,13/06/2021,No Results Posted,,,18/06/2021,https://clinicaltrials.gov/show/NCT04872075,13/06/2021,0,0
3176,NCT04878055,Recruiting,01/06/2021,01/10/2021,No Results Posted,,,23/06/2021,https://clinicaltrials.gov/show/NCT04878055,01/06/2021,0,0
3177,NCT04878809,Completed,17/06/2021,17/06/2021,No Results Posted,,,18/06/2021,https://clinicaltrials.gov/show/NCT04878809,17/06/2021,0,0
3178,NCT04881227,Recruiting,01/05/2023,01/05/2023,No Results Posted,,,22/06/2021,https://clinicaltrials.gov/show/NCT04881227,01/05/2023,0,0
3179,NCT04888949,Recruiting,30/09/2022,30/09/2022,No Results Posted,,,21/06/2021,https://clinicaltrials.gov/show/NCT04888949,30/09/2022,0,0
3180,NCT04889209,Recruiting,28/05/2023,28/05/2025,No Results Posted,,,25/06/2021,https://clinicaltrials.gov/show/NCT04889209,28/05/2023,0,0
3181,NCT04902911,Recruiting,17/03/2022,17/03/2022,No Results Posted,,,23/06/2021,https://clinicaltrials.gov/show/NCT04902911,17/03/2022,0,0
3182,NCT04911777,Not yet recruiting,01/12/2021,01/03/2022,No Results Posted,,,24/06/2021,https://clinicaltrials.gov/show/NCT04911777,01/12/2021,0,0
3183,NCT04915820,Recruiting,06/08/2021,06/08/2021,No Results Posted,,,02/07/2021,https://clinicaltrials.gov/show/NCT04915820,06/08/2021,0,0
3184,NCT04920942,Recruiting,01/12/2021,01/01/2022,No Results Posted,,,21/06/2021,https://clinicaltrials.gov/show/NCT04920942,01/12/2021,0,0
3185,NCT04926428,Completed,30/03/2021,30/03/2021,No Results Posted,,,21/06/2021,https://clinicaltrials.gov/show/NCT04926428,30/03/2021,0,0
3186,NCT04926779,Recruiting,20/09/2021,21/09/2021,No Results Posted,,,15/06/2021,https://clinicaltrials.gov/show/NCT04926779,20/09/2021,0,0
3187,NCT04927065,"Active, not recruiting",05/06/2022,05/06/2022,No Results Posted,,,15/06/2021,https://clinicaltrials.gov/show/NCT04927065,05/06/2022,0,0
3188,NCT04927169,Recruiting,30/12/2021,30/06/2022,No Results Posted,,"['Zhou F, Yu T, Du R, Fan G, Liu Y, Liu Z, Xiang J, Wang Y, Song B, Gu X, Guan L, Wei Y, Li H, Wu X, Xu J, Tu S, Zhang Y, Chen H, Cao B. Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study. Lancet. 2020 Mar 28;395(10229):1054-1062. doi: 10.1016/S0140-6736(20)30566-3. Epub 2020 Mar 11. Erratum in: Lancet. 2020 Mar 28;395(10229):1038. Lancet. 2020 Mar 28;395(10229):1038.', 'Wang D, Hu B, Hu C, Zhu F, Liu X, Zhang J, Wang B, Xiang H, Cheng Z, Xiong Y, Zhao Y, Li Y, Wang X, Peng Z. Clinical Characteristics of 138 Hospitalized Patients With 2019 Novel Coronavirus-Infected Pneumonia in Wuhan, China. JAMA. 2020 Mar 17;323(11):1061-1069. doi: 10.1001/jama.2020.1585. Erratum in: JAMA. 2021 Mar 16;325(11):1113.', 'Francois B, Jeannet R, Daix T, Walton AH, Shotwell MS, Unsinger J, Monneret G, Rimmel√© T, Blood T, Morre M, Gregoire A, Mayo GA, Blood J, Durum SK, Sherwood ER, Hotchkiss RS. Interleukin-7 restores lymphocytes in septic shock: the IRIS-7 randomized clinical trial. JCI Insight. 2018 Mar 8;3(5). pii: 98960. doi: 10.1172/jci.insight.98960.', 'Venet F, Chung CS, Kherouf H, Geeraert A, Malcus C, Poitevin F, Boh√© J, Lepape A, Ayala A, Monneret G. Increased circulating regulatory T cells (CD4(+)CD25 (+)CD127 (-)) contribute to lymphocyte anergy in septic shock patients. Intensive Care Med. 2009 Apr;35(4):678-86. doi: 10.1007/s00134-008-1337-8. Epub 2008 Oct 23.']",18/06/2021,https://clinicaltrials.gov/show/NCT04927169,30/12/2021,0,1
3189,NCT04927182,Recruiting,01/07/2021,01/07/2021,No Results Posted,,,15/06/2021,https://clinicaltrials.gov/show/NCT04927182,01/07/2021,0,0
3190,NCT04927845,Enrolling by invitation,31/05/2022,30/06/2022,No Results Posted,,,21/06/2021,https://clinicaltrials.gov/show/NCT04927845,31/05/2022,0,0
3191,NCT04927936,Recruiting,01/09/2022,01/09/2022,No Results Posted,,,30/06/2021,https://clinicaltrials.gov/show/NCT04927936,01/09/2022,0,0
3192,NCT04928430,Recruiting,31/08/2021,31/08/2021,No Results Posted,,,16/06/2021,https://clinicaltrials.gov/show/NCT04928430,31/08/2021,0,0
3193,NCT04928456,Recruiting,01/09/2022,30/12/2022,No Results Posted,,,16/06/2021,https://clinicaltrials.gov/show/NCT04928456,01/09/2022,0,0
3194,NCT04928495,Not yet recruiting,09/04/2022,09/06/2022,No Results Posted,,,30/06/2021,https://clinicaltrials.gov/show/NCT04928495,09/04/2022,0,0
3195,NCT04929691,Recruiting,01/12/2021,01/12/2021,No Results Posted,,,23/06/2021,https://clinicaltrials.gov/show/NCT04929691,01/12/2021,0,0
3196,NCT04930003,"Active, not recruiting",01/12/2021,01/12/2021,No Results Posted,,,18/06/2021,https://clinicaltrials.gov/show/NCT04930003,01/12/2021,0,0
3197,NCT04930770,Not yet recruiting,01/12/2021,01/03/2022,No Results Posted,,,18/06/2021,https://clinicaltrials.gov/show/NCT04930770,01/12/2021,0,0
3198,NCT04930861,"Active, not recruiting",27/05/2021,15/07/2021,No Results Posted,,,28/06/2021,https://clinicaltrials.gov/show/NCT04930861,27/05/2021,0,0
3199,NCT04930874,Not yet recruiting,16/12/2021,16/02/2022,No Results Posted,,,18/06/2021,https://clinicaltrials.gov/show/NCT04930874,16/12/2021,0,0
3200,NCT04930965,Not yet recruiting,31/12/2021,31/12/2021,No Results Posted,,,25/06/2021,https://clinicaltrials.gov/show/NCT04930965,31/12/2021,0,0
3201,NCT04931004,Not yet recruiting,01/12/2021,01/02/2022,No Results Posted,,,23/06/2021,https://clinicaltrials.gov/show/NCT04931004,01/12/2021,0,0
3202,NCT04931238,Recruiting,31/12/2021,31/12/2022,No Results Posted,,"['Yang L, Liu W, Yu X, Wu M, Reichert JM, Ho M. COVID-19 antibody therapeutics tracker: a global online database of antibody therapeutics for the prevention and treatment of COVID-19. Antib Ther. 2020 Jul;3(3):205-212. doi: 10.1093/abt/tbaa020. Epub 2020 Aug 19. Review.']",18/06/2021,https://clinicaltrials.gov/show/NCT04931238,31/12/2021,0,1
3203,NCT04931888,Not yet recruiting,31/08/2021,31/12/2021,No Results Posted,,,24/06/2021,https://clinicaltrials.gov/show/NCT04931888,31/08/2021,0,0
3204,NCT04932824,Recruiting,31/05/2023,14/09/2023,No Results Posted,,,21/06/2021,https://clinicaltrials.gov/show/NCT04932824,31/05/2023,0,0
3205,NCT04932850,"Active, not recruiting",01/10/2021,01/10/2021,No Results Posted,,,21/06/2021,https://clinicaltrials.gov/show/NCT04932850,01/10/2021,0,0
3206,NCT04932915,Not yet recruiting,30/10/2021,30/11/2021,No Results Posted,,,21/06/2021,https://clinicaltrials.gov/show/NCT04932915,30/10/2021,0,0
3207,NCT04932941,Not yet recruiting,01/01/2022,01/01/2022,No Results Posted,,,21/06/2021,https://clinicaltrials.gov/show/NCT04932941,01/01/2022,0,0
3208,NCT04933474,Not yet recruiting,31/12/2023,31/03/2024,No Results Posted,,,28/06/2021,https://clinicaltrials.gov/show/NCT04933474,31/12/2023,0,0
3209,NCT04933799,Recruiting,06/03/2022,06/05/2022,No Results Posted,,,22/06/2021,https://clinicaltrials.gov/show/NCT04933799,06/03/2022,0,0
3210,NCT04933864,Completed,20/05/2020,30/07/2020,No Results Posted,,,22/06/2021,https://clinicaltrials.gov/show/NCT04933864,20/05/2020,0,0
3211,NCT04933929,Recruiting,01/12/2021,01/03/2022,No Results Posted,,,22/06/2021,https://clinicaltrials.gov/show/NCT04933929,01/12/2021,0,0
3212,NCT04934111,Not yet recruiting,01/06/2022,01/08/2022,No Results Posted,,,22/06/2021,https://clinicaltrials.gov/show/NCT04934111,01/06/2022,0,0
3213,NCT04935437,Recruiting,01/09/2021,01/09/2021,No Results Posted,,,23/06/2021,https://clinicaltrials.gov/show/NCT04935437,01/09/2021,0,0
3214,NCT04935476,Not yet recruiting,09/12/2021,03/01/2022,No Results Posted,,,23/06/2021,https://clinicaltrials.gov/show/NCT04935476,09/12/2021,0,0
3215,NCT04935489,Not yet recruiting,15/07/2022,15/09/2022,No Results Posted,,,25/06/2021,https://clinicaltrials.gov/show/NCT04935489,15/07/2022,0,0
3216,NCT04935502,Recruiting,30/06/2021,30/06/2021,No Results Posted,,,23/06/2021,https://clinicaltrials.gov/show/NCT04935502,30/06/2021,0,0
3217,NCT04935515,Completed,09/05/2021,06/06/2021,No Results Posted,,,23/06/2021,https://clinicaltrials.gov/show/NCT04935515,09/05/2021,0,0
3218,NCT04935528,Recruiting,02/06/2022,02/06/2022,No Results Posted,,,23/06/2021,https://clinicaltrials.gov/show/NCT04935528,02/06/2022,0,0
3219,NCT04936503,Completed,02/03/2021,02/03/2021,No Results Posted,,,23/06/2021,https://clinicaltrials.gov/show/NCT04936503,02/03/2021,0,0
3220,NCT04936893,"Active, not recruiting",31/03/2021,31/07/2021,No Results Posted,,,23/06/2021,https://clinicaltrials.gov/show/NCT04936893,31/03/2021,0,0
3221,NCT04936997,Recruiting,01/09/2021,01/09/2021,No Results Posted,,,28/06/2021,https://clinicaltrials.gov/show/NCT04936997,01/09/2021,0,0
3222,NCT04937088,Not yet recruiting,30/06/2022,30/06/2022,No Results Posted,,,23/06/2021,https://clinicaltrials.gov/show/NCT04937088,30/06/2022,0,0
3223,NCT04937543,Not yet recruiting,30/10/2021,30/01/2022,No Results Posted,,,30/06/2021,https://clinicaltrials.gov/show/NCT04937543,30/10/2021,0,0
3224,NCT04937556,Not yet recruiting,31/12/2021,30/04/2022,No Results Posted,,,24/06/2021,https://clinicaltrials.gov/show/NCT04937556,31/12/2021,0,0
3225,NCT04937569,Not yet recruiting,01/09/2021,01/11/2021,No Results Posted,,,29/06/2021,https://clinicaltrials.gov/show/NCT04937569,01/09/2021,0,0
3226,NCT04937582,Not yet recruiting,01/01/2023,01/01/2025,No Results Posted,,,24/06/2021,https://clinicaltrials.gov/show/NCT04937582,01/01/2023,0,0
3227,NCT04937595,,,,,,,,https://clinicaltrials.gov/show/NCT04937595,,0,0
3228,NCT04939402,Recruiting,01/05/2022,01/06/2022,No Results Posted,,,25/06/2021,https://clinicaltrials.gov/show/NCT04939402,01/05/2022,0,0
3229,NCT04939415,Not yet recruiting,01/07/2022,31/12/2022,No Results Posted,,,25/06/2021,https://clinicaltrials.gov/show/NCT04939415,01/07/2022,0,0
3230,NCT04939428,Not yet recruiting,25/02/2022,25/02/2022,No Results Posted,,,25/06/2021,https://clinicaltrials.gov/show/NCT04939428,25/02/2022,0,0
3231,NCT04939506,Not yet recruiting,01/03/2023,01/06/2023,No Results Posted,,,25/06/2021,https://clinicaltrials.gov/show/NCT04939506,01/03/2023,0,0
3232,NCT04939519,Recruiting,22/09/2022,22/09/2022,No Results Posted,,,25/06/2021,https://clinicaltrials.gov/show/NCT04939519,22/09/2022,0,0
3233,NCT04939532,Recruiting,01/09/2022,01/09/2022,No Results Posted,,,25/06/2021,https://clinicaltrials.gov/show/NCT04939532,01/09/2022,0,0
3234,NCT04939714,Recruiting,01/12/2021,01/12/2021,No Results Posted,,,25/06/2021,https://clinicaltrials.gov/show/NCT04939714,01/12/2021,0,0
3235,NCT04940182,Recruiting,01/12/2021,01/12/2021,No Results Posted,,,01/07/2021,https://clinicaltrials.gov/show/NCT04940182,01/12/2021,0,0
3236,NCT04940195,,,,,,,,https://clinicaltrials.gov/show/NCT04940195,,0,0
3237,ACTRN12620000443998,Not yet recruiting,,,,,,06/04/2020,https://anzctr.org.au/ACTRN12620000443998.aspx,31/12/2020,0,0
3238,ACTRN12620000472976,Not yet recruiting,,27/10/2020,,,,15/04/2020,https://anzctr.org.au/ACTRN12620000472976.aspx,13/10/2020,0,0
3239,ACTRN12620000470998,Not yet recruiting,,30/06/2020,,,,14/04/2020,https://anzctr.org.au/ACTRN12620000470998.aspx,01/05/2020,0,0
3240,ACTRN12620000480987,Not yet recruiting,,18/10/2020,,,,16/04/2020,https://anzctr.org.au/ACTRN12620000480987.aspx,16/07/2020,0,0
3241,ACTRN12620000492954,Not yet recruiting,,,,,,20/04/2020,https://anzctr.org.au/ACTRN12620000492954.aspx,,0,0
3242,ACTRN12620000482965,"Active, not recruiting",,26/04/2020,,"{'citations': [], 'basic_reporting_doc': ''}",,17/04/2020,https://anzctr.org.au/ACTRN12620000482965.aspx,18/03/2020,0,1
3243,ACTRN12620000524998,Not yet recruiting,,30/04/2021,,,,28/04/2020,https://anzctr.org.au/ACTRN12620000524998.aspx,01/12/2020,0,0
3244,ACTRN12620000635965,Not yet recruiting,,30/09/2020,,,,29/05/2020,https://anzctr.org.au/ACTRN12620000635965.aspx,31/08/2020,0,0
3245,ACTRN12620000500954,Not yet recruiting,,01/06/2020,,,,22/04/2020,https://anzctr.org.au/ACTRN12620000500954.aspx,01/06/2020,0,0
3246,ACTRN12620000676910,Not yet recruiting,,31/07/2021,,,,15/06/2020,https://anzctr.org.au/ACTRN12620000676910.aspx,30/06/2021,0,0
3247,ACTRN12620000688987,Completed,,05/06/2020,,"{'citations': [], 'basic_reporting_doc': ''}",,19/06/2020,https://anzctr.org.au/ACTRN12620000688987.aspx,05/06/2020,0,1
3248,ACTRN12620000740998,Not yet recruiting,,,,,,16/07/2020,https://anzctr.org.au/ACTRN12620000740998.aspx,,0,0
3249,ACTRN12620000731998,Not yet recruiting,,,,,,13/07/2020,https://anzctr.org.au/ACTRN12620000731998.aspx,,0,0
3250,ACTRN12620000737932,"Active, not recruiting",,30/09/2020,,"{'citations': [], 'basic_reporting_doc': ''}",,14/07/2020,https://anzctr.org.au/ACTRN12620000737932.aspx,15/06/2020,0,1
3251,ACTRN12620000588998,Withdrawn,,,,,,30/07/2020,https://anzctr.org.au/ACTRN12620000588998.aspx,,0,0
3252,ACTRN12620000566932,Not yet recruiting,,30/06/2023,,,,28/07/2020,https://anzctr.org.au/ACTRN12620000566932.aspx,03/08/2022,0,0
3253,ACTRN12620000674932,Recruiting,,,,,,24/07/2020,https://anzctr.org.au/ACTRN12620000674932.aspx,,0,0
3254,ACTRN12620000787987,Not yet recruiting,,29/03/2022,,,,04/08/2020,https://anzctr.org.au/ACTRN12620000787987.aspx,29/01/2021,0,0
3255,ACTRN12620000786998,Not yet recruiting,,19/10/2020,,,,04/08/2020,https://anzctr.org.au/ACTRN12620000786998.aspx,12/10/2020,0,0
3256,ACTRN12620000795998,"Active, not recruiting",,31/03/2021,,"{'citations': [], 'basic_reporting_doc': ''}",,07/08/2020,https://anzctr.org.au/ACTRN12620000795998.aspx,15/06/2020,0,1
3257,ACTRN12620000811909,Not yet recruiting,,29/03/2022,,,,13/08/2020,https://anzctr.org.au/ACTRN12620000811909.aspx,29/01/2021,0,0
3258,ACTRN12620000840987,Recruiting,,31/03/2021,,,,26/08/2020,https://anzctr.org.au/ACTRN12620000840987.aspx,30/12/2020,0,0
3259,ACTRN12620000843954,Not yet recruiting,,01/12/2021,,,,26/08/2020,https://anzctr.org.au/ACTRN12620000843954.aspx,01/09/2021,0,0
3260,ACTRN12620000842965,Not yet recruiting,,01/12/2021,,,,26/08/2020,https://anzctr.org.au/ACTRN12620000842965.aspx,01/09/2021,0,0
3261,ACTRN12620000841976,Not yet recruiting,,01/12/2021,,,,26/08/2020,https://anzctr.org.au/ACTRN12620000841976.aspx,01/09/2021,0,0
3262,ACTRN12620000844943,Not yet recruiting,,01/12/2021,,,,26/08/2020,https://anzctr.org.au/ACTRN12620000844943.aspx,01/09/2021,0,0
3263,ACTRN12620000876998,Recruiting,,25/07/2021,,,,03/09/2020,https://anzctr.org.au/ACTRN12620000876998.aspx,22/02/2021,0,0
3264,ACTRN12620000477921,Completed,,23/04/2020,,"{'citations': [], 'basic_reporting_doc': ''}",,08/09/2020,https://anzctr.org.au/ACTRN12620000477921.aspx,20/04/2020,0,1
3265,ACTRN12620000454976,Recruiting,,09/04/2021,,,,04/09/2020,https://anzctr.org.au/ACTRN12620000454976.aspx,09/03/2021,0,0
3266,ACTRN12620000517976,Recruiting,,25/07/2021,,,,08/09/2020,https://anzctr.org.au/ACTRN12620000517976.aspx,26/05/2021,0,0
3267,ACTRN12620000580976,Not yet recruiting,,,,,,08/09/2020,https://anzctr.org.au/ACTRN12620000580976.aspx,,0,0
3268,ACTRN12620000698976,Recruiting,,16/12/2020,,,,04/09/2020,https://anzctr.org.au/ACTRN12620000698976.aspx,30/11/2020,0,0
3269,ACTRN12620000707965,Withdrawn,,30/03/2021,,,,08/09/2020,https://anzctr.org.au/ACTRN12620000707965.aspx,30/09/2020,0,0
3270,ACTRN12620000817943,Recruiting,,30/03/2021,,,,08/09/2020,https://anzctr.org.au/ACTRN12620000817943.aspx,30/11/2020,0,0
3271,ACTRN12620000860965,Not yet recruiting,,,,,,28/08/2020,https://anzctr.org.au/ACTRN12620000860965.aspx,,0,0
3272,ACTRN12620000571976,"Active, not recruiting",,20/09/2020,,"{'citations': [], 'basic_reporting_doc': ''}",,17/09/2020,https://anzctr.org.au/ACTRN12620000571976.aspx,20/07/2020,0,1
3273,ACTRN12620000834954,Not yet recruiting,,27/11/2020,,,,24/08/2020,https://anzctr.org.au/ACTRN12620000834954.aspx,10/11/2020,0,0
3274,ACTRN12620000457943,Withdrawn,,29/01/2021,,,,23/10/2020,https://anzctr.org.au/ACTRN12620000457943.aspx,01/01/2021,0,0
3275,ACTRN12620000557932,Recruiting,,30/06/2021,,,,23/10/2020,https://anzctr.org.au/ACTRN12620000557932.aspx,31/05/2021,0,0
3276,ACTRN12620000788976,Recruiting,,17/04/2021,,,,03/12/2020,https://anzctr.org.au/ACTRN12620000788976.aspx,03/04/2021,0,0
3277,ACTRN12620000417987,Stopped early,,28/09/2020,,"{'citations': [], 'basic_reporting_doc': ''}",,17/12/2020,https://anzctr.org.au/ACTRN12620000417987.aspx,15/10/2020,0,1
3278,ACTRN12620000555954,"Active, not recruiting",,31/03/2021,,"{'citations': [], 'basic_reporting_doc': ''}",,09/12/2020,https://anzctr.org.au/ACTRN12620000555954.aspx,30/06/2020,0,1
3279,ACTRN12620000501943,Recruiting,,30/04/2021,,,,09/12/2020,https://anzctr.org.au/ACTRN12620000501943.aspx,31/12/2020,0,0
3280,ACTRN12620000640909,Recruiting,,31/08/2021,,,,17/12/2020,https://anzctr.org.au/ACTRN12620000640909.aspx,31/07/2021,0,0
3281,ACTRN12620000636954,Recruiting,,,,,,09/12/2020,https://anzctr.org.au/ACTRN12620000636954.aspx,,0,0
3282,ACTRN12620000779976,Completed,,30/09/2020,,"{'citations': [], 'basic_reporting_doc': ''}",,17/12/2020,https://anzctr.org.au/ACTRN12620000779976.aspx,30/09/2020,0,1
3283,ACTRN12620000975998,Not yet recruiting,,,,,,17/12/2020,https://anzctr.org.au/ACTRN12620000975998.aspx,,0,0
3284,ACTRN12620001308987,Not yet recruiting,,,,,,04/12/2020,https://anzctr.org.au/ACTRN12620001308987.aspx,,0,0
3285,ACTRN12620001371987,Completed,,29/03/2021,,"{'citations': [], 'basic_reporting_doc': ''}",,08/07/2021,https://anzctr.org.au/ACTRN12620001371987.aspx,05/02/2021,0,1
3286,ACTRN12621000016831,Not yet recruiting,,,,,,21/04/2021,https://anzctr.org.au/ACTRN12621000016831.aspx,,0,0
3287,ACTRN12621000034831,Recruiting,,30/11/2021,,,,15/01/2021,https://anzctr.org.au/ACTRN12621000034831.aspx,31/01/2021,0,0
3288,ACTRN12621000048886,Recruiting,,26/02/2021,,,,19/01/2021,https://anzctr.org.au/ACTRN12621000048886.aspx,29/01/2021,0,0
3289,ACTRN12621000031864,Not yet recruiting,,07/06/2021,,,,15/01/2021,https://anzctr.org.au/ACTRN12621000031864.aspx,08/03/2021,0,0
3290,ACTRN12620000516987,"Active, not recruiting",,15/03/2021,,"{'citations': [], 'basic_reporting_doc': ''}",,22/01/2021,https://anzctr.org.au/ACTRN12620000516987.aspx,14/12/2020,0,1
3291,ACTRN12620000634976,Completed,,17/09/2020,,"{'citations': [], 'basic_reporting_doc': ''}",,22/01/2021,https://anzctr.org.au/ACTRN12620000634976.aspx,02/07/2020,0,1
3292,ACTRN12621000067875,Not yet recruiting,,26/03/2021,,,,27/01/2021,https://anzctr.org.au/ACTRN12621000067875.aspx,18/03/2021,0,0
3293,ACTRN12620000982910,Not yet recruiting,,,,,,27/01/2021,https://anzctr.org.au/ACTRN12620000982910.aspx,,0,0
3294,ACTRN12620000445976,Recruiting,,,,,,04/02/2021,https://anzctr.org.au/ACTRN12620000445976.aspx,,0,0
3295,ACTRN12621000112864,Recruiting,,,,,,04/02/2021,https://anzctr.org.au/ACTRN12621000112864.aspx,,0,0
3296,ACTRN12620000468921,"Active, not recruiting",,12/05/2021,,"{'citations': [], 'basic_reporting_doc': ''}",,05/02/2021,https://anzctr.org.au/ACTRN12620000468921.aspx,13/07/2020,0,1
3297,ACTRN12621000131853,Not yet recruiting,,31/05/2021,,,,09/02/2021,https://anzctr.org.au/ACTRN12621000131853.aspx,25/05/2021,0,0
3298,ACTRN12621000183886,Not yet recruiting,,22/02/2023,,,,22/02/2021,https://anzctr.org.au/ACTRN12621000183886.aspx,22/02/2022,0,0
3299,ACTRN12620000447954,Withdrawn,,31/08/2020,,,,11/03/2021,https://anzctr.org.au/ACTRN12620000447954.aspx,31/07/2020,0,0
3300,ACTRN12620000473965,"Active, not recruiting",,30/04/2021,,"{'citations': [], 'basic_reporting_doc': ''}",,09/03/2021,https://anzctr.org.au/ACTRN12620000473965.aspx,30/09/2020,0,1
3301,ACTRN12621000283875,Not yet recruiting,,,,,,16/03/2021,https://anzctr.org.au/ACTRN12621000283875.aspx,,0,0
3302,ACTRN12620000612910,Recruiting,,,,,,22/03/2021,https://anzctr.org.au/ACTRN12620000612910.aspx,,0,0
3303,ACTRN12620001355965,Completed,,22/03/2021,,"{'citations': [], 'basic_reporting_doc': ''}",,24/03/2021,https://anzctr.org.au/ACTRN12620001355965.aspx,11/02/2021,0,1
3304,ACTRN12621000344897,Recruiting,,01/07/2021,,,,25/03/2021,https://anzctr.org.au/ACTRN12621000344897.aspx,01/06/2021,0,0
3305,ACTRN12621000309886,Not yet recruiting,,21/05/2021,,,,19/03/2021,https://anzctr.org.au/ACTRN12621000309886.aspx,30/04/2021,0,0
3306,ACTRN12620001048976,Not yet recruiting,,28/05/2021,,,,29/03/2021,https://anzctr.org.au/ACTRN12620001048976.aspx,28/05/2021,0,0
3307,ACTRN12621000387820,Not yet recruiting,,,,,,08/04/2021,https://anzctr.org.au/ACTRN12621000387820.aspx,,0,0
3308,ACTRN12620001249943,Recruiting,,01/10/2021,,,,22/03/2021,https://anzctr.org.au/ACTRN12620001249943.aspx,26/04/2021,0,0
3309,ACTRN12621000347864,Not yet recruiting,,15/05/2021,,,,26/03/2021,https://anzctr.org.au/ACTRN12621000347864.aspx,30/04/2021,0,0
3310,ACTRN12621000420842,Not yet recruiting,,,,,,15/04/2021,https://anzctr.org.au/ACTRN12621000420842.aspx,,0,0
3311,ACTRN12621000468820,Not yet recruiting,,15/12/2021,,,,20/04/2021,https://anzctr.org.au/ACTRN12621000468820.aspx,01/11/2021,0,0
3312,ACTRN12620000478910,Not yet recruiting,,31/12/2022,,,,03/05/2021,https://anzctr.org.au/ACTRN12620000478910.aspx,31/03/2022,0,0
3313,ACTRN12620001104943,Completed,,26/02/2021,,"{'citations': [], 'basic_reporting_doc': ''}",,10/05/2021,https://anzctr.org.au/ACTRN12620001104943.aspx,18/12/2020,0,1
3314,ACTRN12621000567820,Not yet recruiting,,31/10/2022,,,,14/05/2021,https://anzctr.org.au/ACTRN12621000567820.aspx,01/08/2021,0,0
3315,ACTRN12621000607875,Not yet recruiting,,,,,,20/05/2021,https://anzctr.org.au/ACTRN12621000607875.aspx,,0,0
3316,ACTRN12621000532808,Recruiting,,01/12/2021,,,,06/05/2021,https://anzctr.org.au/ACTRN12621000532808.aspx,31/05/2021,0,0
3317,ACTRN12621000661875,Recruiting,,,,,,01/06/2021,https://anzctr.org.au/ACTRN12621000661875.aspx,,0,0
3318,ACTRN12620000579998,Completed,,16/06/2020,,"{'citations': [], 'basic_reporting_doc': '/Steps11and12/379818-(Uploaded-08-06-2021-14-11-16)-Basic results summary.docx'}",,10/06/2021,https://anzctr.org.au/ACTRN12620000579998.aspx,01/06/2020,0,1
3319,ACTRN12621000704897,Not yet recruiting,,,,,,08/06/2021,https://anzctr.org.au/ACTRN12621000704897.aspx,27/06/2022,0,0
3320,ACTRN12621000722897,Not yet recruiting,,,,,,09/06/2021,https://anzctr.org.au/ACTRN12621000722897.aspx,30/07/2021,0,0
3321,ACTRN12621000738820,Recruiting,,15/03/2022,,,,11/06/2021,https://anzctr.org.au/ACTRN12621000738820.aspx,20/09/2021,0,0
3322,ACTRN12620000448943,Recruiting,,01/10/2021,,,,28/06/2021,https://anzctr.org.au/ACTRN12620000448943.aspx,30/06/2021,0,0
3323,ACTRN12621000637842,Not yet recruiting,,06/02/2023,,,,27/05/2021,https://anzctr.org.au/ACTRN12621000637842.aspx,02/08/2022,0,0
3324,ACTRN12620000816954,Completed,,01/11/2020,,"{'citations': [], 'basic_reporting_doc': ''}",,28/06/2021,https://anzctr.org.au/ACTRN12620000816954.aspx,16/10/2020,0,1
3325,ChiCTR2000029947,Not yet recruiting,,01/06/2020,,,,17/02/2020,http://www.chictr.org.cn/showproj.aspx?proj=49599,01/06/2020,0,0
3326,ChiCTR2000029941,Not yet recruiting,,01/06/2020,,,,17/02/2020,http://www.chictr.org.cn/showproj.aspx?proj=49596,01/06/2020,0,0
3327,ChiCTR2000029939,Recruiting,,06/02/2021,,,,17/02/2020,http://www.chictr.org.cn/showproj.aspx?proj=49612,06/02/2021,0,0
3328,ChiCTR2000029935,Recruiting,,06/02/2021,,,,17/02/2020,http://www.chictr.org.cn/showproj.aspx?proj=49607,06/02/2021,0,0
3329,ChiCTR2000029869,Not yet recruiting,,30/06/2020,,,,17/03/2020,http://www.chictr.org.cn/showproj.aspx?proj=49486,30/06/2020,0,0
3330,ChiCTR2000029867,Recruiting,,28/02/2021,,,,16/02/2020,http://www.chictr.org.cn/showproj.aspx?proj=49514,28/02/2021,0,0
3331,ChiCTR2000029855,Recruiting,,,,,,18/02/2020,http://www.chictr.org.cn/showproj.aspx?proj=49543,,0,0
3332,ChiCTR2000029853,Recruiting,,16/04/2020,,,,16/02/2020,http://www.chictr.org.cn/showproj.aspx?proj=49532,16/04/2020,0,0
3333,ChiCTR2000029850,Recruiting,,15/02/2022,,,,15/02/2020,http://www.chictr.org.cn/showproj.aspx?proj=49533,15/02/2022,0,0
3334,ChiCTR2000029849,Recruiting,,01/02/2021,,,,15/02/2020,http://www.chictr.org.cn/showproj.aspx?proj=49530,01/02/2021,0,0
3335,ChiCTR2000029821,Not yet recruiting,,01/06/2020,,,,14/02/2020,http://www.chictr.org.cn/showproj.aspx?proj=49306,01/06/2020,0,0
3336,ChiCTR2000029819,Recruiting,,11/08/2020,,,,14/02/2020,http://www.chictr.org.cn/showproj.aspx?proj=49490,11/08/2020,0,0
3337,ChiCTR2000029814,Recruiting,,31/12/2020,,,,14/02/2020,http://www.chictr.org.cn/showproj.aspx?proj=49387,31/12/2020,0,0
3338,ChiCTR2000029813,Recruiting,,14/08/2020,,,,14/02/2020,http://www.chictr.org.cn/showproj.aspx?proj=49425,14/08/2020,0,0
3339,ChiCTR2000029811,Not yet recruiting,,20/02/2021,,,,15/03/2020,http://www.chictr.org.cn/showproj.aspx?proj=49355,20/02/2021,0,0
3340,ChiCTR2000029806,Recruiting,,31/01/2021,,,,14/02/2020,http://www.chictr.org.cn/showproj.aspx?proj=49161,31/01/2021,0,0
3341,ChiCTR2000029790,Recruiting,,31/10/2020,,,,14/02/2020,http://www.chictr.org.cn/showproj.aspx?proj=49453,31/10/2020,0,0
3342,ChiCTR2000029789,Recruiting,,30/06/2021,,,,16/02/2020,http://www.chictr.org.cn/showproj.aspx?proj=49348,30/06/2021,0,0
3343,ChiCTR2000029788,Not yet recruiting,,30/12/2020,,,,13/02/2020,http://www.chictr.org.cn/showproj.aspx?proj=49452,30/12/2020,0,0
3344,ChiCTR2000029778,Recruiting,,13/05/2020,,,,13/02/2020,http://www.chictr.org.cn/showproj.aspx?proj=49422,13/05/2020,0,0
3345,ChiCTR2000029777,Recruiting,,30/06/2020,,,,13/02/2020,http://www.chictr.org.cn/showproj.aspx?proj=49380,30/06/2020,0,0
3346,ChiCTR2000029776,Recruiting,,31/12/2020,,,,13/02/2020,http://www.chictr.org.cn/showproj.aspx?proj=49342,31/12/2020,0,0
3347,ChiCTR2000029769,Not yet recruiting,,30/04/2020,,,,14/02/2020,http://www.chictr.org.cn/showproj.aspx?proj=49415,30/04/2020,0,0
3348,ChiCTR2000029768,Recruiting,,12/05/2020,,,,13/02/2020,http://www.chictr.org.cn/showproj.aspx?proj=49131,12/05/2020,0,0
3349,ChiCTR2000029765,Recruiting,,10/05/2020,,,,13/02/2020,http://www.chictr.org.cn/showproj.aspx?proj=49409,10/05/2020,0,0
3350,ChiCTR2000029763,Recruiting,,31/05/2020,,,,14/02/2020,http://www.chictr.org.cn/showproj.aspx?proj=49408,31/05/2020,0,0
3351,ChiCTR2000029756,Recruiting,,15/02/2022,,,,12/02/2020,http://www.chictr.org.cn/showproj.aspx?proj=49222,15/02/2022,0,0
3352,ChiCTR2000029747,Recruiting,,10/02/2021,,,,13/02/2020,http://www.chictr.org.cn/showproj.aspx?proj=49287,10/02/2021,0,0
3353,ChiCTR2000029742,Recruiting,,31/12/2020,,,,17/02/2020,http://www.chictr.org.cn/showproj.aspx?proj=49297,31/12/2020,0,0
3354,ChiCTR2000029741,Recruiting,,31/12/2020,,,,13/02/2020,http://www.chictr.org.cn/showproj.aspx?proj=49263,31/12/2020,0,0
3355,ChiCTR2000029739,Recruiting,,31/08/2021,,,,12/02/2020,http://www.chictr.org.cn/showproj.aspx?proj=49283,31/08/2021,0,0
3356,ChiCTR2000029656,Not yet recruiting,,14/04/2020,,,,12/02/2020,http://www.chictr.org.cn/showproj.aspx?proj=49086,14/04/2020,0,0
3357,ChiCTR2000029639,Recruiting,,30/09/2020,,,,12/02/2020,http://www.chictr.org.cn/showproj.aspx?proj=49187,30/09/2020,0,0
3358,ChiCTR2000029636,Recruiting,,30/07/2020,,,,12/02/2020,http://www.chictr.org.cn/showproj.aspx?proj=49215,30/07/2020,0,0
3359,ChiCTR2000029621,Recruiting,,31/12/2020,,,,12/02/2020,http://www.chictr.org.cn/showproj.aspx?proj=49165,31/12/2020,0,0
3360,ChiCTR2000029609,Not yet recruiting,,31/12/2020,,,,12/02/2020,http://www.chictr.org.cn/showproj.aspx?proj=49145,31/12/2020,0,0
3361,ChiCTR2000029606,Recruiting,,31/12/2022,,,,12/02/2020,http://www.chictr.org.cn/showproj.aspx?proj=49146,31/12/2022,0,0
3362,ChiCTR2000029603,Recruiting,,31/05/2020,,,,12/02/2020,http://www.chictr.org.cn/showproj.aspx?proj=49075,31/05/2020,0,0
3363,ChiCTR2000029602,Recruiting,,01/08/2020,,,,12/02/2020,http://www.chictr.org.cn/showproj.aspx?proj=48985,01/08/2020,0,0
3364,ChiCTR2000029601,Recruiting,,01/08/2020,,,,12/02/2020,http://www.chictr.org.cn/showproj.aspx?proj=48988,01/08/2020,0,0
3365,ChiCTR2000029600,Recruiting,,29/04/2020,,,,12/02/2020,http://www.chictr.org.cn/showproj.aspx?proj=49042,29/04/2020,0,0
3366,ChiCTR2000029578,Recruiting,,30/04/2020,,,,12/02/2020,http://www.chictr.org.cn/showproj.aspx?proj=49080,30/04/2020,0,0
3367,ChiCTR2000029559,Recruiting,,29/02/2020,,,,12/02/2020,http://www.chictr.org.cn/showproj.aspx?proj=48880,29/02/2020,0,0
3368,ChiCTR2000029558,Recruiting,,01/05/2020,,,,12/02/2020,http://www.chictr.org.cn/showproj.aspx?proj=48792,01/05/2020,0,0
3369,ChiCTR2000029548,Not yet recruiting,,03/06/2020,,,,12/02/2020,http://www.chictr.org.cn/showproj.aspx?proj=49015,03/06/2020,0,0
3370,ChiCTR2000029544,Not yet recruiting,,31/05/2020,,,,12/02/2020,http://www.chictr.org.cn/showproj.aspx?proj=49013,31/05/2020,0,0
3371,ChiCTR2000029542,Recruiting,,30/07/2020,,,,12/02/2020,http://www.chictr.org.cn/showproj.aspx?proj=48968,30/07/2020,0,0
3372,ChiCTR2000029541,Not yet recruiting,,01/12/2020,,,,12/02/2020,http://www.chictr.org.cn/showproj.aspx?proj=48992,01/12/2020,0,0
3373,ChiCTR2000029539,Recruiting,,02/02/2021,,,,12/02/2020,http://www.chictr.org.cn/showproj.aspx?proj=48991,02/02/2021,0,0
3374,ChiCTR2000029518,Recruiting,,30/04/2020,,,,12/02/2020,http://www.chictr.org.cn/showproj.aspx?proj=48860,30/04/2020,0,0
3375,ChiCTR2000029517,Recruiting,,30/04/2020,,,,12/02/2020,http://www.chictr.org.cn/showproj.aspx?proj=48861,30/04/2020,0,0
3376,ChiCTR2000029495,Not yet recruiting,,31/12/2021,,,,12/02/2020,http://www.chictr.org.cn/showproj.aspx?proj=48971,31/12/2021,0,0
3377,ChiCTR2000029493,Not yet recruiting,,31/12/2021,,,,12/02/2020,http://www.chictr.org.cn/showproj.aspx?proj=48931,31/12/2021,0,0
3378,ChiCTR2000029487,Not yet recruiting,,31/03/2020,,,,12/02/2020,http://www.chictr.org.cn/showproj.aspx?proj=48965,31/03/2020,0,0
3379,ChiCTR2000029468,Not yet recruiting,,30/06/2020,,,,12/02/2020,http://www.chictr.org.cn/showproj.aspx?proj=48919,30/06/2020,0,0
3380,ChiCTR2000029461,Not yet recruiting,,31/12/2021,,,,12/02/2020,http://www.chictr.org.cn/showproj.aspx?proj=48927,31/12/2021,0,0
3381,ChiCTR2000029460,Not yet recruiting,,31/12/2021,,,,12/02/2020,http://www.chictr.org.cn/showproj.aspx?proj=48930,31/12/2021,0,0
3382,ChiCTR2000029459,Not yet recruiting,,31/12/2021,,,,12/02/2020,http://www.chictr.org.cn/showproj.aspx?proj=48929,31/12/2021,0,0
3383,ChiCTR2000029439,Not yet recruiting,,31/12/2021,,,,12/02/2020,http://www.chictr.org.cn/showproj.aspx?proj=48904,31/12/2021,0,0
3384,ChiCTR2000029438,Not yet recruiting,,01/12/2021,,,,12/02/2020,http://www.chictr.org.cn/showproj.aspx?proj=48911,01/12/2021,0,0
3385,ChiCTR2000029436,Not yet recruiting,,31/12/2020,,,,12/02/2020,http://www.chictr.org.cn/showproj.aspx?proj=48884,31/12/2020,0,0
3386,ChiCTR2000029435,Not yet recruiting,,31/03/2020,,,,12/02/2020,http://www.chictr.org.cn/showproj.aspx?proj=48827,31/03/2020,0,0
3387,ChiCTR2000029432,Not yet recruiting,,30/04/2020,,,,12/02/2020,http://www.chictr.org.cn/showproj.aspx?proj=48881,30/04/2020,0,0
3388,ChiCTR2000029431,Recruiting,,31/12/2021,,,,12/02/2020,http://www.chictr.org.cn/showproj.aspx?proj=48907,31/12/2021,0,0
3389,ChiCTR2000029418,Recruiting,,31/08/2020,,,,12/02/2020,http://www.chictr.org.cn/showproj.aspx?proj=48886,31/08/2020,0,0
3390,ChiCTR2000029400,Recruiting,,31/12/2020,,,,12/02/2020,http://www.chictr.org.cn/showproj.aspx?proj=48824,31/12/2020,0,0
3391,ChiCTR2000029381,Completed,,31/12/2020,,,,19/04/2021,http://www.chictr.org.cn/showproj.aspx?proj=48768,31/12/2020,0,0
3392,ChiCTR2000030188,Recruiting,,30/03/2020,,,,17/03/2020,http://www.chictr.org.cn/showproj.aspx?proj=50025,30/03/2020,0,0
3393,ChiCTR2000030179,Recruiting,,24/04/2020,,,,24/02/2020,http://www.chictr.org.cn/showproj.aspx?proj=50059,24/04/2020,0,0
3394,ChiCTR2000030173,Not yet recruiting,,17/04/2020,,,,24/02/2020,http://www.chictr.org.cn/showproj.aspx?proj=49229,17/04/2020,0,0
3395,ChiCTR2000030170,Recruiting,,31/07/2020,,,,24/02/2020,http://www.chictr.org.cn/showproj.aspx?proj=50017,31/07/2020,0,0
3396,ChiCTR2000030167,Not yet recruiting,,01/09/2020,,,,24/02/2020,http://www.chictr.org.cn/showproj.aspx?proj=49567,01/09/2020,0,0
3397,ChiCTR2000030166,Not yet recruiting,,14/05/2020,,,,17/03/2020,http://www.chictr.org.cn/showproj.aspx?proj=49696,14/05/2020,0,0
3398,ChiCTR2000030165,Recruiting,,31/12/2020,,,,24/02/2020,http://www.chictr.org.cn/showproj.aspx?proj=49947,31/12/2020,0,0
3399,ChiCTR2000030138,Not yet recruiting,,31/05/2020,,,,24/02/2020,http://www.chictr.org.cn/showproj.aspx?proj=50004,31/05/2020,0,0
3400,ChiCTR2000030136,Not yet recruiting,,15/05/2020,,,,14/03/2020,http://www.chictr.org.cn/showproj.aspx?proj=50005,15/05/2020,0,0
3401,ChiCTR2000030118,Not yet recruiting,,29/06/2020,,,,17/03/2020,http://www.chictr.org.cn/showproj.aspx?proj=49594,29/06/2020,0,0
3402,ChiCTR2000030117,Recruiting,,14/12/2021,,,,23/02/2020,http://www.chictr.org.cn/showproj.aspx?proj=49762,14/12/2021,0,0
3403,ChiCTR2000030116,Recruiting,,31/08/2020,,,,23/02/2020,http://www.chictr.org.cn/showproj.aspx?proj=49901,31/08/2020,0,0
3404,ChiCTR2000030113,Recruiting,,31/05/2020,,,,24/02/2020,http://www.chictr.org.cn/showproj.aspx?proj=49988,31/05/2020,0,0
3405,ChiCTR2000030102,Recruiting,,31/05/2020,,,,23/02/2020,http://www.chictr.org.cn/showproj.aspx?proj=49747,31/05/2020,0,0
3406,ChiCTR2000030093,Not yet recruiting,,31/03/2021,,,,23/02/2020,http://www.chictr.org.cn/showproj.aspx?proj=49932,31/03/2021,0,0
3407,ChiCTR2000030090,Not yet recruiting,,22/03/2020,,,,23/02/2020,http://www.chictr.org.cn/showproj.aspx?proj=49910,22/03/2020,0,0
3408,ChiCTR2000030089,Not yet recruiting,,31/08/2020,,,,23/02/2020,http://www.chictr.org.cn/showproj.aspx?proj=49889,31/08/2020,0,0
3409,ChiCTR2000030088,Not yet recruiting,,31/12/2021,,,,23/02/2020,http://www.chictr.org.cn/showproj.aspx?proj=49902,31/12/2021,0,0
3410,ChiCTR2000030084,Recruiting,,01/02/2022,,,,22/02/2020,http://www.chictr.org.cn/showproj.aspx?proj=49952,01/02/2022,0,0
3411,ChiCTR2000030058,Not yet recruiting,,30/05/2020,,,,22/02/2020,http://www.chictr.org.cn/showproj.aspx?proj=49831,30/05/2020,0,0
3412,ChiCTR2000030054,Not yet recruiting,,21/05/2020,,,,22/02/2020,http://www.chictr.org.cn/showproj.aspx?proj=49869,21/05/2020,0,0
3413,ChiCTR2000030046,Recruiting,,07/04/2020,,,,21/02/2020,http://www.chictr.org.cn/showproj.aspx?proj=49861,07/04/2020,0,0
3414,ChiCTR2000030043,Not yet recruiting,,31/12/2020,,,,21/02/2020,http://www.chictr.org.cn/showproj.aspx?proj=49866,31/12/2020,0,0
3415,ChiCTR2000030041,Not yet recruiting,,30/06/2020,,,,21/02/2020,http://www.chictr.org.cn/showproj.aspx?proj=49891,30/06/2020,0,0
3416,ChiCTR2000030039,Recruiting,,01/02/2020,,,,21/02/2020,http://www.chictr.org.cn/showproj.aspx?proj=49544,01/02/2020,0,0
3417,ChiCTR2000030034,Recruiting,,30/06/2020,,,,21/02/2020,http://www.chictr.org.cn/showproj.aspx?proj=49647,30/06/2020,0,0
3418,ChiCTR2000030033,Not yet recruiting,,30/06/2020,,,,21/02/2020,http://www.chictr.org.cn/showproj.aspx?proj=49703,30/06/2020,0,0
3419,ChiCTR2000030029,Not yet recruiting,,30/05/2020,,,,21/02/2020,http://www.chictr.org.cn/showproj.aspx?proj=49824,30/05/2020,0,0
3420,ChiCTR2000030027,Recruiting,,18/02/2021,,,,20/02/2020,http://www.chictr.org.cn/showproj.aspx?proj=49852,18/02/2021,0,0
3421,ChiCTR2000030020,Recruiting,,05/02/2022,,,,24/02/2020,http://www.chictr.org.cn/showproj.aspx?proj=49812,05/02/2022,0,0
3422,ChiCTR2000030016,Recruiting,,31/12/2022,,,,20/02/2020,http://www.chictr.org.cn/showproj.aspx?proj=49799,31/12/2022,0,0
3423,ChiCTR2000030012,Not yet recruiting,,,,,,19/02/2020,http://www.chictr.org.cn/showproj.aspx?proj=49718,,0,0
3424,ChiCTR2000030010,Not yet recruiting,,31/05/2020,,,,19/02/2020,http://www.chictr.org.cn/showproj.aspx?proj=49777,31/05/2020,0,0
3425,ChiCTR2000030007,Not yet recruiting,,10/04/2020,,,,28/02/2020,http://www.chictr.org.cn/showproj.aspx?proj=49619,10/04/2020,0,0
3426,ChiCTR2000030006,Recruiting,,19/05/2020,,,,19/02/2020,http://www.chictr.org.cn/showproj.aspx?proj=49737,19/05/2020,0,0
3427,ChiCTR2000030003,Not yet recruiting,,01/07/2020,,,,19/02/2020,http://www.chictr.org.cn/showproj.aspx?proj=49770,01/07/2020,0,0
3428,ChiCTR2000030002,Recruiting,,30/07/2020,,,,24/02/2020,http://www.chictr.org.cn/showproj.aspx?proj=49738,30/07/2020,0,0
3429,ChiCTR2000030001,Recruiting,,28/05/2020,,,,17/06/2020,http://www.chictr.org.cn/showproj.aspx?proj=49723,28/05/2020,0,0
3430,ChiCTR2000030000,Recruiting,,,,,,19/02/2020,http://www.chictr.org.cn/showproj.aspx?proj=49748,,0,0
3431,ChiCTR2000029999,Not yet recruiting,,,,,,19/02/2020,http://www.chictr.org.cn/showproj.aspx?proj=49717,,0,0
3432,ChiCTR2000029996,Recruiting,,20/04/2020,,,,21/02/2020,http://www.chictr.org.cn/showproj.aspx?proj=49510,20/04/2020,0,0
3433,ChiCTR2000029994,Not yet recruiting,,19/08/2020,,,,19/02/2020,http://www.chictr.org.cn/showproj.aspx?proj=49309,19/08/2020,0,0
3434,ChiCTR2000029992,Not yet recruiting,,20/05/2020,,,,19/02/2020,http://www.chictr.org.cn/showproj.aspx?proj=49574,20/05/2020,0,0
3435,ChiCTR2000029990,Recruiting,,31/03/2020,,,,18/02/2020,http://www.chictr.org.cn/showproj.aspx?proj=49674,31/03/2020,0,0
3436,ChiCTR2000029989,Not yet recruiting,,31/05/2020,,,,18/02/2020,http://www.chictr.org.cn/showproj.aspx?proj=49720,31/05/2020,0,0
3437,ChiCTR2000029988,Recruiting,,31/05/2020,,,,18/02/2020,http://www.chictr.org.cn/showproj.aspx?proj=49218,31/05/2020,0,0
3438,ChiCTR2000029978,Not yet recruiting,,31/07/2020,,,,17/03/2020,http://www.chictr.org.cn/showproj.aspx?proj=49702,31/07/2020,0,0
3439,ChiCTR2000029974,Recruiting,,31/08/2020,,,,18/02/2020,http://www.chictr.org.cn/showproj.aspx?proj=49321,31/08/2020,0,0
3440,ChiCTR2000029972,Recruiting,,17/05/2020,,,,17/02/2020,http://www.chictr.org.cn/showproj.aspx?proj=49664,17/05/2020,0,0
3441,ChiCTR2000029960,Not yet recruiting,,31/05/2020,,,,17/02/2020,http://www.chictr.org.cn/showproj.aspx?proj=49639,31/05/2020,0,0
3442,ChiCTR2000029956,Not yet recruiting,,01/07/2020,,,,17/03/2020,http://www.chictr.org.cn/showproj.aspx?proj=49618,01/07/2020,0,0
3443,ChiCTR2000029954,Recruiting,,10/02/2020,,,,17/02/2020,http://www.chictr.org.cn/showproj.aspx?proj=49402,10/02/2020,0,0
3444,ChiCTR2000029851,Recruiting,,10/03/2020,,,,24/02/2020,http://www.chictr.org.cn/showproj.aspx?proj=49534,10/03/2020,0,0
3445,ChiCTR2000029803,Suspending,,20/02/2021,,,,30/12/2020,http://www.chictr.org.cn/showproj.aspx?proj=49428,20/02/2021,0,0
3446,ChiCTR2000029781,Recruiting,,30/06/2020,,,,18/02/2020,http://www.chictr.org.cn/showproj.aspx?proj=49138,30/06/2020,0,0
3447,ChiCTR2000029780,Recruiting,,09/06/2020,,,,18/02/2020,http://www.chictr.org.cn/showproj.aspx?proj=49220,09/06/2020,0,0
3448,ChiCTR2000029740,Recruiting,,29/02/2020,,,,24/02/2020,http://www.chictr.org.cn/showproj.aspx?proj=49317,29/02/2020,0,0
3449,ChiCTR2000030442,Not yet recruiting,,15/05/2020,,,,14/03/2020,http://www.chictr.org.cn/showproj.aspx?proj=50380,15/05/2020,0,0
3450,ChiCTR2000030433,Not yet recruiting,,01/10/2020,,,,03/03/2020,http://www.chictr.org.cn/showproj.aspx?proj=50273,01/10/2020,0,0
3451,ChiCTR2000030432,Not yet recruiting,,27/08/2020,,,,01/03/2020,http://www.chictr.org.cn/showproj.aspx?proj=50268,27/08/2020,0,0
3452,ChiCTR2000030424,Not yet recruiting,,02/05/2022,,,,01/03/2020,http://www.chictr.org.cn/showproj.aspx?proj=50174,02/05/2022,0,0
3453,ChiCTR2000030420,Not yet recruiting,,31/08/2020,,,,20/03/2020,http://www.chictr.org.cn/showproj.aspx?proj=50286,31/08/2020,0,0
3454,ChiCTR2000030418,Recruiting,,01/03/2021,,,,03/03/2020,http://www.chictr.org.cn/showproj.aspx?proj=50341,01/03/2021,0,0
3455,ChiCTR2000030398,Not yet recruiting,,,,,,01/03/2020,http://www.chictr.org.cn/showproj.aspx?proj=50173,,0,0
3456,ChiCTR2000030386,Not yet recruiting,,31/12/2020,,,,01/03/2020,http://www.chictr.org.cn/showproj.aspx?proj=50323,31/12/2020,0,0
3457,ChiCTR2000030333,Recruiting,,07/07/2020,,,,29/02/2020,http://www.chictr.org.cn/showproj.aspx?proj=48801,07/07/2020,0,0
3458,ChiCTR2000030324,Not yet recruiting,,28/05/2020,,,,28/02/2020,http://www.chictr.org.cn/showproj.aspx?proj=50231,28/05/2020,0,0
3459,ChiCTR2000030317,Not yet recruiting,,30/03/2021,,,,28/02/2020,http://www.chictr.org.cn/showproj.aspx?proj=50247,30/03/2021,0,0
3460,ChiCTR2000030314,Not yet recruiting,,28/04/2020,,,,28/02/2020,http://www.chictr.org.cn/showproj.aspx?proj=50248,28/04/2020,0,0
3461,ChiCTR2000030265,Not yet recruiting,,23/02/2021,,,,27/02/2020,http://www.chictr.org.cn/showproj.aspx?proj=49691,23/02/2021,0,0
3462,ChiCTR2000030261,Not yet recruiting,,31/05/2020,,,,26/02/2020,http://www.chictr.org.cn/showproj.aspx?proj=49963,31/05/2020,0,0
3463,ChiCTR2000030260,Not yet recruiting,,26/02/2021,,,,26/02/2020,http://www.chictr.org.cn/showproj.aspx?proj=50130,26/02/2021,0,0
3464,ChiCTR2000030258,Not yet recruiting,,20/08/2020,,,,26/02/2020,http://www.chictr.org.cn/showproj.aspx?proj=49887,20/08/2020,0,0
3465,ChiCTR2000030255,Not yet recruiting,,31/07/2020,,,,26/02/2020,http://www.chictr.org.cn/showproj.aspx?proj=50089,31/07/2020,0,0
3466,ChiCTR2000030225,Not yet recruiting,,31/12/2020,,,,26/02/2020,http://www.chictr.org.cn/showproj.aspx?proj=49945,31/12/2020,0,0
3467,ChiCTR2000030219,Recruiting,,31/12/2020,,,,29/02/2020,http://www.chictr.org.cn/showproj.aspx?proj=50110,31/12/2020,0,0
3468,ChiCTR2000030218,Recruiting,,25/06/2020,,,,26/02/2020,http://www.chictr.org.cn/showproj.aspx?proj=50115,25/06/2020,0,0
3469,ChiCTR2000030215,Not yet recruiting,,31/12/2020,,,,17/03/2020,http://www.chictr.org.cn/showproj.aspx?proj=50107,31/12/2020,0,0
3470,ChiCTR2000030196,Not yet recruiting,,31/05/2020,,,,25/02/2020,http://www.chictr.org.cn/showproj.aspx?proj=49883,31/05/2020,0,0
3471,ChiCTR2000030091,Not yet recruiting,,22/03/2020,,,,27/02/2020,http://www.chictr.org.cn/showproj.aspx?proj=49914,22/03/2020,0,0
3472,ChiCTR2000030022,Not yet recruiting,,22/05/2020,,,,01/03/2020,http://www.chictr.org.cn/showproj.aspx?proj=49797,22/05/2020,0,0
3473,ChiCTR2000030013,Not yet recruiting,,30/06/2020,,,,01/03/2020,http://www.chictr.org.cn/showproj.aspx?proj=49796,30/06/2020,0,0
3474,ChiCTR2000029991,Recruiting,,18/07/2020,,,,16/03/2020,http://www.chictr.org.cn/showproj.aspx?proj=49666,18/07/2020,0,0
3475,ChiCTR2000029975,Not yet recruiting,,31/05/2020,,,,02/03/2020,http://www.chictr.org.cn/showproj.aspx?proj=49592,31/05/2020,0,0
3476,ChiCTR2000029899,Recruiting,,30/04/2020,,,,01/03/2020,http://www.chictr.org.cn/showproj.aspx?proj=49536,30/04/2020,0,0
3477,ChiCTR2000029898,Recruiting,,30/04/2020,,,,02/03/2020,http://www.chictr.org.cn/showproj.aspx?proj=49482,30/04/2020,0,0
3478,ChiCTR2000029755,Recruiting,,30/05/2020,,,,02/03/2020,http://www.chictr.org.cn/showproj.aspx?proj=49301,30/05/2020,0,0
3479,ChiCTR2000029387,Recruiting,,25/01/2021,,,,02/03/2020,http://www.chictr.org.cn/showproj.aspx?proj=48782,25/01/2021,0,0
3480,ChiCTR2000029386,Recruiting,,29/01/2021,,,,02/03/2020,http://www.chictr.org.cn/showproj.aspx?proj=48777,29/01/2021,0,0
3481,ChiCTR2000030627,Recruiting,,30/05/2020,,,,08/03/2020,http://www.chictr.org.cn/showproj.aspx?proj=50727,30/05/2020,0,0
3482,ChiCTR2000030578,Not yet recruiting,,01/02/2021,,,,08/03/2020,http://www.chictr.org.cn/showproj.aspx?proj=50690,01/02/2021,0,0
3483,ChiCTR2000030540,Not yet recruiting,,08/06/2020,,,,07/03/2020,http://www.chictr.org.cn/showproj.aspx?proj=50658,08/06/2020,0,0
3484,ChiCTR2000030535,Recruiting,,30/03/2020,,,,06/03/2020,http://www.chictr.org.cn/showproj.aspx?proj=49790,30/03/2020,0,0
3485,ChiCTR2000030518,Recruiting,,31/05/2020,,,,05/03/2020,http://www.chictr.org.cn/showproj.aspx?proj=50586,31/05/2020,0,0
3486,ChiCTR2000030503,Recruiting,,30/06/2022,,,,05/03/2020,http://www.chictr.org.cn/showproj.aspx?proj=49632,30/06/2022,0,0
3487,ChiCTR2000030490,Recruiting,,31/03/2020,,,,04/03/2020,http://www.chictr.org.cn/showproj.aspx?proj=50487,31/03/2020,0,0
3488,ChiCTR2000030487,Recruiting,,04/05/2020,,,,04/03/2020,http://www.chictr.org.cn/showproj.aspx?proj=50507,04/05/2020,0,0
3489,ChiCTR2000030484,Not yet recruiting,,31/01/2021,,,,03/03/2020,http://www.chictr.org.cn/showproj.aspx?proj=50263,31/01/2021,0,0
3490,ChiCTR2000030481,Recruiting,,30/04/2020,,,,03/03/2020,http://www.chictr.org.cn/showproj.aspx?proj=50453,30/04/2020,0,0
3491,ChiCTR2000030480,Recruiting,,03/07/2020,,,,03/03/2020,http://www.chictr.org.cn/showproj.aspx?proj=50470,03/07/2020,0,0
3492,ChiCTR2000030479,Not yet recruiting,,25/02/2021,,,,16/03/2020,http://www.chictr.org.cn/showproj.aspx?proj=50450,25/02/2021,0,0
3493,ChiCTR2000030477,Not yet recruiting,,25/06/2020,,,,03/03/2020,http://www.chictr.org.cn/showproj.aspx?proj=50458,25/06/2020,0,0
3494,ChiCTR2000030475,Not yet recruiting,,25/06/2020,,,,03/03/2020,http://www.chictr.org.cn/showproj.aspx?proj=50452,25/06/2020,0,0
3495,ChiCTR2000030472,Recruiting,,30/06/2020,,,,03/03/2020,http://www.chictr.org.cn/showproj.aspx?proj=49753,30/06/2020,0,0
3496,ChiCTR2000030471,Recruiting,,30/04/2020,,,,08/03/2020,http://www.chictr.org.cn/showproj.aspx?proj=50421,30/04/2020,0,0
3497,ChiCTR2000030469,Recruiting,,27/05/2020,,,,17/03/2020,http://www.chictr.org.cn/showproj.aspx?proj=50082,27/05/2020,0,0
3498,ChiCTR2000030467,Not yet recruiting,,31/08/2020,,,,02/03/2020,http://www.chictr.org.cn/showproj.aspx?proj=50378,31/08/2020,0,0
3499,ChiCTR2000029993,Recruiting,,20/08/2020,,,,09/03/2020,http://www.chictr.org.cn/showproj.aspx?proj=49435,20/08/2020,0,0
3500,ChiCTR2000029757,Recruiting,,05/02/2021,,,,09/03/2020,http://www.chictr.org.cn/showproj.aspx?proj=49081,05/02/2021,0,0
3501,ChiCTR2000029580,Recruiting,,31/12/2020,,,,09/03/2020,http://www.chictr.org.cn/showproj.aspx?proj=49088,31/12/2020,0,0
3502,ChiCTR2000029550,Recruiting,,01/05/2020,,,,09/03/2020,http://www.chictr.org.cn/showproj.aspx?proj=48775,01/05/2020,0,0
3503,ChiCTR2000029549,Recruiting,,01/05/2020,,,,09/03/2020,http://www.chictr.org.cn/showproj.aspx?proj=49014,01/05/2020,0,0
3504,ChiCTR2000029308,Recruiting,,10/01/2021,,,,09/03/2020,http://www.chictr.org.cn/showproj.aspx?proj=48684,10/01/2021,0,0
3505,ChiCTR2000030897,Recruiting,,01/05/2021,,,,16/03/2020,http://www.chictr.org.cn/showproj.aspx?proj=50462,01/05/2021,0,0
3506,ChiCTR2000030896,Recruiting,,30/03/2021,,,,16/03/2020,http://www.chictr.org.cn/showproj.aspx?proj=51028,30/03/2021,0,0
3507,ChiCTR2000030894,Recruiting,,31/05/2020,,,,16/03/2020,http://www.chictr.org.cn/showproj.aspx?proj=51126,31/05/2020,0,0
3508,ChiCTR2000030892,Recruiting,,30/12/2020,,,,16/03/2020,http://www.chictr.org.cn/showproj.aspx?proj=51118,30/12/2020,0,0
3509,ChiCTR2000030864,Recruiting,,31/07/2020,,,,16/03/2020,http://www.chictr.org.cn/showproj.aspx?proj=50662,31/07/2020,0,0
3510,ChiCTR2000030855,Not yet recruiting,,01/05/2020,,,,16/03/2020,http://www.chictr.org.cn/showproj.aspx?proj=51090,01/05/2020,0,0
3511,ChiCTR2000030853,Not yet recruiting,,31/05/2020,,,,16/03/2020,http://www.chictr.org.cn/showproj.aspx?proj=51081,31/05/2020,0,0
3512,ChiCTR2000030849,Not yet recruiting,,01/03/2021,,,,15/03/2020,http://www.chictr.org.cn/showproj.aspx?proj=51086,01/03/2021,0,0
3513,ChiCTR2000030841,Recruiting,,31/05/2020,,,,16/03/2020,http://www.chictr.org.cn/showproj.aspx?proj=51072,31/05/2020,0,0
3514,ChiCTR2000030836,Not yet recruiting,,30/06/2020,,,,16/03/2020,http://www.chictr.org.cn/showproj.aspx?proj=51054,30/06/2020,0,0
3515,ChiCTR2000030835,Recruiting,,14/02/2021,,,,15/03/2020,http://www.chictr.org.cn/showproj.aspx?proj=51050,14/02/2021,0,0
3516,ChiCTR2000030832,Not yet recruiting,,30/07/2020,,,,15/03/2020,http://www.chictr.org.cn/showproj.aspx?proj=51044,30/07/2020,0,0
3517,ChiCTR2000030810,Recruiting,,30/03/2020,,,,16/03/2020,http://www.chictr.org.cn/showproj.aspx?proj=50986,30/03/2020,0,0
3518,ChiCTR2000030804,Recruiting,,31/03/2021,,,,16/03/2020,http://www.chictr.org.cn/showproj.aspx?proj=51018,31/03/2021,0,0
3519,ChiCTR2000030779,Recruiting,,31/05/2020,,,,14/03/2020,http://www.chictr.org.cn/showproj.aspx?proj=50973,31/05/2020,0,0
3520,ChiCTR2000030773,Recruiting,,12/07/2020,,,,14/03/2020,http://www.chictr.org.cn/showproj.aspx?proj=50934,12/07/2020,0,0
3521,ChiCTR2000030761,Not yet recruiting,,01/04/2020,,,,14/03/2020,http://www.chictr.org.cn/showproj.aspx?proj=50956,01/04/2020,0,0
3522,ChiCTR2000030759,Not yet recruiting,,17/05/2020,,,,16/03/2020,http://www.chictr.org.cn/showproj.aspx?proj=49284,17/05/2020,0,0
3523,ChiCTR2000030751,Not yet recruiting,,25/12/2020,,,,13/03/2020,http://www.chictr.org.cn/showproj.aspx?proj=50941,25/12/2020,0,0
3524,ChiCTR2000030744,Recruiting,,31/08/2020,,,,13/03/2020,http://www.chictr.org.cn/showproj.aspx?proj=50910,31/08/2020,0,0
3525,ChiCTR2000030720,Recruiting,,31/08/2020,,,,12/03/2020,http://www.chictr.org.cn/showproj.aspx?proj=50793,31/08/2020,0,0
3526,ChiCTR2000030718,Recruiting,,30/05/2020,,,,12/03/2020,http://www.chictr.org.cn/showproj.aspx?proj=50843,30/05/2020,0,0
3527,ChiCTR2000030703,Recruiting,,31/05/2020,,,,16/03/2020,http://www.chictr.org.cn/showproj.aspx?proj=50251,31/05/2020,0,0
3528,ChiCTR2000030702,Recruiting,,15/08/2020,,,,10/03/2020,http://www.chictr.org.cn/showproj.aspx?proj=50537,15/08/2020,0,0
3529,ChiCTR2000030701,Not yet recruiting,,30/09/2020,,,,10/03/2020,http://www.chictr.org.cn/showproj.aspx?proj=50795,30/09/2020,0,0
3530,ChiCTR2000030700,Not yet recruiting,,30/09/2020,,,,10/03/2020,http://www.chictr.org.cn/showproj.aspx?proj=50786,30/09/2020,0,0
3531,ChiCTR2000030681,Not yet recruiting,,16/11/2021,,,,09/03/2020,http://www.chictr.org.cn/showproj.aspx?proj=50763,16/11/2021,0,0
3532,ChiCTR2000030580,Recruiting,,30/04/2020,,,,15/03/2020,http://www.chictr.org.cn/showproj.aspx?proj=50693,30/04/2020,0,0
3533,ChiCTR2000030545,Recruiting,,30/04/2020,,,,16/03/2020,http://www.chictr.org.cn/showproj.aspx?proj=50126,30/04/2020,0,0
3534,ChiCTR2000030476,Recruiting,,01/07/2020,,,,09/07/2020,http://www.chictr.org.cn/showproj.aspx?proj=50455,01/07/2020,0,0
3535,ChiCTR2000030187,Recruiting,,25/03/2020,,,,16/03/2020,http://www.chictr.org.cn/showproj.aspx?proj=50057,25/03/2020,0,0
3536,ChiCTR2000031139,Recruiting,,19/03/2021,,,,23/03/2020,http://www.chictr.org.cn/showproj.aspx?proj=51404,19/03/2021,0,0
3537,ChiCTR2000031138,Recruiting,,31/12/2020,,,,23/03/2020,http://www.chictr.org.cn/showproj.aspx?proj=51416,31/12/2020,0,0
3538,ChiCTR2000031090,Not yet recruiting,,23/03/2022,,,,22/03/2020,http://www.chictr.org.cn/showproj.aspx?proj=51148,23/03/2022,0,0
3539,ChiCTR2000031089,Not yet recruiting,,30/04/2020,,,,22/03/2020,http://www.chictr.org.cn/showproj.aspx?proj=51136,30/04/2020,0,0
3540,ChiCTR2000031023,Recruiting,,16/05/2020,,,,21/03/2020,http://www.chictr.org.cn/showproj.aspx?proj=50984,16/05/2020,0,0
3541,ChiCTR2000030996,Recruiting,,26/10/2020,,,,20/03/2020,http://www.chictr.org.cn/showproj.aspx?proj=51349,26/10/2020,0,0
3542,ChiCTR2000030989,Not yet recruiting,,08/08/2020,,,,20/03/2020,http://www.chictr.org.cn/showproj.aspx?proj=51331,08/08/2020,0,0
3543,ChiCTR2000030987,Recruiting,,25/06/2020,,,,20/03/2020,http://www.chictr.org.cn/showproj.aspx?proj=51329,25/06/2020,0,0
3544,ChiCTR2000030946,Recruiting,,10/04/2020,,,,19/03/2020,http://www.chictr.org.cn/showproj.aspx?proj=51265,10/04/2020,0,0
3545,ChiCTR2000030944,Not yet recruiting,,31/08/2020,,,,19/03/2020,http://www.chictr.org.cn/showproj.aspx?proj=50199,31/08/2020,0,0
3546,ChiCTR2000030939,Recruiting,,01/10/2020,,,,18/03/2020,http://www.chictr.org.cn/showproj.aspx?proj=51059,01/10/2020,0,0
3547,ChiCTR2000030933,Not yet recruiting,,31/12/2020,,,,18/03/2020,http://www.chictr.org.cn/showproj.aspx?proj=51184,31/12/2020,0,0
3548,ChiCTR2000030929,Not yet recruiting,,16/06/2020,,,,18/03/2020,http://www.chictr.org.cn/showproj.aspx?proj=50696,16/06/2020,0,0
3549,ChiCTR2000030922,Recruiting,,26/08/2020,,,,17/03/2020,http://www.chictr.org.cn/showproj.aspx?proj=51141,26/08/2020,0,0
3550,ChiCTR2000030920,Recruiting,,01/05/2021,,,,23/03/2020,http://www.chictr.org.cn/showproj.aspx?proj=50476,01/05/2021,0,0
3551,ChiCTR2000030906,Recruiting,,31/12/2020,,,,18/03/2020,http://www.chictr.org.cn/showproj.aspx?proj=51154,31/12/2020,0,0
3552,ChiCTR2000030539,Not yet recruiting,,05/03/2021,,,,20/03/2020,http://www.chictr.org.cn/showproj.aspx?proj=50660,05/03/2021,0,0
3553,ChiCTR2000030254,Completed,,20/03/2020,,,,23/03/2020,http://www.chictr.org.cn/showproj.aspx?proj=50137,20/03/2020,0,0
3554,ChiCTR2000029868,Completed,,30/06/2020,,,,22/03/2020,http://www.chictr.org.cn/showproj.aspx?proj=49524,30/06/2020,0,0
3555,ChiCTR2000029658,Suspending,,06/04/2020,,,,17/03/2020,http://www.chictr.org.cn/showproj.aspx?proj=49074,06/04/2020,0,0
3556,ChiCTR2000029573,Recruiting,,30/06/2020,,,,22/03/2020,http://www.chictr.org.cn/showproj.aspx?proj=49065,30/06/2020,0,0
3557,ChiCTR2000029496,Recruiting,,29/01/2021,,,,22/03/2020,http://www.chictr.org.cn/showproj.aspx?proj=48809,29/01/2021,0,0
3558,ChiCTR2000031328,Recruiting,,30/04/2020,,,,27/03/2020,http://www.chictr.org.cn/showproj.aspx?proj=51425,30/04/2020,0,0
3559,ChiCTR2000031319,Not yet recruiting,,31/07/2020,,,,27/03/2020,http://www.chictr.org.cn/showproj.aspx?proj=51647,31/07/2020,0,0
3560,ChiCTR2000031272,Completed,,02/03/2020,,,,26/03/2020,http://www.chictr.org.cn/showproj.aspx?proj=51455,02/03/2020,0,0
3561,ChiCTR2000031271,Not yet recruiting,,31/03/2021,,,,26/03/2020,http://www.chictr.org.cn/showproj.aspx?proj=51194,31/03/2021,0,0
3562,ChiCTR2000031204,Recruiting,,30/04/2020,,,,24/03/2020,http://www.chictr.org.cn/showproj.aspx?proj=49420,30/04/2020,0,0
3563,ChiCTR2000031203,Recruiting,,28/02/2022,,,,30/03/2020,http://www.chictr.org.cn/showproj.aspx?proj=51030,28/02/2022,0,0
3564,ChiCTR2000031196,Recruiting,,31/12/2020,,,,23/03/2020,http://www.chictr.org.cn/showproj.aspx?proj=51112,31/12/2020,0,0
3565,ChiCTR2000030988,Not yet recruiting,,31/05/2020,,,,23/03/2020,http://www.chictr.org.cn/showproj.aspx?proj=51317,31/05/2020,0,0
3566,ChiCTR2000030940,Not yet recruiting,,30/06/2020,,,,23/03/2020,http://www.chictr.org.cn/showproj.aspx?proj=51061,30/06/2020,0,0
3567,ChiCTR2000030937,Recruiting,,30/08/2020,,,,23/03/2020,http://www.chictr.org.cn/showproj.aspx?proj=51240,30/08/2020,0,0
3568,ChiCTR2000030936,Recruiting,,10/05/2020,,,,23/03/2020,http://www.chictr.org.cn/showproj.aspx?proj=51100,10/05/2020,0,0
3569,ChiCTR2000030923,Recruiting,,16/04/2020,,,,23/03/2020,http://www.chictr.org.cn/showproj.aspx?proj=51139,16/04/2020,0,0
3570,ChiCTR2000030704,Suspending,,10/03/2020,,,,26/03/2020,http://www.chictr.org.cn/showproj.aspx?proj=50778,10/03/2020,0,0
3571,ChiCTR2000030288,Recruiting,,31/12/2020,,,,27/02/2020,http://www.chictr.org.cn/showproj.aspx?proj=50202,31/12/2020,0,0
3572,ChiCTR2000030198,Not yet recruiting,,24/08/2020,,,,27/03/2020,http://www.chictr.org.cn/showproj.aspx?proj=50066,24/08/2020,0,0
3573,ChiCTR2000030028,Not yet recruiting,,31/08/2020,,,,24/03/2020,http://www.chictr.org.cn/showproj.aspx?proj=49840,31/08/2020,0,0
3574,ChiCTR2000031639,Not yet recruiting,,27/03/2021,,,,05/04/2020,http://www.chictr.org.cn/showproj.aspx?proj=51119,27/03/2021,0,0
3575,ChiCTR2000031630,Recruiting,,17/06/2020,,,,05/04/2020,http://www.chictr.org.cn/showproj.aspx?proj=50474,17/06/2020,0,0
3576,ChiCTR2000031540,Recruiting,,05/12/2020,,,,04/04/2020,http://www.chictr.org.cn/showproj.aspx?proj=51684,05/12/2020,0,0
3577,ChiCTR2000031503,Not yet recruiting,,31/10/2022,,,,03/04/2020,http://www.chictr.org.cn/showproj.aspx?proj=51911,31/10/2022,0,0
3578,ChiCTR2000031494,Recruiting,,02/12/2020,,,,02/04/2020,http://www.chictr.org.cn/showproj.aspx?proj=51904,02/12/2020,0,0
3579,ChiCTR2000031454,Recruiting,,31/07/2021,,,,01/04/2020,http://www.chictr.org.cn/showproj.aspx?proj=51693,31/07/2021,0,0
3580,ChiCTR2000031453,Not yet recruiting,,01/08/2020,,,,01/04/2020,http://www.chictr.org.cn/showproj.aspx?proj=51859,01/08/2020,0,0
3581,ChiCTR2000031430,Recruiting,,31/12/2021,,,,31/03/2020,http://www.chictr.org.cn/showproj.aspx?proj=49254,31/12/2021,0,0
3582,ChiCTR2000031834,Not yet recruiting,,20/10/2020,,,,11/04/2020,http://www.chictr.org.cn/showproj.aspx?proj=52216,20/10/2020,0,0
3583,ChiCTR2000031781,Not yet recruiting,,31/01/2021,,,,10/04/2020,http://www.chictr.org.cn/showproj.aspx?proj=52006,31/01/2021,0,0
3584,ChiCTR2000031772,Recruiting,,31/10/2020,,,,09/04/2020,http://www.chictr.org.cn/showproj.aspx?proj=52165,31/10/2020,0,0
3585,ChiCTR2000031735,Not yet recruiting,,28/02/2021,,,,08/04/2020,http://www.chictr.org.cn/showproj.aspx?proj=50613,28/02/2021,0,0
3586,ChiCTR2000030750,Not yet recruiting,,28/02/2021,,,,12/04/2020,http://www.chictr.org.cn/showproj.aspx?proj=50928,28/02/2021,0,0
3587,ChiCTR2000032098,Recruiting,,31/07/2020,,,,20/04/2020,http://www.chictr.org.cn/showproj.aspx?proj=52477,31/07/2020,0,0
3588,ChiCTR2000032013,Completed,,30/06/2020,,,,17/04/2020,http://www.chictr.org.cn/showproj.aspx?proj=52483,30/06/2020,0,0
3589,ChiCTR2000032011,Not yet recruiting,,17/05/2020,,,,17/04/2020,http://www.chictr.org.cn/showproj.aspx?proj=52142,17/05/2020,0,0
3590,ChiCTR2000031944,Recruiting,,31/12/2020,,,,15/04/2020,http://www.chictr.org.cn/showproj.aspx?proj=52414,31/12/2020,0,0
3591,ChiCTR2000031888,Recruiting,,30/11/2020,,,,13/04/2020,http://www.chictr.org.cn/showproj.aspx?proj=52106,30/11/2020,0,0
3592,ChiCTR2000029976,Recruiting,,19/02/2022,,,,19/04/2020,http://www.chictr.org.cn/showproj.aspx?proj=49631,19/02/2022,0,0
3593,ChiCTR2000029434,Completed,,01/12/2020,,,,17/04/2020,http://www.chictr.org.cn/showproj.aspx?proj=48889,01/12/2020,0,0
3594,ChiCTR2000029433,Completed,,01/12/2020,,,,17/04/2020,http://www.chictr.org.cn/showproj.aspx?proj=48898,01/12/2020,0,0
3595,ChiCTR2000032400,Recruiting,,01/06/2020,,,,27/04/2020,http://www.chictr.org.cn/showproj.aspx?proj=52958,01/06/2020,0,0
3596,ChiCTR2000032399,Recruiting,,01/07/2020,,,,27/04/2020,http://www.chictr.org.cn/showproj.aspx?proj=52942,01/07/2020,0,0
3597,ChiCTR2000032367,Recruiting,,31/07/2020,,,,09/07/2020,http://www.chictr.org.cn/showproj.aspx?proj=52972,31/07/2020,0,0
3598,ChiCTR2000032346,Recruiting,,31/12/2020,,,,26/04/2020,http://www.chictr.org.cn/showproj.aspx?proj=52692,31/12/2020,0,0
3599,ChiCTR2000032314,Recruiting,,31/12/2020,,,,25/04/2020,http://www.chictr.org.cn/showproj.aspx?proj=52867,31/12/2020,0,0
3600,ChiCTR2000032313,Not yet recruiting,,31/12/2020,,,,26/04/2020,http://www.chictr.org.cn/showproj.aspx?proj=52916,31/12/2020,0,0
3601,ChiCTR2000032242,Not yet recruiting,,01/05/2021,,,,24/04/2020,http://www.chictr.org.cn/showproj.aspx?proj=52824,01/05/2021,0,0
3602,ChiCTR2000032237,Recruiting,,30/06/2020,,,,23/04/2020,http://www.chictr.org.cn/showproj.aspx?proj=52699,30/06/2020,0,0
3603,ChiCTR2000032214,Not yet recruiting,,10/07/2020,,,,23/04/2020,http://www.chictr.org.cn/showproj.aspx?proj=52781,10/07/2020,0,0
3604,ChiCTR2000032205,Not yet recruiting,,15/07/2020,,,,23/04/2020,http://www.chictr.org.cn/showproj.aspx?proj=52662,15/07/2020,0,0
3605,ChiCTR2000032632,Recruiting,,22/05/2020,,,,04/05/2020,http://www.chictr.org.cn/showproj.aspx?proj=53190,22/05/2020,0,0
3606,ChiCTR2000032487,Not yet recruiting,,30/09/2020,,,,29/04/2020,http://www.chictr.org.cn/showproj.aspx?proj=52394,30/09/2020,0,0
3607,ChiCTR2000032456,Completed,,01/05/2020,,,,04/05/2020,http://www.chictr.org.cn/showproj.aspx?proj=53048,01/05/2020,0,0
3608,ChiCTR2000032455,Recruiting,,31/12/2021,,,,04/05/2020,http://www.chictr.org.cn/showproj.aspx?proj=53050,31/12/2021,0,0
3609,ChiCTR2000032135,Not yet recruiting,,31/12/2020,,,,27/04/2020,http://www.chictr.org.cn/showproj.aspx?proj=52506,31/12/2020,0,0
3610,ChiCTR2000031174,Not yet recruiting,,30/09/2020,,,,04/05/2020,http://www.chictr.org.cn/showproj.aspx?proj=51437,30/09/2020,0,0
3611,ChiCTR2000032769,Recruiting,,,,,,09/05/2020,http://www.chictr.org.cn/showproj.aspx?proj=53368,,0,0
3612,ChiCTR2000032737,Not yet recruiting,,08/06/2021,,,,08/05/2020,http://www.chictr.org.cn/showproj.aspx?proj=53458,08/06/2021,0,0
3613,ChiCTR2000032717,Completed,,31/01/2021,,,,10/05/2020,http://www.chictr.org.cn/showproj.aspx?proj=53322,31/01/2021,0,0
3614,ChiCTR2000032716,Completed,,30/04/2020,,,,08/05/2020,http://www.chictr.org.cn/showproj.aspx?proj=53389,30/04/2020,0,0
3615,ChiCTR2000032635,Not yet recruiting,,31/03/2021,,,,10/05/2020,http://www.chictr.org.cn/showproj.aspx?proj=52671,31/03/2021,0,0
3616,ChiCTR2000033003,Not yet recruiting,,30/04/2022,,,,17/05/2020,http://www.chictr.org.cn/showproj.aspx?proj=53790,30/04/2022,0,0
3617,ChiCTR2000032919,Recruiting,,08/05/2021,,,,09/07/2020,http://www.chictr.org.cn/showproj.aspx?proj=53274,08/05/2021,0,0
3618,ChiCTR2000032915,Recruiting,,31/12/2020,,,,15/05/2020,http://www.chictr.org.cn/showproj.aspx?proj=53658,31/12/2020,0,0
3619,ChiCTR2000030262,Recruiting,,31/12/2020,,,,16/05/2020,http://www.chictr.org.cn/showproj.aspx?proj=50136,31/12/2020,0,0
3620,ChiCTR2000029638,Recruiting,,01/08/2020,,,,16/05/2020,http://www.chictr.org.cn/showproj.aspx?proj=49224,01/08/2020,0,0
3621,ChiCTR2000029605,Recruiting,,05/02/2021,,,,15/05/2020,http://www.chictr.org.cn/showproj.aspx?proj=49051,05/02/2021,0,0
3622,ChiCTR2000033133,Completed,,20/04/2020,,,,25/05/2020,http://www.chictr.org.cn/showproj.aspx?proj=53925,20/04/2020,0,0
3623,ChiCTR2000033057,Recruiting,,01/09/2020,,,,19/05/2020,http://www.chictr.org.cn/showproj.aspx?proj=53529,01/09/2020,0,0
3624,ChiCTR2000033056,Completed,,30/04/2020,,,,19/05/2020,http://www.chictr.org.cn/showproj.aspx?proj=53859,30/04/2020,0,0
3625,ChiCTR2000033049,Recruiting,,31/12/2020,,,,25/05/2020,http://www.chictr.org.cn/showproj.aspx?proj=53840,31/12/2020,0,0
3626,ChiCTR2000033433,Not yet recruiting,,01/04/2022,,,,31/05/2020,http://www.chictr.org.cn/showproj.aspx?proj=54482,01/04/2022,0,0
3627,ChiCTR2000033372,Completed,,17/05/2020,,,,29/05/2020,http://www.chictr.org.cn/showproj.aspx?proj=54408,17/05/2020,0,0
3628,ChiCTR2000033323,Completed,,19/05/2020,,,,28/05/2020,http://www.chictr.org.cn/showproj.aspx?proj=54346,19/05/2020,0,0
3629,ChiCTR2000033320,Recruiting,,31/12/2020,,,,28/05/2020,http://www.chictr.org.cn/showproj.aspx?proj=54321,31/12/2020,0,0
3630,ChiCTR2000033318,Recruiting,,30/12/2020,,,,28/05/2020,http://www.chictr.org.cn/showproj.aspx?proj=54326,30/12/2020,0,0
3631,ChiCTR2000033286,Completed,,09/03/2020,,,,26/05/2020,http://www.chictr.org.cn/showproj.aspx?proj=54176,09/03/2020,0,0
3632,ChiCTR2000033284,Not yet recruiting,,31/05/2025,,,,01/06/2020,http://www.chictr.org.cn/showproj.aspx?proj=49590,31/05/2025,0,0
3633,ChiCTR2000033261,Completed,,08/02/2021,,,,01/06/2020,http://www.chictr.org.cn/showproj.aspx?proj=54185,08/02/2021,0,0
3634,ChiCTR2000029479,Completed,,01/05/2020,,,,31/05/2020,http://www.chictr.org.cn/showproj.aspx?proj=48773,01/05/2020,0,0
3635,ChiCTR2000033627,Not yet recruiting,,31/07/2020,,,,09/07/2020,http://www.chictr.org.cn/showproj.aspx?proj=54707,31/07/2020,0,0
3636,ChiCTR2000033491,Completed,,12/05/2020,,,,02/06/2020,http://www.chictr.org.cn/showproj.aspx?proj=54278,12/05/2020,0,0
3637,ChiCTR2000033774,Not yet recruiting,,31/12/2020,,,,11/06/2020,http://www.chictr.org.cn/showproj.aspx?proj=55097,31/12/2020,0,0
3638,ChiCTR2000033936,Recruiting,,15/06/2021,,,,17/06/2020,http://www.chictr.org.cn/showproj.aspx?proj=55291,15/06/2021,0,0
3639,ChiCTR2000034164,Not yet recruiting,,31/03/2021,,,,29/06/2020,http://www.chictr.org.cn/showproj.aspx?proj=55154,31/03/2021,0,0
3640,ChiCTR2000034112,Not yet recruiting,,31/12/2021,,,,09/07/2020,http://www.chictr.org.cn/showproj.aspx?proj=55524,31/12/2021,0,0
3641,ChiCTR2000034076,Recruiting,,15/04/2022,,,,22/06/2020,http://www.chictr.org.cn/showproj.aspx?proj=55582,15/04/2022,0,0
3642,ChiCTR2000029589,Recruiting,,31/12/2021,,,,28/06/2020,http://www.chictr.org.cn/showproj.aspx?proj=49104,31/12/2021,0,0
3643,ChiCTR2000034795,Completed,,29/02/2020,,,,19/07/2020,http://www.chictr.org.cn/showproj.aspx?proj=56756,29/02/2020,0,0
3644,ChiCTR2000034794,Recruiting,,30/04/2021,,,,20/07/2020,http://www.chictr.org.cn/showproj.aspx?proj=56771,30/04/2021,0,0
3645,ChiCTR2000031734,Recruiting,,29/05/2020,,,,04/08/2020,http://www.chictr.org.cn/showproj.aspx?proj=52103,29/05/2020,0,0
3646,ChiCTR2000030259,Recruiting,,30/04/2020,,,,04/08/2020,http://www.chictr.org.cn/showproj.aspx?proj=49918,30/04/2020,0,0
3647,ChiCTR2000035691,Not yet recruiting,,31/12/2021,,,,16/08/2020,http://www.chictr.org.cn/showproj.aspx?proj=58207,31/12/2021,0,0
3648,ChiCTR2000032459,Recruiting,,28/11/2021,,,,14/08/2020,http://www.chictr.org.cn/showproj.aspx?proj=53003,28/11/2021,0,0
3649,ChiCTR2000029822,Suspending,,30/04/2020,,,,10/08/2020,http://www.chictr.org.cn/showproj.aspx?proj=49502,30/04/2020,0,0
3650,ChiCTR2000035633,Not yet recruiting,,13/08/2023,,,,30/08/2020,http://www.chictr.org.cn/showproj.aspx?proj=57741,13/08/2023,0,0
3651,ChiCTR2000032165,Completed,,31/03/2021,,,,31/08/2020,http://www.chictr.org.cn/showproj.aspx?proj=52679,31/03/2021,0,0
3652,ChiCTR2000034825,Completed,,31/12/2020,,,,10/09/2020,http://www.chictr.org.cn/showproj.aspx?proj=56834,31/12/2020,0,0
3653,ChiCTR2000031672,Not yet recruiting,,31/12/2020,,,,14/09/2020,http://www.chictr.org.cn/showproj.aspx?proj=51940,31/12/2020,0,0
3654,ChiCTR2000031955,Completed,,31/12/2020,,,,21/09/2020,http://www.chictr.org.cn/showproj.aspx?proj=52364,31/12/2020,0,0
3655,ChiCTR2000031501,Suspending,,17/07/2020,,,,21/09/2020,http://www.chictr.org.cn/showproj.aspx?proj=50254,17/07/2020,0,0
3656,ChiCTR2000029572,Not yet recruiting,,30/04/2021,,,,29/09/2020,http://www.chictr.org.cn/showproj.aspx?proj=41760,30/04/2021,0,0
3657,ChiCTR2000029569,Not yet recruiting,,30/04/2021,,,,29/09/2020,http://www.chictr.org.cn/showproj.aspx?proj=49062,30/04/2021,0,0
3658,ChiCTR2000030522,Completed,,09/09/2020,,,,05/10/2020,http://www.chictr.org.cn/showproj.aspx?proj=44213,09/09/2020,0,0
3659,ChiCTR2000038740,Not yet recruiting,,01/08/2021,,,,30/09/2020,http://www.chictr.org.cn/showproj.aspx?proj=62250,01/08/2021,0,0
3660,ChiCTR2000037782,Not yet recruiting,,01/10/2021,,,,08/09/2020,http://www.chictr.org.cn/showproj.aspx?proj=55421,01/10/2021,0,0
3661,ChiCTR2000037524,Not yet recruiting,,31/12/2020,,,,26/10/2020,http://www.chictr.org.cn/showproj.aspx?proj=60034,31/12/2020,0,0
3662,ChiCTR2000037518,Not yet recruiting,,28/08/2021,,,,26/10/2020,http://www.chictr.org.cn/showproj.aspx?proj=60581,28/08/2021,0,0
3663,ChiCTR2000036871,Not yet recruiting,,24/04/2021,,,,20/09/2020,http://www.chictr.org.cn/showproj.aspx?proj=55984,24/04/2021,0,0
3664,ChiCTR2000036333,Completed,,30/04/2020,,,,22/08/2020,http://www.chictr.org.cn/showproj.aspx?proj=57115,30/04/2020,0,0
3665,ChiCTR2000038256,Recruiting,,31/12/2020,,,,07/12/2020,http://www.chictr.org.cn/showproj.aspx?proj=61345,31/12/2020,0,0
3666,ChiCTR2000038255,Recruiting,,31/12/2020,,,,07/12/2020,http://www.chictr.org.cn/showproj.aspx?proj=61390,31/12/2020,0,0
3667,ChiCTR2000038672,Not yet recruiting,,05/08/2021,,,,13/12/2020,http://www.chictr.org.cn/showproj.aspx?proj=59313,05/08/2021,0,0
3668,ChiCTR2000038343,Recruiting,,01/08/2021,,,,14/12/2020,http://www.chictr.org.cn/showproj.aspx?proj=61668,01/08/2021,0,0
3669,ChiCTR2000038333,Recruiting,,01/09/2021,,,,14/12/2020,http://www.chictr.org.cn/showproj.aspx?proj=61769,01/09/2021,0,0
3670,ChiCTR2000038866,Not yet recruiting,,31/12/2021,,,,28/12/2020,http://www.chictr.org.cn/showproj.aspx?proj=61662,31/12/2021,0,0
3671,ChiCTR2000038827,Not yet recruiting,,02/12/2021,,,,27/12/2020,http://www.chictr.org.cn/showproj.aspx?proj=61884,02/12/2021,0,0
3672,ChiCTR2000040044,Not yet recruiting,,31/12/2021,,,,19/11/2020,http://www.chictr.org.cn/showproj.aspx?proj=64544,31/12/2021,0,0
3673,ChiCTR2000039002,Recruiting,,31/12/2021,,,,10/01/2021,http://www.chictr.org.cn/showproj.aspx?proj=62120,31/12/2021,0,0
3674,ChiCTR2000039000,Recruiting,,31/12/2020,,,,10/01/2021,http://www.chictr.org.cn/showproj.aspx?proj=62581,31/12/2020,0,0
3675,ChiCTR2000040153,Not yet recruiting,,31/12/2021,,,,22/11/2020,http://www.chictr.org.cn/showproj.aspx?proj=64718,31/12/2021,0,0
3676,ChiCTR2000034780,Completed,,15/07/2021,,,,18/01/2021,http://www.chictr.org.cn/showproj.aspx?proj=56651,15/07/2021,0,0
3677,ChiCTR2000039212,Recruiting,,31/12/2021,,,,19/01/2021,http://www.chictr.org.cn/showproj.aspx?proj=63183,31/12/2021,0,0
3678,ChiCTR2000038152,Completed,,13/09/2021,,,,20/01/2021,http://www.chictr.org.cn/showproj.aspx?proj=59326,13/09/2021,0,0
3679,ChiCTR2000032573,Recruiting,,01/05/2021,,,,25/01/2021,http://www.chictr.org.cn/showproj.aspx?proj=53225,01/05/2021,0,0
3680,ChiCTR2000040146,Completed,,31/01/2021,,,,29/01/2021,http://www.chictr.org.cn/showproj.aspx?proj=64452,31/01/2021,0,0
3681,ChiCTR2000039462,Recruiting,,26/04/2022,,,,30/01/2021,http://www.chictr.org.cn/showproj.aspx?proj=63353,26/04/2022,0,0
3682,ChiCTR2000039369,Completed,,03/06/2020,,,,27/01/2021,http://www.chictr.org.cn/showproj.aspx?proj=63048,03/06/2020,0,0
3683,ChiCTR2000032457,Recruiting,,31/05/2020,,,,01/02/2021,http://www.chictr.org.cn/showproj.aspx?proj=52925,31/05/2020,0,0
3684,ChiCTR2000039640,Recruiting,,29/11/2021,,,,08/02/2021,http://www.chictr.org.cn/showproj.aspx?proj=61895,29/11/2021,0,0
3685,ChiCTR2000039592,Completed,,13/10/2020,,,,07/02/2021,http://www.chictr.org.cn/showproj.aspx?proj=62882,13/10/2020,0,0
3686,ChiCTR2000040324,Recruiting,,30/11/2022,,,,27/11/2020,http://www.chictr.org.cn/showproj.aspx?proj=65022,30/11/2022,0,0
3687,ChiCTR2000039715,Recruiting,,17/12/2021,,,,11/02/2021,http://www.chictr.org.cn/showproj.aspx?proj=63754,17/12/2021,0,0
3688,ChiCTR2000039994,Recruiting,,18/11/2021,,,,22/02/2021,http://www.chictr.org.cn/showproj.aspx?proj=64449,18/11/2021,0,0
3689,ChiCTR2000041375,Recruiting,,07/05/2021,,,,08/03/2021,http://www.chictr.org.cn/showproj.aspx?proj=62474,07/05/2021,0,0
3690,ChiCTR2100041706,Recruiting,,27/03/2021,,,,21/03/2021,http://www.chictr.org.cn/showproj.aspx?proj=66405,27/03/2021,0,0
3691,ChiCTR2100041705,Recruiting,,27/03/2021,,,,21/03/2021,http://www.chictr.org.cn/showproj.aspx?proj=66407,27/03/2021,0,0
3692,ChiCTR2100041704,Completed,,27/03/2021,,,,21/03/2021,http://www.chictr.org.cn/showproj.aspx?proj=66464,27/03/2021,0,0
3693,ChiCTR2000040632,Completed,,30/06/2020,,,,04/12/2020,http://www.chictr.org.cn/showproj.aspx?proj=65372,30/06/2020,0,0
3694,ChiCTR2100041956,Recruiting,,31/07/2021,,,,29/03/2021,http://www.chictr.org.cn/showproj.aspx?proj=64751,31/07/2021,0,0
3695,ChiCTR2100041855,Recruiting,,31/03/2022,,,,26/03/2021,http://www.chictr.org.cn/showproj.aspx?proj=119719,31/03/2022,0,0
3696,ChiCTR2100043012,Not yet recruiting,,01/12/2021,,,,04/02/2021,http://www.chictr.org.cn/showproj.aspx?proj=120867,01/12/2021,0,0
3697,ChiCTR2100042192,Recruiting,,31/12/2021,,,,10/04/2021,http://www.chictr.org.cn/showproj.aspx?proj=119629,31/12/2021,0,0
3698,ChiCTR2100042150,Not yet recruiting,,15/08/2021,,,,09/04/2021,http://www.chictr.org.cn/showproj.aspx?proj=66096,15/08/2021,0,0
3699,ChiCTR2100042069,Recruiting,,31/03/2021,,,,12/04/2021,http://www.chictr.org.cn/showproj.aspx?proj=120071,31/03/2021,0,0
3700,ChiCTR2100042068,Recruiting,,31/03/2021,,,,12/04/2021,http://www.chictr.org.cn/showproj.aspx?proj=120075,31/03/2021,0,0
3701,ChiCTR2100042066,Recruiting,,31/03/2021,,,,12/04/2021,http://www.chictr.org.cn/showproj.aspx?proj=120077,31/03/2021,0,0
3702,ChiCTR2100042004,Suspending,,31/12/2020,,,,11/04/2021,http://www.chictr.org.cn/showproj.aspx?proj=65719,31/12/2020,0,0
3703,ChiCTR2100042003,Completed,,31/07/2020,,,,11/04/2021,http://www.chictr.org.cn/showproj.aspx?proj=64795,31/07/2020,0,0
3704,ChiCTR2000040847,Recruiting,,31/12/2023,,,,01/04/2021,http://www.chictr.org.cn/showproj.aspx?proj=53028,31/12/2023,0,0
3705,ChiCTR2100042356,Completed,,30/06/2020,,,,19/04/2021,http://www.chictr.org.cn/showproj.aspx?proj=120364,30/06/2020,0,0
3706,ChiCTR2100042401,Recruiting,,31/12/2021,,,,24/04/2021,http://www.chictr.org.cn/showproj.aspx?proj=120319,31/12/2021,0,0
3707,ChiCTR2100042374,Recruiting,,29/04/2022,,,,23/04/2021,http://www.chictr.org.cn/showproj.aspx?proj=120494,29/04/2022,0,0
3708,ChiCTR2100042726,Completed,,25/06/2020,,,,09/05/2021,http://www.chictr.org.cn/showproj.aspx?proj=66123,25/06/2020,0,0
3709,ChiCTR2100042717,Recruiting,,01/07/2021,,,,09/05/2021,http://www.chictr.org.cn/showproj.aspx?proj=121027,01/07/2021,0,0
3710,ChiCTR2000029618,Recruiting,,31/12/2022,,,,10/05/2021,http://www.chictr.org.cn/showproj.aspx?proj=48903,31/12/2022,0,0
3711,ChiCTR2100046272,Not yet recruiting,,31/12/2022,,,,12/05/2021,http://www.chictr.org.cn/showproj.aspx?proj=126252,31/12/2022,0,0
3712,ChiCTR2100046227,Not yet recruiting,,28/02/2022,,,,11/05/2021,http://www.chictr.org.cn/showproj.aspx?proj=126385,28/02/2022,0,0
3713,ChiCTR2100046174,Not yet recruiting,,31/12/2021,,,,17/05/2021,http://www.chictr.org.cn/showproj.aspx?proj=126277,31/12/2021,0,0
3714,ChiCTR2100045993,Not yet recruiting,,01/12/2021,,,,01/05/2021,http://www.chictr.org.cn/showproj.aspx?proj=126032,01/12/2021,0,0
3715,ChiCTR2100045991,Not yet recruiting,,31/12/2022,,,,01/05/2021,http://www.chictr.org.cn/showproj.aspx?proj=126041,31/12/2022,0,0
3716,ChiCTR2100045984,Recruiting,,25/05/2022,,,,01/05/2021,http://www.chictr.org.cn/showproj.aspx?proj=126046,25/05/2022,0,0
3717,ChiCTR2100045845,Completed,,31/05/2021,,,,25/04/2021,http://www.chictr.org.cn/showproj.aspx?proj=125761,31/05/2021,0,0
3718,ChiCTR2100045109,Recruiting,,09/04/2022,,,,17/05/2021,http://www.chictr.org.cn/showproj.aspx?proj=124650,09/04/2022,0,0
3719,ChiCTR2100045108,Recruiting,,30/06/2022,,,,07/04/2021,http://www.chictr.org.cn/showproj.aspx?proj=124140,30/06/2022,0,0
3720,ChiCTR2100045107,Not yet recruiting,,30/07/2022,,,,07/04/2021,http://www.chictr.org.cn/showproj.aspx?proj=124702,30/07/2022,0,0
3721,ChiCTR2100044860,Not yet recruiting,,31/12/2021,,,,30/03/2021,http://www.chictr.org.cn/showproj.aspx?proj=124310,31/12/2021,0,0
3722,ChiCTR2100044249,Recruiting,,01/02/2022,,,,12/03/2021,http://www.chictr.org.cn/showproj.aspx?proj=65034,01/02/2022,0,0
3723,ChiCTR2100044026,Completed,,15/01/2021,,,,12/07/2021,http://www.chictr.org.cn/showproj.aspx?proj=122577,15/01/2021,0,0
3724,ChiCTR2100043907,Recruiting,,28/12/2022,,,,05/07/2021,http://www.chictr.org.cn/showproj.aspx?proj=122756,28/12/2022,0,0
3725,ChiCTR2100042822,Recruiting,,28/01/2022,,,,11/05/2021,http://www.chictr.org.cn/showproj.aspx?proj=121247,28/01/2022,0,0
3726,ChiCTR2000030388,Recruiting,,,,,,19/04/2021,http://www.chictr.org.cn/showproj.aspx?proj=50306,,0,0
3727,ChiCTR2100043210,Recruiting,,29/04/2021,,,,24/05/2021,http://www.chictr.org.cn/showproj.aspx?proj=121519,29/04/2021,0,0
3728,ChiCTR2100043108,Recruiting,,31/12/2022,,,,22/05/2021,http://www.chictr.org.cn/showproj.aspx?proj=66027,31/12/2022,0,0
3729,ChiCTR2100043045,Recruiting,,31/03/2022,,,,20/05/2021,http://www.chictr.org.cn/showproj.aspx?proj=121511,31/03/2022,0,0
3730,ChiCTR2100043319,Not yet recruiting,,31/12/2023,,,,30/05/2021,http://www.chictr.org.cn/showproj.aspx?proj=121890,31/12/2023,0,0
3731,ChiCTR2100043682,Not yet recruiting,,30/09/2023,,,,21/06/2021,http://www.chictr.org.cn/showproj.aspx?proj=122412,30/09/2023,0,0
3732,IRCT20190809044488N1,Recruitment complete,,,,,,13/01/2020,http://en.irct.ir/trial/41571,,0,0
3733,IRCT20200310046736N1,Not yet recruiting,,,,,,01/04/2020,http://en.irct.ir/trial/46424,,0,0
3734,IRCT20100228003449N30,Recruitment complete,,,,,,24/03/2020,http://en.irct.ir/trial/46536,,0,0
3735,IRCT20100228003449N28,Recruitment complete,,,,,,26/03/2020,http://en.irct.ir/trial/46538,,0,0
3736,IRCT20100228003449N27,Recruitment complete,,,,,,25/03/2020,http://en.irct.ir/trial/46545,,0,0
3737,IRCT20200316046792N1,Recruitment complete,,,,,,24/03/2020,http://en.irct.ir/trial/46554,,0,0
3738,IRCT20151227025726N12,Recruitment complete,,,,,,23/03/2020,http://en.irct.ir/trial/46561,,0,0
3739,IRCT20100228003449N29,Recruitment complete,,,,,,25/03/2020,http://en.irct.ir/trial/46567,,0,0
3740,IRCT20200317046797N1,Recruitment complete,,,,,,03/04/2020,http://en.irct.ir/trial/46573,,0,0
3741,IRCT20160625028622N1,Recruitment complete,,,,,,22/03/2020,http://en.irct.ir/trial/46576,,0,0
3742,IRCT20120826010664N6,Recruitment complete,,,,,,05/04/2020,http://en.irct.ir/trial/46603,,0,0
3743,IRCT20131113015393N6,Recruitment complete,,,,,,30/03/2020,http://en.irct.ir/trial/46609,,0,0
3744,IRCT20140528017891N8,Recruitment complete,,,,,,28/03/2020,http://en.irct.ir/trial/46623,,0,0
3745,IRCT20200321046828N1,Recruitment complete,,,,,,26/03/2020,http://en.irct.ir/trial/46624,,0,0
3746,IRCT20190727044343N1,Recruitment complete,,09/04/2020,,,,05/04/2020,http://en.irct.ir/trial/46629,09/04/2020,0,0
3747,IRCT20140617018126N2,Recruitment complete,,,,,,29/03/2020,http://en.irct.ir/trial/46637,,0,0
3748,IRCT20150914024017N1,Recruitment complete,,,,,,03/04/2020,http://en.irct.ir/trial/46665,,0,0
3749,IRCT20140911019125N6,Recruitment complete,,,,,,04/04/2020,http://en.irct.ir/trial/46668,,0,0
3750,IRCT20160316027081N1,Recruitment complete,,,,,,31/03/2020,http://en.irct.ir/trial/46678,,0,0
3751,IRCT20151227025726N13,Recruitment complete,,,,,,26/03/2020,http://en.irct.ir/trial/46681,,0,0
3752,IRCT20160310026998N11,Recruitment complete,,,,,,27/03/2020,http://en.irct.ir/trial/46690,,0,0
3753,IRCT20160310026998N10,Recruitment complete,,,,,,26/03/2020,http://en.irct.ir/trial/46693,,0,0
3754,IRCT20180610040049N3,Recruitment complete,,,,,,05/04/2020,http://en.irct.ir/trial/46697,,0,0
3755,IRCT20200324046852N1,Recruitment complete,,,,,,05/04/2020,http://en.irct.ir/trial/46706,,0,0
3756,IRCT20200324046851N1,Recruitment complete,,,,,,03/04/2020,http://en.irct.ir/trial/46712,,0,0
3757,IRCT20200324046847N1,Recruitment complete,,,,,,31/03/2020,http://en.irct.ir/trial/46720,,0,0
3758,IRCT20140907019073N4,Recruitment complete,,,,,,29/03/2020,http://en.irct.ir/trial/46736,,0,0
3759,IRCT20200325046860N1,Recruitment complete,,,,,,30/03/2020,http://en.irct.ir/trial/46759,,0,0
3760,IRCT20101219005416N2,Recruitment complete,,,,,,03/04/2020,http://en.irct.ir/trial/46775,,0,0
3761,IRCT20200317046797N2,Recruitment complete,,,,,,03/04/2020,http://en.irct.ir/trial/46786,,0,0
3762,IRCT20200325046860N2,Recruitment complete,,29/04/2020,,,,01/04/2020,http://en.irct.ir/trial/46789,29/04/2020,0,0
3763,IRCT20170611034452N11,Recruitment complete,,,,,,31/03/2020,http://en.irct.ir/trial/46803,,0,0
3764,IRCT20190917044805N2,Recruitment complete,,,,,,10/07/2021,http://en.irct.ir/trial/46804,,0,0
3765,IRCT20120225009124N4,Recruitment complete,,,,,,02/04/2020,http://en.irct.ir/trial/46810,,0,0
3766,IRCT20180802040678N4,Recruitment complete,,,,,,01/04/2020,http://en.irct.ir/trial/46824,,0,0
3767,IRCT20150704023055N2,Recruitment complete,,,,,,03/04/2020,http://en.irct.ir/trial/46837,,0,0
3768,IRCT20200319046819N1,Recruitment complete,,,,,,04/04/2020,http://en.irct.ir/trial/46838,,0,0
3769,IRCT20200314046764N1,Recruitment complete,,,,,,20/04/2020,http://en.irct.ir/trial/46533,,0,0
3770,IRCT20150303021315N17,Recruitment complete,,,,,,04/05/2020,http://en.irct.ir/trial/46550,,0,0
3771,IRCT20200312046749N1,Recruitment complete,,,,,,12/04/2020,http://en.irct.ir/trial/46551,,0,0
3772,IRCT20190727044343N2,Recruitment complete,,,,,,19/04/2020,http://en.irct.ir/trial/46639,,0,0
3773,IRCT20171122037571N2,Recruitment complete,,,,,,12/04/2020,http://en.irct.ir/trial/46660,,0,0
3774,IRCT20200324046850N2,Recruitment complete,,,,,,01/05/2020,http://en.irct.ir/trial/46713,,0,0
3775,IRCT20200323046841N1,Recruitment complete,,,,,,11/04/2020,http://en.irct.ir/trial/46715,,0,0
3776,IRCT20200322046833N1,Recruitment complete,,,,,,14/04/2020,http://en.irct.ir/trial/46731,,0,0
3777,IRCT20190804044429N1,Recruitment complete,,,,,,11/04/2020,http://en.irct.ir/trial/46741,,0,0
3778,IRCT20160313027033N2,Recruitment complete,,,,,,16/04/2020,http://en.irct.ir/trial/46762,,0,0
3779,IRCT20180712040449N2,Recruitment complete,,,,,,28/04/2020,http://en.irct.ir/trial/46782,,0,0
3780,IRCT20130812014333N145,Recruitment complete,,,,,,07/04/2020,http://en.irct.ir/trial/46790,,0,0
3781,IRCT20200325046859N1,Recruitment complete,,,,,,23/04/2020,http://en.irct.ir/trial/46811,,0,0
3782,IRCT20161204031229N3,Recruitment complete,,,,,,08/04/2020,http://en.irct.ir/trial/46814,,0,0
3783,IRCT20130917014693N10,Recruitment complete,,,,,,08/04/2020,http://en.irct.ir/trial/46849,,0,0
3784,IRCT20180610040049N4,Recruitment complete,,,,,,10/04/2020,http://en.irct.ir/trial/46850,,0,0
3785,IRCT20130812014333N147,Recruitment complete,,,,,,12/05/2020,http://en.irct.ir/trial/46853,,0,0
3786,IRCT20081019001369N2,Recruitment complete,,,,,,07/04/2020,http://en.irct.ir/trial/46868,,0,0
3787,IRCT20200402046923N1,Recruitment complete,,,,,,09/04/2020,http://en.irct.ir/trial/46879,,0,0
3788,IRCT20200328046886N1,Recruitment complete,,04/05/2020,,,,12/04/2020,http://en.irct.ir/trial/46885,04/05/2020,0,0
3789,IRCT20131215015805N2,Recruitment complete,,,,,,04/05/2020,http://en.irct.ir/trial/46887,,0,0
3790,IRCT20200404046933N1,Recruitment complete,,,,,,12/04/2020,http://en.irct.ir/trial/46893,,0,0
3791,IRCT20200404046937N1,Recruitment complete,,,,,,18/04/2020,http://en.irct.ir/trial/46903,,0,0
3792,IRCT20080901001157N16,Recruitment complete,,,,,,08/04/2020,http://en.irct.ir/trial/46907,,0,0
3793,IRCT20200404046934N1,Recruitment complete,,,,,,13/04/2020,http://en.irct.ir/trial/46913,,0,0
3794,IRCT20200403046926N1,Recruitment complete,,,,,,11/04/2020,http://en.irct.ir/trial/46926,,0,0
3795,IRCT20200405046953N1,Recruitment complete,,,,,,06/04/2020,http://en.irct.ir/trial/46930,,0,0
3796,IRCT20151228025732N53,Recruitment complete,,,,,,10/04/2020,http://en.irct.ir/trial/46931,,0,0
3797,IRCT20200404046935N1,Recruitment complete,,,,,,20/04/2020,http://en.irct.ir/trial/46940,,0,0
3798,IRCT20151227025726N14,Recruitment complete,,,,,,10/04/2020,http://en.irct.ir/trial/46942,,0,0
3799,IRCT20200405046958N1,Recruitment complete,,,,,,14/04/2020,http://en.irct.ir/trial/46946,,0,0
3800,IRCT20200406046965N1,Recruitment complete,,,,,,12/04/2020,http://en.irct.ir/trial/46958,,0,0
3801,IRCT20200405046960N1,Recruitment complete,,,,,,08/04/2020,http://en.irct.ir/trial/46961,,0,0
3802,IRCT20200318046812N2,Recruitment complete,,,,,,08/04/2020,http://en.irct.ir/trial/46968,,0,0
3803,IRCT20200317046797N4,Recruitment complete,,,,,,14/04/2020,http://en.irct.ir/trial/46969,,0,0
3804,IRCT20200404046948N1,Recruitment complete,,,,,,15/04/2020,http://en.irct.ir/trial/46973,,0,0
3805,IRCT20180520039738N2,Recruitment complete,,,,,,10/04/2020,http://en.irct.ir/trial/46974,,0,0
3806,IRCT20081019001369N4,Recruitment complete,,,,,,13/04/2020,http://en.irct.ir/trial/46977,,0,0
3807,IRCT20081019001369N3,Recruitment complete,,,,,,11/04/2020,http://en.irct.ir/trial/46978,,0,0
3808,IRCT20200408046992N1,Recruitment complete,,,,,,14/04/2020,http://en.irct.ir/trial/47006,,0,0
3809,IRCT20180129038542N1,Recruitment complete,,13/04/2020,,,,13/04/2020,http://en.irct.ir/trial/47013,13/04/2020,0,0
3810,IRCT20200317046797N3,Recruitment complete,,,,,,11/04/2020,http://en.irct.ir/trial/47014,,0,0
3811,IRCT20200317046797N5,Recruitment complete,,,,,,19/04/2020,http://en.irct.ir/trial/47015,,0,0
3812,IRCT20180923041093N5,Recruitment complete,,,,,,21/04/2020,http://en.irct.ir/trial/47018,,0,0
3813,IRCT20200406046968N1,Recruitment complete,,,,,,14/04/2020,http://en.irct.ir/trial/47021,,0,0
3814,IRCT20150808023559N20,Recruitment complete,,,,,,11/04/2020,http://en.irct.ir/trial/47022,,0,0
3815,IRCT20130616013690N7,Recruitment complete,,,,,,08/05/2020,http://en.irct.ir/trial/47034,,0,0
3816,IRCT20200410047009N1,Recruitment complete,,,,,,26/04/2020,http://en.irct.ir/trial/47052,,0,0
3817,IRCT20200408046990N1,Recruitment complete,,,,,,18/04/2020,http://en.irct.ir/trial/47061,,0,0
3818,IRCT20200217046526N2,Recruitment complete,,,,,,13/04/2020,http://en.irct.ir/trial/47073,,0,0
3819,IRCT20200411047025N1,Recruitment complete,,,,,,14/04/2020,http://en.irct.ir/trial/47078,,0,0
3820,IRCT20080901001165N46,Recruitment complete,,,,,,15/04/2020,http://en.irct.ir/trial/47087,,0,0
3821,IRCT20200406046963N1,Recruitment complete,,,,,,22/04/2020,http://en.irct.ir/trial/47088,,0,0
3822,IRCT20190122042450N4,Recruitment complete,,,,,,16/04/2020,http://en.irct.ir/trial/47090,,0,0
3823,IRCT20200411047030N1,Recruitment complete,,,,,,17/04/2020,http://en.irct.ir/trial/47099,,0,0
3824,IRCT20200406046968N2,Recruitment complete,,,,,,22/04/2020,http://en.irct.ir/trial/47115,,0,0
3825,IRCT20170207032444N3,Recruitment complete,,,,,,17/04/2020,http://en.irct.ir/trial/47119,,0,0
3826,IRCT20200413047053N1,Recruitment complete,,,,,,15/04/2020,http://en.irct.ir/trial/47139,,0,0
3827,IRCT20081019001369N5,Recruitment complete,,,,,,26/04/2020,http://en.irct.ir/trial/47141,,0,0
3828,IRCT20200408046988N1,Recruitment complete,,,,,,29/04/2020,http://en.irct.ir/trial/47142,,0,0
3829,IRCT20200413047062N1,Recruitment complete,,,,,,04/05/2020,http://en.irct.ir/trial/47146,,0,0
3830,IRCT20191125045492N2,Recruitment complete,,,,,,18/04/2020,http://en.irct.ir/trial/47149,,0,0
3831,IRCT20200406046968N3,Recruitment complete,,,,,,08/05/2020,http://en.irct.ir/trial/47152,,0,0
3832,IRCT20200413047063N1,Recruitment complete,,,,,,04/05/2020,http://en.irct.ir/trial/47156,,0,0
3833,IRCT20200413047052N1,Recruitment complete,,,,,,07/05/2020,http://en.irct.ir/trial/47160,,0,0
3834,IRCT20200414047070N1,Recruitment complete,,,,,,21/04/2020,http://en.irct.ir/trial/47169,,0,0
3835,IRCT20200413047056N1,Recruitment complete,,,,,,17/04/2020,http://en.irct.ir/trial/47212,,0,0
3836,IRCT20200418047116N1,Recruitment complete,,,,,,04/05/2020,http://en.irct.ir/trial/47219,,0,0
3837,IRCT20200415047089N1,Recruitment complete,,,,,,19/04/2020,http://en.irct.ir/trial/47234,,0,0
3838,IRCT20200415047092N1,Recruitment complete,,,,,,20/04/2020,http://en.irct.ir/trial/47244,,0,0
3839,IRCT20200416047104N1,Recruitment complete,,,,,,23/04/2020,http://en.irct.ir/trial/47251,,0,0
3840,IRCT20200417047113N1,Recruitment complete,,,,,,24/04/2020,http://en.irct.ir/trial/47264,,0,0
3841,IRCT20200419047128N1,Recruitment complete,,,,,,04/07/2021,http://en.irct.ir/trial/47265,,0,0
3842,IRCT20200416047099N1,Recruitment complete,,,,,,21/04/2020,http://en.irct.ir/trial/47266,,0,0
3843,IRCT20200418047122N1,Recruitment complete,,,,,,03/05/2020,http://en.irct.ir/trial/47268,,0,0
3844,IRCT20200418047121N2,Recruitment complete,,,,,,05/05/2020,http://en.irct.ir/trial/47275,,0,0
3845,IRCT20200329046892N1,Recruitment complete,,,,,,02/05/2020,http://en.irct.ir/trial/47300,,0,0
3846,IRCT20080901001165N48,Recruitment complete,,,,,,22/04/2020,http://en.irct.ir/trial/47318,,0,0
3847,IRCT20200420047147N1,Recruitment complete,,,,,,23/04/2020,http://en.irct.ir/trial/47334,,0,0
3848,IRCT20190618043923N4,Recruitment complete,,,,,,04/05/2020,http://en.irct.ir/trial/47363,,0,0
3849,IRCT20200421047155N1,Recruitment complete,,,,,,25/04/2020,http://en.irct.ir/trial/47387,,0,0
3850,IRCT20200419047128N2,Recruitment complete,,,,,,04/07/2021,http://en.irct.ir/trial/47396,,0,0
3851,IRCT20080901001165N49,Recruitment complete,,,,,,25/04/2020,http://en.irct.ir/trial/47401,,0,0
3852,IRCT20200422047168N1,Recruitment complete,,,,,,29/04/2020,http://en.irct.ir/trial/47437,,0,0
3853,IRCT20200408046990N2,Recruitment complete,,,,,,25/04/2020,http://en.irct.ir/trial/47468,,0,0
3854,IRCT20180114038350N3,Recruitment complete,,,,,,01/05/2020,http://en.irct.ir/trial/47475,,0,0
3855,IRCT20200426047206N1,Recruitment complete,,,,,,28/04/2020,http://en.irct.ir/trial/47495,,0,0
3856,IRCT20120215009014N353,Recruitment complete,,,,,,27/04/2020,http://en.irct.ir/trial/47501,,0,0
3857,IRCT20140305016852N4,Recruitment complete,,,,,,04/05/2020,http://en.irct.ir/trial/47508,,0,0
3858,IRCT20180425039414N2,Recruitment complete,,,,,,13/05/2020,http://en.irct.ir/trial/47516,,0,0
3859,IRCT20200427047215N1,Recruitment complete,,,,,,05/05/2020,http://en.irct.ir/trial/47520,,0,0
3860,IRCT20200426047212N1,Recruitment complete,,,,,,02/05/2020,http://en.irct.ir/trial/47572,,0,0
3861,IRCT20080901001165N50,Recruitment complete,,,,,,01/05/2020,http://en.irct.ir/trial/47576,,0,0
3862,IRCT20080901001165N51,Recruitment complete,,,,,,01/05/2020,http://en.irct.ir/trial/47577,,0,0
3863,IRCT20200418047121N1,Recruitment complete,,,,,,01/05/2020,http://en.irct.ir/trial/47578,,0,0
3864,IRCT20150808023559N21,Recruitment complete,,,,,,09/05/2020,http://en.irct.ir/trial/47594,,0,0
3865,IRCT20200501047258N1,Recruitment complete,,,,,,04/05/2020,http://en.irct.ir/trial/47629,,0,0
3866,IRCT20131129015584N2,Recruitment complete,,,,,,08/05/2020,http://en.irct.ir/trial/47639,,0,0
3867,IRCT20080901001165N52,Recruitment complete,,,,,,05/05/2020,http://en.irct.ir/trial/47641,,0,0
3868,IRCT20160706028815N5,Recruitment complete,,,,,,05/05/2020,http://en.irct.ir/trial/47682,,0,0
3869,IRCT20171213037866N2,Recruitment complete,,,,,,07/05/2020,http://en.irct.ir/trial/47684,,0,0
3870,IRCT20200326046868N1,Recruitment complete,,,,,,09/05/2020,http://en.irct.ir/trial/47934,,0,0
3871,IRCT20200508047346N1,Recruitment complete,,,,,,13/05/2020,http://en.irct.ir/trial/47953,,0,0
3872,IRCT20200509047366N1,Recruitment complete,,,,,,12/05/2020,http://en.irct.ir/trial/48020,,0,0
3873,IRCT20120215009014N354,Recruitment complete,,,,,,12/05/2020,http://en.irct.ir/trial/48043,,0,0
3874,IRCT20200128046294N2,Recruitment complete,,18/05/2020,,,,01/06/2020,http://en.irct.ir/trial/46463,18/05/2020,0,0
3875,IRCT20200314046774N1,Recruitment complete,,13/06/2020,,,,12/06/2020,http://en.irct.ir/trial/46519,13/06/2020,0,0
3876,IRCT20200324046850N3,Recruitment complete,,,,,,18/05/2020,http://en.irct.ir/trial/46718,,0,0
3877,IRCT20180923041093N3,Recruitment complete,,,,,,03/06/2020,http://en.irct.ir/trial/46721,,0,0
3878,IRCT20180923041093N4,Recruitment complete,,,,,,06/06/2020,http://en.irct.ir/trial/46728,,0,0
3879,IRCT20200324046850N1,Recruitment complete,,,,,,03/06/2020,http://en.irct.ir/trial/46732,,0,0
3880,IRCT20200401046909N1,Recruitment complete,,,,,,01/06/2020,http://en.irct.ir/trial/46875,,0,0
3881,IRCT20200404046947N1,Recruitment complete,,,,,,22/05/2020,http://en.irct.ir/trial/46904,,0,0
3882,IRCT20151228025732N52,Recruitment complete,,,,,,25/05/2020,http://en.irct.ir/trial/46963,,0,0
3883,IRCT20081027001411N3,Recruitment complete,,,,,,01/06/2020,http://en.irct.ir/trial/46975,,0,0
3884,IRCT20091201002804N12,Recruitment complete,,,,,,01/06/2020,http://en.irct.ir/trial/46983,,0,0
3885,IRCT20200401046909N2,Recruitment complete,,,,,,27/05/2020,http://en.irct.ir/trial/47010,,0,0
3886,IRCT20200217046526N1,Recruitment complete,,25/04/2020,,,,10/06/2020,http://en.irct.ir/trial/47030,25/04/2020,0,0
3887,IRCT20200411047016N1,Recruitment complete,,,,,,31/05/2020,http://en.irct.ir/trial/47044,,0,0
3888,IRCT20190727044343N3,Recruitment complete,,,,,,12/06/2020,http://en.irct.ir/trial/47062,,0,0
3889,IRCT20200223046586N2,Recruitment complete,,,,,,30/05/2020,http://en.irct.ir/trial/47091,,0,0
3890,IRCT20081019001369N6,Recruitment complete,,,,,,17/05/2020,http://en.irct.ir/trial/47188,,0,0
3891,IRCT20091012002582N21,Recruitment complete,,,,,,18/05/2020,http://en.irct.ir/trial/47197,,0,0
3892,IRCT20200325046859N2,Recruitment complete,,,,,,12/06/2020,http://en.irct.ir/trial/47200,,0,0
3893,IRCT20190418043307N1,Recruitment complete,,,,,,17/05/2020,http://en.irct.ir/trial/47209,,0,0
3894,IRCT20200411047019N1,Recruitment complete,,,,,,18/05/2020,http://en.irct.ir/trial/47279,,0,0
3895,IRCT20150303021315N19,Recruitment complete,,,,,,27/05/2020,http://en.irct.ir/trial/47335,,0,0
3896,IRCT20200209046427N1,Recruitment complete,,,,,,07/06/2020,http://en.irct.ir/trial/47504,,0,0
3897,IRCT20200428047228N1,Recruitment complete,,,,,,16/05/2020,http://en.irct.ir/trial/47559,,0,0
3898,IRCT20200501047259N1,Recruitment complete,,,,,,17/05/2020,http://en.irct.ir/trial/47609,,0,0
3899,IRCT20200115046144N2,Recruitment complete,,,,,,21/05/2020,http://en.irct.ir/trial/47645,,0,0
3900,IRCT20131129015584N3,Recruitment complete,,,,,,20/05/2020,http://en.irct.ir/trial/47665,,0,0
3901,IRCT20150107020592N25,Recruitment complete,,,,,,13/06/2020,http://en.irct.ir/trial/47666,,0,0
3902,IRCT20200502047268N1,Recruitment complete,,,,,,16/05/2020,http://en.irct.ir/trial/47692,,0,0
3903,IRCT20200503047280N1,Recruitment complete,,,,,,02/06/2020,http://en.irct.ir/trial/47704,,0,0
3904,IRCT20200418047126N1,Recruitment complete,,,,,,14/05/2020,http://en.irct.ir/trial/47707,,0,0
3905,IRCT20200405046951N1,Recruitment complete,,,,,,11/06/2020,http://en.irct.ir/trial/47722,,0,0
3906,IRCT20170211032494N3,Recruitment complete,,,,,,25/05/2020,http://en.irct.ir/trial/47735,,0,0
3907,IRCT20081011001323N25,Recruitment complete,,,,,,17/05/2020,http://en.irct.ir/trial/47935,,0,0
3908,IRCT20200421047150N1,Recruitment complete,,,,,,14/05/2020,http://en.irct.ir/trial/47964,,0,0
3909,IRCT20180923041093N6,Recruitment complete,,,,,,11/06/2020,http://en.irct.ir/trial/47974,,0,0
3910,IRCT20200509047360N1,Recruitment complete,,,,,,16/05/2020,http://en.irct.ir/trial/47979,,0,0
3911,IRCT20140428017469N1,Recruitment complete,,,,,,23/05/2020,http://en.irct.ir/trial/47989,,0,0
3912,IRCT20200506047323N2,Recruitment complete,,,,,,31/05/2020,http://en.irct.ir/trial/47990,,0,0
3913,IRCT20200509047373N1,Recruitment complete,,,,,,23/05/2020,http://en.irct.ir/trial/48001,,0,0
3914,IRCT20151227025726N15,Recruitment complete,,,,,,18/05/2020,http://en.irct.ir/trial/48018,,0,0
3915,IRCT20150716023235N15,Recruitment complete,,,,,,29/05/2020,http://en.irct.ir/trial/48019,,0,0
3916,IRCT20200510047383N1,Recruitment complete,,,,,,15/05/2020,http://en.irct.ir/trial/48024,,0,0
3917,IRCT20120215009014N355,Recruitment complete,,,,,,18/05/2020,http://en.irct.ir/trial/48039,,0,0
3918,IRCT20090609002017N35,Recruitment complete,,,,,,17/05/2020,http://en.irct.ir/trial/48058,,0,0
3919,IRCT20080901001165N55,Recruitment complete,,,,,,23/05/2020,http://en.irct.ir/trial/48061,,0,0
3920,IRCT20080901001165N53,Recruitment complete,,,,,,14/05/2020,http://en.irct.ir/trial/48066,,0,0
3921,IRCT20200428047228N2,Recruitment complete,,,,,,10/06/2020,http://en.irct.ir/trial/48096,,0,0
3922,IRCT20080901001165N60,Recruitment complete,,,,,,28/05/2020,http://en.irct.ir/trial/48102,,0,0
3923,IRCT20200506047323N1,Recruitment complete,,,,,,23/05/2020,http://en.irct.ir/trial/48114,,0,0
3924,IRCT20080901001165N56,Recruitment complete,,,,,,23/05/2020,http://en.irct.ir/trial/48116,,0,0
3925,IRCT20200405046960N2,Recruitment complete,,,,,,19/05/2020,http://en.irct.ir/trial/48126,,0,0
3926,IRCT20200516047462N1,Recruitment complete,,,,,,17/05/2020,http://en.irct.ir/trial/48141,,0,0
3927,IRCT20151227025726N17,Recruitment complete,,,,,,31/05/2020,http://en.irct.ir/trial/48153,,0,0
3928,IRCT20200516047468N1,Recruitment complete,,,,,,19/05/2020,http://en.irct.ir/trial/48176,,0,0
3929,IRCT20150107020592N23,Recruitment complete,,,,,,31/05/2020,http://en.irct.ir/trial/48185,,0,0
3930,IRCT20160809029275N1,Recruitment complete,,,,,,30/05/2020,http://en.irct.ir/trial/48187,,0,0
3931,IRCT20151226025699N3,Recruitment complete,,,,,,20/05/2020,http://en.irct.ir/trial/48213,,0,0
3932,IRCT20180608040007N2,Recruitment complete,,,,,,13/06/2020,http://en.irct.ir/trial/48218,,0,0
3933,IRCT20200517047485N1,Recruitment complete,,,,,,29/05/2020,http://en.irct.ir/trial/48226,,0,0
3934,IRCT20150107020592N22,Recruitment complete,,,,,,25/05/2020,http://en.irct.ir/trial/48262,,0,0
3935,IRCT20200518047497N1,Recruitment complete,,,,,,21/05/2020,http://en.irct.ir/trial/48289,,0,0
3936,IRCT20200519047510N1,Recruitment complete,,,,,,28/05/2020,http://en.irct.ir/trial/48292,,0,0
3937,IRCT20151227025726N18,Recruitment complete,,,,,,10/06/2020,http://en.irct.ir/trial/48312,,0,0
3938,IRCT20161206031256N3,Recruitment complete,,,,,,02/06/2020,http://en.irct.ir/trial/48329,,0,0
3939,IRCT20160126026217N4,Recruitment complete,,,,,,08/06/2020,http://en.irct.ir/trial/48403,,0,0
3940,IRCT20200422047168N2,Recruitment complete,,,,,,30/05/2020,http://en.irct.ir/trial/48444,,0,0
3941,IRCT20200523047550N1,Recruitment complete,,25/05/2020,,,,06/06/2020,http://en.irct.ir/trial/48495,25/05/2020,0,0
3942,IRCT20160118026097N3,Recruitment complete,,,,,,31/05/2020,http://en.irct.ir/trial/48517,,0,0
3943,IRCT20150107020592N24,Recruitment complete,,,,,,08/06/2020,http://en.irct.ir/trial/48534,,0,0
3944,IRCT20200518047497N2,Recruitment complete,,,,,,06/06/2020,http://en.irct.ir/trial/48644,,0,0
3945,IRCT20120703010178N20,Recruitment complete,,,,,,13/06/2020,http://en.irct.ir/trial/48702,,0,0
3946,IRCT20200412047042N1,Recruitment complete,,,,,,11/06/2020,http://en.irct.ir/trial/48749,,0,0
3947,IRCT20151113025025N3,Recruitment complete,,,,,,06/07/2020,http://en.irct.ir/trial/46531,,0,0
3948,IRCT20200416047099N2,Recruitment complete,,,,,,04/07/2020,http://en.irct.ir/trial/47357,,0,0
3949,IRCT20200428047229N1,Recruitment complete,,,,,,27/06/2020,http://en.irct.ir/trial/47530,,0,0
3950,IRCT20200428047232N1,Recruitment complete,,,,,,05/07/2020,http://en.irct.ir/trial/47637,,0,0
3951,IRCT20200504047298N2,Recruitment complete,,,,,,15/06/2020,http://en.irct.ir/trial/47675,,0,0
3952,IRCT20171105037262N4,Recruitment complete,,,,,,18/06/2020,http://en.irct.ir/trial/47696,,0,0
3953,IRCT20200508047345N1,Recruitment complete,,,,,,14/06/2020,http://en.irct.ir/trial/47987,,0,0
3954,IRCT20200511047396N1,Recruitment complete,,,,,,28/06/2020,http://en.irct.ir/trial/48048,,0,0
3955,IRCT20180425039414N3,Recruitment complete,,,,,,17/06/2020,http://en.irct.ir/trial/48083,,0,0
3956,IRCT20200510047385N1,Recruitment complete,,,,,,07/07/2020,http://en.irct.ir/trial/48099,,0,0
3957,IRCT20200513047426N1,Recruitment complete,,,,,,27/06/2020,http://en.irct.ir/trial/48236,,0,0
3958,IRCT20110726007117N11,Recruitment complete,,,,,,06/07/2021,http://en.irct.ir/trial/48287,,0,0
3959,IRCT20200112046089N1,Recruitment complete,,,,,,25/06/2020,http://en.irct.ir/trial/48330,,0,0
3960,IRCT20200330046899N1,Recruitment complete,,,,,,17/06/2020,http://en.irct.ir/trial/48365,,0,0
3961,IRCT20200525047562N1,Recruitment complete,,,,,,24/06/2020,http://en.irct.ir/trial/48493,,0,0
3962,IRCT20200317046797N6,Recruitment complete,,,,,,18/06/2020,http://en.irct.ir/trial/48500,,0,0
3963,IRCT20200504047298N1,Recruitment complete,,,,,,14/06/2020,http://en.irct.ir/trial/48640,,0,0
3964,IRCT20200505047305N1,Recruitment complete,,,,,,30/06/2020,http://en.irct.ir/trial/48683,,0,0
3965,IRCT20150107020592N29,Recruitment complete,,21/05/2020,,,,21/06/2020,http://en.irct.ir/trial/48695,21/05/2020,0,0
3966,IRCT20200607047675N1,Recruitment complete,,,,,,15/06/2020,http://en.irct.ir/trial/48700,,0,0
3967,IRCT20200608047686N1,Recruitment complete,,,,,,30/06/2020,http://en.irct.ir/trial/48717,,0,0
3968,IRCT20150107020592N26,Recruitment complete,,21/05/2020,,,,15/06/2020,http://en.irct.ir/trial/48746,21/05/2020,0,0
3969,IRCT20200609047707N1,Recruitment complete,,,,,,24/06/2020,http://en.irct.ir/trial/48764,,0,0
3970,IRCT20200611047735N1,Recruitment complete,,,,,,19/06/2020,http://en.irct.ir/trial/48843,,0,0
3971,IRCT20150107020592N27,Recruitment complete,,,,,,15/06/2020,http://en.irct.ir/trial/48907,,0,0
3972,IRCT20200515047456N1,Recruitment complete,,,,,,28/06/2020,http://en.irct.ir/trial/48929,,0,0
3973,IRCT20200611047727N1,Recruitment complete,,,,,,24/06/2020,http://en.irct.ir/trial/48941,,0,0
3974,IRCT20150107020592N28,Recruitment complete,,,,,,18/06/2020,http://en.irct.ir/trial/48972,,0,0
3975,IRCT20150107020592N30,Recruitment complete,,,,,,10/07/2020,http://en.irct.ir/trial/48992,,0,0
3976,IRCT20150725023332N3,Recruitment complete,,,,,,27/06/2020,http://en.irct.ir/trial/49112,,0,0
3977,IRCT20180712040446N2,Recruitment complete,,,,,,01/07/2020,http://en.irct.ir/trial/49120,,0,0
3978,IRCT20190121042444N3,Recruitment complete,,,,,,04/07/2020,http://en.irct.ir/trial/49132,,0,0
3979,IRCT20111224008507N3,Recruitment complete,,,,,,27/06/2020,http://en.irct.ir/trial/49174,,0,0
3980,IRCT20180519039711N6,Recruitment complete,,,,,,29/06/2020,http://en.irct.ir/trial/49186,,0,0
3981,IRCT20200426047206N2,Recruitment complete,,,,,,06/07/2020,http://en.irct.ir/trial/49385,,0,0
3982,IRCT20180725040596N2,Recruitment complete,,,,,,04/08/2020,http://en.irct.ir/trial/46897,,0,0
3983,IRCT20200408046987N1,Recruitment complete,,,,,,21/07/2020,http://en.irct.ir/trial/47012,,0,0
3984,IRCT20200404046937N2,Recruitment complete,,01/06/2020,,,,01/08/2020,http://en.irct.ir/trial/47016,01/06/2020,0,0
3985,IRCT20200414047076N1,Recruitment complete,,,,,,01/08/2020,http://en.irct.ir/trial/47286,,0,0
3986,IRCT20170922036314N4,Recruitment complete,,,,,,08/08/2020,http://en.irct.ir/trial/47383,,0,0
3987,IRCT20200503047281N1,Recruitment complete,,,,,,25/07/2020,http://en.irct.ir/trial/47632,,0,0
3988,IRCT20200505047318N1,Recruitment complete,,,,,,06/08/2020,http://en.irct.ir/trial/48007,,0,0
3989,IRCT20110907007511N4,Recruitment complete,,,,,,25/07/2020,http://en.irct.ir/trial/48013,,0,0
3990,IRCT20200511047399N1,Recruitment complete,,,,,,23/07/2020,http://en.irct.ir/trial/48045,,0,0
3991,IRCT20200522047545N1,Recruitment complete,,,,,,05/08/2020,http://en.irct.ir/trial/48351,,0,0
3992,IRCT20200522047542N1,Recruitment complete,,,,,,04/08/2020,http://en.irct.ir/trial/48379,,0,0
3993,IRCT20080901001165N58,Recruitment complete,,,,,,27/07/2020,http://en.irct.ir/trial/48394,,0,0
3994,IRCT20200525047570N1,Recruitment complete,,,,,,30/07/2020,http://en.irct.ir/trial/48583,,0,0
3995,IRCT20200607047682N1,Recruitment complete,,,,,,27/07/2020,http://en.irct.ir/trial/48727,,0,0
3996,IRCT20190602043787N3,Recruitment complete,,,,,,20/07/2020,http://en.irct.ir/trial/49180,,0,0
3997,IRCT20190624043993N3,Recruitment complete,,,,,,23/07/2020,http://en.irct.ir/trial/49257,,0,0
3998,IRCT20190624043993N2,Recruitment complete,,,,,,12/07/2020,http://en.irct.ir/trial/49280,,0,0
3999,IRCT20200105046009N4,Recruitment complete,,,,,,18/07/2020,http://en.irct.ir/trial/49365,,0,0
4000,IRCT20200506047323N3,Recruitment complete,,,,,,22/07/2020,http://en.irct.ir/trial/49463,,0,0
4001,IRCT20200705048013N1,Recruitment complete,,05/07/2020,,,,19/07/2020,http://en.irct.ir/trial/49525,05/07/2020,0,0
4002,IRCT20190406043175N3,recruiting,,,,,,12/07/2020,http://en.irct.ir/trial/49530,,0,0
4003,IRCT20170117032025N7,Recruitment complete,,,,,,12/07/2020,http://en.irct.ir/trial/49534,,0,0
4004,IRCT20190415043279N6,Recruitment complete,,,,,,24/07/2020,http://en.irct.ir/trial/49544,,0,0
4005,IRCT20200426047206N3,Recruitment complete,,,,,,25/07/2020,http://en.irct.ir/trial/49579,,0,0
4006,IRCT20200408046990N3,Recruitment complete,,,,,,16/07/2020,http://en.irct.ir/trial/49629,,0,0
4007,IRCT20151227025726N20,Recruitment complete,,,,,,26/07/2020,http://en.irct.ir/trial/49638,,0,0
4008,IRCT20101020004976N6,Recruitment complete,,,,,,18/07/2020,http://en.irct.ir/trial/49670,,0,0
4009,IRCT20180513039641N2,Recruitment complete,,,,,,27/07/2020,http://en.irct.ir/trial/49803,,0,0
4010,IRCT20200506047323N4,Recruitment complete,,,,,,01/08/2020,http://en.irct.ir/trial/49881,,0,0
4011,IRCT20200723048178N1,Recruitment complete,,,,,,28/07/2020,http://en.irct.ir/trial/49901,,0,0
4012,IRCT20160131026298N4,Recruitment complete,,,,,,04/08/2020,http://en.irct.ir/trial/49925,,0,0
4013,IRCT20200402046917N1,Recruitment complete,,,,,,31/08/2020,http://en.irct.ir/trial/46938,,0,0
4014,IRCT20170128032241N3,Recruitment complete,,,,,,17/08/2020,http://en.irct.ir/trial/47031,,0,0
4015,IRCT20200409047007N1,Recruitment complete,,27/06/2020,,,,10/08/2020,http://en.irct.ir/trial/47058,27/06/2020,0,0
4016,IRCT20200418047119N1,Recruitment complete,,,,,,01/09/2020,http://en.irct.ir/trial/47231,,0,0
4017,IRCT20151222025660N2,Recruitment complete,,,,,,20/08/2020,http://en.irct.ir/trial/47319,,0,0
4018,IRCT20200514047445N1,Recruitment complete,,,,,,10/08/2020,http://en.irct.ir/trial/48275,,0,0
4019,IRCT20190131042569N5,Recruitment complete,,,,,,23/08/2020,http://en.irct.ir/trial/48311,,0,0
4020,IRCT20200527047581N1,Recruitment complete,,,,,,23/08/2020,http://en.irct.ir/trial/48447,,0,0
4021,IRCT20200616047792N1,Recruitment complete,,,,,,16/08/2020,http://en.irct.ir/trial/48978,,0,0
4022,IRCT20200616047799N1,Recruitment complete,,,,,,23/08/2020,http://en.irct.ir/trial/49012,,0,0
4023,IRCT20090304001739N3,Recruitment complete,,05/09/2020,,,,01/09/2020,http://en.irct.ir/trial/49065,05/09/2020,0,0
4024,IRCT20200623047897N1,Recruitment complete,,,,,,16/08/2020,http://en.irct.ir/trial/49277,,0,0
4025,IRCT20200630047962N1,Recruitment complete,,,,,,21/08/2020,http://en.irct.ir/trial/49309,,0,0
4026,IRCT20200705048011N1,Recruitment complete,,,,,,16/08/2020,http://en.irct.ir/trial/49481,,0,0
4027,IRCT20190312043030N2,Recruitment complete,,,,,,19/08/2020,http://en.irct.ir/trial/49508,,0,0
4028,IRCT20170716035126N4,Recruitment complete,,,,,,26/08/2020,http://en.irct.ir/trial/49519,,0,0
4029,IRCT20200711048076N1,Recruitment complete,,,,,,05/09/2020,http://en.irct.ir/trial/49555,,0,0
4030,IRCT20200509047364N2,Recruitment complete,,,,,,17/08/2020,http://en.irct.ir/trial/49657,,0,0
4031,IRCT20200718048129N1,Recruitment complete,,,,,,11/08/2020,http://en.irct.ir/trial/49729,,0,0
4032,IRCT20200725048199N1,Recruitment complete,,,,,,11/08/2020,http://en.irct.ir/trial/49853,,0,0
4033,IRCT20160808029264N9,Recruitment complete,,,,,,15/08/2020,http://en.irct.ir/trial/49890,,0,0
4034,IRCT20190831044653N5,Recruitment complete,,,,,,24/08/2020,http://en.irct.ir/trial/49893,,0,0
4035,IRCT20200730048253N1,Recruitment complete,,,,,,08/08/2020,http://en.irct.ir/trial/50031,,0,0
4036,IRCT20091012002582N22,Recruitment complete,,,,,,08/08/2020,http://en.irct.ir/trial/50079,,0,0
4037,IRCT20101219005416N3,Recruitment complete,,,,,,26/08/2020,http://en.irct.ir/trial/50101,,0,0
4038,IRCT20200806048318N1,Recruitment complete,,,,,,20/08/2020,http://en.irct.ir/trial/50227,,0,0
4039,IRCT20200506047323N5,recruiting,,,,,,14/08/2020,http://en.irct.ir/trial/50239,,0,0
4040,IRCT20090701002113N2,Recruitment complete,,,,,,25/08/2020,http://en.irct.ir/trial/50275,,0,0
4041,IRCT20180922041089N4,Recruitment complete,,,,,,23/08/2020,http://en.irct.ir/trial/50305,,0,0
4042,IRCT20161108030776N3,Recruitment complete,,,,,,26/08/2020,http://en.irct.ir/trial/50341,,0,0
4043,IRCT20170117032004N3,Recruitment complete,,,,,,29/09/2020,http://en.irct.ir/trial/46564,,0,0
4044,IRCT20200318046812N1,Recruitment complete,,20/08/2020,,,,19/09/2020,http://en.irct.ir/trial/46783,20/08/2020,0,0
4045,IRCT20190810044500N7,Recruitment complete,,,,,,19/09/2020,http://en.irct.ir/trial/46826,,0,0
4046,IRCT20151228025732N51,Recruitment complete,,,,,,26/09/2020,http://en.irct.ir/trial/46828,,0,0
4047,IRCT20190717044241N2,Recruitment complete,,,,,,14/09/2020,http://en.irct.ir/trial/47110,,0,0
4048,IRCT20081019001369N7,recruiting,,,,,,27/09/2020,http://en.irct.ir/trial/47441,,0,0
4049,IRCT20200504047295N1,Recruitment complete,,,,,,16/09/2020,http://en.irct.ir/trial/47661,,0,0
4050,IRCT20160118026097N4,Recruitment complete,,,,,,13/09/2020,http://en.irct.ir/trial/48310,,0,0
4051,IRCT20160118026097N5,Recruitment complete,,,,,,19/09/2020,http://en.irct.ir/trial/48401,,0,0
4052,IRCT20190226042851N1,Recruitment complete,,,,,,05/10/2020,http://en.irct.ir/trial/48462,,0,0
4053,IRCT20180624040213N2,Recruitment complete,,,,,,14/09/2020,http://en.irct.ir/trial/49420,,0,0
4054,IRCT20200504047298N3,Recruitment complete,,,,,,09/09/2020,http://en.irct.ir/trial/49696,,0,0
4055,IRCT20191228045924N1,Recruitment complete,,,,,,20/09/2020,http://en.irct.ir/trial/49767,,0,0
4056,IRCT20200802048266N1,Recruitment complete,,,,,,22/09/2020,http://en.irct.ir/trial/50035,,0,0
4057,IRCT20131112015390N5,Recruitment complete,,10/08/2020,,,,26/09/2020,http://en.irct.ir/trial/50268,10/08/2020,0,0
4058,IRCT20200317046797N7,Recruitment complete,,,,,,14/09/2020,http://en.irct.ir/trial/50556,,0,0
4059,IRCT20200831048568N1,Recruitment complete,,,,,,11/09/2020,http://en.irct.ir/trial/50601,,0,0
4060,IRCT20181203041832N1,Recruitment complete,,,,,,05/10/2020,http://en.irct.ir/trial/50750,,0,0
4061,IRCT20200902048598N1,Recruitment complete,,,,,,28/09/2020,http://en.irct.ir/trial/50796,,0,0
4062,IRCT20140911019125N8,Recruitment complete,,,,,,26/09/2020,http://en.irct.ir/trial/50848,,0,0
4063,IRCT20200913048701N1,Recruitment complete,,,,,,22/09/2020,http://en.irct.ir/trial/50912,,0,0
4064,IRCT20200907048644N1,Recruitment complete,,,,,,04/10/2020,http://en.irct.ir/trial/50932,,0,0
4065,IRCT20200913048708N1,Recruitment complete,,,,,,01/10/2020,http://en.irct.ir/trial/50959,,0,0
4066,IRCT20131115015405N4,Recruitment complete,,,,,,03/10/2020,http://en.irct.ir/trial/50977,,0,0
4067,IRCT20131125015536N13,Recruitment complete,,,,,,03/10/2020,http://en.irct.ir/trial/51310,,0,0
4068,IRCT20201001048893N1,Recruitment complete,,14/05/2020,,,,03/10/2020,http://en.irct.ir/trial/51328,14/05/2020,0,0
4069,IRCT20100623004251N13,Recruitment complete,,,,,,09/10/2020,http://en.irct.ir/trial/42393,,0,0
4070,IRCT20200324046850N5,Recruitment complete,,,,,,17/10/2020,http://en.irct.ir/trial/46751,,0,0
4071,IRCT20200414047072N1,Recruitment complete,,,,,,22/10/2020,http://en.irct.ir/trial/47163,,0,0
4072,IRCT20200328046885N1,Recruitment complete,,,,,,12/10/2020,http://en.irct.ir/trial/47565,,0,0
4073,IRCT20170731035423N2,Recruitment complete,,,,,,21/10/2020,http://en.irct.ir/trial/48049,,0,0
4074,IRCT20200531047619N1,Recruitment complete,,,,,,18/10/2020,http://en.irct.ir/trial/48766,,0,0
4075,IRCT20200802048267N1,Recruitment complete,,,,,,20/10/2020,http://en.irct.ir/trial/50162,,0,0
4076,IRCT20200816048422N1,Recruitment complete,,,,,,16/10/2020,http://en.irct.ir/trial/50363,,0,0
4077,IRCT20150808023559N23,Recruitment complete,,,,,,11/10/2020,http://en.irct.ir/trial/50405,,0,0
4078,IRCT20200825048514N1,Recruitment complete,,,,,,10/10/2020,http://en.irct.ir/trial/50543,,0,0
4079,IRCT20200328046886N2,Recruitment complete,,,,,,12/10/2020,http://en.irct.ir/trial/50980,,0,0
4080,IRCT20080901001165N63,Recruitment complete,,,,,,26/10/2020,http://en.irct.ir/trial/51157,,0,0
4081,IRCT20100228003449N31,Recruitment complete,,,,,,08/10/2020,http://en.irct.ir/trial/51163,,0,0
4082,IRCT20200923048815N1,Recruitment complete,,,,,,15/10/2020,http://en.irct.ir/trial/51166,,0,0
4083,IRCT20200922048804N1,Recruitment complete,,,,,,06/10/2020,http://en.irct.ir/trial/51177,,0,0
4084,IRCT20200404046937N5,Recruitment complete,,,,,,14/10/2020,http://en.irct.ir/trial/51178,,0,0
4085,IRCT20200928048867N1,Recruitment complete,,,,,,22/10/2020,http://en.irct.ir/trial/51319,,0,0
4086,IRCT20201003048904N1,Recruitment complete,,,,,,11/10/2020,http://en.irct.ir/trial/51364,,0,0
4087,IRCT20201003048905N1,Recruitment complete,,31/07/2020,,,,07/10/2020,http://en.irct.ir/trial/51394,31/07/2020,0,0
4088,IRCT20201004048922N1,Recruitment complete,,,,,,10/10/2020,http://en.irct.ir/trial/51443,,0,0
4089,IRCT20201005048936N1,Recruitment complete,,,,,,26/10/2020,http://en.irct.ir/trial/51499,,0,0
4090,IRCT20181208041886N1,Recruitment complete,,,,,,18/10/2020,http://en.irct.ir/trial/51501,,0,0
4091,IRCT20200128046294N3,Recruitment complete,,,,,,22/10/2020,http://en.irct.ir/trial/51585,,0,0
4092,IRCT20200930048892N1,Recruitment complete,,,,,,18/10/2020,http://en.irct.ir/trial/51595,,0,0
4093,IRCT20160131026298N2,Recruitment complete,,24/03/2020,,,,05/11/2020,http://en.irct.ir/trial/46733,24/03/2020,0,0
4094,IRCT20160131026298N3,Recruitment complete,,,,,,02/11/2020,http://en.irct.ir/trial/47019,,0,0
4095,IRCT20200415047080N2,Recruitment complete,,,,,,07/11/2020,http://en.irct.ir/trial/47186,,0,0
4096,IRCT20121216011763N46,Recruitment complete,,,,,,31/10/2020,http://en.irct.ir/trial/47529,,0,0
4097,IRCT20200415047080N1,Recruitment complete,,,,,,02/11/2020,http://en.irct.ir/trial/47982,,0,0
4098,IRCT20200608047686N2,Recruitment complete,,,,,,19/11/2020,http://en.irct.ir/trial/48933,,0,0
4099,IRCT20151227025726N24,Recruitment complete,,,,,,25/11/2020,http://en.irct.ir/trial/49043,,0,0
4100,IRCT20200624047908N1,Recruitment complete,,,,,,09/11/2020,http://en.irct.ir/trial/49198,,0,0
4101,IRCT20150623022884N3,Recruitment complete,,14/06/2020,,,,18/11/2020,http://en.irct.ir/trial/49249,14/06/2020,0,0
4102,IRCT20130428013151N2,Recruitment complete,,,,,,28/10/2020,http://en.irct.ir/trial/49356,,0,0
4103,IRCT20200506047323N6,Recruitment complete,,,,,,17/11/2020,http://en.irct.ir/trial/49501,,0,0
4104,IRCT20160131026298N6,Recruitment complete,,,,,,01/11/2020,http://en.irct.ir/trial/50246,,0,0
4105,IRCT20160919029870N3,Recruitment complete,,20/06/2020,,,,24/11/2020,http://en.irct.ir/trial/50425,20/06/2020,0,0
4106,IRCT20200711048077N1,Recruitment complete,,,,,,16/11/2020,http://en.irct.ir/trial/50721,,0,0
4107,IRCT20200408046987N2,Recruitment complete,,,,,,07/11/2020,http://en.irct.ir/trial/51007,,0,0
4108,IRCT20200921048786N1,Recruitment complete,,,,,,11/11/2020,http://en.irct.ir/trial/51086,,0,0
4109,IRCT20151227025726N23,Recruitment complete,,,,,,10/11/2020,http://en.irct.ir/trial/51473,,0,0
4110,IRCT20181030041504N1,Recruitment complete,,,,,,08/11/2020,http://en.irct.ir/trial/51482,,0,0
4111,IRCT20200428047229N3,Recruitment complete,,,,,,25/11/2020,http://en.irct.ir/trial/51516,,0,0
4112,IRCT20201012049010N1,Recruitment complete,,30/10/2020,,,,12/11/2020,http://en.irct.ir/trial/51591,30/10/2020,0,0
4113,IRCT20200426047206N4,Recruitment complete,,,,,,01/11/2020,http://en.irct.ir/trial/51687,,0,0
4114,IRCT20150825023753N17,Recruitment complete,,20/07/2020,,,,01/11/2020,http://en.irct.ir/trial/51709,20/07/2020,0,0
4115,IRCT20201015049030N1,Recruitment complete,,,,,,07/11/2020,http://en.irct.ir/trial/51736,,0,0
4116,IRCT20201020049088N1,Recruitment complete,,,,,,15/11/2020,http://en.irct.ir/trial/51748,,0,0
4117,IRCT20201016049048N1,Recruitment complete,,,,,,04/11/2020,http://en.irct.ir/trial/51767,,0,0
4118,IRCT20201015049036N1,Recruitment complete,,16/11/2020,,,,27/11/2020,http://en.irct.ir/trial/51772,16/11/2020,0,0
4119,IRCT20181208041886N2,Recruitment complete,,,,,,29/10/2020,http://en.irct.ir/trial/51774,,0,0
4120,IRCT20200720048139N1,Recruitment complete,,,,,,09/11/2020,http://en.irct.ir/trial/51784,,0,0
4121,IRCT20200927048848N2,Recruitment complete,,,,,,04/11/2020,http://en.irct.ir/trial/51922,,0,0
4122,IRCT20170809035597N2,Recruitment complete,,,,,,16/11/2020,http://en.irct.ir/trial/51927,,0,0
4123,IRCT20191211045691N2,Recruitment complete,,,,,,02/11/2020,http://en.irct.ir/trial/51951,,0,0
4124,IRCT20190713044192N2,Recruitment complete,,,,,,21/11/2020,http://en.irct.ir/trial/52153,,0,0
4125,IRCT20170315033086N7,recruiting,,,,,,12/11/2020,http://en.irct.ir/trial/52223,,0,0
4126,IRCT20190804044429N4,Recruitment complete,,,,,,25/11/2020,http://en.irct.ir/trial/52284,,0,0
4127,IRCT20200204046369N1,Recruitment complete,,15/11/2020,,,,07/12/2020,http://en.irct.ir/trial/46776,15/11/2020,0,0
4128,IRCT20200415047082N1,Recruitment complete,,,,,,02/12/2020,http://en.irct.ir/trial/47193,,0,0
4129,IRCT20200421047153N1,Recruitment complete,,,,,,19/12/2020,http://en.irct.ir/trial/47337,,0,0
4130,IRCT20140312016968N2,Recruitment complete,,,,,,07/12/2020,http://en.irct.ir/trial/47381,,0,0
4131,IRCT20080901001165N59,Recruitment complete,,27/09/2020,,,,12/12/2020,http://en.irct.ir/trial/47477,27/09/2020,0,0
4132,IRCT20180610040049N6,Recruitment complete,,,,,,04/12/2020,http://en.irct.ir/trial/47626,,0,0
4133,IRCT20200621047859N2,Recruitment complete,,08/12/2020,,,,29/12/2020,http://en.irct.ir/trial/49382,08/12/2020,0,0
4134,IRCT20200516047462N2,Recruitment complete,,,,,,27/12/2020,http://en.irct.ir/trial/49628,,0,0
4135,IRCT20120703010178N22,Recruitment complete,,,,,,06/07/2021,http://en.irct.ir/trial/49850,,0,0
4136,IRCT20160131026298N5,Recruitment complete,,,,,,13/12/2020,http://en.irct.ir/trial/49886,,0,0
4137,IRCT20200727048217N1,Recruitment complete,,,,,,10/12/2020,http://en.irct.ir/trial/49924,,0,0
4138,IRCT20200731048257N1,Recruitment complete,,,,,,02/12/2020,http://en.irct.ir/trial/50012,,0,0
4139,IRCT20161206031255N4,Recruitment complete,,,,,,07/12/2020,http://en.irct.ir/trial/50229,,0,0
4140,IRCT20170611034452N12,Recruitment complete,,14/05/2020,,,,20/12/2020,http://en.irct.ir/trial/50289,14/05/2020,0,0
4141,IRCT20200818048444N1,Recruitment complete,,,,,,13/12/2020,http://en.irct.ir/trial/50780,,0,0
4142,IRCT20150830023823N3,Recruitment complete,,,,,,06/12/2020,http://en.irct.ir/trial/50854,,0,0
4143,IRCT20200921048783N1,Recruitment complete,,,,,,06/12/2020,http://en.irct.ir/trial/51199,,0,0
4144,IRCT20200927048849N1,Recruitment complete,,25/11/2020,,,,05/12/2020,http://en.irct.ir/trial/51259,25/11/2020,0,0
4145,IRCT20201004048923N1,Recruitment complete,,,,,,13/12/2020,http://en.irct.ir/trial/51442,,0,0
4146,IRCT20201001048894N1,Recruitment complete,,,,,,15/12/2020,http://en.irct.ir/trial/51492,,0,0
4147,IRCT20181208041886N3,Recruitment complete,,,,,,22/12/2020,http://en.irct.ir/trial/51633,,0,0
4148,IRCT20201028049175N1,Recruitment complete,,,,,,12/12/2020,http://en.irct.ir/trial/51946,,0,0
4149,IRCT20200408046987N3,Recruitment complete,,,,,,06/12/2020,http://en.irct.ir/trial/51999,,0,0
4150,IRCT20080901001157N17,Recruitment complete,,,,,,29/11/2020,http://en.irct.ir/trial/52070,,0,0
4151,IRCT20180625040232N7,Recruitment complete,,,,,,30/11/2020,http://en.irct.ir/trial/52081,,0,0
4152,IRCT20110302005952N2,Recruitment complete,,,,,,17/12/2020,http://en.irct.ir/trial/52356,,0,0
4153,IRCT20180205038626N7,Recruitment complete,,,,,,27/12/2020,http://en.irct.ir/trial/52374,,0,0
4154,IRCT20201003048904N2,Recruitment complete,,,,,,10/12/2020,http://en.irct.ir/trial/52607,,0,0
4155,IRCT20201128049508N1,Recruitment complete,,,,,,28/12/2020,http://en.irct.ir/trial/52648,,0,0
4156,IRCT20171219037964N3,Recruitment complete,,,,,,02/12/2020,http://en.irct.ir/trial/52696,,0,0
4157,IRCT20201202049567N1,Recruitment complete,,,,,,15/12/2020,http://en.irct.ir/trial/52701,,0,0
4158,IRCT20171219037964N2,Recruitment complete,,,,,,02/12/2020,http://en.irct.ir/trial/52709,,0,0
4159,IRCT20100130003227N15,recruiting,,,,,,10/12/2020,http://en.irct.ir/trial/52719,,0,0
4160,IRCT20190415043279N9,Recruitment complete,,,,,,22/12/2020,http://en.irct.ir/trial/52853,,0,0
4161,IRCT20170218032635N3,recruiting,,,,,,27/12/2020,http://en.irct.ir/trial/53134,,0,0
4162,IRCT20200818048444N2,Recruitment complete,,,,,,31/12/2020,http://en.irct.ir/trial/53165,,0,0
4163,IRCT20190409043215N2,Recruitment complete,,,,,,14/02/2021,http://en.irct.ir/trial/46581,,0,0
4164,IRCT20150303021315N22,Recruitment complete,,,,,,27/01/2021,http://en.irct.ir/trial/46955,,0,0
4165,IRCT20170210032478N3,Recruitment complete,,,,,,02/01/2021,http://en.irct.ir/trial/47173,,0,0
4166,IRCT20140407017169N2,Recruitment complete,,30/08/2020,,,,02/02/2021,http://en.irct.ir/trial/47295,30/08/2020,0,0
4167,IRCT20200424047184N1,Recruitment complete,,30/12/2020,,,,16/01/2021,http://en.irct.ir/trial/47775,30/12/2020,0,0
4168,IRCT20081027001411N4,Recruitment complete,,,,,,27/01/2021,http://en.irct.ir/trial/48396,,0,0
4169,IRCT20200611047727N3,Recruitment complete,,,,,,03/01/2021,http://en.irct.ir/trial/49116,,0,0
4170,IRCT20180103038199N3,recruiting,,,,,,27/01/2021,http://en.irct.ir/trial/49775,,0,0
4171,IRCT20191211045691N1,Recruitment complete,,,,,,05/01/2021,http://en.irct.ir/trial/49879,,0,0
4172,IRCT20200906048638N1,Recruitment complete,,,,,,01/02/2021,http://en.irct.ir/trial/50860,,0,0
4173,IRCT20200921048794N1,Recruitment complete,,,,,,09/01/2021,http://en.irct.ir/trial/51120,,0,0
4174,IRCT20200928048865N1,Recruitment complete,,29/01/2021,,,,01/01/2021,http://en.irct.ir/trial/51258,29/01/2021,0,0
4175,IRCT20191125045496N3,Recruitment complete,,01/10/2020,,,,25/01/2021,http://en.irct.ir/trial/51644,01/10/2020,0,0
4176,IRCT20201024049134N1,Recruitment complete,,,,,,17/01/2021,http://en.irct.ir/trial/51847,,0,0
4177,IRCT20111121008146N34,Recruitment complete,,,,,,24/01/2021,http://en.irct.ir/trial/51948,,0,0
4178,IRCT20201111049348N1,Recruitment complete,,,,,,03/01/2021,http://en.irct.ir/trial/52276,,0,0
4179,IRCT20200611047735N2,Recruitment complete,,,,,,13/02/2021,http://en.irct.ir/trial/52426,,0,0
4180,IRCT20201122049463N1,Recruitment complete,,10/03/2021,,,,18/01/2021,http://en.irct.ir/trial/52495,10/03/2021,0,0
4181,IRCT20200927048849N2,Recruitment complete,,,,,,06/01/2021,http://en.irct.ir/trial/52537,,0,0
4182,IRCT20201125049486N1,Recruitment complete,,,,,,14/02/2021,http://en.irct.ir/trial/52541,,0,0
4183,IRCT20170123032129N9,Recruitment complete,,,,,,05/01/2021,http://en.irct.ir/trial/52574,,0,0
4184,IRCT20201128049520N1,Recruitment complete,,,,,,22/02/2021,http://en.irct.ir/trial/52677,,0,0
4185,IRCT20201119049445N1,Recruitment complete,,,,,,13/02/2021,http://en.irct.ir/trial/52747,,0,0
4186,IRCT20201202049566N1,Recruitment complete,,,,,,22/01/2021,http://en.irct.ir/trial/52800,,0,0
4187,IRCT20190717044241N3,Recruitment complete,,,,,,02/01/2021,http://en.irct.ir/trial/52820,,0,0
4188,IRCT20160808029255N10,Recruitment complete,,,,,,10/01/2021,http://en.irct.ir/trial/52822,,0,0
4189,IRCT20200621047859N4,Recruitment complete,,,,,,03/01/2021,http://en.irct.ir/trial/52947,,0,0
4190,IRCT20201213049693N1,Recruitment complete,,,,,,13/02/2021,http://en.irct.ir/trial/53006,,0,0
4191,IRCT20180316039112N3,Recruitment complete,,21/12/2020,,,,01/02/2021,http://en.irct.ir/trial/53059,21/12/2020,0,0
4192,IRCT20200318046812N3,Recruitment complete,,,,,,12/01/2021,http://en.irct.ir/trial/53187,,0,0
4193,IRCT20201127049505N1,Recruitment complete,,,,,,06/02/2021,http://en.irct.ir/trial/53212,,0,0
4194,IRCT20170807035551N2,Recruitment complete,,,,,,16/01/2021,http://en.irct.ir/trial/53252,,0,0
4195,IRCT20160110025929N34,recruiting,,,,,,16/01/2021,http://en.irct.ir/trial/53265,,0,0
4196,IRCT20201223049816N1,Recruitment complete,,,,,,11/01/2021,http://en.irct.ir/trial/53342,,0,0
4197,IRCT20201028049175N3,recruiting,,,,,,15/01/2021,http://en.irct.ir/trial/53410,,0,0
4198,IRCT20200223046586N3,Recruitment complete,,,,,,11/01/2021,http://en.irct.ir/trial/53538,,0,0
4199,IRCT20210109049978N1,Recruitment complete,,,,,,13/01/2021,http://en.irct.ir/trial/53594,,0,0
4200,IRCT20110425006280N11,Recruitment complete,,,,,,27/01/2021,http://en.irct.ir/trial/53644,,0,0
4201,IRCT20210111050011N1,Recruitment complete,,,,,,16/02/2021,http://en.irct.ir/trial/53741,,0,0
4202,IRCT20210120050092N1,recruiting,,,,,,19/02/2021,http://en.irct.ir/trial/53834,,0,0
4203,IRCT20190804044429N6,Recruitment complete,,,,,,20/02/2021,http://en.irct.ir/trial/54008,,0,0
4204,IRCT20210205050247N1,Recruitment complete,,,,,,13/02/2021,http://en.irct.ir/trial/54178,,0,0
4205,IRCT20200506047323N7,recruiting,,,,,,16/02/2021,http://en.irct.ir/trial/54268,,0,0
4206,IRCT20210214050350N1,Recruitment complete,,,,,,22/02/2021,http://en.irct.ir/trial/54295,,0,0
4207,IRCT20210214050356N1,recruiting,,,,,,22/02/2021,http://en.irct.ir/trial/54351,,0,0
4208,IRCT20200509047364N3,Recruitment complete,,,,,,20/02/2021,http://en.irct.ir/trial/54372,,0,0
4209,IRCT20190804044429N5,Recruitment complete,,,,,,18/02/2021,http://en.irct.ir/trial/54385,,0,0
4210,IRCT20190810044500N5,Recruitment complete,,14/01/2021,,,,12/04/2021,http://en.irct.ir/trial/46867,14/01/2021,0,0
4211,IRCT20200610047722N1,Recruitment complete,,,,,,29/03/2021,http://en.irct.ir/trial/48869,,0,0
4212,IRCT20150725023332N4,Recruitment complete,,,,,,08/03/2021,http://en.irct.ir/trial/49124,,0,0
4213,IRCT20150725023332N5,Recruitment complete,,,,,,06/04/2021,http://en.irct.ir/trial/49150,,0,0
4214,IRCT20200629047953N1,recruiting,,,,,,17/03/2021,http://en.irct.ir/trial/49449,,0,0
4215,IRCT20200707048047N1,recruiting,,,,,,27/03/2021,http://en.irct.ir/trial/49766,,0,0
4216,IRCT20200509047373N2,Recruitment complete,,,,,,13/04/2021,http://en.irct.ir/trial/50551,,0,0
4217,IRCT20150815023620N9,Recruitment complete,,01/08/2020,,,,13/03/2021,http://en.irct.ir/trial/52045,01/08/2020,0,0
4218,IRCT20130812014333N164,Recruitment complete,,,,,,01/04/2021,http://en.irct.ir/trial/52416,,0,0
4219,IRCT20200927048849N3,Recruitment complete,,,,,,17/03/2021,http://en.irct.ir/trial/52429,,0,0
4220,IRCT20200823048495N1,Recruitment complete,,01/07/2020,,,,21/03/2021,http://en.irct.ir/trial/52742,01/07/2020,0,0
4221,IRCT20110423006257N3,Recruitment complete,,,,,,03/04/2021,http://en.irct.ir/trial/53279,,0,0
4222,IRCT20201111049348N2,Recruitment complete,,,,,,25/02/2021,http://en.irct.ir/trial/53645,,0,0
4223,IRCT20160516027929N8,Recruitment complete,,21/11/2020,,,,02/03/2021,http://en.irct.ir/trial/53646,21/11/2020,0,0
4224,IRCT20150902023864N2,Recruitment complete,,,,,,15/03/2021,http://en.irct.ir/trial/53653,,0,0
4225,IRCT20210102049912N1,recruiting,,,,,,07/04/2021,http://en.irct.ir/trial/53693,,0,0
4226,IRCT20201212049681N1,Recruitment complete,,19/04/2021,,,,28/02/2021,http://en.irct.ir/trial/53702,19/04/2021,0,0
4227,IRCT20150711023153N2,Recruitment complete,,,,,,28/02/2021,http://en.irct.ir/trial/53860,,0,0
4228,IRCT20210123050116N1,recruiting,,,,,,04/03/2021,http://en.irct.ir/trial/53872,,0,0
4229,IRCT20111224008507N4,recruiting,,,,,,06/03/2021,http://en.irct.ir/trial/53949,,0,0
4230,IRCT20140810018754N12,Recruitment complete,,,,,,15/03/2021,http://en.irct.ir/trial/54036,,0,0
4231,IRCT20210203050233N1,Recruitment complete,,,,,,14/04/2021,http://en.irct.ir/trial/54085,,0,0
4232,IRCT20210202050219N1,Recruitment complete,,,,,,08/04/2021,http://en.irct.ir/trial/54110,,0,0
4233,IRCT20210204050238N1,recruiting,,,,,,02/03/2021,http://en.irct.ir/trial/54136,,0,0
4234,IRCT20111224008507N5,recruiting,,,,,,04/03/2021,http://en.irct.ir/trial/54402,,0,0
4235,IRCT20210218050404N1,recruiting,,,,,,10/03/2021,http://en.irct.ir/trial/54447,,0,0
4236,IRCT20180728040617N3,Recruitment complete,,,,,,14/03/2021,http://en.irct.ir/trial/54613,,0,0
4237,IRCT20200405046958N2,Recruitment complete,,,,,,14/04/2021,http://en.irct.ir/trial/54653,,0,0
4238,IRCT20160808029264N10,recruiting,,,,,,13/04/2021,http://en.irct.ir/trial/54655,,0,0
4239,IRCT20210223050466N1,Recruitment complete,,,,,,27/03/2021,http://en.irct.ir/trial/54662,,0,0
4240,IRCT20201124049480N1,Recruitment complete,,,,,,28/03/2021,http://en.irct.ir/trial/54675,,0,0
4241,IRCT20210301050536N1,Recruitment complete,,,,,,16/03/2021,http://en.irct.ir/trial/54698,,0,0
4242,IRCT20210213050344N1,Recruitment complete,,,,,,06/04/2021,http://en.irct.ir/trial/54710,,0,0
4243,IRCT20180226038870N1,recruiting,,,,,,05/03/2021,http://en.irct.ir/trial/54725,,0,0
4244,IRCT20201202049568N3,Recruitment complete,,,,,,05/03/2021,http://en.irct.ir/trial/54758,,0,0
4245,IRCT20200329046892N2,Recruitment complete,,,,,,09/03/2021,http://en.irct.ir/trial/54800,,0,0
4246,IRCT20200413047063N2,Recruitment complete,,,,,,08/07/2021,http://en.irct.ir/trial/54828,,0,0
4247,IRCT20201202049567N3,Recruitment complete,,,,,,13/03/2021,http://en.irct.ir/trial/54881,,0,0
4248,IRCT20200527047581N2,Recruitment complete,,,,,,17/03/2021,http://en.irct.ir/trial/54884,,0,0
4249,IRCT20201202049567N2,Recruitment complete,,,,,,13/03/2021,http://en.irct.ir/trial/54885,,0,0
4250,IRCT20210302050555N1,Recruitment complete,,,,,,28/03/2021,http://en.irct.ir/trial/54915,,0,0
4251,IRCT20180721040538N1,Recruitment complete,,,,,,25/03/2021,http://en.irct.ir/trial/54933,,0,0
4252,IRCT20180619040147N6,Recruitment complete,,,,,,01/04/2021,http://en.irct.ir/trial/54971,,0,0
4253,IRCT20210311050671N1,Recruitment complete,,,,,,13/04/2021,http://en.irct.ir/trial/54973,,0,0
4254,IRCT20171219037964N4,recruiting,,,,,,20/03/2021,http://en.irct.ir/trial/55028,,0,0
4255,IRCT20180302038915N1,recruiting,,,,,,05/04/2021,http://en.irct.ir/trial/55052,,0,0
4256,IRCT20151226025699N5,Recruitment complete,,,,,,07/04/2021,http://en.irct.ir/trial/55074,,0,0
4257,IRCT20131129015584N4,recruiting,,,,,,04/04/2021,http://en.irct.ir/trial/55081,,0,0
4258,IRCT20190303042889N1,recruiting,,,,,,30/03/2021,http://en.irct.ir/trial/55153,,0,0
4259,IRCT20210324050760N1,recruiting,,,,,,17/04/2021,http://en.irct.ir/trial/55187,,0,0
4260,IRCT20200329046892N3,Recruitment complete,,,,,,29/03/2021,http://en.irct.ir/trial/55216,,0,0
4261,IRCT20201214049709N2,Recruitment complete,,,,,,13/04/2021,http://en.irct.ir/trial/55238,,0,0
4262,IRCT20111210008348N51,recruiting,,,,,,10/04/2021,http://en.irct.ir/trial/55240,,0,0
4263,IRCT20210325050769N1,recruiting,,,,,,12/04/2021,http://en.irct.ir/trial/55493,,0,0
4264,IRCT20200330046897N1,Recruitment complete,,,,,,22/04/2021,http://en.irct.ir/trial/46918,,0,0
4265,IRCT20180429039463N2,Recruitment complete,,31/07/2020,,,,04/05/2021,http://en.irct.ir/trial/46933,31/07/2020,0,0
4266,IRCT20201111049347N1,recruiting,,,,,,27/04/2021,http://en.irct.ir/trial/52245,,0,0
4267,IRCT20201127049504N1,Recruitment complete,,24/03/2021,,,,17/05/2021,http://en.irct.ir/trial/52621,24/03/2021,0,0
4268,IRCT20201204049600N1,recruiting,,,,,,27/04/2021,http://en.irct.ir/trial/52772,,0,0
4269,IRCT20200904048616N1,recruiting,,,,,,06/05/2021,http://en.irct.ir/trial/52777,,0,0
4270,IRCT20201229049872N1,Recruitment complete,,,,,,22/04/2021,http://en.irct.ir/trial/53333,,0,0
4271,IRCT20201229049873N1,Recruitment complete,,,,,,23/05/2021,http://en.irct.ir/trial/53791,,0,0
4272,IRCT20171203037733N3,recruiting,,,,,,11/05/2021,http://en.irct.ir/trial/54252,,0,0
4273,IRCT20170903036041N3,recruiting,,,,,,23/05/2021,http://en.irct.ir/trial/54376,,0,0
4274,IRCT20210222050457N1,Recruitment complete,,,,,,20/04/2021,http://en.irct.ir/trial/54525,,0,0
4275,IRCT20210111050007N1,recruiting,,,,,,18/05/2021,http://en.irct.ir/trial/54533,,0,0
4276,IRCT20180612040068N1,Recruitment complete,,,,,,19/04/2021,http://en.irct.ir/trial/54625,,0,0
4277,IRCT20210303050558N1,Recruitment complete,,,,,,23/06/2021,http://en.irct.ir/trial/54833,,0,0
4278,IRCT20180103038199N4,recruiting,,,,,,24/04/2021,http://en.irct.ir/trial/54965,,0,0
4279,IRCT20200611047727N4,Recruitment complete,,,,,,28/04/2021,http://en.irct.ir/trial/55024,,0,0
4280,IRCT20200325046854N2,Recruitment complete,,,,,,03/05/2021,http://en.irct.ir/trial/55085,,0,0
4281,IRCT20210317050734N1,recruiting,,,,,,03/05/2021,http://en.irct.ir/trial/55130,,0,0
4282,IRCT20180205038626N8,recruiting,,,,,,09/05/2021,http://en.irct.ir/trial/55208,,0,0
4283,IRCT20200721048159N2,recruiting,,,,,,22/04/2021,http://en.irct.ir/trial/55368,,0,0
4284,IRCT20190101042197N2,Recruitment complete,,,,,,19/04/2021,http://en.irct.ir/trial/55380,,0,0
4285,IRCT20210327050775N1,recruiting,,,,,,25/05/2021,http://en.irct.ir/trial/55405,,0,0
4286,IRCT20210406050871N1,recruiting,,,,,,25/04/2021,http://en.irct.ir/trial/55531,,0,0
4287,IRCT20201129049525N1,Recruitment complete,,,,,,16/05/2021,http://en.irct.ir/trial/55602,,0,0
4288,IRCT20200411047029N1,Recruitment complete,,,,,,24/04/2021,http://en.irct.ir/trial/55615,,0,0
4289,IRCT20200914048719N2,Recruitment complete,,,,,,03/05/2021,http://en.irct.ir/trial/55619,,0,0
4290,IRCT20210413050957N1,recruiting,,,,,,01/05/2021,http://en.irct.ir/trial/55660,,0,0
4291,IRCT20210416050988N1,Recruitment complete,,,,,,24/05/2021,http://en.irct.ir/trial/55671,,0,0
4292,IRCT20151020024625N12,Recruitment complete,,,,,,30/04/2021,http://en.irct.ir/trial/55690,,0,0
4293,IRCT20160516027929N10,recruiting,,,,,,03/05/2021,http://en.irct.ir/trial/55715,,0,0
4294,IRCT20111224008507N6,Recruitment complete,,,,,,07/05/2021,http://en.irct.ir/trial/55727,,0,0
4295,IRCT20210408050899N1,Recruitment complete,,,,,,25/05/2021,http://en.irct.ir/trial/55757,,0,0
4296,IRCT20200723048178N2,recruiting,,,,,,28/04/2021,http://en.irct.ir/trial/55771,,0,0
4297,IRCT20210424051067N1,Recruitment complete,,,,,,11/05/2021,http://en.irct.ir/trial/55820,,0,0
4298,IRCT20160316027081N2,Recruitment complete,,,,,,13/05/2021,http://en.irct.ir/trial/56035,,0,0
4299,IRCT20210315050710N1,Recruitment complete,,,,,,10/05/2021,http://en.irct.ir/trial/56041,,0,0
4300,IRCT20121216011763N52,Recruitment complete,,,,,,23/05/2021,http://en.irct.ir/trial/56149,,0,0
4301,IRCT20150303021315N23,recruiting,,,,,,08/07/2021,http://en.irct.ir/trial/56287,,0,0
4302,IRCT20210510051243N1,recruiting,,,,,,25/05/2021,http://en.irct.ir/trial/56289,,0,0
4303,IRCT20080901001165N64,recruiting,,,,,,21/05/2021,http://en.irct.ir/trial/56367,,0,0
4304,IRCT20200223046586N4,recruiting,,,,,,24/05/2021,http://en.irct.ir/trial/56369,,0,0
4305,IRCT20200506047323N8,recruiting,,,,,,24/05/2021,http://en.irct.ir/trial/56388,,0,0
4306,IRCT20160305026917N2,Not yet recruiting,,,,,,25/05/2021,http://en.irct.ir/trial/56417,,0,0
4307,IRCT20191231045967N1,Recruitment complete,,,,,,15/06/2021,http://en.irct.ir/trial/45331,,0,0
4308,IRCT20200404046937N3,Recruitment complete,,,,,,02/06/2021,http://en.irct.ir/trial/49029,,0,0
4309,IRCT20200509047364N1,recruiting,,,,,,26/05/2021,http://en.irct.ir/trial/49282,,0,0
4310,IRCT20200404046937N4,Recruitment complete,,,,,,11/06/2021,http://en.irct.ir/trial/49935,,0,0
4311,IRCT20170315033086N10,Recruitment complete,,,,,,12/06/2021,http://en.irct.ir/trial/51631,,0,0
4312,IRCT20201101049219N1,Recruitment complete,,,,,,10/06/2021,http://en.irct.ir/trial/52099,,0,0
4313,IRCT20201024049130N1,recruiting,,,,,,21/06/2021,http://en.irct.ir/trial/52381,,0,0
4314,IRCT20200818048444N3,Recruitment complete,,,,,,20/06/2021,http://en.irct.ir/trial/52565,,0,0
4315,IRCT20201220049771N1,Recruitment complete,,,,,,13/06/2021,http://en.irct.ir/trial/53131,,0,0
4316,IRCT20210216050373N1,recruiting,,,,,,28/05/2021,http://en.irct.ir/trial/54375,,0,0
4317,IRCT20210310050663N1,Recruitment complete,,,,,,31/05/2021,http://en.irct.ir/trial/54929,,0,0
4318,IRCT20200721048159N3,recruiting,,,,,,03/06/2021,http://en.irct.ir/trial/54937,,0,0
4319,IRCT20210316050722N1,Recruitment complete,,,,,,30/05/2021,http://en.irct.ir/trial/55500,,0,0
4320,IRCT20210422051044N1,recruiting,,,,,,28/05/2021,http://en.irct.ir/trial/55824,,0,0
4321,IRCT20210427051100N1,recruiting,,,,,,19/06/2021,http://en.irct.ir/trial/55898,,0,0
4322,IRCT20210427051101N1,recruiting,,,,,,19/06/2021,http://en.irct.ir/trial/55906,,0,0
4323,IRCT20150711023153N3,recruiting,,,,,,04/06/2021,http://en.irct.ir/trial/55948,,0,0
4324,IRCT20210508051225N1,recruiting,,,,,,14/06/2021,http://en.irct.ir/trial/56223,,0,0
4325,IRCT20201129049524N1,recruiting,,,,,,26/05/2021,http://en.irct.ir/trial/56329,,0,0
4326,IRCT20140824018915N9,Recruitment complete,,,,,,04/06/2021,http://en.irct.ir/trial/56384,,0,0
4327,IRCT20210426051090N1,recruiting,,,,,,12/06/2021,http://en.irct.ir/trial/56387,,0,0
4328,IRCT20140804018677N9,recruiting,,,,,,19/06/2021,http://en.irct.ir/trial/56509,,0,0
4329,IRCT20141209020258N160,recruiting,,,,,,06/06/2021,http://en.irct.ir/trial/56545,,0,0
4330,IRCT20201024049134N2,recruiting,,,,,,04/06/2021,http://en.irct.ir/trial/56613,,0,0
4331,IRCT20201024049134N3,recruiting,,,,,,21/06/2021,http://en.irct.ir/trial/56624,,0,0
4332,IRCT20210522051363N1,Not yet recruiting,,,,,,13/06/2021,http://en.irct.ir/trial/56697,,0,0
4333,IRCT20210423051056N1,recruiting,,,,,,18/06/2021,http://en.irct.ir/trial/56733,,0,0
4334,IRCT20120215009014N398,recruiting,,,,,,20/06/2021,http://en.irct.ir/trial/56922,,0,0
4335,NL9553,"Inclusion stopped, follow up",,01/09/2022,,,,23/06/2021,https://trialregister.nl/trial/9553,01/09/2022,0,0
4336,NL9485,Open for patient inclusion,,01/07/2022,,,,18/05/2021,https://trialregister.nl/trial/9485,01/07/2022,0,0
4337,NL9436,Open for patient inclusion,,22/04/2022,,,,03/05/2021,https://trialregister.nl/trial/9436,22/04/2022,0,0
4338,NL9430,Open for patient inclusion,,01/06/2021,,,,26/04/2021,https://trialregister.nl/trial/9430,01/06/2021,0,0
4339,NL9419,Open for patient inclusion,,19/10/2022,,,,19/04/2021,https://trialregister.nl/trial/9419,19/10/2022,0,0
4340,NL9379,Open for patient inclusion,,31/03/2023,,,,29/03/2021,https://trialregister.nl/trial/9379,31/03/2023,0,0
4341,NL9365,Open for patient inclusion,,30/04/2021,,,,25/03/2021,https://trialregister.nl/trial/9365,30/04/2021,0,0
4342,NL9354,Open for patient inclusion,,01/07/2021,,,,23/03/2021,https://trialregister.nl/trial/9354,01/07/2021,0,0
4343,NL9334,Open for patient inclusion,,20/12/2021,,,,10/03/2021,https://trialregister.nl/trial/9334,20/12/2021,0,0
4344,NL9320,Planned,,31/12/2021,,,,17/03/2021,https://trialregister.nl/trial/9320,31/12/2021,0,0
4345,NL9275,Planned,,01/08/2022,,,,16/02/2021,https://trialregister.nl/trial/9275,01/08/2022,0,0
4346,NL9220,Open for patient inclusion,,31/12/2021,,,,25/01/2021,https://trialregister.nl/trial/9220,31/12/2021,0,0
4347,NL9161,Recruitment status not public,,23/10/2022,,,,08/01/2021,https://trialregister.nl/trial/9161,23/10/2022,0,0
4348,NL9141,Planned,,23/12/2022,,,,13/01/2021,https://trialregister.nl/trial/9141,23/12/2022,0,0
4349,NL9081,"Stopped, trial finished",,09/06/2021,,,,10/06/2021,https://trialregister.nl/trial/9081,09/06/2021,0,0
4350,NL9019,Recruitment status not public,,23/10/2022,,,,08/11/2020,https://trialregister.nl/trial/9019,23/10/2022,0,0
4351,NL9007,Open for patient inclusion,,31/01/2021,,,,29/10/2020,https://trialregister.nl/trial/9007,31/01/2021,0,0
4352,NL8993,Open for patient inclusion,,01/07/2022,,,,18/05/2021,https://trialregister.nl/trial/8993,01/07/2022,0,0
4353,NL8954,Open for patient inclusion,,01/06/2021,,,,24/11/2020,https://trialregister.nl/trial/8954,01/06/2021,0,0
4354,NL8947,Open for patient inclusion,,05/10/2022,,,,30/04/2021,https://trialregister.nl/trial/8947,05/10/2022,0,0
4355,NL8922,Planned,,01/10/2022,,,,23/09/2020,https://trialregister.nl/trial/8922,01/10/2022,0,0
4356,NL8903,Open for patient inclusion,,31/03/2022,,,,15/09/2020,https://trialregister.nl/trial/8903,31/03/2022,0,0
4357,NL8842,Open for patient inclusion,,09/04/2021,,,,18/08/2020,https://trialregister.nl/trial/8842,09/04/2021,0,0
4358,NL8835,"Inclusion stopped, follow up",,31/12/2021,,,,24/06/2021,https://trialregister.nl/trial/8835,31/12/2021,0,0
4359,NL8787,Open for patient inclusion,,31/12/2020,,,,21/07/2020,https://trialregister.nl/trial/8787,31/12/2020,0,0
4360,NL8726,Open for patient inclusion,,09/09/2020,,,,23/06/2020,https://trialregister.nl/trial/8726,09/09/2020,0,0
4361,NL8633,Open for patient inclusion,,01/05/2021,,,,25/05/2020,https://trialregister.nl/trial/8633,01/05/2021,0,0
4362,NL8609,Planned,,08/06/2020,,,,11/05/2020,https://trialregister.nl/trial/8609,08/06/2020,0,0
4363,NL8578,Planned,,13/07/2022,,,,08/05/2020,https://trialregister.nl/trial/8578,13/07/2022,0,0
4364,NL8577,Planned,,31/12/2022,,,,11/05/2020,https://trialregister.nl/trial/8577,31/12/2022,0,0
4365,NL8547,Open for patient inclusion,,18/04/2022,,,,22/04/2020,https://trialregister.nl/trial/8547,18/04/2022,0,0
4366,NL8538,Stopped,,17/04/2021,,,,06/07/2020,https://trialregister.nl/trial/8538,17/04/2021,0,0
4367,NL8523,Planned,,31/05/2020,,,,14/04/2020,https://trialregister.nl/trial/8523,31/05/2020,0,0
4368,NL8521,Planned,,08/11/2020,,,,07/05/2020,https://trialregister.nl/trial/8521,08/11/2020,0,0
4369,NL8504,"Stopped, trial finished",,01/06/2021,,,,22/06/2021,https://trialregister.nl/trial/8504,01/06/2021,0,0
4370,NL8491,Open for patient inclusion,,30/06/2020,,,,31/03/2020,https://trialregister.nl/trial/8491,30/06/2020,0,0
4371,NL8490,Stopped,,12/04/2021,,,,06/06/2020,https://trialregister.nl/trial/8490,12/04/2021,0,0
4372,NL8483,Open for patient inclusion,,29/03/2020,,,,26/03/2020,https://trialregister.nl/trial/8483,29/03/2020,0,0
4373,NL8477,Planned,,31/03/2021,,,,19/08/2020,https://trialregister.nl/trial/8477,31/03/2021,0,0
4374,CTRI/2020/03/024402,Not Yet Recruiting,,,,,,31/03/2020,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=42638,,0,0
4375,CTRI/2020/04/024479,Not Yet Recruiting,,,,,,31/08/2020,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=42713,,0,0
4376,CTRI/2020/04/024659,Completed,,28/05/2020,,,,02/06/2020,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=42967,28/05/2020,0,0
4377,CTRI/2020/04/024706,Completed,,30/05/2020,,,,04/06/2020,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=43039,30/05/2020,0,0
4378,CTRI/2020/04/024731,Not Yet Recruiting,,,,,,18/04/2020,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=42912,,0,0
4379,CTRI/2020/04/024729,Not Yet Recruiting,,,,,,20/04/2020,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=42933,,0,0
4380,CTRI/2020/04/024747,Not Yet Recruiting,,,,"Mouli TC, Davuluri A, Vijaya S, Priyanka AD, Mishra SK. Effectiveness of simulation based teaching of ventilatory management among non-anaesthesiology residents to manage COVID 19 pandemic - A quasi experimental cross sectional pilot study. Indian J Anaesth 2020;64:S136-40.",,27/05/2020,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=43115,,0,1
4381,CTRI/2020/04/024775,Completed,,10/08/2020,,"Agarwal Anup, Mukherjee Aparna, Kumar Gunjan, Chatterjee Pranab, Bhatnagar Tarun, Malhotra Pankaj et al. Convalescent plasma in the management of moderate covid-19 in adults in India: open label phase II multicentre randomised controlled trial (PLACID Trial) BMJ 2020; 371 :m3939",,02/02/2021,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=43149,10/08/2020,0,1
4382,CTRI/2020/04/024773,Open to Recruitment,,,,,,27/08/2020,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=42897,,0,0
4383,CTRI/2020/04/024749,Closed to Recruitment of Participants,,,,,,22/07/2020,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=42972,,0,0
4384,CTRI/2020/04/024806,Open to Recruitment,,,,,,20/05/2020,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=42843,,0,0
4385,CTRI/2020/04/024804,Completed,,23/10/2020,,,,16/06/2021,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=42849,23/10/2020,0,0
4386,CTRI/2020/04/024776,Open to Recruitment,,,,,,23/04/2020,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=43160,,0,0
4387,CTRI/2020/04/024833,Not Yet Recruiting,,,,,,01/06/2020,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=43105,,0,0
4388,CTRI/2020/04/024846,Open to Recruitment,,,,,,25/01/2021,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=43004,,0,0
4389,CTRI/2020/04/024857,Not Yet Recruiting,,,,,,25/04/2020,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=43212,,0,0
4390,CTRI/2020/04/024858,Not Yet Recruiting,,,,,,25/04/2020,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=43236,,0,0
4391,CTRI/2020/04/024882,Not Yet Recruiting,,,,,,17/12/2020,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=42899,,0,0
4392,CTRI/2020/04/024904,Not Yet Recruiting,,,,,,28/04/2020,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=43130,,0,0
4393,CTRI/2020/04/024883,Completed,,24/08/2020,,,,06/05/2021,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=43168,24/08/2020,0,0
4394,CTRI/2020/04/024915,Not Yet Recruiting,,,,,,05/05/2020,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=43332,,0,0
4395,CTRI/2020/04/024948,Not Yet Recruiting,,,,,,30/04/2020,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=43364,,0,0
4396,CTRI/2020/04/024949,Open to Recruitment,,,,,,27/07/2020,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=43400,,0,0
4397,CTRI/2020/04/024947,Not Yet Recruiting,,,,,,30/04/2020,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=43259,,0,0
4398,CTRI/2020/05/024967,Completed,,,,,,14/09/2020,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=43338,,0,0
4399,CTRI/2020/05/024959,Completed,,07/07/2020,,,,21/08/2020,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=42878,07/07/2020,0,0
4400,CTRI/2020/05/024969,Not Yet Recruiting,,,,,,28/09/2020,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=43393,,0,0
4401,CTRI/2020/05/024962,Open to Recruitment,,,,,,06/07/2021,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=43237,,0,0
4402,CTRI/2020/05/024981,Completed,,15/10/2020,,,,14/03/2021,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=43374,15/10/2020,0,0
4403,CTRI/2020/05/024983,Not Yet Recruiting,,,,,,02/05/2020,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=43204,,0,0
4404,CTRI/2020/05/024986,Not Yet Recruiting,,,,,,03/05/2020,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=43455,,0,0
4405,CTRI/2020/05/025013,Not Yet Recruiting,,,,,,04/05/2020,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=42858,,0,0
4406,CTRI/2020/05/025022,Not Yet Recruiting,,,,,,05/05/2020,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=43183,,0,0
4407,CTRI/2020/05/025067,Closed to Recruitment of Participants,,,,,,12/05/2021,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=43019,,0,0
4408,CTRI/2020/05/025049,Not Yet Recruiting,,,,,,05/05/2020,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=43313,,0,0
4409,CTRI/2020/05/025069,Not Yet Recruiting,,,,,,16/10/2020,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=43522,,0,0
4410,CTRI/2020/05/025068,Not Yet Recruiting,,,,,,07/05/2020,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=43449,,0,0
4411,CTRI/2020/05/025071,Not Yet Recruiting,,,,,,08/05/2020,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=43447,,0,0
4412,CTRI/2020/05/025088,Not Yet Recruiting,,,,,,08/05/2020,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=43555,,0,0
4413,CTRI/2020/05/025093,Not Yet Recruiting,,,,,,10/05/2020,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=43539,,0,0
4414,CTRI/2020/05/025114,Completed,,15/06/2020,,,,27/07/2020,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=43504,15/06/2020,0,0
4415,CTRI/2020/05/025156,Completed,,01/11/2020,,,,01/07/2021,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=43590,01/11/2020,0,0
4416,CTRI/2020/05/025162,Other (Terminated),,,,,,08/06/2021,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=43650,,0,0
4417,CTRI/2020/05/025161,Completed,,15/06/2020,,,,27/10/2020,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=43442,15/06/2020,0,0
4418,CTRI/2020/05/025166,Not Yet Recruiting,,,,,,13/05/2020,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=43553,,0,0
4419,CTRI/2020/05/025178,Not Yet Recruiting,,,,,,13/05/2020,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=43557,,0,0
4420,CTRI/2020/05/025167,Open to Recruitment,,,,,,17/08/2020,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=43378,,0,0
4421,CTRI/2020/05/025171,Not Yet Recruiting,,,,,,13/05/2020,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=43487,,0,0
4422,CTRI/2020/05/025213,Not Yet Recruiting,,,,,,15/05/2020,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=43698,,0,0
4423,CTRI/2020/05/025205,Not Yet Recruiting,,,,,,20/05/2020,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=43721,,0,0
4424,CTRI/2020/05/025214,Completed,,19/08/2020,,,,13/04/2021,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=43727,19/08/2020,0,0
4425,CTRI/2020/05/025209,Completed,,15/10/2020,,,,02/02/2021,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=43251,15/10/2020,0,0
4426,CTRI/2020/05/025215,Completed,,15/06/2020,,,,12/10/2020,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=43769,15/06/2020,0,0
4427,CTRI/2020/05/025222,Other (Terminated),,,,,,24/06/2021,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=43803,,0,0
4428,CTRI/2020/05/025224,Not Yet Recruiting,,,,,,16/05/2020,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=43728,,0,0
4429,CTRI/2020/05/025242,Not Yet Recruiting,,,,,,18/05/2020,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=43057,,0,0
4430,CTRI/2020/05/025272,Not Yet Recruiting,,,,,,20/05/2020,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=43790,,0,0
4431,CTRI/2020/05/025254,Completed,,14/08/2020,,,,13/10/2020,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=43630,14/08/2020,0,0
4432,CTRI/2020/05/025276,Completed,,17/06/2020,,,,21/06/2020,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=43892,17/06/2020,0,0
4433,CTRI/2020/05/025273,Completed,,14/06/2020,,,,17/03/2021,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=43900,14/06/2020,0,0
4434,CTRI/2020/05/025275,Completed,,21/09/2020,,,,09/10/2020,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=43917,21/09/2020,0,0
4435,CTRI/2020/05/025271,Open to Recruitment,,,,,,03/02/2021,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=43206,,0,0
4436,CTRI/2020/05/025248,Not Yet Recruiting,,,,,,19/05/2020,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=43479,,0,0
4437,CTRI/2020/05/025277,Open to Recruitment,,,,,,03/02/2021,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=43176,,0,0
4438,CTRI/2020/05/025299,Completed,,28/08/2020,,,,22/12/2020,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=43752,28/08/2020,0,0
4439,CTRI/2020/05/025298,Not Yet Recruiting,,,,,,21/05/2020,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=43761,,0,0
4440,CTRI/2020/05/025320,Open to Recruitment,,,,,,22/05/2020,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=43576,,0,0
4441,CTRI/2020/05/025317,Completed,,09/07/2020,,,,26/07/2020,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=43754,09/07/2020,0,0
4442,CTRI/2020/05/025319,Open to Recruitment,,,,,,17/06/2020,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=42751,,0,0
4443,CTRI/2020/05/025331,Not Yet Recruiting,,,,,,23/05/2020,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=43339,,0,0
4444,CTRI/2020/05/025326,Completed,,17/09/2020,,,,09/11/2020,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=43951,17/09/2020,0,0
4445,CTRI/2020/05/025328,Completed,,,,,,26/11/2020,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=43703,,0,0
4446,CTRI/2020/05/025338,Completed,,01/09/2020,,,,30/03/2021,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=44033,01/09/2020,0,0
4447,CTRI/2020/05/025336,Not Yet Recruiting,,,,,,23/05/2020,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=43934,,0,0
4448,CTRI/2020/05/025334,Not Yet Recruiting,,,,,,23/05/2020,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=43935,,0,0
4449,CTRI/2020/05/025337,Not Yet Recruiting,,,,,,23/05/2020,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=43940,,0,0
4450,CTRI/2020/05/025335,Completed,,11/08/2020,,,,19/10/2020,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=43949,11/08/2020,0,0
4451,CTRI/2020/05/025341,Open to Recruitment,,,,,,22/07/2020,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=44013,,0,0
4452,CTRI/2020/05/025343,Not Yet Recruiting,,,,,,22/05/2020,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=43919,,0,0
4453,CTRI/2020/05/025346,Not Yet Recruiting,,,,,,25/05/2020,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=43005,,0,0
4454,CTRI/2020/05/025350,Not Yet Recruiting,,,,,,26/05/2020,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=43559,,0,0
4455,CTRI/2020/05/025370,Not Yet Recruiting,,,,,,25/05/2020,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=44064,,0,0
4456,CTRI/2020/05/025385,Completed,,17/08/2020,,,,30/12/2020,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=43953,17/08/2020,0,0
4457,CTRI/2020/05/025369,Completed,,12/10/2020,,,,01/10/2020,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=43485,12/10/2020,0,0
4458,CTRI/2020/05/025425,Completed,,18/08/2020,,,,09/10/2020,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=44043,18/08/2020,0,0
4459,CTRI/2020/05/025398,Open to Recruitment,,,,,,22/07/2020,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=43831,,0,0
4460,CTRI/2020/05/025397,Completed,,19/08/2020,,,,22/10/2020,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=43702,19/08/2020,0,0
4461,CTRI/2020/05/025429,Open to Recruitment,,,,"6.	Acharya YT, editor. Charaka Samhita (Ch. Chi. 3/). Varanasi: Chowkhamba Surbharati; 2000
7.	Peruski, A. H., & Peruski, L. F., Jr (2003). Immunological methods for detection and identification of infectious disease and biological warfare agents. Clinical and diagnostic laboratory immunology, 10(4), 506‚Äì513. https://doi.org/10.1128/cdli.10.4.506-513.2003
8.	KamWa Chan, Vivian Taam Wong, and Sydney Chi Wai Tang, COVID-19: An Update on the Epidemiological, Clinical, Preventive and Therapeutic Evidence and Guidelines of Integrative Chinese‚ÄìWestern Medicine for the Management of 2019 Novel Coronavirus Disease, The American Journal of Chinese Medicine, Vol. 48, No. 3, 1‚Äì26 , Published 13 March 2020, DOI: 10.1142/S0192415X20500378",,10/07/2020,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=44058,,0,1
4462,CTRI/2020/05/025434,Open to Recruitment,,,,,,10/08/2020,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=43957,,0,0
4463,CTRI/2020/05/025483,Completed,,30/06/2020,,,,11/07/2020,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=44041,30/06/2020,0,0
4464,CTRI/2020/05/025485,Open to Recruitment,,,,,,12/10/2020,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=44052,,0,0
4465,CTRI/2020/05/025484,Open to Recruitment,,,,,,04/08/2020,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=44055,,0,0
4466,CTRI/2020/05/025490,Open to Recruitment,,,,,,07/06/2020,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=44042,,0,0
4467,CTRI/2020/05/025488,Not Yet Recruiting,,,,,,28/05/2020,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=44062,,0,0
4468,CTRI/2020/05/025491,Open to Recruitment,,,,,,10/06/2020,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=44065,,0,0
4469,CTRI/2020/05/025489,Completed,,,,,,09/06/2021,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=43376,,0,0
4470,CTRI/2020/05/025492,Not Yet Recruiting,,,,,,30/05/2020,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=43382,,0,0
4471,CTRI/2020/05/025496,Open to Recruitment,,,,,,01/09/2020,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=44192,,0,0
4472,CTRI/2020/06/025523,Completed,,21/08/2020,,,,26/08/2020,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=43396,21/08/2020,0,0
4473,CTRI/2020/06/025522,Completed,,,,,,07/08/2020,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=43438,,0,0
4474,CTRI/2020/06/025527,Completed,,,,,,23/02/2021,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=43968,,0,0
4475,CTRI/2020/06/025557,Closed to Recruitment of Participants,,,,,,13/04/2021,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=43812,,0,0
4476,CTRI/2020/06/025530,Completed,,28/10/2020,,,,01/11/2020,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=43305,28/10/2020,0,0
4477,CTRI/2020/06/025556,Completed,,21/08/2020,,,,01/01/2021,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=44144,21/08/2020,0,0
4478,CTRI/2020/06/025558,Not Yet Recruiting,,,,,,02/06/2020,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=43411,,0,0
4479,CTRI/2020/06/025575,Open to Recruitment,,,,,,12/08/2020,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=43076,,0,0
4480,CTRI/2020/06/025590,Completed,,28/09/2020,,,,16/10/2020,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=44121,28/09/2020,0,0
4481,CTRI/2020/06/025589,Not Yet Recruiting,,,,,,03/06/2020,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=44164,,0,0
4482,CTRI/2020/06/025613,Not Yet Recruiting,,,,,,04/06/2020,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=44346,,0,0
4483,CTRI/2020/06/025637,Not Yet Recruiting,,,,,,05/06/2020,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=43550,,0,0
4484,CTRI/2020/06/025625,Open to Recruitment,,,,,,15/06/2020,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=43345,,0,0
4485,CTRI/2020/06/025664,Completed,,17/09/2020,,,,19/05/2021,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=44369,17/09/2020,0,0
4486,CTRI/2020/06/025650,Completed,,,,,,16/04/2021,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=44412,,0,0
4487,CTRI/2020/06/025672,Not Yet Recruiting,,,,,,06/06/2020,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=44415,,0,0
4488,CTRI/2020/06/025671,Not Yet Recruiting,,,,,,05/06/2020,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=44425,,0,0
4489,CTRI/2020/06/025702,Completed,,,,,,17/09/2020,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=44376,,0,0
4490,CTRI/2020/06/025704,Completed,,07/11/2020,,,,16/02/2021,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=44170,07/11/2020,0,0
4491,CTRI/2020/06/025714,Not Yet Recruiting,,,,,,31/05/2020,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=44020,,0,0
4492,CTRI/2020/06/025763,Completed,,,,,,24/10/2020,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=44340,,0,0
4493,CTRI/2020/06/025766,Not Yet Recruiting,,,,"https://pubmed.ncbi.nlm.nih.gov/29732571/
https://pubmed.ncbi.nlm.nih.gov/31930543/",,09/06/2020,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=44171,,0,1
4494,CTRI/2020/06/025760,Not Yet Recruiting,,,,,,09/06/2020,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=44441,,0,0
4495,CTRI/2020/06/025768,Completed,,11/12/2020,,,,22/04/2021,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=44445,11/12/2020,0,0
4496,CTRI/2020/06/025762,Suspended,,,,,,22/04/2021,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=44259,,0,0
4497,CTRI/2020/06/025769,Completed,,,,,,13/04/2021,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=44260,,0,0
4498,CTRI/2020/06/025801,Completed,,25/08/2020,,,,14/10/2020,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=44293,25/08/2020,0,0
4499,CTRI/2020/06/025796,Not Yet Recruiting,,,,,,10/06/2020,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=44181,,0,0
4500,CTRI/2020/06/025798,Not Yet Recruiting,,,,,,09/06/2020,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=44460,,0,0
4501,CTRI/2020/06/025779,Not Yet Recruiting,,,,,,08/06/2020,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=44463,,0,0
4502,CTRI/2020/06/025799,Not Yet Recruiting,,,,,,06/08/2020,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=44480,,0,0
4503,CTRI/2020/06/025800,Completed,,30/06/2020,,,,24/07/2020,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=44485,30/06/2020,0,0
4504,CTRI/2020/06/025804,Not Yet Recruiting,,,,,,11/06/2020,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=44572,,0,0
4505,CTRI/2020/06/025803,Completed,,15/12/2020,,,,18/06/2021,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=44478,15/12/2020,0,0
4506,CTRI/2020/06/025849,Completed,,10/10/2020,,,,14/06/2021,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=44408,10/10/2020,0,0
4507,CTRI/2020/06/025852,Not Yet Recruiting,,,,,,12/06/2020,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=44204,,0,0
4508,CTRI/2020/06/025844,Completed,,31/10/2020,,,,04/06/2021,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=43760,31/10/2020,0,0
4509,CTRI/2020/06/025854,Open to Recruitment,,,,,,06/04/2021,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=44078,,0,0
4510,CTRI/2020/06/025856,Not Yet Recruiting,,,,,,13/06/2020,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=44606,,0,0
4511,CTRI/2020/06/025855,Completed,,13/08/2020,,,,18/09/2020,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=44386,13/08/2020,0,0
4512,CTRI/2020/06/025861,Open to Recruitment,,,,,,11/07/2020,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=44072,,0,0
4513,CTRI/2020/06/025862,Open to Recruitment,,,,,,15/06/2020,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=43858,,0,0
4514,CTRI/2020/06/025874,Not Yet Recruiting,,,,,,15/06/2020,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=44684,,0,0
4515,CTRI/2020/06/025927,Not Yet Recruiting,,,,,,16/06/2020,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=43316,,0,0
4516,CTRI/2020/06/025928,Closed to Recruitment of Participants,,,,,,23/05/2021,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=44664,,0,0
4517,CTRI/2020/06/025917,Not Yet Recruiting,,,,,,,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=44505,,0,0
4518,CTRI/2020/06/025957,Completed,,27/08/2020,,,,02/05/2021,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=44709,27/08/2020,0,0
4519,CTRI/2020/06/025977,Completed,,28/11/2020,,,,06/07/2021,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=44449,28/11/2020,0,0
4520,CTRI/2020/06/025996,Closed to Recruitment of Participants,,,,,,25/09/2020,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=44622,,0,0
4521,CTRI/2020/06/025998,Not Yet Recruiting,,,,"1. Raj kumar, Ramakant Yadav, Ramakant Rawat, Prashant Kumar Bajpai, Indra Kumar Sharma, Sushil Kumar, Prashant Yadav. Role of Raj Nirvan Bati in treatment of COVID19 RT-PCR positive cases. IJSRM June 2020; Accepted for publication
2. 1. Raj kumar, Ramakant Yadav, Ramakant Rawat, Prashant Kumar Bajpai, Indra Kumar Sharma, Sushil Kumar, Prashant Yadav. Raj Nirvan Bati (A novel ayurvedic preparation) in RT PCR positive COVID19 cases: An interventional study. IJMSCR June 2020;3(3)",,18/06/2020,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=44707,,0,1
4522,CTRI/2020/06/026001,Completed,,,,,,02/04/2021,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=44196,,0,0
4523,CTRI/2020/06/025999,Not Yet Recruiting,,,,,,20/06/2020,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=44764,,0,0
4524,CTRI/2020/06/026002,Not Yet Recruiting,,,,,,20/06/2020,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=44799,,0,0
4525,CTRI/2020/06/026045,Not Yet Recruiting,,,,,,22/06/2020,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=44677,,0,0
4526,CTRI/2020/06/026055,Not Yet Recruiting,,,,,,23/06/2020,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=44306,,0,0
4527,CTRI/2020/06/026056,Not Yet Recruiting,,,,,,23/06/2020,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=44130,,0,0
4528,CTRI/2020/06/026087,Completed,,04/09/2020,,,,01/10/2020,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=43775,04/09/2020,0,0
4529,CTRI/2020/06/026123,Not Yet Recruiting,,,,,,15/10/2020,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=44667,,0,0
4530,CTRI/2020/06/026119,Not Yet Recruiting,,,,,,24/06/2020,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=44218,,0,0
4531,CTRI/2020/06/026147,Not Yet Recruiting,,,,,,25/06/2020,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=43778,,0,0
4532,CTRI/2020/06/026151,Not Yet Recruiting,,,,,,25/06/2020,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=43770,,0,0
4533,CTRI/2020/06/026161,Closed to Recruitment of Participants,,,,,,15/02/2021,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=44832,,0,0
4534,CTRI/2020/06/026181,Completed,,,,,,23/02/2021,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=44976,,0,0
4535,CTRI/2020/06/026190,Not Yet Recruiting,,,,,,26/06/2020,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=45005,,0,0
4536,CTRI/2020/06/026187,Not Yet Recruiting,,,,,,26/06/2020,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=45027,,0,0
4537,CTRI/2020/06/026189,Not Yet Recruiting,,,,,,26/06/2020,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=45029,,0,0
4538,CTRI/2020/06/026191,Not Yet Recruiting,,,,,,27/06/2020,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=45075,,0,0
4539,CTRI/2020/06/026192,Completed,,30/09/2020,,,,16/12/2020,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=44815,30/09/2020,0,0
4540,CTRI/2020/06/026194,Other (Terminated),,,,,,08/02/2021,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=44341,,0,0
4541,CTRI/2020/06/026195,Not Yet Recruiting,,,,,,,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=45129,,0,0
4542,CTRI/2020/06/026196,Not Yet Recruiting,,,,,,12/03/2021,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=43482,,0,0
4543,CTRI/2020/06/026193,Open to Recruitment,,,,,,28/06/2020,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=44766,,0,0
4544,CTRI/2020/06/026197,Not Yet Recruiting,,,,,,28/06/2020,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=45052,,0,0
4545,CTRI/2020/06/026228,Not Yet Recruiting,,,,,,03/08/2020,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=44554,,0,0
4546,CTRI/2020/06/026222,Completed,,12/09/2020,,,,03/10/2020,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=44299,12/09/2020,0,0
4547,CTRI/2020/06/026227,Completed,,27/07/2020,,,,13/10/2020,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=44584,27/07/2020,0,0
4548,CTRI/2020/06/026229,Open to Recruitment,,,,,,06/11/2020,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=45105,,0,0
4549,CTRI/2020/06/026220,Completed,,05/09/2020,,,,20/10/2020,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=44350,05/09/2020,0,0
4550,CTRI/2020/06/026232,Not Yet Recruiting,,,,,,29/06/2020,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=45156,,0,0
4551,CTRI/2020/06/026231,Not Yet Recruiting,,,,,,29/06/2020,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=44497,,0,0
4552,CTRI/2020/06/026221,Completed,,10/08/2020,,,,13/10/2020,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=44542,10/08/2020,0,0
4553,CTRI/2020/06/026262,Completed,,29/10/2020,,,,07/10/2020,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=43889,29/10/2020,0,0
4554,CTRI/2020/07/026301,Not Yet Recruiting,,,,,,01/07/2020,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=44651,,0,0
4555,CTRI/2020/07/026337,Completed,,31/08/2020,,,,29/06/2021,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=44863,31/08/2020,0,0
4556,CTRI/2020/07/026338,Not Yet Recruiting,,,,,,02/07/2020,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=45181,,0,0
4557,CTRI/2020/07/026340,Not Yet Recruiting,,,,,,02/07/2020,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=44929,,0,0
4558,CTRI/2020/07/026343,Completed,,23/12/2021,,,,29/06/2021,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=45204,23/12/2021,0,0
4559,CTRI/2020/07/026349,Open to Recruitment,,,,,,04/07/2020,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=42918,,0,0
4560,CTRI/2020/07/026355,Not Yet Recruiting,,,,,,04/07/2020,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=45327,,0,0
4561,CTRI/2020/07/026354,Completed,,04/09/2020,,,,12/09/2020,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=45173,04/09/2020,0,0
4562,CTRI/2020/07/026353,Completed,,31/07/2020,,,,28/09/2020,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=45266,31/07/2020,0,0
4563,CTRI/2020/07/026352,Closed to Recruitment of Participants,,,,,,08/11/2020,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=45306,,0,0
4564,CTRI/2020/07/026371,Completed,,,,,,25/11/2020,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=45272,,0,0
4565,CTRI/2020/07/026431,Not Yet Recruiting,,,,,,04/07/2020,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=45340,,0,0
4566,CTRI/2020/07/026433,Completed,,09/10/2020,,,,13/01/2021,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=45252,09/10/2020,0,0
4567,CTRI/2020/07/026463,Open to Recruitment,,,,,,22/07/2020,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=43844,,0,0
4568,CTRI/2020/07/026462,Completed,,12/09/2020,,,,13/10/2020,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=44637,12/09/2020,0,0
4569,CTRI/2020/07/026471,Not Yet Recruiting,,,,,,18/08/2020,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=45318,,0,0
4570,CTRI/2020/07/026469,Completed,,18/07/2020,,,,30/10/2020,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=45336,18/07/2020,0,0
4571,CTRI/2020/07/026468,Closed to Recruitment of Participants,,,,,,06/07/2021,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=44844,,0,0
4572,CTRI/2020/07/026470,Not Yet Recruiting,,,,,,09/07/2020,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=45363,,0,0
4573,CTRI/2020/07/026514,Not Yet Recruiting,,,,,,13/07/2020,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=45580,,0,0
4574,CTRI/2020/07/026515,Not Yet Recruiting,,,,,,13/07/2020,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=45584,,0,0
4575,CTRI/2020/07/026532,Not Yet Recruiting,,,,,,13/07/2020,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=44354,,0,0
4576,CTRI/2020/07/026534,Not Yet Recruiting,,,,,,13/07/2020,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=45137,,0,0
4577,CTRI/2020/07/026529,Not Yet Recruiting,,,,,,13/07/2020,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=45475,,0,0
4578,CTRI/2020/07/026528,Not Yet Recruiting,,,,,,13/07/2020,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=45269,,0,0
4579,CTRI/2020/07/026530,Not Yet Recruiting,,,,,,13/07/2020,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=45532,,0,0
4580,CTRI/2020/07/026535,Completed,,31/08/2020,,,,11/09/2020,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=45535,31/08/2020,0,0
4581,CTRI/2020/07/026560,Completed,,09/12/2020,,,,13/04/2021,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=45385,09/12/2020,0,0
4582,CTRI/2020/07/026575,Not Yet Recruiting,,,,,,14/07/2020,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=45500,,0,0
4583,CTRI/2020/07/026570,Completed,,03/09/2020,,,,02/12/2020,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=45007,03/09/2020,0,0
4584,CTRI/2020/07/026579,Completed,,07/09/2020,,1)Evaluation of the Clinical Efficacy and safety of IM-133N as an Immunomodulator in various carcinoma :A prospective Clinical Study 2)A Clinical Analysis of Evaluating the Usefulness and Efficacy of the Ayurvedic Drug Tinospora cordifolia in Humans,,04/12/2020,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=45034,07/09/2020,0,1
4585,CTRI/2020/07/026568,Open to Recruitment,,,,,,10/05/2021,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=45035,,0,0
4586,CTRI/2020/07/026602,Not Yet Recruiting,,,,,,14/07/2020,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=45628,,0,0
4587,CTRI/2020/07/026608,Not Yet Recruiting,,,,,,15/07/2020,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=45638,,0,0
4588,CTRI/2020/07/026609,Not Yet Recruiting,,,,,,15/07/2020,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=45139,,0,0
4589,CTRI/2020/07/026607,Not Yet Recruiting,,,,,,15/07/2020,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=43998,,0,0
4590,CTRI/2020/07/026601,Completed,,23/08/2020,,,,02/01/2021,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=45564,23/08/2020,0,0
4591,CTRI/2020/07/026630,Open to Recruitment,,,,,,02/10/2020,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=45581,,0,0
4592,CTRI/2020/07/026632,Not Yet Recruiting,,,,,,16/07/2020,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=45680,,0,0
4593,CTRI/2020/07/026631,Completed,,03/09/2020,,,,05/09/2020,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=45494,03/09/2020,0,0
4594,CTRI/2020/07/026667,Not Yet Recruiting,,,,,,17/08/2020,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=44342,,0,0
4595,CTRI/2020/07/026669,Not Yet Recruiting,,,,,,18/07/2020,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=45623,,0,0
4596,CTRI/2020/07/026673,Not Yet Recruiting,,,,,,16/07/2020,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=45673,,0,0
4597,CTRI/2020/07/026668,Open to Recruitment,,,,,,03/02/2021,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=45677,,0,0
4598,CTRI/2020/07/026670,Not Yet Recruiting,,,,,,18/07/2020,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=45713,,0,0
4599,CTRI/2020/07/026671,Not Yet Recruiting,,,,,,18/07/2020,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=45728,,0,0
4600,CTRI/2020/07/026674,Not Yet Recruiting,,,,,,19/07/2020,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=45712,,0,0
4601,CTRI/2020/07/026675,Not Yet Recruiting,,,,,,08/10/2020,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=45731,,0,0
4602,CTRI/2020/07/026705,Not Yet Recruiting,,,,,,20/07/2020,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=45088,,0,0
4603,CTRI/2020/07/026700,Not Yet Recruiting,,,,,,28/09/2020,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=45207,,0,0
4604,CTRI/2020/07/026757,Not Yet Recruiting,,,,,,22/07/2020,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=45824,,0,0
4605,CTRI/2020/07/026756,Not Yet Recruiting,,,,,,22/07/2020,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=45755,,0,0
4606,CTRI/2020/07/026791,Completed,,27/01/2021,,,,24/03/2021,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=44814,27/01/2021,0,0
4607,CTRI/2020/07/026796,Not Yet Recruiting,,,,,,24/07/2020,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=45868,,0,0
4608,CTRI/2020/07/026789,Open to Recruitment,,,,,,15/02/2021,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=45111,,0,0
4609,CTRI/2020/07/026790,Not Yet Recruiting,,,,,,24/07/2020,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=45143,,0,0
4610,CTRI/2020/07/026799,Open to Recruitment,,,,,,18/08/2020,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=45964,,0,0
4611,CTRI/2020/07/026793,Completed,,15/12/2020,,,,20/03/2021,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=45721,15/12/2020,0,0
4612,CTRI/2020/07/026831,Open to Recruitment,,,,,,29/01/2021,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=44605,,0,0
4613,CTRI/2020/07/026820,Not Yet Recruiting,,,,,,26/07/2020,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=45936,,0,0
4614,CTRI/2020/07/026834,Not Yet Recruiting,,,,,,27/07/2020,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=45953,,0,0
4615,CTRI/2020/07/026840,Completed,,11/09/2020,,,,13/10/2020,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=45981,11/09/2020,0,0
4616,CTRI/2020/07/026839,Completed,,23/09/2020,,"Dound YA, Suryavanshi S, Sehgal R, Naik A (2020) Comparative Clinical Study to Evaluate the Activity of CureqovitaaTM Formulation for
Management of SARS-CoV-2 Infection (COVID-19). J Clin Trials. S3:004.",,14/01/2021,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=45994,23/09/2020,0,1
4617,CTRI/2020/07/026835,Completed,,31/12/2020,,,,23/02/2021,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=44539,31/12/2020,0,0
4618,CTRI/2020/07/026841,Not Yet Recruiting,,,,,,27/07/2020,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=45659,,0,0
4619,CTRI/2020/07/026925,Not Yet Recruiting,,,,,,22/07/2020,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=45587,,0,0
4620,CTRI/2020/07/026922,Not Yet Recruiting,,,,,,30/07/2020,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=45909,,0,0
4621,CTRI/2020/07/026953,Not Yet Recruiting,,,,,,07/12/2020,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=45668,,0,0
4622,CTRI/2020/07/026952,Not Yet Recruiting,,,,,,28/07/2020,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=45683,,0,0
4623,CTRI/2020/08/026957,Completed,,01/12/2020,,,,19/12/2020,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=45825,01/12/2020,0,0
4624,CTRI/2020/08/026980,Not Yet Recruiting,,,,,,04/08/2020,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=46082,,0,0
4625,CTRI/2020/08/026977,Not Yet Recruiting,,,,,,04/08/2020,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=44057,,0,0
4626,CTRI/2020/08/026985,Not Yet Recruiting,,,,,,04/08/2020,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=46168,,0,0
4627,CTRI/2020/08/026978,Not Applicable,,,,,,04/08/2020,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=44435,,0,0
4628,CTRI/2020/08/027007,Not Yet Recruiting,,,,,,05/08/2020,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=45827,,0,0
4629,CTRI/2020/08/026999,Completed,,08/11/2020,,,,19/11/2020,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=46134,08/11/2020,0,0
4630,CTRI/2020/08/027005,Open to Recruitment,,,,,,04/12/2020,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=46189,,0,0
4631,CTRI/2020/08/027009,Completed,,,,,,25/11/2020,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=46269,,0,0
4632,CTRI/2020/08/027033,Not Yet Recruiting,,,,,,05/08/2020,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=46096,,0,0
4633,CTRI/2020/08/027032,Completed,,28/10/2020,,,,16/06/2021,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=45920,28/10/2020,0,0
4634,CTRI/2020/08/027038,Not Yet Recruiting,,,,,,18/09/2020,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=46197,,0,0
4635,CTRI/2020/08/027035,Not Yet Recruiting,,,,,,06/08/2020,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=46262,,0,0
4636,CTRI/2020/08/027037,Open to Recruitment,,,,,,18/08/2020,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=46324,,0,0
4637,CTRI/2020/08/027040,Not Yet Recruiting,,,,,,08/08/2020,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=45846,,0,0
4638,CTRI/2020/08/027048,Open to Recruitment,,,,,,18/08/2020,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=46344,,0,0
4639,CTRI/2020/08/027045,Not Yet Recruiting,,,,,,07/08/2020,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=46226,,0,0
4640,CTRI/2020/08/027043,Not Yet Recruiting,,,,,,29/09/2020,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=43175,,0,0
4641,CTRI/2020/08/027041,Completed,,,,,,19/10/2020,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=46258,,0,0
4642,CTRI/2020/08/027044,Not Yet Recruiting,,,,,,08/08/2020,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=44249,,0,0
4643,CTRI/2020/08/027084,Open to Recruitment,,,,,,14/03/2021,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=44420,,0,0
4644,CTRI/2020/08/027061,Completed,,01/11/2020,,,,04/11/2020,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=45729,01/11/2020,0,0
4645,CTRI/2020/08/027080,Not Yet Recruiting,,,,,,10/08/2020,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=46272,,0,0
4646,CTRI/2020/08/027081,Not Yet Recruiting,,,,,,10/08/2020,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=46289,,0,0
4647,CTRI/2020/08/027085,Completed,,10/09/2020,,,,14/10/2020,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=46278,10/09/2020,0,0
4648,CTRI/2020/08/027102,Not Yet Recruiting,,,,,,10/08/2020,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=45658,,0,0
4649,CTRI/2020/08/027106,Completed,,,,,,12/07/2021,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=44639,,0,0
4650,CTRI/2020/08/027109,Open to Recruitment,,,,,,18/03/2021,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=44387,,0,0
4651,CTRI/2020/08/027120,Completed,,24/11/2020,,"Rajesh Biswas, Kakoli Biswas, Parikshit Bansal and Shashi Gupta; ANTI-VIRAL (ANTI-FLU), ANTI-BACTERIAL IMMUNOBOOSTING ORAL COMPOSITION OF HERBAL EXTRACTS FOR TREATING RESPIRATORY INFECTIONS ‚Äì A CASE STUDY; ejpmr, 2020,7(6), 760-765.",,01/01/2021,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=46319,24/11/2020,0,1
4652,CTRI/2020/08/027163,Closed to Recruitment of Participants,,,,,,14/04/2021,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=46406,,0,0
4653,CTRI/2020/08/027162,Closed to Recruitment of Participants,,,,,,29/10/2020,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=46240,,0,0
4654,CTRI/2020/08/027168,Open to Recruitment,,,,,,28/08/2020,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=45750,,0,0
4655,CTRI/2020/08/027170,Completed,,02/06/2021,,,,12/06/2021,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=46186,02/06/2021,0,0
4656,CTRI/2020/08/027171,Not Yet Recruiting,,,,,,13/08/2020,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=46527,,0,0
4657,CTRI/2020/08/027224,Completed,,21/02/2021,,,,13/04/2021,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=46608,21/02/2021,0,0
4658,CTRI/2020/08/027225,Completed,,31/10/2020,,,,05/01/2021,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=46660,31/10/2020,0,0
4659,CTRI/2020/08/027205,Closed to Recruitment of Participants,,,,,,07/07/2021,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=45488,,0,0
4660,CTRI/2020/08/027222,Not Yet Recruiting,,,,,,12/08/2020,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=46308,,0,0
4661,CTRI/2020/08/027282,Not Yet Recruiting,,,,,,19/08/2020,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=46676,,0,0
4662,CTRI/2020/08/027284,Suspended,,,,,,09/02/2021,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=46679,,0,0
4663,CTRI/2020/08/027283,Not Yet Recruiting,,,,,,19/08/2020,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=46591,,0,0
4664,CTRI/2020/08/027316,Not Yet Recruiting,,,,,,21/08/2020,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=46680,,0,0
4665,CTRI/2020/08/027286,Completed,,31/12/2020,,,,13/04/2021,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=46511,31/12/2020,0,0
4666,CTRI/2020/08/027300,Not Yet Recruiting,,,,,,20/08/2020,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=44285,,0,0
4667,CTRI/2020/08/027324,Not Yet Recruiting,,,,,,21/08/2020,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=46339,,0,0
4668,CTRI/2020/08/027345,Not Yet Recruiting,,,,,,24/08/2020,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=45932,,0,0
4669,CTRI/2020/08/027346,Not Yet Recruiting,,,,,,24/08/2020,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=46229,,0,0
4670,CTRI/2020/08/027359,Not Yet Recruiting,,,,"1. 	Arshad MS, Khan U, Sadiq A, Khalid W, Hussain M, Yasmeen A, et al. Coronavirus disease (COVID-19) and immunity booster green foods: A mini review. Food Sci Nutr. 2020;(June). 
2. 	AYUSH M of. Ayurveda‚Äôs immunity boosting measures for self care during COVID 19 crisis. 2020;1(1):4. 
3. 	Ministry of AYUSH RK. ADVISORY FROM MINISTRY OF AYUSH FOR MEETING THE CHALLENGE ARISING OUT OF SPREAD OF CORONA VIRUS (COVID-19) IN INDIA. 2020;9‚Äì12. 
4. 	Abascal K, Yarnell E. Herbal treatments for pandemic influenza: Learning from the eclectics‚Äô experience. Altern Complement Ther. 2006;12(5):214‚Äì21. 
5.       Ravi Philip Rajkumar. Ayurveda and COVID-19: Where psychoneuroimmunology and the meaning   response meet.  Brain Behav Immun. 2020 Jul; 87: 8‚Äì9. Published online 2020 Apr 22.
6. 	AYUSH, ministy of N. GUIDELINES for NATUROPATHY PRACTITIONERS for COVID 19. 2020;",,24/08/2020,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=46829,,0,1
4671,CTRI/2020/08/027394,Closed to Recruitment of Participants,,,,,,05/07/2021,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=46873,,0,0
4672,CTRI/2020/08/027397,Open to Recruitment,,,,,,03/09/2020,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=46165,,0,0
4673,CTRI/2020/08/027465,Completed,,05/01/2021,,,,10/01/2021,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=45634,05/01/2021,0,0
4674,CTRI/2020/08/027501,Closed to Recruitment of Participants,,,,,,29/10/2020,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=44303,,0,0
4675,CTRI/2020/08/027475,Open to Recruitment,,,,,,01/10/2020,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=45627,,0,0
4676,CTRI/2020/08/027502,Not Yet Recruiting,,,,,,31/08/2020,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=44862,,0,0
4677,CTRI/2020/08/027477,Completed,,08/10/2020,,,,06/12/2020,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=46654,08/10/2020,0,0
4678,CTRI/2020/08/027499,Open to Recruitment,,,,,,03/09/2020,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=46927,,0,0
4679,CTRI/2020/08/027491,Completed,,20/10/2020,,,,21/10/2020,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=46256,20/10/2020,0,0
4680,CTRI/2020/08/027503,Not Yet Recruiting,,,,,,31/08/2020,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=44980,,0,0
4681,CTRI/2020/08/027467,Not Yet Recruiting,,,,,,31/08/2020,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=46524,,0,0
4682,CTRI/2020/09/027535,Open to Recruitment,,,,,,26/11/2020,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=45236,,0,0
4683,CTRI/2020/09/027548,Completed,,21/10/2020,,,,06/11/2020,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=47125,21/10/2020,0,0
4684,CTRI/2020/09/027616,Not Yet Recruiting,,,,,,05/09/2020,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=47155,,0,0
4685,CTRI/2020/09/027615,Not Yet Recruiting,,,,,,04/09/2020,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=46648,,0,0
4686,CTRI/2020/09/027622,Open to Recruitment,,,,,,12/12/2020,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=46908,,0,0
4687,CTRI/2020/09/027661,Not Yet Recruiting,,,,,,07/09/2020,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=47273,,0,0
4688,CTRI/2020/09/027674,Completed,,,,,,06/05/2021,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=46312,,0,0
4689,CTRI/2020/09/027684,Open to Recruitment,,,,,,29/09/2020,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=47179,,0,0
4690,CTRI/2020/09/027680,Not Yet Recruiting,,,,,,14/09/2020,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=46451,,0,0
4691,CTRI/2020/09/027687,Completed,,25/10/2020,,"Satomura K, Kitamura T, Kawamura T, Shimbo T, Watanabe M, Kamei M, et al. Prevention of Upper Respiratory Tract Infections by Gargling A Randomized Trial. American Journal of Preventive Medicine. 2005 Nov;29(4):302‚Äì7. 

12.Ananthanarayan R, Paniker Jayaram CK. Ananthanarayans and Panikers textbook of microbiology.7th ed. Hyderabad: Orient Longman Private Limited; 2005. p.434",,22/03/2021,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=47280,25/10/2020,0,1
4692,CTRI/2020/09/027685,Completed,,,,,,01/03/2021,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=47321,,0,0
4693,CTRI/2020/09/027741,Open to Recruitment,,,,,,29/09/2020,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=47197,,0,0
4694,CTRI/2020/09/027775,Completed,,06/12/2020,,,,21/12/2020,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=47367,06/12/2020,0,0
4695,CTRI/2020/09/027786,Not Yet Recruiting,,,,,,11/09/2020,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=46950,,0,0
4696,CTRI/2020/09/027817,Open to Recruitment,,,,,,11/02/2021,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=46041,,0,0
4697,CTRI/2020/09/027841,Open to Recruitment,,,,,,17/12/2020,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=47174,,0,0
4698,CTRI/2020/09/027829,Closed to Recruitment of Participants,,,,,,11/03/2021,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=45521,,0,0
4699,CTRI/2020/09/027842,Not Yet Recruiting,,,,,,16/09/2020,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=47591,,0,0
4700,CTRI/2020/09/027833,Not Yet Recruiting,,,,,,16/09/2020,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=46839,,0,0
4701,CTRI/2020/09/027882,Not Yet Recruiting,,,,,,17/09/2020,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=47632,,0,0
4702,CTRI/2020/09/027904,Not Yet Recruiting,,,,,,18/09/2020,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=47392,,0,0
4703,CTRI/2020/09/027903,Completed,,,,,,05/01/2021,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=47147,,0,0
4704,CTRI/2020/09/027910,Open to Recruitment,,,,,,28/02/2021,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=45292,,0,0
4705,CTRI/2020/09/027914,Completed,,14/01/2021,,,,13/04/2021,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=47442,14/01/2021,0,0
4706,CTRI/2020/09/027915,Open to Recruitment,,,,,,24/06/2021,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=46754,,0,0
4707,CTRI/2020/09/027941,Open to Recruitment,,,,,,11/02/2021,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=46023,,0,0
4708,CTRI/2020/09/027938,Not Yet Recruiting,,,,,,15/01/2021,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=47586,,0,0
4709,CTRI/2020/09/027916,Not Yet Recruiting,,,,,,19/09/2020,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=47333,,0,0
4710,CTRI/2020/09/027974,Not Yet Recruiting,,,,,,21/10/2020,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=47658,,0,0
4711,CTRI/2020/09/027944,Not Yet Recruiting,,,,,,21/09/2020,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=46392,,0,0
4712,CTRI/2020/09/027975,Not Yet Recruiting,,,,,,22/09/2020,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=47748,,0,0
4713,CTRI/2020/09/027992,Not Yet Recruiting,,,,,,16/09/2020,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=46389,,0,0
4714,CTRI/2020/09/028045,Not Yet Recruiting,,,,,,24/09/2020,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=44046,,0,0
4715,CTRI/2020/09/028044,Open to Recruitment,,,,,,02/10/2020,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=47432,,0,0
4716,CTRI/2020/09/028043,Not Yet Recruiting,,,,,,24/09/2020,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=47443,,0,0
4717,CTRI/2020/09/028046,Other (Terminated),,,,,,20/10/2020,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=45038,,0,0
4718,CTRI/2020/09/028086,Not Yet Recruiting,,,,,,25/09/2020,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=47819,,0,0
4719,CTRI/2020/09/028088,Not Yet Recruiting,,,,,,25/09/2020,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=47829,,0,0
4720,CTRI/2020/09/028131,Completed,,21/03/2021,,,,13/05/2021,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=46887,21/03/2021,0,0
4721,CTRI/2020/09/028122,Not Yet Recruiting,,,,,,06/10/2020,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=47851,,0,0
4722,CTRI/2020/09/028133,Completed,,,,,,15/04/2021,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=47866,,0,0
4723,CTRI/2020/09/028158,Completed,,,,,,15/04/2021,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=47896,,0,0
4724,CTRI/2020/09/028164,Not Yet Recruiting,,,,,,29/09/2020,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=47843,,0,0
4725,CTRI/2020/10/028195,Closed to Recruitment of Participants,,,,,,20/05/2021,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=47893,,0,0
4726,CTRI/2020/10/028179,Not Applicable,,,,,,11/10/2020,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=47847,,0,0
4727,CTRI/2020/10/028230,Not Yet Recruiting,,,,,,02/10/2020,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=47188,,0,0
4728,CTRI/2020/10/028233,Not Yet Recruiting,,,,,,02/10/2020,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=47982,,0,0
4729,CTRI/2020/10/028231,Completed,,01/12/2020,,,,03/12/2020,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=47237,01/12/2020,0,0
4730,CTRI/2020/10/028234,Not Yet Recruiting,,,,,,02/10/2020,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=47844,,0,0
4731,CTRI/2020/10/028253,Completed,,02/12/2020,,,,05/01/2021,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=47986,02/12/2020,0,0
4732,CTRI/2020/10/028256,Not Yet Recruiting,,,,,,05/10/2020,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=48118,,0,0
4733,CTRI/2020/10/028250,Other (Terminated),,,,,,12/03/2021,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=48119,,0,0
4734,CTRI/2020/10/028280,Not Yet Recruiting,,,,,,07/10/2020,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=48199,,0,0
4735,CTRI/2020/10/028277,Not Yet Recruiting,,,,,,31/03/2021,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=47691,,0,0
4736,CTRI/2020/10/028279,Not Yet Recruiting,,,,,,06/10/2020,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=48085,,0,0
4737,CTRI/2020/10/028297,Not Yet Recruiting,,,,,,07/10/2020,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=48268,,0,0
4738,CTRI/2020/10/028333,Completed,,26/02/2021,,,,09/03/2021,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=48137,26/02/2021,0,0
4739,CTRI/2020/10/028335,Not Yet Recruiting,,,,,,11/11/2020,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=45359,,0,0
4740,CTRI/2020/10/028324,Completed,,,,,,09/03/2021,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=47697,,0,0
4741,CTRI/2020/10/028326,Not Yet Recruiting,,,,,,08/10/2020,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=48214,,0,0
4742,CTRI/2020/10/028325,Not Yet Recruiting,,,,,,,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=48319,,0,0
4743,CTRI/2020/10/028364,Completed,,14/04/2021,,,,04/05/2021,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=48152,14/04/2021,0,0
4744,CTRI/2020/10/028362,Not Yet Recruiting,,,,,,10/10/2020,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=48109,,0,0
4745,CTRI/2020/10/028376,Not Yet Recruiting,,,,,,12/10/2020,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=48426,,0,0
4746,CTRI/2020/10/028414,Not Yet Recruiting,,,,,,14/10/2020,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=48010,,0,0
4747,CTRI/2020/10/028423,Open to Recruitment,,,,,,20/11/2020,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=47514,,0,0
4748,CTRI/2020/10/028424,Not Yet Recruiting,,,,,,13/10/2020,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=48294,,0,0
4749,CTRI/2020/10/028437,Not Yet Recruiting,,,,,,14/10/2020,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=47956,,0,0
4750,CTRI/2020/10/028472,Closed to Recruitment of Participants,,,,,,03/06/2021,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=47524,,0,0
4751,CTRI/2020/10/028471,Not Yet Recruiting,,,,,,16/10/2020,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=48593,,0,0
4752,CTRI/2020/10/028486,Completed,,11/01/2021,,,,19/04/2021,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=48223,11/01/2021,0,0
4753,CTRI/2020/10/028485,Completed,,22/12/2020,,,,19/04/2021,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=48619,22/12/2020,0,0
4754,CTRI/2020/10/028568,Completed,,14/12/2020,,,,09/01/2021,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=45761,14/12/2020,0,0
4755,CTRI/2020/10/028566,Completed,,31/01/2021,,,,19/04/2021,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=48585,31/01/2021,0,0
4756,CTRI/2020/10/028537,Completed,,05/02/2021,,,,22/02/2021,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=48342,05/02/2021,0,0
4757,CTRI/2020/10/028570,Not Yet Recruiting,,,,,,21/10/2020,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=48600,,0,0
4758,CTRI/2020/10/028597,Open to Recruitment,,,,,,29/05/2021,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=48730,,0,0
4759,CTRI/2020/10/028602,Not Yet Recruiting,,,,,,06/11/2020,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=48797,,0,0
4760,CTRI/2020/10/028581,Not Yet Recruiting,,,,,,22/10/2020,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=47042,,0,0
4761,CTRI/2020/10/028580,Not Yet Recruiting,,,,,,22/10/2020,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=48581,,0,0
4762,CTRI/2020/10/028637,Not Yet Recruiting,,,,,,25/10/2020,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=44357,,0,0
4763,CTRI/2020/10/028635,Not Yet Recruiting,,,,,,24/10/2020,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=48783,,0,0
4764,CTRI/2020/10/028695,Not Yet Recruiting,,,,,,27/10/2020,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=43749,,0,0
4765,CTRI/2020/10/028731,Open to Recruitment,,,,"Munch MW, Granholm A, Myatra SN, Vijayaraghavan B, Cronhjort M, Wahlin RR, Jakob SM, Cioccari L, Kjaer MN, Vesterlund GK, Meyhoff TS, Helleberg M, M√∏ller MH, Benfield T, Venkatesh B, Hammond N, Micallef S, Bassi A, John O, Jha V, Kristiansen KT, Ulrik CS, J√∏rgensen VL, Smitt M, Bestle MH, Andreasen AS, Poulsen LM, Rasmussen BS, Br√∏chner AC, Str√∏m T, M√∏ller A, Khan MS, Padmanaban A, Divatia JV, Saseedharan S, Borawake K, Kapadia F, Dixit S, Chawla R, Shukla U, Amin P, Chew MS, Gluud C, Lange T, Perner A. Higher vs lower doses of dexamethasone in patients with COVID-19 and severe hypoxia (COVID STEROID 2) trial: Protocol and statistical analysis plan. Acta Anaesthesiol Scand. 2021 Feb 14:10.1111/aas.13795. doi: 10.1111/aas.13795. Epub ahead of print. PMID: 33583034; PMCID: PMC8014264.",,11/05/2021,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=46442,,0,1
4766,CTRI/2020/11/028799,Not Yet Recruiting,,,,,,28/10/2020,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=45864,,0,0
4767,CTRI/2020/11/028811,Completed,,30/01/2021,,,,17/03/2021,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=48960,30/01/2021,0,0
4768,CTRI/2020/11/028779,Closed to Recruitment of Participants,,,,,,29/06/2021,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=48578,,0,0
4769,CTRI/2020/11/028827,Not Yet Recruiting,,,,,,03/11/2020,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=46946,,0,0
4770,CTRI/2020/11/028905,Not Yet Recruiting,,,,,,11/11/2020,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=48668,,0,0
4771,CTRI/2020/11/028903,Completed,,07/02/2021,,,,16/06/2021,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=48964,07/02/2021,0,0
4772,CTRI/2020/11/028897,Not Yet Recruiting,,,,,,30/10/2020,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=48480,,0,0
4773,CTRI/2020/11/028959,Not Yet Recruiting,,,,,,06/11/2020,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=48272,,0,0
4774,CTRI/2020/11/028976,Closed to Recruitment of Participants,,,,,,17/03/2021,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=48057,,0,0
4775,CTRI/2020/11/029025,Open to Recruitment,,,,,,10/11/2020,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=49174,,0,0
4776,CTRI/2020/11/029032,Closed to Recruitment of Participants,,,,,,13/01/2021,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=48329,,0,0
4777,CTRI/2020/11/029038,Completed,,06/04/2021,,,,06/07/2021,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=48233,06/04/2021,0,0
4778,CTRI/2020/11/029058,Open to Recruitment,,,,,,05/07/2021,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=49392,,0,0
4779,CTRI/2020/11/029063,Open to Recruitment,,,,,,03/06/2021,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=48939,,0,0
4780,CTRI/2020/11/029130,Not Yet Recruiting,,,,,,13/11/2020,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=49155,,0,0
4781,CTRI/2020/11/029146,Not Yet Recruiting,,,,,,12/11/2020,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=48879,,0,0
4782,CTRI/2020/11/029170,Not Yet Recruiting,,,,,,16/11/2020,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=49412,,0,0
4783,CTRI/2020/11/029166,Completed,,16/05/2021,,,,08/07/2021,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=46785,16/05/2021,0,0
4784,CTRI/2020/11/029233,Not Yet Recruiting,,,,,,18/11/2020,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=49177,,0,0
4785,CTRI/2020/11/029232,Not Yet Recruiting,,,,,,19/11/2020,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=49293,,0,0
4786,CTRI/2020/11/029230,Not Yet Recruiting,,,,,,19/11/2020,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=49295,,0,0
4787,CTRI/2020/11/029263,Open to Recruitment,,,,,,21/05/2021,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=46353,,0,0
4788,CTRI/2020/11/029265,Completed,,19/01/2021,,,,31/03/2021,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=48401,19/01/2021,0,0
4789,CTRI/2020/11/029289,Not Yet Recruiting,,,,,,09/05/2021,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=48077,,0,0
4790,CTRI/2020/11/029305,Not Yet Recruiting,,,,,,23/11/2020,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=48195,,0,0
4791,CTRI/2020/11/029328,Not Yet Recruiting,,,,,,12/07/2021,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=49552,,0,0
4792,CTRI/2020/11/029356,Not Yet Recruiting,,,,,,25/11/2020,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=49432,,0,0
4793,CTRI/2020/11/029346,Not Yet Recruiting,,,,,,24/11/2020,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=48444,,0,0
4794,CTRI/2020/11/029345,Open to Recruitment,,,,,,05/07/2021,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=48213,,0,0
4795,CTRI/2020/11/029396,Other (Terminated),,,,,,07/06/2021,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=49442,,0,0
4796,CTRI/2020/11/029399,Not Yet Recruiting,,,,,,07/12/2020,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=49714,,0,0
4797,CTRI/2020/11/029388,Suspended,,,,,,30/05/2021,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=49529,,0,0
4798,CTRI/2020/11/029444,Not Yet Recruiting,,,,,,24/11/2020,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=49712,,0,0
4799,CTRI/2020/12/029475,Not Yet Recruiting,,,,,,27/11/2020,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=49723,,0,0
4800,CTRI/2020/12/029476,Not Yet Recruiting,,,,,,29/11/2020,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=48455,,0,0
4801,CTRI/2020/12/029575,Not Yet Recruiting,,,,,,04/12/2020,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=49430,,0,0
4802,CTRI/2020/12/029587,Not Yet Recruiting,,,,,,02/12/2020,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=49803,,0,0
4803,CTRI/2020/12/029585,Not Yet Recruiting,,,,,,01/12/2020,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=49854,,0,0
4804,CTRI/2020/12/029614,Not Yet Recruiting,,,,,,05/12/2020,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=49680,,0,0
4805,CTRI/2020/12/029615,Not Yet Recruiting,,,,,,04/12/2020,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=49731,,0,0
4806,CTRI/2020/12/029613,Not Yet Recruiting,,,,,,04/12/2020,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=50026,,0,0
4807,CTRI/2020/12/029668,Not Yet Recruiting,,,,,,08/12/2020,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=45821,,0,0
4808,CTRI/2020/12/029669,Not Yet Recruiting,,,,,,08/12/2020,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=50175,,0,0
4809,CTRI/2020/12/029713,Open to Recruitment,,,,,,16/12/2020,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=46813,,0,0
4810,CTRI/2020/12/029714,Open to Recruitment,,,,,,16/12/2020,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=46814,,0,0
4811,CTRI/2020/12/029735,Completed,,30/03/2021,,,,13/05/2021,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=48763,30/03/2021,0,0
4812,CTRI/2020/12/029745,Completed,,28/02/2021,,,,05/07/2021,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=49613,28/02/2021,0,0
4813,CTRI/2020/12/029783,Open to Recruitment,,,,,,22/06/2021,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=49405,,0,0
4814,CTRI/2020/12/029805,Not Yet Recruiting,,,,,,14/12/2020,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=50445,,0,0
4815,CTRI/2020/12/029803,Not Yet Recruiting,,,,,,15/12/2020,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=49947,,0,0
4816,CTRI/2020/12/029814,Completed,,31/03/2021,,,,02/06/2021,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=49778,31/03/2021,0,0
4817,CTRI/2020/12/029793,Not Yet Recruiting,,,,,,14/12/2020,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=50303,,0,0
4818,CTRI/2020/12/029841,Not Yet Recruiting,,,,,,15/12/2020,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=48427,,0,0
4819,CTRI/2020/12/029855,Closed to Recruitment of Participants,,,,,,30/03/2021,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=49858,,0,0
4820,CTRI/2020/12/029869,Not Yet Recruiting,,,,,,09/03/2021,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=50422,,0,0
4821,CTRI/2020/12/029885,Not Yet Recruiting,,,,,,17/12/2020,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=50606,,0,0
4822,CTRI/2020/12/029894,Not Yet Recruiting,,,,,,17/12/2020,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=49273,,0,0
4823,CTRI/2020/12/029898,Open to Recruitment,,,,,,16/02/2021,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=48811,,0,0
4824,CTRI/2020/12/029902,Open to Recruitment,,,,,,31/01/2021,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=49842,,0,0
4825,CTRI/2020/12/029957,Not Yet Recruiting,,,,,,18/12/2020,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=48186,,0,0
4826,CTRI/2020/12/029954,Not Yet Recruiting,,,,,,18/12/2020,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=50385,,0,0
4827,CTRI/2020/12/029985,Open to Recruitment,,,,,,24/05/2021,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=50354,,0,0
4828,CTRI/2020/12/030013,Not Yet Recruiting,,,,,,12/02/2021,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=50222,,0,0
4829,CTRI/2020/12/030072,Open to Recruitment,,,,,,25/03/2021,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=50013,,0,0
4830,CTRI/2020/12/030051,Not Yet Recruiting,,,,,,24/12/2020,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=48880,,0,0
4831,CTRI/2020/12/030083,Not Yet Recruiting,,,,,,01/01/2021,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=46899,,0,0
4832,CTRI/2020/12/030085,Not Yet Recruiting,,,,,,28/12/2020,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=50812,,0,0
4833,CTRI/2020/12/030165,Completed,,24/02/2021,,,,19/02/2021,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=50753,24/02/2021,0,0
4834,CTRI/2020/12/030143,Not Yet Recruiting,,,,,,30/12/2020,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=50886,,0,0
4835,CTRI/2021/01/030169,Not Yet Recruiting,,,,,,31/12/2020,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=50842,,0,0
4836,CTRI/2021/01/030231,Closed to Recruitment of Participants,,,,,,26/05/2021,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=50985,,0,0
4837,CTRI/2021/01/030236,Not Yet Recruiting,,,,,,04/01/2021,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=50290,,0,0
4838,CTRI/2021/01/030333,Not Yet Recruiting,,,,,,08/01/2021,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=50964,,0,0
4839,CTRI/2021/01/030373,Not Yet Recruiting,,,,,,06/01/2021,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=50288,,0,0
4840,CTRI/2021/01/030416,Open to Recruitment,,,,,,01/07/2021,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=51254,,0,0
4841,CTRI/2021/01/030454,Open to Recruitment,,,,,,15/06/2021,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=51491,,0,0
4842,CTRI/2021/01/030477,Not Yet Recruiting,,,,,,14/01/2021,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=48197,,0,0
4843,CTRI/2021/01/030529,Not Yet Recruiting,,,,,,16/01/2021,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=51315,,0,0
4844,CTRI/2021/01/030533,Not Yet Recruiting,,,,,,15/01/2021,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=51393,,0,0
4845,CTRI/2021/01/030601,Open to Recruitment,,,,,,24/02/2021,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=50754,,0,0
4846,CTRI/2021/01/030651,Not Yet Recruiting,,,,,,21/01/2021,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=49805,,0,0
4847,CTRI/2021/01/030733,Completed,,,,,,15/06/2021,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=51715,,0,0
4848,CTRI/2021/01/030729,Completed,,01/03/2021,,,,20/06/2021,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=51654,01/03/2021,0,0
4849,CTRI/2021/01/030752,Not Yet Recruiting,,,,,,25/01/2021,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=51380,,0,0
4850,CTRI/2021/01/030795,Closed to Recruitment of Participants,,,,,,09/06/2021,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=51391,,0,0
4851,CTRI/2021/01/030793,Open to Recruitment,,,,,,07/07/2021,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=48850,,0,0
4852,CTRI/2021/01/030826,Not Yet Recruiting,,,,,,28/01/2021,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=47638,,0,0
4853,CTRI/2021/01/030829,Completed,,28/04/2021,,,,03/05/2021,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=51297,28/04/2021,0,0
4854,CTRI/2021/01/030830,Not Yet Recruiting,,,,,,28/01/2021,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=52067,,0,0
4855,CTRI/2021/01/030825,Open to Recruitment,,,,,,04/03/2021,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=51863,,0,0
4856,CTRI/2021/01/030824,Open to Recruitment,,,,,,10/02/2021,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=50900,,0,0
4857,CTRI/2021/02/030887,Open to Recruitment,,,,,,31/05/2021,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=48386,,0,0
4858,CTRI/2021/02/030892,Open to Recruitment,,,,,,31/05/2021,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=49972,,0,0
4859,CTRI/2021/02/030897,Open to Recruitment,,,,,,20/03/2021,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=52184,,0,0
4860,CTRI/2021/02/030957,Completed,,16/05/2021,,,,07/06/2021,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=52251,16/05/2021,0,0
4861,CTRI/2021/02/030986,Open to Recruitment,,,,,,24/05/2021,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=51800,,0,0
4862,CTRI/2021/02/031012,Open to Recruitment,,,,,,19/02/2021,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=51954,,0,0
4863,CTRI/2021/02/031036,Not Yet Recruiting,,,,,,04/02/2021,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=51219,,0,0
4864,CTRI/2021/02/031052,Not Yet Recruiting,,,,,,04/02/2021,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=46372,,0,0
4865,CTRI/2021/02/031176,Not Yet Recruiting,,,,,,08/02/2021,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=52050,,0,0
4866,CTRI/2021/02/031232,Not Yet Recruiting,,,,,,10/02/2021,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=52011,,0,0
4867,CTRI/2021/02/031256,Completed,,17/03/2021,,,,17/04/2021,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=52613,17/03/2021,0,0
4868,CTRI/2021/02/031295,Completed,,,,,,25/03/2021,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=51327,,0,0
4869,CTRI/2021/02/031286,Not Yet Recruiting,,,,,,14/02/2021,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=52451,,0,0
4870,CTRI/2021/02/031322,Not Yet Recruiting,,,,,,15/02/2021,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=52024,,0,0
4871,CTRI/2021/02/031353,Completed,,,,,,24/06/2021,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=52810,,0,0
4872,CTRI/2021/02/031375,Completed,,20/05/2021,,,,24/05/2021,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=52608,20/05/2021,0,0
4873,CTRI/2021/02/031420,Not Yet Recruiting,,,,,,17/02/2021,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=52957,,0,0
4874,CTRI/2021/02/031430,Completed,,31/03/2021,,,,15/06/2021,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=47292,31/03/2021,0,0
4875,CTRI/2021/02/031479,Completed,,03/05/2021,,,,31/05/2021,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=48898,03/05/2021,0,0
4876,CTRI/2021/02/031484,Not Yet Recruiting,,,,,,17/02/2021,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=52585,,0,0
4877,CTRI/2021/02/031520,Open to Recruitment,,,,,,01/03/2021,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=52515,,0,0
4878,CTRI/2021/02/031570,Completed,,30/05/2021,,,,31/05/2021,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=53018,30/05/2021,0,0
4879,CTRI/2021/02/031566,Open to Recruitment,,,,,,07/06/2021,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=51849,,0,0
4880,CTRI/2021/02/031547,Open to Recruitment,,,,,,25/02/2021,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=43929,,0,0
4881,CTRI/2021/02/031543,Not Yet Recruiting,,,,,,19/02/2021,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=52892,,0,0
4882,CTRI/2021/02/031554,Open to Recruitment,,,,,,15/06/2021,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=49327,,0,0
4883,CTRI/2021/03/031665,Not Yet Recruiting,,,,,,01/03/2021,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=53325,,0,0
4884,CTRI/2021/03/031664,Not Yet Recruiting,,,,,,12/05/2021,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=52574,,0,0
4885,CTRI/2021/03/031667,Not Yet Recruiting,,,,,,28/02/2021,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=53117,,0,0
4886,CTRI/2021/03/031684,Not Yet Recruiting,,,,,,02/03/2021,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=52741,,0,0
4887,CTRI/2021/03/031686,Not Yet Recruiting,,,,,,27/02/2021,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=53215,,0,0
4888,CTRI/2021/03/031721,Not Yet Recruiting,,,,,,04/03/2021,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=53532,,0,0
4889,CTRI/2021/03/031720,Not Yet Recruiting,,,,,,01/03/2021,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=53161,,0,0
4890,CTRI/2021/03/031790,Not Yet Recruiting,,,,,,07/03/2021,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=53090,,0,0
4891,CTRI/2021/03/031815,Not Yet Recruiting,,,,,,08/03/2021,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=52987,,0,0
4892,CTRI/2021/03/031939,Not Yet Recruiting,,,,,,12/03/2021,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=49214,,0,0
4893,CTRI/2021/03/031940,Open to Recruitment,,,,,,13/05/2021,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=53172,,0,0
4894,CTRI/2021/03/031969,Not Yet Recruiting,,,,,,15/03/2021,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=52816,,0,0
4895,CTRI/2021/03/032051,Open to Recruitment,,,,,,30/03/2021,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=53226,,0,0
4896,CTRI/2021/03/032072,Completed,,10/05/2021,,,,12/07/2021,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=53003,10/05/2021,0,0
4897,CTRI/2021/03/032059,Not Yet Recruiting,,,,,,16/03/2021,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=53115,,0,0
4898,CTRI/2021/03/032060,Not Yet Recruiting,,,,,,16/03/2021,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=53231,,0,0
4899,CTRI/2021/03/032135,Not Yet Recruiting,,,,,,18/03/2021,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=51532,,0,0
4900,CTRI/2021/03/032158,Open to Recruitment,,,,,,19/03/2021,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=54015,,0,0
4901,CTRI/2021/03/032199,Not Yet Recruiting,,,,,,19/03/2021,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=49593,,0,0
4902,CTRI/2021/03/032225,Not Yet Recruiting,,,,,,31/03/2021,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=50734,,0,0
4903,CTRI/2021/03/032293,Not Yet Recruiting,,,,,,24/03/2021,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=45649,,0,0
4904,CTRI/2021/03/032410,Not Yet Recruiting,,,,,,27/03/2021,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=54078,,0,0
4905,CTRI/2021/03/032369,Not Yet Recruiting,,,,,,26/03/2021,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=52318,,0,0
4906,CTRI/2021/03/032385,Not Yet Recruiting,,,,,,25/03/2021,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=54420,,0,0
4907,CTRI/2021/03/032444,Not Yet Recruiting,,,,,,30/03/2021,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=54405,,0,0
4908,CTRI/2021/04/032501,Not Yet Recruiting,,,,,,08/04/2021,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=54364,,0,0
4909,CTRI/2021/04/032541,Open to Recruitment,,,,,,17/04/2021,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=54622,,0,0
4910,CTRI/2021/04/032531,Open to Recruitment,,,,,,31/05/2021,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=53930,,0,0
4911,CTRI/2021/04/032555,Open to Recruitment,,,,,,21/05/2021,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=54560,,0,0
4912,CTRI/2021/04/032593,Open to Recruitment,,,,,,30/04/2021,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=54510,,0,0
4913,CTRI/2021/04/032647,Not Yet Recruiting,,,,,,07/04/2021,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=53666,,0,0
4914,CTRI/2021/04/032688,Open to Recruitment,,,,,,23/06/2021,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=54697,,0,0
4915,CTRI/2021/04/032648,Open to Recruitment,,,,,,11/05/2021,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=51131,,0,0
4916,CTRI/2021/04/032755,Open to Recruitment,,,,,,01/07/2021,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=54896,,0,0
4917,CTRI/2021/04/032766,Not Yet Recruiting,,,,,,15/05/2021,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=54786,,0,0
4918,CTRI/2021/04/032804,Not Yet Recruiting,,,,,,11/06/2021,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=54539,,0,0
4919,CTRI/2021/04/032791,Open to Recruitment,,,,,,09/07/2021,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=53300,,0,0
4920,CTRI/2021/04/032788,Not Yet Recruiting,,,,,,12/04/2021,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=55016,,0,0
4921,CTRI/2021/04/032845,Not Yet Recruiting,,,,,,13/04/2021,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=52521,,0,0
4922,CTRI/2021/04/032952,Not Yet Recruiting,,,,,,19/04/2021,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=55118,,0,0
4923,CTRI/2021/04/032976,Not Yet Recruiting,,,,,,17/03/2021,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=50046,,0,0
4924,CTRI/2021/04/032989,Closed to Recruitment of Participants,,,,,,16/06/2021,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=55273,,0,0
4925,CTRI/2021/04/033058,Open to Recruitment,,,,,,23/04/2021,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=46761,,0,0
4926,CTRI/2021/04/033073,Open to Recruitment,,,,,,30/06/2021,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=55218,,0,0
4927,CTRI/2021/04/033118,Open to Recruitment,,,,,,07/07/2021,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=53211,,0,0
4928,CTRI/2021/04/033175,Open to Recruitment,,,,,,12/05/2021,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=44604,,0,0
4929,CTRI/2021/04/033158,Not Yet Recruiting,,,,,,26/04/2021,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=55418,,0,0
4930,CTRI/2021/04/033143,Open to Recruitment,,,,,,24/06/2021,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=55493,,0,0
4931,CTRI/2021/04/033142,Not Yet Recruiting,,,,,,26/04/2021,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=55513,,0,0
4932,CTRI/2021/04/033188,Open to Recruitment,,,,,,24/06/2021,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=55568,,0,0
4933,CTRI/2021/04/033201,Not Yet Recruiting,,,,,,27/04/2021,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=52520,,0,0
4934,CTRI/2021/04/033257,Not Yet Recruiting,,,,,,28/04/2021,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=55549,,0,0
4935,CTRI/2021/04/033263,Not Yet Recruiting,,,,,,29/04/2021,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=55585,,0,0
4936,CTRI/2021/04/033264,Not Yet Recruiting,,,,,,30/04/2021,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=51322,,0,0
4937,CTRI/2021/04/033260,Not Yet Recruiting,,,,,,29/04/2021,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=54998,,0,0
4938,CTRI/2021/05/033303,Not Yet Recruiting,,,,,,30/04/2021,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=48255,,0,0
4939,CTRI/2021/05/033339,Completed,,06/06/2021,,,,23/06/2021,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=55649,06/06/2021,0,0
4940,CTRI/2021/05/033374,Not Yet Recruiting,,,,,,03/05/2021,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=55771,,0,0
4941,CTRI/2021/05/033402,Not Yet Recruiting,,,,,,04/05/2021,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=55460,,0,0
4942,CTRI/2021/05/033472,Open to Recruitment,,,,,,21/05/2021,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=55846,,0,0
4943,CTRI/2021/05/033523,Not Yet Recruiting,,,,,,06/05/2021,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=55876,,0,0
4944,CTRI/2021/05/033499,Open to Recruitment,,,,,,11/05/2021,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=55679,,0,0
4945,CTRI/2021/05/033537,Not Yet Recruiting,,,,,,10/05/2021,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=55323,,0,0
4946,CTRI/2021/05/033543,Open to Recruitment,,,,,,03/06/2021,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=55879,,0,0
4947,CTRI/2021/05/033544,Open to Recruitment,,,,,,02/06/2021,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=55941,,0,0
4948,CTRI/2021/05/033546,Open to Recruitment,,,,,,25/06/2021,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=48547,,0,0
4949,CTRI/2021/05/033576,Not Yet Recruiting,,,,,,11/05/2021,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=54949,,0,0
4950,CTRI/2021/05/033599,Not Yet Recruiting,,,,,,12/05/2021,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=55286,,0,0
4951,CTRI/2021/05/033622,Not Yet Recruiting,,,,,,14/05/2021,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=56002,,0,0
4952,CTRI/2021/05/033623,Not Yet Recruiting,,,,,,14/05/2021,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=56044,,0,0
4953,CTRI/2021/05/033626,Completed,,23/07/2021,,,,12/07/2021,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=54292,23/07/2021,0,0
4954,CTRI/2021/05/033651,Not Yet Recruiting,,,,,,13/05/2021,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=55951,,0,0
4955,CTRI/2021/05/033665,Not Yet Recruiting,,,,,,,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=56122,,0,0
4956,CTRI/2021/05/033703,Not Yet Recruiting,,,,,,17/05/2021,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=56095,,0,0
4957,CTRI/2021/05/033693,Open to Recruitment,,,,,,29/06/2021,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=55936,,0,0
4958,CTRI/2021/05/033696,Not Yet Recruiting,,,,,,19/05/2021,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=56026,,0,0
4959,CTRI/2021/05/033695,Not Yet Recruiting,,,,,,19/05/2021,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=56031,,0,0
4960,DRKS00021447,"Recruiting complete, follow-up complete",,,,"[{'document_type': 'Approval of ethics comm. (mandatory for transfer to Studybox)', 'link_to_document': 'https://www.drks.de/drks_web/AttachmentDownstreamServlet?ID=b9e5f46a-f347-48b2-90e3-fe4b70c1b05b&LOCALE=en&FILENAME=069_20 Enghard 2.pdf'}, {'document_type': 'trial protocol (mandatory for transfer to Studybox)', 'link_to_document': 'https://www.drks.de/drks_web/AttachmentDownstreamServlet?ID=40e74eeb-cd3d-4b5f-b8bb-631311f34d4e&LOCALE=en&FILENAME=Studienprotokoll CytoResc_new.pdf'}, {'document_type': 'Approval of ethics comm. (mandatory for transfer to Studybox)', 'link_to_document': 'https://www.drks.de/drks_web/AttachmentDownstreamServlet?ID=facec8e3-9c30-4c09-bf36-fe8c6235fb3f&LOCALE=en&FILENAME=EA1_069_20 Votum vom 27.11.2020.pdf'}]",,17/05/2021,http://www.drks.de/DRKS00021447,,0,1
4961,DRKS00021420,Recruiting ongoing,,,,"[{'document_type': 'trial protocol (mandatory for transfer to Studybox)', 'link_to_document': 'https://www.drks.de/drks_web/AttachmentDownstreamServlet?ID=575eb75e-6a49-456f-a8cc-2db0bbc02711&LOCALE=en&FILENAME=3_Protokoll.pdf'}]",,16/04/2020,http://www.drks.de/DRKS00021420,,0,1
4962,DRKS00021527,"Recruiting complete, follow-up complete",,,,"[{'document_type': 'Trial results', 'link_to_document': 'http://preprints.jmir.org/preprint/27865'}]",,27/05/2021,http://www.drks.de/DRKS00021527,,0,1
4963,DRKS00022857,Recruiting ongoing,,,,,,19/03/2021,http://www.drks.de/DRKS00022857,,0,0
4964,DRKS00021573,"Recruiting complete, follow-up complete",,23/07/2020,,,,27/07/2020,http://www.drks.de/DRKS00021573,23/07/2020,0,0
4965,DRKS00021585,"Recruiting complete, follow-up complete",,21/04/2021,,,,30/04/2021,http://www.drks.de/DRKS00021585,21/04/2021,0,0
4966,DRKS00021588,Recruiting ongoing,,,,,,10/06/2020,http://www.drks.de/DRKS00021588,,0,0
4967,DRKS00021582,Recruiting planned,,,,,,12/05/2020,http://www.drks.de/DRKS00021582,,0,0
4968,DRKS00023822,Recruiting ongoing,,,,,,22/06/2021,http://www.drks.de/DRKS00023822,,0,0
4969,DRKS00021214,Recruiting ongoing,,,,,,11/02/2021,http://www.drks.de/DRKS00021214,,0,0
4970,DRKS00022553,Recruiting ongoing,,,,,,15/03/2021,http://www.drks.de/DRKS00022553,,0,0
4971,DRKS00023880,Recruiting ongoing,,,,,,07/01/2021,http://www.drks.de/DRKS00023880,,0,0
4972,DRKS00021153,Recruiting ongoing,,,,,,15/04/2020,http://www.drks.de/DRKS00021153,,0,0
4973,DRKS00022484,"Recruiting complete, follow-up complete",,31/07/2020,,,,10/02/2021,http://www.drks.de/DRKS00022484,31/07/2020,0,0
4974,DRKS00023911,"Recruiting complete, follow-up complete",,26/03/2021,,,,30/04/2021,http://www.drks.de/DRKS00023911,26/03/2021,0,0
4975,DRKS00021301,"Recruiting complete, follow-up continuing",,,,,,02/07/2021,http://www.drks.de/DRKS00021301,,0,0
4976,DRKS00023971,"Recruiting complete, follow-up continuing",,,,,,05/07/2021,http://www.drks.de/DRKS00023971,,0,0
4977,DRKS00021273,Recruiting ongoing,,,,,,15/02/2021,http://www.drks.de/DRKS00021273,,0,0
4978,DRKS00022305,Enrolling by invitation,,,,"[{'document_type': 'Approval of ethics comm. (mandatory for transfer to Studybox)', 'link_to_document': 'https://www.drks.de/drks_web/AttachmentDownstreamServlet?ID=1d2f0cd4-b4ce-45c5-bc69-bcbe206e18bd&LOCALE=en&FILENAME=2020-498-f-S_abschlie%C3%9Fendes Votum Antrag_17.07.2020.pdf'}, {'document_type': 'trial protocol (mandatory for transfer to Studybox)', 'link_to_document': 'https://www.drks.de/drks_web/AttachmentDownstreamServlet?ID=63c57106-04a9-42bc-805c-8fda71ef1fa6&LOCALE=en&FILENAME=23062020Studienplan.pdf'}]",,31/07/2020,http://www.drks.de/DRKS00022305,,0,1
4979,DRKS00023650,Recruiting planned,,,,,,18/03/2021,http://www.drks.de/DRKS00023650,,0,0
4980,DRKS00023567,Recruiting ongoing,,,,,,06/05/2021,http://www.drks.de/DRKS00023567,,0,0
4981,DRKS00023721,Recruiting ongoing,,,,,,15/12/2020,http://www.drks.de/DRKS00023721,,0,0
4982,DRKS00023406,Recruiting planned,,,,"[{'document_type': 'Approval of ethics comm. (mandatory for transfer to Studybox)', 'link_to_document': 'https://www.drks.de/drks_web/AttachmentDownstreamServlet?ID=b2f935b5-780e-4b65-9609-56b99eec160b&LOCALE=en&FILENAME=20-1465_2020-10-26_ANDERE Erf%C3%BCllung Bedingungen_signatur.pdf'}, {'document_type': 'trial protocol (mandatory for transfer to Studybox)', 'link_to_document': 'https://www.drks.de/drks_web/AttachmentDownstreamServlet?ID=63f1b7f9-ebf2-40fd-a052-4254e45397ab&LOCALE=en&FILENAME=version_22_10_2020_Ethikantrag_COVID_VieScope.pdf'}]",,09/11/2020,http://www.drks.de/DRKS00023406,,0,1
4983,DRKS00024664,Recruiting ongoing,,,,,,26/02/2021,http://www.drks.de/DRKS00024664,,0,0
4984,DRKS00022067,Recruiting planned,,,,,,12/06/2020,http://www.drks.de/DRKS00022067,,0,0
4985,DRKS00022083,Recruiting ongoing,,,,,,09/06/2020,http://www.drks.de/DRKS00022083,,0,0
4986,DRKS00023500,"Recruiting complete, follow-up complete",,10/09/2020,,,,05/11/2020,http://www.drks.de/DRKS00023500,10/09/2020,0,0
4987,DRKS00024845,Recruiting planned,,,,,,18/03/2021,http://www.drks.de/DRKS00024845,,0,0
4988,DRKS00023553,"Recruiting complete, follow-up complete",,,,,,21/06/2021,http://www.drks.de/DRKS00023553,,0,0
4989,DRKS00022203,Recruiting ongoing,,,,,,29/09/2020,http://www.drks.de/DRKS00022203,,0,0
4990,DRKS00024787,Recruiting planned,,,,,,05/05/2021,http://www.drks.de/DRKS00024787,,0,0
4991,DRKS00024520,"Recruiting complete, follow-up complete",,,,,,29/06/2021,http://www.drks.de/DRKS00024520,,0,0
4992,DRKS00024440,Recruiting planned,,,,,,08/03/2021,http://www.drks.de/DRKS00024440,,0,0
4993,DRKS00024412,Recruiting ongoing,,,,,,08/03/2021,http://www.drks.de/DRKS00024412,,0,0
4994,DRKS00024422,Recruiting planned,,,,,,19/02/2021,http://www.drks.de/DRKS00024422,,0,0
4995,DRKS00024455,Recruiting planned,,,,,,09/02/2021,http://www.drks.de/DRKS00024455,,0,0
4996,DRKS00024454,"Recruiting complete, follow-up complete",,06/02/2021,,,,08/02/2021,http://www.drks.de/DRKS00024454,06/02/2021,0,0
4997,DRKS00023184,Recruiting ongoing,,,,,,07/10/2020,http://www.drks.de/DRKS00023184,,0,0
4998,DRKS00023171,Recruiting planned,,,,"[{'document_type': 'Approval of ethics comm. (mandatory for transfer to Studybox)', 'link_to_document': None}]",,26/10/2020,http://www.drks.de/DRKS00023171,,0,1
4999,DRKS00024531,Recruiting ongoing,,,,,,18/02/2021,http://www.drks.de/DRKS00024531,,0,0
5000,DRKS00023271,"Recruiting complete, follow-up complete",,18/12/2020,,"[{'document_type': 'Approval of ethics comm. (mandatory for transfer to Studybox)', 'link_to_document': 'https://www.drks.de/drks_web/AttachmentDownstreamServlet?ID=7acbb167-380e-4a7f-b239-636f316a2dd1&LOCALE=en&FILENAME=Ethikvotum_2020-11-02 ZB 79020.pdf'}, {'document_type': 'trial protocol (mandatory for transfer to Studybox)', 'link_to_document': 'https://www.drks.de/drks_web/AttachmentDownstreamServlet?ID=d51a0d38-d78d-4799-b201-b9fc69e61e35&LOCALE=en&FILENAME=Surveillance_Studienprotokoll_03Nov2020_v1_2.pdf'}, {'document_type': 'Approval of ethics comm. (mandatory for transfer to Studybox)', 'link_to_document': 'https://www.drks.de/drks_web/AttachmentDownstreamServlet?ID=a1b88b4e-05ed-4a9f-9870-20179482cc57&LOCALE=en&FILENAME=Ethikvotum_2020-11-09 ZB 79020.pdf'}]",,12/04/2021,http://www.drks.de/DRKS00023271,18/12/2020,0,1
5001,DRKS00024585,Recruiting ongoing,,,,,,25/02/2021,http://www.drks.de/DRKS00024585,,0,0
5002,DRKS00023091,"Recruiting complete, follow-up complete",,15/11/2020,,,,09/04/2021,http://www.drks.de/DRKS00023091,15/11/2020,0,0
5003,DRKS00024028,Recruiting ongoing,,,,,,11/02/2021,http://www.drks.de/DRKS00024028,,0,0
5004,DRKS00024117,Recruiting ongoing,,,,,,09/02/2021,http://www.drks.de/DRKS00024117,,0,0
5005,DRKS00024162,Recruiting planned,,,,,,09/02/2021,http://www.drks.de/DRKS00024162,,0,0
5006,DRKS00025199,"Recruiting complete, follow-up complete",,12/11/2020,,,,30/04/2021,http://www.drks.de/DRKS00025199,12/11/2020,0,0
5007,DRKS00022958,Recruiting planned,,,,"[{'document_type': 'Background literature', 'link_to_document': 'https://www.drks.de/drks_web/AttachmentDownstreamServlet?ID=95a91263-edba-4c33-96c4-c0877a517bc0&LOCALE=en&FILENAME=Hintergrundliteratur_Studie 2_Care +.pdf'}]",,07/10/2020,http://www.drks.de/DRKS00022958,,0,1
5008,DRKS00021706,Enrolling by invitation,,,,,,27/05/2021,http://www.drks.de/DRKS00021706,,0,0
5009,DRKS00025271,Recruiting ongoing,,,,,,11/05/2021,http://www.drks.de/DRKS00025271,,0,0
5010,2020-000890-25,,,,,,,,,,0,0
5011,2020-000919-69,,,,,,,,,,0,0
5012,2020-001023-14,,,,,,,,,,0,0
5013,2020-000936-23,,,,,,,,,,0,0
5014,2020-001386-37,,,,,,,,,,0,0
5015,2020-001301-23,,,,,,,,,,0,0
5016,2020-001188-96,,,,,,,,,,0,0
5017,2020-001373-70,,,,,,,,,,0,0
5018,2020-001381-11,,,,,,,,,,0,0
5019,2020-001457-43,,,,,,,,,,0,0
5020,2020-001442-19,,,,,,,,,,0,0
5021,2020-001385-11,,,,,,,,,,0,0
5022,2020-001409-21,,,,,,,,,,0,0
5023,2020-001492-33,,,,,,,,,,0,0
5024,2020-001194-69,,,,,,,,,,0,0
5025,2020-001565-37,,,,,,,,,,0,0
5026,2020-001421-31,,,,,,,,,,0,0
5027,2020-001606-33,,,,,,,,,,0,0
5028,2020-001039-29,,,,,,,,,,0,0
5029,2020-001303-16,,,,,,,,,,0,0
5030,2020-001156-18,,,,,,,,,,0,0
5031,2020-001160-28,,,,,,,,,,0,0
5032,2020-001262-11,,,,,,,,,,0,0
5033,2020-001290-74,,,,,,,,,,0,0
5034,2020-001321-31,,,,,,,,,,0,0
5035,2020-001437-12,,,,,,,,,,0,0
5036,2020-001587-29,,,,,,,,,,0,0
5037,2020-001689-12,,,18/12/2020,,,,,,18/12/2020,0,0
5038,2020-001331-26,,,,,,,,,,0,0
5039,2020-001379-34,,,,,,,,,,0,0
5040,2020-001682-36,,,,,,,,,,0,0
5041,2020-001511-25,,,,,,,,,,0,0
5042,2020-001448-24,,,,,,,,,,0,0
5043,2020-001570-30,,,,,,,,,,0,0
5044,2020-001254-22,,,,,,,,,,0,0
5045,2020-001329-30,,,,,,,,,,0,0
5046,2020-001527-14,,,,,,,,,,0,0
5047,2020-001366-11,,,,,,,,,,0,0
5048,2020-001255-40,,,,,,,,,,0,0
5049,2020-001531-27,,,,,,,,,,0,0
5050,2020-001459-42,,,,,,,,,,0,0
5051,2020-001500-41,,,,,,,,,,0,0
5052,2020-001723-13,,,,,,,,,,0,0
5053,2020-001823-15,,,,,,,,,,0,0
5054,2020-001678-31,,,,,,,,,,0,0
5055,2020-001364-29,,,,,,,,,,0,0
5056,2020-001717-20,,,,,,,,,,0,0
5057,2020-000982-18,,,,,,,,,,0,0
5058,2020-001700-42,,,,,,,,,,0,0
5059,2020-001766-11,,,,,,,,,,0,0
5060,2020-001370-30,,,22/12/2020,,,,,,22/12/2020,0,0
5061,2020-001709-21,,,,,,,,,,0,0
5062,2020-001768-27,,,,,,,,,,0,0
5063,2020-001598-66,,,,,,,,,,0,0
5064,2020-001909-22,,,,,,,,,,0,0
5065,2020-001449-38,,,,,,,,,,0,0
5066,2020-001786-36,,,,,,,,,,0,0
5067,2020-001721-31,,,,,,,,,,0,0
5068,2020-001783-28,,,,,,,,,,0,0
5069,2020-001882-36,,,,,,,,,,0,0
5070,2020-001206-35,,,,,,,,,,0,0
5071,2020-001696-32,,,,,,,,,,0,0
5072,2020-001805-21,,,,,,,,,,0,0
5073,2020-001886-35,,,,,,,,,,0,0
5074,2020-001614-38,,,,,,,,,,0,0
5075,2020-001573-78,,,,,,,,,,0,0
5076,2020-001754-21,,,09/07/2021,,,,,,09/07/2021,0,0
5077,2020-001963-10,,,,,,,,,,0,0
5078,2020-001536-98,,,27/04/2020,,,,,,27/04/2020,0,0
5079,2020-001497-30,,,,,,,,,,0,0
5080,2020-001684-89,,,,,,,,,,0,0
5081,2020-001296-33,,,26/04/2021,,,,,,26/04/2021,0,0
5082,2020-001759-42,,,,,,,,,,0,0
5083,2020-001597-30,,,,,,,,,,0,0
5084,2020-002111-22,,,,,,,,,,0,0
5085,2020-001849-39,,,,,,,,,,0,0
5086,2020-001951-42,,,,,,,,,,0,0
5087,2020-001571-32,,,,,,,,,,0,0
5088,2020-001363-85,,,,View results,,,,,,1,0
5089,2020-001411-25,,,13/01/2021,,,,,,13/01/2021,0,0
5090,2020-001937-11,,,,,,,,,,0,0
5091,2020-001636-95,,,,,,,,,,0,0
5092,2020-001481-11,,,,,,,,,,0,0
5093,2020-001889-10,,,,,,,,,,0,0
5094,2020-002120-37,,,,,,,,,,0,0
5095,2020-001497-30,,,,,,,,,,0,0
5096,2020-001767-86,,,,,,,,,,0,0
5097,2020-002060-31,,,,,,,,,,0,0
5098,2020-001777-71,,,,View results,,,,,,1,0
5099,2020-001435-27,,,,,,,,,,0,0
5100,2020-001271-33,,,,,,,,,,0,0
5101,2020-001258-23,,,,,,,,,,0,0
5102,2020-002230-32,,,,,,,,,,0,0
5103,2020-002448-21,,,,,,,,,,0,0
5104,2020-001740-26,,,,,,,,,,0,0
5105,2020-001366-11,,,,,,,,,,0,0
5106,2020-001413-20,,,,,,,,,,0,0
5107,2020-001270-29,,,25/06/2020,View results,,,,,25/06/2020,1,0
5108,2020-001198-55,,,,View results,,,,,,1,0
5109,2020-001750-22,,,,,,,,,,0,0
5110,2020-001504-42,,,,,,,,,,0,0
5111,2020-001747-21,,,,,,,,,,0,0
5112,2020-002106-68,,,,,,,,,,0,0
5113,2020-001808-42,,,,,,,,,,0,0
5114,2020-002193-27,,,,,,,,,,0,0
5115,2020-001445-39,,,29/06/2020,,,,,,29/06/2020,0,0
5116,2020-001765-37,,,26/06/2020,,,,,,26/06/2020,0,0
5117,2020-001707-16,,,,,,,,,,0,0
5118,2020-001890-56,,,,,,,,,,0,0
5119,2020-001794-77,,,,,,,,,,0,0
5120,2020-001929-31,,,,,,,,,,0,0
5121,2020-002186-34,,,,,,,,,,0,0
5122,2020-002310-41,,,,,,,,,,0,0
5123,2020-002166-13,,,,,,,,,,0,0
5124,2020-002449-41,,,,,,,,,,0,0
5125,2020-001904-41,,,,,,,,,,0,0
5126,2020-002668-29,,,,,,,,,,0,0
5127,2020-002632-75,,,,,,,,,,0,0
5128,2020-002494-10,,,,,,,,,,0,0
5129,2020-002476-13,,,,,,,,,,0,0
5130,2020-002952-18,,,,,,,,,,0,0
5131,2020-001417-21,,,26/06/2020,View results,,,,,26/06/2020,1,0
5132,2020-001770-30,,,,,,,,,,0,0
5133,2020-002574-27,,,,,,,,,,0,0
5134,2020-001333-13,,,07/08/2020,,,,,,07/08/2020,0,0
5135,2020-001739-28,,,04/05/2021,,,,,,04/05/2021,0,0
5136,2020-001408-41,,,31/08/2020,,,,,,31/08/2020,0,0
5137,2020-001888-90,,,,,,,,,,0,0
5138,2020-002394-94,,,,,,,,,,0,0
5139,2020-001644-25,,,17/11/2020,,,,,,17/11/2020,0,0
5140,2020-001673-75,,,16/04/2021,,,,,,16/04/2021,0,0
5141,2020-002503-19,,,,,,,,,,0,0
5142,2020-002314-40,,,,,,,,,,0,0
5143,2020-001860-27,,,,,,,,,,0,0
5144,2020-001466-11,,,,,,,,,,0,0
5145,2020-001643-13,,,,,,,,,,0,0
5146,2020-001281-11,,,28/04/2020,,,,,,28/04/2020,0,0
5147,2020-001530-35,,,,,,,,,,0,0
5148,2020-001634-36,,,,,,,,,,0,0
5149,2020-001622-64,,,,,,,,,,0,0
5150,2020-001722-66,,,,,,,,,,0,0
5151,2020-001505-22,,,,,,,,,,0,0
5152,2020-001541-39,,,,,,,,,,0,0
5153,2020-001618-39,,,,,,,,,,0,0
5154,2020-000705-86,,,,,,,,,,0,0
5155,2020-001825-29,,,,,,,,,,0,0
5156,2020-001697-30,,,,,,,,,,0,0
5157,2020-001376-15,,,03/09/2020,,,,,,03/09/2020,0,0
5158,2020-002728-35,,,,,,,,,,0,0
5159,2020-001640-26,,,,,,,,,,0,0
5160,2020-003470-47,,,,,,,,,,0,0
5161,2020-001686-36,,,,,,,,,,0,0
5162,2020-001367-88,,,,View results,,,,,,1,0
5163,2020-001395-15,,,03/09/2020,,,,,,03/09/2020,0,0
5164,2020-002542-16,,,,,,,,,,0,0
5165,2020-001807-18,,,21/04/2021,,,,,,21/04/2021,0,0
5166,2020-001327-13,,,14/06/2021,,,,,,14/06/2021,0,0
5167,2020-002110-41,,,,,,,,,,0,0
5168,2020-001610-38,,,,,,,,,,0,0
5169,2020-001498-63,,,,,,,,,,0,0
5170,2020-004928-42,,,,,,,,,,0,0
5171,2020-001473-79,,,,,,,,,,0,0
5172,2020-002211-21,,,12/05/2021,,,,,,12/05/2021,0,0
5173,2020-001803-17,,,,,,,,,,0,0
5174,2020-001010-38,,,20/05/2020,,,,,,20/05/2020,0,0
5175,2020-001455-40,,,,,,,,,,0,0
5176,2020-002295-13,,,,,,,,,,0,0
5177,2020-001734-36,,,,,,,,,,0,0
5178,2020-001867-94,,,,,,,,,,0,0
5179,2020-001745-40,,,,,,,,,,0,0
5180,2020-001732-10,,,,,,,,,,0,0
5181,2020-003486-19,,,,,,,,,,0,0
5182,2020-001162-12,,,02/09/2020,View results,,,,,02/09/2020,1,0
5183,2020-003689-37,,,,,,,,,,0,0
5184,2020-002677-95,,,,,,,,,,0,0
5185,2020-001662-11,,,17/10/2020,View results,,,,,17/10/2020,1,0
5186,2020-001689-12,,,18/12/2020,,,,,,18/12/2020,0,0
5187,2020-004123-16,,,,,,,,,,0,0
5188,2020-001275-32,,,09/10/2020,,,,,,09/10/2020,0,0
5189,2020-002122-82,,,,,,,,,,0,0
5190,2020-001891-14,,,,,,,,,,0,0
5191,2020-002032-69,,,,,,,,,,0,0
5192,2020-001827-15,,,,,,,,,,0,0
5193,2020-001603-16,,,,,,,,,,0,0
5194,2020-001994-66,,,,,,,,,,0,0
5195,2020-001934-37,,,,,,,,,,0,0
5196,2020-001474-29,,,,,,,,,,0,0
5197,2020-001953-36,,,,,,,,,,0,0
5198,2020-001512-26,,,12/10/2020,,,,,,12/10/2020,0,0
5199,2020-001903-17,,,,,,,,,,0,0
5200,2020-002114-40,,,,,,,,,,0,0
5201,2020-001852-16,,,,,,,,,,0,0
5202,2020-002056-20,,,13/06/2021,,,,,,13/06/2021,0,0
5203,2020-004144-28,,,,,,,,,,0,0
5204,2020-002497-27,,,,,,,,,,0,0
5205,2020-001736-95,,,,,,,,,,0,0
5206,2020-002293-28,,,,,,,,,,0,0
5207,2020-001072-15,,,,,,,,,,0,0
5208,2020-002225-29,,,,,,,,,,0,0
5209,2020-001467-82,,,,,,,,,,0,0
5210,2020-004743-83,,,,,,,,,,0,0
5211,2020-004356-16,,,,,,,,,,0,0
5212,2020-001553-48,,,18/08/2020,,,,,,18/08/2020,0,0
5213,2020-001357-52,,,,,,,,,,0,0
5214,2020-001319-26,,,,,,,,,,0,0
5215,2020-001995-13,,,,,,,,,,0,0
5216,2020-002274-28,,,,,,,,,,0,0
5217,2020-001704-42,,,,,,,,,,0,0
5218,2020-002287-31,,,,,,,,,,0,0
5219,2020-002037-15,,,,,,,,,,0,0
5220,2020-001960-28,,,,,,,,,,0,0
5221,2020-001841-38,,,,,,,,,,0,0
5222,2020-002456-21,,,03/09/2020,,,,,,03/09/2020,0,0
5223,2020-001605-23,,,,,,,,,,0,0
5224,2020-002312-43,,,,,,,,,,0,0
5225,2020-001671-32,,,,,,,,,,0,0
5226,2020-002009-25,,,,,,,,,,0,0
5227,2020-001971-33,,,,,,,,,,0,0
5228,2020-002567-57,,,,,,,,,,0,0
5229,2020-004682-39,,,,,,,,,,0,0
5230,2020-001689-12,,,18/12/2020,,,,,,18/12/2020,0,0
5231,2020-001113-21,,,,,,,,,,0,0
5232,2020-001784-88,,,,,,,,,,0,0
5233,2020-001654-21,,,,,,,,,,0,0
5234,2020-000936-23,,,,,,,,,,0,0
5235,2020-001228-32,,,,,,,,,,0,0
5236,2020-003643-29,,,,,,,,,,0,0
5237,2020-002502-75,,,,,,,,,,0,0
5238,2020-001928-34,,,,,,,,,,0,0
5239,2020-003654-71,,,,,,,,,,0,0
5240,2020-004994-27,,,,,,,,,,0,0
5241,2020-002504-39,,,,,,,,,,0,0
5242,2020-001558-23,,,,,,,,,,0,0
5243,2020-004323-16,,,,,,,,,,0,0
5244,2020-001921-30,,,,,,,,,,0,0
5245,2020-004285-19,,,,,,,,,,0,0
5246,2020-001645-40,,,,,,,,,,0,0
5247,2020-003936-25,,,,,,,,,,0,0
5248,2020-004719-28,,,,,,,,,,0,0
5249,2020-003367-26,,,,,,,,,,0,0
5250,2020-003368-24,,,,,,,,,,0,0
5251,2020-001370-30,,,22/12/2020,,,,,,22/12/2020,0,0
5252,2020-002259-39,,,15/01/2021,,,,,,15/01/2021,0,0
5253,2020-002234-32,,,,,,,,,,0,0
5254,2020-001857-31,,,,,,,,,,0,0
5255,2020-001513-20,,,,,,,,,,0,0
5256,2020-001795-15,,,,,,,,,,0,0
5257,2020-001987-28,,,,,,,,,,0,0
5258,2020-002458-25,,,,,,,,,,0,0
5259,2020-001390-76,,,,,,,,,,0,0
5260,2020-001528-32,,,,,,,,,,0,0
5261,2020-002119-23,,,,,,,,,,0,0
5262,2020-001501-24,,,,,,,,,,0,0
5263,2020-002283-32,,,,,,,,,,0,0
5264,2020-001854-23,,,,,,,,,,0,0
5265,2020-001441-39,,,,,,,,,,0,0
5266,2020-003872-42,,,,,,,,,,0,0
5267,2020-001257-51,,,16/12/2020,,,,,,16/12/2020,0,0
5268,2020-000982-18,,,,,,,,,,0,0
5269,2020-001498-63,,,,,,,,,,0,0
5270,2020-001172-15,,,26/12/2020,,,,,,26/12/2020,0,0
5271,2020-004206-59,,,,,,,,,,0,0
5272,2020-003505-58,,,,,,,,,,0,0
5273,2020-002233-15,,,,,,,,,,0,0
5274,2020-001366-11,,,,,,,,,,0,0
5275,2020-001608-40,,,15/02/2021,,,,,,15/02/2021,0,0
5276,2021-000166-15,,,,,,,,,,0,0
5277,2020-005539-62,,,,,,,,,,0,0
5278,2021-000516-37,,,,,,,,,,0,0
5279,2020-005915-39,,,,,,,,,,0,0
5280,2021-001072-41,,,,,,,,,,0,0
5281,2020-005315-44,,,,,,,,,,0,0
5282,2020-001936-86,,,,,,,,,,0,0
5283,2020-001224-33,,,26/02/2021,,,,,,26/02/2021,0,0
5284,2020-001420-34,,,25/01/2021,,,,,,25/01/2021,0,0
5285,2020-003904-15,,,,,,,,,,0,0
5286,2021-001054-57,,,,,,,,,,0,0
5287,2020-002130-33,,,,,,,,,,0,0
5288,2021-001279-18,,,,,,,,,,0,0
5289,2020-005979-12,,,,,,,,,,0,0
5290,2020-002345-42,,,,,,,,,,0,0
5291,2020-005963-29,,,,,,,,,,0,0
5292,2020-005961-16,,,,,,,,,,0,0
5293,2021-000320-35,,,,,,,,,,0,0
5294,2021-000710-42,,,,,,,,,,0,0
5295,2020-001504-42,,,,,,,,,,0,0
5296,2021-000842-16,,,,,,,,,,0,0
5297,2020-002982-33,,,,,,,,,,0,0
5298,2020-005801-14,,,,,,,,,,0,0
5299,2021-000182-33,,,,,,,,,,0,0
5300,2021-000206-17,,,,,,,,,,0,0
5301,2021-000349-42,,,,,,,,,,0,0
5302,2020-005291-35,,,,,,,,,,0,0
5303,2020-005763-31,,,,,,,,,,0,0
5304,2021-000454-26,,,,,,,,,,0,0
5305,2020-005828-11,,,,,,,,,,0,0
5306,2020-001602-34,,,,,,,,,,0,0
5307,2020-002091-12,,,08/10/2020,,,,,,08/10/2020,0,0
5308,2020-001498-63,,,,,,,,,,0,0
5309,2020-004408-32,,,,,,,,,,0,0
5310,2020-002772-12,,,,,,,,,,0,0
5311,2020-001749-38,,,,,,,,,,0,0
5312,2020-002345-42,,,,,,,,,,0,0
5313,2020-003614-13,,,,,,,,,,0,0
5314,2020-001325-31,,,21/01/2021,,,,,,21/01/2021,0,0
5315,2020-004571-41,,,,,,,,,,0,0
5316,2020-005919-51,,,,,,,,,,0,0
5317,2020-001038-36,,,,,,,,,,0,0
5318,2020-001632-10,,,,,,,,,,0,0
5319,2020-003349-12,,,,,,,,,,0,0
5320,2020-005447-23,,,,,,,,,,0,0
5321,2020-003363-25,,,,,,,,,,0,0
5322,2020-001335-28,,,,,,,,,,0,0
5323,2020-002027-10,,,,,,,,,,0,0
5324,2020-002190-10,,,,,,,,,,0,0
5325,2020-001644-25,,,17/11/2020,,,,,,17/11/2020,0,0
5326,2020-001659-42,,,15/01/2021,,,,,,15/01/2021,0,0
5327,2021-000515-24,,,,,,,,,,0,0
5328,2020-002123-11,,,,,,,,,,0,0
5329,2020-003734-20,,,,,,,,,,0,0
5330,2020-005410-18,,,,,,,,,,0,0
5331,2021-000868-30,,,,,,,,,,0,0
5332,2021-000412-28,,,,,,,,,,0,0
5333,2021-000461-33,,,,,,,,,,0,0
5334,2020-001760-29,,,,,,,,,,0,0
5335,2020-006042-39,,,,,,,,,,0,0
5336,2020-001236-10,,,,,,,,,,0,0
5337,2020-004715-27,,,,,,,,,,0,0
5338,2021-000413-17,,,,,,,,,,0,0
5339,2020-002542-16,,,,,,,,,,0,0
5340,2020-001251-41,,,29/01/2021,,,,,,29/01/2021,0,0
5341,2020-001870-32,,,24/12/2020,,,,,,24/12/2020,0,0
5342,2020-003654-71,,,,,,,,,,0,0
5343,2020-000936-23,,,,,,,,,,0,0
5344,2020-001244-26,,,,,,,,,,0,0
5345,2020-002913-16,,,,,,,,,,0,0
5346,2020-002299-11,,,,,,,,,,0,0
5347,2020-001411-25,,,13/01/2021,,,,,,13/01/2021,0,0
5348,2020-001406-27,,,08/06/2020,,,,,,08/06/2020,0,0
5349,2020-001307-16,,,03/06/2020,,,,,,03/06/2020,0,0
5350,2020-001440-26,,,08/04/2020,,,,,,08/04/2020,0,0
5351,2020-005827-35,,,,,,,,,,0,0
5352,2020-001310-38,,,22/02/2021,,,,,,22/02/2021,0,0
5353,2021-000880-63,,,,,,,,,,0,0
5354,2021-000905-26,,,,,,,,,,0,0
5355,2021-000864-32,,,,,,,,,,0,0
5356,2020-001391-15,,,12/04/2021,,,,,,12/04/2021,0,0
5357,2020-005128-12,,,,,,,,,,0,0
5358,2020-005214-18,,,,,,,,,,0,0
5359,2021-000566-14,,,,,,,,,,0,0
5360,2020-006130-12,,,,,,,,,,0,0
5361,2021-000365-33,,,,,,,,,,0,0
5362,2020-005759-18,,,,,,,,,,0,0
5363,2020-006075-15,,,,,,,,,,0,0
5364,2021-000701-24,,,,,,,,,,0,0
5365,2021-001655-13,,,,,,,,,,0,0
5366,2021-001414-10,,,,,,,,,,0,0
5367,2021-001080-24,,,,,,,,,,0,0
5368,2021-000440-22,,,,,,,,,,0,0
5369,2021-001665-20,,,,,,,,,,0,0
5370,2021-000455-39,,,,,,,,,,0,0
5371,2020-004272-17,,,,,,,,,,0,0
5372,2020-002584-63,,,,,,,,,,0,0
5373,2021-000175-37,,,,,,,,,,0,0
5374,2021-000872-13,,,,,,,,,,0,0
5375,2020-002282-33,,,,,,,,,,0,0
5376,2020-004070-22,,,,,,,,,,0,0
5377,2020-001493-29,,,,,,,,,,0,0
5378,2020-002869-34,,,,,,,,,,0,0
5379,2020-001857-31,,,,,,,,,,0,0
5380,2020-006003-42,,,,,,,,,,0,0
5381,2020-003998-22,,,,,,,,,,0,0
5382,2020-003779-17,,,,,,,,,,0,0
5383,2020-001306-35,,,26/04/2021,,,,,,26/04/2021,0,0
5384,2020-001490-68,,,15/04/2021,,,,,,15/04/2021,0,0
5385,2020-001411-25,,,13/01/2021,,,,,,13/01/2021,0,0
5386,2020-002038-33,,,30/01/2021,,,,,,30/01/2021,0,0
5387,2020-003210-13,,,,,,,,,,0,0
5388,2020-001264-28,,,23/02/2021,,,,,,23/02/2021,0,0
5389,2020-001623-13,,,,,,,,,,0,0
5390,2020-001673-75,,,16/04/2021,,,,,,16/04/2021,0,0
5391,2021-000893-27,,,,,,,,,,0,0
5392,2021-000930-32,,,,,,,,,,0,0
5393,2021-001040-10,,,,,,,,,,0,0
5394,2020-005580-32,,,,,,,,,,0,0
5395,2021-000492-36,,,,,,,,,,0,0
5396,2021-001144-98,,,,,,,,,,0,0
5397,2020-005849-16,,,,,,,,,,0,0
5398,2020-004066-19,,,,,,,,,,0,0
5399,2020-002102-58,,,,,,,,,,0,0
5400,2020-002208-37,,,,,,,,,,0,0
5401,2020-005015-40,,,,,,,,,,0,0
5402,2021-000235-30,,,23/04/2021,,,,,,23/04/2021,0,0
5403,2020-005020-11,,,,,,,,,,0,0
5404,2020-005280-31,,,,,,,,,,0,0
5405,2020-003369-20,,,,,,,,,,0,0
5406,2021-000988-68,,,,,,,,,,0,0
5407,2021-000981-13,,,,,,,,,,0,0
5408,2021-001304-15,,,,,,,,,,0,0
5409,2021-001520-18,,,,,,,,,,0,0
5410,2021-001357-31,,,,,,,,,,0,0
5411,2020-005952-39,,,,,,,,,,0,0
5412,2020-001635-27,,,,,,,,,,0,0
5413,2021-001202-30,,,,,,,,,,0,0
5414,2021-001978-37,,,,,,,,,,0,0
5415,2020-001243-15,,,10/06/2020,View results,,,,,10/06/2020,1,0
5416,2020-001266-11,,,11/11/2020,,,,,,11/11/2020,0,0
5417,2020-001469-35,,,31/12/2020,,,,,,31/12/2020,0,0
5418,2020-001546-19,,,26/10/2020,,,,,,26/10/2020,0,0
5419,2020-001345-38,,,,,,,,,,0,0
5420,2020-001264-28,,,23/02/2021,,,,,,23/02/2021,0,0
5421,2020-001236-10,,,,,,,,,,0,0
5422,2020-004356-16,,,,,,,,,,0,0
5423,2020-002472-12,,,25/02/2021,,,,,,25/02/2021,0,0
5424,2021-000683-30,,,,,,,,,,0,0
5425,2020-005759-18,,,,,,,,,,0,0
5426,2021-001031-72,,,,,,,,,,0,0
5427,2020-005576-35,,,,,,,,,,0,0
5428,2021-001512-28,,,,,,,,,,0,0
5429,2021-002014-14,,,,,,,,,,0,0
5430,2020-001302-30,,,,,,,,,,0,0
5431,2020-005299-36,,,,,,,,,,0,0
5432,2020-003403-33,,,,,,,,,,0,0
5433,2020-005315-44,,,,,,,,,,0,0
5434,2020-001324-33,,,02/02/2021,,,,,,02/02/2021,0,0
5435,2020-001748-24,,,17/05/2021,,,,,,17/05/2021,0,0
5436,2020-001172-15,,,26/12/2020,,,,,,26/12/2020,0,0
5437,2020-001782-37,,,05/03/2021,,,,,,05/03/2021,0,0
5438,2021-001769-19,,,,,,,,,,0,0
5439,2020-005979-12,,,,,,,,,,0,0
5440,2020-005366-34,,,,,,,,,,0,0
5441,2021-002245-15,,,,,,,,,,0,0
5442,2020-005759-18,,,,,,,,,,0,0
5443,2021-002327-38,,,,,,,,,,0,0
5444,2021-002098-25,,,,,,,,,,0,0
5445,2021-000724-35,,,,,,,,,,0,0
5446,2021-001177-22,,,,,,,,,,0,0
5447,2021-000307-20,,,,,,,,,,0,0
5448,2020-001793-30,,,,,,,,,,0,0
5449,2021-000408-39,,,,,,,,,,0,0
5450,2021-002348-57,,,,,,,,,,0,0
5451,2021-000291-11,,,,,,,,,,0,0
5452,2020-006082-11,,,,,,,,,,0,0
5453,2021-001735-10,,,,,,,,,,0,0
5454,2020-005752-38,,,,,,,,,,0,0
5455,2020-002322-85,,,,,,,,,,0,0
5456,2020-004695-18,,,,,,,,,,0,0
5457,2020-003267-26,,,,,,,,,,0,0
5458,2020-002039-31,,,16/06/2021,,,,,,16/06/2021,0,0
5459,2020-001431-27,,,,,,,,,,0,0
5460,2020-001549-38,,,,,,,,,,0,0
5461,2020-005763-31,,,,,,,,,,0,0
5462,2021-000627-12,,,,,,,,,,0,0
5463,2021-002184-22,,,,,,,,,,0,0
5464,2020-005227-37,,,,,,,,,,0,0
5465,2020-001675-33,,,,,,,,,,0,0
5466,2021-001036-25,,,,,,,,,,0,0
5467,2020-005997-82,,,,,,,,,,0,0
5468,2021-000673-83,,,,,,,,,,0,0
5469,2020-005366-34,,,,,,,,,,0,0
5470,2020-005911-27,,,,,,,,,,0,0
5471,2020-001250-21,,,10/06/2021,,,,,,10/06/2021,0,0
5472,2020-001320-34,,,25/05/2021,,,,,,25/05/2021,0,0
5473,2020-001375-32,,,,,,,,,,0,0
5474,2020-001206-35,,,,,,,,,,0,0
5475,2020-005524-11,,,02/06/2021,,,,,,02/06/2021,0,0
5476,2020-003936-25,,,,,,,,,,0,0
5477,2021-001070-38,,,,,,,,,,0,0
5478,2020-005759-18,,,,,,,,,,0,0
5479,2021-000045-41,,,,,,,,,,0,0
5480,2021-002174-52,,,,,,,,,,0,0
5481,2020-005523-37,,,,,,,,,,0,0
5482,2021-003388-90,,,,,,,,,,0,0
5483,2020-000936-23,,,,,,,,,,0,0
5484,2020-001335-28,,,,,,,,,,0,0
5485,ISRCTN16993428,Ongoing,,31/08/2029,,,2020 genome-wide association study results in https://doi.org/10.1038/s41586-020-03065-y (added 01/06/2021) 2021 preprint results in https://doi.org/10.1101/2021.03.10.21252820 (added 01/06/2021) 2021 preprint results https://doi.org/10.1101/2021.03.04.21252931 (added 01/06/2021) 2021 preprint results in https://www.biorxiv.org/content/10.1101/2021.04.21.440697v1 (added 01/06/2021),25/06/2021,http://isrctn.com/ISRCTN16993428,31/08/2029,0,1
5486,ISRCTN16269648,Ongoing,,28/06/2022,,,,24/06/2021,http://isrctn.com/ISRCTN16269648,28/06/2022,0,0
5487,ISRCTN23403781,Ongoing,,28/07/2021,,,,08/07/2021,http://isrctn.com/ISRCTN23403781,28/07/2021,0,0
5488,ISRCTN15162325,Completed,,22/06/2021,,,,15/06/2021,http://isrctn.com/ISRCTN15162325,22/06/2021,0,0
5489,ISRCTN38734433,Ongoing,,30/06/2023,,,,15/06/2021,http://isrctn.com/ISRCTN38734433,30/06/2023,0,0
5490,ISRCTN29153109,Ongoing,,27/07/2021,,,,08/07/2021,http://isrctn.com/ISRCTN29153109,27/07/2021,0,0
5491,ISRCTN48554326,Ongoing,,30/08/2021,,,,14/06/2021,http://isrctn.com/ISRCTN48554326,30/08/2021,0,0
5492,ISRCTN31161020,Ongoing,,01/04/2022,,,,08/06/2021,http://isrctn.com/ISRCTN31161020,01/04/2022,0,0
5493,ISRCTN82492510,Ongoing,,01/09/2022,,,,12/05/2021,http://isrctn.com/ISRCTN82492510,01/09/2022,0,0
5494,ISRCTN15317247,Completed,,01/07/2021,,,,08/07/2021,http://isrctn.com/ISRCTN15317247,01/07/2021,0,0
5495,ISRCTN23016116,Ongoing,,30/07/2021,,,,02/06/2021,http://isrctn.com/ISRCTN23016116,30/07/2021,0,0
5496,ISRCTN17395671,Ongoing,,30/11/2023,,,,24/05/2021,http://isrctn.com/ISRCTN17395671,30/11/2023,0,0
5497,ISRCTN18003630,Ongoing,,31/08/2021,,,,18/05/2021,http://isrctn.com/ISRCTN18003630,31/08/2021,0,0
5498,ISRCTN47802196,Ongoing,,31/12/2021,,,,19/05/2021,http://isrctn.com/ISRCTN47802196,31/12/2021,0,0
5499,ISRCTN73765130,Ongoing,,01/08/2022,,,,25/06/2021,http://isrctn.com/ISRCTN73765130,01/08/2022,0,0
5500,ISRCTN13857593,Ongoing,,31/07/2021,,,,12/05/2021,http://isrctn.com/ISRCTN13857593,31/07/2021,0,0
5501,ISRCTN13848929,Completed,,08/03/2020,,,2021 results in https://pubmed.ncbi.nlm.nih.gov/34217258/ (added 05/07/2021),05/07/2021,http://isrctn.com/ISRCTN13848929,08/03/2020,0,1
5502,ISRCTN18100261,Completed,,30/06/2021,,,,04/05/2021,http://isrctn.com/ISRCTN18100261,30/06/2021,0,0
5503,ISRCTN12721265,Ongoing,,20/10/2021,,,,04/05/2021,http://isrctn.com/ISRCTN12721265,20/10/2021,0,0
5504,ISRCTN10839729,Completed,,28/02/2021,,,,29/04/2021,http://isrctn.com/ISRCTN10839729,28/02/2021,0,0
5505,ISRCTN79815558,Ongoing,,30/06/2022,,,,07/06/2021,http://isrctn.com/ISRCTN79815558,30/06/2022,0,0
5506,ISRCTN12272130,Suspended,,31/10/2022,,,,14/06/2021,http://isrctn.com/ISRCTN12272130,31/10/2022,0,0
5507,ISRCTN48563324,Ongoing,,31/07/2023,,,,22/04/2021,http://isrctn.com/ISRCTN48563324,31/07/2023,0,0
5508,ISRCTN15851697,Ongoing,,31/01/2024,,,,21/04/2021,http://isrctn.com/ISRCTN15851697,31/01/2024,0,0
5509,ISRCTN18304314,Completed,,10/01/2021,,,,14/04/2021,http://isrctn.com/ISRCTN18304314,10/01/2021,0,0
5510,ISRCTN14396374,Ongoing,,31/12/2022,,,,20/04/2021,http://isrctn.com/ISRCTN14396374,31/12/2022,0,0
5511,ISRCTN17472338,Ongoing,,31/12/2022,,,,07/04/2021,http://isrctn.com/ISRCTN17472338,31/12/2022,0,0
5512,ISRCTN22331899,Completed,,01/08/2020,,,,04/05/2021,http://isrctn.com/ISRCTN22331899,01/08/2020,0,0
5513,ISRCTN14081521,Ongoing,,30/09/2023,,,,01/04/2021,http://isrctn.com/ISRCTN14081521,30/09/2023,0,0
5514,ISRCTN14391248,Ongoing,,31/08/2021,,,,07/05/2021,http://isrctn.com/ISRCTN14391248,31/08/2021,0,0
5515,ISRCTN27841311,Ongoing,,01/09/2022,,,,24/06/2021,http://isrctn.com/ISRCTN27841311,01/09/2022,0,0
5516,ISRCTN72605600,Completed,,28/06/2021,,,,06/04/2021,http://isrctn.com/ISRCTN72605600,28/06/2021,0,0
5517,ISRCTN16393332,Ongoing,,31/07/2021,,,,24/03/2021,http://isrctn.com/ISRCTN16393332,31/07/2021,0,0
5518,ISRCTN21085622,Completed,,10/03/2021,,,,22/03/2021,http://isrctn.com/ISRCTN21085622,10/03/2021,0,0
5519,ISRCTN70307341,Ongoing,,03/12/2023,,,,23/03/2021,http://isrctn.com/ISRCTN70307341,03/12/2023,0,0
5520,ISRCTN17441953,Ongoing,,31/05/2023,,,,22/03/2021,http://isrctn.com/ISRCTN17441953,31/05/2023,0,0
5521,ISRCTN17846723,Ongoing,,31/03/2023,,,,24/03/2021,http://isrctn.com/ISRCTN17846723,31/03/2023,0,0
5522,ISRCTN46897021,Ongoing,,31/12/2021,,,,08/06/2021,http://isrctn.com/ISRCTN46897021,31/12/2021,0,0
5523,ISRCTN15328700,Ongoing,,28/02/2022,,,,16/06/2021,http://isrctn.com/ISRCTN15328700,28/02/2022,0,0
5524,ISRCTN16806663,Completed,,05/02/2021,,,,19/03/2021,http://isrctn.com/ISRCTN16806663,05/02/2021,0,0
5525,ISRCTN51046126,Ongoing,,30/04/2022,,,,06/04/2021,http://isrctn.com/ISRCTN51046126,30/04/2022,0,0
5526,ISRCTN39426207,Ongoing,,30/01/2023,,,,11/03/2021,http://isrctn.com/ISRCTN39426207,30/01/2023,0,0
5527,ISRCTN16205138,Ongoing,,01/09/2021,,,,18/05/2021,http://isrctn.com/ISRCTN16205138,01/09/2021,0,0
5528,ISRCTN15615992,Ongoing,,28/02/2022,,,,23/02/2021,http://isrctn.com/ISRCTN15615992,28/02/2022,0,0
5529,ISRCTN11204126,Ongoing,,31/01/2023,,,,17/02/2021,http://isrctn.com/ISRCTN11204126,31/01/2023,0,0
5530,ISRCTN15638344,Ongoing,,30/09/2022,,,,09/06/2021,http://isrctn.com/ISRCTN15638344,30/09/2022,0,0
5531,ISRCTN85874083,Ongoing,,01/10/2021,,,,13/05/2021,http://isrctn.com/ISRCTN85874083,01/10/2021,0,0
5532,ISRCTN11203922,Ongoing,,31/10/2022,,,,19/05/2021,http://isrctn.com/ISRCTN11203922,31/10/2022,0,0
5533,ISRCTN85436698,Ongoing,,01/09/2021,,,,25/03/2021,http://isrctn.com/ISRCTN85436698,01/09/2021,0,0
5534,ISRCTN69254139,Ongoing,,05/11/2022,,,2021 early results of reactogenicity data in https://doi.org/10.1016/S0140-6736(21)01115-6 (added 18/05/2021),24/06/2021,http://isrctn.com/ISRCTN69254139,05/11/2022,0,1
5535,ISRCTN13593711,Completed,,28/07/2020,,,2020 non-peer-reviewed results in preprint https://doi.org/10.1101/2020.08.27.20183442 (added 21/01/2021) 2021 results in https://doi.org/10.1056/NEJMoa2028700 (added 17/03/2021),17/03/2021,http://isrctn.com/ISRCTN13593711,28/07/2020,0,1
5536,ISRCTN17941313,Ongoing,,20/02/2022,,,,20/01/2021,http://isrctn.com/ISRCTN17941313,20/02/2022,0,0
5537,ISRCTN51124684,Ongoing,,31/08/2022,,,,11/05/2021,http://isrctn.com/ISRCTN51124684,31/08/2022,0,0
5538,ISRCTN37254291,Completed,,01/02/2021,,,2021 results in https://pubmed.ncbi.nlm.nih.gov/33991482/ (added 17/05/2021),17/05/2021,http://isrctn.com/ISRCTN37254291,01/02/2021,0,1
5539,ISRCTN18107122,Completed,,14/10/2020,,,,11/01/2021,http://isrctn.com/ISRCTN18107122,14/10/2020,0,0
5540,ISRCTN85787008,Completed,,12/10/2020,,,2021 results in https://pubmed.ncbi.nlm.nih.gov/33682592/ (added 09/03/2021),09/03/2021,http://isrctn.com/ISRCTN85787008,12/10/2020,0,1
5541,ISRCTN14037053,Ongoing,,31/01/2022,,,,30/12/2020,http://isrctn.com/ISRCTN14037053,31/01/2022,0,0
5542,ISRCTN82411169,Ongoing,,31/08/2021,,,,25/03/2021,http://isrctn.com/ISRCTN82411169,31/08/2021,0,0
5543,ISRCTN69564614,Ongoing,,06/01/2022,,,,17/02/2021,http://isrctn.com/ISRCTN69564614,06/01/2022,0,0
5544,ISRCTN27106947,Ongoing,,30/11/2021,,,2020 protocol in https://doi.org/10.1186/s13063-020-04473-1 (added 03/12/2020),04/05/2021,http://isrctn.com/ISRCTN27106947,30/11/2021,0,1
5545,ISRCTN11713182,Ongoing,,30/09/2021,,,,02/12/2020,http://isrctn.com/ISRCTN11713182,30/09/2021,0,0
5546,ISRCTN19845486,Completed,,31/03/2021,,,,01/12/2020,http://isrctn.com/ISRCTN19845486,31/03/2021,0,0
5547,ISRCTN77689525,Completed,,31/05/2021,,,,02/06/2021,http://isrctn.com/ISRCTN77689525,31/05/2021,0,0
5548,ISRCTN11466448,Ongoing,,31/08/2022,,,2020 protocol in https://doi.org/10.1186/s13063-020-04978-9 (added 07/01/2021),10/06/2021,http://isrctn.com/ISRCTN11466448,31/08/2022,0,1
5549,ISRCTN77941736,Completed,,30/03/2021,,,,04/12/2020,http://isrctn.com/ISRCTN77941736,30/03/2021,0,0
5550,ISRCTN11970082,Completed,,01/01/2021,,,2020 non-peer-reviewed results in preprint https://doi.org/10.1101/2020.12.14.20245266 (added 17/03/2021),17/03/2021,http://isrctn.com/ISRCTN11970082,01/01/2021,0,1
5551,ISRCTN12792822,Completed,,30/06/2021,,,,16/03/2021,http://isrctn.com/ISRCTN12792822,30/06/2021,0,0
5552,ISRCTN90437126,Ongoing,,30/06/2022,,,,31/03/2021,http://isrctn.com/ISRCTN90437126,30/06/2022,0,0
5553,ISRCTN16842454,Completed,,13/12/2020,,,,10/11/2020,http://isrctn.com/ISRCTN16842454,13/12/2020,0,0
5554,ISRCTN25647404,Completed,,27/12/2020,,,,09/11/2020,http://isrctn.com/ISRCTN25647404,27/12/2020,0,0
5555,ISRCTN10989132,Ongoing,,01/02/2023,,,,11/05/2021,http://isrctn.com/ISRCTN10989132,01/02/2023,0,0
5556,ISRCTN14722499,Ongoing,,10/05/2023,,,,20/04/2021,http://isrctn.com/ISRCTN14722499,10/05/2023,0,0
5557,ISRCTN79623250,Completed,,02/09/2020,,,2020 protocol in https://pubmed.ncbi.nlm.nih.gov/33237877/ (added 12/01/2021),10/05/2021,http://isrctn.com/ISRCTN79623250,02/09/2020,0,1
5558,ISRCTN15874265,Completed,,30/06/2020,,"https://www.clinicaltrialsregister.eu/ctr-search/trial/2020-000841-15/results, https://clinicaltrials.gov/ct2/show/results/NCT04292899",2020 results in https:doi.org/10.1056/NEJMoa2015301 (added 29/10/2020),19/03/2021,http://isrctn.com/ISRCTN15874265,30/06/2020,0,1
5559,ISRCTN12890382,Ongoing,,30/05/2022,,,,29/04/2021,http://isrctn.com/ISRCTN12890382,30/05/2022,0,0
5560,ISRCTN18428598,Ongoing,,31/01/2023,,,,01/10/2020,http://isrctn.com/ISRCTN18428598,31/01/2023,0,0
5561,ISRCTN10197987,Completed,,20/11/2020,,See additional files,2020 non-peer-reviewed results in preprint https://doi.org/10.1101/2020.11.27.20234997 (added 16/03/2021),05/05/2021,http://isrctn.com/ISRCTN10197987,20/11/2020,0,1
5562,ISRCTN57085639,Ongoing,,04/09/2021,,,2020 protocol in https://pubmed.ncbi.nlm.nih.gov/32736596/ (added 25/03/2021),09/04/2021,http://isrctn.com/ISRCTN57085639,04/09/2021,0,1
5563,ISRCTN53038326,Ongoing,,15/11/2021,,,,21/05/2021,http://isrctn.com/ISRCTN53038326,15/11/2021,0,0
5564,ISRCTN51232965,Ongoing,,22/09/2021,,,,10/09/2020,http://isrctn.com/ISRCTN51232965,22/09/2021,0,0
5565,ISRCTN34160010,Completed,,02/09/2020,,,2021 results in https://pubmed.ncbi.nlm.nih.gov/34098889/ (added 09/06/2021),09/06/2021,http://isrctn.com/ISRCTN34160010,02/09/2020,0,1
5566,ISRCTN13177364,Ongoing,,19/10/2021,,,2021 protocol in https://pubmed.ncbi.nlm.nih.gov/34039574/ (added 28/05/2021),28/05/2021,http://isrctn.com/ISRCTN13177364,19/10/2021,0,1
5567,ISRCTN95933274,Completed,,16/06/2021,,,2020 results in https://pubmed.ncbi.nlm.nih.gov/33315181/ (added 16/12/2020),16/12/2020,http://isrctn.com/ISRCTN95933274,16/06/2021,0,1
5568,ISRCTN31062548,Ongoing,,31/12/2021,,,2020 protocol in https://pubmed.ncbi.nlm.nih.gov/33213530/ (added 23/11/2020),19/03/2021,http://isrctn.com/ISRCTN31062548,31/12/2021,0,1
5569,ISRCTN33260034,Ongoing,,31/12/2021,,,,18/01/2021,http://isrctn.com/ISRCTN33260034,31/12/2021,0,0
5570,ISRCTN14602359,Completed,,10/03/2021,,,2021 protocol in https://pubmed.ncbi.nlm.nih.gov/33836825/ (added 12/04/2021),20/04/2021,http://isrctn.com/ISRCTN14602359,10/03/2021,0,1
5571,ISRCTN74727214,Completed,,15/08/2020,,,2020 results in https://pubmed.ncbi.nlm.nih.gov/33217576/ (added 15/01/2021),15/01/2021,http://isrctn.com/ISRCTN74727214,15/08/2020,0,1
5572,ISRCTN13455972,Completed,,30/09/2020,,,,30/10/2020,http://isrctn.com/ISRCTN13455972,30/09/2020,0,0
5573,ISRCTN93382525,Ongoing,,30/11/2024,,,,23/11/2020,http://isrctn.com/ISRCTN93382525,30/11/2024,0,0
5574,ISRCTN17896927,Completed,,24/07/2020,,,2020 non-peer-reviewed results in preprint https://doi.org/10.21203/rs.3.rs-96261/v1 (added 19/03/2021),19/03/2021,http://isrctn.com/ISRCTN17896927,24/07/2020,0,1
5575,ISRCTN13035264,Completed,,30/08/2020,,,2020 results in https://pubmed.ncbi.nlm.nih.gov/32445440/ (added 14/04/2021),14/04/2021,http://isrctn.com/ISRCTN13035264,30/08/2020,0,1
5576,ISRCTN14212905,Ongoing,,01/12/2021,,,,17/03/2021,http://isrctn.com/ISRCTN14212905,01/12/2021,0,0
5577,ISRCTN10207947,Ongoing,,30/12/2021,,,,03/06/2021,http://isrctn.com/ISRCTN10207947,30/12/2021,0,0
5578,ISRCTN14241621,Completed,,31/05/2021,,,2020 pilot results in hospitalised patients in https://doi.org/10.1016/S2213-2600(20)30511-7 (added 26/11/2020),26/11/2020,http://isrctn.com/ISRCTN14241621,31/05/2021,0,1
5579,ISRCTN67000769,Ongoing,,31/12/2023,,,2020 protocol in https://pubmed.ncbi.nlm.nih.gov/32267771/ (added 16/07/2020) 2020 results for hydrocortisone in https://pubmed.ncbi.nlm.nih.gov/32876697/ (added 03/09/2020) 2021 results for tocilizumab and sarilumab in preprint https://doi.org/10.1101/2021.01.07.21249390 (added 08/01/2021) 2021 results for tocilizumab and sarilumab in https://doi.org/10.1056/NEJMoa2100433 (added 18/03/2021),06/07/2021,http://isrctn.com/ISRCTN67000769,31/12/2023,0,1
5580,ISRCTN60069084,Ongoing,,01/10/2021,,,,03/08/2020,http://isrctn.com/ISRCTN60069084,01/10/2021,0,0
5581,ISRCTN48734830,Ongoing,,31/01/2022,,,,16/02/2021,http://isrctn.com/ISRCTN48734830,31/01/2022,0,0
5582,ISRCTN10378358,Ongoing,,01/03/2022,,,,14/09/2020,http://isrctn.com/ISRCTN10378358,01/03/2022,0,0
5583,ISRCTN68675756,Completed,,22/03/2020,,,2020 results in https://pubmed.ncbi.nlm.nih.gov/33192723/ (added 17/11/2020),17/11/2020,http://isrctn.com/ISRCTN68675756,22/03/2020,0,1
5584,ISRCTN54917435,Completed,,25/06/2021,,,2021 results in https://pubmed.ncbi.nlm.nih.gov/34127046/ (added 17/06/2021),17/06/2021,http://isrctn.com/ISRCTN54917435,25/06/2021,0,1
5585,ISRCTN89951424,Ongoing,,31/12/2021,,,2020 interim results in https://pubmed.ncbi.nlm.nih.gov/33306989/ (added 09/12/2020) 2021 results in https://pubmed.ncbi.nlm.nih.gov/33617777/ (added 23/02/2021),23/02/2021,http://isrctn.com/ISRCTN89951424,31/12/2021,0,1
5586,ISRCTN94091479,Ongoing,,31/12/2021,,,,09/06/2020,http://isrctn.com/ISRCTN94091479,31/12/2021,0,0
5587,ISRCTN59048638,Completed,,30/11/2020,,See additional files (ISRCTN59048638_BasicResults_04Dec2020),2021 results in https://pubmed.ncbi.nlm.nih.gov/33677827/ (added 08/03/2021),08/03/2021,http://isrctn.com/ISRCTN59048638,30/11/2020,0,1
5588,ISRCTN17072692,Ongoing,,31/07/2021,,,,27/07/2020,http://isrctn.com/ISRCTN17072692,31/07/2021,0,0
5589,ISRCTN33578935,Completed,,31/12/2020,,,,08/06/2020,http://isrctn.com/ISRCTN33578935,31/12/2020,0,0
5590,ISRCTN99248812,Completed,,10/07/2020,,,,28/08/2020,http://isrctn.com/ISRCTN99248812,10/07/2020,0,0
5591,ISRCTN12107048,Ongoing,,31/12/2021,,,,15/06/2021,http://isrctn.com/ISRCTN12107048,31/12/2021,0,0
5592,ISRCTN40302986,Completed,,06/10/2020,,,2021 results in https://doi.org/10.1093/qjmed/hcab035 (added 23/03/2021),23/03/2021,http://isrctn.com/ISRCTN40302986,06/10/2020,0,1
5593,ISRCTN11384058,Completed,,15/06/2020,,,2020 non-peer-reviewed results in preprint https://doi.org/10.1101/2020.07.21.20157719 (added 17/03/2021) 2020 results in https://pubmed.ncbi.nlm.nih.gov/33640936/ (added 16/04/2021) 2021 results in https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7845497/ (added 17/03/2021),16/04/2021,http://isrctn.com/ISRCTN11384058,15/06/2020,0,1
5594,ISRCTN15254871,Completed,,15/12/2020,,,,21/05/2020,http://isrctn.com/ISRCTN15254871,15/12/2020,0,0
5595,ISRCTN13447477,Completed,,28/02/2021,,,,23/10/2020,http://isrctn.com/ISRCTN13447477,28/02/2021,0,0
5596,ISRCTN50212645,Ongoing,,31/07/2021,,,,26/04/2021,http://isrctn.com/ISRCTN50212645,31/07/2021,0,0
5597,ISRCTN21363594,Completed,,29/12/2020,,,2020 protocol in https://doi.org/10.1186/s13063-020-04454-4 (added 10/06/2020),10/06/2020,http://isrctn.com/ISRCTN21363594,29/12/2020,0,1
5598,ISRCTN11188345,Ongoing,,01/05/2022,,,2020 protocol in https://pubmed.ncbi.nlm.nih.gov/32641154/ (added 10/07/2020),03/11/2020,http://isrctn.com/ISRCTN11188345,01/05/2022,0,1
5599,ISRCTN88057279,Ongoing,,03/05/2025,,,,25/03/2021,http://isrctn.com/ISRCTN88057279,03/05/2025,0,0
5600,ISRCTN85216856,Completed,,31/12/2020,,,,08/05/2020,http://isrctn.com/ISRCTN85216856,31/12/2020,0,0
5601,ISRCTN90906759,Ongoing,,30/09/2021,,,2020 results in https://pubmed.ncbi.nlm.nih.gov/33220855/ (added 19/11/2020) 2020 interim results in https://doi.org/10.1016/S0140-6736(20)32661-1 (added 09/12/2020) 2021 results in https://pubmed.ncbi.nlm.nih.gov/33617777/ (added 23/02/2021),24/05/2021,http://isrctn.com/ISRCTN90906759,30/09/2021,0,1
5602,ISRCTN44152751,Suspended,,30/09/2020,,,,07/09/2020,http://isrctn.com/ISRCTN44152751,30/09/2020,0,0
5603,ISRCTN13311119,Completed,,26/06/2020,,,,19/03/2021,http://isrctn.com/ISRCTN13311119,26/06/2020,0,0
5604,ISRCTN17898730,Completed,,20/12/2020,,,2020 results in https://pubmed.ncbi.nlm.nih.gov/33240180/ (added 27/11/2020),27/11/2020,http://isrctn.com/ISRCTN17898730,20/12/2020,0,1
5605,ISRCTN14326006,Ongoing,,30/01/2022,,,2020 structured summary of protocol in https://pubmed.ncbi.nlm.nih.gov/32665039/ (added 17/07/2020),20/07/2020,http://isrctn.com/ISRCTN14326006,30/01/2022,0,1
5606,ISRCTN43900695,Ongoing,,06/04/2022,,,2020 protocol in https://pubmed.ncbi.nlm.nih.gov/32771068/ (added 13/08/2020),06/10/2020,http://isrctn.com/ISRCTN43900695,06/04/2022,0,1
5607,ISRCTN15281137,Ongoing,,30/11/2021,,,2020 preliminary results in https://pubmed.ncbi.nlm.nih.gov/32702298/ (added 20/07/2020) 2020 interim results in https://doi.org/10.1016/S0140-6736(20)32661-1 (added 09/12/2020) 2021 results in https://pubmed.ncbi.nlm.nih.gov/33617777/ (added 23/02/2021) 2021 results of efficacy against in SARS-CoV-2 variant B.1.1.7 in https://pubmed.ncbi.nlm.nih.gov/33798499/ (added 06/04/2021),24/05/2021,http://isrctn.com/ISRCTN15281137,30/11/2021,0,1
5608,ISRCTN16912075,Completed,,02/06/2021,,,2020 protocol in https://pubmed.ncbi.nlm.nih.gov/32727624/ (added 03/08/2020),05/05/2021,http://isrctn.com/ISRCTN16912075,02/06/2021,0,1
5609,ISRCTN83971151,Completed,,25/03/2021,,,"2020 interim non-peer-reviewed results in preprint https://doi.org/10.1101/2020.10.15.20209817 (added 19/10/2020) 2021 interim results for remdesivir, hydroxychloroquine, lopinavir and interferon in https://pubmed.ncbi.nlm.nih.gov/33264556/ (added 25/03/2021)",25/03/2021,http://isrctn.com/ISRCTN83971151,25/03/2021,0,1
5610,ISRCTN86534580,Ongoing,,24/09/2022,,,2021 azithromycin results in https://pubmed.ncbi.nlm.nih.gov/33676597/ (added 08/03/2021) 2021 non-peer-reviewed budesonide results in preprint https://doi.org/10.1101/2021.04.10.21254672 (added 13/04/2021) 2021 protocol in https://pubmed.ncbi.nlm.nih.gov/34145016/ (added 21/06/2021),21/06/2021,http://isrctn.com/ISRCTN86534580,24/09/2022,0,1
5611,ISRCTN14966673,Completed,,01/04/2021,,,2020 results in https://pubmed.ncbi.nlm.nih.gov/33038974/ (added 13/10/2020),13/10/2020,http://isrctn.com/ISRCTN14966673,01/04/2021,0,1
5612,ISRCTN14966097,Completed,,01/04/2021,,,,30/03/2021,http://isrctn.com/ISRCTN14966097,01/04/2021,0,0
5613,ISRCTN47591507,Suspended,,28/02/2021,,,,01/03/2021,http://isrctn.com/ISRCTN47591507,28/02/2021,0,0
5614,ISRCTN37530113,Ongoing,,31/12/2021,,,2020 protocol in https://pubmed.ncbi.nlm.nih.gov/33203621/ (added 19/11/2020),09/12/2020,http://isrctn.com/ISRCTN37530113,31/12/2021,0,1
5615,ISRCTN10974028,Ongoing,,01/10/2021,,,,08/03/2021,http://isrctn.com/ISRCTN10974028,01/10/2021,0,0
5616,JPRN-jRCT2031190264,Not Recruiting,,,,,,08/05/2020,https://jrct.niph.go.jp/latest-detail/jRCT2031190264,,0,0
5617,JPRN-jRCTs031190227,Complete,,,,,,30/06/2021,https://jrct.niph.go.jp/latest-detail/jRCTs031190227,,0,0
5618,JPRN-jRCTs032200044,Recruiting,,,,,,03/06/2020,https://jrct.niph.go.jp/latest-detail/jRCTs032200044,,0,0
5619,JPRN-jRCTs031190226,Not Recruiting,,,,,,18/06/2021,https://jrct.niph.go.jp/latest-detail/jRCTs031190226,,0,0
5620,JPRN-jRCTs041200025,Complete,,,,,,01/07/2020,https://jrct.niph.go.jp/latest-detail/jRCTs041200025,,0,0
5621,JPRN-jRCTs041190120,Complete,,,,,,31/08/2020,https://jrct.niph.go.jp/latest-detail/jRCTs041190120,,0,0
5622,JPRN-jRCT1030200309,Recruiting,,,,,,18/01/2021,https://jrct.niph.go.jp/latest-detail/jRCT1030200309,,0,0
5623,JPRN-jRCT1030200310,Recruiting,,,,,,18/01/2021,https://jrct.niph.go.jp/latest-detail/jRCT1030200310,,0,0
5624,JPRN-jRCTs052200134,Recruiting,,,,,,27/05/2021,https://jrct.niph.go.jp/latest-detail/jRCTs052200134,,0,0
5625,JPRN-jRCT2032200381,Recruiting,,,,,,08/03/2021,https://jrct.niph.go.jp/latest-detail/jRCT2032200381,,0,0
5626,JPRN-jRCT2051200153,Recruiting,,,,,,28/04/2021,https://jrct.niph.go.jp/latest-detail/jRCT2051200153,,0,0
5627,JPRN-jRCT1030200279,Recruiting,,,,,,05/02/2021,https://jrct.niph.go.jp/latest-detail/jRCT1030200279,,0,0
5628,JPRN-jRCT1030210037,Recruiting,,,,,,14/04/2021,https://jrct.niph.go.jp/latest-detail/jRCT1030210037,,0,0
5629,JPRN-jRCT1051200078,Not Recruiting,,,,,,13/05/2021,https://jrct.niph.go.jp/latest-detail/jRCT1051200078,,0,0
5630,JPRN-jRCT2021200018,Not Recruiting,,,,,,26/03/2021,https://jrct.niph.go.jp/latest-detail/jRCT2021200018,,0,0
5631,JPRN-jRCT2031200035,Not Recruiting,,,,,,24/12/2020,https://jrct.niph.go.jp/latest-detail/jRCT2031200035,,0,0
5632,JPRN-jRCT2031200092,Not Recruiting,,,,,,24/12/2020,https://jrct.niph.go.jp/latest-detail/jRCT2031200092,,0,0
5633,JPRN-jRCT2031200120,Recruiting,,,,,,14/06/2021,https://jrct.niph.go.jp/latest-detail/jRCT2031200120,,0,0
5634,JPRN-jRCT2031200126,Suspended,,,,,,12/02/2021,https://jrct.niph.go.jp/latest-detail/jRCT2031200126,,0,0
5635,JPRN-jRCT2031200180,Recruiting,,,,,,06/05/2021,https://jrct.niph.go.jp/latest-detail/jRCT2031200180,,0,0
5636,JPRN-jRCT2031200198,Not Recruiting,,,,,,14/06/2021,https://jrct.niph.go.jp/latest-detail/jRCT2031200198,,0,0
5637,JPRN-jRCT2031200252,Recruiting,,,,,,12/03/2021,https://jrct.niph.go.jp/latest-detail/jRCT2031200252,,0,0
5638,JPRN-jRCT2031200368,Recruiting,,,,,,19/03/2021,https://jrct.niph.go.jp/latest-detail/jRCT2031200368,,0,0
5639,JPRN-jRCT2031210010,Not Recruiting,,,,,,09/07/2021,https://jrct.niph.go.jp/latest-detail/jRCT2031210010,,0,0
5640,JPRN-jRCT2051200085,Not Recruiting,,,,,,16/03/2021,https://jrct.niph.go.jp/latest-detail/jRCT2051200085,,0,0
5641,JPRN-jRCT2051200088,Not Recruiting,,,,,,19/02/2021,https://jrct.niph.go.jp/latest-detail/jRCT2051200088,,0,0
5642,JPRN-jRCT2051200159,Recruiting,,,,,,21/06/2021,https://jrct.niph.go.jp/latest-detail/jRCT2051200159,,0,0
5643,JPRN-jRCT2071200023,Recruiting,,,,,,05/03/2021,https://jrct.niph.go.jp/latest-detail/jRCT2071200023,,0,0
5644,JPRN-jRCT2071200041,Recruiting,,,,,,08/02/2021,https://jrct.niph.go.jp/latest-detail/jRCT2071200041,,0,0
5645,JPRN-jRCT2071200045,Not Recruiting,,,,,,09/06/2021,https://jrct.niph.go.jp/latest-detail/jRCT2071200045,,0,0
5646,JPRN-jRCT2071200078,Recruiting,,,,,,21/06/2021,https://jrct.niph.go.jp/latest-detail/jRCT2071200078,,0,0
5647,JPRN-jRCT2071200109,Complete,,,,,,17/06/2021,https://jrct.niph.go.jp/latest-detail/jRCT2071200109,,0,0
5648,JPRN-jRCT2071200110,Not Recruiting,,,,,,09/07/2021,https://jrct.niph.go.jp/latest-detail/jRCT2071200110,,0,0
5649,JPRN-jRCT2071200117,Not Recruiting,,,,,,30/04/2021,https://jrct.niph.go.jp/latest-detail/jRCT2071200117,,0,0
5650,JPRN-jRCTs021200020,Recruiting,,,,,,17/03/2021,https://jrct.niph.go.jp/latest-detail/jRCTs021200020,,0,0
5651,JPRN-jRCTs031190269,Not Recruiting,,,,,,24/09/2020,https://jrct.niph.go.jp/latest-detail/jRCTs031190269,,0,0
5652,JPRN-jRCTs031200026,Recruiting,,,,,,02/07/2021,https://jrct.niph.go.jp/latest-detail/jRCTs031200026,,0,0
5653,JPRN-jRCTs031200124,Recruiting,,,,,,30/06/2021,https://jrct.niph.go.jp/latest-detail/jRCTs031200124,,0,0
5654,JPRN-jRCTs031200150,Recruiting,,,,,,15/06/2021,https://jrct.niph.go.jp/latest-detail/jRCTs031200150,,0,0
5655,JPRN-jRCTs032200131,Recruiting,,,,,,22/06/2021,https://jrct.niph.go.jp/latest-detail/jRCTs032200131,,0,0
5656,JPRN-jRCTs051200036,Recruiting,,,,,,25/02/2021,https://jrct.niph.go.jp/latest-detail/jRCTs051200036,,0,0
5657,JPRN-jRCTs052200053,Recruiting,,,,,,15/06/2021,https://jrct.niph.go.jp/latest-detail/jRCTs052200053,,0,0
5658,JPRN-jRCTs052200157,Recruiting,,,,,,31/03/2021,https://jrct.niph.go.jp/latest-detail/jRCTs052200157,,0,0
5659,JPRN-jRCTs071200048,Recruiting,,,,,,01/07/2021,https://jrct.niph.go.jp/latest-detail/jRCTs071200048,,0,0
5660,JPRN-jRCT2021210006,Recruiting,,,,,,28/06/2021,https://jrct.niph.go.jp/latest-detail/jRCT2021210006,,0,0
5661,JPRN-jRCT2031200443,Pending,,,,,,09/07/2021,https://jrct.niph.go.jp/latest-detail/jRCT2031200443,,0,0
5662,JPRN-jRCT2041210004,Recruiting,,,,,,12/07/2021,https://jrct.niph.go.jp/latest-detail/jRCT2041210004,,0,0
5663,JPRN-jRCT2041210013,Suspended,,,,,,21/05/2021,https://jrct.niph.go.jp/latest-detail/jRCT2041210013,,0,0
5664,JPRN-jRCT2051200092,Recruiting,,,,,,07/06/2021,https://jrct.niph.go.jp/latest-detail/jRCT2051200092,,0,0
5665,JPRN-jRCT2071200106,Not Recruiting,,,,,,17/05/2021,https://jrct.niph.go.jp/latest-detail/jRCT2071200106,,0,0
5666,JPRN-jRCT2071200111,Recruiting,,,,,,28/05/2021,https://jrct.niph.go.jp/latest-detail/jRCT2071200111,,0,0
5667,JPRN-jRCTs031200196,Not Recruiting,,,,,,26/05/2021,https://jrct.niph.go.jp/latest-detail/jRCTs031200196,,0,0
5668,JPRN-jRCTs031200374,Recruiting,,,,,,22/06/2021,https://jrct.niph.go.jp/latest-detail/jRCTs031200374,,0,0
5669,JPRN-jRCTs031200436,Recruiting,,,,,,31/05/2021,https://jrct.niph.go.jp/latest-detail/jRCTs031200436,,0,0
5670,JPRN-jRCTs031210123,Recruiting,,,,,,31/05/2021,https://jrct.niph.go.jp/latest-detail/jRCTs031210123,,0,0
5671,JPRN-jRCTs041200072,Recruiting,,,,,,09/07/2021,https://jrct.niph.go.jp/latest-detail/jRCTs041200072,,0,0
5672,JPRN-jRCTs051200049,Recruiting,,,,,,15/06/2021,https://jrct.niph.go.jp/latest-detail/jRCTs051200049,,0,0
5673,JPRN-jRCTs051200060,Suspended,,,,,,20/05/2021,https://jrct.niph.go.jp/latest-detail/jRCTs051200060,,0,0
5674,JPRN-jRCTs061200002,Recruiting,,,,,,20/05/2021,https://jrct.niph.go.jp/latest-detail/jRCTs061200002,,0,0
5675,JPRN-jRCTs071210011,Recruiting,,,,,,28/06/2021,https://jrct.niph.go.jp/latest-detail/jRCTs071210011,,0,0
5676,KCT0005003,Not yet recruiting,31/03/2021,21/04/2021,,,,07/05/2020,http://cris.nih.go.kr/cris/en/search/search_result_st01.jsp?seq=16635,31/03/2021,0,0
5677,KCT0005105,Recruiting,16/04/2021,16/04/2021,,,,10/06/2020,http://cris.nih.go.kr/cris/en/search/search_result_st01.jsp?seq=16795,16/04/2021,0,0
5678,KCT0005307,Recruiting,30/11/2021,30/11/2021,,,,04/08/2020,http://cris.nih.go.kr/cris/en/search/search_result_st01.jsp?seq=17062,30/11/2021,0,0
5679,KCT0005344,Recruiting,,,,,,11/08/2020,http://cris.nih.go.kr/cris/en/search/search_result_st01.jsp?seq=17363,,0,0
5680,KCT0005649,Recruiting,31/12/2020,28/02/2021,,,,19/10/2020,http://cris.nih.go.kr/cris/en/search/search_result_st01.jsp?seq=17659,31/12/2020,0,0
5681,KCT0005711,Not yet recruiting,06/08/2021,06/08/2021,,,,21/12/2020,http://cris.nih.go.kr/cris/en/search/search_result_st01.jsp?seq=18369,06/08/2021,0,0
5682,KCT0005834,Recruiting,12/05/2021,12/05/2021,,,,08/02/2021,http://cris.nih.go.kr/cris/en/search/search_result_st01.jsp?seq=18138,12/05/2021,0,0
5683,KCT0005896,"Active, not recruiting",,,,,,23/11/2020,http://cris.nih.go.kr/cris/en/search/search_result_st01.jsp?seq=18143,,0,0
5684,KCT0006152,Not yet recruiting,31/12/2021,31/01/2023,,,,30/04/2021,https://cris.nih.go.kr/cris/search/detailSearchEn.do?seq=19307,31/12/2021,0,0
5685,KCT0006252,Not yet recruiting,,,,,,09/06/2021,https://cris.nih.go.kr/cris/search/detailSearchEn.do?seq=19179,,0,0
5686,RBR-8969zg,Not yet recruiting,,,,,,13/04/2020,http://ensaiosclinicos.gov.br/rg/RBR-8969zg,,0,0
5687,RBR-658khm,Recruiting,,,,,,22/04/2020,http://ensaiosclinicos.gov.br/rg/RBR-658khm,,0,0
5688,RBR-6w5tbk,Not yet recruiting,,,,,,29/04/2020,http://ensaiosclinicos.gov.br/rg/RBR-6w5tbk,,0,0
5689,RBR-5s2mqg,Recruiting,,,,,,05/05/2020,http://ensaiosclinicos.gov.br/rg/RBR-5s2mqg,,0,0
5690,RBR-3k4wxb,Not yet recruiting,,,,,,05/05/2020,http://ensaiosclinicos.gov.br/rg/RBR-3k4wxb,,0,0
5691,RBR-4vm3yy,Recruiting,,,,,,15/05/2020,http://ensaiosclinicos.gov.br/rg/RBR-4vm3yy,,0,0
5692,RBR-9d8z6m,Recruitment completed,,,,,,28/05/2020,http://ensaiosclinicos.gov.br/rg/RBR-9d8z6m,,0,0
5693,RBR-2dxyx4,Not yet recruiting,,,,,,02/06/2020,http://ensaiosclinicos.gov.br/rg/RBR-2dxyx4,,0,0
5694,RBR-949z6v,Recruiting,,,,,,04/06/2020,http://ensaiosclinicos.gov.br/rg/RBR-949z6v,,0,0
5695,RBR-876qb5,Recruiting,,,,,,08/06/2020,http://ensaiosclinicos.gov.br/rg/RBR-876qb5,,0,0
5696,RBR-3zdynp,Recruiting,,,,,,23/06/2020,http://ensaiosclinicos.gov.br/rg/RBR-3zdynp,,0,0
5697,RBR-4wnx2q,Recruiting,,,,,,26/06/2020,http://ensaiosclinicos.gov.br/rg/RBR-4wnx2q,,0,0
5698,RBR-5kkpg6,Not yet recruiting,,,,,,28/06/2020,http://ensaiosclinicos.gov.br/rg/RBR-5kkpg6,,0,0
5699,RBR-7jqpnw,Not yet recruiting,,,,,,29/06/2020,http://ensaiosclinicos.gov.br/rg/RBR-7jqpnw,,0,0
5700,RBR-3rywwg,Recruiting,,,,,,10/07/2020,http://ensaiosclinicos.gov.br/rg/RBR-3rywwg,,0,0
5701,RBR-7jrxqm,Recruiting,,,,,,10/07/2020,http://ensaiosclinicos.gov.br/rg/RBR-7jrxqm,,0,0
5702,RBR-45kf9p,Recruiting,,,,,,13/07/2020,http://ensaiosclinicos.gov.br/rg/RBR-45kf9p,,0,0
5703,RBR-7drpyr,Recruitment completed,,,,,,13/07/2020,http://ensaiosclinicos.gov.br/rg/RBR-7drpyr,,0,0
5704,RBR-5ysj54,Not yet recruiting,,,,,,27/07/2020,http://ensaiosclinicos.gov.br/rg/RBR-5ysj54,,0,0
5705,RBR-3g5f9f,Not yet recruiting,,,,,,29/07/2020,http://ensaiosclinicos.gov.br/rg/RBR-3g5f9f,,0,0
5706,RBR-8jyhxh,Recruiting,,,,,,30/07/2020,http://ensaiosclinicos.gov.br/rg/RBR-8jyhxh,,0,0
5707,RBR-35734p,Recruiting,,,,,,05/08/2020,http://ensaiosclinicos.gov.br/rg/RBR-35734p,,0,0
5708,RBR-2w7ghc,Recruiting,,,,,,07/08/2020,http://ensaiosclinicos.gov.br/rg/RBR-2w7ghc,,0,0
5709,RBR-7d7ngw,Recruiting,,,,,,07/08/2020,http://ensaiosclinicos.gov.br/rg/RBR-7d7ngw,,0,0
5710,RBR-2k66ft,Not yet recruiting,,,,,,10/08/2020,http://ensaiosclinicos.gov.br/rg/RBR-2k66ft,,0,0
5711,RBR-9y32yy,Not yet recruiting,,,,,,10/08/2020,http://ensaiosclinicos.gov.br/rg/RBR-9y32yy,,0,0
5712,RBR-4vy54v,Not yet recruiting,,,,,,11/08/2020,http://ensaiosclinicos.gov.br/rg/RBR-4vy54v,,0,0
5713,RBR-4pfygr,Not yet recruiting,,,,,,13/08/2020,http://ensaiosclinicos.gov.br/rg/RBR-4pfygr,,0,0
5714,RBR-3rdhgm,Recruiting,,,,,,24/08/2020,http://ensaiosclinicos.gov.br/rg/RBR-3rdhgm,,0,0
5715,RBR-9xs978,Recruiting,,,,,,24/08/2020,http://ensaiosclinicos.gov.br/rg/RBR-9xs978,,0,0
5716,RBR-2z3f7k,Recruiting,,,,,,25/08/2020,http://ensaiosclinicos.gov.br/rg/RBR-2z3f7k,,0,0
5717,RBR-2kjm6y,Recruiting,,,,,,26/08/2020,http://ensaiosclinicos.gov.br/rg/RBR-2kjm6y,,0,0
5718,RBR-72bg24,Not yet recruiting,,,,,,27/08/2020,http://ensaiosclinicos.gov.br/rg/RBR-72bg24,,0,0
5719,RBR-5vpyh4,Recruiting,,,,,,31/08/2020,http://ensaiosclinicos.gov.br/rg/RBR-5vpyh4,,0,0
5720,RBR-2fvjjm,Recruiting,,,,,,04/09/2020,http://ensaiosclinicos.gov.br/rg/RBR-2fvjjm,,0,0
5721,RBR-9rnkbs,Recruiting,,,,,,22/09/2020,http://ensaiosclinicos.gov.br/rg/RBR-9rnkbs,,0,0
5722,RBR-8nfx26,Not yet recruiting,,,,,,30/06/2021,http://ensaiosclinicos.gov.br/rg/RBR-8nfx26,,0,0
5723,RBR-97nt6j,Not yet recruiting,,,,,,24/09/2020,http://ensaiosclinicos.gov.br/rg/RBR-97nt6j,,0,0
5724,RBR-5v3k5d,Recruiting,,,,,,02/10/2020,http://ensaiosclinicos.gov.br/rg/RBR-5v3k5d,,0,0
5725,RBR-8h7q82,Recruitment completed,,,,,,02/10/2020,http://ensaiosclinicos.gov.br/rg/RBR-8h7q82,,0,0
5726,RBR-2xxrrq,Recruitment completed,,,,,,02/10/2020,http://ensaiosclinicos.gov.br/rg/RBR-2xxrrq,,0,0
5727,RBR-825p57,Recruiting,,,,,,08/10/2020,http://ensaiosclinicos.gov.br/rg/RBR-825p57,,0,0
5728,RBR-4nr86m,Recruiting,,,,,,27/10/2020,http://ensaiosclinicos.gov.br/rg/RBR-4nr86m,,0,0
5729,RBR-58ftdj,Recruiting,,,,,,28/10/2020,http://ensaiosclinicos.gov.br/rg/RBR-58ftdj,,0,0
5730,RBR-9b6kvp,Not yet recruiting,,,,,,29/10/2020,http://ensaiosclinicos.gov.br/rg/RBR-9b6kvp,,0,0
5731,RBR-4kjqtg,Recruiting,,,,,,29/10/2020,http://ensaiosclinicos.gov.br/rg/RBR-4kjqtg,,0,0
5732,RBR-8x8g36,Not yet recruiting,,,,,,29/10/2020,http://ensaiosclinicos.gov.br/rg/RBR-8x8g36,,0,0
5733,RBR-5d7hkv,Recruiting,,,,,,03/11/2020,http://ensaiosclinicos.gov.br/rg/RBR-5d7hkv,,0,0
5734,RBR-2fvw6v,Not yet recruiting,,,,,,16/11/2020,http://ensaiosclinicos.gov.br/rg/RBR-2fvw6v,,0,0
5735,RBR-2z5t7z,Recruiting,,,,,,16/11/2020,http://ensaiosclinicos.gov.br/rg/RBR-2z5t7z,,0,0
5736,PACTR202004801273802,Recruiting,,15/01/2021,,,,04/08/2020,https://pactr.samrc.ac.za/TrialDisplay.aspx?TrialID=10928,15/01/2021,0,0
5737,PACTR202004693933092,Not yet recruiting,,30/06/2020,,,,16/04/2020,https://pactr.samrc.ac.za/TrialDisplay.aspx?TrialID=10953,30/06/2020,0,0
5738,PACTR202004761408382,Not yet recruiting,,31/08/2020,,,,15/04/2020,https://pactr.samrc.ac.za/TrialDisplay.aspx?TrialID=10957,31/08/2020,0,0
5739,PACTR202005599385499,Not yet recruiting,,21/05/2020,,,,05/11/2020,https://pactr.samrc.ac.za/TrialDisplay.aspx?TrialID=10971,21/05/2020,0,0
5740,PACTR202004893013257,Not yet recruiting,,25/04/2021,,,,23/04/2020,https://pactr.samrc.ac.za/TrialDisplay.aspx?TrialID=10981,25/04/2021,0,0
5741,PACTR202005681895696,Recruiting,,31/05/2022,,,,05/11/2020,https://pactr.samrc.ac.za/TrialDisplay.aspx?TrialID=10988,31/05/2022,0,0
5742,PACTR202009786901147,Recruiting,,30/04/2022,,,,16/09/2020,https://pactr.samrc.ac.za/TrialDisplay.aspx?TrialID=11019,30/04/2022,0,0
5743,PACTR202006473370201,Not yet recruiting,,31/08/2021,,,,17/06/2020,https://pactr.samrc.ac.za/TrialDisplay.aspx?TrialID=11037,31/08/2021,0,0
5744,PACTR202007653923168,Not yet recruiting,,31/12/2021,,,,16/07/2020,https://pactr.samrc.ac.za/TrialDisplay.aspx?TrialID=11047,31/12/2021,0,0
5745,PACTR202005622389003,Not yet recruiting,,15/07/2020,,,,28/05/2020,https://pactr.samrc.ac.za/TrialDisplay.aspx?TrialID=11053,15/07/2020,0,0
5746,PACTR202006717277937,Not yet recruiting,,28/02/2021,,,,06/10/2020,https://pactr.samrc.ac.za/TrialDisplay.aspx?TrialID=11088,28/02/2021,0,0
5747,PACTR202006899597082,Completed,,25/11/2020,,,,06/10/2020,https://pactr.samrc.ac.za/TrialDisplay.aspx?TrialID=11103,25/11/2020,0,0
5748,PACTR202007589336711,Not yet recruiting,,31/12/2021,,,,14/07/2020,https://pactr.samrc.ac.za/TrialDisplay.aspx?TrialID=11115,31/12/2021,0,0
5749,PACTR202010519682638,Not yet recruiting,,03/01/2021,,,,26/10/2020,https://pactr.samrc.ac.za/TrialDisplay.aspx?TrialID=12147,03/01/2021,0,0
5750,PACTR202006537901307,Recruiting,,31/12/2021,,,,24/06/2020,https://pactr.samrc.ac.za/TrialDisplay.aspx?TrialID=12150,31/12/2021,0,0
5751,PACTR202007606032743,Recruiting,,31/07/2020,,,,07/07/2020,https://pactr.samrc.ac.za/TrialDisplay.aspx?TrialID=12158,31/07/2020,0,0
5752,PACTR202006922165132,Recruiting,,30/12/2021,,,,23/06/2020,https://pactr.samrc.ac.za/TrialDisplay.aspx?TrialID=12166,30/12/2021,0,0
5753,PACTR202006760881890,Recruiting,,30/11/2020,,,,24/06/2020,https://pactr.samrc.ac.za/TrialDisplay.aspx?TrialID=12168,30/11/2020,0,0
5754,PACTR202006883882711,Not yet recruiting,,01/01/2021,,,,30/06/2020,https://pactr.samrc.ac.za/TrialDisplay.aspx?TrialID=12175,01/01/2021,0,0
5755,PACTR202007720062393,Not yet recruiting,,20/10/2020,,,,13/07/2020,https://pactr.samrc.ac.za/TrialDisplay.aspx?TrialID=12183,20/10/2020,0,0
5756,PACTR202007611764617,Not yet recruiting,,23/10/2020,,,,07/07/2020,https://pactr.samrc.ac.za/TrialDisplay.aspx?TrialID=12192,23/10/2020,0,0
5757,PACTR202007700757139,Not yet recruiting,,31/07/2021,,,,14/07/2020,https://pactr.samrc.ac.za/TrialDisplay.aspx?TrialID=12194,31/07/2021,0,0
5758,PACTR202008485004797,Not yet recruiting,,31/03/2021,,,,08/06/2020,https://pactr.samrc.ac.za/TrialDisplay.aspx?TrialID=12214,31/03/2021,0,0
5759,PACTR202008855701534,Not yet recruiting,,21/01/2021,,,,13/08/2020,https://pactr.samrc.ac.za/TrialDisplay.aspx?TrialID=12266,21/01/2021,0,0
5760,PACTR202009726132275,"Closed to recruitment,follow-up continuing",,30/09/2020,,,,14/09/2020,https://pactr.samrc.ac.za/TrialDisplay.aspx?TrialID=12319,30/09/2020,0,0
5761,PACTR202009769021840,Not yet recruiting,,15/12/2020,,,,09/02/2020,https://pactr.samrc.ac.za/TrialDisplay.aspx?TrialID=12333,15/12/2020,0,0
5762,PACTR202009642148520,Recruiting,,11/01/2022,,,,29/09/2020,https://pactr.samrc.ac.za/TrialDisplay.aspx?TrialID=12343,11/01/2022,0,0
5763,PACTR202010537777617,Not yet recruiting,,31/01/2021,,,,15/10/2020,https://pactr.samrc.ac.za/TrialDisplay.aspx?TrialID=12365,31/01/2021,0,0
5764,PACTR202009483194545,Recruiting,,30/03/2021,,,,21/09/2020,https://pactr.samrc.ac.za/TrialDisplay.aspx?TrialID=13381,30/03/2021,0,0
5765,PACTR202010729372570,Not yet recruiting,,31/01/2021,,,,10/01/2020,https://pactr.samrc.ac.za/TrialDisplay.aspx?TrialID=13392,31/01/2021,0,0
5766,PACTR202010690466874,Not yet recruiting,,29/01/2021,,,,10/07/2020,https://pactr.samrc.ac.za/TrialDisplay.aspx?TrialID=13403,29/01/2021,0,0
5767,PACTR202010781639956,Recruiting,,31/05/2022,,,,10/08/2020,https://pactr.samrc.ac.za/TrialDisplay.aspx?TrialID=13420,31/05/2022,0,0
5768,PACTR202010472402152,"Active, not recruiting",,30/04/2021,,,,10/09/2020,https://pactr.samrc.ac.za/TrialDisplay.aspx?TrialID=13421,30/04/2021,0,0
5769,PACTR202010718451278,Not yet recruiting,,06/01/2021,,,,19/10/2020,https://pactr.samrc.ac.za/TrialDisplay.aspx?TrialID=13432,06/01/2021,0,0
5770,PACTR202101544570971,"Active, not recruiting",,30/12/2021,,,,21/01/2021,https://pactr.samrc.ac.za/TrialDisplay.aspx?TrialID=13461,30/12/2021,0,0
5771,PACTR202011523101903,Withdrawn,,30/04/2022,,,,11/03/2020,https://pactr.samrc.ac.za/TrialDisplay.aspx?TrialID=13475,30/04/2022,0,0
5772,PACTR202101794986980,Not yet recruiting,,29/11/2021,,,,19/01/2021,https://pactr.samrc.ac.za/TrialDisplay.aspx?TrialID=14507,29/11/2021,0,0
5773,PACTR202012892855610,Not yet recruiting,,30/06/2021,,,,17/12/2020,https://pactr.samrc.ac.za/TrialDisplay.aspx?TrialID=14510,30/06/2021,0,0
5774,PACTR202012898601759,Not yet recruiting,,27/08/2021,,,,12/04/2020,https://pactr.samrc.ac.za/TrialDisplay.aspx?TrialID=14547,27/08/2021,0,0
5775,PACTR202102846261362,Not yet recruiting,,30/09/2021,,,,17/02/2021,https://pactr.samrc.ac.za/TrialDisplay.aspx?TrialID=14631,30/09/2021,0,0
5776,PACTR202101875903773,Completed,,07/01/2021,,,,25/01/2021,https://pactr.samrc.ac.za/TrialDisplay.aspx?TrialID=14632,07/01/2021,0,0
5777,PACTR202102867544936,Recruiting,,07/07/2021,,,,22/02/2021,https://pactr.samrc.ac.za/TrialDisplay.aspx?TrialID=14657,07/07/2021,0,0
5778,PACTR202102588777597,Recruiting,,02/03/2022,,,,02/12/2021,https://pactr.samrc.ac.za/TrialDisplay.aspx?TrialID=14661,02/03/2022,0,0
5779,PACTR202102616421588,"Closed to recruitment,follow-up continuing",,31/07/2021,,,,17/02/2021,https://pactr.samrc.ac.za/TrialDisplay.aspx?TrialID=14670,31/07/2021,0,0
5780,PACTR202102848675636,Not yet recruiting,,31/10/2021,,,,02/11/2021,https://pactr.samrc.ac.za/TrialDisplay.aspx?TrialID=14678,31/10/2021,0,0
5781,PACTR202102855526180,Recruiting,,30/09/2023,,,,15/02/2021,https://pactr.samrc.ac.za/TrialDisplay.aspx?TrialID=15686,30/09/2023,0,0
5782,PACTR202102535686338,Not yet recruiting,,22/08/2021,,,,16/02/2021,https://pactr.samrc.ac.za/TrialDisplay.aspx?TrialID=15689,22/08/2021,0,0
5783,PACTR202103574924457,"Closed to recruitment,follow-up continuing",,22/05/2021,,,,26/03/2021,https://pactr.samrc.ac.za/TrialDisplay.aspx?TrialID=15726,22/05/2021,0,0
5784,PACTR202103845381761,Not yet recruiting,,31/08/2022,,,,03/04/2021,https://pactr.samrc.ac.za/TrialDisplay.aspx?TrialID=15727,31/08/2022,0,0
5785,PACTR202103601407640,Recruiting,,30/06/2021,,,,24/03/2021,https://pactr.samrc.ac.za/TrialDisplay.aspx?TrialID=15764,30/06/2021,0,0
5786,PACTR202104601572565,Not yet recruiting,,12/01/2021,,,,16/04/2021,https://pactr.samrc.ac.za/TrialDisplay.aspx?TrialID=15817,12/01/2021,0,0
5787,PACTR202106588702901,Not yet recruiting,,30/11/2022,,,,06/01/2021,https://pactr.samrc.ac.za/TrialDisplay.aspx?TrialID=15870,30/11/2022,0,0
5788,PACTR202105817814362,Not yet recruiting,,14/12/2022,,,,24/05/2021,https://pactr.samrc.ac.za/TrialDisplay.aspx?TrialID=15890,14/12/2022,0,0
5789,JPRN-UMIN000040286,Preinitiation,,,,,,01/05/2020,https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000045966,,0,0
5790,JPRN-UMIN000040401,Enrolling by invitation,,,,,,14/05/2020,https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000046104,,0,0
5791,JPRN-UMIN000040341,No longer recruiting,,,,,,17/05/2020,https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000046023,,0,0
5792,JPRN-UMIN000040407,No longer recruiting,,,,,,17/05/2020,https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000046108,,0,0
5793,JPRN-UMIN000040479,Open public recruiting,,,,,,27/05/2020,https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000046202,,0,0
5794,JPRN-UMIN000040694,Preinitiation,,,,,,09/06/2020,https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000046448,,0,0
5795,JPRN-UMIN000040733,Preinitiation,,,,,,12/06/2020,https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000046461,,0,0
5796,JPRN-UMIN000040838,Preinitiation,,,,,,25/06/2020,https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000046628,,0,0
5797,JPRN-UMIN000041160,Preinitiation,,,,,,20/07/2020,https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000047000,,0,0
5798,JPRN-UMIN000040837,No longer recruiting,,,,,,30/08/2020,https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000046623,,0,0
5799,JPRN-UMIN000041458,Preinitiation,,,,,,23/06/2021,https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000047327,,0,0
5800,JPRN-UMIN000042034,Preinitiation,,,,,,07/10/2020,https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000047574,,0,0
5801,JPRN-UMIN000042270,Preinitiation,,,,,,28/10/2020,https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000048258,,0,0
5802,JPRN-UMIN000042599,Preinitiation,,,,,,30/11/2020,https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000048622,,0,0
5803,JPRN-UMIN000042807,Preinitiation,,,,,,22/12/2020,https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000048854,,0,0
5804,JPRN-UMIN000043400,Preinitiation,,,,,,21/02/2021,https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000049552,,0,0
5805,JPRN-UMIN000043537,Open public recruiting,,,,,,05/03/2021,https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000049715,,0,0
5806,JPRN-UMIN000043566,No longer recruiting,,,,,,13/05/2021,https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000049753,,0,0
5807,JPRN-UMIN000040744,No longer recruiting,,,,,,25/12/2020,https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000046508,,0,0
5808,JPRN-UMIN000041421,Completed,,,,https://www.researchsquare.com/article/rs-156774/v1,,03/02/2021,https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000047290,,0,1
5809,JPRN-UMIN000041990,No longer recruiting,,,,,,15/10/2020,https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000047925,,0,0
5810,JPRN-UMIN000042384,Enrolling by invitation,,,,,,13/02/2021,https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000048379,,0,0
5811,JPRN-UMIN000042477,No longer recruiting,,,,,,02/03/2021,https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000048432,,0,0
5812,JPRN-UMIN000043350,No longer recruiting,,,,,,24/03/2021,https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000049495,,0,0
5813,JPRN-UMIN000043369,Preinitiation,,,,,,20/03/2021,https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000049195,,0,0
5814,JPRN-UMIN000043769,Preinitiation,,,,,,28/03/2021,https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000049963,,0,0
5815,JPRN-UMIN000043788,Enrolling by invitation,,,,,,30/03/2021,https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000049983,,0,0
5816,JPRN-UMIN000043820,Enrolling by invitation,,,,,,02/04/2021,https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000049505,,0,0
5817,JPRN-UMIN000043867,Preinitiation,,,,,,08/04/2021,https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000050077,,0,0
5818,JPRN-UMIN000040235,Completed,,,,,,31/05/2021,https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000045901,,0,0
5819,JPRN-UMIN000040602,Completed,,,,,,08/06/2021,https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000046338,,0,0
5820,JPRN-UMIN000042556,No longer recruiting,,,,,,24/05/2021,https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000048548,,0,0
5821,JPRN-UMIN000044145,Preinitiation,,,,,,08/05/2021,https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000050128,,0,0
5822,JPRN-UMIN000044519,Preinitiation,,,,,,13/06/2021,https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000050864,,0,0
5823,RPCEC00000306,Recruiting,,15/07/2020,,,,07/07/2020,https://rpcec.sld.cu/en/trials/RPCEC00000306-En,15/07/2020,0,0
5824,RPCEC00000307,Recruiting,,30/07/2020,,,,09/07/2020,https://rpcec.sld.cu/en/trials/RPCEC00000307-En,30/07/2020,0,0
5825,RPCEC00000308,Pending,,06/09/2020,,,,13/07/2020,https://rpcec.sld.cu/en/trials/RPCEC00000308-En,06/09/2020,0,0
5826,RPCEC00000309,Recruiting,,15/01/2021,,,,01/03/2021,https://rpcec.sld.cu/en/trials/RPCEC00000309-En,15/01/2021,0,0
5827,RPCEC00000311,Recruiting,,31/07/2020,,,,13/08/2020,https://rpcec.sld.cu/en/trials/RPCEC00000311-En,31/07/2020,0,0
5828,RPCEC00000313,Complete,,30/04/2020,,,,13/08/2020,https://rpcec.sld.cu/en/trials/RPCEC00000313-En,30/04/2020,0,0
5829,RPCEC00000314,Recruiting,,30/06/2020,,,,21/10/2020,https://rpcec.sld.cu/en/trials/RPCEC00000314-En,30/06/2020,0,0
5830,RPCEC00000315,Recruiting,,30/06/2020,,,,21/10/2020,https://rpcec.sld.cu/en/trials/RPCEC00000315-En,30/06/2020,0,0
5831,RPCEC00000316,Complete,,18/09/2020,,,,30/10/2020,https://rpcec.sld.cu/en/trials/RPCEC00000316-En,18/09/2020,0,0
5832,RPCEC00000317,Pending,,29/06/2020,,,,14/09/2020,https://rpcec.sld.cu/en/trials/RPCEC00000317-En,29/06/2020,0,0
5833,RPCEC00000320,Pending,,23/08/2020,,,,14/09/2020,https://rpcec.sld.cu/en/trials/RPCEC00000320-En,23/08/2020,0,0
5834,RPCEC00000321,Recruiting,,30/08/2020,,,,14/09/2020,https://rpcec.sld.cu/en/trials/RPCEC00000321-En,30/08/2020,0,0
5835,RPCEC00000322,Recruiting,,15/12/2020,,,,14/09/2020,https://rpcec.sld.cu/en/trials/RPCEC00000322-En,15/12/2020,0,0
5836,RPCEC00000330,Pending,,30/09/2020,,,,05/10/2020,https://rpcec.sld.cu/en/trials/RPCEC00000330-En,30/09/2020,0,0
5837,RPCEC00000332,Recruiting,,01/11/2021,,,,08/09/2020,https://rpcec.sld.cu/en/trials/RPCEC00000332-En,01/11/2021,0,0
5838,RPCEC00000334,Recruiting,,31/12/2020,,,,23/10/2020,https://rpcec.sld.cu/en/trials/RPCEC00000334-En,31/12/2020,0,0
5839,RPCEC00000335,Recruiting,,31/12/2020,,,,23/10/2020,https://rpcec.sld.cu/en/trials/RPCEC00000335-En,31/12/2020,0,0
5840,RPCEC00000337,Pending,,11/06/2020,,,,05/10/2020,https://rpcec.sld.cu/en/trials/RPCEC00000337-En,11/06/2020,0,0
5841,RPCEC00000338,Complete,,31/01/2021,,,,23/11/2020,https://rpcec.sld.cu/en/trials/RPCEC00000338-En,31/01/2021,0,0
5842,RPCEC00000340,Complete,,01/06/2021,,,,15/06/2021,https://rpcec.sld.cu/en/trials/RPCEC00000340-En,01/06/2021,0,0
5843,RPCEC00000345,Pending,,31/05/2021,,,,27/11/2020,https://rpcec.sld.cu/en/trials/RPCEC00000345-En,31/05/2021,0,0
5844,RPCEC00000346,Pending,,31/05/2021,,,,27/11/2020,https://rpcec.sld.cu/en/trials/RPCEC00000346-En,31/05/2021,0,0
5845,RPCEC00000347,Complete,,03/12/2021,,,,15/06/2021,https://rpcec.sld.cu/en/trials/RPCEC00000347-En,03/12/2021,0,0
5846,RPCEC00000348,Pending,,07/11/2021,,,,26/01/2021,https://rpcec.sld.cu/en/trials/RPCEC00000348-En,07/11/2021,0,0
5847,RPCEC00000349,Complete,,13/02/2021,,,,27/04/2021,https://rpcec.sld.cu/en/trials/RPCEC00000349-En,13/02/2021,0,0
5848,RPCEC00000353,Pending,,30/04/2022,,,,02/03/2021,https://rpcec.sld.cu/en/trials/RPCEC00000353-En,30/04/2022,0,0
5849,RPCEC00000354,Pending,,11/07/2021,,,,04/03/2021,https://rpcec.sld.cu/en/trials/RPCEC00000354-En,11/07/2021,0,0
5850,RPCEC00000356,Pending,,08/12/2021,,,,15/03/2021,https://rpcec.sld.cu/en/trials/RPCEC00000356-En,08/12/2021,0,0
5851,RPCEC00000357,Complete,,20/11/2020,,,,22/03/2021,https://rpcec.sld.cu/en/trials/RPCEC00000357-En,20/11/2020,0,0
5852,RPCEC00000359,Pending,,31/07/2021,,,,19/03/2021,https://rpcec.sld.cu/en/trials/RPCEC00000359-En,31/07/2021,0,0
5853,RPCEC00000360,Pending,,08/01/2022,,,,22/03/2021,https://rpcec.sld.cu/en/trials/RPCEC00000360-En,08/01/2022,0,0
5854,RPCEC00000361,Pending,,30/06/2021,,,,26/03/2021,https://rpcec.sld.cu/en/trials/RPCEC00000361-En,30/06/2021,0,0
5855,RPCEC00000363,Pending,,30/09/2021,,,,08/04/2021,https://rpcec.sld.cu/en/trials/RPCEC00000363-En,30/09/2021,0,0
5856,RPCEC00000366,Pending,,14/06/2021,,,,12/04/2021,https://rpcec.sld.cu/en/trials/RPCEC00000366-En,14/06/2021,0,0
5857,RPCEC00000369,Pending,,31/07/2021,,,,15/06/2021,https://rpcec.sld.cu/en/trials/RPCEC00000369-En,31/07/2021,0,0
5858,RPCEC00000374,Pending,,22/10/2021,,,,16/06/2021,https://rpcec.sld.cu/en/trials/RPCEC00000374-En,22/10/2021,0,0
5859,RPCEC00000375,Pending,,30/05/2022,,,,21/06/2021,https://rpcec.sld.cu/en/trials/RPCEC00000375-En,30/05/2022,0,0
5860,RPCEC00000376,Pending,,30/05/2022,,,,21/06/2021,https://rpcec.sld.cu/en/trials/RPCEC00000376-En,30/05/2022,0,0
5861,JPRN-JapicCTI-205238,completed,,14/10/2020,,,,08/07/2021,https://www.clinicaltrials.jp/user/showCteDetailE.jsp?japicId=JapicCTI-205238,14/10/2020,0,0
5862,JPRN-JapicCTI-205270,progressing,,31/03/2021,,,,04/11/2020,https://www.clinicaltrials.jp/user/showCteDetailE.jsp?japicId=JapicCTI-205270,31/03/2021,0,0
5863,JPRN-JapicCTI-205326,completed,,17/08/2020,,,,15/06/2021,https://www.clinicaltrials.jp/user/showCteDetailE.jsp?japicId=JapicCTI-205326,17/08/2020,0,0
5864,JPRN-JapicCTI-205416,completed,,02/02/2021,,,,06/07/2021,https://www.clinicaltrials.jp/user/showCteDetailE.jsp?japicId=JapicCTI-205416,02/02/2021,0,0
5865,JPRN-JapicCTI-205465,progressing,,30/09/2021,,,,02/04/2021,https://www.clinicaltrials.jp/user/showCteDetailE.jsp?japicId=JapicCTI-205465,30/09/2021,0,0
5866,LBCTR2020043495,Pending,,01/04/2021,,,,,https://lbctr.moph.gov.lb/LBCTR/Trials/Details/4658,01/04/2021,0,0
5867,LBCTR2021014651,Pending,,31/12/2020,,,,,https://lbctr.moph.gov.lb/LBCTR/Trials/Details/4651,31/12/2020,0,0
5868,LBCTR2021034768,Complete,,31/12/2020,,,,,https://lbctr.moph.gov.lb/LBCTR/Trials/Details/4770,31/12/2020,0,0
5869,LBCTR2021044780,Pending,,31/12/2021,,,,,https://lbctr.moph.gov.lb/LBCTR/Trials/Details/4780,31/12/2021,0,0
5870,PER-010-20,In enrollment,,,,,,,https://www.ins.gob.pe/ensayosclinicos/rpec/recuperarECPBNuevoEN.asp?numec=010-20,,0,0
5871,PER-013-20,Enrollment stopped,,,,,,,https://www.ins.gob.pe/ensayosclinicos/rpec/recuperarECPBNuevoEN.asp?numec=013-20,,0,0
5872,PER-016-20,Enrollement closed,,17/04/2021,,,,,https://www.ins.gob.pe/ensayosclinicos/rpec/recuperarECPBNuevoEN.asp?numec=016-20,17/04/2021,0,0
5873,PER-018-20,In enrollment,,12/11/2020,,,,,https://www.ins.gob.pe/ensayosclinicos/rpec/recuperarECPBNuevoEN.asp?numec=018-20,12/11/2020,0,0
5874,PER-030-20,Enrollement closed,,19/10/2020,,,,,https://www.ins.gob.pe/ensayosclinicos/rpec/recuperarECPBNuevoEN.asp?numec=030-20,19/10/2020,0,0
5875,PER-031-20,Without starting enrollment,,,,,,,https://www.ins.gob.pe/ensayosclinicos/rpec/recuperarECPBNuevoEN.asp?numec=031-20,,0,0
5876,PER-032-20,In enrollment,,,,,,,https://www.ins.gob.pe/ensayosclinicos/rpec/recuperarECPBNuevoEN.asp?numec=032-20,,0,0
5877,PER-034-20,In enrollment,,28/04/2021,,,,,https://www.ins.gob.pe/ensayosclinicos/rpec/recuperarECPBNuevoEN.asp?numec=034-20,28/04/2021,0,0
5878,PER-042-20,Enrollement closed,,,,,,,https://www.ins.gob.pe/ensayosclinicos/rpec/recuperarECPBNuevoEN.asp?numec=042-20,,0,0
5879,PER-048-20,,,,,,,,https://www.ins.gob.pe/ensayosclinicos/rpec/recuperarECPBNuevoEN.asp?numec=048-20,,0,0
5880,PER-050-20,Without starting enrollment,,,,,,,https://www.ins.gob.pe/ensayosclinicos/rpec/recuperarECPBNuevoEN.asp?numec=050-20,,0,0
5881,PER-054-20,Enrollement closed,,,,,,,https://www.ins.gob.pe/ensayosclinicos/rpec/recuperarECPBNuevoEN.asp?numec=054-20,,0,0
5882,PER-055-20,In enrollment,,24/12/2020,,,,,https://www.ins.gob.pe/ensayosclinicos/rpec/recuperarECPBNuevoEN.asp?numec=055-20,24/12/2020,0,0
5883,PER-059-20,In enrollment,,,,,,,https://www.ins.gob.pe/ensayosclinicos/rpec/recuperarECPBNuevoEN.asp?numec=059-20,,0,0
5884,PER-060-20,In enrollment,,,,,,,https://www.ins.gob.pe/ensayosclinicos/rpec/recuperarECPBNuevoEN.asp?numec=060-20,,0,0
5885,PER-064-20,In enrollment,,,,,,,https://www.ins.gob.pe/ensayosclinicos/rpec/recuperarECPBNuevoEN.asp?numec=064-20,,0,0
5886,PER-067-20,Without starting enrollment,,,,,,,https://www.ins.gob.pe/ensayosclinicos/rpec/recuperarECPBNuevoEN.asp?numec=067-20,,0,0
5887,PER-069-20,Without starting enrollment,,,,,,,https://www.ins.gob.pe/ensayosclinicos/rpec/recuperarECPBNuevoEN.asp?numec=069-20,,0,0
5888,PER-090-20,In enrollment,,,,,,,https://www.ins.gob.pe/ensayosclinicos/rpec/recuperarECPBNuevoEN.asp?numec=090-20,,0,0
5889,PER-093-20,Without starting enrollment,,,,,,,https://www.ins.gob.pe/ensayosclinicos/rpec/recuperarECPBNuevoEN.asp?numec=093-20,,0,0
5890,PER-095-20,Enrollement closed,,,,,,,https://www.ins.gob.pe/ensayosclinicos/rpec/recuperarECPBNuevoEN.asp?numec=095-20,,0,0
5891,PER-099-20,In enrollment,,,,,,,https://www.ins.gob.pe/ensayosclinicos/rpec/recuperarECPBNuevoEN.asp?numec=099-20,,0,0
5892,PER-101-20,Without starting enrollment,,,,,,,https://www.ins.gob.pe/ensayosclinicos/rpec/recuperarECPBNuevoEN.asp?numec=101-20,,0,0
5893,PER-106-20,In enrollment,,,,,,,https://www.ins.gob.pe/ensayosclinicos/rpec/recuperarECPBNuevoEN.asp?numec=106-20,,0,0
5894,PER-108-20,Without starting enrollment,,,,,,,https://www.ins.gob.pe/ensayosclinicos/rpec/recuperarECPBNuevoEN.asp?numec=108-20,,0,0
5895,SLCTR/2020/011,Terminated,,31/05/2020,,,,02/10/2020,https://slctr.lk/trials/slctr-2020-011,31/05/2020,0,0
5896,SLCTR/2020/026,Suspended,,15/03/2021,,,,02/07/2021,https://slctr.lk/trials/slctr-2020-026,15/03/2021,0,0
5897,SLCTR/2021/001,Recruiting,,31/01/2021,,,,25/02/2021,https://slctr.lk/trials/slctr-2021-001,31/01/2021,0,0
5898,SLCTR/2021/002,Pending,,31/03/2021,,,,08/01/2021,https://slctr.lk/trials/slctr-2021-002,31/03/2021,0,0
5899,SLCTR/2021/005,Pending,,15/09/2021,,,,01/03/2021,https://slctr.lk/trials/slctr-2021-005,15/09/2021,0,0
5900,SLCTR/2021/008,Pending,,01/06/2021,,,,16/03/2021,https://slctr.lk/trials/slctr-2021-008,01/06/2021,0,0
5901,TCTR20200404004,Pending (Not yet recruiting),31/07/2020,31/08/2020,,,,02/04/2020,www.thaiclinicaltrials.org/show/TCTR20200404004,31/07/2020,0,0
5902,TCTR20200409006,Pending (Not yet recruiting),01/05/2021,01/05/2022,,,,09/04/2020,www.thaiclinicaltrials.org/show/TCTR20200409006,01/05/2021,0,0
5903,TCTR20200514001,Pending (Not yet recruiting),31/03/2021,31/05/2021,,,,13/05/2020,www.thaiclinicaltrials.org/show/TCTR20200514001,31/03/2021,0,0
5904,TCTR20200601002,Recruiting,30/06/2020,31/07/2020,,,,31/05/2020,www.thaiclinicaltrials.org/show/TCTR20200601002,30/06/2020,0,0
5905,TCTR20201015003,Recruiting,01/11/2020,01/11/2021,,,,15/10/2020,www.thaiclinicaltrials.org/show/TCTR20201015003,01/11/2020,0,0
5906,TCTR20210125002,"Active, not recruiting",18/05/2021,18/05/2021,,,,25/01/2021,www.thaiclinicaltrials.org/show/TCTR20210125002,18/05/2021,0,0
5907,TCTR20210308003,Recruiting,31/05/2021,31/05/2022,,,,08/03/2021,www.thaiclinicaltrials.org/show/TCTR20210308003,31/05/2021,0,0
5908,TCTR20210310002,Pending (Not yet recruiting),31/10/2021,31/01/2023,,,,10/03/2021,www.thaiclinicaltrials.org/show/TCTR20210310002,31/10/2021,0,0
5909,TCTR20210412005,Recruiting,30/06/2021,30/11/2021,,,,12/04/2021,www.thaiclinicaltrials.org/show/TCTR20210412005,30/06/2021,0,0
5910,TCTR20210514003,Pending (Not yet recruiting),31/10/2021,30/11/2021,,,,14/05/2021,www.thaiclinicaltrials.org/show/TCTR20210514003,31/10/2021,0,0
5911,TCTR20210517006,Recruiting,31/07/2021,31/07/2022,,,,17/05/2021,www.thaiclinicaltrials.org/show/TCTR20210517006,31/07/2021,0,0
5912,TCTR20210523002,Recruiting,18/07/2021,31/08/2021,,,,18/07/2021,www.thaiclinicaltrials.org/show/TCTR20210523002,18/07/2021,0,0
5913,TCTR20210524002,Recruiting,31/08/2021,31/08/2021,,,,18/07/2021,www.thaiclinicaltrials.org/show/TCTR20210524002,31/08/2021,0,0
5914,TCTR20210602002,Completed (Has Results),27/11/2020,27/11/2020,,,,01/06/2021,www.thaiclinicaltrials.org/show/TCTR20210602002,27/11/2020,0,0
5915,TCTR20210609001,Pending (Not yet recruiting),31/10/2021,31/12/2021,,,,09/06/2021,www.thaiclinicaltrials.org/show/TCTR20210609001,31/10/2021,0,0
5916,TCTR20210615002,Pending (Not yet recruiting),31/10/2021,31/12/2021,,,,15/06/2021,www.thaiclinicaltrials.org/show/TCTR20210615002,31/10/2021,0,0